PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Al-Ta'ii, HMJ; Periasamy, V; Amin, YM				Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh; Amin, Yusoff Mohd			Electronic Characterization of Au/DNA/ITO Metal-Semiconductor-Metal Diode and Its Application as a Radiation Sensor	PLOS ONE			English	Article							VOLTAGE CHARACTERISTICS; DNA-MOLECULES; THIN-FILMS; INTERFACE; HUMIDITY; CONDUCTIVITY; TEMPERATURE; IRRADIATION; EXTRACTION; PARAMETERS	Deoxyribonucleic acid or DNA molecules expressed as double-stranded (DSS) negatively charged polymer plays a significant role in electronic states of metal/silicon semiconductor structures. Electrical parameters of an Au/DNA/ITO device prepared using self-assembly method was studied by using current-voltage (I-V) characteristic measurements under alpha bombardment at room temperature. The results were analyzed using conventional thermionic emission model, Cheung and Cheung's method and Norde's technique to estimate the barrier height, ideality factor, series resistance and Richardson constant of the Au/DNA/ITO structure. Besides demonstrating a strongly rectifying (diode) characteristic, it was also observed that orderly fluctuations occur in various electrical parameters of the Schottky structure. Increasing alpha radiation effectively influences the series resistance, while the barrier height, ideality factor and interface state density parameters respond linearly. Barrier height determined from I-V measurements were calculated at 0.7284 eV for non-radiated, increasing to about 0.7883 eV in 0.036 Gy showing an increase for all doses. We also demonstrate the hypersensitivity phenomena effect by studying the relationship between the series resistance for the three methods, the ideality factor and low-dose radiation. Based on the results, sensitive alpha particle detectors can be realized using Au/DNA/ITO Schottky junction sensor.	[Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh] Univ Malaya, Fac Sci, Dept Phys, LDMRC, Kuala Lumpur 50603, Malaysia; [Amin, Yusoff Mohd] Univ Malaya, Fac Sci, Dept Phys, Kuala Lumpur 50603, Malaysia; [Al-Ta'ii, Hassan Maktuff Jaber] Univ Al Muthana, Dept Phys, Fac Sci, Al Muthana 66001, Iraq	Universiti Malaya; Universiti Malaya	Al-Ta'ii, HMJ; Periasamy, V (corresponding author), Univ Malaya, Fac Sci, Dept Phys, LDMRC, Kuala Lumpur 50603, Malaysia.; Al-Ta'ii, HMJ (corresponding author), Univ Al Muthana, Dept Phys, Fac Sci, Al Muthana 66001, Iraq.	hassankirkukly@gmail.com; vengadeshp@um.edu.my	PERIASAMY, VENGADESH/B-9993-2010; Al-Ta'ii, Hassan/E-7794-2019	PERIASAMY, VENGADESH/0000-0002-0435-4944; Al-Ta'ii, Hassan/0000-0002-5852-868X	Fundamental Research Grant Scheme, FRGS [FP004-2013A]; University of Malaya Postgraduate Research Fund, PPP [PG202-2014B]; University of Malaya Research Grant, UMRG [RG321-15AFR]; Ministry of Higher Education and Scientific Research of Iraq	Fundamental Research Grant Scheme, FRGS; University of Malaya Postgraduate Research Fund, PPP; University of Malaya Research Grant, UMRG; Ministry of Higher Education and Scientific Research of Iraq	This work was supported by Fundamental Research Grant Scheme, FRGS (FP004-2013A), University of Malaya Postgraduate Research Fund, PPP (PG202-2014B) and University of Malaya Research Grant, UMRG (RG321-15AFR).; Financial assistances provided by Fundamental Research Grant Scheme, FRGS (FP004-2013A), University of Malaya Research Grant, UMRG (RG321-15AFR) and University of Malaya Postgraduate Research Fund, PPP (PG202-2014B) grant are greatly appreciated. The first author would also like to thank the Ministry of Higher Education and Scientific Research of Iraq for financial assistance provided for his PhD study.	Al-Ta'ii HMJ, 2015, SENSORS-BASEL, V15, P4810, DOI 10.3390/s150304810; Al-Ta'ii HMJ, 2015, RADIAT MEAS, V72, P85, DOI 10.1016/j.radmeas.2014.11.011; Aydogan S, 2008, MAT SCI SEMICON PROC, V11, P53, DOI 10.1016/j.mssp.2008.11.004; Banihashemian SM, 2013, MOLECULES, V18, P11797, DOI 10.3390/molecules181011797; Batcup S, 2012, INT CONF MICROELECTR, P81, DOI 10.1109/MIEL.2012.6222801; Bazlov NV, 2013, APPL SURF SCI, V267, P224, DOI 10.1016/j.apsusc.2012.11.002; Bellido EP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175102; Bixon M, 1999, P NATL ACAD SCI USA, V96, P11713, DOI 10.1073/pnas.96.21.11713; Bonea A, 2012, J OPTOELECTRON ADV M, V14, P511; Borhani M, 2007, NUKLEONIKA, V52, P77; CHEUNG SK, 1986, APPL PHYS LETT, V49, P85, DOI 10.1063/1.97359; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dugasani SR, 2015, RSC ADV, V5, P55839, DOI 10.1039/c5ra07360j; Dugasani SR, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4923377; Dugasani SR, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/27/275604; Gullu O, 2008, APPL SURF SCI, V254, P5175, DOI 10.1016/j.apsusc.2008.02.019; Gullu O, 2012, J APPL PHYS, V111, DOI 10.1063/1.3684989; Gullu O, 2011, J ALLOY COMPD, V509, P571, DOI 10.1016/j.jallcom.2010.09.146; Gullu O, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936086; Gupta RK, 2012, SOL ENERGY, V86, P1539, DOI 10.1016/j.solener.2012.02.015; Ha DH, 2002, CHEM PHYS LETT, V355, P405, DOI 10.1016/S0009-2614(02)00142-2; Hassan M, 2009, J RAFIDEN SCI, V20, P113; Hassan M.A.-T., 2012, J KERBALA U, V10, P41; Heim T, 2004, J APPL PHYS, V96, P2927, DOI 10.1063/1.1769606; Hibbett D, 2013, FORENSIC DNA MINI PR; Holbert KE, 2012, RAD EFFECTS DAMAGE; Imtiaj A., 2011, Micologia Aplicada International, V23, P1; Jayavel P, 2000, VACUUM, V57, P51, DOI 10.1016/S0042-207X(99)00211-0; Jo YS, 2003, J KOREAN PHYS SOC, V43, P909, DOI 10.3938/jkps.43.909; Karatas S, 2004, VACUUM, V74, P45, DOI 10.1016/j.vacuum.2003.11.006; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Kilicoglu T, 2011, MICROELECTRON ENG, V88, P150, DOI 10.1016/j.mee.2010.10.001; Kulkarni A, 2013, SCI REPORT, P3; Lu JJ, 2009, BIOPHYS CHEM, V145, P91, DOI 10.1016/j.bpc.2009.09.005; Mahmoudi Khatir N, 2013, ELECT CHARACTERIZATI; Martin LM, 2013, CANCER LETT, V338, P209, DOI 10.1016/j.canlet.2013.05.021; Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w; Okur S, 2009, MICROELECTRON ENG, V86, P2305, DOI 10.1016/j.mee.2009.04.017; Otsuka Y, 2002, JPN J APPL PHYS 1, V41, P891, DOI 10.1143/JJAP.41.891; Reddy MSP, 2014, OPT EXPRESS, V22, P908, DOI 10.1364/OE.22.000908; Reddy VS, 2006, SEMICOND SCI TECH, V21, P1747, DOI 10.1088/0268-1242/21/12/043; Sabet M, 2012, POLYM BULL, V68, P2323, DOI 10.1007/s00289-012-0741-y; Schmitsdorf RF, 1997, J VAC SCI TECHNOL B, V15, P1221, DOI 10.1116/1.589442; Shinde KN, 2012, BASIC MECH PHOTOLUMI, P41; Sonmezoglu S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3447985; Sonmezoglu S, 2011, MAT SCI ENG C-MATER, V31, P1619, DOI 10.1016/j.msec.2011.08.003; Tahir M., 2012, INT C ADV EL EL ENG; Takada T, 2007, P NATL ACAD SCI USA, V104, P11179, DOI 10.1073/pnas.0700795104; Tikhomirov G, 2011, NAT NANOTECHNOL, V6, P485, DOI [10.1038/nnano.2011.100, 10.1038/NNANO.2011.100]; Tsoulou E, 2003, RADIAT RES, V159, P33, DOI 10.1667/0033-7587(2003)159[0033:CIDFAI]2.0.CO;2; Tugluoglu N, 2012, CURR APPL PHYS, V12, P1529, DOI 10.1016/j.cap.2012.04.027	52	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145423	10.1371/journal.pone.0145423	http://dx.doi.org/10.1371/journal.pone.0145423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799703	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300006
J	Bi, XY; Tey, SL; Leong, C; Quek, R; Henry, CJ				Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar			Prevalence of Vitamin D Deficiency in Singapore: Its Implications to Cardiovascular Risk Factors	PLOS ONE			English	Article							PLASMA 25-HYDROXYVITAMIN D; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; SERUM 25-HYDROXYVITAMIN-D; FASTING GLUCOSE; HEALTH; ASSOCIATION; PREVENTION; CALCIUM; DISEASE	Objective Vitamin D deficiency is a global health challenge and has been linked to type 2 diabetes and other chronic diseases. However, the relationship between vitamin D status, body composition, and cardiovascular risks has not been well characterized in Asian populations. The objectives of this study were to examine the factors associated with the low vitamin D levels in a sunny tropical region and to assess the role of vitamin D status in cardiovascular risk factors. Design and Methods This was a cross-sectional study. One hundred and fourteen healthy participants (59 males and 55 females) residing in Singapore took part in this study. Plasma 25OH-D-3 concentration was measured by using LC-MS/MS. Body fat (%) was measured by using three different techniques including bioelectrical impedance analysis (BIA), BOD POD, and dual-energy X-ray absorptiometry (DEXA). Basic anthropometric measurements, fasting blood glucose (FBG), fasting serum insulin (FSI), and lipid profiles were obtained using standard protocols. Results Approximately 42% of the participants were vitamin D deficient (< 20 ng/mL). Vitamin D status was inversely associated with body fat (%), homeostasis model assessment of insulin resistance (HOMA-IR), and total cholesterol/high density lipoprotein (TC/HDL) ratio, while positively associated with lean body mass (LBM) and hand grip strength (HGS). Conclusions The high prevalence of vitamin D deficiency in a sunny tropical region reinforces the need to recognize that sunlight alone is not the precursor for optimal vitamin D status. This raises the need to investigate public health measures that will encourage exposure to sunlight without overexposure that is harmful to skin. More importantly, vitamin D deficiency is associated with increased cardiovascular risks, i.e. HOMA-IR, TC/HDL, and LDL/HDL. Future studies should attempt to elucidate the potential mechanisms.	[Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar] Clin Nutr Res Ctr, Ctr Translat Med, 14 Med Dr 07-02,MD 6 Bldg, Singapore 117599, Singapore; [Bi, Xinyan; Tey, Siew Ling; Leong, Claudia; Quek, Rina; Henry, Christiani Jeyakumar] ASTAR, Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore; [Henry, Christiani Jeyakumar] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Henry, CJ (corresponding author), Clin Nutr Res Ctr, Ctr Translat Med, 14 Med Dr 07-02,MD 6 Bldg, Singapore 117599, Singapore.; Henry, CJ (corresponding author), ASTAR, Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore.; Henry, CJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117599, Singapore.	jeya_henry@sics.a-star.edu.sg	Tey, Siew Ling/AAV-8115-2021; Henry, Christiani Jeyakumar/AHB-2632-2022	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Tey, Siew Ling/0000-0002-5064-5283; Leong, Claudia/0000-0002-6388-4646				Alsuwaida AO, 2013, SAUDI MED J, V34, P814; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Brouwer-Brolsma EM, 2013, EUR J NUTR, V52, P917, DOI 10.1007/s00394-012-0399-0; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Choi HS, 2011, J NUTR, V141, P1524, DOI 10.3945/jn.111.139121; CLEMENS TL, 1982, LANCET, V1, P74; Creo AL, 2013, J PEDIATR ENDOCR MET, V26, P97, DOI 10.1515/jpem-2012-0244; Davis CD, 2007, JNCI-J NATL CANCER I, V99, P1563, DOI 10.1093/jnci/djm211; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Gilsanz V, 2010, J CLIN ENDOCR METAB, V95, P1595, DOI 10.1210/jc.2009-2309; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Joshi L, 2014, SCAND J IMMUNOL, V79, P113, DOI 10.1111/sji.12127; Karhapaa P, 2010, J Intern Med, V268, P604, DOI 10.1111/j.1365-2796.2010.02279.x; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Lim JS, 2012, J CLIN ENDOCR METAB, V97, P1995, DOI 10.1210/jc.2011-3098; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mathieu C, 2005, TRENDS ENDOCRIN MET, V16, P261, DOI 10.1016/j.tem.2005.06.004; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Nimitphong H, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-60; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; Remuzzi A, 2007, KIDNEY INT, V71, P96, DOI 10.1038/sj.ki.5002047; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Sterling KA, 2012, NAT REV NEPHROL, V8, P403, DOI 10.1038/nrneph.2012.93; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	41	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147616	10.1371/journal.pone.0147616	http://dx.doi.org/10.1371/journal.pone.0147616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799569	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300132
J	van Unen, J; Stumpf, AD; Schmid, B; Reinhard, NR; Hordijk, PL; Hoffmann, C; Gadella, TWJ; Goedhart, J				van Unen, Jakobus; Stumpf, Anette D.; Schmid, Benedikt; Reinhard, Nathalie R.; Hordijk, Peter L.; Hoffmann, Carsten; Gadella, Theodorus W. J.; Goedhart, Joachim			A New Generation of FRET Sensors for Robust Measurement of G alpha(i1), G alpha(i2) and G alpha(i3) Activation Kinetics in Single Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; RESONANCE ENERGY-TRANSFER; LIVING CELLS; SIGNALING PATHWAYS; FLUORESCENT PROTEINS; CROSS-TALK; CHO-CELLS; SUBUNITS; CANCER	G-protein coupled receptors (GPCRs) can activate a heterotrimeric G-protein complex with subsecond kinetics. Genetically encoded biosensors based on Forster resonance energy transfer (FRET) are ideally suited for the study of such fast signaling events in single living cells. Here we report on the construction and characterization of three FRET biosensors for the measurement of G alpha(i1), G alpha(i2) and G alpha(i3) activation. To enable quantitative long-term imaging of FRET biosensors with high dynamic range, fluorescent proteins with enhanced photophysical properties are required. Therefore, we use the currently brightest and most photostable CFP variant, mTurquoise2, as donor fused to G alpha(i) subunit, and cp173Venus fused to the G beta 2 subunit as acceptor. The G alpha(i) FRET biosensors constructs are expressed together with G beta 1 from a single plasmid, providing preferred relative expression levels with reduced variation in mammalian cells. The G alpha(i) FRET sensors showed a robust response to activation of endogenous or over-expressed alpha-2A-adrenergic receptors, which was inhibited by pertussis toxin. Moreover, we observed activation of the G alpha(i) FRET sensor in single cells upon stimulation of several GPCRs, including the LPA(2), M-3 and BK2 receptor. Furthermore, we show that the sensors are well suited to extract kinetic parameters from fast measurements in the millisecond time range. This new generation of FRET biosensors for G alpha(i1), G alpha(i2') and G alpha(i3) activation will be valuable for live-cell measurements that probe G alpha(i) activation.	[van Unen, Jakobus; Reinhard, Nathalie R.; Hordijk, Peter L.; Gadella, Theodorus W. J.; Goedhart, Joachim] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, van Leeuwenhoek Ctr Adv Microscopy, POB 94215, NL-1090 GE Amsterdam, Netherlands; [Stumpf, Anette D.; Schmid, Benedikt; Hoffmann, Carsten] Univ Wurzburg, Bioimaging Ctr, Rudolf Virchow Zentrum, Versbacher Str 9, D-97078 Wurzburg, Germany; [Stumpf, Anette D.; Schmid, Benedikt; Hoffmann, Carsten] Univ Wurzburg, Dept Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany; [Reinhard, Nathalie R.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Mol Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; University of Wurzburg; University of Wurzburg; University of Amsterdam; Academic Medical Center Amsterdam	Goedhart, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, van Leeuwenhoek Ctr Adv Microscopy, POB 94215, NL-1090 GE Amsterdam, Netherlands.	j.goedhart@uva.nl		Gadella, Theodorus/0000-0002-7639-219X; van Unen, Jakobus/0000-0002-7931-0989; Goedhart, Joachim/0000-0002-0630-3825; Hordijk, Peter/0000-0002-3348-078X				Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Appleton KM, 2014, BIOORGAN MED CHEM, V22, P3423, DOI 10.1016/j.bmc.2014.04.035; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Daaka Y., 2004, SCI STKE, V2004, pre2, DOI [10.1126/stke.2162004re2, DOI 10.1126/STKE.2162004RE2]; Devanathan V, 2015, P NATL ACAD SCI USA, V112, P6491, DOI 10.1073/pnas.1505887112; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Hamers D, 2014, PROTOPLASMA, V251, P333, DOI 10.1007/s00709-013-0590-z; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hill SJ, 2003, BRIT J PHARMACOL, V138, P1188, DOI 10.1038/sj.bjp.0705192; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2012, MOL PHARMACOL, V82, P236, DOI 10.1124/mol.112.077578; Hornigold DC, 2003, BRIT J PHARMACOL, V138, P1340, DOI 10.1038/sj.bjp.0705178; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jongsma M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029260; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Kue PF, 2000, J UROLOGY, V164, P2162, DOI 10.1016/S0022-5347(05)66990-X; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; Raymond JR, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-6; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Sparta B, 2015, J BIOL CHEM, V290, P24784, DOI 10.1074/jbc.M115.662247; SUKI WN, 1987, FEBS LETT, V220, P187, DOI 10.1016/0014-5793(87)80900-6; van Unen J, 2015, MOL PHARMACOL, V88, P589, DOI 10.1124/mol.115.098897; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060	48	40	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146789	10.1371/journal.pone.0146789	http://dx.doi.org/10.1371/journal.pone.0146789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799488	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300035
J	Kim, DK; Choi, H; Nishida, H; Oh, JY; Gregory, C; Lee, RH; Yu, JM; Watanabe, J; An, SY; Bartosh, TJ; Prockop, DJ				Kim, Dong-Ki; Choi, Hosoon; Nishida, Hidetaka; Oh, Joo Youn; Gregory, Carl; Lee, Ryang Hwa; Yu, Ji Min; Watanabe, Jun; An, Su Yeon; Bartosh, Thomas J.; Prockop, Darwin J.			Scalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It	PLOS ONE			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; COLLAGEN-INDUCED ARTHRITIS; MULTIPOTENT STROMAL CELLS; LINK MODULE; HEAVY-CHAINS; CHROMOSOMAL LOCALIZATION; CONSTITUTIVE EXPRESSION; NEUTROPHIL MIGRATION; ANTIBODY-PRODUCTION	TNF-alpha stimulated gene/protein 6 (TNFAIP6/TSG-6) is a multifunctional protein that has a number of potential therapeutic applications. Experiments and clinical trials with TSG-6, however, have been limited by the technical difficulties of producing the recombinant protein. We prepared stable clones of CHO cells that expressed recombinant human TSG-6 (rhTSG-6) as a secreted glycoprotein. Paradoxically, both cell number and protein production decreased dramatically when the clones were expanded. The decreases occurred because the protein aggregated the synthesizing CHO cells by binding to the brush border of hyaluronan that is found around many cultured cells. In addition, the rhTSG-6 readily self-aggregated. To address these problems, we added to the medium an inhibitor of hyaluronan synthesis and heparin to compete with the binding of TSG-6 to hyaluronan. Also, we optimized the composition of the culture medium, and transferred the CHO cells from a spinner culture system to a bioreactor that controlled pH and thereby decreased pH-dependent binding properties of the protein. With these and other improvements in the culture conditions, we obtained 57.0 mg +/- 9.16 S.D. of rhTSG-6 in 5 or 6 liter of medium. The rhTSG-6 accounted for 18.0% +/- 3.76 S.D. of the total protein in the medium. We then purified the protein with a Ni-chelate column that bound the His tag engineered into the C-terminus of the protein followed by an anion exchange column. The yield of the purified monomeric rhTSG-6 was 4.1 mg to 5.6 mg per liter of culture medium. After intravenous injection into mice, the protein had a longer plasma half-life than commercially available rhTSG-6 isolated from a mammalian cell lysate, apparently because it was recovered as a secreted glycoprotein. The bioactivity of the rhTSG-6 in suppressing inflammation was demonstrated in a murine model.	[Kim, Dong-Ki; Choi, Hosoon; Nishida, Hidetaka; Oh, Joo Youn; Gregory, Carl; Lee, Ryang Hwa; Yu, Ji Min; Watanabe, Jun; An, Su Yeon; Bartosh, Thomas J.; Prockop, Darwin J.] Texas A&M Hlth Sci Ctr, Coll Med Scott & White, Inst Regenerat Med, Temple, TX USA; [Oh, Joo Youn] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Yu, Ji Min] CHA Bio & Diostech Co Ltd, Dept Translat Res, Yeoksam Dong, South Korea; [Watanabe, Jun] Showa Univ, Sch Med, Dept Anat, Shinakawa Ku, Tokyo 142, Japan	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Seoul National University (SNU); Seoul National University Hospital; Showa University	Prockop, DJ (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med Scott & White, Inst Regenerat Med, Temple, TX USA.	Prockop@medicine.tamhsc.edu		Gregory, Carl/0000-0001-6444-5541	TAMU HSC COM	TAMU HSC COM	The work was supported by funds from TAMU HSC COM.	Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Blundell CD, 2005, THE JOURNAL OF BIOLO, V280, P18182; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; Buetler TM, 2011, MOL NUTR FOOD RES, V55, P291, DOI 10.1002/mnfr.201000140; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Chen F, 2012, J BIOSCI BIOENG, V114, P347, DOI 10.1016/j.jbiosc.2012.04.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Jones DC, 2003, J IMMUNOL, V171, P196, DOI 10.4049/jimmunol.171.1.196; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kuznetsova SA, 2005, J BIOL CHEM, V280, P30899, DOI 10.1074/jbc.M500701200; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Li L, 2011, MOL BIOTECHNOL, V47, P9, DOI 10.1007/s12033-010-9306-1; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Okroj M, 2012, J BIOL CHEM, V287, P20100, DOI 10.1074/jbc.M111.324913; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Scavenius C, 2011, BBA-PROTEINS PROTEOM, V1814, P1624, DOI 10.1016/j.bbapap.2011.08.017; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Velez-Suberbie ML, 2013, BIOTECHNOL PROGR, V29, P116, DOI 10.1002/btpr.1647; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873	53	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147553	10.1371/journal.pone.0147553	http://dx.doi.org/10.1371/journal.pone.0147553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26793973	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300039
J	Chan, KO; Grismer, LL; Zachariah, A; Brown, RM; Abraham, RK				Chan, Kin Onn; Grismer, L. Lee; Zachariah, Anil; Brown, Rafe M.; Abraham, Robin Kurian			Polyphyly of Asian Tree Toads, Genus Pedostibes Gunther, 1876 (Anura: Bufonidae), and the Description of a New Genus from Southeast Asia	PLOS ONE			English	Article							R-PACKAGE; AMPHIBIA; REPRODUCTION; RADIATION; FROGS; SIZE	The Asian Tree Toad genus Pedostibes, as currently understood, exhibits a conspicuously disjunct distribution, posing several immediate questions relating to the biogeography and taxonomy of this poorly known group. The type species, P. tuberculosus and P. kempi, are known only from India, whereas P. hosii, P. rugosus, and P. everetti are restricted to Southeast Asia. Several studies have shown that these allopatric groups are polyphyletic, with the Indian Pedostibes embedded within a primarily South Asian clade of toads, containing the genera Adenomus, Xanthophryne, and Duttaphrynus. Southeast Asian Pedostibes on the other hand, are nested within a Southeast Asian clade, which is the sister lineage to the Southeast Asian river toad genus Phrynoidis. We demonstrate that Indian and Southeast Asian Pedostibes are not only allopatric and polyphyletic, but also exhibit significant differences in morphology and reproductive mode, indicating that the Southeast Asian species' are not congeneric with the true Pedostibes of India. As a taxonomic solution, we describe a new genus, Rentapia gen. nov. to accommodate the Southeast Asian species.	[Chan, Kin Onn; Brown, Rafe M.; Abraham, Robin Kurian] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Chan, Kin Onn; Brown, Rafe M.; Abraham, Robin Kurian] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Grismer, L. Lee] La Sierra Univ, Dept Biol, 4500 Riverwalk Pkwy, Riverside, CA USA; [Zachariah, Anil] Beagle, Wayanad, Kerala, India	University of Kansas; University of Kansas	Chan, KO (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.; Chan, KO (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	chankinonn@gmail.com	Onn, Chan Kin/AAH-1021-2020	Onn, Chan Kin/0000-0001-6270-0983				Altig R, 2007, HERPETOL MONOGR, V21, P1, DOI 10.1655/06-005.1; Barbour T., 1938, Proceedings of the Biological Society of Washington, V51, P191; Biju Sd, 2009, BMC Res Notes, V2, P241, DOI 10.1186/1756-0500-2-241; Boulenger G. A., 1919, Records of the Indian Museum, V16; Boulenger G.A., 1892, P ZOOL SOC LOND, V1892, P505; Boulenger GA, 1896, ANN MAGAZINE NATUR 6, V17, P449; Chan KO, 2014, REAPPRAISAL JAVANESE, V3900, P569; Dinesh K. P., 2013, Journal of Threatened Taxa, V5, P4910; Duellman W. E., 1986, BIOL AMPHIBIANS; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; INGER RF, 1968, COPEIA, P602, DOI 10.2307/1442031; INGER ROBERT F., 1966, FIELDI ANA ZOOL, V52, P1; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Malkmus R., 2002, AMPHIBIANS REPTILES; Manamendra-Arachchi Kelum, 1998, Journal of South Asian Natural History, V3, P213; Manthey U., 1997, AMPHIBIEN REPTILIEN; Matsui M, 2007, ZOOL SCI, V24, P1159, DOI 10.2108/zsj.24.1159; Miller M.A., 2010, P GAT COMP ENV WORKS; Ngo BV, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-12; Peters W.C.H., 1875, MONATSBERICHTE KONIG, V1875, P196; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2014, LANG ENV STAT COMP; Rambaut A., 2014, TRACER V1 6; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ron SR, 2015, ZOOTAXA, V3947, P347, DOI 10.11646/zootaxa.3947.3.3; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TEJEDO M, 1992, J ZOOL, V228, P545, DOI 10.1111/j.1469-7998.1992.tb04454.x; Van Bocxlaer I, 2010, SCIENCE, V327, P679, DOI 10.1126/science.1181707; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131	36	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145903	10.1371/journal.pone.0145903	http://dx.doi.org/10.1371/journal.pone.0145903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788854	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100019
J	Hui, CW; Zhang, Y; Herrup, K				Hui, Chin Wai; Zhang, Yang; Herrup, Karl			Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System	PLOS ONE			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; A-BETA; PHOSPHORYLATION; ACTIVATION; NEUROTOXICITY; EXCITOTOXICITY; TRANSCRIPTION; INFLAMMATION	Chronic inflammation is associated with activated microglia and reactive astrocytes and plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer's. Both in vivo and in vitro studies have demonstrated that inflammatory cytokine responses to immune challenges contribute to neuronal death during neurodegeneration. In order to investigate the role of glial cells in this phenomenon, we developed a modified method to remove the non-neuronal cells in primary cultures of E16.5 mouse cortex. We modified previously reported methods as we found that a brief treatment with the thymidine analog, 5-fluorodeoxyuridine (FdU), is sufficient to substantially deplete dividing non-neuronal cells in primary cultures. Cell cycle and glial markers confirm the loss of similar to 99% of all microglia, astrocytes and oligodendrocyte precursor cells (OPCs). More importantly, under this milder treatment, the neurons suffered neither cell loss nor any morphological defects up to 2.5 weeks later; both pre-and post-synaptic markers were retained. Further, neurons in FdU-treated cultures remained responsive to excitotoxicity induced by glutamate application. The immunobiology of the FdU culture, however, was significantly changed. Compared with mixed culture, the protein levels of NF kappa B p65 and the gene expression of several cytokine receptors were altered. Individual cytokines or conditioned medium from alpha-amyloid-stimulated THP-1 cells that were, potent neurotoxins in normal, mixed cultures, were virtually inactive in the absence of glial cells. The results highlight the importance of our glial-depleted culture system and identifies and offer unexpected insights into the complexity of-brain neuroinflammation.	[Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Hui, Chin Wai] Univ Laval, CHU Quebec, Ctr Rech, Axe Neurosci, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Laval University	Herrup, K (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	herrup@ust.hk			National Key Basic Research Program of China [2013CB530900]; Research Grants Council, HKSAR [GRF660813]; Hong Kong University of Science and Technology [R9321]	National Key Basic Research Program of China(National Basic Research Program of China); Research Grants Council, HKSAR(Hong Kong Research Grants Council); Hong Kong University of Science and Technology	Research Grants Council, HKSAR (GRF660813) and the Hong Kong University of Science and Technology (R9321) provided the support for most of the supplies and reagents used in the work described. The National Key Basic Research Program of China (2013CB530900) provided travel money so that the results could be presented at an international meeting. The National Institute of Neurological Diseases and Stroke (US) provided support for the early experiments that formed the foundation for the work described.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahlemeyer B, 2003, NEUROCHEM INT, V42, P567, DOI 10.1016/S0197-0186(02)00164-X; Bate C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-7; Bhaskar K, 2014, NEUROBIOL DIS, V62, P273, DOI 10.1016/j.nbd.2013.10.007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033177; Chiarini Anna, 2006, Italian Journal of Anatomy and Embryology, V111, P221; DUGAN LL, 1995, J NEUROSCI, V15, P4545; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Geller HM, 2001, J NEUROCHEM, V78, P265, DOI 10.1046/j.1471-4159.2001.00395.x; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hui CW, 2015, ENEURO, V2, DOI [10.1523/eneuro.0032-15.2015, DOI 10.1523/ENEUR0.0032-15.2015]; Irobi J, 2010, HUM MOL GENET, V19, P3254, DOI 10.1093/hmg/ddq234; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Lee HS, 2012, INT IMMUNOPHARMACOL, V13, P232, DOI 10.1016/j.intimp.2012.04.013; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARTIN DP, 1990, J NEUROSCI, V10, P184; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nguyen V, 2010, NEUROBIOL DIS, V37, P195, DOI 10.1016/j.nbd.2009.10.002; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Thirumangalakudi L, 2009, NEUROSCI LETT, V452, P172, DOI 10.1016/j.neulet.2009.01.045; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Varvel NH, 2009, J CLIN INVEST, V119, P3692, DOI 10.1172/JCI39716; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu Q, 2000, NEUROBIOL AGING, V21, P797, DOI 10.1016/S0197-4580(00)00219-0; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou C, 2012, CYTOTECHNOLOGY, V64, P173, DOI 10.1007/s10616-011-9405-2; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82	50	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147134	10.1371/journal.pone.0147134	http://dx.doi.org/10.1371/journal.pone.0147134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788729	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100060
J	Pesciarelli, F; Leo, I; Sarlo, M				Pesciarelli, Francesca; Leo, Irene; Sarlo, Michela			Implicit Processing of the Eyes and Mouth: Evidence from Human Electrophysiology	PLOS ONE			English	Article							EARLY FACE; TIME-COURSE; PERCEPTION; INVERSION; N170; SENSITIVITY; ADAPTATION; OBJECTS; ERP	The current study examined the time course of implicit processing of distinct facial features and the associate event-related potential (ERP) components. To this end, we used a masked priming paradigm to investigate implicit processing of the eyes and mouth in upright and inverted faces, using a prime duration of 33 ms. Two types of prime-target pairs were used: 1. congruent (e.g., open eyes only in both prime and target or open mouth only in both prime and target); 2. incongruent (e.g., open mouth only in prime and open eyes only in target or open eyes only in prime and open mouth only in target). The identity of the faces changed between prime and target. Participants pressed a button when the target face had the eyes open and another button when the target face had the mouth open. The behavioral results showed faster RTs for the eyes in upright faces than the eyes in inverted faces, the mouth in upright and inverted faces. Moreover they also revealed a congruent priming effect for the mouth in upright faces. The ERP findings showed a face orientation effect across all ERP components studied (P1, N1, N170, P2, N2, P3) starting at about 80 ms, and a congruency/priming effect on late components (P2, N2, P3), starting at about 150 ms. Crucially, the results showed that the orientation effect was driven by the eye region (N170, P2) and that the congruency effect started earlier (P2) for the eyes than for the mouth (N2). These findings mark the time course of the processing of internal facial features and provide further evidence that the eyes are automatically processed and that they are very salient facial features that strongly affect the amplitude, latency, and distribution of neural responses to faces.	[Pesciarelli, Francesca] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurol Sci, Modena, Italy; [Leo, Irene] Univ Padua, Dept Dev Psychol, Padua, Italy; [Sarlo, Michela] Univ Padua, Dept Gen Psychol, Padua, Italy; [Sarlo, Michela] Univ Padua, Ctr Cognit Neurosci, Padua, Italy	Universita di Modena e Reggio Emilia; University of Padua; University of Padua; University of Padua	Pesciarelli, F (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurol Sci, Modena, Italy.	francesca.pesciarelli@unimore.it	Sarlo, Michela/AAP-4606-2020; Pesciarelli, Francesca/AAK-1692-2020; PESCIARELLI, Francesca/ABE-9870-2021	Sarlo, Michela/0000-0001-6652-7604; Pesciarelli, Francesca/0000-0003-3007-4775; LEO, IRENE/0000-0002-4925-4373				Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2002, PSYCHOL SCI, V13, P190, DOI 10.1111/1467-9280.00435; Boutsen L, 2006, NEUROIMAGE, V32, P352, DOI 10.1016/j.neuroimage.2006.03.023; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Guillaume C, 2009, BRAIN RES, V1248, P149, DOI 10.1016/j.brainres.2008.10.069; Haig ND, 1986, PERCEPTION, V15, P505; Hills PJ, 2011, J EXP PSYCHOL HPP, V37; Hole G, 2011, COGNITION, V119, P216, DOI 10.1016/j.cognition.2011.01.011; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Itier RJ, 2011, NEUROIMAGE, V54, P705, DOI 10.1016/j.neuroimage.2010.07.031; Jacques C, 2007, J VISION, V7, DOI 10.1167/7.8.3; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Nemrodov D, 2014, NEUROIMAGE, V97, P81, DOI 10.1016/j.neuroimage.2014.04.042; Nemrodov D, 2011, BRIT J PSYCHOL, V102, P783, DOI 10.1111/j.2044-8295.2011.02033.x; Pesciarelli F, 2011, NEUROPSYCHOLOGIA, V49, P1154, DOI 10.1016/j.neuropsychologia.2011.02.003; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Shepherd J, 1981, PERCEIVING REMEMBERI; Shepherd JW., 1981, PERCEIVING REMEMBERI, P55; Taylor MJ, 2001, NEUROREPORT, V12, P1671, DOI 10.1097/00001756-200106130-00031; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Wallis G, 2008, J VISION, V8, DOI 10.1167/8.3.20; Williams MA, 2004, COGNITION, V91, P155, DOI 10.1016/j.cognition.2003.08.002	37	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147415	10.1371/journal.pone.0147415	http://dx.doi.org/10.1371/journal.pone.0147415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790153	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100087
J	Cedergreen, N; Norhave, NJ; Svendsen, C; Spurgeon, DJ				Cedergreen, Nina; Norhave, Nils Jakob; Svendsen, Claus; Spurgeon, David J.			Variable Temperature Stress in the Nematode Caenorhabditis elegans (Maupas) and Its Implications for Sensitivity to an Additional Chemical Stressor	PLOS ONE			English	Article							MULTIPLE END-POINTS; ENERGY BUDGET MODEL; MIXTURE TOXICITY; SIZE RULE; COPPER; RESPONSES; GROWTH; TOLERANCE; VIABILITY; GENETICS	A wealth of studies has investigated how chemical sensitivity is affected by temperature, however, almost always under different constant rather than more realistic fluctuating regimes. Here we compared how the nematode Caenorhabditis elegans responds to copper at constant temperatures (8-24 degrees C) and under fluctuation conditions of low (+/- 4 degrees C) and high (+/- 8 degrees C) amplitude (averages of 12, 16, 20 degrees C and 16 degrees C respectively). The DEBkiss model was used to interpret effects on energy budgets. Increasing constant temperature from 12-24 degrees C reduced time to first egg, life-span and population growth rates consistent with temperature driven metabolic rate change. Responses at 8 degrees C did not, however, accord with this pattern (including a deviation from the Temperature Size Rule), identifying a cold stress effect. High amplitude variation and low amplitude variation around a mean temperature of 12 degrees C impacted reproduction and body size compared to nematodes kept at the matching average constant temperatures. Copper exposure affected reproduction, body size and life-span and consequently population growth. Sensitivity to copper (EC50 values), was similar at intermediate temperatures (12, 16, 20 degrees C) and higher at 24 degrees C and especially the innately stressful 8 degrees C condition. Temperature variation did not increase copper sensitivity. Indeed under variable conditions including time at the stressful 8 degrees C condition, sensitivity was reduced. DEBkiss identified increased maintenance costs and increased assimilation as possible mechanisms for cold and higher copper concentration effects. Model analysis of combined variable temperature effects, however, demonstrated no additional joint stressor response. Hence, concerns that exposure to temperature fluctuations may sensitise species to co-stressor effects seem unfounded in this case.	[Cedergreen, Nina; Norhave, Nils Jakob] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Copenhagen, Denmark; [Svendsen, Claus; Spurgeon, David J.] Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England	University of Copenhagen; UK Centre for Ecology & Hydrology (UKCEH)	Spurgeon, DJ (corresponding author), Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	dasp@ceh.ac.uk	Cedergreen, Nina/F-6731-2014; Spurgeon, David J/E-9466-2010; Svendsen, Claus/A-1250-2009	Cedergreen, Nina/0000-0003-4724-9447; Svendsen, Claus/0000-0001-7281-647X; Spurgeon, David/0000-0003-3264-8760	Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark; University of Copenhagen; Centre for Ecology and Hydrology National Capability funding; core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme; NERC [ceh020007] Funding Source: UKRI; Natural Environment Research Council [ceh020007] Funding Source: researchfish	Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark; University of Copenhagen; Centre for Ecology and Hydrology National Capability funding; core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DJS and CS were supported by core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme. NJN was supported by the Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark and a PhD grant given jointly by the University of Copenhagen and Centre for Ecology and Hydrology National Capability funding.r DJS and CSV were supported by core NERC national capability funding under the Centre for Ecology and Hydrology Pollution and Ecological Risk science theme. NN was supported by the Research School of Environmental Chemistry, Microbiology and Toxicology in Denmark and a PhD grant given jointly from the University of Copenhagen and Centre for Ecology and Hydrology National Capability funding.	Aguilar-Alberola JA, 2014, J THERM BIOL, V42, P15, DOI 10.1016/j.jtherbio.2014.02.016; Alvarez OA, 2005, FUNCT ECOL, V19, P656, DOI 10.1111/j.1365-2435.2005.01012.x; Alvarez OA, 2006, ENVIRON TOXICOL CHEM, V25, P3230, DOI 10.1897/06-097R.1; Amarasekare P, 2013, J ANIM ECOL, V82, P1240, DOI 10.1111/1365-2656.12112; Angilletta MJ, 2003, AM NAT, V162, P332; Baas J, 2010, SCI TOTAL ENVIRON, V408, P3740, DOI 10.1016/j.scitotenv.2009.09.037; Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Ben-Horin T, 2013, ECOLOGY, V94, P161, DOI 10.1890/11-2257.1; Bindesbol AM, 2005, ENVIRON TOXICOL CHEM, V24, P1462, DOI 10.1897/04-397R.1; Bindesbol AM, 2009, ENVIRON SCI TECHNOL, V43, P5495, DOI 10.1021/es900898y; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; Boonstra R, 2013, FUNCT ECOL, V27, P7, DOI 10.1111/1365-2435.12048; BRENNER S, 1974, GENETICS, V77, P71; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Caswell H, 2000, DEMOGRAPHY IN ECOTOX; Cedergreen N, 2012, ENCY ENV MANAGEMENT, P2601; Cedergreen N, 2013, ENVIRON TOXICOL CHEM, V32, P2274, DOI 10.1002/etc.2274; Goranson NC, 2005, EVOL ECOL RES, V7, P325; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Guinnee MA, 2007, J EVOLUTION BIOL, V20, P577, DOI 10.1111/j.1420-9101.2006.01253.x; Gupta RC, 2014, BIOMAKERS TOXICOLOGY; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Hill RW, 1989, ANIMAL PHYSL, V6; Hoss S, 2011, ENVIRON SCI TECHNOL, V45, P10219, DOI 10.1021/es2027136; Holmstrup M, 1998, ENVIRON TOXICOL CHEM, V17, P897, DOI [10.1002/etc.5620170518, 10.1897/1551-5028(1998)017&lt;0897:CEOCDA&gt;2.3.CO;2]; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hosseini MJ, 2014, CELL BIOCHEM BIOPHYS, V70, P367, DOI 10.1007/s12013-014-9922-7; Jansch S, 2006, ENVIRON TOXICOL CHEM, V25, P2490, DOI 10.1897/05-439R.1; Jager T, 2004, ENVIRON SCI TECHNOL, V38, P2894, DOI 10.1021/es0352348; Jager T, 2006, ECOTOXICOLOGY, V15, P305, DOI 10.1007/s10646-006-0060-x; Jager T, 2014, ENVIRON SCI TECHNOL, V48, P7026, DOI 10.1021/es501306t; Jager T, 2013, J THEOR BIOL, V328, P9, DOI 10.1016/j.jtbi.2013.03.011; Jager T, 2012, ECOL MODEL, V225, P74, DOI 10.1016/j.ecolmodel.2011.11.012; Jager T, 2011, ENVIRON SCI TECHNOL, V45, P2529, DOI 10.1021/es103092a; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; Kammenga JE, 1996, FUNCT ECOL, V10, P106, DOI 10.2307/2390268; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kooijman SALM, 1996, WATER RES, V30, P1711, DOI 10.1016/0043-1354(96)00054-1; Kooijman SALM, 2000, DYNAMIC ENERGY BUDGE; Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Norhave NJ, 2014, ENVIRON TOXICOL CHEM, V33, P1363, DOI 10.1002/etc.2563; Norhave NJ, 2012, ENVIRON TOXICOL CHEM, V31, P787, DOI 10.1002/etc.1746; Petersen C, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-4; Philipp E.E.R., 2012, PLOS ONE, V7; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Ritz C, 2005, J STAT SOFTW, V12, P1; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sivasundar A, 2003, GENETICS, V163, P147; Spurgeon DJ, 2005, ENVIRON POLLUT, V136, P443, DOI 10.1016/j.envpol.2005.01.013; Stelzer CP, 2001, ECOLOGY, V82, P2521; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Swain S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-32; Terrell KA, 2013, J EXP BIOL, V216, P4204, DOI 10.1242/jeb.089896; Van Straalen N, 2003, ENVIRON SCI TECHNOL, V37, p324A; Wren JF, 2011, ECOTOXICOLOGY, V20, P397, DOI 10.1007/s10646-010-0591-z; Xing K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099500	64	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0140277	10.1371/journal.pone.0140277	http://dx.doi.org/10.1371/journal.pone.0140277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784453	gold, Green Published			2022-12-27	WOS:000368528400001
J	Chen, FL; Xu, L; Zhao, TT; Xiao, X; Pan, YQ; Hou, SP				Chen, Feilan; Xu, Lei; Zhao, Tingting; Xiao, Xiang; Pan, Yongquan; Hou, Shengping			Genetic Variation in the REL Gene Increases Risk of Behcet's Disease in a Chinese Han Population but That of PRKCQ Does Not	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REL; SUSCEPTIBILITY; IL23R-IL12RB2; METAANALYSIS; LOCUS; IL10	Genome-wide association studies (GWAS) and candidate gene studies have identified the REL and PRKCQ genes as risk loci for various autoimmune diseases. The purpose of the present study was to investigate the association of the REL and PRKCQ genes with Behcet's disease (BD) in a Chinese Han population. A case-control study was conducted on three single nucleotide polymorphisms (SNPs), rs13031237, rs702873, and rs842647 of the REL gene and three SNPs (rs4750316, rs11258747, and rs947474) of the PRKCQ gene using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in a total of 623 BD patients and 1,074 healthy controls. Multiple variables were assessed, including age, sex distribution, and extra-ocular findings. In the present study, the frequencies of rs842647 GG genotypes and rs842647 G alleles were significantly higher in patients than in controls and those of the rs842647 AG genotypes were lower in patients than in controls [GG genotype: Bonferroni corrected P-value for gender adjustment (P-c(a)) = 0.0074, odds ratio (OR) = 1.63; G allele: P-c(a) = 0.0072, OR = 1.57; AG genotype: P-c(a) = 0.024, OR = 0.63, respectively]. No statistically significant differences in the frequencies of rs702873, rs13031237, rs4750316, rs11258747, and rs947474 between BD patients and controls were observed. Stratification analysis indicated that the REL rs842647 polymorphism was associated with BD patients with skin lesions. No significant association of the other five SNPs between BD patients with other extra-ocular findings, including genital ulcer, arthritis, and positive pathergy test results was found. The REL rs842647 polymorphism may be a susceptibility factor for BD pathogenesis and skin lesions, which indicate that c-Rel may be involved in the pathogenesis and skin lesions of BD through the NF-kappa B pathway.	[Chen, Feilan; Xu, Lei; Zhao, Tingting; Pan, Yongquan] Chongqing Med Univ, Chongqing, Peoples R China; [Chen, Feilan; Xu, Lei; Zhao, Tingting; Pan, Yongquan] Chongqing Engn Res Ctr, Rodent Lab Anim, Chongqing, Peoples R China; [Xiao, Xiang; Hou, Shengping] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Xiao, Xiang; Hou, Shengping] Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, FL (corresponding author), Chongqing Med Univ, Chongqing, Peoples R China.; Chen, FL (corresponding author), Chongqing Engn Res Ctr, Rodent Lab Anim, Chongqing, Peoples R China.	cfl761219@163.com	Chen, Feilan/AAE-8397-2022	Chen, Feilan/0000-0001-8645-3382	National Natural Science Foundation Project [81200677]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ120303]	National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Scientific and Technological Research Program of Chongqing Municipal Education Commission	Support was provided by the National Natural Science Foundation Project (81200677), [http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list] and Scientific and Technological Research Program of Chongqing Municipal Education Commission (Grant No. KJ120303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Ortiz-Fernandez L, 2014, ANN RHEUM DIS, V73, P1433, DOI 10.1136/annrheumdis-2013-205156; Park UC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/653539; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Todaro M, 2005, ARTHRITIS RHEUM-US, V52, P2179, DOI 10.1002/art.21145; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Varade J, 2011, ANN RHEUM DIS, V70, P711, DOI 10.1136/ard.2010.134593; Yenmis G, 2015, SCAND J IMMUNOL, V81, P81, DOI 10.1111/sji.12251; Zhou XJ, 2012, ARTHRITIS RHEUM-US, V64, P222, DOI 10.1002/art.33318	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147350	10.1371/journal.pone.0147350	http://dx.doi.org/10.1371/journal.pone.0147350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784953	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400138
J	Gupta, G; Song, JX				Gupta, Garvita; Song, Jianxing			C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRAL REPLICATION; STRUCTURAL BASIS; NMR BINDING; PROTEIN; IDENTIFICATION; MOLECULES; MECHANISM; REVEAL	Hepatitis C virus (HCV) is a pathogen of global importance and nearly 200 million people are chronically infected with HCV. HCV is an enveloped single-stranded RNA virus, which is characteristic of the formation of the host membrane associated replication complex. Previous functional studies have already established that the human ER-anchored VAPB protein acts as a host factor to form a complex with HCV NS5A and NS5B, which may be established as a drug target. However, there is lacking of biophysical characterization of the structures and interfaces of the complex, partly due to the dynamic nature of the complex formation and dissociation, which is extensively involved in intrinsically-disordered domains. Here by an integrated use of domain dissection and NMR spectroscopy, for the first time we have successfully deciphered that the HCV NS5B utilizes its auto-regulatory Clinker to bind the VAPB-MSP domain to form a dynamic complex. This finding implies that the NS5B C-linker is capable of playing dual roles by a switch between the folded and disordered states. Interestingly, our previous and present studies together reveal that both HCV NS5A and NS5B bind to the MSP domains of the dimeric VAP with significantly overlapped interfaces and similar affinities. The identification that EphA2 and EphA5 bind to the MSP domain with higher affinity than EphA4 provides a biophysical basis for further exploring whether other than inducing ALS-like syndrome, the HCV infection might also trigger pathogenesis associated with signalling pathways mediated by EphA2 and EphA5.	[Gupta, Garvita; Song, Jianxing] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore	National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore.	dbssjx@nus.edu.sg	Song, Jianxing/H-8026-2012	Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) [R-154-002-580-112]	Ministry of Education of Singapore (MOE)	This study was supported by Ministry of Education of Singapore (MOE) Tier 3 R-154-002-580-112 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Akhvlediani T, 2009, Georgian Med News, P70; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Bastos AF, 2011, NEUROL INT, V3, P12, DOI 10.4081/ni.2011.e4; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dutta S, 2012, BIOCHEM J, V446, P37, DOI 10.1042/BJ20120001; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goyal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040341; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Huan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074040; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Leveque VJP, 2003, J VIROL, V77, P9020, DOI 10.1128/JVI.77.16.9020-9028.2003; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2015, ACS CHEM BIOL, V10, P372, DOI 10.1021/cb500413n; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reich S, 2010, J BIOL CHEM, V285, P13685, DOI 10.1074/jbc.M109.082206; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Song JX, 2001, J BIOL CHEM, V276, P41205, DOI 10.1074/jbc.M103449200; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Thiel HJ, 2005, VIRUS TAXONOMY, P979; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Wang W, 2013, BIOCHEM BIOPH RES CO, V438, P169, DOI 10.1016/j.bbrc.2013.07.047; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	54	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147278	10.1371/journal.pone.0147278	http://dx.doi.org/10.1371/journal.pone.0147278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784321	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400132
J	Kaileh, M; Vazquez, E; MacFarlane, AW; Campbell, K; Kurosaki, T; Siebenlist, U; Sen, R				Kaileh, Mary; Vazquez, Estefania; MacFarlane, Alexander W.; Campbell, Kerry; Kurosaki, Tomohiro; Siebenlist, Ulrich; Sen, Ranjan			mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes	PLOS ONE			English	Article							NF-KAPPA-B; CELL DEVELOPMENT; BAFF-R; IKK-ALPHA; RECEPTOR; ACTIVATION; MICE; INHIBITOR; CD19; PATHWAY	Peripheral B lymphocyte survival requires the B cell receptor (BCR) and B cell activating factor (BAFF) binding to its receptor (BAFF-R). Deletion of the BCR, or its signal transducing chaperone Ig beta, leads to rapid loss of mature B cells, indicating that signals initiated at the BCR are crucial for B cell survival. BAFF or BAFF-R deficiency also significantly reduces the numbers of mature B cells despite normal BCR expression. Together, these observations indicate that continued BCR and BAFF-R signaling are essential for the survival of mature resting B cells in the periphery. Here we demonstrate that tonic BCR signals up-regulate p100 (Nfkb2) as well as Mcl-1 protein expression at a post-transcriptional level via a PI3K-dependent pathway. p100 expression is mTOR-independent, whereas Mcl-1 expression is mTOR-dependent. BAFF treatment further elevated Mcl-1 levels by an mTOR-independent pathway, while consuming p100. Accordingly, Mcl-1 induction by BAFF is abrogated in Nfkb2(-/-) B cells. We propose that the cumulative effects of the BCR and BAFF-R signaling pathways increase Mcl-1 levels beyond the threshold required for B cell survival.	[Kaileh, Mary; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Vazquez, Estefania; Siebenlist, Ulrich] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [MacFarlane, Alexander W.; Campbell, Kerry] Fox Chase Canc Ctr, Inst Canc Res, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fox Chase Cancer Center; Osaka University	Sen, R (corresponding author), NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	ranjan.sen@nih.gov	Campbell, Kerry S./T-1381-2019	MacFarlane IV, Alexander/0000-0003-1740-4848	Intramural research Program of the NIH, National institute on Aging (Baltimore, MD); NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000376] Funding Source: NIH RePORTER	Intramural research Program of the NIH, National institute on Aging (Baltimore, MD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural research Program of the NIH, National institute on Aging (Baltimore, MD).	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brightbill HD, 2015, J IMMUNOL; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Herold MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.409; Jellusova J, 2013, CELL REP, V5, P1022, DOI 10.1016/j.celrep.2013.10.022; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin WY, 2007, BLOOD, V110, P3959, DOI 10.1182/blood-2007-04-088088; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Mills DM, 2007, P NATL ACAD SCI USA, V104, P6359, DOI 10.1073/pnas.0700296104; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146955	10.1371/journal.pone.0146955	http://dx.doi.org/10.1371/journal.pone.0146955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785352	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400085
J	Rao, M; Singh, PV; Katyal, A; Samarth, A; Bergkvist, S; Renton, A; Netuveli, G				Rao, Mala; Singh, Prabal Vikram; Katyal, Anuradha; Samarth, Amit; Bergkvist, Sofi; Renton, Adrian; Netuveli, Gopalakrishnan			Has the Rajiv Aarogyasri Community Health Insurance Scheme of Andhra Pradesh Addressed the Educational Divide in Accessing Health Care?	PLOS ONE			English	Article							IMPOVERISHMENT	Background Equity of access to healthcare remains a major challenge with families continuing to face financial and non-financial barriers to services. Lack of education has been shown to be a key risk factor for' catastrophic' health expenditure (CHE), in many countries including India. Consequently, ways to address the education divide need to be explored. We aimed to assess whether the innovative state-funded Rajiv Aarogyasri Community Health Insurance Scheme of Andhra Pradesh state launched in 2007, has achieved equity of access to hospital inpatient care among households with varying levels of education. Methods We used the National Sample Survey Organization 2004 survey as our baseline and the same survey design to collect post-intervention data from 8623 households in the state in 2012. Two outcomes, hospitalisation and CHE for inpatient care, were estimated using education as a measure of socio-economic status and transforming levels of education into ridit scores. We derived relative indices of inequality by regressing the outcome measures on education, transformed as a ridit score, using logistic regression models with appropriate weights and accounting for the complex survey design. Findings Between 2004 and 2012, there was a 39% reduction in the likelihood of the most educated person being hospitalised compared to the least educated, with reductions observed in all households as well as those that had used the Aarogyasri. For CHE the inequality disappeared in 2012 in both groups. Sub-group analyses by economic status, social groups and rural-urban residence showed a decrease in relative indices of inequality in most groups. Nevertheless, inequalities in hospitalisation and CHE persisted across most groups. Conclusion During the time of the Aarogyasri scheme implementation inequalities in access to hospital care were substantially reduced but not eliminated across the education divide. Universal access to education and schemes such as Aarogyasri have the synergistic potential to achieve equity of access to healthcare.	[Rao, Mala] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Singh, Prabal Vikram] Oxford Policy Management, Delhi, India; [Katyal, Anuradha; Bergkvist, Sofi] ACCESS Hlth Int, Hyderabad, Andhra Pradesh, India; [Samarth, Amit] SughaVazhvu Healthcare, Thanjavur, India; [Renton, Adrian; Netuveli, Gopalakrishnan] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Netuveli, Gopalakrishnan] UCL, ESRC Int Ctr Life Course Studies Soc & Hlth, London, England	Imperial College London; University of East London; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London	Rao, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	mala.rao@imperial.ac.uk		Katyal, Anuradha/0000-0001-8564-6174	Wellcome Trust; International Development Research Centre, Canada; Rockefeller Foundation; UK Department for International Development; Government of Andhra Pradesh; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); International Development Research Centre, Canada(CGIAR); Rockefeller Foundation; UK Department for International Development; Government of Andhra Pradesh; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by: Wellcome Trust, International Development Research Centre, Canada, Rockefeller Foundation, and the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Role of the study sponsor: The study was carried out in response to the formal invitation of the Government of Andhra Pradesh which supported our applications for funding (by providing formal letters of support). The Government did not provide any funding, and had no role in study design, data collection, analysis, interpretation or reporting, or in submission decision. Prabal Singh and Amit Samarth worked at ACCESS Health International at the time of the study and Mala Rao worked at University of East London at the time of the study. The specific roles of all authors are articulated in the 'author contributions' section."; The study was funded by the International Development Research Centre, Canada, the Wellcome Trust, the UK Department for International Development, and Rockefeller Foundation. The World Bank supported the contribution of Adam Wagstaff whose advice on survey design we gratefully acknowledge. We also gratefully acknowledge the financial support of our funding organisations, as well as the enthusiastic encouragement we have received from them throughout the study. Our thanks also go to Bhimasankaram Pochiraju, Sundaresh Peri, C Ravi, and Rahul Ahluwalia for their advice and guidance at various stages of the survey design and data analysis, and to colleagues at the University of East London and Administrative Staff College of India Hyderabad for their administrative support. The authors also thank P Suryanarayana, CM Reddy, D Chakrapani and K Pandu Ranga Reddy for their contribution to the training of the survey teams, verification of the survey and data collection and acknowledge the IMRB International Social Research Institute team's support in carrying out the survey.	Acharya A., 2012, IMPACT NATL HLTH INS; [Anonymous], 2010, HINDU; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Cutler D.M., 2006, NBER WORKING PAPER S; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Giedion U, 2013, UNIVERSAL HLTH COVER, V25; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Kunst AE, 1994, MEASURING SOCIOECONO; La Forgia G, 2012, ARE YOU COVERED; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; National Sample Survey Organization, 2009, HOUS CONS EXP 66 ROU; National Sample Survey Organization, 2004, MORB HEALTHC COND AG; Palacios RJ, 2011, INDIAS HLTH INSURANC; Rao M, 2011, NATL MED J INDIA, V24, P335; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036; Twelfth Five Year Plan, 2012, SOC SECT, VIII, P1; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WOR HEALT REP, P1	18	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145707	10.1371/journal.pone.0145707	http://dx.doi.org/10.1371/journal.pone.0145707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784962	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000368528400017
J	Wan, YD; Sun, TW; Kan, QC; Guan, FX; Liu, ZQ; Zhang, SG				Wan, You-Dong; Sun, Tong-Wen; Kan, Quan-Cheng; Guan, Fang-Xia; Liu, Zi-Qi; Zhang, Shu-Guang			The Effects of Intra-Aortic Balloon Pumps on Mortality in Patients Undergoing High-Risk Coronary Revascularization: A Meta-Analysis of Randomized Controlled Trials of Coronary Artery Bypass Grafting and Stenting Era	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; CARDIOGENIC-SHOCK; COUNTERPULSATION; SUPPORT; INTERVENTION; SURGERY; DYSFUNCTION; EFFICACY; IMPROVE	Background Intra-aortic balloon pumps (IABP) have generally been used for patients undergoing high-risk mechanical coronary revascularization. However, there is still insufficient evidence to determine whether they can improve outcomes in reperfusion therapy patients, mainly by percutaneous coronary intervention (PCI) with stenting or coronary artery bypass graft (CABG). This study was designed to determine the difference between high-risk mechanical coronary revascularization with and without IABPs on mortality, by performing a meta-analysis on randomized controlled trials of the current era. Methods Pubmed and Embase databases were searched from inception to May 2015. Unpublished data were obtained from the investigators. Randomized clinical trials of IABP and non-IABP in high-risk coronary revascularization procedures (PCI or CABG) were included. In the case of PCI procedures, stents should be used in more than 80% of patients. Numbers of events at the short-term and long-term follow-up were extracted. Results A total of 12 randomized trials enrolling 2155 patients were included. IABPs did not significantly decrease short-term mortality (relative risk (RR) 0.66; 95% CI, 0.42-1.01), or long-term mortality (RR 0.79; 95% CI, 0.47-1.35), with low heterogeneity across the studies. The findings remained stable in patients with acute myocardial infarction with or without cardiogenic shock. But in high-risk CABG patients, IABP was associated with reduced mortality (71 events in 846 patients; RR 0.40; 95% CI 0.25-0.67). Conclusion In patients undergoing high-risk coronary revascularization, IABP did not significantly decrease mortality. But high-risk CABG patients may be benefit from IABP. Rigorous criteria should be applied to the use of IABPs.	[Wan, You-Dong; Sun, Tong-Wen; Liu, Zi-Qi; Zhang, Shu-Guang] Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China; [Kan, Quan-Cheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmaceut, Zhengzhou 450052, Peoples R China; [Guan, Fang-Xia] Acad Med Sci, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University; Zhengzhou University	Sun, TW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China.; Kan, QC (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmaceut, Zhengzhou 450052, Peoples R China.	suntongwen@163.com; wanyoudong130@163.com	Sun, Tongwen/AAQ-7741-2020		Henan Province of Medical Scientific Province & Ministry Research Project, China [201301005]	Henan Province of Medical Scientific Province & Ministry Research Project, China	This study was supported by Henan Province of Medical Scientific Province & Ministry Research Project (201301005, http://www.hnwst.gov.cn/), China, to TWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2004, J AM COLL CARDIOL, V43, P1291, DOI 10.1016/j.jacc.2003.11.034; Bahekar A, 2012, J CARDIOVASC PHARM T, V17, P44, DOI 10.1177/1074248410395019; Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295; Chen SJ, 2014, HEART, V100, P303, DOI 10.1136/heartjnl-2013-304198; Christenson JT, 1997, EUR J CARDIO-THORAC, V11, P1097, DOI 10.1016/S1010-7940(97)00087-0; Christenson JT, 1997, ANN THORAC SURG, V64, P1237, DOI 10.1016/S0003-4975(97)00898-9; Christenson JT, 2003, J CARDIAC SURG, V18, P286, DOI 10.1046/j.1540-8191.2003.02030.x; Christenson JT, 1997, THORAC CARDIOV SURG, V45, P60, DOI 10.1055/s-2007-1013688; Christenson JT, 1999, ANN THORAC SURG, V68, P934, DOI 10.1016/S0003-4975(99)00687-6; Dyub AM, 2008, J CARDIAC SURG, V23, P79, DOI 10.1111/j.1540-8191.2007.00499.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gu J, 2011, ACTA CARDIOL, V66, P499, DOI 10.1080/AC.66.4.2126599; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; LaFleur J, 2011, HEART, V97, P1862, DOI 10.1136/hrt.2011.223289; Lee JM, 2015, INT J CARDIOL, V184, P36, DOI 10.1016/j.ijcard.2015.01.081; Lu JK, 2012, CHINESE MED J-PEKING, V125, P2099, DOI 10.3760/cma.j.issn.0366-6999.2012.12.004; Marra C, 2002, INT J ARTIF ORGANS, V25, P141, DOI 10.1177/039139880202500209; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MUELLER HS, 1994, CARDIOLOGY, V84, P168, DOI 10.1159/000176395; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Ohman EM, 2005, J THROMB THROMBOLYS, V19, P33, DOI 10.1007/s11239-005-0938-0; OHMAN EM, 1994, CIRCULATION, V90, P792, DOI 10.1161/01.CIR.90.2.792; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Perera D, 2013, CIRCULATION, V127, P207, DOI 10.1161/CIRCULATIONAHA.112.132209; Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190; Pilarczyk K, 2016, EUR J CARDIO-THORAC, V49, P5, DOI 10.1093/ejcts/ezv258; Prondzinsky R, 2010, CRIT CARE MED, V38, P152, DOI 10.1097/CCM.0b013e3181b78671; Ranucci M, 2013, CRIT CARE MED, V41, P2476, DOI 10.1097/CCM.0b013e3182978dfc; Romeo F, 2013, INT J CARDIOL, V167, P1783, DOI 10.1016/j.ijcard.2012.12.027; Romeo F, 2013, AM HEART J, V165, P679, DOI 10.1016/j.ahj.2013.02.020; Sa MPBO, 2012, CORONARY ARTERY DIS, V23, P480, DOI 10.1097/MCA.0b013e328358784d; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Stone GW, 1997, J AM COLL CARDIOL, V29, P1459, DOI 10.1016/S0735-1097(97)00088-0; Su D, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000876; Theologou T, 2011, COCHRANE DB SYST REV, pD4472; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Vijayalakshmi Kunadian, 2007, J Invasive Cardiol, V19, P339; Wilczynski M, 2010, KARDIOL POL, V68, P1361	39	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147291	10.1371/journal.pone.0147291	http://dx.doi.org/10.1371/journal.pone.0147291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784578	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400134
J	Wang, Z; Jin, Y; Shen, CY; Li, TT; Huang, YF; Li, BG				Wang, Zhan; Jin, Yan; Shen, Chongyang; Li, Tiantian; Huang, Yuanfang; Li, Baoguo			Spontaneous Detachment of Colloids from Primary Energy Minima by Brownian Diffusion	PLOS ONE			English	Article							MICROMETER-SCALE PARTICLES; POROUS-MEDIA; SURFACE-ROUGHNESS; SOLUTION CHEMISTRY; DLVO INTERACTION; CARBON NANOTUBES; IONIC-STRENGTH; RELEASE; DEPOSITION; TRANSPORT	The Derjaguin-Landau-Verwey-Overbeek (DLVO) interaction energy profile has been frequently used to interpret the mechanisms controlling colloid attachment/detachment and aggregation/disaggregation behavior. This study highlighted a type of energy profile that is characterized by a shallow primary energy well (i.e., comparable to the average kinetic energy of a colloid) at a small separation distance and a monotonic decrease of interaction energy with separation distance beyond the primary energy well. This energy profile is present due to variations of height, curvature, and density of discrete physical heterogeneities on collector surfaces. The energy profile indicates that colloids can be spontaneously detached from the shallow primary energy well by Brownian diffusion. The spontaneous detachment from primary minima was unambiguously confirmed by conducting laboratory column transport experiments involving flow interruptions for two model colloids (polystyrene latex microspheres) and engineered nanoparticles (fullerene C-60 aggregates). Whereas the spontaneous detachment has been frequently attributed to attachment in secondary minima in the literature, our study indicates that the detached colloids could be initially attached at primary minima. Our study further suggests that the spontaneous disaggregation from primary minima is more significant than spontaneous detachment because the primary minimum depth between colloid themselves is lower than that between a colloid and a collector surface.	[Wang, Zhan; Shen, Chongyang; Li, Tiantian; Huang, Yuanfang; Li, Baoguo] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China; [Wang, Zhan] Shenyang Agr Univ, Coll Land & Environm, Shenyang 110866, Liaoning, Peoples R China; [Jin, Yan] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA	China Agricultural University; Shenyang Agricultural University; University of Delaware	Shen, CY; Li, BG (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China.	chongyang.shen@gmail.com; libg@cau.edu.cn	Shen, Chongyang/W-8463-2019		Chinese Universities Scientific Fund [2015QC061]; National Natural Science Foundation of China [41271009]; Program for New Century Excellent Talents in University [NCET-13-0560]; National Key Technology RD Program [2012BAD05B02]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Key Technology RD Program(National Key Technology R&D Program)	The authors acknowledge the financial support provided by the Chinese Universities Scientific Fund (2015QC061, http://www.moe.edu.cn) (CS), National Natural Science Foundation of China (no. 41271009, http://www.nsfc.gov.cn) (CS), Program for New Century Excellent Talents in University (NCET-13-0560, http://www.moe.edu.cn) (CS), and National Key Technology R&D Program (no. 2012BAD05B02, http://www.most.gov.cn) (BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna SM, 2008, LANGMUIR, V24, P4881, DOI 10.1021/la703866g; Assemi S, 2006, COLLOID SURFACE A, V286, P70, DOI 10.1016/j.colsurfa.2006.03.024; BALES RC, 1991, ENVIRON SCI TECHNOL, V25, P2088, DOI 10.1021/es00024a016; BALES RC, 1993, WATER RESOUR RES, V29, P957, DOI 10.1029/92WR02986; Batra A, 2001, AICHE J, V47, P2557, DOI 10.1002/aic.690471118; Bergendahl J, 2000, CHEM ENG SCI, V55, P1523, DOI 10.1016/S0009-2509(99)00422-4; Bergendahl JA, 2003, ENVIRON SCI TECHNOL, V37, P2317, DOI 10.1021/es0209316; Bhattacharjee S, 1997, J COLLOID INTERF SCI, V193, P273, DOI 10.1006/jcis.1997.5076; Bhattacharjee S, 1998, LANGMUIR, V14, P3365, DOI 10.1021/la971360b; Bhattacharjee S, 1998, CROAT CHEM ACTA, V71, P883; Bradford SA, 2015, J CONTAM HYDROL, V181, P141, DOI 10.1016/j.jconhyd.2015.04.003; Bradford SA, 2013, LANGMUIR, V29, P6944, DOI 10.1021/la4011357; Brant JA, 2002, ENVIRON ENG SCI, V19, P413, DOI 10.1089/109287502320963409; Burdick GM, 2005, THIN SOLID FILMS, V488, P116, DOI 10.1016/j.tsf.2005.04.112; Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176; CHAN DYC, 1984, J COLLOID INTERF SCI, V102, P400, DOI 10.1016/0021-9797(84)90242-X; Chen KL, 2006, LANGMUIR, V22, P10994, DOI 10.1021/la062072v; Clar JG, 2013, J AM CHEM SOC, V135, P17758, DOI 10.1021/ja4052526; CLAYFIELD EJ, 1970, ENVIRON SCI TECHNOL, V4, P413, DOI 10.1021/es60040a005; Considine RF, 2001, LANGMUIR, V17, P7777, DOI 10.1021/la0017227; DAHNEKE B, 1975, J COLLOID INTERF SCI, V50, P89, DOI 10.1016/0021-9797(75)90257-X; Desset S, 2000, LANGMUIR, V16, P10495, DOI 10.1021/la000734p; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; Duffadar RD, 2008, J COLLOID INTERF SCI, V326, P18, DOI 10.1016/j.jcis.2008.07.004; Duffadar RD, 2007, J COLLOID INTERF SCI, V308, P20, DOI 10.1016/j.jcis.2006.12.068; ELIMELECH M, 1990, LANGMUIR, V6, P1153, DOI 10.1021/la00096a023; ELIMELECH M, 1990, ENVIRON SCI TECHNOL, V24, P1528, DOI 10.1021/es00080a012; Fuerstenau DW, 2005, ADV COLLOID INTERFAC, V114, P9, DOI 10.1016/j.cis.2004.08.006; Grolimund D, 2001, WATER RESOUR RES, V37, P559, DOI 10.1029/2000WR900285; Grolimund D, 2001, WATER RESOUR RES, V37, P571, DOI 10.1029/2000WR900286; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P5915, DOI 10.1021/es049746d; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P210, DOI 10.1021/es030416n; Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7; HAPPEL J, 1958, AICHE J, V4, P197, DOI 10.1002/aic.690040214; Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031; Hoek EMV, 2003, LANGMUIR, V19, P4836, DOI 10.1021/la027083c; HOGG R, 1966, T FARADAY SOC, V62, P1638, DOI 10.1039/tf9666201638; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Huang XF, 2010, LANGMUIR, V26, P2528, DOI 10.1021/la9028113; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; KALLAY N, 1987, ADV COLLOID INTERFAC, V27, P1, DOI 10.1016/0001-8686(87)85008-X; Kim JU, 2008, MACROMOLECULES, V41, P246, DOI 10.1021/ma071906t; Kovalchuk NM, 2012, ADV COLLOID INTERFAC, V179, P99, DOI 10.1016/j.cis.2011.05.009; Ninham BW, 1999, ADV COLLOID INTERFAC, V83, P1, DOI 10.1016/S0001-8686(99)00008-1; Oliveira R, 1997, EXP THERM FLUID SCI, V14, P316, DOI 10.1016/S0894-1777(96)00134-3; Pazmino E, 2014, ENVIRON SCI TECHNOL, V48, P9227, DOI 10.1021/es502503y; Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es034887l; Roy SB, 1996, COLLOID SURFACE A, V119, P133, DOI 10.1016/S0927-7757(96)03764-8; RYAN JN, 1994, ENVIRON SCI TECHNOL, V28, P1717, DOI 10.1021/es00058a025; RYAN JN, 1994, J COLLOID INTERF SCI, V164, P21, DOI 10.1006/jcis.1994.1139; Ryan JN, 1996, COLLOID SURFACE A, V107, P1, DOI 10.1016/0927-7757(95)03384-X; Ryde NP, 2000, COLLOID SURFACE A, V165, P59, DOI 10.1016/S0927-7757(99)00447-1; Schijven JF, 2000, CRIT REV ENV SCI TEC, V30, P49, DOI 10.1080/10643380091184174; Schowalter WR, 2001, P NATL ACAD SCI USA, V98, P3644, DOI 10.1073/pnas.061028498; Shay JS, 2001, J RHEOL, V45, P913, DOI 10.1122/1.1378030; Shen C, 2012, COLLOID SURF A, V107, P1; Shen CY, 2007, ENVIRON SCI TECHNOL, V41, P6976, DOI 10.1021/es070210c; Shen CY, 2015, J CONTAM HYDROL, V177, P18, DOI 10.1016/j.jconhyd.2015.03.003; Shen CY, 2015, J HAZARD MATER, V290, P60, DOI 10.1016/j.jhazmat.2015.02.067; Shen CY, 2014, J COLLOID INTERF SCI, V421, P103, DOI 10.1016/j.jcis.2014.01.033; Shen CY, 2013, COLLOID SURFACE A, V433, P14, DOI 10.1016/j.colsurfa.2013.04.048; Shen CY, 2012, LANGMUIR, V28, P14681, DOI 10.1021/la303163c; Shen CY, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0057; Shen CY, 2011, VADOSE ZONE J, V10, P1071, DOI 10.2136/vzj2011.0011; Shen CY, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009218; Suresh L, 1996, J COLLOID INTERF SCI, V183, P199, DOI 10.1006/jcis.1996.0535; Suresh L, 1997, J COLLOID INTERF SCI, V196, P177, DOI 10.1006/jcis.1997.5216; Tian Y, 2012, J HAZARD MATER, V231, P79, DOI 10.1016/j.jhazmat.2012.06.039; Torkzaban S, 2007, LANGMUIR, V23, P9652, DOI 10.1021/la700995e; Torkzaban S, 2016, WATER RES, V88, P274, DOI 10.1016/j.watres.2015.10.022; Torkzaban S, 2013, ENVIRON SCI TECHNOL, V47, P11528, DOI 10.1021/es402075f; Tosco T, 2009, ENVIRON SCI TECHNOL, V43, P4425, DOI 10.1021/es900245d; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Verwey E.J., 1948, THEORY STABILITY LYO; Walz JY, 1998, ADV COLLOID INTERFAC, V74, P119, DOI 10.1016/S0001-8686(97)00042-0; Wu KL, 2005, LANGMUIR, V21, P3238, DOI 10.1021/la0476682; Wu L, 2012, ENVIRON SCI TECHNOL, V46, P8878, DOI 10.1021/es301365f; Yi P, 2013, ENVIRON SCI TECHNOL, V47, P12211, DOI 10.1021/es403133r; Zhuang J, 2005, ENVIRON SCI TECHNOL, V39, P7853, DOI 10.1021/es050265j	79	10	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147368	10.1371/journal.pone.0147368	http://dx.doi.org/10.1371/journal.pone.0147368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784446	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400144
J	Boraas, LC; Guidry, JB; Pineda, ET; Ahsan, T				Boraas, Liana C.; Guidry, Julia B.; Pineda, Emma T.; Ahsan, Tabassum			Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells	PLOS ONE			English	Article							SHEAR-STRESS; LINEAGE SPECIFICATION; DIFFERENTIATION; GENERATION; ADULT; FIBROBLASTS; TRANSITIONS; INDUCTION; MIGRATION; SYSTEM	Many emerging cell-based therapies are based on pluripotent stem cells, though complete understanding of the properties of these cells is lacking. In these cells, much is still unknown about the cytoskeletal network, which governs the mechanoresponse. The objective of this study was to determine the cytoskeletal state in undifferentiated pluripotent stem cells and remodeling with differentiation. Mouse embryonic stem cells (ESCs) and reprogrammed induced pluripotent stem cells (iPSCs), as well as the original un-reprogrammed embryonic fibroblasts (MEFs), were evaluated for expression of cytoskeletal markers. We found that pluripotent stem cells overall have a less developed cytoskeleton compared to fibroblasts. Gene and protein expression of smooth muscle cell actin, vimentin, lamin A, and nestin were markedly lower for ESCs than MEFs. Whereas, iPSC samples were heterogeneous with most cells expressing patterns of cytoskeletal proteins similar to ESCs with a small subpopulation similar to MEFs. This indicates that dedifferentiation during reprogramming is associated with cytoskeletal remodeling to a less developed state. In differentiation studies, it was found that shear stress-mediated differentiation resulted in an increase in expression of cytoskeletal intermediate filaments in ESCs, but not in iPSC samples. In the embryoid body model of spontaneous differentiation of pluripotent stem cells, however, both ESCs and iPSCs had similar gene expression for cytoskeletal proteins during early differentiation. With further differentiation, however, gene levels were significantly higher for iPSCs compared to ESCs. These results indicate that reprogrammed iPSCs more readily reacquire cytoskeletal proteins compared to the ESCs that need to form the network de novo. The strategic selection of the parental phenotype is thus critical not only in the context of reprogramming but also the ultimate functionality of the iPSC-differentiated cell population. Overall, this increased characterization of the cytoskeleton in pluripotent stem cells will allow for the better understanding and design of stem cell-based therapies.	[Boraas, Liana C.; Guidry, Julia B.; Pineda, Emma T.; Ahsan, Tabassum] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Tulane University	Ahsan, T (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	tahsan@tulane.edu	Ahsan, Tabassum/G-6447-2010		National Institutes of Health [P20 GM103629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health #P20 GM103629 (LCB JBG ETP TA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Bober BG, 2015, CYTOSKELETON, V72, P193, DOI 10.1002/cm.21219; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; Constantinescu D, 2006, STEM CELLS, V24, P177, DOI 10.1634/stemcells.2004-0159; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gopalakrishnan J, 2012, NAT CELL BIOL, V14, P865, DOI 10.1038/ncb2527; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Hammerick KE, 2011, TISSUE ENG PT A, V17, P495, DOI [10.1089/ten.tea.2010.0211, 10.1089/ten.TEA.2010.0211]; Hayes Michael, 2013, Methods Mol Biol, V1029, P77, DOI 10.1007/978-1-62703-478-4_6; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lai WH, 2010, CELL REPROGRAM, V12, P641, DOI 10.1089/cell.2010.0051; Lee J., 2014, NATURE COMMUNICATION, V5; Li X, 2014, PROTEIN CELL, V5, P580, DOI 10.1007/s13238-014-0064-x; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Luo W, 2011, ACTA BIOCH BIOPH SIN, V43, P210, DOI 10.1093/abbs/gmr004; Madonna R, 2014, BBA-MOL BASIS DIS, V1842, P2266, DOI 10.1016/j.bbadis.2014.07.030; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Mao J, 2014, STEM CELLS DEV, V23, P779, DOI 10.1089/scd.2013.0325; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mulhall H, 2011, J TISSUE ENG REGEN M, V5, P629, DOI 10.1002/term.355; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakurai K, 2014, CELL STEM CELL, V14, P523, DOI 10.1016/j.stem.2014.03.001; Sanchez-Freire V, 2014, J AM COLL CARDIOL, V64, P436, DOI 10.1016/j.jacc.2014.04.056; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f; Yamada M, 2006, ANAL CHEM, V78, P1357, DOI 10.1021/ac0520083; Zhao BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-488	40	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0145084	10.1371/journal.pone.0145084	http://dx.doi.org/10.1371/journal.pone.0145084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771179	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300004
J	Chung, SJ; Park, E; Ye, BS; Lee, HS; Chang, HJ; Song, D; Kim, YD; Heo, JH; Nam, HS				Chung, Seok Jong; Park, Eunjeong; Ye, Byoung Seok; Lee, Hye Sun; Chang, Hyuk-Jae; Song, Dongbeom; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk			The Computerized Table Setting Test for Detecting Unilateral Neglect	PLOS ONE			English	Article							HEMISPATIAL NEGLECT; LINE BISECTION; VISUOSPATIAL NEGLECT; SPATIAL NEGLECT; STROKE PATIENTS; BREAST-CANCER; HAND-HELD; SENSITIVITY; METASTASIS; HEMIANOPIA	Background Patients with unilateral neglect fail to respond normally to stimuli on the left side. To facilitate the evaluation of unilateral spatial neglect, we developed a new application that runs on a tablet device and investigated its feasibility in stroke patients. Methods We made the computerized table setting test (CTST) to run on the tablet computer. Forty acute ischemic stroke patients (20 patients with right hemispheric infarction with neglect, 10 patients with right hemispheric infarction without neglect, and 10 patients with left hemispheric infarction) and 10 healthy controls were prospectively enrolled to validate the CTST. The test requires subjects to set a table by dragging 12 dishes located below the table on the tablet screen. The horizontal deviation of the 12 dishes from the midline of the table, the selection tendency measured by the sequence of the dish selection, and the elapsed time for table setting were calculated automatically. Results Parameters measured by the CTST were correlated with the results of conventional neglect tests. The horizontal deviation was significantly higher in patients with right hemispheric infarction with neglect compared with the other groups. The selection tendency and elapsed time also were significantly different in patients with right hemispheric infarction with neglect compared with the left hemispheric infarction and control groups, but were similar to those with right hemispheric infarction without neglect. Conclusions The CTST is feasible to administer and comparable with conventional neglect tests. This new application may be useful for the initial diagnosis and follow-up of neglect patients.	[Chung, Seok Jong; Ye, Byoung Seok; Song, Dongbeom; Kim, Young Dae; Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Eunjeong] Univ Calif Los Angeles, Wireless Hlth Inst, Los Angeles, CA USA; [Park, Eunjeong; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Dept Cardiol, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Nam, HS (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	hsnam@yuhs.ac	; Lee, Hye Sun/J-2154-2015	Heo, Ji Hoe/0000-0001-9898-3321; Ye, Byoung Seok/0000-0003-0187-8440; NAM, HYO SUK/0000-0002-4415-3995; Kim, Young Dae/0000-0001-5750-2616; Chung, Seok Jong/0000-0001-6086-3199; Chang, Hyuk-Jae/0000-0002-6139-7545; Lee, Hye Sun/0000-0001-6328-6948	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [HI08C2149]; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP) [2012027176]; Yonsei University College of Medicine [6-2014-0181]	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP); Yonsei University College of Medicine(General Electric)	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149); the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) (2012027176); and a faculty research grant from Yonsei University College of Medicine for 2014 (6-2014-0181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; Bailey MJ, 2000, NEUROREHABILITATION, V14, P139; Bartolomeo P, 1999, NEUROPSYCHOLOGIA, V37, P881, DOI 10.1016/S0028-3932(98)00150-X; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Brazis PW, 2011, LOCALIZATION CLIN NE; Busis N, 2010, NEUROL CLIN, V28, P395, DOI 10.1016/j.ncl.2009.11.001; Friederichs H, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0113-7; Graesslin O, 2010, J CLIN ONCOL, V28, P2032, DOI 10.1200/JCO.2009.24.6314; HALLIGAN PW, 1989, LANCET, V2, P908; Nam HS, 2012, THROMB HAEMOSTASIS, V107, P786, DOI 10.1160/TH11-08-0585; Jalas MJ, 2002, J CLIN EXP NEUROPSYC, V24, P479, DOI 10.1076/jcen.24.4.479.1036; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Jehkonen M, 1998, LANCET, V351, P727, DOI 10.1016/S0140-6736(05)78497-X; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; Kim H, 2014, GERIATR GERONTOL INT, V14, P969, DOI 10.1111/ggi.12182; Lee BH, 2004, NEUROPSYCHOLOGIA, V42, P1715, DOI 10.1016/j.neuropsychologia.2004.02.015; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Luukkainen-Markkula R, 2011, NEUROPSYCHOL REHABIL, V21, P103, DOI 10.1080/09602011.2010.531619; Machner B, 2012, J NEUROL NEUROSUR PS, V83, P1032, DOI 10.1136/jnnp-2012-303296; MARSHALL JC, 1975, NEUROPSYCHOLOGIA, V13, P315, DOI 10.1016/0028-3932(75)90008-1; Na DL, 2000, CORTEX, V36, P455, DOI 10.1016/S0010-9452(08)70532-X; Nam HS, 2012, EUR J NEUROL, V19, P426, DOI 10.1111/j.1468-1331.2011.03530.x; Nam HS, 2013, J STROKE, V15, P135, DOI 10.5853/jos.2013.15.3.135; Nam HS, 2014, YONSEI MED J, V55, P25, DOI 10.3349/ymj.2014.55.1.25; Nurmi L, 2010, J INT NEUROPSYCH SOC, V16, P902, DOI 10.1017/S1355617710000792; Parton A, 2004, J NEUROL NEUROSUR PS, V75, P13; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Rouzier R, 2005, J CLIN ONCOL, V23, P8331, DOI 10.1200/JCO.2005.01.2898; Shin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041544; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Toomey RJ, 2010, AM J ROENTGENOL, V194, P469, DOI 10.2214/AJR.09.3418; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147030	10.1371/journal.pone.0147030	http://dx.doi.org/10.1371/journal.pone.0147030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771512	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300055
J	Zeale, MRK; Bennitt, E; Newson, SE; Packman, C; Browne, WJ; Harris, S; Jones, G; Stone, E				Zeale, Matt R. K.; Bennitt, Emily; Newson, Stuart E.; Packman, Charlotte; Browne, William J.; Harris, Stephen; Jones, Gareth; Stone, Emma			Mitigating the Impact of Bats in Historic Churches: The Response of Natterer's Bats Myotis nattereri to Artificial Roosts and Deterrence	PLOS ONE			English	Article							PIPISTRELLUS-PIPISTRELLUS; BIODIVERSITY IMPACTS; FORAGING BEHAVIOR; HABITAT SELECTION; CONSERVATION; CHIROPTERA; KUHL	Bats frequently roost in historic churches, and these colonies are of considerable conservation value. Inside churches, bat droppings and urine can cause damage to the historic fabric of the building and to items of cultural significance. In extreme cases, large quantities of droppings can restrict the use of a church for worship and/or other community functions. In the United Kingdom, bats and their roosts are protected by law, and striking a balance between conserving the natural and cultural heritage can be a significant challenge. We investigated mitigation strategies that could be employed in churches and other historic buildings to alleviate problems caused by bats without adversely affecting their welfare or conservation status. We used a combination of artificial roost provision and deterrence at churches in Norfolk, England, where significant maternity colonies of Natterer's bats Myotis nattereri damage church features. Radio-tracking data and population modelling showed that excluding M. nattereri from churches is likely to have a negative impact on their welfare and conservation status, but that judicious use of deterrents, especially high intensity ultrasound, can mitigate problems caused by bats. We show that deterrence can be used to move bats humanely from specific roosting sites within a church and limit the spread of droppings and urine so that problems to congregations and damage to cultural heritage can be much reduced. In addition, construction of bespoke roost spaces within churches can allow bats to continue to roost within the fabric of the building without flying in the church interior. We highlight that deterrence has the potential to cause serious harm to M. nattereri populations if not used judiciously, and so the effects of deterrents will need careful monitoring, and their use needs strict regulation.	[Zeale, Matt R. K.; Bennitt, Emily; Packman, Charlotte; Harris, Stephen; Jones, Gareth; Stone, Emma] Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Newson, Stuart E.] British Trust Ornithol, Thetford IP24 2PU, Norfolk, England; [Browne, William J.] Univ Bristol, Grad Sch Educ, 2 Priory Rd, Bristol BS8 1TX, Avon, England; [Browne, William J.] Univ Bristol, Ctr Multilevel Modelling, 2 Priory Rd, Bristol BS8 1TX, Avon, England	University of Bristol; British Trust for Ornithology; University of Bristol; University of Bristol	Jones, G (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	gareth.jones@bristol.ac.uk	Bennitt, Emily/AAB-6032-2020; Browne, William J/A-8686-2010	Browne, William J/0000-0002-6659-6885; Jones, Gareth/0000-0002-1904-3735; Zeale, Matt/0000-0002-4997-9577; Stone, Emma/0000-0002-3415-3967	Department for Environment, Food and Rural Affairs (Defra) [WM0322]; English Heritage [6199]; Bat Conservation International	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); English Heritage; Bat Conservation International	The project was funded by the Department for Environment, Food and Rural Affairs (Defra), and by English Heritage. The website for Defra is: https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs, and the grant number is: WM0322. The website for English Heritage is: http://www.english-heritage.org.uk, and the grant number is: 6199. The funding was received by GJ and SH. The funder provided a project brief on which experimental procedures were designed. Members of a Project Advisory Group (PAG) provided advice and support throughout the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the church wardens, members of the clergy, and parishioners for their help and assistance and for their understanding during experimental trials, and we are grateful to the Diocese of Norwich for permitting experiments in some of their churches. We thank the Bats and Wind Energy Cooperative (USA) and Deaton Engineering Inc. for providing acoustic deterrents, and Bat Conservation International for funding the shipping of Deaton devices to the United Kingdom. We thank Concept Research Ltd for developing and building the CR devices. We are grateful to members of the Project Advisory Group (Defra) and the Project Steering Group (English Heritage) for their helpful advice and for valuable comments on an earlier version of the manuscript. Project Advisory Group and Steering Group members included Richard Brand-Hardy (Defra), Alison Elliott (Defra), Stephen Rudd (Natural England), Katherine Walsh (Natural England), Jen Heathcote (English Heritage), Linda Monkton (English Heritage), Dr David Bullock (National Trust), Julia Hanmer (BCT), Dr Karen Haysom (BCT), Philip Parker (Philip Parker Associates Ltd), the Revd Canon Nigel Cooper (Church Buildings Council), the Revd Stephen Thorp (Church of England) and Simon Marks (Coordinator with Ecclesiastical Architects and Surveyors Association). We also thank Henrietta Bellman, David Bennett, Lucy Buckingham, Andrew Carr, Alexandra Cripps, Kara Davies, James Goldsmith, Joanna Haddock, Charles Harris, Joseph Kendrick, Laura Murdoch, Emma Northcote-Smith, Jess O'Doherty, Thomas Pringle, Sonia Reveley, Emma Taylor and John Worthington-Hill who made significant contributions to data collection, and Rob Robinson who advised on population modelling.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arnett EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065794; Bohnenstengel Thierry, 2012, Bulletin de la Societe Neuchateloise des Sciences Naturelles, V132, P57; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Browne W., 2009, MCMC ESTIMATION MLWI; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; Dietz C., 2009, BATS BRITAIN EUROPE; Galimberti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040122; Hales J, 2014, ARCHAEOL INT, V17, P94, DOI 10.5334/ai.1703; Hatton L, 2000, SCOTT BATS, V5, P29; Hillen J, 2010, ACTA CHIROPTEROL, V12, P187, DOI 10.3161/150811010X504680; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Jones G., 1992, P521; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; Long R., 2006, CALIF AGR, V60, P91; Marnell F., 2010, EUROBATS PUBLICATION, V4; Michaelsen T. C., 2011, BATS, V29, P9; Mitchell-Jones A.J., 2004, BAT WORKERS MANUAL, V3rd; Mortimer G., 2006, THESIS U ST ANDREWS; Packman C, 2015, MANAGEMENT BATS CHUR; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Puechmaille SJ, 2012, MAMM BIOL, V77, P224, DOI 10.1016/j.mambio.2011.11.004; Rasbash J, 2009, MLWIN VERSION 21; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Russ J, 2021, BAT CALLS BRITAIN EU; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Salicini I, 2013, J BIOGEOGR, V40, P1182, DOI 10.1111/jbi.12062; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 1999, Z SAUGETIERKD, V64, P241; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; Smith PG, 2008, J ZOOL, V275, P314, DOI 10.1111/j.1469-7998.2008.00445.x; Smith P. G., 2008, MAMMALS BRIT ISLES H, P323; Smith PG, 2005, J ZOOL, V266, P171, DOI 10.1017/S0952836905006758; STEBBINGS R. E., 1993, GREYWELL TUNNEL INT; Stone E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131825; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Tuljapurkar S., 1997, STRUCTURED POPULATIO; White G.C., 1990, ANAL WILDLIFE RADIO; Young JC, 2010, BIODIVERS CONSERV, V19, P3973, DOI 10.1007/s10531-010-9941-7; Zeale MRK, 2012, J MAMMAL, V93, P1110, DOI 10.1644/11-MAMM-A-366.1	43	15	15	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146782	10.1371/journal.pone.0146782	http://dx.doi.org/10.1371/journal.pone.0146782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771548	Green Published, gold			2022-12-27	WOS:000368628300035
J	Christiansen, SC; Eilertsen, TB; Vanky, E; Carlsen, SM				Christiansen, Sverre C.; Eilertsen, Tina B.; Vanky, Eszter; Carlsen, Sven M.			Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; POLYCYSTIC-OVARY-SYNDROME; ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; ANTRAL FOLLICLE; ULTRASOUND; PREVALENCE; EXPRESSION; DIAGNOSIS; EXCESS	Context Increased Anti-Mullerian Hormone in polycystic ovary syndrome, may be due to overactive follicles rather than reflect antral follicle count. Objective Does Anti-Mullerian Hormone reflect antral follicle count similarly in women with or without polycystic ovary syndrome or polycystic ovarian morphology? Design Cross-sectional, case-control. Setting Women who delivered preterm in 1999-2006. For each index woman, a woman with a term delivery was identified. Patients Participation rate was 69%. Between 2006-2008, 262 women were included, and diagnosed to have polycystic ovary syndrome, polycystic ovarian morphology or to be normal controls. Intervention(s) Blood tests, a clinical examination and vaginal ultrasound. Main Outcome Measure(s) Anti-Mullerian Hormone / antral follicle count -ratio, SHBG, androstenedione and insulin, to test potential influence on the Anti-Mullerian Hormone / antral follicle count -ratio. Results Mean Anti-Mullerian Hormone / antral follicle count ratio in women with polycystic ovary syndrome or polycystic ovarian morphology was similar to that of the controls (polycystic ovary syndrome: 1,2 p = 0,10 polycystic ovarian morphology: 1,2, p = 0,27 Controls 1,3). Anti-Mullerian Hormone showed a positive linear correlation to antral follicle count in all groups. Multivariate analysis did not change the results. Conclusions We confirmed the positive correlation between AMH and follicle count. Anti-Mullerian Hormone seems to be a reliable predictor of antral follicle count, independent of polycystic ovary syndrome diagnosis or ovarian morphology.	[Christiansen, Sverre C.; Carlsen, Sven M.] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Christiansen, Sverre C.; Carlsen, Sven M.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Eilertsen, Tina B.] Nord Trondelag Hosp Trust, Hosp Namsos, Dept Obstet & Gynaecol, Namsos, Norway; [Eilertsen, Tina B.; Vanky, Eszter] Norwegian Univ Sci & Technol, Childrens & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Vanky, Eszter] Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynecol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Carlsen, SM (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway.; Carlsen, SM (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	sverre.christiansen@ntnu.no	Carlsen, Sven Magnus/AAI-4635-2020; Christiansen, Sverre/AAD-5214-2020	Christiansen, Sverre Christian/0000-0002-0378-0474	Liaison Committee	Liaison Committee	The study was funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (TBE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2010, HUM REPROD, V25, P1282, DOI 10.1093/humrep/deq019; Bentzen JG, 2013, J CLIN ENDOCR METAB, V98, P1602, DOI 10.1210/jc.2012-1829; Bhide P, 2015, FERTIL STERIL, V103, P537, DOI 10.1016/j.fertnstert.2014.10.033; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1; Das M, 2008, HUM REPROD, V23, P2122, DOI 10.1093/humrep/den185; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Dewailly D, 2011, HUM REPROD, V26, P3123, DOI 10.1093/humrep/der297; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Eilertsen TB, 2012, BJOG-INT J OBSTET GY, V119, P266, DOI 10.1111/j.1471-0528.2011.03206.x; Eilertsen TB, 2012, HUM REPROD, V27, P2494, DOI 10.1093/humrep/des213; Fanchin R, 2005, HUM REPROD, V20, P923, DOI 10.1093/humrep/deh688; Fenton A, 2013, CLIMACTERIC, V16, P1, DOI 10.3109/13697137.2013.756623; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Homburg R, 2014, HUM REPROD, V29, P1117, DOI 10.1093/humrep/deu076; Jeppesen JV, 2013, MOL HUM REPROD, V19, P519, DOI 10.1093/molehr/gat024; Jonard S, 2003, HUM REPROD, V18, P598, DOI 10.1093/humrep/deg115; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; Naver KV, 2014, BJOG-INT J OBSTET GY, V121, P575, DOI 10.1111/1471-0528.12558; PACHE TD, 1992, RADIOLOGY, V183, P421, DOI 10.1148/radiology.183.2.1561343; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Rosenfield RL, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.059; Singh KL, 2007, BRIT J CANCER, V96, P1808, DOI 10.1038/sj.bjc.6603814; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; vanSantbrink EJP, 1997, FERTIL STERIL, V67, P452, DOI 10.1016/S0015-0282(97)80068-4; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015	30	19	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146739	10.1371/journal.pone.0146739	http://dx.doi.org/10.1371/journal.pone.0146739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799212	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300032
J	Cui, T; Li, WH; Liu, L; Huang, QY; He, ZG				Cui, Tao; Li, Weihui; Liu, Lei; Huang, Qiaoyun; He, Zheng-Guo			Uncovering New Pathogen-Host Protein-Protein Interactions by Pairwise Structure Similarity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS H37RV; BACTERIAL PATHOGENS; VIRUS; INFECTION; RESOURCE; NETWORKS; PATHWAYS; SURVIVAL; REVEALS; MANIPULATION	Pathogens usually evade and manipulate host-immune pathways through pathogen-host protein-protein interactions (PPIs) to avoid being killed by the host immune system. Therefore, uncovering pathogen-host PPIs is critical for determining the mechanisms underlying pathogen infection and survival. In this study, we developed a computational method, which we named pairwise structure similarity (PSS)-PPI, to predict pathogen-host PPIs. First, a high-quality and non-redundant structure-structure interaction (SSI) template library was constructed by exhaustively exploring heteromeric protein complex structures in the PDB database. New interactions were then predicted by searching for PSS with complex structures in the SSI template library. A quantitative score named the PSS score, which integrated structure similarity and residue-residue contact-coverage information, was used to describe the overall similarity of each predicted interaction with the corresponding SSI template. Notably, PSS-PPI yielded experimentally confirmed pathogen-host PPIs of human immunodeficiency virus type 1 (HIV-1) with performance close to that of in vitro high-throughput screening approaches. Finally, a pathogen-host PPI network of human pathogen Mycobacterium tuberculosis, the causative agent of tuberculosis, was constructed using PSS-PPI and refined using filtration steps based on cellular localization information. Analysis of the resulting network indicated that secreted proteins of the STPK, ESX-1, and PE/PPE family in M. tuberculosis targeted human proteins involved in immune response and phagocytosis. M. tuberculosis also targeted host factors known to regulate HIV replication. Taken together, our findings provide insights into the survival mechanisms of M. tuberculosis in human hosts, as well as co-infection of tuberculosis and HIV. With the rapid pace of three-dimensional protein structure discovery, the SSI template library we constructed and the PSS-PPI method we devised can be used to uncover new pathogen-host PPIs in the future.	[Cui, Tao; Li, Weihui; Liu, Lei; Huang, Qiaoyun; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	Huang, Qiaoyun/A-8418-2012; He, Zheng-Guo/P-3647-2014	Huang, Qiaoyun/0000-0002-2733-8066; 	National Natural Science Foundation of China [31300079, 81471996, 31421064]; China Postdoctoral Science Foundation [2013M540586]; Chang Jiang Scholars Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	TC is funded by the National Natural Science Foundation of China (31300079) and the China Postdoctoral Science Foundation (2013M540586). ZGH is funded by the National Natural Science Foundation of China (81471996 and 31421064) and the Chang Jiang Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blasche S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07531; Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cui T, 2014, EXPERT REV PROTEOMIC, V11, P745, DOI 10.1586/14789450.2014.971762; Davis ZH, 2015, MOL CELL, V57, P349, DOI 10.1016/j.molcel.2014.11.026; de Chassey B, 2013, EMBO REP, V14, P938, DOI 10.1038/embor.2013.130; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954; Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Liu XW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0393-z; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Mehra A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003734; Mei SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08034; Memisevic V, 2013, MOL CELL PROTEOMICS, V12, P3036, DOI 10.1074/mcp.M113.029041; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Nourani E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00094; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rapanoel HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067472; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robert CH, 1998, J MOL BIOL, V283, P1037, DOI 10.1006/jmbi.1998.2152; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Srinivasan L, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a022459; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yang HY, 2011, INFECT IMMUN, V79, P4413, DOI 10.1128/IAI.05622-11; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	57	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147612	10.1371/journal.pone.0147612	http://dx.doi.org/10.1371/journal.pone.0147612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799490	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300131
J	Roberson, S; Dutton, M; Macdonald, M; Odoi, A				Roberson, Shamarial; Dutton, Matthew; Macdonald, Megan; Odoi, Agricola			Does Place of Residence or Time of Year Affect the Risk of Stroke Hospitalization and Death? A Descriptive Spatial and Temporal Epidemiologic Study	PLOS ONE			English	Article							HEART-DISEASE; GEOGRAPHIC DISPARITIES; UNITED-STATES; CARE; MORTALITY; BURDEN; ATTACK	Background Identifying geographic areas with significantly high risks of stroke is important for informing public health prevention and control efforts. The objective of this study was to investigate geographic and temporal patterns of stroke hospitalization and mortality risks so as to identify areas and seasons with significantly high burden of the disease in Florida. The information obtained will be useful for resource allocation for disease prevention and control. Methods Stroke hospitalization and mortality data from 1992 to 2012 were obtained from the Florida Agency for Health Care Administration. Age-adjusted stroke hospitalization and mortality risks for time periods 1992-94, 1995-97, 1998-2000, 2001-03, 2004-06, 2007-09 and 2010-12 were computed at the county spatial scale. Global Moran's I statistics were computed for each of the time periods to test for evidence of global spatial clustering. Local Moran indicators of spatial association (LISA) were also computed to identify local areas with significantly high risks. Results There were approximately 1.5 million stroke hospitalizations and over 196,000 stroke deaths during the study period. Based on global Moran's I tests, there was evidence of significant (p<0.05) global spatial clustering of stroke mortality risks but no evidence (p>0.05) of significant global clustering of stroke hospitalization risks. However, LISA showed evidence of local spatial clusters of both hospitalization and mortality risks with significantly high risks being observed in the north while the south had significantly low risks of stroke deaths. There were decreasing temporal trends and seasonal patterns of both hospitalization and mortality risks with peaks in the winter. Conclusions Although stroke hospitalization and mortality risks have declined in the past two decades, disparities continue to exist across Florida and it is evident from the results of this study that north Florida may, in fact, be part of the stroke belt despite not being in any of the traditional stroke belt states. These findings are useful for guiding public health efforts to reduce/eliminate inequities in stroke outcomes and inform policy decisions. There is need to continually identify populations with significantly high risks of stroke to better guide the targeting of limited resources to the highest risk populations.	[Roberson, Shamarial; Macdonald, Megan] Bur Chron Dis Prevent, Florida Dept Hlth, Tallahassee, FL USA; [Dutton, Matthew] Florida A&M Univ, Tallahassee, FL USA; [Odoi, Agricola] Univ Tennessee, Knoxville, TN USA	Florida Department of Health; State University System of Florida; Florida A&M University; University of Tennessee System; University of Tennessee Knoxville	Odoi, A (corresponding author), Univ Tennessee, Knoxville, TN USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737	CDC through NACDD [5U58DP0002759-04]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002759] Funding Source: NIH RePORTER	CDC through NACDD(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The authors wish to state that CDC, through partnership with NACDD, only funded mentoring support through CDC Cooperative Agreement Number 5U58DP0002759-04 for the study and was not involved in any way in the conception, design, interpretation of study results, writing of the manuscript, or in the decision to submit the manuscript for publication.	Anselin L, 2003, GEO DA VERSION 0 95I; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Busingye D, 2011, SPAT SPATIO-TEMPORAL, V2, P247, DOI 10.1016/j.sste.2011.07.010; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; ESRI, 2010, ARCGIS VERS 10 1; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Gillum RF, 1996, AM J EPIDEMIOL, V144, P665, DOI 10.1093/oxfordjournals.aje.a008979; Glymour MM, 2007, STROKE, V38, P2415, DOI 10.1161/STROKEAHA.107.482059; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Halverson J.A., 2002, ETHNIC DIS, V12, P82; Harris T, 2013, TIBETAN TRADE GLOBAL; Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004; Khan JA, 2011, PREV CHRONIC DIS, V8; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Leira EC, 2008, ARCH NEUROL-CHICAGO, V65, P887, DOI 10.1001/archneur.65.7.887; Liao YL, 2009, STROKE, V40, P3336, DOI 10.1161/STROKEAHA.109.561688; Lichtman JH, 2009, STROKE, V40, P3574, DOI 10.1161/STROKEAHA.109.561472; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Microsoft, 2010, EXCEL; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Odoi A, 2014, SPAT SPATIO-TEMPORAL, V11, P109, DOI 10.1016/j.sste.2014.10.001; Pandian JD, 2013, J STROKE, V15, P128, DOI 10.5853/jos.2013.15.3.128; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, P1471; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-644; Raj K, 2015, J STROKE CEREBROVASC, V24, P10, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.051; Rich DQ, 2007, STROKE, V38, P2221, DOI 10.1161/STROKEAHA.107.483719; Schieb LJ, 2013, STROKE, V44, P146, DOI 10.1161/STROKEAHA.112.669705; SIEGEL PZ, 1992, PUBLIC HEALTH REP, V107, P540; Tassone EC, 2009, EPIDEMIOLOGY, V20, P234, DOI 10.1097/EDE.0b013e3181935aee; The SAS Institute, 2013, SAS VERS 9 4; Towfighi A, 2011, STROKE, V42, P2740, DOI 10.1161/STROKEAHA.110.612648; United States Census Bureau, 2014, CART BOUND SHAP 2014	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145224	10.1371/journal.pone.0145224	http://dx.doi.org/10.1371/journal.pone.0145224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799559	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300004
J	Bruning, O; Rodenburg, W; Wackers, PFK; van Oostrom, C; Jonker, MJ; Dekker, RJ; Rauwerda, H; Ensink, WA; de Vries, A; Breit, TM				Bruning, Oskar; Rodenburg, Wendy; Wackers, Paul F. K.; van Oostrom, Conny; Jonker, Martijs J.; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; de Vries, Annemieke; Breit, Timo M.			Confounding Factors in the Transcriptome Analysis of an In-Vivo Exposure Experiment	PLOS ONE			English	Article							GENE-EXPRESSION; EXPERIMENTAL-DESIGN; DIFFERENTIAL EXPRESSION; STATISTICAL TESTS; MICROARRAY DATA; RNA-SEQ; DECONVOLUTION; INFORMATION; COMPONENTS; EFFICIENT	Confounding factors In transcriptomics experimentation, confounding factors frequently exist alongside the intended experimental factors and can severely influence the outcome of a transcriptome analysis. Confounding factors are regularly discussed in methodological literature, but their actual, practical impact on the outcome and interpretation of transcriptomics experiments is, to our knowledge, not documented. For instance, in-vivo experimental factors; like Individual, Sample-Composition and Time-of-Day are potentially formidable confounding factors. To study these confounding factors, we designed an extensive in-vivo transcriptome experiment (n = 264) with UVR exposure of murine skin containing six consecutive samples from each individual mouse (n = 64). Analysis Approach Evaluation of the confounding factors: Sample-Composition, Time-of-Day, Handling-Stress, and Individual-Mouse resulted in the identification of many genes that were affected by them. These genes sometimes showed over 30-fold expression differences. The most prominent confounding factor was Sample-Composition caused by mouse-dependent skin composition differences, sampling variation and/or influx/efflux of mobile cells. Although we can only evaluate these effects for known cell type specifically expressed genes in our complex heterogeneous samples, it is clear that the observed variations also affect the cumulative expression levels of many other non-cell-type-specific genes. ANOVA ANOVA analysis can only attempt to neutralize the effects of the well-defined confounding factors, such as Individual-Mouse, on the experimental factors UV-Dose and Recovery-Time. Also, by definition, ANOVA only yields reproducible gene-expression differences, but we found that these differences were very small compared to the fold changes induced by the confounding factors, questioning the biological relevance of these ANOVA-detected differences. Furthermore, it turned out that many of the differentially expressed genes found by ANOVA were also present in the gene clusters associated with the confounding factors. Conclusion Hence our overall conclusion is that confounding factors have a major impact on the outcome of in-vivo transcriptomics experiments. Thus the set-up, analysis, and interpretation of such experiments should be approached with the utmost prudence.	[Bruning, Oskar; Wackers, Paul F. K.; Jonker, Martijs J.; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; Breit, Timo M.] Univ Amsterdam, Fac Sci, RNA Biol & Appl Bioinformat Res Grp, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Rodenburg, Wendy; van Oostrom, Conny; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	University of Amsterdam; Netherlands National Institute for Public Health & the Environment	Breit, TM (corresponding author), Univ Amsterdam, Fac Sci, RNA Biol & Appl Bioinformat Res Grp, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	t.m.breit@uva.nl		Wackers, Paul/0000-0002-6598-4173; Rauwerda, Han/0000-0003-4360-0797	National Institute of Environmental Health Sciences NIEHS 72-SNP grant [1R01 ES015587-01A2]; University of Amsterdam; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015587] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences NIEHS 72-SNP grant; University of Amsterdam; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly supported by the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) NIEHS 72-SNP grant 1R01 ES015587-01A2 received by AdV. All additional funding was provided by the University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Altman RB, 2001, CURR OPIN STRUC BIOL, V11, P340, DOI 10.1016/S0959-440X(00)00212-8; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Bruning O, 2010, TRANSCR-AUSTIN, V1, P159, DOI 10.4161/trns.1.3.13487; Bruning O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097089; Bruning Oskar, 2011, BMC Res Notes, V4, P438, DOI 10.1186/1756-0500-4-438; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; de Ridder D, 2005, LEUKEMIA, V19, P618, DOI 10.1038/sj.leu.2403685; Flaherty P, 2005, ADV NEURAL INF PROCE; Hu W, 2013, J LEUKOCYTE BIOL, V94, P409, DOI 10.1189/jlb.0413207; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118; Kagawa Shinichiro, 2009, Legal Medicine, V11, P70, DOI 10.1016/j.legalmed.2008.09.004; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2007, GENET RES, V89, P509, DOI 10.1017/S0016672308009713; Kerr MK, 2003, BIOMETRICS, V59, P822; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Montagna W., 1974, STRUCTURE FUNCTION S, V3rd, P28; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Pan W, 2002, GENOME BIOL, V3; Pavlidis P, 2003, BIOINFORMATICS, V19, P1620, DOI 10.1093/bioinformatics/btg227; Quackenbush J, 2006, ANIM GENET, V37, P48, DOI 10.1111/j.1365-2052.2006.01476.x; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Quackenbush J, 2007, J EXP BIOL, V210, P1507, DOI 10.1242/jeb.004432; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rosenfeld S, 2010, GENE REGUL SYST BIO, V4, P61, DOI 10.4137/GRSB.S4657; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tay SS, 2014, CURR DERMATOL REP, V3, P13, DOI 10.1007/s13671-013-0063-9; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang MCK, 2003, PHYSIOL GENOMICS, V16, P24, DOI 10.1152/physiolgenomics.00037.2003; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zhao YD, 2010, GENOME MED, V2, DOI 10.1186/gm214; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646; Zien A, 2003, J COMPUT BIOL, V10, P653, DOI 10.1089/10665270360688246	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145252	10.1371/journal.pone.0145252	http://dx.doi.org/10.1371/journal.pone.0145252			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789003	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100007
J	Riley, C; Dellicour, S; Ouma, P; Kioko, U; ter Kuile, FO; Omar, A; Kariuki, S; Buff, AM; Desai, M; Gutman, J				Riley, Christina; Dellicour, Stephanie; Ouma, Peter; Kioko, Urbanus; ter Kuile, Feiko O.; Omar, Ahmeddin; Kariuki, Simon; Buff, Ann M.; Desai, Meghna; Gutman, Julie			Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLUSTER RANDOMIZED-TRIAL; TEXT-MESSAGE REMINDERS; ANTIMALARIAL-DRUGS; WOMEN; SURVEILLANCE; UGANDA; LUMEFANTRINE; PREVALENCE; ARTEMETHER	Background Although prompt, effective treatment is a cornerstone of malaria control, information on provider adherence to malaria in pregnancy (MIP) treatment guidelines is limited. Incorrect or sub-optimal treatment can adversely affect the mother and fetus. This study assessed provider knowledge of and adherence to national case management guidelines for uncomplicated MIP. Methods We conducted a cross-sectional study from September to November 2013, in 51 health facilities (HF) and a randomly-selected sample of 39 drug outlets (DO) in the KEMRI/CDC Health and Demographic Surveillance System area in western Kenya. Provider knowledge of national treatment guidelines was assessed with standardized questionnaires. Correct practice required adequate diagnosis, pregnancy assessment, and treatment with correct drug and dosage. In HF, we conducted exit interviews in all women of childbearing age assessed for fever. In DO, simulated clients posing as first trimester pregnant women or as relatives of third trimester pregnant women collected standardized information. Results Correct MIP case management knowledge and practice were observed in 45% and 31% of HF and 0% and 3% of DO encounters, respectively. The correct drug and dosage for pregnancy trimester was prescribed in 62% of HF and 42% of DO encounters; correct prescription occurred less often in first than in second/third trimesters (HF: 24% vs. 65%, p<0.01; DO: 0% vs. 40%, p<0.01). Sulfadoxine-pyrimethamine, which is not recommended for malaria treatment, was prescribed in 3% of HF and 18% of DO encounters. Exposure to artemether-lumefantrine in first trimester, which is contraindicated, occurred in 29% and 49% of HF and DO encounters, respectively. Conclusion This study highlights knowledge inadequacies and incorrect prescribing practices in the treatment of MIP. Particularly concerning is the prescription of contraindicated medications in the first trimester. These issues should be addressed through comprehensive trainings and increased supportive supervision. Additional innovative means to improve care should be explored.	[Riley, Christina] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Dellicour, Stephanie; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Ouma, Peter; Kariuki, Simon] Ctr Global Hlth Res, KEMRI, Kisumu, Kenya; [Kioko, Urbanus; Omar, Ahmeddin] Minist Hlth, Malaria Control Unit, Nairobi, Kenya; [Buff, Ann M.; Desai, Meghna; Gutman, Julie] US Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Buff, Ann M.] US Presidents Malaria Initiat, Nairobi, Kenya; [Desai, Meghna] Ctr Dis Control & Prevent, Kisumu, Kenya	Emory University; Rollins School Public Health; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA	Riley, C (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.; Gutman, J (corresponding author), US Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA.	riley.christinam@gmail.com; jgutman@cdc.gov	Kariuki, Simon/AFT-6596-2022; Kuile, Feiko ter/ABD-6681-2020	Kuile, Feiko ter/0000-0003-3663-5617	United States President's Malaria Initiative; U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention (CDC)	United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); U.S. Agency for International Development(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was made possible through support provided by the United States President's Malaria Initiative, U.S. Agency for International Development and U.S. Centers for Disease Control and Prevention (CDC), under the terms of an Interagency Agreement with CDC and through a Cooperative Agreement between the CDC and the Kenya Medical Research Institute (KEMRI). The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 2007, ASS SAF ART COMP PRE; AVIV RI, 1993, S AFR MED J, V83, P657; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Brantuo MNA, 2014, TROP MED INT HEALTH, V19, P417, DOI 10.1111/tmi.12270; Bruxvoort K, 2014, AM J TROP MED HYG, V91, P844, DOI 10.4269/ajtmh.14-0126; Cheruiyot J, 2014, ANTIMICROB AGENTS CH, V58, P3737, DOI 10.1128/AAC.02472-14; Dellicour S, 2015, TREATMENT PRAC UNPUB; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2015, CLIN INFECT DIS; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DOMC, 2010, DIV MAL CONTR NAT GU; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Hanson C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-41; Hill J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001688; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P187, DOI 10.2307/2939233; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Kamuhabwa A, 2011, INDIAN J PHARMACOL, V43, P345, DOI 10.4103/0253-7613.81503; Kebede B, 2009, PHARMACOEPIDEM DR S, V18, P462, DOI 10.1002/pds.1732; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2011, KEN DEM HLTH SURV 20; Kioko U, 2015, AVAILABILITY C UNPUB; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x; Perlman SE, 2001, J REPROD MED, V46, P163; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Pettinelli FO, 2004, AM J TROP MED HYG, V70, P635, DOI 10.4269/ajtmh.2004.70.635; Riley C, 2015, HLTH FACILITY UNPUB; Rohra DK, 2008, BMC PREGNANCY CHILDB, V8, P24, DOI DOI 10.1186/1471-2393-8-24; Sangare LR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-152; Tarning J, 2013, ANTIMICROB AGENTS CH, V57, P5096, DOI 10.1128/AAC.00683-13; Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization (WHO), 2003, ASS SAF ART COMP PRE; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092782; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	39	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145616	10.1371/journal.pone.0145616	http://dx.doi.org/10.1371/journal.pone.0145616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789638	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000368529100012
J	Sun, JT; Yang, MX; Ban, YL; Gao, WJ; Song, BF; Wang, Y; Zhang, Y; Shao, QQ; Kong, BH; Qu, X				Sun, Jintang; Yang, Meixiang; Ban, Yanli; Gao, Wenjuan; Song, Bingfeng; Wang, Yang; Zhang, Yun; Shao, Qianqian; Kong, Beihua; Qu, Xun			Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway	PLOS ONE			English	Article							PERIPHERAL-BLOOD; PHENOTYPE; CONVERSION; GAMMA	NK cells accumulate at the maternal-fetal interface (MFI) and play essential roles in maintaining immune tolerance during pregnancy. The mechanisms that facilitate NK cells tolerance to fetal tissue are largely unknown. T cell Ig and mucin domain-containing protein 3 (Tim-3) is a newly defined molecule with essential immunological function in many physiological and pathological processes. Recent study showed that Tim-3 was involved in the regulation of immune tolerance at MFI. However, whether Tim-3 regulates NK cells cytotoxicity toward trophoblasts is unclear. Here, we showed Tim-3 was mainly expressed by decidual NK cells (dNK) and Tim-3 level in dNK was higher than peripheral NK cells (pNK). Tim-3(+) dNK expressed more levels of mature markers CD94 and CD69 than Tim-3(-) dNK cells and blocking Tim-3 significantly inhibited dNK IFN-gamma and TNF-alpha secretion. Furthermore, we found TGF-beta 1 may contribute to such up-regulation of Tim-3 in NK cells. Interestingly, blocking Tim-3 enhanced NK cytotoxicity toward trophoblast cell line HTR-8 but not K562. We found HTR-8 expressed Tim-3 ligand Galectin-9, in contrast K562 did not. Small interfering RNA-mediated silencing of Galectin-9 expression enhanced NK cytotoxicity toward HTR-8. We further showed Tim-3/Galecin-9 inhibited NK cytotoxicity toward trophoblast partially via impairing the degranulation process. In addition, clinical data showed that abnormal Tim-3 level on pNK might be associated with recurrent spontaneous abortion (RSA). Thus, our data demonstrate Tim-3/Galectin-9 pathway maintains local tolerance by suppressing NK cytotoxicity toward trophoblasts which may represent a new immunologic tolerance mechanism at MFI.	[Sun, Jintang; Yang, Meixiang; Gao, Wenjuan; Song, Bingfeng; Wang, Yang; Zhang, Yun; Shao, Qianqian; Qu, Xun] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Ban, Yanli; Kong, Beihua] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Qu, X (corresponding author), Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	quxun@sdu.edu.cn		Ban, Yanli/0000-0002-2299-0362	National Natural Science Foundation of China [31470885, 31300752, 31270971, 81300510, 30901326, 81072406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China: No. 31470885 (XQ), No. 31300752 (JS), No. 31270971 (XQ), No. 81300510 (QS), No. 30901326 (MY), No. 81072406 (XQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbadiaMolina AC, 1996, J REPROD IMMUNOL, V31, P109, DOI 10.1016/0165-0378(96)00965-5; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fu B, P NATL ACAD SCI US; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hou HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110585; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; KING A, 1990, CELL IMMUNOL, V129, P435, DOI 10.1016/0008-8749(90)90219-H; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Lachapelle MH, 1996, J IMMUNOL, V156, P4027; Li YH, CELLULAR MOL IMMUNOL; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Miko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071811; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Murphy SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.043; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Wu XY, 2006, CELL MOL IMMUNOL, V3, P131; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	31	49	55	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147186	10.1371/journal.pone.0147186	http://dx.doi.org/10.1371/journal.pone.0147186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789128	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100064
J	Wagener, BM; Marjon, NA; Prossnitz, ER				Wagener, Brant M.; Marjon, Nicole A.; Prossnitz, Eric R.			Regulation of N-Formyl Peptide Receptor Signaling and Trafficking by Arrestin-Src Kinase Interaction	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTOR; ANGIOTENSIN-II RECEPTOR; CLATHRIN ADAPTER AP-2; CARBOXYL-TERMINUS; AGONIST AFFINITY; PHOSPHORYLATION; INTERNALIZATION; DESENSITIZATION; ACTIVATION	Arrestins were originally described as proteins recruited to ligand-activated, phosphorylated G protein-coupled receptors (GPCRs) to attenuate G protein-mediated signaling. It was later revealed that arrestins also mediate GPCR internalization and recruit a number of signaling proteins including, but not limited to, Src family kinases, ERK1/2, and JNK3. GPCR-arrestin binding and trafficking control the spatial and temporal activity of these multi-protein complexes. In previous reports, we concluded that N-formyl peptide receptor (FPR)-mediated apoptosis, which occurs upon receptor stimulation in the absence of arrestins, is associated with FPR accumulation in perinuclear recycling endosomes. Under these conditions, inhibition of Src kinase and ERK1/2 prevented FPR-mediated apoptosis. To better understand the role of Src kinase in this process, in the current study we employed a previously described arrestin-2 (arr2) mutant deficient in Src kinase binding (arr2-P91G/P121E). Unlike wild type arrestin, arr2-P91G/P121E did not inhibit FPR-mediated apoptosis, suggesting that Src binding to arrestin-2 prevents apoptotic signaling. However, in cells expressing this mutant, FPR-mediated apoptosis was still blocked by inhibition of Src kinase activity, suggesting that activation of Src independent of arrestin-2 binding is involved in FPR-mediated apoptosis. Finally, while Src kinase inhibition prevented FPR-mediated-apoptosis in the presence of arr2-P91G/P121E, it did not prevent FPR-arr2-P91G/P121E accumulation in the perinuclear recycling endosome. On the contrary, inhibition of Src kinase activity mediated the accumulation of activated FPR-wild type arrestin-2 in recycling endosomes without initiating FPR-mediated apoptosis. Based on these observations, we conclude that Src kinase has two independent roles following FPR activation that regulate both FPR-arrestin-2 signaling and trafficking.	[Prossnitz, Eric R.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA; [Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Alabama System; University of Alabama Birmingham	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA.	eprossnitz@salud.unm.edu	Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008; Wagener, Brant/AAI-7480-2020	Prossnitz, Eric/0000-0001-9190-8302; 	NIH [GM68901, CA163890]; Department of Defense Breast Cancer Research Program [BC030217]; Foundation for Anesthesia Education and Research; University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL CANCER INSTITUTE [R01CA163890, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Foundation for Anesthesia Education and Research; University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants GM68901 and CA163890 to E.R.P. and BC030217 from the Department of Defense Breast Cancer Research Program and a Research Fellowship Grant from the Foundation for Anesthesia Education and Research to B.M.W. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.; We thank Charlotte Vines for helpful comments during the preparation of this manuscript. Flow cytometry data were generated in the Flow Cytometry Shared Resource Center supported by the University of New Mexico Health Sciences Center and the University of New Mexico Cancer Center. Images in this paper were generated in the University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on: http://hsc.unm.edu/crtc/microscopy/Facility.html.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bennett TA, 2001, J BIOL CHEM, V276, P22453, DOI 10.1074/jbc.M009679200; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Key TA, 2005, TRAFFIC, V6, P87, DOI 10.1111/j.1600-0854.2004.00248.x; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Khoury E, 2014, J BIOL CHEM, V289, P23302, DOI 10.1074/jbc.M114.568147; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moaven H, 2013, P NATL ACAD SCI USA, V110, P9463, DOI 10.1073/pnas.1301126110; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Strungs Erik G, 2014, Handb Exp Pharmacol, V219, P225, DOI 10.1007/978-3-642-41199-1_12; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Wu XF, 2003, MOL BIOL CELL, V14, P516, DOI 10.1091/mbc.E02-06-0353; Yang XH, 2012, APOPTOSIS, V17, P1019, DOI 10.1007/s10495-012-0741-2; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhan X., 2015, CURR PROTOC PHARM, V68; Zhan Xuanzhi, 2014, Handb Exp Pharmacol, V219, P259, DOI 10.1007/978-3-642-41199-1_13; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	60	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147442	10.1371/journal.pone.0147442	http://dx.doi.org/10.1371/journal.pone.0147442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788723	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100088
J	Yue, Y; Kong, L; Wang, JJ; Li, CB; Tan, L; Su, H; Xu, YF				Yue, Ying; Kong, Li; Wang, Jijun; Li, Chunbo; Tan, Ling; Su, Hui; Xu, Yifeng			Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?	PLOS ONE			English	Article							INSULAR CORTEX ABNORMALITIES; TENSOR-BASED MORPHOMETRY; SUPERIOR TEMPORAL GYRUS; VOXEL-BASED MORPHOMETRY; 1ST-EPISODE SCHIZOPHRENIA; ANTIPSYCHOTIC TREATMENT; VOLUME ABNORMALITIES; NAIVE SCHIZOPHRENIA; NEUROLEPTIC-NAIVE; BRAIN STRUCTURE	Both schizophrenia and antipsychotic treatment are known to modulate brain morphology. However, it is difficult to establish whether observed structural brain abnormalities are due to disease or the effects of treatment. The aim of this study was to investigate the effects of illness and antipsychotic treatment on brain structures in antipsychotic-naive first-episode schizophrenia based on a longitudinal short-term design. Twenty antipsychotic-naive subjects with first-episode schizophrenia and twenty-four age-and sex-matched healthy controls underwent 3T MRI scans. Voxel-based morphometry (VBM) was used to examine the brain structural abnormality in patients compared to healthy controls. Nine patients were included in the follow-up examination after 8 weeks of treatment. Tensor-based morphometry (TBM) was used to identify longitudinal brain structural changes. We observed significantly reduced grey matter volume in the right superior temporal gyrus in antipsychotic-naive patients with schizophrenia compared with healthy controls. After 8 weeks of treatment, patients showed significantly increased grey matter volume primarily in the bilateral prefrontal cortex, insula, right thalamus, left superior occipital cortex and the bilateral cerebellum. In addition, a greater enlargement of the prefrontal cortex is associated with the improvement in negative symptoms, and a more enlarged thalamus is associated with greater improvement in positive symptoms. Our results suggest the following: (1) the abnormality in the right superior temporal gyrus is present in the early stages of schizophrenia, possibly representing the core region related to schizophrenia; and (2) atypical antipsychotics could modulate brain morphology involving the thalamus, cortical grey matter and cerebellum. In addition, examination of the prefrontal cortex and thalamus might facilitate an efficient response to atypical antipsychotics in terms of symptom improvement.	[Yue, Ying] Shanghai Huangpu Second Mental Hlth Ctr, Shanghai 200023, Peoples R China; [Kong, Li] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China; [Kong, Li; Wang, Jijun; Li, Chunbo; Su, Hui; Xu, Yifeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Wang, Jijun; Li, Chunbo; Su, Hui; Xu, Yifeng] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Tan, Ling] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200025, Peoples R China	Shanghai Normal University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China.; Xu, YF (corresponding author), Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	hyyyyb@online.sh.cn	Xu, Yifeng/AAA-2064-2021	Xu, Yifeng/0000-0002-0403-1141	Shanghai Huangpu District Leadership in Health Research Program [LWK0911]; Science and Technology Commission of the Shanghai Municipality [13dz2260500]; Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development	Shanghai Huangpu District Leadership in Health Research Program; Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development	This study was jointly funded by the Shanghai Huangpu District Leadership in Health Research Program (LWK0911), the Science and Technology Commission of the Shanghai Municipality (13dz2260500) and Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development.	Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; Andreasen NC, 1997, CAN J PSYCHIAT, V42, P27, DOI 10.1177/070674379704200104; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Byne W, 2009, ACTA NEUROPATHOL, V117, P347, DOI 10.1007/s00401-008-0404-0; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Cohen BM, 1998, PSYCHOPHARMACOLOGY, V135, P37, DOI 10.1007/s002130050483; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; CROSSON B, 1987, SCHIZOPHRENIA BULL, V13, P605, DOI 10.1093/schbul/13.4.605; Dazzan P, 2005, NEUROPSYCHOPHARMACOL, V30, P765, DOI 10.1038/sj.npp.1300603; Deng MY, 2009, PSYCHOPHARMACOLOGY, V206, P437, DOI 10.1007/s00213-009-1619-z; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Garver DL, 2005, BIOL PSYCHIAT, V58, P62, DOI 10.1016/j.biopsych.2005.02.008; Goghari VM, 2013, SCHIZOPHR RES, V149, P149, DOI 10.1016/j.schres.2013.06.025; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Guo XF, 2014, SCHIZOPHR RES, V152, P339, DOI 10.1016/j.schres.2013.12.015; Gur RE, 1998, AM J PSYCHIAT, V155, P1711, DOI 10.1176/ajp.155.12.1711; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Ichimiya T, 2001, BIOL PSYCHIAT, V49, P20, DOI 10.1016/S0006-3223(00)01081-7; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keshavan MS, 1998, J PSYCHIAT RES, V32, P161, DOI 10.1016/S0022-3956(97)00038-1; Kim JJ, 2000, AM J PSYCHIAT, V157, P542, DOI 10.1176/appi.ajp.157.4.542; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Kong L, 2015, PSYCHIAT RES-NEUROIM, V231, P176, DOI 10.1016/j.pscychresns.2014.12.004; Kong L, 2012, SCHIZOPHR RES, V134, P27, DOI 10.1016/j.schres.2011.09.015; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Malla AK, 2011, SCHIZOPHR RES, V125, P13, DOI 10.1016/j.schres.2010.09.021; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; Miller DD, 2001, BIOL PSYCHIAT, V49, P704, DOI 10.1016/S0006-3223(00)01001-5; Nakamura M, 2007, BIOL PSYCHIAT, V62, P773, DOI 10.1016/j.biopsych.2007.03.030; Narayanaswamy JC, 2015, J NEUROPSYCH CLIN N, V27, pE128, DOI 10.1176/appi.neuropsych.14030049; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Pressler M, 2005, BIOL PSYCHIAT, V57, P394, DOI 10.1016/j.biopsych.2004.11.010; Scherk H, 2006, CURR OPIN PSYCHIATR, V19, P145, DOI 10.1097/01.yco.0000214339.06507.d8; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Strungas S, 2003, PSYCHIAT RES-NEUROIM, V124, P121, DOI 10.1016/S0925-4927(03)00092-1; Szulc A, 2005, PHARMACOPSYCHIATRY, V38, P214, DOI 10.1055/s-2005-873156; Whitford TJ, 2006, NEUROIMAGE, V32, P511, DOI 10.1016/j.neuroimage.2006.03.041; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yeganeh-Doost P, 2011, CLINICS, V66, P71, DOI 10.1590/S1807-59322011001300009; Zheng Lia-rong, 2013, Zhonghua Yi Xue Za Zhi, V93, P3252	47	20	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147204	10.1371/journal.pone.0147204	http://dx.doi.org/10.1371/journal.pone.0147204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789520	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100067
J	Abu-Farha, M; Sriraman, D; Cherian, P; AlKhairi, I; Elkum, N; Behbehani, K; Abubaker, J				Abu-Farha, Mohamed; Sriraman, Devarajan; Cherian, Preethi; AlKhairi, Irina; Elkum, Naser; Behbehani, Kazem; Abubaker, Jehad			Circulating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN; TYPE-2 DIABETES-MELLITUS; BETA-CELL; BETATROPHIN CONCENTRATIONS; GLUCOSE; LIPASIN; LIFE; PREVENTION; METABOLISM; GENE	Objective ANGPTL8 is a liver and adipose tissue produced protein that regulates the level of triglyceride in plasma as well as glucose homeostasis. This study was designed to evaluate the level of ANGPTL8 in obese and non-obese subjects before and after exercise training. Methods A total of 82 non-obese and 62 adult obese were enrolled in this study. Subjects underwent a three months of exercise training. Both full length and C-terminal 139-198 form of ANGPTL8 were measured by ELISA. Results Our data show that the full length ANGPTL8 level was increased in obese subjects (1150.04 +/- 108.10 pg/mL) compared to non-obese (775.54 +/- 46.12) pg/mL (p-Value = 0.002). C-terminal 139-198 form of ANGPTL8 was also increased in obese subjects 0.28 +/- 0.04 ng/mL vs 0.20 +/- 0.02 ng/mL in non-obese (p-value = 0.058). In obese subjects, the levels of both forms were reduced after three months of exercise training; full length was reduced from 1150.04 +/- 108.10 pg/mL to 852.04 +/- 51.95 pg/mL (p-Values 0.015) and c-terminal form was reduced from 0.28 +/- 0.04 ng/mL to 0.19 +/- 0.03 ng/mL (p-Value = 0.058). Interestingly, full length ANGPTL8 was positively associated with fasting blood glucose (FBG) in non-obese (r = 0.317, p-Value = 0.006) and obese subjects (r = 0.346, p-Value = 0.006) C-terminal 139-198 form of ANGPTL8 on the other hand, did not show any correlation in both groups. Conclusion In conclusion, our data demonstrate that ANGPTL8 was increased in obesity and reduced after exercise training supporting the potential therapeutic benefit of reducing ANGPTL8. The various forms of ANGPTL8 associated differently with FBG suggesting that they have different roles in glucose homeostasis.	[Abu-Farha, Mohamed; Cherian, Preethi; AlKhairi, Irina; Behbehani, Kazem; Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Sriraman, Devarajan; Behbehani, Kazem] Dasman Diabet Inst, Tissue Banking Unit, Kuwait, Kuwait; [Elkum, Naser] Sidra Med & Res Ctr, Doha, Qatar	Sidra Medical & Research Center	Abu-Farha, M; Abubaker, J (corresponding author), Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait.	mohamed.abufarha@dasmaninstitute.org; jehad.abubakr@dasmaninstitute.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Abubaker, Jehad/0000-0003-0681-7305; Abu-Farha, Mohamed/0000-0001-8357-1252	Kuwait Foundation for the Advancement of Sciences (KFAS) [RA-2014-021]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	The authors are indebted to Kuwait Foundation for the Advancement of Sciences (KFAS) for financial support of this research project (RA-2014-021). The funding agency was not involved in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study.	Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Abu-Farha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075342; Abubaker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069217; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Chen JX, 2015, DIABETOLOGIA, V58, P1036, DOI 10.1007/s00125-015-3521-z; Chen X, 2015, J CLIN ENDOCR METAB, V100, pE96, DOI 10.1210/jc.2014-2300; Espes D., 2013, DIABETOLOGIA; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Fodor JG, 2001, NEW ENGL J MED, V345, P696; Fu Zhiyao, 2014, Diabetologia, V57, P2232, DOI 10.1007/s00125-014-3346-1; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Guo KF, 2015, OBESITY, V23, P793, DOI 10.1002/oby.21038; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kugelberg Elisabeth, 2013, Nat Rev Endocrinol, V9, P379, DOI 10.1038/nrendo.2013.98; Lickert H, 2013, CELL METAB, V18, P5, DOI 10.1016/j.cmet.2013.06.006; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yamada H, 2015, ENDOCR J; Yi P, 2014, CELL, V159, P467, DOI 10.1016/j.cell.2014.09.028; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zheng C., 2015, TRENDS ENDOCRINOL ME	34	54	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147367	10.1371/journal.pone.0147367	http://dx.doi.org/10.1371/journal.pone.0147367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784326	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400143
J	Matsuyama, M; Ishii, Y; Sakurai, H; Ano, S; Morishima, Y; Yoh, K; Takahashi, S; Ogawa, K; Hizawa, N				Matsuyama, Masashi; Ishii, Yukio; Sakurai, Hirofumi; Ano, Satoshi; Morishima, Yuko; Yoh, Keigyou; Takahashi, Satoru; Ogawa, Kenji; Hizawa, Nobuyuki			Overexpression of ROR gamma t Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium	PLOS ONE			English	Article							HUMAN TH17 CELLS; IFN-GAMMA; INTRACELLULARE INFECTION; BCG VACCINATION; T(H)17 CELLS; TUBERCULOSIS; IL-17; DISEASE; MICE; INTERLEUKIN-17	Mycobacterium avium complex (MAC) is the most common cause of nontuberculous mycobacterial disease in humans. The role of Th17 immunity in the pathogenesis of intracellular bacteria, such as MAC, is not currently understood. Transcription factor RAR-related orphan receptor gamma t (ROR gamma t) is known as the master regulator for Th17 cell development. Here, we investigated the role of ROR gamma t in host responses against MAC infection. Wild-type (WT) mice and ROR gamma t-overexpressing mice were infected with MAC via intratracheal inoculation. Systemic MAC growth was not different between WT mice and ROR gamma t-overexpressing mice. However, neutrophilic pulmonary inflammation following MAC infection was enhanced in ROR gamma t-overexpressing mice compared with that in WT mice. The cytokine expression shifted toward a Th17 phenotype in the lungs of ROR gamma t-overexpressing mice following MAC infection; the levels of IL-6 and IL-17 were significantly higher in the lung of these mice than in WT mice. In addition to the increase in IL-17 single-positive T cells, T cells producing both IL-17 and interferon-. were elevated in the lung of ROR gamma t-overexpressing mice following MAC infection. These findings suggest that ROR gamma t overexpression-mediated Th17 bias contributes to local inflammation rather than systemic responses, by regulating neutrophil recruitment into the sites of infection during MAC infection.	[Matsuyama, Masashi; Ishii, Yukio; Sakurai, Hirofumi; Ano, Satoshi; Morishima, Yuko; Hizawa, Nobuyuki] Univ Tsukuba, Dept Resp Med, Div Clin Med, Tsukuba, Ibaraki, Japan; [Yoh, Keigyou] Univ Tsukuba, Dept Nephrol, Div Clin Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Ogawa, Kenji] Higashinagoya Natl Hosp, Natl Hosp Org, Dept Clin Res, Nagoya, Aichi, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Ishii, Y (corresponding author), Univ Tsukuba, Dept Resp Med, Div Clin Med, Tsukuba, Ibaraki, Japan.	ishii-y@md.tsukuba.ac.jp			Japan Society for the Promotion of Science [24591152]; Grants-in-Aid for Scientific Research [16K15454] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research (C) (KAKENHI) Grant Number 24591152, Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) to YI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ano S, 2013, J IMMUNOL, V190, P1056, DOI 10.4049/jimmunol.1202386; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jung YJ, 2002, INFECT IMMUN, V70, P6436, DOI 10.1128/IAI.70.11.6436-6443.2002; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Matsuyama M, 2014, J IMMUNOL, V192, P1707, DOI 10.4049/jimmunol.1302258; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Plotinsky RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077385; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rook GAW, 2007, CURR MOL MED, V7, P327; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang YH, 2008, CURR OPIN IMMUNOL, V20, P697, DOI 10.1016/j.coi.2008.09.004; Yamazaki Y, 1999, AM J RESP CRIT CARE, V160, P1851, DOI 10.1164/ajrccm.160.6.9902019; Yamazaki Y, 1998, EUR RESPIR J, V11, P1227, DOI 10.1183/09031936.98.11061227; Yoh K, 2012, EUR J IMMUNOL, V42, P1999, DOI 10.1002/eji.201142250; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147064	10.1371/journal.pone.0147064	http://dx.doi.org/10.1371/journal.pone.0147064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784959	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400103
J	Nelson, MI; Pollett, S; Ghersi, B; Silva, M; Simons, MP; Icochea, E; Gonzalez, AE; Segovia, K; Kasper, MR; Montgomery, JM; Bausch, DG				Nelson, Martha I.; Pollett, Simon; Ghersi, Bruno; Silva, Maria; Simons, Mark P.; Icochea, Eliana; Gonzalez, Armando E.; Segovia, Karen; Kasper, Matthew R.; Montgomery, Joel M.; Bausch, Daniel G.			The Genetic Diversity of Influenza A Viruses in Wild Birds in Peru	PLOS ONE			English	Article							AVIAN INFLUENZA; ARGENTINA; AMERICA	Our understanding of the global ecology of avian influenza A viruses (AIVs) is impeded by historically low levels of viral surveillance in Latin America. Through sampling and whole-genome sequencing of 31 AIVs from wild birds in Peru, we identified 10 HA subtypes (H1H4, H6-H7, H10-H13) and 8 NA subtypes (N1-N3, N5-N9). The majority of Peruvian AIVs were closely related to AIVs found in North America. However, unusual reassortants, including a H13 virus containing a PA segment related to extremely divergent Argentinian viruses, suggest that substantial AIV diversity circulates undetected throughout South America.	[Nelson, Martha I.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Pollett, Simon; Ghersi, Bruno; Silva, Maria; Simons, Mark P.; Segovia, Karen; Kasper, Matthew R.; Montgomery, Joel M.; Bausch, Daniel G.] US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Callao, Peru; [Pollett, Simon] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Pollett, Simon] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Icochea, Eliana; Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Bausch, Daniel G.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Sydney; University of California System; University of California San Francisco; Universidad Nacional Mayor de San Marcos; Tulane University	Pollett, S (corresponding author), US Naval Med Res Unit 6, Virol & Emerging Infect Dept, Callao, Peru.; Pollett, S (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.; Pollett, S (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	spollett@med.usyd.edu.au		Icochea D'Arrigo, Maria Eliana/0000-0001-7102-0584; Ghersi, Bruno/0000-0002-1577-6042; Gonzalez, Armando/0000-0003-1909-1873	Global Emerging Infections Surveillance (GEIS) Work unit [847705 82000 25GB B0016]	Global Emerging Infections Surveillance (GEIS) Work unit	This work was supported by Global Emerging Infections Surveillance (GEIS) Work unit no.: 847705 82000 25GB B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghersi BM, 2011, J WILDLIFE DIS, V47, P792, DOI 10.7589/0090-3558-47.3.792; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Gonzalez-Reiche AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032873, 10.1371/journal.pone.0046852]; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang YY, 2014, VIROLOGY, V456, P353, DOI 10.1016/j.virol.2014.04.009; Jhung MA, 2015, MMWR-MORBID MORTAL W, V64, P111; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Lewis NS, 2015, J GEN VIROL, V96, P2050, DOI 10.1099/vir.0.000155; Mathieu C, 2015, VIRUS RES, V199, P42, DOI 10.1016/j.virusres.2015.01.008; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Rimondi A, 2011, J VIROL, V85, P13354, DOI 10.1128/JVI.05946-11; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664	18	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146059	10.1371/journal.pone.0146059	http://dx.doi.org/10.1371/journal.pone.0146059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784331	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400022
J	Treweeke, AT; Maskrey, BH; Hickson, K; Miller, JH; Leslie, SJ; Megson, IL				Treweeke, Andrew T.; Maskrey, Benjamin H.; Hickson, Kirsty; Miller, John H.; Leslie, Stephen J.; Megson, Ian L.			Iodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; NONIONIC CONTRAST-MEDIA; CIRCADIAN VARIATION; ANTIOXIDANT PROPERTIES; ENDOTHELIAL FUNCTION; PLATELET ACTIVATION; THROMBUS FORMATION; N-ACETYLCYSTEINE; IN-VITRO; TRIAL	Background There is no consensus and a limited evidence base for choice of contrast agents (CA) in angiography. This study evaluated the impact of iohexol and iodixanol CA on fibrinolytic factors (tissue plasminogen activator [t-PA] and plasminogen activator inhibitor-1 [PAI-1]), as well as platelet-monocyte conjugates in cardiac patients undergoing elective angiography in a double-blind, randomised parallel group study. Methods Patients (men, 50-70 years old; n = 12) were randomised to receive either iohexol (Omnipaque; n = 6) or iodixanol (Visipaque; n = 6) during elective angiography at Raigmore Hospital, Inverness, UK. Arterial and venous blood samples were drawn prior to CA delivery and following angiography. Assessment of platelet-monocyte conjugation, t-PA and PAI-1 antigen and activity was conducted in samples pre- and post-angiography. Outcome Plasma t-PA antigen was depressed equally in the study groups after angiography, but there was a greater reduction in PAI-1 antigen in the group receiving iodixanol. These findings corresponded to a substantial reduction in t-PA activity in patients receiving iohexol, with no change in those receiving iodixanol (P = 0.023 between the CA groups). Both CAs caused a reduction in platelet-monocyte conjugation, with no difference between the groups. No adverse events were reported during the trial. Conclusion Avoiding reduced plasma t-PA activity might be an important consideration in choosing iodixanol over iohexol in patients at risk of thrombosis following angiography. The trial is registered on the ISRCTN register (ISRCTN51509735) and funded by the Coronary Thrombosis Trust and National Health Service (Highland) R&D Endowments. The funders had no influence over study design or reporting.	[Treweeke, Andrew T.; Maskrey, Benjamin H.; Hickson, Kirsty; Leslie, Stephen J.; Megson, Ian L.] Univ Highlands & Isl, Dept Diabet & Cardiovasc Sci, Inverness, Scotland; [Miller, John H.] NHS Highland, Radiol, Inverness, Scotland; [Leslie, Stephen J.] NHS Highland, Cardiol, Inverness, Scotland; [Leslie, Stephen J.] Univ Stirling, Sch Nursing Midwifery & Hlth, Inverness, Scotland	UHI Millennium Institute; University of Stirling	Megson, IL (corresponding author), Univ Highlands & Isl, Dept Diabet & Cardiovasc Sci, Inverness, Scotland.	ian.megson@uhi.ac.uk	Miller, John J/GZG-5663-2022; Megson, Ian/K-2195-2012	Megson, Ian/0000-0001-8287-2459	Coronary Thrombosis Trust; National Health Service Highland Research & Development Endowments; NHS Highland RD Endowments	Coronary Thrombosis Trust; National Health Service Highland Research & Development Endowments; NHS Highland RD Endowments	This study was funded by The Coronary Thrombosis Trust and the National Health Service Highland Research & Development Endowments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Coronary Thrombosis Trust and NHS Highland R&D Endowments.	ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; Barstad RM, 1996, ACTA RADIOL, V37, P954; Berg K, 2005, ACTA RADIOL, V46, P815, DOI 10.1080/02841850500336224; BETTMANN MA, 1985, INVEST RADIOL, V20, pS70, DOI 10.1097/00004424-198501002-00017; Corot C, 1996, BLOOD COAGUL FIBRIN, V7, P602, DOI 10.1097/00001721-199609000-00005; Davidson CJ, 2000, CIRCULATION, V101, P2172, DOI 10.1161/01.CIR.101.18.2172; De Tassigny AD, 2001, INVEST RADIOL, V36, P276, DOI 10.1097/00004424-200105000-00005; Elherik K, 2002, CLIN SCI, V102, P547, DOI 10.1042/CS20010278; FAREED J, 1990, RADIOLOGY, V174, P321, DOI 10.1148/radiology.174.2.2296640; Flinck A, 2001, INT J CARDIOL, V80, P143, DOI 10.1016/S0167-5273(01)00460-0; Freedman JE, 2002, CIRCULATION, V105, P2130, DOI 10.1161/01.CIR.0000017140.26466.F5; Gibson KR, 2009, J CARDIOVASC PHARM, V54, P319, DOI 10.1097/FJC.0b013e3181b6e77b; Grabowski EF, 1996, ACAD RADIOL, V3, pS485, DOI 10.1016/S1076-6332(05)80363-0; Jones CI, 2003, THROMB RES, V112, P65, DOI 10.1016/j.thromres.2003.09.031; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Maruo T, 2006, AM J CARDIOL, V97, P699, DOI 10.1016/j.amjcard.2005.09.118; MASUDA T, 1994, BRIT HEART J, V71, P156; Oliver JJ, 2005, ARTERIOSCL THROM VAS, V25, P2470, DOI 10.1161/01.ATV.0000189309.05924.88; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Scheer FAJL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024549; Shoji T, 2005, J ATHEROSCLER THROMB, V12, P344, DOI 10.5551/jat.12.344; Treweeke AT, 2012, DIABETOLOGIA, V55, P2920, DOI 10.1007/s00125-012-2685-z; VANBEEK EJR, 1994, RADIOLOGY, V193, P821, DOI 10.1148/radiology.193.3.7972831; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Wang JH, 2007, INT J CARDIOL, V115, P361, DOI 10.1016/j.ijcard.2006.03.019; Zhang SZ, 2007, CLIN CARDIOL, V30, P26, DOI 10.1002/clc.2	26	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147196	10.1371/journal.pone.0147196	http://dx.doi.org/10.1371/journal.pone.0147196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784323	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400121
J	Ayatollahitafti, V; Ngadi, MA; Sharif, JB; Abdullahi, M				Ayatollahitafti, Vahid; Ngadi, Md Asri; Sharif, Johan bin Mohamad; Abdullahi, Mohammed			An Efficient Next Hop Selection Algorithm for Multi-Hop Body Area Networks	PLOS ONE			English	Article							AWARE ROUTING PROTOCOL; WIRELESS SENSOR	Body Area Networks (BANs) consist of various sensors which gather patient's vital signs and deliver them to doctors. One of the most significant challenges faced, is the design of an energy-efficient next hop selection algorithm to satisfy Quality of Service (QoS) requirements for different healthcare applications. In this paper, a novel efficient next hop selection algorithm is proposed in multi-hop BANs. This algorithm uses the minimum hop count and a link cost function jointly in each node to choose the best next hop node. The link cost function includes the residual energy, free buffer size, and the link reliability of the neighboring nodes, which is used to balance the energy consumption and to satisfy QoS requirements in terms of end to end delay and reliability. Extensive simulation experiments were performed to evaluate the efficiency of the proposed algorithm using the NS-2 simulator. Simulation results show that our proposed algorithm provides significant improvement in terms of energy consumption, number of packets forwarded, end to end delay and packet delivery ratio compared to the existing routing protocol.	[Ayatollahitafti, Vahid] Islamic Azad Univ, Taft Branch, Dept Comp Sci, Taft, Yazd, Iran; [Ngadi, Md Asri; Sharif, Johan bin Mohamad] Univ Teknol Malaysia, Dept Comp Sci, Johor Baharu 81310, Malaysia; [Abdullahi, Mohammed] Ahmadu Bello Univ Zaria, Dept Math, Zaria, Nigeria	Islamic Azad University; Universiti Teknologi Malaysia; Ahmadu Bello University	Abdullahi, M (corresponding author), Ahmadu Bello Univ Zaria, Dept Math, Zaria, Nigeria.	abdullahilwafu@abu.edu.ng	Ayatollahitafti, Vahid/AAO-5918-2021; NGADI, ASRI/G-3174-2011; Abdullahi, Mohammed/Y-3519-2019; Abdullahi, Mohammed/AAN-9860-2020; Abdullahi, Mohammed/GRF-6308-2022	Ayatollahitafti, Vahid/0000-0003-4083-0263; NGADI, ASRI/0000-0003-4907-6359; Abdullahi, Mohammed/0000-0002-0214-6340; Abdullahi, Mohammed/0000-0001-7844-9527; Abdullahi, Mohammed/0000-0001-7844-9527				Acampora G, 2013, P IEEE, V101, P2470, DOI 10.1109/JPROC.2013.2262913; Almashaqbeh G, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0121-2; Alwan H, 2013, MQOSR MULTIOBJECTIVE; Ameen MA, 2008, THIRD 2008 INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, VOL 1, PROCEEDINGS, P801, DOI 10.1109/ICCIT.2008.130; [Anonymous], 1998, NS 2 NETWORK SIMULAT; Ben Elhadj H, 2012, INT J E-HEALTH MED C, V3, P1, DOI 10.4018/jehmc.2012040101; Braem Bart, 2007, 2007 International Conference on Sensor Technologies and Applications - SensorComm 2007, P566, DOI 10.1109/SENSORCOMM.2007.4394980; Chen J, 2011, J NETW COMPUT APPL, V34, P1225, DOI 10.1016/j.jnca.2011.01.008; Chen M, 2014, IEEE COMMUN SURV TUT, V16, P98, DOI 10.1109/SURV.2013.110113.00249; Djenouri D., 2009, P 2009 6 INT C BROAD, P1, DOI DOI 10.4108/ICST.BROADNETS2009.7188; Elias J., 2012, IEEE International Conference on Communications (ICC 2012), P3409, DOI 10.1109/ICC.2012.6363949; Elias J, 2014, AD HOC NETW, V13, P560, DOI 10.1016/j.adhoc.2013.10.010; Fortino G, 2014, WIREL NETW, V20, P1925, DOI 10.1007/s11276-014-0714-1; Hayajneh T, 2014, WIREL NETW, V20, P2165, DOI 10.1007/s11276-014-0736-8; He DJ, 2012, IEEE T INF TECHNOL B, V16, P1164, DOI 10.1109/TITB.2012.2199996; He DJ, 2012, IEEE T INF TECHNOL B, V16, P623, DOI 10.1109/TITB.2012.2194788; Jun Zhou, 2013, IEEE Wireless Communications, V20, P12, DOI 10.1109/MWC.2013.6590046; Khan Z, 2012, PROCEDIA COMPUT SCI, V10, P188, DOI 10.1016/j.procs.2012.06.027; Khan Z, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON BROADBAND, WIRELESS COMPUTING, COMMUNICATION AND APPLICATIONS (BWCCA 2012), P178, DOI 10.1109/BWCCA.2012.37; Khan ZA, 2013, PROCEDIA COMPUT SCI, V19, P171, DOI 10.1016/j.procs.2013.06.027; Lai XC, 2013, SENSORS-BASEL, V13, P5406, DOI 10.3390/s130505406; Latre B, 2011, WIREL NETW, V17, P1, DOI 10.1007/s11276-010-0252-4; Lee CC, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9973-0; Liang L, 2012, IEEE GLOB COMM CONF, P572, DOI 10.1109/GLOCOM.2012.6503174; Liang X., 2008, P 2008 1 INT S APPL, P1, DOI DOI 10.1109/ISABEL20084712578; Lifei Wei, 2010, Proceedings 2010 30th International Conference on Distributed Computing Systems Workshops (ICDCS 2010 Workshops), P52, DOI 10.1109/ICDCSW.2010.36; Milenkovic A, 2006, COMPUT COMMUN, V29, P2521, DOI 10.1016/j.comcom.2006.02.011; Min Chen, 2011, Mobile Networks and Applications, V16, P171, DOI 10.1007/s11036-010-0260-8; Movassaghi Samaneh, 2013, Journal of Networks, V8, P559, DOI 10.4304/jnw.8.3.559-575; Natarajan A., 2009, P 6 ANN IEEE COMM SO, P1; Ortiz A.M., 2012, P SOFTCOM 2012 20 IN; Patel M, 2010, IEEE WIREL COMMUN, V17, P80, DOI 10.1109/MWC.2010.5416354; RAHIMI MR, 2012, P 2012 IEEE ACM 5 IN, P83, DOI DOI 10.1109/UCC.2012.25; Razzaque MA, 2011, SENSORS-BASEL, V11, P917, DOI 10.3390/s110100917; Ullah S, 2012, J MED SYST, V36, P1065, DOI 10.1007/s10916-010-9571-3; Wan JF, 2013, IEEE NETWORK, V27, P56, DOI 10.1109/MNET.2013.6616116; Wei LF, 2014, INFORM SCIENCES, V258, P371, DOI 10.1016/j.ins.2013.04.028; Xiong NX, 2009, IEEE J SEL AREA COMM, V27, P495, DOI 10.1109/JSAC.2009.090512; Zeng YY, 2013, COMPUT COMMUN, V36, P988, DOI 10.1016/j.comcom.2012.07.016; Zhang ZY, 2012, IEEE T INF TECHNOL B, V16, P1070, DOI 10.1109/TITB.2012.2206115; Zhou J, 2015, INFORM SCIENCES, V314, P255, DOI 10.1016/j.ins.2014.09.003	41	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146464	10.1371/journal.pone.0146464	http://dx.doi.org/10.1371/journal.pone.0146464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771586	Green Published, gold			2022-12-27	WOS:000368628300022
J	Myamoto, DT; Pidde-Queiroz, G; Goncalves-de-Andrade, RM; Pedroso, A; van den Berg, CW; Tambourgi, DV				Myamoto, Daniela Tiemi; Pidde-Queiroz, Giselle; Goncalves-de-Andrade, Rute Maria; Pedroso, Aurelio; van den Berg, Carmen W.; Tambourgi, Denise V.			Characterization of a Gene Coding for the Complement System Component FB from Loxosceles laeta Spider Venom Glands	PLOS ONE			English	Article							FACTOR-B; HOMOLOG; EVOLUTION; CLONING; C3	The human complement system is composed of more than 30 proteins and many of these have conserved domains that allow tracing the phylogenetic evolution. The complement system seems to be initiated with the appearance of C3 and factor B (FB), the only components found in some protostomes and cnidarians, suggesting that the alternative pathway is the most ancient. Here, we present the characterization of an arachnid homologue of the human complement component FB from the spider Loxosceles laeta. This homologue, named Lox-FB, was identified from a total RNA L. laeta spider venom gland library and was amplified using RACE-PCR techniques and specific primers. Analysis of the deduced amino acid sequence and the domain structure showed significant similarity to the vertebrate and invertebrate FB/C2 family proteins. Lox-FB has a classical domain organization composed of a control complement protein domain (CCP), a von Willebrand Factor domain (vWFA), and a serine protease domain (SP). The amino acids involved in Mg2+ metal ion dependent adhesion site (MIDAS) found in the vWFA domain in the vertebrate C2/FB proteins are well conserved; however, the classic catalytic triad present in the serine protease domain is not conserved in Lox-FB. Similarity and phylogenetic analyses indicated that Lox-FB shares a major identity (43%) and has a close evolutionary relationship with the third isoform of FB-like protein (FB-3) from the jumping spider Hasarius adansoni belonging to the Family Salcitidae.	[Myamoto, Daniela Tiemi; Pidde-Queiroz, Giselle; Goncalves-de-Andrade, Rute Maria; Pedroso, Aurelio; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.	denise.tambourgi@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Tambourgi, Denise/H-7114-2016	Tambourgi, Denise/0000-0003-1896-9074; Pedroso Junior, Aurelio/0000-0002-9170-2088	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq); CeTICS Program FAPESP [2013/07467-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CeTICS Program FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP), CeTICS Program FAPESP (2013/07467-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Ausubel FM, 1988, MOL REPROD DEV; BENTLEY DR, 1986, BIOCHEM SOC SYMP, P7; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Loker E., 2012, FRONTIERS IMMUNOLOGY, V3, P1; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; NONAKA M, 1994, J IMMUNOL, V152, P2263; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Sekiguchi R, 2015, DEV COMP IMMUNOL, V50, P58, DOI 10.1016/j.dci.2014.12.008; Smith LC, 1998, J IMMUNOL, V161, P6784; Sunyer JO, 1998, IMMUNOL REV, V27, P549; Tagawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036783; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848; Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027; Yoshizaki FY, 2005, IMMUNOGENETICS, V56, P930, DOI 10.1007/s00251-004-0752-4; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P745, DOI 10.1016/S0145-305X(01)00034-9; Zhong L, 2012, FISH SHELLFISH IMMUN, V33, P504, DOI 10.1016/j.fsi.2012.06.001; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	32	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146992	10.1371/journal.pone.0146992	http://dx.doi.org/10.1371/journal.pone.0146992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771533	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000368628300049
J	Suzuki, T; Brown, JJ; Swift, LL				Suzuki, Takashi; Brown, Judy J.; Swift, Larry L.			Identification of a Novel Transcript and Regulatory Mechanism for Microsomal Triglyceride Transfer Protein	PLOS ONE			English	Article							OPEN READING FRAMES; ANGIOTENSIN-II RECEPTOR; APOLIPOPROTEIN-B; LIPOPROTEIN SECRETION; GENOMIC ORGANIZATION; GENE-EXPRESSION; TYPE-1 RECEPTOR; MESSENGER-RNAS; CELLS; ABETALIPOPROTEINEMIA	Microsomal triglyceride transfer protein (MTP) is essential for the assembly of triglyceride-rich apolipoprotein B-containing lipoproteins. Previous studies in our laboratory identified a novel splice variant of MTP in mice that we named MTP-B. MTP-B has a unique first exon (1B) located 2.7 kB upstream of the first exon (1A) for canonical MTP (MTP-A). The two mature isoforms, though nearly identical in sequence and function, have different tissue expression patterns. In this study we report the identification of a second MTP splice variant (MTP-C), which contains both exons 1B and 1A. MTP-C is expressed in all the tissues we tested. In cells transfected with MTP-C, protein expression was less than 15% of that found when the cells were transfected with MTP-A or MTP-B. In silico analysis of the 5'-UTR of MTP-C revealed seven ATGs upstream of the start site for MTP-A, which is the only viable start site in frame with the main coding sequence. One of those ATGs was located in the 5'-UTR for MTP-A. We generated reporter constructs in which the 5'-UTRs of MTP-A or MTPC were inserted between an SV40 promoter and the coding sequence of the luciferase gene and transfected these constructs into HEK 293 cells. Luciferase activity was significantly reduced by the MTP-C 5'-UTR, but not by the MTP-A 5'-UTR. We conclude that alternative splicing plays a key role in regulating MTP expression by introducing unique 5'-UTRs, which contain elements that alter translation efficiency, enabling the cell to optimize MTP levels and activity.	[Suzuki, Takashi; Brown, Judy J.; Swift, Larry L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Swift, Larry L.] Tennessee Valley Hlth Care Syst, Res Serv, Vet Affairs, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Suzuki, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	takashi.suzuki@vanderbilt.edu			VA Merit Award from the Tennessee Valley Health Care System [IBX000735A]; Department of Veterans Affairs	VA Merit Award from the Tennessee Valley Health Care System(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was funded by a VA Merit Award (IBX000735A) from the Tennessee Valley Health Care System and Department of Veterans Affairs (LS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Cadar AG, 2014, BIOCHEM BIOPH RES CO, V453, P185, DOI 10.1016/j.bbrc.2014.09.085; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; CURNOW KM, 1992, MOL ENDOCRINOL, V6, P1113, DOI 10.1210/me.6.7.1113; CURNOW KM, 1995, MOL ENDOCRINOL, V9, P1250, DOI 10.1210/me.9.9.1250; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; GUO DF, 1994, BIOCHEM BIOPH RES CO, V200, P313, DOI 10.1006/bbrc.1994.1450; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krzystanek M, 2010, J BIOL CHEM, V285, P10583, DOI 10.1074/jbc.M109.078006; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Love JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135598; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; MORRIS DR, 1995, PROG NUCLEIC ACID RE, V51, P339, DOI 10.1016/S0079-6603(08)60883-1; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakamuta M, 1996, GENOMICS, V33, P313, DOI 10.1006/geno.1996.0200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rakhshandehroo M, 2014, J BIOL CHEM, V289, P22128, DOI 10.1074/jbc.M114.551242; Shelton JM, 2000, J LIPID RES, V41, P532; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; SU BG, 1994, BIOCHEM BIOPH RES CO, V204, P1039, DOI 10.1006/bbrc.1994.2567; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Swift LL, 2003, J LIPID RES, V44, P1841, DOI 10.1194/jlr.M300276-JLR200; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Tietge UJF, 1999, J LIPID RES, V40, P2134; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751	41	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147252	10.1371/journal.pone.0147252	http://dx.doi.org/10.1371/journal.pone.0147252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771188	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300074
J	Kim, H; Kim, S; Jung, Y; Han, J; Yun, JH; Chang, I; Lee, W				Kim, Heeyoun; Kim, Sangyeol; Jung, Youngjin; Han, Jeongmin; Yun, Ji-Hye; Chang, Iksoo; Lee, Weontae			Probing the Folding-Unfolding Transition of a Thermophilic Protein, MTH1880	PLOS ONE			English	Article							STRUCTURAL PROTEOMICS; MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; STABILITY; KINETICS; DENATURATION; 2-STATE; UREA; GUANIDINIUM; DOMAIN	The folding mechanism of typical proteins has been studied widely, while our understanding of the origin of the high stability of thermophilic proteins is still elusive. Of particular interest is how an atypical thermophilic protein with a novel fold maintains its structure and stability under extreme conditions. Folding-unfolding transitions of MTH1880, a thermophilic protein from Methanobacterium thermoautotrophicum, induced by heat, urea, and GdnHCl, were investigated using spectroscopic techniques including circular dichorism, fluorescence, NMR combined with molecular dynamics (MD) simulations. Our results suggest that MTH1880 undergoes a two-state N to D transition and it is extremely stable against temperature and denaturants. The reversibility of refolding was confirmed by spectroscopic methods and size exclusion chromatography. We found that the hyper-stability of the thermophilic MTH1880 protein originates from an extensive network of both electrostatic and hydrophobic interactions coordinated by the central beta-sheet. Spectroscopic measurements, in combination with computational simulations, have helped to clarify the thermodynamic and structural basis for hyper-stability of the novel thermophilic protein MTH1880.	[Kim, Heeyoun; Jung, Youngjin; Han, Jeongmin; Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120740, South Korea; [Kim, Sangyeol] Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea; [Kim, Sangyeol; Chang, Iksoo] Daegu Gyeongbuk Inst Sci & Technol, Ctr Proteome Biophys, Daegu 711873, South Korea; [Chang, Iksoo] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 711873, South Korea	Yonsei University; Pusan National University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Chang, I (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Ctr Proteome Biophys, Daegu 711873, South Korea.	iksoochang@dgist.ac.kr; wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262	Ministry of Future Creation and Science (MFCS) of Korea; Translational Research Center for Protein Function Control [2009-0083522]; Mid-career Researcher Program [2012-010285]; BK21plus program from the MFCS; Creative Research Initiatives (Center for Proteome Biophysics) of National Research Foundation, Korea [2008-0061984]; MIREBraiN program from Daegu Gyeongbuk Institute of Science and Technology [2015010013]; MIREBraiN program from DGIST [2015010013]	Ministry of Future Creation and Science (MFCS) of Korea; Translational Research Center for Protein Function Control; Mid-career Researcher Program; BK21plus program from the MFCS; Creative Research Initiatives (Center for Proteome Biophysics) of National Research Foundation, Korea; MIREBraiN program from Daegu Gyeongbuk Institute of Science and Technology; MIREBraiN program from DGIST	This work was funded by the Ministry of Future Creation and Science (MFCS) of Korea, the Translational Research Center for Protein Function Control (2009-0083522), and the Mid-career Researcher Program (2012-010285). HK, YJ and JH were supported by a BK21plus program from the MFCS. It was also supported by the Creative Research Initiatives (Center for Proteome Biophysics) of National Research Foundation, Korea (No. 2008-0061984 to SK and IC), and MIREBraiN program (I.C: No. 2015010013) from Daegu Gyeongbuk Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Ministry of Future Creation and Science (MFCS) of Korea, the Translational Research Center for Protein Function Control (2009-0083522), and the Mid-career Researcher Program (2012-010285). HK, YJ, JY and JH were supported by a BK21plus program from the MFCS. It was also supported by the Creative Research Initiatives (Center for Proteome Biophysics) of National Research Foundation, Korea (No. 2008-0061984 to S.K, and I.C) and MIREBraiN program (I.C: No. 2015010013) from DGIST.	Almarza J, 2009, BIOCHEMISTRY-US, V48, P7608, DOI 10.1021/bi9007116; Batchelor JD, 2004, J AM CHEM SOC, V126, P1958, DOI 10.1021/ja039335h; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Camilloni C, 2008, BIOPHYS J, V94, P4654, DOI 10.1529/biophysj.107.125799; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; Connell KB, 2009, J MOL BIOL, V391, P450, DOI 10.1016/j.jmb.2009.05.085; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Paolo A, 2010, BIOCHEMISTRY-US, V49, P8646, DOI 10.1021/bi101126f; England JL, 2011, ANNU REV PHYS CHEM, V62, P257, DOI 10.1146/annurev-physchem-032210-103531; Fiorentino G, 2014, BBA-PROTEINS PROTEOM, V1844, P1167, DOI 10.1016/j.bbapap.2014.03.011; FRANK HS, 1968, J CHEM PHYS, V48, P4746, DOI 10.1063/1.1668057; FRIEDEN C, 1993, PROTEIN SCI, V2, P2007, DOI 10.1002/pro.5560021202; Geer MA, 2014, ANNU REV ANAL CHEM, V7, P209, DOI 10.1146/annurev-anchem-071213-020024; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; GRONENBORN AM, 1990, ANAL CHEM, V62, P2, DOI 10.1021/ac00200a003; Henry ER, 2004, CHEM PHYS, V307, P163, DOI 10.1016/j.chemphys.2004.06.064; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung JW, 2004, J BIOCHEM MOL BIOL, V37, P28; Kathuria SV, 2013, BIOPOLYMERS, V99, P888, DOI 10.1002/bip.22355; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kennedy Michael A., 2002, Journal of Structural and Functional Genomics, V2, P155, DOI 10.1023/A:1021261026670; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; Ko S, 2011, PROTEINS, V79, P1347, DOI 10.1002/prot.22956; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Krantz BA, 2000, BIOCHEMISTRY-US, V39, P11696, DOI 10.1021/bi000792+; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lamba J, 2009, BIOCHEMISTRY-MOSCOW+, V74, P393, DOI 10.1134/S0006297909040063; Lee CH, 2004, PROTEIN SCI, V13, P1148, DOI 10.1110/ps.03472104; Lee DW, 2005, FEBS LETT, V579, P1261, DOI 10.1016/j.febslet.2005.01.027; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; Okada J, 2012, BIOCHEMISTRY-US, V51, P9178, DOI 10.1021/bi300973n; Pandit AD, 2006, J MOL BIOL, V361, P755, DOI 10.1016/j.jmb.2006.06.041; Plaxco KW, 1996, CURR OPIN STRUC BIOL, V6, P630, DOI 10.1016/S0959-440X(96)80029-7; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Rashid F, 2005, PROTEIN J, V24, P283, DOI 10.1007/s10930-005-6749-5; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Reed CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089452; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; Sathish HA, 2002, BIOCHEMISTRY-US, V41, P5340, DOI 10.1021/bi0115784; Sen S, 2006, PROTEINS, V62, P450, DOI 10.1002/prot.20765; Serrano AL, 2012, PROTEIN SCI, V21, P157, DOI 10.1002/pro.2006; Stumpe MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000221; Sung YH, 2001, J BIOL CHEM, V276, P44229, DOI 10.1074/jbc.M104239200; van Mierlo CPM, 2000, J BIOTECHNOL, V79, P281, DOI 10.1016/S0168-1656(00)00244-3; Vreuls C, 2004, BIOCHEM J, V384, P179, DOI 10.1042/BJ20040658; Waldner JC, 1999, BIOPOLYMERS, V49, P471, DOI 10.1002/(SICI)1097-0282(199905)49:6<471::AID-BIP5>3.3.CO;2-Q; Waudby CA, 2013, PROG NUCL MAG RES SP, V74, P57, DOI 10.1016/j.pnmrs.2013.07.003; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Yan CL, 2010, J MOL GRAPH MODEL, V29, P2, DOI 10.1016/j.jmgm.2010.03.011; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Yu W, 2008, P NATL ACAD SCI USA, V105, P2397, DOI 10.1073/pnas.0708480105; Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g; Zhang J, 2009, IUBMB LIFE, V61, P627, DOI 10.1002/iub.223; Zhang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053125; Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148	63	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145853	10.1371/journal.pone.0145853	http://dx.doi.org/10.1371/journal.pone.0145853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766214	Green Submitted, gold, Green Published			2022-12-27	WOS:000368459300010
J	Watanabe, H; Nakano, T; Saito, R; Akasaka, D; Saito, K; Ogasawara, H; Minashima, T; Miyazawa, K; Kanaya, T; Takakura, I; Inoue, N; Ikeda, I; Chen, X; Miyake, M; Kitazawa, H; Shirakawa, H; Sato, K; Tahara, K; Nagasawa, Y; Rose, MT; Ohwada, S; Watanabe, K; Aso, H				Watanabe, Hitoshi; Nakano, Tatsuya; Saito, Ryo; Akasaka, Daisuke; Saito, Kazuki; Ogasawara, Hideki; Minashima, Takeshi; Miyazawa, Kohtaro; Kanaya, Takashi; Takakura, Ikuro; Inoue, Nao; Ikeda, Ikuo; Chen, Xiangning; Miyake, Masato; Kitazawa, Haruki; Shirakawa, Hitoshi; Sato, Kan; Tahara, Kohji; Nagasawa, Yuya; Rose, Michael T.; Ohwada, Shyuichi; Watanabe, Kouichi; Aso, Hisashi			Serotonin Improves High Fat Diet Induced Obesity in Mice	PLOS ONE			English	Article							TRYPTOPHAN-HYDROXYLASE ISOFORM; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL COACTIVATOR; HYPOTHALAMIC SEROTONIN; NEURONAL SIGNALS; ADIPOSE-TISSUE; PGC-1-ALPHA; MECHANISMS; RECEPTORS	There are two independent serotonin (5-HT) systems of organization: one in the central nervous system and the other in the periphery. 5-HT affects feeding behavior and obesity in the central nervous system. On the other hand, peripheral 5-HT also may play an important role in obesity, as it has been reported that 5-HT regulates glucose and lipid metabolism. Here we show that the intraperitoneal injection of 5-HT to mice inhibits weight gain, hyperglycemia and insulin resistance and completely prevented the enlargement of intra-abdominal adipocytes without having any effect on food intake when on a high fat diet, but not on a chow diet. 5-HT increased energy expenditure, O-2 consumption and CO2 production. This novel metabolic effect of peripheral 5-HT is critically related to a shift in the profile of muscle fiber type from fast/glycolytic to slow/oxidative in soleus muscle. Additionally, 5-HT dramatically induced an increase in the mRNA expression of peroxisome proliferator-activated receptor coactivator 1 alpha (PGC-1 alpha)-b and PGC-1 alpha-c in soleus muscle. The elevation of these gene mRNA expressions by 5-HT injection was inhibited by treatment with 5-HT receptor (5HTR) 2A or 7 antagonists. Our results demonstrate that peripheral 5-HT may play an important role in the relief of obesity and other metabolic disorders by accelerating energy consumption in skeletal muscle.	[Watanabe, Hitoshi; Nakano, Tatsuya; Saito, Ryo; Akasaka, Daisuke; Saito, Kazuki; Ogasawara, Hideki; Minashima, Takeshi; Miyazawa, Kohtaro; Kanaya, Takashi; Takakura, Ikuro; Chen, Xiangning; Miyake, Masato; Nagasawa, Yuya; Ohwada, Shyuichi; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Cellar Biol Lab, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Inoue, Nao; Ikeda, Ikuo] Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Prod Chem, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Shirakawa, Hitoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Nutr, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Sato, Kan] Tokyo Univ Agr & Technol, Dept Biol Prod, Anim Sci, Fuchu, Tokyo 1838509, Japan; [Tahara, Kohji] BML Inc, Dept Adv Med & Dev, Saitama 3501101, Japan; [Rose, Michael T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Cardigan, Wales	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tokyo University of Agriculture & Technology; BML, Inc.; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Aso, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Cellar Biol Lab, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	asosan@bios.tohoku.ac.jp	Shirakawa, Hitoshi/D-1406-2009; Rose, Michael/AAI-6335-2021; Miyazawa, Kohtaro/ABB-1464-2021; INOUE, Nao/GLV-5671-2022	Kitazawa, Haruki/0000-0003-4586-5553; Watanabe, Hitoshi/0000-0002-9236-7744; Kanaya, Takashi/0000-0002-9863-1673; SHIRAKAWA, HITOSHI/0000-0002-4828-5274; Chen, XN/0000-0002-9011-4946; Rose, Michael/0000-0001-6058-1319; Miyake, Masato/0000-0003-2242-1706	Ministry of Agriculture, Forestry and Fisheries; Japan Society for the Promotion of Science (JSPS) [23.7413]; BML Inc.; Grants-in-Aid for Scientific Research [25450461, 15H04586, 26660217] Funding Source: KAKEN	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BML Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO) from the Ministry of Agriculture, Forestry and Fisheries and by Research Fellowship (23.7413) for Young Scientists Program from Japan Society for the Promotion of Science (JSPS). Co-author Kohji Tahara is employed by BML Inc. BML Inc. provided support in the form of salary for author KT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Bertrand RL, 2011, ENDOCRINOLOGY, V152, P36, DOI 10.1210/en.2010-0377; BLUNDELL JE, 1986, APPETITE, V7, P39, DOI 10.1016/S0195-6663(86)80051-4; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; CURZON G, 1990, ANN NY ACAD SCI, V600, P521, DOI 10.1111/j.1749-6632.1990.tb16907.x; Hampson LJ, 2007, DIABETOLOGIA, V50, P1743, DOI 10.1007/s00125-007-0696-y; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heisler LK, 1998, ANN NY ACAD SCI, V861, P74, DOI 10.1111/j.1749-6632.1998.tb10175.x; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; LEIBOWITZ SF, 1988, CLIN NEUROPHARMACOL, V11, pS51; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MERRITT JH, 1978, RADIAT ENVIRON BIOPH, V15, P367, DOI 10.1007/BF01323461; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; RUAT M, 1993, P NATL ACAD SCI USA, V90, P8547, DOI 10.1073/pnas.90.18.8547; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Uchida-Kitajima S, 2008, FEBS LETT, V582, P3037, DOI 10.1016/j.febslet.2008.07.044; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; WOOLLEY DW, 1954, P NATL ACAD SCI USA, V40, P228, DOI 10.1073/pnas.40.4.228; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	38	31	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147143	10.1371/journal.pone.0147143	http://dx.doi.org/10.1371/journal.pone.0147143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766570	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300072
J	Bhandari, TR; Kutty, VR; Ravindran, TKS				Bhandari, Tulsi Ram; Kutty, V. Raman; Ravindran, T. K. Sundari			Women's Autonomy and Its Correlates in Western Nepal: A Demographic Study	PLOS ONE			English	Article							HEALTH; SERVICES; IMPACT; INDIA	Despite various efforts for enhancing women's autonomy in developing countries, many women are deprived of their capacity in decision -making on their household affairs as well as social issues. This paper aimed to examine women's autonomy and its associated factors in the Kapilvastu district of Nepal. We measured women's autonomy using a recently developed women's autonomy measurement scale from June to October 2014. Descriptive statistics, chi-square test and logistic multivariate modeling technique were applied for assessing the association of demographic and socio-economic characteristics of women and their autonomy. Mean score for women's autonomy was 23.34 8.06 out of the possible maximum 48. It was found to be positively associated with higher age difference at marriage, advantaged caste/ethnicity, better employment for the husband, couple's education more than 10 years schooling, and higher economic status of the household. We found strong direct effect of women's education (OR = 8.14, CI = 3.77-17.57), husband's education (OR = 2.63, CI = 1.69-4.10) and economic status of household (OR = 1.42, CI = 1.012.03) on women's autonomy. When we adjusted women's education for husband's education, the odds ratio decreased by around 22% {from (OR = 8.14, CI = 3.77-17.57) to (OR = 6.32, CI = 2.77-14.46)1 and was a mediator effect. The economic status of household also had mediator effect on women's autonomy through their education. Education status of women is a key predictor of women's autonomy in Kapilvastu district. Husband's education and economic status of the household are other important predictors of women's autonomy which have a mediator effect on women's autonomy. Improving educational status and economic conditions of both women and their husbands may be the best solution to promote women's autonomy.	[Bhandari, Tulsi Ram] Pokhara Univ, Dept Publ Hlth, Sch Hlth & Allied Sci, Lekhnath 12, Kaski, Nepal; [Bhandari, Tulsi Ram; Kutty, V. Raman; Ravindran, T. K. Sundari] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram 695011, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Bhandari, TR (corresponding author), Pokhara Univ, Dept Publ Hlth, Sch Hlth & Allied Sci, Lekhnath 12, Kaski, Nepal.; Bhandari, TR (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram 695011, Kerala, India.	tulsib2004@gmail.com			Pokhara University; University Grants Commission, Nepal	Pokhara University; University Grants Commission, Nepal(University Grants Commission, India)	This article is a part of a Ph.D. study of the first author, which was partially supported by Pokhara University and University Grants Commission, Nepal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadian S, 1996, WORLD DEV, V24, P1793, DOI 10.1016/S0305-750X(96)00075-7; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Allendorf K, 2007, STUD FAMILY PLANN, V38, P35, DOI 10.1111/j.1728-4465.2007.00114.x; Bhandari TR, 2014, J NEPAL MED ASSOC, V52, P925; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Dangal G, 2014, GJMEDPH, V3, P1; Dean AG, 2015, OPENEPI OPEN SOURCE; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Gunasekaran S., 2010, WOMENS AUTONOMY REPR; HKFSD, 2013, ANN REP HONG KONG FI; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Liebeck H, 2013, COMPACT OXFORD ENGLI; Makinwa-Adebusoye P, 1995, WOMENS POSITION DEMO; Malhotra A., 2005, MEASURING EMPOWERMEN, V1, P71; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Sharma SK, 2007, J BIOSOC SCI, V39, P671, DOI 10.1017/S0021932007001952; Thapa DK, 2013, SOC SCI MED; Tuladhar J, 1997, Nepal Popul Dev J, P19; Woldemicael G., 2007, DO WOMEN HIGHER AUTO	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147473	10.1371/journal.pone.0147473	http://dx.doi.org/10.1371/journal.pone.0147473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799217	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300112
J	Kim, AJ; Ro, H; Kim, H; Chang, JH; Lee, HH; Chung, W; Jung, JY				Kim, Ae Jin; Ro, Han; Kim, Hyunsook; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Klotho and S100A8/A9 as Discriminative Markers between Pre-Renal and Intrinsic Acute Kidney Injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MYELOID-RELATED PROTEIN-14; URINARY BIOMARKER; TISSUE EXPRESSION; CALPROTECTIN; CREATININE; NGAL; GENE; MYELOID-RELATED-PROTEIN-8/14; MORTALITY	Early detection and accurate differentiation of the cause of AKI may improve the prognosis of the patient. However, to date, there are few reliable biomarkers that can discriminate between pre-renal and intrinsic AKI. In this study, we determined whether AKI is associated with altered serum and urinary levels of Klotho, S100A8/A9 (an endogenous ligand of toll-like receptor 4), and neutrophil gelatinase-associated lipocalin (NGAL), which may allow differentiation between pre-renal and intrinsic AKI. A volume-depleted pre-renal AKI model was induced in male Sprague Dawley rats fed a low-salt diet (0.03%) without water 96 h before two intraperitoneal (IP) injections of furosemide (20 mg/kg) at a 24 h interval. In contrast, in the cisplatin-induced intrinsic AKI model, animals were given a single IP injection of cisplatin (5 mg/kg). All of the animals were euthanized 72 h after the first IP injection. Serum and urinary levels of Klotho, S100A8/A9, and NGAL were measured using an enzyme-linked immunosorbent assay. We also performed a proof-of-concept cross-sectional study to measure serum and urinary biomarkers in 61 hospitalized patients with established AKI. Compared to the intrinsic AKI group, the pre-renal AKI group showed a marked depression in urinary Klotho levels (13.21 +/- 17.32 vs. 72.97 +/- 17.96 pg/mL; P = 0.002). In addition, the intrinsic AKI group showed marked elevation of S100A8/A9 levels compared to the pre-renal AKI group (2629.97 +/- 598.05 ng/mL vs. 685.09 +/- 111.65 ng/mL; P = 0.002 in serum; 3361.11 +/- 250.86 ng/mL vs. 741.72 +/- 101.96 ng/mL; P = 0.003 in urine). There was no difference in serum and urinary NGAL levels between the pre-renal and intrinsic AKI groups. The proof-of-concept study with the hospitalized AKI patients also demonstrated decreased urinary Klotho in pre-renal AKI patients and increased urinary S100A8/A9 concentrations in intrinsic AKI patients. The attenuation of urinary Klotho and increase in urinary S100A8/A9 may allow differentiation between pre-renal and intrinsic AKI.	[Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Gil Med Ctr, Div Nephrol,Dept Internal Med, Inchon, South Korea; [Kim, Ae Jin; Ro, Han; Kim, Hyunsook; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Inchon, South Korea	Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Sch Med, Gil Med Ctr, Div Nephrol,Dept Internal Med, Inchon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Gachon Med Res Inst, Gil Med Ctr, Inchon, South Korea.	jyjung@gachon.ac.kr			Fresenius Medical Care Korea [141008-HRH2-A-59]	Fresenius Medical Care Korea	This work was supported by Fresenius Medical Care Korea (141008-HRH2-A-59, http://www.fmc-korea.co.kr). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; BORREGAARD N, 1995, BLOOD, V85, P812, DOI 10.1182/blood.V85.3.812.bloodjournal853812; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Constantin JM, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.05.010; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Fagerhol MK, 2005, SCAND J CLIN LAB INV, V65, P211, DOI 10.1080/00365510510013587; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Fukino K, 2002, BIOCHEM BIOPH RES CO, V293, P332, DOI 10.1016/S0006-291X(02)00216-4; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; He Y, 2004, J NEPHROL, V17, P34; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Herrera J, 1998, NEPHROL DIAL TRANSPL, V13, P623, DOI 10.1093/ndt/13.3.623; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Montagnana M, 2014, CLIN BIOCHEM, V47, P996, DOI 10.1016/j.clinbiochem.2014.02.021; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; Muller H, 2008, J UROLOGY, V180, P1309, DOI 10.1016/j.juro.2008.06.025; Muramatsu Y, 2002, KIDNEY INT, V62, P1601, DOI 10.1046/j.1523-1755.2002.00633.x; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Schrier RW, 2004, J AM SOC NEPHROL, V15, P2756, DOI 10.1097/01.ASN.0000141324.49873.11; Seibert FS, 2013, ACTA PHYSIOL, V207, P700, DOI 10.1111/apha.12064; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Tang C, 2011, AM J PHYSIOL-RENAL, V301, pF745, DOI 10.1152/ajprenal.00037.2011; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wadey RM, 2014, TOXICOL PATHOL, V42, P591, DOI 10.1177/0192623313492044; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	52	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147255	10.1371/journal.pone.0147255	http://dx.doi.org/10.1371/journal.pone.0147255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799323	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300081
J	Rodrigues-da-Silva, RN; da Silva, JHM; Singh, B; Jiang, JL; Meyer, EVS; Santos, F; Banic, DM; Moreno, A; Galinski, MR; Oliveira-Ferreira, J; Lima, JD				Rodrigues-da-Silva, Rodrigo Nunes; Martins da Silva, Joao Herminio; Singh, Balwan; Jiang, Jianlin; Meyer, Esmeralda V. S.; Santos, Fatima; Banic, Dalma Maria; Moreno, Alberto; Galinski, Mary R.; Oliveira-Ferreira, Joseli; Lima-Junior, Josue da Costa			In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9	PLOS ONE			English	Article							BLOOD-STAGE MALARIA; IMMUNE-RESPONSES; WEB SERVER; REDUCED RISK; FALCIPARUM; ANTIGENICITY; ANTIBODIES; RECOMBINANT; REGIONS; SEARCH	Synthetic peptide vaccines provide the advantages of safety, stability and low cost. The success of this approach is highly dependent on efficient epitope identification and synthetic strategies for efficacious delivery. In malaria, the Merozoite Surface Protein-9 of Plasmodium vivax (PvMSP9) has been considered a vaccine candidate based on the evidence that specific antibodies were able to inhibit merozoite invasion and recombinant proteins were highly immunogenic in mice and humans. However the identities of linear B-cell epitopes within PvMSP9 as targets of functional antibodies remain undefined. We used several publicly-available algorithms for in silico analyses and prediction of relevant B-cell epitopes within PMSP9. We show that the tandem repeat sequence EAAPENAEPVHENA (PvMSP9(E795-A808)) present at the C-terminal region is a promising target for antibodies, given its high combined score to be a linear epitope and located in a putative intrinsically unstructured region of the native protein. To confirm the predictive value of the computational approach, plasma samples from 545 naturally exposed individuals were screened for IgG reactivity against the recombinant PvMSP9-RIRII729-972 and a synthetic peptide representing the predicted B-cell epitope PvMSP9(E795-A808). 316 individuals (58%) were responders to the full repetitive region PvMSP9-RIRII, of which 177 (56%) also presented total IgG reactivity against the synthetic peptide, confirming it validity as a B cell epitope. The reactivity indexes of anti-PvMSP9-RIRII and anti-PvMSP9(E795-A808) antibodies were correlated. Interestingly, a potential role in the acquisition of protective immunity was associated with the linear epitope, since the IgG1 subclass against PvMSP9(E795-A808) was the prevalent subclass and this directly correlated with time elapsed since the last malaria episode; however this was not observed in the antibody responses against the full PvMSP9-RIRII. In conclusion, our findings identified and experimentally confirmed the potential of PvMSP9(E795-A808) as an immunogenic linear B cell epitope within the P. vivax malaria vaccine candidate PvMSP9 and support its inclusion in future subunit vaccines.	[Rodrigues-da-Silva, Rodrigo Nunes; Oliveira-Ferreira, Joseli; Lima-Junior, Josue da Costa] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil; [Martins da Silva, Joao Herminio] FIOCRUZ CE, Computat Modeling Group, Fortaleza, Ceara, Brazil; [Singh, Balwan; Jiang, Jianlin; Moreno, Alberto; Galinski, Mary R.] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Meyer, Esmeralda V. S.] Emory Univ, Environm Hlth & Safety Off, Atlanta, GA 30322 USA; [Santos, Fatima] Natl Hlth Fdn, Dept Entomol, Cent Lab, Porto Velho, RO, Brazil; [Banic, Dalma Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Simulids & Onchocerciasis Malaria & Onchocerc, Rio De Janeiro, Brazil; [Moreno, Alberto; Galinski, Mary R.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Emory University; Emory University; Fundacao Oswaldo Cruz; Emory University	Oliveira-Ferreira, J; Lima, JD (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunoparasitol, Rio De Janeiro, RJ, Brazil.	lila@ioc.fiocruz.br; josue@ioc.fiocruz.br	da Costa Lima-Junior, Josue/AAI-4746-2021; Oliveira-Ferreira, Joseli/E-7942-2014	da Costa Lima-Junior, Josue/0000-0002-5848-404X; Oliveira-Ferreira, Joseli/0000-0002-6063-465X; Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X; Moreno, Alberto/0000-0002-3031-7194	Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz; National Institute of Health (NIH) [RO1 1R01AI24710]; Yerkes National Primate Research Center Base Grant - National Center for Research Resources of the National Institutes of Health [ORIP/OD P51OD011132]; FAPERJ-APQ1 [E-26/111.248/2014]; CPNq-Universal research grants [445150/2014-9]; CNPq Productivity Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024710] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research Center Base Grant - National Center for Research Resources of the National Institutes of Health; FAPERJ-APQ1(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CPNq-Universal research grants; CNPq Productivity Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Brazilian National Research Council - CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz, the National Institute of Health (NIH Grant #RO1 1R01AI24710), and the Yerkes National Primate Research Center Base Grant (ORIP/OD P51OD011132) awarded by the National Center for Research Resources of the National Institutes of Health. JCLJ is recipient of a FAPERJ-APQ1 (E-26/111.248/2014) and CPNq-Universal research grants (445150/2014-9), JOF is recipient of CNPq Productivity Fellowship.; We are grateful to all individuals who participated in this study, for their cooperation and generous donation of blood, which made this study possible. We thank the Secretary of Health of Rondonia State and the Laboratorio Central-LACEN of Rondonia for supporting fieldwork. This work was supported by Brazilian National Research Council-CNPq/PAPES, (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Programa de Apoio Pesquisa Estrategica em Saude) Fiocruz, the National Institute of Health (NIH Grant #RO1 1R01AI24710), and the Yerkes National Primate Research Center Base Grant (ORIP/OD P51OD011132) awarded by the National Center for Research Resources of the National Institutes of Health. JCLJ is recipient of a FAPERJ-APQ1 (E-26/111.248/2014) and CPNq-Universal research grants (445150/2014-9), JOF is recipient of CNPq Productivity Fellowship.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amante Fiona H, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1904s93; ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnwell JW, 1999, EXP PARASITOL, V91, P238, DOI 10.1006/expr.1998.4372; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Caro-Aguilar I, 2005, MICROBES INFECT, V7, P1324, DOI 10.1016/j.micinf.2005.04.020; Cespedes N, 2014, VACCINE, V32, P3179, DOI 10.1016/j.vaccine.2014.04.007; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Chenet SM, 2013, INFECT GENET EVOL, V20, P239, DOI 10.1016/j.meegid.2013.09.011; Cheng Y, 2014, PARASITOL RES, V113, P2559, DOI 10.1007/s00436-014-3907-8; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315; Gougoutsi A, 2014, VECTOR-BORNE ZOONOT, V14, P378, DOI 10.1089/vbz.2012.1192; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2004, INT J PARASITOL, V34, P1535, DOI 10.1016/j.ijpara.2004.10.009; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Kristensen KL, 2014, SCAND J INFECT DIS, V46, P63, DOI 10.3109/00365548.2013.822093; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima JC, 2010, VACCINE, V28, P3185, DOI 10.1016/j.vaccine.2010.02.046; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Lopera-Mesa TM, 2008, VACCINE, V26, P1335, DOI 10.1016/j.vaccine.2007.12.042; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Nayar JK, 1997, J PARASITOL, V83, P739, DOI 10.2307/3284254; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; O'Brien AT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-404; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Organization WH, TABL MAL VACC PROJ G; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Polley SD, 2004, TRENDS PARASITOL, V20, P99, DOI 10.1016/j.pt.2003.12.003; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Rahimi BA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-481; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Schrodinger L., 2020, PYMOL; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Silva-Flannery LM, 2009, MICROBES INFECT, V11, P83, DOI 10.1016/j.micinf.2008.10.009; Singh S, 2005, INFECT IMMUN, V73, P1235, DOI 10.1128/IAI.73.2.1235-1238.2005; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soares LA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/671050; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Storti-Melo LM, 2011, AM J TROP MED HYG, V84, P58, DOI 10.4269/ajtmh.2011.10-0044; SVS-SIVEP-Malaria MdS, SIST INF VIG EP NOT; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Vargas-Serrato E, 2003, INFECT GENET EVOL, V3, P67, DOI 10.1016/S1567-1348(03)00007-8; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zubairi ABS, 2013, EMERG INFECT DIS, V19, P1851, DOI 10.3201/eid1911.130495	75	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146951	10.1371/journal.pone.0146951	http://dx.doi.org/10.1371/journal.pone.0146951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788998	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100049
J	Yunusova, Y; Graham, NL; Shellikeri, S; Phuong, K; Kulkarni, M; Rochon, E; Tang-Wai, DF; Chow, TW; Black, SE; Zinman, LH; Green, JR				Yunusova, Yana; Graham, Naida L.; Shellikeri, Sanjana; Phuong, Kent; Kulkarni, Madhura; Rochon, Elizabeth; Tang-Wai, David F.; Chow, Tiffany W.; Black, Sandra E.; Zinman, Lorne H.; Green, Jordan R.			Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)	PLOS ONE			English	Article							PRIMARY PROGRESSIVE APHASIA; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; NONFLUENT APHASIA; BREATH GROUP; CRITERIA; PAUSES; DYSARTHRIA; DIAGNOSIS	Objective This study examines reading aloud in patients with amyotrophic lateral sclerosis (ALS) and those with frontotemporal dementia (FTD) in order to determine whether differences in patterns of speaking and pausing exist between patients with primary motor vs. primary cognitive-linguistic deficits, and in contrast to healthy controls. Design 136 participants were included in the study: 33 controls, 85 patients with ALS, and 18 patients with either the behavioural variant of FTD (FTD-BV) or progressive nonfluent aphasia (FTD-PNFA). Participants with ALS were further divided into 4 non-overlapping subgroups-mild, respiratory, bulbar (with oral-motor deficit) and bulbar-respiratory-based on the presence and severity of motor bulbar or respiratory signs. All participants read a passage aloud. Custom-made software was used to perform speech and pause analyses, and this provided measures of speaking and articulatory rates, duration of speech, and number and duration of pauses. These measures were statistically compared in different subgroups of patients. Results The results revealed clear differences between patient groups and healthy controls on the passage reading task. A speech-based motor function measure (i.e., articulatory rate) was able to distinguish patients with bulbar ALS or FTD-PNFA from those with respiratory ALS or FTD-BV. Distinguishing the disordered groups proved challenging based on the pausing measures. Conclusions and Relevance This study demonstrated the use of speech measures in the identification of those with an oral-motor deficit, and showed the usefulness of performing a relatively simple reading test to assess speech versus pause behaviors across the ALS-FTD disease continuum. The findings also suggest that motor speech assessment should be performed as part of the diagnostic workup for patients with FTD.	[Yunusova, Yana; Graham, Naida L.; Shellikeri, Sanjana; Phuong, Kent; Rochon, Elizabeth] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Yunusova, Yana; Kulkarni, Madhura] Sunnybrook Res Inst, Toronto, ON, Canada; [Yunusova, Yana; Graham, Naida L.; Rochon, Elizabeth] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Tang-Wai, David F.; Chow, Tiffany W.; Black, Sandra E.; Zinman, Lorne H.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Tang-Wai, David F.] Univ Hlth Network, Div Neurol, Toronto Western Hosp, Toronto, ON, Canada; [Chow, Tiffany W.] Rotman Res Inst, Toronto, ON, Canada; [Black, Sandra E.] Sunnybrook Hlth Sci Ctr, LC Campbell Cognit Neurol Res Unit, Toronto, ON M4N 3M5, Canada; [Black, Sandra E.; Zinman, Lorne H.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Green, Jordan R.] MGH Inst Hlth Profess, Boston, MA USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Yunusova, Y (corresponding author), Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada.; Yunusova, Y (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.; Yunusova, Y (corresponding author), Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada.	yana.yunusova@utoronto.ca	Yunusova, Yana/E-3428-2010; Green, Jordan/N-3585-2019	Yunusova, Yana/0000-0002-2353-2275; Green, Jordan/0000-0002-1464-1373; Shellikeri, Sanjana/0000-0002-6436-292X; Rochon, Elizabeth/0000-0001-5521-0513	National Institutes of Health - National Institutes of Deafness and Communication Disorders [R01-DC009890]; ALS Society of Canada - Bernice Ramsay Discovery Grant; Canadian Institutes of Health Research;  [CIHR 82744];  [CIHR 130462]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013547, R01DC009890] Funding Source: NIH RePORTER	National Institutes of Health - National Institutes of Deafness and Communication Disorders; ALS Society of Canada - Bernice Ramsay Discovery Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by: National Institutes of Health - National Institutes of Deafness and Communication Disorders; R01-DC009890 - YY, JRG, LHZ; ALS Society of Canada - Bernice Ramsay Discovery Grant - YY, LHZ, SEB (https://www.als.ca/en/bernice-ramsay-innovation-grants); Canadian Institutes of Health Research; CIHR 82744 - ER, SEB, NLG, DTW, TWC; Canadian Institutes of Health Research; CIHR 130462 - ER, SEB, NLG, DTW, TWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Amici S, 2006, BEHAV NEUROL, V17, P77, DOI 10.1155/2006/260734; Ash S, 2006, NEUROLOGY, V66, P1405, DOI 10.1212/01.wnl.0000210435.72614.38; Ash S, 2009, J NEUROLINGUIST, V22, P370, DOI 10.1016/j.jneuroling.2008.12.001; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Ballard KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089864; Benedict RHB, 2011, J INT NEUROPSYCH SOC, V17, P643, DOI 10.1017/S1355617711000403; Brambati SM, 2009, NEUROPSYCHOLOGIA, V47, P1893, DOI 10.1016/j.neuropsychologia.2009.02.033; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Butterworth Brian L., 1980, EVIDENCE PAUSES SPEE; D'Orio VL, 2012, J NEUROL SCI, V316, P42, DOI 10.1016/j.jns.2012.02.003; Esposito A, 2008, INT J PATTERN RECOGN, V22, P1073, DOI 10.1142/S0218001408006508; Feenaughty L, 2013, CLIN LINGUIST PHONET, V27, P134, DOI 10.3109/02699206.2012.751624; Garrett M. F., 1982, NORMALITY PATHOLOGY, P19; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Graham NL, 2000, NEUROPSYCHOLOGIA, V38, P143, DOI 10.1016/S0028-3932(99)00060-3; GREDEN JF, 1980, BIOL PSYCHIAT, V15, P575; Green JR, 2013, AMYOTROPH LAT SCL FR, V14, P494, DOI 10.3109/21678421.2013.817585; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; GROSJEAN F, 1979, PHONETICA, V36, P98, DOI 10.1159/000259950; Hammen VL, 1996, J COMMUN DISORD, V29, P429, DOI 10.1016/0021-9924(95)00037-2; Huber JE, 2012, AM J SPEECH-LANG PAT, V21, P368, DOI 10.1044/1058-0360(2012/11-0059); Huber JE, 2011, J SPEECH LANG HEAR R, V54, P33, DOI 10.1044/1092-4388(2010/09-0184); Huber JE, 2008, RESP PHYSIOL NEUROBI, V164, P323, DOI 10.1016/j.resp.2008.08.007; Jung Y, 2013, SEMIN NEUROL, V33, P342, DOI 10.1055/s-0033-1359317; KENT RD, 1983, J SPEECH HEAR RES, V26, P231, DOI 10.1044/jshr.2602.231; Knibb JA, 2009, BRAIN, V132, P2734, DOI 10.1093/brain/awp207; LEE L, 1993, AM REV RESPIR DIS, V147, P1199, DOI 10.1164/ajrccm/147.5.1199; Lillo P, 2012, AMYOTROPH LATERAL SC, V13, P102, DOI 10.3109/17482968.2011.639376; Mattys SL, 2002, J MEM LANG, V47, P343, DOI 10.1016/S0749-596X(02)00037-2; Mitchell HL, 1996, J SPEECH HEAR RES, V39, P93, DOI 10.1044/jshr.3901.93; Moser BK, 2 SAMPLE T TEST VERS, P3963; Ogar JM, 2007, ALZ DIS ASSOC DIS, V21, pS23, DOI 10.1097/WAD.0b013e31815d19fe; Osborne RA, 2014, J NEUROL SCI, V336, P191, DOI 10.1016/j.jns.2013.10.038; Pakhomov SVS, 2010, COGN BEHAV NEUROL, V23, P165, DOI 10.1097/WNN.0b013e3181c5dde3; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; ROCHESTER SR, 1973, J PSYCHOLINGUIST RES, V2, P51, DOI 10.1007/BF01067111; Rodgers JD, 2013, J INT NEUROPSYCH SOC, V19, P173, DOI 10.1017/S1355617712001166; Rosen K, 2010, CLIN LINGUIST PHONET, V24, P141, DOI 10.3109/02699200903440983; Schilperoord J., 2002, CONT TOOLS TECHNIQUE, P61, DOI [DOI 10.1007/978-94-010-0468-8_4, 10.1007/978-94-010-0468-8_4]; Skodda S, 2008, MOVEMENT DISORD, V23, P985, DOI 10.1002/mds.21996; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Thompson CK, 2012, APHASIOLOGY, V26, P20, DOI 10.1080/02687038.2011.584691; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Wang YT, 2010, FOLIA PHONIATR LOGO, V62, P297, DOI 10.1159/000316976; Warkentin S, 2008, NEUROPSYCHOLOGIA, V46, P1193, DOI 10.1016/j.neuropsychologia.2007.08.029; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; WINKWORTH AL, 1994, J SPEECH HEAR RES, V37, P535, DOI 10.1044/jshr.3703.535; Woollams AM, 2012, NEUROPSYCHOLOGIA, V50, P3469, DOI 10.1016/j.neuropsychologia.2012.09.020; Yorkston KM., 1993, J MED SPEECH-LANG PA, V1, P35, DOI DOI 10.1044/1058-0360.0404.139	53	50	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147573	10.1371/journal.pone.0147573	http://dx.doi.org/10.1371/journal.pone.0147573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789001	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100091
J	Baumgart, DC; le Claire, M				Baumgart, Daniel C.; le Claire, Marie			The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds	PLOS ONE			English	Article							COSTS; CLASSIFICATION; SYSTEM	Background Crohn's disease (CD) and ulcerative colitis (UC) challenge economies worldwide. Detailed health economic data of DRG based academic inpatient care for inflammatory bowel disease (IBD) patients in Europe is unavailable. Methods IBD was identified through ICD-10 K50 and K51 code groups. We took an actual costing approach, compared expenditures to G-DRG and non-DRG proceeds and performed detailed cost center and type accounting to identify coverage determinants. Results Of all 3093 hospitalized cases at our department, 164 were CD and 157 UC inpatients in 2012. On average, they were 44.1 (CD 44.9 UC 43.3 all 58) years old, stayed 10.1 (CD 11.8 UC 8.4 vs. all 8) days, carried 5.8 (CD 6.4 UC 5.2 vs. all 6.8) secondary diagnoses, received 7.4 (CD 7.7 UC 7 vs. all 6.2) procedures, had a higher cost weight (CD 2.8 UC 2.4 vs. all 1.6) and required more intense nursing. Their care was more costly (means: total cost IBD 8477(sic)CD 9051(sic)UC 7903(sic) vs. all 5078(sic)). However, expenditures were not fully recovered by DRG proceeds (means: IBD 7413(sic), CD 8441(sic), UC 6384(sic) vs all 4758(sic)). We discovered substantial disease specific mismatches in cost centers and types and identified the medical ward personnel and materials budgets to be most imbalanced. Non-DRG proceeds were almost double (IBD 16.1% vs. all 8.2%), but did not balance deficits at total coverage analysis, that found medications (antimicrobials, biologics and blood products), medical materials (mostly endoscopy items) to contribute most to the deficit. Conclusions DRGs challenge sophisticated IBD care.	[Baumgart, Daniel C.] Humboldt Univ, Ctr Inflammatory Bowel Dis, Dept Gastroenterol & Hepatol, Charite Med Sch, D-10099 Berlin, Germany; [le Claire, Marie] Humboldt Univ, Enterprise Controlling, Charite Med Sch, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Baumgart, DC (corresponding author), Humboldt Univ, Ctr Inflammatory Bowel Dis, Dept Gastroenterol & Hepatol, Charite Med Sch, D-10099 Berlin, Germany.	daniel.baumgart@charite.de	Baumgart, Daniel C./AAU-2930-2021	Baumgart, Daniel C./0000-0003-2146-507X				[Anonymous], 2016, INT STAT CLASS DIS R, V5th ed., DOI DOI 10/2016/EN; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bernstein CN, 2012, INFLAMM BOWEL DIS, V18, P1498, DOI 10.1002/ibd.21878; Bernstein CN, 2000, AM J GASTROENTEROL, V95, P677; Busse R, 2011, DIAGNOSIS RELATED GR; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Cohen RD, 2010, ALIMENT PHARM THER, V31, P693, DOI 10.1111/j.1365-2036.2010.04234.x; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Farrokhyar F, 2002, CAN J GASTROENTEROL, V16, P519, DOI 10.1155/2002/619574; FETTER RB, 1976, YALE J BIOL MED, V49, P123; Ott C, 2008, EUR J GASTROEN HEPAT, V20, P917, DOI 10.1097/MEG.0b013e3282f97b33; Porter ME, 2015, REDEFINING GERMAN HL; Preyra C, 2004, HEALTH SERV RES, V39, P1027, DOI 10.1111/j.1475-6773.2004.00270.x; Quentin W, 2013, HEALTH AFFAIR, V32, P713, DOI 10.1377/hlthaff.2012.0876; Rogowski J R, 1990, Health Care Financ Rev, V12, P87; Scheller-Kreinsen D, 2011, VALUE HEALTH, V14, P1166, DOI 10.1016/j.jval.2011.07.001; Schreyogg Jonas, 2006, Health Care Manag Sci, V9, P215, DOI 10.1007/s10729-006-9040-1; Shiralkar AP, 2012, SAP NETWEAVER BW 7 3; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sutherland JM, 2015, HOSP PAYMENT MECH OV; Union E, 2006, OFFICIAL J EUROPEA C, VC323, P1; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; VULGAROPULOS SP, 1990, DIGEST DIS SCI, V35, P577, DOI 10.1007/BF01540404; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Yu AP, 2008, CURR MED RES OPIN, V24, P319, DOI 10.1185/03007990SX260790	26	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147364	10.1371/journal.pone.0147364	http://dx.doi.org/10.1371/journal.pone.0147364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784027	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400142
J	Ben-Dov, IZ; Whalen, VM; Goilav, B; Max, KEA; Tuschl, T				Ben-Dov, Iddo Z.; Whalen, Veronica M.; Goilav, Beatrice; Max, Klaas E. A.; Tuschl, Thomas			Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies	PLOS ONE			English	Article							EXPRESSION ANALYSIS; BIOCONDUCTOR	Background Urine is a potential source of biomarkers for diseases of the kidneys and urinary tract. RNA, including microRNA, is present in the urine enclosed in detached cells or in extracellular vesicles (EVs) or bound and protected by extracellular proteins. Detection of cell-and disease-specific microRNA in urine may aid early diagnosis of organ-specific pathology. In this study, we applied barcoded deep sequencing to profile microRNAs in urine of healthy volunteers, and characterized the effects of sex, urine fraction (cells vs. EVs) and repeated voids by the same individuals. Results Compared to urine-cell-derived small RNA libraries, urine-EV-derived libraries were relatively enriched with miRNA, and accordingly had lesser content of other small RNA such as rRNA, tRNA and sn/snoRNA. Unsupervised clustering of specimens in relation to miRNA expression levels showed prominent bundling by specimen type (urine cells or EVs) and by sex, as well as a tendency of repeated (first and second void) samples to neighbor closely. Likewise, miRNA profile correlations between void repeats, as well as fraction counterparts (cells and EVs from the same specimen) were distinctly higher than correlations between miRNA profiles overall. Differential miRNA expression by sex was similar in cells and EVs. Conclusions miRNA profiling of both urine EVs and sediment cells can convey biologically important differences between individuals. However, to be useful as urine biomarkers, careful consideration is needed for biofluid fractionation and sex-specific analysis, while the time of voiding appears to be less important.	[Ben-Dov, Iddo Z.] Hadassah Hebrew Univ, Med Ctr, Nephrol & Hypertens, Jerusalem, Israel; [Whalen, Veronica M.] Rockefeller Univ, Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA; [Goilav, Beatrice] Childrens Hosp Montefiore, Albert Einstein Coll Med, Pediat Nephrol, Bronx, NY USA; [Max, Klaas E. A.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Whalen, Veronica M.] Appeals Metro Plus Hlth Plan, New York, NY USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Rockefeller University	Ben-Dov, IZ (corresponding author), Hadassah Hebrew Univ, Med Ctr, Nephrol & Hypertens, Jerusalem, Israel.	iddo@hadassah.org.il	Ben-Dov, Iddo/F-3282-2010; Goilav, Beatrice/AAF-8349-2021	Ben-Dov, Iddo/0000-0002-9180-3604; 	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH [UH2TR000933]; NATIONAL CANCER INSTITUTE [U19CA179564] Funding Source: NIH RePORTER	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	IZB-D is supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 41/11). The work described in this manuscript was also supported by grant number UH2TR000933 awarded to TT by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dov IZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086856; Carey V, MLIINTERFACES UNIFOR; Emerson JW, 2008, BIOMETRICS, V64, P1301, DOI [10.1111/j.1541-0420.2008.01138_4.x, DOI 10.1111/J.1541-0420.2008.01138_]; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; International Federation of Clinical Chemistry (IFCC), 1984, CLIN CHIMICA ACTA, V139, p205F; Li X, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0039-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swayne DF, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P477; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027	15	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147249	10.1371/journal.pone.0147249	http://dx.doi.org/10.1371/journal.pone.0147249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785265	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400129
J	Irazoki, O; Mayola, A; Campoy, S; Barbe, J				Irazoki, Oihane; Mayola, Albert; Campoy, Susana; Barbe, Jordi			SOS System Induction Inhibits the Assembly of Chemoreceptor Signaling Clusters in Salmonella enterica	PLOS ONE			English	Article							ESCHERICHIA-COLI; SWARMING MOTILITY; PSEUDOMONAS-AERUGINOSA; CELL-DIFFERENTIATION; CHEMOTAXIS SYSTEM; RECA PROTEIN; WILD-TYPE; GENE; DNA; SURFACE	Swarming, a flagellar-driven multicellular form of motility, is associated with bacterial virulence and increased antibiotic resistance. In this work we demonstrate that activation of the SOS response reversibly inhibits swarming motility by preventing the assembly of chemoreceptor-signaling polar arrays. We also show that an increase in the concentration of the RecA protein, generated by SOS system activation, rather than another function of this genetic network impairs chemoreceptor polar cluster formation. Our data provide evidence that the molecular balance between RecA and CheW proteins is crucial to allow polar cluster formation in Salmonella enterica cells. Thus, activation of the SOS response by the presence of a DNA-injuring compound increases the RecA concentration, thereby disturbing the equilibrium between RecA and CheW and resulting in the cessation of swarming. Nevertheless, when the DNA-damage decreases and the SOS response is no longer activated, basal RecA levels and thus polar cluster assembly are reestablished. These results clearly show that bacterial populations moving over surfaces make use of specific mechanisms to avoid contact with DNA-damaging compounds.	[Irazoki, Oihane; Mayola, Albert; Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Edifici C, Bellaterra 08193, Barcelona, Spain	Autonomous University of Barcelona	Campoy, S (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Edifici C, Bellaterra 08193, Barcelona, Spain.	Susana.Campoy@uab.cat	campoy, susana/E-4346-2010; Campoy, Susana/C-7335-2008; Irazoki, Oihane/G-8416-2015	campoy, susana/0000-0003-1369-0197; Campoy, Susana/0000-0003-1369-0197; Irazoki, Oihane/0000-0002-8896-7480	Ministerio de Ciencia e Innovacion de Espana [BFU2011-23478]; Generalitat de Catalunya [2014SGR572]	Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants BFU2011-23478 from the Ministerio de Ciencia e Innovacion de Espana (http://www.idi.mineco.gob.es/) and 2014SGR572 from the Generalitat de Catalunya (http://web.gencat.cat).; This study was supported by grants BFU2011-23478 from the Ministerio de Ciencia e Innovacion de Espana and 2014SGR572 from the Generalitat de Catalunya. The funders had no role in the design of the study, in data collection and analysis, in the decision to publish, or in preparation of the manuscript.	Attmannspacher U, 2008, MOL MICROBIOL, V68, P328, DOI 10.1111/j.1365-2958.2008.06170.x; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Barak JD, 2009, MICROBIOL-SGM, V155, P3701, DOI 10.1099/mic.0.032029-0; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Bi SY, 2015, CELL MOL LIFE SCI, V72, P691, DOI 10.1007/s00018-014-1770-5; Brennan CA, 2013, APPL ENVIRON MICROB, V79, P1889, DOI 10.1128/AEM.03794-12; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; Cardozo MJ, 2010, MOL MICROBIOL, V75, P1171, DOI 10.1111/j.1365-2958.2009.07032.x; CAYROL C, 1995, P NATL ACAD SCI USA, V92, P11806, DOI 10.1073/pnas.92.25.11806; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Du HJ, 2012, BIOPHYS J, V103, P601, DOI 10.1016/j.bpj.2012.06.035; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gestwicki JE, 2000, J BACTERIOL, V182, P6499, DOI 10.1128/JB.182.22.6499-6502.2000; GINSBURG H, 1982, MOL GEN GENET, V187, P4, DOI 10.1007/BF00384376; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Green M, LAB MANUAL; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Ingham CJ, 2011, P NATL ACAD SCI USA, V108, P19731, DOI 10.1073/pnas.1102097108; Jurica MS, 1998, STRUCT FOLD DES, V6, P809, DOI 10.1016/S0969-2126(98)00082-3; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Khursigara CM, 2011, EMBO J, V30, P1719, DOI 10.1038/emboj.2011.77; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Kim W, 2003, J BACTERIOL, V185, P3111, DOI 10.1128/JB.185.10.3111-3117.2003; Kim Wook, 2003, Biological Procedures Online, V5, P189, DOI 10.1251/bpo61; Latasa C, 2012, J BACTERIOL, V194, P3708, DOI 10.1128/JB.00361-12; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; MADDOCK JR, 1993, SCIENCE, V259, P1717; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; Martinez I a., 2013, PLOS ONE, V8, P17, DOI [10.1371/journal.pone.0061630, DOI 10.1371/J0URNAL.P0NE.0061630]; Mayola A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105578; MCCARTER L, 1990, MOL MICROBIOL, V4, P1057, DOI 10.1111/j.1365-2958.1990.tb00678.x; Medina-Ruiz L, 2010, INFECT IMMUN, V78, P3217, DOI 10.1128/IAI.01321-09; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Nakajima K, 2008, BIOMED RES-TOKYO, V29, P9, DOI 10.2220/biomedres.29.9; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; POWER EGM, 1992, J MED MICROBIOL, V36, P78, DOI 10.1099/00222615-36-2-78; Raterman EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054133; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Roth D, 2013, ENVIRON MICROBIOL, V15, P2532, DOI 10.1111/1462-2920.12160; SALLES B, 1987, J BACTERIOL, V169, P5028, DOI 10.1128/jb.169.11.5028-5034.1987; Santos TMA, 2014, MOL MICROBIOL, V92, P985, DOI 10.1111/mmi.12609; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SCHOEMAKER JM, 1984, J BACTERIOL, V158, P551, DOI 10.1128/JB.158.2.551-561.1984; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; SWENSON PA, 1978, J BACTERIOL, V135, P1167, DOI 10.1128/JB.135.3.1167-1170.1978; WALKER GC, 1985, ENVIRON HEALTH PERSP, V62, P115, DOI 10.2307/3430102; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x	74	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146685	10.1371/journal.pone.0146685	http://dx.doi.org/10.1371/journal.pone.0146685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784887	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400058
J	Martin-Fernandez, L; Ziyatdinov, A; Carrasco, M; Millon, JA; Martinez-Perez, A; Vilalta, N; Brunel, H; Font, M; Hamsten, A; Souto, JC; Soria, JM				Martin-Fernandez, Laura; Ziyatdinov, Andrey; Carrasco, Marina; Antonio Millon, Juan; Martinez-Perez, Angel; Vilalta, Noelia; Brunel, Helena; Font, Montserrat; Hamsten, Anders; Carlos Souto, Juan; Manuel Soria, Jose			Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PLASMA; THROMBOEMBOLISM; SUSCEPTIBILITY; DISEASE; RISK; COAGULATION; HEMOSTASIS; PHENOTYPES; STROKE	Background Venous thromboembolism (VTE) is a common disease where known genetic risk factors explain only a small portion of the genetic variance. Then, the analysis of intermediate phenotypes, such as thrombin generation assay, can be used to identify novel genetic risk factors that contribute to VTE. Objectives To investigate the genetic basis of distinct quantitative phenotypes of thrombin generation and its relationship to the risk of VTE. Patients/Methods Lag time, thrombin peak and endogenous thrombin potential (ETP) were measured in the families of the Genetic Analysis of Idiopathic Thrombophilia 2 (GAIT-2) Project. This sample consisted of 935 individuals in 35 extended families selected through a proband with idiopathic thrombophilia. We performed also genome wide association studies (GWAS) with thrombin generation phenotypes. Results The results showed that 67% of the variation in the risk of VTE is attributable to genetic factors. The heritabilities of lag time, thrombin peak and ETP were 49%, 54% and 52%, respectively. More importantly, we demonstrated also the existence of positive genetic correlations between thrombin peak or ETP and the risk of VTE. Moreover, the major genetic determinant of thrombin generation was the F2 gene. However, other suggestive signals were observed. Conclusions The thrombin generation phenotypes are strongly genetically determined. The thrombin peak and ETP are significantly genetically correlated with the risk of VTE. In addition, F2 was identified as a major determinant of thrombin generation. We reported suggestive signals that might increase our knowledge to explain the variability of this important phenotype. Validation and functional studies are required to confirm GWAS results.	[Martin-Fernandez, Laura; Ziyatdinov, Andrey; Martinez-Perez, Angel; Brunel, Helena; Manuel Soria, Jose] Biomed Res Inst St Pau IIB St Pau, Unit Genom Complex Dis, Barcelona, Spain; [Carrasco, Marina; Antonio Millon, Juan; Vilalta, Noelia; Font, Montserrat; Carlos Souto, Juan] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Hematol, Unit Hemostasis & Thrombosis, Barcelona, Spain; [Hamsten, Anders] Karolinska Univ Hosp Solna, Karolinska Inst, Cardiovasc Genet & Genom Grp, Atherosclerosis Res Unit,Dept Med, Stockholm, Sweden	Hospital of Santa Creu i Sant Pau; Karolinska Institutet; Karolinska University Hospital	Souto, JC (corresponding author), Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Hematol, Unit Hemostasis & Thrombosis, Barcelona, Spain.	jsouto@santpau.cat	Soria Fernández, José Manuel/AAD-6761-2019; Martinez-Perez, Angel/AAC-4339-2019	Soria Fernández, José Manuel/0000-0002-6226-4293; Martinez-Perez, Angel/0000-0002-5934-1454; Martin-Fernandez, Laura/0000-0002-8909-508X; , Noelia Vilalta/0000-0002-3961-3563	Instituto de Salud Carlos III Fondo de Investigacion Sanitaria [PI 11/0184]; Red Investigacion Cardiovascular [RD12/0042/0032]; Generalitat de Catalunya [AGAUR 2009 SGR 1147]; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) [FI12/00322]; Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC)	Instituto de Salud Carlos III Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Red Investigacion Cardiovascular; Generalitat de Catalunya(Generalitat de Catalunya); Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS); Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC)	This study was supported by funds from the Instituto de Salud Carlos III Fondo de Investigacion Sanitaria PI 11/0184, Red Investigacion Cardiovascular RD12/0042/0032 and AGAUR 2009 SGR 1147 from Generalitat de Catalunya. Laura Martin-Fernandez was supported by Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) FI12/00322. Juan Antonio Millon was supported by Fundacio Josep Carreras contra la leucemia and Institut Josep Carreras (IJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Besser M, 2008, J THROMB HAEMOST, V6, P1720, DOI 10.1111/j.1538-7836.2008.03117.x; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Comuzzie AG, 1996, J CLIN ENDOCR METAB, V81, P597, DOI 10.1210/jc.81.2.597; Dargaud Y, 2006, THROMB HAEMOSTASIS, V96, P562, DOI 10.1160/TH06-03-0179; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; Faber CG, 2003, PATHOPHYSIOL HAEMO T, V33, P52, DOI 10.1159/000071642; Heit JA, 2004, J THROMB HAEMOST, V2, P731, DOI 10.1111/j.1538-7933.2004.00660.x; Hemker HC, 2000, THROMB HAEMOSTASIS, V84, P747; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Kyrle PA, 1998, ARTERIOSCL THROM VAS, V18, P1287, DOI 10.1161/01.ATV.18.8.1287; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; Lynch M., 1998, GENETICS ANAL QUANTI; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morange PE, 2010, BRIT J HAEMATOL, V148, P495, DOI 10.1111/j.1365-2141.2009.07975.x; Orbe J, 2008, THROMB HAEMOSTASIS, V99, P382, DOI 10.1160/TH07-07-0443; Rocanin-Arjo A, 2014, BLOOD, V123, P777, DOI 10.1182/blood-2013-10-529628; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal Frits R, 2005, Hematology Am Soc Hematol Educ Program, P1; Segers O, 2010, THROMB HAEMOSTASIS, V103, P114, DOI 10.1160/TH09-06-0356; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2002, PATHOPHYSIOL HAEMO T, V32, P338, DOI 10.1159/000073593; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Souto JC, 2001, THROMB HAEMOSTASIS, V85, P88; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Tripodi A, 2008, J THROMB HAEMOST, V6, P1327, DOI 10.1111/j.1538-7836.2008.03018.x; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Vlieg AV, 2007, BRIT J HAEMATOL, V138, P769, DOI 10.1111/j.1365-2141.2007.06738.x; Wichers IM, 2009, THROMB HAEMOSTASIS, V101, P465, DOI 10.1160/TH08-06-0405	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146922	10.1371/journal.pone.0146922	http://dx.doi.org/10.1371/journal.pone.0146922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784699	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400079
J	Miyashita, A; Kizaki, H; Sekimizu, K; Kaito, C				Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara			No Effect of Body Size on the Frequency of Calling and Courtship Song in the Two-Spotted Cricket, Gryllus bimaculatus	PLOS ONE			English	Article							VOCAL-TRACT LENGTH; SOUND PRODUCTION; FIELD CRICKET; SYMMETRY; SIGNALS; GEER	The relationship between body size and vocalization parameters has been studied in many animal species. In insect species, however, the effect of body size on song frequency has remained unclear. Here we analyzed the effect of body size on the frequency spectra of mating songs produced by the two-spotted cricket, Gryllus bimaculatus. We recorded the calling songs and courtship songs of male crickets of different body sizes. The calling songs contained a frequency component that peaked at 5.7 kHz. On the other hand, courtship songs contained two frequency components that peaked at 5.8 and 14.7 kHz. The dominant frequency of each component in both the calling and courtship songs was constant regardless of body size. The size of the harp and mirror regions in the cricket forewings, which are the acoustic sources of the songs, correlated positively with body size. These findings suggest that the frequency contents of both the calling and courtship songs of the cricket are unaffected by whole body, harp, or mirror size.	[Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Japan Society for the Promotion of Science [26670025, 25-8664]; Mishima Kaiun Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This study was supported by Grants-in-Aid for Scientific Research 26670025, the Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 25-8664 (to A.M.), and the Mishima Kaiun Memorial Foundation (to A.M.). The funders had no role in the study design, data collection, or analysis; decision to publish; or preparation of the manuscript.	Bennet-Clark HC, 2002, J EXP BIOL, V205, P613; Cardoso GC, 2008, ETHOLOGY, V114, P1084, DOI 10.1111/j.1439-0310.2008.01552.x; DOHERTY JA, 1985, J EXP BIOL, V114, P17; ELLIOTT CJH, 1985, NATURWISSENSCHAFTEN, V72, P150, DOI 10.1007/BF00490404; Ferreira M, 2002, J ZOOL, V257, P163, DOI 10.1017/S0952836902000766; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Hall ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056717; KATSUKI Y, 1960, J EXP BIOL, V37, P279; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; LIBERSAT F, 1994, J COMP PHYSIOL A, V174, P485, DOI 10.1007/BF00191714; McClelland BE, 1996, J EXP BIOL, V199, P1907; Montealegre-Z F, 2012, SCIENCE, V338, P968, DOI 10.1126/science.1225271; POPOV AV, 1977, J COMP PHYSIOL, V119, P111, DOI 10.1007/BF00655876; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Riede T, 1999, J EXP BIOL, V202, P2859; Rodriguez RL, 2015, BEHAV ECOL, V26, P168, DOI 10.1093/beheco/aru174; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; Simmons LW, 1995, BEHAV ECOL, V6, P376, DOI 10.1093/beheco/6.4.376; STEPHEN RO, 1995, J EXP BIOL, V198, P2139; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; WEBB KL, 1992, ANIM BEHAV, V44, P823, DOI 10.1016/S0003-3472(05)80578-0; Yamamoto K, 2000, DYN DES C 2000, P333	24	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146999	10.1371/journal.pone.0146999	http://dx.doi.org/10.1371/journal.pone.0146999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785351	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400095
J	Murakami, Y; Hashimoto, S; Kawado, M; Ohta, A; Taniguchi, K; Sunagawa, T; Matsui, T; Nagai, M				Murakami, Yoshitaka; Hashimoto, Shuji; Kawado, Miyuki; Ohta, Akiko; Taniguchi, Kiyosu; Sunagawa, Tomimasa; Matsui, Tamano; Nagai, Masaki			Estimated Number of Patients with Influenza A(H1)pdm09, or Other Viral Types, from 2010 to 2014 in Japan	PLOS ONE			English	Article							SURVEILLANCE DATA; DISEASES; LESSONS	Infectious disease surveillance systems provide information crucial for protecting populations from influenza epidemics. However, few have reported the nationwide number of patients with influenza-like illness (ILI), detailing virological type. Using data from the infectious disease surveillance system in Japan, we estimated the weekly number of ILI cases by virological type, including pandemic influenza (A(H1)pdm09) and seasonal-type influenza (A(H3) and B) over a four-year period (week 36 of 2010 to week 18 of 2014). We used the reported number of influenza cases from nationwide sentinel surveillance and the proportions of virological types from infectious agents surveillance and estimated the number of cases and their 95% confidence intervals. For the 2010/11 season, influenza type A(H1) pdm09 was dominant: 6.48 million (6.33-6.63), followed by types A(H3): 4.05 million (3.90-4.21) and B: 2.84 million (2.71-2.97). In the 2011/12 season, seasonal influenza type A(H3) was dominant: 10.89 million (10.64-11.14), followed by type B: 5.54 million (5.32-5.75). In conclusion, close monitoring of the estimated number of ILI cases by virological type not only highlights the huge impact of previous influenza epidemics in Japan, it may also aid the prediction of future outbreaks, allowing for implementation of control and prevention measures.	[Murakami, Yoshitaka] Toho Univ, Dept Med Stat, Tokyo, Japan; [Hashimoto, Shuji; Kawado, Miyuki] Fujita Hlth Univ, Sch Med, Dept Hyg, Toyoake, Aichi, Japan; [Ohta, Akiko; Nagai, Masaki] Saitama Med Univ, Dept Publ Hlth, Fac Med, Saitama, Japan; [Taniguchi, Kiyosu] Natl Mie Hosp, Dept Pediat, Tsu, Mie, Japan; [Sunagawa, Tomimasa; Matsui, Tamano] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Toho University; Fujita Health University; Saitama Medical University; National Institute of Infectious Diseases (NIID)	Murakami, Y (corresponding author), Toho Univ, Dept Med Stat, Tokyo, Japan.	yoshitaka.murakami@med.toho-u.ac.jp	Kawado, Miyuki/GPW-9240-2022	Kawado, Miyuki/0000-0002-5824-3289	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease)	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease)	This research was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Emerging and Re-emerging Infectious Disease). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 2002, STAT METHODS MED RES, P161; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Hashimoto S, 2003, J EPIDEMIOL, V13, P136, DOI 10.2188/jea.13.136; Hashimoto S, 2014, J EPIDEMIOL, V24, P183, DOI 10.2188/jea.JE20130077; Kawado M, 2007, J EPIDEMIOL, V17, pS32, DOI 10.2188/jea.17.S32; Lee JS, 2007, EPIDEMIOL INFECT, V135, P1117, DOI 10.1017/S0950268807007820; Nakamura Y, 2015, JPN J INFECT DIS, V68, P27, DOI 10.7883/yoken.JJID.2014.092; Ohshiro H, 1996, J Epidemiol, V6, pS81; Ohta A, 2014, JPN J INFECT DIS, V67, P368, DOI 10.7883/yoken.67.368; Reed C, 2014, MMWR-MORBID MORTAL W, V63, P1151; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shimada T, 2009, EUROSURVEILLANCE, V14; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Tuberculosis and Infectious Diseases Control Division Health Service Bureau the Ministry of Health Labour and Welfare of Japan, 1999, WEEKLY NEWS PUBLIC H, V998, P14; Wang XL, 2010, EMERG INFECT DIS, V16, P1786, DOI 10.3201/eid1611.100323	17	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146520	10.1371/journal.pone.0146520	http://dx.doi.org/10.1371/journal.pone.0146520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784031	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400043
J	Ravva, SV; Sarreal, CZ				Ravva, Subbarao V.; Sarreal, Chester Z.			Persistence of F-Specific RNA Coliphages in Surface Waters from a Produce Production Region along the Central Coast of California	PLOS ONE			English	Article							MICROBIAL SOURCE TRACKING; TROPICAL URBAN CATCHMENT; ESCHERICHIA-COLI; ENTERIC VIRUSES; FECAL CONTAMINATION; RIVER WATER; WASTE-WATER; Q-BETA; SURVIVAL; BACTERIOPHAGES	F+RNA coliphages (FRNA) are used to source-track fecal contamination and as surrogates for enteric pathogen persistence in the environment. However, the environmental persistence of FRNA is not clearly understood and necessitates the evaluation of the survival of prototype and environmental isolates of FRNA representing all four genogroups in surface waters from the central coast of California. Water temperature played a significant role in persistence-all prototype and environmental strains survived significantly longer at 10 degrees C compared to 25 degrees C. Similarly, the availability of host bacterium was found to be critical in FRNA survival. In the absence of E. coli F-amp, all prototypes of FRNA disappeared rapidly with a D-value (days for one log reduction) of < 1.2 d from water samples incubated at 25 degrees C; the longest surviving prototype was SP. However, in the presence of the host, the order of persistence at 25 degrees C was QB>MS2>SP>GA and at 10 degrees C it was QB = MS2> GA> SP. Significant differences in survival were observed between prototypes and environmental isolates of FRNA. While most environmental isolates disappeared rapidly at 25 degrees C and in the absence of the host, members of genogroups GIII and GI persisted longer with the host compared to members of GII and GIV. Consequentially, FRNA based source tracking methods can be used to detect phages from recent fecal contamination along with those that persist longer in the environment as a result of cooler temperatures and increased host presence.	[Ravva, Subbarao V.; Sarreal, Chester Z.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	subbarao.ravva@ars.usda.gov			U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project [2030-42000-046]	U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project	The work was funded by the U.S. Department of Agricuture (USDA), Agricultural Research Service CRIS project 2030-42000-046.	Allwood PB, 2004, J FOOD PROTECT, V67, P2387, DOI 10.4315/0362-028X-67.11.2387; [Anonymous], 2001, 821R01030 USEPA; Ballester Nicola A., 2005, Journal of Water and Health, V3, P59; Benjamin LA, 2015, EPIDEMIOL INFECT, V143, P81, DOI 10.1017/S0950268814000521; Benjamin L, 2013, INT J FOOD MICROBIOL, V165, P65, DOI 10.1016/j.ijfoodmicro.2013.04.003; Blanch AR, 2006, APPL ENVIRON MICROB, V72, P5915, DOI 10.1128/AEM.02453-05; Brion GM, 2002, WATER RES, V36, P2419, DOI 10.1016/S0043-1354(01)00547-4; Cole D, 2003, APPL ENVIRON MICROB, V69, P6507, DOI 10.1128/AEM.69.11.6507-6514.2003; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; FURUSE K, 1979, MICROBIOL IMMUNOL, V23, P867, DOI 10.1111/j.1348-0421.1979.tb02820.x; FURUSE K, 1978, APPL ENVIRON MICROB, V35, P995, DOI 10.1128/AEM.35.6.995-1002.1978; Gordon C, 2003, J APPL MICROBIOL, V95, P536, DOI 10.1046/j.1365-2672.2003.02010.x; Gourmelon M, 2010, WATER RES, V44, P4812, DOI 10.1016/j.watres.2010.07.061; Haramoto E, 2012, LETT APPL MICROBIOL, V54, P367, DOI 10.1111/j.1472-765X.2012.03221.x; Haramoto E, 2011, T ROY SOC TROP MED H, V105, P711, DOI 10.1016/j.trstmh.2011.08.004; HAVELAAR AH, 1993, APPL ENVIRON MICROB, V59, P2956, DOI 10.1128/AEM.59.9.2956-2962.1993; HAVELAAR AH, 1990, J APPL BACTERIOL, V69, P30, DOI 10.1111/j.1365-2672.1990.tb02908.x; Kirs M, 2007, APPL ENVIRON MICROB, V73, P808, DOI 10.1128/AEM.00399-06; Lee JE, 2011, SCI TOTAL ENVIRON, V412, P127, DOI 10.1016/j.scitotenv.2011.09.061; Liang L, 2015, APPL ENVIRON MICROB, V81, P850, DOI 10.1128/AEM.02670-14; Long SC, 2004, J WATER HEALTH, V2, P15, DOI 10.2166/wh.2004.0002; Love DC, 2008, J APPL MICROBIOL, V104, P1203, DOI 10.1111/j.1365-2672.2007.03646.x; Mieszkin S, 2013, J APPL MICROBIOL, V115, P897, DOI 10.1111/jam.12260; Mills S, 2013, GUT MICROBES, V4, P4, DOI 10.4161/gmic.22371; Muniesa M, 2009, WATER RES, V43, P1559, DOI 10.1016/j.watres.2008.12.038; Ogorzaly L, 2010, APPL ENVIRON MICROB, V76, P8019, DOI 10.1128/AEM.00917-10; Ogorzaly L, 2009, WATER RES, V43, P1257, DOI 10.1016/j.watres.2008.12.011; RAO VC, 1984, APPL ENVIRON MICROB, V48, P404, DOI 10.1128/AEM.48.2.404-409.1984; Ravva SV, 2015, ENVIRON SCI-PROC IMP, V17, P1249, DOI [10.1039/c4em00537f, 10.1039/C4EM00537F]; Rezaeinejad S, 2014, WATER RES, V58, P122, DOI 10.1016/j.watres.2014.03.051; Schaper M, 2002, APPL ENVIRON MICROB, V68, P3702, DOI 10.1128/AEM.68.8.3702-3707.2002; Sinton LW, 1999, APPL ENVIRON MICROB, V65, P3605; Skraber S, 2007, WATER SCI TECHNOL, V55, P377, DOI 10.2166/wst.2007.280; Tung-Thompson G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134277; Wilkes G, 2014, APPL ENVIRON MICROB, V80, P3708, DOI 10.1128/AEM.00254-14; Woody MA, 1997, J APPL MICROBIOL, V82, P431, DOI 10.1046/j.1365-2672.1997.00130.x; WOODY MA, 1995, APPL ENVIRON MICROB, V61, P1520, DOI 10.1128/AEM.61.4.1520-1526.1995; Yang YH, 2013, APPL ENVIRON MICROB, V79, P4564, DOI 10.1128/AEM.00612-13; YATES MV, 1985, APPL ENVIRON MICROB, V49, P778, DOI 10.1128/AEM.49.4.778-781.1985	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146623	10.1371/journal.pone.0146623	http://dx.doi.org/10.1371/journal.pone.0146623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784030	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400054
J	Wiltink, J; Hoyer, J; Beutel, ME; Ruckes, C; Herpertz, S; Joraschky, P; Koranyi, S; Michal, M; Nolting, B; Pohlmann, K; Salzer, S; Strauss, B; Leibing, E; Leichsenring, F				Wiltink, Joerg; Hoyer, Juergen; Beutel, Manfred E.; Ruckes, Christian; Herpertz, Stephan; Joraschky, Peter; Koranyi, Susan; Michal, Matthias; Nolting, Bjoern; Poehlmann, Karin; Salzer, Simone; Strauss, Bernhard; Leibing, Eric; Leichsenring, Falk			Do Patient Characteristics Predict Outcome of Psychodynamic Psychotherapy for Social Anxiety Disorder?	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; INTERPERSONAL PROBLEMS; PANIC DISORDER; PHOBIA	Objectives Little is known about patient characteristics as predictors for outcome in manualized short term psychodynamic psychotherapy (PDT). No study has addressed which patient variables predict outcome of PDT for social anxiety disorder. Research Design and Methods In the largest multicenter trial on psychotherapy of social anxiety (SA) to date comparing cognitive therapy, PDT and wait list condition N = 230 patients were assigned to receive PDT, of which N = 166 completed treatment. Treatment outcome was assessed based on diverse parameters such as endstate functioning, remission, response, and drop-out. The relationship between patient characteristics (demographic variables, mental co-morbidity, personality, interpersonal problems) and outcome was analysed using logistic and linear regressions. Results Pre-treatment SA predicted up to 39 percent of variance of outcome. Only few additional baseline characteristics predicted better treatment outcome (namely, lower comorbidity and interpersonal problems) with a limited proportion of incremental variance (5.5 to 10 percent), while, e.g., shame, self-esteem or harm avoidance did not. Conclusions We argue that the central importance of pre-treatment symptom severity for predicting outcomes should advocate alternative treatment strategies (e.g. longer treatments, combination of psychotherapy and medication) in those who are most disturbed. Given the relatively small amount of variance explained by the other patient characteristics, process variables and patient-therapist interaction should additionally be taken into account in future research.	[Wiltink, Joerg; Beutel, Manfred E.; Michal, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Hoyer, Juergen] Tech Univ Dresden, Clin Psychol & Psychotherapy, D-01062 Dresden, Germany; [Ruckes, Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Interdisciplinary Ctr Clin Trials IZKS, D-55122 Mainz, Germany; [Herpertz, Stephan] Ruhr Univ Bochum, LWL Univ Clin Bochum, Clin Psychosomat Med & Psychotherapy, Univ Str 150, Bochum, Germany; [Joraschky, Peter; Poehlmann, Karin] Tech Univ Dresden, Clin Psychotherapy & Psychosomat Med, D-01062 Dresden, Germany; [Koranyi, Susan; Strauss, Bernhard] Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Nolting, Bjoern] Clin Psychosomat & Psychotherapeut Med, Esslingen, Germany; [Salzer, Simone; Leibing, Eric] Univ Goettingen, Univ Med, Clin Psychosomat Med & Psychotherapy, Gottingen, Germany; [Leichsenring, Falk] Univ Giessen, Clin Psychosomat & Psychotherapy, D-35390 Giessen, Germany	Johannes Gutenberg University of Mainz; Technische Universitat Dresden; Johannes Gutenberg University of Mainz; Ruhr University Bochum; Technische Universitat Dresden; Friedrich Schiller University of Jena; University of Gottingen; Justus Liebig University Giessen	Wiltink, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany.	joerg.wiltink@unimedizin-mainz.de	Hoyer, Juergen/AAP-6071-2020	Hoyer, Juergen/0000-0002-1697-6732	German Ministry of Education and Research (BMBF) [01GV0607]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant of the German Ministry of Education and Research (BMBF), 01GV0607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a grant of the German Ministry of Education and Research (BMBF), 01GV0607; Controlled-trials.com/ISRCTN53517394.	Bandelow B, 2006, J CLIN PSYCHIAT, V67, P1428, DOI 10.4088/JCP.v67n0914; Bandelow B, 2015, INT CLIN PSYCHOPHARM, V30, P183, DOI 10.1097/YIC.0000000000000078; Bandelow B, 2014, DTSCH ARZTEBL INT, V111, P473, DOI 10.3238/arztebl.2014.0473; Barber J.P., 2013, BERGIN AND GARFIELD, V6th, P443; Barber JP, 2012, J CLIN PSYCHIAT, V73, P66, DOI 10.4088/JCP.11m06831; Birtchnell J, 2014, CLIN PSYCHOL PSYCHOT, V21, P62, DOI 10.1002/cpp.1819; Bohart A.C., 2013, BERGIN GARFIELDS HDB, V6, P219, DOI DOI 10.1093/SCHBUL/SBP148; Brown T. A., 1994, ANXIETY DISORDERS IN; Clarkin J. F., 2004, HDB PSYCHOTHERAPY BE, V5th, P194; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Deusinger IM, 1986, FRANKFURT SELF CONCE; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; GABBARD GO, 1992, B MENNINGER CLIN, V56, pA3; Gloster AT, 2015, PSYCHOTHER PSYCHOSOM, V84, P100, DOI 10.1159/000370162; Hautzinger M., 1995, BECK DEPRESSION INVE; HOROWITZ LM, 1993, J CONSULT CLIN PSYCH, V61, P549, DOI 10.1037/0022-006X.61.4.549; Horowitz LM, 2000, INVENTORY ASSESSMENT; Hoyer J, 2016, CLIN PSYCHOL PSYCHOT, V23, P35, DOI 10.1002/cpp.1936; Kocherscheidt K., 2002, Z DIFFERENTIELLE DIA, V23, P217, DOI [10.1024//0170-1789.23.2.217, DOI 10.1024//0170-1789.23.2.217]; Krebs H, 1998, PERS INDIV DIFFER, V24, P805, DOI 10.1016/S0191-8869(98)00008-7; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Lambert M.J., 2013, BERGIN GARFIELDS HDB, V6th ed., P169; Leichsenring F, 2009, PSYCHOTHER PSYCHOSOM, V78, P35, DOI 10.1159/000162299; Leichsenring F, 2007, B MENNINGER CLIN, V71, P56, DOI 10.1521/bumc.2007.71.1.56; Leichsenring F, 2014, AM J PSYCHIAT, V171, P1074, DOI 10.1176/appi.ajp.2014.13111514; Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI [10.1176/appi.ajp.2013.13060744r, 10.1176/appi.ajp.2013.12081125]; Levy KN, 2011, J CLIN PSYCHOL, V67, P193, DOI 10.1002/jclp.20756; Liebowitz MR, 2005, J CLIN PSYCHIAT, V66, P238, DOI 10.4088/JCP.v66n0213; Lincoln TM, 2005, PSYCHOTHER RES, V15, P210, DOI 10.1080/10503300512331387834; Luborsky L., 1984, PRINCIPLES PSYCHOANA; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; Milrod BL, 2007, J CLIN PSYCHIAT, V68, P885, DOI 10.4088/JCP.v68n0610; Mortberg E, 2007, PSYCHIAT RES, V152, P81, DOI 10.1016/j.psychres.2006.10.003; Norcross JC., 2011, PSYCHOTHERAPY RELATI, V2nd; Renner F, 2012, J AFFECT DISORDERS, V138, P458, DOI 10.1016/j.jad.2011.12.044; Salzer S, 2008, J PERS ASSESS, V90, P292, DOI 10.1080/00223890701885076; Stangier U, 2011, ARCH GEN PSYCHIAT, V68, P692, DOI 10.1001/archgenpsychiatry.2011.67; Uhmann S, 2010, J NERV MENT DIS, V198, P846, DOI 10.1097/NMD.0b013e3181f98063; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen H-U., 1997, STRUCTURED CLIN INTE	40	13	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147165	10.1371/journal.pone.0147165	http://dx.doi.org/10.1371/journal.pone.0147165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785255	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400117
J	Li, B; Du, CL; Yuan, XZ; Willison, JHM; Xiao, HY				Li, Bo; Du, Chunlan; Yuan, Xingzhong; Willison, J. H. Martin; Xiao, Hongyan			Suitability of Taxodium distichum for Afforesting the Littoral Zone of the Three Gorges Reservoir	PLOS ONE			English	Article							RIPARIAN VEGETATION; FORESTED WETLANDS; ORGANIC-MATTER; CARBON POOLS; WATER-LEVEL; WINYAH BAY; SEED BANKS; KNEE ROOTS; L. RICH.; GROWTH	The littoral zone ecosystem of the Three Gorges Reservoir (TGR) has become significantly degraded by annual cycles of prolonged winter flooding and summer drought. For purposes of flood control and sediment management, the water level in the reservoir is lowered by 30 m during the summer monsoon season and raised again to 175 m above sea level each year at the end of the monsoon period. To explore an effective way to promote biodiversity and associated ecosystem services, we examined Taxodium distichum as a species for afforesting the littoral zone. Sapling growth variations were measured after two rounds of winter flooding. Dominant influence factors were determined by redundancy analysis. Herb community similarities between the experimental afforested areas and nearby control areas were assessed to detect the ecosystem influence of the experimental afforestation. 94.5% of saplings planted at elevations above 168 m survived. All measured growth indices (tree height, diameter at breast height, crown width and foliage density) decreased as the flood depth increased. Completely submerged saplings had a mean dieback height of -0.65 m. Greater initial foliage density led to increased tree height and stem diameter. Shannon-Wiener indices were not significantly different between plots in experimental and control areas, but the low similarity of herb communities between experimental and control areas (0.242 on average) suggested that afforestation would enrich plant community structure and improve littoral zone ecosystem stability. Because littoral zone afforestation provides several ecosystem services (habitat, carbon sink, water purification and landscaping), it is a promising revegetation model for the TGR.	[Li, Bo; Du, Chunlan] Chongqing Univ, Fac Architecture & Urban Planning, Chongqing 630044, Peoples R China; [Li, Bo] Chongqing Univ, Postdoctoral Stn Urban Rural Planning, Chongqing 630044, Peoples R China; [Yuan, Xingzhong] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China; [Willison, J. H. Martin] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada; [Xiao, Hongyan] Yangtze Normal Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University; Dalhousie University; Yangtze Normal University	Du, CL (corresponding author), Chongqing Univ, Fac Architecture & Urban Planning, Chongqing 630044, Peoples R China.; Yuan, XZ (corresponding author), Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 630044, Peoples R China.	cldu@163.com; xzyuan63@aliyun.com		Willison, J.H. Martin/0000-0003-3024-296X	National Natural Science Foundation of China [51278505]; Postdoctoral Foundation of China [2014M550458]; Special Postdoctoral Science Fund of Chongqing [Xm2014098]; Pengxi River Wetland Natural Reserve Management Bureau; Pengxi River Wetland Research Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Special Postdoctoral Science Fund of Chongqing; Pengxi River Wetland Natural Reserve Management Bureau; Pengxi River Wetland Research Station	This work was supported by the National Natural Science Foundation of China (grant number: 51278505 http://www.nsfc.gov.cn/publish/portal1/). This funder will afford the publication fee. It was also supported by the Postdoctoral Foundation of China (grant number: 2014M550458, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx) and Special Postdoctoral Science Fund of Chongqing (grant number: Xm2014098, URL: http://zhuanji.cqhrss.gov.cn/u/zhuanji/). These funders support for the preparation work of this manuscript.; We appreciate support from the Pengxi River Wetland Natural Reserve Management Bureau and the Pengxi River Wetland Research Station. We thank Kang Liu for his excellent picture of the LWE in Hanfeng Lake (Fig 5). The field assistance of Yazhou Huang is gratefully acknowledged.	Ai LiJiao, 2013, Journal of Nanjing Forestry University (Natural Sciences Edition), V37, P23; Awad J, 2015, SCI TOTAL ENVIRON, V529, P72, DOI 10.1016/j.scitotenv.2015.05.037; Berkley J, 2013, ECOL SOC, V18, DOI 10.5751/ES-05988-180469; Bernal B, 2012, GLOBAL CHANGE BIOL, V18, P1636, DOI 10.1111/j.1365-2486.2011.02619.x; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Butt MJ, 2010, WATER RESOUR MANAG, V24, P3701, DOI 10.1007/s11269-010-9627-7; Chen FangQing, 2015, Ecological Processes, V4; Chow AT, 2013, BIOGEOCHEMISTRY, V112, P571, DOI 10.1007/s10533-012-9750-z; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clewell AF, 1999, RESTOR ECOL, V7, P1, DOI 10.1046/j.1526-100X.1999.07101.x; CONNER WH, 1992, AM MIDL NAT, V127, P290, DOI 10.2307/2426535; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Day RH, 2006, ENVIRON EXP BOT, V55, P163, DOI 10.1016/j.envexpbot.2004.10.009; de Lima JA, 2009, REV ARVORE, V33, P685, DOI 10.1590/S0100-67622009000400011; Ernst KA, 2003, FOREST ECOL MANAG, V173, P261, DOI 10.1016/S0378-1127(02)00004-X; Faulkner SP, 2009, WETLANDS, V29, P809, DOI 10.1672/08-211.1; Giese LAB, 2003, FOREST ECOL MANAG, V180, P493, DOI 10.1016/S0378-1127(02)00644-8; Godinho C, 2010, ECOL RES, V25, P283, DOI 10.1007/s11284-009-0655-9; Gois KS, 2012, HYDROBIOLOGIA, V685, P109, DOI 10.1007/s10750-011-0843-9; Goni MA, 2003, ESTUAR COAST SHELF S, V57, P1023, DOI 10.1016/S0272-7714(03)00008-8; Haynes R. J., 2004, Ecological Restoration, V22, P170, DOI 10.3368/er.22.3.170; Hoeppner SS, 2008, FOREST ECOL MANAG, V256, P937, DOI 10.1016/j.foreco.2008.05.040; Holland EP, 2013, AUSTRAL ECOL, V38, P121, DOI 10.1111/j.1442-9993.2012.02384.x; HOSNER JF, 1958, ECOLOGY, V39, P371, DOI 10.2307/1931886; Jimenez MN, 2014, AGROFOREST SYST, V88, P935, DOI 10.1007/s10457-014-9737-y; Keeland BD, 1999, WETLANDS, V19, P149, DOI 10.1007/BF03161743; Keeland BD, 1997, WETLANDS, V17, P559, DOI 10.1007/BF03161522; Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394; Li B, 2011, ECOL ENG, V37, P1718, DOI 10.1016/j.ecoleng.2011.06.028; Li CX, 2010, WETL ECOL MANAG, V18, P485, DOI 10.1007/s11273-010-9181-3; Li CX, 2010, PLANT SOIL, V329, P481, DOI 10.1007/s11104-009-0174-z; Li ChangXiao, 2008, Scientia Silvae Sinicae, V44, P124; [李昌晓 LI ChangXiao], 2007, [生态学报, Acta Ecologica Sinica], V27, P4394; Li Y, 2014, FOREST ECOL MANAG, V327, P118, DOI 10.1016/j.foreco.2014.04.039; Liu Y, 2013, ENVIRON SCI POLLUT R, V20, P7142, DOI 10.1007/s11356-013-1896-2; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Matic V, 2009, ARCH BIOL SCI, V61, P475, DOI 10.2298/ABS0903475M; McKee SE, 2013, BIOMASS BIOENERG, V55, P130, DOI 10.1016/j.biombioe.2013.01.022; Middleton B, 2000, PLANT ECOL, V146, P169; Middleton BA, 2003, J APPL ECOL, V40, P1025, DOI 10.1111/j.1365-2664.2003.00866.x; Middleton BA., 2002, FLOOD PULSING WETLAN, P1; Mitsch WJ, 2013, LANDSCAPE ECOL, V28, P583, DOI 10.1007/s10980-012-9758-8; Mitsch WJ, 2007, WETLANDS, P201; MYERS RS, 1995, WETLANDS, V15, P141, DOI 10.1007/BF03160667; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Newmaster SG, 2006, CAN J FOREST RES, V36, P1218, DOI 10.1139/X06-021; Riggsbee JA, 2012, RIVER RES APPL, V28, P1439, DOI 10.1002/rra.1536; SCHIFF SL, 1990, WATER RESOUR RES, V26, P2949, DOI 10.1029/WR026i012p02949; Senzota R, 2010, AFR J ECOL, V48, P321, DOI 10.1111/j.1365-2028.2009.01110.x; Skeesick DG., 1991, WARMWATER FISHERIES, P149; Su XL, 2010, ACTA ECOLOGICA SINIC, V30, P2582; Sun Rong, 2011, Shengtaixue Zazhi, V30, P208; Susskind L, 2012, J APPL ECOL, V49, P47, DOI 10.1111/j.1365-2664.2011.02070.x; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; [谭淑端 TAN Shu-Duan], 2009, [生态学报, Acta Ecologica Sinica], V29, P3685; Tang Luo-Zhong, 2008, Zhiwu Shengtai Xuebao, V32, P1258, DOI 10.3773/j.issn.1005-264x.2008.06.006; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Waiser MJ, 2004, BIOGEOCHEMISTRY, V69, P263, DOI 10.1023/B:BIOG.0000031048.20050.4e; Wang GB, 2012, S AFR J BOT, V81, P71, DOI 10.1016/j.sajb.2012.05.008; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; Wang Q, 2009, J CHONGQING NORMAL U, V26, P48; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100889; [王晓荣 Wang Xiaorong], 2010, [生态学报, Acta Ecologica Sinica], V30, P5821; Wang YH, 2013, J SICHUAN FORESTRY S, V34, P10; [王育松 Wang Yusong], 2010, [山西大学学报. 自然科学版, Journal of Shanxi University], V33, P312; Watson JEM, 2005, BIODIVERS CONSERV, V14, P523, DOI 10.1007/s10531-004-3913-8; Willison JHM, 2013, ENVIRON SCI POLLUT R, V20, P6907, DOI 10.1007/s11356-012-1438-3; Xian XD, 2015, ENVIRON SCI POLLUT R, V22, P12576, DOI 10.1007/s11356-015-4524-5; Xiao Y, 2009, AQUAT BOT, V91, P231, DOI 10.1016/j.aquabot.2009.07.001; Xu Haigen, 2012, NeoBiota, V15, P1; Xu SJ, 2011, ACTA PEDOLOGICA SINI, V48, P161; YAMAMOTO F, 1992, IAWA BULL, V13, P93, DOI 10.1163/22941932-90000560; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108725; Yin YL, 2014, CHINA FORESTRY SCI T, V28, P110; Yuan XZ, 2013, ENVIRON SCI POLLUT R, V20, P7092, DOI 10.1007/s11356-012-1404-0; [No title captured]	78	2	6	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146664	10.1371/journal.pone.0146664	http://dx.doi.org/10.1371/journal.pone.0146664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771509	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300027
J	Galan-Vasquez, E; Sanchez-Osorio, I; Martinez-Antonio, A				Galan-Vasquez, Edgardo; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino			Transcription Factors Exhibit Differential Conservation in Bacteria with Reduced Genomes	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; REGULATORY NETWORKS; GENE-EXPRESSION; GROWTH; EVOLUTION; SYSTEMS; DEMAND; MOTIFS; LAWS	The description of transcriptional regulatory networks has been pivotal in the understanding of operating principles under which organisms respond and adapt to varying conditions. While the study of the topology and dynamics of these networks has been the subject of considerable work, the investigation of the evolution of their topology, as a result of the adaptation of organisms to different environmental conditions, has received little attention. In this work, we study the evolution of transcriptional regulatory networks in bacteria from a genome reduction perspective, which manifests itself as the loss of genes at different degrees. We used the transcriptional regulatory network of Escherichia coli as a reference to compare 113 smaller, phylogenetically-related gamma-proteobacteria, including 19 genomes of symbionts. We found that the type of regulatory action exerted by transcription factors, as genomes get progressively smaller, correlates well with their degree of conservation, with dual regulators being more conserved than repressors and activators in conditions of extreme reduction. In addition, we found that the preponderant conservation of dual regulators might be due to their role as both global regulators and nucleoid-associated proteins. We summarize our results in a conceptual model of how each TF type is gradually lost as genomes become smaller and give a rationale for the order in which this phenomenon occurs.	[Galan-Vasquez, Edgardo; Sanchez-Osorio, Ismael; Martinez-Antonio, Agustino] Natl Polytech Inst, Ctr Res & Adv Studies, Genet Engn Dept, CINVESTAV, Irapuato Leon 36821, Irapuato Gto, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Martinez-Antonio, A (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Genet Engn Dept, CINVESTAV, Campus Irapuato,Km 9-6 Libramiento Norte Carr, Irapuato Leon 36821, Irapuato Gto, Mexico.	amartinez@ira.cinvestav.mx	Martínez-Antonio, Agustino/GQQ-2363-2022; Antonio, Agustino Martínez/AAG-4309-2021; Galán-Vásquez, Edgardo/AFP-3050-2022	Martínez-Antonio, Agustino/0000-0003-2231-5014; Antonio, Agustino Martínez/0000-0003-2231-5014; Galán-Vásquez, Edgardo/0000-0002-9165-1241				Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Alexopoulos EC, 2010, HIPPOKRATIA, V14, P23; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2010, BIOCHEM SOC T, V38, P1155, DOI 10.1042/BST0381155; Babu M. Madan, 2009, V541, P163, DOI 10.1007/978-1-59745-243-4_8; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Balderas-Martinez YI, 2013, PLOS ONE, V8, P1; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Briza L, 2013, BMC GENOMICS, V14, P1; Chernick M.R., 2011, ESSENTIALS BIOSTATIS; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; Davis J.H., 2011, STAT COMPENSATION PR; Delaye L., 2010, OPEN EVOL J, V4, P12, DOI [10.2174/1874404401004010012, DOI 10.2174/1874404401004010012]; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fisher R. A, 1934, STATISTICAL METHODS, P103; Galan-Vasquez E, 2011, MICROB INFORM EXP, V1, P1; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; GOTTESMAN S, 1984, ANNU REV GENET, V18, P415; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Junker B. H., 2008, WILEY SERIES BIOINFO; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Latchman D., 2005, GENE REGULATION, V5th; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Madar D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-111; Maddison WP., 2021, MESQUITE MODULAR SYS; Martinez-Antonio A, 2006, TRENDS MICROBIOL, V14, P22, DOI 10.1016/j.tim.2005.11.002; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.ge.19.120185.002035; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Savageau MA, 1998, GENETICS, V149, P1677; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Stracy M, 2015, P NATL ACAD SCI USA, V112, pE4390, DOI 10.1073/pnas.1507592112; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146901	10.1371/journal.pone.0146901	http://dx.doi.org/10.1371/journal.pone.0146901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766575	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300049
J	Ek, A; Sorjonen, K; Eli, K; Lindberg, L; Nyman, J; Marcus, C; Nowicka, P				Ek, Anna; Sorjonen, Kimmo; Eli, Karin; Lindberg, Louise; Nyman, Jonna; Marcus, Claude; Nowicka, Paulina			Associations between Parental Concerns about Preschoolers' Weight and Eating and Parental Feeding Practices: Results from Analyses of the Child Eating Behavior Questionnaire, the Child Feeding Questionnaire, and the Lifestyle Behavior Checklist	PLOS ONE			English	Article							BODY-MASS INDEX; CONFIRMATORY FACTOR-ANALYSIS; MATERNAL SELF-EFFICACY; FACTORIAL VALIDATION; RESTRICTING ACCESS; VEGETABLE INTAKE; RELATIVE WEIGHT; FOOD-INTAKE; LOW-INCOME; OBESITY	Introduction Insight into parents' perceptions of their children's eating behaviors is crucial for the development of successful childhood obesity programs. However, links between children's eating behaviors and parental feeding practices and concerns have yet to be established. This study aims to examine associations between parental perceptions of preschoolers' eating behaviors and parental feeding practices. First, it tests the original 8-factor structure of the Child Eating Behavior Questionnaire (CEBQ). Second, it examines the associations with parental feeding practices, measured with the Child Feeding Questionnaire (CFQ). Materials and Methods Questionnaires were sent to parents from 25 schools/preschools in Stockholm, Sweden and to parents starting a childhood obesity intervention. The CEBQ factor structure was tested with confirmatory factor analysis (CFA). Associations between CEBQ subscales Food approach and Food avoidance and CFQ factors Restriction, Pressure to eat and Monitoring were examined with structural equation modelling (SEM), adjusting for child and parental characteristics, and parental confidence, measured with the Lifestyle Behavior Checklist (LBC). CFQ Concern for child weight and Perceived responsibility for child eating were used as mediators. Results 478 parents completed the questionnaires (children: 52% girls, mean age 5.5 years, 20% overweight/obese). A modified 8-factor structure showed an acceptable fit (TLI = 0.91, CFI = 0.92, RMSEA = 0.05 and SRMR = 0.06) after dropping one item and allowing three pairs of error terms to correlate. The SEM model demonstrated that Food approach had a weak direct effect on Restriction, but a moderate (beta = 0.30) indirect effect via Concern, resulting in a substantial total effect (beta = 0.37). Food avoidance had a strong positive effect on Pressure to eat (beta = 0.71). Discussion The CEBQ is a valid instrument for assessing parental perceptions of preschoolers' eating behaviors. Parental pressure to eat was strongly associated with children's food avoidance. Parental restriction, however, was more strongly associated with parents' concerns about their children's weights than with children's food approach. This suggests that childhood obesity interventions should address parents' perceptions of healthy weight alongside perceptions of healthy eating.	[Ek, Anna; Lindberg, Louise; Nyman, Jonna; Marcus, Claude; Nowicka, Paulina] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Sorjonen, Kimmo] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Solna, Sweden; [Eli, Karin] Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England; [Nowicka, Paulina] Uppsala Univ, Dept Food Nutr & Dietet, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; University of Oxford; Uppsala University	Nowicka, P (corresponding author), Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	paulina.nowicka@ki.se	Ek, Anna/S-4421-2019; Marcus, Claude/ABE-1177-2020	Ek, Anna/0000-0002-2179-8408; Marcus, Claude/0000-0003-0890-2650; Lindberg, Louise/0000-0002-9517-5000; Eli, Karin/0000-0001-9132-8404; Nowicka, Paulina/0000-0001-9707-8768	Vinnova Marie Curie International Qualification funds [2011-03443]; Swedish Research Council; Karolinska Institutet; Jerring Foundation; Samariten Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thurings Foundation; Swedish Society of Medicine; Helge Ax: son Johnsson Foundation; iShizu Matsumurais Donation; Foundation Frimurare Barnhuset in Stockholm; Foundation Barnavard; Crown Princess Lovisa Foundation for Pediatric Care	Vinnova Marie Curie International Qualification funds(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Jerring Foundation; Samariten Foundation; Magnus Bergvall Foundation; Fredrik and Ingrid Thurings Foundation; Swedish Society of Medicine; Helge Ax: son Johnsson Foundation; iShizu Matsumurais Donation; Foundation Frimurare Barnhuset in Stockholm; Foundation Barnavard; Crown Princess Lovisa Foundation for Pediatric Care	Research related to this study was supported by funds to PN by Vinnova Marie Curie International Qualification funds (2011-03443), Swedish Research Council, Karolinska Institutet, Jerring Foundation, Samariten Foundation, Magnus Bergvall Foundation, Fredrik and Ingrid Thurings Foundation, Swedish Society of Medicine, Helge Ax: son Johnsson Foundation, iShizu Matsumurais Donation, Foundation Frimurare Barnhuset in Stockholm, Foundation Barnavard and Crown Princess Lovisa Foundation for Pediatric Care. AE was supported by Jerring Foundation and Crown Princess Lovisa Foundation for Pediatric Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainuki T., 2011, Food and Nutrition Sciences, V2, P228, DOI 10.4236/fns.2011.23032; [Anonymous], 2013, PRIMARY CHILD HLTH C; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; Birch LL, 1998, PEDIATRICS, V101, P539; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Blissett J, 2013, EUR J CLIN NUTR, V67, P180, DOI 10.1038/ejcn.2012.198; Blissett J, 2006, APPETITE, V47, P212, DOI 10.1016/j.appet.2006.04.002; Bollen KA, 1989, STRUCTURAL EQUATIONS; Burrows T, 2010, INT J PEDIATR OBES, V5, P43, DOI 10.3109/17477160902957158; Campbell K, 2010, INT J PEDIATR OBES, V5, P501, DOI 10.3109/17477161003777425; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Carnell S, 2014, INT J EAT DISORDER, V47, P705, DOI 10.1002/eat.22324; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COSTANZO PR, 1985, J SOC CLIN PSYCHOL, V3, P425, DOI 10.1521/jscp.1985.3.4.425; Crouch P, 2007, NUTR DIET, V64, P151, DOI 10.1111/j.1747-0080.2007.00180.x; Daniels LA, 2012, INT J OBESITY, V36, P1292, DOI 10.1038/ijo.2012.96; Daniels LA, 2015, PEDIATRICS, V136, pE40, DOI 10.1542/peds.2014-4108; Daniels LA, 2014, OBESITY, V22, pE104, DOI 10.1002/oby.20693; Daniels LA, 2013, PEDIATRICS, V132, pE109, DOI 10.1542/peds.2012-2882; Danielsson P, 2012, OBESITY FACTS, V5, P34, DOI 10.1159/000336060; de Lauzon-Guillain B, 2013, AM J CLIN NUTR, V98, P804, DOI 10.3945/ajcn.112.057026; de Lauzon-Guillain B, 2012, J ACAD NUTR DIET, V112, P1578, DOI 10.1016/j.jand.2012.06.356; de Vet H.C.W., 2011, MEASUREMENT MED PRAC; Ek A., 2015, International Journal of Behavioral Nutrition and Physical Activity, V12; Ek A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1912-1; Eli K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006609; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2006, OBESITY, V14, P131, DOI 10.1038/oby.2006.16; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Faith MS, 2013, HUM HERED, V75, P80, DOI 10.1159/000353879; Farrow CV, 2009, APPETITE, V52, P307, DOI 10.1016/j.appet.2008.10.009; Farrow C, 2011, INT J PEDIATR OBES, V6, P306, DOI 10.3109/17477166.2011.575160; Fildes A, 2014, AM J CLIN NUTR, V99, P911, DOI 10.3945/ajcn.113.077867; Fisher JO, 2015, APPETITE, V84, P61, DOI 10.1016/j.appet.2014.09.007; Fisher JO, 1999, APPETITE, V32, P405, DOI 10.1006/appe.1999.0231; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; Fisher JO, 2002, J AM DIET ASSOC, V102, P58, DOI 10.1016/S0002-8223(02)90017-9; Galloway AT, 2006, APPETITE, V46, P318, DOI 10.1016/j.appet.2006.01.019; Gerards SMPL, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-37; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; Gregory JE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-55; Gregory JE, 2010, APPETITE, V54, P550, DOI 10.1016/j.appet.2010.02.013; Harris H, 2014, EAT BEHAV, V15, P519, DOI 10.1016/j.eatbeh.2014.07.003; Haycraft E, 2012, J NUTR EDUC BEHAV, V44, P390, DOI 10.1016/j.jneb.2010.03.001; Hill C, 2008, INT J OBESITY, V32, P1499, DOI 10.1038/ijo.2008.113; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jani R, 2015, APPETITE, V84, P188, DOI 10.1016/j.appet.2014.10.020; Jansen E, 2007, APPETITE, V49, P572, DOI 10.1016/j.appet.2007.03.229; Jansen PW, 2014, AM J CLIN NUTR, V100, P1329, DOI 10.3945/ajcn.114.088922; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Keller KL, 2006, INT J OBESITY, V30, P1670, DOI 10.1038/sj.ijo.0803318; Kral TVE, 2007, ACTA PAEDIATR, V96, P29, DOI 10.1111/j.1651-2227.2007.00167.x; Llewellyn CH, 2008, AM J CLIN NUTR, V88, P1560, DOI 10.3945/ajcn.2008.26175; Loh DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082885; Luttikhuis HGMO, 2010, ACTA PAEDIATR, V99, P263, DOI 10.1111/j.1651-2227.2009.01576.x; Mallan KM, 2013, APPETITE, V64, P48, DOI 10.1016/j.appet.2013.01.003; Matheson DM, 2006, J AM DIET ASSOC, V106, P1861, DOI 10.1016/j.jada.2006.08.004; May AL, 2007, J AM DIET ASSOC, V107, P1167, DOI 10.1016/j.jada.2007.04.009; Morrison H, 2013, APPETITE, V63, P77, DOI 10.1016/j.appet.2012.12.017; Norman GR, 2009, BIOSTATISTICS BARE E; Nowicka P, 2014, APPETITE, V81, P232, DOI 10.1016/j.appet.2014.06.027; Payne LO, 2011, INT J PEDIATR OBES, V6, pE540, DOI 10.3109/17477166.2011.575144; Pianta RC, 1997, EARLY CHILD RES Q, V12, P263, DOI 10.1016/S0885-2006(97)90003-X; Powell FC, 2011, APPETITE, V57, P683, DOI 10.1016/j.appet.2011.08.011; Regber S, 2013, PEDIATR OBES, V8, P118, DOI 10.1111/j.2047-6310.2012.00093.x; Reichenbach H., 1956, DIRECTION TIME; Reinehr T, 2010, AM J CLIN NUTR, V91, P1165, DOI 10.3945/ajcn.2009.28705; Rimm-Kaufman SE, 2000, J APPL DEV PSYCHOL, V21, P491, DOI 10.1016/S0193-3973(00)00051-4; Rodgers Rachel F, 2013, Int J Behav Nutr Phys Act, V10, P24, DOI 10.1186/1479-5868-10-24; Rollins BY, 2014, AM J CLIN NUTR, V99, P249, DOI 10.3945/ajcn.113.063545; Rollins BY, 2014, APPETITE, V73, P31, DOI 10.1016/j.appet.2013.10.005; Salari R, 2014, SCAND J PUBLIC HEALT, V42, P547, DOI 10.1177/1403494814541595; Sanders MR, 2005, CHILD CARE HLTH DEV, V31, P65, DOI 10.1111/j.1365-2214.2005.00487.x; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Sparks MA, 2012, EAT BEHAV, V13, P267, DOI 10.1016/j.eatbeh.2012.03.002; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; Spruijt-Metz D, 2002, AM J CLIN NUTR, V75, P581, DOI 10.1093/ajcn/75.3.581; Spruit-Metz D, 2006, J PEDIATR-US, V148, P314, DOI 10.1016/j.jpeds.2005.10.035; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; Tripicchio GL, 2014, PEDIATRICS, V134, pE1399, DOI 10.1542/peds.2013-3828; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; WARDLE J, 1992, APPETITE, V18, P167, DOI 10.1016/0195-6663(92)90195-C; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2005, J AM DIET ASSOC, V105, P227, DOI 10.1016/j.jada.2004.11.006; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Webber L, 2010, EUR J CLIN NUTR, V64, P259, DOI 10.1038/ejcn.2009.146; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007; West F, 2010, CHILD CARE HLTH DEV, V36, P508, DOI 10.1111/j.1365-2214.2010.01074.x; West F, 2010, BEHAV RES THER, V48, P1170, DOI 10.1016/j.brat.2010.08.008; West F, 2009, INT J PEDIATR OBES, V4, P266, DOI 10.3109/17477160902811199	98	79	88	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147257	10.1371/journal.pone.0147257	http://dx.doi.org/10.1371/journal.pone.0147257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799397	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300082
J	Mei, Y; Zhao, S; Lu, XF; Liu, HX; Li, XY; Ma, R				Mei, Yu; Zhao, Song; Lu, Xiaofei; Liu, Haixia; Li, Xiangyi; Ma, Rong			Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; METASTASIS; HYPERFIBRINOGENEMIA; ANGIOGENESIS; CARCINOMA; RESECTION; GROWTH	Purpose Elevated plasma fibrinogen levels are associated with tumor progression and poor outcomes in different cancer patients. The objective of this study was to investigate the clinical and prognostic value of preoperative plasma fibrinogen levels in patients with operable breast cancer. Methods Two hundred and twenty-three patients diagnosed with breast cancer were retrospectively evaluated in this study. Plasma fibrinogen levels were examined before treatment and analyzed along with patient clinicopathological parameters, disease-free survival (DFS) and overall survival(OS). Both univariate and multivariate analyses were performed to identify the clinicopathological parameters associated with DFS and OS. Results Elevated preoperative plasma fibrinogen levels were directly associated with age of diagnose (<= 47 vs. > 47, p<0.001), menopause (yes vs. no, p<0.001), tumor size (T1&T2 vs. T3&T4, p = 0.033), tumor stage (Ivs.IIvs.III, p = 0.034) and lymph node involvement (N = 0 vs. 1 <= N >= 3 vs. N >= 4, p<0.001), but not with histological grade, molecular type and other Immunohistochemical parameters(ER, PR, HER2 and Ki-67). In a univariate survival analysis, tumor stage, tumor size, lymph node involvement (p<0.001/p<0.001) and plasma fibrinogen (p<0.001/p<0.001) levels were associated with disease-free and overall survival, but just lymph nodes involvement (p<0.001, hazard ratio [HR] = 2.9, 95% confidence interval [CI] = 1.6-5.3/p = 0.006, HR = 3.2, 95% CI = 1.4-7.3) and plasma fibrinogen levels (p = 0.006, HR = 3.4, 95% CI = 1.4-8.3/p = 0.002, HR = 10.1, 95% CI = 2.3-44.6) were associated with disease-free and overall survival in a multivariate survival analysis, respectively. Conclusions This study demonstrates that elevated preoperative plasma fibrinogen levels are associated with breast cancer progression and are independently associated with a poor prognosis in patients with operable breast cancer.	[Mei, Yu; Zhao, Song; Ma, Rong] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Mei, Yu] Jinan Matern & Child Care Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Lu, Xiaofei] Shandong Univ, Jinan Cent Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China; [Liu, Haixia] Jinan Matern & Child Care Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Li, Xiangyi] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Ma, R (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	marongw2000@163.com	ma, rong/GVU-3096-2022					Amrani D L, 1990, Blood Coagul Fibrinolysis, V1, P443, DOI 10.1097/00001721-199010000-00013; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; Goldenberg N, 2003, J CLIN ONCOL, V21, P4194, DOI 10.1200/JCO.2003.05.165; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; HUMPHRIES SE, 1995, EUR HEART J, V16, P16, DOI 10.1093/eurheartj/16.suppl_A.16; Humphries SE., 1995, EUROPEAN HEART J SA, V16; Jones JM, 2006, LUNG CANCER, V53, P97, DOI 10.1016/j.lungcan.2006.03.012; Kanz R, 2011, J THROMB HAEMOST, V9, P57, DOI 10.1111/j.1538-7836.2010.04069.x; Kato F, 2016, SURG TODAY, V46, P445, DOI 10.1007/s00595-015-1196-1; Kinoshita A, 2013, ONCOLOGY-BASEL, V85, P269, DOI 10.1159/000355502; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Polterauer S, 2009, ONCOLOGIST, V14, P979, DOI 10.1634/theoncologist.2009-0079; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Qi Q, 2015, PANCREAS, V44, P977, DOI 10.1097/MPA.0000000000000353; ROKITA H, 1993, CYTOKINE, V5, P454, DOI 10.1016/1043-4666(93)90035-4; Romano S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.109; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Seebacher V, 2010, BRIT J CANCER, V102, P952, DOI 10.1038/sj.bjc.6605547; Shu YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-566; Sicking I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111306; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Takeuchi H, 2007, J GASTROEN HEPATOL, V22, P2222, DOI 10.1111/j.1440-1746.2006.04736.x; Tang LA, 2010, J SURG ONCOL, V102, P428, DOI 10.1002/jso.21668; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang JB, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0543-4; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147; Zhao KL, 2015, GYNECOL OBSTET INVES, V79, P25, DOI 10.1159/000365477; Zhu LR, 2016, CLIN TRANSL ONCOL, V18, P178, DOI 10.1007/s12094-015-1350-7	37	18	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146233	10.1371/journal.pone.0146233	http://dx.doi.org/10.1371/journal.pone.0146233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799214	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300016
J	Rogacev, KS; Heine, GH; Silbernagel, G; Kleber, ME; Seiler, S; Emrich, I; Lennartz, S; Werner, C; Zawada, AM; Fliser, D; Bohm, M; Marz, W; Scharnagl, H; Laufs, U				Rogacev, Kyrill S.; Heine, Gunnar H.; Silbernagel, Guenther; Kleber, Marcus E.; Seiler, Sarah; Emrich, Insa; Lennartz, Simone; Werner, Christian; Zawada, Adam M.; Fliser, Danilo; Boehm, Michael; Maerz, Winfried; Scharnagl, Hubert; Laufs, Ulrich			PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK; HEART; HEMODIALYSIS; CHOLESTEROL; PROTECTION; MORTALITY; LDL	Background Impaired renal function causes dyslipidemia that contributes to elevated cardiovascular risk in patients with chronic kidney disease (CKD). The proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of the LDL receptor and plasma cholesterol concentrations. Its relationship to kidney function and cardiovascular events in patients with reduced glomerular filtration rate (GFR) has not been explored. Methods Lipid parameters including PCSK9 were measured in two independent cohorts. CARE FOR HOMe (Cardiovascular and Renal Outcome in CKD 2-4 Patients-The Forth Homburg evaluation) enrolled 443 patients with reduced GFR (between 90 and 15ml/min/1.73 m(2)) referred for nephrological care that were prospectively followed for the occurrence of a composite cardiovascular endpoint. As a replication cohort, PCSK9 was quantitated in 1450 patients with GFR between 90 and 15ml/min/1.73m(2) enrolled in the Ludwigshafen Risk and Cardiovascular Health Study (LURIC) that were prospectively followed for cardiovascular deaths. Results PCSK9 concentrations did not correlate with baseline GFR (CARE FOR HOMe: r = -0.034; p = 0.479; LURIC: r = -0.017; p = 0.512). 91 patients in CARE FOR HOMe and 335 patients in LURIC reached an endpoint during a median follow-up of 3.0 [1.8-4.1] years and 10.0 [7.3-10.6] years, respectively. Kaplan-Meier analyses showed that PCSK9 concentrations did not predict cardiovascular events in either cohort [CARE FOR HOMe (p = 0.622); LURIC (p = 0.729)]. Sensitivity analyses according to statin intake yielded similar results. Conclusion In two well characterized independent cohort studies, PCSK9 plasma levels did not correlate with kidney function. Furthermore, PCSK9 plasma concentrations were not associated with cardiovascular events in patients with reduced renal function.	[Rogacev, Kyrill S.; Werner, Christian; Boehm, Michael; Laufs, Ulrich] Univ Saarland, Dept Internal Med 3, Cardiol Angiol & Intens Care Med, Med Ctr, Homburg, Germany; [Rogacev, Kyrill S.; Heine, Gunnar H.; Seiler, Sarah; Emrich, Insa; Lennartz, Simone; Zawada, Adam M.; Fliser, Danilo] Univ Saarland, Dept Internal Med 4, Nephrol & Hypertens, Med Ctr, Homburg, Germany; [Silbernagel, Guenther] Univ Hosp Bern, Swiss Cardiovasc Ctr, Div Angiol, CH-3010 Bern, Switzerland; [Kleber, Marcus E.; Maerz, Winfried] Heidelberg Univ, Dept Med 5, Med Fac Mannheim, Nephrol,Hypertensiol,Endocrinol,Diabetol,Rheumato, Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Augsburg, Germany; [Maerz, Winfried; Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Saarland University; Saarland University; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg; SYNLAB Group; SYNLAB Group; Medical University of Graz	Rogacev, KS (corresponding author), Univ Saarland, Dept Internal Med 3, Cardiol Angiol & Intens Care Med, Med Ctr, Homburg, Germany.; Rogacev, KS (corresponding author), Univ Saarland, Dept Internal Med 4, Nephrol & Hypertens, Med Ctr, Homburg, Germany.	kyrill.rogacev@uksh.de	Böhm, Michael/C-3638-2011	Silbernagel, Guenther/0000-0001-9323-329X; Kleber, Marcus/0000-0003-0663-7275; Heine, Gunnar/0000-0001-8320-5260	Else Kroner-Fresenius Stiftung; Dr. Marija Orlovic Stiftung; Jubilaumsfond der Oesterreichischen Nationalbank [14219]	Else Kroner-Fresenius Stiftung; Dr. Marija Orlovic Stiftung; Jubilaumsfond der Oesterreichischen Nationalbank	The CARE FOR HOMe study was supported by a grant from the Else Kroner-Fresenius Stiftung. PCSK9 analyses in CARE FOR HOMe were funded by a grant from the Dr. Marija Orlovic Stiftung awarded to Christian Werner. The LURIC study was supported by a grant from the Jubilaumsfond der Oesterreichischen Nationalbank (No. 14219 to H.S.). WM is employed at synlab Services GmbH, Augsburg, Germany, as a board licensed specialist for laboratory medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujrad H, 2014, ATHEROSCLEROSIS, V233, P123, DOI 10.1016/j.atherosclerosis.2013.12.030; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Brandenburg VM, 2014, ATHEROSCLEROSIS, V237, P53, DOI 10.1016/j.atherosclerosis.2014.08.037; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Heine GH, 2013, EUR HEART J, V34, P1112, DOI 10.1093/eurheartj/ehs353; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Jin K, 2014, AM J KIDNEY DIS, V63, P584, DOI 10.1053/j.ajkd.2013.10.042; Kwakernaak AJ, 2013, ATHEROSCLEROSIS, V226, P459, DOI 10.1016/j.atherosclerosis.2012.11.009; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Landmesser U, 2013, J LIPID RES; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Rogacev KS, 2013, CKD EPI EQUATION INC; Rogacev KS, 2014, ARTERIOSCL THROM VAS, V34, P2120, DOI 10.1161/ATVBAHA.114.304172; Rogacev KS, 2012, CLIN J AM SOC NEPHRO, V7, P943, DOI 10.2215/CJN.05170511; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seiler S, 2014, CLIN J AM SOC NEPHRO; Seiler S, 2014, CLIN J AM SOC NEPHRO, V9, P1049, DOI 10.2215/CJN.07870713; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Thygesen K, 2007, EUR HEART J, V28, P2525; Urban D, 2013, J AM COLL CARDIOL, V62, P1401, DOI 10.1016/j.jacc.2013.07.056; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Werner C, 2014, VASCULAR PHARM; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1	27	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146920	10.1371/journal.pone.0146920	http://dx.doi.org/10.1371/journal.pone.0146920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799206	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300048
J	Rune, I; Rolin, B; Larsen, C; Nielsen, DS; Kanter, JE; Bornfeldt, KE; Lykkesfeldt, J; Buschard, K; Kirk, RK; Christoffersen, B; Fels, JJ; Josefsen, K; Kihl, P; Hansen, AK				Rune, Ida; Rolin, Bidda; Larsen, Christian; Nielsen, Dennis Sandris; Kanter, Jenny E.; Bornfeldt, Karin E.; Lykkesfeldt, Jens; Buschard, Karsten; Kirk, Rikke Kaae; Christoffersen, Berit; Fels, Johannes Josef; Josefsen, Knud; Kihl, Pernille; Hansen, Axel Kornerup			Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice	PLOS ONE			English	Article							GLUTEN-FREE DIET; NOD MICE; METABOLISM; OBESITY; INFLAMMATION; ANTIBIOTICS; DISEASE; PROMOTES; NUMBER	The importance of the gut microbiota (GM) in disease development has recently received increased attention, and numerous approaches have been made to better understand this important interplay. For example, metabolites derived from the GM have been shown to promote atherosclerosis, the underlying cause of cardiovascular disease (CVD), and to increase CVD risk factors. Popular interest in the role of the intestine in a variety of disease states has now resulted in a significant proportion of individuals without coeliac disease switching to gluten-free diets. The effect of gluten-free diets on atherosclerosis and cardiovascular risk factors is largely unknown. We therefore investigated the effect of a gluten-free high-fat cholesterol-rich diet, as compared to the same diet in which the gluten peptide gliadin had been added back, on atherosclerosis and several cardiovascular risk factors in apolipoprotein E-deficient (Apoe(-/-)) mice. The gluten-free diet transiently altered GM composition in these mice, as compared to the gliadin-supplemented diet, but did not alter body weights, glucose tolerance, insulin levels, plasma lipids, or atherosclerosis. In parallel, other Apoe(-/-) mice fed the same diets were treated with ampicillin, a broad-spectrum antibiotic known to affect GM composition. Ampicillin-treatment had a marked and sustained effect on GM composition, as expected. Furthermore, although ampicillin-treated mice were slightly heavier than controls, ampicillin-treatment transiently improved glucose tolerance both in the absence or presence of gliadin, reduced plasma LDL and VLDL cholesterol levels, and reduced aortic atherosclerotic lesion area. These results demonstrate that a gluten-free diet does not seem to have beneficial effects on atherosclerosis or several CVD risk factors in this mouse model, but that sustained alteration of GM composition with a broad-spectrum antibiotic has beneficial effects on CVD risk factors and atherosclerosis. These findings support the concept that altering the microbiota might provide novel treatment strategies for CVD.	[Rune, Ida; Larsen, Christian; Lykkesfeldt, Jens; Kihl, Pernille; Hansen, Axel Kornerup] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Thorvaldsensvej 57, DK-1871 Frederiksberg C, Denmark; [Rolin, Bidda; Kirk, Rikke Kaae; Christoffersen, Berit; Fels, Johannes Josef] Novo Nordisk AS, Global Res, Novo Nordisk Pk 1, DK-2760 Malov, Denmark; [Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, Fac Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark; [Kanter, Jenny E.; Bornfeldt, Karin E.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA; [Buschard, Karsten; Josefsen, Knud] Bartholin Inst, Rigshosp Dept 3733, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Novo Nordisk; University of Copenhagen; University of Washington; University of Washington Seattle; Rigshospitalet	Rune, I (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Thorvaldsensvej 57, DK-1871 Frederiksberg C, Denmark.	idarune@hotmail.com	Nielsen, Dennis/A-9769-2015; Bornfeldt, Karin/AAI-2241-2019; Lykkesfeldt, Jens/A-1072-2011	Nielsen, Dennis/0000-0001-8121-1114; Bornfeldt, Karin/0000-0001-9208-6523; Lykkesfeldt, Jens/0000-0002-6514-8407; Buschard, Karsten/0000-0002-0126-7423; Kanter, Jenny/0000-0003-3212-772X	Danish Ministry of Science, Technology and Innovation; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01HL062887, P01HL092969, R01HL097365, R01HL126028, P30DK017047]; American Heart Association [14GRNT20410033]; National Institutes of Health [R01HL062887, P01HL092969, R01HL126028, P30DK017047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097365, R01HL126028, P01HL092969, R01HL062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Danish Ministry of Science, Technology and Innovation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was carried out as a part of the 3G research program (Guts, grains and greens; http://www.3g-center.dk/). The 3G program is supported by the Danish Ministry of Science, Technology and Innovation. Ida Rune is part of LIFEPHARM (www.lifepharm.dk). Research reported in this publication was also supported in part by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers R01HL062887, P01HL092969, R01HL097365, R01HL126028 and P30DK017047; and by the American Heart Association, 14GRNT20410033, to KEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Christian Larsen, Lene Winther Takla, Line Rasmussen, Nicolai Hansen, Jane Larsen, Bettina Brandrup, Trine Pagh Ludvigsen, Cecilie Loe Licht and Annie Bjergby Kristensen are kindly thanked for their technical assistance. Karin E. Bornfeldt's laboratory is supported by the National Institutes of Health grants R01HL062887, P01HL092969, R01HL126028, and P30DK017047 and The American Heart Association (14GRNT20410033).	Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Antvorskov JC, 2014, DIABETOLOGIA; Bech-Nielsen GV, 2012, RES VET SCI, V92, P501, DOI 10.1016/j.rvsc.2011.04.005; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; Ejsing-Duun M, 2008, SCAND J IMMUNOL, V67, P553, DOI 10.1111/j.1365-3083.2008.02104.x; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Hansen AK, 2006, DIABETES-METAB RES, V22, P220, DOI 10.1002/dmrr.609; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Hansen CHF, 2014, DIABETES; Helmerhorst EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013264; Hennessy AA, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0515-2; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lima LFO, 2008, APPL BIOCHEM BIOTECH, V151, P283, DOI 10.1007/s12010-008-8187-2; Lykkesfeldt J, 2001, CLIN CHEM, V47, P1725; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miyata M, 2009, J PHARMACOL EXP THER, V331, P1079, DOI 10.1124/jpet.109.160093; Nash David T, 2014, Proc (Bayl Univ Med Cent), V27, P377; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sildorf SM, 2012, BMJ CASE REP; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	41	31	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146439	10.1371/journal.pone.0146439	http://dx.doi.org/10.1371/journal.pone.0146439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799618	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300021
J	Hsieh, CC; Huang, YS				Hsieh, Chia-Chien; Huang, Yu-Shan			Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TUMOR PROGRESSION; OBESITY; PREVENTION; INHIBITION; SURVIVAL; FOCUS	Breast cancer is one of the most common cancers in women worldwide. The obesity process is normally accompanied by chronic, low-grade inflammation. Infiltration by inflammatory cytokines and immune cells provides a favorable microenvironment for tumor growth, migration, and metastasis. Epidemiological evidence has shown that aspirin is an effective agent against several types of cancer. The aim of this study is to investigate the anti-inflammatory and anti-cancer effects of aspirin on 3T3-L1 adipocytes, 4T1 murine breast cancer cells, and their crosstalk. The results showed that aspirin treatment inhibited differentiation and lipid accumulation by 3T3-L1 preadipocytes, and decreased the secretion of the inflammatory adipokine MCP-1 after stimulation with tumor necrosis factor (TNF)-alpha or conditioned medium from RAW264.7 cells. In 4T1 cells, treatment with aspirin decreased cell viability and migration, possibly by suppressing MCP-1 and VEGF secretion. Subsequently, culture of 4T1 cells in 3T3-L1 adipocyte-conditioned medium (Ad-CM) and co-culture of 3T3-L1 and 4T1 cells using a transwell plate were performed to clarify the relationship between these two cell lines. Aspirin exerted its inhibitory effects in the transwell co-culture system, as well as the conditioned-medium model. Aspirin treatment significantly inhibited the proliferation of 4T1 cells, and decreased the production of MCP-1 and PAI-1 in both the Ad-CM model and co-culture system. Aspirin inhibited inflammatory MCP-1 adipokine production by 3T3-L1 adipocytes and the cell growth and migration of 4T1 cells. It also broke the crosstalk between these two cell lines, possibly contributing to its chemopreventive properties in breast cancer. This is the first report that aspirin's chemopreventive activity supports the potential application in auxiliary therapy against obesity-related breast cancer development.	[Hsieh, Chia-Chien; Huang, Yu-Shan] Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan	National Taiwan Normal University	Hsieh, CC (corresponding author), Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan.	hsieh@ntnu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2320-B-003-003-MY3]; National Taiwan Normal University, Taiwan [T10207000473, T10407000803]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University, Taiwan	This work was supported by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/en/public) MOST 103-2320-B-003-003-MY3 and the National Taiwan Normal University, Taiwan (http://www2.ntnu.edu.tw/) (#T10207000473, #T10407000803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre MM, 2013, ASIAN PAC J CANCER P, V14, P2207, DOI 10.7314/APJCP.2013.14.4.2207; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; An Y, 2009, INFLAMMATION, V32, P296, DOI 10.1007/s10753-009-9135-1; Ansara AJ, 2010, ANN PHARMACOTHER, V44, P851, DOI 10.1345/aph.1M346; Carter JS, 2009, J SOCIOL RES, V1, P1, DOI [DOI 10.1155/2009/345320, DOI 10.5296/JSR.V1I1.156]; Catalan V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00275; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P723, DOI 10.1016/j.bcp.2011.12.019; Chen CT, 2012, MOL CANCER THER, V11, P2212, DOI 10.1158/1535-7163.MCT-12-0180; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Dubois V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058541; Ferlay J., 2013, INT AGENCY RES CANC; Ford NA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00209; Hitchcock JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0573-4; Holmes MD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3336; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang XZ, 2015, CANCER CAUSE CONTROL, V26, P589, DOI 10.1007/s10552-015-0539-y; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Madera L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133385; Maity G, 2015, LAB INVEST, V95, P702, DOI 10.1038/labinvest.2015.49; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Ogston NC, 2008, INT J OBESITY, V32, P1807, DOI 10.1038/ijo.2008.190; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Pelucchi C, 2011, ANN ONCOL, V22, P1487, DOI 10.1093/annonc/mdq610; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Saxena NK, 2013, J MAMMARY GLAND BIOL, V18, P309, DOI 10.1007/s10911-013-9308-2; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Song H, 2015, J NUTR BIOCHEM, V26, P1368, DOI 10.1016/j.jnutbio.2015.07.005; Su YF, 2014, EUR J PHARMACOL, V738, P101, DOI 10.1016/j.ejphar.2014.03.009; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Thorat MA, 2013, CURR ONCOL REP, V15, P533, DOI 10.1007/s11912-013-0351-3; Usman MW, 2015, BBA-REV CANCER, V1855, P254, DOI 10.1016/j.bbcan.2015.03.007; Viana CTR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138408; World Cancer Research Fund International (WCRF), 2012, BREAST CANC STAT; World Health Organization (WHO) Media Center Geneva, 2015, OB OV FACTS OV OB; Zarogoulidis P, 2015, J CANCER, V6, P9, DOI 10.7150/jca.10560; Zhong SL, 2015, CANCER EPIDEM BIOMAR, V24, P1645, DOI 10.1158/1055-9965.EPI-15-0452; Zhou Y, 2008, INFLAMMATION, V31, P355, DOI 10.1007/s10753-008-9086-y	43	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147161	10.1371/journal.pone.0147161	http://dx.doi.org/10.1371/journal.pone.0147161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794215	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300020
J	Le, MH; Weissmiller, AM; Monte, L; Lin, PH; Hexom, TC; Natera, O; Wu, CB; Rissman, RA				Le, Michelle H.; Weissmiller, April M.; Monte, Louise; Lin, Po Han; Hexom, Tia C.; Natera, Orlangie; Wu, Chengbiao; Rissman, Robert A.			Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon Transport	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENTS; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; NEUROFIBRILLARY TANGLES; CRF RECEPTORS; MESSENGER-RNAS; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION	Stress exposure or increased levels of corticotropin-releasing factor (CRF) induce hippocampal tau phosphorylation (tau-P) in rodent models, a process that is dependent on the type-1 CRF receptor (CRFR1). Although these preclinical studies on stress-induced tau-P provide mechanistic insight for epidemiological work that identifies stress as a risk factor for Alzheimer's disease (AD), the actual impact of stress-induced tau-P on neuronal function remains unclear. To determine the functional consequences of stress-induced tau-P, we developed a novel mouse neuronal cell culture system to explore the impact of acute (0.5hr) and chronic (2hr) CRF treatment on tau-P and integral cell processes such as axon transport. Consistent with in vivo reports, we found that chronic CRF treatment increased tau-P levels and caused globular accumulations of phosphorylated tau in dendritic and axonal processes. Furthermore, while both acute and chronic CRF treatment led to significant reduction in CREB activation and axon transport of brain-derived neurotrophic factor (BDNF), this was not the case with mitochondrial transport. Acute CRF treatment caused increased mitochondrial velocity and distance traveled in neurons, while chronic CRF treatment modestly decreased mitochondrial velocity and greatly increased distance traveled. These results suggest that transport of cellular energetics may take priority over growth factors during stress. Tau-P was required for these changes, as co-treatment of CRF with a GSK kinase inhibitor prevented CRF-induced tau-P and all axon transport changes. Collectively, our results provide mechanistic insight into the consequences of stress peptide-induced tau-P and provide an explanation for how chronic stress via CRF may lead to neuronal vulnerability in AD.	[Le, Michelle H.; Weissmiller, April M.; Monte, Louise; Lin, Po Han; Hexom, Tia C.; Natera, Orlangie; Wu, Chengbiao; Rissman, Robert A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Rissman, Robert A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Rissman, RA (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Rissman, RA (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	rrissman@ucsd.edu		Weissmiller, April/0000-0003-4505-0530	NIH [AG032755, AG047484, AG010483, BX003040, AG005131, PN2 EY016525]; Alzheimer's Art Quilt Initiative; Alzheimer's Association; Down syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032755, U01AG010483, R21AG047484, U19AG010483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Art Quilt Initiative; Alzheimer's Association(Alzheimer's Association); Down syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH AG032755, AG047484, AG010483, BX003040 and a pilot grant through AG005131; the Alzheimer's Art Quilt Initiative and the Alzheimer's Association, NIH (PN2 EY016525) and The Down syndrome Research and Treatment Foundation, and the Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bremner J. Douglas, 2006, CNS & Neurological Disorders-Drug Targets, V5, P503; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Campbell SN, 2015, J ALZHEIMERS DIS, V43, P967, DOI 10.3233/JAD-141281; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Chadwick D, 1993, CORTICOTROPIN RELEAS, Vx; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Choi JS, 2006, J KOREAN MED SCI, V21, P518, DOI 10.3346/jkms.2006.21.3.518; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Davis KL, 1999, ARCH GEN PSYCHIAT, V56, P981, DOI 10.1001/archpsyc.56.11.981; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; Dong HX, 2014, PSYCHOPHARMACOLOGY, V231, P4711, DOI 10.1007/s00213-014-3629-8; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Goebel M, 2010, NEUROSCI LETT, V473, P11, DOI 10.1016/j.neulet.2010.01.068; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Guo QX, 2012, NEUROBIOL AGING, V33, P2678, DOI 10.1016/j.neurobiolaging.2012.01.002; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Heinrichs SC, 1996, NEUROSCIENCE, V74, P303, DOI 10.1016/0306-4522(96)00140-6; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kosik KS, 1990, CURR OPIN CELL BIOL, V2, P101, DOI 10.1016/S0955-0674(05)80038-9; KOSIK KS, 1990, MOL NEUROBIOL, V4, P171, DOI 10.1007/BF02780339; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1997, MOL PSYCHIATR, V2, P255, DOI 10.1038/sj.mp.4000254; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Oliff HS, 1998, MOL BRAIN RES, V61, P147, DOI 10.1016/S0169-328X(98)00222-8; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Rehman Habib U, 2002, Curr Opin Investig Drugs, V3, P1637; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rissman RA, 2007, J NEUROSCI, V27, P6552, DOI 10.1523/JNEUROSCI.5173-06.2007; Rissman RA, 2012, P NATL ACAD SCI USA, V109, P6277, DOI 10.1073/pnas.1203140109; Rissman RA, 2009, J ALZHEIMERS DIS, V18, P453, DOI 10.3233/JAD-2009-1153; Roe AD, 2011, EUR J NEUROSCI, V34, P448, DOI 10.1111/j.1460-9568.2011.07764.x; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAWCHENKO PE, 2008, NEW ENCY NEUROSCIENC; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Touma C, 2004, NEUROBIOL AGING, V25, P893, DOI 10.1016/j.neurobiolaging.2003.09.004; Trinczek B, 1999, J CELL SCI, V112, P2355; Turnbull AV, 1997, P SOC EXP BIOL MED, V215, P1; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Weissmiller AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118379; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Wilson RS, 2005, PSYCHONEUROENDOCRINO, V30, P11, DOI 10.1016/j.psyneuen.2004.04.005; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Zhao XB, 2014, JOVE-J VIS EXP, DOI 10.3791/51899; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	82	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147250	10.1371/journal.pone.0147250	http://dx.doi.org/10.1371/journal.pone.0147250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790099	Green Published, gold			2022-12-27	WOS:000368529100072
J	Carneiro, LRD; Lima, AP; Machado, RB; Magnusson, WE				Carneiro, Lorena Ribeiro de A.; Lima, Albertina P.; Machado, Ricardo B.; Magnusson, William E.			Limitations to the Use of Species-Distribution Models for Environmental-Impact Assessments in the Amazon	PLOS ONE			English	Article							SAMPLE-SIZE; PERFORMANCE; RANGE; BIODIVERSITY; COMMUNITIES; PREDICTION; ACCURACY; PATTERNS; BRAZIL; TOOLS	Species-distribution models (SDM) are tools with potential to inform environmental-impact studies (EIA). However, they are not always appropriate and may result in improper and expensive mitigation and compensation if their limitations are not understood by decision makers. Here, we examine the use of SDM for frogs that were used in impact assessment using data obtained from the EIA of a hydroelectric project located in the Amazon Basin in Brazil. The results show that lack of knowledge of species distributions limits the appropriate use of SDM in the Amazon region for most target species. Because most of these targets are newly described and their distributions poorly known, data about their distributions are insufficient to be effectively used in SDM. Surveys that are mandatory for the EIA are often conducted only near the area under assessment, and so models must extrapolate well beyond the sampled area to inform decisions made at much larger spatial scales, such as defining areas to be used to offset the negative effects of the projects. Using distributions of better-known species in simulations, we show that geographical-extrapolations based on limited information of species ranges often lead to spurious results. We conclude that the use of SDM as evidence to support project-licensing decisions in the Amazon requires much greater area sampling for impact studies, or, alternatively, integrated and comparative survey strategies, to improve biodiversity sampling. When more detailed distribution information is unavailable, SDM will produce results that generate uncertain and untestable decisions regarding impact assessment. In many cases, SDM is unlikely to be better than the use of expert opinion.	[Carneiro, Lorena Ribeiro de A.; Lima, Albertina P.; Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Machado, Ricardo B.] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade de Brasilia	Carneiro, LRD (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.; Carneiro, LRD (corresponding author), Inst Meio Ambiente & Recursos Hidr Dist Fed Brasi, Coordenacao Unidades Conservacao Uso Sustentavel, Brasilia, DF, Brazil.	lribeirocarneiro@gmail.com	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Ribeiro de Almeida Carneiro, Lorena/0000-0002-2861-4085; Lima, Albertina Pimentel/0000-0003-4586-5633	Brazilian National Council for Scientific and Technological Development (CNPq); Amazonas State Research Support Foundation (FAPEAM); CNPq; Wildlife Conservation Program of Santo Antonio Energia	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Amazonas State Research Support Foundation (FAPEAM); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wildlife Conservation Program of Santo Antonio Energia	The Brazilian National Council for Scientific and Technological Development (CNPq) provided a scholarship to LRAC and productivity grant for RBM, APL and WEM. The Wildlife Conservation Program of Santo Antonio Energia financed the construction of plot systems and data collection, but they had no direct involvement in those and other tasks (e.g. analysis, decision to publish, preparation of the manuscript). The Programa de Pesquisa em Biodiversidade (PPBio), the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) coordinated data management and supported some the field work. The Amazonas State Research Support Foundation (FAPEAM) financed the publication of this manuscript.; We are grateful to CNPq for providing a research fellowship for LRAC and productivity grant for RBM, APL and WEM. The herpetofauna monitoring team of the Santo Antonio Hydroelectric plant provided the data with the support of the Wildlife Conservation Program of Santo Antonio Energia. Coordination was undertaken by the Program for Biodiversity Research (PPBio) and the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM). We thank the Biodiversity Conservation Planning Laboratory/UnB team, for contributions to analyses, and P.I. Simoes, I. Kaffer, V.J.T. Perdigao, J.B. Oliveira, S. Watzel, A. Sousa, D. Norris, D. Cho, and S.H.C. Carvalho for suggestions. V. Landeiro provided the Generic Graphic Script in R software. D. Tonks, L. Robichaud and S. DeAlmeida helped with translations. J.D. Filho, E. Vertincinque, B.W. Nelson, K. Didier, and M. Gordo provided comments on previous drafts. James J. Roper reviewed the English and provided helpful comments. The Amazonas State Research Support Foundation (FAPEAM) provided support for publication of this manuscript.	Acerbi MA, 2014, 34 ANN C INT ASS IMP; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Araujo MB, 2004, J BIOGEOGR, V31, P1037, DOI 10.1111/j.1365-2699.2004.01051.x; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Brazil, 2007, 146 IBAMA; Caldwell JP, 2003, HERPETOLOGICA, V59, P219, DOI 10.1655/0018-0831(2003)059[0219:ANASOC]2.0.CO;2; Caro T. M, 2010, CONSERVATION PROXY I; Carroll SS, 1998, ECOGRAPHY, V21, P401, DOI 10.1111/j.1600-0587.1998.tb00405.x; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; de Fraga R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105453; Dias-Terceiro RG, 2015, BIOTROPICA, V47, P259, DOI 10.1111/btp.12197; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Ferreira LV, 2013, AN ACAD BRAS CIENC, V85, P1013, DOI 10.1590/S0001-37652013000300012; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ficetola GF, 2014, GLOBAL ECOL BIOGEOGR, V23, P1303, DOI 10.1111/geb.12201; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kaefer IL, 2013, EVOL BIOL, V40, P228, DOI 10.1007/s11692-012-9205-4; Kaefer IL, 2012, ACTA ETHOL, V15, P187, DOI 10.1007/s10211-012-0126-0; Lima AP, 2007, COPEIA, P114; Lima Albertina P., 2010, Zootaxa, V2337, P1; Loyola R.D., 2009, MEGADIVERSIDADE, V5, P29; Magnusson W.E., 2005, BIOTA NEOTROP, V5, P1, DOI DOI 10.1590/S0101-81751996000200002; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ribas CC, 2007, REV BRAS ORNITOL, V15, P245; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Simoes PI, 2010, ZOOTAXA, P1; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Syfert MM, 2014, BIOL CONSERV, V177, P174, DOI 10.1016/j.biocon.2014.06.012; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Torres NM, 2012, NAT CONSERVACAO, V10, P228, DOI 10.4322/natcon.2012.023; Villarroya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107144; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	59	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146543	10.1371/journal.pone.0146543	http://dx.doi.org/10.1371/journal.pone.0146543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784891	Green Published, gold			2022-12-27	WOS:000368528400047
J	Dann, LM; Paterson, JS; Newton, K; Oliver, R; Mitchell, JG				Dann, Lisa M.; Paterson, James S.; Newton, Kelly; Oliver, Rod; Mitchell, James G.			Distributions of Virus-Like Particles and Prokaryotes within Microenvironments	PLOS ONE			English	Article							FLOODPLAIN SYSTEM DANUBE; FRESH-WATER; MARINE VIRUSES; FLOW-CYTOMETRY; SPATIAL AUTOCORRELATION; PSEUDOMONAS-AERUGINOSA; HETEROTROPHIC BACTERIA; MICROSCALE PATCHINESS; VIRAL ABUNDANCE; BACTERIOPLANKTON	Microbial interactions are important for ecosystem function, but occur at the microscale and so are difficult to observe. Previous studies in marine systems have shown significant shifts in microbial community abundance and composition over scales of micrometres to centimetres. This study investigates the microscale abundance distributions of virus-like particles (VLPs) and prokaryotes in the lower reaches of a river to determine the extent to which microscale microbial patchiness exists in freshwater systems. Here we report local hotspots surrounded by gradients that reach a maximum 80 and 107 fold change in abundance over 0.9 cm for prokaryotic and VLP subpopulations. Changes in prokaryotic and VLP hotspots were tightly coupled. There were no gradients at tens of centimetres across the boundary layers, which is consistent with strong mixing and turbulence-driven aggregation found in river systems. Quantification of the patchiness shows a marked asymmetry with patches 10 times greater than background common, but depletions being rare or absent in most samples. This consistent asymmetry suggests that coldspots depleted by grazing and lysis are rapidly mixed to background concentrations, while the prevalence of hotspots indicates persistence against disruption. The hotspot to coldspot relative abundance may be useful for understanding microbial river dynamics. The patchiness indicates that the mean-field approach of bulk phase sampling misses the microbially relevant community variation and may underestimate the concentrations of these important microbial groups.	[Dann, Lisa M.; Paterson, James S.; Newton, Kelly; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Oliver, Rod] CSIRO, Land & Water Res Div, Adelaide, SA, Australia	Flinders University South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dann, LM (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	lisa.dann@flinders.edu.au	Oliver, Roderick L/D-4195-2011	Oliver, Roderick L/0000-0003-2238-1740; Newton, Kelly/0000-0001-8405-7140; Mitchell, Jim/0000-0002-8445-0935; Paterson, James/0000-0002-1193-5739	Commonwealth Scientific and Industrial Research Organisation; Australian Research Council	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council(Australian Research Council)	Commonwealth Scientific and Industrial Research Organisation provided a PhD top up scholarship and consumbables for LD. General support was provided by Australian Research Council grants to JGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Barbara GM, 2003, FEMS MICROBIOL ECOL, V43, P99, DOI 10.1111/j.1574-6941.2003.tb01049.x; Besemer K, 2005, APPL ENVIRON MICROB, V71, P609, DOI 10.1128/AEM.71.2.609-620.2005; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruce C., 2008, CRIMESTAT 3 USER WOR; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Dann LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102805; DUARTE CM, 1992, MAR ECOL PROG SER, V84, P95, DOI 10.3354/meps084095; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Geary R.C., 1954, INC STAT, V5, P115, DOI [DOI 10.2307/2986645, 10.2307/2986645]; Goddard VJ, 2005, AQUAT MICROB ECOL, V39, P211, DOI 10.3354/ame039211; Griffith DA, 1987, RESOURCE PUBLICATION; Griffith PC, 1990, MAR ECOL PROG SER, V108, P1; GROSSART HP, 1993, LIMNOL OCEANOGR, V38, P532, DOI 10.4319/lo.1993.38.3.0532; Grossart HP, 1998, AQUAT MICROB ECOL, V15, P127, DOI 10.3354/ame015127; HENNES KP, 1995, APPL ENVIRON MICROB, V61, P333, DOI 10.1128/AEM.61.1.333-340.1995; HOLM S, 1979, SCAND J STAT, V6, P65; Hondzo M, 1999, FRESHWATER BIOL, V41, P51, DOI 10.1046/j.1365-2427.1999.00389.x; IRIBERRI J, 1987, APPL ENVIRON MICROB, V53, P2308, DOI 10.1128/AEM.53.10.2308-2314.1987; Jacquet S, 2005, FRESHWATER BIOL, V50, P627, DOI 10.1111/j.1365-2427.2005.01349.x; Jacquet S., 2010, ADV OCEANOGR LIMNOL, V1, P97, DOI [10.1080/19475721003743843, DOI 10.1080/19475721003743843]; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; KAPUSCINSKI RB, 1980, WATER RES, V14, P363, DOI 10.1016/0043-1354(80)90084-6; KIRCHMAN D, 1982, APPL ENVIRON MICROB, V43, P200, DOI 10.1128/AEM.43.1.200-209.1982; KOKJOHN TA, 1991, J GEN MICROBIOL, V137, P661, DOI 10.1099/00221287-137-3-661; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V32, P16; Larsen A, 2004, LIMNOL OCEANOGR, V49, P180, DOI 10.4319/lo.2004.49.1.0180; Lear G, 2014, ISME J, V8, P1715, DOI 10.1038/ismej.2014.21; Liu Z, 2011, FEMS MICROBIOLOGY EC, V80, P30; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Luef B, 2007, FRESHWATER BIOL, V52, P1043, DOI 10.1111/j.1365-2427.2007.01752.x; Luef B, 2009, APPL ENVIRON MICROB, V75, P5952, DOI 10.1128/AEM.00186-09; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Meyer KA, 2014, HARMFUL ALGAE, V38, P110, DOI 10.1016/j.hal.2014.04.015; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; MITCHELL JG, 1989, MAR ECOL PROG SER, V54, P141, DOI 10.3354/meps054141; MITCHELL JG, 1985, NATURE, V316, P58, DOI 10.1038/316058a0; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ortmann AC, 2002, MICROB ECOL, V43, P225, DOI 10.1007/s00248-001-1058-9; Palijan G, 2012, MICROB ECOL, V64, P39, DOI 10.1007/s00248-012-0016-z; Parvathi Ammini, 2012, Advances in Oceanography and Limnology, V3, P171, DOI 10.1080/19475721.2012.738157; Paterson JS, 2012, ESTUAR COAST SHELF S, V96, P197, DOI 10.1016/j.ecss.2011.11.009; Patten NL, 2006, J MAR BIOL ASSOC UK, V86, P563, DOI 10.1017/S0025315406013476; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peduzzi P, 2004, ENVIRON MICROBIOL, V6, P707, DOI 10.1111/j.1462-2920.2004.00602.x; Peduzzi P, 2008, AQUAT SCI, V70, P186, DOI 10.1007/s00027-008-8068-3; Peduzzi P, 2016, BIOL REV, V91, P937, DOI 10.1111/brv.12202; Pollard PC, 2011, LIMNOL OCEANOGR, V56, P1115, DOI 10.4319/lo.2011.56.3.1115; RIPP S, 1995, APPL ENVIRON MICROB, V61, P1214, DOI 10.1128/AEM.61.4.1214-1219.1995; Roudnew B, 2014, GROUNDWATER, V52, P118, DOI 10.1111/gwat.12044; Roudnew B, 2012, GROUND WATER MONIT R, V32, P72, DOI 10.1111/j.1745-6592.2011.01393.x; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Seymour JR, 2010, AQUAT MICROB ECOL, V59, P161, DOI 10.3354/ame01400; Seymour JR, 2008, ESTUAR COAST SHELF S, V80, P589, DOI 10.1016/j.ecss.2008.09.011; Seymour JR, 2000, AQUAT MICROB ECOL, V22, P143, DOI 10.3354/ame022143; Seymour JR, 2005, MAR ECOL PROG SER, V288, P1, DOI 10.3354/meps288001; Seymour JR, 2006, J MAR BIOL ASSOC UK, V86, P551, DOI 10.1017/S0025315406013464; Seymour JR, 2005, MAR ECOL PROG SER, V300, P21, DOI 10.3354/meps300021; Seymour JR, 2004, AQUAT MICROB ECOL, V35, P1, DOI 10.3354/ame035001; Siegel DA, 1998, LIMNOL OCEANOGR, V43, P1133, DOI 10.4319/lo.1998.43.6.1133; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Smith RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129004; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Thomas R, 2011, ENVIRON MICROBIOL, V13, P616, DOI 10.1111/j.1462-2920.2010.02364.x; WaterConnect Government of South Australia Department of Environment Water and Natural Resources, 2012, RIVER MURRAY DATA; Waters RL, 2003, MAR ECOL PROG SER, V251, P49, DOI 10.3354/meps251049; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; WIEBE PH, 1970, LIMNOL OCEANOGR, V15, P205, DOI 10.4319/lo.1970.15.2.0205; Wilhelm SW, 2008, FRESHWATER BIOL, V53, P1076, DOI 10.1111/j.1365-2427.2008.01980.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561; Zhong X, 2014, MICROB ECOL, V67, P66, DOI 10.1007/s00248-013-0320-2; Zimmermann-Timm H, 2002, INT REV HYDROBIOL, V87, P197, DOI 10.1002/1522-2632(200205)87:2/3<197::AID-IROH197>3.0.CO;2-7	95	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146984	10.1371/journal.pone.0146984	http://dx.doi.org/10.1371/journal.pone.0146984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785114	Green Published, gold			2022-12-27	WOS:000368528400093
J	Groves, C; German, T; Dasgupta, R; Mueller, D; Smith, DL				Groves, Carol; German, Thomas; Dasgupta, Ranjit; Mueller, Daren; Smith, Damon L.			Seed Transmission of Soybean vein necrosis virus: The First Tospovirus Implicated in Seed Transmission	PLOS ONE			English	Article							DISCOVERY	Soybean vein necrosis virus (SVNV; genus Tospovirus; Family Bunyaviridae) is a negativesense single-stranded RNA virus that has been detected across the United States and in Ontario, Canada. In 2013, a seed lot of a commercial soybean variety (Glycine max) with a high percentage of discolored, deformed and undersized seed was obtained. A random sample of this seed was planted in a growth room under standard conditions. Germination was greater than 90% and the resulting seedlings looked normal. Four composite samples of six plants each were tested by reverse transcription polymerase chain reaction (RT-PCR) using published primers complimentary to the S genomic segment of SVNV. Two composite leaflet samples retrieved from seedlings yielded amplicons with a size and sequence predictive of SVNV. Additional testing of twelve arbitrarily selected individual plants resulted in the identification of two SVNV positive plants. Experiments were repeated by growing seedlings from the same seed lot in an isolated room inside a thrips-proof cage to further eliminate any external source of infection. Also, increased care was taken to reduce any possible PCR contamination. Three positive plants out of forty-eight were found using these measures. Published and newly designed primers for the L and M RNAs of SVNV were also used to test the extracted RNA and strengthen the diagnosis of viral infection. In experiments, by three scientists, in two different labs all three genomic RNAs of SVNV were amplified in these plant materials. RNA-seq analysis was also conducted using RNA extracted from a composite seedling sample found to be SVNV-positive and a symptomatic sample collected from the field. This analysis revealed both sense and anti-sense reads from all three gene segments in both samples. We have shown that SVNV can be transmitted in seed to seedlings from an infected seed lot at a rate of 6%. To our knowledge this is the first report of seed-transmission of a Tospovirus.	[Groves, Carol; Smith, Damon L.] Univ Wisconsin, Dept Plant Pathol, 1630 Linden Dr, Madison, WI 53706 USA; [German, Thomas; Dasgupta, Ranjit] Univ Wisconsin, Dept Entomol, 1630 Linden Dr, Madison, WI 53706 USA; [Mueller, Daren] Iowa State Univ, Dept Plant Pathol & Microbiol, 351 Bessey Hall, Ames, IA 50011 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Smith, DL (corresponding author), Univ Wisconsin, Dept Plant Pathol, 1630 Linden Dr, Madison, WI 53706 USA.	damon.smith@wisc.edu		Smith, Damon/0000-0003-3436-3718	Wisconsin Soybean Marketing Board; USDA-ARS Floriculture and Nursery Research Initiative	Wisconsin Soybean Marketing Board; USDA-ARS Floriculture and Nursery Research Initiative(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided in part by the Wisconsin Soybean Marketing Board and the USDA-ARS Floriculture and Nursery Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Hyun Jin Hwang for assistance in conducting experiments and Anna Whitfield and Medhi Kabbage for thorough review of this manuscript. Funding for this work was provided in part by the Wisconsin Soybean Marketing Board and the USDA-ARS Floriculture and Nursery Research Initiative.	[Anonymous], 2015, SOYB ACR PLANT HARV; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; DEMSKI JW, 1971, PHYTOPATHOLOGY, V61, P308, DOI 10.1094/Phyto-61-308; DEMSKI JW, 1975, PHYTOPATHOLOGY, V65, P1154, DOI 10.1094/Phyto-65-1154; Demski JW, 1999, TOBACCO RINGSPOT COM; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Hajimorad M. R., 2015, Plant Health Progress, pPHP; Hartman GL., 1999, COMPENDIUM SOYBEAN D, V4th ed.; Khatabi B, 2012, EUR J PLANT PATHOL, V133, P783, DOI 10.1007/s10658-012-9969-5; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mitter N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076276; Moyer J. W., 1999, APSNET FEATURES, DOI [10.1094/APSnetFeatures-1999-0499, DOI 10.1094/APSNETFEATURES-1999-0499]; NCSRP-Soybean Research & Information Initiative, 2014, SOYB VIR; Nischwitz C, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524B; Pappu S. S., 1999, Peanut Science, V26, P98, DOI 10.3146/i0095-3679-26-2-7; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Smith DL, 2013, PHYTOPATHOLOGY, V103, P135; Smith DL, 2013, PLANT DIS, V97, P693, DOI 10.1094/PDIS-11-12-1096-PDN; Tolin S.A., 1999, COMPENDIUM SOYBEAN D; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9; Zhou J, 2013, PHYTOPATHOLOGY, V103, P966, DOI 10.1094/PHYTO-12-12-0322-R	25	26	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147342	10.1371/journal.pone.0147342	http://dx.doi.org/10.1371/journal.pone.0147342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784931	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400137
J	Liu, S; Hu, B; Zhang, YY; Li, WY; Song, JL				Liu, Shan; Hu, Bo; Zhang, Yuanyuan; Li, Wenyang; Song, Jinlin			Minimally Invasive Surgery Combined with Regenerative Biomaterials in Treating Intra-Bony Defects: A Meta-Analysis	PLOS ONE			English	Article							ENAMEL MATRIX PROTEINS; GUIDED TISSUE REGENERATION; RANDOMIZED-CONTROLLED-TRIAL; SINGLE-FLAP APPROACH; SURGICAL TECHNIQUE; PERIODONTAL THERAPY; CLINICAL-OUTCOMES; INTRAOSSEOUS DEFECTS; 4 MODALITIES; MORBIDITY	Background With the popularity of minimally invasive surgery (MIS) in periodontics, numerous publications have evaluated the benefits of MIS with or without various regenerative biomaterials in the treatment of periodontal intra-bony defects. However, it is unclear if it is necessary to use biomaterials in MIS. Thus, we conducted a meta-analysis of randomized clinical trials in patients with intra-bony defects to compare the clinical outcomes of MIS with regenerative biomaterials for MIS alone. Methods The authors retrieved English publications on relevant studies from Cochrane CENTRAL, PubMed, Medline, Embase, Clinical Evidence, and ClinicalTrails.gov (up to June 30, 2015). The main clinical outcomes were the reduction of probing pocket depths (PPDs), gain of clinical attachment level (CAL), recession of gingival margin (REC) and radiographic bone fill. Review Manager 5.2 (Cochrane Collaboration, Oxford, England) was used to calculate the heterogeneity and mean differences of the main clinical outcomes. Results In total, 464 studies in the literature were identified but only four were ultimately feasible. The results showed no significant difference regarding CAL gain (P = 0.32) and PPD reduction (P = 0.40) as well as REC increase (P = 0.81) and radiographic bone fill (P = 0.64) between the MIS plus biomaterials group and the MIS alone group. Conclusions The meta-analysis suggested no significant difference in treatment of intra-bony defects between the MIS plus biomaterials group and the MIS alone group, indicating that it is important to take costs and benefits into consideration when a decision is made about a therapeutic approach. There needs to be an in-depth exploration of the induction of intrinsic tissue healing of MIS without biomaterials to achieve optimal outcomes.	[Liu, Shan; Hu, Bo; Li, Wenyang; Song, Jinlin] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China; [Liu, Shan; Hu, Bo; Li, Wenyang; Song, Jinlin] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Liu, Shan; Hu, Bo; Li, Wenyang; Song, Jinlin] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Zhang, Yuanyuan] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA	Chongqing Medical University; Wake Forest University	Song, JL (corresponding author), Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.; Song, JL (corresponding author), Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China.; Song, JL (corresponding author), Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China.	soongjl@163.com	zhang, yuanyuan/GYA-4428-2022		National Natural Science Foundation of China [81570981]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2014jcyjA10039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	This research was funded by National Natural Science Foundation of China (No. 81570981), and Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2014jcyjA10039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W, 2001, J PERIODONTOL, V72, P1675, DOI 10.1902/jop.2001.72.12.1675; Bokan I, 2006, J CLIN PERIODONTOL, V33, P885, DOI 10.1111/j.1600-051X.2006.01010.x; Cortellini P, 2008, J CLIN PERIODONTOL, V35, P605, DOI 10.1111/j.1600-051X.2008.01242.x; Cortellini P, 2007, J CLIN PERIODONTOL, V34, P1082, DOI 10.1111/j.1600-051X.2007.01144.x; Cortellini Pierpaolo, 2012, J Evid Based Dent Pract, V12, P89, DOI 10.1016/S1532-3382(12)70021-0; Cortellini P, 2011, J CLIN PERIODONTOL, V38, P365, DOI 10.1111/j.1600-051X.2011.01705.x; Cortellini P, 2009, INT J PERIODONT REST, V29, P257; Cortellini P, 2009, J CLIN PERIODONTOL, V36, P157, DOI 10.1111/j.1600-051X.2008.01352.x; Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x; Darby IB, 2013, J PERIODONTOL, V84, P465, DOI 10.1902/jop.2012.120145; Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub2; Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P247; Froum SJ, 2001, J PERIODONTOL, V72, P25, DOI 10.1902/jop.2001.72.1.25; Harrel S K, 1995, Compend Contin Educ Dent, V16, ppassim; Harrel SK, 2005, J PERIODONTOL, V76, P380, DOI 10.1902/jop.2005.76.3.380; Harrel SK, 1999, J PERIODONTOL, V70, P1547, DOI 10.1902/jop.1999.70.12.1547; Harrel SK, 2010, J PERIODONTOL, V81, P435, DOI 10.1902/jop.2009.090393; HOLM-PEDERSEN P, 1971, Scandinavian Journal of Dental Research, V79, P40; Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186; ISIDOR F, 1985, J CLIN PERIODONTOL, V12, P687, DOI 10.1111/j.1600-051X.1985.tb00940.x; Kaldahl WB, 1996, J PERIODONTOL, V67, P93, DOI 10.1902/jop.1996.67.2.93; KALDAHL WB, 1988, J PERIODONTOL, V59, P783, DOI 10.1902/jop.1988.59.12.783; Lang NP, 2000, PERIODONTOL 2000, V22, P51, DOI 10.1034/j.1600-0757.2000.2220105.x; Mishra A, 2013, J CLIN PERIODONTOL, V40, P172, DOI 10.1111/jcpe.12030; Needleman IG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001724.pub2; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pontoriero R, 1999, J CLIN PERIODONTOL, V26, P833; RAMFJORD SP, 1987, J CLIN PERIODONTOL, V14, P445, DOI 10.1111/j.1600-051X.1987.tb02249.x; Rethman MP, 2010, J PERIODONTOL, V81, P1390, DOI 10.1902/jop.2010.100150; Ribeiro FV, 2011, J PERIODONTOL, V82, P522, DOI 10.1902/jop.2010.100454; Ribeiro Fernanda Vieira, 2010, Braz. Dent. J., V21, P60, DOI 10.1590/S0103-64402010000100010; Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x; Sculean A, 2007, J CLIN PERIODONTOL, V34, P72, DOI 10.1111/j.1600-051X.2006.01007.x; Sipos PM, 2005, J CLIN PERIODONTOL, V32, P765, DOI 10.1111/j.1600-051X.2005.00754.x; TAKEI H H, 1991, Dental Clinics of North America, V35, P531; Tonetti MS, 2002, J CLIN PERIODONTOL, V29, P317, DOI 10.1034/j.1600-051X.2002.290407.x; Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x; Trombelli L, 2010, J PERIODONTOL, V81, P1256, DOI 10.1902/jop.2010.100113; Trombelli L, 2009, J PERIODONTOL, V80, P353, DOI [10.1902/jop.2009.080420, 10.1902/jop.2009.080420 ]; Zadeh Homayoun H, 2004, J Calif Dent Assoc, V32, P1022	41	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147001	10.1371/journal.pone.0147001	http://dx.doi.org/10.1371/journal.pone.0147001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785405	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400096
J	Saez-Lopez, E; Guiral, E; Fernandez-Orth, D; Villanueva, S; Gonce, A; Lopez, M; Teixido, I; Pericot, A; Figueras, F; Palacio, M; Cobo, T; Bosch, J; Soto, SM				Saez-Lopez, Emma; Guiral, Elisabet; Fernandez-Orth, Dietmar; Villanueva, Sonia; Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa; Bosch, Jordi; Soto, Sara M.			Vaginal versus Obstetric Infection Escherichia coli Isolates among Pregnant Women: Antimicrobial Resistance and Genetic Virulence Profile	PLOS ONE			English	Article							PATHOGENICITY ISLANDS; NEONATAL SEPSIS; STRAINS; COLONIZATION; PREVALENCE; PHYLOGENY; SUSCEPTIBILITY; EPIDEMIOLOGY; TRACT	Vaginal Escherichia coli colonization is related to obstetric infections and the consequent development of infections in newborns. Ampicillin resistance among E. coli strains is increasing, which is the main choice for treating empirically many obstetric and neonatal infections. Vaginal E. coli strains are very similar to extraintestinal pathogenic E. coli with regards to the virulence factors and the belonging to phylogroup B2. We studied the antimicrobial resistance and the genetic virulence profile of 82 E. coli isolates from 638 vaginal samples and 63 isolated from endometrial aspirate, placental and amniotic fluid samples from pregnant women with obstetric infections. The prevalence of E. coli in the vaginal samples was 13%, which was significant among women with associated risk factors during pregnancy, especially premature preterm rupture of membranes (p<0.0001). Sixty-five percent of the strains were ampicillin-resistant. The E. coli isolates causing obstetric infections showed higher resistance levels than vaginal isolates, particularly for gentamicin (p = 0.001). The most prevalent virulence factor genes were those related to the iron uptake systems revealing clear targets for interventions. More than 50% of the isolates belonged to the virulent B2 group possessing the highest number of virulence factor genes. The ampicillin-resistant isolates had high number of virulence factors primarily related to pathogenicity islands, and the remarkable gentamicin resistance in E. coli isolates from women presenting obstetric infections, the choice of the most appropriate empiric treatment and clinical management of pregnant women and neonates should be carefully made. Taking into account host-susceptibility, the heterogeneity of E. coli due to evolution over time and the geographical area, characterization of E. coli isolates colonizing the vagina and causing obstetric infections in different regions may help to develop interventions and avoid the aetiological link between maternal carriage and obstetric and subsequent puerperal infections.	[Saez-Lopez, Emma; Guiral, Elisabet; Bosch, Jordi; Soto, Sara M.] Univ Barcelona, Dept Microbiol, Hosp Clin, Barcelona, Spain; [Saez-Lopez, Emma; Guiral, Elisabet; Fernandez-Orth, Dietmar; Villanueva, Sonia; Bosch, Jordi; Soto, Sara M.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Hosp Clin Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Hosp St Joan de Deu, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Inst Invest Biomed August Pi & Sunyer DIBAPS, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Univ Barcelona, Barcelona, Spain; [Gonce, Anna; Lopez, Marta; Teixido, Irene; Pericot, Anna; Figueras, Francesc; Palacio, Montse; Cobo, Teresa] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Soto, SM (corresponding author), Univ Barcelona, Dept Microbiol, Hosp Clin, Barcelona, Spain.; Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	sara.soto@isglobal.org	Soto, Sara M/J-6297-2012; Orth, Dietmar Fernandez/P-2925-2019; Sáez-López, Emma/AAA-8170-2020; Guiral, Elisabet/K-4241-2017; Fernandez Orth, Dietmar/M-3738-2014; Cobo, Teresa/K-2770-2017	Soto, Sara M/0000-0002-9507-105X; Orth, Dietmar Fernandez/0000-0002-1237-3192; Guiral, Elisabet/0000-0001-5386-8610; Fernandez Orth, Dietmar/0000-0002-1237-3192; Saez-Lopez, Emma/0000-0001-8313-3017; Cobo, Teresa/0000-0003-3130-1829; Bosch, Jordi/0000-0001-9263-3371; Palacio, Montse/0000-0002-5869-4629	Fondo de Investigaciones Sanitarias - ISCIII-Subdireccion General de Evaluacion [PI10/01579, PI13/00137]; Fondo Europeo de Desarrollo Regional (FEDER)	Fondo de Investigaciones Sanitarias - ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	Sara M. Soto has a fellowship from the program I3, of the Instituo de Salud Carlos III (ISCIII, www.isciii.es). This material is based upon work supported by the "Fondo de Investigaciones Sanitarias" (PI10/01579 and PI13/00137) integrated in the "Plan Nacional de I+D+I" and co-funded by the "ISCIII-Subdireccion General de Evaluacion" and the "Fondo Europeo de Desarrollo Regional (FEDER)".	Bauer HW, 2013, VACCINATION AGAINST, V2013, P487; Birosova E, 2004, CLIN MICROBIOL INFEC, V10, P569, DOI 10.1111/j.1469-0691.2004.00922.x; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI, V34; Cook S W, 2001, Infect Dis Obstet Gynecol, V9, P203, DOI 10.1155/S1064744901000333; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; Edwards RK, 2005, OBSTET GYN CLIN N AM, V32, P287, DOI 10.1016/j.ogc.2004.12.002; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Guiral E, 2015, J CLIN MICROBIOL, V53, P1745, DOI 10.1128/JCM.00487-15; Guiral E, 2012, CHEMOTHERAPY, V58, P123, DOI 10.1159/000337062; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Hart A, 2001, J INFECT DIS, V183, P1526, DOI 10.1086/320196; Iranpour D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846219; Johnson JR, 2005, ANTIMICROB AGENTS CH, V49, P26, DOI 10.1128/AAC.49.1.26-31.2005; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson JR, 2001, INFECT IMMUN; Kaluzna E, 2014, POSTEP HIG MED DOSW, V68, P808; Kankuri E, 2003, ACTA OBSTET GYN SCAN, V82, P730, DOI 10.1034/j.1600-0412.2003.00265.x; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Lefort A, 2014, CLIN MICROBIOL INFEC, V20, P01035; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Moreno E, 2006, J ANTIMICROB CHEMOTH, V57, P204, DOI 10.1093/jac/dki468; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; Petkovsek Z, 2009, J CLIN MICROBIOL, V47, P1811, DOI 10.1128/JCM.01421-08; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Rani S, 2014, ASIAN J MED SCI, V5, P58, DOI [10.3126/ajms.v5i4.9889, DOI 10.3126/AJMS.V5I4.9889]; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Saez-Lopez E., 2012, CLIN MICROBIOL OPEN, P02; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Shariff VAAR, 2013, J CLIN DIAGN RES, V7, P1027, DOI 10.7860/JCDR/2013/4917.3038; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Soto SM, 2006, ANTIMICROB AGENTS CH, V50, P649, DOI 10.1128/AAC.50.2.649-653.2006; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; van den Hoogen A, 2010, NEONATOLOGY, V97, P22, DOI 10.1159/000226604; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003	40	27	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146531	10.1371/journal.pone.0146531	http://dx.doi.org/10.1371/journal.pone.0146531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784330	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400044
J	Wingenbach, TSH; Ashwin, C; Brosnan, M				Wingenbach, Tanja S. H.; Ashwin, Chris; Brosnan, Mark			Validation of the Amsterdam Dynamic Facial Expression Set - Bath Intensity Variations (ADFES-BIV): A Set of Videos Expressing Low, Intermediate, and High Intensity Emotions	PLOS ONE			English	Article							ACCURATE IDENTIFICATION; RECOGNITION; FACE; DISCRIMINATION; JUDGMENTS; STATE; VOICE	Most of the existing sets of facial expressions of emotion contain static photographs. While increasing demand for stimuli with enhanced ecological validity in facial emotion recognition research has led to the development of video stimuli, these typically involve full-blown (apex) expressions. However, variations of intensity in emotional facial expressions occur in real life social interactions, with low intensity expressions of emotions frequently occurring. The current study therefore developed and validated a set of video stimuli portraying three levels of intensity of emotional expressions, from low to high intensity. The videos were adapted from the Amsterdam Dynamic Facial Expression Set (ADFES) and termed the Bath Intensity Variations (ADFES-BIV). A healthy sample of 92 people recruited from the University of Bath community (41 male, 51 female) completed a facial emotion recognition task including expressions of 6 basic emotions (anger, happiness, disgust, fear, surprise, sadness) and 3 complex emotions (contempt, embarrassment, pride) that were expressed at three different intensities of expression and neutral. Accuracy scores (raw and unbiased (Hu) hit rates) were calculated, as well as response times. Accuracy rates above chance level of responding were found for all emotion categories, producing an overall raw hit rate of 69% for the ADFES-BIV. The three intensity levels were validated as distinct categories, with higher accuracies and faster responses to high intensity expressions than intermediate intensity expressions, which had higher accuracies and faster responses than low intensity expressions. To further validate the intensities, a second study with standardised display times was conducted replicating this pattern. The ADFES-BIV has greater ecological validity than many other emotion stimulus sets and allows for versatile applications in emotion research. It can be retrieved free of charge for research purposes from the corresponding author.	[Wingenbach, Tanja S. H.; Ashwin, Chris; Brosnan, Mark] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England	University of Bath	Wingenbach, TSH (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.	tshw20@bath.ac.uk	Wingenbach, Tanja S. H./U-5321-2019	Wingenbach, Tanja S. H./0000-0002-1727-2374; Ashwin, Chris/0000-0003-4606-7318	Department of Psychology of the University of Bath; German Academic Exchange Service (DAAD); FAZIT Stiftung; University of Bath Graduate School	Department of Psychology of the University of Bath; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); FAZIT Stiftung; University of Bath Graduate School	This work was supported by the Department of Psychology of the University of Bath and doctoral scholarships to TSHW, from the German Academic Exchange Service (DAAD), the FAZIT Stiftung, and the University of Bath Graduate School.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Anderson AK, 2003, J NEUROSCI, V23, P5627; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Banziger T, 2009, EMOTION, V9, P691, DOI 10.1037/a0017088; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P603; Battocchi A., 2005, P 7 INT C MULT INT T, P214, DOI DOI 10.1145/1088463.1088501; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bould E, 2008, BRIT J PSYCHOL, V99, P167, DOI 10.1348/000712607X206702; Bould E, 2008, COGNITION EMOTION, V22, P1569, DOI 10.1080/02699930801921156; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; Calder AJ, 1997, P ROY SOC B-BIOL SCI, V264, P919, DOI 10.1098/rspb.1997.0127; Calder AJ, 2000, COGNITION, V76, P105, DOI 10.1016/S0010-0277(00)00074-3; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Calvo MG, 2014, J NONVERBAL BEHAV, V38, P549, DOI 10.1007/s10919-014-0191-3; Calvo MG, 2011, VISION RES, V51, P1751, DOI 10.1016/j.visres.2011.06.001; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; DARWIN C., 1872, EXPRESSION EMOTIONS, V6; de Gelder B, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00054; Derogatis L.R., 1994, USE PSYCHOL TESTING, P217; Du SC, 2011, J VISION, V11, DOI 10.1167/11.13.24; Duchenne G.-B., 1990, MECH HUMAN FACIAL EX; Dyck MJ, 2012, AUST PSYCHOL, V47, P49, DOI 10.1111/j.1742-9544.2011.00047.x; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; EKMAN P, 1986, MOTIV EMOTION, V10, P159, DOI 10.1007/BF00992253; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elfenbein HA, 2002, EMOTION, V2, P75, DOI 10.1037/1528-3542.2.1.75; Freeman JB, 2015, CEREB CORTEX, V25, P415, DOI 10.1093/cercor/bht238; Fridlund AJ, 1994, HUMAN FACIAL EXPRESS, Vxiv; GOSSELIN P, 1995, J PERS SOC PSYCHOL, V68, P83, DOI 10.1037/0022-3514.68.1.83; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; HESS U, 1990, EUR J SOC PSYCHOL, V20, P369, DOI 10.1002/ejsp.2420200502; Hess U, 2009, PHILOS T R SOC B, V364, P3497, DOI 10.1098/rstb.2009.0165; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131; Kaulard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032321; KESTENBAUM R, 1992, J EXP CHILD PSYCHOL, V54, P1, DOI 10.1016/0022-0965(92)90014-W; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Lander K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00255; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; Loughead J, 2008, BRAIN RES, V1194, P37, DOI 10.1016/j.brainres.2007.10.105; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Matsumoto D, 2004, J PERS SOC PSYCHOL, V87, P529, DOI 10.1037/0022-3514.87.4.529; Matsumoto D, 2011, SCI BRIEF, V25; Matsumoto D, 2004, CULTURE PSYCHOL, Vxxiii; Matsumoto D, 2014, EMOTION, V14, P349, DOI 10.1037/a0035237; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Motley M. T., 1988, W J SPEECH COMMUNICA, V52, P1, DOI [10.1080/10570318809389622, DOI 10.1080/10570318809389622]; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Pollick FE, 2003, PERCEPTION, V32, P813, DOI 10.1068/p3319; Psychology Software Tools Inc., 2012, E PRIM 2 0; Recio G, 2013, COGNITION EMOTION, V27, P1486, DOI 10.1080/02699931.2013.794128; Reeve J, 1992, UNDERSTANDING MOTIVA, Vxvii; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Rojahn J, 2002, J CHILD FAM STUD, V11, P203; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Scherer KR, 2013, EMOT REV, V5, P47, DOI 10.1177/1754073912451504; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Stein N.L., 2008, HDB EMOTIONS, P574; Suzuki A, 2006, COGNITION, V99, P327, DOI 10.1016/j.cognition.2005.04.003; Tamietto M, 2005, NEUROCASE, V11, P399, DOI 10.1080/13554790500259717; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; Tracy JL, 2009, EMOTION, V9, P554, DOI 10.1037/a0015766; Tracy JL, 2007, SELF CONSCIOUS EMOTI, Vxviii; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Wagner HL, 2000, COGNITION EMOTION, V14, P689, DOI 10.1080/02699930050117675; Walker JJ, 1997, POWDER TECHNOL, V92, P9, DOI 10.1016/S0032-5910(97)03208-7; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; Yoshikawa S, 2008, COGN AFFECT BEHAV NE, V8, P25, DOI 10.3758/CABN.8.1.25; Yoshikawa S, 2006, JPN PSYCHOL RES, V48, P213, DOI 10.1111/j.1468-5884.2006.00321.x	93	48	48	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147112	10.1371/journal.pone.0147112	http://dx.doi.org/10.1371/journal.pone.0147112			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784347	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000368528400110
J	Van Opstal, D; Srebniak, MI; Polak, J; de Vries, F; Govaerts, LCP; Joosten, M; Go, ATJI; Knapen, MFCM; van den Berg, C; Diderich, KEM; Galjaard, RJH				Van Opstal, Diane; Srebniak, Malgorzata I.; Polak, Joke; de Vries, Femke; Govaerts, Lutgarde C. P.; Joosten, Marieke; Go, Attie T. J. I.; Knapen, Maarten F. C. M.; van den Berg, Cardi; Diderich, Karin E. M.; Galjaard, Robert-Jan H.			False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review	PLOS ONE			English	Article							FREE FETAL DNA; CONFINED PLACENTAL MOSAICISM; PRENATAL-DIAGNOSIS; ANEUPLOIDY; CULTURE; SAMPLES; TERM	Non-invasive prenatal testing (NIPT) demonstrated a small chance for a false negative result. Since the "fetal" DNA in maternal blood originates from the cytotrophoblast of chorionic villi (CV), some false negative results will have a biological origin. Based on our experience with cytogenetic studies of CV, we tried to estimate this risk. 5967 CV samples of pregnancies at high risk for common aneuplodies were cytogenetically investigated in our centre between January 2000 and December 2011. All cases of fetal trisomy 13, 18 and 21 were retrospectively studied for the presence of a normal karyotype or mosaicism < 30% in short-term cultured (STC-) villi. 404 cases of trisomies 13, 18 and 21 were found amongst 5967 samples (6,8%). Of these 404 cases, 14 (3,7%) had a normal or low mosaic karyotype in STC-villi and therefore would potentially be missed with NIPT. It involved 2% (5/242) of all trisomy 21 cases and 7.3% (9/123) of all trisomy 18 cases. In 1:426 (14/5967) NIPT samples of patients at high risk for common aneuploidies, a trisomy 18 or 21 will potentially be missed due to the biological phenomenon of absence of the chromosome aberration in the cytotrophoblast.	[Van Opstal, Diane; Srebniak, Malgorzata I.; Polak, Joke; de Vries, Femke; Govaerts, Lutgarde C. P.; Joosten, Marieke; van den Berg, Cardi; Diderich, Karin E. M.; Galjaard, Robert-Jan H.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Go, Attie T. J. I.; Knapen, Maarten F. C. M.] Erasmus MC, Dept Obstet & Prenatal Med, Rotterdam, Netherlands; [Knapen, Maarten F. C. M.] Stichting Prenatale Screening Zuidwest Nederland, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Van Opstal, D (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	a.vanopstal@erasmusmc.nl		Diderich, Karin/0000-0003-2637-9998; Srebniak, Malgorzata/0000-0003-3429-6156				Battaglia P, 2014, PRENATAL DIAG, V34, P739, DOI 10.1002/pd.4358; Benn P, 2013, ULTRASOUND OBST GYN, V42, P15, DOI 10.1002/uog.12513; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bianchi DW, 2014, CLIN CHEM, V60, P78, DOI 10.1373/clinchem.2013.202663; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; BIANCHI DW, 1993, AM J MED GENET, V46, P542, DOI 10.1002/ajmg.1320460517; Canick JA, 2013, PRENATAL DIAG, V33, P667, DOI 10.1002/pd.4126; CRANE JP, 1988, PRENATAL DIAG, V8, P119, DOI 10.1002/pd.1970080206; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Flori E, 2004, HUM REPROD, V19, P723, DOI 10.1093/humrep/deh117; Gao Y, 2014, ULTRASOUND OBST GYN, V43, P477, DOI 10.1002/uog.13240; Gerovassili A, 2007, PRENATAL DIAG, V27, P104, DOI 10.1002/pd.1607; GIBAS LM, 1987, PRENATAL DIAG, V7, P323, DOI 10.1002/pd.1970070505; Gil MM, 2014, FETAL DIAGN THER, V35, P156, DOI 10.1159/000358326; Grati FR, 2014, GENET MED, V16, P620, DOI 10.1038/gim.2014.3; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; KALOUSEK DK, 1994, PEDIATR PATHOL, V14, P151, DOI 10.3109/15513819409022034; PITTALIS MC, 1994, PRENATAL DIAG, V14, P267, DOI 10.1002/pd.1970140406; Porreco RP, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.042; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; SACHS ES, 1990, AM J MED GENET, V37, P268, DOI 10.1002/ajmg.1320370222; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SMIDTJENSEN S, 1989, PRENATAL DIAG, V9, P309, DOI 10.1002/pd.1970090503; Srebniak MI, 2014, ULTRASOUND OBST GYN, V44, P109, DOI 10.1002/uog.13334; Toutain J, 2010, EUR J OBSTET GYN R B, V149, P143, DOI 10.1016/j.ejogrb.2009.12.015; Toutain J, 2013, PRENATAL DIAG, V33, P1115, DOI 10.1002/pd.4202; van den Berg C, 2000, PRENATAL DIAG, V20, P956, DOI 10.1002/1097-0223(200012)20:12<956::AID-PD956>3.3.CO;2-P; van den Berg C, 2006, PRENATAL DIAG, V26, P401, DOI 10.1002/pd.1421; Van Opstal D, 2015, HUM MUTAT, V36, P319, DOI 10.1002/humu.22742; Vora NL, 2012, PRENATAL DIAG, V32, P912, DOI 10.1002/pd.3919; Wolstenholme J, 1996, PRENATAL DIAG, V16, P511, DOI 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8; Wolstenholme J, 2008, PRENATAL DIAG, V28, P266, DOI 10.1002/pd.1961	33	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146794	10.1371/journal.pone.0146794	http://dx.doi.org/10.1371/journal.pone.0146794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771677	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300036
J	Zhang, H; Zhang, P; Fan, J; Qiu, BH; Pan, J; Zhang, X; Fang, LX; Qi, ST				Zhang, Hui; Zhang, Peng; Fan, Jun; Qiu, Binghui; Pan, Jun; Zhang, Xi'an; Fang, Luxiong; Qi, Songtao			Determining an Optimal Cutoff of Serum beta-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas	PLOS ONE			English	Article							GERM-CELL TUMORS; PRIMARY CHEMOTHERAPY; RADIATION-THERAPY; CNS GERMINOMA; BRAIN-TUMORS; RADIOTHERAPY; MANAGEMENT; CHILDREN; MARKERS	Background Beta (beta)-human chorionic gonadotropin (beta-HCG) is used to confirm the diagnosis and plan treatment of intracranial germinomas. However, the cutoff values of serum beta-HCG in diagnosis of intracranial germinomas reported in the literature are inconsistent. To establish an appropriate cutoff value of serum beta-HCG for diagnosis of intracranial germinomas, we retrospectively reviewed the records of intracranial tumor patients who received serum beta-HCG and a-fetoprotein (AFP) tests for diagnostic purposes at our hospital from 2005 to 2014. Methods A total of 93 intracranial germinomas and 289 intracranial non-germ cell tumors were included in this study. Receiver operating characteristic (ROC) analysis was used to evaluate the sensitivity and specificity of 3 cutoffs (0.1, 0.4, and 0.5 mIU/mL) for diagnosing intracranial germinomas. The serum beta-HCG level of intracranial germinoma patients was further analyzed to investigate the effect of metastasis status and tumor location on serum beta-HCG level. Results The area under the ROC curve was 0.81 (P < .001), suggesting beta-HCG is an effective marker. Of the 3 cutoff values, 0.1 mIU/mL possessed a highest sensitivity (66.67%) and good specificity (91%). Although there was no beta-HCG level difference between metastatic and non-metastatic intracranial germinoma patients, the diagnostic rate of metastatic neurohypophyseal germinomas was significantly higher than that of its non-metastatic counterpart (P < .05), implying that the location of the germinoma might need to be considered when beta-HCG is used as a marker to predict metastasis. Conclusions Determining an optimal cutoff of serum beta-HCG is helpful for assisting the diagnosis of intracranial germinoma.	[Zhang, Hui; Fan, Jun; Qiu, Binghui; Pan, Jun; Zhang, Xi'an; Fang, Luxiong; Qi, Songtao] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Peng] Southern Med Univ, Nanfang Hosp, Dept Lab Med, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China.	zhanghuinf@163.com	Pan, Jun/GQQ-7313-2022					Alapetite C, 2010, NEURO-ONCOLOGY, V12, P1318, DOI 10.1093/neuonc/noq093; Allen J, 2012, PEDIATR BLOOD CANCER, V59, P1180, DOI 10.1002/pbc.24097; [Anonymous], 1979, Lancet, V2, P651; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Bamberg M, 1999, J CLIN ONCOL, V17, P2585, DOI 10.1200/JCO.1999.17.8.2585; Bhatty Usman Najeeb, 2013, Case Rep Urol, V2013, P490638, DOI 10.1155/2013/490638; BLOOM HJG, 1983, CLIN ONCOL, V2, P233; Brandes AA, 2000, CANCER TREAT REV, V26, P233, DOI 10.1053/ctrv.2000.0169; Chen YW, 2012, CANCER-AM CANCER SOC, V118, P2752, DOI 10.1002/cncr.26564; Cho DY, 1997, CHILD NERV SYST, V13, P42, DOI 10.1007/s003810050038; Cho KT, 2002, CHILD NERV SYST, V18, P30, DOI 10.1007/s00381-001-0547-y; Cuccia V, 2006, ACTA NEUROCHIR, V148, P865, DOI 10.1007/s00701-006-0846-x; da Silva NS, 2010, PEDIATR BLOOD CANCER, V54, P377, DOI 10.1002/pbc.22381; Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037; Goodwin TL, 2009, J PEDIAT HEMATOL ONC, V31, P541, DOI 10.1097/MPH.0b013e3181983af5; Loto MG, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/936937; Guzzo MF, 2013, ARQ BRAS ENDOCRINOL, V57, P566, DOI 10.1590/S0004-27302013000700012; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jorsal T, 2012, ACTA ONCOL, V51, P3, DOI 10.3109/0284186X.2011.586000; Kawaguchi T, 2011, J NEURO-ONCOL, V104, P779, DOI 10.1007/s11060-011-0544-2; Kellie SJ, 2004, PEDIATR BLOOD CANCER, V43, P126, DOI 10.1002/pbc.20026; Kim JS, 2007, J CLIN NEUROL, V3, P150, DOI 10.3988/jcn.2007.3.3.150; Lee D, 2010, VIRCHOWS ARCH, V457, P347, DOI 10.1007/s00428-010-0951-3; Legault G, 2013, PEDIATR BLOOD CANCER, V60, P1647, DOI 10.1002/pbc.24620; Liu ZY, 2014, ACTA RADIOL, V55, P874, DOI 10.1177/0284185113507824; Lou X, 2009, AM J NEURORADIOL, V30, P1694, DOI 10.3174/ajnr.A1696; Maher CO, 2004, PEDIATR CLIN N AM, V51, P327, DOI 10.1016/S0031-3955(03)00206-2; Malati T, 2007, INDIAN J CLIN BIOCHE, V22, P17, DOI 10.1007/BF02913308; Martens T, 2014, NEUROSURG REV, V37, P445, DOI 10.1007/s10143-014-0544-8; Murray MJ, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.333; Ogawa K, 2004, INT J RADIAT ONCOL, V58, P705, DOI 10.1016/j.ijrobp.2003.07.001; Ogino H, 2005, INT J RADIAT ONCOL, V62, P803, DOI 10.1016/j.ijrobp.2004.10.026; Ozbey Nese, 2006, Hormones (Athens), V5, P67; Packer R J, 2000, Oncologist, V5, P312; Paulino AC, 1999, ONCOLOGY-NY, V13, P513; Pettorini BL, 2013, CHILD NERV SYST, V29, P433, DOI 10.1007/s00381-012-1954-y; Qaddoumi I, 2012, CHILD NERV SYST, V28, P1017, DOI 10.1007/s00381-012-1762-4; Qi ST, 2014, J NEURO-ONCOL, V119, P159, DOI 10.1007/s11060-014-1468-4; Shibamoto Y, 2001, RADIOLOGY, V218, P452, DOI 10.1148/radiology.218.2.r01ja08452; Shibamoto Y, 2009, PROG NEUROL SURG, V23, P119, DOI 10.1159/000210058; Thurnher Majda M, 2009, Cancer Imaging, V9 Spec No A, pS1, DOI 10.1102/1470-7330.2009.9001; TIEN RD, 1990, AM J ROENTGENOL, V155, P143, DOI 10.2214/ajr.155.1.2162137; XIAO Gang, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P429; Yoshida Yoshinobu, 2005, Medical Molecular Morphology, V38, P104, DOI 10.1007/s00795-004-0258-z	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147023	10.1371/journal.pone.0147023	http://dx.doi.org/10.1371/journal.pone.0147023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771195	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300053
J	Atyame, CM; Labbe, P; Lebon, C; Weill, M; Moretti, R; Marini, F; Gouagna, LC; Calvitti, M; Tortosa, P				Atyame, Celestine M.; Labbe, Pierrick; Lebon, Cyrille; Weill, Mylene; Moretti, Riccardo; Marini, Francesca; Gouagna, Louis Clement; Calvitti, Maurizio; Tortosa, Pablo			Comparison of Irradiation and Wolbachia Based Approaches for Sterile-Male Strategies Targeting Aedes albopictus	PLOS ONE			English	Article							CULEX-PIPIENS-QUINQUEFASCIATUS; FILARIASIS VECTOR ELIMINATION; BLOOD-FEEDING BEHAVIOR; IN-FIELD POPULATIONS; LA-REUNION-ISLAND; CYTOPLASMIC INCOMPATIBILITY; MATING COMPETITIVENESS; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; SEMIFIELD CONDITIONS	The global expansion of Aedes albopictus together with the absence of vaccines for most of the arboviruses transmitted by this mosquito has stimulated the development of sterile-male strategies aiming at controlling disease transmission through the suppression of natural vector populations. In this context, two environmentally friendly control strategies, namely the Sterile Insect Technique (SIT) and the Wolbachia-based Incompatible Insect Technique (IIT) are currently being developed in several laboratories worldwide. So far however, there is a lack of comparative assessment of these strategies under the same controlled conditions. Here, we compared the mating capacities, i.e. insemination capacity, sterilization capacity and mating competitiveness of irradiated (35 Gy) and incompatible Ae. albopictus males at different ages and ratios under laboratory controlled conditions. Our data show that there was no significant difference in insemination capacity of irradiated and incompatible males, both male types showing lower capacities than untreated males at 1 day but recovering full capacity within 5 days following emergence. Regarding mating competitiveness trials, a global observed trend is that incompatible males tend to induce a lower hatching rate than irradiated males in cage controlled confrontations. More specifically, incompatible males were found more competitive than irradiated males in 5:1 ratio regardless of age, while irradiated males were only found more competitive than incompatible males in the 1:1 ratio at 10 days old. Overall, under the tested conditions, IIT seemed to be slightly more effective than SIT. However, considering that a single strategy will likely not be adapted to all environments, our data stimulates the need for comparative assessments of distinct strategies in up-scaled conditions in order to identify the most suitable and safe sterilizing technology to be implemented in a specific environmental setting and to identify the parameters requiring fine tuning in order to reach optimal release conditions.	[Atyame, Celestine M.; Lebon, Cyrille; Gouagna, Louis Clement; Tortosa, Pablo] CRVOI, Plateforme Rech CYROI, Ste Clotilde, Reunion, France; [Atyame, Celestine M.; Tortosa, Pablo] Univ La Reunion, Plateforme Rech CYROI, UMR PIMIT, INSERM 1187,CNRS 9192,IRD 249, Ste Clotilde, Reunion, France; [Labbe, Pierrick; Weill, Mylene] Univ Montpellier, CNRS, IRD, ISEM UMR 5554, F-34059 Montpellier, France; [Lebon, Cyrille; Gouagna, Louis Clement] UM1 UM2, CNRS 5290, IRD 224, Unite Mixte Rech MIVEGEC, Montpellier, France; [Moretti, Riccardo; Marini, Francesca; Calvitti, Maurizio] ENEA, CR Casaccia, Biotecnol & Agroind Div, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Italian National Agency New Technical Energy & Sustainable Economics Development	Atyame, CM (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.	celestine.atyame-nten@pasteur.fr	Labbé, Pïerrick/AAL-5806-2020; Marini, Francesca/AAE-9300-2020	Labbé, Pïerrick/0000-0003-0806-1919; Marini, Francesca/0000-0002-7207-5891; Tortosa, Pablo/0000-0002-7928-7264; Moretti, Riccardo/0000-0003-1654-9383; Weill, Mylene/0000-0002-4043-1601	European Union [263958]; French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	European Union(European Commission); French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	Celestine M. Atyame Post-Doctoral position was funded by the European Union's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement no263958 (RUN-Emerge project). This investigation had received the joint financial supports from the French Ministry of Health and the European Regional Development Fund (FEDER-Reunion) under the Convergence 2007-2013 Programme.	Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271; Crawley M.J., 2007, R BOOK; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Dyck V.A., 2006, STERILE INSECT TECHN; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Fu YQ, 2010, APPL ENVIRON MICROB, V76, P5887, DOI 10.1128/AEM.00218-10; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoffmann AA, 2005, NATURE, V436, P189, DOI 10.1038/436189a; Jamnongluk W, 2000, J MED ENTOMOL, V37, P53, DOI 10.1603/0022-2585-37.1.53; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724; Labbe P, 2005, J EVOLUTION BIOL, V18, P1471, DOI 10.1111/j.1420-9101.2005.00938.x; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020; Maiga H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-460; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; Noda H, 2001, MOL ECOL, V10, P2101, DOI 10.1046/j.0962-1083.2001.01334.x; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019; Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884; Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Rasgon JL, 2003, GENETICS, V165, P2029; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; SMITH C E G, 1956, J Trop Med Hyg, V59, P243; Stone CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076228; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; TURELLI M, 1995, GENETICS, V140, P1319; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126	76	27	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146834	10.1371/journal.pone.0146834	http://dx.doi.org/10.1371/journal.pone.0146834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765951	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300045
J	Feng, JC; Wang, LH; Zhou, LX; Yang, X; Zhao, X				Feng, Junchang; Wang, Lihong; Zhou, Luoxiong; Yang, Xin; Zhao, Xin			Using In Vitro Immunomodulatory Properties of Lactic Acid Bacteria for Selection of Probiotics against Salmonella Infection in Broiler Chicks	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LACTOBACILLUS-SALIVARIUS; ANTAGONISTIC ACTIVITY; GENE-EXPRESSION; INNATE IMMUNITY; ENTERITIDIS; CYTOKINES; INVASION; STRAINS; CELLS	Poultry is known to be a major reservoir of Salmonella. The use of lactic acid bacteria has become one of successful strategies to control Salmonella in poultry. The purpose of this study was to select lactic acid bacteria strains by their in vitro immunomodulatory properties for potential use as probiotics against Salmonella infection in broiler chicks. Among 101 isolated lactic acid bacteria strains, 13 strains effectively survived under acidic (pH 2.5) and bile salt (ranging from 0.1% to 1.0%) conditions, effectively inhibited growth of 6 pathogens, and adhered to Caco-2 cells. However, their in vitro immunomodulatory activities differed significantly. Finally, three strains with higher in vitro immunomodulatory properties (Lactobacillus plantarum PZ01, Lactobacillus salivarius JM32 and Pediococcus acidilactici JH231) and three strains with lower in vitro immunomodulatory activities (Enterococcus faecium JS11, Lactobacillus salivarius JK22 and Lactobacillus salivarius JM2A1) were compared for their inhibitory effects on Salmonella adhesion and invasion to Caco-2 cells in vitro and their antimicrobial effects in vivo. The former three strains inhibited Salmonella adhesion and invasion to Caco-2 cells in vitro, reduced the number of Salmonella in intestinal content, spleen and liver, reduced the levels of lipopolysaccharide-induced TNF-alpha factor (LITAF), IL-1 beta, IL-6 and IL-12 in serum and increased the level of IL-10 in serum during a challenge study in vivo more efficiently than the latter three strains. These results suggest that in vitro immunomodulatory activities could be used as additional parameters to select more effective probiotics as feed supplements for poultry.	[Feng, Junchang; Wang, Lihong; Zhou, Luoxiong; Yang, Xin; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zhao, X (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	innovation project of science and technology plan project of Shaanxi Province, China [2014KTCL02-21]; Ministry of Agriculture [2013-S16]; thousand talent program; Natural Science Foundation of China [31402095]; Northwest A&F University PhD Research Start-up funds [2012BSJJ094]	innovation project of science and technology plan project of Shaanxi Province, China; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); thousand talent program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A&F University PhD Research Start-up funds	This work was supported by funding from an innovation project of science and technology plan project of Shaanxi Province, China (2014KTCL02-21); the Ministry of Agriculture (No. 2013-S16); the thousand talent program to X.Z.; and Natural Science Foundation of China (No. 31402095) and Northwest A&F University PhD Research Start-up funds (No. 2012BSJJ094) to X.Y.	Al-Madboly LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00347; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bianchi MA, 2004, LETT APPL MICROBIOL, V39, P301, DOI 10.1111/j.1472-765X.2004.01589.x; Bolcato-Bellemin AL, 2004, J ENDOTOXIN RES, V10, P15, DOI 10.1179/096805104225003780; Botta C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094457; Brisbin JT, 2011, CLIN VACCINE IMMUNOL, V18, P1447, DOI 10.1128/CVI.05100-11; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Chen CY, 2013, J MED MICROBIOL, V62, P1657, DOI 10.1099/jmm.0.061010-0; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dawoud TM, 2011, POULTRY SCI, V90, P1134, DOI 10.3382/ps.2010-01182; Ganguly NK, 2011, INDIAN J MED RES, V134, P22; Haghighi HR, 2008, VET MICROBIOL, V126, P225, DOI 10.1016/j.vetmic.2007.06.026; Higgins SE, 2008, POULTRY SCI, V87, P27, DOI 10.3382/ps.2007-00210; Hirose Y, 2010, MICROBIOL IMMUNOL, V54, P143, DOI 10.1111/j.1348-0421.2009.00189.x; Husakova E, 2015, ACTA VET BRNO, V84, P29, DOI 10.2754/avb201585010029; Kang C, 2014, TOXICON, V86, P116, DOI 10.1016/j.toxicon.2014.04.005; Lin WH, 2007, J APPL MICROBIOL, V102, P22, DOI 10.1111/j.1365-2672.2006.03073.x; Liu XM, 2013, FOOD CONTROL, V30, P563, DOI 10.1016/j.foodcont.2012.09.002; Messaoudi S, 2013, FOOD MICROBIOL, V36, P296, DOI 10.1016/j.fm.2013.05.010; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Osmanagaoglu O, 2010, PROBIOTICS ANTIMICRO, V2, P162, DOI 10.1007/s12602-010-9050-7; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Tellez G, 2012, FOOD RES INT, V45, P628, DOI 10.1016/j.foodres.2011.03.047; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Tsai CC, 2011, FEMS IMMUNOL MED MIC, V63, P44, DOI 10.1111/j.1574-695X.2011.00826.x; Waewdee P, 2012, J ANIM VET ADV, V11, P955; Withanage GSK, 2005, INFECT IMMUN, V73, P5173, DOI 10.1128/IAI.73.8.5173-5182.2005; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yamawaki RA, 2013, POULTRY SCI, V92, P1560, DOI 10.3382/ps.2012-02936	30	39	49	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147630	10.1371/journal.pone.0147630	http://dx.doi.org/10.1371/journal.pone.0147630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799658	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300133
J	Kumase, F; Takeuchi, K; Morizane, Y; Suzuki, J; Matsumoto, H; Kataoka, K; Al-Moujahed, A; Maidana, DE; Miller, JW; Vavvas, DG				Kumase, Fumiaki; Takeuchi, Kimio; Morizane, Yuki; Suzuki, Jun; Matsumoto, Hidetaka; Kataoka, Keiko; Al-Moujahed, Ahmad; Maidana, Daniel E.; Miller, Joan W.; Vavvas, Demetrios G.			AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-kappa B Pathway in RAW264.7 Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; DEPENDENT TRANSCRIPTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; TNF-ALPHA; C-REL; INFLAMMATION; MECHANISM; POLARIZATION	C-C chemokine receptor 2 (Ccr2) is a key pro-inflammatory marker of classic (M1) macrophage activation. Although Ccr2 is known to be expressed both constitutively and inductively, the full regulatory mechanism of its expression remains unclear. AMP-activated protein kinase (AMPK) is not only a master regulator of energy homeostasis but also a central regulator of inflammation. In this study, we sought to assess AMPK's role in regulating RAW264.7 macrophage Ccr2 protein levels in resting (M0) or LPS-induced M1 states. In both M0 and M1 RAW264.7 macrophages, knockdown of the AMPKa1 subunit by siRNA led to increased Ccr2 levels whereas pharmacologic (A769662) activation of AMPK, attenuated LPS-induced increases in Ccr2 expression in an AMPK dependent fashion. The increases in Ccr2 levels by AMPK downregulation were partially reversed by NF-kappa B inhibition whereas TNF-alpha inhibition had minimal effects. Our results indicate that AMPK is a negative regulator of Ccr2 expression in RAW264.7 macrophages, and that the mechanism of action of AMPK inhibition of Ccr2 is mediated, in part, through the NF-kappa B pathway.	[Kumase, Fumiaki; Takeuchi, Kimio; Morizane, Yuki; Suzuki, Jun; Matsumoto, Hidetaka; Kataoka, Keiko; Al-Moujahed, Ahmad; Maidana, Daniel E.; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Angiogenesis Lab,Massachusetts Eye &, Boston, MA USA; [Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan; [Suzuki, Jun] Tokyo Med Univ, Dept Ophthalmol, Tokyo 1608402, Japan	Harvard University; Harvard Medical School; Okayama University; Tokyo Medical University	Vavvas, DG (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Angiogenesis Lab,Massachusetts Eye &, Boston, MA USA.	Demetrios_Vavvas@meei.harvard.edu	Kataoka, Keiko/B-2806-2016	Kataoka, Keiko/0000-0002-8795-6536; /0000-0002-5435-8804; Vavvas, Demetrios/0000-0002-8622-6478	Foundation Lions Eye Research Fund; Yeatts Family Foundation; Macula Society; Bausch & Lomb Vitreoretinal Fellowship; Physician Scientist Award; Research to Prevent Blindness Foundation; NEI [R21EY023079-01A1, EY014104]; NATIONAL EYE INSTITUTE [P30EY014104, R21EY023079, R01EY025362] Funding Source: NIH RePORTER	Foundation Lions Eye Research Fund; Yeatts Family Foundation; Macula Society; Bausch & Lomb Vitreoretinal Fellowship; Physician Scientist Award; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Foundation Lions Eye Research Fund (DGV); The Yeatts Family Foundation (DGV, JWM); a 2013 Macula Society Research Grant award (DGV); a Bausch & Lomb Vitreoretinal Fellowship (FK); a Physician Scientist Award (DGV), and a unrestricted grant (JWM) from the Research to Prevent Blindness Foundation; NEI R21EY023079-01A1 (DGV); and NEI Grant EY014104 (MEEI Core Grant).	Akbarshahi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042654; Avni D, 2012, BIOCHEM PHARMACOL, V83, P106, DOI 10.1016/j.bcp.2011.09.025; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen YB, 2014, INTELL SYST SER, P1, DOI 10.1016/B978-0-12-397199-9.00001-X; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hickman SE, 2013, J ALZHEIMERS DIS, V33, pS295, DOI 10.3233/JAD-2012-129027; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Kagoya Y, 2014, J CLIN INVEST, V124, P528, DOI 10.1172/JCI68101; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee HY, 2005, BIOCHEM BIOPH RES CO, V336, P716, DOI 10.1016/j.bbrc.2005.08.154; Liu Z, 2013, J IMMUNOL, V191, P857, DOI 10.4049/jimmunol.1300790; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oeckinghaus A, 2009, COLD SPRING HARB PER, V1, DOI [10.1101/cshperspect.a000034, DOI 10.1101/CSHPERSPECT.A000034]; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Pujari R, 2013, IMMUNOL RES, V57, P166, DOI 10.1007/s12026-013-8463-2; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Steinberg GR, 2014, IMMUNOL CELL BIOL, V92, P340, DOI 10.1038/icb.2014.11; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takeuchi K, 2013, J BIOL CHEM, V288, P20581, DOI 10.1074/jbc.M113.460832; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu L, 1999, EUROPEAN J IMMUNOLOG, V30, P227; Yamasaki R., 2012, CLIN EXP NEUROIMMUNO, V3, P16, DOI [DOI 10.1111/J.1759-1961.2011.00024.X, 10.1111/j.1759-1961.2011.00024.x]; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265	57	18	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147279	10.1371/journal.pone.0147279	http://dx.doi.org/10.1371/journal.pone.0147279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799633	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300085
J	Yun, S; Donovan, MH; Ross, MN; Richardson, DR; Reister, R; Farnbauch, LA; Fischer, SJ; Riethmacher, D; Gershenfeld, HK; Lagace, DC; Eisch, AJ				Yun, Sanghee; Donovan, Michael H.; Ross, Michele N.; Richardson, Devon R.; Reister, Robin; Farnbauch, Laure A.; Fischer, Stephanie J.; Riethmacher, Dieter; Gershenfeld, Howard K.; Lagace, Diane C.; Eisch, Amelia J.			Stress-Induced Anxiety- and Depressive-Like Phenotype Associated with Transient Reduction in Neurogenesis in Adult Nestin-CreER(T2)/Diphtheria Toxin Fragment A Transgenic Mice	PLOS ONE			English	Article							TAIL-SUSPENSION TEST; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; CELL-PROLIFERATION; PROGENITOR CELLS; ANIMAL-MODELS; NEURAL STEM; SYNAPTIC PLASTICITY; GRANULE CELLS; BEHAVIOR	Depression and anxiety involve hippocampal dysfunction, but the specific relationship between these mood disorders and adult hippocampal dentate gyrus neurogenesis remains unclear. In both humans with MDD and rodent models of depression, administration of antidepressants increases DG progenitor and granule cell number, yet rodents with induced ablation of DG neurogenesis typically do not demonstrate depressive-or anxiety-like behaviors. The conflicting data may be explained by the varied duration and degree to which adult neurogenesis is reduced in different rodent neurogenesis ablation models. In order to test this hypothesis we examined how a transient-rather than permanent-inducible reduction in neurogenesis would alter depressive-and anxiety-like behaviors. Transgenic Nestin-CreER(T2)/floxed diphtheria toxin fragment A (DTA) mice (Cre+DTA+) and littermates (Cre+DTA-; control) were given tamoxifen (TAM) to induce recombination and decrease nestin-expressing stem cells and their progeny. The decreased neurogenesis was transient: 12 days post-TAM Cre+DTA+ mice had fewer DG proliferating Ki67+ cells and fewer DCX+ neuroblasts/immature neurons relative to control, but 30 days post-TAM Cre+DTA+ mice had the same DCX+ cell number as control. This ability of DG neurogenesis to recover after partial ablation also correlated with changes in behavior. Relative to control, Cre+DTA+ mice tested between 12-30 days post-TAM displayed indices of a stress-induced anxiety phenotype-longer latency to consume highly palatable food in the unfamiliar cage in the novelty-induced hypophagia test, and a depression phenotype-longer time of immobility in the tail suspension test, but Cre+DTA+ mice tested after 30 days post-TAM did not. These findings suggest a functional association between adult neurogenesis and stress induced anxiety- and depressive-like behaviors, where induced reduction in DCX+ cells at the time of behavioral testing is coupled with stress-induced anxiety and a depressive phenotype, and recovery of DCX+ cell number corresponds to normalization of these behaviors.	[Yun, Sanghee; Donovan, Michael H.; Ross, Michele N.; Richardson, Devon R.; Reister, Robin; Farnbauch, Laure A.; Fischer, Stephanie J.; Gershenfeld, Howard K.; Lagace, Diane C.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Riethmacher, Dieter] Nazarbayev Univ, Sch Med, Dept Biomed Sci, Astana, Kazakhstan; [Riethmacher, Dieter] Univ Southampton, Southampton Gen Hosp, Sch Med, Human Dev & Hlth, Southampton, Hants, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; Nazarbayev University; University of Southampton	Lagace, DC; Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	diane.lagace@uottawa.ca; amelia.eisch@utsouthwestern.edu	Riethmacher, Dieter/AAB-8690-2022; Yun, Sanghee/AAL-7543-2020; Riethmacher, Dieter/AAP-2227-2021	Yun, Sanghee/0000-0001-7505-0836; Riethmacher, Dieter/0000-0002-4206-5529; Eisch, Amelia/0000-0001-6476-5385; Donovan, Michael/0000-0001-8235-3851; Gershenfeld, Howard/0000-0002-4107-1513	National Institutes of Health [DA023701, DA023555, MH107945]; National Aeronautics and Space Administration [NNX12AB55G, NNX07AP84G]; Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Canadian Institute for Health Research (CIHR) postdoctoral fellowship; CIHR operating grant; Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Early Research Award from the Ontario Ministry of Research and Innovation; NIH [F31-DA021045]; NIH, Basic Science Training Program in Drug Abuse Research [T32-DA007290]; NIH, Basic Science Training Program in the Neurobiology of Mental Illness [T32-MH076690];  [F31-MH075457]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075457, R21MH107945, T32MH076690, R01MH096913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290, K02DA023555, F31DA021045, R01DA016765, R21DA023701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Canadian Institute for Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR operating grant(Canadian Institutes of Health Research (CIHR)); Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation; Early Research Award from the Ontario Ministry of Research and Innovation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Basic Science Training Program in Drug Abuse Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Basic Science Training Program in the Neurobiology of Mental Illness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to AJE from the National Institutes of Health (DA023701, DA023555, MH107945), the National Aeronautics and Space Administration (NNX12AB55G, NNX07AP84G), and an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation. DCL was funded by a Canadian Institute for Health Research (CIHR) postdoctoral fellowship and CIHR operating grant, as well as a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation, and an Early Research Award from the Ontario Ministry of Research and Innovation. MHD was funded by F31-MH075457. MNR was funded by NIH F31-DA021045. MNR and SJF were supported by NIH T32-DA007290, Basic Science Training Program in Drug Abuse Research, PI: Amelia J. Eisch. SY was funded by NIH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI: Carol A. Tamminga.; This work was supported by grants to AJE from the National Institutes of Health (DA023701, DA023555, MH107945), the National Aeronautics and Space Administration (NNX12AB55G, NNX07AP84G), and an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation. DCL was funded by a Canadian Institute for Health Research (CIHR) postdoctoral fellowship and CIHR operating grant, as well as a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression/Brain and Behavior Foundation, and an Early Research Award from the Ontario Ministry of Research and Innovation. MHD was funded by F31-MH075457. MNR was funded by NIH F31-DA021045. MNR and SJF were supported by NIH T32-DA007290, Basic Science Training Program in Drug Abuse Research, PI: Amelia J. Eisch. SY is funded by NIH T32-MH076690, Basic Science Training Program in the Neurobiology of Mental Illness, PI: Carol A. Tamminga. The authors acknowledge David Petrik with interim figure help. Current contact information, MHD: Center for Neurobiology and Psychiatry, University of California, San Francisco, 401 Parnassus Ave., San Francisco, California 94143-0984, U.S.A., michael.donovan@ucsf.edu. LAF: lfarnbau@kent.edu, Department of Psychological Sciences, 144 Kent Hall, 600 Hilltop Drive, Kent State University, Kent, OH 44242. HKG: hkgersh@gmail.com, Unit 7100 Box 1505, DPO, AE 09842-1505. DCL: Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario K1H 8M5, Canada, diane.lagace@uottawa.ca. DR (dual): Department of Biomedical Sciences, Nazarbayev University, School of Medicine, 53 Kabanbay Batyr Ave., Astana, 01000, Kazakhstan, dieter.riethmacher@nu.edu.kz; and Human Development and Health, Southampton University, School of Medicine, Duthie Building (Mail Point 808), Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom. d.riethmacher@southampton.ac.uk.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cummings DM, 2014, J NEUROSCI, V34, P13801, DOI 10.1523/JNEUROSCI.2463-14.2014; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Deng W, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00034; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dere E, 2010, BEHAV BRAIN RES, V215, P162, DOI 10.1016/j.bbr.2010.03.017; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Epp JR, 2013, NEUROPSYCHOPHARMACOL, V38, P2297, DOI 10.1038/npp.2013.132; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; Fuss J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012769; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Gebara E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00145; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Groves JO, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003718; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hall CS, 1936, J COMP PSYCHOL, V22, P345, DOI 10.1037/h0059253; Hill A.S., 2015, NEUROPSYCHOPHARMACOL; Iascone DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079651; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Kaidanovich-Beilin O, 2011, JOVE; Karten YJG, 2005, TRENDS NEUROSCI, V28, P171, DOI 10.1016/j.tins.2005.01.009; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim S, 2009, BIOL PSYCHIAT, V65, P425, DOI 10.1016/j.biopsych.2008.09.015; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Latchney SE, 2015, FASEB J; Liu XQ, 2001, BIOL PSYCHIAT, V49, P575, DOI 10.1016/S0006-3223(00)01028-3; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mamdani F, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.134; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Mateus-Pinheiro A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.141; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Seri B, 2004, J COMP NEUROL, V480, P427, DOI 10.1002/cne.20395; Sheline YI, 2002, EUR PSYCHIAT, V17, p300S; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Snyder JS, 2012, BEHAV BRAIN RES, V227, P384, DOI 10.1016/j.bbr.2011.06.024; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Suri D, 2015, REV NEUROSCIENCE, V26, P415, DOI 10.1515/revneuro-2014-0083; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; WEBSTER DG, 1979, B PSYCHONOMIC SOC, V13, P90, DOI 10.3758/BF03335022; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Xiang JX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005175; Zaccaria KJ, 2010, GENES BRAIN BEHAV, V9, P985, DOI 10.1111/j.1601-183X.2010.00638.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005	110	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147256	10.1371/journal.pone.0147256	http://dx.doi.org/10.1371/journal.pone.0147256			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795203	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000368530300025
J	Glaser, K; Fehrholz, M; Curstedt, T; Kunzmann, S; Speer, CP				Glaser, Kirsten; Fehrholz, Markus; Curstedt, Tore; Kunzmann, Steffen; Speer, Christian P.			Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14(+) Monocytes	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NATURAL PORCINE SURFACTANT; NECROSIS-FACTOR-ALPHA; MITOGEN-ACTIVATED PROTEIN; BRONCHOPULMONARY DYSPLASIA; PULMONARY INFLAMMATION; LUNG MORPHOGENESIS; MESSENGER-RNA; PRETERM LUNG; RECEPTOR	Background Surfactant replacement therapy is the standard of care for the prevention and treatment of neonatal respiratory distress syndrome. New generation synthetic surfactants represent a promising alternative to animal-derived surfactants. CHF5633, a new generation reconstituted synthetic surfactant containing SP-B and SP-C analogs and two synthetic phospholipids has demonstrated biophysical effectiveness in vitro and in vivo. While several surfactant preparations have previously been ascribed immunomodulatory capacities, in vitro data on immunomodulation by CHF5633 are limited, so far. Our study aimed to investigate pro- and anti-inflammatory effects of CHF5633 on native and LPS-stimulated human adult monocytes. Methods Highly purified adult CD14(+) cells, either native or simultaneously stimulated with LPS, were exposed to CHF5633, its components, or poractant alfa (Curosurf (R)). Subsequent expression of TNF-alpha, IL-1 beta, IL-8 and IL-10 mRNA was quantified by real-time quantitative PCR, corresponding intracellular cytokine synthesis was analyzed by flow cytometry. Potential effects on TLR2 and TLR4 mRNA and protein expression were monitored by qPCR and flow cytometry. Results Neither CHF5633 nor any of its components induced inflammation or apoptosis in native adult CD14+ monocytes. Moreover, LPS-induced pro-inflammatory responses were not aggravated by simultaneous exposure of monocytes to CHF5633 or its components. In LPS-stimulated monocytes, exposure to CHF5633 led to a significant decrease in TNF-alpha mRNA (0.57 +/- 0.23-fold, p = 0.043 at 4h; 0.56 +/- 0.27- fold, p = 0.042 at 14h). Reduction of LPS-induced IL-1 beta mRNA expression was not significant (0.73 +/- 0.16, p = 0.17 at 4h). LPS-induced IL-8 and IL-10 mRNA and protein expression were unaffected by CHF5633. For all cytokines, the observed CHF5633 effects paralleled a Curosurf (R)-induced modulation of cytokine response. TLR2 and TLR4 mRNA and protein expression were not affected by CHF5633 and Curosurf (R), neither in native nor in LPS- stimulated adult monocytes. Conclusion The new generation reconstituted synthetic surfactant CHF5633 was tested for potential immunomodulation on native and LPS- activated adult human monocytes. Our data confirm that CHF5633 does not exert unintended pro-inflammatory effects in both settings. On the contrary, CHF5633 significantly suppressed TNF-alpha mRNA expression in LPS- stimulated adult monocytes, indicating potential anti-inflammatory effects.	[Glaser, Kirsten; Fehrholz, Markus; Kunzmann, Steffen; Speer, Christian P.] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany; [Curstedt, Tore] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital	Glaser, K (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	Glaser_K@ukw.de			Chiesi Farmaceutici S.p.A. [CHF5633]	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc)	CP Speer has a consultancy agreement with Chiesi Farmaceutici S.p.A. (Parma, Italy). This project was supported by Chiesi Farmaceutici S.p.A., supplying CHF5633, its synthetic components and Poractant alfa (Curosurf (R)). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; [Anonymous], 2008, PEDIATRICS, V121, P419, DOI 10.1542/peds.2007-3283; Antal JM, 1996, AM J RESP CELL MOL, V14, P374, DOI 10.1165/ajrcmb.14.4.8600942; Baier RJ, 2004, PEDIATR PULM, V37, P137, DOI 10.1002/ppul.10417; Bancalari E, 2001, AM J PERINAT, V18, P1, DOI 10.1055/s-2001-12940; Baur FM, 1998, PEDIATR RES, V44, P32, DOI 10.1203/00006450-199807000-00005; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; Bersani I, 2013, EXPERT REV ANTI-INFE, V11, P99, DOI [10.1586/ERI.12.156, 10.1586/eri.12.156]; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Bry K, 2007, AM J RESP CELL MOL, V36, P32, DOI 10.1165/rcmb.2006-0116OC; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Chaudhuri N, 2007, CHEST, V131, P1550, DOI 10.1378/chest.06-2869; Curstedt T, 2015, NEONATOLOGY, V107, P321, DOI 10.1159/000381117; Curstedt T, 2013, NEONATOLOGY, V103, P327, DOI 10.1159/000349942; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Glaser K, 2015, IMMUNOL LETT, V166, P19, DOI 10.1016/j.imlet.2015.05.003; Glaser K, 2013, EXPERT REV CLIN IMMU, V9, P1239, DOI 10.1586/1744666X.2013.857275; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; GRONECK P, 1994, PEDIATRICS, V93, P712; Halliday Henry L, 2005, Biol Neonate, V87, P317, DOI 10.1159/000084879; Hallman M, 2013, NEONATOLOGY, V103, P316, DOI 10.1159/000349948; Hallman M, 2013, NEONATOLOGY, V103, P320, DOI 10.1159/000349994; Hart PH, 1996, J IMMUNOL, V157, P3672; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hogmalm A, 2014, AM J PHYSIOL-LUNG C, V306, pL23, DOI 10.1152/ajplung.00154.2013; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Jones CA, 1996, PEDIATR RES, V39, P966, DOI 10.1203/00006450-199606000-00007; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerecman J, 2008, INFLAMM RES, V57, P118, DOI 10.1007/s00011-007-7212-1; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lavoie PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031351; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; de Guevara YLL, 2014, INT IMMUNOPHARMACOL, V21, P369, DOI 10.1016/j.intimp.2014.05.020; Manimtim WM, 2001, INFECT IMMUN, V69, P3906, DOI 10.1128/IAI.69.6.3906-3915.2001; Martin RJ, 2013, PEDIATR NEONATOL, V54, P228, DOI 10.1016/j.pedneo.2013.03.001; Morris RHK, 2000, CYTOKINE, V12, P1717, DOI 10.1006/cyto.2000.0762; Mosca F, 2011, J MATERN-FETAL NEO M, V24, P80, DOI 10.3109/14767058.2011.607675; Moya F, 2007, CLIN PERINATOL, V34, P145, DOI 10.1016/j.clp.2006.12.005; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Pfister RH, 2007, COCHRANE DATABASE SY; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Polin RA, 2014, PEDIATRICS, V133, P156, DOI 10.1542/peds.2013-3443; Raychaudhuri B, 2004, AM J RESP CELL MOL, V30, P228, DOI 10.1165/rcmb.2003-0263OC; Reyburn B, 2012, NEONATOLOGY, V101, P345, DOI 10.1159/000337355; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sakonidou S, 2015, ARCH DIS CHILD ED PR; Salvesen B, 2014, NEONATOLOGY, V105, P128, DOI 10.1159/000356065; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Seehase M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047631; Speer CP, 2011, NEONATOLOGY, V99, P316, DOI 10.1159/000326619; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Speer CR, 2013, EARLY HUM DEV, V89, pS22, DOI 10.1016/S0378-3782(13)70008-2; SPEER CP, 1991, PEDIATR RES, V30, P69, DOI 10.1203/00006450-199107000-00015; Speer CP, 2001, BIOL NEONATE, V79, P205; STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9; Sweet DG, 2013, J MATERN-FETAL NEO M, V26, P27, DOI 10.3109/14767058.2013.829695; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; THOMASSEN MJ, 1994, AM J RESP CELL MOL, V10, P399, DOI 10.1165/ajrcmb.10.4.8136155; Tonks A, 2001, CLIN EXP IMMUNOL, V124, P86, DOI 10.1046/j.1365-2249.2001.01479.x; van Zyl JM, 2013, DRUG DES DEV THER, V7, DOI 10.2147/DDDT.S47270; Walti H, 1997, PEDIATR RES, V41, P114, DOI 10.1203/00006450-199701000-00018; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; Willems CHMP, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-17; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	78	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146898	10.1371/journal.pone.0146898	http://dx.doi.org/10.1371/journal.pone.0146898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790130	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100044
J	Inoue, A; Impellizzeri, FM; Pires, FO; Pompeu, FAMS; Deslandes, AC; Santos, TM				Inoue, Allan; Impellizzeri, Franco M.; Pires, Flavio O.; Pompeu, Fernando A. M. S.; Deslandes, Andrea C.; Santos, Tony M.			Effects of Sprint versus High-Intensity Aerobic Interval Training on Cross-Country Mountain Biking Performance: A Randomized Controlled Trial	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; OFF-ROAD CYCLISTS; ENDURANCE PERFORMANCE; EXERCISE INTENSITY; ADAPTATIONS; CAPACITY; DURATION; WORK; TIME; INCREASES	Objectives The current study compared the effects of high-intensity aerobic training (HIT) and sprint interval training (SIT) on mountain biking (MTB) race simulation performance and physiological variables, including peak power output (PPO), lactate threshold (LT) and onset of blood lactate accumulation (OBLA). Methods Sixteen mountain bikers (mean +/- SD: age 32.1 +/- 6.4 yr, body mass 69.2 +/- 5.3 kg and VO2max 63.4 +/- 4.5 mL.kg(-1).min(-1)) completed graded exercise and MTB performance tests before and after six weeks of training. The HIT (7-10 x [4-6 min-highest sustainable intensity / 4-6 min-CR100 10-15]) and SIT (8-12 x [30 s-all-out intensity / 4 min-CR100 10-15]) protocols were included in the participants' regular training programs three times per week. Results Post-training analysis showed no significant differences between training modalities (HIT vs. SIT) in body mass, PPO, LT or OBLA (p = 0.30 to 0.94). The Cohen's d effect size (ES) showed trivial to small effects on group factor (p = 0.00 to 0.56). The interaction between MTB race time and training modality was almost significant (p = 0.08), with a smaller ES in HIT vs. SIT training (ES = -0.43). A time main effect (pre-vs. post-phases) was observed in MTB race performance and in several physiological variables (p = 0.001 to 0.046). Co-variance analysis revealed that the HIT (p = 0.043) group had significantly better MTB race performance measures than the SIT group. Furthermore, magnitude-based inferences showed HIT to be of likely greater benefit (83.5%) with a lower probability of harmful effects (0.8%) compared to SIT. Conclusion The results of the current study suggest that six weeks of either HIT or SIT may be effective at increasing MTB race performance; however, HIT may be a preferable strategy.	[Inoue, Allan] Univ Estacio Sa, Dept Phys Educ, Nova Friburgo, RJ, Brazil; [Inoue, Allan] Brazilian Navy, Phys Educ Ctr Admiral Adalberto Nunes, Rio De Janeiro, RJ, Brazil; [Inoue, Allan; Pires, Flavio O.; Santos, Tony M.] Performance Lab, Recife, PE, Brazil; [Inoue, Allan; Pires, Flavio O.; Santos, Tony M.] Univ Sao Paulo, Exercise Psychophysiol Grp, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil; [Impellizzeri, Franco M.] Schulthess Clin, Zurich, Switzerland; [Pompeu, Fernando A. M. S.] Univ Fed Rio de Janeiro, Sch Phys Educ & Sports, Rio De Janeiro, RJ, Brazil; [Deslandes, Andrea C.] Univ Estado Rio De Janeiro, Exercise & Sports Sci Postgrad Program, Rio De Janeiro, RJ, Brazil; [Deslandes, Andrea C.; Santos, Tony M.] Neurosci Lab Exercise, Rio De Janeiro, RJ, Brazil; [Santos, Tony M.] Univ Fed Pernambuco, Phys Educ Grad Program, Recife, PE, Brazil; [Santos, Tony M.] Univ Fed Pernambuco, Grad Program Phys Therapy, Recife, PE, Brazil	Universidade Estacio de Sa; Universidade de Sao Paulo; Schulthess Clinic; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Santos, TM (corresponding author), Performance Lab, Recife, PE, Brazil.; Santos, TM (corresponding author), Univ Sao Paulo, Exercise Psychophysiol Grp, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.; Santos, TM (corresponding author), Neurosci Lab Exercise, Rio De Janeiro, RJ, Brazil.; Santos, TM (corresponding author), Univ Fed Pernambuco, Phys Educ Grad Program, Recife, PE, Brazil.; Santos, TM (corresponding author), Univ Fed Pernambuco, Grad Program Phys Therapy, Recife, PE, Brazil.	tony.meireles@ufpe.br	DOS SANTOS, TONY MEIRELES/V-2650-2019; Deslandes, Andrea C/F-3545-2010; Deslandes, Andrea C/E-8594-2016; Impellizzeri, Franco M./M-6980-2019; Pires, Flavio/I-2714-2012; Inoue, Allan/AAB-7221-2022; Deslandes, Andrea/AAF-4525-2021; Santos, Tony M/F-2288-2011	DOS SANTOS, TONY MEIRELES/0000-0002-5242-0117; Deslandes, Andrea C/0000-0001-5941-9111; Impellizzeri, Franco M./0000-0002-1703-2573; Pires, Flavio/0000-0003-4538-1751; Deslandes, Andrea/0000-0001-5941-9111; Santos, Tony M/0000-0002-5242-0117; Pompeu, Fernando/0000-0002-7370-2471; Inoue, Allan/0000-0003-3068-0839	Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/190.127/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 131148/2009-5]	Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TMS was sponsored by a grant from the Fundacao Carlos Chagas de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (E-26/190.127/2010). AI was sponsored by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 131148/2009-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2001, MED SCI SPORT EXER, V33, P1387, DOI 10.1097/00005768-200108000-00022; Billat VL, 1999, MED SCI SPORT EXER, V31, P156, DOI 10.1097/00005768-199901000-00024; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2007, AM J PHYSIOL-REG I, V292, pR1970, DOI 10.1152/ajpregu.00503.2006; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Clark B, 2014, J SCI CYCLING, V3, P29; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gregory J, 2007, J STRENGTH COND RES, V21, P17, DOI 10.1519/00124278-200702000-00004; HAGBERG JM, 1983, MED SCI SPORT EXER, V15, P287, DOI 10.1249/00005768-198315040-00006; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Impellizzeri F, 2002, MED SCI SPORT EXER, V34, P1808, DOI 10.1097/00005768-200211000-00018; Impellizzeri FM, 2005, BRIT J SPORT MED, V39, P747, DOI 10.1136/bjsm.2004.017236; Impellizzeri FM, 2005, J SPORT SCI, V23, P41, DOI 10.1080/02640410410001730061; Impellizzeri FM, 2007, SPORTS MED, V37, P59, DOI 10.2165/00007256-200737010-00005; Inoue A, 2012, J STRENGTH COND RES, V26, P1589, DOI 10.1519/JSC.0b013e318234eb89; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kentta G, 1998, SPORTS MED, V26, P1; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Laursen PB, 2005, J STRENGTH COND RES, V19, P527; Laursen PB, 2002, MED SCI SPORT EXER, V34, P1801, DOI 10.1097/00005768-200211000-00017; Lee H, 2002, J SPORT SCI, V20, P1001, DOI 10.1080/026404102321011760; Lindsay FH, 1996, MED SCI SPORT EXER, V28, P1427, DOI 10.1097/00005768-199611000-00013; Lucia A, 2004, BRIT J SPORT MED, V38, P636, DOI 10.1136/bjsm.2003.008490; Macdermid PW, 2014, J BIOMECH, V47, P1829, DOI 10.1016/j.jbiomech.2014.03.024; Macdermid PW, 2012, J SPORT SCI, V30, P1491, DOI 10.1080/02640414.2012.711487; Prins L, 2007, J SPORT SCI, V25, P927, DOI 10.1080/02640410600907938; Sandbakk O, 2013, J STRENGTH COND RES, V27, P1974, DOI 10.1519/JSC.0b013e3182752f08; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Seiler S, 2010, INT J SPORT PHYSIOL, V5, P276, DOI 10.1123/ijspp.5.3.276; SJODIN B, 1981, INT J SPORTS MED, V2, P23, DOI 10.1055/s-2008-1034579; Stapelfeldt B, 2004, INT J SPORTS MED, V25, P294, DOI 10.1055/s-2004-819937; Stepto NK, 1999, MED SCI SPORT EXER, V31, P736, DOI 10.1097/00005768-199905000-00018; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; WestgarthTaylor C, 1997, EUR J APPL PHYSIOL O, V75, P298, DOI 10.1007/s004210050164; Weston AR, 1997, EUR J APPL PHYSIOL O, V75, P7; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576	42	14	14	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145298	10.1371/journal.pone.0145298	http://dx.doi.org/10.1371/journal.pone.0145298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789124	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100008
J	Prins, D; Plank, T; Baseler, HA; Gouws, AD; Beer, A; Morland, AB; Greenlee, MW; Cornelissen, FW				Prins, Doety; Plank, Tina; Baseler, Heidi A.; Gouws, Andre D.; Beer, Anton; Morland, Antony B.; Greenlee, Mark W.; Cornelissen, Frans W.			Surface-Based Analyses of Anatomical Properties of the Visual Cortex in Macular Degeneration	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; CAUSE-SPECIFIC PREVALENCE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORTICAL SURFACE; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; OLDER POPULATION; GANGLION-CELLS; REORGANIZATION	Introduction Macular degeneration (MD) can cause a central visual field defect. In a previous study, we found volumetric reductions along the entire visual pathways of MD patients, possibly indicating degeneration of inactive neuronal tissue. This may have important implications. In particular, new therapeutic strategies to restore retinal function rely on intact visual pathways and cortex to reestablish visual function. Here we reanalyze the data of our previous study using surface-based morphometry (SBM) rather than voxel-based morphometry (VBM). This can help determine the robustness of the findings and will lead to a better understanding of the nature of neuroanatomical changes associated with MD. Methods The metrics of interest were acquired by performing SBM analysis on T1-weighted MRI data acquired from 113 subjects: patients with juvenile MD (JMD; n = 34), patients with age-related MD (AMD; n = 24) and healthy age-matched controls (HC; n = 55). Results Relative to age-matched controls, JMD patients showed a thinner cortex, a smaller cortical surface area and a lower grey matter volume in V1 and V2, while AMD patients showed thinning of the cortex in V2. Neither patient group showed a significant difference in mean curvature of the visual cortex. Discussion The thinner cortex, smaller surface area and lower grey matter volume in the visual cortex of JMD patients are consistent with our previous results showing a volumetric reduction in their visual cortex. Finding comparable results using two rather different analysis techniques suggests the presence of marked cortical degeneration in the JMD patients. In the AMD patients, we found a thinner cortex in V2 but not in V1. In contrast to our previous VBM analysis, SBM revealed no volumetric reductions of the visual cortex. This suggests that the cortical changes in AMD patients are relatively subtle, as they apparently can be missed by one of the methods.	[Prins, Doety; Cornelissen, Frans W.] Univ Groningen, Univ Med Ctr Groningen, Lab Expt Ophthalmol, Dept Ophthalmol, Groningen, Netherlands; [Plank, Tina; Beer, Anton; Greenlee, Mark W.] Univ Regensburg, Inst Expt Psychol, D-93053 Regensburg, Germany; [Baseler, Heidi A.; Morland, Antony B.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Baseler, Heidi A.; Gouws, Andre D.; Morland, Antony B.] Hull York Med Sch, Ctr Neurosci, York, N Yorkshire, England	University of Groningen; University of Regensburg; University of York - UK; University of Hull; University of York - UK	Prins, D; Cornelissen, FW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Lab Expt Ophthalmol, Dept Ophthalmol, Groningen, Netherlands.	d.prins@umcg.nl; f.w.cornelissen@umcg.nl	Baseler, Heidi/AAI-7387-2020; Greenlee, Mark/M-6414-2018	Baseler, Heidi/0000-0003-0995-8453; Greenlee, Mark/0000-0003-2305-9286; Morland, Antony/0000-0002-6754-5545; Beer, Anton L./0000-0002-0297-6838; Plank, Tina/0000-0001-5329-7037	University Medical Center Groningen; Stichting Nederlands Oogheelkundig Onderzoek (SNOO); Nelly Reef Fund; UitZicht - Stichting MD Fonds, Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB); German Research Foundation (DFG) [FOR 1075, TP8]; UK Medical Research Council; MRC [G0401339] Funding Source: UKRI; Medical Research Council [G0401339] Funding Source: researchfish	University Medical Center Groningen; Stichting Nederlands Oogheelkundig Onderzoek (SNOO); Nelly Reef Fund; UitZicht - Stichting MD Fonds, Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB); German Research Foundation (DFG)(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DP was supported by the "Junior Scientific Masterclass MD/PhD Programme" of the University Medical Center Groningen. This work was further supported by research grants from Stichting Nederlands Oogheelkundig Onderzoek (SNOO), Nelly Reef Fund, and - via UitZicht - Stichting MD Fonds, Landelijke Stichting voor Blinden en Slechtzienden (LSBS), and Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB) to FWC, the German Research Foundation (DFG: Project FOR 1075, TP8) to TP and MWG, and the UK Medical Research Council to ABM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden G B, 2006, J Br Menopause Soc, V12, P64, DOI 10.1258/136218006777525703; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2011, NAT NEUROSCI, V14, P649, DOI 10.1038/nn.2793; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Bridge H, 2014, CORTEX, V56, P64, DOI 10.1016/j.cortex.2012.08.010; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Hernowo AT, 2014, CORTEX, V56, P99, DOI 10.1016/j.cortex.2013.01.003; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Ikram MK, 2012, J NEUROL NEUROSUR PS, V83, P917, DOI 10.1136/jnnp-2011-301628; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; Liu TT, 2010, INVEST OPHTH VIS SCI, V51, P6826, DOI 10.1167/iovs.09-4926; Lyoo IK, 2006, BIPOLAR DISORD, V8, P65, DOI 10.1111/j.1399-5618.2006.00284.x; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Palaniyappan L, 2012, NEUROIMAGE, V60, P693, DOI 10.1016/j.neuroimage.2011.12.058; Pham TQ, 2006, GERONTOLOGY, V52, P353, DOI 10.1159/000094984; Plank T, 2011, NEUROIMAGE, V56, P1556, DOI 10.1016/j.neuroimage.2011.02.055; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Rahmani B, 1996, OPHTHALMOLOGY, V103, P1721, DOI 10.1016/S0161-6420(96)30435-1; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Szlyk JP, 2009, INVEST OPHTH VIS SCI, V50, P4487, DOI 10.1167/iovs.08-2258; van Zeeburg EJT, 2012, AM J OPHTHALMOL, V153, P120, DOI 10.1016/j.ajo.2011.06.007; VanNewkirk MR, 2001, OPHTHALMOLOGY, V108, P960, DOI 10.1016/S0161-6420(01)00554-1; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; von Glehn F, 2014, MULT SCLER J, V20, P1189, DOI 10.1177/1352458513519838; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; Whitwell JL, 2013, NEUROIMAGE-CLIN, V2, P249, DOI 10.1016/j.nicl.2013.01.006; Woo SJ, 2012, OPHTHALMOLOGY, V119, P2094, DOI 10.1016/j.ophtha.2012.04.026; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	48	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146684	10.1371/journal.pone.0146684	http://dx.doi.org/10.1371/journal.pone.0146684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789126	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000368529100036
J	Chen, PW; Fonseca, LL; Hannun, YA; Voit, EO				Chen, Po-Wei; Fonseca, Luis L.; Hannun, Yusuf A.; Voit, Eberhard O.			Analysis of the Involvement of Different Ceramide Variants in the Response to Hydroxyurea Stress in Baker's Yeast	PLOS ONE			English	Article							SPHINGOLIPID METABOLISM; DISEASE	Sphingolipids have been identified as important signaling compounds in stress responses. However, it is not always clear how different sphingolipid profiles are achieved in a particular stress situation. Here we propose a detailed mass action model, containing 42 dependent variables and 137 reactions, that offers explanations of the roles of variant ceramides species, which differ in the lengths of their fatty acyl chains and their saturation state, in the response to hydroxyurea stress. The simulations demonstrate that the cells manage to achieve hydroxyurea tolerance through a well-coordinated, differential usage of the variant ceramide species. Moreover, the results suggest that key enzymes have different affinities toward saturated and unsaturated fatty acyl chains, which implies that the saturation state affords the cells with an additional mode of regulation that had not been recognized so far. These conclusions from our computational analysis are yet to be validated experimentally.	[Chen, Po-Wei; Fonseca, Luis L.; Voit, Eberhard O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Po-Wei] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Hlth Sci Ctr, Canc Ctr Stony Brook Med, Stony Brook, NY 11794 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Voit, EO (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu	Fonseca, Luis L/B-2265-2009	Fonseca, Luis L/0000-0002-7902-742X	National Institutes of Health [NIH-GM063265]; National Science Foundation [MCB-0946595];  [NSF-MCB-0946595]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118128, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (Project NIH-GM063265; PI: YAH), and the National Science Foundation (Project MCB-0946595; PI: EOV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by grant NIH-GM063265, Yusuf Hannun (PI), and by grant NSF-MCB-0946595, Eberhard Voit (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alvarez-Vasquez F, 2004, J THEOR BIOL, V226, P265, DOI 10.1016/j.jtbi.2003.08.010; Alvarez-Vasquez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028344; Alvarez-Vasquez F, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-42; Chen PC, 2013, J NANOMATER, V2013, P9, DOI DOI 10.1371/J0URNAL.PCBI.1003078; Chen PW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004373; ELHAZMI MAF, 1992, ACTA HAEMATOL-BASEL, V88, P170; Engstrom KG, 1998, TREATMENT MYELOPROLI; Fonseca LL, 2012, METABOLITES, V2, P221, DOI 10.3390/metabo2010221; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Jessen H, 2014, NEW ENGL J MED, V370, P682, DOI 10.1056/NEJMc1308413; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lisziewicz J, 2003, DRUG SAFETY, V26, P605, DOI 10.2165/00002018-200326090-00002; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matmati N, 2013, J BIOL CHEM, V288, P17272, DOI 10.1074/jbc.M112.444802; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200	19	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146839	10.1371/journal.pone.0146839	http://dx.doi.org/10.1371/journal.pone.0146839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784947	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400071
J	Laughlin, RC; Drake, KL; Morrill, JC; Adams, LG				Laughlin, Richard C.; Drake, Kenneth L.; Morrill, John C.; Adams, L. Garry			Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates	PLOS ONE			English	Article							VIRUS-INFECTION; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; SET ENRICHMENT; MP-12 VACCINE; SHEEP; IMMUNOGENICITY; PROTEIN; NSS; INFLUENZA	Rift Valley fever Virus (RVFV), a negative-stranded RNA virus, is the etiological agent of the vector-borne zoonotic disease, Rift Valley fever (RVF). In both humans and livestock, protective immunity can be achieved through vaccination. Earlier and more recent vaccine trials in cattle and sheep demonstrated a strong neutralizing antibody and total IgG response induced by the RVF vaccine, authentic recombinant MP-12 (arMP-12). From previous work, protective immunity in sheep and cattle vaccinates normally occurs from 7 to 21 days after inoculation with arMP-12. While the serology and protective response induced by arMP-12 has been studied, little attention has been paid to the underlying molecular and genetic events occurring prior to the serologic immune response. To address this, we isolated RNA from whole blood of vaccinated calves over a time course of 21 days before and after vaccination with arMP-12. The time course RNAs were sequenced by RNASeq and bioinformatically analyzed. Our results revealed time-dependent activation or repression of numerous gene ontologies and pathways related to the vaccine induced immune response and its regulation. Additional bioinformatic analyses identified a correlative relationship between specific host immune response genes and protective immunity prior to the detection of protective serum neutralizing antibody responses. These results contribute an important proof of concept for identifying molecular and genetic components underlying the immune response to RVF vaccination and protection prior to serologic detection.	[Laughlin, Richard C.; Adams, L. Garry] Texas A&M Univ, Dept Vet Pathol, College Stn, TX 77843 USA; [Drake, Kenneth L.] Seralogix LLC, 335 Bee Cave Rd,Suite 607, Austin, TX 78746 USA; [Morrill, John C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Laughlin, Richard C.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX 78353 USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University Kingsville	Adams, LG (corresponding author), Texas A&M Univ, Dept Vet Pathol, College Stn, TX 77843 USA.	lgadams@cvm.tamu.edu		Laughlin, Richard/0000-0002-3321-8642	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center [2010-ST-061-AG0002]; National Institutes of Health [NIH-NIAID-DMID-02-24]; Texas AgriLife Research [504064]; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center(United States Department of Homeland Security (DHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries	United States Department of Homeland Security - Foreign Animal & Zoonotic Disease Center http://iiad.tamu.edu 2010-ST-061-AG0002; National Institutes of Health http://www.nih.gov NIH-NIAID-DMID-02-24; Texas AgriLife Research http://agriliferesearch.tamu.edu 504064. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Clay Ashley, Destiny Taylor, and Melissa Walker of the Veterinary Medical Park for their efforts in assuring the welfare and care of the animals for the duration of the experiment. Roberta Pugh (Department of Veterinary Pathobiology, Texas A&M University, College Station, TX) provided technical support and advice during sample collection and RNA processing. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Ahmed J, 2009, EURO SURVEILLANCE B, V14; Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bolger AM, 2014, BIOINFORMATICS; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Camon Evelyn, 2004, In Silico Biology, V4, P5; Christou L, 2011, CLIN MICROBIOL INFEC, V17, P326, DOI 10.1111/j.1469-0691.2010.03441.x; Colwell DD, 2011, VET PARASITOL, V182, P14, DOI 10.1016/j.vetpar.2011.07.012; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Demasius W, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-93; do Valle TZ, 2010, J IMMUNOL, V185, P6146, DOI 10.4049/jimmunol.1000949; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guo H, 2011, GENE THER, V18, P106, DOI 10.1038/gt.2010.154; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Illumina I., IGENOME READ TO US R; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kirouac DC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-29; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lihoradova OA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002181; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Marco Di Luca FS, 2011, EUR INFECT DIS, V2, P98; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; MORRILL JC, 1989, REV INFECT DIS, V11, pS815; Morrill JC, 2013, VACCINE, V31, P4988, DOI 10.1016/j.vaccine.2013.08.003; Morrill JC, 2013, VACCINE, V31, P559, DOI 10.1016/j.vaccine.2012.10.118; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; Murphy K. P., 2002, THESIS U C BERKELEY; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; NIKLASSON BS, 1984, ACTA PATH MICRO IM C, V92, P197; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters C, 2009, RIFT VALLEY FEVER MP; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratovonjato J, 2011, VECTOR-BORNE ZOONOT, V11, P753, DOI 10.1089/vbz.2010.0031; Rossetti CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081719; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Simmons DP, 2012, J IMMUNOL, V188, P3116, DOI 10.4049/jimmunol.1101313; Strimmer K, 2014, FDRTOOL ESTIMATION L; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Weeks JN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-167; Weingartl HM, 2014, VACCINE, V32, P2345, DOI 10.1016/j.vaccine.2013.12.064; Weingartl HM, 2014, VACCINE, V32, P2337, DOI 10.1016/j.vaccine.2014.02.066; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	68	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147027	10.1371/journal.pone.0147027	http://dx.doi.org/10.1371/journal.pone.0147027			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783758	Green Published, gold			2022-12-27	WOS:000368528400097
J	Litwiniuk, A; Pijet, B; Pijet-Kucicka, M; Gajewska, M; Pajak, B; Orzechowski, A				Litwiniuk, Anna; Pijet, Barbara; Pijet-Kucicka, Maja; Gajewska, Malgorzata; Pajak, Beata; Orzechowski, Arkadiusz			FOXO1 and GSK-3 beta Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; IMPAIRED MITOCHONDRIAL ACTIVITY; HUMAN SKELETAL-MUSCLE; GROWTH-FACTOR-I; TRANSCRIPTIONAL COACTIVATOR; SIGNALING PATHWAYS; NUCLEAR CONTROL; GENE; RECEPTOR; RESISTANCE	Myogenesis and muscle hypertrophy account for muscle growth and adaptation to work overload, respectively. In adults, insulin and insulin-like growth factor 1 stimulate muscle growth, although their links with cellular energy homeostasis are not fully explained. Insulin plays critical role in the control of mitochondrial activity in skeletal muscle cells, and mitochondria are essential for insulin action. The aim of this study was to elucidate molecular mechanism(s) involved in mitochondrial control of insulin-dependent myogenesis. The effects of several metabolic inhibitors (LY294002, PD98059, SB216763, LiCl, rotenone, oligomycin) on the differentiation of C2C12 myoblasts in culture were examined in the short-term (hours) and long-term (days) experiments. Muscle cell viability and mitogenicity were monitored and confronted with the activities of selected genes and proteins expression. These indices focus on the roles of insulin, glycogen synthase kinase 3 beta (GSK-3 beta) and forkhead box protein O1 (FOXO1) on myogenesis using a combination of treatments and inhibitors. Long-term insulin (10 nM) treatment in "normoglycemic" conditions led to increased myogenin expression and accelerated myogenesis in C2C12 cells. Insulin-dependent myogenesis was accompanied by the rise of mtTFA, MtSSB, Mfn2, and mitochondrially encoded Cox-1 gene expressions and elevated levels of proteins which control functions of mitochondria (kinase-PKB/AKT, mitofusin 2 protein-Mfn-2). Insulin, via the phosphatidylinositol 3-kinase (PI3-K)/AKT-dependent pathway reduced transcription factor FOXO1 activity and altered GSK-3 beta phosphorylation status. Once FOXO1 and GSK-3 beta activities were inhibited the rise in Cox-1 gene action and nuclear encoded cytochrome c oxidase subunit IV (COX IV) expressions were observed, even though some mRNA and protein results varied. In contrast to SB216763, LiCl markedly elevated Mfn2 and COX IV protein expression levels when given together with insulin. Thus, inhibition of GSK-3 beta activity by insulin alone or together with LiCl raised the expression of genes and some proteins central to the metabolic activity of mitochondria resulting in higher ATP synthesis and accelerated myogenesis. The results of this study indicate that there are at least two main targets in insulin-mediated myogenesis: notably FOXO1 and GSK-3 beta both playing apparent negative role in muscle fiber formation.	[Litwiniuk, Anna] Ctr Postgrad Med Educ, Dept Neuroendocrinol, Marymoncka 99-103, PL-01813 Warsaw, Poland; [Pijet, Barbara] Nencki Inst Expt Biol PAS, Dept Mol & Cellular Neurobiol, Neurobiol Lab, Pasteura 3, PL-02093 Warsaw, Poland; [Pijet-Kucicka, Maja] Med Univ Warsaw, Dept Dermatol, Koszykowa 82A, PL-02008 Warsaw, Poland; [Gajewska, Malgorzata; Pajak, Beata; Orzechowski, Arkadiusz] Warsaw Univ Life Sci SGGW, Dept Physiol Sci, Nowoursynowska 159, PL-02776 Warsaw, Poland; [Pajak, Beata; Orzechowski, Arkadiusz] Mossakowski Med Res Ctr PAS, Electron Microscopy Platform, Pawinskiego 5, PL-02106 Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University of Warsaw; Warsaw University of Life Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Orzechowski, A (corresponding author), Warsaw Univ Life Sci SGGW, Dept Physiol Sci, Nowoursynowska 159, PL-02776 Warsaw, Poland.; Orzechowski, A (corresponding author), Mossakowski Med Res Ctr PAS, Electron Microscopy Platform, Pawinskiego 5, PL-02106 Warsaw, Poland.	orzechowski_arkadiusz@wp.pl	Pijet, Barbara/B-6559-2019; Litwiniuk, Anna/ABG-2099-2020	Pijet, Barbara/0000-0002-9268-5208; Gajewska, Malgorzata/0000-0001-7249-8627; Pijet-Kucicka, Maja/0000-0001-6400-9352; Pajak, Beata/0000-0002-3565-8860; Litwiniuk, Anna/0000-0003-1115-733X	Ministry of Science and Higher Education in Poland [N401 033 32/0759]; National Science Centre in Poland [UMO-2013/11/B/NZ5/03106]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	Funded by Ministry of Science and Higher Education in Poland grant No N401 033 32/0759 (BP) and National Science Centre in Poland grant No UMO-2013/11/B/NZ5/03106 (AO).	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cong HL, 2011, HUM GENE THER, V22, P313, DOI 10.1089/hum.2010.057; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Evenson AR, 2005, INT J BIOCHEM CELL B, V37, P2226, DOI 10.1016/j.biocel.2005.06.002; Fang CH, 2005, ENDOCRINOLOGY, V146, P3141, DOI 10.1210/en.2004-0869; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Henriksen EJ, 2010, CURR DIABETES REV, V6, P285, DOI 10.2174/157339910793360888; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Lara-Pezzi E, 1997, J CELL SCI, V179, P1205; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li BG, 2005, INT J BIOCHEM CELL B, V37, P2207, DOI 10.1016/j.biocel.2005.04.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015; MANDEL JL, 1974, NATURE, V251, P618, DOI 10.1038/251618a0; Mikula M., 2005, INT J BIOCHEM CELL B, V37, P127; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pajak B, 2010, RES VET SCI, V89, P445, DOI 10.1016/j.rvsc.2010.04.013; Pawlikowska P, 2006, CELL PROLIFERAT, V39, P127, DOI 10.1111/j.1365-2184.2006.00376.x; Pawlikowska P, 2007, CELL TISSUE RES, V327, P571, DOI 10.1007/s00441-006-0320-3; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pijet B, 2013, MEDIAT INFLAMM, DOI DOI 10.1155/2013/171437; Pijet M, 2013, CYTOKINE, V61, P445, DOI 10.1016/j.cyto.2012.11.002; Potter RA, 2013, J EXERCISE PHYSL, V16, P32; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 1998, MOL ENDOCRINOL, V12, P1870, DOI 10.1210/me.12.12.1870; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Scarpulla RC, 2011, BIOCHIM BIOPHYS ACTA, V17, P132; Short KR, 2004, NEW ENGL J MED, V350, P2419; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Spangenburg EE, 2004, ENDOCRINOLOGY, V145, P2054, DOI 10.1210/en.2003-1476; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van der Velden JLJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1636, DOI 10.1152/ajpcell.00504.2006; Verhees KJP, 2011, AM J PHYSIOL-CELL PH, V301, pC995, DOI 10.1152/ajpcell.00520.2010; Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008; Welsh GI, 1997, FEBS LETT, V410, P418, DOI 10.1016/S0014-5793(97)00579-6; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu Y-J, 2013, PLOS ONE, V9, DOI [10.1371/journal.pone.0088450, DOI 10.1371/J0URNAL.P0NE.0088450]; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang CJ, 2012, BIOSCIENCE REP, V32, P465, DOI 10.1042/BSR20120034; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335	72	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146726	10.1371/journal.pone.0146726	http://dx.doi.org/10.1371/journal.pone.0146726			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785133	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400061
J	Sockeel, S; Schwartz, D; Pelegrini-Issac, M; Benali, H				Sockeel, Stephane; Schwartz, Denis; Pelegrini-Issac, Melanie; Benali, Habib			Large-Scale Functional Networks Identified from Resting-State EEG Using Spatial ICA	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FMRI; DISEASE; MEG	Several methods have been applied to EEG or MEG signals to detect functional networks. In recent works using MEG/EEG and fMRI data, temporal ICA analysis has been used to extract spatial maps of resting-state networks with or without an atlas-based parcellation of the cortex. Since the links between the fMRI signal and the electromagnetic signals are not fully established, and to avoid any bias, we examined whether EEG alone was able to derive the spatial distribution and temporal characteristics of functional networks. To do so, we propose a two-step original method: 1) An individual multi-frequency data analysis including EEG-based source localisation and spatial independent component analysis, which allowed us to characterize the resting-state networks. 2) A group-level analysis involving a hierarchical clustering procedure to identify reproducible large-scale networks across the population. Compared with large-scale resting-state networks obtained with fMRI, the proposed EEG-based analysis revealed smaller independent networks thanks to the high temporal resolution of EEG, hence hierarchical organization of networks. The comparison showed a substantial overlap between EEG and fMRI networks in motor, premotor, sensory, frontal, and parietal areas. However, there were mismatches between EEG-based and fMRI-based networks in temporal areas, presumably resulting from a poor sensitivity of fMRI in these regions or artefacts in the EEG signals. The proposed method opens the way for studying the high temporal dynamics of networks at the source level thanks to the high temporal resolution of EEG. It would then become possible to study detailed measures of the dynamics of connectivity.	[Sockeel, Stephane; Pelegrini-Issac, Melanie; Benali, Habib] Univ Paris 06, Sorbonne Univ, CNRS, INSERM,LIB, Paris, France; [Schwartz, Denis] Univ Paris 06, Sorbonne Univ, CNRS, Inserm U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Schwartz, D (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Inserm U1127,UMR 7225,UMR S 1127,Inst Cerveau & M, Paris, France.	Denis.Schwartz@upmc.fr		Schwartz, Denis/0000-0002-8557-2934; Pelegrini-Issac, Melanie/0000-0003-3260-5795	program "Investissements d'avenir" [ANR-10-IAIHU-06]	program "Investissements d'avenir"(French National Research Agency (ANR))	The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (http://www.agence-nationale-recherche.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Barnes JJ, 2016, DEVELOPMENTAL SCI, V19, P19, DOI 10.1111/desc.12297; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Bullmore E, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2618; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Coynel D, 2010, I S BIOMED IMAGING, P652, DOI 10.1109/ISBI.2010.5490092; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; David O., 2003, INT J COMPUT COGN, V1, P53; Deligianni F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00258; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ducorps A, 2010, FRONT NEUROSCI, DOI [10.3389/conf.fnins.2010.06.00107, DOI 10.10.3389/C0NF.FNINS.2010.06.00107]; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Geffroy D, 2011, PYTH NEUR WORKSH PAR; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Grova C, 2006, NEUROIMAGE, V31, P1475, DOI 10.1016/j.neuroimage.2006.02.049; Hartigan J., 1975, CLUSTERING ALGORITHM; HOLMES CJ, 1998, J COMPUT ASSIST TOMO, V22; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Lei X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024642; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Marzetti L, 2007, NEUROIMAGE, V36, P48, DOI 10.1016/j.neuroimage.2007.02.034; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perlbarg V, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/218519; Perlbarg V, 2009, NEUROIMAGE, V47, pS80, DOI [10.1016/S1053-8119(09)70568-3, DOI 10.1016/S1053-8119(09)70568-3]; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Regan D., 1989, HUMAN BRAIN ELECTROP; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Shepard D., 1968, P 23 ACM NAT C ACM 6, P517; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Wens V, 2015, HUM BRAIN MAPP, V36, P4604, DOI 10.1002/hbm.22943; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	48	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146845	10.1371/journal.pone.0146845	http://dx.doi.org/10.1371/journal.pone.0146845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785116	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400072
J	Upadhye, DS; Jain, DL; Trivedi, YL; Nadkarni, AH; Ghosh, K; Colah, RB				Upadhye, Dipti S.; Jain, Dipty L.; Trivedi, Yogesh L.; Nadkarni, Anita H.; Ghosh, Kanjaksha; Colah, Roshan B.			Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India	PLOS ONE			English	Article							NATURAL-HISTORY; FETAL HEMOGLOBIN; RISK-FACTORS; ALPHA-THALASSEMIA; ANEMIA; STROKE; COHORT; TRANSFUSIONS; DACTYLITIS; HAPLOTYPE	Background Sickle cell disease (SCD) is a major health burden in India. The objective of the study was to establish a neonatal screening program and to understand the clinical course of children with SCD in central India. Methods and Findings Pregnant mothers were screened for sickle hemoglobin using the solubility test. Babies were screened by high performance liquid chromatography if the mother was positive for sickle hemoglobin. The diagnosis was confirmed by molecular analysis. They received early prophylactic treatment and vaccination. Of 2134 newborns screened, 104 were sickle homozygous (SS), seven had sickle beta-thalassemia (S-beta thal) and 978 were sickle heterozygous (AS). The other hemoglobin abnormalities detected included HbS-delta beta thalassemia-1, HbSD disease-2, HbE traits-5, beta-thalassemia traits-4, alpha chain variants-3 and HbH disease-1. These babies were followed up regularly for hematological and clinical evaluation. Pain, severe anemia requiring blood transfusions and acute febrile illness were the major complications with 59.7, 45.1 and 42.6 cases per 100 person years. Fetal hemoglobin (HbF) levels were inversely associated with vaso-oclussive crisis (VOC) and severe anemia while presence of alpha thalassemia increased the rate of painful events and sepsis. Six early deaths occurred among the SS babies. Conclusion A systematic follow up of this first newborn SCD cohort in central India showed that 47% of babies presented within 1 year of age. In spite of the presence of the Arab-Indian haplotype many babies had severe manifestations.	[Upadhye, Dipti S.; Nadkarni, Anita H.; Ghosh, Kanjaksha; Colah, Roshan B.] Indian Council Med Res, Natl Inst Immunohematol, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India; [Jain, Dipty L.; Trivedi, Yogesh L.] Govt Med Coll, Nagpur 440003, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Colah, RB (corresponding author), Indian Council Med Res, Natl Inst Immunohematol, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.	colahrb@gmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Department of Biotechnology, Government of India [BT/PR5958/MED/14/721/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India (BT/PR5958/MED/14/721/2005, Dated - 28.08.09). Dr. RC and Dr. DJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY K, 1992, ARCH DIS CHILD, V67, P517, DOI 10.1136/adc.67.4.517; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; BAUM KF, 1987, ARCH INTERN MED, V147, P1231, DOI 10.1001/archinte.147.7.1231; Colah RB., 1997, INDIAN J HEMATOL BLO, V15, P10; Colah R, 2014, CURR OPIN HEMATOL, V21, P215, DOI 10.1097/MOH.0000000000000029; Dixit S, 2015, J COMMUN GENET, V6, P383, DOI 10.1007/s12687-015-0223-7; Donaldson A, 2001, CLIN LAB HAEMATOL, V23, P285, DOI 10.1046/j.1365-2257.2001.00412.x; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; Foucan L, 2006, PAEDIATR PERINAT EP, V20, P59, DOI 10.1111/j.1365-3016.2006.00692.x; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gulbis B, 2009, J CLIN PATHOL, V62, P49, DOI 10.1136/jcp.2008.060517; Italia K, 2015, BRIT J HAEMATOL, V168, P156, DOI 10.1111/bjh.13083; Italia Y, 2015, J MED SCREEN, V22, P1, DOI 10.1177/0969141314557372; Jain D, 2012, INDIAN PEDIATR, V49, P911, DOI 10.1007/s13312-012-0217-z; Jain DL, 2012, HEMOGLOBIN, V36, P316, DOI 10.3109/03630269.2012.691434; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Mukherjee MB, 1997, AM J HEMATOL, V55, P104, DOI 10.1002/(SICI)1096-8652(199706)55:2<104::AID-AJH9>3.0.CO;2-X; Panigrahi S, 2012, INDIAN J PEDIATR, V79, P747, DOI 10.1007/s12098-011-0682-8; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1978, AM J MED, V65, P461, DOI 10.1016/0002-9343(78)90772-6; POWARS DR, 1975, SEMIN HEMATOL, V12, P267; POWARS DR, 1980, J CLIN INVEST, V65, P732, DOI 10.1172/JCI109720; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; SARNAIK S, 1979, AM J DIS CHILD, V133, P1254, DOI 10.1001/archpedi.1979.02130120046009; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; STEVENS MCG, 1981, CLIN PEDIATR, V20, P311, DOI 10.1177/000992288102000501; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; VICHINSKY E, 1988, PEDIATRICS, V81, P749	34	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147081	10.1371/journal.pone.0147081	http://dx.doi.org/10.1371/journal.pone.0147081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785407	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400107
J	Biraro, IA; Kimuda, S; Egesa, M; Cose, S; Webb, EL; Joloba, M; Smith, SG; Elliott, AM; Dockrell, HM; Katamba, A				Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Cose, Stephen; Webb, Emily L.; Joloba, Moses; Smith, Steven G.; Elliott, Alison M.; Dockrell, Hazel M.; Katamba, Achilles			The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; DELAYED-TYPE HYPERSENSITIVITY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; WHOLE-BLOOD; BCG VACCINATION; IP-10; ASSAY; RELEASE; CONTACT	Background In the absence of a gold standard for the diagnosis of latent tuberculosis (TB) infection (LTBI), the current tests available for the diagnosis of LTBI are limited by their inability to differentiate between LTBI and active TB disease. We investigated IP-10 as a potential biomarker for LTBI among household contacts exposed to sputum positive active TB cases. Methods Active TB cases and contacts were recruited into a cohort with six months' follow-up. Contacts were tested for LTBI using QuantiFERON (R)-TB Gold In-Tube (QFN) assay and the tuberculin skin test (TST). Baseline supernatants from the QFN assay of 237 contacts and 102 active TB cases were analysed for Mycobacterium tuberculosis (MTB) specific and mitogen specific IP-10 responses. Results Contacts with LTBI (QFN(+)TST(+)) had the highest MTB specific IP-10 responses at baseline, compared to uninfected contacts (QFN(-)TST(-)) p<0.0001; and active cases, p = 0.01. Using a cut-off of 8,239 pg/ml, MTB specific IP-10 was able to diagnose LTBI with a sensitivity of 87.1% (95% CI, 76.2-94.3) and specificity of 90.9%(95% CI, 81.3-96.6). MTB specific to mitogen specific IP-10 ratio was higher in HIV negative active TB cases, compared to HIV negative latently infected contacts, p = 0.0004. Concentrations of MTB specific IP-10 were higher in contacts with TST conversion (negative at baseline, positive at 6-months) than in those that were persistently TST negative, p = 0.001. Conclusion IP-10 performed well in differentiating contacts with either latent or active TB from those who were uninfected but was not able to differentiate LTBI from active disease except when MTB specific to mitogen specific ratios were used in HIV negative adults. In addition, IP-10 had the potential to diagnose 'recent TB infection' in persons classified as having LTBI using the TST. Such individuals with strong IP-10 responses would likely benefit from chemoprophylaxis.	[Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Joloba, Moses; Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Cose, Stephen; Elliott, Alison M.] Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Biraro, IA (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Biraro, IA (corresponding author), Uganda Virus Res Inst, Med Res Council, Uganda Res Unit AIDS, Entebbe, Uganda.	andiaodanga@yahoo.com	Cose, Stephen/H-4851-2019	Cose, Stephen/0000-0002-5156-037X; Joloba, Moses/0000-0002-0334-9983; Smith, Steven/0000-0001-5623-7806; Egesa, Moses/0000-0001-5136-868X; Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; European Community's Seventh Framework Programme (FP7) under EC-GA [241642]; IDEA Consortium; Wellcome Trust Senior Fellowship [095778]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; European Community's Seventh Framework Programme (FP7) under EC-GA; IDEA Consortium; Wellcome Trust Senior Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by IAB, funded by a Wellcome Trust Strategic Award, grant number 084344. The work also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under EC-GA number 241642, IDEA Consortium (http://www.idearesearch.eu/). AME is supported by a Wellcome Trust Senior Fellowship, grant number 095778.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; BD Bioscience O, HUM IP 10 ELISA SET; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Biraro IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111517; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Buchwald UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116268; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Diel R, 2006, EUR RESPIR J, V28, P16, DOI 10.1183/09031936.06.00107005; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Floyd S, 2002, J INFECT DIS, V186, P807, DOI 10.1086/342416; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Holm LL, 2014, PEDIATRICS, V134, pE1568, DOI 10.1542/peds.2014-1570; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2008, EUR RESPIR J, V32, P1428, DOI 10.1183/09031936.00148308; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nkurunungi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047340; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Petrone L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/589471; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; Wergeland I, 2015, J INFECTION, V70, P381, DOI 10.1016/j.jinf.2014.12.019; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146098	10.1371/journal.pone.0146098	http://dx.doi.org/10.1371/journal.pone.0146098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771653	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000368628300009
J	Wang, HH; Turechek, WW				Wang, Hehe; Turechek, William W.			A Loop-Mediated Isothermal Amplification Assay and Sample Preparation Procedure for Sensitive Detection of Xanthomonas fragariae in Strawberry	PLOS ONE			English	Article							REAL-TIME PCR; ARBORICOLA PV. PRUNI; DNA EXTRACTION; IDENTIFICATION; PATHOVAR; PRIMERS; TISSUE	Xanthomonas fragariae is a bacterium that causes angular leaf spot of strawberry. Asymptomatic infection is common and contributes to the difficulties in disease management. The aim of this study was to develop a loop-mediated isothermal amplification (LAMP) assay as an efficient method for detection of asymptomatic infections of X. fragariae. In addition, a new method of sample preparation was developed that allows sampling of a larger amount of plant tissue, hence increasing the detection rate in real-life samples. The sample preparation procedure includes an overnight incubation of strawberry tissues in phosphate-buffered saline (PBS), followed by a quick sample concentration and a boiling step to extract DNA for amplification. The detection limit of the LAMP assay was approximately 2x10(3') CFU/mL for pure bacteria culture and 300 CFU/mL for bacteria spiked strawberry leaf and petiole samples. LAMP provided a 2-3 fold lower detection limit than the standard qPCR assay but was faster, and more user-friendly. The LAMP assay should serve as a rapid, sensitive and cost-effective tool for detecting asymptomatic infections of X. fragariae in strawberry nursery stock and contribute to improved disease management.	[Wang, Hehe; Turechek, William W.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Turechek, WW (corresponding author), ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA.	william.turechek@ars.usda.gov			United States Department of Agriculture-Foreign Agricultural Service-Technical Assistance for Specialty Crops Grant [21012-51]; United States Department of Agriculture-Current Research Information System [6034-22000-039-00D]; ARS [ARS-0423073, ARS-0426560] Funding Source: Federal RePORTER	United States Department of Agriculture-Foreign Agricultural Service-Technical Assistance for Specialty Crops Grant; United States Department of Agriculture-Current Research Information System(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was supported through a United States Department of Agriculture-Foreign Agricultural Service-Technical Assistance for Specialty Crops Grant #21012-51 (http://www.fas.usda.gov/programs/technical-assistance-specialtycrops-tasc, recipient: WWT); and United States Department of Agriculture-Current Research Information System No. 6034-22000-039-00D (http://cris.csrees.usda.gov/, recipient: WWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, B OEPP, V36, P135, DOI [DOI 10.1111/J.1365-2338.2006.00926.X, 10.1111/j.1365-2338.2006.00926.x]; Arrausi-Subiza M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0192-9; Bekele B, 2011, PLANT PATHOL, V60, P345, DOI 10.1111/j.1365-3059.2010.02384.x; Buhlmann A, 2013, PLANT PATHOL, V62, P475, DOI 10.1111/j.1365-3059.2012.02654.x; Buhlmann A, 2013, J MICROBIOL METH, V92, P332, DOI 10.1016/j.mimet.2012.12.017; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; Dugan L, 2012, J MICROBIOL METH, V90, P280, DOI 10.1016/j.mimet.2012.05.022; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; HAYWARD AC, 1960, NATURE, V186, P405, DOI 10.1038/186405a0; HAZEL W J, 1980, Plant Disease, V64, P178; Hodgetts J, 2015, J APPL MICROBIOL, V119, P1651, DOI 10.1111/jam.12959; Hyeon JY, 2010, J VET SCI, V11, P143, DOI 10.4142/jvs.2010.11.2.143; Janse JD, 2001, PLANT PATHOL, V50, P653, DOI 10.1046/j.1365-3059.2001.00644.x; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kastelein P, 2014, PLANT PATHOL, V63, P255, DOI 10.1111/ppa.12090; Lang JM, 2014, APPL ENVIRON MICROB, V80, P4519, DOI 10.1128/AEM.00274-14; Lanza S. T., 2011, PROC LCA PROC LTA US; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Maas J.L., 1995, ADV STRAWBERRY RES, V14, P18; Manjunath LK, 2015, CROP PROT, V68, P41; Moltmann E., 2005, Bulletin OEPP, V35, P53, DOI 10.1111/j.1365-2338.2005.00812.x; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Opgenorth DC, 1996, PLANT DIS, V80, P868, DOI 10.1094/PD-80-0868; Palacio-Bielsa A, 2015, J MICROBIOL METH, V112, P36, DOI 10.1016/j.mimet.2015.03.005; Pooler MR, 1996, APPL ENVIRON MICROB, V62, P3121, DOI 10.1128/AEM.62.9.3121-3127.1996; Rigano LA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-176; Roberts PD, 1996, PLANT DIS, V80, P1283, DOI 10.1094/PD-80-1283; ROWHANI A, 1994, PLANT DIS, V78, P248, DOI 10.1094/PD-78-0248; SMITH IM, 1992, QUARANTINE PESTS EUR, P829; Sowmya N, 2012, J APPL MICROBIOL, V113, P106, DOI 10.1111/j.1365-2672.2012.05315.x; Temple TN, 2013, PLANT DIS, V97, P1585, DOI 10.1094/PDIS-03-13-0262-RE; Tomlinson JA, 2010, PLANT PATHOL, V59, P465, DOI 10.1111/j.1365-3059.2009.02233.x; Turechek WW, 2008, PHYTOPATHOLOGY, V98, P359, DOI 10.1094/PHYTO-98-3-0359; Turechek WW, 2013, PHYTOPATHOLOGY, V103, P1243, DOI 10.1094/PHYTO-03-13-0071-R; Vandroemme J, 2008, PLANT PATHOL, V57, P438, DOI 10.1111/j.1365-3059.2007.01813.x; Wang H, 2013, PHYTOPATHOLOGY, V103, P155; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; Weller SA, 2007, J MICROBIOL METH, V70, P379, DOI 10.1016/j.mimet.2007.05.018; Zimmermann C, 2004, Z PFLANZENK PFLANZEN, V111, P39	40	20	21	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147122	10.1371/journal.pone.0147122	http://dx.doi.org/10.1371/journal.pone.0147122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766068	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300069
J	Eloot, S; Schneditz, D; Cornelis, T; Van Biesen, W; Glorieux, G; Dhondt, A; Kooman, J; Vanholder, R				Eloot, Sunny; Schneditz, Daniel; Cornelis, Tom; Van Biesen, Wim; Glorieux, Griet; Dhondt, Annemie; Kooman, Jeroen; Vanholder, Raymond			Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis	PLOS ONE			English	Article							INCREASING DIALYSATE FLOW; INDOXYL SULFATE; P-CRESOL; PHOSPHORUS MOBILIZATION; RETENTION SOLUTES; REMOVAL; UREA; CRESYLSULPHATE; CLEARANCE; KINETICS	Aim We studied various hemodialysis strategies for the removal of protein-bound solutes, which are associated with cardiovascular damage. Methods This study included 10 patients on standard (3x4h/week) high-flux hemodialysis. Blood was collected at the dialyzer inlet and outlet at several time points during a midweek session. Total and free concentration of several protein-bound solutes was determined as well as urea concentration. Per solute, a two-compartment kinetic model was fitted to the measured concentrations, estimating plasmatic volume (V-1), total distribution volume (V-tot) and inter-compartment clearance (K-21). This calibrated model was then used to calculate which hemodialysis strategy offers optimal removal. Our own in vivo data, with the strategy variables entered into the mathematical simulations, was then validated against independent data from two other clinical studies. Results Dialyzer clearance K, V-1 and V-tot correlated inversely with percentage of protein binding. All Ks were different from each other. Of all protein-bound solutes, K-21 was 2.7-5.3 times lower than that of urea. Longer and/or more frequent dialysis that processed the same amount of blood per week as standard 3x4h dialysis at 300mL/min blood flow showed no difference in removal of strongly bound solutes. However, longer and/or more frequent dialysis strategies that processed more blood per week than standard dialysis were markedly more adequate. These conclusions were successfully validated. Conclusion When blood and dialysate flow per unit of time and type of hemodialyzer are kept the same, increasing the amount of processed blood per week by increasing frequency and/or duration of the sessions distinctly increases removal.	[Eloot, Sunny; Van Biesen, Wim; Glorieux, Griet; Dhondt, Annemie; Vanholder, Raymond] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Schneditz, Daniel] Med Univ Graz, Inst Physiol, Graz, Austria; [Cornelis, Tom; Kooman, Jeroen] Maastricht Univ, Med Ctr, Dept Internal Med, Div Nephrol, NL-6200 MD Maastricht, Netherlands	Ghent University; Ghent University Hospital; Medical University of Graz; Maastricht University	Eloot, S (corresponding author), Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium.	Sunny.Eloot@UGent.be	Schneditz, Daniel/E-6580-2010	Schneditz, Daniel/0000-0002-0124-1012	FWO Vlaanderen [G0A4614N]	FWO Vlaanderen(FWO)	This study was supported by FWO Vlaanderen - G0A4614N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adijiang A, 2008, NEPHROL DIAL TRANSPL, V23, P1892, DOI 10.1093/ndt/gfm861; Agar BU, 2011, CLIN J AM SOC NEPHRO, V6, P2854, DOI 10.2215/CJN.03860411; Agar BU, 2011, HEMODIAL INT, V15, pS9, DOI 10.1111/j.1542-4758.2011.00596.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Bammens B, 2005, CONTRIB NEPHROL, V149, P175, DOI 10.1159/000085487; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Basile C, 2011, NEPHROL DIAL TRANSPL, V26, P1296, DOI 10.1093/ndt/gfq543; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cornelis T, 2014, AM J KIDNEY DIS, V64, P247, DOI 10.1053/j.ajkd.2014.02.016; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; Eloot S, 2005, KIDNEY INT, V67, P1566, DOI 10.1111/j.1523-1755.2005.00238.x; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P4021, DOI 10.1093/ndt/gfs367; Eloot S, 2009, NEPHROL DIAL TRANSPL, V24, P2225, DOI 10.1093/ndt/gfp059; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Krieter DH, 2010, NEPHROL DIAL TRANSPL, V25, P212, DOI 10.1093/ndt/gfp437; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; MAASRANI M, 1995, INT J ARTIF ORGANS, V18, P122, DOI 10.1177/039139889501800303; Maduell F, 2012, NEPHROL DIAL TRANSPL, V27, P1619, DOI 10.1093/ndt/gfr491; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meert N, 2011, NEPHROL DIAL TRANSPL, V26, P2624, DOI 10.1093/ndt/gfq803; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers B, 2011, AM J NEPHROL, V34, P226, DOI 10.1159/000330176; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Meyer TW, 2005, KIDNEY INT, V68, P867, DOI 10.1111/j.1523-1755.2005.00469.x; Meyer TW, 2004, J AM SOC NEPHROL, V15, P1927, DOI 10.1097/01.asn.0000131521.62256.f0; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; NIWA T, 1988, CLIN CHEM, V34, P2264; ODELL RA, 1991, KIDNEY INT, V39, P909, DOI 10.1038/ki.1991.114; Ouseph R, 2001, AM J KIDNEY DIS, V37, P316, DOI 10.1053/ajkd.2001.21296; Ouseph R, 2008, NEPHROL DIAL TRANSPL, V23, P1704, DOI 10.1093/ndt/gfm916; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schneditz D, 2001, SEMIN DIALYSIS, V14, P271, DOI 10.1046/j.1525-139X.2001.00066.x; Schulman G, 2006, AM J KIDNEY DIS, V47, P565, DOI 10.1053/j.ajkd.2005.12.036; Scribner BH, 2015, DIALYSIS TRANSPLANT, V31, P13; Sirich TL, 2012, NEPHROL DIAL TRANSPL, V27, P1574, DOI 10.1093/ndt/gfr691; Spalding EM, 2002, KIDNEY INT, V61, P655, DOI 10.1046/j.1523-1755.2002.00146.x; Stiller S, 2002, INT J ARTIF ORGANS, V25, P411, DOI 10.1177/039139880202500511; VANHOLDER R, 1992, KIDNEY INT, V41, P1707, DOI 10.1038/ki.1992.244; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; VANHOLDER RC, 1992, CLIN CHEM, V38, P1429; Ward RA, 2006, KIDNEY INT, V69, P1431, DOI 10.1038/sj.ki.5000048; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	53	37	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147159	10.1371/journal.pone.0147159	http://dx.doi.org/10.1371/journal.pone.0147159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799394	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300066
J	Zhang, YX; Moore, DR; Guiraud, J; Molloy, K; Yan, TT; Amitay, S				Zhang, Yu-Xuan; Moore, David R.; Guiraud, Jeanne; Molloy, Katharine; Yan, Ting-Ting; Amitay, Sygal			Auditory Discrimination Learning: Role of Working Memory	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; CONTRAST DISCRIMINATION; INDIVIDUAL-DIFFERENCES; SPECIFICITY; PERCEPTION; INTERFERENCE; INHIBITION; MECHANISMS; PITCH	Perceptual training is generally assumed to improve perception by modifying the encoding or decoding of sensory information. However, this assumption is incompatible with recent demonstrations that transfer of learning can be enhanced by across-trial variation of training stimuli or task. Here we present three lines of evidence from healthy adults in support of the idea that the enhanced transfer of auditory discrimination learning is mediated by working memory (WM). First, the ability to discriminate small differences in tone frequency or duration was correlated with WM measured with a tone n-back task. Second, training frequency discrimination around a variable frequency transferred to and from WM learning, but training around a fixed frequency did not. The transfer of learning in both directions was correlated with a reduction of the influence of stimulus variation in the discrimination task, linking WM and its improvement to across-trial stimulus interaction in auditory discrimination. Third, while WM training transferred broadly to other WM and auditory discrimination tasks, variable -frequency training on duration discrimination did not improve WM, indicating that stimulus variation challenges and trains WM only if the task demands stimulus updating in the varied dimension. The results provide empirical evidence as well as a theoretic framework for interactions between cognitive and sensory plasticity during perceptual experience.	[Zhang, Yu-Xuan; Moore, David R.; Guiraud, Jeanne; Molloy, Katharine; Amitay, Sygal] MRC, Inst Hearing Res, Univ Pk, Nottingham, England; [Zhang, Yu-Xuan; Yan, Ting-Ting] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Yu-Xuan; Yan, Ting-Ting] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Zhang, Yu-Xuan] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Moore, David R.] Cincinnati Childrens Hosp Med Ctr, Commun Sci Res Ctr, Cincinnati, OH 45229 USA; [Guiraud, Jeanne] Univ London, Dept Psychol, Egham, Surrey, England; [Molloy, Katharine] UCL, Inst Cognit Neurosci, London, England	University of Nottingham; Beijing Normal University; Beijing Normal University; Beijing Normal University; Cincinnati Children's Hospital Medical Center; University of London; Royal Holloway University London; University of London; University College London	Zhang, YX (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham, England.; Zhang, YX (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Zhang, YX (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.; Zhang, YX (corresponding author), Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China.	zhangyuxuan@bnu.edu.cn			Medical Research Council (UK) [U135097130]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council (UK) Grant U135097130 as part of core funding to the Institute of Hearing Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2014, VISION RES, V99, P69, DOI 10.1016/j.visres.2013.11.006; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Banai K, 2012, VISION RES, V61, P83, DOI 10.1016/j.visres.2012.01.009; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; BRAIDA LD, 1984, J ACOUST SOC AM, V76, P722, DOI 10.1121/1.391258; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Deary LJ, 2004, AM J PSYCHOL, V117, P1, DOI 10.2307/1423593; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Irvine DRF, 2000, J ACOUST SOC AM, V108, P2964, DOI 10.1121/1.1323465; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jeter PE, 2010, VISION RES, V50, P1928, DOI 10.1016/j.visres.2010.06.016; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; KEPPEL G, 1962, J EXP PSYCHOL, V64, P400, DOI 10.1037/h0040424; Kleiner M, 2007, PERCEPTION, V36, P14; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Mollon JD, 1996, SPATIAL VISION, V10, P51, DOI 10.1163/156856896X00051; Molloy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036929; Moore B., 2003, INTRO PSYCHOL HEARIN; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Oberauer K, 2005, J EXP PSYCHOL GEN, V134, P368, DOI 10.1037/0096-3445.134.3.368; PECHMANN T, 1992, MEM COGNITION, V20, P314, DOI 10.3758/BF03199668; Roberts R, 2002, J PSYCHOLINGUIST RES, V31, P573, DOI 10.1023/A:1021213004302; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Thorndike EL, 1909, AM J PSYCHOL, V20, P364, DOI 10.2307/1413366; Troche SJ, 2014, INTELLIGENCE, V44, P40, DOI 10.1016/j.intell.2014.02.009; WATSON CS, 1980, ANN OTO RHINOL LARYN, V89, P96; Webb BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001323; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Wright BA, 2010, J NEUROSCI, V30, P11635, DOI 10.1523/JNEUROSCI.1441-10.2010; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010	54	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147320	10.1371/journal.pone.0147320	http://dx.doi.org/10.1371/journal.pone.0147320			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799068	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300095
J	Guo, BY; Amano, Y; Nozaki, K				Guo, Boyang; Amano, Yoshihiko; Nozaki, Kouichi			Improvements in Glucose Sensitivity and Stability of Trichoderma reesei beta-Glucosidase Using Site-Directed Mutagenesis	PLOS ONE			English	Article							TERMITE NEOTERMES-KOSHUNENSIS; MICROBIAL METAGENOME; ASPERGILLUS-ORYZAE; TOLERANT; CLONING; PURIFICATION; EXPRESSION; CELLULASE; XYLOSE	Glucose sensitivity and pH and thermal stabilities of Trichoderma reesei Cel1A (Bgl II) were improved by site-directed mutagenesis of only two amino acid residues (L167W or P172L) at the entrance of the active site. The Cel1A mutant showed high glucose tolerance (50% of inhibitory concentration = 650 mM), glucose stimulation (2.0 fold at 50 mM glucose), and enhanced specific activity (2.4-fold) compared with those of the wild-type Cel1A. Furthermore, the mutant enzyme showed stability at a wide pH range of 4.5-9.0 and possessed high thermal stability up to 50 degrees C with 80% of the residual activities compared with the stability seen at the pH range of 6.5-7.0 and temperatures of up to 40 degrees C in the wild-type Cel1A. Kinetic studies for hydrolysis revealed that the Cel1A mutant was competitively inhibited by glucose at similar levels as the wild-type enzyme. Additionally, the mutant enzyme exhibited substrate inhibition, which gradually disappeared with an increasing glucose concentration. These data suggest that the glucose stimulation was caused by relieve the substrate inhibition in the presence of glucose. To conclude, all the properties improved by the mutagenesis would be great advantages in degradation of cellulosic biomass together with cellulases.	[Guo, Boyang; Amano, Yoshihiko; Nozaki, Kouichi] Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan	Shinshu University	Nozaki, K (corresponding author), Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan.	knoza@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the Grant-in-Aid for the Global COE Program by the Ministry of Education, Culture, Sports, Science and Technology of Japan and was also sponsored by the New Energy and Industrial Technology Development Organization (NEDO), from the Ministry of Economy, Trade and Industry of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-014-0090-3; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; KUBICEK CP, 1987, J GEN MICROBIOL, V133, P1481; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2013, ACTA BIOCH BIOPH SIN, V45, P664, DOI 10.1093/abbs/gmt061; Mai ZM, 2013, APPL BIOCHEM BIOTECH, V169, P1512, DOI 10.1007/s12010-012-0080-3; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Michaelis L, 1913, BIOCHEM Z, V49, P333; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Souza FHM, 2010, PROCESS BIOCHEM, V45, P272, DOI 10.1016/j.procbio.2009.09.018; Nakazawa H, 2012, BIOTECHNOL BIOENG, V109, P92, DOI 10.1002/bit.23296; Nascimento CV, 2010, J MICROBIOL, V48, P53, DOI 10.1007/s12275-009-0159-x; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Rahman Z, 2009, BIOSCI BIOTECH BIOCH, V73, P1083, DOI 10.1271/bbb.80852; Ramani G, 2015, J IND MICROBIOL BIOT, V42, P553, DOI 10.1007/s10295-014-1549-6; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Saloheimo M, 2002, APPL ENVIRON MICROB, V68, P4546, DOI 10.1128/AEM.68.9.4546-4553.2002; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; Treebupachatsakul T, 2016, J BIOSCI BIOENG, V121, P27, DOI 10.1016/j.jbiosc.2015.05.002; Treebupachatsakul T, 2015, J BIOSCI BIOENG, V120, P657, DOI 10.1016/j.jbiosc.2015.04.015; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00548; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Wang BB, 2011, BIORESOURCE TECHNOL, V102, P4568, DOI 10.1016/j.biortech.2010.12.099; Yang F, 2015, APPL MICROBIOL BIOT, V99, P8903, DOI 10.1007/s00253-015-6619-9; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021	33	45	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147301	10.1371/journal.pone.0147301	http://dx.doi.org/10.1371/journal.pone.0147301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790148	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100073
J	Kitahara, Y; Ohta, K; Hasuo, H; Shuto, T; Kuroiwa, M; Sotogaku, N; Togo, A; Nakamura, K; Nishi, A				Kitahara, Yosuke; Ohta, Keisuke; Hasuo, Hiroshi; Shuto, Takahide; Kuroiwa, Mahomi; Sotogaku, Naoki; Togo, Akinobu; Nakamura, Kei-ichiro; Nishi, Akinori			Chronic Fluoxetine Induces the Enlargement of Perforant Path-Granule Cell Synapses in the Mouse Dentate Gyrus	PLOS ONE			English	Article							DEPENDENT STRUCTURAL PLASTICITY; SCANNING-ELECTRON-MICROSCOPY; DENDRITIC SPINES; HIPPOCAMPAL NEUROGENESIS; PROTEIN-SYNTHESIS; MATURATION; INCREASES; TRKB; DIFFERENTIATION; RELEASE	A selective serotonin reuptake inhibitor is the most commonly prescribed antidepressant for the treatment of major depression. However, the mechanisms underlying the actions of selective serotonin reuptake inhibitors are not fully understood. In the dentate gyrus, chronic fluoxetine treatment induces increased excitability of mature granule cells (GCs) as well as neurogenesis. The major input to the dentate gyrus is the perforant path axons (boutons) from the entorhinal cortex (layer II). Through voltage-sensitive dye imaging, we found that the excitatory neurotransmission of the perforant path synapse onto the GCs in the middle molecular layer of the mouse dentate gyrus (perforant path-GC synapse) is enhanced after chronic fluoxetine treatment (15 mg/kg/day, 14 days). Therefore, we further examined whether chronic fluoxetine treatment affects the morphology of the perforant path-GC synapse, using FIB/SEM (focused ion beam/scanning electron microscopy). A three-dimensional reconstruction of dendritic spines revealed the appearance of extremely large-sized spines after chronic fluoxetine treatment. The large-sized spines had a postsynaptic density with a large volume. However, chronic fluoxetine treatment did not affect spine density. The presynaptic boutons that were in contact with the large-sized spines were large in volume, and the volumes of the mitochondria and synaptic vesicles inside the boutons were correlated with the size of the boutons. Thus, the large-sized perforant path-GC synapse induced by chronic fluoxetine treatment contains synaptic components that correlate with the synapse size and that may be involved in enhanced glutamatergic neurotransmission.	[Kitahara, Yosuke; Shuto, Takahide; Kuroiwa, Mahomi; Sotogaku, Naoki; Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Ohta, Keisuke; Togo, Akinobu; Nakamura, Kei-ichiro] Kurume Univ, Sch Med, Dept Anat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Hasuo, Hiroshi] Kurume Univ, Sch Med, Dept Physiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan	Kurume University; Kurume University; Kurume University	Nishi, A (corresponding author), Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	nishia@med.kurume-u.ac.jp	Ohta, Keisuke/GSD-8525-2022	Ohta, Keisuke/0000-0002-2040-5297	CREST of Japan Science and Technology Agency; JSPS [26293040]	CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a grant from CREST of Japan Science and Technology Agency (to AN) and JSPS Grant-in-Aid for Scientific Research (B) 26293040 (to KN, KO, AT).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Ampuero E, 2010, NEUROSCIENCE, V169, P98, DOI 10.1016/j.neuroscience.2010.04.035; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Baj G, 2012, NEUROPSYCHOPHARMACOL, V37, P1600, DOI 10.1038/npp.2012.5; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bosch C, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.2015.00060, 10.3389/fnana.7015.00060]; Bourne JN, 2013, J COMP NEUROL, V521, P3898, DOI 10.1002/cne.23384; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dringenberg HC, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/571285; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; EBNER TJ, 1995, PROG NEUROBIOL, V46, P463, DOI 10.1016/0301-0082(95)00010-S; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Greenwood JSF, 2009, ANN NEUROL, V66, P644, DOI 10.1002/ana.21775; Hajszan T, 2005, EUR J NEUROSCI, V21, P1299, DOI 10.1111/j.1460-9568.2005.03968.x; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMA K, 1989, J ELECTRON MICR TECH, V12, P80, DOI 10.1002/jemt.1060120203; Hasuo H, 2013, J KURUME MED ASS, V76, P126; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Jiang CG, 2002, TRENDS BIOCHEM SCI, V27, P506, DOI 10.1016/S0968-0004(02)02190-4; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lin MY, 2015, EXP CELL RES, V334, P35, DOI 10.1016/j.yexcr.2015.01.004; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Ohno N, 2015, MICROSCOPY-JPN, V64, P17, DOI 10.1093/jmicro/dfu112; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Pasaoglu T, 2016, HIPPOCAMPUS, V26, P151, DOI 10.1002/hipo.22499; Pilar-Cuellar F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/537265; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Popov VI, 2009, SYNAPSE, V63, P369, DOI 10.1002/syn.20613; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ramiro-Cortes Y, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0157; Rantamaki T, 2016, PROG NEURO-PSYCHOPH, V64, P285, DOI 10.1016/j.pnpbp.2015.06.001; Rollenhagen A, 2015, BRAIN STRUCT FUNCT, V220, P3185, DOI 10.1007/s00429-014-0850-5; Rubio FJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00066; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 1997, J NEUROSCI, V17, P5858; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stahl S, 2009, STAHLS ILLUSTRATED A; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Takeya Mitsue, 2001, Kurume Medical Journal, V48, P205; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337, DOI 10.1177/27.10.512319; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	71	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147307	10.1371/journal.pone.0147307	http://dx.doi.org/10.1371/journal.pone.0147307			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788851	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100075
J	Liu, XG; Xu, H; Ma, ZJ; Zhang, YJ; Tian, CF; Cheng, GF; Zou, HS; Lu, SM; Liu, SJ; Tang, R				Liu, Xingguo; Xu, Hao; Ma, Zhuojun; Zhang, Yongjun; Tian, Changfeng; Cheng, Guofeng; Zou, Haisheng; Lu, Shimin; Liu, Shijing; Tang, Rong			Design and Application of a Solar Mobile Pond Aquaculture Water Quality-Regulation Machine Based in Bream Pond Aquaculture	PLOS ONE			English	Article							PHOSPHORUS; SEDIMENTS	Bream pond aquaculture plays a very important role in China's aquaculture industry and is the main source of aquatic products. To regulate and control pond water quality and sediment, a movable solar pond aquaculture water quality regulation machine (SMWM) was designed and used. This machine is solar-powered and moves on water, and its primary components are a solar power supply device, a sediment lifting device, a mechanism for walking on the water's surface and a control system. The solar power supply device provides power for the machine, and the water walking mechanism drives the machine's motion on the water. The sediment lifting device orbits the main section of the machine and affects a large area of the pond. Tests of the machine's mechanical properties revealed that the minimum illumination necessary for the SMWM to function is 13,000 Lx and that its stable speed on the water is 0.02-0.03 m/s. For an illumination of 13,000-52,500 Lx, the sediment lifting device runs at 0.13-0.35 m/s, and its water delivery capacity is 110-208 m(3)/h. The sediment lifting device is able to fold away, and the angle of the suction chamber can be adjusted, making the machine work well in ponds at different water depths from 0.5 m to 2 m. The optimal distance from the sediment lifting device to the bottom of the pond is 10-15 cm. In addition, adjusting the length of the connecting rod and the direction of the traction rope allows the SMWM to work in a pond water area greater than 80%. The analysis of water quality in Wuchang bream (Parabramis pekinensis) and silver carp (Hypophthalmichthys molitrix) culture ponds using the SMWM resulted in decreased NH3+-N and available phosphorus concentrations and increased TP concentrations. The TN content and the amount of available phosphorus in the sediment were reduced. In addition, the fish production showed that the SMWM enhanced the yields of Wuchang bream and silver carp by more than 30% and 24%, respectively. These results indicate that the SMWM may be suitable for Wuchang bream pond aquaculture in China and that it can be used in pond aquaculture for regulating and controlling water quality.	[Liu, Xingguo; Xu, Hao; Ma, Zhuojun; Tian, Changfeng; Cheng, Guofeng; Lu, Shimin] Minist Agr, Key Lab Fishery Equipment & Engn, Shanghai 200092, Peoples R China; [Liu, Xingguo; Xu, Hao; Zhang, Yongjun; Tian, Changfeng; Cheng, Guofeng; Zou, Haisheng; Liu, Shijing; Tang, Rong] Chinese Acad Fishery Sci, Fishery Machinery & Instrument Inst, Shanghai 200092, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Fishery Machinery & Instrument Research Institute, CAFS	Liu, XG (corresponding author), Minist Agr, Key Lab Fishery Equipment & Engn, Shanghai 200092, Peoples R China.; Liu, XG (corresponding author), Chinese Acad Fishery Sci, Fishery Machinery & Instrument Inst, Shanghai 200092, Peoples R China.	liuxingguo@fmiri.ac.cn			National \ Science Foundation of China NSFC [31372570]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD25B01]; National Science Foundation of China NSFC [31372570]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (in China) [2012BAD25B01]	National \ Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (in China)	Dr. XGL received a grant by the National vertical bar Science Foundation of China NSFC(31372570) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD25B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work were supported by the National Science Foundation of China NSFC (31372570) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD25B01) (in China).	[Anonymous], 983788 GB UDC; Boyd CE, 1995, HANDBOOK, P1; [蔡惠凤 CAI Huifeng], 2006, [中国水产科学, Journal of Fishery Sciences of China], V13, P140; Diaz-Espejo A, 1999, HYDROBIOLOGIA, V392, P21, DOI 10.1023/A:1003557408640; Editorial Board of Monitoring and Analytical Method of Water and Wastewater State Environmental Protection Administration of China, 2002, MON AN METH WAT WAST; Ekka SA, 2006, ECOL ENG, V26, P375, DOI 10.1016/j.ecoleng.2006.01.002; Honglu Y, 2010, STUDY ECOLOGY INTEGR, P138; Imai Masae, 1997, Phycological Research, V45, P233, DOI 10.1111/j.1440-1835.1997.tb00082.x; Jiang XL, 2006, AQUACULT ENG, V35, P147, DOI 10.1016/j.aquaeng.2005.10.002; Jin XC, 2006, ENVIRON POLLUT, V139, P288, DOI 10.1016/j.envpol.2005.05.010; Lake BA, 2007, SCI TOTAL ENVIRON, V373, P534, DOI 10.1016/j.scitotenv.2006.12.021; [李柯 Li Ke], 2010, [地理科学进展, Progress in Geography], V29, P1049; Liu XingGuo, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P1; [苗爽 Miao Shuang], 2011, [吉林农业科学, Journal of Jilin Agricultural Sciences], V36, P17; National Bureau of Statistics of China, 2014, CHIN FISH STAT YB, P36; Shidan B, 2000, SOIL AGR CHEM ANAL, P39; Shrestha MK, 1997, J I AGR ANIMAL SCI, V117, P1; Tian ChangFeng, 2013, Journal of Shanghai Ocean University, V22, P616; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; [王春德 Wang Chunde], 2012, [生命科学研究, Life Science Research], V16, P345; Wei L, 2014, J NATURAL SCI HEILON, V31, P646; Wu W, 2000, SCI FISH CULTURE PRO, P136; Xingguo L, 2011, STUDY FRESHWATER PON, P20; Yoo JH, 2006, ECOL ENG, V27, P109, DOI 10.1016/j.ecoleng.2005.12.001; Zhaohui W, 1999, CHINESE J APPL ECOLO, V10, P345	25	3	3	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146637	10.1371/journal.pone.0146637	http://dx.doi.org/10.1371/journal.pone.0146637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789004	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100035
J	Onouchi, Y; Fukazawa, R; Yamamura, K; Suzuki, H; Kakimoto, N; Suenaga, T; Takeuchi, T; Hamada, H; Honda, T; Yasukawa, K; Terai, M; Ebata, R; Higashi, K; Saji, T; Kemmotsu, Y; Takatsuki, S; Ouchi, K; Kishi, F; Yoshikawa, T; Nagai, T; Hamamoto, K; Sato, Y; Honda, A; Kobayashi, H; Sato, J; Shibuta, S; Miyawaki, M; Oishi, K; Yamaga, H; Aoyagi, N; Yoshiyama, M; Miyashita, R; Murata, Y; Fujino, A; Ozaki, K; Kawasaki, T; Abe, J; Seki, M; Kobayashi, T; Arakawa, H; Ogawa, S; Hara, T; Hata, A; Tanaka, T				Onouchi, Yoshihiro; Fukazawa, Ryuji; Yamamura, Kenichiro; Suzuki, Hiroyuki; Kakimoto, Nobuyuki; Suenaga, Tomohiro; Takeuchi, Takashi; Hamada, Hiromichi; Honda, Takafumi; Yasukawa, Kumi; Terai, Masaru; Ebata, Ryota; Higashi, Kouji; Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi; Ouchi, Kazunobu; Kishi, Fumio; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Sato, Yoshitake; Honda, Akihito; Kobayashi, Hironobu; Sato, Junichi; Shibuta, Shoichi; Miyawaki, Masakazu; Oishi, Ko; Yamaga, Hironobu; Aoyagi, Noriyuki; Yoshiyama, Megumi; Miyashita, Ritsuko; Murata, Yuji; Fujino, Akihiro; Ozaki, Kouichi; Kawasaki, Tomisaku; Abe, Jun; Seki, Mitsuru; Kobayashi, Tohru; Arakawa, Hirokazu; Ogawa, Shunichi; Hara, Toshiro; Hata, Akira; Tanaka, Toshihiro			Variations in ORAI1 Gene Associated with Kawasaki Disease	PLOS ONE			English	Article							INTERACTION MOLECULE-1 STIM1; CRAC CHANNEL; CALCIUM SENSOR; NUCLEAR-FACTOR; PORE SUBUNIT; STORE; ACTIVATION; RELEASE; CELLS; ENTRY	Kawasaki disease (KD; MIM#61175) is a systemic vasculitis syndrome with unknown etiology which predominantly affects infants and children. Recent findings of susceptibility genes for KD suggest possible involvement of the Ca2+/NFAT pathway in the pathogenesis of KD. ORAI1 is a Ca2+ release activated Ca2+ (CRAC) channel mediating store-operated Ca2+ entry (SOCE) on the plasma membrane. The gene for ORAI1 is located in chromosome 12q24 where a positive linkage signal was observed in our previous affected sib-pair study of KD. A common non-synonymous single nucleotide polymorphism located within exon 2 of ORAI1 (rs3741596) was significantly associated with KD (P = 0.028 in the discovery sample set (729 KD cases and 1,315 controls), P = 0.0056 in the replication sample set (1,813 KD cases vs. 1,097 controls) and P = 0.00041 in a meta-analysis by the Mantel-Haenszel method). Interestingly, frequency of the risk allele of rs3741596 is more than 20 times higher in Japanese compared to Europeans. We also found a rare 6 base-pair in-frame insertion variant associated with KD (rs141919534; 2,544 KD cases vs. 2,414 controls, P = 0.012). These data indicate that ORAI1 gene variations are associated with KD and may suggest the potential importance of the Ca2+'/NFAT pathway in the pathogenesis of this disorder.	[Onouchi, Yoshihiro; Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Fukazawa, Ryuji; Ogawa, Shunichi] Nippon Med Sch, Dept Pediat, 1-1-5 Sendagi, Tokyo 113, Japan; [Yamamura, Kenichiro; Hara, Toshiro] Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Hiroyuki; Kakimoto, Nobuyuki; Suenaga, Tomohiro; Takeuchi, Takashi] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Hamada, Hiromichi; Honda, Takafumi; Yasukawa, Kumi; Terai, Masaru] Tokyo Womens Med Univ Yachiyo, Med Ctr, Dept Pediat, Yachiyo, Japan; [Ebata, Ryota] Chiba Univ, Dept Pediat, Grad Sch Med, Chiba, Japan; [Higashi, Kouji] Chiba Childrens Hosp, Dept Cardiol, Chiba, Japan; [Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi] Toho Univ, Dept Pediat, Med Ctr, Omori Hosp, Tokyo, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch, Dept Pediat, Kurashiki, Okayama, Japan; [Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, Kurashiki, Okayama, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Dept Pediat, Koshigaya Hosp, Koshigaya, Japan; [Hamamoto, Kunihiro] Int Univ Hlth & Welf, Dept Occupat Therapy, Okawa, Japan; [Sato, Yoshitake] Fuji Heavy Ind Hlth Insurance Soc Ota Mem Hosp, Dept Pediat, Ota, Japan; [Honda, Akihito; Kobayashi, Hironobu] Asahi Gen Hosp, Dept Pediat, Asahi, Japan; [Sato, Junichi] Funabashi Municipal Med Ctr, Dept Pediat, Funabashi, Chiba, Japan; [Shibuta, Shoichi; Miyawaki, Masakazu] Kinan Hosp, Dept Pediat, Tanabe, Japan; [Oishi, Ko] Hashimoto Municipal Hosp, Dept Pediat, Hashimoto, Japan; [Yamaga, Hironobu] Naga Hosp, Dept Pediat, Kinokawa, Japan; [Aoyagi, Noriyuki] Wakayama Rosai Hosp, Dept Pediat, Wakayama, Japan; [Yoshiyama, Megumi] Hidaka Gen Hosp, Dept Pediat, Gobo, Japan; [Miyashita, Ritsuko] Izumiotsu Municipal Hosp, Dept Pediat, Izumiotsu, Japan; [Murata, Yuji] Sendai City Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Fujino, Akihiro] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo, Japan; [Kawasaki, Tomisaku] Japan Kawasaki Dis Res Ctr, Tokyo, Japan; [Abe, Jun] Natl Ctr Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Seki, Mitsuru; Arakawa, Hirokazu] Gunma Univ, Sch Med, Dept Pediat, Maebashi, Gunma 371, Japan; [Kobayashi, Tohru] Natl Ctr Child Hlth & Dev, Dept Dev Strategy, Ctr Clin Res & Dev, Tokyo, Japan; [Hata, Akira] Chiba Univ, Dept Publ Hlth, Grad Sch Med, Chiba, Japan; [Tanaka, Toshihiro] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Hara, Toshiro] Fukuoka Childrens Hosp, Fukuoka, Japan; [Hara, Toshiro] Med Ctr Infect Dis, Fukuoka, Japan	RIKEN; Nippon Medical School; Kyushu University; Wakayama Medical University; Chiba University; Chiba Children's Hospital; Toho University; Kawasaki Medical School; Kawasaki Medical School; Fujita Health University; Dokkyo Medical University; International University of Health & Welfare; Keio University; National Center for Child Health & Development - Japan; Gunma University; National Center for Child Health & Development - Japan; Chiba University; Tokyo Medical & Dental University (TMDU)	Onouchi, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan.	onouchy@chiba-u.jp	Ebata, Ryota/AAQ-5832-2021; Fujino, Akihiro/AAH-2243-2019; Sato, Yurie/B-2144-2014	Ebata, Ryota/0000-0001-8471-1042; Fujino, Akihiro/0000-0003-2987-5081; Ozaki, Kouichi/0000-0003-0028-1570	Millennium Project; Japan Kawasaki Disease Research Center; Ministry of Health, Labour and Welfare [0401040]; Japan Society for the Promotion of Science [25293139]; Grants-in-Aid for Scientific Research [26461624] Funding Source: KAKEN	Millennium Project; Japan Kawasaki Disease Research Center; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Millennium Project (http://www.kantei.go.jp/jp/mille/), Japan Kawasaki Disease Research Center (http://www.kawasaki-disease.org/) [2011 to YO], the Ministry of Health, Labour and Welfare [0401040 to A. Hata] and Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html) [25293139 to YO].	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burns JC, 2002, PEDIATR INFECT DIS J, V21, P993, DOI 10.1097/00006454-200211000-00002; Chang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029387; Chou YH, 2011, J UROLOGY, V185, P1742, DOI 10.1016/j.juro.2010.12.094; DAVIS RL, 1995, ARCH PEDIAT ADOL MED, V149, P66, DOI 10.1001/archpedi.1995.02170130068016; Deveci M, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-74, 10.1186/1471-2105-15-73]; Felix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061595; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FUJITA Y, 1989, PEDIATRICS, V84, P666; FURUSHO K, 1983, LANCET, V2, P1359; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Holman Robert C, 2010, Hawaii Med J, V69, P194; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T, 1967, Arerugi, V16, P178; Kuo HC, 2011, J CLIN IMMUNOL, V31, P650, DOI 10.1007/s10875-011-9524-8; LEUNG DYM, 1989, J ALLERGY CLIN IMMUN, V84, P588, DOI 10.1016/0091-6749(89)90195-4; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Sogkas G, 2015, EUR J IMMUNOL, V45, P2143, DOI 10.1002/eji.201445337; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Tolhurst G, 2008, PLATELETS, V19, P308, DOI 10.1080/09537100801935710; Uehara R, 2004, ARCH PEDIAT ADOL MED, V158, P1166, DOI 10.1001/archpedi.158.12.1166; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang JY, 2015, ONCOGENE, V34, P4358, DOI 10.1038/onc.2014.366; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wu WF, 2006, J BIOL CHEM, V281, P10682, DOI 10.1074/jbc.M511759200; Yen JH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/834831; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang H, 2014, BLOOD, V123, P2238, DOI 10.1182/blood-2012-08-450403; Zhang L, 2015, ASIAN J ANDROL, V17, P86, DOI 10.4103/1008-682X.138186; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	52	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145486	10.1371/journal.pone.0145486	http://dx.doi.org/10.1371/journal.pone.0145486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789410	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100010
J	Riess, K; Schon, ME; Lutz, M; Butin, H; Oberwinkler, F; Garnica, S				Riess, Kai; Schoen, Max E.; Lutz, Matthias; Butin, Heinz; Oberwinkler, Franz; Garnica, Sigisfredo			On the Evolutionary History of Uleiella chilensis, a Smut Fungus Parasite of Araucaria araucana in South America: Uleiellales ord. nov in Ustilaginomycetes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; NUCLEAR; MUSHROOMS; SEQUENCES; INFERENCE; RNA; SPECIATION; INOCYBE; SCALE; GENUS	The evolutionary history, divergence times and phylogenetic relationships of Uleiella chilensis (Ustilaginomycotina, smut fungi) associated with Araucaria araucana were analysed. DNA sequences from multiple gene regions and morphology were analysed and compared to other members of the Basidiomycota to determine the phylogenetic placement of smut fungi on gymnosperms. Divergence time estimates indicate that the majority of smut fungal orders diversified during the Triassic-Jurassic period. However, the origin and relationships of several orders remain uncertain. The most recent common ancestor between Uleiella chilensis and Violaceomyces palustris has been dated to the Lower Cretaceous. Comparisons of divergence time estimates between smut fungi and host plants lead to the hypothesis that the early Ustilaginomycotina had a saprobic lifestyle. As there are only two extant species of Araucaria in South America, each hosting a unique Uleiella species, we suggest that either coevolution or a host shift followed by allopatric speciation are the most likely explanations for the current geographic restriction of Uleiella and its low diversity. Phylogenetic and age estimation analyses, ecology, the unusual life-cycle and the peculiar combination of septal and haustorial characteristics support Uleiella chilensis as a distinct lineage among the Ustilaginomycotina. Here, we describe a new ustilaginomycetous order, the Uleiellales to accommodate Uleiella. Within the Ustilaginomycetes, Uleiellales are sister taxon to the Violaceomycetales.	[Riess, Kai; Schoen, Max E.; Lutz, Matthias; Oberwinkler, Franz; Garnica, Sigisfredo] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Garnica, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, Morgenstelle 5, D-72076 Tubingen, Germany.	sigisfredo.garnica@uni-tuebingen.de	Riess, Kai/B-5491-2015; Sigisfredo, Garnica/P-6506-2014	Riess, Kai/0000-0002-8804-0175; Schon, Max Emil/0000-0002-4453-4173; Lutz, Matthias/0000-0002-0938-1079	German Research Foundation (DFG) [BA 75/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG), grant BA 75/3-1.	Albu S, 2015, MYCOLOGIA, V107, P1193, DOI 10.3852/14-260; Amend A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004277; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Axsmith BJ, 2008, PALAEONTOL ELECTRON, V11; Bauer R, 2005, MYCOL RES, V109, P1250, DOI 10.1017/S0953756205003783; Bauer R, 1999, MYCOLOGIA, V91, P669, DOI 10.2307/3761254; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bauer R, 1999, MYCOLOGIA, V91, P475, DOI 10.2307/3761348; Bauer R, 2001, MYCOL RES, V105, P416, DOI 10.1017/S0953756201003690; Bauer R, 2001, MYCOTA, V7, P57; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Begerow D, 2000, MYCOL RES, V104, P53, DOI 10.1017/S0953756299001161; Begerow D, 2001, MYCOL RES, V105, P798, DOI 10.1017/S0953756201004208; Begerow D, 2014, THE MYCOTA A, P295, DOI DOI 10.1007/978-3-642-55318-9_11; Begerow D, 2006, MYCOLOGIA, V98, P906, DOI 10.3852/mycologia.98.6.906; Butin H.L., 1986, BIBLIOTHECA MYCOLOGI, V101, P1; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Garnica S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hopple JS, 1999, MOL PHYLOGENET EVOL, V13, P1, DOI 10.1006/mpev.1999.0634; INGOLD CT, 1987, T BRIT MYCOL SOC, V89, P471, DOI 10.1016/S0007-1536(87)80080-3; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kranitz ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110308; LePage BA, 1997, AM J BOT, V84, P410, DOI 10.2307/2446014; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; MILLER CN, 1977, BOT REV, V43, P217, DOI 10.1007/BF02860718; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; PIEPENBRING M, 1995, MYCOL RES, V99, P853, DOI 10.1016/S0953-7562(09)80741-7; Piepenbring M, 1998, PROTOPLASMA, V204, P155, DOI 10.1007/BF01280322; Rambaut A., 2014, TRACER V1 6; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Riess K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-102; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schroter J., 1894, HEDWIGIA BEIBL, V33, P64; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STOCKEY RA, 1982, REV PALAEOBOT PALYNO, V37, P133, DOI 10.1016/0034-6667(82)90041-0; STOCKEY RA, 1992, REV PALAEOBOT PALYNO, V72, P27, DOI 10.1016/0034-6667(92)90172-D; Subramanian AR, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-6; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Vanky K, 2001, FUNGAL DIVERS, V6, P131; Vanky K, 2002, ILLUSTRATED GENERA S; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang QM, 2015, STUD MYCOL, P55, DOI 10.1016/j.simyco.2015.10.004; Wang QM, 2014, PERSOONIA, V33, P41, DOI 10.3767/003158514X682313; Willis K. J., 2002, EVOLUTION PLANTS	56	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147107	10.1371/journal.pone.0147107	http://dx.doi.org/10.1371/journal.pone.0147107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790149	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100059
J	Verhoeven, H; Simons, D; Van Dyck, D; Van Cauwenberg, J; Clarys, P; De Bourdeaudhuij, I; de Geus, B; Vandelanotte, C; Deforche, B				Verhoeven, Hannah; Simons, Dorien; Van Dyck, Delfien; Van Cauwenberg, Jelle; Clarys, Peter; De Bourdeaudhuij, Ilse; de Geus, Bas; Vandelanotte, Corneel; Deforche, Benedicte			Psychosocial and Environmental Correlates of Walking, Cycling, Public Transport and Passive Transport to Various Destinations in Flemish Older Adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PATTERNS; ACTIVE SCHOOL TRANSPORT; YOUTH; BENEFITS; VALIDITY; QUESTIONNAIRE; ASSOCIATIONS; RELIABILITY; PREVALENCE; ADULTHOOD	Background Active transport is a convenient way to incorporate physical activity in adolescents' daily life. The present study aimed to investigate which psychosocial and environmental factors are associated with walking, cycling, public transport (train, tram, bus, metro) and passive transport (car, motorcycle, moped) over short distances (maximum eight kilometres) among older adolescents (17-18 years), to school and to other destinations. Methods 562 older adolescents completed an online questionnaire assessing socio-demographic variables, psychosocial variables, environmental variables and transport to school/other destinations. Zero-inflated negative binomial regression models were performed. Results More social modelling and a higher residential density were positively associated with walking to school and walking to other destinations, respectively. Regarding cycling, higher self-efficacy and a higher social norm were positively associated with cycling to school and to other destinations. Regarding public transport, a higher social norm, more social modelling of siblings and/or friends, more social support and a higher land use mix access were positively related to public transport to school and to other destinations, whereas a greater distance to school only related positively to public transport to school. Regarding passive transport, more social support and more perceived benefits were positively associated with passive transport to school and to other destinations. Perceiving less walking and cycling facilities at school was positively related to passive transport to school only, and more social modelling was positively related to passive transport to other destinations. Conclusions Overall, psychosocial variables seemed to be more important than environmental variables across the four transport modes. Social norm, social modelling and social support were the most consistent psychosocial factors which indicates that it is important to target both older adolescents and their social environment in interventions promoting active transport. Walking or cycling together with siblings or friends has the potential to increase social norm, social modelling and social support towards active transport.	[Verhoeven, Hannah; Simons, Dorien; Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, De Pintelaan 185, B-9000 Ghent, Belgium; [Verhoeven, Hannah; Simons, Dorien; Van Cauwenberg, Jelle; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Pleinlaan 2, B-1050 Brussels, Belgium; [Verhoeven, Hannah; Simons, Dorien; Van Dyck, Delfien; Van Cauwenberg, Jelle] Fund Sci Res Flanders FWO, Egmontstr 5, B-1000 Brussels, Belgium; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Watersportlaan 2, B-9000 Ghent, Belgium; [de Geus, Bas] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Physiol, Pleinlaan 2, B-1050 Brussels, Belgium; [Vandelanotte, Corneel] Cent Queensland Univ, Inst Hlth & Social Sci Res, Phys Act Res Grp, Bruce Highway, Rockhampton, Qld 4702, Australia	Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Central Queensland University	Verhoeven, H (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, De Pintelaan 185, B-9000 Ghent, Belgium.; Verhoeven, H (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Pleinlaan 2, B-1050 Brussels, Belgium.; Verhoeven, H (corresponding author), Fund Sci Res Flanders FWO, Egmontstr 5, B-1000 Brussels, Belgium.	hannah.verhoeven@ugent.be	de Geus, Bas/F-5335-2011; Van Dyck, Delfien/AAO-8981-2020; Vandelanotte, Corneel/ABF-5580-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	de Geus, Bas/0000-0001-7447-0230; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Dyck, Delfien/0000-0003-1783-9075; Van Cauwenberg, Jelle/0000-0003-1292-6241	Fund for Scientific Research Flanders (FWO) [GA11111N]; FWO [11U8114N, 11N0313N, FWO12/PDO/158]; Future Leader Fellowship from the National Heart Foundation of Australia [100427]	Fund for Scientific Research Flanders (FWO)(FWO); FWO(FWO); Future Leader Fellowship from the National Heart Foundation of Australia(National Heart Foundation of Australia)	Hannah Verhoeven is supported by Fund for Scientific Research Flanders (FWO, http://www.fwo.be/en) (GA11111N). Dorien Simons is supported by a FWO fellowship (11U8114N). Jelle Van Cauwenberg is supported by a FWO fellowship (11N0313N). Delfien Van Dyck is supported by a FWO post-doctoral research mandate (FWO12/PDO/158). Corneel Vandelanotte is supported by a Future Leader Fellowship from the National Heart Foundation of Australia (ID: 100427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, BELGIAN OFFICIAL J; Armstrong N, 2006, SPORTS MED, V36, P1067, DOI 10.2165/00007256-200636120-00005; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Babey SH, 2009, J PUBLIC HEALTH POL, V30, pS203, DOI 10.1057/jphp.2008.61; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Bere E, 2008, PREV MED, V47, P412, DOI 10.1016/j.ypmed.2008.06.019; Besser LM, 2005, AM J PREV MED, V29, P273, DOI 10.1016/j.amepre.2005.06.010; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Brown WJ, 2003, AM J PREV MED, V25, P140, DOI 10.1016/S0749-3797(03)00119-3; Bungum TJ, 2009, J COMMUN HEALTH, V34, P129, DOI 10.1007/s10900-008-9135-3; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalton MA, 2011, AM J PREV MED, V40, P312, DOI 10.1016/j.amepre.2010.11.008; de Geus B, 2008, HEALTH EDUC RES, V23, P697, DOI 10.1093/her/cym055; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Emond CR, 2012, J TRANSP GEOGR, V20, P71, DOI 10.1016/j.jtrangeo.2011.07.008; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Frank L, 2007, AM J HEALTH PROMOT, V21, P305, DOI 10.4278/0890-1171-21.4s.305; Ghekiere A, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0216-2; Ghekiere A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106696; Gordon-Larsen P, 2005, OBES RES, V13, P868, DOI 10.1038/oby.2005.100; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jones A, 2012, HEALTH PLACE, V18, P605, DOI 10.1016/j.healthplace.2012.01.003; Jones L, 2012, CONTEMP CLIN TRIALS, V33, P268, DOI 10.1016/j.cct.2011.10.011; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Klacicner CA., 2004, 4 INT C TRAFF TRANSP; Moudon AV, 2005, TRANSPORT RES D-TR E, V10, P245, DOI 10.1016/j.trd.2005.04.001; Nelson NM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-1; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Owen CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030932; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Robertson-Wilson JE, 2008, J ADOLESCENT HEALTH, V42, P486, DOI 10.1016/j.jadohealth.2007.10.006; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2002, SCORING PROCEDURES P; Sallis JF, 2008, ECOLOGICAL MODELS HL; Shaw C., 2011, GUIDELINES RES CHILD; Simons D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-323; Spittaels H., 2014, MANUAL ALPHA ENV QUE; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Van Dyck D, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-87; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; WHO, 2015, GLOB STRAT DIET PHYS, P3; Wong BYM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-618	49	46	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147128	10.1371/journal.pone.0147128	http://dx.doi.org/10.1371/journal.pone.0147128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784933	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400114
J	Zhou, JY; Jiang, N; Wang, SG; Hu, XP; Jiao, KL; He, XY; Li, ZQ; Wang, JZ				Zhou, Jianye; Jiang, Nan; Wang, Shaoguo; Hu, Xiaopan; Jiao, Kangli; He, Xiangyi; Li, Zhiqiang; Wang, Jizeng			Exploration of Human Salivary Microbiomes-Insights into the Novel Characteristics of Microbial Community Structure in Caries and Caries-Free Subjects	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; ORAL MICROBIOTA; PYROSEQUENCING ANALYSIS; DENTAL-CARIES; DIVERSITY; CHILDREN; BIOFILMS; BACTERIA; GALAXY	Recently, high-throughput sequencing has improved the understanding of the microbiological etiology of caries, but the characteristics of the microbial community structure in the human oral cavity with and without caries are not completely clear. To better understand these characteristics, Illumina MiSeq high-throughput sequencing was utilized to analyze 20 salivary samples (10 caries-free and 10 caries) from subjects from the same town in Dongxiang, Gansu, China. A total of 5,113 OTUs (Operational Taxonomic Units, 97% cutoff) were characterized in all of the salivary samples obtained from the 20 subjects. A comparison of the two groups revealed that (i) the predominant phyla were constant between the two groups; (ii) the relative abundance of the genera Veillonella, Bifidobacterium, Selenomonas, Olsenella, Parascardovia, Scardovia, Chryseobacterium, Terrimonas, Burkholderia and Sporobacter was significantly higher in the group with caries (P < 0.05); and (iii) four genera with low relative abundance (< 0.01% on average), including two characteristic genera in caries (Chryseobacterium and Scardovia), significantly influenced the microbial community structure at the genus and OTU levels. Moreover, via co-occurrence and principal component analyses, the co-prevalence of the pathogenic genera was detected in the caries samples, but in the caries-free samples, the function of clustered genera was more random. This result suggests that a synergistic effect may be influencing the assembly of the caries microbial community, whereas competition may play a more dominant role in governing the microbial community in the caries-free group. Our findings regarding the characteristics of the microbial communities of the groups with and without caries might improve the understanding of the microbiological etiology of caries and might improve the prevention and cure of caries in the future.	[Zhou, Jianye; Wang, Jizeng] Lanzhou Univ, Coll Civil Engn & Mech, Lanzhou 730000, Gansu, Peoples R China; [Jiang, Nan] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning, Peoples R China; [Wang, Shaoguo; He, Xiangyi] Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Gansu, Peoples R China; [Hu, Xiaopan; Jiao, Kangli; Li, Zhiqiang] Northwest Univ Nationalities, Sch Stomatol, Key Lab Oral Dis Gansu Prov, Lanzhou 730030, Gansu, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Lanzhou University; Northwest Minzu University	Wang, JZ (corresponding author), Lanzhou Univ, Coll Civil Engn & Mech, Lanzhou 730000, Gansu, Peoples R China.; Li, ZQ (corresponding author), Northwest Univ Nationalities, Sch Stomatol, Key Lab Oral Dis Gansu Prov, Lanzhou 730030, Gansu, Peoples R China.	xbmuzjy@163.com; jzwang@lzu.edu.cn	; Wang, Jizeng/A-2706-2008	He, Xiangyi/0000-0002-5687-0991; Wang, Jizeng/0000-0002-8383-5868	National Natural Science Fund [31160124/C0309, 31360124/C0309]; Special International Technology Cooperation of Gansu Province [144WCGA167]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Special International Technology Cooperation of Gansu Province	This work was supported by National Natural Science Fund (http://www.nsfc.gov.cn/): NO. 31160124/C0309 and NO. 31360124/C0309 for study design, data collection and analysis; and by Special International Technology Cooperation of Gansu Province (http://www.gsstc.gov.cn/): NO. 144WCGA167 for preparation of the manuscript. All the fundings were received by ZL.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Alcaraz LD, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2012.03857.x; Arif N, 2008, J DENT RES, V87, P278, DOI 10.1177/154405910808700308; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; Benitez-Paez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057782; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117064; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; DELWICHE EA, 1985, ANNU REV MICROBIOL, V39, P175, DOI 10.1146/annurev.mi.39.100185.001135; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Doungudomdacha S, 2001, J CLIN PERIODONTOL, V28, P437, DOI 10.1034/j.1600-051x.2001.028005437.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fontana Margherita, 2010, Dent Clin North Am, V54, P423, DOI 10.1016/j.cden.2010.03.007; Giannobile W V, 2011, Adv Dent Res, V23, P375, DOI 10.1177/0022034511420434; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; He JZ, 2015, FOLIA MICROBIOL, V60, P69, DOI 10.1007/s12223-014-0342-2; Jagathrakshakan Sri Nisha, 2015, Eur J Dent, V9, P127, DOI 10.4103/1305-7456.149661; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Kianoush N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092940; Kidd E, 2011, J DENT, V39, pS3, DOI 10.1016/j.jdent.2011.11.004; Lakhtin M, 2010, PROBIOTICS ANTIMICRO, V2, P186, DOI 10.1007/s12602-010-9046-3; Liu Y, 2009, CURR MICROBIOL, V58, P449, DOI 10.1007/s00284-008-9341-3; Ma C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122075; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsh P D, 1994, Adv Dent Res, V8, P263; Mashima I, 2014, ANAEROBE, V28, P54, DOI 10.1016/j.anaerobe.2014.05.003; McCune, 2002, MJM SOFTWARE DESIGN, V289, P448; Mielke PW, 2010, SANKHYA, V3, P350; Oksanen J, 2013, MULTIVARIATE ANAL EC; Otten Timothy G, 2015, Curr Environ Health Rep, V2, P75, DOI 10.1007/s40572-014-0041-9; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; SCHOENER TW, 1992, CC/AGR BIOL ENVIRON, P10; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Seow WK, 2012, INT J PAEDIATR DENT, V22, P157, DOI 10.1111/j.1365-263X.2011.01186.x; Simon-Soro A, 2013, CARIES RES, V47, P591, DOI 10.1159/000351663; Simon-Soro A, 2015, TRENDS MICROBIOL, V23, P76, DOI 10.1016/j.tim.2014.10.010; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Thurnheer T, 2016, MOL ORAL MICROBIOL, V31, P125, DOI 10.1111/omi.12108; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wickham H, 2015, PACKAGE GGPLOT2; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Yip KHK, 2012, J BIOMED RES, V26, P1, DOI 10.1016/S1674-8301(12)60001-3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang J., 2015, PACKAGE SPAA	61	27	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147039	10.1371/journal.pone.0147039	http://dx.doi.org/10.1371/journal.pone.0147039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784334	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400099
J	Bienertova-Vasku, J; Zlamal, F; Necesanek, I; Konecny, D; Vasku, A				Bienertova-Vasku, Julie; Zlamal, Filip; Necesanek, Ivo; Konecny, David; Vasku, Anna			Calculating Stress: From Entropy to a Thermodynamic Concept of Health and Disease	PLOS ONE			English	Article							PRINCIPLE	To date, contemporary science has lacked a satisfactory tool for the objective expression of stress. This text thus introduces a new-thermodynamically derived-approach to stress measurement, based on entropy production in time and independent of the quality or modality of a given stressor or a combination thereof. Hereto, we propose a novel model of stress response based on thermodynamic modelling of entropy production, both in the tissues/organs and in regulatory feedbacks. Stress response is expressed in our model on the basis of stress entropic load (SEL), a variable we introduced previously; the mathematical expression of SEL, provided here for the first time, now allows us to describe the various states of a living system, including differentiating between states of health and disease. The resulting calculation of stress response regardless of the type of stressor(s) in question is thus poised to become an entirely new tool for predicting the development of a living system.	[Bienertova-Vasku, Julie; Zlamal, Filip; Necesanek, Ivo; Konecny, David; Vasku, Anna] Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5 A18, Brno 62500, Czech Republic	Masaryk University Brno	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5 A18, Brno 62500, Czech Republic.	jbienert@med.muni.cz	Bienertova-Vasku, Julie/G-9763-2017; Vasku, Julie Bienertova/AAV-6821-2020	Bienertova-Vasku, Julie/0000-0001-5327-808X; Vasku, Julie Bienertova/0000-0001-5327-808X				Andersen M, 2013, MATH BIOSCI, V246, P122, DOI 10.1016/j.mbs.2013.08.010; Annamalai K, 2012, ENTROPY-SWITZ, V14, P2550, DOI 10.3390/e14122550; AOKI I, 1991, J THEOR BIOL, V150, P215, DOI 10.1016/S0022-5193(05)80333-9; AOKI I, 1990, J THEOR BIOL, V145, P421, DOI 10.1016/S0022-5193(05)80120-1; AOKI I, 1989, J THEOR BIOL, V141, P11, DOI 10.1016/S0022-5193(89)80004-9; Boonen E, 2014, AM J PHYSIOL-ENDOC M, V306, pE883, DOI 10.1152/ajpendo.00009.2014; Boregowda S.C, 2012, INT SCH RES NOT, V2012, P1, DOI 10.5402/2012/830103; Demetrius LA, 2014, ENTROPY-SWITZ, V16, P5428, DOI 10.3390/e16105428; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Goldstein DS, 2013, COMPR PHYSIOL, V3, P1569, DOI 10.1002/cphy.c130006; Ikegami T, 2008, BIOSYSTEMS, V91, P388, DOI 10.1016/j.biosystems.2007.05.014; Latora V, 1999, PHYS REV LETT, V82, P520, DOI 10.1103/PhysRevLett.82.520; Manke T, 2006, J R SOC INTERFACE, V3, P843, DOI 10.1098/rsif.2006.0140; MASON JW, 1971, J PSYCHIAT RES, V8, P323, DOI 10.1016/0022-3956(71)90028-8; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Rahman MA, 2007, THERM SCI, V11, P75, DOI 10.2298/TSCI0701075R; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Silva C., 2009, J THERMODYN, P1, DOI [10.1155/2009/186723, DOI 10.1155/2009/186723]; Sterling P, HDB LIFE STRESS COGN; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802	21	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146667	10.1371/journal.pone.0146667	http://dx.doi.org/10.1371/journal.pone.0146667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771542	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300028
J	da Silva, SG; de Almeida, AA; Fernandes, J; Lopim, GM; Cabral, FR; Scerni, DA; de Oliveira-Pinto, AV; Lent, R; Arida, RM				da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Fernandes, Jansen; Lopim, Glauber Menezes; Cabral, Francisco Romero; Scerni, Debora Amado; de Oliveira-Pinto, Ana Virginia; Lent, Roberto; Arida, Ricardo Mario			Maternal Exercise during Pregnancy Increases BDNF Levels and Cell Numbers in the Hippocampal Formation but Not in the Cerebral Cortex of Adult Rat Offspring	PLOS ONE			English	Article							SHORT-TERM-MEMORY; BRAIN-DEVELOPMENT; WATER-MAZE; PUPS; EXPRESSION; NEUROGENESIS; ANXIETY; VEGF	Clinical evidence has shown that physical exercise during pregnancy may alter brain development and improve cognitive function of offspring. However, the mechanisms through which maternal exercise might promote such effects are not well understood. The present study examined levels of brain-derived neurotrophic factor (BDNF) and absolute cell numbers in the hippocampal formation and cerebral cortex of rat pups born from mothers exercised during pregnancy. Additionally, we evaluated the cognitive abilities of adult offspring in different behavioral paradigms (exploratory activity and habituation in open field tests, spatial memory in a water maze test, and aversive memory in a step-down inhibitory avoidance task). Results showed that maternal exercise during pregnancy increased BDNF levels and absolute numbers of neuronal and non-neuronal cells in the hippocampal formation of offspring. No differences in BDNF levels or cell numbers were detected in the cerebral cortex. It was also observed that offspring from exercised mothers exhibited better cognitive performance in nonassociative (habituation) and associative (spatial learning) mnemonic tasks than did offspring from sedentary mothers. Our findings indicate that maternal exercise during pregnancy enhances offspring cognitive function (habituation behavior and spatial learning) and increases BDNF levels and cell numbers in the hippocampal formation of offspring.	[da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Fernandes, Jansen; Lopim, Glauber Menezes; Arida, Ricardo Mario] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil; [da Silva, Sergio Gomes; Cabral, Francisco Romero] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [da Silva, Sergio Gomes] Univ Mogi das Cruzes, Mogi das Cruzes, SP, Brazil; [Scerni, Debora Amado] Univ Fed Sao Paulo UNIFESP, Disciplina Neurol Expt, Sao Paulo, SP, Brazil; [de Oliveira-Pinto, Ana Virginia; Lent, Roberto] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, RJ, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	da Silva, SG; Arida, RM (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil.; da Silva, SG (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.; da Silva, SG (corresponding author), Univ Mogi das Cruzes, Mogi das Cruzes, SP, Brazil.	sgomesilva@hotmail.com; arida.nexp@epm.br	Arida, Ricardo M/E-2667-2013; Arida, Ricardo Mario/P-7408-2016; Fernandes, Jansen/D-1814-2017; da Silva, Sérgio Gomes/F-1847-2013; de Almeida, Alexandre Aparecido/AAB-8101-2020; Lopim, Glauber/W-3166-2019	Arida, Ricardo M/0000-0002-0908-3274; Arida, Ricardo Mario/0000-0002-7771-6133; Fernandes, Jansen/0000-0002-6177-5884; da Silva, Sérgio Gomes/0000-0002-9650-809X; de Almeida, Alexandre Aparecido/0000-0002-9045-7826; Lopim, Glauber/0000-0002-9291-981X; Cabral, Francisco Romero/0000-0003-2582-6960	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/06953-4, 10/11353-3]; Instituto Nacional de Neurociencia Translacional (INNT, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Neurociencia Translacional (INNT, Brazil)	Research supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Processes 09/06953-4 and 10/11353-3), and Instituto Nacional de Neurociencia Translacional (INNT, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JL, 2013, INT J DEV NEUROSCI, V31, P382, DOI 10.1016/j.ijdevneu.2012.11.002; Akhavan MM, 2008, NEUROSCIENCE, V151, P1173, DOI 10.1016/j.neuroscience.2007.10.051; Akhavan MM, 2013, IRAN J BASIC MED SCI, V16, P955; Aksu I, 2012, NEUROSCI LETT, V516, P221, DOI 10.1016/j.neulet.2012.03.091; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bick-Sander A, 2006, P NATL ACAD SCI USA, V103, P3852, DOI 10.1073/pnas.0502644103; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; CRUZMORALES SE, 1992, BEHAV NEURAL BIOL, V57, P256, DOI 10.1016/0163-1047(92)90248-3; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; da Silva SG, 2015, EXPERT REV NEUROTHER, V15, P1041, DOI 10.1586/14737175.2015.1077115; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herring A, 2012, FASEB J, V26, P117, DOI 10.1096/fj.11-193193; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Parnpiansil P, 2003, NEUROSCI LETT, V352, P45, DOI 10.1016/j.neulet.2003.08.023; Robinson AM, 2014, NEUROSCIENCE, V256, P53, DOI 10.1016/j.neuroscience.2013.10.012; Stafstrom CE, 2002, PROG BRAIN RES, V135, P377; Uysal N, 2011, NEUROSCI LETT, V505, P273, DOI 10.1016/j.neulet.2011.10.039; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P661, DOI [10.1139/H06-060, 10.1139/h06-060]; Wolfe L A, 1994, Exerc Sport Sci Rev, V22, P145	25	53	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147200	10.1371/journal.pone.0147200	http://dx.doi.org/10.1371/journal.pone.0147200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771675	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300071
J	Gierthmuehlen, M; Stieglitz, T; Zentner, J; Plachta, DTT				Gierthmuehlen, Mortimer; Stieglitz, Thomas; Zentner, Josef; Plachta, Dennis T. T.			Haemodynamic Responses to Selective Vagal Nerve Stimulation under Enalapril Medication in Rats	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; RESISTANT HYPERTENSION; BLOOD-PRESSURE; HEART-FAILURE; DIABETIC-RATS; BAROREFLEX; ACTIVATION; THERAPY; CAPTOPRIL; SYSTEM	Selective vagal nerve stimulation (sVNS) has been demonstrated to lower blood pressure (BP) in rats without causing major side effects. This method might be adapted for the treatment of therapy-resistant hypertension in patients. Converting enzyme inhibitors (CEIs) are among the first drugs that are administered for arterial hypertension and prominently reduce BP primarily by interacting with the renin-angiotensin system of the kidneys. Beyond the reduction of BP, CEI have a positive effect on the survival rate after myocardial infarction; they reduce the rates of stroke and improve the neurohormonal status in heart-failure patients. If sVNS might be introduced as a therapy against resistant hypertension, patients will at least partially stay on their CEI medication. It is therefore the aim of this study to investigate the influence of the CEI enalapril on the haemodynamic and respiratory effects of sVNS. In 10 male Wistar rats, a polyimide-based multichannel-cuff-electrode was placed around the vagal nerve bundle to selectively stimulate the aortic depressor nerve fibres. Stimulation parameters were adapted to the thresholds of the individual animals and included repetition frequencies between 30 and 50 Hz, amplitudes of 0.5 to 1.5 mA and pulse widths between 0.4 ms and 1.0 ms. BP responses were detected with a microtip transducer in the left carotid artery, and electrocardiography was recorded with subcutaneous electrodes. After intravenous administration of enalapril (2 mg/kg bodyweight), the animals' mean arterial blood pressures (MAPs) decreased significantly, while the heart rates (HRs) were not significantly influenced. The effects of sVNS on BP and HR were attenuated by enalapril but were still present. We conclude that sVNS can lower the MAP during enalapril treatment without relevant side effects.	[Gierthmuehlen, Mortimer; Zentner, Josef; Plachta, Dennis T. T.] Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany; [Stieglitz, Thomas; Plachta, Dennis T. T.] Univ Freiburg, Dept Microsyst Engn IMTEK, Lab Biomed Microtechnol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Gierthmuehlen, M (corresponding author), Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany.	mortimer.gierthmuehlen@uniklinik-freiburg.de	Stieglitz, Thomas/C-7916-2013	Stieglitz, Thomas/0000-0002-7349-4254; Gierthmuehlen, Mortimer/0000-0001-8575-6445	B. Braun Melsungen Foundation; Deutsche Gesellschaft fuer Neurochirurgie - Stiftung Neurochirurgische Forschung	B. Braun Melsungen Foundation; Deutsche Gesellschaft fuer Neurochirurgie - Stiftung Neurochirurgische Forschung	This work was supported by the B. Braun Melsungen Foundation (http://www.bbraun-stiftung.de/, to MG, DP) and Deutsche Gesellschaft fuer Neurochirurgie - Stiftung Neurochirurgische Forschung (www.dgnc.de, to MG, DP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akselrod S., 1985, AM J PHYSIOL, V249, pH867; Augustyniak RA, 2007, AM J PHYSIOL-REG I, V293, pR2260, DOI 10.1152/ajpregu.00509.2007; BILGUTAY AM, 1965, J AMER MED ASSOC, V191, P649, DOI 10.1001/jama.1965.03080080039010; BILGUTAY AM, 1966, AM J CARDIOL, V17, P663, DOI 10.1016/0002-9149(66)90404-8; Birincioglu M, 1997, FREE RADICAL RES, V27, P389, DOI 10.3109/10715769709065778; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Bloch MJ, 2012, J CLIN HYPERTENS, V14, P184, DOI 10.1111/j.1751-7176.2011.00584.x; GRICHOIS ML, 1992, J CARDIOVASC PHARM, V19, P863, DOI 10.1097/00005344-199206000-00004; Heesch CM, 1996, AM J PHYSIOL-REG I, V270, pR728, DOI 10.1152/ajpregu.1996.270.4.R728; Kaplan NM, 2005, J HYPERTENS, V23, P1441, DOI 10.1097/01.hjh.0000174968.72212.ac; Maliszewska-Scislo M, 2003, AM J PHYSIOL-HEART C, V284, pH1601, DOI 10.1152/ajpheart.00578.2002; McMullan S, 2009, RESP PHYSIOL NEUROBI, V166, P80, DOI 10.1016/j.resp.2009.02.006; NEISTADT A, 1967, SURGERY, V61, P923; NELISSENVRANCKEN HJMG, 1992, J CARDIOVASC PHARM, V19, P163, DOI 10.1097/00005344-199202000-00002; Plachta DTT, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036011; Plachta DTT, 2012, IEEE ENG MED BIO, P3416, DOI 10.1109/EMBC.2012.6346699; Ramani R, 2008, J NEUROSURG ANESTH, V20, P29, DOI 10.1097/ANA.0b013e31815b7df1; Shearer F, 2013, CLIN PHARMACOL THER, V94, P459, DOI 10.1038/clpt.2013.135; Stieglitz T, 2000, BIOMED MICRODEVICES, V2, P283, DOI 10.1023/A:1009955222114; TAKEDA K, 1987, CLIN EXP HYPERTENS A, V9, P329, DOI 10.3109/10641968709164192; TAKEDA K, 1986, JPN HEART J, V27, P511; Waynforth H., 1992, EXPT SURG TECHNIQUE; Zariffa J, 2009, IEEE T NEUR SYS REH, V17, P420, DOI 10.1109/TNSRE.2009.2023301; Zhang WG, 2001, LIFE SCI, V68, P2769, DOI 10.1016/S0024-3205(01)01078-5	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147045	10.1371/journal.pone.0147045	http://dx.doi.org/10.1371/journal.pone.0147045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766419	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300060
J	Backlund, S; Jonsson, M; Strengbom, J; Frisch, A; Thor, G				Backlund, Sofia; Jonsson, Mari; Strengbom, Joachim; Frisch, Andreas; Thor, Goran			A Pine Is a Pine and a Spruce - Is a Spruce The Effect of Tree Species and Stand Age on Epiphytic Lichen Communities	PLOS ONE			English	Article							PICEA-ABIES; FOREST LANDSCAPES; LODGEPOLE PINE; OLD-GROWTH; DIVERSITY; PLANTATIONS; BIODIVERSITY; VEGETATION; PATTERNS; SOUTHERN	With an increasing demand for forest-based products, there is a growing interest in introducing fast-growing non-native tree species in forest management. Such introductions often have unknown consequences for native forest biodiversity. In this study, we examine epiphytic lichen species richness and species composition on the trunks of non-native Pinus contorta and compare these to the native Pinus sylvestris and Picea abies in managed boreal forests in northern Sweden across a chronosequence of age classes. Overall, we recorded a total of 66,209 lichen occurrences belonging to 57 species in the 96 studied forest stands. We found no difference in species richness of lichens between stands of P. contorta and P. sylvestris, but stands of P. abies had higher total species richness. However, species richness of lichens in stands of P. abies decreased with increasing stand age, while no such age effect was detected for P. contorta and P. sylvestris. Lichen species composition progressively diverged with increasing stand age, and in 30-year-old stands all three tree species showed species-specific assemblages. Epiphytic lichen assemblages in stands of 30-year-old P. contorta were influenced by greater basal area, canopy closure, and average diameter at breast height, P. abies stands by higher branch density and canopy closure, and stands of P. sylvestris by greater bark crevice depth. Differences in lichen species richness and composition were mainly explained by canopy closure and habitat availability, and the greater canopy closure in mature P. abies stands promoted the colonization and growth of calicioid lichen species. Our results indicate that the non-native P. contorta have similar species richness as the native P. sylvestris. The main difference in lichen species richness and composition is between P. abies and Pinus spp. in managed forests of boreal Sweden.	[Backlund, Sofia; Strengbom, Joachim; Frisch, Andreas; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, POB 7044, SE-75007 Uppsala, Sweden; [Jonsson, Mari] Swedish Species Informat Ctr, POB 7007, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Backlund, S (corresponding author), Swedish Univ Agr Sci, Dept Ecol, POB 7044, SE-75007 Uppsala, Sweden.	sofia.backlund@slu.se	Strengbom, Joachim/AAE-7645-2022	Strengbom, Joachim/0000-0002-1720-5016	"Stiftelsen Oscar och Lili Lamms minne" [D02008-0003]; "The Royal Swedish Academy of Sciences" [FOA10H-155]	"Stiftelsen Oscar och Lili Lamms minne"; "The Royal Swedish Academy of Sciences"	The work was mainly funded by "Stiftelsen Oscar och Lili Lamms minne", grant number D02008-0003 (http://www.stiftelsenlamm.a.se/). Additional funding for field work was provided by "The Royal Swedish Academy of Sciences", grant number FOA10H-155 (http://www.kva.se/sv/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Carrillo-Gavilan MA, 2010, DIVERS DISTRIB, V16, P203, DOI 10.1111/j.1472-4642.2010.00648.x; ArtDatabanken, 2015, RODL ART SVER 2015, P83; Backlund S, 2015, SILVA FENN, V49; Barton K., 2011, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2010, MODEL SELECTION MULT; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V291, P386, DOI 10.1016/j.foreco.2012.11.023; Caruso A, 2007, SCAND J FOREST RES, V22, P219, DOI 10.1080/02827580701346031; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Dettki H, 1998, ECOGRAPHY, V21, P613, DOI 10.1111/j.1600-0587.1998.tb00554.x; Dodet M, 2012, BIOL INVASIONS, V14, P1765, DOI 10.1007/s10530-012-0202-4; Elfving B, 2001, FOREST ECOL MANAG, V141, P15, DOI 10.1016/S0378-1127(00)00485-0; Ellis CJ, 2012, PERSPECT PLANT ECOL, V14, P131, DOI 10.1016/j.ppees.2011.10.001; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Eversman S, 2002, BRYOLOGIST, V105, P27, DOI 10.1639/0007-2745(2002)105[0027:POLDIY]2.0.CO;2; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Food and Agriculture Organization of the United Nations, 2011, STAT WORLDS FOR 2011; Gauslaa Y, 2007, CAN J FOREST RES, V37, P1832, DOI 10.1139/X07-048; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Hauck M, 2011, FLORA, V206, P81, DOI 10.1016/j.flora.2010.02.001; Hilmo O, 2009, LICHENOLOGIST, V41, P97, DOI 10.1017/S0024282909007865; HYVARINEN M, 1992, LICHENOLOGIST, V24, P165; Jansson U., 2011, AGR FORESTRY SWEDEN; Johansson P, 2007, ECOSCIENCE, V14, P81, DOI 10.2980/1195-6860(2007)14[81:TARWEL]2.0.CO;2; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Kuusinen M, 1998, J VEG SCI, V9, P283, DOI 10.2307/3237127; Ledgard N. J., 2008, New Zealand Plant Protection, V61, P98; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Lohmus A, 2011, SILVA FENN, V45, P1015, DOI 10.14214/sf.84; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; Marmor L, 2012, ANN BOT FENN, V49, P352, DOI 10.5735/085.049.0606; McCune B, 2000, BRYOLOGIST, V103, P417, DOI 10.1639/0007-2745(2000)103[0417:EHIAOC]2.0.CO;2; Nabuurs GJ, 2007, EUR J FOREST RES, V126, P391, DOI 10.1007/s10342-006-0158-y; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Nascimbene J, 2009, CAN J FOREST RES, V39, P785, DOI 10.1139/X09-013; Nilsson C, 2008, FOREST ECOL MANAG, V255, P1900, DOI 10.1016/j.foreco.2007.12.012; Odor P, 2013, FOREST ECOL MANAG, V306, P256, DOI 10.1016/j.foreco.2013.07.001; Official statistics of Sweden, 2014, OFF STAT SWED FOR ST; Palsson L, 1998, VEGETATIONSTYPER NOR; Peck J. E., 2010, MULTIVARIATE ANAL CO; Quine CP, 2010, BIODIVERS CONSERV, V19, P1503, DOI 10.1007/s10531-009-9771-7; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roberge JM, 2014, FOREST ECOL MANAG, V318, P239, DOI 10.1016/j.foreco.2014.01.026; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Sanderson LA, 2012, FORESTRY, V85, P329, DOI 10.1093/forestry/cps033; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3, P94; Strengbom J, 2011, FORESTS, V2, P610, DOI 10.3390/f2030610; Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067; Uliczka H, 1999, ECOGRAPHY, V22, P396, DOI 10.1111/j.1600-0587.1999.tb00576.x; [No title captured]	63	21	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147004	10.1371/journal.pone.0147004	http://dx.doi.org/10.1371/journal.pone.0147004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799558	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300052
J	Hu, J; Leng, X; Hu, YJ; Atik, A; Song, X; Li, ZX; Liu, YH; Lu, L				Hu, Jie; Leng, Xuan; Hu, Yijun; Atik, Alp; Song, Xin; Li, Zhixi; Liu, Yuhua; Lu, Lin			The Features of Inflammation Factors Concentrations in Aqueous Humor of Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE INJECTION; COMBINED PHOTODYNAMIC THERAPY; EPITHELIUM-DERIVED FACTOR; TUMOR-NECROSIS-FACTOR; MACULAR DEGENERATION; NEOVASCULARIZATION SECONDARY; PATHOLOGICAL MYOPIA; RISK-FACTORS; MEMBRANES	Purpose To investigate the cytokine concentrations in the aqueous humor of patients with refractory polypoidal choroidal vasculopathy (PCV). Methods Three separate groups of patients were studied refractory PCV (Group A, 41 eyes), stable PCV (Group B, 39 eyes) and senile cataract (Group C, 44 eyes). Aqueous humor samples were collected at two time points for Groups A and B before the first intravitreal ranibizumab injection and before the last injection. Aqueous humor samples were collected prior to phacoemulsification in Group C. The cytokine concentrations of interleukin 2, 6, and 8 (IL-2, IL-6, and IL-8), tumor necrosis factor a (TNF-a), monocyte chemotactic protein 1 (MCP-1), and vascular endothelial growth factor (VEGF) were measured by cytometric bead array and flow cytometry. Results Before the first treatment, the MCP-1, VEGF, and TNF-a levels in Group A were significantly higher than those in Group C (P < 0.05), and the MCP-1 and VEGF levels in Group A were significantly higher than those in Group B (P < 0.05). Significantly higher MCP-1 and VEGF levels were seen in Group B compared to Group C (P < 0.05). Before the final treatment, the MCP-1, VEGF, and TNF-a concentrations in Group A were significantly higher than those in Group B (P < 0.05) and Group C (P < 0.05). IL-2 levels were significantly lower in Group A compared to Group B (P < 0.05) and Group C (P < 0.05). Conclusion Inflammatory cytokines such as MCP-1, VEGF, and TNF-alpha may be associated with the pathogenesis of both stable and refractory PCV.	[Hu, Jie; Leng, Xuan; Hu, Yijun; Song, Xin; Li, Zhixi; Liu, Yuhua; Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Atik, Alp] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	Sun Yat Sen University; Royal Victorian Eye & Ear Hospital	Hu, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	hehujie@126.com	Hu, Yijun/J-4044-2016	Hu, Yijun/0000-0002-6424-7905	National Natural Science Foundation of China [81271009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81271009), JH. JH conceived and designed the experiments for this manuscript.	Agawa T, 2014, RETINA-J RET VIT DIS, V34, P1811, DOI 10.1097/IAE.0000000000000157; Ahn JK, 2009, AM J OPHTHALMOL, V148, P718, DOI 10.1016/j.ajo.2009.06.012; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chan WM, 2007, BRIT J OPHTHALMOL, V91, P174, DOI 10.1136/bjo.2006.103606; Chen SJ, 2008, INVEST OPHTH VIS SCI, V49, P3126, DOI 10.1167/iovs.08-1803; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fruebis J, 1997, ARTERIOSCL THROM VAS, V17, P1289, DOI 10.1161/01.ATV.17.7.1289; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Kuroiwa S, 2004, CLIN EXP OPHTHALMOL, V32, P297, DOI 10.1111/j.1442-9071.2004.00827.x; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee MY, 2013, AM J OPHTHALMOL, V156, P343, DOI 10.1016/j.ajo.2013.04.001; Lin JT, 2014, CURR PHARM DESIGN, V20, P4580, DOI 10.2174/1381612820666140522115801; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Miao H, 2012, MOL VIS, V18, P574; Montero JA, 2007, BRIT J OPHTHALMOL, V91, P131, DOI 10.1136/bjo.2006.106526; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Sakurada Y, 2015, OPHTHALMIC RES, V53, P2, DOI 10.1159/000365487; Sasaki S, 2012, INVEST OPHTH VIS SCI, V53, P3424, DOI 10.1167/iovs.11-7913; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Tatar O, 2007, RETINA-J RET VIT DIS, V27, P713, DOI 10.1097/IAE.0b013e318042d3b0; Tong JP, 2006, AM J OPHTHALMOL, V141, P456, DOI 10.1016/j.ajo.2005.10.012; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005	28	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147346	10.1371/journal.pone.0147346	http://dx.doi.org/10.1371/journal.pone.0147346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799405	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300098
J	Campbell, C; Andersen, L; Mutsikiwa, A; Madanhire, C; Nyamukapa, C; Gregson, S				Campbell, Catherine; Andersen, Louise; Mutsikiwa, Alice; Madanhire, Claudius; Nyamukapa, Constance; Gregson, Simon			Can Schools Support HIV/AIDS-Affected Children? Exploring the 'Ethic of Care' amongst Rural Zimbabwean Teachers	PLOS ONE			English	Article							VULNERABLE CHILDREN; ORPHANS; CONTEXT; STIGMA; HEALTH; HIV	How realistic is the international policy emphasis on schools 'substituting for families' of HIV/AIDS-affected children? We explore the ethic of care in Zimbabwean schools to highlight the poor fit between the western caring schools literature and daily realities of schools in different material and cultural contexts. Interviews and focus groups were conducted with 44 teachers and 55 community members, analysed in light of a companion study of HIV/AIDS-affected pupils' own accounts of their care-related experiences. We conceptualise schools as spaces of engagement between groups with diverse needs and interests (teachers, pupils and surrounding community members), with attention to the pathways through which extreme adversity impacts on those institutional contexts and social identifications central to giving and receiving care. Whilst teachers were aware of how they might support children, they seldom put these ideas into action. Multiple factors undermined caring teacher-pupil relationships in wider contexts of poverty and political uncertainty: loss of morale from low salaries and falling professional status; the inability of teachers to solve HIV/AIDS-related problems in their own lives; the role of stigma in deterring HIV/AIDS-affected children from disclosing their situations to teachers; authoritarian teacher-learner relations and harsh punishments fuelling pupil fear of teachers; and lack of trust in the wider community. These factors undermined: teacher confidence in their skills and capacity to support affected pupils and motivation to help children with complex problems; solidarity and common purpose amongst teachers, and between teachers and affected children; and effective bridging alliances between schools and their surrounding communities-all hallmarks of HIV-competent communities. We caution against ambitious policy expansions of teachers' roles without recognition of the personal and social costs of emotional labour, and the need for significant increases in resources and institutional recognition to enable teachers to adopt support roles. We highlight the need for research into how best to create opportunities for teacher recognition in deprived and disorganised institutional settings, and the development of more culturally appropriate notions of caring.	[Campbell, Catherine; Andersen, Louise] Univ London London Sch Econ & Polit Sci, Dept Social Psychol, Houghton St, London WC2A 2AE, England; [Mutsikiwa, Alice] Biomed Res & Training Inst, Harare, Zimbabwe; [Madanhire, Claudius] Univ KwaZulu Natal, Sch Appl Human Sci, Durban, South Africa; [Nyamukapa, Constance; Gregson, Simon] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	University of London; London School Economics & Political Science; Biomedical Research Training Institute; University of Kwazulu Natal; Imperial College London	Campbell, C (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Social Psychol, Houghton St, London WC2A 2AE, England.	c.campbell@lse.ac.uk		Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069	Economic and Social Research Council - Department for International Development (ESRC-DFID) [RES-167-25-0672]; Wellcome Trust [084401/Z/07/Z]; ESRC [ES/I033459/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033459/1] Funding Source: researchfish	Economic and Social Research Council - Department for International Development (ESRC-DFID)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by: The Economic and Social Research Council - Department for International Development (ESRC-DFID) joint fund (RES-167-25-0672) http://www.esrc.ac.uk/funding-and-guidance/funding-opportunities/international-funding/esrc-dfid/, and The Wellcome Trust (084401/Z/07/Z) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joel, 1995, STRUGGLE RECOGNITION; [Anonymous], 2013, ZIMB TEACH WARN STRI; [Anonymous], CHILDRENS REPRESENTA, DOI DOI 10.1186/1471-2458-14-402; Ansell N, 2008, ANTIPODE, V40, P802, DOI 10.1111/j.1467-8330.2008.00638.x; Bialobrzeska M., 2009, CREATING CARING SCH; Campbell C, 2014, CONCEPTUALISING SCH; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Campbell C, 2007, AM J COMMUN PSYCHOL, V39, P347, DOI 10.1007/s10464-007-9116-1; Campbell C, 2015, HEALTH PLACE, V31, P54, DOI 10.1016/j.healthplace.2014.09.008; Campbell C, 2013, AIDS CARE, V25, pS114, DOI 10.1080/09540121.2012.748170; Campbell C, 2012, HEALTH PLACE, V18, P447, DOI 10.1016/j.healthplace.2011.10.006; Campbell C, 2012, HEALTH PLACE, V18, P123, DOI 10.1016/j.healthplace.2011.07.008; Castro A, 2005, AM J PUBLIC HEALTH, V95, P53, DOI 10.2105/AJPH.2003.028563; Chitiyo M, 2008, INT J EDUC DEV, V28, P384, DOI 10.1016/j.ijedudev.2007.05.009; CIA, 2015, WORLD FACTB ZIMB; Ebersohn L, 2011, HEALTH EDUC RES, V26, P596, DOI 10.1093/her/cyr016; FLICK U, 1992, J THEOR SOC BEHAV, V22, P175, DOI 10.1111/j.1468-5914.1992.tb00215.x; Freire, 2005, ED CRITICAL CONSCIOU; Garutsa T., 2013, ROLE NGOS ADDRESSING; Giese S., 2013, STRENGTHENING SCH NO; Hoadley U, 2007, AJAR-AFR J AIDS RES, V6, P251, DOI 10.2989/16085900709490421; LeRoux-Rutledge E, 2015, AIDS CARE, V27, P1367, DOI 10.1080/09540121.2015.1093592; Machawira P, 2009, J EDUC POLICY, V24, P753, DOI 10.1080/02680930903244888; Makaripe T., 2015, ZIM TEACHERS LOWEST; Mangwaya E, 2013, ASIAN SOC SCI, V9; Marist International Solidarity Foundation, 2011, U PER REV REP ZIMB; Massey Doreen., 1999, HUMAN GEOGRAPHY TODA, P279; Mead G. H., 1934, MIND SELF SOC; Morrell R., 2001, S AFR J EDUC, V21, P292; Moscovici S, 2000, SOCIAL REPRESENTATIO, P18; Noddings N., 2003, CARING FEMININE APPR; Nyazema NZ, 2010, J DEV SOC, V26, P233, DOI 10.1177/0169796X1002600204; Ogara C., 2007, COMPARE, V37, P5, DOI DOI 10.1080/03057920601061695; Parsons R., 2012, GROWING HIV ZIMBABWE; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Save the Children, 2011, ITS ALL CHILDR; Save the Children, 2010, SPEAK OUT BEING HEAR; Shizha E, 2011, ED DEV ZIMBABWE SOCI; Skovdal M, 2015, INT J EDUC DEV, V41, P175, DOI 10.1016/j.ijedudev.2015.02.005; Skovdal M, 2010, VULNERABLE CHILD YOU, V5, P19, DOI 10.1080/17450120903281173; Smith M., 2009, SOCIAL PEDAGOGY DEV; UNAIDS, 2014, AIDS INF STAT; UNAIDS, 2014, GAP REP; UNAIDS, 2014, GLOB AIDS RESP COUNT; UNESCO, 2008, HIV AIDS SUPP LEARN; UNICEF, 2013, AIDS FREE GEN CHILDR; UNICEF, 2012, STAT WORLDS CHILDR 2; UNICEF, 2010, CHILD FRIENDL SCH; Whitney T., 2010, THESIS U NEBRASKA LI; Zagheni E, 2011, POPUL DEV REV, V37, P761, DOI 10.1111/j.1728-4457.2011.00456.x; Zembylas M., 2008, INT PERSPECTIVES ED, P159	51	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146322	10.1371/journal.pone.0146322	http://dx.doi.org/10.1371/journal.pone.0146322			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26790103	Green Published, Green Accepted, gold			2022-12-27	WOS:000368529100030
J	Kim, TY; Song, DS; Kim, HY; Sinn, DH; Yoon, EL; Kim, CW; Jung, YK; Suk, KT; Lee, SS; Lee, CH; Kim, TH; Kim, JH; Choe, WH; Yim, HJ; Kim, SE; Baik, SK; Lee, BS; Jang, JY; Suh, JI; Kim, HS; Nam, SW; Kwon, HC; Kim, YS; Kim, SG; Chae, HB; Yang, JM; Sohn, JH; Lee, HJ; Park, SH; Han, BH; Choi, EH; Kim, CH; Kim, DJ				Kim, Tae Yeob; Song, Do Seon; Kim, Hee Yeon; Sinn, Dong Hyun; Yoon, Eileen L.; Kim, Chang Wook; Jung, Young Kul; Suk, Ki Tae; Lee, Sang Soo; Lee, Chang Hyeong; Kim, Tae Hun; Kim, Jeong Han; Choe, Won Hyeok; Yim, Hyung Joon; Kim, Sung Eun; Baik, Soon Koo; Lee, Byung Seok; Jang, Jae Young; Suh, Jeong Ill; Kim, Hyoung Su; Nam, Seong Woo; Kwon, Hyeok Choon; Kim, Young Seok; Kim, Sang Gyune; Chae, Hee Bok; Yang, Jin Mo; Sohn, Joo Hyun; Lee, Heon Ju; Park, Seung Ha; Han, Byung Hoon; Choi, Eun Hee; Kim, Chang H.; Kim, Dong Joon		KACLiF Study Grp	Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition	PLOS ONE			English	Article							ASIAN-PACIFIC ASSOCIATION; ORGAN FAILURE; CONSENSUS RECOMMENDATIONS; ACUTE DECOMPENSATION; CIRRHOTIC-PATIENTS; MORTALITY; VALIDATION; DISTINCT; DISEASE; SYSTEM	Background & Aim To investigate the prevalence, mortalities, and patient characteristics of Acute-on-chronic liver failure (ACLF) according to the AARC (Asian Pacific Association for the Study of the Liver ACLF Research Consortium) and European Association for the Study of the Liver CLIF-C (Chronic Liver Failure Consortium) definitions. Methods We collected retrospective data for 1470 hospitalized patients with chronic liver disease (CLD) and acute deterioration between January 2013 and December 2013 from 21 university hospitals in Korea. Results Of the patients assessed, the prevalence of ACLF based on the AARC and CLIF-C definitions was 9.5% and 18.6%, respectively. The 28-day and 90-day mortality rates were higher in patients with ACLF than in those without ACLF. Patients who only met the CLIF-C definition had significantly lower 28-day and 90-day survival rates than those who only met the AARC definition (68.0% vs. 93.9%, P<0.001; 55.1% vs. 92.4%, P<0.001). Among the patients who had non-cirrhotic CLD, the 90-day mortality of the patients with ACLF was higher than of those without ACLF, although not significant (33.3% vs. 6.0%, P = 0.192). Patients with previous acute decompensation (AD) within 1-year had a lower 90-day survival rate than those with AD more than 1 year prior or without previous AD (81.0% vs. 91.9% or 89.4%, respectively, all P<0.001). Patients who had extra-hepatic organ failure without liver failure had a similar 90-day survival rate to those who had liver failure as a prerequisite (57.0% vs. 60.6%, P = 0.391). Conclusions The two ACLF definitions result in differences in mortality and patient characteristics among ACLF patients. We suggest that non-cirrhotic CLD, previous AD within 1 year, and extrahepatic organ failure should be included in the ACLF diagnostic criteria. In addition, further studies are necessary to develop a universal definition of ACLF.	[Kim, Tae Yeob] Hanyang Univ, Inst Med Sci, Seoul 133791, South Korea; [Song, Do Seon; Kim, Hee Yeon; Kim, Chang Wook; Yang, Jin Mo] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Sinn, Dong Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Yoon, Eileen L.] Inje Univ, Dept Internal Med, Sanggye Paik Hosp, Seoul, South Korea; [Jung, Young Kul; Yim, Hyung Joon] Korea Univ, Dept Internal Med, Ansan Hosp, Ansan, South Korea; [Suk, Ki Tae; Kim, Dong Joon] Hallym Univ, Dept Internal Med, Coll Med, Chunchon, South Korea; [Lee, Sang Soo] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea; [Lee, Chang Hyeong] Catholic Univ, Dept Internal Med, Daegu Sch Med, Daegu, South Korea; [Kim, Tae Hun] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Jeong Han; Choe, Won Hyeok] Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Sung Eun] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, South Korea; [Baik, Soon Koo] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea; [Lee, Byung Seok] Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea; [Jang, Jae Young] Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Suh, Jeong Ill] Dongguk Univ, Dept Internal Med, Gyeongju Hosp, Gyeongju, South Korea; [Kim, Hyoung Su] Hallym Univ, Dept Internal Med, Kangdong Sacred Heart Hosp, Seoul, South Korea; [Nam, Seong Woo; Kwon, Hyeok Choon] Natl Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Young Seok; Kim, Sang Gyune] Soonchunhyang Univ, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea; [Chae, Hee Bok] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea; [Chae, Hee Bok] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Sohn, Joo Hyun] Hanyang Univ, Dept Internal Med, Guri Hosp, Guri, South Korea; [Lee, Heon Ju] Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea; [Park, Seung Ha] Inje Univ, Dept Internal Med, Haeundae Paik Hosp, Coll Med, Busan, South Korea; [Han, Byung Hoon] Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Choi, Eun Hee] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Wonju, South Korea; [Kim, Chang H.] Univ Hosp Case Med Ctr, Dept Internal Med, Cleveland, OH USA	Hanyang University; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Gyeongsang National University; Gyeongsang National University Hospital; Catholic University of Daegu; Ewha Womans University; Konkuk University; Konkuk University Medical Center; Hallym University; Yonsei University; Chungnam National University; Soonchunhyang University; Dongguk University; Hallym University; National Medical Center - Korea; Soonchunhyang University; Chungbuk National University; Chungbuk National University; Hanyang University; Yeungnam University; Inje University; Yonsei University; Case Western Reserve University; Case Western Reserve University Hospital	Kim, DJ (corresponding author), Hallym Univ, Dept Internal Med, Coll Med, Chunchon, South Korea.	djkim@hallym.ac.kr	Kim, Sang gyune/AAI-5704-2020; Sinn, Dong Hyun/L-3701-2019; Sinn, Dong Hyun/O-5941-2014; Lee, Sang Soo/X-9628-2019; Lee, Sang Soo/P-7617-2019	Sinn, Dong Hyun/0000-0002-7126-5554; Lee, Sang Soo/0000-0003-1029-3436; Yoon, Eileen/0000-0003-0474-048X; Kim, Chang Wook/0000-0003-1184-0358; Choi, Eunhee/0000-0002-3449-0672; Song, Do Seon/0000-0002-8278-4878; Kim, Sang gyune/0000-0001-8694-777X; Jung, Young Kul/0000-0002-6566-1382	Korean Association for the Study of the Liver (KASL); Korean Liver Foundation	Korean Association for the Study of the Liver (KASL); Korean Liver Foundation	This study was supported by the Korean Association for the Study of the Liver (KASL) and the Korean Liver Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, J GASTROEN HEPATOL, V30, P575, DOI 10.1111/jgh.12778; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Bajaj JS, 2013, GASTROENTEROLOGY, V144, P1337, DOI 10.1053/j.gastro.2013.04.024; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cheng SH, 2013, WORLD J GASTROENTERO, V19, P5904, DOI 10.3748/wjg.v19.i35.5904; Choi JY, 2005, LIVER INT, V25, P740, DOI 10.1111/j.1478-3231.2005.01074.x; Cholongitas E, 2006, ALIMENT PHARM THER, V23, P883, DOI 10.1111/j.1365-2036.2006.02842.x; D'Amico G, 2014, ALIMENT PHARM THER, V39, P1180, DOI 10.1111/apt.12721; Du WB, 2005, TRANSPL P, V37, P4359, DOI 10.1016/j.transproceed.2005.11.044; Duseja A, 2010, DIGEST DIS SCI, V55, P3188, DOI 10.1007/s10620-010-1377-0; Jalan R, 2015, J HEPATOL, V62, P831, DOI 10.1016/j.jhep.2014.11.012; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; Jalan R, 2014, GASTROENTEROLOGY, V147, P4, DOI 10.1053/j.gastro.2014.05.005; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; KASL, 2012, CLIN MOL HEPATOL, V18, P109, DOI 10.3350/cmh.2012.18.2.109; Kedarisetty CK, 2014, HEPATOLOGY, V60, p556A; Kim TY, 2013, CLIN MOL HEPATOL, V19, P349, DOI 10.3350/cmh.2013.19.4.349; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sarin SK, 2014, HEPATOL INT, V8, P453, DOI 10.1007/s12072-014-9580-2; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Shi Y, 2015, HEPATOLOGY, V62, P232, DOI 10.1002/hep.27795; Silva PESE, 2015, LIVER INT, V35, P1516, DOI 10.1111/liv.12597; Song HJ, 2007, J KOREAN MED SCI, V22, P218, DOI 10.3346/jkms.2007.22.2.218; Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1; Wlodzimirow KA, 2013, LIVER INT, V33, P40, DOI 10.1111/j.1478-3231.2012.02790.x	28	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146745	10.1371/journal.pone.0146745	http://dx.doi.org/10.1371/journal.pone.0146745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789409	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100038
J	Soto-Mendez, MJ; Aguilera, CM; Mesa, MD; Campana-Martin, L; Martin-Laguna, V; Solomons, NW; Schumann, K; Gil, A				Soto-Mendez, Maria J.; Aguilera, Concepcion M.; Mesa, Maria D.; Campana-Martin, Laura; Martin-Laguna, Victoria; Solomons, Noel W.; Schuemann, Klaus; Gil, Angel			Strong Associations Exist among Oxidative Stress and Antioxidant Biomarkers in the Circulating, Cellular and Urinary Anatomical Compartments in Guatemalan Children from the Western Highlands	PLOS ONE			English	Article							VITAMIN-E; SUPEROXIDE-DISMUTASE; COENZYME Q(9); DNA-REPAIR; GLUTATHIONE; 8-HYDROXYDEOXYGUANOSINE; RADICALS; WEIGHT; HUMANS	Background A series of antioxidant enzymes and non-enzymatic compounds act to protect cells from uncontrolled propagation of free radicals. It is poorly understood, though, to what extent and how their interaction is harmonized. Objectives To explore associative interactions among a battery of urinary and blood biomarkers of oxidative stress and enzymatic and non-enzymatic markers of the antioxidant defense system in children from low income households. Methods For this cross-sectional descriptive study, urine, red cells, and plasma were sampled in 82 preschool children attending three daycare centers in Quetzaltenango Guatemala. The urinary oxidative stress biomarkers studied were F2-isoprostanes and 8-hydroxy-deoxy-guanosine. Red cell enzyme activities measured were: catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase. Circulating non-enzymatic antioxidants selected were: retinol, tocopherols, beta-carotene and coenzymes Q(9) and Q(10). Results In a Spearman rank-order correlation hemi-matrix, of 55 paired combinations of the 11 biomarkers, 28 (51%) were significantly correlated among each other (p <= 0.05), with the strongest association being retinol and tocopherols (r = 0.697, p<0.001), and 4 associations (9%) showed a trend (p> 0.5 to <= 0.10). F2-isoprostanes showed the greatest number of cross-associations, having significant interactions with 8 of the 10 remaining biomarkers. Goodness-of-fit modeling improved or maintained the r value for 24 of the significant interactions and for one of the 5 borderline associations. Multiple regression backward stepwise analysis indicated that plasma retinol, beta-carotene and coenzyme Q(10) were independent predictors of urinary F2-isoprostanes. Conclusion Numerous significant associations resulted among biomarkers of oxidation and responders to oxidation. Interesting findings were the apparent patterns of harmonious interactions among the elements of the oxidation-antioxidation systems in this population.	[Soto-Mendez, Maria J.; Solomons, Noel W.] CeSSIAM, Guatemala City, Guatemala; [Aguilera, Concepcion M.; Mesa, Maria D.; Campana-Martin, Laura; Martin-Laguna, Victoria; Gil, Angel] Univ Granada, Ctr Biomed Res, Inst Nutr & Food Technol Jose Mataix, Dept Biochem & Mol Biol 2, Granada, Spain; [Aguilera, Concepcion M.; Gil, Angel] CIBERobn, Networking Biomed Res Obes & Nutr, Madrid, Spain; [Mesa, Maria D.] Gen Sub Directorate Res Assessment & Promot, Themat Networks Cooperat Res, Carlos Hlth Inst 3, RETIC,ISCIII, Madrid, Spain; [Mesa, Maria D.] European Reg Dev Fund, Madrid, Spain; [Schuemann, Klaus] Tech Univ Munich, Res Ctr Nutr & Food Sci, ZIEL, Mol Nutr Unit, Freising Weihenstephan, Germany	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Technical University of Munich	Soto-Mendez, MJ (corresponding author), CeSSIAM, Guatemala City, Guatemala.	clinicanutricion@gmail.com	Gil, Angel/L-2275-2014; Méndez, María José Soto/X-6982-2019; Aguilera, Concepcion M/M-1663-2014; Gil, Angel/ABA-7621-2020; Mesa, María D/M-3523-2014	Gil, Angel/0000-0001-7663-0939; Méndez, María José Soto/0000-0002-1012-4715; Aguilera, Concepcion M/0000-0002-1451-4788; Gil, Angel/0000-0001-7663-0939; Mesa, María D/0000-0003-4079-6464	Departamente of Biochemistry and Molecular Biology II, University of Granada; Hildegard Grunow Foundation	Departamente of Biochemistry and Molecular Biology II, University of Granada; Hildegard Grunow Foundation	The Hildegard Grunow Foundation provided support by funding all the fieldwork expenses, and the Departamente of Biochemistry and Molecular Biology II, University of Granada, funded all the laboratory assays.	Aebi H, 1984, Methods Enzymol, V105, P121; Akohoue SA, 2007, PEDIATR RES, V61, P233, DOI 10.1203/pdr.0b013e31802d7754; Andersen HR, 1997, CLIN CHEM, V43, P562; Barregard L, 2013, ANTIOXID REDOX SIGN, V18, P2377, DOI 10.1089/ars.2012.4714; Battino M, 2004, METHOD ENZYMOL, V378, P156; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-74; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143, DOI 10.1007/BF00231175; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; DRABKIN DL, 1948, AM J MED SCI, V215, P110, DOI 10.1097/00000441-194801000-00017; Drury JA, 1998, FREE RADICAL RES, V28, P423, DOI 10.3109/10715769809070811; Evans MD, 2010, MUTAGENESIS, V25, P433, DOI 10.1093/mutage/geq031; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; Soto-Mendez MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129158; Leger C, 2008, CHEM REV, V108, P2379, DOI 10.1021/cr0680742; LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391, DOI 10.1080/15287399309531806; Lukaszewicz-Hussain A, 2004, POL J ENVIRON STUD, V13, P303; Lunec J, 2002, FREE RADICAL BIO MED, V33, P875, DOI 10.1016/S0891-5849(02)00882-1; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; Milne GL, 2015, BBA-MOL CELL BIOL L, V1851, P433, DOI 10.1016/j.bbalip.2014.10.007; Molyneux S, 2007, CLIN CHEM, V53, P802, DOI 10.1373/clinchem.2006.083568; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MSPAS, 2010, ENSMI200809 MSPAS; Prabhulkar S, 2010, BIOSENS BIOELECTRON, V26, P1743, DOI 10.1016/j.bios.2010.08.029; Pratico D, 1999, ATHEROSCLEROSIS, V147, P1, DOI 10.1016/S0021-9150(99)00257-9; Rangel-Huerta OD, 2015, J NUTR, V145, P1808, DOI 10.3945/jn.115.213660; Rizzo AM, 2010, ADV EXP MED BIOL, V698, P52, DOI 10.1007/978-1-4419-7347-4_5; Roberts LJ, 2009, J LIPID RES, V50, pS219, DOI 10.1194/jlr.R800037-JLR200; Rosales FJ, 2004, NUTR RES, V24, P875, DOI 10.1016/j.nutres.2004.06.008; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Soto-Mendez M, 2014, SPANISH J COMMUNITY, V20, P13; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Traber MG, 2014, ADV NUTR, V5, P503, DOI 10.3945/an.114.006254; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Watanabe K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/140165; Winbauer AN, 1999, ANN CLIN LAB SCI, V29, P185; Zempleni J, 1991, HDB VITAMINS, V11, DOI [10.1016/0891-5849(91)90176-4, DOI 10.1016/0891-5849(91)90176-4]; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146921	10.1371/journal.pone.0146921	http://dx.doi.org/10.1371/journal.pone.0146921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790155	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100045
J	Yoshida, T; Song, LX; Bai, Y; Kinose, F; Li, JN; Ohaegbulam, KC; Munoz-Antonia, T; Qu, XT; Eschrich, S; Uramoto, H; Tanaka, F; Nasarre, P; Gemmill, RM; Roche, J; Drabkin, HA; Haura, EB				Yoshida, Takeshi; Song, Lanxi; Bai, Yun; Kinose, Fumi; Li, Jiannong; Ohaegbulam, Kim C.; Munoz-Antonia, Teresita; Qu, Xiaotao; Eschrich, Steven; Uramoto, Hidetaka; Tanaka, Fumihiro; Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.; Haura, Eric B.			ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; E-CADHERIN; MIR-200 FAMILY; TGF-BETA; SIGNALING PATHWAYS; TARGETED THERAPY; REPRESSORS ZEB1; GEFITINIB; MECHANISMS; SENSITIVITY	Epithelial-mesenchymal transition (EMT) is one mechanism of acquired resistance to inhibitors of the epidermal growth factor receptor-tyrosine kinases (EGFR-TKIs) in non-small cell lung cancer (NSCLC). The precise mechanisms of EMT-related acquired resistance to EGFR-TKIs in NSCLC remain unclear. We generated erlotinib-resistant HCC4006 cells (HCC4006ER) by chronic exposure of EGFR-mutant HCC4006 cells to increasing concentrations of erlotinib. HCC4006ER cells acquired an EMT phenotype and activation of the TGF-beta/SMAD pathway, while lacking both T790M secondary EGFR mutation and MET gene amplification. We employed gene expression microarrays in HCC4006 and HCC4006ER cells to better understand the mechanism of acquired EGFR-TKI resistance with EMT. At the mRNA level, ZEB1 (TCF8), a known regulator of EMT, was >20-fold higher in HCC4006ER cells than in HCC4006 cells, and increased ZEB1 protein level was also detected. Furthermore, numerous ZEB1 responsive genes, such as CDH1 (E-cadherin), ST14, and vimentin, were coordinately regulated along with increased ZEB1 in HCC4006ER cells. We also identified ZEB1 overexpression and an EMT phenotype in several NSCLC cells and human NSCLC samples with acquired EGFR-TKI resistance. Short-interfering RNA against ZEB1 reversed the EMT phenotype and, importantly, restored erlotinib sensitivity in HCC4006ER cells. The level of micro-RNA-200c, which can negatively regulate ZEB1, was significantly reduced in HCC4006ER cells. Our results suggest that increased ZEB1 can drive EMT-related acquired resistance to EGFR-TKIs in NSCLC. Attempts should be made to explore targeting ZEB1 to resensitize TKI-resistant tumors.	[Yoshida, Takeshi; Song, Lanxi; Bai, Yun; Kinose, Fumi; Li, Jiannong; Haura, Eric B.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Ohaegbulam, Kim C.; Munoz-Antonia, Teresita] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Qu, Xiaotao; Eschrich, Steven] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Uramoto, Hidetaka; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 807, Japan; [Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.] Med Univ S Carolina, Dept Med, Div Hematol Oncol, Charleston, SC 29425 USA; [Nasarre, Patrick; Gemmill, Robert M.; Roche, Joelle; Drabkin, Harry A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Occupational & Environmental Health - Japan; Medical University of South Carolina; Medical University of South Carolina	Haura, EB (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA.	eric.haura@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788	Moffitt Cancer Center SPORE in Lung Cancer [P50-CA119997]; NCI [1R01 CA121182]; Colorado Lung Cancer SPORE [NCI-CA58187]; Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [R01CA121182, P50CA119997, P50CA058187, P30CA076292] Funding Source: NIH RePORTER	Moffitt Cancer Center SPORE in Lung Cancer; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colorado Lung Cancer SPORE; Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially funded by grants from the Moffitt Cancer Center SPORE in Lung Cancer (P50-CA119997), NCI 1R01 CA121182, and the Colorado Lung Cancer SPORE NCI-CA58187 (HD, PN, RMG). This work has also been supported in part by the Molecular Biology and Sequencing Core, the Tissue Core, and the Microarray Core at the H. Lee Moffitt Cancer Center & Research Institute, an NCI designated Comprehensive Cancer Center (P30-CA076292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi U, 2014, ONCOTARGET, V5, P2016, DOI 10.18632/oncotarget.1875; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davis FM, 2014, TRENDS PHARMACOL SCI, V35, P479, DOI 10.1016/j.tips.2014.06.006; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ekins S, 2007, METH MOL B, V356, P319; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hall JG, 2000, P NATL ACAD SCI USA, V97, P8272, DOI 10.1073/pnas.140225597; Haura EB, 2011, J PROTEOME RES, V10, P182, DOI 10.1021/pr100863f; Kakihana M, 2009, J THORAC ONCOL, V4, P1455, DOI 10.1097/JTO.0b013e3181bc9419; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kothari AN, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0035-0; La Monica S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078656; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Machida K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013470; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Mishra VK, 2014, CELL TISSUE RES, V356, P617, DOI 10.1007/s00441-014-1912-y; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Roche Joelle, 2013, Cancers (Basel), V5, P334, DOI 10.3390/cancers5020334; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Uramoto H, 2011, LUNG CANCER, V30, P2513; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	61	57	58	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147344	10.1371/journal.pone.0147344	http://dx.doi.org/10.1371/journal.pone.0147344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789630	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100082
J	Behr, JG; Diaz, R				Behr, Joshua G.; Diaz, Rafael			Emergency Department Frequent Utilization for Non-Emergent Presentments: Results from a Regional Urban Trauma Center Study	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; SELF-REPORTED HEALTH; BEHAVIORAL-MODEL; SERVICE UTILIZATION; VULNERABLE POPULATIONS; PATIENT SATISFACTION; NONURGENT EMERGENCY; ETHNIC-MINORITIES; PUBLIC EMERGENCY; HOMELESS ADULTS	Objectives First, to test a model of the drivers of frequent emergency department utilization conceptualized as falling within predisposing, enabling, and need dimensions. Second, to extend the model to include social networks and service quality as predictors of frequent utilization. Third, to illustrate the variation in thresholds that define frequent utilization in terms of the number of emergency department encounters by the predictors within the model. Data Source Primary data collection over an eight week period within a level-1 trauma urban hospital's emergency department. Study Design Representative randomized sample of 1,443 adult patients triaged ESI levels 4-5. Physicians and research staff interviewed patients as they received services. Relationships with the outcome variable, utilization, were tested using logistic regression to establish odds-ratios. Principal Findings 70.6 percent of patients have two or more, 48.3 percent have three or more, 25.3 percent have four or more, and 14.9 percent have five or more emergency department visits within 12 months. Factors associated with frequent utilization include gender, race, poor mental health, mental health drugs, prescription drug abuse, social networks, employment, perceptions of service quality, seriousness of condition, persistence of condition, and previous hospital admittance. Conclusions Interventions targeting associated factors will change global emergency department encounters, although the mutability varies. Policy interventions to address predisposing factors such as substance abuse or access to mental health treatment as well as interventions that speak to enabling factors such as promoting the resiliency of social networks may result in decreased frequency of emergency department utilization.	[Behr, Joshua G.] Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, Suffolk, VA USA; [Diaz, Rafael] MIT, Zaragoza Logist Ctr, Zaragoza, Spain		Behr, JG (corresponding author), Old Domin Univ, Virginia Modeling Anal & Simulat Ctr, Suffolk, VA USA.	jbehr@odu.edu			Sentara Health Foundation [07-08-EX-0198]	Sentara Health Foundation	The project was supported by Sentara Health Foundation, #07-08-EX-0198, http://www.sentara.com/AboutSentara/Foundation/Pages/Foundation.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; ADAY LA, 1981, MED CARE, V19, P4, DOI 10.1097/00005650-198112001-00004; Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Andersen R., 1968, RES SER; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Baker DW, 1996, ANN EMERG MED, V28, P677, DOI 10.1016/S0196-0644(96)70093-8; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; BAUM SA, 1987, J AM GERIATR SOC, V35, P398, DOI 10.1111/j.1532-5415.1987.tb04660.x; Behr JG, 2013, J PUBLIC HEALTH MAN, V19, pS55, DOI 10.1097/PHH.0b013e318297226a; Bentley J, 2004, J ADV NURS, V48, P149, DOI 10.1111/j.1365-2648.2004.03182.x; Bertakis KD, 2005, OBES RES, V13, P372, DOI 10.1038/oby.2005.49; Bertakis KD, 2011, J AM BOARD FAM MED, V24, P229, DOI 10.3122/jabfm.2011.03.100170; Bethell Jennifer, 2008, Curr Psychiatry Rep, V10, P53, DOI 10.1007/s11920-008-0010-9; Blank FSJ, 2005, J EMERG NURS, V31, P139, DOI 10.1016/j.jen.2005.02.008; Boudreaux ED, 2004, J EMERG MED, V26, P13, DOI 10.1016/j.jemermed.2003.04.003; Byrne M, 2003, ANN EMERG MED, V41, P309, DOI 10.1067/mem.2003.68; Chan BT, 2002, CAN FAM PHYSICIAN, V48, P1654; Cook LJ, 2004, ACAD EMERG MED, V11, P256, DOI 10.1197/j.aem.2003.10.023; Davidson PL, 2004, INQUIRY-J HEALTH CAR, V41, P21, DOI 10.5034/inquiryjrnl_41.1.21; Dent Andrew Wesley, 2003, Emerg Med (Fremantle), V15, P322, DOI 10.1046/j.1442-2026.2003.00470.x; Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fan L, 2011, J RURAL HEALTH, V27, P39, DOI 10.1111/j.1748-0361.2010.00313.x; Fertel BS, 2012, ANN EMERG MED, V60, P693, DOI 10.1016/j.annemergmed.2012.05.009; Folsom DP, 2005, AM J PSYCHIAT, V162, P370, DOI 10.1176/appi.ajp.162.2.370; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gilboy N., 2005, EMERGENCY SEVERITY I, P1; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Goetzel RZ, 2010, J OCCUP ENVIRON MED, V52, pS52, DOI 10.1097/JOM.0b013e3181c95b84; Goetzel RZ, 2004, J OCCUP ENVIRON MED, V46, P398, DOI 10.1097/01.jom.0000121151.40413.bd; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Grumbach K., 2010, OUTCOMES IMPLEMENTIN; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Harman JS, 2004, PSYCHIAT SERV, V55, P937, DOI 10.1176/appi.ps.55.8.937; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1197/j.aem.2003.09.014; Heithoff KA, 1997, CLIN THER, V19, P811, DOI 10.1016/S0149-2918(97)80104-X; Honda K, 2004, AM J HEALTH PROMOT, V18, P370, DOI 10.4278/0890-1171-18.5.370; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; JOHNSON J, 1992, JAMA-J AM MED ASSOC, V267, P1478, DOI 10.1001/jama.267.11.1478; Keene J, 2001, HEALTH SOC CARE COMM, V9, P205, DOI 10.1046/j.1365-2524.2001.00296.x; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Knowlton A, 2013, ACAD EMERG MED, V20, P1101, DOI 10.1111/acem.12253; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Lasser KE, 2012, ARCH INTERN MED, V172, P278, DOI 10.1001/archinternmed.2011.709; Lin MT, 2012, SOC PSYCH PSYCH EPID, V47, P939, DOI 10.1007/s00127-011-0401-9; Locker TE, 2007, EMERG MED J, V24, P398, DOI 10.1136/emj.2006.043844; Lucas RH, 1998, ANN EMERG MED, V32, P563, DOI 10.1016/S0196-0644(98)70033-2; MALONE RE, 1995, SOC SCI MED, V40, P469, DOI 10.1016/0277-9536(94)E0116-A; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Martinez TE, 2006, PSYCHIAT SERV, V57, P992, DOI 10.1176/appi.ps.57.7.992; McCusker J, 1997, ACAD EMERG MED, V4, P581, DOI 10.1111/j.1553-2712.1997.tb03582.x; Meyer JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042416; Milbrett P, 2009, J EMERG NURS, V35, P191, DOI 10.1016/j.jen.2008.04.032; Miller JE, 2000, AM J PUBLIC HEALTH, V90, P428, DOI 10.2105/AJPH.90.3.428; Neuman B., 2011, NEUMAN SYSTEMS MODEL; NHAMCS National Hospital Ambulatory Medical Care Survey, 2010, EM DEP SUMM TABL; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Olsson M, 2001, EMERG MED J, V18, P430, DOI 10.1136/emj.18.6.430; PADGETT DK, 1992, AM J ORTHOPSYCHIAT, V62, P525, DOI 10.1037/h0079369; PADGETT DK, 1995, SOC SCI MED, V41, P547, DOI 10.1016/0277-9536(94)00364-Y; Petersen LA, 1998, MED CARE, V36, P1249, DOI 10.1097/00005650-199808000-00012; Phillips KA, 2000, HEALTH AFFAIR, V19, P65, DOI 10.1377/hlthaff.19.4.65; Phillips KA, 1998, HEALTH SERV RES, V33, P571; Pinkhasov RM, 2010, INT J CLIN PRACT, V64, P475, DOI 10.1111/j.1742-1241.2009.02290.x; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Quesenberry CP, 1998, ARCH INTERN MED, V158, P466, DOI 10.1001/archinte.158.5.466; Rask KJ, 1994, JAMA J AM MED ASS, V1931; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rongey C, 2011, TRANSL BEHAV MED, V1, P644, DOI 10.1007/s13142-011-0098-z; Sachs-Ericsson N, 1999, J HEALTH CARE POOR U, V10, P443; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Sandoval E, 2010, J EMERG MED, V38, P115, DOI 10.1016/j.jemermed.2007.09.042; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shen C, 2008, DIS MANAGE, V11, P153, DOI 10.1089/dis.2007.0012; Short ME, 2009, J OCCUP ENVIRON MED, V51, P786, DOI 10.1097/JOM.0b013e3181a86671; Spillane LL, 1997, ACAD EMERG MED, V4, P574, DOI 10.1111/j.1553-2712.1997.tb03581.x; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; Sun BC, 2000, ANN EMERG MED, V35, P426, DOI 10.1067/mem.2000.104195; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67; Vortmann M, 2008, OBESITY, V16, P146, DOI 10.1038/oby.2007.7; Wagner JA, 2008, SOC PSYCH PSYCH EPID, V43, P878, DOI 10.1007/s00127-008-0377-2; Wang FF, 2005, OBES RES, V13, P1450, DOI 10.1038/oby.2005.175; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023; WHITEMEANS SI, 1989, MILBANK Q, V67, P35, DOI 10.2307/3350069; Zuckerman S, 2004, MED CARE, V42, P176, DOI 10.1097/01.mlr.0000108747.51198.41	90	42	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147116	10.1371/journal.pone.0147116	http://dx.doi.org/10.1371/journal.pone.0147116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784515	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400111
J	Lanz, C; Mattsson, J; Soydaner, U; Brenneisen, R				Lanz, Christian; Mattsson, Johan; Soydaner, Umut; Brenneisen, Rudolf			Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis	PLOS ONE			English	Article							RECEPTOR; TETRAHYDROCANNABINOL; PLANT; THC	Inhalation by vaporization is a promising application mode for cannabis in medicine. An in vitro validation of 5 commercial vaporizers was performed with THC-type and CBD-type cannabis. Gas chromatography/mass spectrometry was used to determine recoveries of total THC (THCtot) and total CBD (CBDtot) in the vapor. High-performance liquid chromatography with photodiode array detection was used for the quantitation of acidic cannabinoids in the residue and to calculate decarboxylation efficiencies. Recoveries of THCtot and CBDtot in the vapor of 4 electrically-driven vaporizers were 58.4 and 51.4%, 66.8 and 56.1%, 82.7 and 70.0% and 54.6 and 56.7% for Volcano Medic (R), Plenty Vaporizer (R), Arizer Solo (R) and DaVinci Vaporizer (R), respectively. Decarboxylation efficiency was excellent for THC (>= 97.3%) and CBD (>= 94.6%). The gas-powered Vape-or-Smoke (TM) showed recoveries of THCtot and CBDtot in the vapor of 55.9 and 45.9%, respectively, and a decarboxylation efficiency of >= 87.7 for both cannabinoids. However, combustion of cannabis was observed with this device. Temperature-controlled, electrically-driven vaporizers efficiently decarboxylate inactive acidic cannabinoids and reliably release their corresponding neutral, active cannabinoids. Thus, they offer a promising application mode for the safe and efficient administration of medicinal cannabis.	[Lanz, Christian; Soydaner, Umut; Brenneisen, Rudolf] Univ Bern, Dept Clin Res, Lab Phytopharmacol Bioanalyt & Pharmacokinet, Bern, Switzerland; [Mattsson, Johan] Univ Hosp Bern, Ctr Lab Med, Univ Inst Clin Chem, Inselspital, CH-3010 Bern, Switzerland; [Lanz, Christian] Apotheke Dr Lanz, Langenthal, Switzerland; [Soydaner, Umut] AiFame AiLab, Wald Schonengrund, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Brenneisen, R (corresponding author), Univ Bern, Dept Clin Res, Lab Phytopharmacol Bioanalyt & Pharmacokinet, Bern, Switzerland.	rudolf.brenneisen@dkf.unibe.ch						Abrams DI, 2007, CLIN PHARMACOL THER, V82, P572, DOI 10.1038/sj.clpt.6100200; AGURELL S, 1986, PHARMACOL REV, V38, P21; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Baker D, 2003, LANCET NEUROL, V2, P291, DOI 10.1016/S1474-4422(03)00381-8; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEWEY WL, 1986, PHARMACOL REV, V38, P151; Dussy FE, 2005, FORENSIC SCI INT, V149, P3, DOI 10.1016/j.forsciint.2004.05.015; Earleywine Mitch, 2007, Harm Reduct J, V4, P11, DOI 10.1186/1477-7517-4-11; Fischedick J, 2010, CHEM PHARM BULL, V58, P201, DOI 10.1248/cpb.58.201; Food and Drug Administration, 2001, GUIDANCE FOR INDUSTR; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Gieringer D., 2004, Journal of Cannabis Therapeutics, V4, P7, DOI 10.1300/J175v04n01_02; Gieringer D, 1996, MAPS, V6, P59; Gieringer DH., 2001, J CANNABIS THERAPEUT, V1, P153, DOI [DOI 10.1300/J175V01N03_10, 10.1300/J175v01n03_10]; Grotenhermen F, 2012, DTSCH ARZTEBL INT, V109, P495, DOI 10.3238/arztebl.2012.0495; Hanus LO, 2009, MED RES REV, V29, P213, DOI 10.1002/med.20135; Hazekamp A, 2006, J PHARM SCI-US, V95, P1308, DOI 10.1002/jps.20574; LI HL, 1974, ECON BOT, V28, P437; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1963, TETRAHEDRON, V19, P2073, DOI 10.1016/0040-4020(63)85022-X; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Naef M, 2004, J PHARM SCI-US, V93, P1176, DOI 10.1002/jps.20037; O'Shaughnessy WB, 1838, T MED PHYS SOC BENGA, V1838-1840, P421; Pomahacova B, 2009, INHAL TOXICOL, V21, P1108, DOI 10.3109/08958370902748559; Pryce G, 2015, J NEUROIMMUNE PHARM, V10, P281, DOI 10.1007/s11481-014-9575-8; Radwan MM, 2009, J NAT PROD, V72, P906, DOI 10.1021/np900067k; Radwan MM, 2008, PHYTOCHEMISTRY, V69, P2627, DOI 10.1016/j.phytochem.2008.07.010; Russo E, 2006, MED HYPOTHESES, V66, P234, DOI 10.1016/j.mehy.2005.08.026; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Van Dam NT, 2010, INT J DRUG POLICY, V21, P511, DOI 10.1016/j.drugpo.2010.04.001; Zuurman L, 2008, J PSYCHOPHARMACOL, V22, P707, DOI 10.1177/0269881108089581	34	53	60	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147286	10.1371/journal.pone.0147286	http://dx.doi.org/10.1371/journal.pone.0147286			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784441	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400133
J	Matsushita, M; Otsuka, Y; Tsutsumida, N; Tanaka, C; Uchiumi, A; Ozawa, K; Suzuki, T; Ichikawa, D; Aburatani, H; Okamoto, S; Kawakami, Y; Hattori, Y				Matsushita, Maiko; Otsuka, Yohei; Tsutsumida, Naoya; Tanaka, Chiaki; Uchiumi, Akane; Ozawa, Koji; Suzuki, Takuma; Ichikawa, Daiju; Aburatani, Hiroyuki; Okamoto, Shinichiro; Kawakami, Yutaka; Hattori, Yutaka			Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; MYELOID-LEUKEMIA; IMMUNE-RESPONSE; T-LYMPHOCYTES; STEM-CELLS; CANCER; GENE; ANTIGENS; IMMUNOTHERAPY; INDUCTION	The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2 that is recognized by cytotoxic T cells (CTLs) is unknown. In this study, we revealed that PEPP2 gene was highly expressed in myeloid leukemia cells and some other hematological malignancies. This gene was also expressed in leukemic stem-like cells. We next identified the first reported epitope peptide (PEPP2(271-279)). The CTLs induced by PEPP2(271-279) recognized PEPP2-positive target cells in an HLA-A*24:02-restricted manner. We also found that a demethylating agent, 5-aza-2'-deoxycytidine, could enhance PEPP2 expression in leukemia cells but not in blood mononuclear cells from healthy donors. The cytotoxic activity of anti-PEPP2 CTL against leukemic cells treated with 5-aza-2'-deoxycytidine was higher than that directed against untreated cells. These results suggest a clinical rationale that combined treatment with this novel antigen-specific immunotherapy together with demethylating agents might be effective in therapy-resistant myeloid leukemia patients.	[Matsushita, Maiko; Otsuka, Yohei; Tsutsumida, Naoya; Tanaka, Chiaki; Uchiumi, Akane; Ozawa, Koji; Ichikawa, Daiju; Hattori, Yutaka] Keio Univ, Fac Pharm, Div Clin Physiol & Therapeut, Tokyo, Japan; [Suzuki, Takuma] Natl Canc Ctr, Div Pharm, 1-1 Tsukiji 5 chome, Tokyo, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Lab, Tokyo, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan	Keio University; National Cancer Center - Japan; University of Tokyo; Keio University; Keio University	Matsushita, M (corresponding author), Keio Univ, Fac Pharm, Div Clin Physiol & Therapeut, Tokyo, Japan.	matsushita-mk@pha.keio.ac.jp		Hattori, Yutaka/0000-0003-1080-9738	Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan; Friends of Leukemia Research Fund; Keio Gijuku Academic Development Funds	Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan; Friends of Leukemia Research Fund; Keio Gijuku Academic Development Funds	This work was supported by a Grant-in-Aid for Scientific Research and a grant from the Private University Strategic Research Base Development Program of MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan, Friends of Leukemia Research Fund, and Keio Gijuku Academic Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Aruga A, 2013, CLIN CANCER RES, V19, P2224, DOI 10.1158/1078-0432.CCR-12-3592; Bae J, 2015, LEUKEMIA, V29, P218, DOI 10.1038/leu.2014.159; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Coral S, 2012, BRIT J CANCER, V107, P1116, DOI 10.1038/bjc.2012.361; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; Jain N, 2009, CANCER-AM CANCER SOC, V115, P3924, DOI 10.1002/cncr.24468; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Li Q, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-63; Li Q, 2009, MOL PHARMACOL, V76, P1072, DOI 10.1124/mol.109.056291; Lin C, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-13; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Pandolfi A, 2013, STEM CELL TRANSL MED, V2, P143, DOI 10.5966/sctm.2012-0109; Pemmaraju N, 2013, CL LYMPH MYELOM LEUK, V13, P485, DOI 10.1016/j.clml.2013.02.023; Rezvani K, 2011, INT J HEMATOL, V93, P274, DOI 10.1007/s12185-011-0781-3; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; She MR, 2012, CANCER LETT, V318, P173, DOI 10.1016/j.canlet.2011.12.017; Shibata-Minoshima F, 2012, INT J ONCOL, V40, P93, DOI 10.3892/ijo.2011.1173; Terwijn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107587; Toor AA, 2012, BRIT J HAEMATOL, V158, P700, DOI 10.1111/j.1365-2141.2012.09225.x; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wong Rebecca S Y, 2012, Malays J Pathol, V34, P77; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146371	10.1371/journal.pone.0146371	http://dx.doi.org/10.1371/journal.pone.0146371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784514	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400034
J	Nealis, LJ; van Allen, ZM; Zelenski, JM				Nealis, Logan J.; van Allen, Zack M.; Zelenski, John M.			Positive Affect and Cognitive Restoration: Investigating the Role of Valence and Arousal	PLOS ONE			English	Article							SELF-CONTROL FAILURE; EGO DEPLETION; MODEL; EXPERIENCE; EMOTIONS	Positive moods are thought to restore self-control resources following depletion. However, it is not well understood whether this effect is due to affective valence (pleasantness), arousal (activation), or a combination of both. Across four studies, we set out to investigate the role of positive moods on cognitive and behavioral measures of self-regulation in an ego-depletion paradigm. In studies 1 and 2, we independently manipulated affective valence and arousal and assessed self-regulation with a Stroop task. Results did not suggest a restorative effect of either on cognitive resources. In study 3, we employed both behavioral (the 'handgrip task') and cognitive (Stroop) assessments of self-regulation. Again, no significant effect of mood was observed on the Stroop task. Additionally, participants did not persist significantly longer on the handgrip task following a positive mood induction. Finally, in study 4, high vs. low states of arousal were manipulated and self-regulation was assessed via pre- and post-manipulation Stroop performance. In study 4, Stroop performance improved slightly more across time points for those in the high arousal condition than for those in the low arousal condition. Therefore, across four studies, we failed to find a consistent pattern of results suggesting that positive moods restore cognitive resources.	[Nealis, Logan J.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [van Allen, Zack M.; Zelenski, John M.] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Dalhousie University; Carleton University	Zelenski, JM (corresponding author), Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada.	john_zelenski@carleton.ca		Zelenski, John/0000-0002-3668-5764; van Allen, Zack/0000-0002-5778-6441; Nealis, Logan/0000-0002-7176-8098	Social Sciences and Humanities Research Council of Canada [410-2009-1004, 435-2014-1068]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a Standard Research Grant (#410-2009-1004) and Insight Grant (#435-2014-1068) from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts HJEM, 2007, BRIT J SOC PSYCHOL, V46, P383, DOI 10.1348/014466606X130111; Barber S, 1998, AM ADAGIOS; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Dvorak A, 2007, DVORAK SLAVONIC DANC; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hagger MS, 2014, FRONT PSYCHOL, V5; Holst G, 1987, HOLST PLANETS CD ROM; Inzlicht M, 2015, NEWS EGO DEPLETIONS; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; Izzard CE, 1977, HUMAN EMOTIONS; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kuppens P, 2008, J RES PERS, V42, P1053, DOI 10.1016/j.jrp.2007.10.007; Kuppens P, 2013, PSYCHOL BULL, V139, P917, DOI 10.1037/a0030811; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lanski HJ, 1920, POLITICAL THOUGHT BR; Larsen R.J., 1992, EMOTION, P25; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; MURAVEN M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI DOI 10.1177/0146167203253209; Nicol Pegi, 2005, SOMETHING DANCING HE; Nisbet EK, 2011, PSYCHOL SCI, V22, P1101, DOI 10.1177/0956797611418527; PALLAK MS, 1975, B PSYCHONOMIC SOC, V6, P248, DOI 10.3758/BF03336652; R Core Team, 2021, R LANGUAGE ENV STAT; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAKLOFSKE DH, 1992, PERS INDIV DIFFER, V13, P623, DOI 10.1016/0191-8869(92)90204-3; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; Simonsohn U, 2015, PSYCHOL SCI, P1; Spielberg S, 1982, EXTRA TERRESTRIAL; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tice DM, 2007, J EXP SOC PSYCHOL, V43, P379, DOI 10.1016/j.jesp.2006.05.007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1980, J PERS SOC PSYCHOL, V38, P719, DOI 10.1037/0022-3514.38.5.719; Wenzel M, 2014, COGNITION EMOTION, V28, P747, DOI 10.1080/02699931.2013.851069; Wenzel M, 2013, EUR J SOC PSYCHOL, V43, P175, DOI 10.1002/ejsp.1936; Whelan DC, 2012, SOC PSYCHOL PERS SCI, V3, P430, DOI 10.1177/1948550611425194; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	43	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147275	10.1371/journal.pone.0147275	http://dx.doi.org/10.1371/journal.pone.0147275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784026	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400131
J	Saroka, KS; Vares, DE; Persinger, MA				Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.			Similar Spectral Power Densities Within the Schumann Resonance and a Large Population of Quantitative Electroencephalographic Profiles: Supportive Evidence for Koenig and Pobachenko	PLOS ONE			English	Article							EARTH-IONOSPHERE CAVITY; GEOMAGNETIC-ACTIVITY; MAGNETIC-FIELDS; BRAIN; EEG; STATES; OSCILLATIONS	In 1954 and 1960 Koenig and his colleagues described the remarkable similarities of spectral power density profiles and patterns between the earth-ionosphere resonance and human brain activity which also share magnitudes for both electric field (mV/m) and magnetic field (pT) components. In 2006 Pobachenko and colleagues reported real time coherence between variations in the Schumann and brain activity spectra within the 6-16 Hz band for a small sample. We examined the ratios of the average potential differences (similar to 3 mu V) obtained by whole brain quantitative electroencephalography (QEEG) between rostral- caudal and left-right (hemispheric) comparisons of 238 measurements from 184 individuals over a 3.5 year period. Spectral densities for the rostral-caudal axis revealed a powerful peak at 10.25 Hz while the left-right peak was 1.95 Hz with beat-differences of similar to 7.5 to 8 Hz. When global cerebral measures were employed, the first (7-8 Hz), second (13-14 Hz) and third (19-20 Hz) harmonics of the Schumann resonances were discernable in averaged QEEG profiles in some but not all participants. The intensity of the endogenous Schumann resonance was related to the 'best-of-fitness' of the traditional 4-class microstate model. Additional measurements demonstrated real-time coherence for durations approximating microstates in spectral power density variations between Schumann frequencies measured in Sudbury, Canada and Cumiana, Italy with the QEEGs of local subjects. Our results confirm the measurements reported by earlier researchers that demonstrated unexpected similarities in the spectral patterns and strengths of electromagnetic fields generated by the human brain and the earth-ionospheric cavity.	[Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.] Laurentian Univ, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada; [Saroka, Kevin S.; Vares, David E.; Persinger, Michael A.] Laurentian Univ, Human Studies Program, Sudbury, ON P3E 2C6, Canada; [Persinger, Michael A.] Laurentian Univ, Biomol Sci Programs, Sudbury, ON P3E 2C6, Canada	Laurentian University; Laurentian University; Laurentian University	Persinger, MA (corresponding author), Laurentian Univ, Behav Neurosci Lab, Sudbury, ON P3E 2C6, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Human Studies Program, Sudbury, ON P3E 2C6, Canada.; Persinger, MA (corresponding author), Laurentian Univ, Biomol Sci Programs, Sudbury, ON P3E 2C6, Canada.	mpersinger@laurentian.ca						Abeysuriya RG, 2014, CLIN NEUROPHYSIOL, V125, P2016, DOI 10.1016/j.clinph.2014.01.025; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; ANNINOS PA, 1991, INT J NEUROSCI, V60, P141, DOI 10.3109/00207459109080636; Babayev ES, 2007, ADV SPACE RES, V40, P1941, DOI 10.1016/j.asr.2007.02.099; Balazsi G, 2000, PHYS LETT A, V265, P304, DOI 10.1016/S0375-9601(99)00894-4; BALSER M, 1960, NATURE, V188, P638, DOI 10.1038/188638a0; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Booth JN, 2005, INT J NEUROSCI, V115, P1053, DOI 10.1080/00207450590901521; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Campbell WH, 1967, PHYS GEOMAGNETIC, P821; Corradini PL, 2014, BRAIN INJURY, V28, P1317, DOI 10.3109/02699052.2014.916819; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FRASERSMITH AC, 1975, J GEOPHYS RES-SPACE, V80, P3141, DOI 10.1029/JA080i022p03141; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Johnson LC, 1980, TECHNIQUES PSYCHOPHY, P329; Khanna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114163; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; KONIG H, 1960, NATURWISSENSCHAFTEN, V47, P486; KONIG HL, 1981, BIOL EFFECTS ENV ELE; LEHMANN D, 1995, INT J PSYCHOPHYSIOL, V19, P41, DOI 10.1016/0167-8760(94)00072-M; Lehmann D, 1998, INT J PSYCHOPHYSIOL, V29, P1, DOI 10.1016/S0167-8760(97)00098-6; MADDEN T, 1965, REV GEOPHYS, V3, P211, DOI 10.1029/RG003i002p00211; MINAKOV AA, 1992, IZV VUZ RADIOFIZ+, V35, P488; Mulligan BP, 2012, NEUROSCI LETT, V516, P54, DOI 10.1016/j.neulet.2012.03.054; Mulligan BP, 2010, ADV SPACE RES, V45, P940, DOI 10.1016/j.asr.2009.12.008; Nickolaenko A, 2014, SCHUMAN RESONANCE TY; Nunez Paul L., 1995, P68; NUNEZ PL, 1978, ELECTROEN CLIN NEURO, V44, P344, DOI 10.1016/0013-4694(78)90309-7; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Park TS, 2007, NEUROIMAGE, V35, P531, DOI 10.1016/j.neuroimage.2007.01.001; Pasqual-Marquis RD, 2002, METHOD FIND EXP CLIN, V24, pD5; Persinger M. A., 1974, ELF VLF ELECTROMAGNE; Persinger MA, 2012, J CONSCIOUSNESS STUD, V19, P128; Persinger MA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00019; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pobachenko S. V., 2006, Biophysics, V51, P480, DOI 10.1134/S0006350906030225; Polk C., 1982, CRC HDB ATMOSPHERICS, P111; ROWLAND VERNON, 1967, COND REFLEX, V2, P3; Ryskin G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063015; Sandyk R, 1997, J Altern Complement Med, V3, P365, DOI 10.1089/acm.1997.3.365; SANDYK R, 1995, INT J NEUROSCI, V81, P199, DOI 10.3109/00207459509004887; Saroka KS, 2014, NEUROSCI LETT, V560, P126, DOI 10.1016/j.neulet.2013.11.024; Saroka KS, 2014, INT LETT CHE PHYS AS, V39, P166; Schlegel K, 1999, J GEOPHYS RES-SPACE, V104, P10111, DOI 10.1029/1999JA900056; SCHUMANN WO, 1954, NATURWISSENSCHAFTEN, V41, P183, DOI 10.1007/BF00638174; TANAHASHI S, 1976, J ATMOS TERR PHYS, V38, P135, DOI 10.1016/0021-9169(76)90120-3; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Whitman JC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00080	50	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146595	10.1371/journal.pone.0146595	http://dx.doi.org/10.1371/journal.pone.0146595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785376	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400051
J	Slusser-Nore, A; Larson-Casey, JL; Zhang, RW; Zhou, XD; Somji, S; Garrett, SH; Sens, DA; Dunlevy, JR				Slusser-Nore, Andrea; Larson-Casey, Jennifer L.; Zhang, Ruowen; Zhou, Xu Dong; Somji, Seema; Garrett, Scott H.; Sens, Donald A.; Dunlevy, Jane R.			SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As+3- and Cd+2-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC	PLOS ONE			English	Article							GROWTH-FACTOR; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; PROTEIN; CANCER; PROGRESSION; CADMIUM; BIOLOGY; SPARC/OSTEONECTIN; OSTEONECTIN	Background This laboratory previously analyzed the expression of SPARC in the parental UROtsa cells, their arsenite (As+3) and cadmium (Cd+2)-transformed cell lines, and tumor transplants generated from the transformed cells. It was demonstrated that SPARC expression was down-regulated to background levels in Cd+2-and As+3-transformed UROtsa cells and tumor transplants compared to parental cells. In the present study, the transformed cell lines were stably transfected with a SPARC expression vector to determine the effect of SPARC expression on the ability of the cells to form tumors in immune-compromised mice. Methods Real time PCR, western blotting, immunohistochemistry, and immunofluorescence were used to define the expression of SPARC in the As+3-and Cd+2-transformed cell lines, and urospheres isolated from these cell lines, following their stable transfection with an expression vector containing the SPARC open reading frame (ORF). Transplantation of the cultured cells into immune-compromised mice by subcutaneous injection was used to assess the effect of SPARC expression on tumors generated from the above cell lines and urospheres. Results It was shown that the As+3-and Cd+2-transformed UROtsa cells could undergo stable transfection with a SPARC expression vector and that the transfected cells expressed both SPARC mRNA and secreted protein. Tumors formed from these SPARC-transfected cells were shown to have no expression of SPARC. Urospheres isolated from cultures of the SPARC-transfected As+3-and Cd+2-transformed cell lines were shown to have only background expression of SPARC. Urospheres from both the non-transfected and SPARC-transfected cell lines were tumorigenic and thus fit the definition for a population of tumor initiating cells. Conclusions Tumor initiating cells isolated from SPARC-transfected As+3-and Cd+2-transformed cell lines have an inherent mechanism to suppress the expression of SPARC mRNA.	[Slusser-Nore, Andrea; Zhang, Ruowen; Zhou, Xu Dong; Somji, Seema; Garrett, Scott H.; Sens, Donald A.] Univ N Dakota, Dept Pathol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Larson-Casey, Jennifer L.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Med, Birmingham, AL 35294 USA; [Slusser-Nore, Andrea; Dunlevy, Jane R.] Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of Alabama System; University of Alabama Birmingham; University of North Dakota Grand Forks	Dunlevy, JR (corresponding author), Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	jane.dunlevy@med.und.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986; Zhang, Ruowen/0000-0003-1403-2356	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, National Institutes of Health [P20 GM103442]; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE program from the National Institute of General Medical Sciences, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funds were provided by the Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota. Undergraduate research, student mentoring and core facilities for bioinformatics and statistics were supported by the ND INBRE program project P20 GM103442 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff CJ, 2009, CURR OPIN ONCOL, V21, P272, DOI 10.1097/CCO.0b013e328329f184; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Cheetham S, 2008, BRIT J CANCER, V98, P1810, DOI 10.1038/sj.bjc.6604377; Delostrinos CF, 2006, J CELL PHYSIOL, V206, P211, DOI 10.1002/jcp.20462; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Gilles C, 1998, CANCER RES, V58, P5529; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Hatina J, 2012, NEOPLASMA, V59, P728, DOI 10.4149/neo_2012_089; Hudson AE, 2005, J CELL PHYSIOL, V202, P453, DOI 10.1002/jcp.20140; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Koukourakis MI, 2003, CANCER RES, V63, P5376; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Mok SC, 1996, ONCOGENE, V12, P1895; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Petzoldt JL, 1995, UROL RES, V23, P377, DOI 10.1007/BF00698738; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Said N, 2013, J CLIN INVEST, V123, P4089, DOI 10.1172/JCI71241; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Watkins G, 2005, PROSTAG LEUKOTR ESS, V72, P267, DOI 10.1016/j.plefa.2004.12.003; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P391, DOI 10.4161/cbt.10.4.12449; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147362	10.1371/journal.pone.0147362	http://dx.doi.org/10.1371/journal.pone.0147362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783756	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400141
J	Krull, CR; Stanley, MC; Burns, BR; Choquenot, D; Etherington, TR				Krull, Cheryl R.; Stanley, Margaret C.; Burns, Bruce R.; Choquenot, David; Etherington, Thomas R.			Reducing Wildlife Damage with Cost-Effective Management Programmes	PLOS ONE			English	Article							PREDATOR-PREY THEORY; FERAL PIG DIGGINGS; SUS-SCROFA; FOREST; BOAR; IMPACTS; CONSERVATION; AUSTRALIA; EMPHASIS	Limiting the impact of wildlife damage in a cost effective manner requires an understanding of how control inputs change the occurrence of damage through their effect on animal density. Despite this, there are few studies linking wildlife management (control), with changes in animal abundance and prevailing levels of wildlife damage. We use the impact and management of wild pigs as a case study to demonstrate this linkage. Ground disturbance by wild pigs has become a conservation issue of global concern because of its potential effects on successional changes in vegetation structure and composition, habitat for other species, and functional soil properties. In this study, we used a 3-year pig control programme (ground hunting) undertaken in a temperate rainforest area of northern New Zealand to evaluate effects on pig abundance, and patterns and rates of ground disturbance and ground disturbance recovery and the cost effectiveness of differing control strategies. Control reduced pig densities by over a third of the estimated carrying capacity, but more than halved average prevailing ground disturbance. Rates of new ground disturbance accelerated with increasing pig density, while rates of ground disturbance recovery were not related to prevailing pig density. Stochastic simulation models based on the measured relationships between control, pig density and rate of ground disturbance and recovery indicated that control could reduce ground disturbance substantially. However, the rate at which prevailing ground disturbance was reduced diminished rapidly as more intense, and hence expensive, pig control regimes were simulated. The model produced in this study provides a framework that links conservation of indigenous ecological communities to control inputs through the reduction of wildlife damage and suggests that managers should consider carefully the marginal cost of higher investment in wildlife damage control, relative to its marginal conservation return.	[Krull, Cheryl R.] AUT Univ, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Stanley, Margaret C.; Burns, Bruce R.] Univ Auckland, Ctr Biodivers & Biosecur, Auckland 1, New Zealand; [Choquenot, David] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Etherington, Thomas R.] Royal Bot Gardens Kew, Wakehurst Pl, Ardingly, England; [Etherington, Thomas R.] Univ Auckland, Sch Environm, Auckland 1, New Zealand	Auckland University of Technology; University of Auckland; University of Canberra; Royal Botanic Gardens, Kew; University of Auckland	Krull, CR (corresponding author), AUT Univ, Inst Appl Ecol New Zealand, Auckland, New Zealand.	ckrull@aut.ac.nz	Burns, B R/A-1974-2014	Etherington, Thomas/0000-0002-3187-075X; Burns, Bruce/0000-0002-5002-4823	University of Auckland; Auckland Council; Manaaki Whenua Landcare Research	University of Auckland; Auckland Council; Manaaki Whenua Landcare Research	This study was funded by the University of Auckland (CK), Auckland Council (CK) and Manaaki Whenua Landcare Research (CK). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. However, council staff members were involved in the collection of data.	Alexiou P. N., 1983, Proceedings of the Ecological Society of Australia, V12, P135; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 1996, MANAGING VERTEBRATE; Barrios-Garcia MN, 2013, AUSTRAL ECOL, V38, P884, DOI 10.1111/aec.12027; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; BOWMAN DMJS, 1991, WILDLIFE RES, V18, P761, DOI 10.1071/WR9910761; BRATTON SP, 1975, ECOLOGY, V56, P1356, DOI 10.2307/1934702; Bueno CG, 2009, J ZOOL, V279, P195, DOI 10.1111/j.1469-7998.2009.00607.x; CALEY P, 1995, WILDLIFE RES, V22, P147, DOI 10.1071/WR9950147; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; Caughley G., 1977, Analysis of vertebrate populations.; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chavarria Pedro M., 2007, Human-Wildlife Conflicts, V1, P199; Choquenot D, 1998, J ANIM ECOL, V67, P887, DOI 10.1046/j.1365-2656.1998.6760887.x; Choquenot D, 1999, WILDLIFE RES, V26, P251, DOI 10.1071/WR98006; Choquenot D, 2001, BIOL CONSERV, V99, P29, DOI 10.1016/S0006-3207(00)00186-5; Choquenot D, 2005, P 13 AUSTR VERT PEST, P275; Conover MR, 2001, RESOLVING HUMAN WILD; Conway GR, 1981, THEORETICAL ECOLOGY, P356; Cushman JH, 2004, ECOL APPL, V14, P1746, DOI 10.1890/03-5142; Cuthbert R, 2002, BIOL CONSERV, V108, P69, DOI 10.1016/S0006-3207(02)00091-5; Dexter N, 1990, R1190 BUR RUR RES; Diong CH., 1982, T INT UNION GAME BIO, V14, P381; Engeman RM, 2007, BIOL CONSERV, V134, P440, DOI 10.1016/j.biocon.2006.08.033; Esler A.E, 1983, TANE, V29, P109, DOI DOI 10.1093/ANALYS/ANY035; Fordham D, 2006, BIOL CONSERV, V133, P379, DOI 10.1016/j.biocon.2006.07.001; GARROTT RA, 1993, CONSERV BIOL, V7, P946, DOI 10.1046/j.1523-1739.1993.740946.x; Giles J., 1980, DISSERTATION; Holling C. S., 1959, Canadian Entomologist, V91, P385; HONE J, 1990, AUST WILDLIFE RES, V17, P123, DOI 10.1071/WR9900123; HONE J, 1983, AUST WILDLIFE RES, V10, P269; HONE J, 1990, AUST WILDLIFE RES, V17, P131; HONE J, 1988, AUST J ECOL, V13, P393, DOI 10.1111/j.1442-9993.1988.tb00987.x; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; HONE J, 1989, WILDLIFE SOC B, V17, P419; HONE J, 1995, J APPL ECOL, V32, P311, DOI 10.2307/2405098; Hone J., 1994, ANAL VERTEBRATE PEST; Hone J., 2012, APPL POPULATION COMM; Hone J., 2007, WILDLIFE DAMAGE CONT; HOWE TD, 1981, J WILDLIFE MANAGE, V45, P748, DOI 10.2307/3808713; Ickes K, 2003, J ECOL, V91, P222, DOI 10.1046/j.1365-2745.2003.00767.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Krull CR, 2016, NEW ZEAL J ECOL, V40, P191; Krull CR, 2013, BIOL INVASIONS, V15, P2193, DOI 10.1007/s10530-013-0444-9; Krull CR, 2013, AUSTRAL ECOL, V38, P534, DOI 10.1111/j.1442-9993.2012.02444.x; Laurance WF, 1997, WILDLIFE RES, V24, P579, DOI 10.1071/WR96029; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Li A, 2010, 5 IUFRO PHYT DIS FOR; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mitchell J, 2007, WILDLIFE RES, V34, P597, DOI 10.1071/WR06064; Mitchell J, 2007, WILDLIFE RES, V34, P603, DOI 10.1071/WR06065; Mohr D, 2005, SOIL BIOL BIOCHEM, V37, P693, DOI 10.1016/j.soilbio.2004.10.002; Peters HA, 2001, BIOTROPICA, V33, P60, DOI 10.1111/j.1744-7429.2001.tb00157.x; RALPH CJ, 1984, BIOL CONSERV, V30, P291, DOI 10.1016/0006-3207(84)90048-X; Rollins D, 2001, WILDLIFE SOC B, V29, P39; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; SINGER FJ, 1984, J WILDLIFE MANAGE, V48, P464, DOI 10.2307/3801179; SPATZ G, 1975, Phytocoenologia, V3, P346; Sweitzer R. A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P219; THOMSON C, 1988, NEW ZEAL J ECOL, V11, P73	61	12	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146765	10.1371/journal.pone.0146765	http://dx.doi.org/10.1371/journal.pone.0146765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771384	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300033
J	Qiu, ZX; Sun, RF; Mo, XM; Li, WM				Qiu, Zhi-Xin; Sun, Rong-Fei; Mo, Xian-Ming; Li, Wei-Min			The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth	PLOS ONE			English	Article							S6 KINASE; PHOSPHORYLATION; OVEREXPRESSION; AMPLIFICATION; TRANSLATION; EXPRESSION; PREDICTS; TARGET; MTOR	Background As a serine/threonine protein kinase, p70S6K plays an important role in tumor cells. Evidence has revealed overexpression of p70S6K and phosphorylated p70S6K (p-p70S6K) in various tumor tissues, with these proteins identified as independent prognostic markers in non-small cell lung cancer (NSCLC). In this study, we explored the role of the p70S6K specific inhibitor PF-4708671 in NSCLC. Methods Three NSCLC cell lines (A549, SK-MES-1, and NCI-H460) were treated with PF-4708671 at five different concentrations, including 0.1 mu M, 0.3 mu M, 1 mu M, 3 mu M and 10 mu M, and protein levels were determined by Western-blot. Then, PF-4708671's effects were assessed both in vitro (cell proliferation, apoptosis, cell cycle distribution, and invasion) and in vivo. Results The expression levels of p-p70S6K and the downstream effector S6 were significantly reduced by PF-4708671. Diametrically opposite, the downstream protein levels of BAD, Caspase3 and ERK had increased after treatment with PF-4708671. In addition, PF-4708671 drastically inhibited cell proliferation and invasion ability in A549, SK-MES-1 and NCI-H460 cells in vitro, causing cell cycle arrest in G0-G1 phase. Limited effects of PF-4708671 were observed on apoptosis in the three NSCLC cell lines assessed. Importantly, PF-4708671 could inhibit tumorigenesis in nude mice in vivo. Conclusion These findings demonstrated that the p70S6K specific inhibitor PF-4708671 has inhibitory effects on NSCLC tumorigenesis in vitro and in vivo. Therefore, P70S6K should be considered a new potential therapeutic target, and PF-470867 may be used as targeted drug for cancer treatment.	[Qiu, Zhi-Xin; Li, Wei-Min] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China; [Sun, Rong-Fei] Tianjin First Cent Hosp, Dept Resp Med, Tianjin 300192, Peoples R China; [Mo, Xian-Ming] Sichuan Univ, Lab Stem Cell Biol, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Tianjin Medical University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China.	weimi003@yahoo.com	qiu, zhixin/HHC-0554-2022	qiu, zhixin/0000-0003-0256-4419	National Natural Science Foundation of China [81372504]; Science and Technology Support Program of Science and Technology Department of Sichuan Province [2014SZ-0148]; International Cooperation Program of Science and Technology Department of Sichuan Province [2014AA022202-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Science and Technology Department of Sichuan Province; International Cooperation Program of Science and Technology Department of Sichuan Province	This work was supported by the National Natural Science Foundation of China (No. 81372504), the Science and Technology Support Program of Science and Technology Department of Sichuan Province (2014SZ-0148), and the International Cooperation Program of Science and Technology Department of Sichuan Province (2014AA022202-2).	Baba HA, 2009, LIVER INT, V29, P399, DOI 10.1111/j.1478-3231.2008.01798.x; Barlund M, 2000, CANCER RES, V60, P5340; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Bussenius J, 2012, BIOORG MED CHEM LETT, V22, P2283, DOI 10.1016/j.bmcl.2012.01.105; Du W, 2013, LAB INVEST, V93, P1115, DOI 10.1038/labinvest.2013.98; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filonenko VV, 2004, EXP ONCOL, V26, P294; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Ip CKM, 2012, EXPERT OPIN THER TAR, V16, P619, DOI 10.1517/14728222.2012.684680; Kim EK, 2013, ANTICANCER RES, V33, P4073; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Li PD, 2012, MED ONCOL, V29, P3070, DOI 10.1007/s12032-012-0268-y; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Tolcher A, 2014, EUR J CANCER, V50, P867, DOI 10.1016/j.ejca.2013.11.039; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yoshida S, 2013, ANTICANCER RES, V33, P469; Zhang Y, 2013, ASIAN PAC J CANCER P, V14, P3725, DOI 10.7314/APJCP.2013.14.6.3725	29	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147185	10.1371/journal.pone.0147185	http://dx.doi.org/10.1371/journal.pone.0147185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771549	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300070
J	Moen, EL; Fricano-Kugler, CJ; Luikart, BW; O'Malley, AJ				Moen, Erika L.; Fricano-Kugler, Catherine J.; Luikart, Bryan W.; O'Malley, A. James			Analyzing Clustered Data: Why and How to Account for Multiple Observations Nested within a Study Participant?	PLOS ONE			English	Article							MODELS	A conventional study design among medical and biological experimentalists involves collecting multiple measurements from a study subject. For example, experiments utilizing mouse models in neuroscience often involve collecting multiple neuron measurements per mouse to increase the number of observations without requiring a large number of mice. This leads to a form of statistical dependence referred to as clustering. Inappropriate analyses of clustered data have resulted in several recent critiques of neuroscience research that suggest the bar for statistical analyses within the field is set too low. We compare naive analytical approaches to marginal, fixed-effect, and mixed-effect models and provide guidelines for when each of these models is most appropriate based on study design. We demonstrate the influence of clustering on a between-mouse treatment effect, a within-mouse treatment effect, and an interaction effect between the two. Our analyses demonstrate that these statistical approaches can give substantially different results, primarily when the analyses include a between-mouse treatment effect. In a novel analysis from a neuroscience perspective, we also refine the mixed-effect approach through the inclusion of an aggregate mouse-level counterpart to a within-mouse (neuron level) treatment as an additional predictor by adapting an advanced modeling technique that has been used in social science research and show that this yields more informative results. Based on these findings, we emphasize the importance of appropriate analyses of clustered data, and we aim for this work to serve as a resource for when one is deciding which approach will work best for a given study.	[Moen, Erika L.; O'Malley, A. James] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA; [Moen, Erika L.] Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH USA; [Fricano-Kugler, Catherine J.; Luikart, Bryan W.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [O'Malley, A. James] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Moen, EL (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA.	Erika.L.Moen@dartmouth.edu		Moen, Erika/0000-0002-9800-8742; Luikart, Bryan/0000-0002-3181-6075	National Institutes of Health [R25 CA134286, R01 MH097949-01]; Autism Speaks [7359]; NATIONAL CANCER INSTITUTE [R25CA134286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors received funding from the National Institutes of Health (www.nih.gov), under Award Numbers R25 CA134286 (ELM) and R01 MH097949-01 (BWL), as well as the Autism Speaks (www.autismspeaks.org) Pilot Grant #7359 (BWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Austin PC, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1195; Chu R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-21; Fleiss JL, 1973, EDUC PSYCHOL MEAS, V2, P113; Fricano CJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00030; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Gelman A, 2001, J ROY STAT SOC A STA, V164, P101, DOI 10.1111/1467-985X.00190; Hardin J.W., 2005, GEN ESTIMATING EQUAT; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; King G, 2014, POLIT ANAL, P1; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; Neter J., 1996, APPL LINEAR STAT MOD; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Parker RMA, 2014, ILAR J, V55, P477, DOI 10.1093/ilar/ilu044; Raudenbush SW, 2002, HIERARCHICAL LINEAR; StataCorp, 2013, STATA STAT SOFTW REL; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zyzanski SJ, 2004, ANN FAM MED, V2, P199, DOI 10.1370/afm.197	20	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146721	10.1371/journal.pone.0146721	http://dx.doi.org/10.1371/journal.pone.0146721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766425	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300036
J	Santos, EMM; Niessen, WJ; Yoo, AJ; Berkhemer, OA; Beenen, LF; Majoie, CB; Marquering, HA				Santos, Emilie M. M.; Niessen, Wiro J.; Yoo, Albert J.; Berkhemer, Olvert A.; Beenen, Ludo F.; Majoie, Charles B.; Marquering, Henk. A.		MR CLEAN Investigators	Automated Entire Thrombus Density Measurements for Robust and Comprehensive Thrombus Characterization in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; SUCCESSFUL RECANALIZATION; CT; SIGN; ATTENUATION; THROMBOLYSIS; PREDICTION; OCCLUSION; EFFICACY	Background and Purpose In acute ischemic stroke (AIS) management, CT-based thrombus density has been associated with treatment success. However, currently used thrombus measurements are prone to inter-observer variability and oversimplify the heterogeneous thrombus composition. Our aim was first to introduce an automated method to assess the entire thrombus density and then to compare the measured entire thrombus density with respect to current standard manual measurements. Materials and Method In 135 AIS patients, the density distribution of the entire thrombus was determined. Density distributions were described using medians, interquartile ranges (IQR), kurtosis, and skewedness. Differences between the median of entire thrombus measurements and commonly applied manual measurements using 3 regions of interest were determined using linear regression. Results Density distributions varied considerably with medians ranging from 20.0 to 62.8 HU and IQRs ranging from 9.3 to 55.8 HU. The average median of the thrombus density distributions (43.5 +/- 10.2 HU) was lower than the manual assessment (49.6 +/- 8.0 HU) (p<0.05). The difference between manual measurements and median density of entire thrombus decreased with increasing density (r = 0.64; p<0.05), revealing relatively higher manual measurements for low density thrombi such that manual density measurement tend overestimates the real thrombus density. Conclusions Automatic measurements of the full thrombus expose a wide variety of thrombi density distribution, which is not grasped with currently used manual measurement. Furthermore, discrimination of low and high density thrombi is improved with the automated method.	[Santos, Emilie M. M.; Niessen, Wiro J.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Santos, Emilie M. M.; Niessen, Wiro J.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Santos, Emilie M. M.; Berkhemer, Olvert A.; Beenen, Ludo F.; Majoie, Charles B.; Marquering, Henk. A.] AMC, Dept Radiol, Amsterdam, Netherlands; [Santos, Emilie M. M.; Marquering, Henk. A.] AMC, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Appl Phys, Delft, Netherlands; [Yoo, Albert J.] Texas Stroke Inst, Dept Radiol, Div Intervent Neuroradiol, Plano, TX USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Delft University of Technology	Santos, EMM (corresponding author), Erasmus MC, Dept Radiol, Rotterdam, Netherlands.	e.santos@erasmusmc.nl	Beenen, Ludo F/AAA-3114-2021; Demchuk, Andrew M/E-1103-2012; Jenniskens, S.F.M./L-4415-2015; van Dijk, Ewoud J/J-7951-2012	Beenen, Ludo F/0000-0001-9204-1026; Demchuk, Andrew M/0000-0002-4930-7789; Marquering, Henk/0000-0002-1414-6313; Emmer, Bart/0000-0001-8462-4037; Dippel, Diederik/0000-0002-9234-3515; Santos, Emilie/0000-0003-2153-1938; Brouwer, Patrick A./0000-0003-0041-2833; Niessen, Wiro/0000-0002-5822-1995; Van den Berg-Vos, Renske/0000-0003-3448-9441	Technology Foundation STW [11632]; MRCLEAN (Dutch Heart Foundation); ITEA2 project MEDUSA [10004]; Dutch Heart Foundation; AngioCare BV; Covidien/EV3(R); MEDAC Gmbh/LAMEPRO; Penumbra Inc.	Technology Foundation STW(Technologiestichting STW); MRCLEAN (Dutch Heart Foundation); ITEA2 project MEDUSA; Dutch Heart Foundation(Netherlands Heart Foundation); AngioCare BV; Covidien/EV3(R); MEDAC Gmbh/LAMEPRO; Penumbra Inc.	Part of this study has been funded by Technology Foundation STW under Grant 11632, MRCLEAN (Dutch Heart Foundation) (http://www.carisma-airspace.nl), and the rest by ITEA2 project MEDUSA under grant number 10004 (https://itea3.org/project/medusa.html). The MR CLEAN trial-from which the study data were retrospectively collected-was funded by the Dutch Heart Foundation (http://www.carisma-airspace.nl), and through unrestricted grants from AngioCare BV, Covidien/EV3 (R), MEDAC Gmbh/LAMEPRO and Penumbra Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MR CLEAN trial was funded by the Dutch Heart Foundation and through unrestricted grants from AngioCare BV, Covidien/EV3 (R), MEDAC Gmbh/LAMEPRO and Penumbra Inc.	Abul-Kasim K, 2009, ACTA NEUROL SCAND, V1983, P132; Ahn SS, 2012, EUR RADIOL, V22, P2392, DOI 10.1007/s00330-012-2518-y; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Brass LF, 2011, J THROMB HAEMOST, V9, P66, DOI 10.1111/j.1538-7836.2011.04364.x; Fanshawe TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002925; Fitzsimmons PR, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/843607; Froehler MT, 2013, J NEUROINTERV SURG, V5, P289, DOI 10.1136/neurintsurg-2012-010313; Heckel F, 2009, LECT NOTES INFORM; Jang I, 2015, DIFFERENTIAL SENSITI, P920; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kim EY, 2006, NEUROLOGY, V67, P1846, DOI 10.1212/01.wnl.0000244492.99737.a8; Kim EY, 2005, STROKE, V36, P2745, DOI 10.1161/01.STR.0000185720.03803.41; Kirchhof K, 2003, RADIOLOGY, V228, P126, DOI 10.1148/radiol.2273020530; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Krings T, 2006, STROKE, V37, P399, DOI 10.1161/01.STR.0000199062.09010.77; LEYS D, 1992, STROKE, V23, P317, DOI 10.1161/01.STR.23.3.317; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Manelfe C, 1999, STROKE, V30, P769, DOI 10.1161/01.STR.30.4.769; Moftakhar P, 2013, STROKE, V44, P243, DOI 10.1161/STROKEAHA.112.674127; Mortimer AM, 2011, CLIN RADIOL, V66, P551, DOI 10.1016/j.crad.2010.09.022; Niesten JM, 2014, CEREBROVASC DIS, V37, P116, DOI 10.1159/000357420; Niesten JM, 2013, NEURORADIOLOGY, V55, P1071, DOI 10.1007/s00234-013-1217-y; Niesten JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088882; Ozdemir O, 2008, STROKE, V39, P2011, DOI 10.1161/STROKEAHA.107.505230; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Riedel CH, 2012, STROKE, V43, P2319, DOI 10.1161/STROKEAHA.112.649921; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Santos EMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101985; Santos EMM, 2015, OBSERVER VARIABILITY; Tomsick T, 1996, AM J NEURORADIOL, V17, P79; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Yilmaz U, 2013, AM J NEURORADIOL, V34, P2184, DOI 10.3174/ajnr.A3565; Yoo AJ, 2011, EXPERT REV CARDIOVAS, V9, P857, DOI [10.1586/erc.11.56, 10.1586/ERC.11.56]	33	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145641	10.1371/journal.pone.0145641	http://dx.doi.org/10.1371/journal.pone.0145641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765847	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300008
J	Choi, YJ; Baek, GY; Park, HR; Jo, SK; Jung, U				Choi, Yeo-Jin; Baek, Ga-Young; Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee			Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; STEM-CELLS; GROWTH-FACTOR; TUMOR PROGRESSION; RADIOTHERAPY; IDENTIFICATION; METASTASIS; MIGRATION; BIOMARKER; INVASION	The control of radioresistance and metastatic potential of surviving cancer cells is important for improving cancer eradication by radiotheraphy. The distal-less homeobox2 (DLX2) gene encodes for a homeobox transcription factor involved in morphogenesis and its deregulation was found in human solid tumors and hematologic malignancies. Here we investigated the role of DLX2 in association with radiation-induced epithelial to mesenchymal transition (EMT) and stem cell-like properties and its regulation by Smad2/3 signaling in irradiated A549 and MDA-MB-231 human cancer cell lines. In irradiated A549 and MDA-MB-231 cells, EMT was induced as demonstrated by EMT marker expression, phosphorylation of Smad2/3, and migratory and invasive ability. Also, irradiated A549 and MDA-MB-231 cells showed increased cancer stem cells (CSCs) marker. Interestingly, DLX2 was overexpressed upon irradiation. Therefore, we examined the role of DLX2 in radiation-induced EMT and radioresistance. The overexpression of DLX2 alone induced EMT, migration and invasion, and CSC marker expression. The reduced colony-forming ability in irradiated cells was partially restored by DLX2 overexpression. On the other hand, the depletion of DLX2 using si-RNA abolished radiation-induced EMT, CSC marker expression, and phosphorylation of Smad2/3 in irradiated A549 and MDA-MB-231 cells. Also, depletion of DLX2 increased the radiation sensitivity in both cell lines. Moreover, knockdown of Smad2/3, a key activator of TGF-131 pathway, abrogated the radiation-induced DLX2 expression, indicating that radiation-induced DLX2 expression is dependent on Smad2/3 signaling. These results demonstrated that DLX2 plays a crucial role in radioresistance, radiation-induced EMT and CSC marker expression, and the expression of DLX2 is regulated by Smad2/3 signaling in A549 and MDA-MB-231 cell lines.	[Choi, Yeo-Jin; Baek, Ga-Young; Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee] KAERI, Radiat Biotechnol Res Div, Adv Radiat Technol Inst, Jeongeup, South Korea; [Park, Hae-Ran; Jo, Sung-Kee; Jung, Uhee] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea	Korea Atomic Energy Research Institute (KAERI); University of Science & Technology (UST)	Jung, U (corresponding author), KAERI, Radiat Biotechnol Res Div, Adv Radiat Technol Inst, Jeongeup, South Korea.; Jung, U (corresponding author), Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea.	uhjung@kaeri.re.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2013M2A2A7043663]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) grant funded by Korea government (MSIP) (No. 2013M2A2A7043663).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Baumann M, 2010, CLIN CANCER RES, V16, P5091, DOI 10.1158/1078-0432.CCR-10-2244; Bentzen SM, 2010, INT J RADIAT ONCOL, V76, pS145, DOI 10.1016/j.ijrobp.2009.08.076; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brunner TB, 2012, SEMIN RADIAT ONCOL, V22, P151, DOI 10.1016/j.semradonc.2011.12.003; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Du S, 2013, SEMIN RADIAT ONCOL, V23, P242, DOI 10.1016/j.semradonc.2013.05.001; Dubrovska A, 2014, INT J RADIAT BIOL, V90, P607, DOI 10.3109/09553002.2014.920968; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferrari N, 2003, J LEUKOCYTE BIOL, V74, P302, DOI 10.1189/jlb.1102581; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuonen F, 2012, CLIN CANCER RES, V18, P5196, DOI 10.1158/1078-0432.CCR-11-1758; Lee SY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-113; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Mizutani H, 2010, ONCOL LETT, V1, P1011, DOI 10.3892/ol.2010.190; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Ogawa K, 2013, ANTICANCER RES, V33, P747; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Samuel S, 2005, EUR J CANCER, V41, P2428, DOI 10.1016/j.ejca.2005.08.014; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Starkova J, 2011, HAEMATOL-HEMATOL J, V96, P820, DOI 10.3324/haematol.2010.031179; Tang P, 2013, WORLD J GASTROENTERO, V19, P2697, DOI 10.3748/wjg.v19.i17.2697; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319; Zhao B, 2014, SCI CAIRO, V2014; Zielske SP, 2011, TRANSL ONCOL, V4, P217, DOI 10.1593/tlo.10247	45	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147343	10.1371/journal.pone.0147343	http://dx.doi.org/10.1371/journal.pone.0147343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799321	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300097
J	Madani, N; Kimball, JS; Nazeri, M; Kumar, L; Affleck, DLR				Madani, Nima; Kimball, John S.; Nazeri, Mona; Kumar, Lalit; Affleck, David L. R.			Remote Sensing Derived Fire Frequency, Soil Moisture and Ecosystem Productivity Explain Regional Movements in Emu over Australia	PLOS ONE			English	Article							PATTERNS; BIRDS; DISTRIBUTIONS; DISPERSAL; EMISSIONS; HABITAT; AREA	Species distribution modeling has been widely used in studying habitat relationships and for conservation purposes. However, neglecting ecological knowledge about species, e.g. their seasonal movements, and ignoring the proper environmental factors that can explain key elements for species survival (shelter, food and water) increase model uncertainty. This study exemplifies how these ecological gaps in species distribution modeling can be addressed by modeling the distribution of the emu (Dromaius novaehollandiae) in Australia. Emus cover a large area during the austral winter. However, their habitat shrinks during the summer months. We show evidence of emu summer habitat shrinkage due to higher fire frequency, and low water and food availability in northern regions. Our findings indicate that emus prefer areas with higher vegetation productivity and low fire recurrence, while their distribution is linked to an optimal intermediate (similar to 0.12 m(3) m(-3)) soil moisture range. We propose that the application of three geospatial data products derived from satellite remote sensing, namely fire frequency, ecosystem productivity, and soil water content, provides an effective representation of emu general habitat requirements, and substantially improves species distribution modeling and representation of the species' ecological habitat niche across Australia.	[Madani, Nima; Kimball, John S.] Univ Montana, Numer Terradynam Simulat Grp, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA; [Nazeri, Mona] Univ Montana, Sch Journalism, Dept Environm Journalism, 32 Campus Dr, Missoula, MT 59812 USA; [Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Ecosyst Management, Ring Rd, Armidale, NSW 2351, Australia; [Affleck, David L. R.] Univ Montana, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of New England; University of Montana System; University of Montana	Madani, N (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Coll Forestry & Conservat, 32 Campus Dr, Missoula, MT 59812 USA.	nima.madani@ntsg.umt.edu	Madani, Nima/A-2840-2016; Kumar, Lalit/A-6397-2011; Kimball, John S/B-9234-2011	Madani, Nima/0000-0003-2853-7611; Kumar, Lalit/0000-0002-9205-756X; 	NASA [NX14AI50G, NNX15AB59G]	NASA(National Aeronautics & Space Administration (NASA))	This study was conducted with funding provided by NASA Earth Science Program (NNX14AI50G, NNX15AB59G).	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barrett G., NEW ATLAS AUSTR BIRD; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; BirdLife International, 2012, DROM NOV IUCN RED LI; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; Calvino-Cancela M, 2006, ECOGRAPHY, V29, P632, DOI 10.1111/j.0906-7590.2006.04677.x; Chuang TW, 2012, REMOTE SENS ENVIRON, V125, P147, DOI 10.1016/j.rse.2012.07.018; DAWSON TJ, 1984, EMU, V84, P93, DOI 10.1071/MU9840093; Diaz-Delgado R, 2002, ECOLOGY, V83, P2293, DOI 10.1890/0012-9658(2002)083[2293:SEODRI]2.0.CO;2; Dingle D. H., 1996, MIGRATION BIOL LIFE; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dunstan H, 2013, EMU, V113, P168, DOI 10.1071/MU12061; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Google Earth Engine Team, 2015, GOOGL EARTH ENG PLAN; Griffioen PA, 2002, EMU, V102, P99, DOI 10.1071/MU01024; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kozhoridze G, 2015, ECOGRAPHY, V38, P1141, DOI 10.1111/ecog.01496; Kumar M., 1981, Plants and the daylight spectrum. [Smith, H. (Editor)]., P133; Leavesley AJ, 2010, INT J WILDLAND FIRE, V19, P949, DOI 10.1071/WF09028; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Madani N, 2014, J GEOPHYS RES-BIOGEO, V119, P1755, DOI 10.1002/2014JG002709; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Morin X, 2013, ECOGRAPHY, V36, P300, DOI 10.1111/j.1600-0587.2012.07340.x; Myneni RB, 1999, NASA GODDARD SP FLIG, V121, P126; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Nield AP, 2015, EMU, V115, P29, DOI 10.1071/MU13113; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; R Core Team, 2013, R LANG ENV STAT COMP; Ramon S., 2010, MODIS VEGETATION IND; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; SCHWARTZ CC, 1991, WILDLIFE MONOGR, P1; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Szabo JK, 2007, EMU, V107, P89, DOI 10.1071/MU06020; Wagner W., 2012, ISPRS ANN PHOTOGRAMM, V17, P315, DOI [10.5194/isprsannals-I-7-315-2012, DOI 10.5194/ISPRSANNALS-I-7-315-2012]; Whetton P, 2012, CLIMATIC CHANGE, V115, P433, DOI 10.1007/s10584-012-0471-z; Wiedinmyer C, 2006, ATMOS ENVIRON, V40, P3419, DOI 10.1016/j.atmosenv.2006.02.010; Wood S.N, 2006, GEN ADDITIVE MODELS, DOI DOI 10.1201/9781315370279; World Resources Institute, 2005, MILL EC ASS EC HUM W; Zager P.E., 1983, INT C BEAR RES MANAG, V5, P124, DOI DOI 10.2307/3872529; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	54	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147285	10.1371/journal.pone.0147285	http://dx.doi.org/10.1371/journal.pone.0147285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799732	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300086
J	Ohde, D; Moeller, M; Brenmoehl, J; Walz, C; Ponsuksili, S; Schwerin, M; Fuellen, G; Hoeflich, A				Ohde, Daniela; Moeller, Mark; Brenmoehl, Julia; Walz, Christina; Ponsuksili, Siriluck; Schwerin, Manfred; Fuellen, Georg; Hoeflich, Andreas			Advanced Running Performance by Genetic Predisposition in Male Dummerstorf Marathon Mice (DUhTP) Reveals Higher Sterol Regulatory Element-Binding Protein (SREBP) Related mRNA Expression in the Liver and Higher Serum Levels of Progesterone	PLOS ONE			English	Article							MASS-SPECTROMETRY ASSAY; ARTIFICIAL SELECTION; EXERCISE; GLUCOKINASE; QUANTIFICATION; ADAPTATIONS; METABOLISM; CAPACITY; MUSCLE; BORN	Long-term-selected DUhTP mice represent a non-inbred model for inborn physical high-performance without previous training. Abundance of hepatic mRNA in 70-day male DUhTP and control mice was analyzed using the Affymetrix mouse array 430A 2.0. Differential expression analysis with PLIER corrected data was performed using AltAnalyze. Searching for over-representation in biochemical pathways revealed cholesterol metabolism being most prominently affected in DUhTP compared to unselected control mice. Furthermore, pathway analysis by AltAnalyze plus PathVisio indicated significant induction of glycolysis, fatty acid synthesis and cholesterol biosynthesis in the liver of DUhTP mice versus unselected control mice. In contrast, gluconeogenesis was partially inactivated as judged from the analysis of hepatic mRNA transcript abundance in DUhTP mice. Analysis of mRNA transcripts related to steroid hormone metabolism inferred elevated synthesis of progesterone and reduced levels of sex steroids. Abundance of steroid delta isomerase-5 mRNA (Hsd3b5, FC 4.97) was increased and steroid 17-alpha-monooxygenase mRNA (Cyp17a1, FC -11.6) was massively diminished in the liver of DUhTP mice. Assessment of steroid profiles by LC-MS revealed increased levels of progesterone and decreased levels of sex steroids in serum from DUhTP mice versus controls. Analysis of hepatic mRNA transcript abundance indicates that sterol regulatory element-binding protein-1 (SREBP-1) may play a major role in metabolic pathway activation in the marathon mouse model DUhTP. Thus, results from bioinformatics modeling of hepatic mRNA transcript abundance correlated with direct steroid analysis by mass spectrometry and further indicated functions of SREBP-1 and steroid hormones for endurance performance in DUhTP mice.	[Ohde, Daniela; Brenmoehl, Julia; Walz, Christina; Ponsuksili, Siriluck; Schwerin, Manfred; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Moeller, Mark; Fuellen, Georg] Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock	Hoeflich, A (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.; Fuellen, G (corresponding author), Univ Rostock, Med Ctr, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany.	fuellen@uni-rostock.de; hoeflich@fbn-dummerstorf.de		Ohde, Daniela/0000-0002-0669-8409	H. Wilhelm Schaumann Stiftung; BMBF as part of the GerontoSys initiative (ROSAge project) [FKZ 0315892]; Deutsche Forschungsgemeinschaft [DFG HO 2003/6-1]; BMBF Verbundprojekt ROSAge [FKZ 0315892A]; EU [633589]	H. Wilhelm Schaumann Stiftung; BMBF as part of the GerontoSys initiative (ROSAge project)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF Verbundprojekt ROSAge(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	D.O. received a stipend from the H. Wilhelm Schaumann Stiftung. G.F. and A. H. were supported by grants from the BMBF as part of the GerontoSys initiative (ROSAge project), FKZ 0315892 and from the Deutsche Forschungsgemeinschaft (DFG HO 2003/6-1), respectively. M.M. and G.F. were supported by the BMBF Verbundprojekt ROSAge, FKZ 0315892A and the EU's Horizon 2020 research and innovation program under grant agreement No. 633589. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Ben-Zaken S, 2015, GROWTH HORM IGF RES, V25, P196, DOI 10.1016/j.ghir.2015.04.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; BONEN A, 1979, EUR J APPL PHYSIOL O, V42, P15, DOI 10.1007/BF00421100; Brenmoehl J, 2013, MED SCI SPORT EXER, V45, P841, DOI 10.1249/MSS.0b013e31827e0fca; Cai HL, 2010, ANAL BIOCHEM, V396, P103, DOI 10.1016/j.ab.2009.09.015; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Falkenberg H, 2000, ARCH TIERZUCHT, V43, P513, DOI 10.5194/aab-43-513-2000; Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427; Gomes M, 2015, OMICS, V19, P499, DOI 10.1089/omi.2015.0065; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Hawley JA, 2014, CLIN EXP PHARMACOL P, V41, P608, DOI 10.1111/1440-1681.12246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JENSEN CE, 1995, FERTIL STERIL, V64, P1189, DOI 10.1016/S0015-0282(16)57983-7; JEZOVA D, 1985, EUR J APPL PHYSIOL, V54, P62, DOI 10.1007/BF00426300; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Keski-Rahkonen P, 2011, J STEROID BIOCHEM, V127, P396, DOI 10.1016/j.jsbmb.2011.06.006; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kunze M, 2015, J CHROMATOGR B, V1007, P132, DOI 10.1016/j.jchromb.2015.10.010; Kushnir MM, 2008, AM J CLIN PATHOL, V129, P530, DOI 10.1309/LC03BHQ5XJPJYEKG; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Lazovic B, 2015, EUR REV MED PHARMACO, V19, P2269; Lira FS, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/809576; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Marwah A, 2001, J CHROMATOGR B, V757, P333, DOI 10.1016/S0378-4347(01)00171-2; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miles JL, 2009, ENDOCRINOLOGY, V150, P179, DOI 10.1210/en.2008-1035; Murray A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-76; Nirogi R, 2013, J CHROMATOGR B, V913, P41, DOI 10.1016/j.jchromb.2012.09.034; O'Shaughnessy PJ, 2013, MOL HUM REPROD, V19, P177, DOI 10.1093/molehr/gas059; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Seifert T, 2009, AM J PHYSIOL-REG I, V297, pR867, DOI 10.1152/ajpregu.00277.2009; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Templeman NM, 2012, AM J PHYSIOL-REG I, V303, pR101, DOI 10.1152/ajpregu.00511.2011; THORENS B, 1992, INT REV CYTOL, V137A, P209; Vaanholt LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P148, DOI 10.1086/525289; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vesterinen V, 2016, INT J SPORT PHYSIOL, V11, P393, DOI 10.1123/ijspp.2015-0366; Wasfy MM, 2015, JOURNAL OF THE AMERI, DOI [10.1016/j.echo.2015.08.002, DOI 10.1016/J.ECH0.2015.08.002]; Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089; ZAWALICH W, 1982, AM J PHYSIOL, V243, pE464, DOI 10.1152/ajpendo.1982.243.6.E464; Zhan WZ, 1999, J APPL PHYSIOL, V87, P2326, DOI 10.1152/jappl.1999.87.6.2326; Zhang SM, 2008, J PHARMACEUT BIOMED, V48, P1174, DOI 10.1016/j.jpba.2008.08.024; Znazen H, 2015, THE JOURNAL OF SPORT	56	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146748	10.1371/journal.pone.0146748	http://dx.doi.org/10.1371/journal.pone.0146748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799318	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300033
J	Kubo, T; Kubo, MO				Kubo, Tai; Kubo, Mugino O.			Nonplantigrade Foot Posture: A Constraint on Dinosaur Body Size	PLOS ONE			English	Article							BASAL METABOLIC-RATE; ORNITHISCHIAN DINOSAURS; RANDOM-WALKS; EVOLUTION; MAMMALS; MASS; DIVERSITY; SELECTIVITY; EXTINCTION; RADIATION	Dinosaurs had functionally digitigrade or sub-unguligrade foot postures. With their immediate ancestors, dinosaurs were the only terrestrial nonplantigrades during the Mesozoic. Extant terrestrial mammals have different optimal body sizes according to their foot posture (plantigrade, digitigrade, and unguligrade), yet the relationship of nonplantigrade foot posture with dinosaur body size has never been investigated, even though the body size of dinosaurs has been studied intensively. According to a large dataset presented in this study, the body sizes of all nonplantigrades (including nonvolant dinosaurs, nonvolant terrestrial birds, extant mammals, and extinct Nearctic mammals) are above 500 g, except for macroscelid mammals (i.e., elephant shrew), a few alvarezsauroid dinosaurs, and nondinosaur ornithodirans (i.e., the immediate ancestors of dinosaurs). When nonplantigrade tetrapods evolved from plantigrade ancestors, lineages with nonplantigrade foot posture exhibited a steady increase in body size following Cope's rule. In contrast, contemporaneous plantigrade lineages exhibited no trend in body size evolution and were largely constrained to small body sizes. This evolutionary pattern of body size specific to foot posture occurred repeatedly during both the Mesozoic and the Cenozoic eras. Although disturbed by the end-Cretaceous extinction, species of mid to large body size have predominantly been nonplantigrade animals from the Jurassic until the present; conversely, species with small body size have been exclusively composed of plantigrades in the nonvolant terrestrial tetrapod fauna.	[Kubo, Tai] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo, Japan; [Kubo, Mugino O.] Univ Tokyo, Dept Nat Environm Studies, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo, Japan.	taikubo@um.u-tokyo.ac.jp		Kubo, Mugino/0000-0002-7748-7377; Kubo, Tai/0000-0003-3207-0399	Japan Society for the Promotion of Science (JSPS KAKENHI) [26800267]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26800267) to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bates KT, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0215; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Brassey CA, 2015, BIOL LETT, V11, P3; Brown CM, 2013, J VERTEBR PALEONTOL, V33, P495, DOI 10.1080/02724634.2013.746229; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carrano MT, 1997, ZOOL J LINN SOC-LOND, V121, P77; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Damuth J., 1990, BODY SIZE MAMMALIAN, P412; Dunning J. B., 2008, CRC HDB AVIAN BODY M, P672; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fara E, 2000, GEOBIOS-LYON, V33, P387, DOI 10.1016/S0016-6995(00)80166-7; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hunt G., 2010, QUANTITATIVE METHODS, P245; Hunt G, 2008, EVOLUTION GEOBIOLOGY, P578; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Lovegrove BG, 2013, J EVOLUTION BIOL, V26, P1317, DOI 10.1111/jeb.12138; Lovegrove BG, 2014, J EXP BIOL, V217, P1316, DOI 10.1242/jeb.095737; Lovegrove BG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P916, DOI 10.1086/425189; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Lovegrove BG, 2004, OECOLOGIA, V138, P13, DOI 10.1007/s00442-003-1376-3; Lovegrove BG, 2001, EVOLUTION, V55, P1464; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Macdonald DW, 2006, PRINCETON ENCY MAMMA, P936; Maidment SCR, 2014, NATURWISSENSCHAFTEN, V101, P989, DOI 10.1007/s00114-014-1239-2; Moreno K, 2007, J MORPHOL, V268, P50, DOI 10.1002/jmor.10498; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Parrish MJ, 1986, HUNTERIA, V1, P1; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Polly P. David, 2010, P374; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Tanaka I, 2015, LETHAIA, V48, P188, DOI 10.1111/let.12098; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2013, GEOL SOC SPEC PUBL, V379, P573, DOI 10.1144/SP379.15; Van der Geer A., 2010, EVOLUTION ISLAND MAM, DOI [10.1002/9781444323986, DOI 10.1002/9781444323986]; Wilson GP, 2013, PALEOBIOLOGY, V39, P429, DOI 10.1666/12041	49	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145716	10.1371/journal.pone.0145716	http://dx.doi.org/10.1371/journal.pone.0145716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790003	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100015
J	Lakshminarayanan, V; Supekar, NT; Wei, J; McCurry, DB; Dueck, AC; Kosiorek, HE; Trivedi, PP; Bradley, JM; Madsen, CS; Pathangey, LB; Hoelzinger, DB; Wolfert, MA; Boons, GJ; Cohen, PA; Gendler, SJ				Lakshminarayanan, Vani; Supekar, Nitin T.; Wei, Jie; McCurry, Dustin B.; Dueck, Amylou C.; Kosiorek, Heidi E.; Trivedi, Priyanka P.; Bradley, Judy M.; Madsen, Cathy S.; Pathangey, Latha B.; Hoelzinger, Dominique B.; Wolfert, Margreet A.; Boons, Geert-Jan; Cohen, Peter A.; Gendler, Sandra J.			MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; CELL LUNG-CANCER; BREAST-CANCER; DENDRITIC CELLS; T-CELLS; PANCREATIC-CANCER; ERADICATE TUMORS; SELF-TOLERANCE; IN-VIVO; ANTIGEN	It remains challenging to produce decisive vaccines against MUC1, a tumor-associated antigen widely expressed by pancreas, breast and other tumors. Employing clinically relevant mouse models, we ruled out such causes as irreversible T-cell tolerance, inadequate avidity, and failure of T-cells to recognize aberrantly glycosylated tumor MUC1. Instead, every tested MUC1 preparation, even non-glycosylated synthetic 9mer peptides, induced interferon gamma-producing CD4(+) and CD8(+) T-cells that recognized glycosylated variants including tumor-associated MUC1. Vaccination with synthetic peptides conferred protection as long as vaccination was repeated post tumor challenge. Failure to revaccinate post challenge was associated with down-regulated tumor MUC1 and MHC molecules. Surprisingly, direct admixture of MUC1-expressing tumor with MUC1-hyperimmune T-cells could not prevent tumor outgrowth or MUC1 immunoediting, whereas ex vivo activation of the hyperimmune T-cells prior to tumor admixture rendered them curative. Therefore, surrogate T-cell preactivation outside the tumor bed, either in culture or by repetitive vaccination, can over-come tumor escape.	[Lakshminarayanan, Vani; Wei, Jie; Trivedi, Priyanka P.; Bradley, Judy M.; Madsen, Cathy S.; Pathangey, Latha B.; Hoelzinger, Dominique B.; Cohen, Peter A.; Gendler, Sandra J.] Mayo Clin Arizona, Dept Immunol, Scottsdale, AZ USA; [Gendler, Sandra J.] Mayo Clin Arizona, Dept Biochem Mol Biol, Scottsdale, AZ USA; [McCurry, Dustin B.; Cohen, Peter A.; Gendler, Sandra J.] Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA; [Dueck, Amylou C.; Kosiorek, Heidi E.] Mayo Clin Arizona, Biostat, Scottsdale, AZ USA; [Supekar, Nitin T.; Wolfert, Margreet A.; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University System of Georgia; University of Georgia	Cohen, PA; Gendler, SJ (corresponding author), Mayo Clin Arizona, Dept Immunol, Scottsdale, AZ USA.; Gendler, SJ (corresponding author), Mayo Clin Arizona, Dept Biochem Mol Biol, Scottsdale, AZ USA.; Cohen, PA; Gendler, SJ (corresponding author), Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA.; Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu; cohen.peter@mayo.edu; gendler.sandra@mayo.edu	Boons, Geert-Jan P H/J-3211-2016; Supekar, Nitin/K-5737-2019; Wolfert, Margreet A/J-1726-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Supekar, Nitin/0000-0002-7006-7177; Wolfert, Margreet A/0000-0003-4864-0026; Lakshminarayanan, Vani/0000-0002-1750-7858; McCurry, Dustin/0000-0003-0585-3259	National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant [P50 CA116201]; Mayo Pancreas SPORE Grant [P50 CA102701, RO1 CA64389, RO1 CA88986]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA088986, P50CA116201, P30CA015083, P50CA102701, R01CA064389] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant; Mayo Pancreas SPORE Grant; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute of the US National Institutes of Health Mayo Breast Specialized Programs of Research Excellence (SPORE) Grant P50 CA116201 (to S.J.G.), Mayo Pancreas SPORE Grant P50 CA102701 (to P.A.C. and S.J.G.), RO1 CA64389 (to S.J.G.), RO1 CA88986 (to G.-J.B.) and the Mayo Foundation.	Apostolopoulos V, 1998, J IMMUNOL, V161, P767; Beatty P, 2012, ONCOIMMUNOLOGY, V1, P263, DOI 10.4161/onci.18950; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Carmon L, 2015, BRIT J HAEMATOL, V169, P44, DOI 10.1111/bjh.13245; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chawla A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28325; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cloosen S, 2007, CANCER RES, V67, P3919, DOI 10.1158/0008-5472.CAN-06-2112; Cohen PA, 2008, BLOOD, V112, P1832, DOI 10.1182/blood-2007-12-130138; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fu J, 2014, CANCER RES, V74, P4042, DOI 10.1158/0008-5472.CAN-13-2685; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; Gong JL, 1998, P NATL ACAD SCI USA, V95, P6279, DOI 10.1073/pnas.95.11.6279; Grinstead JS, 2003, BIOCHEMISTRY-US, V42, P14293, DOI 10.1021/bi0301237; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hanisch FG, 2003, EUR J IMMUNOL, V33, P3242, DOI 10.1002/eji.200324189; Hattrup CL, 2008, BREAST CANCER-BASIC, V1, P57; Hemmer B, 2000, INT IMMUNOL, V12, P375, DOI 10.1093/intimm/12.3.375; Inderberg-Suso EM, 2012, ONCOIMMUNOLOGY, V1, P670, DOI 10.4161/onci.20426; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kmieciak M, 2007, EUR J IMMUNOL, V37, P675, DOI 10.1002/eji.200636639; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Kohlgraf KG, 2004, CANCER IMMUNOL IMMUN, V53, P1068, DOI 10.1007/s00262-004-0557-1; Koido S, 2014, ANTICANCER RES, V34, P3917; Kondo H, 2008, ANTICANCER RES, V28, P379; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lutz M, 2015, BLOOD, V125, P261, DOI 10.1182/blood-2014-09-601302; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Matsuzaki J, 2014, CANCER IMMUNOL RES, V2, P341, DOI 10.1158/2326-6066.CIR-13-0138; Mittendorf EA, 2006, SURGERY, V139, P407, DOI 10.1016/j.surg.2005.06.059; Morikane K, 2001, INT IMMUNOL, V13, P233, DOI 10.1093/intimm/13.2.233; Mukherjee P, 2007, VACCINE, V25, P1607, DOI 10.1016/j.vaccine.2006.11.007; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Mukherjee P, 2001, CLIN CANCER RES, V7, p848S; Mukherjee P, 2000, J IMMUNOL, V165, P3451, DOI 10.4049/jimmunol.165.6.3451; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Nemunaitis B, 2013, J IMMUNOTHERAPY CANC, V240; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pestano C, 2011, CANCER RES, V71, P762; Picco G, 2014, EUR J IMMUNOL, V44, P1947, DOI 10.1002/eji.201344076; Quoix E, 2011, LANCET ONCOL, V12, P1125, DOI 10.1016/S1470-2045(11)70259-5; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Romagnoli P, 2012, J IMMUNOL, V189, P3831, DOI 10.4049/jimmunol.1201564; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Roulois D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/871936; Rowse GJ, 1998, CANCER RES, V58, P315; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Sugiura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044770; Tempero RM, 1998, J IMMUNOL, V161, P5500; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turner MS, 2007, J IMMUNOL, V178, P2787, DOI 10.4049/jimmunol.178.5.2787; Vassilaros S, 2013, IMMUNOTHERAPY-UK, V5, P1177, DOI [10.2217/IMT.13.126, 10.2217/imt.13.126]; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; WANG KC, 1980, INT J CANCER, V25, P487, DOI 10.1002/ijc.2910250410; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Xu YF, 2004, J EXP MED, V199, P707, DOI 10.1084/jem.20031865	67	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145920	10.1371/journal.pone.0145920	http://dx.doi.org/10.1371/journal.pone.0145920			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788922	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100020
J	Liu, Y; Chen, LL; Zhi, CC; Shen, M; Sun, WW; Miao, DS; Yuan, XQ				Liu, Yun; Chen, Lulu; Zhi, Chunchun; Shen, Ming; Sun, Weiwei; Miao, Dengshun; Yuan, Xiaoqin			1,25(OH)(2)D-3 Deficiency Induces Colon Inflammation via Secretion of Senescence-Associated Inflammatory Cytokines	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CARCINOMA-CELLS; CANCER CELLS; ENDOCRINE; RISK; PHENOTYPE; PROMOTES; KLOTHO; DIFFERENTIATION; CHEMOPREVENTION	Epidemiological studies showed that 1,25-Dihydroxyvitamin D[1,25(OH)(2)D-3] insufficiency appears to be associated with aging and colon cancer while underlying biological mechanisms remain largely unknown. Inflammatory bowel disease is one of the risk factors for colon cancer. In this study, we investigated whether 1,25(OH)(2)D-3 deficiency has an impact on the colon of 25-hydroxyvitamin D 1 alpha-hydroxylase knockout [Cyp27b1(-/-]) mice fed on a rescue diet (high calcium, phosphate, and lactose) from weaning to 10 months of age. We found that 1,25(OH)(2)D-3 deficient mice displayed significant colon inflammation phenotypes including shortened colon length, thinned and disordered mucosal structure, and inflammatory cell infiltration. DNA damage, cellular senescence and the production of senescence-associated inflammatory cytokines were also increased significantly in the colon of Cyp27b1(-/-) mice. Furthermore, the levels of ROS in the colon were increased significantly, whereas the expression levels of antioxidative genes were down-regulated dramatically in the colon of Cyp27b1(-/-) mice. Taken together, our results demonstrated that 1,25(OH)(2)D-3 deficiency could induce colon inflammation, which may result from increased oxidative stress and DNA damage, subsequently, induced cell senescence and overproduction of senescence-associated secretory factors. Therefore, our findings suggest that 1,25(OH)(2)D-3 may play an important role in preventing the development and progression of colon inflammation and colon cancer.	[Liu, Yun; Chen, Lulu; Zhi, Chunchun; Sun, Weiwei; Miao, Dengshun; Yuan, Xiaoqin] Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Shen, Ming] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, XQ (corresponding author), Nanjing Med Univ, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China.	yuanxq@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Natural Science Foundation of China [81201529, 81200431, 81230009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (81201529 to X Yuan, 81200431 to W Sun and 81230009 to D Miao) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DELUCA HF, 1973, NEW ENGL J MED, V289, P359, DOI 10.1056/NEJM197308162890710; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Huerta S, 2002, CANCER RES, V62, P741; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lin R, 2002, MOL ENDOCRINOL, V16, P1243, DOI 10.1210/me.16.6.1243; Liu N, 2008, ENDOCRINOLOGY, V149, P4799, DOI 10.1210/en.2008-0060; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lofano Katia, 2013, J Gastrointest Cancer, V44, P1, DOI 10.1007/s12029-012-9425-y; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meeker S, 2014, CANCER RES, V74, P4398, DOI 10.1158/0008-5472.CAN-13-2820; Murillo G, 2005, J STEROID BIOCHEM, V97, P129, DOI 10.1016/j.jsbmb.2005.06.008; Nagai Taku, 2003, FASEB Journal, V17, P50; Nakai K, 2014, AM J HYPERTENS, V27, P586, DOI 10.1093/ajh/hpt160; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schutze N, 1999, BIOFACTORS, V10, P329, DOI 10.1002/biof.5520100403; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Shen M, 2013, BONE, V55, P400, DOI 10.1016/j.bone.2013.04.015; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321	55	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146426	10.1371/journal.pone.0146426	http://dx.doi.org/10.1371/journal.pone.0146426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790152	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100031
J	Venot, Q; Delaunay, JL; Fouassier, L; Delautier, D; Falguieres, T; Housset, C; Maurice, M; Ait-Slimane, T				Venot, Quitterie; Delaunay, Jean-Louis; Fouassier, Laura; Delautier, Daniele; Falguieres, Thomas; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia			A PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMAIN INTERACTION CONTROLS; BINDING; PHOSPHOPROTEIN; PHOSPHORYLATION; RECOGNITION; CHOLESTASIS; MEMBRANE; SPECTRUM; RECEPTOR	ABCB4/MDR3, a member of the ABC superfamily, is an ATP-dependent phosphatidylcholine translocator expressed at the canalicular membrane of hepatocytes. Defects in the ABCB4 gene are associated with rare biliary diseases. It is essential to understand the mechanisms of its canalicular membrane expression in particular for the development of new therapies. The stability of several ABC transporters is regulated through their binding to PDZ (PSD95/DglA/ZO-1) domain-containing proteins. ABCB4 protein ends by the sequence glutamineasparagine-leucine (QNL), which shows some similarity to PDZ-binding motifs. The aim of our study was to assess the potential role of the QNL motif on the surface expression of ABCB4 and to determine if PDZ domain-containing proteins are involved. We found that truncation of the QNL motif decreased the stability of ABCB4 in HepG2-transfected cells. The deleted mutant ABCB4-Delta QNL also displayed accelerated endocytosis. EBP50, a PDZ protein highly expressed in the liver, strongly colocalized and coimmunoprecipitated with ABCB4, and this interaction required the QNL motif. Down-regulation of EBP50 by siRNA or by expression of an EBP50 dominant-negative mutant caused a significant decrease in the level of ABCB4 protein expression, and in the amount of ABCB4 localized at the canalicular membrane. Interaction of ABCB4 with EBP50 through its PDZ-like motif plays a critical role in the regulation of ABCB4 expression and stability at the canalicular plasma membrane.	[Venot, Quitterie; Delaunay, Jean-Louis; Fouassier, Laura; Delautier, Daniele; Falguieres, Thomas; Housset, Chantal; Maurice, Michele; Ait-Slimane, Tounsia] Univ Paris 06, Sorbonne Univ, INSERM, UMR S 938,Ctr Rech St Antoine, Paris, France; [Housset, Chantal] Hop St Antoine, Assistance Publ Hop Paris, Ctr Reference Malad Rares Malad Inflammatoires Vo, F-75571 Paris, France; [Housset, Chantal] Serv Hepatol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Ait-Slimane, T (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, UMR S 938,Ctr Rech St Antoine, Paris, France.	tounsia.ait-slimane@inserm.fr	Fouassier, Laura/M-7556-2017	Fouassier, Laura/0000-0001-6377-5610; Delaunay, jean-louis/0000-0002-6512-5483; Falguieres, Thomas/0000-0003-2867-0500; Housset, Chantal/0000-0001-6469-0651; AIT SLIMANE, Tounsia/0000-0002-7459-859X; Venot, Quitterie/0000-0001-5964-5370	French association for the study of the liver (AFEF); Association Mucoviscidose - ABCF2; "Ministere de l'Enseignement Superieur et de la Recherche"; "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)"; INSERM; Fondation pour la Recherche Medicale (FRM)	French association for the study of the liver (AFEF); Association Mucoviscidose - ABCF2; "Ministere de l'Enseignement Superieur et de la Recherche"(Estonian Research CouncilEuropean Commission); "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)"; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by grants from the French association for the study of the liver (AFEF), and the Association Mucoviscidose - ABCF2. QV received a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche" and "Association pour la lutte contre les maladies inflammatoires du foie et des voies biliaires (Albi)". TF was supported by fellowships from INSERM and Fondation pour la Recherche Medicale (FRM).	Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Galmes R, 2013, J CELL SCI, V126, P3409, DOI 10.1242/jcs.126250; Gautherot J, 2014, HEPATOLOGY, V60, P610, DOI 10.1002/hep.27170; Gautherot J, 2012, J BIOL CHEM, V287, P5070, DOI 10.1074/jbc.M111.275438; Giral H, 2011, J BIOL CHEM, V286, P15032, DOI 10.1074/jbc.M110.199752; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jacquemin E, 2001, GASTROENTEROLOGY, V120, P1448, DOI 10.1053/gast.2001.23984; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Lam P, 2012, HEPATOLOGY, V55, P1901, DOI 10.1002/hep.25523; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Wang DQH, 2009, J LIPID RES, V50, pS406, DOI 10.1194/jlr.R800075-JLR200; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146962	10.1371/journal.pone.0146962	http://dx.doi.org/10.1371/journal.pone.0146962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789121	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100050
J	Abhimanyu; Bose, M; Varma-Basil, M; Jain, A; Sethi, T; Tiwari, PK; Agrawal, A; Banavaliker, JN; Bhowmick, KT				Abhimanyu; Bose, Mridula; Varma-Basil, Mandira; Jain, Ashima; Sethi, Tavpritesh; Tiwari, Pradeep Kumar; Agrawal, Anurag; Banavaliker, Jayant Nagesh; Bhowmick, Kumar Tapas			Establishment of Elevated Serum Levels of IL-10, IL-8 and TNF-beta as Potential Peripheral Blood Biomarkers in Tubercular Lymphadenitis: A Prospective Observational Cohort Study	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; ACTIVE TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; INFECTION; PULMONARY	Background Tubercular lymphadenitis (TL) is the most common form of extra-pulmonary tuberculosis (TB) consisting about 15-20% of all TB cases. The currently available diagnostic modalities for (TL), are invasive and involve a high index of suspicion, having limited accuracy. We hypothesized that TL would have a distinct cytokine signature that would distinguish it from pulmonary TB (PTB), peripheral tubercular lymphadenopathy (LNTB), healthy controls (HC), other lymphadenopathies (LAP) and cancerous LAP. To assess this twelve cytokines (Tumor Necrosis Factor (TNF)-alpha, Interferon (IFN) -gamma, Interleukin (IL)-2, IL-12, IL-18, IL-1 beta, IL-10, IL-6, IL-4, IL-1Receptor antagonist (IL-1Ra), IL-8 and TNF-beta, which have a role in pathogenesis of tuberculosis, were tested as potential peripheral blood biomarkers to aid the diagnosis of TL when routine investigations prove to be of limited value. Methods and Findings A prospective observational cohort study carried out during 2010-2013. This was a multicenter study with three participating hospitals in Delhi, India where through random sampling cohorts were established. The subjects were above 15 years of age, HIV-negative with no predisposing ailments to TB (n = 338). The discovery cohort (n = 218) had LNTB (n = 50), PTB (n = 84) and HC (n = 84). The independent validation cohort (n = 120) composed of patients with cancerous LAP (n = 35), other LAP (n = 20) as well as with independent PTB (n = 30), LNTB (n = 15) and HC (n = 20). Eight out of twelve cytokines achieved statistical relevance upon evaluation by pairwise and ROC analysis. Further, variable selection using random forest backward elimination revealed six serum biosignatures including IL-12, IL-4, IL-6, IL-10, IL-8 and TNF-beta as optimal for classifying the LNTB status of an individual. For the sake of clinical applicability we further selected a three analyte panel (IL-8, IL-10 and TNF-beta) which was subjected to multinomial modeling in the independent validation cohort which was randomised into training and test cohorts, achieving an overwhelming 95.9% overall classifying accuracy for correctly classifying LNTB cases with a minimal (7%) misclassification error rate in the test cohort. Conclusions In our study, a three analyte serum biosignatures and probability equations were established which can guide the physician in their clinical decision making and step wise management of LNTB patients. This set of biomarkers has the potential to be a valuable adjunct to the diagnosis of TL in cases where AFB positivity and granulomatous findings elude the clinician.	[Abhimanyu; Bose, Mridula; Varma-Basil, Mandira; Jain, Ashima] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, New Delhi, India; [Sethi, Tavpritesh; Tiwari, Pradeep Kumar; Agrawal, Anurag] CSIR Inst Genom & Integrat Biol, New Delhi, India; [Banavaliker, Jayant Nagesh] RajanBabu Inst Pulm Med & TB, New Delhi, India; [Bhowmick, Kumar Tapas] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Radiotherapy, New Delhi, India; [Abhimanyu] Univ Johannesburg, Dept Biochem, Auckland Pk Campus, Johannesburg, Gauteng, South Africa	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Vardhman Mahavir Medical College & Safdarjung Hospital; University of Johannesburg	Bose, M (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Microbiol, New Delhi, India.	bosemridula@yahoo.co.in	Abhimanyu, Abhimanyu/P-4463-2019; Agrawal, Anurag/GZL-5821-2022; Tiwari, Dr. Pradeep/V-8314-2018	Abhimanyu, Abhimanyu/0000-0001-7888-8722; Agrawal, Anurag/0000-0002-0340-5252; Tiwari, Dr. Pradeep/0000-0003-0387-9236; Sethi, Tavpritesh/0000-0002-4776-7941	Council for Scientific and Industrial Research, Government of India [60/80 EMR-II]; CSIR	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Council for Scientific and Industrial Research, Government of India funded the Research and Fellowship for Dr. Abhimanyu via Grant Number: 60/80 EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the results were submitted to the funders as a part of the final project report.; The Authors thank CSIR for providing Junior Research Fellowship to Dr. Abhimanyu. We are indebted to the patients and volunteers who served as control and to the clinicians Dr Anuj Bhatnagar, Dr. Anil Choudhry and Dr Nilang Tale at Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Kingsway Camp, New Delhi and Lok Nayak Jai Prakash Hospital, New Delhi. We wish to acknowledge the help of Dr. Ashwani Khanna, of the Chest Clinic, LNJP to facilitate in patient recruitment and Dr. Shyama Jain, Department of Pathology, Maulana Azad Medical College for the help with histological findings for LNTB cases. We are also thankful to Drs Rupa Das, Pooja Mate and Neha of Department of Radiotherapy, Vardhman Mahavir Medical College and Safdarjung Hospital for their help in patient recruitment. Help in statistics from Dr. Koundinya Desiraju and Mr. Rintu Kutum from CSIR-IGIB is also acknowledged.	April MM, 1996, ARCH OTOLARYNGOL, V122, P1214; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Borgia JA, 2009, J THORAC ONCOL, V4, P338, DOI 10.1097/JTO.0b013e3181982abf; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fitzgerald D, PRINCIPLES PRACTICE, V2, P3158; Fortun J, 2014, INFECTION, V42, P649, DOI 10.1007/s15010-014-0602-8; Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Kim YK, 2011, TOHOKU J EXP MED, V224, P189, DOI 10.1620/tjem.224.189; Kohane IS, 2012, NEW ENGL J MED, V367, P2538, DOI 10.1056/NEJMe1213371; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Manitchotpisit Boonchu, 1999, Journal of the Medical Association of Thailand, V82, P363; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Polesky A, 2005, MEDICINE, V84, P350, DOI 10.1097/01.md.0000189090.52626.7a; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Song KH, 2009, DIAGN MICR INFEC DIS, V63, P182, DOI 10.1016/j.diagmicrobio.2008.10.013; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang Y, 2009, ZHONGHUA JIE HE HE H, V25, P535; WHO, GLOB TUB REP 2014	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145576	10.1371/journal.pone.0145576	http://dx.doi.org/10.1371/journal.pone.0145576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784906	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400015
J	Bishai, DM; Cohen, R; Alfonso, YN; Adam, T; Kuruvilla, S; Schweitzer, J				Bishai, David M.; Cohen, Robert; Alfonso, Y. Natalia; Adam, Taghreed; Kuruvilla, Shyama; Schweitzer, Julian			Factors Contributing to Maternal and Child Mortality Reductions in 146 Low- and Middle-Income Countries between 1990 and 2010	PLOS ONE			English	Article							HEALTH EXPENDITURES; UNDER-5 MORTALITY; COUNTDOWN; NEWBORN; PROGRESS; OUTCOMES	Introduction From 1990-2010, worldwide child mortality declined by 43%, and maternal mortality declined by 40%. This paper compares two sources of progress: improvements in societal coverage of health determinants versus improvements in the impact of health determinants as a result of technical change. Methods This paper decomposes the progress made by 146 low-and middle-income countries (LMICs) in lowering childhood and maternal mortality into one component due to better health determinants like literacy, income, and health coverage and a second component due to changes in the impact of these health determinants. Health determinants were selected from eight distinct health-impacting sectors. Health determinants were selected from eight distinct health-impacting sectors. Regression models are used to estimate impact size in 1990 and again in 2010. Changes in the levels of health determinants were measured using secondary data. Findings The model shows that respectively 100% and 89% of the reductions in maternal and child mortality since 1990 were due to improvements in nationwide coverage of health determinants. The relative share of overall improvement attributable to any single determinant varies by country and by model specification. However, in aggregate, approximately 50% of the mortality reductions were due to improvements in the health sector, and the other 50% of the mortality reductions were due to gains outside the health sector. Conclusions Overall, countries improved maternal and child health (MCH) from 1990 to 2010 mainly through improvements in the societal coverage of a broad array of health system, social, economic and environmental determinants of child health. These findings vindicate efforts by the global community to obtain such improvements, and align with the post-2015 development agenda that builds on the lessons from the MDGs and highlights the importance of promoting health and sustainable development in a more integrated manner across sectors.	[Bishai, David M.; Cohen, Robert; Alfonso, Y. Natalia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Adam, Taghreed] WHO, Hlth Syst & Innovat, CH-1211 Geneva, Switzerland; [Kuruvilla, Shyama] WHO, Family Womens & Childrens Hlth, CH-1211 Geneva, Switzerland; [Schweitzer, Julian] Results Dev, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; World Health Organization	Bishai, DM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.	dbishai@jhsph.edu	, David Bishai/GRO-4211-2022	Cohen, Robert/0000-0002-5666-117X; Kuruvilla, Shyama/0000-0002-0327-4467	Alliance for Health Systems and Policy Research; Partnership for Maternal, Newborn & Child Health (PMNCH); Alliance for Health Policy and Systems Research (AHPSR); World Bank; World Health Organization; Partnership for Maternal, Newborn Child Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Alliance for Health Systems and Policy Research; Partnership for Maternal, Newborn & Child Health (PMNCH); Alliance for Health Policy and Systems Research (AHPSR); World Bank(The World Bank India); World Health Organization(World Health Organization); Partnership for Maternal, Newborn Child Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for the study was received from the Alliance for Health Systems and Policy Research and Partnership for Maternal, Newborn & Child Health. At the time of the study, KS and TA were employees of Partnership for Maternal, Newborn & Child Health and Alliance for Health Policy and Systems Research that funded the study. The funders had no role in the study design, data collection and analysis, but KS and TA participated in interpreting the findings and drafting the report.; This analysis is part of the Success Factors for Women's and Children's Health Study supported by the Partnership for Maternal, Newborn & Child Health (PMNCH), Alliance for Health Policy and Systems Research (AHPSR), the World Bank, and the World Health Organization.	Anyanwu JC, 2009, AFR DEV REV, V21, P400, DOI 10.1111/j.1467-8268.2009.00215.x; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Blinder A., 1973, J HUMAN RESOURCES, V8; Bokhari FAS, 2007, HEALTH ECON, V16, P257, DOI 10.1002/hec.1157; Burstrom B, 2005, AM J PUBLIC HEALTH, V95, P208, DOI 10.2105/AJPH.2003.034900; Chadwick E., 1842, REPORT SANITARY COND; Farag M, 2013, INT J HEALTH CARE FI, V13, P33, DOI 10.1007/s10754-012-9120-3; Fenton PM, 2008, LANCET, V372, P369, DOI 10.1016/S0140-6736(08)61148-4; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Hanf M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6427; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Hum RJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00051; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Kuruvilla S, 2014, B WORLD HEALTH ORGAN, V92, P533, DOI 10.2471/BLT.14.138131; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Marmot M, 2006, LANCET, V368, P2081, DOI 10.1016/S0140-6736(06)69746-8; Oaxaca R., 1973, INT EC REV, V14, p693?709, DOI [10.2307/2525981, DOI 10.2307/2525981]; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; UN Interagency Group for Child Mortality Estimation (IGME), 2014, LEV TRENDS CHILD MOR; Verguet S, 2014, HEALTH POLICY PLANN, V29, P151, DOI 10.1093/heapol/czs143; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Bank, 2013, WOR DEV REP, P1, DOI 10.1596/978-0-8213-9575-2	23	144	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144908	10.1371/journal.pone.0144908	http://dx.doi.org/10.1371/journal.pone.0144908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26783759	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400009
J	Dwyer, JB; Leslie, FM				Dwyer, Jennifer B.; Leslie, Frances M.			Adolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in Rodents	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; STRIA TERMINALIS; BED NUCLEUS; PREFRONTAL CORTEX; C-FOS; POSTNATAL-DEVELOPMENT; D1/D2 SYNERGISM; METABOLIC-RATES; BRAIN-REGIONS; COCAINE	Adolescence is a developmental period characterized by heightened vulnerability to illicit drug use and the onset of neuropsychiatric disorders. These clinical phenomena likely share common neurobiological substrates, as mesocorticolimbic dopamine systems actively mature during this period. Whereas prior studies have examined age-dependent changes in dopamine receptor binding, there have been fewer functional analyses. The aim of the present study was therefore to determine whether the functional consequences of D1 and D2-like activation are age-dependent. Adolescent and adult rats were given direct D1 and D2 agonists, alone and in combination. Locomotor and stereotypic behaviors were measured, and brains were collected for analysis of mRNA expression for the immediate early genes (IEGs), cfos and arc. Adolescents showed enhanced D2-like receptor control of locomotor and repetitive behaviors, which transitioned to dominant D1-like mechanisms in adulthood. When low doses of agonists were co-administered, adults showed supra-additive behavioral responses to D1/D2 combinations, whereas adolescents did not, which may suggest age differences in D1/D2 synergy. D1/D2-stimulated IEG expression was particularly prominent in the bed nucleus of the stria terminalis (BNST). Given the BNST's function as an integrator of corticostriatal, hippocampal, and stress-related circuitry, and the importance of neural network dynamics in producing behavior, an exploratory functional network analysis of regional IEG expression was performed. This data-driven analysis demonstrated similar developmental trajectories as those described in humans and suggested that dopaminergic drugs alter forebrain coordinated gene expression age dependently. D1/D2 recruitment of stress nuclei into functional networks was associated with low behavioral output in adolescents. Network analysis presents a novel tool to assess pharmacological action, and highlights critical developmental changes in functional neural circuitry. Immature D1/D2 interactions in adolescents may underlie their unique responses to drugs of abuse and vulnerability to psychopathology. These data highlight the need for age-specific pharmacotherapy design and clinical application in adolescence.	[Dwyer, Jennifer B.; Leslie, Frances M.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Dwyer, JB (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	Jennifer.dwyer@yale.edu	Dwyer, Jennifer/AAW-8701-2021		National Institute of Drug Abuse [DA19138]; PhRMA Foundation Paul Calabresi Medical Student Fellowship; NIH [DA19138]; PhRMA Foundation fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019138] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PhRMA Foundation Paul Calabresi Medical Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by (1) National Institute of Drug Abuse, Grant number DA19138, funding to FML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2) The PhRMA Foundation Paul Calabresi Medical Student Fellowship (http://www.phrmafoundation.org/2015-awards/other-awards/clinical-pharmacology/paul-calabresi-medical-student-fellowship/) to JBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant DA19138. Stipend support for JBD was provided in part from a PhRMA Foundation fellowship. A special thanks to the NIMH for generously providing SKF83822.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ANDERSEN PH, 1990, EUR J PHARM-MOLEC PH, V188, P335, DOI 10.1016/0922-4106(90)90194-3; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2002, BEHAV BRAIN RES, V130, P197, DOI 10.1016/S0166-4328(01)00417-X; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bolanos CA, 1998, DEV BRAIN RES, V111, P25, DOI 10.1016/S0165-3806(98)00116-3; Bowman BP, 1997, PSYCHOPHARMACOLOGY, V129, P121, DOI 10.1007/s002130050171; BRAUN AR, 1986, EUR J PHARMACOL, V131, P301, DOI 10.1016/0014-2999(86)90588-1; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao J, 2007, NEUROPSYCHOPHARMACOL, V32, P2279, DOI 10.1038/sj.npp.1301349; Caster JM, 2009, NEUROSCIENCE, V160, P13, DOI 10.1016/j.neuroscience.2009.01.001; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Correll CU, 2008, J CLIN PSYCHIAT, V69, P26; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; DELFS JM, 1990, NEUROSCIENCE, V39, P59, DOI 10.1016/0306-4522(90)90221-O; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frantz KJ, 1999, PHARMACOL BIOCHEM BE, V64, P821, DOI 10.1016/S0091-3057(99)00162-8; Frantz KJ, 2007, NEUROPSYCHOPHARMACOL, V32, P625, DOI 10.1038/sj.npp.1301130; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Gali RA, 2015, NEUROPSYCHOPHARMACOL, V40, pS109; Gardner EL, 2002, SYNAPSE, V46, P240, DOI 10.1002/syn.10138; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; HORWITZ B, 1984, J CEREBR BLOOD F MET, V4, P484, DOI 10.1038/jcbfm.1984.73; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; HORWITZ B, 1986, ANN NEUROL, V19, P60, DOI 10.1002/ana.410190111; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Johnston LD OMP, 2005, NIH PUBLICATION, V06-5884:278; Johnstone TB, 2011, J PHARMACOL EXP THER, V336, P908, DOI 10.1124/jpet.110.176255; LAHOSTE GJ, 1992, SYNAPSE, V12, P14, DOI 10.1002/syn.890120103; LAHOSTE GJ, 1993, BRAIN RES, V611, P108, DOI 10.1016/0006-8993(93)91782-N; LaHoste GJ, 1996, BRAIN RES, V728, P97; LAVIOLA G, 1995, J PHARMACOL EXP THER, V275, P345; Lewis DA, 2004, ANN NY ACAD SCI, V1021, P64, DOI 10.1196/annals.1308.008; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Macey DJ, 2003, J NEUROSCI, V23, P12; MAHAN LC, 1990, P NATL ACAD SCI USA, V87, P2196, DOI 10.1073/pnas.87.6.2196; Mathews IZ, 2011, INT J DEV NEUROSCI, V29, P501, DOI 10.1016/j.ijdevneu.2011.05.003; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; McQuown SC, 2009, PSYCHOPHARMACOLOGY, V207, P143, DOI 10.1007/s00213-009-1642-0; Mojica CY, 2014, NEUROPHARMACOLOGY, V77, P285, DOI 10.1016/j.neuropharm.2013.10.012; MOODY CA, 1992, PSYCHOPHARMACOLOGY, V106, P161, DOI 10.1007/BF02801967; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Sullivan GJ, 2004, EUR J PHARMACOL, V486, P273, DOI 10.1016/j.ejphar.2004.01.004; Pollack Alexia, 2004, Sci STKE, V2004, ppe50, DOI 10.1126/stke.2552004pe50; RAPOPORT JL, 1980, ARCH GEN PSYCHIAT, V37, P933; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rodrigues AJ, 2011, PSYCHOPHARMACOLOGY, V214, P107, DOI 10.1007/s00213-010-2085-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Svenningsson P, 2000, NEUROSCIENCE, V98, P749, DOI 10.1016/S0306-4522(00)00155-X; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tarazi FI, 1999, DEV NEUROSCI-BASEL, V21, P43, DOI 10.1159/000017365; Teicher MH, 2003, NEUROSCI LETT, V339, P169, DOI 10.1016/S0304-3940(02)01475-1; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wei L, 2015, DEV NEUROSCI-BASEL, V37, P476, DOI 10.1159/000430861; Winzer-Serhan UH, 1999, BRAIN RES PROTOC, V3, P229, DOI 10.1016/S1385-299X(98)00043-9; Xu HY, 2012, NEUROSCIENCE, V221, P21, DOI 10.1016/j.neuroscience.2012.06.056; Yuan ML, 2015, J PHYSIOL-LONDON, V593, P3397, DOI 10.1113/JP270492; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	82	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146966	10.1371/journal.pone.0146966	http://dx.doi.org/10.1371/journal.pone.0146966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784516	Green Published, gold			2022-12-27	WOS:000368528400089
J	Helmer, M; Kozyrev, V; Stephan, V; Treue, S; Geisel, T; Battaglia, D				Helmer, Markus; Kozyrev, Vladislav; Stephan, Valeska; Treue, Stefan; Geisel, Theo; Battaglia, Demian			Model-Free Estimation of Tuning Curves and Their Attentional Modulation, Based on Sparse and Noisy Data	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; AREA MT; NEURONAL POPULATIONS; CORTICAL-CELLS; MACAQUE; DIRECTION; VARIABILITY; DIVERSITY; INFERENCE	Tuning curves are the functions that relate the responses of sensory neurons to various values within one continuous stimulus dimension (such as the orientation of a bar in the visual domain or the frequency of a tone in the auditory domain). They are commonly determined by fitting a model e.g. a Gaussian or other bell-shaped curves to the measured responses to a small subset of discrete stimuli in the relevant dimension. However, as neuronal responses are irregular and experimental measurements noisy, it is often difficult to determine reliably the appropriate model from the data. We illustrate this general problem by fitting diverse models to representative recordings from area MT in rhesus monkey visual cortex during multiple attentional tasks involving complex composite stimuli. We find that all models can be well-fitted, that the best model generally varies between neurons and that statistical comparisons between neuronal responses across different experimental conditions are affected quantitatively and qualitatively by specific model choices. As a robust alternative to an often arbitrary model selection, we introduce a model-free approach, in which features of interest are extracted directly from the measured response data without the need of fitting any model. In our attentional datasets, we demonstrate that data-driven methods provide descriptions of tuning curve features such as preferred stimulus direction or attentional gain modulations which are in agreement with fit-based approaches when a good fit exists. Furthermore, these methods naturally extend to the frequent cases of uncertain model selection. We show that model-free approaches can identify attentional modulation patterns, such as general alterations of the irregular shape of tuning curves, which cannot be captured by fitting stereotyped conventional models. Finally, by comparing datasets across different conditions, we demonstrate effects of attention that are cell-and even stimulus-specific. Based on these proofs-of-concept, we conclude that our data-driven methods can reliably extract relevant tuning information from neuronal recordings, including cells whose seemingly haphazard response curves defy conventional fitting approaches.	[Helmer, Markus; Geisel, Theo] Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany; [Helmer, Markus; Stephan, Valeska; Treue, Stefan; Geisel, Theo; Battaglia, Demian] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Kozyrev, Vladislav] Ruhr Univ Bochum, Inst Neuroinformat, Univ Str 150, Bochum, Germany; [Kozyrev, Vladislav; Stephan, Valeska; Treue, Stefan] German Primate Ctr, Cognit Neurosci Lab, Gottingen, Germany; [Battaglia, Demian] Aix Marseille Univ, Inst Neurosci Syst, Marseille, France	Max Planck Society; Ruhr University Bochum; Deutsches Primatenzentrum (DPZ); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Helmer, M (corresponding author), Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany.; Helmer, M (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.	markus@nld.ds.mpg.de	Battaglia, Demian/C-1281-2017; 889, CRC/L-1607-2018	Battaglia, Demian/0000-0003-2021-7920; 889, CRC/0000-0002-6678-3138; Helmer, Markus/0000-0001-9680-0595	Volkswagen Foundation [I/79868]; Bernstein Center of Computational Neuroscience Goettingen; Bundesministerium fuer Bildung und Forschung (BMBF) [01GQ0433, 01GQ1005C]; German Research Foundation (DFG) Collaborative Research Center "Cellular Mechanisms of Sensory Processing" [889]; Marie Curie career development fellowship ("DynViB") [FP7-IEF 330792]	Volkswagen Foundation(Volkswagen); Bernstein Center of Computational Neuroscience Goettingen; Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) Collaborative Research Center "Cellular Mechanisms of Sensory Processing"; Marie Curie career development fellowship ("DynViB")	This research was supported by Volkswagen Foundation (www.volkswagenstiftung.de), grant I/79868, by the Bernstein Center of Computational Neuroscience Goettingen (www.bccngoettingen.de), grants 01GQ0433 and 01GQ1005C of the Bundesministerium fuer Bildung und Forschung (BMBF, www.bmbf.de) and the German Research Foundation (DFG, www.dfg.de) Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing". DB was supported by the Marie Curie career development fellowship (http://ec.europa.eu/research/mariecurieactions/) FP7-IEF 330792 ("DynViB").	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Battaglia D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002176; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Charalambides CA, 2000, PROBABILITY AND STAT; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cronin B, 2010, J NEUROPHYSIOL, V103, P591, DOI 10.1152/jn.00379.2009; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeBello WM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00112; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Etzold A, 2004, J NEUROSCI METH, V134, P109, DOI 10.1016/j.jneumeth.2003.11.009; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Jupp PE, 1999, WILEY SERIES PROBABI; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kozyrev V, 2009, SOC NEUROSCIENCE; Lochte A, 2009, SOC NEUROSCIENCE; Maldonado PE, 1996, VISUAL NEUROSCI, V13, P509, DOI 10.1017/S095252380000818X; Maynard EM, 1999, J NEUROSCI, V19, P8083; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 1999, NEURAL COMPUT, V11, P85, DOI 10.1162/089976699300016818; Press WH, 2007, ART SCI COMPUTING, Vthird; Ringach DL, 2002, J NEUROSCI, V22, P5639; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Stevenson IH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002775; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Ubeyli ED, 2009, J MED SYST, V33, P353, DOI 10.1007/s10916-008-9197-x; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	52	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146500	10.1371/journal.pone.0146500	http://dx.doi.org/10.1371/journal.pone.0146500			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785378	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400041
J	Liu, BP; Yue, Y; Yang, Y; Jin, YF				Liu, Baoping; Yue, Yuan; Yang, Yun; Jin, Yongfeng			Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; REGULATORY T-CELLS; NOD MICE; FUSION PROTEIN; TOLERANCE INDUCTION; IMMUNE TOLERANCE; SUBUNIT; VACCINE; PLANTS; CHAIN	Induction of mucosal tolerance by oral administration of protein antigens is a potential therapeutic strategy for preventing and treating type 1 diabetes (T1D); however, the requirement for a large dosage of protein limits clinical applications because of the low efficacy. In this study, we generated a fusion protein CTB-Ins-GAD composed of CTB (cholera toxin B subunit), insulin, and three copies of GAD65 peptide 531-545, which were efficiently produced in silkworm pupae, to evaluate its protective effect against T1D. We demonstrate that oral administration of CTB-Ins-GAD suppressed T1D by up to 78%, which is much more effective than GAD65 single-antigen treatment. Strikingly, CTB-Ins-GAD enhance insulin-and GAD65-specific Th2-like immune responses, which repairs the Th1/Th2 imbalance and increases the number of CD4(+) CD25(+) Foxp3(+) T cell and suppresses insulin-and GAD65-reactive spleen T lymphocyte proliferation and migration. Our results strongly suggest that the combined dual antigens promote the induction of oral tolerance, thus providing an effective and economic immunotherapy against T1D in combination with a silkworm bioreactor.	[Liu, Baoping; Yue, Yuan; Yang, Yun; Jin, Yongfeng] Zhejiang Univ, Coll Life Sci, Inst Biochem, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Jin, YF (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jinyf@zju.edu.cn	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022		National Science and Technology Project [2012ZX09102301-009]; National Natural Science Foundation of China [31125011]	National Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by research grants from the National Science and Technology Project (2012ZX09102301-009) and the National Natural Science Foundation of China (31125011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 1998, NAT BIOTECHNOL, V16, P934, DOI 10.1038/nbt1098-934; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Boettler T, 2013, J AUTOIMMUN, V44, P40, DOI 10.1016/j.jaut.2013.05.002; Bregenholt S, 2003, SCAND J IMMUNOL, V57, P432, DOI 10.1046/j.1365-3083.2003.01248.x; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Clemente-Casares X, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007773; Denes B, 2005, J IMMUNOTHER, V28, P438, DOI 10.1097/01.cji.0000171315.82997.9a; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; DiLorenzo TP, 2002, CLIN IMMUNOL, V105, P332, DOI 10.1006/clim.2002.5298; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Gong ZH, 2005, J BIOTECHNOL, V119, P93, DOI 10.1016/j.jbiotec.2005.05.027; Gong ZH, 2007, VACCINE, V25, P1444, DOI 10.1016/j.vaccine.2006.10.039; Gong ZH, 2010, VACCINE, V28, P4052, DOI 10.1016/j.vaccine.2010.04.005; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Jaeckel E, 2003, J EXP MED, V197, P1635, DOI 10.1084/jem.20030215; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim HJ, 2014, LETT APPL MICROBIOL, V58, P285, DOI 10.1111/lam.12188; Li D, 2006, PLANT CELL REP, V25, P417, DOI 10.1007/s00299-005-0069-2; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Ma SW, 2004, P NATL ACAD SCI USA, V101, P5680, DOI 10.1073/pnas.0307420101; Ma SW, 1997, NAT MED, V3, P793, DOI 10.1038/nm0797-793; Ma SW, 1999, ADV EXP MED BIOL, V464, P179; Mamchak AA, 2012, DIABETES, V61, P1490, DOI 10.2337/db11-1304; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Meng QH, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/831704; Mundkur L, 2014, INT J CARDIOL, V175, P340, DOI 10.1016/j.ijcard.2014.06.001; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Ploix C, 1999, DIABETES, V48, P2150, DOI 10.2337/diabetes.48.11.2150; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Ramiya VK, 1997, AUTOIMMUNITY, V26, P139, DOI 10.3109/08916939708994736; Robert S, 2014, DIABETES, V63, P2876, DOI 10.2337/db13-1236; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P14, DOI 10.1196/annals.1447.054; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894; Tong JC, 2002, J BIOTECHNOL, V97, P183, DOI 10.1016/S0168-1656(02)00060-3; Wang XM, 2013, ADV DRUG DELIVER REV, V65, P759, DOI 10.1016/j.addr.2012.10.013; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/580463; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Zhang WP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005353; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	50	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147260	10.1371/journal.pone.0147260	http://dx.doi.org/10.1371/journal.pone.0147260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783749	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400130
J	Munari, E; Chaux, A; Vaghasia, AM; Taheri, D; Karram, S; Bezerra, SM; Roibon, NG; Nelson, WG; Yegnasubramanian, S; Netto, GJ; Haffner, MC				Munari, Enrico; Chaux, Alcides; Vaghasia, Ajay M.; Taheri, Diana; Karram, Sarah; Bezerra, Stephania M.; Roibon, Nilda Gonzalez; Nelson, William G.; Yegnasubramanian, Srinivasan; Netto, George J.; Haffner, Michael C.			Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; DNA DEMETHYLATION; MAMMALIAN DNA; HUMAN CANCERS; HYDROXYMETHYLATION; 5-METHYLCYTOSINE; METHYLATION; DYNAMICS; MARKS; IDH1	Solid tumors are characterized by a plethora of epigenetic changes. In particular, patterns methylation of cytosines at the 5-position (5mC) in the context of CpGs are frequently altered in tumors. Recent evidence suggests that 5mC can get converted to 5-hydroxylmethylcytosine (5hmC) in an enzymatic process involving ten eleven translocation (TET) protein family members, and this process appears to be important in facilitating plasticity of cytosine methylation. Here we evaluated the global levels of 5hmC using a validated immunohistochemical staining method in a large series of clear cell renal cell carcinoma (n = 111), urothelial cell carcinoma (n = 55) and testicular germcell tumors (n = 84) and matched adjacent benign tissues. Whereas tumor-adjacent benign tissues were mostly characterized by high levels of 5hmC, renal cell carcinoma and urothelial cell carcinoma showed dramatically reduced staining for 5hmC. 5hmC levels were low in both primary tumors and metastases of clear cell renal cell carcinoma and showed no association with disease outcomes. In normal testis, robust 5hmC staining was only observed in stroma and Sertoli cells. Seminoma showed greatly reduced 5hmC immunolabeling, whereas differentiated teratoma, embryonal and yolk sack tumors exhibited high 5hmC levels. The substantial tumor specific loss of 5hmC, particularly in clear cell renal cell carcinoma and urothelial cell carcinoma, suggests that alterations in pathways involved in establishing and maintaining 5hmC levels might be very common in cancer and could potentially be exploited for diagnosis and treatment.	[Munari, Enrico; Chaux, Alcides; Taheri, Diana; Karram, Sarah; Bezerra, Stephania M.; Roibon, Nilda Gonzalez; Nelson, William G.; Netto, George J.; Haffner, Michael C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; [Vaghasia, Ajay M.; Nelson, William G.; Yegnasubramanian, Srinivasan; Netto, George J.; Haffner, Michael C.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Nelson, William G.; Netto, George J.] Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD 21231 USA; [Chaux, Alcides] Norte Univ, Dept Sci Res, Asuncion, Paraguay; [Chaux, Alcides] Ctr Desarrollo Invest Cient CEDIC Asuncion, Asuncion, Paraguay; [Taheri, Diana] Isfahan Univ Med Sci, Dept Pathol, Isfahan Kidney Dis Res Ctr, Esfahan, Iran	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Universidad del Norte; Isfahan University Medical Science	Netto, GJ; Haffner, MC (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA.; Netto, GJ; Haffner, MC (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.; Netto, GJ (corresponding author), Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD 21231 USA.	gnetto1@jhmi.edu; michael.c.haffner@gmail.com	taheri, diana/V-6369-2017; Bezerra, Stephania M/X-9260-2018; Chaux, Alcides/H-4656-2019; Munari, Enrico/J-7516-2016	Chaux, Alcides/0000-0002-5824-9867; Munari, Enrico/0000-0002-3867-6685; Netto, George/0000-0003-3915-9134	PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grant [P30CA006973, P50CA58236, R01CA070196]; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA070196, P30CA006973] Funding Source: NIH RePORTER	PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the PATANA Brady Research Fund; Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Award; NIH/NCI grants P30CA006973, P50CA58236 and R01CA070196.	Aryee MJ, 2013, AMERICAN ASSOCIATION, V5, DOI [10.1126/scitranslmed.3005211, DOI 10.1126/SCITRANSLMED.3005211]; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fedor HL, 2005, METH MOLEC MED, V103, P89; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guibert S, 2013, CURR TOP DEV BIOL, V104, P47, DOI 10.1016/B978-0-12-416027-9.00002-4; Haffner MC, 2013, CELL CYCLE, V12, P1835, DOI 10.4161/cc.25010; Haffner MC, 2011, ONCOTARGET, V2, P627; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kristensen DG, 2013, NATURE          1128, P1; Kroeze LI, 2014, BLOOD, V124, P1110, DOI 10.1182/blood-2013-08-518514; Larsson AO, 2016, NEW MEDIA SOC, V18, P274, DOI 10.1177/1461444814538798; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062828; Muller T, 2012, AM J PATHOL, V181, P675, DOI 10.1016/j.ajpath.2012.04.017; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Pfeifer GP, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-10; Plongthongkum N, 2014, NAT REV GENET, V15, P647, DOI 10.1038/nrg3772; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Shim E-H, 2014, CANC DISCOVERY; Smith ZD, 2013, EMBO J, V32, P318, DOI 10.1038/emboj.2012.349; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	45	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146302	10.1371/journal.pone.0146302	http://dx.doi.org/10.1371/journal.pone.0146302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785262	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400030
J	Price, CC; Tanner, J; Nguyen, PT; Schwab, NA; Mitchell, S; Slonena, E; Brumback, B; Okun, MS; Mareci, TH; Bowers, D				Price, Catherine C.; Tanner, Jared; Nguyen, Peter T.; Schwab, Nadine A.; Mitchell, Sandra; Slonena, Elizabeth; Brumback, Babette; Okun, Michael S.; Mareci, Thomas H.; Bowers, Dawn			Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease	PLOS ONE			English	Article							WORKING-MEMORY; BASAL GANGLIA; FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; RESPONSE-INHIBITION; PROCESSING SPEED; FRONTAL-CORTEX; IMPAIRMENT; DEMENTIA; AGE	Objective This prospective investigation examined: 1) processing speed and working memory relative to other cognitive domains in non-demented medically managed idiopathic Parkinson's disease, and 2) the predictive role of cortical/subcortical gray thickness/volume and white matter fractional anisotropy on processing speed and working memory. Methods Participants completed a neuropsychological protocol, Unified Parkinson's Disease Rating Scale, brain MRI, and fasting blood draw to rule out vascular contributors. Within group a priori anatomical contributors included bilateral frontal thickness, caudate nuclei volume, and prefrontal white matter fractional anisotropy. Results Idiopathic Parkinson's disease (n = 40; Hoehn & Yahr stages 1-3) and non-Parkinson's disease 'control' peers (n = 40) matched on demographics, general cognition, comorbidity, and imaging/blood vascular metrics. Cognitively, individuals with Parkinson's disease were significantly more impaired than controls on tests of processing speed, secondary deficits on working memory, with subtle impairments in memory, abstract reasoning, and visuoperceptual/spatial abilities. Anatomically, Parkinson's disease individuals were not statistically different in cortical gray thickness or subcortical gray volumes with the exception of the putamen. Tract Based Spatial Statistics showed reduced prefrontal fractional anisotropy for Parkinson's disease relative to controls. Within Parkinson's disease, prefrontal fractional anisotropy and caudate nucleus volume partially explained processing speed. For controls, only prefrontal white matter was a significant contributor to processing speed. There were no significant anatomical predictors of working memory for either group. Conclusions Caudate nuclei volume and prefrontal fractional anisotropy, not frontal gray matter thickness, showed unique and combined significance for processing speed in Parkinson's disease. Findings underscore the relevance for examining gray-white matter interactions and also highlight clinical processing speed metrics as potential indicators of early cognitive impairment in PD.	[Price, Catherine C.; Tanner, Jared; Nguyen, Peter T.; Schwab, Nadine A.; Mitchell, Sandra; Slonena, Elizabeth; Bowers, Dawn] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Brumback, Babette] Univ Florida, Dept Biostat, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Price, Catherine C.; Okun, Michael S.; Bowers, Dawn] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Mareci, Thomas H.] Univ Florida, Biochem & Mol Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Price, CC (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA.; Price, CC (corresponding author), Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA.	cep23@phhp.ufl.edu	Mareci, Thomas Harold/D-7745-2011; Slonena, Elizabeth/ABD-7403-2020	Mareci, Thomas Harold/0000-0003-4700-2364; Price, Catherine/0000-0001-5994-0644; Tanner, Jared/0000-0001-6821-0029	National Institutes of Health National Institute of Neurological Disorders and Stroke [K23NS60660, R01NS082386]; Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award [UL1TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082386, K23NS060660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020499] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke K23NS60660 (CP) and R01NS082386 (CP), and in part by the Center for Movement Disorders and Neurorestoration, and the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award to the University of Florida UL1TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2012, J NEUROSCI, V32, P1329, DOI 10.1523/JNEUROSCI.5826-11.2012; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agosta F, 2013, HUM BRAIN MAPP, V34, P2798, DOI 10.1002/hbm.22101; Aichelburg C, 2014, CEREB CORTEX; Aita Y, 2010, J NEUROENDOCRINOL, V22, P83, DOI 10.1111/j.1365-2826.2009.01944.x; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], 1994, ASSESSMENT CLIN MANU; Auning E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003976; Babcock L, 2015, NEUROPSYCHOLOGIA, V67, P91, DOI 10.1016/j.neuropsychologia.2014.12.010; Bedwell JS, 2005, INT J NEUROSCI, V115, P1017, DOI 10.1080/00207450590901530; BENTON A, 1975, NEUROLOGY, V25, P907, DOI 10.1212/WNL.25.10.907; Benton A L, 1968, Trans Am Neurol Assoc, V93, P38; Bohnen NI, 2014, JAMA NEUROLOGY; Bohnen NI, 2015, JAMA NEUROL, V72, P194, DOI 10.1001/jamaneurol.2014.2757; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; BRIGGS G G, 1975, Cortex, V11, P230; Bruck A, 2001, NEUROSCI LETT, V311, P81, DOI 10.1016/S0304-3940(01)02124-3; Brzezicka A, 2011, ACTA NEUROBIOL EXP, V71, P479; Bublak P, 2002, NEUROPSYCHOLOGY, V16, P577, DOI 10.1037//0894-4105.16.4.577; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Choi SA, 2010, J MOV DISORD, V3, P6, DOI 10.14802/jmd.10002; Choi SA, 2010, ACTA NEUROPATHOL, V119, P147, DOI 10.1007/s00401-009-0620-2; Chou KL, 2014, PARKINSONISM RELAT D, V20, P1076, DOI 10.1016/j.parkreldis.2014.07.008; Colon-Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131493; Cook SE, 2009, J GERIATR PSYCH NEUR, V22, P103, DOI 10.1177/0891988708328214; Dalaker TO, 2009, NEUROIMAGE, V47, P2083, DOI 10.1016/j.neuroimage.2009.06.020; de la Fuente-Fernandez R, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/561046; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; Duncan GW, 2015, MOVEMENT DISORDERS O; Ebisch SJH, 2013, NEUROIMAGE, V78, P426, DOI 10.1016/j.neuroimage.2013.04.058; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Filoteo JV, 2014, MOVEMENT DISORD, V29, P360, DOI 10.1002/mds.25633; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fitoussi A, 2015, BRAIN STRUCT FUNCT, V220, P3485, DOI 10.1007/s00429-014-0868-8; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Fujibuchi T, 2011, RADIAT PROT DOSIM, V147, P394, DOI 10.1093/rpd/ncq493; Gallagher C, 2013, J INT NEUROPSYCH SOC, V19, P349, DOI 10.1017/S1355617712001373; Goldman-Rakic PS, 1987, HDB PHYSL NERVOUS SY, P4787; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; Goodglass H., 1983, BOSTON NAMING TEST; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Grossman M, 2002, NEUROPSYCHOLOGY, V16, P174, DOI 10.1037//0894-4105.16.2.174; GROWDON JH, 1990, ADV NEUROL, V53, P365; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hanganu A, 2013, MOVEMENT DISORD, V28, P1360, DOI 10.1002/mds.25541; Heaton RK, 2004, REVISED COMPREHENSIV, Vvi; Helie S, 2015, CORTEX, V64, P123, DOI 10.1016/j.cortex.2014.10.011; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Huang PY, 2014, J NEUROL SCI, V346, P145, DOI 10.1016/j.jns.2014.08.011; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Isobe K, 2010, NEW BIOTECHNOL, V27, P751, DOI 10.1016/j.nbt.2010.05.001; Jentsch JD, 1999, NEUROSCIENCE, V90, P823, DOI 10.1016/S0306-4522(98)00481-3; Jokinen P, 2013, J NEUROL SCI, V329, P23, DOI 10.1016/j.jns.2013.03.006; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kuznetsova KA, 2015, BRAIN WHITE MATTER S; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JE, 2010, MOVEMENT DISORD, V25, P28, DOI 10.1002/mds.22858; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Litvan I., 2011, MOVEMENT DISORD, V27, P349; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marklund P, 2009, BRAIN, V132, P336, DOI 10.1093/brain/awn309; Matsui H, 2007, ACTA NEUROL SCAND, V116, P108, DOI 10.1111/j.1600-0404.2006.00795.x; Matteau E, 2011, AM J ALZHEIMERS DIS, V26, P389, DOI 10.1177/1533317511412046; Middleton FA, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P44; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nemmi F, 2015, NEUROBIOL AGING, V36, P424, DOI 10.1016/j.neurobiolaging.2014.07.010; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Pagonabarraga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054980; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Price CC, 2012, NEUROLOGY, V79, P734, DOI 10.1212/WNL.0b013e3182661ef6; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sanchez-Benavides G, 2010, J INT NEUROPSYCH SOC, V16, P836, DOI 10.1017/S135561771000069X; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Segura B, 2014, MOVEMENT DISORD, V29, P1495, DOI 10.1002/mds.25982; Shuvaev V T, 1995, Neurosci Behav Physiol, V25, P63, DOI 10.1007/BF02359252; Slawek J, 2008, NEUROL NEUROCHIR POL, V42, P505; Smith S.M., 2002, HUMAN BRAIN MAPPING; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song IU, 2013, ARCH GERONTOL GERIAT, V57, P288, DOI 10.1016/j.archger.2013.04.015; Speilberger CD, 1968, SELF EVALUATION QUES; Stebbins GT, 1999, NEUROPSYCHOLOGIA, V37, P503, DOI 10.1016/S0028-3932(98)00068-2; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1994, HDB NEUROPSYCHOLOGY; Suzuki H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-72; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tanner JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133792; Theilmann RJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00037; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tranel D, 2008, CLIN NEUROPSYCHOL, V22, P242, DOI 10.1080/13854040701218410; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Vaillancourt DE, 2013, MOVEMENT DISORD, V28, P1920, DOI 10.1002/mds.25687; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Wurster CD, 2015, BRAIN STRUCT FUNCT, V220, P1637, DOI 10.1007/s00429-014-0749-1; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669; Zgaljardic DJ, 2006, J CLIN EXP NEUROPSYC, V28, P1127, DOI 10.1080/13803390500246910; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001; Zgaljardic DJ, 2003, ENCY NEUROLOGICAL SC, P774	118	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147332	10.1371/journal.pone.0147332	http://dx.doi.org/10.1371/journal.pone.0147332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784744	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400135
J	Rebbapragada, I; Birkus, G; Perry, J; Xing, WM; Kwon, H; Pflanz, S				Rebbapragada, Indrani; Birkus, Gabriel; Perry, Jason; Xing, Weimei; Kwon, HyockJoo; Pflanz, Stefan			Molecular Determinants of GS-9620-Dependent TLR7 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; TLR4-MD-2 COMPLEX; RECOGNITION; AGONISTS; INNATE; SENSITIVITY; LYSOSOMES; INDUCTION	GS-9620 is an orally administered agonist of Toll-like receptor (TLR) 7 currently being evaluated in clinical studies for the treatment of chronic HBV and HIV patients. GS-9620 has shown antiviral efficacy in preclinical models of chronic hepadnavirus infection in woodchuck as well as chimpanzee. However, the molecular determinants of GS-9620-dependent activation of TLR7 are not well defined. The studies presented here elucidate GS-9620 subcellular distribution and characterize its molecular interactions with human TLR7 using structure-guided mutational analysis. Based on our results we present a molecular model of TLR7 bound to GS-9620. We also determine that several coding SNPs had no effect on GS-9620-dependent TLR7 activation. In addition, our studies provide evidence that TLR7 exists in a ligand-independent oligomeric state and that, TLR7 activation by GS-9620 is likely associated with compound-induced conformational changes. Finally, we demonstrate that activation of NF-kappa B and Akt pathways in primary plasmacytoid dendritic cells occur as immediate downstream cellular responses to GS-9620 stimulation. The data presented here further our understanding of the molecular parameters governing TLR7 activation by GS-9620, and more generally by nucleos/tide-related ligands.	[Rebbapragada, Indrani; Birkus, Gabriel; Xing, Weimei; Kwon, HyockJoo; Pflanz, Stefan] Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA; [Perry, Jason] Gilead Sci Inc, Dept Struct Chem, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences; Gilead Sciences	Pflanz, S (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	Stefan.Pflanz@gilead.com	Birkus, Gabriel/GNW-3123-2022; Birkus, Gabriel/G-7765-2016	Birkus, Gabriel/0000-0002-5537-9447	Gilead Sciences Inc	Gilead Sciences Inc(Gilead Sciences)	The funder of this study, Gilead Sciences Inc, provided support in the form of salaries, employee benefits, and company stock for authors IR, GB, JP, WX, HK, and SP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Birkus G, 2011, ANTIMICROB AGENTS CH, V55, P2166, DOI 10.1128/AAC.01603-10; Birmachu W, 2007, BMC IMMUNOL, V8, P1, DOI 10.1186/1471-2172-8-26; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Colak E, 2014, J IMMUNOL, V192, P5963, DOI 10.4049/jimmunol.1303058; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fosdick A, 2014, J PHARMACOL EXP THER, V348, P96, DOI 10.1124/jpet.113.207878; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Holtzman E., 1989, LYSOSOMES; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lawitz E, 2015, ANTIVIR THER, V20, P699, DOI 10.3851/IMP2845; Lopatin U, 2013, ANTIVIR THER, V18, P409, DOI 10.3851/IMP2548; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Roethle PA, 2013, J MED CHEM, V56, P7324, DOI 10.1021/jm400815m; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159	43	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146835	10.1371/journal.pone.0146835	http://dx.doi.org/10.1371/journal.pone.0146835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784926	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400070
J	Southey, BR; Zhu, P; Carr-Markell, MK; Liang, ZZS; Zayed, A; Li, RQ; Robinson, GE; Rodriguez-Zas, SL				Southey, Bruce R.; Zhu, Ping; Carr-Markell, Morgan K.; Liang, Zhengzheng S.; Zayed, Amro; Li, Ruiqiang; Robinson, Gene E.; Rodriguez-Zas, Sandra L.			Characterization of Genomic Variants Associated with Scout and Recruit Behavioral Castes in Honey Bees Using Whole-Genome Sequencing	PLOS ONE			English	Article							DIACYLGLYCEROL KINASE THETA; DIVISION-OF-LABOR; APIS-MELLIFERA; SOCIAL INSECTS; GENE-EXPRESSION; BOMBYX-MORI; DROSOPHILA; CERANA; RECOMBINATION; TRANSCRIPTION	Among forager honey bees, scouts seek new resources and return to the colony, enlisting recruits to collect these resources. Differentially expressed genes between these behaviors and genetic variability in scouting phenotypes have been reported. Whole-genome sequencing of 44 Apis mellifera scouts and recruits was undertaken to detect variants and further understand the genetic architecture underlying the behavioral differences between scouts and recruits. The median coverage depth in recruits and scouts was 10.01 and 10.7 X, respectively. Representation of bacterial species among the unmapped reads reflected a more diverse microbiome in scouts than recruits. Overall, 1,412,705 polymorphic positions were analyzed for associations with scouting behavior, and 212 significant (p-value < 0.0001) associations with scouting corresponding to 137 positions were detected. Most frequent putative transcription factor binding sites proximal to significant variants included Broad-complex 4, Broad-complex 1, Hunchback, and CF2-II. Three variants associated with scouting were located within coding regions of ncRNAs including one codon change (LOC102653644) and 2 frameshift indels (LOC102654879 and LOC102655256). Significant variants were also identified on the 5'UTR of membrin, and 3'UTRs of laccase 2 and diacylglycerol kinase theta. The 60 significant variants located within introns corresponded to 39 genes and most of these positions were > 1000 bp apart from each other. A number of these variants were mapped to ncRNA LOC100578102, solute carrier family 12 member 6-like gene, and LOC100576965 (meprin and TRAF-C homology domain containing gene). Functional categories represented among the genes corresponding to significant variants included: neuronal function, exoskeleton, immune response, salivary gland development, and enzymatic food processing. These categories offer a glimpse into the molecular support to the behaviors of scouts and recruits. The level of association between genomic variants and scouting behavior observed in this study may be linked to the honey bee's genomic plasticity and fluidity of transition between castes.	[Southey, Bruce R.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA; [Zhu, Ping] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Carr-Markell, Morgan K.] Univ Illinois, Sch Integrat Biol, Ecol Evolut & Conservat Biol Program, Urbana, IL 61801 USA; [Liang, Zhengzheng S.] Univ Illinois, Sch Mol & Cell Biol, Urbana, IL 61801 USA; [Liang, Zhengzheng S.; Robinson, Gene E.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Zayed, Amro] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Carle Woese Inst Genom Biol, 320 Morrill Hall, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Neurosci Program, Dept Stat, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Peking University; Peking University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; York University - Canada; Peking University; Peking University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Neurosci Program, Dept Stat, Dept Anim Sci, Urbana, IL 61801 USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu	Zayed, Amro/G-6405-2011	Zayed, Amro/0000-0003-3233-4585; Zhu, Ping/0000-0002-4521-7524; Liang, Zhengzheng/0000-0002-3969-4199; Southey, Bruce/0000-0002-8959-7709; Carr-Markell, Morgan/0000-0002-7787-9194; Rodriguez-Zas, Sandra/0000-0003-1122-4758	NIH [R21 DA027548, P30 DA018310]; USDA NIFA [ILLU-538-909, ILLU-538-632]; NSF [EF 0425852]; Discovery grant from the Natural Sciences and Engineering Council of Canada; Early Researcher Award from the Ontario Ministry of Research and Innovation;  [1DP10D006416]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310, R21DA027548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Discovery grant from the Natural Sciences and Engineering Council of Canada(CGIAR); Early Researcher Award from the Ontario Ministry of Research and Innovation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R21 DA027548 and P30 DA018310 (SRZ, BRS), USDA NIFA grants ILLU-538-909 and ILLU-538-632 (SRZ), 1DP10D006416 and NSF grant EF 0425852 (GER), a Discovery grant from the Natural Sciences and Engineering Council of Canada, and an Early Researcher Award from the Ontario Ministry of Research and Innovation (AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-503; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arnold G, 2002, ETHOLOGY, V108, P751, DOI 10.1046/j.1439-0310.2002.00809.x; Beekman M, 2007, BEHAV ECOL SOCIOBIOL, V61, P985, DOI 10.1007/s00265-006-0331-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Calabria LK, 2011, J INSECT PHYSIOL, V57, P1300, DOI 10.1016/j.jinsphys.2011.06.005; Carr-Markell MK, 2014, J INSECT BEHAV, V27, P736, DOI 10.1007/s10905-014-9465-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Denis GV, 2010, DISCOV MED, V10, P489; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dreller C, 1998, BEHAV ECOL SOCIOBIOL, V43, P191, DOI 10.1007/s002650050480; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Gajewski KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010713; Ganesh K, 2014, FEBS LETT, V588, P21, DOI 10.1016/j.febslet.2013.11.013; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Guan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073628; Guo FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041877; Guo J, 2015, J INVERTEBR PATHOL, V127, P110, DOI 10.1016/j.jip.2015.03.010; Han Z, 2004, P NATL ACAD SCI USA, V101, P12567, DOI 10.1073/pnas.0405085101; Higginson AD, 2011, EXPT WING DAMAGE AFF; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Kapheim KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123911; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; Liu HX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0566-0; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mattila HR, 2014, APIDOLOGIE, V45, P347, DOI 10.1007/s13592-013-0252-3; Mattila HR, 2011, BEHAV ECOL SOCIOBIOL, V65, P799, DOI 10.1007/s00265-010-1083-0; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Mondet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10454; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Page RE, 2012, ANNU REV GENET, V46, P97, DOI 10.1146/annurev-genet-110711-155610; Pan CY, 2009, PESTIC BIOCHEM PHYS, V93, P105, DOI 10.1016/j.pestbp.2008.12.003; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; Percudani R, 2013, BIOINFORM BIOL INSIG, V7, P55, DOI 10.4137/BBI.S11064; Robinson G, 1988, THE GENETICS OF SOCI, P61; Rodriguez-Zas SL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-233; Rodriguez-Zas SL, 2012, J BIOL RHYTHM, V27, P12, DOI 10.1177/0748730411431404; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Seehuus SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069870; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Shiomi K, 2007, MOL CELL NEUROSCI, V34, P209, DOI 10.1016/j.mcn.2006.10.015; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Tarpy DR, 2015, APPL ENVIRON MICROB, V81, P3182, DOI 10.1128/AEM.00307-15; Tsuruda JM, 2009, BEHAV BRAIN RES, V205, P132, DOI 10.1016/j.bbr.2009.07.022; Tu-Sekine Becky, 2013, Advances in Biological Regulation, V53, P118, DOI 10.1016/j.jbior.2012.09.007; Tyvand PA, 2010, J THEOR BIOL, V266, P470, DOI 10.1016/j.jtbi.2010.07.005; Ueda S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-35; Vance JT, 2014, J INSECT PHYSIOL, V65, P27, DOI 10.1016/j.jinsphys.2014.04.003; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson MJ, 2011, DEVELOPMENT, V138, P3497, DOI 10.1242/dev.067926; Yan H, 2015, ANNU REV ENTOMOL, V60, P435, DOI 10.1146/annurev-ento-010814-020803; Yang CW, 2014, BBA-GEN SUBJECTS, V1840, P2674, DOI 10.1016/j.bbagen.2014.05.013; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432	69	7	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146430	10.1371/journal.pone.0146430	http://dx.doi.org/10.1371/journal.pone.0146430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784945	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400037
J	Yang, K; Wu, WM; Chen, YC; Lo, SH; Liao, YC				Yang, Kuan; Wu, Wei-Ming; Chen, Ya-Chi; Lo, Su Hao; Liao, Yi-Chun			Delta Np63 alpha Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion	PLOS ONE			English	Article							P53 HOMOLOG P63; KERATINOCYTE PROLIFERATION; EPIDERMAL DIFFERENTIATION; GENOTOXIC STRESS; STEM-CELLS; CANCER; ISOFORMS; GENE; METASTASIS; TARGET	p63 is a member of the p53 transcription factor family and a linchpin of epithelial development and homeostasis. p63 drives the expression of many target genes involved in cell survival, adhesion, migration and cancer. In this study, we identify C-terminal tensin-like (CTEN) molecule as a downstream target of Delta Np63 alpha, the predominant p63 isoform expressed in epithelium. CTEN belongs to the tensin family and is mainly localized to focal adhesions, which mediate many biological events such as cell adhesion, migration, proliferation and gene expression. Our study demonstrate that Delta Np63 and CTEN are both highly expressed in normal prostate epithelial cells and are down-regulated in prostate cancer. In addition, reduced expression of CTEN and Delta Np63 is correlated with prostate cancer progression from primary tumors to metastatic lesions. Silencing of Delta Np63 leads to decreased mRNA and protein levels of CTEN Delta Np63 alpha induces transcriptional activity of the CTEN promoter and a 140-bp fragment upstream of the transcription initiation site is the minimal promoter region required for activation. A putative binding site for p63 is located between -61 and -36 within the CTEN promoter and mutations of the critical nucleotides in this region abolish Delta Np63 alpha-induced promoter activity. The direct interaction of Delta Np63 alpha-mediated with the CTEN promoter was demonstrated using a chromatin immunoprecipitation (ChIP) assay. Moreover, impaired cell adhesion caused by Delta Np63 alpha depletion is rescued by over-expression of CTEN, suggesting that CTEN is a downstream effector of Delta Np63 alpha-mediated cell adhesion. In summary, our findings demonstrate that Delta Np63 alpha functions as a trans-activation factor of CTEN promoter and regulates cell adhesion through modulating CTEN. Our study further contributes to the potential regulatory mechanisms of CTEN in prostate cancer progression.	[Yang, Kuan; Wu, Wei-Ming; Chen, Ya-Chi; Liao, Yi-Chun] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Lo, Su Hao] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	National Taiwan University; University of California System; University of California Davis	Liao, YC (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	yliao@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Wu, Wei-Ming/0000-0001-5998-0478; Liao, Yi-Chun/0000-0002-0399-0201; Lo, Su Hao/0000-0002-2675-9387	Ministry of Science and Technology, Taiwan [NSC-102-2628-B-002-028-MY3]; National Taiwan University [NTU-CESRP-104R76262]; NATIONAL CANCER INSTITUTE [R01CA102537] Funding Source: NIH RePORTER	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded from the Ministry of Science and Technology, Taiwan, grant NSC-102-2628-B-002-028-MY3 (http://www.most.gov.tw/) and National Taiwan University grant NTU-CESRP-104R76262 (http://www.ntu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chia-Chung Chang for providing the pGL-923 plasmid. This study was supported by grants from the Ministry of Science and Technology, Taiwan (NSC-102-2628-B-002-028-MY3) and National Taiwan University (NTU-CESRP-104R76262).	Bamberger C, 2001, FEBS LETT, V501, P121, DOI 10.1016/S0014-5793(01)02643-6; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celardo I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.175; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen NT, 2013, GENE, V520, P90, DOI 10.1016/j.gene.2013.02.041; Coppola V, 2013, ONCOGENE, V32, P1843, DOI 10.1038/onc.2012.194; Dellavalle RP, 2001, J DERMATOL SCI, V27, P82, DOI 10.1016/S0923-1811(01)00105-0; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Duijf PHG, 2002, HUM MOL GENET, V11, P799, DOI 10.1093/hmg/11.7.799; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Hong SY, 2013, CANCER RES, V73, P5266, DOI 10.1158/0008-5472.CAN-12-4441; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Kommagani R, 2009, J CELL SCI, V122, P2828, DOI 10.1242/jcs.049619; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2004, DIFFERENTIATION, V72, P364, DOI 10.1111/j.1432-0436.2004.07208002.x; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Kouwenhoven EN, 2015, EMBO REP, V16, P863, DOI 10.15252/embr.201439941; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; Li YQ, 2010, PROSTATE, V70, P48, DOI 10.1002/pros.21037; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 2014, INT J BIOCHEM CELL B, V51, P150, DOI 10.1016/j.biocel.2014.04.003; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Martynova E, 2012, ONCOTARGET, V3, P132; Massion PP, 2003, CANCER RES, V63, P7113; McDade SS, 2014, NUCLEIC ACIDS RES, V42, P6270, DOI 10.1093/nar/gku299; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Olsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062547; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Parsons JK, 2009, PROSTATE, V69, P559, DOI 10.1002/pros.20904; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seo EY, 2012, BRIT J DERMATOL, V166, P337, DOI 10.1111/j.1365-2133.2011.10665.x; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang TY, 2001, HUM PATHOL, V32, P479, DOI 10.1053/hupa.2001.24324; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	68	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147542	10.1371/journal.pone.0147542	http://dx.doi.org/10.1371/journal.pone.0147542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784942	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400148
J	Zhang, JT; Yi, M; Zha, LY; Chen, SQ; Li, ZJ; Li, C; Gong, MX; Deng, H; Chu, XW; Chen, JH; Zhang, ZQ; Mao, LM; Sun, SX				Zhang, Jintao; Yi, Man; Zha, Longying; Chen, Siqiang; Li, Zhijia; Li, Cheng; Gong, Mingxing; Deng, Hong; Chu, Xinwei; Chen, Jiehua; Zhang, Zheqing; Mao, Limei; Sun, Suxia			Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; CYCLE ARREST; CANCER; DEATH; PATHWAYS; PROLIFERATION; INFLAMMATION; INHIBITOR; MECHANISM; TARGET	Purpose Butyrate, a short-chain fatty acid derived from dietary fiber, inhibits proliferation and induces cell death in colorectal cancer cells. However, clinical trials have shown mixed results regarding the anti-tumor activities of butyrate. We have previously shown that sodium butyrate increases endoplasmic reticulum stress by altering intracellular calcium levels, a well-known autophagy trigger. Here, we investigated whether sodium butyrate-induced endoplasmic reticulum stress mediated autophagy, and whether there was crosstalk between autophagy and the sodium butyrate-induced apoptotic response in human colorectal cancer cells. Methods Human colorectal cancer cell lines (HCT-116 and HT-29) were treated with sodium butyrate at concentrations ranging from 0.5-5mM. Cell proliferation was assessed using MTT tetrazolium salt formation. Autophagy induction was confirmed through a combination of Western blotting for associated proteins, acridine orange staining for acidic vesicles, detection of autolysosomes (MDC staining), and electron microscopy. Apoptosis was quantified by flow cytometry using standard annexinV/propidium iodide staining and by assessing PARP-1 cleavage by Western blot. Results Sodium butyrate suppressed colorectal cancer cell proliferation, induced autophagy, and resulted in apoptotic cell death. The induction of autophagy was supported by the accumulation of acidic vesicular organelles and autolysosomes, and the expression of autophagya-ssociated proteins, including microtubule-associated protein II light chain 3 (LC3-II), beclin-1, and autophagocytosis-associated protein (Atg)3. The autophagy inhibitors 3-methyladenine (3-MA) and chloroquine inhibited sodium butyrate induced autophagy. Furthermore, sodium butyrate treatment markedly enhanced the expression of endoplasmic reticulum stress-associated proteins, including BIP, CHOP, PDI, and IRE-1a. When endoplasmic reticulum stress was inhibited by pharmacological (cycloheximide and mithramycin) and genetic (siRNA targeting BIP and CHOP) methods, the induction of BIP, PDI, IRE1a, and LC3-II was blocked, but PARP cleavage was markedly enhanced. Discussion Taken together, these results suggested that sodium butyrate-induced autophagy was mediated by endoplasmic reticulum stress, and that preventing autophagy by blocking the endoplasmic reticulum stress response enhanced sodium butyrate-induced apoptosis. These results provide novel insights into the anti-tumor mechanisms of butyric acid.	[Zhang, Jintao; Yi, Man; Zha, Longying; Li, Zhijia; Li, Cheng; Gong, Mingxing; Deng, Hong; Chu, Xinwei; Chen, Jiehua; Zhang, Zheqing; Mao, Limei; Sun, Suxia] Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Nutr & Food Hyg, Sch Publ Hlth, 1023 South Sha Tai Rd, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Siqiang] Guangdong Entry Exit Inspect & Quarantine Bur, Dept Certificat Supervis, Guojian Bldg,66,Huacheng Ave, Guangzhou 510623, Guangdong, Peoples R China	Southern Medical University - China	Sun, SX (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Dept Nutr & Food Hyg, Sch Publ Hlth, 1023 South Sha Tai Rd, Guangzhou 510515, Guangdong, Peoples R China.	suxiasun@hotmail.com		Sun, Suxia/0000-0002-1159-6191	National Natural Science Foundation of China [81202204]; Guangdong National Natural Science Foundation [S2012010009467]; Project for Excellent Young University Teacher	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong National Natural Science Foundation; Project for Excellent Young University Teacher	Financial support for this study was provided by National Natural Science Foundation of China (No. 81202204), Guangdong National Natural Science Foundation (No. S2012010009467), Project for Excellent Young University Teacher awarded to Southern Medical University.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; [Anonymous], 1993, HLTH CLAIMS FIBER CO; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Bultman SJ, 2014, CLIN CANCER RES, V20, P799, DOI 10.1158/1078-0432.CCR-13-2483; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; CUMMINGS JH, 1984, SCAND J GASTROENTERO, V19, P89; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Fauser JK, 2014, CANCER BIOL THER, V11, P724; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gurusamy N, 2009, ACTA PHYSIOL HUNG, V96, P267, DOI 10.1556/APhysiol.96.2009.3.2; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kawakami T, 2009, NEPHROL DIAL TRANSPL, V24, P2665, DOI 10.1093/ndt/gfp215; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lee S, 2014, EMBO MOL MED, V6, P732, DOI 10.15252/emmm.201302561; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Louis M, 2004, INT J ONCOL, V25, P1701; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nelson RS, 2009, CURR ONCOL REP, V11, P482, DOI 10.1007/s11912-009-0065-8; Nemchenko A, 2011, J MOL CELL CARDIOL, V51, P584, DOI 10.1016/j.yjmcc.2011.06.010; Paglin S, 2001, CANCER RES, V61, P439; Park M, 2015, J CELL PHYSIOL, V230, P630, DOI 10.1002/jcp.24781; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stankiewicz M, 1996, INT J PARASITOL, V26, P445, DOI 10.1016/0020-7519(96)00003-3; Su CC, 2015, MOL MED REP, V11, P3160, DOI 10.3892/mmr.2014.3090; Sun SX, 2012, BIOSCIENCE REP, V32, P83, DOI 10.1042/BSR20110062; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tang Y, 2011, AUTOPHAGY, V7, P235, DOI 10.4161/auto.7.2.14277; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang YJ, 2014, TOXICOLOGY, V326, P9, DOI 10.1016/j.tox.2014.09.010; Wang YF, 2006, MOL CELL BIOCHEM, V285, P51, DOI 10.1007/s11010-005-9054-x; Wang Z, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.503; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653	50	58	63	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147218	10.1371/journal.pone.0147218	http://dx.doi.org/10.1371/journal.pone.0147218			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784903	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400125
J	Byun, JI; Lee, ST; Jung, KH; Sunwoo, JS; Moon, J; Lim, JA; Lee, DY; Shin, YW; Kim, TJ; Lee, KJ; Lee, WJ; Lee, HS; Jun, J; Kim, DY; Kim, MY; Kim, H; Kim, HJ; Suh, HI; Lee, Y; Kim, DW; Jeong, JH; Choi, WC; Bae, DW; Shin, JW; Jeon, D; Park, KI; Jung, KY; Chu, K; Lee, SK				Byun, Jung-Ick; Lee, Soon-Tae; Jung, Keun-Hwa; Sunwoo, Jun-Sang; Moon, Jangsup; Lim, Jung-Ah; Lee, Doo Young; Shin, Yong-Won; Kim, Tae-Joon; Lee, Keon-Joo; Lee, Woo-Jin; Lee, Han-Sang; Jun, Jinsun; Kim, Dong-Yub; Kim, Man-Young; Kim, Hyunjin; Kim, Hyeon Jin; Suh, Hong Il; Lee, Yoojin; Kim, Dong Wook; Jeong, Jin Ho; Choi, Woo Chan; Bae, Dae Woong; Shin, Jung-Won; Jeon, Daejong; Park, Kyung-Il; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun			Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study	PLOS ONE			English	Article							NMDA-RECEPTOR ENCEPHALITIS; FACIOBRACHIAL DYSTONIC SEIZURES; CLINICAL-MANIFESTATIONS; STATUS EPILEPTICUS; LIMBIC ENCEPHALITIS; ANTIBODIES; EPILEPSY; RITUXIMAB; UTILITY; SYSTEM	Objective To evaluate the seizure characteristics and outcome after immunotherapy in adult patients with autoimmune encephalitis (AE) and new-onset seizure. Methods Adult (age >= 18 years) patients with AE and new-onset seizure who underwent immunotherapy and were followed-up for at least 6 months were included. Seizure frequency was evaluated at 2-4 weeks and 6 months after the onset of the initial immunotherapy and was categorized as "seizure remission", "> 50% seizure reduction", or "no change" based on the degree of its decrease. Results Forty-one AE patients who presented with new-onset seizure were analysed. At 2-4 weeks after the initial immunotherapy, 51.2% of the patients were seizure free, and 24.4% had significant seizure reduction. At 6 months, seizure remission was observed in 73.2% of the patients, although four patients died during hospitalization. Rituximab was used as a second-line immunotherapy in 12 patients who continued to have seizures despite the initial immunotherapy, and additional seizure remission was achieved in 66.6% of them. In particular, those who exhibited partial response to the initial immunotherapy had a better seizure outcome after rituximab, with low adverse events. Conclusion AE frequently presented as seizure, but only 18.9% of the living patients suffered from seizure at 6 months after immunotherapy. Aggressive immunotherapy can improve seizure outcome in patients with AE.	[Byun, Jung-Ick; Lee, Soon-Tae; Jung, Keun-Hwa; Sunwoo, Jun-Sang; Lim, Jung-Ah; Lee, Doo Young; Shin, Yong-Won; Kim, Tae-Joon; Lee, Keon-Joo; Lee, Woo-Jin; Lee, Han-Sang; Jun, Jinsun; Jeon, Daejong; Park, Kyung-Il; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Byun, Jung-Ick; Lee, Soon-Tae; Jung, Keun-Hwa; Sunwoo, Jun-Sang; Lim, Jung-Ah; Shin, Yong-Won; Kim, Tae-Joon; Lee, Keon-Joo; Lee, Woo-Jin; Lee, Han-Sang; Jun, Jinsun; Park, Kyung-Il; Jung, Ki-Young; Chu, Kon; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Program Neurosci, Seoul, South Korea; [Moon, Jangsup] Ewha Womans Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Moon, Jangsup] Ewha Med Res Inst, Seoul, South Korea; [Kim, Dong-Yub] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Man-Young] Chosun Univ Hosp, Dept Neurol, Gwangju, South Korea; [Kim, Hyunjin; Lee, Yoojin] Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Hyeon Jin] Ewha Womans Univ Hosp, Dept Neurol, Seoul, South Korea; [Suh, Hong Il] Ajou Univ, Med Ctr, Dept Neurol, Suwon 441749, South Korea; [Kim, Dong Wook] Konkuk Univ, Med Ctr, Dept Neurol, Seoul, South Korea; [Jeong, Jin Ho] Inje Univ, Busan Paik Hosp, Dept Neurol, Busan, South Korea; [Choi, Woo Chan] Kyungpook Natl Univ Hosp, Dept Neurol, Daegu, South Korea; [Bae, Dae Woong] St Marys Hosp, Dept Neurol, Seoul, South Korea; [Shin, Jung-Won] Cha Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Chosun University; University of Ulsan; Asan Medical Center; Ewha Womans University; Ajou University; Konkuk University; Konkuk University Medical Center; Inje University; Kyungpook National University; Kyungpook National University Hospital; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Pochon Cha University	Chu, K; Lee, SK (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.; Chu, K; Lee, SK (corresponding author), Seoul Natl Univ, Coll Med, Program Neurosci, Seoul, South Korea.	stemcell.snu@gmail.com; sangkun2923@gmail.com	Kim, Hyeonjin/M-3761-2019	Moon, Jangsup/0000-0003-1282-4528; Jung, Keun-Hwa/0000-0003-1433-8005; Sunwoo, Jun-Sang/0000-0001-8834-0568; Lee, Soon-Tae/0000-0003-4767-7564; Kim, Hyeon Jin/0000-0003-1401-9258; Park, Kyung-Il/0000-0001-8064-6749; Chu, Kon/0000-0001-5863-0302; Jeon, Daejong/0000-0002-6998-7603	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C25020000]; Seoul National University Hospital Research Fund [2520140040]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Seoul National University Hospital Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C25020000). Dr. Kon Chu was supported by the Seoul National University Hospital Research Fund (2520140040).	Bien CG, 2014, NEUROTHERAPEUTICS, V11, P311, DOI 10.1007/s13311-014-0264-3; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Dale RC, 2014, NEUROLOGY, V83, P142, DOI 10.1212/WNL.0000000000000570; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2014, NEURO-ONCOLOGY, V16, P771, DOI 10.1093/neuonc/nou030; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Davies G, 2010, CRIT CARE MED, V38, P679, DOI 10.1097/CCM.0b013e3181cb0968; Davis R, 2013, EPILEPSIA, V54, P46, DOI 10.1111/epi.12276; Dericioglu N, 2013, EPILEPTIC DISORD, V15, P166, DOI 10.1684/epd.2013.0566; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Holzer FJ, 2012, EUR NEUROL, V68, P310, DOI 10.1159/000341143; Iorio R, 2015, EUR J NEUROL, V22, P70, DOI 10.1111/ene.12529; Irani SR, 2014, JAMA NEUROL, V71, P896, DOI 10.1001/jamaneurol.2014.463; Irani SR, 2013, BRAIN, V136, P3151, DOI 10.1093/brain/awt212; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; Lancaster E, 2011, NEUROLOGY, V77, P179, DOI 10.1212/WNL.0b013e318224afde; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Lim JA, 2014, J CLIN NEUROL, V10, P157, DOI 10.3988/jcn.2014.10.2.157; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Melzer N, 2013, J NEUROL, V260, P1215, DOI 10.1007/s00415-012-6657-5; Moon J, 2014, J NEUROIMMUNOL, V274, P209, DOI 10.1016/j.jneuroim.2014.07.011; Quek AML, 2012, ARCH NEUROL-CHICAGO, V69, P582, DOI 10.1001/archneurol.2011.2985; Sarkis RA, 2014, EPILEPSY BEHAV, V39, P21, DOI 10.1016/j.yebeh.2014.07.018; Sen A, 2014, LANCET, V383, P2018, DOI 10.1016/S0140-6736(14)60684-X; Shin YW, 2013, J NEUROIMMUNOL, V265, P75, DOI 10.1016/j.jneuroim.2013.10.005; Spatola M, 2015, NEUROLOGY, V85, P464, DOI 10.1212/WNL.0000000000001717; Sunwoo JS, 2015, J NEUROIMMUNOL, V281, P17, DOI 10.1016/j.jneuroim.2015.03.005; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Toledano M, 2014, NEUROLOGY, V82, P1578, DOI 10.1212/WNL.0000000000000383; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; Zuliani L, 2012, J NEUROL NEUROSUR PS, V83, P638, DOI 10.1136/jnnp-2011-301237	32	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146455	10.1371/journal.pone.0146455	http://dx.doi.org/10.1371/journal.pone.0146455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771547	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300021
J	Sumie, M; Shiokawa, H; Yamaura, K; Karashima, Y; Hoka, S; Yoshimura, M				Sumie, Makoto; Shiokawa, Hiroaki; Yamaura, Ken; Karashima, Yuji; Hoka, Sumio; Yoshimura, Megumu			Direct Effect of Remifentanil and Glycine Contained in Ultiva (R) on Nociceptive Transmission in the Spinal Cord: In Vivo and Slice Patch Clamp Analyses	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; OPIOID-INDUCED HYPERALGESIA; D-ASPARTATE RECEPTOR; ANTINOCICEPTIVE TOLERANCE; DORSAL-HORN; NO EVIDENCE; RAT; HUMANS; PAIN; FACILITATION	Background Ultiva (R) is commonly administered intravenously for analgesia during general anaesthesia and its main constituent remifentanil is an ultra-short-acting mu-opioid receptor agonist. Ultiva (R) is not approved for epidural or intrathecal use in clinical practice. Previous studies have reported that Ultiva (R) provokes opioid-induced hyperalgesia by interacting with spinal dorsal horn neurons. Ultiva (R) contains glycine, an inhibitory neurotransmitter but also an N-methyl-D-aspartate receptor co-activator. The presence of glycine in the formulation of Ultiva (R) potentially complicates its effects. We examined how Ultiva (R) directly affects nociceptive transmission in the spinal cord. Methods We made patch-clamp recordings from substantia gelatinosa (SG) neurons in the adult rat spinal dorsal horn in vivo and in spinal cord slices. We perfused Ultiva (R) onto the SG neurons and analysed its effects on the membrane potentials and synaptic responses activated by noxious mechanical stimuli. Results Bath application of Ultiva (R) hyperpolarized membrane potentials under current-clamp conditions and produced an outward current under voltage-clamp conditions. A barrage of excitatory postsynaptic currents (EPSCs) evoked by the stimuli was suppressed by Ultiva (R). Miniature EPSCs (mEPSCs) were depressed in frequency but not amplitude. Ultiva (R)-induced outward currents and suppression of mEPSCs were not inhibited by the mu-opioid receptor antagonist naloxone, but were inhibited by the glycine receptor antagonist strychnine. The Ultiva (R)-induced currents demonstrated a specific equilibrium potential similar to glycine. Conclusions We found that intrathecal administration of Ultiva (R) to SG neurons hyperpolarized membrane potentials and depressed presynaptic glutamate release predominantly through the activation of glycine receptors. No Ultiva (R)-induced excitatory effects were observed in SG neurons. Our results suggest different analgesic mechanisms of Ultiva (R) between intrathecal and intravenous administrations.	[Sumie, Makoto; Karashima, Yuji; Hoka, Sumio] Kyushu Univ, Grad Sch Med Sci, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan; [Shiokawa, Hiroaki] Kyushu Univ, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan; [Yamaura, Ken] Fukuoka Univ, Sch Med, Dept Anesthesiol, Fukuoka 81401, Japan; [Yoshimura, Megumu] Kumamoto Hlth Sci Univ, Div Hlth Sci, Grad Sch Hlth Sci, Kumamoto, Japan	Kyushu University; Kyushu University; Fukuoka University; Kumamoto Health Science University	Shiokawa, H (corresponding author), Kyushu Univ, Dept Anesthesiol & Crit Care Med, Fukuoka 812, Japan.	salt@kuaccm.med.kyushu-u.ac.jp	Karashima, Yuji/AGY-5391-2022	Karashima, Yuji/0000-0002-2866-8999	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology https://www.jsps.go.jp/j-grantsinaid/.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Albertin A, 2005, ANESTH ANALG, V101, P125, DOI 10.1213/01.ANE.0000153012.35120.FE; Angst MS, 2009, PAIN, V142, P17, DOI 10.1016/j.pain.2008.11.001; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Angst MS, 2003, PAIN, V106, P49, DOI 10.1016/S0304-3959(03)00276-8; Bonnet MP, 2007, INTENS CARE MED, V33, P1179, DOI 10.1007/s00134-007-0574-6; Buerkle H, 1996, ANESTHESIOLOGY, V84, P926, DOI 10.1097/00000542-199604000-00021; Buerkle H, 1996, ANESTHESIOLOGY, V84, P94; DERSHWITZ M, 1995, ANESTH ANALG, V81, P619, DOI 10.1097/00000539-199509000-00035; Fujita T, 2006, NEUROSCIENCE, V139, P1095, DOI 10.1016/j.neuroscience.2006.01.010; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Guntz E, 2005, ANESTHESIOLOGY, V102, P1235, DOI 10.1097/00000542-200506000-00025; Hahnenkamp K, 2004, ANESTHESIOLOGY, V100, P1531, DOI 10.1097/00000542-200406000-00028; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; Ikoma M, 2007, ANESTHESIOLOGY, V107, P807, DOI 10.1097/01.anes.0000286985.80301.5e; Ishii H, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-11; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kawamata M, 2006, ANESTHESIOLOGY, V104, P432, DOI 10.1097/00000542-200603000-00009; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kohno T, 2000, ANESTHESIOLOGY, V92, P507, DOI 10.1097/00000542-200002000-00034; Koppert W, 2003, ANESTHESIOLOGY, V99, P152, DOI 10.1097/00000542-200307000-00025; Kostera-Pruszczyk A, 2002, ACTA NEUROL SCAND, V106, P34, DOI 10.1034/j.1600-0404.2002.00149.x; Lee LHY, 2005, ANESTHESIOLOGY, V102, P398, DOI 10.1097/00000542-200502000-00024; Maxwell DJ, 1999, EUR J NEUROSCI, V11, P2151, DOI 10.1046/j.1460-9568.1999.00632.x; MITCHELL K, 1993, J NEUROSCI, V13, P2371, DOI 10.1523/JNEUROSCI.13-06-02371.1993; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Terashima Y, 2011, PAIN, V152, P1024, DOI 10.1016/j.pain.2010.12.039; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Xie JY, 2005, J NEUROSCI, V25, P409, DOI 10.1523/JNEUROSCI.4054-04.2005; Xu XB, 2007, ANESTH ANALG, V104, P1004, DOI 10.1213/01.ane.0000258822.21787.db; Yajiri Y, 1997, NEUROSCIENCE, V76, P673, DOI 10.1016/S0306-4522(96)00291-6; Zhao M, 2008, ANESTHESIOLOGY, V109, P308, DOI 10.1097/ALN.0b013e31817f4c5d	37	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147339	10.1371/journal.pone.0147339	http://dx.doi.org/10.1371/journal.pone.0147339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771515	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000368628300076
J	Xu, M; Mu, XD; Dick, JTA; Fang, M; Gu, DG; Luo, D; Zhang, JE; Luo, JR; Hu, YC				Xu, Meng; Mu, Xidong; Dick, Jaimie T. A.; Fang, Miao; Gu, Dangen; Luo, Du; Zhang, Jiaen; Luo, Jianren; Hu, Yinchang			Comparative Functional Responses Predict the Invasiveness and Ecological Impacts of Alien Herbivorous Snails	PLOS ONE			English	Article							POMACEA-CANALICULATA; APPLE SNAILS; BODY-MASS; PREDATOR; TEMPERATURE; MACROPHYTES; SURVIVAL; INVASION; MODEL	Understanding determinants of the invasiveness and ecological impacts of alien species is amongst the most sought-after and urgent research questions in ecology. Several studies have shown the value of comparing the functional responses (FRs) of alien and native predators towards native prey, however, the technique is under-explored with herbivorous alien species and as a predictor of invasiveness as distinct from ecological impact. Here, in China, we conducted a mesocosm experiment to compare the FRs among three herbivorous snail species: the golden apple snail, Pomacea canaliculata, a highly invasive and high impact alien listed in "100 of the World's Worst Invasive Alien Species"; Planorbarius corneus, a non-invasive, low impact alien; and the Chinese native snail, Bellamya aeruginosa, when feeding on four locally occurring plant species. Further, by using a numerical response equation, we modelled the population dynamics of the snail consumers. For standard FR parameters, we found that the invasive and damaging alien snail had the highest "attack rates" a, shortest "handling times" h and also the highest estimated maximum feeding rates, 1/hT, whereas the native species had the lowest attack rates, longest handling times and lowest maximum feeding rates. The non-invasive, low impact alien species had consistently intermediate FR parameters. The invasive alien species had higher population growth potential than the native snail species, whilst that of the non-invasive alien species was intermediate. Thus, while the comparative FR approach has been proposed as a reliable method for predicting the ecological impacts of invasive predators, our results further suggest that comparative FRs could extend to predict the invasiveness and ecological impacts of alien herbivores and should be explored in other taxa and trophic groups to determine the general utility of the approach.	[Xu, Meng; Mu, Xidong; Fang, Miao; Gu, Dangen; Luo, Du; Luo, Jianren; Hu, Yinchang] Chinese Acad Fishery Sci, Pearl River Fisheries Res Inst, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Dick, Jaimie T. A.] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, MBC, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Fang, Miao] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Zhang, Jiaen] South China Agr Univ, Dept Ecol, Key Lab Agroenvironm Trop, Coll Agr,Minist Agr, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Fishery Sciences; Pearl River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Queens University Belfast; Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Hu, YC (corresponding author), Chinese Acad Fishery Sci, Pearl River Fisheries Res Inst, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Guangzhou, Guangdong, Peoples R China.	huyc22@163.com		Xu, Meng/0000-0002-2906-6471; Mu, Xidong/0000-0003-4091-7430	National Natural Science Foundation of China [31400487, 31300468, U1131006]; Agricultural Biological Resources Protection and Utilization Project of China [2130108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Biological Resources Protection and Utilization Project of China	This work was funded by the National Natural Science Foundation of China (grant number 31400487, 31300468 and U1131006), and Agricultural Biological Resources Protection and Utilization Project of China (2130108).	Alexander ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0946; Alexander ME, 2012, MAR ECOL PROG SER, V468, P191, DOI 10.3354/meps09978; Barrios-O'Neill D, 2015, FUNCT ECOL, V29, P377, DOI 10.1111/1365-2435.12347; Barrios-O'Neill D, 2014, J ANIM ECOL, V83, P693, DOI 10.1111/1365-2656.12155; Bolker B., 2011, EMDBOOK ECOLOGICAL M; Bollache L, 2008, BIOL LETTERS, V4, P166, DOI 10.1098/rsbl.2007.0554; Carlsson NOL, 2006, FRESHWATER BIOL, V51, P695, DOI 10.1111/j.1365-2427.2006.01523.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Chen Q., 1987, Acta Hydrobiologica Sinica, V11, P117; Chen Q.Y., 1975, ACTA HYDROBIOL SIN, V5, P371; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Costil K, 1997, J MOLLUS STUD, V63, P293, DOI 10.1093/mollus/63.2.293; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Crawley MJ, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P89; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dick JTA, 2014, BIOL INVASIONS, V16, P735, DOI 10.1007/s10530-013-0550-8; Dick JTA, 2013, BIOL INVASIONS, V15, P837, DOI 10.1007/s10530-012-0332-8; Dodd JA, 2014, FRESHWATER BIOL, V59, P337, DOI 10.1111/fwb.12268; Durant D, 2003, J ANIM ECOL, V72, P220, DOI 10.1046/j.1365-2656.2003.00689.x; Englund G, 2008, ECOL LETT, V11, P440, DOI 10.1111/j.1461-0248.2008.01159.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Fang L, 2010, FRESHWATER BIOL, V55, P1191, DOI 10.1111/j.1365-2427.2009.02343.x; Farnsworth KD, 1996, FUNCT ECOL, V10, P678; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Haddaway NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032229; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hobbs NT, 2003, ECOLOGY, V84, P666; Holling C. S., 1959, Canadian Entomologist, V91, P385; Hu YC, 2014, BIOCHEM SYST ECOL, V57, P203, DOI 10.1016/j.bse.2014.08.016; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jopp F, 2006, LIMNOLOGICA, V36, P17, DOI 10.1016/j.limno.2005.10.003; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178; Kalinkat G, 2013, ECOL LETT, V16, P1126, DOI 10.1111/ele.12147; Kestrup AM, 2011, BIOL INVASIONS, V13, P769, DOI 10.1007/s10530-010-9867-8; Kriska G., 2013, FRESHWATER INVERTEBR; Kulhanek SA, 2011, ECOL APPL, V21, P189, DOI 10.1890/09-1452.1; Lin Jin-xiang, 2005, Chinese Journal of Zoonoses, V21, P24; Liu Jun, 2012, Yingyong Shengtai Xuebao, V23, P559; Liu YY., 1993, MED MALACOLOGY; Lowe S., 2000, ENCY BIOL INVASIONS; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mccoy MW, 2012, ECOL LETT, V15, P1449, DOI 10.1111/ele.12005; Morrison WE, 2011, BIOL INVASIONS, V13, P945, DOI 10.1007/s10530-010-9881-x; MURDOCH W W, 1975, P1; Paterson RA, 2015, J ANIM ECOL, V84, P453, DOI 10.1111/1365-2656.12292; Poznanska M, 2015, HYDROBIOLOGIA, V747, P177, DOI 10.1007/s10750-014-2130-z; R Development Core Team, 2014, R LANG ENV STAT COMP; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; ROSENZWEIG ML, 1969, AM NAT, V103, P81, DOI 10.1086/282584; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Toscano BJ, 2014, J ANIM ECOL, V83, P1469, DOI 10.1111/1365-2656.12236; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Leeuwen E, 2007, ECOLOGY, V88, P1571, DOI 10.1890/06-1335; Yearsley J, 2001, P NUTR SOC, V60, P145, DOI 10.1079/PNS200062; Zhao W, 2013, AQUARIUM, P128	61	24	27	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147017	10.1371/journal.pone.0147017	http://dx.doi.org/10.1371/journal.pone.0147017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771658	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300051
J	Roehr, S; Luck, T; Heser, K; Fuchs, A; Ernst, A; Wiese, B; Werle, J; Bickel, H; Brettschneider, C; Koppara, A; Pentzek, M; Lange, C; Prokein, J; Weyerer, S; Mosch, E; Konig, HH; Maier, W; Scherer, M; Jessen, F; Riedel-Heller, SG				Roehr, Susanne; Luck, Tobias; Heser, Kathrin; Fuchs, Angela; Ernst, Annette; Wiese, Birgitt; Werle, Jochen; Bickel, Horst; Brettschneider, Christian; Koppara, Alexander; Pentzek, Michael; Lange, Carolin; Prokein, Jana; Weyerer, Siegfried; Moesch, Edelgard; Koenig, Hans-Helmut; Maier, Wolfgang; Scherer, Martin; Jessen, Frank; Riedel-Heller, Steffi G.		AgeCoDe Study Grp	Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly - Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe)	PLOS ONE			English	Article							MEMORY COMPLAINTS; ASSOCIATION; IMPAIRMENT; SURVIVAL; PEOPLE; RISK; HEALTH; ADULTS; DEATH	Objective Subjective cognitive decline (SCD) might represent the first symptomatic representation of Alzheimer's disease (AD), which is associated with increased mortality. Only few studies, however, have analyzed the association of SCD and mortality, and if so, based on prevalent cases. Thus, we investigated incident SCD in memory and mortality. Methods Data were derived from the German AgeCoDe study, a prospective longitudinal study on the epidemiology of mild cognitive impairment (MCI) and dementia in primary care patients over 75 years covering an observation period of 7.5 years. We used univariate and multivariate Cox regression analyses to examine the relationship of SCD and mortality. Further, we estimated survival times by the KaplanMeier method and case-fatality rates with regard to SCD. Results Among 971 individuals without objective cognitive impairment, 233 (24.0%) incidentally expressed SCD at follow-up I. Incident SCD was not significantly associated with increased mortality in the univariate (HR = 1.0, 95% confidence interval = 0.8-1.3, p = .90) as well as in the multivariate analysis (HR = 0.9, 95% confidence interval = 0.7-1.2, p = .40). The same applied for SCD in relation to concerns. Mean survival time with SCD was 8.0 years (SD = 0.1) after onset. Conclusion Incident SCD in memory in individuals with unimpaired cognitive performance does not predict mortality. The main reason might be that SCD does not ultimately lead into future cognitive decline in any case. However, as prevalence studies suggest, subjectively perceived decline in non-memory cognitive domains might be associated with increased mortality. Future studies may address mortality in such other cognitive domains of SCD in incident cases.	[Roehr, Susanne; Luck, Tobias; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany; [Luck, Tobias] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Heser, Kathrin; Koppara, Alexander; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Fuchs, Angela; Pentzek, Michael] Univ Dusseldorf, Fac Med, Inst Gen Practice, Dusseldorf, Germany; [Ernst, Annette; Lange, Carolin; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Ctr Psychosocial Med, Dept Primary Med Care, Hamburg, Germany; [Wiese, Birgitt; Prokein, Jana] Hannover Med Sch, Inst Gen Practice, Work Grp Med Stat & IT Infrastruct, Hannover, Germany; [Werle, Jochen; Weyerer, Siegfried] Mannheim Heidelberg Univ, Fac Med, Cent Inst Mental Hlth, Mannheim, Germany; [Bickel, Horst; Moesch, Edelgard] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat, D-80290 Munich, Germany; [Brettschneider, Christian; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Maier, Wolfgang; Jessen, Frank] DZNE, German Ctr Neurodegenerat Dis, Bonn, Germany; [Jessen, Frank] Univ Cologne, Dept Psychiat, D-50931 Cologne, Germany	Leipzig University; Leipzig University; University of Bonn; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Technical University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne	Roehr, S (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany.	Susanne.Roehr@medizin.uni-leipzig.de	Wagner, Michael/E-2325-2011; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Jessen, Frank/AAK-6170-2020; Roehr, Susanne/P-9831-2019; Brettschneider, Christian/H-5920-2019	Wagner, Michael/0000-0003-2589-6440; König, Hans-Helmut/0000-0001-5711-6862; Roehr, Susanne/0000-0001-9385-0669; Brettschneider, Christian/0000-0002-5280-1075; Koppara, Alexander/0000-0002-3577-6349; Pentzek, Michael/0000-0001-6538-0241; Luck, Tobias/0000-0001-7551-4397	German Federal Ministry of Education and Research [KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434, KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716, 01ET1006B, AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This publication is part of the German Research Network on Dementia (KND), the German Research Network on Degenerative Dementia (KNDD), and the Study on Needs, Health Service Use, Costs and Health-related Quality of Life in a large Sample of Oldest-old Primary Care Patients (85+) (AgeQualiDe) and was funded by the German Federal Ministry of Education and Research (grants KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433 and 01GI0434; grants KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716 and 01ET1006B; and grants AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G).	Ayalon L, 2008, INT J GERIATR PSYCH, V23, P830, DOI 10.1002/gps.1991; BARBERGERGATEAU P, 1992, J AM GERIATR SOC, V40, P1129, DOI 10.1111/j.1532-5415.1992.tb01802.x; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; HIXSON JE, 1990, J LIPID RES, V31, P545; Hotte SD, 2010, PSYCHIAT PRAX, V37, P78, DOI 10.1055/s-0029-1223473; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P76, DOI 10.1016/j.jalz.2012.09.017; Jessen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016852; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Konig W., 1988, 12 CASMIN U MANNH; Koppara Alexander, 2015, Alzheimers Dement (Amst), V1, P194, DOI 10.1016/j.dadm.2015.02.005; Lahr D, 2007, COGN NEUROPSYCHIATRY, V12, P24; Luck T, 2015, ACTA PSYCHIAT SCAND, V131, P290, DOI 10.1111/acps.12328; Luck T, 2014, ACTA PSYCHIAT SCAND, V129, P63, DOI 10.1111/acps.12129; Luck T, 2015, J ALZHEIMERS DIS, V48, pS33, DOI 10.3233/JAD-150090; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Ogata S, 2015, ARCH GERONTOL GERIAT, V60, P201, DOI 10.1016/j.archger.2014.10.015; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Peres K, 2011, J ALZHEIMERS DIS, V27, P39, DOI 10.3233/JAD-2011-110428; Rabin LA, 2015, J ALZHEIMERS DIS, V48, pS63, DOI 10.3233/JAD-150154; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Roehr S, 2015, ACTA PSYCHIAT SCAND, V132, P257, DOI 10.1111/acps.12454; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SCHROTER K, 2014, FORSA STUDIE 94 PROZ; Sheikh JA, 1986, CLIN GERONTOLOGY GUI; Siersma V, 2013, SCAND J PRIM HEALTH, V31, P7, DOI 10.3109/02813432.2012.754092; Singh-Manoux A, 2014, J PSYCHIATR RES, V48, P73, DOI 10.1016/j.jpsychires.2013.10.005; St John P, 2002, INT J GERIATR PSYCH, V17, P814, DOI 10.1002/gps.559; St John P, 2013, J GERIATR PSYCH NEUR, V26, P41, DOI 10.1177/0891988713476369; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Treves IA, 2005, INT PSYCHOGERIATR, V17, P265, DOI 10.1017/S1041610205001596; van Oijen M, 2007, ALZHEIMERS DEMENT, V3, P92, DOI 10.1016/j.jalz.2007.01.011; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; Waldofff FB, 2009, INT J GERIATR PSYCH, V24, P602, DOI 10.1002/gps.2163; Waldorff FB, 2012, INT J GERIATR PSYCH, V27, P1180, DOI 10.1002/gps.3765; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolfsgruber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100812; World Health Organization, 1995, ALC HLTH IMPL PUBL H; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003; Zaudig M, 1996, SIDAM STRUCTURED INT	48	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147050	10.1371/journal.pone.0147050	http://dx.doi.org/10.1371/journal.pone.0147050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26766555	Green Submitted, gold, Green Published			2022-12-27	WOS:000368459300061
J	Koronowicz, AA; Kopec, A; Master, A; Smolen, S; Piatkowska, E; Biezanowska-Kopec, R; Ledwozyw-Smolen, I; Skoczylas, L; Rakoczy, R; Leszczynska, T; Kapusta-Duch, J; Pysz, M				Koronowicz, Aneta A.; Kopec, Aneta; Master, Adam; Smolen, Sylwester; Piatkowska, Ewa; Biezanowska-Kopec, Renata; Ledwozyw-Smolen, Iwona; Skoczylas, Lukasz; Rakoczy, Roksana; Leszczynska, Teresa; Kapusta-Duch, Joanna; Pysz, Miroslaw			Transcriptome Profiling of Caco-2 Cancer Cell Line following Treatment with Extracts from Iodine-Biofortified Lettuce (Lactuca sativa L.)	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; THYROID-HORMONE; C-MYC; VAPOR GENERATION; DIFFERENTIATION; PROTEINS; APOPTOSIS; E2F1; 6-IODOLACTONE; EXPRESSION	Although iodization of salt is the most common method used to obtain iodine-enriched food, iodine deficiency disorders are still a global health problem and profoundly affect the quality of human life. Iodine is required for the synthesis of thyroid hormones, which are crucial regulators of human metabolism, cell growth, proliferation, apoptosis and have been reported to be involved in carcinogenesis. In this study, for the first time, we evaluated the effect of iodine-biofortified lettuce on transcriptomic profile of Caco-2 cancer cell line by applying the Whole Human Genome Microarray assay. We showed 1326 differentially expressed Caco2 transcripts after treatment with iodine-biofortified (BFL) and non-fortified (NFL) lettuce extracts. We analysed pathways, molecular functions, biological processes and protein classes based on comparison between BFL and NFL specific genes. Iodine, which was expected to act as a free ion (KI-NFL) or at least in part to be incorporated into lettuce macromolecules (BFL), differently regulated pathways of numerous transcription factors leading to different cellular effects. In this study we showed the inhibition of Caco-2 cells proliferation after treatment with BFL, but not potassium iodide (KI), and BFL-mediated induction of mitochondrial apoptosis and/or cell differentiation. Our results showed that iodine-biofortified plants can be effectively used by cells as an alternative source of this trace element. Moreover, the observed differences in action of both iodine sources may suggest a potential of BFL in cancer treatment.	[Koronowicz, Aneta A.; Kopec, Aneta; Piatkowska, Ewa; Biezanowska-Kopec, Renata; Leszczynska, Teresa; Kapusta-Duch, Joanna; Pysz, Miroslaw] Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland; [Master, Adam] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Smolen, Sylwester; Rakoczy, Roksana] Univ Agr, Unit Plant Nutr, Inst Plant Biol & Biotechnol, Fac Hort, Krakow, Poland; [Ledwozyw-Smolen, Iwona] Univ Agr, Biochem Unit, Inst Plant Biol & Biotechnol, Fac Biotechnol & Hort, Krakow, Poland; [Skoczylas, Lukasz] Univ Agr, Fac Food Technol, Dept Fruit Vegetable & Mushroom Proc, Krakow, Poland	Agricultural University Krakow; Centre of Postgraduate Medical Education - Poland; Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow	Koronowicz, AA (corresponding author), Univ Agr, Fac Food Technol, Dept Human Nutr, Krakow, Poland.	aneta.koronowicz@gmail.com	Smoleń, Sylwester/S-4081-2019; Kapusta-Duch, Joanna/AAF-9894-2019	Rakoczy-Lelek, Roksana/0000-0002-9782-3200; Kapusta-Duch, Joanna/0000-0003-3882-2483; Piatkowska, Ewa/0000-0003-3699-314X; Skoczylas, Lukasz/0000-0002-8349-4477; Smolen, Sylwester/0000-0001-8093-3801	Polish National Science Center [DEC-2011/03/D/NZ9/05560]	Polish National Science Center	This work was financed by the 2012-2015 Polish National Science Center, grant no. DEC-2011/03/D/NZ9/05560, "I and Se biofortification of selected vegetables, including the influence of these microelements on yield quality as well as evaluation of iodine absorption and selected biochemical parameters in rats fed with vegetables biofortified with iodine."	Aceves C, 2013, THYROID, V23, P938, DOI 10.1089/thy.2012.0579; Aceves C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-33; [Anonymous], 2011, PHIE; Arroyo-Helguera O, 2006, ENDOCR-RELAT CANCER, V13, P1147, DOI 10.1677/erc.1.01250; Asadpour E, 2014, ACTA POL PHARM, V71, P409; Avram M, 2014, J MED AR, VXVII, P64; BELFIORE A, 1987, CANCER, V60, P3096, DOI 10.1002/1097-0142(19871215)60:12<3096::AID-CNCR2820601240>3.0.CO;2-V; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Dai JL, 2004, BIOL TRACE ELEM RES, V101, P265, DOI 10.1385/BTER:101:3:265; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Enechi O. C., 2014, African Journal of Biotechnology, V13, P4215, DOI 10.5897/AJB2013.13128; Eskin B A, 1977, Adv Exp Med Biol, V91, P293; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Henson DE, 2013, CANCER CAUSE CONTROL, V24, P609, DOI 10.1007/s10552-012-0135-3; Kawa S, 2002, PANCREAS, V24, P1, DOI 10.1097/00006676-200201000-00001; Knudsen N, 2001, J CLIN ENDOCR METAB, V86, P3599, DOI 10.1210/jc.86.8.3599; Kopec A, 2015, J FUNCT FOODS, V14, P479, DOI 10.1016/j.jff.2015.02.027; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Master A., 2014, ATLAS GENET CYTOGENE, V18, P400, DOI 10.4267/2042/53769; Master A, 2010, BBA-MOL BASIS DIS, V1802, P995, DOI 10.1016/j.bbadis.2010.07.025; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; MILLARD MM, 1988, PLANT CELL PHYSIOL, V29, P901; Nava-Villalba M, 2014, PROSTAG OTH LIPID M, V112, P27, DOI 10.1016/j.prostaglandins.2014.07.001; Olvera-Caltzontzin P, 2013, MOL MED, V19, P409, DOI 10.2119/molmed.2013.00093; Perez-Juste G, 2000, J BIOL CHEM, V275, P1307, DOI 10.1074/jbc.275.2.1307; Romaris-Hortas V, 2014, TALANTA, V127, P175, DOI 10.1016/j.talanta.2014.04.003; Romaris-Hortas V, 2013, J CHROMATOGR A, V1309, P33, DOI 10.1016/j.chroma.2013.08.022; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rusanescu G, 2014, J CELL MOL MED, V18, P2103, DOI 10.1111/jcmm.12362; Sainmont J., 2014, STRATEGIES SUCCESS C; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Smolen S, 2014, SCI HORTIC-AMSTERDAM, V166, P9, DOI 10.1016/j.scienta.2013.11.011; Soriguer F, 2011, NUTR ENDOCRINOLOGY, V105, P1783, DOI DOI 10.1017/S0007114510005568; Swanson CA, 2012, J NUTR, V142, p1175S, DOI 10.3945/jn.111.156448; Thomasz L, 2013, PROSTAG LEUKOTR ESS, V88, P273, DOI 10.1016/j.plefa.2013.01.002; Tonacchera M, 2013, J CLIN ENDOCR METAB, V98, pE694, DOI 10.1210/jc.2012-3509; Turowska O, 2007, THYROID, V17, P1039, DOI 10.1089/thy.2007.0075; Vejbjerg P, 2009, EUR J ENDOCRINOL, V161, P475, DOI 10.1530/EJE-09-0262; Venturi S, 2000, Adv Clin Path, V4, P11; Vtorushina EA, 2008, J ANAL CHEM+, V63, P643, DOI 10.1134/S1061934808070071; Vtorushina EA, 2009, J ANAL CHEM+, V64, P129, DOI 10.1134/S1061934809020063; Wang B, 2014, HEPATOLOGY, V59, P555, DOI 10.1002/hep.26712; Weng HX, 2008, BIOL TRACE ELEM RES, V125, P59, DOI 10.1007/s12011-008-8155-2; Weng HX, 2009, ENVIRON GEOCHEM HLTH, V31, P401, DOI 10.1007/s10653-008-9193-6; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zanirato V, 2009, Patent No. [PCT/EP2009/ 050142, 2009050142, PCT/EP2009/050142]; Zhang WX, 2015, MOL MED REP, V11, P3148, DOI 10.3892/mmr.2014.3096; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	50	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147336	10.1371/journal.pone.0147336	http://dx.doi.org/10.1371/journal.pone.0147336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799209	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300096
J	Lee, SW; Yu, MY; Baek, SH; Ahn, SY; Kim, S; Na, KY; Chae, DW; Chin, HJ				Lee, Sung Woo; Yu, Mi-Yeon; Baek, Seon Ha; Ahn, Shin-Young; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun			Glomerular Immune Deposits Are Predictive of Poor Long-Term Outcome in Patients with Adult Biopsy-Proven Minimal Change Disease: A Cohort Study in Korea	PLOS ONE			English	Article							C1Q NEPHROPATHY; IGM NEPHROPATHY; NEPHROTIC SYNDROME; PRIMARY GLOMERULONEPHRITIS; SINGLE-CENTER; CHILDREN; PATHOLOGY	Background and Objectives There has been little published information on risk factors for poor long-term outcome in adult biopsy-proven minimal change disease (MCD). Methods Data from sixty-three adult, biopsy-proven primary MCD patients treated at a tertiary university hospital between 2003 and 2013 were analyzed. Baseline clinical and pathologic factors were assessed for the associations with composite outcome of creatinine doubling, end stage renal disease, or all-cause mortality. Results During a median (interquartile) 5.0 (2.8-5.0) years, the composite outcome occurred in 11.1% (7/63) of patients. The rate of glomerular immune deposits was 23.8% (15/63). Patients with glomerular immune deposits showed a significantly lower urine protein creatinine ratio than those without deposits (P = 0.033). The rate of non-responders was significantly higher in patients with glomerular immune deposits than in those without deposits (P = 0.033). In patients with deposits, 26.7% (4/15) developed the composite outcome, while only 6.3% (3/48) developed the composite outcome among those without deposits (P = 0.049). In multivariate Cox proportional hazards regression analysis, the presence of glomerular immune deposits was the only factor associated with development of the composite outcome (hazard ratio: 2.310, 95% confidence interval: 1.031-98.579, P = 0.047). Conclusion Glomerular immune deposits were associated with increased risk of a composite outcome in adult MCD patients. The higher rate of non-responders in patients with deposits might be related to the poor outcome. Future study is needed.	[Lee, Sung Woo; Ahn, Shin-Young; Chin, Ho Jun] Seoul Natl Univ, Postgrad Sch, Dept Immunol, Seoul, South Korea; [Lee, Sung Woo; Yu, Mi-Yeon; Baek, Seon Ha; Ahn, Shin-Young; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Postgrad Sch, Dept Immunol, Seoul, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Songnam, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	mednep@snubh.org	Kim, Sejoong/J-5356-2015; Yu, Mi-Yeon/ABB-7937-2021	Kim, Sejoong/0000-0002-7238-9962; 				Arias LF, 2013, NEFROLOGIA, V33, P532, DOI 10.3265/Nefrologia.pre2013.Mar.11962; BHASIN HK, 1978, LAB INVEST, V39, P21; Chembo CL, 2015, NEPHROLOGY, V20, P899, DOI 10.1111/nep.12538; Chou YH, 2012, CLIN J AM SOC NEPHRO, V7, P1401, DOI 10.2215/CJN.04500511; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; COHEN AH, 1978, LAB INVEST, V38, P610; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fukuma Y, 2006, AM J KIDNEY DIS, V47, P412, DOI 10.1053/j.ajkd.2005.11.013; Garin EH, 2009, J AM SOC NEPHROL, V20, P260, DOI 10.1681/ASN.2007080836; Gunasekara VN, 2014, PEDIATR NEPHROL, V29, P407, DOI 10.1007/s00467-013-2692-4; JENNETTE JC, 1985, AM J KIDNEY DIS, V6, P103, DOI 10.1016/S0272-6386(85)80150-5; Lai KW, 2007, J AM SOC NEPHROL, V18, P1476, DOI 10.1681/ASN.2006070710; Lau KK, 2005, PEDIATR NEPHROL, V20, P744, DOI 10.1007/s00467-004-1810-8; Lee H, 2013, AM J NEPHROL, V37, P74, DOI 10.1159/000345960; Levart TK, 2005, PEDIATR NEPHROL, V20, P1756, DOI 10.1007/s00467-005-2040-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malafronte P, 2006, NEPHROL DIAL TRANSPL, V21, P3098, DOI 10.1093/ndt/gfl237; Mubarak M, 2011, APMIS, V119, P180, DOI 10.1111/j.1600-0463.2010.02708.x; Myllymaki J, 2003, AM J KIDNEY DIS, V41, P343, DOI 10.1053/ajkd.2003.50042; Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016; Shakeel S, 2012, J CLIN PATHOL, V65, P1072, DOI 10.1136/jclinpath-2012-200933; SHALHOUB RJ, 1974, LANCET, V2, P556; SHARPSTONE P, 1969, BMJ-BRIT MED J, V2, P533, DOI 10.1136/bmj.2.5656.533; Szeto CC, 2015, AM J KIDNEY DIS, V65, P710, DOI 10.1053/j.ajkd.2014.09.022; Vanikar Aruna, 2013, J Nephropathol, V2, P98, DOI 10.12860/JNP.2013.16; Vanikar AV, 2012, INDIAN J PEDIATR, V79, P1025, DOI 10.1007/s12098-012-0693-0; Vizjak A, 2008, J AM SOC NEPHROL, V19, P2237, DOI 10.1681/ASN.2007080929; Wenderfer SE, 2010, PEDIATR NEPHROL, V25, P1385, DOI 10.1007/s00467-009-1429-x; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147387	10.1371/journal.pone.0147387	http://dx.doi.org/10.1371/journal.pone.0147387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799663	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300101
J	Mehta, K; Appleman, L; Wang, H; Tarhini, AA; Parikh, RA				Mehta, Kathan; Appleman, Leonard; Wang, Hong; Tarhini, Ahmad A.; Parikh, Rahul A.			Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients	PLOS ONE			English	Article							METASTATIC MELANOMA; BRAF; VEMURAFENIB; SURVIVAL; THERAPY	Background Immunotherapy using high dose interleukin-2 (HD IL2) in patients with renal cell carcinoma (RCC) and melanoma is associated with severe toxicities. The association between annual hospital volume of HD IL2 and inpatient mortality is not well studied. In this study we aim to quantify the impact of annual hospital volume of HD IL2 on inpatient mortality using National Inpatient Sample (NIS) data. Methods We did a cross-sectional study using NIS, one of the largest inpatient datasets in United States, from 2003 to 2011. Patients with melanoma and RCC receiving HD IL2 were identified by ICD9 procedure code 00.15. The primary outcome was inpatient mortality. Using Joinpoint regression, which detects change in trend of inpatient mortality with change in annual volume, the hospitals were classified in three volume categories (low: 1-40, medium: 41-120, high: >120). Multivariate logistic regression was used to identify predictors of inpatient mortality controlling for confounders. Results From 2003 to 2011, 29,532 patients with RCC or melanoma who received HD IL2 were identified, and 124 died during the hospitalization (0.4%). The hospitals with low, medium and high annual volume had significant difference in inpatient mortality (0.83%, 0.29% and 0.13% respectively, p = 0.0003). On multivariate analysis, low volume hospitals were associated with significantly higher odds of inpatient mortality (OR 6.1, 95% CI 1.6-23.2, p = 0.003) as compared to high volume hospitals. Additionally, the hospitals with annual volume of 1-20 had even higher rates (1.31% vs. 0.13%, p<0.0001) and multivariate odds (OR 8.9, 95% CI 2.4-33.2, p = 0.0006) of inpatient mortality as compared to high volume hospitals. Conclusions Lower annual hospital volume of HD IL2 is associated with worse outcomes. Annual hospital volume of 1-40 and 1-20 treatments per year is associated with 6 and 9 times higher odds of inpatient mortality respectively as compared to high volume hospitals. Our findings provide preliminary evidence for a volume-outcome relationship for RCC and melanoma patients undergoing HD IL2 treatment. They support future volume-outcome analyses in relation to other anti-cancer therapies that require special training and expertise.	[Mehta, Kathan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Appleman, Leonard; Wang, Hong; Tarhini, Ahmad A.; Parikh, Rahul A.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Parikh, RA (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA.	parikhr@upmc.edu		Parikh, Rahul/0000-0002-3372-7914; Wang, Hong/0000-0003-0477-2908	NCI NIH HHS [P50 CA121973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA121973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dutcher J, 2002, ONCOLOGY-NY, V16, P4; Dutcher JP, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0026-0; FDA, 2013, APPR DRUGS SOR NEXAV; FDA, 2006, 2006 FDA APPR NEW TR; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; HCUP, 2015, APP A CLIN CLASS SOF; Hewitt M PD, 2001, INT VOL OUTC REL CON; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOROWITZ MM, 1992, BLOOD, V79, P2771; Hospital cost and utilization project (HCUP), 2012, HCUP NAT INP SAMPL N; HOWS J, 1993, BONE MARROW TRANSPL, V12, P371; Kim HJ, 2014, STAT MED, V33, P4087, DOI 10.1002/sim.6221; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McDermott DF, 2015, CLIN CANCER RES, V21, P561, DOI 10.1158/1078-0432.CCR-14-1520; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Steiner Claudia, 2002, Eff Clin Pract, V5, P143	25	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147153	10.1371/journal.pone.0147153	http://dx.doi.org/10.1371/journal.pone.0147153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799322	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000368655300065
J	Rauwerda, H; Wackers, P; Pagano, JFB; de Jong, M; Ensink, W; Dekker, R; Nehrdich, U; Spaink, HP; Jonker, M; Breit, TM				Rauwerda, Han; Wackers, Paul; Pagano, Johanna F. B.; de Jong, Mark; Ensink, Wim; Dekker, Rob; Nehrdich, Ulrike; Spaink, Herman P.; Jonker, Martijs; Breit, Timo M.			Mother-Specific Signature in the Maternal Transcriptome Composition of Mature, Unfertilized Zebrafish Eggs	PLOS ONE			English	Article							TRANSLATIONAL CONTROL; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; GENE-EXPRESSION; BIOINFORMATICS; IDENTIFICATION; LOCALIZATION; TRANSITION; DYNAMICS; PATTERNS	Maternal mRNA present in mature oocytes plays an important role in the proper development of the early embryo. As the composition of the maternal transcriptome in general has been studied with pooled mature eggs, potential differences between individual eggs are unknown. Here we present a transcriptome study on individual zebrafish eggs from clutches of five mothers in which we focus on the differences in maternal mRNA abundance per gene between and within clutches. To minimize technical interference, we used mature, unfertilized eggs from siblings. About half of the number of analyzed genes was found to be expressed as maternal RNA. The expressed and non-expressed genes showed that maternal mRNA accumulation is a non-random process, as it is related to specific biological pathways and processes relevant in early embryogenesis. Moreover, it turned out that overall the composition of the maternal transcriptome is tightly regulated as about half of the expressed genes display a less than twofold expression range between the observed minimum and maximum expression values of a gene in the experiment. Even more, the maximum gene-expression difference within clutches is for 88% of the expressed genes lower than twofold. This means that expression differences observed in maternally expressed genes are primarily caused by differences between mothers, with only limited variability between eggs from the same mother. This was underlined by the fact that 99% of the expressed genes were found to be differentially expressed between any of the mothers in an ANOVA test. Furthermore, linking chromosome location, transcription factor binding sites, and miRNA target sites of the genes in clusters of distinct and unique mother-specific gene-expression, suggest biological relevance of the mother-specific signatures in the maternal transcriptome composition. Altogether, the maternal transcriptome composition of mature zebrafish oocytes seems to be tightly regulated with a distinct mother-specific signature.	[Rauwerda, Han; Wackers, Paul; Pagano, Johanna F. B.; de Jong, Mark; Ensink, Wim; Dekker, Rob; Jonker, Martijs; Breit, Timo M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands; [Nehrdich, Ulrike; Spaink, Herman P.] Leiden Univ, Inst Biol Leiden, Fac Sci, Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University - Excl LUMC	Breit, TM (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands.	t.m.breit@uva.nl	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; Wackers, Paul/0000-0002-6598-4173; Rauwerda, Han/0000-0003-4360-0797	University of Amsterdam	University of Amsterdam	The University of Amsterdam has provided the funding for this work but had no role as such in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-331; Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Abramov R, 2013, GEN COMP ENDOCR, V188, P309, DOI 10.1016/j.ygcen.2013.02.012; Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002; Amaral IPG, 2012, J EXP BIOL, V215, P3895, DOI 10.1242/jeb.068908; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bouleau A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119925; Brooks S, 1997, REV FISH BIOL FISHER, P416; Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HYLLNER SJ, 1994, MOL REPROD DEV, V39, P166, DOI 10.1002/mrd.1080390208; Juanchich A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105361; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Li SF, 1997, CANCER RES, V57, P4356; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Liebers R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004296; Lindeman RE, 2010, MOL REPROD DEV, V77, P299, DOI 10.1002/mrd.21128; Marlow F.L., 2010, MATERNAL CONTROL DEV; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; OLSZANSKA B, 1993, J EXP ZOOL, V265, P317, DOI 10.1002/jez.1402650313; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Preuss KM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-671; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Rauwerda Han, 2010, BMC Res Notes, V3, P192, DOI 10.1186/1756-0500-3-192; Reich A, 2011, J BIOL CHEM, V286, P40743, DOI 10.1074/jbc.M111.289868; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; TATA JR, 1986, BIOESSAYS, V4, P197, DOI 10.1002/bies.950040503; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yao YG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-117; Yartseva V, 2015, CURR TOP DEV BIOL; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7	58	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147151	10.1371/journal.pone.0147151	http://dx.doi.org/10.1371/journal.pone.0147151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799215	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300064
J	Wang, SB; Niu, CC				Wang, Shibo; Niu, Chengchao			Torsional Tribological Behavior and Torsional Friction Model of Polytetrafluoroethylene against 1045 Steel	PLOS ONE			English	Article							FRETTING WEAR BEHAVIOR; CONTACT; BODIES	In this work, the plane-on-plane torsional fretting tribological behavior of polytetrafluoroethylene ( PTFE) was studied. A model of a rigid, flat-ended punch acting on an elastic half-space was built according to the experimental conditions. The results indicate that the shape of T-theta curves was influenced by both the torsional angle and the normal load. The torsion friction torque and wear rate of PTFE exponentially decreased when the torsion angle rose. The torsional torque increased from 0.025 N.m under a normal load of 43 N to 0.082 N.m under a normal load of 123 N. With sequentially increasing normal load, the value of torque was maintained. With rising normal load, the wear mass loss of PTFE disks was increased and the wear rate was decreased. Good agreement was found with the calculated torque according to the model and the experimental torque except for that under a normal load of 163 N. The difference under a normal load of 163 N was caused by the coefficient of friction. Usually the coefficient of friction of a polymer decreases with increasing normal load, whereas a constant coefficient of friction was applied in the model.	[Wang, Shibo; Niu, Chengchao] China Univ Min & Technol, Sch Mech & Elect Engn, Xuzhou 221116, Jiangsu, Peoples R China; [Wang, Shibo] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China	China University of Mining & Technology; Tsinghua University	Wang, SB (corresponding author), China Univ Min & Technol, Sch Mech & Elect Engn, Xuzhou 221116, Jiangsu, Peoples R China.; Wang, SB (corresponding author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.	wangshb@cumt.edu.cn			Fundamental Research Funds for the Central University - Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2012QA29]	Fundamental Research Funds for the Central University - Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The research was financially supported by the Fundamental Research Funds for the Central University (2012QA29), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Briscoe BJ, 1998, TRIBOL INT, V31, P701, DOI 10.1016/S0301-679X(98)00093-0; Briscoe BJ, 2000, WEAR, V240, P27, DOI 10.1016/S0043-1648(99)00366-X; Cai ZB, 2011, WEAR, V270, P230, DOI 10.1016/j.wear.2010.10.063; Cai ZB, 2009, TRIBOL INT, V42, P1676, DOI 10.1016/j.triboint.2009.04.031; Cai ZB, 2010, TRIBOL INT, V43, P361, DOI 10.1016/j.triboint.2009.06.016; [蔡振兵 CAI Zhenbing], 2008, [摩擦学学报, Tribology], V28, P18; Chateauminois A, 2003, SURF COAT TECH, V163, P435, DOI 10.1016/S0257-8972(02)00640-0; [陈聚文 Chen Juwen], 2004, [高分子材料科学与工程, Polymer Materials Science & Engineering], V20, P114; Dorin G, 2011, FASCICLE MANAGEMENT, V5, P46; Gallego L, 2007, J TRIBOL-T ASME, V129, P528, DOI 10.1115/1.2736436; Gallego L, 2010, WEAR, V268, P208, DOI 10.1016/j.wear.2009.07.019; Hetenyi M., 1958, T ASME J APPL MECH, V25, P396; Hills DA, 1986, J APPL MECH-T ASME, V54, P8; JAGER J, 1995, ARCH APPL MECH, V65, P478, DOI 10.1007/BF00835661; Jeong SH, 2007, TRIBOL T, V50, P564, DOI 10.1080/10402000701691076; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kim JS, 2012, TRIBOL T, V55, P730, DOI 10.1080/10402004.2012.700764; Kumar SA, 2012, TRIBOL T, V55, P615, DOI 10.1080/10402004.2012.686087; Lu Y, 2000, INT J PROD ECON, V67, P17, DOI 10.1016/S0925-5273(00)00006-2; LUBKIN JL, 1951, J APPL MECH-T ASME, V18, P183; Qiu H, 2008, J MECH PHYS SOLIDS, V56, P3352, DOI 10.1016/j.jmps.2008.09.008; Rae PJ, 2004, POLYMER, V45, P7615, DOI 10.1016/j.polymer.2004.08.064; Timothy TL, 2010, PHYS REV LETT, V104, P39; VINGSBO O, 1988, WEAR, V126, P131, DOI 10.1016/0043-1648(88)90134-2; Wang SB, 2012, TRIBOL LETT, V45, P445, DOI 10.1007/s11249-011-9904-5; Wang SB, 2013, TRIBOL T, V56, P178, DOI 10.1080/10402004.2012.734548; Wang SB, 2013, MATER DESIGN, V43, P507, DOI 10.1016/j.matdes.2012.07.048; Yu J, 2008, THESIS SW JIAOTONG U; Yu J, 2008, APPL SURF SCI, V255, P616, DOI 10.1016/j.apsusc.2008.06.179; Zhou ZR, 2006, TRIBOL INT, V39, P1068, DOI 10.1016/j.triboint.2006.02.001	30	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147598	10.1371/journal.pone.0147598	http://dx.doi.org/10.1371/journal.pone.0147598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799324	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300129
J	Yabas, M; Jing, WD; Shafik, S; Broer, S; Enders, A				Yabas, Mehmet; Jing, Weidong; Shafik, Sarah; Broeer, Stefan; Enders, Anselm			ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes	PLOS ONE			English	Article							P-TYPE ATPASES; ANNEXIN-V BINDS; B-CELLS; PHOSPHATIDYLSERINE; FLIPPASES; EXPRESSION; LYMPHOCYTES; DEFICIENCY; ASYMMETRY; EXPOSURE	Organization of the plasma membrane into specialized substructures in different blood lineages facilitates important biological functions including proper localization of receptors at the plasma membrane as well as the initiation of crucial intracellular signaling cascades. The eukaryotic plasma membrane is a lipid bilayer that consists of asymmetrically distributed phospholipids. This asymmetry is actively maintained by membrane-embedded lipid transporters, but there is only limited data available about the molecular identity of the predominantly active transporters and their substrate specificity in different leukocyte subsets. We demonstrate here that the P4-type ATPase ATP11C mediates significant flippase activity in all murine leukocyte subsets. Loss of ATP11C resulted in a defective internalization of phosphatidylserine (PS) and phosphatidylethanolamine (PE) in comparison to control cells. The diminished flippase activity caused increased PS exposure on 7-aminoactinomycin D- (7-AAD(-)) viable pro-B cells freshly isolated from the bone marrow of ATP11C-deficient mice, which was corrected upon a 2-hour resting period in vitro. Despite the impaired flippase activity in all immune cell subsets, the only other blood cell type with an accumulation of PS on the surface were viable 7-AAD(-) developing T cells but this did not result in any discernable effect on their development in the thymus. These findings show that all leukocyte lineages exhibit flippase activity, and identify ATP11C as an aminophospholipid translocase in immune cells.	[Yabas, Mehmet; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Yabas, Mehmet] Trakya Univ, Dept Genet & Bioengn, Fac Engn, Edirne, Turkey; [Jing, Weidong; Shafik, Sarah; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Trakya University; Australian National University	Enders, A (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia.; Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia.	stefan.broeer@anu.edu.au; anselm.enders@anu.edu.au	Broer, Stefan/A-1286-2008; Jing, Weidong/D-7145-2019; Yabas, Mehmet/D-9513-2012; Shafik, Sarah/AAW-5156-2020; Enders, Anselm/B-1165-2011	Broer, Stefan/0000-0002-8040-1634; Jing, Weidong/0000-0002-6747-6076; Yabas, Mehmet/0000-0002-3462-5389; Enders, Anselm/0000-0001-5933-6463; Shafik, Sarah/0000-0001-6503-3565	National Health and Medical Research Council [GNT1061288]; Ministry of National Education, Republic of Turkey; National Health and Medical Research Council Career Development Fellowship [GNT1035858]; Ramaciotti Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti Foundation	This work was supported by National Health and Medical Research Council Grant GNT1061288. MY was supported by a postgraduate award from the Ministry of National Education, Republic of Turkey, and AE was supported by a National Health and Medical Research Council Career Development Fellowship GNT1035858 and by the Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dillon SR, 2001, J IMMUNOL, V166, P58, DOI 10.4049/jimmunol.166.1.58; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Gorter E, 1925, J EXP MED, V41, P439, DOI 10.1084/jem.41.4.439; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kok JW, 1999, FLUORESCENT LUMINESC, P136; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pozarowski Piotr, 2004, Curr Protoc Cell Biol, VChapter 18, DOI [10.1002/0471142956.cy0719s25, 10.1002/0471143030.cb1808s21]; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; VAN GENDEREN I, 1995, J CELL BIOL, V131, P645, DOI 10.1083/jcb.131.3.645; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	34	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146774	10.1371/journal.pone.0146774	http://dx.doi.org/10.1371/journal.pone.0146774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799398	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300034
J	Martill, DM; Vidovic, SU; Howells, C; Nudds, JR				Martill, David M.; Vidovic, Steven U.; Howells, Cindy; Nudds, John R.			The Oldest Jurassic Dinosaur: A Basal Neotheropod from the Hettangian of Great Britain	PLOS ONE			English	Article							THEROPOD DINOSAUR; SOUTH-WALES; NORTH-AMERICA; BOUNDARY; SECTION; SYSTEM; EXTINCTION; MOUNTAINS; EVOLUTION; AUSTRIA	Approximately 40% of a skeleton including cranial and postcranial remains representing a new genus and species of basal neotheropod dinosaur is described. It was collected from fallen blocks from a sea cliff that exposes Late Triassic and Early Jurassic marine and quasi marine strata on the south Wales coast near the city of Cardiff. Matrix comparisons indicate that the specimen is from the lithological Jurassic part of the sequence, below the first occurrence of the index ammonite Psiloceras planorbis and above the last occurrence of the Rhaetian conodont Chirodella verecunda. Associated fauna of echinoderms and bivalves indicate that the specimen had drifted out to sea, presumably from the nearby Welsh Massif and associated islands (St David's Archipelago). Its occurrence close to the base of the Blue Lias Formation (Lower Jurassic, Hettangian) makes it the oldest known Jurassic dinosaur and it represents the first dinosaur skeleton from the Jurassic of Wales. A cladistic analysis indicates basal neotheropodan affinities, but the specimen retains plesio-morphic characters which it shares with Tawa and Daemonosaurus.	[Martill, David M.; Vidovic, Steven U.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Howells, Cindy] Amgueddfa Cymru Natl Museum Wales, Dept Nat Sci, Cardiff, S Glam, Wales; [Nudds, John R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Portsmouth; University of Manchester	Martill, DM (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	david.martill@port.ac.uk	Vidovic, Steven Uros/I-1141-2019	Vidovic, Steven Uros/0000-0002-4726-8018; Martill, David/0000-0002-3208-5702				Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Andrews C. W., 1921, Annals & Magazine of Natural History Series 9, V8, P570; [Anonymous], 1974, CASOPIS PRO MINERALO; Arkell W. J., 1933, JURASSIC SYSTEM GREA; Bakker RT., 1986, DINOSAUR HERESIES; Barrett PM, 2009, PALAEONTOLOGY, V52, P681, DOI 10.1111/j.1475-4983.2009.00887.x; BENTON MJ, 1995, SCOT J GEOL, V31, P177, DOI 10.1144/sjg31020177; Brazeau MD, 2011, BIOL J LINN SOC, V104, P489, DOI 10.1111/j.1095-8312.2011.01755.x; Bristowe Anthea, 2004, Palaeontologia Africana, V40, P31; Carrano MT, 2005, J VERTEBR PALEONTOL, V25, P835, DOI 10.1671/0272-4634(2005)025[0835:NIOSHA]2.0.CO;2; Cope JCW, 1980, CORRELATION JURASSIC, V14, P1; Cuny Gilles, 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V187, P261; Dean WT, 1961, GEOLOGY, V4, P438; Delsate D, 2014, GEOL BELG, V17, P175; Ezcurra MD, 2007, J VERTEBR PALEONTOL, V27, P73, DOI 10.1671/0272-4634(2007)27[73:TCLAGN]2.0.CO;2; Ezcurra MD, 2011, PALAEONTOLOGY, V54, P763, DOI 10.1111/j.1475-4983.2011.01069.x; Galton PM, 2007, NEUES JAHRB GEOL P-A, V243, P119, DOI 10.1127/0077-7749/2007/0243-0119; Galton Peter M., 2005, Revue de Paleobiologie, V24, P51; Guerin-Franiatte S, 1979, CR SOMM SOC GEOL FR, V3, P125; Guex J, 2004, EARTH PLANET SC LETT, V225, P29, DOI 10.1016/j.epsl.2004.06.006; HAMMER WR, 1994, SCIENCE, V264, P828, DOI 10.1126/science.264.5160.828; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hillebrandt AV, 2013, EPISODES, V36, P162, DOI 10.18814/epiiugs/2013/v36i3/001; HODGES P, 1994, GEOL MAG, V131, P841, DOI 10.1017/S0016756800012905; Huene F, 1932, MONOGRAPHIEN GEOLOGI, V1, P1; IvimeyCook H.C., 1974, UPPER PALEOZOIC POST, P295; KERMACK D, 1984, ZOOL J LINN SOC-LOND, V82, P101, DOI 10.1111/j.1096-3642.1984.tb00538.x; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; McRoberts C. A., 2007, INT SUBCOMMISSION JU, V34, P43; McRoberts CA, 1997, PALAEOGEOGR PALAEOCL, V136, P79, DOI 10.1016/S0031-0182(97)00074-6; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Newton E.T., 1899, Q J GEOLOGICAL SOC L, V55, P89; Orbell G, 1973, GEOLOGICAL SURVEY GR, V44, P1; Owen R, 1842, 11 M BRIT ASS ADV SC, P60; Owen R, 1863, PALAEONTOGRAPHICAL S, V14, P1, DOI DOI 10.1080/02693445.1863.12027933; Page KN, 1995, GEOSCIENCE S W ENGLA, V9, P231; Palfy J, 2001, GEOLOGY, V29, P1047, DOI 10.1130/0091-7613(2001)029<1047:CIAAOG>2.0.CO;2; POLUBOTKO IV, 1981, DOKL AKAD NAUK SSSR+, V261, P1394; Raath M.A., 1990, P91, DOI 10.1017/CBO9780511608377.010; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Simms M.J., 2004, GEOLOGICAL CONSERVAT, V30, P458; SOWERBY JD, 1823, MINERAL CONCHOLOGY G; Storrs Glenn W., 1999, Palaeontological Association Field Guides to Fossils, V9, P223; Suan G, 2012, J GEOL SOC LONDON, V169, P191, DOI 10.1144/0016-76492011-045; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; SWEET WC, 1971, GEOL SOC AM MEM, V127, P441; SWIFT A, 1989, PALAEONTOLOGY, V32, P325; Swift A, 1995, MONOGRAPH PALAEONTOG, V147, P1; Talbot M, 1911, AM J SCI, V31, P469; TUCKER ME, 1977, PALAEOGEOGR PALAEOCL, V22, P195, DOI 10.1016/0031-0182(77)90028-1; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P728, DOI 10.1671/0272-4634(2002)022[0728:AFITCT]2.0.CO;2; von Hillebrandt A.V., 2007, INT SUBCOM JURASSIC, V34, P2; Ward PD, 2007, PALAEOGEOGR PALAEOCL, V244, P281, DOI 10.1016/j.palaeo.2006.06.042; Waters RA, 1987, MEMOIRE BRIT GEOLOGI; WELLES SP, 1954, GEOL SOC AM BULL, V65, P591, DOI 10.1130/0016-7606(1954)65[591:NJDFTK]2.0.CO;2; Woodward A. Smith, 1908, Annals & Magazine of Natural History, V1; Woollam R., 1983, 83 I GEOL SCI, V2, P1; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; You HL, 2014, ZOOTAXA, V3873, P233, DOI 10.11646/zootaxa.3873.3.3	63	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145713	10.1371/journal.pone.0145713	http://dx.doi.org/10.1371/journal.pone.0145713			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789843	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000368529100014
J	Salomons, EM; Lohman, WJA; Zhou, H				Salomons, Erik M.; Lohman, Walter J. A.; Zhou, Han			Simulation of Sound Waves Using the Lattice Boltzmann Method for Fluid Flow: Benchmark Cases for Outdoor Sound Propagation	PLOS ONE			English	Article							MODEL; SITUATIONS; FDTD	Propagation of sound waves in air can be considered as a special case of fluid dynamics. Consequently, the lattice Boltzmann method (LBM) for fluid flow can be used for simulating sound propagation. In this article application of the LBM to sound propagation is illustrated for various cases: free-field propagation, propagation over porous and non-porous ground, propagation over a noise barrier, and propagation in an atmosphere with wind. LBM results are compared with solutions of the equations of acoustics. It is found that the LBM works well for sound waves, but dissipation of sound waves with the LBM is generally much larger than real dissipation of sound waves in air. To circumvent this problem it is proposed here to use the LBM for assessing the excess sound level, i.e. the difference between the sound level and the free-field sound level. The effect of dissipation on the excess sound level is much smaller than the effect on the sound level, so the LBM can be used to estimate the excess sound level for a non-dissipative atmosphere, which is a useful quantity in atmospheric acoustics. To reduce dissipation in an LBM simulation two approaches are considered: i) reduction of the kinematic viscosity and ii) reduction of the lattice spacing.	[Salomons, Erik M.; Lohman, Walter J. A.; Zhou, Han] TNO, Netherlands Org Appl Sci Res, Delft, Netherlands	Netherlands Organization Applied Science Research	Salomons, EM (corresponding author), TNO, Netherlands Org Appl Sci Res, Delft, Netherlands.	erik.salomons@tno.nl			National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands	National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands	This work was performed within the framework of the ITEA2 project MACH. The Dutch partner TNO of the MACH project has received funding from the National Public Authority "Rijksdienst voor Ondernemend Nederland" in The Netherlands within the framework of the ITEA2 PROGRAMME. URL: http://www.rvo.nl/. URL Mach: http://www.mach-project.org.	[Anonymous], 2008, CHOICE UNITS LATTICE; Buick JM, 1998, EUROPHYS LETT, V43, P235, DOI 10.1209/epl/i1998-00346-7; Crespo AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020685; d'Humieres D, 2002, PHILOS T ROY SOC A, V360, P437, DOI 10.1098/rsta.2001.0955; Dellar PJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031203; Feichtinger C, 2012, THESIS ERLANGEN NUMB; Guo ZL, 2002, INT J NUMER METH FL, V39, P325, DOI 10.1002/fld.337; HADDEN WJ, 1981, J ACOUST SOC AM, V69, P1266, DOI 10.1121/1.385809; Hecht M, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/02/E02001; Hecht M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/01/P01018; Hornikx M, 2010, J ACOUST SOC AM, V128, P1632, DOI 10.1121/1.3474234; Hughes WF, 1967, FLUID DYNAMICS SCHAU, P1; Kinsler, 1999, FUNDAMENTALS ACOUSTI; Latt J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056703; Mohamad AA, 2011, LATTICE BOLTZMANN METHOD: FUNDAMENTALS AND ENGINEERING APPLICATIONS WITH COMPUTER CODES, P1, DOI 10.1007/978-0-85729-455-5; Pierce A. D., 1991, ACOUSTICS INTRO ITS; Reichl LE, 1980, MODERN COURSE STAT P, P468; Salomons EM, 1999, J ACOUST SOC AM, V105, P2287, DOI 10.1121/1.426835; Salomons EM, 1997, ACUSTICA, V83, P436; Salomons EM, 2002, ACTA ACUST UNITED AC, V88, P483; Salomons EM, 2001, COMPUTATIONAL ATMOSP; Salomons EM, 2015, P 4 INT C PART BAS M; Sukop M.C., 2007, LATTICE BOLTZMANN MO; Tolke J, 2008, INT J COMPUT FLUID D, V22, P443, DOI 10.1080/10618560802238275; Ul Islam S, 2012, J MECH SCI TECHNOL, V26, P1027, DOI 10.1007/s12206-012-0328-4; Van Renterghem T, 2007, APPL ACOUST, V68, P201, DOI 10.1016/j.apacoust.2005.10.003; Van Renterghem T, 2005, ACTA ACUST UNITED AC, V91, P671; Viggen E. M., 2009, THESIS NTNU NORWAY; Viggen EM, 2014, THESIS NTNU NORWAY; Viggen EM, 2013, COMMUN COMPUT PHYS, V13, P671, DOI 10.4208/cicp.271011.020212s; Viggen EM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.023306; Viggen EM, 2011, PHILOS T R SOC A, V369, P2246, DOI 10.1098/rsta.2011.0040; Zou QS, 1997, PHYS FLUIDS, V9, P1591, DOI 10.1063/1.869307; Zwikker C, 1949, SOUND ABSORBING MAT	34	18	20	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147206	10.1371/journal.pone.0147206	http://dx.doi.org/10.1371/journal.pone.0147206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789631	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100068
J	Soto, M; Sampietro-Colom, L; Vilella, A; Pantoja, E; Asenjo, M; Arjona, R; Hurtado, JC; Trilla, A; Alvarez-Martinez, MJ; Mira, A; Vila, J; Marcos, MA				Soto, Marcelo; Sampietro-Colom, Laura; Vilella, Anna; Pantoja, Efrain; Asenjo, Mara; Arjona, Ruth; Carlos Hurtado, Juan; Trilla, Antoni; Jose Alvarez-Martinez, Miriam; Mira, Aurea; Vila, Jordi; Angeles Marcos, Maria			Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients	PLOS ONE			English	Article							RESPIRATORY VIRUSES; PANDEMIC INFLUENZA; A H1N1; OSELTAMIVIR; INFECTIONS; PREVENTION	Seasonal influenza causes significant morbidity and mortality and has a substantial economic impact on the healthcare system. The main objective of this study was to compare the cost per patient for a rapid commercial PCR assay (Xpert (R) Flu) with an in-house realtime PCR test for detecting influenza virus. Community patients with influenza like-illness attending the Emergency Department (ED) as well as hospitalized patients in the Hospital Clinic of Barcelona were included. Costs were evaluated from the perspective of the hospital considering the use of resources directly related to influenza testing and treatment. For the purpose of this study, 366 and 691 patients were tested in 2013 and 2014, respectively. The Xpert (R) Flu test reduced the mean waiting time for patients in the ED by 9.1 hours and decreased the mean isolation time of hospitalized patients by 23.7 hours. This was associated with a 103(sic) (or about $113) reduction in the cost per patient tested in the ED and 64(sic) ($70) per hospitalized patient. Sensitivity analyses showed that Xpert (R) Flu is likely to be cost-saving in hospitals with different contexts and prices.	[Soto, Marcelo] Fundacio Clin Recerca Biomed, Barcelona, Spain; [Sampietro-Colom, Laura] Univ Barcelona, Hlth Technol Assessment Unit, Hosp Clin, Barcelona, Spain; [Vilella, Anna; Pantoja, Efrain; Trilla, Antoni] Univ Barcelona, Dept Publ Hlth, Hosp Clin, Barcelona, Spain; [Vilella, Anna; Arjona, Ruth; Carlos Hurtado, Juan; Trilla, Antoni; Jose Alvarez-Martinez, Miriam; Vila, Jordi; Angeles Marcos, Maria] ISGlobal Barcelona Inst Global Hlth, Barcelona, Spain; [Asenjo, Mara] Univ Barcelona, Emergency Dept, Hosp Clin, Barcelona, Spain; [Arjona, Ruth; Carlos Hurtado, Juan; Jose Alvarez-Martinez, Miriam; Vila, Jordi; Angeles Marcos, Maria] Univ Barcelona, Dept Clin Microbiol, Hosp Clin, CDB, Barcelona, Spain; [Mira, Aurea] Univ Barcelona, CDB, Hosp Clin, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Soto, M (corresponding author), Fundacio Clin Recerca Biomed, Barcelona, Spain.	soto@clinic.ub.es	Hurtado, Juan Carlos/O-1064-2019; Trilla, Antoni/G-2446-2018; Vila, Jordi/P-3613-2016; Negreiros, Juan Carlos Hurtado/K-5448-2017	Hurtado, Juan Carlos/0000-0001-9519-6082; Vila, Jordi/0000-0002-8025-3926; Negreiros, Juan Carlos Hurtado/0000-0001-9519-6082; PANTOJA BUSTILLOS, PERCY EFRAIN/0000-0003-4095-8988; marcos, maria angeles/0000-0001-8250-3311; Alvarez-Martinez, Miriam Jose/0000-0003-4157-0117; Soto, Marcelo/0000-0002-2455-5700	Cepheid; Plataforma ITEMAS [PT13/0006/0009 (FCRB PI043029)]	Cepheid; Plataforma ITEMAS	This study was partially funded by Cepheid. Study sponsors had no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication. The authors made the final decisions about when and where to publish the data. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit it for publication. Marcelo Soto received financial support from Plataforma ITEMAS PT13/0006/0009 (FCRB PI043029).	Anton A, 2010, DIAGN MICR INFEC DIS, V68, P214, DOI 10.1016/j.diagmicrobio.2010.08.003; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Bouscambert M, 2015, J HOSP INFECT, V89, P314, DOI 10.1016/j.jhin.2014.12.017; CDC, INFL LIK ILLN CAS DE; CDC, PEOPL HIGH RISK DEV; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cox D.R., 1984, ANAL SURVIVAL DATA, V5, DOI [10.1093/biostatistics/5.3.415, DOI 10.1093/BIOSTATISTICS/5.3.415]; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Henrickson KJ, 2005, PEDIATR ANN, V34, P24, DOI 10.3928/0090-4481-20050101-08; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Marcos MA, 2011, EUR RESPIR J, V38, P739, DOI 10.1183/09031936.00168610; McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Novak-Weekley SM, 2012, J CLIN MICROBIOL, V50, P1704, DOI 10.1128/JCM.06520-11; Rao S, 2014, CURR OPIN INFECT DIS, V27, P342, DOI 10.1097/QCO.0000000000000079; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Sambol AR, 2010, J CLIN VIROL, V48, P234, DOI 10.1016/j.jcv.2010.06.001; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; WHO, 2014, INFL SEAS	20	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146620	10.1371/journal.pone.0146620	http://dx.doi.org/10.1371/journal.pone.0146620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788921	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100034
J	Betancourt, AB; Emery, JL; Recino, A; Wong, FS; Cooke, A; Okkenhaug, K; Wallberg, M				Betancourt, Ariana Barbera; Emery, Juliet L.; Recino, Asha; Wong, F. Susan; Cooke, Anne; Okkenhaug, Klaus; Wallberg, Maja			Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DENDRITIC CELLS; NOD MICE; P110-DELTA; PI3K; INFLAMMATION; ACTIVATION; RESPONSES; GENERATION	Type 1 diabetes is caused by the destruction of insulin producing beta cells by the immune system. The p110d isoform of PI3K is expressed primarily in cells of haematopoietic origin and the catalytic activity of p110d is important for the activation of these cells. Targeting of this pathway offers an opportunity to reduce immune cell activity without unwanted side effects. We have explored the effects of a specific p110d isoform inhibitor, IC87114, on diabetogenic T cells both in vitro and in vivo, and find that although pharmacological inhibition of p110d has a considerable impact on the production of pro-inflammatory cytokines, it does not delay the onset of diabetes after adoptive transfer of diabetogenic cells. Further, we demonstrate that combination treatment with CTLA4-Ig does not improve the efficacy of treatment, but instead attenuates the protective effects seen with CTLA4-Ig treatment alone. Our results suggest that decreased IL-10 production by Foxp3(+) CD4(+) T cells in the presence of IC87114 negates individual anti-inflammatory effects of IC8114 and CTLA4-Ig.	[Betancourt, Ariana Barbera; Recino, Asha; Cooke, Anne; Wallberg, Maja] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Emery, Juliet L.; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Wong, F. Susan] Cardiff Univ, Inst Mol & Expt Med, Cardiff Sch Med, Diabet Res Grp, Cardiff CF14 4XN, S Glam, Wales	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cardiff University	Wallberg, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mw394@cam.ac.uk	Okkenhaug, Klaus/H-3154-2019; Cooke, Anne/S-4763-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Cooke, Anne/0000-0003-3327-6081; Wong, F. Susan/0000-0002-2812-8845	Diabetes UK [09/0003840]; Juvenile Diabetes Research Foundation [5-2006-229]; European Research Council 7th Frame Programme [health-f5-2009-241883]; Britain Israel Research and Academic Exchange Partnership (BIRAX) [02BX12ACYD]; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236]; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI; The British Council [02BX12ACYD] Funding Source: researchfish	Diabetes UK(Diabetes UK); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Research Council 7th Frame Programme; Britain Israel Research and Academic Exchange Partnership (BIRAX); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council	This work was supported by Grant number 09/0003840, Diabetes UK https://www.diabetes.org.uk/ (MW); Grant number 5-2006-229, Juvenile Diabetes Research Foundation https://www.jdrf.org.uk/ (KO); Grant number BBS/E/B/0000C236 Biotechnology and Biological Sciences Research Council (KO); Grant number health-f5-2009-241883 European Research Council 7th Frame Programme http://ec.europa.eu/research/fp7/index_en.cfm (AC); and Grant number 02BX12ACYD, the Britain Israel Research and Academic Exchange Partnership (BIRAX) http://www.britishcouncil.org.il/en/programmes/science/birax. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Ambery P, 2014, DIABETIC MED, V31, P399, DOI 10.1111/dme.12361; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Banting FG, 1922, CAN MED ASSOC J, V7, P141; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Durand CA, 2013, AUTOIMMUNITY, V46, P62, DOI 10.3109/08916934.2012.732130; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Raine T, 2006, J IMMUNOL, V177, P2224, DOI 10.4049/jimmunol.177.4.2224; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Szot Gregory L, 2007, J Vis Exp, P404, DOI 10.3791/404; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Thomas DC, 2013, DIABETES, V62, P3132, DOI 10.2337/db12-1740; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; von Herrath MG, 2016, CLIN EXP IMMUNOL, V183, P1, DOI 10.1111/cei.12656; Wallberg M, 2013, TRENDS IMMUNOL, V34, P583, DOI 10.1016/j.it.2013.08.005; Wallberg M, 2011, J IMMUNOL, V186, P2543, DOI 10.4049/jimmunol.1002098; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Wong FS, 2009, DIABETES, V58, P1156, DOI 10.2337/db08-0800; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146516	10.1371/journal.pone.0146516	http://dx.doi.org/10.1371/journal.pone.0146516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783747	Green Published, gold			2022-12-27	WOS:000368528400042
J	Bowen, HJ; Spaniol, J; Patel, R; Voss, A				Bowen, Holly J.; Spaniol, Julia; Patel, Ronak; Voss, Andreas			A Diffusion Model Analysis of Decision Biases Affecting Delayed Recognition of Emotional Stimuli	PLOS ONE			English	Article							COGNITIVE-PROCESSES; RESPONSE BIAS; MEMORY; VALENCE; WORDS; NEUROSCIENCE; AMYGDALA; AROUSAL; DISTINCTIVENESS; CONSOLIDATION	Previous empirical work suggests that emotion can influence accuracy and cognitive biases underlying recognition memory, depending on the experimental conditions. The current study examines the effects of arousal and valence on delayed recognition memory using the diffusion model, which allows the separation of two decision biases thought to underlie memory: response bias and memory bias. Memory bias has not been given much attention in the literature but can provide insight into the retrieval dynamics of emotion modulated memory. Participants viewed emotional pictorial stimuli; half were given a recognition test 1-day later and the other half 7-days later. Analyses revealed that emotional valence generally evokes liberal responding, whereas high arousal evokes liberal responding only at a short retention interval. The memory bias analyses indicated that participants experienced greater familiarity with high-arousal compared to low-arousal items and this pattern became more pronounced as study-test lag increased; positive items evoke greater familiarity compared to negative and this pattern remained stable across retention interval. The findings provide insight into the separate contributions of valence and arousal to the cognitive mechanisms underlying delayed emotion modulated memory.	[Bowen, Holly J.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [Spaniol, Julia] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Patel, Ronak] Univ Manitoba, Dept Clin Hlth Psychol, Coll Med, Winnipeg, MB, Canada; [Voss, Andreas] Heidelberg Univ, Psychol Inst, Heidelberg, Germany	Boston College; Toronto Metropolitan University; University of Manitoba; Ruprecht Karls University Heidelberg	Bowen, HJ (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	holly.bowen@bc.edu	Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660; Bowen, Holly/0000-0002-3855-8961	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [358797]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant # 358797 (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp). It was awarded to JS, who was involved in study design, data analysis, decision to publish and preparation of the manuscript.	Anderson AK, 2006, LEARN MEMORY, V13, P711, DOI 10.1101/lm.388906; Bowen HJ, 2011, APPL COGNITIVE PSYCH, V25, P906, DOI 10.1002/acp.1767; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Dewhurst SA, 2000, EUR J COGN PSYCHOL, V12, P541, DOI 10.1080/095414400750050222; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Greder RC, 2008, MEM COGNITION, V36, P933, DOI 10.3758/MC.36.5.933; Green DM, 1966, SIGNAL DETECTION THE; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; HEALY AF, 1978, MEM COGNITION, V6, P544, DOI 10.3758/BF03198243; Kapucu A, 2008, J EXP PSYCHOL LEARN, V34, P703, DOI 10.1037/0278-7393.34.3.703; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kensinger EA, 2006, PSYCHON B REV, V13, P757, DOI 10.3758/BF03193993; Kensinger EA, 2007, J MEM LANG, V56, P575, DOI 10.1016/j.jml.2006.05.004; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LaBar KS, 2000, NEUROPSYCHOLOGIA, V38, P1734, DOI 10.1016/S0028-3932(00)00077-4; Lang PJ, 2008, TECH REP A 8; Leite FP, 2011, JUDGM DECIS MAK, V6, P651; LOFTUS EF, 1974, J VERB LEARN VERB BE, V13, P585, DOI 10.1016/S0022-5371(74)80011-3; Luce R. D., 1963, HDB MATH PSYCHOL, V1, P103; Macmillan NA, 2005, DETECTION THEORY USE; Maratos EJ, 2000, NEUROPSYCHOLOGIA, V38, P1452, DOI 10.1016/S0028-3932(00)00061-0; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McGaugh JL, 1989, INVOLVEMENT OF HORMO; Oates JM, 2011, MEMORY PICTURES SOME, P1; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Payne JD, 2010, CURR DIR PSYCHOL SCI, V19, P290, DOI 10.1177/0963721410383978; Pierce BH, 2011, EMOTION, V11, P139, DOI 10.1037/a0021287; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Ratcliff R, 2003, PERCEPT PSYCHOPHYS, V65, P523, DOI 10.3758/BF03194580; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sharot T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001068; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spaniol J, 2011, PSYCHOL AGING, V26, P932, DOI 10.1037/a0023297; Spaniol J, 2008, PSYCHOL AGING, V23, P859, DOI 10.1037/a0014218; Talmi D, 2007, J MEM LANG, V56, P555, DOI 10.1016/j.jml.2007.01.002; Thapar A, 2009, PSYCHON B REV, V16, P699, DOI 10.3758/PBR.16.4.699; Tukey JW, 1977, EXPLORATORY DATA ANA; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Voss A, 2008, J EXP SOC PSYCHOL, V44, P1048, DOI 10.1016/j.jesp.2007.10.009; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Voss A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00336; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067; Weymar M, 2011, HUM BRAIN MAPP, V32, P632, DOI 10.1002/hbm.21051; Weymar M, 2009, PSYCHOPHYSIOLOGY, V46, P1200, DOI 10.1111/j.1469-8986.2009.00869.x; White C, 2009, COGNITION EMOTION, V23, P181, DOI 10.1080/02699930801976770; White CN, 2014, J EXP PSYCHOL LEARN, V40, P385, DOI 10.1037/a0034851; White CN, 2010, J MATH PSYCHOL, V54, P39, DOI 10.1016/j.jmp.2010.01.004; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341	63	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146769	10.1371/journal.pone.0146769	http://dx.doi.org/10.1371/journal.pone.0146769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784108	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400065
J	Marinello, J; Bertoncini, S; Aloisi, I; Cristini, A; Tagliazucchi, GM; Forcato, M; Sordet, O; Capranico, G				Marinello, Jessica; Bertoncini, Stefania; Aloisi, Iris; Cristini, Agnese; Tagliazucchi, Guidantonio Malagoli; Forcato, Mattia; Sordet, Olivier; Capranico, Giovanni			Dynamic Effects of Topoisomerase I Inhibition on R-Loops and Short Transcripts at Active Promoters	PLOS ONE			English	Article							RNA-POLYMERASE-II; CPG-ISLAND PROMOTERS; DOUBLE-STRAND BREAKS; ANTISENSE TRANSCRIPTION; DNA TOPOISOMERASES; HUMAN-CELLS; CAMPTOTHECIN; REPLICATION; ACTIVATION; SITES	Topoisomerase I-DNA-cleavage complexes (Top1cc) stabilized by camptothecin (CPT) have specific effects at transcriptional levels. We recently reported that Top1cc increase antisense transcript (aRNAs) levels at divergent CpG-island promoters and, transiently, DNA/RNA hybrids (R-loop) in nuclear and mitochondrial genomes of colon cancer HCT116 cells. However, the relationship between R-loops and aRNAs was not established. Here, we show that aRNAs can form R-loops in N-TERA-2 cells under physiological conditions, and that promoter-associated R-loops are somewhat increased and extended in length immediately upon cell exposure to CPT. In contrast, persistent Top1ccs reduce the majority of R-loops suggesting that CPT-accumulated aRNAs are not commonly involved in R-loops. The enhancement of aRNAs by Top1ccs is present both in human colon cancer HCT116 cells and WI38 fibroblasts suggesting a common response of cancer and normal cells. Although Top1ccs lead to DSB and DDR kinases activation, we do not detect a dependence of aRNA accumulation on ATM or DNA-PK activation. However, we showed that the cell response to persistent Top1ccs can involve an impairment of aRNA turnover rather than a higher synthesis rate. Finally, a genome-wide analysis shows that persistent Top1ccs also determine an accumulation of sense transcripts at 5'-end gene regions suggesting an increased occurrence of truncated transcripts. Taken together, the results indicate that Top1 may regulate transcription initiation by modulating RNA polymerase-generated negative supercoils, which can in turn favor R-loop formation at promoters, and that transcript accumulation at TSS is a response to persistent transcriptional stress by Top1 poisoning.	[Marinello, Jessica; Bertoncini, Stefania; Aloisi, Iris; Capranico, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Cristini, Agnese; Sordet, Olivier] Canc Res Ctr Toulouse, INSERM UMR1037, Toulouse, France; [Tagliazucchi, Guidantonio Malagoli; Forcato, Mattia] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, Modena, Italy; [Aloisi, Iris] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Tagliazucchi, Guidantonio Malagoli] IRCCS Osped Maggiore Policlin, Ist Nazl Genet Mol, Milan, Italy	University of Bologna; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universita di Modena e Reggio Emilia; University of Bologna; IRCCS Ca Granda Ospedale Maggiore Policlinico	Capranico, G (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	giovanni.capranico@unibo.it	Sordet, Olivier/M-3271-2014; Tagliazucch, Guidantonio Malagoli/E-5026-2018; Capranico, Giovanni/K-1678-2014; Forcato, Mattia/B-7733-2015	Sordet, Olivier/0000-0001-6027-4925; Tagliazucch, Guidantonio Malagoli/0000-0001-5581-4851; Capranico, Giovanni/0000-0002-8708-6454; Forcato, Mattia/0000-0002-7383-6576; Cristini, Agnese/0000-0003-0235-8770; Aloisi, Iris/0000-0001-5053-4818; Marinello, Jessica/0000-0002-2356-869X	"Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG15886, IG-15886]; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20140931166]; CIB (Consorzio Interuniversitario per le Biotecnologie)	"Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CIB (Consorzio Interuniversitario per le Biotecnologie)	This work was supported by a grant from the "Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG15886 grant to GC]. AC is supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation pour la Recherche Medicale [FDT20140931166]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the "Associazione Italiana per la Ricerca sul Cancro" (AIRC), Milan, Italy [IG-15886 grant to G. Capranico]. A.C. was supported by grant from the Ministere de l'Enseignement Superieur et de la Recherche and from the Fondation pour la Recherche Medicale [FDT20140931166]. S.B. was partially supported by CIB (Consorzio Interuniversitario per le Biotecnologie).	Baranello L, 2010, NUCLEIC ACIDS RES, V38, P159, DOI 10.1093/nar/gkp817; Bertozzi D, 2014, MOL CANCER THER, V13, P239, DOI 10.1158/1535-7163.MCT-13-0729; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boque-Sastre R, 2015, P NATL ACAD SCI USA, V112, P5785, DOI 10.1073/pnas.1421197112; Capranico G, 2007, BIOCHIMIE, V89, P482, DOI 10.1016/j.biochi.2007.01.001; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen PB, 2015, NAT STRUCT MOL BIOL, V22, P999, DOI 10.1038/nsmb.3122; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; Cristini A, 2015, NUCL ACIDS RES; Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004630; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jeanblanc M, 2012, ONCOGENE, V31, P3072, DOI 10.1038/onc.2011.481; Khobta A, 2006, J MOL BIOL, V357, P127, DOI 10.1016/j.jmb.2005.12.069; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Lombrana R, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00158; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Powell WT, 2013, P NATL ACAD SCI USA, V110, P13938, DOI 10.1073/pnas.1305426110; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sollier J, 2015, TRENDS CELL BIOL; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Stuckey R, 2015, P NATL ACAD SCI USA, V112, P5779, DOI 10.1073/pnas.1501769112; Sun QW, 2013, SCIENCE, V340, P619, DOI 10.1126/science.1234848; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veloso A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078190; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	47	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147053	10.1371/journal.pone.0147053	http://dx.doi.org/10.1371/journal.pone.0147053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784695	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400101
J	Polosa, A; Liu, WW; Lachapelle, P				Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre			Retinotopic Distribution of Structural and Functional Damages following Bright Light Exposure of Juvenile Rats	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; CELL INTRAOCULAR IMPLANTS; PHOTORECEPTOR DEGENERATION; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; INDUCED RETINOPATHY; RETINAL-DEGENERATION; ALBINO-RATS; AGE; CNTF	In the present study, we aimed at better understanding the short (acute) and long term (chronic) degenerative processes characterizing the juvenile rat model of light-induced retinopathy. Electroretinograms, visual evoked potentials (VEP), retinal histology and western blots were obtained from juvenile albino Sprague-Dawley rats at preselected postnatal ages (from P30 to P400) following exposure to 10,000 lux from P14 to P28. Our results show that while immediately following the cessation of exposure, photoreceptor degeneration was concentrated within a well delineated area of the superior retina (i.e. the photoreceptor hole), with time, this hole continued to expand to form an almost photoreceptor-free region covering most of superior-inferior axis. By the end of the first year of life, only few photoreceptors remained in the far periphery of the superior hemiretina. Interestingly, despite a significant impairment of the outer retinal function, the retinal output (VEP) was maintained in the early phase of this retinopathy. Our findings thus suggest that postnatal exposure to a bright luminous environment triggers a degenerative process that continues to impair the retinal structure and function (mostly at the photoreceptor level) long after the cessation of the exposure regimen (more than 1 year documented herein). Given the slow degenerative process triggered following postnatal bright light exposure, we believe that our model represents an attractive alternative (to other more genetic models) to study the pathophysiology of photoreceptor-induced retinal degeneration as well as therapeutic strategies to counteract it.	[Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Polosa, Anna; Liu, Wenwen; Lachapelle, Pierre] McGill Univ, Dept Ophthalmol, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Lachapelle, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.; Lachapelle, P (corresponding author), McGill Univ, Dept Ophthalmol, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada.	pierre.lachapelle@mcgill.ca		Lachapelle, Pierre/0000-0002-7792-1102	Natural Sciences and Engineering Research Council of Canada [Rgpin 138448-09]; Natural Sciences and Engineering Research Council (NSERC) of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada. Grant number: Rgpin 138448-09. Receipient: PL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada. Thanks are due to Dr. Allison L. Dorfman for reviewing earlier versions of this manuscript.	Cayouette M, 1998, J NEUROSCI, V18, P9282; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Gordon WC, 2002, INVEST OPHTH VIS SCI, V43, P3511; Green WR, 1999, MOL VIS, V5, P1; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Joly S, 2006, INVEST OPHTH VIS SCI, V47, P3202, DOI 10.1167/iovs.05-1515; Joly S, 2006, DOC OPHTHALMOL, V113, P93, DOI 10.1007/s10633-006-9018-9; Jones BW, 2006, ADV EXP MED BIOL, V572, P405; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; LACHAPELLE P, 1987, CAN J OPHTHALMOL, V22, P354; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LI ZY, 1994, EXP EYE RES, V58, P397, DOI 10.1006/exer.1994.1032; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; Marc RE, 2008, MOL VIS, V14, P782; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Noell W K, 1966, Invest Ophthalmol, V5, P450; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; OSTEEN WK, 1974, INVEST OPHTH VISUAL, V13, P334; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; PENN JS, 1986, EXP EYE RES, V43, P915, DOI 10.1016/0014-4835(86)90070-9; Pilli S, 2014, RETINA-J RET VIT DIS, V34, P1384, DOI 10.1097/IAE.0000000000000064; Rapp L, 1985, RETINAL DEGENERATION, P421; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; RAPP LM, 1990, INVEST OPHTH VIS SCI, V31, P1186; RAPP LM, 1980, EFFECTS CONSTANT LIG, P135; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Shao Z, 2011, INVEST OPHTH VIS SCI, V52, P6238, DOI 10.1167/iovs.10-6742; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; SIMONS K, 1993, ARCH OPHTHALMOL-CHIC, V111, P297, DOI 10.1001/archopht.1993.01090030015002; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; Valter K, 2003, BRAIN RES, V985, P169, DOI 10.1016/S0006-8993(03)03130-5; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146979	10.1371/journal.pone.0146979	http://dx.doi.org/10.1371/journal.pone.0146979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784954	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400092
J	Rueda, P; Harley, E; Lu, Y; Stewart, GD; Fabb, S; Diepenhorst, N; Cremers, B; Rouillon, MH; Wehrle, I; Geant, A; Lamarche, G; Leach, K; Charman, WN; Christopoulos, A; Summers, RJ; Sexton, PM; Langmead, CJ				Rueda, Patricia; Harley, Elizabeth; Lu, Yao; Stewart, Gregory D.; Fabb, Stewart; Diepenhorst, Natalie; Cremers, Beatrice; Rouillon, Marie-Helene; Wehrle, Isabelle; Geant, Anne; Lamarche, Gwladys; Leach, Katie; Charman, William N.; Christopoulos, Arthur; Summers, Roger J.; Sexton, Patrick M.; Langmead, Christopher J.			Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; KNOCKOUT MICE; GLA PROTEIN; L-ARGININE; IN-VITRO; BONE; EXPRESSION; SECRETION; PATHWAY; ISLETS	Phenotyping of Gprc6a KO mice has shown that this promiscuous class C G protein coupled receptor is variously involved in regulation of metabolism, inflammation and endocrine function. Such effects are described as mediated by extracellular calcium, L-amino acids, the bone-derived peptide osteocalcin (OCN) and the male hormone testosterone, introducing the concept of a bone-energy-metabolism-reproduction functional crosstalk mediated by GPRC6A. However, whilst the calcium and L-amino acid-sensing properties of GPRC6A are well established, verification of activity of osteocalcin at both human and mouse GPRC6A in vitro has proven somewhat elusive. This study characterises the in vitro pharmacology of mouse GPRC6A in response to its putative ligands in both recombinant and endogenous GPRC6A-expressing cells. Using cell signalling, and glucagon-like peptide (GLP)-1 and insulin release assays, our results confirm that basic L-amino acids act as agonists of the murine GPRC6A receptor in both recombinant cells and immortalised enteroendocrine and pancreatic beta-cells. In contrast, our studies do not support a role for OCN as a direct ligand for mouse GPRC6A, suggesting that the reported in vivo effects of OCN that require GPRC6A may be indirect, rather than via direct activation of the receptor.	[Rueda, Patricia; Lu, Yao; Stewart, Gregory D.; Fabb, Stewart; Diepenhorst, Natalie; Leach, Katie; Charman, William N.; Christopoulos, Arthur; Summers, Roger J.; Sexton, Patrick M.; Langmead, Christopher J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Harley, Elizabeth; Cremers, Beatrice; Rouillon, Marie-Helene; Wehrle, Isabelle; Geant, Anne; Lamarche, Gwladys] Inst Rech Servier, Suresnes, France	Monash University; Servier; Institut de Recherches Internationales Servier	Langmead, CJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.	chris.langmead@monash.edu	Diepenhorst, Natalie/HHS-2496-2022; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Summers, Roger J/F-6351-2011	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Summers, Roger J/0000-0002-8367-4056; Leach, Katherine/0000-0002-9280-1803; Rueda, Patricia/0000-0003-1553-0840; Stewart, Gregory David/0000-0002-9748-4990; Charman, William/0000-0002-7051-2023; Fabb, Stewart/0000-0002-8887-7661; Langmead, Christopher/0000-0003-3483-1120	Servier	Servier(Servier)	Servier provided support in the form of salaries for EH, BC, M-HR, IW, AG, GL and provided research support to Monash University to fund salaries for PR, YL, GDS, SF, ND and CJL. However, Servier did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AC and PMS are NHMRC Principal Research Fellows.	BENTON ME, 1995, BIOCHEMISTRY-US, V34, P9541, DOI 10.1021/bi00029a031; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; De Toni L, 2014, ENDOCRINOLOGY, V155, P4266, DOI 10.1210/en.2014-1283; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gloriam DE, 2011, CHEM BIOL, V18, P1489, DOI 10.1016/j.chembiol.2011.09.012; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Kim JH, 2007, BIOTECHNOL LETT, V29, P1631, DOI 10.1007/s10529-007-9437-z; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149; Wellendorph Petrine, 2014, ASCEPT MGPCR JOINT S	32	36	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146846	10.1371/journal.pone.0146846	http://dx.doi.org/10.1371/journal.pone.0146846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785252	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400073
J	Smieja, M; Warszycki, D				Smieja, Marek; Warszycki, Dawid			Average Information Content Maximization-A New Approach for Fingerprint Hybridization and Reduction	PLOS ONE			English	Article							MACHINE LEARNING-METHODS; DERIVATIVES; DESIGN; CHEMISTRY; ANTIDEPRESSANT; PROTOCOL; LIGANDS; SEARCH; 5-HT7	Fingerprints, bit representations of compound chemical structure, have been widely used in cheminformatics for many years. Although fingerprints with the highest resolution display satisfactory performance in virtual screening campaigns, the presence of a relatively high number of irrelevant bits introduces noise into data and makes their application more time-consuming. In this study, we present a new method of hybrid reduced fingerprint construction, the Average Information Content Maximization algorithm (AIC-MAX ALGORITHM), which selects the most informative bits from a collection of fingerprints. This methodology, applied to the ligands of five cognate serotonin receptors (5-HT2A, 5-HT2B, 5-HT2C, 5-HT5A, 5-HT6), proved that 100 bits selected from four non-hashed fingerprints reflect almost all structural information required for a successful in silico discrimination test. A classification experiment indicated that a reduced representation is able to achieve even slightly better performance than the state-of-the-art 10-times-longer fingerprints and in a significantly shorter time.	[Smieja, Marek] Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland; [Warszycki, Dawid] Polish Acad Sci, Inst Pharmacol, 12 Smetna St, PL-31343 Krakow, Poland	Jagiellonian University; Polish Academy of Sciences	Smieja, M (corresponding author), Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.	marek.smieja@ii.uj.edu.pl	Warszycki, Dawid/T-9712-2017	Warszycki, Dawid/0000-0002-2393-4709	National Centre of Science (Poland) [2014/13/N/ST6/01832]	National Centre of Science (Poland)(National Science Centre, Poland)	This study was fully supported by the National Centre of Science (Poland) grant no. 2014/13/N/ST6/01832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Centre of Science (Poland) grant no. 2014/13/N/ST6/01832.	Alpaydin E., 2009, INTRO MACHINE LEARNI; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bojarski AJ, 2006, CURR TOP MED CHEM, V6, P2005, DOI 10.2174/156802606778522186; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Canale V, 2015, EUR J MED CHEM, V92, P202, DOI 10.1016/j.ejmech.2014.12.041; Chlon-Rzepa G, 2015, ARCH PHARM, V348, P242, DOI 10.1002/ardp.201500015; Cover T. M., 1991, Elements of information theory, DOI 10.1002/0471200611; Czarnecki WM, 2015, EXPERT SYST APPL, V42, P5591, DOI 10.1016/j.eswa.2015.03.007; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gabrielsen M, 2014, J CHEM INF MODEL, V54, P933, DOI 10.1021/ci400742s; HALL LH, 1995, J CHEM INF COMP SCI, V35, P1039, DOI 10.1021/ci00028a014; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; MacKay D. J. C., 2003, INFORM THEORY INFERE; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Nisius B, 2010, CHEM BIOL DRUG DES, V75, P152, DOI 10.1111/j.1747-0285.2009.00930.x; Nisius B, 2009, J CHEM INF MODEL, V49, P1347, DOI 10.1021/ci900087y; Partyka A, 2015, BIOORGAN MED CHEM, V23, P212, DOI 10.1016/j.bmc.2014.11.008; Raevsky OA, 1999, RUSS CHEM REV, V68, P505, DOI [10.1070/RC1999v068n06ABEH000425, DOI 10.1070/RC1999V068N06ABEH000425]; Shemetulskis NE, 1996, J CHEM INF COMP SCI, V36, P862, DOI 10.1021/ci950169+; Smieja M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102069; Smusz S, 2015, J CHEM INF MODEL, V55, P823, DOI 10.1021/ci500564b; Smusz S, 2015, BIOORG MED CHEM LETT, V25, P1827, DOI 10.1016/j.bmcl.2015.03.049; Spurek P, 2013, INFORM SCIENCES, V252, P132, DOI 10.1016/j.ins.2013.06.030; Staron J, 2015, RSC ADV, V5, P25806, DOI 10.1039/c5ra00054h; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Wang Y, 2008, J CHEM INF MODEL, V48, P1754, DOI 10.1021/ci8002045; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; Witek J, 2014, BIOORG MED CHEM LETT, V24, P580, DOI 10.1016/j.bmcl.2013.12.017; Xue L, 2004, J CHEM INF COMP SCI, V44, P2032, DOI 10.1021/ci0400819; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zajdel P, 2009, COMB CHEM HIGH T SCR, V12, P723, DOI 10.2174/138620709788923719; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043; Zajdel P, 2012, BIOORGAN MED CHEM, V20, P1545, DOI 10.1016/j.bmc.2011.12.039	37	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146666	10.1371/journal.pone.0146666	http://dx.doi.org/10.1371/journal.pone.0146666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784447	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400056
J	Steinhausen, HC; Jakobsen, H; Meyer, A; Jorgensen, PM; Lieb, R				Steinhausen, Hans-Christoph; Jakobsen, Helle; Meyer, Andrea; Jorgensen, Povl Munk; Lieb, Roselind			Family Aggregation and Risk Factors in Phobic Disorders over Three-Generations in a Nation-Wide Study	PLOS ONE			English	Article							IV SPECIFIC PHOBIA; DIRECT-INTERVIEW FAMILY; SUBSTANCE USE DISORDERS; MENTAL-HEALTH SURVEY; SOCIAL PHOBIA; PSYCHIATRIC-DISORDERS; EPIDEMIOLOGIC SURVEY; LIFETIME PREVALENCE; ANXIETY DISORDERS; MOOD DISORDERS	Objective This nation-wide register-based study investigated how often phobic disorders (PHO) and co-morbid disorders occur in affected families compared to control families. Furthermore, the study addressed the impact of sex, year of birth, and degree of urbanization in terms of risk factors. Method A total of N = 746 child and adolescent psychiatric participants born between 1969 and 1986 and registered in the Danish Psychiatric Central Research Register (DPCRR) with a diagnosis of a mental disorder before the age of 18, and developed PHO at some point during their life-time until a maximum age of 40 years were included. In addition, N = 2229 controls without any diagnosis of mental disorders before age 18 and that were matched for age, sex, and residential region were included. Diagnoses of mental disorders were also obtained from the first-degree relatives as a part of the Danish Three Generation Study (3GS). A family load component was obtained by using various mixed regression models. Results PHO occurred significantly more often in case than in control families, in particular, in mothers and siblings. Substance use disorders (SUD), Depressive disorders (DEP), anxiety disorders (ANX) and personality disorders (PERS) in the family were significantly associated with specific phobia in the case-probands. After controlling for various mental disorders comorbid to PHO it was found that some of the family transmission could be caused by various other mental disorders in family members rather than the PHO itself. Female sex and more recent year of birth were further risk factors while region of residence was not related to the manifestation of PHO. Case-relatives did not develop PHO earlier than control relatives. After adjusting for various additional explanatory variables, the family load explained only 0.0013% of the variance in the manifestation of PHO in the case-probands Discussion These findings, based on a very large and representative dataset, provide evidence for the family aggregation and further risk factors in PHO. In contrast to anxiety disorders and other major mental disorders the family load of PHO in this nation-wide study was rather low.	[Steinhausen, Hans-Christoph; Jakobsen, Helle] Aalborg Univ Hosp, Hosp Psychiat, Res Unit Child & Adolescent Psychiat, Mollepk Vej 10, DK-9000 Aalborg, Denmark; [Steinhausen, Hans-Christoph; Meyer, Andrea; Lieb, Roselind] Univ Basel, Dept Psychol, Clin Psychol & Epidemiol, Basel, Switzerland; [Steinhausen, Hans-Christoph] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Jorgensen, Povl Munk] Aarhus Univ Hosp, Dept M, Risskov, Denmark	Aalborg University; Aalborg University Hospital; University of Basel; University of Zurich; Aarhus University	Steinhausen, HC (corresponding author), Aalborg Univ Hosp, Hosp Psychiat, Res Unit Child & Adolescent Psychiat, Mollepk Vej 10, DK-9000 Aalborg, Denmark.; Steinhausen, HC (corresponding author), Univ Basel, Dept Psychol, Clin Psychol & Epidemiol, Basel, Switzerland.; Steinhausen, HC (corresponding author), Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland.	hces@rn.dk						Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Capps L, 1996, J CHILD PSYCHOL PSYC, V37, P445, DOI 10.1111/j.1469-7610.1996.tb01425.x; de Graaf R, 2003, SOC PSYCH PSYCH EPID, V38, P1, DOI 10.1007/s00127-003-0597-4; Dekker J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-17; FYER AJ, 1993, ARCH GEN PSYCHIAT, V50, P286; FYER AJ, 1995, ARCH GEN PSYCHIAT, V52, P564; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Helenius D, 2014, PSYCHIAT RES, V216, P351, DOI 10.1016/j.psychres.2014.02.026; Helenius D, 2013, J AFFECT DISORDERS, V150, P146, DOI 10.1016/j.jad.2012.12.013; Helenius D, 2012, SCHIZOPHR RES, V139, P183, DOI 10.1016/j.schres.2012.05.014; Jacobi F, 2014, INT J METH PSYCH RES, V23, P304, DOI 10.1002/mpr.1439; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P273; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Lahey BB, 2014, JAMA PSYCHIAT, V71, P989, DOI 10.1001/jamapsychiatry.2014.359; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; LeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655; Lieb R, 2000, ARCH GEN PSYCHIAT, V57, P859, DOI 10.1001/archpsyc.57.9.859; LOFFLER W, 1994, ACTA PSYCHIAT SCAND, V90, P196, DOI 10.1111/j.1600-0447.1994.tb01577.x; Low NCP, 2008, J PSYCHIATR RES, V42, P596, DOI 10.1016/j.jpsychires.2007.07.002; MANNUZZA S, 1995, ARCH GEN PSYCHIAT, V52, P230; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Merikangas KR, 2002, BIOL PSYCHIAT, V51, P81, DOI 10.1016/S0006-3223(01)01309-9; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Munk-Jorgensen P, 2011, SCAND J PUBLIC HEALT, V39, P170, DOI 10.1177/1403494810390728; Park S, 2013, PSYCHIAT RES, V209, P596, DOI 10.1016/j.psychres.2012.12.025; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; R Core Team, 2021, R LANGUAGE ENV STAT; REICH J, 1988, COMPR PSYCHIAT, V29, P72, DOI 10.1016/0010-440X(88)90039-9; SKRE I, 1993, ACTA PSYCHIAT SCAND, V88, P85, DOI 10.1111/j.1600-0447.1993.tb03419.x; StataCorp, 2013, STAT STAT SOFTW REL; Stein MB, 1998, AM J PSYCHIAT, V155, P90, DOI 10.1176/ajp.155.1.90; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P1, DOI 10.1002/eat.22293; Steinhausen HC, 2013, DEPRESS ANXIETY, V30, P1177, DOI 10.1002/da.22163; Steinhausen HC, 2009, EUR ARCH PSY CLIN N, V259, P270, DOI 10.1007/s00406-008-0865-0; Stinson FS, 2007, PSYCHOL MED, V37, P1047, DOI 10.1017/S0033291707000086; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 1998, PSYCHOL MED, V28, P109, DOI 10.1017/S0033291797005928; World Health Organization, 1994, INT STAT CLASS DIS R	43	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146591	10.1371/journal.pone.0146591	http://dx.doi.org/10.1371/journal.pone.0146591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785257	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400050
J	Zhou, MW; Wang, JW; Wang, W; Huang, WB; Ding, XY; Zhang, XL				Zhou, Minwen; Wang, Jiawei; Wang, Wei; Huang, Wenbin; Ding, Xiaoyan; Zhang, Xiulan			Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; AQUEOUS-HUMOR; CHOROIDAL NEOVASCULARIZATION; ERYTHROPOIETIN; ANGIOGENESIS; BEVACIZUMAB; CONTRIBUTES; HYPOXIA; BINDING; LEVEL	Purpose To evaluate changes in the concentrations of placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A) in aqueous humor of patients with neovascular glaucoma (NVG) before and after an intravitreal injection of ranibizumab (IVR) and to determine the underlying correlation between the levels. Methods The prospective interventional comparative study involved 20 eyes of 20 patients with surgery-required advanced NVG and 20 control subjects from January 2013 to November 2013. The NVG eyes received the IVR treatment before glaucoma surgery. Aqueous humor was collected at the time of the IVR injection (pre- IVR) and at the time of antiglaucomatous surgery (post-IVR). Aqueous humor was also collected at the time of cataract surgery in normal control. Aqueous humor and plasma VEGF-A and PlGF levels were measured with an enzyme-linked immunosorbent assay methods, respectively. Results The mean aqueous humor PlGF and VEGF-A concentrations in the pre-IVR eyes were significantly higher than in those of the control subjects (p<0.001), whereas the plasma levels showed no significant difference. There was a statistically significant correlation between the aqueous humor PlGF and the VEGF-A concentration (r = 0.612, p = 0.003). The mean aqueous humor PlGF in the post-IVR eyes dramatically decreased from 1078.36 +/- 755.83 to 177.64 +/- 151.73 pg/mL (p<0.001). The VEGF-A level showed a similar trend from 3697.64 +/- 2104.47 pg/mL to 183.54 +/- 130.35 pg/mL (p<0.001). Conclusions Aqueous humor concentrations of VEGF-A and PlGF were significantly elevated in the eyes with NVG, and there was a positive correlation between the levels. After an IVR treatment, VEGF-A and PlGF were significantly decreased in NVG eyes.	[Wang, Jiawei; Wang, Wei; Huang, Wenbin; Ding, Xiaoyan; Zhang, Xiulan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Minwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhou, Minwen] Shanghai Key Lab Fundus Dis, Shanghai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University	Zhang, XL (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn	Wang, Wei/J-4000-2016	Wang, Wei/0000-0002-5273-3332	National Natural Science Foundation of China [81170849, 81371008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81170849, 81371008).	Abcouwer SF, 2013, J CLIN CELL IMMUN S1, V1; [Anonymous], 2014, OPHTHALMOLOGY; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cumurcu T, 2007, J GLAUCOMA, V16, P645, DOI 10.1097/IJG.0b013e31804a5eb3; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Dewerchin M, 2012, COLD SPRING HARB PER, V2; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Kim YG, 2009, J GLAUCOMA, V18, P443, DOI 10.1097/IJG.0b013e3181895e5c; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; Krispel C, 2013, WORLD J DIABETES, V4, P310, DOI 10.4239/wjd.v4.i6.310; Lowe J, 2007, EXP EYE RES, V85, P425, DOI 10.1016/j.exer.2007.05.008; Luttun A, 2004, BBA-REV CANCER, V1654, P79, DOI 10.1016/j.bbcan.2003.09.002; Mitamura Y, 2002, DIABETES CARE, V25, P2352, DOI 10.2337/diacare.25.12.2352; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rinaldi M, 2013, RETINA-J RET VIT DIS, V33, P397, DOI 10.1097/IAE.0b013e318261a73c; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; SEMENZA GL, 1994, HEMATOL ONCOL CLIN N, V8, P863, DOI 10.1016/S0889-8588(18)30134-5; Sharma PS, 2011, CURR CANCER DRUG TAR, V11, P624; Tripathi RC, 1998, OPHTHALMOLOGY, V105, P232, DOI 10.1016/S0161-6420(98)92782-8; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang X, 2013, GRAEFES ARCH CLIN EX; WEISS DI, 1963, ARCH OPHTHALMOL-CHIC, V69, P304; Wolf S, 2013, OPHTHALMOLOGY; Yang XJ, 2013, P NATL ACAD SCI USA, V110, P13932, DOI 10.1073/pnas.1309629110; Zaman Y, 2013, PAK J MED SCI, V29, P590, DOI 10.12669/pjms.292.3044; Zhou MW, 2013, INVEST OPHTH VIS SCI, V54, P3874, DOI 10.1167/iovs.12-11507	28	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146993	10.1371/journal.pone.0146993	http://dx.doi.org/10.1371/journal.pone.0146993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785251	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400094
J	Oda, S; Nozawa, T; Nozawa-Minowa, A; Tanaka, M; Aikawa, C; Harada, H; Nakagawa, I				Oda, Seiichiro; Nozawa, Takashi; Nozawa-Minowa, Atsuko; Tanaka, Misako; Aikawa, Chihiro; Harada, Hiroyuki; Nakagawa, Ichiro			Golgi-Resident GTPase Rab30 Promotes the Biogenesis of Pathogen-Containing Autophagosomes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; G-PROTEINS; CELLS; MATURATION; INVASION; NETWORK; FAMILY	Autophagy acts as a host-defense system against pathogenic microorganisms such as Group A Streptococcus (GAS). Autophagy is a membrane-mediated degradation system that is regulated by intracellular membrane trafficking regulators, including small GTPase Rab proteins. Here, we identified Rab30 as a novel regulator of GAS-containing autophago-some-like vacuoles (GcAVs). We found that Rab30, a Golgi-resident Rab, was recruited to GcAVs in response to autophagy induction by GAS infection in epithelial cells. Rab30 recruitment was dependent upon its GTPase activity. In addition, the knockdown of Rab30 expression significantly reduced GcAV formation efficiency and impaired intracellular GAS degradation. Rab30 normally functions to maintain the structural integrity of the Golgi complex, but GcAV formation occurred even when the Golgi apparatus was disrupted. Although Rab30 also colocalized with a starvation-induced autophagosome, Rab30 was not required for autophagosome formation during starvation. These results suggest that Rab30 mediates autophagy against GAS independently of its normal cellular role in the structural maintenance of the Golgi apparatus, and autophagosome biogenesis during bacterial infection involves specific Rab GTPases.	[Oda, Seiichiro; Nozawa, Takashi; Nozawa-Minowa, Atsuko; Tanaka, Misako; Aikawa, Chihiro; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Dept Bacterial Pathogenesis, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Oda, Seiichiro; Harada, Hiroyuki] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Nozawa, Takashi; Nozawa-Minowa, Atsuko; Aikawa, Chihiro; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Kyoto 6068501, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University	Nozawa, T (corresponding author), Tokyo Med & Dent Univ, Dept Bacterial Pathogenesis, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan.; Nozawa, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Kyoto 6068501, Japan.	nozawa.takashi.4r@kyoto-u.ac.jp		Nozawa, Takashi/0000-0002-1822-5553	Funding Programs for Next Generation World-Leading Researchers [LS041]; JSPS KAKENHI [25293370, 70294113, 10598858]	Funding Programs for Next Generation World-Leading Researchers; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Programs for Next Generation World-Leading Researchers (LS041) and JSPS KAKENHI Grant Numbers 25293370, 70294113 (to I.N.) and 10598858 (to T.N.).	Ao X, 2014, CELL DEATH DIFFER; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Bento CF, 2013, J CELL SCI, V126, P1059, DOI 10.1242/jcs.123075; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007; Guo YJ, 2012, J CELL SCI, V125, P1706, DOI 10.1242/jcs.093203; Haobam B, 2014, CELL MICROBIOL, V16, P1806, DOI 10.1111/cmi.12329; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nozawa T, 2012, CELL MICROBIOL, V14, P1149, DOI 10.1111/j.1462-5822.2012.01792.x; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Thomas C, 2009, DEV BIOL, V331, P250, DOI 10.1016/j.ydbio.2009.05.001; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670	32	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147061	10.1371/journal.pone.0147061	http://dx.doi.org/10.1371/journal.pone.0147061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771875	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300059
J	Spetale, FE; Tapia, E; Krsticevic, F; Roda, F; Bulacio, P				Spetale, Flavio E.; Tapia, Elizabeth; Krsticevic, Flavia; Roda, Fernando; Bulacio, Pilar			A Factor Graph Approach to Automated GO Annotation	PLOS ONE			English	Article							GENE-FUNCTION; MOLECULAR CHAPERONES; FUNCTION PREDICTION; PROTEIN FUNCTION; ENSEMBLE	As volume of genomic data grows, computational methods become essential for providing a first glimpse onto gene annotations. Automated Gene Ontology (GO) annotation methods based on hierarchical ensemble classification techniques are particularly interesting when interpretability of annotation results is a main concern. In these methods, raw GO-term predictions computed by base binary classifiers are leveraged by checking the consistency of predefined GO relationships. Both formal leveraging strategies, with main focus on annotation precision, and heuristic alternatives, with main focus on scalability issues, have been described in literature. In this contribution, a factor graph approach to the hierarchical ensemble formulation of the automated GO annotation problem is presented. In this formal framework, a core factor graph is first built based on the GO structure and then enriched to take into account the noisy nature of GO-term predictions. Hence, starting from raw GO-term predictions, an iterative message passing algorithm between nodes of the factor graph is used to compute marginal probabilities of target GO-terms. Evaluations on Saccharomyces cerevisiae, Arabidopsis thaliana and Drosophila melanogaster protein sequences from the GO Molecular Function domain showed significant improvements over competing approaches, even when protein sequences were naively characterized by their physicochemical and secondary structure properties or when loose noisy annotation datasets were considered. Based on these promising results and using Arabidopsis thaliana annotation data, we extend our approach to the identification of most promising molecular function annotations for a set of proteins of unknown function in Solanum lycopersicum.	[Spetale, Flavio E.; Tapia, Elizabeth; Krsticevic, Flavia; Roda, Fernando; Bulacio, Pilar] CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina; [Spetale, Flavio E.; Tapia, Elizabeth; Bulacio, Pilar] Natl Univ Rosario, Fac Cs Exactas Ingn & Agrimensura, Rosario, Santa Fe, Argentina; [Krsticevic, Flavia; Bulacio, Pilar] Natl Technol Univ, Fac Reg San Nicolas, San Nicolas, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Spetale, FE (corresponding author), CIFASIS Conicet Inst, Rosario, Santa Fe, Argentina.; Spetale, FE (corresponding author), Natl Univ Rosario, Fac Cs Exactas Ingn & Agrimensura, Rosario, Santa Fe, Argentina.	spetale@cifasis-conicet.gov.ar	Spetale, Flavio Ezequiel/AAT-6556-2021; Tapia, Elizabeth/AAS-4263-2021	Spetale, Flavio Ezequiel/0000-0002-0226-8372; Tapia, Elizabeth/0000-0002-9363-4824; Roda, Fernando/0000-0002-9878-5947	project PICT, "Multiplex systems for targeted microfluidic amplification and NGS sequencing" [2012-2513]; National Agency for Science and Technology Promotion; Argentina. Institution: National Scientific and Technical Research Council (CONICET); project PID INI, "GO functional annotation based on supervised hierarchical classification" [3600]	project PICT, "Multiplex systems for targeted microfluidic amplification and NGS sequencing"; National Agency for Science and Technology Promotion; Argentina. Institution: National Scientific and Technical Research Council (CONICET); project PID INI, "GO functional annotation based on supervised hierarchical classification"	This work was supported by project PICT 2012-2513, "Multiplex systems for targeted microfluidic amplification and NGS sequencing," National Agency for Science and Technology Promotion, Argentina. Institution: National Scientific and Technical Research Council (CONICET). Researcher: Elizabeth Tapia; and project PID INI 3600, "GO functional annotation based on supervised hierarchical classification", National Technological University, Argentina. Institution: National Scientific and Technical Research Council (CONICET). Researcher: Pilar Bulacio.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2001, GENOME RES, V11, P1425; Bartlett PL, 1997, ADV NEUR IN, V9, P134; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baxevanis AD, 2006, PRACTICAL ASPECTS MU, P172; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bradford JR, 2010, PLANT J, V61, P713, DOI 10.1111/j.1365-313X.2009.04097.x; Burger A, 2004, BIOINFORMATICS, V20, P259, DOI 10.1093/bioinformatics/btg400; Carlson M., 2014, GENOME WIDE ANNOTATI; Cheng Liangxi, 2014, PLoS One, V9, pe107187, DOI 10.1371/journal.pone.0107187; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DAGUM P, 1993, ARTIF INTELL, V60, P141, DOI 10.1016/0004-3702(93)90036-B; DECHTER R, 1985, J ACM, V32, P505, DOI 10.1145/3828.3830; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eisner R, 2005, PROCEEDINGS OF THE 2005 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P354; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045899; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P693, DOI 10.1111/pce.12426; Goyal RK, 2012, PLANTA, V235, P453, DOI 10.1007/s00425-011-1518-5; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Kappen HJ, 2012, MACH LEARN, V87, P159, DOI 10.1007/s10994-012-5278-7; Kohler Sebastian, 2014, Nucleic Acids Res, V42, pD966, DOI 10.1093/nar/gkt1026; Kourmpetis YAI, 2011, PLANT PHYSIOL, V155, P271, DOI 10.1104/pp.110.162164; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Lee BJ, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-27; Loeliger HA, 2004, IEEE SIGNAL PROC MAG, V21, P28, DOI 10.1109/MSP.2004.1267047; MacKay DJC, 1999, IEEE T INFORM THEORY, V45, P399, DOI 10.1109/18.748992; Meyer D, 2014, MISC FUNCTIONS DEP S; Mitsakakis N, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-8; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2014, METHODS MOL BIOL, V1097, P163, DOI 10.1007/978-1-62703-709-9_9; Novak C, 2013, IEEE T SIGNAL PROCES, V61, P4051, DOI 10.1109/TSP.2013.2261989; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Park JH, 2011, NEW PHYTOL, V191, P692, DOI 10.1111/j.1469-8137.2011.03734.x; Platt JC, 2000, ADV NEUR IN, P61; Riley MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-112; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Robinson PN, 2015, LECT NOTES COMPUT SC, V9132, P15, DOI 10.1007/978-3-319-20248-8_2; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schapire R.E., 1997, P 14 INT C MACHINE L, P322; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schuler GD, 2006, SEQUENCE ALIGNMENT D, P145; Sicheritz-Ponten T, 2002, PACKAGE SEQUTILS; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sykacek P, 2012, BIOINFORMATICS, V28, pI603, DOI 10.1093/bioinformatics/bts405; Tanoue J, 2002, BIOINFORMATICS, V18, P1705, DOI 10.1093/bioinformatics/18.12.1705; Tapia E, 2010, PATTERN RECOGN LETT, V31, P210, DOI 10.1016/j.patrec.2009.09.031; Teichmann SA, 2001, CURR OPIN STRUC BIOL, V11, P354, DOI 10.1016/S0959-440X(00)00215-3; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Verspoor K, 2006, PROTEIN SCI, V15, P1544, DOI 10.1110/ps.062184006; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Weeks A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00409; Wei Qiong, 2013, PLoS One, V8, pe67863, DOI 10.1371/journal.pone.0067863	63	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146986	10.1371/journal.pone.0146986	http://dx.doi.org/10.1371/journal.pone.0146986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771463	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300048
J	Wu, YQ; Cheng, TC; Liu, C; Liu, DL; Zhang, Q; Long, RW; Zhao, P; Xia, QY				Wu, Yuqian; Cheng, Tingcai; Liu, Chun; Liu, Duolian; Zhang, Quan; Long, Renwen; Zhao, Ping; Xia, Qingyou			Systematic Identification and Characterization of Long Non-Coding RNAs in the Silkworm, Bombyx mori	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; EMBRYONIC-DEVELOPMENT; EXPRESSION PATTERNS; FUNCTIONAL-ANALYSIS; MULTIPLE TISSUES; REVEALS; PROTEIN; ANNOTATION; EVOLUTION; HONEYBEE	Long noncoding RNAs (lncRNAs) are emerging as important regulators in various biological processes. However, to date, no systematic characterization of lncRNAs has been reported in the silkworm Bombyx mori. In the present study, we generated eighteen RNA-seq data-sets with relatively high depth. Using an in-house designed lncRNA identification pipeline, 11,810 lncRNAs were identified for 5,556 loci. Among these lncRNAs, 474 transcripts were intronic lncRNAs (ilncRNAs), 6,250 transcripts were intergenic lncRNAs (lincRNAs), and 5,086 were natural antisense lncRNAs (lncNATs). Compared with protein-coding mRNAs, silkworm lncRNAs are shorter in terms of full length but longer in terms of exon and intron length. In addition, lncRNAs exhibit a lower level of sequence conservation, more repeat sequences overlapped and higher tissue specificity than protein-coding mRNAs in the silkworm. We found that 69 lncRNA transcripts from 33 gene loci may function as miRNA precursors, and 104 lncRNA transcripts from 72 gene loci may act as competing endogenous RNAs (ceRNAs). In total, 49.47% of all gene loci (2,749/5,556) for which lncRNAs were identified showed sex-biased expression. Co-expression network analysis resulted in 19 modules, 12 of which revealed relatively high tissue specificity. The highlighted darkgoldenrod module was specifically associated with middle and posterior silk glands, and the hub lncRNAs within this module were co-expressed with proteins involved in translation, translocation, and secretory processes, suggesting that these hub lncRNAs may function as regulators of the biosynthesis, translocation, and secretion of silk proteins. This study presents the first comprehensive genome-wide analysis of silkworm lncRNAs and provides an invaluable resource for genetic, evolutionary, and genomic studies of B. mori.	[Wu, Yuqian] Chongqing Univ, Sch Life Sci, Chongqing 400044, Peoples R China; [Wu, Yuqian; Cheng, Tingcai; Liu, Chun; Liu, Duolian; Zhang, Quan; Long, Renwen; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Chongqing University; Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31372380, 31530071]; Chongqing Fundamental and Advanced Research Projects [CSTC2014JCYJA80004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Fundamental and Advanced Research Projects	The work was supported by National Basic Research Program of China (2012CB114600), National Natural Science Foundation of China (31372380), key program of the National Natural Science Foundation of China (31530071) and Chongqing Fundamental and Advanced Research Projects (CSTC2014JCYJA80004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018853; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Deng XX, 2006, TRENDS BIOCHEM SCI, V31, P526, DOI 10.1016/j.tibs.2006.07.007; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Gong J, 2015, NUCLEIC ACIDS RES, V43, pD181, DOI 10.1093/nar/gku1000; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hao ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121800; Humann FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078915; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jayakodi M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1868-7; Jenkins AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1507-3; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Kiya T, 2012, INT J MOL SCI, V13, P15496, DOI 10.3390/ijms131215496; Kolde R., 2015, PHEATMAP PRETTY HEAT, DOI DOI 10.1093/nar/gkv007; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakhotia SC, 2012, CHROMOSOMA, V121, P49, DOI 10.1007/s00412-011-0341-x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DD, 2011, NUCLEIC ACIDS RES, V39, P3792, DOI 10.1093/nar/gkq1317; Li JY, 2015, J PROTEOMICS, V126, P109, DOI 10.1016/j.jprot.2015.06.001; Li JS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-410; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li MX, 2012, NUCLEIC ACIDS RES, V40, P11714, DOI 10.1093/nar/gks943; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu K, 2013, BIOINFORMATICS, V29, P2221, DOI 10.1093/bioinformatics/btt361; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Mohammadin S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0603-5; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Nie HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094185; Noh MY, 2015, DEV BIOL, V399, P315, DOI 10.1016/j.ydbio.2015.01.009; Padron A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-636; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peng JJ, 2015, INT J DEV NEUROSCI, V46, P100, DOI 10.1016/j.ijdevneu.2015.07.006; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Royer C, 2011, INSECT BIOCHEM MOLEC, V41, P118, DOI 10.1016/j.ibmb.2010.11.003; Sawata M, 2004, RNA, V10, P1047, DOI 10.1261/rna.5231504; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soshnev AA, 2011, GENETICS, V189, P455, DOI 10.1534/genetics.111.131706; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tadano H, 2009, INSECT MOL BIOL, V18, P715, DOI 10.1111/j.1365-2583.2009.00911.x; Taguchi S, 2011, NEUROSCI LETT, V496, P176, DOI 10.1016/j.neulet.2011.04.011; TASHIRO Y, 1968, J CELL BIOL, V38, P574, DOI 10.1083/jcb.38.3.574; Tattikota SG, 2015, J BIOL CHEM, V290, P20284, DOI 10.1074/jbc.M115.658625; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang MJ, 2015, NEW PHYTOL, V207, P1181, DOI 10.1111/nph.13429; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhang KS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-845; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhao XM, 2015, J BIOL CHEM, V290, P972, DOI 10.1074/jbc.M114.606921; Zhou ZY, 2014, GENOME BIOL EVOL, V6, P1387, DOI 10.1093/gbe/evu113	88	76	86	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147147	10.1371/journal.pone.0147147	http://dx.doi.org/10.1371/journal.pone.0147147			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771876	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300066
J	Chen, R; Kobewka, M; Addison, W; Lachance, G; Tyrrell, DL				Chen, Ran; Kobewka, Michelle; Addison, William; Lachance, Gerald; Tyrrell, D. Lorne			Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice	PLOS ONE			English	Article							RIBAVIRIN COMBINATION THERAPY; PLASMACYTOID DENDRITIC CELLS; AMINO-ACID SUBSTITUTIONS; GENOME-WIDE ASSOCIATION; PROTEIN 5A GENE; PEGYLATED INTERFERON; PLUS RIBAVIRIN; INFECTED CELLS; IL28B; CLEARANCE	Background Hepatitis C virus infection is a global health problem. New direct-acting antiviral agents have been recently approved. However, due to their high cost and some genotypes remaining difficult to treat, interferon-based therapy with pegylated interferon and ribavirin likely may remain a component of hepatitis C virus treatment for some patients. Unfortunately, pegylated interferon / ribavirin treatment achieved favorable outcomes in less than 50% of patients. Factors determining the outcome to pegylated interferon / ribavirin include both host and viral factors. It has been a major challenge to separate the host and viral factors in most in vivo systems. Aims & Methods We used two hepatitis C virus strains from patients with different interferon-sensitivities and three hepatocyte donors, each with distinct interleukin 28B and interferon lambda 4 single nucleotide polymorphisms to investigate the contributions of viral and host factors to the response of hepatitis C virus to interferon treatment in chimeric mice. Results and Conclusions We found that viral factors were the dominant factors in determining the interferon treatment outcomes in chimeric mice. Host factors, such as pre-treatment liver interferon-stimulated gene expression and single nucleotide polymorphisms near interleukin 28B and interferon lambda 4 coding regions, were less important determinants of the response to interferon in the chimeric mice than they were in patients. Our results also suggest that a complete immune system as seen in patients may be required for host factors such as single nucleotide polymorphisms near interleukin 28B / interferon lambda 4 and pre-treatment liver interferon-stimulated gene upregulation to have an effect on the interferon response.	[Chen, Ran; Kobewka, Michelle; Addison, William; Lachance, Gerald; Tyrrell, D. Lorne] Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Chen, Ran; Kobewka, Michelle; Addison, William; Lachance, Gerald; Tyrrell, D. Lorne] Katz Ctr Hlth Res, Li Ka Shing Inst Virol, Edmonton, AB, Canada		Chen, R (corresponding author), Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	rchen3@ualberta.ca; lorne.tyrrell@ualberta.ca			Canadian Institutes of Health Research grant [MOP-126142]; Li Ka Shing Institute of Virology [RES0005059]; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Institute of Virology; Alberta Innovates	Canadian Institutes of Health Research grant MOP-126142, DLT. Li Ka Shing Institute of Virology RES0005059, DLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Bronowicki JP, 2006, GASTROENTEROLOGY, V131, P1040, DOI 10.1053/j.gastro.2006.07.022; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hiraga N, 2011, HEPATOLOGY, V54, P764, DOI 10.1002/hep.24453; HOOPES BC, 1981, NUCLEIC ACIDS RES, V9, P5493, DOI 10.1093/nar/9.20.5493; KANAZAWA Y, 1994, HEPATOLOGY, V20, P1121, DOI 10.1002/hep.1840200504; Lan KH, 2007, J HEPATOL, V46, P759, DOI 10.1016/j.jhep.2006.11.013; Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Okanoue T, 2009, J GASTROENTEROL, V44, P952, DOI 10.1007/s00535-009-0087-x; Pawlotsky Jean-Michel, 2011, Gastroenterology, V140, P746, DOI 10.1053/j.gastro.2011.01.028; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090343; Watanabe T, 2013, GUT, V62, P1340, DOI 10.1136/gutjnl-2012-302553; Zhang SY, 2013, HEPATOLOGY, V58, P940, DOI 10.1002/hep.25827	39	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147007	10.1371/journal.pone.0147007	http://dx.doi.org/10.1371/journal.pone.0147007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765841	Green Submitted, gold, Green Published			2022-12-27	WOS:000368459300057
J	Osis, ST; Hettinga, BA; Macdonald, S; Ferber, R				Osis, Sean T.; Hettinga, Blayne A.; Macdonald, Shari; Ferber, Reed			Effects of Simulated Marker Placement Deviations on Running Kinematics and Evaluation of a Morphometric-Based Placement Feedback Method	PLOS ONE			English	Article							GAIT; RELIABILITY	In order to provide effective test-retest and pooling of information from clinical gait analyses, it is critical to ensure that the data produced are as reliable as possible. Furthermore, it has been shown that anatomical marker placement is the largest source of inter-examiner variance in gait analyses. However, the effects of specific, known deviations in marker placement on calculated kinematic variables are unclear, and there is currently no mechanism to provide location-based feedback regarding placement consistency. The current study addresses these disparities by: applying a simulation of marker placement deviations to a large (n = 411) database of runners; evaluating a recently published method of morphometric- based deviation detection; and pilot-testing a system of location-based feedback for marker placements. Anatomical markers from a standing neutral trial were moved virtually by up to 30 mm to simulate deviations. Kinematic variables during running were then calculated using the original, and altered static trials. Results indicate that transverse plane angles at the knee and ankle are most sensitive to deviations in marker placement (7.59 degrees of change for every 10 mm of marker error), followed by frontal plane knee angles (5.17 degrees for every 10 mm). Evaluation of the deviation detection method demonstrated accuracies of up to 82% in classifying placements as deviant. Finally, pilot testing of a new methodology for providing location-based feedback demonstrated reductions of up to 80% in the deviation of outcome kinematics.	[Osis, Sean T.; Hettinga, Blayne A.; Ferber, Reed] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Osis, Sean T.; Ferber, Reed] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Osis, Sean T.; Hettinga, Blayne A.; Macdonald, Shari; Ferber, Reed] Running Injury Clin, Calgary, AB, Canada	University of Calgary; University of Calgary	Osis, ST (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	stosis@ucalgary.ca	Ferber, Reed/AAT-3140-2020	Ferber, Reed/0000-0002-6154-9115	Alberta Innovates: Health Solutions [200700478]; Discovery Grant from the Natural Sciences and Engineering Research Council of Canada [1030390]	Alberta Innovates: Health Solutions; Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was partially funded by a grant from Alberta Innovates: Health Solutions (grant # 200700478) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (grant # 1030390). Both received by RF.	COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Della Croce U, 1999, MED BIOL ENG COMPUT, V37, P155, DOI 10.1007/BF02513282; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Ferber R, 2002, J ORTHOPAED RES, V20, P1139, DOI 10.1016/S0736-0266(02)00077-3; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; McClay I, 1999, MED SCI SPORT EXER, V31, P1629, DOI 10.1097/00005768-199911000-00021; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Meldrum D, 2014, GAIT POSTURE, V39, P265, DOI 10.1016/j.gaitpost.2013.07.130; Mills K, 2013, ARCH PHYS MED REHAB, V94, P2241, DOI 10.1016/j.apmr.2013.05.010; Osis ST, 2015, COMPUT METHOD BIOMEC, V18, P1108, DOI 10.1080/10255842.2013.873034; Phinyomark A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105246; Pohl MB, 2010, GAIT POSTURE, V32, P559, DOI 10.1016/j.gaitpost.2010.07.020; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Stagni R, 2000, J BIOMECH, V33, P1479, DOI 10.1016/S0021-9290(00)00093-2; Szczerbik E, 2011, ACTA BIOENG BIOMECH, V13, P43; Weinhandl JT, 2010, J BIOMECH, V43, P2633, DOI 10.1016/j.jbiomech.2010.05.023; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Wolf P, 2009, J APPL BIOMECH, V25, P369, DOI 10.1123/jab.25.4.369	20	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147111	10.1371/journal.pone.0147111	http://dx.doi.org/10.1371/journal.pone.0147111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765846	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300068
J	Voudouris, D; Smeets, JBJ; Brenner, E				Voudouris, Dimitris; Smeets, Jeroen B. J.; Brenner, Eli			Fixation Biases towards the Index Finger in Almost-Natural Grasping	PLOS ONE			English	Article							EYE-MOVEMENTS; OBJECT; THUMB; COORDINATION; GUIDANCE; VISION; MEMORY; ARM	We use visual information to guide our grasping movements. When grasping an object with a precision grip, the two digits need to reach two different positions more or less simultaneously, but the eyes can only be directed to one position at a time. Several studies that have examined eye movements in grasping have found that people tend to direct their gaze near where their index finger will contact the object. Here we aimed at better understanding why people do so by asking participants to lift an object off a horizontal surface. They were to grasp the object with a precision grip while movements of their hand, eye and head were recorded. We confirmed that people tend to look closer to positions that a digit needs to reach more accurately. Moreover, we show that where they look as they reach for the object depends on where they were looking before, presumably because they try to minimize the time during which the eyes are moving so fast that no new visual information is acquired. Most importantly, we confirmed that people have a bias to direct gaze towards the index finger's contact point rather than towards that of the thumb. In our study, this cannot be explained by the index finger contacting the object before the thumb. Instead, it appears to be because the index finger moves to a position that is hidden behind the object that is grasped, probably making this the place at which one is most likely to encounter unexpected problems that would benefit from visual guidance. However, this cannot explain the bias that was found in previous studies, where neither contact point was hidden, so it cannot be the only explanation for the bias.	[Voudouris, Dimitris; Smeets, Jeroen B. J.; Brenner, Eli] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Voudouris, Dimitris] Univ Giessen, Dept Psychol, D-35390 Giessen, Germany	Vrije Universiteit Amsterdam; Justus Liebig University Giessen	Voudouris, D (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	dimitris.voudouris@psychol.uni-giessen.de	Smeets, Jeroen/B-4198-2008; Voudouris, Dimitris/H-7704-2018	Smeets, Jeroen/0000-0002-3794-0579; Voudouris, Dimitris/0000-0001-9110-0928; Brenner, Eli/0000-0002-3611-2843	Netherlands Organization for Scientific Research (NWO) [464-13-169]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant (464-13-169) by the Netherlands Organization for Scientific Research (NWO) to EB as well as by sources from the VU University Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by the Netherlands Organization for Scientific Research (NWO) grant 464-13-169.	Biegstraaten M, 2006, EXP BRAIN RES, V171, P347, DOI 10.1007/s00221-005-0271-z; Brouwer AM, 2009, J VISION, V9, DOI 10.1167/9.1.18; Cavina-Pratesi C, 2013, J VISION, V13, DOI 10.1167/13.5.15; Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; Darling W, 1988, EXP BRAIN RES, V73, P181; de Grave DDJ, 2008, J VISION, V8, DOI 10.1167/8.7.5; Galea MP, 2001, NEUROREPORT, V12, P2185, DOI 10.1097/00001756-200107200-00028; Grant S, 2015, EXP BRAIN RES, V233, P3489, DOI 10.1007/s00221-015-4421-7; Haggard P, 1997, J MOTOR BEHAV, V29, P282, DOI 10.1080/00222899709600842; HARRIS CM, 1995, VISION RES, V35, P691, DOI 10.1016/0042-6989(94)00163-G; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Melmoth DR, 2012, EXP BRAIN RES, V222, P265, DOI 10.1007/s00221-012-3214-5; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Prime SL, 2013, EXP BRAIN RES, V225, P291, DOI 10.1007/s00221-012-3358-3; Riek S, 2003, EXP BRAIN RES, V153, P59, DOI 10.1007/s00221-003-1581-7; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Schot WD, 2010, EXP BRAIN RES, V204, P163, DOI 10.1007/s00221-010-2261-z; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Smeets JBJ, 1996, EXP BRAIN RES, V109, P434; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Vickers JN, 1996, J EXP PSYCHOL HUMAN, V22, P342, DOI 10.1037/0096-1523.22.2.342; Voudouris D, 2013, J NEUROPHYSIOL, V110, P1484, DOI 10.1152/jn.00066.2013; Voudouris D, 2012, J MOTOR BEHAV, V44, P295, DOI 10.1080/00222895.2012.703975; Voudouris D, 2010, EXP BRAIN RES, V206, P15, DOI 10.1007/s00221-010-2382-4; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146864	10.1371/journal.pone.0146864	http://dx.doi.org/10.1371/journal.pone.0146864			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26766551	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300048
J	Yeh, PT; Huang, HW; Yang, CM; Yang, WS; Yang, CH				Yeh, Po-Ting; Huang, Hsin-Wei; Yang, Chung-May; Yang, Wei-Shiung; Yang, Chang-Hao			Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTOXIN-INDUCED UVEITIS; EXPERIMENTAL GALACTOSEMIA; HEME OXYGENASE-1; VITREOUS FLUID; BETA-CAROTENE; HUMAN-DISEASE; HUMAN HEALTH; DB/DB MICE; IN-VITRO	Purpose We evaluated whether orally administered astaxanthin (AST) protects against oxidative damage in the ocular tissues of streptozotocin (STZ)-induced diabetic rats. Methods and Results Fifty 6-week-old female Wistar rats were randomly assigned to receive an injection of STZ to induce diabetes (n = 40) or to remain uninduced (n = 10). The diabetic rats were randomly selected into four groups and they were separately administered normal saline, 0.6 mg/kg AST, 3 mg/kg AST, or 0.5 mg/kg lutein daily for eight weeks. Retinal functions of each group were evaluated by electroretinography. The expression of oxidative stress and inflammatory mediators in the ocular tissues was then assessed by immunohistochemistry, western blot analysis, ELISA, RT-PCR, and electrophoretic mobility shift assay (EMSA). Retinal functions were preserved by AST and lutein in different levels. Ocular tissues from AST-and lutein-treated rats had significantly reduced levels of oxidative stress mediators (8-hydroxy- 2'-deoxyguanosine, nitrotyrosine, and acrolein) and inflammatory mediators (intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and fractalkine), increased levels of antioxidant enzymes (heme oxygenase-1 and peroxiredoxin), and reduced activity of the transcription factor nuclear factor-kappaB (NF-kappa B). Conclusion The xanthophyll carotenoids AST and lutein have neuroprotective effects and reduce ocular oxidative stress, and inflammation in the STZ diabetic rat model, which may be mediated by downregulation of NF-kappa B activity.	[Yeh, Po-Ting; Yang, Chung-May; Yang, Chang-Hao] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yeh, Po-Ting] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Huang, Hsin-Wei] Taipei Med Univ, Wan Fang Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yang, Chung-May; Yang, Chang-Hao] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chyangoph@ntu.edu.tw	Yang, Chung-May/AAV-3737-2020; Yang, Chang-Hao/AAR-3759-2021	YANG, CHUNG-MAY/0000-0003-4082-420X; YANG, WEI-SHIUNG/0000-0001-5087-373X; Yeh, Po-Ting/0000-0002-0461-8778; Huang, Hsin-Wei/0000-0002-1066-2556; YANG, CHANG-HAO/0000-0002-4328-8716	National Taiwan University Hospital [NTUH 101-001781]	National Taiwan University Hospital(National Taiwan University)	This study was supported by National Taiwan University Hospital Grants NTUH 101-001781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1984, CURR EYE RES, V3, P223, DOI 10.3109/02713688408997203; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chen FT, 2012, INVEST OPHTH VIS SCI, V53, P3682, DOI 10.1167/iovs.12-9505; Cosso L, 2001, FREE RADICAL RES, V34, P189, DOI 10.1080/10715760100300171; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; Cutler RG, 2005, ANN NY ACAD SCI, V1055, P93, DOI 10.1196/annals.1323.027; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Fang IM, 2013, EXP EYE RES, V113, P49, DOI 10.1016/j.exer.2013.05.007; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Harada C, 2006, DIABETES RES CLIN PR, V74, P249, DOI 10.1016/j.diabres.2006.04.017; Hernandez C, 2005, DIABETIC MED, V22, P719, DOI 10.1111/j.1464-5491.2005.01538.x; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; Izumi-Nagai K, 2008, INVEST OPHTH VIS SCI, V49, P1679, DOI 10.1167/iovs.07-1426; Jackson H, 2008, AM J CARDIOL, V101, p50D, DOI 10.1016/j.amjcard.2008.02.008; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Kowluru RA, 2004, DIABETES, V53, P3233, DOI 10.2337/diabetes.53.12.3233; Kowluru RA, 1997, FREE RADICAL BIO MED, V22, P587, DOI 10.1016/S0891-5849(96)00347-4; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1266, DOI 10.1001/archopht.126.9.1266; Kubo E, 2009, LIFE SCI, V84, P857, DOI 10.1016/j.lfs.2009.03.019; KURASHIGE M, 1990, PHYSIOL CHEM PHYS M, V22, P27; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li PY, 2011, CURR EYE RES, V36, P673, DOI 10.3109/02713683.2011.572220; Manabe E, 2008, J CELL BIOCHEM, V103, P1925, DOI 10.1002/jcb.21583; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k; Naito Y, 2004, BIOFACTORS, V20, P49, DOI 10.1002/biof.5520200105; Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P345, DOI 10.3177/jnsv.43.345; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; OSHIMA S, 1993, J NUTR SCI VITAMINOL, V39, P607, DOI 10.3177/jnsv.39.607; Ottaviano FG, 2008, CIRC J, V72, P1, DOI 10.1253/circj.72.1; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Pan HZ, 2008, BRIT J OPHTHALMOL, V92, P548, DOI 10.1136/bjo.2007.130542; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; Spiller Gene A., 2003, Journal of Medicinal Food, V6, P51, DOI 10.1089/109662003765184741; Stewart JS, 2008, FOOD CHEM TOXICOL, V46, P3030, DOI 10.1016/j.fct.2008.05.038; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; Uchiyama K, 2002, REDOX REP, V7, P290, DOI 10.1179/135100002125000811; van Reyk DM, 2003, REDOX REP, V8, P187, DOI 10.1179/135100003225002673; Wu TH, 2006, J AGR FOOD CHEM, V54, P2418, DOI 10.1021/jf052651q; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yang CH, 2005, INVEST OPHTH VIS SCI, V46, P1339, DOI 10.1167/iovs.04-0640; Yeh PT, 2008, OPHTHALMOLOGY, V115, P734, DOI 10.1016/j.ophtha.2007.05.041; Younis N, 2003, DIABETIC MED, V20, P758, DOI 10.1046/j.1464-5491.2003.01035.x; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6	63	84	87	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146438	10.1371/journal.pone.0146438	http://dx.doi.org/10.1371/journal.pone.0146438			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765843	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300020
J	Hoeller, AA; Costa, APR; Bicca, MA; Matheus, FC; Lach, G; Spiga, F; Lightman, SL; Walz, R; Collingridge, GL; Bortolotto, ZA; de Lima, TCM				Hoeller, Alexandre A.; Costa, Ana Paula R.; Bicca, Maira A.; Matheus, Filipe C.; Lach, Gilliard; Spiga, Francesca; Lightman, Stafford L.; Walz, Roger; Collingridge, Graham L.; Bortolotto, Zuner A.; de Lima, Thereza C. M.			The Role of Hippocampal NMDA Receptors in Long-Term Emotional Responses following Muscarinic Receptor Activation	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; PITUITARY-ADRENAL AXIS; NUCLEUS-ACCUMBENS; PILOCARPINE MODEL; DEPENDENT MODULATION; DOPAMINE RELEASE; PROLONGED STRESS; SINGLE EXPOSURE; CEREBRAL-CORTEX; WORKING-MEMORY	Extensive evidence indicates the influence of the cholinergic system on emotional processing. Previous findings provided new insights into the underlying mechanisms of long-term anxiety, showing that rats injected with a single systemic dose of pilocarpine-a muscarinic receptor (mAChR) agonist-displayed persistent anxiogenic-like responses when evaluated in different behavioral tests and time-points (24 h up to 3 months later). Herein, we investigated whether the pilocarpine-induced long-term anxiogenesis modulates the HPA axis function and the putative involvement of NMDA receptors (NMDARs) following mAChRs activation. Accordingly, adult male Wistar rats presented anxiogenic-like behavior in the elevated plus-maze (EPM) after 24 h or 1 month of pilocarpine injection (150 mg/kg, i.p.). In these animals, mAChR activation disrupted HPA axis function inducing a long-term increase of corticosterone release associated with a reduced expression of hippocampal GRs, as well as consistently decreased NMDAR subunits expression. Furthermore, in another group of rats injected with memantine-an NMDARs antagonist (4 mg/kg, i.p.)-prior to pilocarpine, we found inhibition of anxiogenic-like behaviors in the EPM but no further alterations in the pilocarpine-induced NMDARs downregulation. Our data provide evidence that behavioral anxiogenesis induced by mAChR activation effectively yields short-and long-term alterations in hippocampal NMDARs expression associated with impairment of hippocampal inhibitory regulation of HPA axis activity. This is a novel mechanism associated with anxiety-like responses in rats, which comprise a putative target to future translational studies.	[Hoeller, Alexandre A.; Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Postgrad Program Med Sci, BR-88040970 Florianopolis, SC, Brazil; [Hoeller, Alexandre A.; Costa, Ana Paula R.; Bicca, Maira A.; Matheus, Filipe C.; Lach, Gilliard; de Lima, Thereza C. M.] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88040970 Florianopolis, SC, Brazil; [Lach, Gilliard] Univ Innsbruck, Inst Pharmacol, A-6020 Innsbruck, Austria; [Spiga, Francesca; Lightman, Stafford L.] Univ Bristol, Sch Clin Sci, Henry Wellcome Labs Integrat Neurosci & Endocrino, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England; [Walz, Roger] Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Dept Clin Med, BR-88040970 Florianopolis, SC, Brazil; [Hoeller, Alexandre A.; Collingridge, Graham L.; Bortolotto, Zuner A.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of Innsbruck; University of Bristol; Universidade Federal de Santa Catarina (UFSC); University of Bristol	Hoeller, AA (corresponding author), Univ Fed Santa Catarina, Univ Hosp, Ctr Hlth Sci, Postgrad Program Med Sci, BR-88040970 Florianopolis, SC, Brazil.; Hoeller, AA; de Lima, TCM (corresponding author), Univ Fed Santa Catarina, Ctr Biol Sci, Dept Pharmacol, BR-88040970 Florianopolis, SC, Brazil.; Hoeller, AA (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England.	alexandrehoeller@gmail.com; thereza.lima@ufsc.br	collingridge, graham/AAI-8362-2020; Lach, Gilliard/P-7136-2019; Hoeller, Alexandre Ademar/F-2823-2013; Matheus, Filipe Carvalho/AAB-9747-2020; de Lima, Thereza Christina Monteiro/AAH-9402-2019; Lima, Thereza CM/C-6812-2015; Bicca, Maíra Assunção/AAG-7560-2020; Collingridge, Graham L/C-4605-2015; Lach, Gilliard/O-9824-2014; Walz, Roger/K-9096-2013	Hoeller, Alexandre Ademar/0000-0001-7526-1502; Lima, Thereza CM/0000-0002-3253-7350; Bicca, Maíra Assunção/0000-0002-3648-8824; Collingridge, Graham L/0000-0002-9572-5359; Lach, Gilliard/0000-0003-3750-7764; Lightman, Stafford/0000-0002-8546-9646; Ramos Costa, Ana Paula/0000-0002-4632-038X; Spiga, Francesca/0000-0002-6904-2247; Walz, Roger/0000-0002-9875-6687	Conselho Nacional de Desenvolvimento Cientfico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC); BBSRC [BB/H015779/01]; MRC [90601813, MR/K023098/1]; CNPq; CAPES/PNPD; National Institute of Translational Neuroscience (INNT); NENASC project (PRONEX Program CNPq/FAPESC); BBSRC [BB/H015779/1] Funding Source: UKRI; MRC [MR/J008893/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H015779/1] Funding Source: researchfish; Medical Research Council [MR/J008893/1, MR/K023098/1] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientfico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Translational Neuroscience (INNT); NENASC project (PRONEX Program CNPq/FAPESC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientfico (CNPq, www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD, www.capes.gov.br), Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional (INNT, inct.cnpq.br), and Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC), Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC) which provided research grants to AAH, APRC, GL, MAB, RW and TCML; by the BBSRC (BB/H015779/01) to FS and SLL; and by the MRC (90601813, MR/K023098/1) to GLC and ZAB. The authors have no financial or personal conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CNPq, CAPES/PNPD, National Institute of Translational Neuroscience (INNT) and NENASC project (PRONEX Program CNPq/FAPESC) which provided research grants to AA Hoeller, APR Costa, MA Bicca, FC Matheus, G Lach, R Walz and TCM de Lima; by the BBSRC (BB/H015779/01) to F Spiga and SL Lightman; by the MRC (90601813, MR/K023098/1) to GL Collingridge and ZA Bortolotto. We would like to acknowledge Zidong Zhao and Dr. Joao Batista Calixto for their technical support.	Acquas E, 1996, J NEUROSCI, V16, P3089; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Aslan N, 1997, EUR J PHARMACOL, V333, P63, DOI 10.1016/S0014-2999(97)01106-0; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bertoglio LJ, 2003, PSYCHOPHARMACOLOGY, V170, P335, DOI 10.1007/s00213-003-1558-z; Bhatnagar S, 1997, BRAIN RES, V766, P244, DOI 10.1016/S0006-8993(97)00684-7; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; BUBSER M, 1992, EUR J PHARMACOL, V229, P75, DOI 10.1016/0014-2999(92)90288-F; Butcher AJ, 2009, J BIOL CHEM, V284, P17147, DOI 10.1074/jbc.M901031200; Calabrese F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037916; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; COLE JC, 1994, PSYCHOPHARMACOLOGY, V114, P288, DOI 10.1007/BF02244851; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Degroot A, 2005, NEUROPSYCHOPHARMACOL, V30, P391, DOI 10.1038/sj.npp.1300624; Demontis F, 2015, EUR J PHARMACOL, V752, P49, DOI 10.1016/j.ejphar.2015.01.041; Di Maio R, 2011, NEUROBIOL DIS, V42, P482, DOI 10.1016/j.nbd.2011.02.012; Duarte FS, 2013, PSYCHOPHARMACOLOGY, V227, P209, DOI 10.1007/s00213-012-2951-2; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; DUNN JD, 1984, EXP BRAIN RES, V54, P1; Dutra RC, 2012, BIOCHEM PHARMACOL, V83, P531, DOI 10.1016/j.bcp.2011.11.026; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Graef S, 2011, PSYCHOPHARMACOLOGY, V215, P205, DOI 10.1007/s00213-010-2153-8; Grishin AA, 2004, J NEUROSCI, V24, P350, DOI 10.1523/JNEUROSCI.4933-03.2004; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Higley MJ, 2014, CURR OPIN NEUROBIOL, V29, P88, DOI 10.1016/j.conb.2014.06.004; Hoeller AA, 2013, BRAIN RES, V1532, P21, DOI 10.1016/j.brainres.2013.07.045; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; IMPERATO A, 1990, EUR J PHARMACOL, V187, P555, DOI 10.1016/0014-2999(90)90387-L; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JASPER MS, 1994, NEUROENDOCRINOLOGY, V59, P97, DOI 10.1159/000126645; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lopes MW, 2013, EXP BRAIN RES, V226, P153, DOI 10.1007/s00221-013-3421-8; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Marti O, 2001, EUR J NEUROSCI, V13, P129, DOI 10.1046/j.1460-9568.2001.01355.x; Martinez G, 2002, PHYSIOL BEHAV, V76, P219, DOI 10.1016/S0031-9384(02)00704-7; Mesulam MM, 1995, PSYCHOPHARMACOLOGY T; Micheau J, 2011, BEHAV BRAIN RES, V221, P424, DOI 10.1016/j.bbr.2010.11.052; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199, DOI 10.1192/S0007125000146513; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Park HJ, 2015, ARCH PHARM RES, V38, P1204, DOI 10.1007/s12272-015-0548-0; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; Power JM, 2008, J NEUROSCI, V28, P3209, DOI 10.1523/JNEUROSCI.4310-07.2008; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; RUBIN RT, 1966, SCIENCE, V153, P767, DOI 10.1126/science.153.3737.767; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Spiga F, 2011, ENDOCRINOLOGY, V152, P1448, DOI 10.1210/en.2010-1209; Steimer Thierry, 2002, Dialogues Clin Neurosci, V4, P231; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Varatharajan R, 2015, NEUROCHEM INT, V90, P255, DOI 10.1016/j.neuint.2015.10.002; Volianskis A, 2015, BRAIN RES, V1621, P5, DOI 10.1016/j.brainres.2015.01.016; Volpicelli LA, 2004, PROG BRAIN RES, V145, P59, DOI 10.1016/S0079-6123(03)45003-6; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wall PM, 2001, PSYCHOPHARMACOLOGY, V155, P58, DOI 10.1007/s002130000671; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yoshida M, 1998, BRAIN RES, V786, P226, DOI 10.1016/S0006-8993(97)00694-X; Zhang LM, 2015, PSYCHOPHARMACOLOGY, V232, P663, DOI 10.1007/s00213-014-3697-9; Zhang LM, 2002, J NEUROPHYSIOL, V88, P3315, DOI 10.1152/jn.01025.2001; Zhe D, 2008, ACTA HISTOCHEM CYTOC, V41, P89, DOI 10.1267/ahc.08013	79	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147293	10.1371/journal.pone.0147293	http://dx.doi.org/10.1371/journal.pone.0147293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795565	Green Published, Green Submitted, gold			2022-12-27	WOS:000368530300027
J	Hua, L; Song, Y; Kim, N; Laing, C; Wang, JTL; Schlick, T				Hua, Lei; Song, Yang; Kim, Namhee; Laing, Christian; Wang, Jason T. L.; Schlick, Tamar			CHSalign: A Web Server That Builds upon Junction-Explorer and RNAJAG for Pairwise Alignment of RNA Secondary Structures with Coaxial Helical Stacking	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; 3D MOTIFS; TERTIARY STRUCTURES; 3-WAY JUNCTIONS; EDIT DISTANCE; FOLDED RNAS; TREE EDIT; CLASSIFICATION; SEQUENCES; IDENTIFICATION	RNA junctions are important structural elements of RNA molecules. They are formed when three or more helices come together in three-dimensional space. Recent studies have focused on the annotation and prediction of coaxial helical stacking (CHS) motifs within junctions. Here we exploit such predictions to develop an efficient alignment tool to handle RNA secondary structures with CHS motifs. Specifically, we build upon our Junction-Explorer software for predicting coaxial stacking and RNAJAG for modelling junction topologies as tree graphs to incorporate constrained tree matching and dynamic programming algorithms into a new method, called CHSalign, for aligning the secondary structures of RNA molecules containing CHS motifs. Thus, CHSalign is intended to be an efficient alignment tool for RNAs containing similar junctions. Experimental results based on thousands of alignments demonstrate that CHSalign can align two RNA secondary structures containing CHS motifs more accurately than other RNA secondary structure alignment tools. CHSalign yields a high score when aligning two RNA secondary structures with similar CHS motifs or helical arrangement patterns, and a low score otherwise. This new method has been implemented in a web server, and the program is also made freely available, at http://bioinformatics.njit.edu/CHSalign/.	[Hua, Lei; Song, Yang; Laing, Christian; Wang, Jason T. L.] New Jersey Inst Technol, Dept Comp Sci, Bioinformat Lab, Newark, NJ 07102 USA; [Kim, Namhee; Schlick, Tamar] NYU, Dept Chem, New York, NY USA; [Schlick, Tamar] NYU, Courant Inst Math Sci, New York, NY USA	New Jersey Institute of Technology; New York University; New York University	Wang, JTL (corresponding author), New Jersey Inst Technol, Dept Comp Sci, Bioinformat Lab, Newark, NJ 07102 USA.; Schlick, T (corresponding author), NYU, Dept Chem, New York, NY USA.; Schlick, T (corresponding author), NYU, Courant Inst Math Sci, New York, NY USA.	wangj@njit.edu; schlick@nyu.edu		Schlick, Tamar/0000-0002-2392-2062	National Science Foundation [IIS-0707571]; National Institute of General Medical Sciences [GM100469, GM081410]; Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group] [TG-MCB080036N]; Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100469, R01GM081410] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group]; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation [grant IIS-0707571 to J.W.], and National Institute of General Medical Sciences [grants GM100469 and GM081410 to T.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Drs. Bruce Shapiro and Kaizhong Zhang for helpful conversations. We also thank Dongrong Wen and Akhila Nagula for their contributions in the early stage of this work. J.W. acknowledges support of this work by the National Science Foundation Grant IIS-0707571. T.S. acknowledges support of this work by the National Institute of General Medical Sciences Grants GM100469 and GM081410. Computing resources, utilized by the NYU team, of the Computational Center for Nanotechnology Innovations and Empire State Development's Division of Science, Technology and Innovation [through National Science Foundation (NSF) Group Award TG-MCB080036N] and the New York Center for Computational Sciences at Stony Brook University/Brookhaven National Laboratory (supported by Department of Energy Grant DE-AC02-98CH10886 and the State of New York) are gratefully acknowledged.	Aalberts DP, 2010, RNA, V16, P1350, DOI 10.1261/rna.1831710; Abraham M, 2008, RNA, V14, P2274, DOI 10.1261/rna.853208; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Bindewald E, 2011, RNA, V17, P1688, DOI 10.1261/rna.2640111; BRIMACOMBE R, 1985, BIOCHEM J, V229, P1; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Byron Kevin, 2013, Recent Pat DNA Gene Seq, V7, P115; Capriotti E, 2009, NUCLEIC ACIDS RES, V37, pW260, DOI 10.1093/nar/gkp433; Chang YF, 2008, NUCLEIC ACIDS RES, V36, pW19, DOI 10.1093/nar/gkn327; Chen SH, 2014, J COMB OPTIM, V27, P778, DOI 10.1007/s10878-012-9552-1; Cohen Adaya, 2008, In Silico Biology, V8, P105; Dror O, 2005, BIOINFORMATICS, V21, P47, DOI 10.1093/bioinformatics/bti1108; Ferre F, 2007, NUCLEIC ACIDS RES, V35, pW659, DOI 10.1093/nar/gkm334; Gardner PP, 2005, NUCLEIC ACIDS RES, V33, P2433, DOI 10.1093/nar/gki541; Goody TA, 2004, J AM CHEM SOC, V126, P4126, DOI 10.1021/ja0319240; Hamada M, 2009, BIOINFORMATICS, V25, P3236, DOI 10.1093/bioinformatics/btp580; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; He GW, 2014, NUCLEIC ACIDS RES, V42, pW377, DOI 10.1093/nar/gku429; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Hoksza D, 2012, BIOINFORMATICS, V28, P1858, DOI 10.1093/bioinformatics/bts301; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; JIANG T, 1995, THEOR COMPUT SCI, V143, P137, DOI 10.1016/0304-3975(95)80015-8; Jiang T, 2002, J COMPUT BIOL, V9, P371, DOI 10.1089/10665270252935511; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Kim J, 1996, BIOCHEMISTRY-US, V35, P13753, DOI 10.1021/bi960913z; Kim N, 2015, METHOD ENZYMOL, V553, P115, DOI 10.1016/bs.mie.2014.10.054; Kim N, 2014, P NATL ACAD SCI USA, V111, P4079, DOI 10.1073/pnas.1318893111; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Lafontaine DA, 2001, EMBO J, V20, P1415, DOI 10.1093/emboj/20.6.1415; Laing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071947; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Laing C, 2009, J MOL BIOL, V393, P67, DOI 10.1016/j.jmb.2009.07.089; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Liu JH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-89; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048460; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; Meyer IM, 2007, PLOS COMPUT BIOL, V3, P1441, DOI 10.1371/journal.pcbi.0030149; Ouellet J, 2010, RNA, V16, P1597, DOI 10.1261/rna.2158410; Petrov AI, 2013, RNA, V19, P1327, DOI 10.1261/rna.039438.113; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; Popovic M, 2012, RNA, V18, P2093, DOI 10.1261/rna.035782.112; Rahrig RR, 2010, BIOINFORMATICS, V26, P2689, DOI 10.1093/bioinformatics/btq506; Sarver M, 2008, J MATH BIOL, V56, P215, DOI 10.1007/s00285-007-0110-x; Sato K, 2012, BIOINFORMATICS, V28, P3218, DOI 10.1093/bioinformatics/bts612; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Shang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039383; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Smit S, 2008, RNA, V14, P410, DOI 10.1261/rna.881308; Tabei Y, 2006, BIOINFORMATICS, V22, P1723, DOI 10.1093/bioinformatics/btl177; Walter F, 1998, RNA, V4, P719, DOI 10.1017/S135583829898030X; Wang CW, 2010, NUCLEIC ACIDS RES, V38, pW340, DOI 10.1093/nar/gkq483; Wang LS, 2003, BIOINFORMATICS, V19, P2237, DOI 10.1093/bioinformatics/btg305; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Yang SC, 2010, J PHYS CHEM B, V114, P10039, DOI 10.1021/jp1057308; Yuan FQ, 2007, NUCLEIC ACIDS RES, V35, P2833, DOI 10.1093/nar/gkm134; Zhong XH, 2007, EMBO J, V26, P3836, DOI 10.1038/sj.emboj.7601812; Zirbel CL, 2015, NUCLEIC ACIDS RES, V43, P7504, DOI 10.1093/nar/gkv651; Zirbel CL, 2009, NUCLEIC ACIDS RES, V37, P4898, DOI 10.1093/nar/gkp468	69	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147097	10.1371/journal.pone.0147097	http://dx.doi.org/10.1371/journal.pone.0147097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789998	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100057
J	Unnerstale, S; Nowakowski, M; Baraznenok, V; Stenberg, G; Lindberg, J; Mayzel, M; Orekhov, V; Agback, T				Unnerstale, Sofia; Nowakowski, Michal; Baraznenok, Vera; Stenberg, Gun; Lindberg, Jimmy; Mayzel, Maxim; Orekhov, Vladislav; Agback, Tatiana			Backbone Assignment of the MALT1 Paracaspase by Solution NMR	PLOS ONE			English	Article							TRIPLE-RESONANCE EXPERIMENTS; B-CELL LYMPHOMA; PROTEASE ACTIVITY; LARGE PROTEINS; TROSY; SPECTROSCOPY; RELAXATION; ACTIVATION; KEY	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is a unique paracaspase protein whose protease activity mediates oncogenic NF-kappa B signalling in activated B cell-like diffuse large B cell lymphomas (ABC-DLBCLs). ABC-DLBCLs are aggressive lymphomas with high resistance to current chemotherapies. Low survival rate among patients emphasizes the urgent need for alternative treatment options. The characterization of the MALT1 will be an essential tool for developing new target-directed drugs against MALT1 dependent disorders. As the first step in the atomic-level NMR studies of the system, here we report, the N-15/C-13/H-1 backbone assignment of the apo form of the MALT1 paracaspase region together with the third immunoglobulin-like (Ig3) domain, 44 kDa, by high resolution NMR. In addition, the non-uniform sampling (NUS) based targeted acquisition procedure is evaluated as a mean of decreasing acquisition and analysis time for larger proteins.	[Unnerstale, Sofia; Baraznenok, Vera; Stenberg, Gun; Lindberg, Jimmy; Agback, Tatiana] Medivir AB, POB 1086, SE-14122 Huddinge, Sweden; [Nowakowski, Michal; Mayzel, Maxim; Orekhov, Vladislav] Univ Gothenburg, Swedish NMR Ctr, POB 465, SE-40530 Gothenburg, Sweden; [Nowakowski, Michal] Univ Warsaw, Ctr New Technol, PL-02097 Warsaw, Poland	Medivir; University of Gothenburg; University of Warsaw	Agback, T (corresponding author), Medivir AB, POB 1086, SE-14122 Huddinge, Sweden.	Tatiana.Agback@medivir.com	Orekhov, Vladislav/AAD-8464-2019; Mayzel, Maksim/AAM-1393-2020; Nowakowski, Michał/G-8973-2012; Orekhov, Vladislav/AAC-8357-2022; Nowakowski, Michal/P-7632-2019	Orekhov, Vladislav/0000-0002-7892-6896; Nowakowski, Michał/0000-0002-1356-0301; Nowakowski, Michal/0000-0002-1356-0301; Agback, Tatiana/0000-0003-1325-6024	National Centre of Science [DEC-2012/07/E/ST4/01386]; Medivir AB	National Centre of Science; Medivir AB	M.N would like to thank the National Centre of Science for support with Sonata Bis 2 Grant No. DEC-2012/07/E/ST4/01386. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medivir AB provided support in the form of salaries for authors SU, VB, GS, JL and TA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Dunleavy K, 2014, ONCOLOGY-NY, V28, P326; Eitelhuber AC, 2015, CHEM BIOL, V22, P129, DOI 10.1016/j.chembiol.2014.10.021; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Goddard T, 2004, SPARKY 3, V14, P15; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Isaksson L, 2013, HIGHLY EFFICIENT NMR, DOI [10.1371/journal.pone.0062947, DOI 10.1371/JOURNAL.PONE.0062947]; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Jong WY, 2011, P NATL ACAD SCI USA, V108, P21004; Lenz G, 2015, CANCERS, V7, P811, DOI 10.3390/cancers7020812; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Niklasson M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004022; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schlauderer F, 2013, ANGEW CHEM INT EDIT, V52, P10384, DOI 10.1002/anie.201304290; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146496	10.1371/journal.pone.0146496	http://dx.doi.org/10.1371/journal.pone.0146496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788853	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100033
J	Hou, FJ				Hou, Fujun			Market Competitiveness Evaluation of Mechanical Equipment with a Pairwise Comparisons Hierarchical Model	PLOS ONE			English	Article							DERIVING WEIGHTS; AHP; MATRICES	This paper provides a description of how market competitiveness evaluations concerning mechanical equipment can be made in the context of multi-criteria decision environments. It is assumed that, when we are evaluating the market competitiveness, there are limited number of candidates with some required qualifications, and the alternatives will be pairwise compared on a ratio scale. The qualifications are depicted as criteria in hierarchical structure. A hierarchical decision model called PCbHDM was used in this study based on an analysis of its desirable traits. Illustration and comparison shows that the PCbHDM provides a convenient and effective tool for evaluating the market competitiveness of mechanical equipment. The researchers and practitioners might use findings of this paper in application of PCbHDM.	[Hou, Fujun] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China	Beijing Institute of Technology	Hou, FJ (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China.	houfj@bit.edu.cn		Hou, Fujun/0000-0002-5719-1237	National Natural Science Foundation of China [71571019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 71571019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank the Editor-in-Chief, the Academic Editor and the anonymous Referees for their helpful comments and suggestions. The work was supported by the National Natural Science Foundation of China (No. 71571019). The study interest of the present paper was triggered by a dissertation [28] where the AHP was used. In addition, the author wishes to thank Mr. Rana Umair Ashraf from COMSATS Institute of Information Technology, Vehari Pakistan, for expert help in improving English language usage in this paper.	Bana E Costa CA, 2008, EUR J OPER RES, V187, P1422, DOI 10.1016/j.ejor.2006.09.022; BARZILAI J, 1990, OPER RES LETT, V9, P407, DOI 10.1016/0167-6377(90)90062-A; Barzilai J, 1997, J OPER RES SOC, V48, P1226, DOI 10.1057/palgrave.jors.2600474; BARZILAI J, 1994, INFOR, V32, P57; BARZILAI J, 1987, OPER RES LETT, V6, P131, DOI 10.1016/0167-6377(87)90026-5; Barzilai J., 1998, J MULTI-CRITERIA DEC, V7, P123, DOI DOI 10.1002/(SICI)1099-1360(199805)7:33.0.CO;2-8; BELTON V, 1983, OMEGA-INT J MANAGE S, V11, P228, DOI 10.1016/0305-0483(83)90047-6; Chang DY, 1996, EUR J OPER RES, V95, P649, DOI 10.1016/0377-2217(95)00300-2; Chiclana F, 2001, FUZZY SET SYST, V122, P277, DOI 10.1016/S0165-0114(00)00004-X; Crawford G. B., 1987, Mathematical Modelling, V9, P327, DOI 10.1016/0270-0255(87)90489-1; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y., 2012, J INF COMPUT SCI, V9, P2421; DYER JS, 1990, MANAGE SCI, V36, P249, DOI 10.1287/mnsc.36.3.249; Elsner L, 2004, LINEAR ALGEBRA APPL, V385, P47, DOI 10.1016/S0024-3795(03)00476-2; Fedrizzi M, 1990, MULTIPERSON DECISION, P231, DOI DOI 10.1007/978-94-009-2109-2_20; Herrera-Viedma E, 2004, EUR J OPER RES, V154, P98, DOI 10.1016/S0377-2217(02)00725-7; Hou F, 2014, COMMUNICATIONS STAT; Hou F, 2014, J DATA ANAL OPERATIO, V1, P25; Hou FJ, 2012, COMMUN STAT-THEOR M, V41, P3831, DOI 10.1080/03610926.2012.688156; Hou FJ, 2011, INFORM SCIENCES, V181, P2166, DOI 10.1016/j.ins.2011.01.020; JOHNSON CR, 1979, J MATH PSYCHOL, V19, P61, DOI 10.1016/0022-2496(79)90005-1; Lootsma F. A., 1993, J MULTI-CRITERIA DEC, V2, P87, DOI DOI 10.1002/MCDA.4020020205; Miller J.R., 1966, THESIS MIT; Nefeslioglu HA, 2013, COMPUT GEOSCI-UK, V59, P1, DOI 10.1016/j.cageo.2013.05.010; Saaty TL, 1984, OMEGA-J DEATH DYING, V12, P513; Saaty TL., 1980, ANAL HIERARCHY PROCE; SCHONER B, 1989, DECISION SCI, V20, P462, DOI 10.1111/j.1540-5915.1989.tb01561.x; TANINO T, 1984, FUZZY SET SYST, V12, P117, DOI 10.1016/0165-0114(84)90032-0; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Tian XY, 2015, THESIS BEIJING I TEC; Triantaphyllou E., 2001, J MULTI-CRITERIA DEC, V10, P11, DOI DOI 10.1002/MCDA.284; VANLAARHOVEN PJM, 1983, FUZZY SET SYST, V11, P229, DOI 10.1016/S0165-0114(83)80083-9; Xu YT, 2009, COMMUN NONLINEAR SCI, V14, P3031, DOI 10.1016/j.cnsns.2008.10.018	33	4	4	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146862	10.1371/journal.pone.0146862	http://dx.doi.org/10.1371/journal.pone.0146862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26783751	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400075
J	Melman, S; Schoorel, ECN; de Boer, K; Burggraaf, H; Derks, JB; van Dijk, D; van Dillen, J; Dirksen, CD; Duvekot, JJ; Franx, A; Hasaart, THM; Huisjes, AJM; Kolkman, D; van Kuijk, S; Kwee, A; Mol, BW; van Pampus, MG; de Roon-Immerzeel, A; van Roosmalen, JJM; Roumen, FJME; Smid-Koopman, E; Smits, L; Spaans, WA; Visser, H; van Wijngaarden, WJ; Willekes, C; Wouters, MGAJ; Nijhuis, JG; Hermens, RPMG; Scheepers, HCJ				Melman, Sonja; Schoorel, Ellen C. N.; de Boer, Karin; Burggraaf, Henriette; Derks, Jan B.; van Dijk, Det; van Dillen, Jeroen; Dirksen, Carmen D.; Duvekot, Johannes J.; Franx, Arie; Hasaart, Tom H. M.; Huisjes, Anjoke J. M.; Kolkman, Diny; van Kuijk, Sander; Kwee, Anneke; Mol, Ben W.; van Pampus, Marille G.; de Roon-Immerzeel, Alieke; van Roosmalen, Jos J. M.; Roumen, Frans J. M. E.; Smid-Koopman, Ellen; Smits, Luc; Spaans, Wilbert A.; Visser, Harry; van Wijngaarden, Wim J.; Willekes, Christine; Wouters, Maurice G. A. J.; Nijhuis, Jan G.; Hermens, Rosella P. M. G.; Scheepers, Hubertina C. J.			Development and Measurement of Guidelines-Based Quality Indicators of Caesarean Section Care in the Netherlands: A RAND-Modified Delphi Procedure and Retrospective Medical Chart Review	PLOS ONE			English	Article							VAGINAL BIRTH; DELIVERY; INTERVENTIONS; REDUCE; TRENDS	Background There is an ongoing discussion on the rising CS rate worldwide. Suboptimal guideline adherence may be an important contributor to this rise. Before improvement of care can be established, optimal CS care in different settings has to be defined. This study aimed to develop and measure quality indicators to determine guideline adherence and identify target groups for improvement of care with direct effect on caesarean section (CS) rates. Method Eighteen obstetricians and midwives participated in an expert panel for systematic CS quality indicator development according to the RAND-modified Delphi method. A multi-center study was performed and medical charts of 1024 women with a CS and a stratified and weighted randomly selected group of 1036 women with a vaginal delivery were analysed. Quality indicator frequency and adherence were scored in 2060 women with a CS or vaginal delivery. Results The expert panel developed 16 indicators on planned CS and 11 indicators on unplanned CS. Indicator adherence was calculated, defined as the number of women in a specific obstetrical situation in which care was performed as recommended in both planned and unplanned CS settings. The most frequently occurring obstetrical situations with low indicator adherence were: 1) suspected fetal distress (frequency 17%, adherence 46%), 2) nonprogressive labour (frequency 12%, CS performed too early in over 75%), 3) continuous support during labour (frequency 88%, adherence 37%) and 4) previous CS (frequency 12%), with adequate counselling in 15%. Conclusions We identified four concrete target groups for improvement of obstetrical care, which can be used as a starting point to reduce CS rates worldwide.	[Melman, Sonja; Schoorel, Ellen C. N.; Willekes, Christine; Nijhuis, Jan G.; Scheepers, Hubertina C. J.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands; [de Boer, Karin] Rijnstate Hosp, Dept Obstet & Gynaecol, POB 9555, NL-6800 TA Arnhem, Netherlands; [Burggraaf, Henriette] Midwives Zaltbommel Maasdriel, Hogeweg 141, NL-5301 LL Zaltbommel, Netherlands; [Derks, Jan B.; Franx, Arie; Kwee, Anneke] Univ Med Hosp Utrecht, Dept Obstet & Gynaecol, POB 85090, NL-3508 AB Utrecht, Netherlands; [van Dijk, Det; van Roosmalen, Jos J. M.] Leiden Univ, Med Ctr, Dept Obstet, POB 9600, NL-2300 RC Leiden, Netherlands; [van Dillen, Jeroen] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Dirksen, Carmen D.] Maastricht Univ, Dept Clin Epidemiol & Med Technol Assessment KEMT, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands; [Duvekot, Johannes J.] Erasmus MC, Dept Obstet & Gynaecol, POB 2060, NL-3000 CB Rotterdam, Netherlands; [Hasaart, Tom H. M.] Catharina Hosp, Dept Obstet & Gynaecol, POB 1350, NL-5602 ZA Eindhoven, Netherlands; [Huisjes, Anjoke J. M.] Gelre Hosp, Dept Obstet & Gynaecol, POB 9014, NL-7300 DS Apeldoorn, Netherlands; [Kolkman, Diny; de Roon-Immerzeel, Alieke] Royal Dutch Org Midw KNOV, Mercatorlaan 1200, NL-3528 BL Utrecht, Netherlands; [van Kuijk, Sander; Smits, Luc] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Mol, Ben W.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1100 DD Amsterdam, Netherlands; [van Pampus, Marille G.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Oosterpk 9, NL-1091 AC Amsterdam, Netherlands; [Roumen, Frans J. M. E.] Atrium Med Ctr Parkstad, Dept Obstet & Gynaecol, POB 4446, NL-6401 CX Heerlen, Netherlands; [Smid-Koopman, Ellen] Ruwaard van Putten Hosp, Dept Obstet & Gynaecol, POB 777, NL-3200 GA Spijkenisse, Netherlands; [Spaans, Wilbert A.] Jeroen Bosch Hosp, Dept Obstet & Gynaecol, POB 90153, NL-5200 ME Shertogenbosch, Netherlands; [Visser, Harry] Tergooi Hosp Blaricum, Dept Obstet & Gynaecol, POB 10016, NL-1201 DA Hilversum, Netherlands; [van Wijngaarden, Wim J.] Bronovo Hosp, Dept Obstet & Gynaecol, POB 96900, NL-2509 JH The Hague, Netherlands; [Wouters, Maurice G. A. J.] VU Univ Med Ctr Amsterdam, Dept Obstet & Gynaecol, POB 7057, NL-1007 MB Amsterdam, Netherlands; [Hermens, Rosella P. M. G.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Sci Inst Qual Healthcare IQ Healthcare, POB 9101, NL-6500 HB Nijmegen, Netherlands	Maastricht University; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Catharina Hospital; Gelre Hospitals; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Atrium Medical Center; Jeroen Bosch Ziekenhuis; Tergooi Blaricum; Haaglanden Medical Center; Bronovo Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Melman, S (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands.	s.melman@mumc.nl	Hermens, Rosella P.M.G./N-3581-2014; Dillen, J./L-4275-2015; Franx, Arie/AAA-1739-2021; van Kuijk, Sander/AAH-3239-2021; Willekes, Christine/GWZ-1205-2022	Hermens, Rosella P.M.G./0000-0001-7624-7120; van Pampus, Maria/0000-0002-3020-8908; Smits, Luc/0000-0003-0785-1345; van Kuijk, Sander/0000-0003-2796-729X	ZonMW [17100.3006]	ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by ZonMW 17100.3006, www.zonmw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P1071, DOI 10.1016/S0002-9378(97)70017-6; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2013, PER CAR NETH 2010; [Anonymous], 2013, PER CAR NETH 2012; Boyle A, 2013, OBSTET GYNECOL, V122, P33, DOI 10.1097/AOG.0b013e3182952242; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Brennan DJ, 2011, OBSTET GYNECOL, V117, P273, DOI 10.1097/AOG.0b013e318204521a; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Delbaere I, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-3; Dexter SC, 2014, BJOG-INT J OBSTET GY, V121, P133, DOI 10.1111/1471-0528.12409; Grol R, 2002, QUAL SAF HEALTH CARE, V11, P110, DOI 10.1136/qhc.11.2.110; Guise Jeanne-Marie, 2010, Evid Rep Technol Assess (Full Rep), P1; Haerskjold A, 2012, J OBSTET GYNAECOL, V32, P543, DOI 10.3109/01443615.2012.689027; *INF CTR, 2009, NHS MAT STAT ENGL 20; Kesmodel US, 2011, ACTA OBSTET GYN SCAN, V90, P295, DOI 10.1111/j.1600-0412.2011.01078.x; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P70, DOI 10.1016/j.ejogrb.2006.06.018; Le Ray C, 2015, BJOG-INT J OBSTET GY, V122, P690, DOI 10.1111/1471-0528.13199; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Luck J, 2000, AM J MED, V108, P642, DOI 10.1016/S0002-9343(00)00363-6; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Lundgren I, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0441-3; Menacker F, 2006, SEMIN PERINATOL, V30, P235, DOI 10.1053/j.semperi.2006.07.002; Menacker Fay, 2010, NCHS Data Brief, P1; NICE, 2011, NICE CLIN GUIDELINE, DOI DOI 10.1007/s00213-019-05249-5; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Robson MS, 1996, AM J OBSTET GYNECOL, V174, P199, DOI 10.1016/S0002-9378(96)70394-0; Rossi AC, 2010, OBSTET GYNECOL, V115, P637, DOI 10.1097/AOG.0b013e3181cfc007; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058; Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145771	10.1371/journal.pone.0145771	http://dx.doi.org/10.1371/journal.pone.0145771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783742	Green Published, gold			2022-12-27	WOS:000368528400020
J	Merilahti, P; Karelehto, E; Susi, P				Merilahti, Pirjo; Karelehto, Eveliina; Susi, Petri			Role of Heparan Sulfate in Cellular Infection of Integrin-Binding Coxsackievirus A9 and Human Parechovirus 1 Isolates	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEQUENCE ALIGNMENT; ALPHA(V)BETA(3); ATTACHMENT; PROTEIN; CELLS; EFFICIENT; RECEPTOR; CULTURE; ENTRY	Heparan sulfate/heparin class of proteoglycans (HSPG) have been shown to function in cellular attachment and infection of numerous viruses including picornaviruses. Coxsackievirus A9 (CV-A9) and human parechovirus 1 (HPeV-1) are integrin-binding members in the family Picornaviridae. CV-A9 Griggs and HPeV-1 Harris (prototype) strains have been reported not to bind to heparin, but it was recently shown that some CV-A9 isolates interact with heparin in vitro via VP1 protein with a specific T132R/K mutation. We found that the infectivity of both CV-A9 Griggs and HPeV-1 Harris was reduced by sodium chlorate and heparinase suggestive of HSPG interactions. We analyzed the T132 site in fifty-four (54) CV-A9 clinical isolates and found that only one of them possessed T132/R mutation while the other nine (9) had T132K. We then treated CV-A9 Griggs and HPeV-1 Harris and eight CV-A9 and six HPeV-1 clinical isolates with heparin and protamine. Although infectivity of Griggs strain was slightly reduced (by 25%), heparin treatment did not affect the infectivity of the CV-A9 isolates that do not possess the T132R/K mutation, which is in line with the previous findings. Some of the HPeV-1 isolates were also affected by heparin treatment, which suggested that there may be a specific heparin binding site in HPeV-1. In contrast, protamine (a specific inhibitor of heparin) completely inhibited the infection of both prototypes and clinical CV-A9 and HPeV-1 isolates. We conclude that T132R/K mutation has a role in heparin binding of CV-A9, but we also show data, which suggest that there are other HSPG binding sites in CV-A9. In all, we suggest that HSPGs play a general role in both CV-A9 and HPeV-1 infections.	[Merilahti, Pirjo; Karelehto, Eveliina; Susi, Petri] Univ Turku, Dept Virol, Turku, Finland; [Karelehto, Eveliina] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Susi, Petri] Turku Univ Appl Sci, Biomat & Diagnost Grp, Turku, Finland	University of Turku; University of Amsterdam; Academic Medical Center Amsterdam; University of Turku	Susi, P (corresponding author), Univ Turku, Dept Virol, Turku, Finland.; Susi, P (corresponding author), Turku Univ Appl Sci, Biomat & Diagnost Grp, Turku, Finland.	pesusi@utu.fi	Susi, Petri/AAL-8194-2020	Susi, Petri/0000-0002-9245-3271	Academy of Finland [128539, 263255]; European Union [612308]; Turku Graduate School of Biomedical Sciences; Turku Doctoral Programme of Molecular Medicine; Finnish Culture Foundation; Jane and Aatos Erkko Foundation; Turku University of Applied Sciences [601129]	Academy of Finland(Academy of Finland); European Union(European Commission); Turku Graduate School of Biomedical Sciences; Turku Doctoral Programme of Molecular Medicine; Finnish Culture Foundation(Finnish Cultural Foundation); Jane and Aatos Erkko Foundation; Turku University of Applied Sciences	This work was supported by Academy of Finland (128539, 263255 to P.S.), European Union (AIROPico, FP7-PEOPLE-2013-IAPP Grant no. 612308), Turku Graduate School of Biomedical Sciences, Turku Doctoral Programme of Molecular Medicine, Finnish Culture Foundation, Jane and Aatos Erkko Foundation and Turku University of Applied Sciences (601129 to P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Katja Wolthers (Academic Medical Center, Amsterdam, the Netherlands) and Dr. Sisko Tauriainen (Department of Virology, University of Turku, Finland) for parechovirus strains. Dr. Juha Himanen (Sloan-Kettering Institute for Cancer Research, New York, USA) is thanked for modelling and fruitful discussions. Dr. Robert M. Badeau (Turku University Language Centre) is gratefully acknowledged for the English proofreading and linguistic editing of this manuscript. We thank Ms. Ritva Kajander for technical assistance. This work was supported by Academy of Finland (128539, 263255 to P.S.), European Union (AIROPico, FP7-PEOPLE-2013-IAPP Grant no. 612308), Turku Graduate School of Biomedical Sciences, Turku Doctoral Programme of Molecular Medicine, Finnish Culture Foundation, Jane and Aatos Erkko Foundation and Turku University of Applied Sciences (601129 to P.S.).	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998; CHANG KH, 1989, J GEN VIROL, V70, P3269, DOI 10.1099/0022-1317-70-12-3269; Ehrenfeld E, 2010, PICORNAVIRUSES; Escribano-Romero E, 2004, J GEN VIROL, V85, P653, DOI 10.1099/vir.0.19603-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Goodfellow IG, 2001, J VIROL, V75, P4918, DOI 10.1128/JVI.75.10.4918-4921.2001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joki-Korpela P, 2001, ANN MED, V33, P466, DOI 10.3109/07853890109002095; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Khan AG, 2007, J VIROL, V81, P4625, DOI 10.1128/JVI.02160-06; Knowles NJ, 2012, PICORNAVIRIDAE, P855; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; McLeish NJ, 2012, J VIROL, V86, P11163, DOI 10.1128/JVI.00640-12; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Pulli T, 1998, VIROLOGY, V240, P202, DOI 10.1006/viro.1997.8908; Reddi HV, 2002, J VIROL, V76, P8400, DOI 10.1128/JVI.76.16.8400-8407.2002; ROIVAINEN M, 1991, J VIROL, V65, P4735, DOI 10.1128/JVI.65.9.4735-4740.1991; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Triantafilou M, 1999, J GEN VIROL, V80, P2591, DOI 10.1099/0022-1317-80-10-2591; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989	38	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147168	10.1371/journal.pone.0147168	http://dx.doi.org/10.1371/journal.pone.0147168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785353	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400118
J	Mullerova, J; Pejcha, V; Altman, J; Plener, T; Dorner, P; Dolezal, J				Muellerova, Jana; Pejcha, Vit; Altman, Jan; Plener, Tomas; Doerner, Petr; Dolezal, Jiri			Detecting Coppice Legacies from Tree Growth	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; FOREST DISTURBANCE; RADIAL-GROWTH; RING SERIES; EUROPE; DENDROCHRONOLOGY; RECONSTRUCTION; MANAGEMENT; RESPONSES; CRITERIA	In coppice-with-standards, once a common type of management in Central European lowland forests, selected trees (standards) were left to grow mature among the regularly harvested coppice stools to obtain construction wood. After the underwood was harvested, the forest canopy opened rapidly, giving standard trees an opportunity to benefit from reduced competition. Although this silvicultural system virtually disappeared after WWII, historical management cycles can still be traced in the tree-rings of remaining standards. Our research aims at answering the question whether tree-ring series of standard trees can be used to reconstruct past management practices. The study was carried out on 117 oak standard trees from five sites situated in formerly coppiced calcareous oak-hornbeam and acidophilous oak forests in the Bohemian Karst Protected Landscape Area, Czech Republic. The evaluation was based on the analysis of growth releases representing the response of the standards to coppicing events, and comparison to the archival records of coppice events. Our results showed that coppicing events can be successfully detected by tree-ring analysis, although there are some limitations. Altogether 241 releases were identified (49% of major releases). Large number of releases could be related to historical records, with the major ones giving better results. The overall probability of correct detection (positive predictive power) was 58%, ranging from 50 to 67%, probability for major releases was 78%, ranging from 63 to 100% for different sites. The ability of individual trees to mirror past coppice events was significantly affected by competition from neighboring trees (their number and the sum of distance-weighted basal areas). A dendro-ecological approach to the study of forest management history can serve as an input for current attempts of coppice reintroduction and for conservation purposes.	[Muellerova, Jana; Pejcha, Vit; Altman, Jan; Plener, Tomas; Doerner, Petr; Dolezal, Jiri] Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic; [Muellerova, Jana] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Mullerova, J (corresponding author), Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic.	jana.mullerova@ibot.cas.cz	Altman, Jan/B-4305-2015; Mullerova, Jana/A-7915-2012	Mullerova, Jana/0000-0001-7331-3479	ERC [278065]; European Research Council; Czech Academy of Sciences [RVO 67985939]; Ministry of Education of the Czech Republic [CZ.1.07/2.3.00/20.0267]; Grant Agency of the Czech Republic [P504/12/1952, 14-12262S]	ERC(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The research leading to these results has received funding from: ERC Grant agreement no 278065, the European Research Council (http://erc.europa.eu; recipient-JM, PD); long-term research development project no. RVO 67985939, The Czech Academy of Sciences (http://www.cas.cz/; recipients-JA, JD, JM, VP, TP, PD); CZ.1.07/2.3.00/20.0267 of the Ministry of Education of the Czech Republic (http://www.msmt.cz/; recipients-JM, VP, TP, PD); P504/12/1952 and 14-12262S of the Grant Agency of the Czech Republic (https://gacr.cz/; recipients-JA, JD, VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altman J, 2014, DENDROCHRONOLOGIA, V32, P107, DOI 10.1016/j.dendro.2014.01.004; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Altman J, 2013, GLOBAL CHANGE BIOL, V19, P498, DOI 10.1111/gcb.12067; Billamboz A, 2008, DENDROCHRONOLOGIA, V26, P145, DOI 10.1016/j.dendro.2008.07.001; Black BA, 2003, ECOL APPL, V13, P1733, DOI 10.1890/02-5122; Black Bryan A., 2004, Dendrochronologia, V22, P31, DOI 10.1016/j.dendro.2004.09.004; Black BA, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008087; Bleicher N, 2014, VEG HIST ARCHAEOBOT, V23, P615, DOI 10.1007/s00334-013-0410-6; BRIDGE MC, 1986, J ECOL, V74, P1095, DOI 10.2307/2260236; Bridge MC, 2000, BOT J LINN SOC, V134, P61, DOI [10.1006/bojl.2000.0364, 10.1111/j.1095-8339.2000.tb02345.x]; Buckley G.P., 1992, ECOLOGY MANAGEMENT C; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Corcuera L, 2006, TREES-STRUCT FUNCT, V20, P91, DOI 10.1007/s00468-005-0016-4; Deforce K, 2014, QUATERN INT, P1, DOI 10.1016/j.quaint.2014.05.056; Druckenbrod DL, 2005, CAN J FOREST RES, V35, P868, DOI [10.1139/x05-020, 10.1139/X05-020]; ESRI, 2012, ARCGIS DESKT 10 1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fonti P, 2006, J VEG SCI, V17, P103, DOI 10.1658/1100-9233(2006)017[0103:TRSCDI]2.0.CO;2; Fraver S, 2005, CAN J FOREST RES, V35, P1648, DOI 10.1139/X05-092; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; Gartner H, 2010, DENDROCHRONOLOGIA, V28, P85, DOI 10.1016/j.dendro.2009.09.002; Haneca K, 2005, ANN FOREST SCI, V62, P797, DOI 10.1051/forest:2005085; Haneca K, 2009, J ARCHAEOL SCI, V36, P1, DOI 10.1016/j.jas.2008.07.005; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Knibbe B., 2008, PAST4 PERSONAL ANAL; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; Nagel TA, 2007, ANN FOREST SCI, V64, P891, DOI 10.1051/forest:2007067; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; Peterken G.F., 1996, NATURAL WOODLAND ECO; Peterken G. F, 1993, WOODLAND CONSERVATIO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rackham O, 2003, ANCIENT WOODLAND ITS; Rackham O, 2008, NEW PHYTOL, V180, P571, DOI 10.1111/j.1469-8137.2008.02579.x; Rubino Darrin L., 2004, Dendrochronologia, V21, P97, DOI 10.1078/1125.7865.00047; Samonil P, 2009, FOREST ECOL MANAG, V257, P1148, DOI 10.1016/j.foreco.2008.11.024; Sjolund MJ, 2013, FORESTRY, V86, P503, DOI 10.1093/forestry/cpt030; Szabo P, 2010, FOREST ECOL MANAG, V259, P650, DOI 10.1016/j.foreco.2009.11.026; Thompson RD, 2007, CAN J FOREST RES, V37, P1034, DOI 10.1139/X06-300; Venables WN., 2002, MODERN APPL STAT S 4; WEINER J, 1984, J ECOL, V72, P183, DOI 10.2307/2260012; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Ziaco E, 2012, FOREST ECOL MANAG, V286, P28, DOI 10.1016/j.foreco.2012.09.005; Zielonka T, 2010, J VEG SCI, V21, P31, DOI 10.1111/j.1654-1103.2009.01121.x	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147205	10.1371/journal.pone.0147205	http://dx.doi.org/10.1371/journal.pone.0147205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784583	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400123
J	Goldberg, A; Kusunose, K; Qamruddin, S; Rodriguez, LL; Mazgalev, TN; Griffin, BP; Van Wagoner, DR; Zhang, YH; Popovic, ZB				Goldberg, Adam; Kusunose, Kenya; Qamruddin, Salima; Rodriguez, L. Leonardo; Mazgalev, Todor N.; Griffin, Brian P.; Van Wagoner, David R.; Zhang, Youhua; Popovic, Zoran B.			Left Atrial Size and Function in a Canine Model of Chronic Atrial Fibrillation and Heart Failure	PLOS ONE			English	Article							VAGAL NERVE-STIMULATION; VENTRICULAR PERFORMANCE; ASSOCIATION; RESTITUTION; TRACKING; STRAIN	Background Our aim was to assess how atrial fibrillation (AF) induction, chronicity, and RR interval irregularity affect left atrial (LA) function and size in the setting of underlying heart failure (HF), and to determine whether AF effects can be mitigated by vagal nerve stimulation (VNS). Methods HF was induced by 4-weeks of rapid ventricular pacing in 24 dogs. Subsequently, AF was induced and maintained by atrial pacing at 600 bpm. Dogs were randomized into control (n = 9) and VNS (n = 15) groups. In the VNS group, atrioventricular node fat pad stimulation (310 mu s, 20 Hz, 3-7 mA) was delivered continuously for 6 months. LA volume and LA strain data were calculated from bi-weekly echocardiograms. Results RR intervals decreased with HF in both groups (p = 0.001), and decreased further during AF in control group (p = 0.014), with a non-significant increase in the VNS group during AF. LA size increased with HF (p<0.0001), with no additional increase during AF. LA strain decreased with HF (p = 0.025) and further decreased after induction of AF (p = 0.0001). LA strain decreased less (p = 0.001) in the VNS than in the control group. Beat-by-beat analysis showed a curvilinear increase of LA strain with longer preceding RR interval, (r = 0.45, p<0.0001) with LA strain 1.1% higher (p = 0.02) in the VNS-treated animals, independent of preceding RR interval duration. The curvilinear relationship between ratio of preceding and pre-preceding RR intervals, and subsequent LA strain was weaker, (r = 0.28, p = 0.001). However, VNS-treated animals again had higher LA strain (by 2.2%, p = 0.002) independently of the ratio of preceding and pre-preceding RR intervals. Conclusions In the underlying presence of pacing-induced HF, AF decreased LA strain, with little impact on LA size. LA strain depends on the preceding RR interval duration.	[Goldberg, Adam; Kusunose, Kenya; Qamruddin, Salima; Rodriguez, L. Leonardo; Griffin, Brian P.; Popovic, Zoran B.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Mazgalev, Todor N.; Van Wagoner, David R.; Zhang, Youhua] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Popovic, ZB (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.	popoviz@ccf.org	Kusunose, Kenya/AAC-9978-2021; Van Wagoner, David R/C-6783-2008	Kusunose, Kenya/0000-0002-4909-754X; Van Wagoner, David R/0000-0001-8250-9828; Goldberg, Adam/0000-0003-1547-2695; popovic, zoran/0000-0001-5692-2299	Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111314] Funding Source: NIH RePORTER	Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Atrial Fibrillation Innovation Center (AFIC), a State of Ohio Wright Center of Innovation, at the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2004, APPL LONGITUDINAL AN; Burstein B, 2009, CIRC RES, V105, P1213, DOI 10.1161/CIRCRESAHA.108.183400; Chao TS, 2000, CHEST, V117, P1546, DOI 10.1378/chest.117.6.1546; Committee on Pain and Distress in Laboratory Animal: Institute of Laboratory Animal Resources CoLS National Research Council, 1992, REC ASS PAIN STRESS, P32; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; GOSSELINK ATM, 1995, J AM COLL CARDIOL, V26, P1516, DOI 10.1016/0735-1097(95)00340-1; Imai M, 2014, RADIOLOGY, V273, P703, DOI 10.1148/radiol.14131971; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Kusunose K, 2014, JACC-CARDIOVASC IMAG, V7, P1085; Kusunose K, 2014, CIRC-HEART FAIL, V7, P320, DOI 10.1161/CIRCHEARTFAILURE.113.000937; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; MARTIN P, 1982, AM J PHYSIOL, V243, pH219, DOI 10.1152/ajpheart.1982.243.2.H219; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Miyauchi Y, 2003, CIRCULATION, V108, P360, DOI 10.1161/01.CIR.0000080327.32573.7C; Nguyen BL, 2009, HEART RHYTHM, V6, P454, DOI 10.1016/j.hrthm.2009.01.010; Popovic ZB, 2002, AM J PHYSIOL-HEART C, V283, pH2706, DOI 10.1152/ajpheart.00571.2002; Saraiva RM, 2010, J AM SOC ECHOCARDIOG, V23, P172, DOI 10.1016/j.echo.2009.11.003; Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774; SCHNEIDER J, 1983, AM J CARDIOL, V51, P1189, DOI 10.1016/0002-9149(83)90367-3; Siniaia MS, 2000, J PHYSIOL-LONDON, V523, P479, DOI 10.1111/j.1469-7793.2000.t01-1-00479.x; Stavrakis S, 2015, J AM COLL CARDIOL, V65, P867, DOI 10.1016/j.jacc.2014.12.026; Suzuki S, 1998, AM J PHYSIOL-HEART C, V275, pH1513, DOI 10.1152/ajpheart.1998.275.5.H1513; Tabata T, 2004, AM J PHYSIOL-HEART C, V286, pH145, DOI 10.1152/ajpheart.00588.2003; Tabata T, 2001, AM J PHYSIOL-HEART C, V281, pH573, DOI 10.1152/ajpheart.2001.281.2.H573; Wallick DW, 2001, AM J PHYSIOL-HEART C, V281, pH1490, DOI 10.1152/ajpheart.2001.281.4.H1490; Yuan Y, 2015, CARDIOVASC PATHOL; Zhang YH, 2013, J CARDIOVASC ELECTR, V24, P86, DOI 10.1111/j.1540-8167.2012.02405.x; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	29	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147015	10.1371/journal.pone.0147015	http://dx.doi.org/10.1371/journal.pone.0147015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771573	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300050
J	Adamowicz, J; Pokrywczynska, M; Tworkiewicz, J; Kowalczyk, T; van Breda, SV; Tyloch, D; Kloskowski, T; Bodnar, M; Skopinska-Wisniewska, J; Marszalek, A; Frontczak-Baniewicz, M; Kowalewski, TA; Drewa, T				Adamowicz, Jan; Pokrywczynska, Marta; Tworkiewicz, Jakub; Kowalczyk, Tomasz; van Breda, Shane V.; Tyloch, Dominik; Kloskowski, Tomasz; Bodnar, Magda; Skopinska-Wisniewska, Joanna; Marszalek, Andrzej; Frontczak-Baniewicz, Malgorzata; Kowalewski, Tomasz A.; Drewa, Tomasz			New Amniotic Membrane Based Biocomposite for Future Application in Reconstructive Urology	PLOS ONE			English	Article							SMOOTH-MUSCLE; URINARY-BLADDER; BUCCAL MUCOSA; CROSS-LINKING; FETAL WOUNDS; STEM-CELLS; REGENERATION; TRANSPLANTATION; MATRIX; GRAFT	Objective Due to the capacity of the amniotic membrane (Am) to support re-epithelisation and inhibit scar formation, Am has a potential to become a considerable asset for reconstructive urology i.e., reconstruction of ureters and urethrae. The application of Am in reconstructive urology is limited due to a poor mechanical characteristic. Am reinforcement with electrospun nanofibers offers a new strategy to improve Am mechanical resistance, without affecting its unique bioactivity profile. This study evaluated biocomposite material composed of Am and nanofibers as a graft for urinary bladder augmentation in a rat model. Material and Methods Sandwich-structured biocomposite material was constructed from frozen Am and covered on both sides with two-layered membranes prepared from electrospun poly-(L-lactide-co-E-caprolactone) (PLCL). Wistar rats underwent hemicystectomy and bladder augmentation with the biocomposite material. Results Immunohistohemical analysis (hematoxylin and eosin [H&E], anti-smoothelin and Masson's trichrome staining [TRI]) revealed effective regeneration of the urothelial and smooth muscle layers. Anti-smoothelin staining confirmed the presence of contractile smooth muscle within a new bladder wall. Sandwich-structured biocomposite graft material was designed to regenerate the urinary bladder wall, fulfilling the requirements for normal bladder tension, contraction, elasticity and compliance. Mechanical evaluation of regenerated bladder wall conducted based on Young's elastic modulus reflected changes in the histological remodeling of the augmented part of the bladder. The structure of the biocomposite material made it possible to deliver an intact Am to the area for regeneration. An unmodified Am surface supported regeneration of the urinary bladder wall and the PLCL membranes did not disturb the regeneration process. Conclusions Am reinforcement with electrospun nanofibers offers a new strategy to improve Am mechanical resistance without affecting its unique bioactivity profile.	[Adamowicz, Jan; Pokrywczynska, Marta; Tworkiewicz, Jakub; Tyloch, Dominik; Kloskowski, Tomasz; Drewa, Tomasz] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Dept Regenerat Med, Chair Urol, Bydgoszcz, Poland; [Adamowicz, Jan; Tyloch, Dominik; Drewa, Tomasz] Nicolaus Copernicus Univ, Dept Gen Oncol & Pediat Urol, Bydgoszcz, Poland; [Tworkiewicz, Jakub; Drewa, Tomasz] Nicolaus Copernicus Hosp Batory, Dept Urol, Torun, Poland; [Kowalczyk, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, Lab Modeling Biol & Med, Warsaw, Poland; [van Breda, Shane V.] Univ Pretoria, Dept Internal Med, Div Infect Dis, ZA-0002 Pretoria, South Africa; [Bodnar, Magda; Marszalek, Andrzej] Nicolaus Copernicus Univ, Fac Med, Dept Clin Pathomorphol, Bydgoszcz, Poland; [Skopinska-Wisniewska, Joanna] Nicolaus Copernicus Univ, Fac Chem, Dept Chem Biomat & Cosmet, Bydgoszcz, Poland; [Frontczak-Baniewicz, Malgorzata] Polish Acad Sci, Mossakowski Med Res Ctr, Electron Microscopy Platform, Warsaw, Poland; [Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Mech & Phys Fluids, Warsaw, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; University of Pretoria; Nicolaus Copernicus University; Nicolaus Copernicus University; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Adamowicz, J (corresponding author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Dept Regenerat Med, Chair Urol, Bydgoszcz, Poland.	adamowicz.jz@gmail.com	Bodnar, Magdalena/D-6131-2014; Kloskowski, Tomasz/D-4353-2014; Skopińska-Wiśniewska, Joanna/O-6445-2015; Kowalewski, Tomasz Aleksander/F-2055-2011; Kowalczyk, Tomasz/H-3872-2012; Pokrywczynska, Marta/E-9323-2014	Bodnar, Magdalena/0000-0003-3748-1058; Kloskowski, Tomasz/0000-0001-5599-9315; Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Kowalczyk, Tomasz/0000-0003-2381-4122; Skopinska-Wisniewska, Joanna/0000-0002-8566-2673; adamowicz, jan/0000-0003-2479-7133; Pokrywczynska, Marta/0000-0003-3259-087X; Drewa, Tomasz/0000-0002-5529-4320				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abrams GA, 2003, UROL RES, V31, P341, DOI 10.1007/s00240-003-0347-9; Adamowicz J, 2012, TRANSPL P, V44, P1429, DOI 10.1016/j.transproceed.2012.01.144; Adamowicz J, 2012, TRANSPL P, V44, P1439, DOI 10.1016/j.transproceed.2012.01.128; Adamowicz J, 2013, CENT EUR J UROL, V66, P202, DOI 10.5173/ceju.2013.02.art23; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Baradaran-Rafii A, 2015, CURR EYE RES, P1; Beanes S., 2001, Wound Repair and Regeneration, V9, P151; Brandt F T, 2000, Int J Surg Investig, V1, P409; Chau DYS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045011; Daher A, 2003, LAB INVEST, V83, P1333, DOI 10.1097/01.LAB.0000086380.23263.52; Davis JW, 1910, J HOPKINS MED, P15; DiSandro MJ, 1997, J UROLOGY, V158, P1058, DOI 10.1016/S0022-5347(01)64389-1; Dogru M, 2003, EYE, V17, P139, DOI 10.1038/sj.eye.6700346; Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158; Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gunes M, 2014, MED HYPOTHESES, V83, P822, DOI 10.1016/j.mehy.2014.10.018; Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687; Ho S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/676493; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057; Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]; Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184; Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103; Kesting MR, 2014, ORAL MAXILLOFAC SURG, V18, P153, DOI 10.1007/s10006-012-0382-1; Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794; Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0; Kloskowski T, 2014, PLOS ONE, P27; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Koziak A, 2007, INT J UROL, V14, P607, DOI 10.1111/j.1442-2042.2007.01781.x; Koziak Andrzej, 2004, Ann Transplant, V9, P21; Lenko J., 1955, POL TYG LEK WARS, V22, P10; Levine LA, 2007, J UROLOGY, V178, P2011, DOI 10.1016/j.juro.2007.07.034; LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011; LORENZ HP, 1995, PLAST RECONSTR SURG, V96, P1251, DOI 10.1097/00006534-199511000-00001; Mahfouz W, 2013, AFR J UROL, V19, P51, DOI 10.1016/j.afju.2013.01.006; Mamede A.C., 2012, CELL TISSUE RES, V11, P349; Master VA, 2003, J UROLOGY, V170, P1628, DOI 10.1097/01.ju.0000084407.24615.f8; Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243; MUENZER J, 1992, J INHERIT METAB DIS, V15, P25, DOI 10.1007/BF01800340; Muqit MMK, 2007, BRIT J OPHTHALMOL, V91, P1569, DOI 10.1136/bjo.2006.112029; Niknejad H, 2008, EUR CELLS MATER, V15, P88; Noszczyk BH, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015011; Nowacki M, 2014, AESTHET SURG J, V34, P1261, DOI 10.1177/1090820X14548212; Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Ockleford CD, 2013, PLACENTA, V34, P727, DOI 10.1016/j.placenta.2013.06.002; Ordorica R, 2014, J UROLOGY, V191, P1301, DOI 10.1016/j.juro.2013.11.027; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Pokrywczynska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105295; Poletajew S, 2015, IRAN J IMMUNOL, V12, P50, DOI IJIv12i1A5; Ramachandran A, 2010, AM J PATHOL, V177, P119, DOI 10.2353/ajpath.2010.090772; ROWLATT U, 1979, VIRCHOWS ARCH A, V381, P353, DOI 10.1007/BF00432477; Sartoneva R, 2012, J R SOC INTERFACE, V9, P3444, DOI 10.1098/rsif.2012.0458; Sartoneva R, 2011, J R SOC INTERFACE, V8, P671, DOI 10.1098/rsif.2010.0520; Sekar S, 2013, P I MECH ENG H, V227, P221, DOI 10.1177/0954411912472423; Shakeri S, 2009, INT UROL NEPHROL, V41, P895, DOI 10.1007/s11255-009-9532-2; Sharifiaghdas F, 2014, UROL J; Shiomi H, 2013, NEUROUROL URODYNAM, V32, P1019, DOI 10.1002/nau.22360; Spaeth Erika L, 2012, Methods Mol Biol, V904, P173, DOI 10.1007/978-1-61779-943-3_15; Spaeth EL, 2011, METHODS MOL BIOL, V750, P241, DOI 10.1007/978-1-61779-145-1_17; Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Tao HR, 2009, EUR SPINE J, V18, P1202, DOI 10.1007/s00586-009-1013-x; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Tolg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059413; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; Tuncel U, 2011, J ORAL MAXILLOFAC SU, V69, P58; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1; Wang YM, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-69; Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7; Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007; WHITBY DJ, 1991, J CELL SCI, V99, P583; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Witjes JA, 2013, EAU GUIDELINES; Wu HY, 1999, J UROLOGY, V162, P1101, DOI 10.1016/S0022-5347(01)68082-0; Yates CC, 2012, BIRTH DEFECTS RES C, V96, P325, DOI 10.1002/bdrc.21024; Zeng B, 2014, INT J OPHTHALMOL-CHI, V7, P785, DOI 10.3980/j.issn.2222-3959.2014.05.08; Zhao H, 2014, PLOS ONE; Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8	82	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146012	10.1371/journal.pone.0146012	http://dx.doi.org/10.1371/journal.pone.0146012			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766636	Green Published, gold			2022-12-27	WOS:000368459300013
J	Leung, MYM; Groes, F; Santaeulalia-Llopis, R				Leung, Man Yee Mallory; Groes, Fane; Santaeulalia-Llopis, Raul			The Relationship between Age at First Birth and Mother's Lifetime Earnings: Evidence from Danish Data	PLOS ONE			English	Article							WAGE PENALTY; FAMILY GAP; WORK; INTERRUPTIONS; EXPERIENCE; CHILDREN; CAREER; MARKET	Background Having children creates career interruptions and reductions in labor income for women. This study documents the relation between the age at first birth (AFB) and women's labor income. We study these dynamics in the short run (i.e. ratio between labor income at AFB and two years prior to AFB) and long run (i.e., positive/negative differences in total lifetime labor income). Methods Using unique Danish administrative register data for the entire Danish population, we estimate the age-income profiles separately for college and non-college women conditional on marital status, and mothers' age at first birth (AFB). We compute the lifetime labor income differentials by taking the differences between the labor income of women with and without children at each AFB. Results The short-run loss in labor income, defined as the difference in percentages between the income earned two years prior to AFB and income earned at AFB, ranges from 37% to 65% for college women and from 40% to 53% for non-college women. These losses decrease monotonically with respect to AFB for both education groups. Our results on the lifetime labor income differentials between mothers and women without children also show a net effect that is monotonic (from negative to positive) in AFB. With AFB<25, the lifetime labor income loss for college women is -204% of their average annual labor income and this figure is -252% for non-college women. There are lifetime labor income gains with AFB>31. The largest gains for college women are 13% of their average annual income and this figure is 50% for non-college women. Conclusion Women have a large and unambiguous short-run reduction in labor income at their AFB. In terms of lifetime labor income, both college and non-college women, compared to childless women, are associated with lower income of more than twice their respective average annual income when bearing a child at AFB<25. In other words, women with AFB<25 are associated with a lower lifetime income of more than two years of annual labor income. The lifetime labor incomes for college and non-college women associated with AFB>31 are relatively higher.	[Leung, Man Yee Mallory] Washington Univ, Dept Surg, Div Publ Hlth, St Louis, MO USA; [Groes, Fane] Copenhagen Business Sch, Dept Econ, Copenhagen, Denmark; [Santaeulalia-Llopis, Raul] Washington Univ, Dept Econ, St Louis, MO 63130 USA	Washington University (WUSTL); Copenhagen Business School; Washington University (WUSTL)	Leung, MYM (corresponding author), Washington Univ, Dept Surg, Div Publ Hlth, St Louis, MO USA.	leungm@wudosis.wustl.edu		Groes, Fane/0000-0001-8683-3449				Anderson DJ, 2003, IND LABOR RELAT REV, V56, P273, DOI 10.2307/3590938; Blatter M, 2012, IZA DISCUSSION PAPER; Budig MJ, 2001, AM SOCIOL REV, V66, P204, DOI 10.2307/2657415; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Ejrnaes M, 2013, SCAND J ECON, V115, P856, DOI 10.1111/sjoe.12025; Fuller S, 2008, AM SOCIOL REV, V73, P158, DOI 10.1177/000312240807300108; Glauber R, 2008, GENDER SOC, V22, P8, DOI 10.1177/0891243207311593; Gupta ND, 2002, ECONOMICA, V69, P609, DOI 10.1111/1468-0335.00303; Karimi A., 2014, 201417 I EV LAB MARK; Katz L.F., 1999, HDB LABOR EC, V3, P1463, DOI DOI 10.1016/S1573-4463(99)03007-2; KORENMAN S, 1992, J HUM RESOUR, V27, P233, DOI 10.2307/145734; Lundberg S, 2002, REV ECON STAT, V84, P251, DOI 10.1162/003465302317411514; Miller AR, 2011, J POPUL ECON, V24, P1071, DOI 10.1007/s00148-009-0296-x; Nielsen HS, 2004, SCAND J ECON, V106, P721, DOI 10.1111/j.0347-0520.2004.00385.x; Olivetti C, 2006, REV ECON DYNAM, V9, P557, DOI 10.1016/j.red.2006.06.001; Phipps S, 2001, CAN J ECON, V34, P411, DOI 10.1111/0008-4085.00081; Simonsen M, 2006, J APPL ECONOMET, V21, P919, DOI 10.1002/jae.893; Staff J, 2012, DEMOGRAPHY, V49, P1, DOI 10.1007/s13524-011-0068-6; Statistics Denmark, 2014, DAN SYST ACC MICR; Waldfogel J, 1997, AM SOCIOL REV, V62, P209, DOI 10.2307/2657300	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146989	10.1371/journal.pone.0146989	http://dx.doi.org/10.1371/journal.pone.0146989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799481	Green Published, gold			2022-12-27	WOS:000368655300051
J	Sandoval, C; Barrera, A; Ferres, M; Cerda, J; Retamal, J; Garcia-Sastre, A; Medina, RA; Hirsch, T				Sandoval, Carmen; Barrera, Aldo; Ferres, Marcela; Cerda, Jaime; Retamal, Javiera; Garcia-Sastre, Adolfo; Medina, Rafael A.; Hirsch, Tamara			Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic	PLOS ONE			English	Article							CARE WORKERS; VIRUS-INFECTION; 1ST OUTBREAK; SEROPREVALENCE; ANTIBODIES; RISK; WAVE	A novel H1N1 influenza A virus caused the first pandemic of the 21st century in 2009. Hospitals had an increased demand of health consultations, that made it difficult to estimate the incidence of infection in hospital personnel due to asymptomatic presentations and the under notification of cases. To estimate and compare the rate of exposure of high versus low risk health personnel to 2009 pandemic H1N1 (H1N1pdm2009) influenza A virus in a University Hospital in Chile, we performed a comparative and prospective study. Serum samples were obtained from 117 individuals that worked in the emergency room (ER) and the operating room (OR) during the peak of the pandemic. Antibody titers were determined by the hemagglutination inhibition (HI) assay. Of the samples analyzed, 65% were workers at the ER and 35% at the OR. Of the total number of the subjects tested, 29.1% were seropositive. One out of 3 (36.8%) workers at the ER had positive HI titers, meanwhile only 1 out of 7 (14.6%) workers from the OR was seropositive to the virus. The possibility of being infected in the ER as compared to the OR was 3.4 times greater (OR 3.4; CI 95%, 1.27-9.1), and the individuals of the ER had almost twice as much antibody titers against H1N1pdm2009 than the personnel in the OR, suggesting the potential of more than one exposure to the virus. Of the 34 seropositive subjects, 12 (35.3%) did not develop influenza like illness, including 2 non-clinical personnel involved in direct contact with patients at the ER. Considering the estimated population attack rate in Chile of 13%, both groups presented a higher exposure and seropositive rate than the general population, with ER personnel showing greater risk of infection and a significantly higher level of antibodies. This data provide a strong rationale to design improved control measures aimed at all the hospital personnel, including those coming into contact with the patients prior to triage, to prevent the propagation and transmission of respiratory viruses, particularly during a pandemic outbreak.	[Sandoval, Carmen; Ferres, Marcela; Cerda, Jaime; Retamal, Javiera; Medina, Rafael A.] Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas & Inmul Pediat, Alameda 340, Santiago, Chile; [Barrera, Aldo; Ferres, Marcela; Medina, Rafael A.] Pontificia Univ Catolica Chile, Escuela Med, Lab Infect Dis & Mol Virol, Ctr Invest Med, Alameda 340, Santiago, Chile; [Cerda, Jaime] Pontificia Univ Catolica Chile, Dept Publ Hlth, Alameda 340, Santiago, Chile; [Garcia-Sastre, Adolfo; Medina, Rafael A.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Medina, Rafael A.] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Medina, Rafael A.] Pontificia Univ Catolica Chile, Inst Milenio Inmunol & Inmunoterapia, Alameda 340, Santiago, Chile; [Hirsch, Tamara] Pontificia Univ Catolica Chile, Escuela Med, Hosp Clin, Alameda 340, Santiago, Chile; [Hirsch, Tamara] Pontificia Univ Catolica Chile, Escuela Med, Div Pediat, Dept Pediat, Alameda 340, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Medina, RA (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas & Inmul Pediat, Alameda 340, Santiago, Chile.; Medina, RA (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Lab Infect Dis & Mol Virol, Ctr Invest Med, Alameda 340, Santiago, Chile.; Medina, RA (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Medina, RA (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Medina, RA (corresponding author), Pontificia Univ Catolica Chile, Inst Milenio Inmunol & Inmunoterapia, Alameda 340, Santiago, Chile.; Hirsch, T (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Hosp Clin, Alameda 340, Santiago, Chile.; Hirsch, T (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Div Pediat, Dept Pediat, Alameda 340, Santiago, Chile.	rmedinas@med.puc.cl; thirschbirn@gmail.com	Medina, Rafael A./AAW-4418-2020	Medina, Rafael A./0000-0002-5013-6884; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Center for Research in Influenza Pathogenesis (CRIP), a NIAID [HHSN266200700010C]; NIAID [U19AI089987]; CONICYT Insertion of Human Capital to the Academy [79100014]; Fondecyt [1121172]; Program Iniciativa Cientifica Milenio from the Chilean Ministry of Economy, Development and Tourism [P09/016-F]; grant Puente UC [1/2015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987] Funding Source: NIH RePORTER	Center for Research in Influenza Pathogenesis (CRIP), a NIAID; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CONICYT Insertion of Human Capital to the Academy; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Program Iniciativa Cientifica Milenio from the Chilean Ministry of Economy, Development and Tourism; grant Puente UC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partly funded by the Center for Research in Influenza Pathogenesis (CRIP), a NIAID funded Center of Excellence in Influenza Research and Surveillance (CEIRS, contract number HHSN266200700010C) to AG-S and RAM, and by the NIAID funded Human Immunology Project Consortium (HIPC), grant number U19AI089987 to AG-S. RAM was also supported by a CONICYT Insertion of Human Capital to the Academy grant (79100014), a Fondecyt grant (1121172), by the Program Iniciativa Cientifica Milenio from the Chilean Ministry of Economy, Development and Tourism grant P09/016-F, and by the grant Puente UC 2015, No 1/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagappan K, 2013, EMERG INFECT DIS, V19, P140, DOI 10.3201/eid1901.111640; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Carlson AL, 2010, CURR OPIN INFECT DIS, V23, P293, DOI 10.1097/QCO.0b013e32833bb804; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; Chokephaibulkit K, 2013, INFLUENZA OTHER RESP, V7, P359, DOI 10.1111/irv.12016; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Kumar S, 2011, PEDIATR EMERG CARE, V27, P804, DOI 10.1097/PEC.0b013e31822c125e; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Marshall C, 2011, EMERG INFECT DIS, V17, P1000, DOI [10.3201/eid1706.101030, 10.3201/eid/1706.101030]; Medina RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005996; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Network WGIS, 2012, MAN LAB DIAGN VIR SU; Nukui Y, 2012, INFECT CONT HOSP EP, V33, P58, DOI 10.1086/663208; Olalla J, 2012, ENFERM INFEC MICR CL, V30, P371, DOI 10.1016/j.eimc.2011.11.019; Perret C, 2010, REV CHIL INFECTOL, V27, P144, DOI /S0716-10182010000200008; Poalillo FE, 2010, CRIT CARE MED, V38, pE98, DOI 10.1097/CCM.0b013e3181d41d45; Smith K, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/407505; Toyokawa T, 2011, J INFECTION, V63, P281, DOI 10.1016/j.jinf.2011.05.001; Wise ME, 2011, CLIN INFECT DIS O S1, V52, pS198, DOI [10.1093/cid/ciq038, DOI 10.1093/CID/CIQ038PMID:21342895]; Yen TY, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-89; Zhou Y, 2011, J HOSP INFECT, V78, P308, DOI 10.1016/j.jhin.2011.02.017; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	24	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147271	10.1371/journal.pone.0147271	http://dx.doi.org/10.1371/journal.pone.0147271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799564	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300084
J	Langford-Smith, A; Tilakaratna, V; Lythgoe, PR; Clark, SJ; Bishop, PN; Day, AJ				Langford-Smith, Alex; Tilakaratna, Viranga; Lythgoe, Paul R.; Clark, Simon J.; Bishop, Paul N.; Day, Anthony J.			Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract Formation	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; HEPARAN-SULFATE; TRACE-ELEMENTS; CADMIUM ACCUMULATION; OXIDATIVE DAMAGE; COPPER; ZINC; SELENIUM; LEAD; TOXICITY	Age-related cataract formation is the primary cause of blindness worldwide and although treatable by surgical removal of the lens the majority of sufferers have neither the finances nor access to the medical facilities required. Therefore, a better understanding of the pathogenesis of cataract may identify new therapeutic targets to prevent or slow its progression. Cataract incidence is strongly correlated with age and cigarette smoking, factors that are often associated with accumulation of metal ions in other tissues. Therefore this study evaluated the age-related changes in 14 metal ions in 32 post mortem human lenses without known cataract from donors of 11 to 82 years of age by inductively coupled plasma mass spectrometry; smoking-related changes in 10 smokers verses 14 non-smokers were also analysed. A significant age-related increase in selenium and decrease in copper ions was observed for the first time in the lens tissue, where cadmium ion levels were also increased as has been seen previously. Aluminium and vanadium ions were found to be increased in smokers compared to non-smokers (an analysis that has only been carried out before in lenses with cataract). These changes in metal ions, i.e. that occur as a consequence of normal ageing and of smoking, could contribute to cataract formation via induction of oxidative stress pathways, modulation of extracellular matrix structure/function and cellular toxicity. Thus, this study has identified novel changes in metal ions in human lens that could potentially drive the pathology of cataract formation.	[Langford-Smith, Alex; Tilakaratna, Viranga; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Lythgoe, Paul R.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Lythgoe, Paul R.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Univ Manchester, Inst Human Dev, Ctr Ophthalmol & Vis Sci, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Univ Manchester, Ctr Adv Discovery & Expt Therapeut, Manchester, Lancs, England; [Clark, Simon J.; Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bishop, Paul N.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; University of Manchester	Langford-Smith, A; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	alexander.langford-smith@manchester.ac.uk; anthony.day@manchester.ac.uk	Day, Anthony/O-1658-2015; Langford-Smith, Alex/K-7624-2017	Day, Anthony/0000-0002-1415-3134; Langford-Smith, Alex/0000-0001-7006-0592; Bishop, Paul/0000-0001-7937-7932; Clark, Simon/0000-0001-8394-8355	Medical Research Council UK [K004441]; MRC [MR/K004441/1, MR/K024418/1] Funding Source: UKRI; Medical Research Council [MR/K004441/1, MR/K024418/1] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge funding from the Medical Research Council UK (http://www.mrc.ac.uk/), grant number K004441 (SJC, PNB, and AJD). The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], 2013, CHEM COMPONENTS TOBA, P1067; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bernhard D, 2006, ARTERIOSCL THROM VAS, V26, P833, DOI 10.1161/01.ATV.0000205616.70614.e5; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; BROWN NAP, 1987, EYE-T OPHTH SOC UK, V1, P234, DOI 10.1038/eye.1987.43; Buratti M, 1986, Med Lav, V77, P208; Cardoso BR, 2015, METALLOMICS, V7, P1213, DOI 10.1039/c5mt00075k; Cekic O, 1998, BRIT J OPHTHALMOL, V82, P186, DOI 10.1136/bjo.82.2.186; Cekic O, 1998, OPHTHALMIC RES, V30, P49, DOI 10.1159/000055454; Cekic O, 1999, OPHTHALMIC RES, V31, P332, DOI 10.1159/000055555; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Choudhury S, 2015, ENVIRON SCI TECHNOL, V49, P2255, DOI 10.1021/es503848s; Christen WG, 2015, JAMA OPHTHALMOL, V133, P17, DOI 10.1001/jamaophthalmol.2014.3478; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dadoukis P, 2013, GRAEF ARCH CLIN EXP, V251, P1929, DOI 10.1007/s00417-013-2349-9; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Fuchs B, 2014, ANTIOXID REDOX SIGN, V21, P1044, DOI 10.1089/ars.2013.5634; Fujiwara Y, 2002, TOXICOLOGY, V170, P89, DOI 10.1016/S0300-483X(01)00538-8; Haddad HH, 2012, J ANAL CHEM+, V03, P4, DOI [10.4236/ajac.2012.310094, DOI 10.4236/AJAC.2012.310094]; Haddad NS, 2012, J ANAL CHEM+, V03, P4, DOI [10.4236/ajac.2012.37065, DOI 10.4236/AJAC.2012.37065]; Hosseini MJ, 2013, METALLOMICS, V5, P152, DOI 10.1039/c2mt20198d; Hou XL, 1996, BIOL TRACE ELEM RES, V55, P89, DOI 10.1007/BF02784171; Imtiaz Ahmad AA, 2014, JOURNAL OF ENVIRONME, V05, DOI [10.4172/2161-0525.1000252, DOI 10.4172/2161-0525.1000252]; Junemann AGM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056734; KAJI T, 1994, TOXICOLOGY, V94, P161; Kalariya NM, 2010, TOXICOL LETT, V198, P56, DOI 10.1016/j.toxlet.2010.04.021; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; KARAKUCUK S, 1995, ACTA OPHTHALMOL SCAN, V73, P329; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Keenan TDL, 2014, INVEST OPHTH VIS SCI, V55, P5370, DOI 10.1167/iovs.14-14126; Kennett EC, 2011, BIOCHEM SOC T, V39, P1279, DOI 10.1042/BST0391279; Kim MH, 2016, J EXPO SCI ENV EPID, V26, P214, DOI 10.1038/jes.2014.75; Kim YJ, 2010, ORAL DIS, V16, P823, DOI 10.1111/j.1601-0825.2010.01698.x; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Kocyigit A, 2001, CLIN BIOCHEM, V34, P629, DOI 10.1016/S0009-9120(01)00271-5; Konz I, 2014, ANAL BIOANAL CHEM, V406, P2343, DOI 10.1007/s00216-014-7617-y; Langford-Smith A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00025; Langford-Smith A, 2014, J INNATE IMMUN, V6, P407, DOI 10.1159/000356513; Lim JC, 2013, EXP EYE RES, V116, P219, DOI 10.1016/j.exer.2013.09.002; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; LYDAHL E, 1984, ACTA OPHTHALMOL, P1; Manikandan R, 2009, CHEM-BIOL INTERACT, V181, P202, DOI 10.1016/j.cbi.2009.05.011; McCarty CA, 1999, BRIT J OPHTHALMOL, V83, P62, DOI 10.1136/bjo.83.1.62; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Misra S, 2010, METALLOMICS, V2, P710, DOI 10.1039/c0mt00008f; Mosad SM, 2010, CURR EYE RES, V35, P23, DOI 10.3109/02713680903362880; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nair AR, 2013, INT J MOL SCI, V14, P6116, DOI 10.3390/ijms14036116; Padmaja S., 2004, Indian Journal of Experimental Biology, V42, P601; Park DU, 2014, ENVIRON MONIT ASSESS, V186, P5209, DOI 10.1007/s10661-014-3770-1; Park SS, 2011, ANAL BIOCHEM, V409, P81, DOI 10.1016/j.ab.2010.10.003; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Rajkumar S, 2013, INVEST OPHTH VIS SCI, V54, P6224, DOI 10.1167/iovs.13-11935; RAMAKRISHNAN S, 1995, BRIT J OPHTHALMOL, V79, P202, DOI 10.1136/bjo.79.3.202; Ramos P, 2014, BIOL TRACE ELEM RES, V161, P190, DOI 10.1007/s12011-014-0093-6; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rembach A., 2013, INT J ALZHEIMERS DIS, V2013; Remko M, 2013, RSC ADV, V3, P9843, DOI 10.1039/c3ra40566d; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Ruiperez F, 2012, J INORG BIOCHEM, V117, P118, DOI 10.1016/j.jinorgbio.2012.09.008; Sabrina K, 2011, 2 NAT HLTH PROM C NH; Saffari A, 2014, ENVIRON SCI-PROC IMP, V16, P2259, DOI 10.1039/c4em00415a; Seo YJ, 2011, INT J MASS SPECTROM, V303, P191, DOI 10.1016/j.ijms.2011.02.003; Shukla N, 1996, SCI TOTAL ENVIRON, V181, P161, DOI 10.1016/0048-9697(95)05006-X; Simmons Steven O, 2011, Curr Chem Genomics, V5, P1, DOI 10.2174/1875397301105010001; Song NH, 2012, MOL VIS, V18, P983; SRIVASTAVA VK, 1992, ACTA OPHTHALMOL, V70, P839; Sulochana K. N., 2002, Indian Journal of Pharmacology, V34, P428; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tyler G., 1995, ICP OPT EMISS SPECTR, V5; Ugarte M, 2013, SURV OPHTHALMOL, V58, P585, DOI 10.1016/j.survophthal.2012.12.002; Ugarte M, 2012, METALLOMICS, V4, P1245, DOI 10.1039/c2mt20157g; Umapathy A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/207250; Unkiewicz-Winiarczyk A, 2009, BIOL TRACE ELEM RES, V132, P41, DOI 10.1007/s12011-009-8390-1; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Watts DL, 1994, J ORTHOMOLECULAR MED, V9, P111; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; Wills NK, 2008, EXP EYE RES, V87, P80, DOI 10.1016/j.exer.2008.04.013; Ye J, 2012, INVEST OPHTH VIS SCI, V53, P3885, DOI 10.1167/iovs.12-9820; Zhang M, 2011, J TOXICOL ENV HEAL A, V74, P380, DOI 10.1080/15287394.2011.538835; Zhang SP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-100; Zhao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083060	85	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147576	10.1371/journal.pone.0147576	http://dx.doi.org/10.1371/journal.pone.0147576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794210	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300040
J	Wang, YR; Jiang, LK; Liu, QY; Yin, MH				Wang, Yuru; Jiang, Longkui; Liu, Qiaoyuan; Yin, Minghao			Optimal Appearance Model for Visual Tracking	PLOS ONE			English	Article							FUSING MULTIPLE CUES; OBJECT TRACKING; COLOR	Many studies argue that integrating multiple cues in an adaptive way increases tracking performance. However, what is the definition of adaptiveness and how to realize it remains an open issue. On the premise that the model with optimal discriminative ability is also optimal for tracking the target, this work realizes adaptiveness and robustness through the optimization of multi-cue integration models. Specifically, based on prior knowledge and current observation, a set of discrete samples are generated to approximate the foreground and background distribution. With the goal of optimizing the classification margin, an objective function is defined, and the appearance model is optimized by introducing optimization algorithms. The proposed optimized appearance model framework is embedded into a particle filter for a field test, and it is demonstrated to be robust against various kinds of complex tracking conditions. This model is general and can be easily extended to other parameterized multi-cue models.	[Wang, Yuru; Liu, Qiaoyuan; Yin, Minghao] North East Normal Univ, Comp Sci & Informat Technol, Changchun, Jilin Province, Peoples R China; [Jiang, Longkui] Jilin Business & Technol Coll, Sch Informat Engn, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China; Jilin Business & Technology College	Wang, YR; Yin, MH (corresponding author), North East Normal Univ, Comp Sci & Informat Technol, Changchun, Jilin Province, Peoples R China.	wangyr915@nenu.edu.cn; ymh@nenu.edu.cn			National Natural Science Foundation of China [61300099, 61403077]; Science and Technology Development Project of Jilin Province [201201069]; China Postdoctoral Science Foundation [2015M570261]; Natural Science Foundation of Jilin Province [20140101179JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Jilin Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jilin Province	This work was supported by the National Natural Science Foundation of China under Grant No. 61300099 (http://www.nsfc.gov.cn/, Yuru Wang is the project leader); the Science and Technology Development Project of Jilin Province under Grant No. 201201069 (http://kjt.jl.gov.cn/kjt/4/tindex.shtml, Yuru Wang is the project leader); the China Postdoctoral Science Foundation funded project under Grant No. 2015M570261 (http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx, Yuru Wang is the project leader); the National Natural Science Foundation of China under Grant No. 61403077 (http://www.nsfc.gov.cn/); and the Natural Science Foundation of Jilin Province under grant No. 20140101179JC (http://kjt.jl.gov.cn/kjt/4/tindex.shtml).	Bai Q., 2013, PROC IEEE INTERNATIO; Birchfield S, 1998, PROC CVPR IEEE, P232, DOI 10.1109/CVPR.1998.698614; Brasnett P, 2007, IMAGE VISION COMPUT, V25, P1217, DOI 10.1016/j.imavis.2006.07.017; Collins RT, 2005, IEEE T PATTERN ANAL, V27, P1631, DOI 10.1109/TPAMI.2005.205; Erdem E, 2012, COMPUT VIS IMAGE UND, V116, P827, DOI 10.1016/j.cviu.2012.03.005; Erdem E, 2012, PATTERN RECOGN, V45, P1948, DOI 10.1016/j.patcog.2011.10.028; Everingham M., 2011, THE PASCAL VISUAL BJ; Gao W, 2013, ARTIF INTELL, V199, P22, DOI 10.1016/j.artint.2013.03.001; Gavrila DM, 2007, INT J COMPUT VISION, V73, P41, DOI 10.1007/s11263-006-9038-7; Huang HT, 2015, PATTERN RECOGN LETT, V56, P52, DOI 10.1016/j.patrec.2015.01.014; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Karaboga D., 2010, SCHOLARPEDIA, V5, P6915, DOI [DOI 10.4249/SCHOLARPEDIA.6915, 10.4249/scholarpedia.6915, DOI 10.4249/SCH0LARPEDIA.6915]; Khanloo BYS, 2012, COMPUT VIS IMAGE UND, V116, P676, DOI 10.1016/j.cviu.2012.01.004; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Lu H, 2015, OPTIK, V126, P148, DOI 10.1016/j.ijleo.2014.08.157; Maggio E., 2005, BRIT MACH VIS C, P659; NejhumShahed S. M., 2008, IEEE C COMP VIS PATT, P1; Nickel K, 2008, LECT NOTES COMPUT SC, V5305, P514, DOI 10.1007/978-3-540-88693-8_38; Perez P, 2004, P IEEE, V92, P495, DOI 10.1109/JPROC.2003.823147; Triesch J, 2001, NEURAL COMPUT, V13, P2049, DOI 10.1162/089976601750399308; Wang YR, 2012, PATTERN RECOGN, V45, P4510, DOI 10.1016/j.patcog.2012.05.010; Yang CJ, 2005, IEEE I CONF COMP VIS, P212; Zoidi O, 2014, SIGNAL PROCESS-IMAGE, V29, P573, DOI 10.1016/j.image.2014.03.004	23	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146763	10.1371/journal.pone.0146763	http://dx.doi.org/10.1371/journal.pone.0146763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789639	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100040
J	Wu, YY; Yang, XH; Yang, YF				Wu, Yingying; Yang, Xiaohong; Yang, Yufang			Eye Movement Evidence for Hierarchy Effects on Memory Representation of Discourses	PLOS ONE			English	Article							RHETORICAL STRUCTURE; LINGUISTIC FOCUS; INFORMATION; FIXATIONS; ATTENTION; SENTENCES; CHINESE; SCENES; DEPTH	In this study, we applied the text-change paradigm to investigate whether and how discourse hierarchy affected the memory representation of a discourse. Three kinds of three-sentence discourses were constructed. In the hierarchy-high condition and the hierarchy-low condition, the three sentences of the discourses were hierarchically organized and the last sentence of each discourse was located at the high level and the low level of the discourse hierarchy, respectively. In the linear condition, the three sentences of the discourses were linearly organized. Critical words were always located at the last sentence of the discourses. These discourses were successively presented twice and the critical words were changed to semantically related words in the second presentation. The results showed that during the early processing stage, the critical words were read for longer times when they were changed in the hierarchy-high and the linear conditions, but not in the hierarchy-low condition. During the late processing stage, the changed-critical words were again found to induce longer reading times only when they were in the hierarchy-high condition. These results suggest that words in a discourse have better memory representation when they are located at the higher rather than at the lower level of the discourse hierarchy. Global discourse hierarchy is established as an important factor in constructing the mental representation of a discourse.	[Wu, Yingying; Yang, Xiaohong; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wu, Yingying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, XH; Yang, YF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	yangxh@psych.ac.cn; yangyf@psych.ac.cn			National Natural Science Foundation of China [61433018, 31400968]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to YY (61433018) and XY (31400968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER L, 1987, MEM COGNITION, V15, P247, DOI 10.3758/BF03197723; Birch S, 2010, MEM COGNITION, V38, P740, DOI 10.3758/MC.38.6.740; Chomsky N., 1957, SYNTACTIC STRUCTURES; Cooreman A., 1996, FOCUS SYNTACTIC SUBO; de Villiers PA, 1974, J EXP PSYCHOL, V103, P263; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; GIVON T, 1992, LINGUISTICS, V30, P5, DOI 10.1515/ling.1992.30.1.5; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; INHOFF AW, 1984, J VERB LEARN VERB BE, V23, P612, DOI 10.1016/S0022-5371(84)90382-7; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1282, DOI 10.1016/j.neuropsychologia.2009.01.013; Johnson RL, 2009, J EXP PSYCHOL LEARN, V35, P943, DOI 10.1037/a0015572; KINTSCH W, 1973, COGNITIVE PSYCHOL, V5, P257, DOI 10.1016/0010-0285(73)90036-4; Kintsch W., 1992, LEARNING PROCESSES C, V2, P261; Klin CM, 2004, MEM COGNITION, V32, P511, DOI 10.3758/BF03195843; LIMA SD, 1985, J EXP PSYCHOL HUMAN, V11, P272, DOI 10.1037/0096-1523.11.3.272; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Mann W., 1988, TEXT, V8, P243; MORROW DG, 1985, J MEM LANG, V24, P304, DOI 10.1016/0749-596X(85)90030-0; Munte TF, 1997, NEUROSCI LETT, V235, P105, DOI 10.1016/S0304-3940(97)00719-2; Ouden Hd, 2009, SPEECH COMMUN, V51, P116; RANEY GE, 1995, CAN J EXP PSYCHOL, V49, P151, DOI 10.1037/1196-1961.49.2.151; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Sanford AJ, 2002, MIND LANG, V17, P188, DOI 10.1111/1468-0017.00195; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Sturt P, 2004, PSYCHON B REV, V11, P882, DOI 10.3758/BF03196716; Taboada M, 2006, DISCOURSE STUD, V8, P423, DOI 10.1177/1461445606061881; TOWNSEND DJ, 1978, J VERB LEARN VERB BE, V17, P509, DOI 10.1016/S0022-5371(78)90304-3; Ward P, 2007, MEM COGNITION, V35, P73, DOI 10.3758/BF03195944; Yang XH, 2014, MEM COGNITION, V42, P325, DOI 10.3758/s13421-013-0363-0; Yang XH, 2012, IEEE T AUDIO SPEECH, V20, P1196, DOI 10.1109/TASL.2011.2173676	32	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147313	10.1371/journal.pone.0147313	http://dx.doi.org/10.1371/journal.pone.0147313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26789002	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100077
J	Zhang, YM; Pan, Y; Bian, ZX; Chen, PH; Zhu, SJ; Gu, HY; Guo, LP; Hu, C				Zhang, Yumei; Pan, Yu; Bian, Zhixiang; Chen, Peihua; Zhu, Shijian; Gu, Huiyi; Guo, Liping; Hu, Chun			Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages	PLOS ONE			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; TUBULAR EPITHELIAL-CELLS; NEUROBLASTOMA-CELLS; IN-VIVO; ANGIOTENSIN; DEATH; SPHINGOLIPIDS; METABOLISM; RECEPTOR; DISEASE	Here, we studied the underlying mechanism of aldosterone (Aldo)-induced vascular endothelial cell damages by focusing on ceramide. We confirmed that Aldo (at nmol/L) inhibited human umbilical vein endothelial cells (HUVEC) survival, and induced considerable cell apoptosis. We propose that ceramide (mainly C18) production might be responsible for Aldo-mediated damages in HUVECs. Sphingosine-1-phosphate (S1P), an anti-ceramide lipid, attenuated Aldo-induced ceramide production and following HUVEC damages. On the other hand, the glucosylceramide synthase (GCS) inhibitor PDMP or the ceramide (C6) potentiated Aldo-induced HUVEC apoptosis. Eplerenone, a mineralocorticoid receptor (MR) antagonist, almost completely blocked Aldo-induced C18 ceramide production and HUVEC damages. Molecularly, ceramide synthase 1 (CerS-1) is required for C18 ceramide production by Aldo. Knockdown of CerS-1 by targeted-shRNA inhibited Aldo-induced C18 ceramide production, and protected HUVECs from Aldo. Reversely, CerS-1 overexpression facilitated Aldo-induced C18 ceramide production, and potentiated HUVEC damages. Together, these results suggest that C18 ceramide production mediates Aldo-mediated HUVEC damages. MR and CerS-1 could be the two signaling molecule regulating C18 ceramide production by Aldo.	[Zhang, Yumei; Pan, Yu; Bian, Zhixiang; Chen, Peihua; Zhu, Shijian; Gu, Huiyi; Guo, Liping; Hu, Chun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Div Nephrol, Shanghai 201999, Peoples R China	Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Div Nephrol, Shanghai 201999, Peoples R China.	huchunjiuyuan@163.com			Science Fund Project of Shanghai Jiaotong University School of Medicine [13XJ10056]; Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning [201440331]	Science Fund Project of Shanghai Jiaotong University School of Medicine; Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning	This study was funded by Science Fund Project of Shanghai Jiaotong University School of Medicine (no. 13XJ10056, to CH) and Science Research Tasks of Shanghai Municipal Commission of Health and Family Planning (201440331, to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babia T, 1998, EUR J BIOCHEM, V258, P233, DOI 10.1046/j.1432-1327.1998.2580233.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Calhoun DA, 2006, CIRCULATION, V114, P2572, DOI 10.1161/CIRCULATIONAHA.106.668715; Chun TY, 2004, TRENDS ENDOCRIN MET, V15, P353, DOI 10.1016/j.tem.2004.08.002; Di Raimondo D, 2012, CURR PHARM DESIGN, V18, P4385, DOI 10.2174/138161212802481282; Dijkhuis AJ, 2006, MOL CANCER THER, V5, P593, DOI 10.1158/1535-7163.MCT-05-0457; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Edmonds Y, 2011, PHARMACOL THERAPEUT, V132, P352, DOI 10.1016/j.pharmthera.2011.08.004; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Farquharson CAJ, 2002, CLIN SCI, V103, P425, DOI 10.1042/cs1030425; Gong L, 2014, CANCER CHEMOTH PHARM, V73, P69, DOI 10.1007/s00280-013-2318-3; Hashikabe Y, 2006, J CARDIOVASC PHARM, V47, P609, DOI 10.1097/01.fjc.0000211738.63207.c3; Hillaert MA, 2011, AM HEART J, V162, P585, DOI 10.1016/j.ahj.2011.06.015; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Huo HZ, 2014, BIOCHEM BIOPH RES CO, V443, P406, DOI 10.1016/j.bbrc.2013.11.099; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Lai LY, 2007, LIFE SCI, V81, P570, DOI 10.1016/j.lfs.2007.06.025; LARAGH JH, 1972, AM J MED, V52, P633, DOI 10.1016/0002-9343(72)90054-X; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Lu JP, 2014, J HUAZHONG U SCI-MED, V34, P821, DOI 10.1007/s11596-014-1359-0; Luo Yang, 2006, Zhonghua Yi Xue Za Zhi, V86, P3133; Maron BA, 2012, CIRCULATION, V126, P963, DOI 10.1161/CIRCULATIONAHA.112.094722; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Myrick D, 1999, LEUKEMIA RES, V23, P569, DOI 10.1016/S0145-2126(99)00048-X; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Palmer BR, 2008, EUR HEART J, V29, P2489, DOI 10.1093/eurheartj/ehn383; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Qiao WW, 2015, MOL MED REP, V12, P1631, DOI 10.3892/mmr.2015.3596; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Sietsma H, 2000, CLIN CANCER RES, V6, P942; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Toda N, 2013, BRIT J PHARMACOL, V168, P519, DOI 10.1111/j.1476-5381.2012.02194.x; Tomaschitz A, 2010, EUR HEART J, V31, P1237, DOI 10.1093/eurheartj/ehq019; Vantrimpont P, 1998, EUR HEART J, V19, P1552, DOI 10.1053/euhj.1998.1093; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Yao C, 2012, CELL BIOCH BIOPHYS; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Yu T, 2012, MOL CELL BIOCHEM, V361, P47, DOI 10.1007/s11010-011-1086-9; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zecevic A, 2009, CELL CYCLE, V8, P2769, DOI 10.4161/cc.8.17.9410	48	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146944	10.1371/journal.pone.0146944	http://dx.doi.org/10.1371/journal.pone.0146944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788916	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100048
J	Zhang, Z; Liu, SY; Wei, JF; Xu, JL; Guo, WQ; Bao, WJ; Jiang, ZL				Zhang, Zhen; Liu, Shiyin; Wei, Junfeng; Xu, Junli; Guo, Wanqin; Bao, Weijia; Jiang, Zongli			Mass Change of Glaciers in Muztag Ata-Kongur Tagh, Eastern Pamir, China from 1971/76 to 2013/14 as Derived from Remote Sensing Data	PLOS ONE			English	Article							TIBETAN PLATEAU; ASTER GDEM; SRTM; MOUNTAINS; VOLUME; STEREO; INVENTORY; ACCURACY; BASIN; SHAN	The assessment of glacier mass budget is crucial for assessing water reserves stored in glaciers. Derived glacier mass changes in the Muztag Ata and Kongur Tagh (MAKT) region in the eastern Pamir, northwestern China, is helpful in improving our knowledge of the dynamics of glaciers under a changing climate in High Mountain Asia. Here, glacier area and mass changes derived from remote sensing data are investigated for the period 1971/76-2013/14 for glaciers in MAKT. We have used ASTER images (2013/14), Cartosat-1 (2014) and Landsat, SRTM (Shuttle Radar Terrain Mission) digital elevation model (DEM) (2000), topographic maps (1971/76) and the first and second Chinese glacier inventories (CGIs). Our results indicated that the glacier area of MAKT decreased from 1018.3 +/- 12.99 km(2) in 1971/76 to 999.2 +/- 31.22 km(2) in 2014 (-1.9 +/- 0.2%). Weak area shrinkage of glaciers by 2.5 +/- 0.5 km(2) (0.2 +/- 0.1%) happened after 2000 and the period 2009-2014 even saw a slight expansion by 0.5 +/- 0.1 km(2) (0.1 +/- 0.0%). The glaciers in this region have experienced an overall loss of -6.99 +/- 0.80 km(3) in ice volume or -0.15 +/- 0.12 m water equivalent (w.e.) a(-1) from 1971/76 to 2013/14. The mass budget of MAKT was -0.19 +/- 0.19 m w.e. a(-1) for the period similar to 1971/76-1999 and -0.14 +/- 0.24 m w.e. a(-1) during 1999-2013/2014. Similar to previous studies, there has been little mass change in the Pamir over recent decades despite such uncertainties. Glacier mass change showed spatial and temporal heterogeneity, with strong mass loss on debris-covered glaciers with an average of -0.32 +/- 0.12 m w.e. a(-1) from the 1970s to 2013/14.	[Zhang, Zhen; Liu, Shiyin; Xu, Junli; Guo, Wanqin; Bao, Weijia; Jiang, Zongli] Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Zhang, Zhen; Xu, Junli; Bao, Weijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wei, Junfeng] Hunan Univ Sci & Technol, Sch Architecture & Urban Planning, Xiangtan, Hunan, Peoples R China; [Jiang, Zongli] Hunan Univ Sci & Technol, Hunan Prov Key Lab Coal Resources Clean Utilizat, Xiangtan, Hunan, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan University of Science & Technology; Hunan University of Science & Technology	Liu, SY (corresponding author), Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China.	liusy@lzb.ac.cn	Liu, Shiyin/AAT-4278-2020; Wei, Junfeng/G-5694-2014; Guo, Wanqin/E-7553-2015	Guo, Wanqin/0000-0002-3211-9300; zhang, zhen/0000-0002-2160-8619	fundamental program from the Ministry of Science and Technology of China (MOST) [2013FY111400]; Key Research Program of Chinese Academy of Sciences [KZZD-EW-12-1]; National Natural Science Foundation of China [41190084, 41471067]; MOST [2006FY110200]; Chinese Academy of Sciences [kzcx2-yw-301]	fundamental program from the Ministry of Science and Technology of China (MOST); Key Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the fundamental program from the Ministry of Science and Technology of China (MOST) (Grant No. 2013FY111400), the Key Research Program of Chinese Academy of Sciences (KZZD-EW-12-1), and the National Natural Science Foundation of China (Grant No. 41190084 and 41471067).; The authors thank the anonymous reviewers for their constructive comments. The glacier inventory data was provided by "Investigation on glacier resources and their change in China" of the MOST (Grant No. 2006FY110200) and "Glacier change monitoring and its impact assessment research in west China" of Chinese Academy of Sciences (Grant No. kzcx2-yw-301) (http://westdc.westgis.ac.cn/glacier, accessed on 7.21.2015). We also thank USGS and NASA for satellite images.	[Anonymous], 2008, GBT1235312008; Bao WJ, 2015, J MT SCI-ENGL, V12, P344, DOI 10.1007/s11629-014-3220-0; Berthier E, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025862; Berthier E, 2005, REMOTE SENS ENVIRON, V95, P14, DOI 10.1016/j.rse.2004.11.005; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Bhambri R, 2013, CRYOSPHERE, V7, P1385, DOI 10.5194/tc-7-1385-2013; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Bolch T, 2010, REMOTE SENS ENVIRON, V114, P127, DOI 10.1016/j.rse.2009.08.015; Brahmbhatt R.M., 2015, CRYOSPHERE DISCUSS, V9, P1555, DOI DOI 10.5194/TCD-9-1555-2015; Braithwaite RJ, 2009, ANN GLACIOL, V50, P127, DOI 10.3189/172756410790595930; [蔡迪花 CAI Dihua], 2006, [兰州大学学报. 自然科学版, Journal of Lanzhou University. Natural Science], V42, P13; Duan KQ, 2015, J HYDROL, V531, P912, DOI 10.1016/j.jhydrol.2015.10.013; [段克勤 DUAN Keqin], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P680; Farajzadeh M, 2014, J MT SCI-ENGL, V11, P215, DOI 10.1007/s11629-013-2714-5; Gardelle J, 2013, CRYOSPHERE, V7, P1263, DOI 10.5194/tc-7-1263-2013; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Ghosh S, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083579; Gianinetto M, 2009, SENSORS-BASEL, V9, P3269, DOI 10.3390/s90503269; Guo WQ, 2015, J GLACIOL, V61, P357, DOI 10.3189/2015JoG14J209; Guo WQ, 2013, ANN GLACIOL, V54, P299, DOI 10.3189/2013AoG63A495; Hirano A, 2003, ISPRS J PHOTOGRAMM, V57, P356, DOI 10.1016/S0924-2716(02)00164-8; Holzer N, 2015, CRYOSPHERE, V9, P2071, DOI 10.5194/tc-9-2071-2015; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Immerzeel WW, 2012, NAT GEOSCI, V5, P841, DOI 10.1038/ngeo1643; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacobsen K., 2005, P ASPRS 2005 ANN C M; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaab A, 2008, IEEE T GEOSCI REMOTE, V46, P2823, DOI 10.1109/TGRS.2008.2000627; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kamp U, 2003, ASPRS 2003 ANN C P A; Ke LH, 2015, REMOTE SENS ENVIRON, V168, P13, DOI 10.1016/j.rse.2015.06.019; Khromova TE, 2006, REMOTE SENS ENVIRON, V102, P24, DOI 10.1016/j.rse.2006.01.019; Koblet T, 2010, CRYOSPHERE, V4, P333, DOI 10.5194/tc-4-333-2010; Kumar S, 2009, J INDIAN SOC REMOTE, V36, P159; Lambrecht A, 2014, J GLACIOL, V60, P233, DOI 10.3189/2014JoG13J110; Langley K, 2008, IEEE T GEOSCI REMOTE, V46, P2506, DOI 10.1109/TGRS.2008.918648; Lehner M, 2008, ISPRS J PHOTOGRAMMET; [刘时银 Liu Shiyin], 2015, [地理学报, Acta Geographica Sinica], V70, P3; Martha TR, 2010, IEEE GEOSCI REMOTE S, V7, P582, DOI 10.1109/LGRS.2010.2041895; Maussion F, 2014, J CLIMATE, V27, P1910, DOI 10.1175/JCLI-D-13-00282.1; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Miliaresis GC, 2011, REMOTE SENS LETT, V2, P127, DOI 10.1080/01431161.2010.503667; Miller P, GEOSCIENCE REMOTE SE, P1971; Minora U., 2013, CRYOSPHERE DISCUSS, V7, P2891, DOI [10.5194/tcd-7-2891-2013, DOI 10.5194/TCD-7-2891-2013]; Neckel N, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014009; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Osipov EY, 2015, ENVIRON EARTH SCI, V74, P1969, DOI 10.1007/s12665-015-4352-4; Osmonov A, 2013, REMOTE SENS LETT, V4, P725, DOI 10.1080/2150704X.2013.789146; Paul F, 2013, ANN GLACIOL, V54, P171, DOI 10.3189/2013AoG63A296; Pellicciotti F, 2015, J GLACIOL, V61, P373, DOI 10.3189/2015JoG13J237; Pieczonka T, 2015, GLOBAL PLANETARY CHA, P128; Pieczonka T, 2013, REMOTE SENS ENVIRON, V130, P233, DOI 10.1016/j.rse.2012.11.020; [蒲健辰 Pu Jianchen], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P680; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Seong YB, 2009, GEOL SOC AM BULL, V121, P348, DOI 10.1130/B26339.1; Seong YB, 2009, GEOMORPHOLOGY, V103, P227, DOI 10.1016/j.geomorph.2008.04.025; Shangguan DH, 2015, CRYOSPHERE, V9, P703, DOI 10.5194/tc-9-703-2015; Shangguan DH, 2006, ANN GLACIOL-SER, V43, P79, DOI 10.3189/172756406781812393; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shen Y., 1997, J GLACIOL GEOCRYOL, V19, P302; Shih Y, 1980, IAHS-AISH PUBL, P111; Tian LD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006249; Tiwari PS, 2008, INT J GEOINFORMATICS, V4, P51; Toutin T, 2008, INT J REMOTE SENS, V29, P1855, DOI 10.1080/01431160701408477; van Zyl JJ, 2001, ACTA ASTRONAUT, V48, P559, DOI 10.1016/S0094-5765(01)00020-0; [王解先 Wang Jiexian], 2003, [大地测量与地球动力学, Journal of Geodesy and Geodynamics], V23, P70; Wang WC, 2012, HYDROL PROCESS, V26, P213, DOI 10.1002/hyp.8127; Wang Z., 2001, GLACIER INVENTORY CH; Wei JF, 2015, J MT SCI-ENGL, V12, P330, DOI 10.1007/s11629-014-3175-1; Wei JF, 2015, ARCT ANTARCT ALP RES, V47, P301, DOI 10.1657/AAAR00C-13-129; Wei JF, 2014, ANN GLACIOL, V55, P213, DOI 10.3189/2014AoG66A038; Xu J, J GLACIOLOG IN PRESS; Xu J, 2015, ADV METEOROL, P1; Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070574; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; [曾磊 Zeng Lei], 2013, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V27, P144; Zhang QB, 2014, MT RES DEV, V34, P56, DOI 10.1659/MRD-JOURNAL-D-12-00074.1; Zhang Z, 1960, J MT SCI EN IN PRESS	82	31	34	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147327	10.1371/journal.pone.0147327	http://dx.doi.org/10.1371/journal.pone.0147327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789404	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100080
J	Circu, ML; Dykes, SS; Carroll, J; Kelly, K; Galiano, F; Greer, A; Cardelli, J; El-Osta, H				Circu, Magdalena L.; Dykes, Samantha S.; Carroll, Jennifer; Kelly, Kinsey; Galiano, Floyd; Greer, Adam; Cardelli, James; El-Osta, Hazem			A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion	PLOS ONE			English	Article							CATHEPSIN-B; QUALITY-CONTROL; HIT SELECTION; LUNG-CANCER; TUMOR-CELLS; ACIDIFICATION; AUTOPHAGY; PROGRESSION; TRANSPORT; PATHWAYS	Lysosome trafficking plays a significant role in tumor invasion, a key event for the development of metastasis. Previous studies from our laboratory have demonstrated that the anterograde (outward) movement of lysosomes to the cell surface in response to certain tumor microenvironment stimulus, such as hepatocyte growth factor (HGF) or acidic extracellular pH (pHe), increases cathepsin B secretion and tumor cell invasion. Anterograde lysosome trafficking depends on sodium-proton exchanger activity and can be reversed by blocking these ion pumps with Troglitazone or EIPA. Since these drugs cannot be advanced into the clinic due to toxicity, we have designed a high-content assay to discover drugs that block peripheral lysosome trafficking with the goal of identifying novel drugs that inhibit tumor cell invasion. An automated high-content imaging system (Cellomics) was used to measure the position of lysosomes relative to the nucleus. Among a total of 2210 repurposed and natural product drugs screened, 18 "hits" were identified. One of the compounds identified as an anterograde lysosome trafficking inhibitor was niclosamide, a marketed human anti-helminthic drug. Further studies revealed that niclosamide blocked acidic pHe, HGF, and epidermal growth factor (EGF)-induced anterograde lysosome redistribution, protease secretion, motility, and invasion of DU145 castrate resistant prostate cancer cells at clinically relevant concentrations. In an effort to identify the mechanism by which niclosamide prevented anterograde lysosome movement, we found that this drug exhibited no significant effect on the level of ATP, microtubules or actin filaments, and had minimal effect on the PI3K and MAPK pathways. Niclosamide collapsed intralysosomal pH without disruption of the lysosome membrane, while bafilomycin, an agent that impairs lysosome acidification, was also found to induce JLA in our model. Taken together, these data suggest that niclosamide promotes juxtanuclear lysosome aggregation (JLA) via modulation of pathways involved in lysosome acidification. In conclusion, we have designed a validated reproducible high-content assay to screen for drugs that inhibit lysosome trafficking and reduce tumor invasion and we summarize the action of one of these drugs.	[Circu, Magdalena L.; Dykes, Samantha S.; Carroll, Jennifer; Kelly, Kinsey; Galiano, Floyd; Greer, Adam; Cardelli, James; El-Osta, Hazem] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Dykes, Samantha S.; Cardelli, James] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	El-Osta, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.	helost@lsuhsc.edu			Pfizer; Feist-Weiller Cancer Center	Pfizer(Pfizer); Feist-Weiller Cancer Center	This research was funded, in part, by grant from Pfizer, and funding from the Feist-Weiller Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; DiCiccio JE, 2011, J GEN PHYSIOL, V137, P385, DOI 10.1085/jgp.201110596; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HOLLENBECK PJ, 1990, NATURE, V346, P864, DOI 10.1038/346864a0; Hosogi S, 2014, J CELL MOL MED, V18, P1124, DOI 10.1111/jcmm.12257; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jedeszko C., 2008, CURR PROTOC CELL BIO; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Li H, 2000, J DIABETES COMPLICAT, V14, P175, DOI 10.1016/S1056-8727(00)00076-3; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MACH L, 1994, J BIOL CHEM, V269, P13030; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Nishimura Y, 2000, CELL TISSUE RES, V301, P341, DOI 10.1007/s004410000243; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Shun TY, 2011, J BIOMOL SCREEN, V16, P1, DOI 10.1177/1087057110389039; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Steffan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087882; Steffan JJ, 2011, CURR PROTEIN PEPT SC, V12, P12; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; Steffan JJ, 2010, TRAFFIC, V11, P274, DOI 10.1111/j.1600-0854.2009.01012.x; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0; Wieland A, 2013, CLIN CANCER RES, V19, P4124, DOI 10.1158/1078-0432.CCR-12-2895; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	56	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146931	10.1371/journal.pone.0146931	http://dx.doi.org/10.1371/journal.pone.0146931			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784896	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400080
J	Libro, S; Vollmer, SV				Libro, Silvia; Vollmer, Steven V.			Genetic Signature of Resistance to White Band Disease in the Caribbean Staghorn Coral Acropora cervicornis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CLIMATE-CHANGE; HOST-DEFENSE; IMMUNITY; NLRC5; ARABIDOPSIS; RESILIENCE; RESPONSES; SYSTEM; REEFS	Coral reefs are declining worldwide due to multiple factors including rising sea surface temperature, ocean acidification, and disease outbreaks. Over the last 30 years, White Band Disease (WBD) alone has killed up to 95% of the Caribbean's dominant shallow-water corals-the staghorn coral Acropora cervicornis and the elkhorn coral A. palmata. Both corals are now listed on the US Endangered Species Act, and while their recovery has been slow, recent transmission surveys indicate that more than 5% of staghorn corals are disease resistant. Here we compared transcriptome-wide gene expression between resistant and susceptible staghorn corals exposed to WBD using in situ transmission assays. We identified constitutive gene expression differences underlying disease resistance that are independent from the immune response associated with disease exposure. Genes involved in RNA interference-mediated gene silencing, including Argonaute were up-regulated in resistant corals, whereas heat shock proteins (HSPs) were down-regulated. Up-regulation of Argonaute proteins indicates that post-transcriptional gene silencing plays a key, but previously unsuspected role in coral immunity and disease resistance. Constitutive expression of HSPs has been linked to thermal resilience in other Acropora corals, suggesting that the down-regulation of HSPs in disease resistant staghorn corals may confer a dual benefit of thermal resilience.	[Libro, Silvia; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, 430 Nahant Rd, Nahant, MA 01908 USA	Northeastern University	Libro, S (corresponding author), Northeastern Univ, Ctr Marine Sci, 430 Nahant Rd, Nahant, MA 01908 USA.; Libro, S (corresponding author), New England Biolabs Inc, Genome Biol Div, Mol Parasitol, 240 Cty Rd, Ipswich, MA USA.	libro.silv@gmail.com	libro, silvia/AAM-7256-2021	libro, silvia/0000-0003-0230-3876	National Science Foundation as part of the Academic Research Infrastructure Recovery and Reinvestment Program [0963010]; NSF Biological Oceanography program [OCE 0751666]	National Science Foundation as part of the Academic Research Infrastructure Recovery and Reinvestment Program; NSF Biological Oceanography program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation (http://www.nsf.gov) Grant 0963010, as part of the Academic Research Infrastructure Recovery and Reinvestment Program and by the NSF Biological Oceanography program to SVV (OCE 0751666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, REORGANIZING PROTEIN; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gignoux-Wolfsohn SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00804; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gould J, 2013, GENE E INTERACT GENE; Hamada M, 2013, MOL BIOL EVOL, V30, P167, DOI 10.1093/molbev/mss213; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hogarth WT, 2005, FED REGISTER, V70, P24359; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Love MI, MODERATED ESTIMATION; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moran Y, 2014, GENOME RES, V24, P651, DOI 10.1101/gr.162503.113; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Nakamura M, 2012, BIOL OPEN, V1, P75, DOI 10.1242/bio.2011036; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010	40	23	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146636	10.1371/journal.pone.0146636	http://dx.doi.org/10.1371/journal.pone.0146636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784329	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400055
J	Wu, LH; Leung, H; Jiang, H; Zheng, H; Ma, L				Wu, Lihua; Leung, Henry; Jiang, Hao; Zheng, Hong; Ma, Li			Incorporating Human Movement Behavior into the Analysis of Spatially Distributed Infrastructure	PLOS ONE			English	Article							MIGRATION	For the first time in human history, the majority of the world's population resides in urban areas. Therefore, city managers are faced with new challenges related to the efficiency, equity and quality of the supply of resources, such as water, food and energy. Infrastructure in a city can be viewed as service points providing resources. These service points function together as a spatially collaborative system to serve an increasing population. To study the spatial collaboration among service points, we propose a shared network according to human's collective movement and resource usage based on data usage detail records (UDRs) from the cellular network in a city in western China. This network is shown to be not scale-free, but exhibits an interesting triangular property governed by two types of nodes with very different link patterns. Surprisingly, this feature is consistent with the urban-rural dualistic context of the city. Another feature of the shared network is that it consists of several spatially separated communities that characterize local people's active zones but do not completely overlap with administrative areas. According to these features, we propose the incorporation of human movement into infrastructure classification. The presence of well-defined spatially separated clusters confirms the effectiveness of this approach. In this paper, our findings reveal the spatial structure inside a city, and the proposed approach provides a new perspective on integrating human movement into the study of a spatially distributed system.	[Wu, Lihua; Jiang, Hao; Zheng, Hong; Ma, Li] Wuhan Univ, Dept Commun Engn, Wuhan 430072, Peoples R China; [Leung, Henry] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada; [Jiang, Hao] Wuhan Univ, Geospatial Informat Technol Cooperat Innovat Ctr, Wuhan 430072, Peoples R China	Wuhan University; University of Calgary; Wuhan University	Jiang, H (corresponding author), Wuhan Univ, Dept Commun Engn, Wuhan 430072, Peoples R China.; Jiang, H (corresponding author), Wuhan Univ, Geospatial Informat Technol Cooperat Innovat Ctr, Wuhan 430072, Peoples R China.	jh@whu.edu.cn			National Natural Science Foundation of China (NSFC) [61371126]; National High Technology Research and Development Program of China (863 Program) [2014AA01A707]; National key Basic Research Program of China (973 Program) [2011CB707106]; Independent Research Program of Central Universities [2042014kf0256]; Natural Science Foundation of Hubei province [2011CDA042]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National key Basic Research Program of China (973 Program)(National Basic Research Program of China); Independent Research Program of Central Universities; Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province)	This work was funded by the National Natural Science Foundation of China (NSFC, grant number: 61371126, http://www.nsfc.gov.cn/), the National High Technology Research and Development Program of China (863 Program, grant number: 2014AA01A707, http://www.863.gov.cn/), the National key Basic Research Program of China (973 Program, grant number: 2011CB707106, http://www.973.gov.cn/), the Independent Research Program of Central Universities (grant number: 2042014kf0256), and the Natural Science Foundation of Hubei province (grant number: 2011CDA042, http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X., 2014, P WORKSHOP DATA SCI, P1; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Clements M, 2011, PERSONALISED TRAVEL, P1; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Gao S, 2013, T GIS, V17, P463, DOI 10.1111/tgis.12042; Gao S, 2013, ENVIRON PLANN B, V40, P135, DOI 10.1068/b38141; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; IBM Global Business Services, 2010, SMART CIT ASS; Jarv O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049171; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Louail T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7007; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ng AY, 2002, ADV NEUR IN, V14, P849; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Paul U, 2012, IEEE CONF COMPUT, P244, DOI 10.1109/INFCOMW.2012.6193499; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shelton T, 2015, CAMB J REG ECON SOC, V8, P13, DOI 10.1093/cjres/rsu026; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Townsend A.M., 2013, SMART CITIES BIG DAT; Vang J, 2015, EUR PLAN STUD, V23, P638, DOI 10.1080/09654313.2014.990607; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	36	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147216	10.1371/journal.pone.0147216	http://dx.doi.org/10.1371/journal.pone.0147216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784749	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400124
J	Zhang, JQ; Gao, BW; Wang, J; Wang, XW; Ren, QL; Chen, JF; Ma, Q; Xing, BS				Zhang, Jia-Qing; Gao, Bin-Wen; Wang, Jing; Wang, Xian-Wei; Ren, Qiao-Ling; Chen, Jun-Feng; Ma, Qiang; Xing, Bao-song			Chronic Exposure to Diquat Causes Reproductive Toxicity in Female Mice	PLOS ONE			English	Article							GRANULOSA-CELL APOPTOSIS; OXIDATIVE STRESS; HEPATIC-NECROSIS; OXYGEN; METHOXYCHLOR; GROWTH; LIVER; SUPEROXIDE; INHIBITION; MECHANISMS	Diquat is a bipyridyl herbicide that has been widely used as a model chemical for in vivo studies of oxidative stress due to its generation of superoxide anions, and cytotoxic effects. There is little information regarding the toxic effects of diquat on the female reproductive system, particularly ovarian function. Thus, we investigated the reproductive toxic effects of diquat on female mice. Chronic exposure to diquat reduced ovary weights, induced ovarian oxidative stress, resulted in granulosa cell apoptosis, and disrupted oocyte developmental competence, as shown by reactive oxygen species (ROS) accumulation, decreased polar body extrusion rates and increased apoptosis-related genes expression. Additionally, after diquat treatment, the numbers of fetal mice and litter sizes were significantly reduced compared to those of control mice. Thus, our results indicated that chronic exposure to diquat induced reproductive toxicity in female mice by promoting the ROS production of gruanousa cells and ooctyes, impairing follicle development, inducing apoptosis, and reducing oocyte quality. In conclusion, our findings indicate that diquat can be used as a potent and efficient chemical for in vivo studies of female reproductive toxicity induced by oxidative stress. Moreover, the findings from this study will further enlarge imitative research investigating the effect of ovarian damage induced by oxidative stress on reproductive performance and possible mechanisms of action in large domestic animals.	[Zhang, Jia-Qing; Gao, Bin-Wen; Wang, Jing; Ren, Qiao-Ling; Chen, Jun-Feng; Ma, Qiang; Xing, Bao-song] Henan Acad Agr Sci, Inst Anim Husb & Vet Sci, Zhengzhou, Peoples R China; [Wang, Xian-Wei] Henan Prov Anim Husb Gen Stn, Zhengzhou, Peoples R China	Henan Academy of Agricultural Sciences	Xing, BS (corresponding author), Henan Acad Agr Sci, Inst Anim Husb & Vet Sci, Zhengzhou, Peoples R China.	xingbaosong502@163.com			Key Program for Science and Technology Development of Henan [152102110126]; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2016YQ19]	Key Program for Science and Technology Development of Henan; Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This work was supported by Key Program for Science and Technology Development of Henan (152102110126) and the Science-Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences (2016YQ19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Droge W, 2008, ANTIOXID REDOX SIGN, V10, P661, DOI 10.1089/ars.2007.1953; Duan X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11562; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Fussell KC, 2011, FREE RADICAL BIO MED, V50, P874, DOI 10.1016/j.freeradbiomed.2010.12.035; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Gupta RK, 2006, TOXICOL APPL PHARM, V216, P436, DOI 10.1016/j.taap.2006.06.013; Gupta RK, 2007, TOXICOL PATHOL, V35, P649, DOI 10.1080/01926230701459960; Gupta RK, 2006, TOXICOL SCI, V93, P382, DOI 10.1093/toxsci/kfl052; Gupta S, 2000, TOXICOL SCI, V54, P203, DOI 10.1093/toxsci/54.1.203; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Lu T, 2010, FOOD CHEM TOXICOL, V48, P764, DOI 10.1016/j.fct.2009.12.018; Lv M, 2012, ANIMAL, V6, P928, DOI 10.1017/S1751731111002382; Mao XB, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-49; Murdoch WJ, 1998, J REPROD FERTIL, V114, P127, DOI 10.1530/jrf.0.1140127; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; RAWLINGS JM, 1994, BIOCHEM PHARMACOL, V47, P1271, DOI 10.1016/0006-2952(94)90401-4; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seino T, 2002, FERTIL STERIL, V77, P1184, DOI 10.1016/S0015-0282(02)03103-5; Sen N, 2015, REPROD TOXICOL, V53, P15, DOI 10.1016/j.reprotox.2015.02.012; Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; SMITH CV, 1985, J PHARMACOL EXP THER, V235, P172; Sugino Norihiro, 2005, Reprod Med Biol, V4, P31, DOI 10.1111/j.1447-0578.2005.00086.x; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; TSOKOSKUHN JO, 1988, MOL PHARMACOL, V34, P209; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wu KC, 2012, FREE RADICAL RES, V46, P1220, DOI 10.3109/10715762.2012.700709; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086589; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	40	9	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147075	10.1371/journal.pone.0147075	http://dx.doi.org/10.1371/journal.pone.0147075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785375	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400106
J	Andruszkow, H; Schweigkofler, U; Lefering, R; Frey, M; Horst, K; Pfeifer, R; Beckers, SK; Pape, HC; Hildebrand, F				Andruszkow, Hagen; Schweigkofler, Uwe; Lefering, Rolf; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Beckers, Stefan Kurt; Pape, Hans-Christoph; Hildebrand, Frank			Impact of Helicopter Emergency Medical Service in Traumatized Patients: Which Patient Benefits Most?	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; INJURY SEVERITY SCORE; MAJOR TRAUMA; TRANSPORT; SURVIVAL; LEVEL; HEMS; ASSOCIATION; OUTCOMES; ADULTS	Introduction The Helicopter Emergency Medical Service (HEMS) was established for the prehospital trauma care of patients. Improved rescue times and increased coverage areas are discussed as specific advantages of HEMS. We recently found evidence that HEMS exerts beneficial effects on outcomes for severely injured patients. However, it still remains unknown which group of trauma patients might benefit most from HEMS rescue. Consequently, the unique aim of this study was to reveal which patients might benefit most from HEMS rescue. Methods Trauma patients (ISS >= 9) primarily treated by HEMS or ground emergency medical services (GEMS) between 2002 and 2012 were analysed using the TraumaRegister DGU. A multivariate regression analysis was used to reveal the survival benefit between different trauma populations. Results The study included 52 281 trauma patients. Of these, 68.8% (35 974) were rescued by GEMS and 31.2% (16 307) by HEMS. HEMS patients were more severely injured compared to GEMS patients (ISS: HEMS 24.8+/-13.5 vs. GEMS 21.7+/-18.0) and more frequently suffered traumatic shock (SBP sys <90mmHg: HEMS 18.3% vs. GEMS 14.8%). However, logistic regression analysis revealed that HEMS rescues resulted in an overall survival benefit compared to GEMS (OR 0.81, 95% CI [0.75-0.87], p<0.001, Nagelkerke's R squared 0.526, area under the ROC curve 0.922, 95% CI [0.919-0.925]). Analysis of specific subgroups demonstrated that patients aged older than 55 years (OR 0.62, 95% CI [0.50-0.77]) had the highest survival benefit after HEMS treatment. Furthermore, HEMS rescue had the most significant impact after 'low falls' (OR 0.68, 95% CI [0.55-0.84]) and in the case of minor severity injuries (ISS 9-15) (OR 0.66, 95% CI [0.49-0.88]). Conclusions In general, trauma patients benefit from HEMS rescue with in-hospital survival as the main outcome parameter. Focusing on special subgroups, middle aged and older patients, low-energy trauma, and minor severity injuries had the highest survival benefit when rescued by HEMS. Further studies are required to determine the potential reasons of this benefit.	[Andruszkow, Hagen; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Pape, Hans-Christoph; Hildebrand, Frank] Univ Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany; [Andruszkow, Hagen; Frey, Magnus; Horst, Klemens; Pfeifer, Roman; Pape, Hans-Christoph; Hildebrand, Frank] Univ Hosp Aachen, Harald Tscherne Lab, Pauwelsstr 30, D-52074 Aachen, Germany; [Schweigkofler, Uwe] Berufsgenossenschaftliche Unfallklin Frankfurt, Dept Trauma & Orthoped Surg, Friedberger Landstr 430, D-60389 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Beckers, Stefan Kurt] Rhein Westfal TH Aachen, Univ Hosp Aachen, Emergency Med Serv Aachen, Dept Anaesthesiol, Pauwelsstr 30, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Witten Herdecke University; RWTH Aachen University; RWTH Aachen University Hospital	Andruszkow, H (corresponding author), Univ Aachen, Dept Orthoped Trauma, Pauwelsstr 30, D-52074 Aachen, Germany.; Andruszkow, H (corresponding author), Univ Hosp Aachen, Harald Tscherne Lab, Pauwelsstr 30, D-52074 Aachen, Germany.	handruszkow@ukaachen.de	Beckers, Stefan K./O-2943-2019; Beckers, Stefan K/C-6776-2011; Hildebrand, Frank/J-3176-2017	Beckers, Stefan K./0000-0002-2896-7948; Beckers, Stefan K/0000-0002-2896-7948; Pape, Hans-Christoph/0000-0002-2059-4980				Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Andruszkow H, 2014, INJURY, V45, pS53, DOI 10.1016/j.injury.2014.08.018; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Andruszkow H, 2012, TECHNOL HEALTH CARE, V20, P435, DOI 10.3233/THC-2012-0691; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bala M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-91; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Butler DP, 2010, EMERG MED J, V27, P692, DOI 10.1136/emj.2009.087486; de Jongh MAC, 2012, INJURY, V43, P1362, DOI 10.1016/j.injury.2012.01.009; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Hannan EL, 2004, J TRAUMA, V56, P1297, DOI 10.1097/01.TA.0000075350.66739.53; Hranjec T, 2012, AM SURGEON, V78, P1369; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Pandya SR, 2011, J TRAUMA, V70, P1326, DOI 10.1097/TA.0b013e31820e327c; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Plevin RE, 2011, HELICOPTER TRANSPORT; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Salottolo KM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-7; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Schweigkofler U, 2014, UNFALLCHIRURG; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Sturm JA, 2013, CLIN ORTHOP RELAT R, V471, P2912, DOI 10.1007/s11999-013-2967-x; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Talving P, 2009, WORLD J SURG, V33, P2469, DOI 10.1007/s00268-009-0185-1; Taylor C, 2012, INJURY, V43, P1843, DOI 10.1016/j.injury.2012.07.184; Taylor CB, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-11; TEASDALE G, 1974, LANCET, V2, P81; Thomas Stephen H, 2002, Prehosp Emerg Care, V6, P359, DOI 10.1080/10903120290938508; Thomas SH, 2014, PREHOSP EMERG CARE, V18, P35, DOI 10.3109/10903127.2013.844872; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Westhoff J, 2003, INJURY, V34, P674, DOI 10.1016/S0020-1383(03)00147-5	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146897	10.1371/journal.pone.0146897	http://dx.doi.org/10.1371/journal.pone.0146897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771462	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300041
J	Paravidino, VB; Mediano, MFF; Hoffman, DJ; Sichieri, R				Paravidino, Vitor Barreto; Felix Mediano, Mauro Felippe; Hoffman, Daniel J.; Sichieri, Rosely			Effect of Exercise Intensity on Spontaneous Physical Activity Energy Expenditure in Overweight Boys: A Crossover Study	PLOS ONE			English	Article							COMPENSATORY RESPONSES; SCHOOL-TIME; WEIGHT-LOSS; OBESE BOYS; CHILDREN; ADOLESCENTS; IMPACT; INTERVENTIONS; HYPOTHESIS; FITNESS	Objective Evaluate the effect of different exercise intensities on spontaneous physical activity energy expenditure in overweight adolescents. Methods A crossover study was developed with a control session, followed by moderate and vigorous exercise sessions, with six days of monitoring each. Twenty-four adolescents, 11-13 years old, male and overweight were selected. Spontaneous physical activity energy expenditure was assessed by accelerometers. Linear mixed effects models were used to evaluate the differences per session across time. Results Energy expenditure during the 1st hour was different between all three sessions, with averages of 82, 286 and 343 kcal to the control, moderate and vigorous sessions, respectively (p<0.001). The same pattern of difference in energy expenditure between the sessions remained after 24 hours (704 vs 970 vs 1056 kcal, p<0.001). However, energy expenditure during the six days indicates compensation from second to the sixth day, although small differences remained at the end of the 6-day period (5102 vs 5193 vs 5271 kcal, p<0.001). Conclusions A single aerobic session seems to modify the spontaneous physical activities in overweight adolescents but still keeping the vigorous session with higher total energy expenditure during the follow-up period. Despite the observed compensatory effect, the greater energy expenditure observed in both moderate and vigorous exercise sessions indicates that physical activity should be recommended to promote an increased energy expenditure in adolescents.	[Paravidino, Vitor Barreto; Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil; [Paravidino, Vitor Barreto] Naval Sch Brazilian Navy, Dept Phys Educ & Sports, Rio De Janeiro, Brazil; [Felix Mediano, Mauro Felippe] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [Hoffman, Daniel J.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Rutgers State University New Brunswick	Paravidino, VB (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil.; Paravidino, VB (corresponding author), Naval Sch Brazilian Navy, Dept Phys Educ & Sports, Rio De Janeiro, Brazil.	vparavidino@gmail.com	Paravidino, Vitor B/A-6957-2018; Paravidino, Vitor/AAV-1711-2020	Paravidino, Vitor B/0000-0002-4972-1269; Paravidino, Vitor/0000-0002-4972-1269	Brazilian National Research Foundation-CNPq [471282/2012-0]	Brazilian National Research Foundation-CNPq	This work was supported by the Brazilian National Research Foundation-CNPq, grant number 471282/2012-0 to RS (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American College of Sports Medicine, 2009, ACSM GUID EX TEST PR; BLAAK EE, 1992, AM J CLIN NUTR, V55, P777, DOI 10.1093/ajcn/55.4.777; Church TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004515; Dale D, 2000, RES Q EXERCISE SPORT, V71, P240, DOI 10.1080/02701367.2000.10608904; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; EPSTEIN LH, 1980, ADDICT BEHAV, V5, P371, DOI 10.1016/0306-4603(80)90011-8; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fremeaux AE, 2011, INT J OBESITY, V35, P1277, DOI 10.1038/ijo.2011.52; Gomersall SR, 2013, SPORTS MED, V43, P135, DOI 10.1007/s40279-012-0008-7; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Institute of Medicine, 2005, DIET REF INT EN CARB; Julious S.A., 2010, SAMPLE SIZE CLIN TRI; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Kriemler S, 1999, PEDIATR RES, V46, P40, DOI 10.1203/00006450-199907000-00007; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Manthou E, 2010, MED SCI SPORT EXER, V42, P1221, DOI 10.1249/MSS.0b013e3181c524b7; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; SHEPHARD RJ, 1981, CAN J PUBLIC HEALTH, V72, P37; Sichieri R., 2013, COMCIENCIA, P145; Thivel D, 2014, PEDIATR OBES, V9, P147, DOI 10.1111/j.2047-6310.2013.00148.x; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Van Belle G., 2008, STAT RULES THUMB; Vasconcellos F, 2014, SPORTS MED, V44, P1139, DOI 10.1007/s40279-014-0193-7; Veses AM, 2014, PEDIATR OBES, V9, P1, DOI 10.1111/j.2047-6310.2012.00138.x; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Washburn RA, 2014, CLIN OBES, V4, P1, DOI 10.1111/cob.12040; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; WHO Experts Committee on Obesity and Overweight, 2009, WHO GLOB STRAT DIET; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Wilkin TJ, 2006, INT J OBESITY, V30, P1050, DOI 10.1038/sj.ijo.0803331; Wolff-Hughes DL, 2014, PLOS ONE, V9, P1	38	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147141	10.1371/journal.pone.0147141	http://dx.doi.org/10.1371/journal.pone.0147141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771742	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300065
J	Casadebaig, P; Zheng, BY; Chapman, S; Huth, N; Faivre, R; Chenu, K				Casadebaig, Pierre; Zheng, Bangyou; Chapman, Scott; Huth, Neil; Faivre, Robert; Chenu, Karine			Assessment of the Potential Impacts of Wheat Plant Traits across Environments by Combining Crop Modeling and Global Sensitivity Analysis	PLOS ONE			English	Article							GENETIC-VARIATION; USE EFFICIENCY; WATER-DEFICIT; YIELD GAINS; BREAD WHEAT; GENOTYPE; ADAPTATION; DROUGHT; SELECTION; IMPROVEMENT	A crop can be viewed as a complex system with outputs (e.g. yield) that are affected by inputs of genetic, physiology, pedo-climatic and management information. Application of numerical methods for model exploration assist in evaluating the major most influential inputs, providing the simulation model is a credible description of the biological system. A sensitivity analysis was used to assess the simulated impact on yield of a suite of traits involved in major processes of crop growth and development, and to evaluate how the simulated value of such traits varies across environments and in relation to other traits (which can be interpreted as a virtual change in genetic background). The study focused on wheat in Australia, with an emphasis on adaptation to low rainfall conditions. A large set of traits (90) was evaluated in a wide target population of environments (4 sites x 125 years), management practices (3 sowing dates x 3 nitrogen fertilization levels) and CO2 (2 levels). The Morris sensitivity analysis method was used to sample the parameter space and reduce computational requirements, while maintaining a realistic representation of the targeted trait x environment x management landscape (similar to 82 million individual simulations in total). The patterns of parameter x environment x management interactions were investigated for the most influential parameters, considering a potential genetic range of +/- 20% compared to a reference cultivar. Main (i.e. linear) and interaction (i.e. non-linear and interaction) sensitivity indices calculated for most of APSIM-Wheat parameters allowed the identification of 42 parameters substantially impacting yield in most target environments. Among these, a subset of parameters related to phenology, resource acquisition, resource use efficiency and biomass allocation were identified as potential candidates for crop (and model) improvement.	[Casadebaig, Pierre] INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France; [Zheng, Bangyou] CSIRO Agr, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4067, Australia; [Chapman, Scott] Univ Queensland, QAAFI, St Lucia, Qld 4350, Australia; [Huth, Neil] CSIRO Agr, 203 Tor St, Toowoomba, Qld 4350, Australia; [Faivre, Robert] INRA, MIAT UR875, F-31326 Castanet Tolosan, France; [Chenu, Karine] Univ Queensland, QAAFI, 203 Tor St, Toowoomba, Qld 4350, Australia	INRAE; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); INRAE; University of Queensland	Casadebaig, P (corresponding author), INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France.	pierre.casadebaig@toulouse.inra.fr	Casadebaig, Pierre/AAL-3307-2020; Casadebaig, Pierre/AAL-6998-2020; Chapman, Scott C/B-9673-2008; Huth, Neil I/F-7882-2010; Huth, Neil/U-3271-2019; Chenu, Karine/A-8967-2009	Casadebaig, Pierre/0000-0001-7225-936X; Chapman, Scott C/0000-0003-4732-8452; Huth, Neil I/0000-0002-4197-830X; Zheng, Bangyou/0000-0003-1551-0970; Chenu, Karine/0000-0001-7273-2057	INRA-Environment and Agronomy Division; Queensland Alliance for Agriculture and Food Innovation (QAAFI); Grains Research & Development Corporation (GRDC); ARC Centre of Excellence for Translational Photosynthesis	INRA-Environment and Agronomy Division; Queensland Alliance for Agriculture and Food Innovation (QAAFI); Grains Research & Development Corporation (GRDC)(Grains R&D Corp); ARC Centre of Excellence for Translational Photosynthesis(Australian Research Council)	This study was partly funded by INRA-Environment and Agronomy Division, the Queensland Alliance for Agriculture and Food Innovation (QAAFI), the Grains Research & Development Corporation (GRDC) and the ARC Centre of Excellence for Translational Photosynthesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbad H, 2004, AGRONOMIE, V24, P19, DOI 10.1051/agro:2003056; Alwala S, 2010, FIELD CROP RES, V119, P225, DOI 10.1016/j.fcr.2010.07.010; [Anonymous], 2014, R LANG ENV STAT COMP; Babar MA, 2006, CROP SCI, V46, P1046, DOI 10.2135/cropsci2005.0211; Bertin N, 2010, J EXP BOT, V61, P955, DOI 10.1093/jxb/erp377; Bogard M, 2014, J EXP BOT, V65, P5849, DOI 10.1093/jxb/eru328; Cabrera-Bosquet L, 2007, ANN APPL BIOL, V151, P277, DOI 10.1111/j.1744-7348.2007.00195.x; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Chan K., 2000, SENSITIVITY ANAL; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chapman S. C., 2002, P167, DOI 10.1079/9780851996011.0167; Chapman SC, 2002, AUST J AGR RES, V53, P379, DOI 10.1071/AR01070; Chapman SC, 2000, AUST J AGR RES, V51, P197, DOI 10.1071/AR99020; Chapman SC, 1997, EUPHYTICA, V95, P1, DOI 10.1023/A:1002918008679; Chapman SC, 2008, EUPHYTICA, V161, P195, DOI 10.1007/s10681-007-9623-z; Chapman SC, 2012, CROP PASTURE SCI, V63, P251, DOI 10.1071/CP11303; Chenu K, 2011, J EXP BOT, V62, P1743, DOI 10.1093/jxb/erq459; Chenu K, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P321, DOI 10.1016/B978-0-12-417104-6.00013-3; Chenu K, 2013, NEW PHYTOL, V198, P801, DOI 10.1111/nph.12192; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; Christopher JT, 2008, AUST J AGR RES, V59, P354, DOI 10.1071/AR07193; Christopher JT, 2014, FUNCT PLANT BIOL, V41, P1035, DOI 10.1071/FP14052; Cooper M, 1997, CROP SCI, V37, P1168, DOI 10.2135/cropsci1997.0011183X003700040024x; COOPER M, 1995, THEOR APPL GENET, V90, P492, DOI 10.1007/BF00221995; Da Silva D, 2014, ANN BOT-LONDON, V114, P739, DOI 10.1093/aob/mcu034; de la Vega AJ, 2007, FIELD CROP RES, V100, P73, DOI 10.1016/j.fcr.2006.05.007; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Dumont B, 2014, ENVIRON MODELL SOFTW, V52, P121, DOI 10.1016/j.envsoft.2013.10.022; Fischer R, 1996, WORKSH P CD OBR MEX, P150; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Hammer GL, 2014, CROP PASTURE SCI, V65, P614, DOI 10.1071/CP14088; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Iooss B, UNCERTAINTY MANAGEME, P101, DOI [10.1007/978-1-4899-7547-8, DOI 10.1007/978-1-4899-7547-8]; Jeuffroy MH, 2014, AGRON SUSTAIN DEV, V34, P121, DOI 10.1007/s13593-013-0170-9; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Lopes MS, 2012, CROP SCI, V52, P1123, DOI 10.2135/cropsci2011.09.0467; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Martre P, 2015, J EXPT BOT SOC EXPT; Mathews KL, 2007, THEOR APPL GENET, V115, P819, DOI 10.1007/s00122-007-0611-4; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Monod H., 2006, WORKING DYNAM CROP M, V4, P55; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; OrtizMonasterio JI, 1997, CROP SCI, V37, P898, DOI 10.2135/cropsci1997.0011183X003700030033x; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Poorter H, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P81; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Potgieter AB, 2002, AUST J AGR RES, V53, P77, DOI 10.1071/AR01002; Pujol G., 2014, SENSITIVITY SENSITIV; Rebetzke G, 2008, THEOR APPL GENET, V118, P123, DOI 10.1007/s00122-008-0882-4; Rebetzke GJ, 2014, FUNCT PLANT BIOL, V41, P107, DOI 10.1071/FP13177; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P1, DOI 10.1071/FP12180; Reynolds M, 2009, J EXPT BOT SOC EXPT, V60, P1899, DOI [10.1093/jxb/erp016, DOI 10.1093/JXB/ERP016PMID:19363203]; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Richards RA, 2014, CROP PASTURE SCI, V65, P676, DOI 10.1071/CP13426; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Sadras VO, 2014, J EXP BOT, V65, P1981, DOI 10.1093/jxb/eru061; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Sadras VO, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P1; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tambussi EA, 2007, CRIT REV PLANT SCI, V26, P1, DOI 10.1080/07352680601147901; Valade A, 2014, GEOSCI MODEL DEV, V7, P1225, DOI 10.5194/gmd-7-1225-2014; Veyradier M., 2013, P 7 INT C FUNCT STRU, P317; Wallach D, 2011, ENVIRON MODELL SOFTW, V26, P386, DOI 10.1016/j.envsoft.2010.09.004; Wang E, 2002, EUR J AGRON, V18, P121, DOI 10.1016/S1161-0301(02)00100-4; Wang J, 2009, CLIMATIC CHANGE, V96, P79, DOI 10.1007/s10584-009-9599-x; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams J., 2002, CSIRO LAND; Yang DQ, 2014, CROP J, V2, P144, DOI 10.1016/j.cj.2014.02.004; Yang RC, 2005, CROP SCI, V45, P106; Yin XY, 2010, J EXP BOT, V61, P2171, DOI 10.1093/jxb/erp375; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zheng B., 2014, APSIM WHEAT MODULE 7; Zheng B, 2013, WHEAT MODELLING CASE; Zheng BY, 2013, J EXP BOT, V64, P3747, DOI 10.1093/jxb/ert209; Zheng BY, 2012, GLOBAL CHANGE BIOL, V18, P2899, DOI 10.1111/j.1365-2486.2012.02724.x; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	82	51	51	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146385	10.1371/journal.pone.0146385	http://dx.doi.org/10.1371/journal.pone.0146385			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799483	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300019
J	Ehrmann, D; Bergis-Jurgan, N; Haak, T; Kulzer, B; Hermanns, N				Ehrmann, Dominic; Bergis-Jurgan, Nikola; Haak, Thomas; Kulzer, Bernhard; Hermanns, Norbert			Comparison of the Efficacy of a Diabetes Education Programme for Type 1 Diabetes (PRIMAS) in a Randomised Controlled Trial Setting and the Effectiveness in a Routine Care Setting: Results of a Comparative Effectiveness Study	PLOS ONE			English	Article							SELF-MANAGEMENT EDUCATION; PATIENT EDUCATION; NATIONAL STANDARDS; METAANALYSIS; HYPOGLYCEMIA; PEOPLE; ADULTS	Background The effectiveness of an intervention in clinical practice is often reduced compared to the efficacy demonstrated in a randomised controlled trial (RCT). In this comparative effectiveness study, the RCT-proven efficacy of a diabetes education programme for type 1 diabetic patients (PRIMAS) was compared to the effectiveness observed in an implementation trial (IT) under routine care conditions. Methods 75 patients with type 1 diabetes received PRIMAS through an RCT, whereas 179 patients were observed in an implementation trial. Baseline characteristics and treatment outcomes at the 6-month follow-up (improvement of HbA1c, hypoglycaemia problems, and diabetes-related distress) were compared. Results At baseline, the type 1 diabetic patients in the RCT had a significant longer diabetes duration (18.7 +/- 12.3 vs. 13.8 +/- 12.7 yrs., p=.005), lower self-efficacy scores (21.9 +/- 4.7 vs. 23.7 +/- 6.1, p=.02) and a greater number of diabetes complications (0.8 +/- 1.3 vs. 0.4 +/- 0.9, p=.02). After 6 months, PRIMAS achieved comparable effects under RCT and implementation trial conditions, as demonstrated by improvement in HbA1c (-0.36%+/- 1.1 vs. -0.37 +/- 1.2; Delta -0.01, 95% CI -0.33 to 0.31) and hypoglycaemia unawareness (-0.5 +/- 1.4 vs. -0.3 +/- 1.4; Delta 0.18, 95% CI -0.21 to 0.57). The likelihood of clinical improvement did not depend on the trial setting (RCT vs. IT: OR 1.18, 95% CI 0.60 to 2.33). The participants with worse glycaemic control (OR 1.40, 95% CI 1.02 to 1.92), hypoglycaemia problems (OR 2.13, 95% CI 1.53 to 2.97) or elevated diabetes distress (OR 1.40, 95% CI 1.03 to 1.89) had a better chance of clinical improvement. Conclusions The effectiveness of PRIMAS under routine care conditions was comparable to the efficacy demonstrated in the RCT. Clinical improvement was independent of the setting in which PRIMAS was evaluated. The PRIMAS education programme for type 1 diabetes can be delivered under conditions of routine care without a loss of effectiveness, compared to its original evaluation in an RCT.	[Ehrmann, Dominic; Bergis-Jurgan, Nikola; Haak, Thomas; Kulzer, Bernhard; Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Johann Hammer Str 24, D-97980 Bad Mergentheim, Germany; [Haak, Thomas; Kulzer, Bernhard; Hermanns, Norbert] Diabet Ctr Mergentheim, Diabet Clin, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany; [Ehrmann, Dominic; Kulzer, Bernhard; Hermanns, Norbert] Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, D-96047 Bamberg, Germany	Otto Friedrich University Bamberg	Ehrmann, D (corresponding author), Otto Friedrich Univ Bamberg, Dept Clin Psychol & Psychotherapy, D-96047 Bamberg, Germany.	ehrmann@diabetes-zentrum.de	Hermanns, Norbert/AAG-7060-2020	Hermanns, Norbert/0000-0002-2903-2677; Ehrmann, Dominic/0000-0002-5794-5596	Berlin Chemie AG/Menarini Diagnostics, Germany	Berlin Chemie AG/Menarini Diagnostics, Germany	The development and evaluation of PRIMAS was supported by an unrestricted grant of Berlin Chemie AG/Menarini Diagnostics, Germany. The funders had no role in the conceptualisation of PRIMAS, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabegi Steven S, 2008, Am J Orthop (Belle Mead NJ), V37, P242; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739; ASSAL JP, 1985, DIABETOLOGIA, V28, P602, DOI 10.1007/BF00281995; Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; Cohen M. J., 1988, STAT POWER ANAL BEHA; Cooke D, 2013, DIABETES CARE, V36, P270, DOI 10.2337/dc12-0080; Craig P, 2008, BMJ, V337; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Dinneen SF, 2013, DIABETES RES CLIN PR, V100, P29, DOI 10.1016/j.diabres.2013.01.017; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI 10.2337/dc12-s101; FUNNELL MM, 1995, DIABETES CARE, V18, P100, DOI 10.2337/diacare.18.1.100; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710; Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Kempe J., 2002, DIABETES STOFFWECHSE, V11, P144; Medical Research Council (MRC), 2000, FRAM DEV EV RCTS COM; MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470; MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989; Muhlhauser I, 2002, DIABETOLOGIA, V45, P1723, DOI 10.1007/s00125-002-0987-2; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; PIEBER TR, 1995, DIABETES CARE, V18, P625, DOI 10.2337/diacare.18.5.625; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; U.S. Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2010, GUID IND NON CLIN TR; Wagner EH, 2002, BMJ-BRIT MED J, V325, P913, DOI 10.1136/bmj.325.7370.913; WEISZ JR, 1992, AM PSYCHOL, V47, P1578, DOI 10.1037/0003-066X.47.12.1578	32	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147581	10.1371/journal.pone.0147581	http://dx.doi.org/10.1371/journal.pone.0147581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799064	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300127
J	Shen, YH; Yang, F; Wang, H; Cai, ZJ; Xu, YP; Zhao, A; Su, Y; Zhang, G; Zhu, SX				Shen, Yue-Hong; Yang, Fei; Wang, Hua; Cai, Zhi-Jian; Xu, Yi-Peng; Zhao, An; Su, Ying; Zhang, Gu; Zhu, Shao-Xing			Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice	PLOS ONE			English	Article							DOUBLE-RESTRICTED ADENOVIRUS; GENE-THERAPY; ONCOLYTIC ADENOVIRUS; INCREASED SURVIVAL; E1A; EXPRESSION; CARCINOMA; INTEGRIN; RECEPTOR; CAR	CAR is a transmembrane protein that is expressed in various epithelial and endothelial cells. CAR mediates adenoviral infection, as well as adenovirus-mediated oncolysis of AxdAdB-3, an E1A/E1B double-restricted oncolytic adenovirus, in prostate cancer cells. This study further assessed the therapeutic efficacy of AxdAdB-3 with Arg-Gly-Asp (RGD)-fiber modification (AxdAdB3-F/RGD), which enables integrin-dependent infection, in prostate cancer. Susceptibility of prostate cancer cells LNCaP, PC3, and DU145 to adenovirus infection was associated with CAR expression. All of the prostate cancer cell lines expressed integrin alpha(v)beta(3) and alpha(v)beta(5). AxdAdB-3 was more cytopathic in CAR-positive prostate cancer cells than in CAR-negative cells, whereas AxdAdB3-F/RGD caused potent oncolysis in both CAR-positive and CAR-negative prostate cancer cells. In contrast, AxdAdB3-F/RGD was not cytopathic against normal prostate epithelial cells, RWPE-1. Intratumoral injection of AxdAdB3-F/RGD into CAR-negative prostate cancer cell xenografts in nude mice inhibited tumor growth. The current study demonstrates that E1A/E1B double-restricted oncolytic adenovirus with an RGD-fiber modification enhances infection efficiency and anti-tumor activity in CAR-deficient prostate cancer cells, while sparing normal cells. Future studies will evaluate the therapeutic potential of AxdAdB3-F/RGD in prostate cancer.	[Shen, Yue-Hong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Fei] Zhejiang Univ, Sch Publ Hlth, Sch Med, Chron Dis Res Inst,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hua; Xu, Yi-Peng; Zhao, An; Zhu, Shao-Xing] Zhejiang Canc Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China; [Cai, Zhi-Jian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Ying; Zhang, Gu] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Zhejiang University; Zhejiang Cancer Hospital	Wang, H (corresponding author), Zhejiang Canc Hosp, Dept Urol, Hangzhou, Zhejiang, Peoples R China.	hwangua@aliyun.com	ZHAO, AN/O-1547-2014; Xu, Yipeng/GZG-2237-2022	Xu, Yipeng/0000-0003-4775-4160; ZHAO, An/0000-0002-2716-9733	Natural Science Foundation of Zhejiang Province, China [LY12H16031]; Health Bureau of Zhejiang Province, China [2012KYA025]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Health Bureau of Zhejiang Province, China	This study was supported in part by a grant from Natural Science Foundation of Zhejiang Province, China (#LY12H16031) and from the Health Bureau of Zhejiang Province, China (#2012KYA025).	Adam V, 2012, HUM GENE THER, V23, P1003, DOI 10.1089/hum.2012.046; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehari H, 2003, CANCER GENE THER, V10, P75, DOI 10.1038/sj.cgt.7700529; Dong WL, 2014, HUM GENE THER, V25, P897, DOI 10.1089/hum.2013.229; Douglas JT, 2001, CANCER RES, V61, P813; Freytag SO, 2014, INT J RADIAT ONCOL, V89, P268, DOI 10.1016/j.ijrobp.2014.02.034; Fukuda K, 2003, CANCER RES, V63, P4434; Gomez-Manzano C, 2004, ONCOGENE, V23, P1821, DOI 10.1038/sj.onc.1207321; Harada JN, 1999, J VIROL, V73, P5333, DOI 10.1128/JVI.73.7.5333-5344.1999; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Hess K, 2014, ANN DIAGN PATHOL, V18, P343, DOI 10.1016/j.anndiagpath.2014.09.001; Jarrard DF, 1997, GENE CHROMOSOME CANC, V19, P90, DOI 10.1002/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Pesonen S, 2012, INT J CANCER, V130, P1937, DOI 10.1002/ijc.26216; Rauen KA, 2002, CANCER RES, V62, P3812; Reeh M, 2013, BRIT J CANCER, V109, P1848, DOI 10.1038/bjc.2013.509; Amaral TMS, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/327253; Satoh M, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.09.031; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taki M, 2005, ONCOGENE, V24, P3130, DOI 10.1038/sj.onc.1208460; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wakayama M, 2007, CLIN CANCER RES, V13, P3043, DOI 10.1158/1078-0432.CCR-06-2103; Yang YF, 2014, GENE THER, V21, P723, DOI 10.1038/gt.2014.46; Zhang L, 2009, ASIAN J ANDROL, V11, P9, DOI 10.1038/aja.2008.21; Zheng DQ, 1999, CANCER RES, V59, P1655	28	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147173	10.1371/journal.pone.0147173	http://dx.doi.org/10.1371/journal.pone.0147173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799485	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300067
J	Wang, SS; Zhang, HY; Scharadin, TM; Zimmermann, M; Hu, B; Pan, AW; Vinall, R; Lin, TY; Cimino, G; Chain, P; Vuyisich, M; Gleasner, C; Mcmurry, K; Malfatti, M; Turteltaub, K; White, RD; Pan, CX; Henderson, PT				Wang, Sisi; Zhang, Hongyong; Scharadin, Tiffany M.; Zimmermann, Maike; Hu, Bin; Pan, Amy Wang; Vinall, Ruth; Lin, Tzu-Yin; Cimino, George; Chain, Patrick; Vuyisich, Momchilo; Gleasner, Cheryl; Mcmurry, Kim; Malfatti, Michael; Turteltaub, Kenneth; White, Ralph de Vere; Pan, Chong-Xian; Henderson, Paul T.			Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; KETO REDUCTASES AKR1C1; ENHANCED DNA-REPAIR; CISPLATIN RESISTANCE; CARRIER LIGAND; PHASE-II; OXALIPLATIN; CHEMOTHERAPY; LUNG; PHARMACOKINETICS	We report herein the development, functional and molecular characterization of an isogenic, paired bladder cancer cell culture model system for studying platinum drug resistance. The 5637 human bladder cancer cell line was cultured over ten months with stepwise increases in oxaliplatin concentration to generate a drug resistant 5637R sub cell line. The MTT assay was used to measure the cytotoxicity of several bladder cancer drugs. Liquid scintillation counting allowed quantification of cellular drug uptake and efflux of radiolabeled oxaliplatin and carboplatin. The impact of intracellular drug inactivation was assessed by chemical modulation of glutathione levels. Oxaliplatin-and carboplatin-DNA adduct formation and repair was measured using accelerator mass spectrometry. Resistance factors including apoptosis, growth factor signaling and others were assessed with RNAseq of both cell lines and included confirmation of selected transcripts by RT-PCR. Oxaliplatin, carboplatin, cisplatin and gemcitabine were significantly less cytotoxic to 5637R cells compared to the 5637 cells. In contrast, doxorubicin, methotrexate and vinblastine had no cell line dependent difference in cytotoxicity. Upon exposure to therapeutically relevant doses of oxaliplatin, 5637R cells had lower drug-DNA adduct levels than 5637 cells. This difference was partially accounted for by pre-DNA damage mechanisms such as drug uptake and intracellular inactivation by glutathione, as well as faster oxaliplatin-DNA adduct repair. In contrast, both cell lines had no significant differences in carboplatin cell uptake, efflux and drug-DNA adduct formation and repair, suggesting distinct resistance mechanisms for these two closely related drugs. The functional studies were augmented by RNAseq analysis, which demonstrated a significant change in expression of 83 transcripts, including 50 known genes and 22 novel transcripts. Most of the transcripts were not previously associated with bladder cancer chemoresistance. This model system and the associated phenotypic and genotypic data has the potential to identify some novel details of resistance mechanisms of clinical importance to bladder cancer.	[Wang, Sisi; Zhang, Hongyong; Scharadin, Tiffany M.; Zimmermann, Maike; Pan, Amy Wang; Lin, Tzu-Yin; Pan, Chong-Xian; Henderson, Paul T.] Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Vinall, Ruth; White, Ralph de Vere; Pan, Chong-Xian] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Malfatti, Michael; Turteltaub, Kenneth] Lawrence Livermore Natl Lab, Livermore, CA USA; [Pan, Chong-Xian] VA Northern Calif Hlth Care Syst, Mather, CA USA; [Hu, Bin; Chain, Patrick; Vuyisich, Momchilo; Gleasner, Cheryl; Mcmurry, Kim] Los Alamos Natl Lab, Los Alamos, NM USA; [Zimmermann, Maike; Cimino, George; Henderson, Paul T.] Accelerated Med Diagnostics Inc, Dublin, CA USA; [Wang, Sisi] Jilin Univ, Hosp 1, Translat Med Res Inst, Changchun 130023, Jilin, Peoples R China; [Pan, Amy Wang] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Vinall, Ruth] Calif Northstate Univ, Coll Pharm, Rancho Cordova, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Jilin University; University of California System; University of California San Diego	Pan, CX; Henderson, PT (corresponding author), Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA.; Pan, CX (corresponding author), Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA.; Pan, CX (corresponding author), VA Northern Calif Hlth Care Syst, Mather, CA USA.; Henderson, PT (corresponding author), Accelerated Med Diagnostics Inc, Dublin, CA USA.	cxpan@ucdavis.edu; paul.henderson@ucdmc.ucdavis.edu	Chain, Patrick/O-4140-2019; Vinall, Ruth/L-7026-2019	Chain, Patrick/0000-0003-3949-3634; Hu, Bin/0000-0002-0278-8466; Zimmermann, Maike/0000-0001-9005-3795	DOE [DE-AC52-07NA27344]; NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry [P41 RR013461]; DOE LDRD [08-LW-100]; American Cancer Society Institutional Research Grant; VA Career Development Award-2; NCI Cancer Center Support Grant a Cancer Clinical Investigator Team Leadership Award; NIH [HHSN261201200048C, HHSN261201200084C, R01CA155642, T32 CA108459-08]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL CANCER INSTITUTE [R01CA155642, T32CA108459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001784] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry; DOE LDRD(United States Department of Energy (DOE)); American Cancer Society Institutional Research Grant(American Cancer Society); VA Career Development Award-2; NCI Cancer Center Support Grant a Cancer Clinical Investigator Team Leadership Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	AMS samples were analyzed at Lawrence Livermore National Laboratory under the auspices of the DOE contract DE-AC52-07NA27344 and supported by NIH/NCRR Resource for Biomedical Accelerator Mass Spectrometry P41 RR013461 and DOE LDRD grant 08-LW-100 (PTH and KT), and by the American Cancer Society Institutional Research Grant (CXP). This study was also supported by the VA Career Development Award-2 (CXP), an NCI Cancer Center Support Grant (RDW) a Cancer Clinical Investigator Team Leadership Award (CXP), and NIH awards HHSN261201200048C, HHSN261201200084C, R01CA155642 (PTH) and T32 CA108459-08 (TS). The authors gratefully acknowledge the Susan and Gerry Knapp Family Fund. This work was performed, in part, under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The work reported here does not represent the views or opinions of the Department of Veterans Affairs or the United States Government.	ALIOSMAN F, 1994, J CELL BIOCHEM, V54, P11, DOI 10.1002/jcb.240540103; Brown K, 2005, METHOD ENZYMOL, V402, P423, DOI 10.1016/S0076-6879(05)02014-8; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Chaney SG, 2004, J INORG BIOCHEM, V98, P1551, DOI 10.1016/j.jinorgbio.2004.04.024; CHAO CCK, 1991, CANCER RES, V51, P601; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen YJ, 2005, GYNECOL ONCOL, V97, P110, DOI 10.1016/j.ygyno.2004.12.031; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cimino GD, 2013, BIOANALYSIS, V5, P369, DOI [10.4155/bio.12.325, 10.4155/BIO.12.325]; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; Ehrsson H, 2002, MED ONCOL, V19, P261, DOI 10.1385/MO:19:4:261; Ferry KV, 2000, BIOCHEM PHARMACOL, V60, P1305, DOI 10.1016/S0006-2952(00)00441-X; Fujiwara K, 2001, CANCER CHEMOTH PHARM, V47, P22, DOI 10.1007/s002800000212; GIBBONS GR, 1990, CANCER RES, V50, P6497; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Graham MA, 2000, CLIN CANCER RES, V6, P1205; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; He XP, 2012, INT J CANCER, V130, P1029, DOI 10.1002/ijc.26044; Hector S, 2007, CANCER LETT, V245, P195, DOI 10.1016/j.canlet.2006.01.007; Henderson PT, 2011, INT J CANCER, V129, P1425, DOI 10.1002/ijc.25814; HILL BT, 1990, INT J RADIAT ONCOL, V19, P75, DOI 10.1016/0360-3016(90)90137-9; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; JJ R, 1986, DNA TARGET CYTOTOXIC; JOHNSON SW, 1994, CANCER RES, V54, P5911; Johnson SW, 1997, CANCER RES, V57, P850; KELLAND LR, 1993, CRIT REV ONCOL HEMAT, V15, P191, DOI 10.1016/1040-8428(93)90042-3; Kool M, 1997, CANCER RES, V57, P3537; Kuhnl A, 2010, BLOOD, V115, P3737, DOI 10.1182/blood-2009-09-241943; LAI GM, 1988, BIOCHEM PHARMACOL, V37, P4597, DOI 10.1016/0006-2952(88)90325-5; Leung CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6092; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Ma XY, 2011, J JIANGSU U MED EDIT, V21, P308; Matsunaga T, 2014, ANTI-CANCER DRUG, V25, P868, DOI 10.1097/CAD.0000000000000112; Matsunaga T, 2013, CHEM-BIOL INTERACT, V202, P234, DOI 10.1016/j.cbi.2012.09.024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MAULDIN SK, 1988, CANCER RES, V48, P5136; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ognibene TJ, 2003, ANAL CHEM, V75, P2192, DOI 10.1021/ac026334j; Plasencia C, 2006, INT J ONCOL, V29, P225; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Saris CP, 1996, CARCINOGENESIS, V17, P2763, DOI 10.1093/carcin/17.12.2763; SHARMA H, 1983, CANCER CHEMOTH PHARM, V11, P5; Shirato A, 2014, ONCOL LETT, V7, P674, DOI 10.3892/ol.2013.1768; Silva MJ, 2005, ENVIRON MOL MUTAGEN, V46, P104, DOI 10.1002/em.20138; Sweeney CJ, 2006, J CLIN ONCOL, V24, P3451, DOI 10.1200/JCO.2005.03.6699; Tamashiro DAA, 2012, DIFFERENTIATION, V83, P282, DOI 10.1016/j.diff.2012.02.010; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trigueros-Motos L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-434; Vaisman A, 1998, CANCER RES, V58, P3579; Vaughn DJ, 2002, J CLIN ONCOL, V20, P937, DOI 10.1200/JCO.20.4.937; Virag P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-480; Virag P, 2012, ANTI-CANCER DRUG, V23, P1032, DOI 10.1097/CAD.0b013e328355076f; Virag P, 2011, CELL BIOCHEM FUNCT, V29, P351, DOI 10.1002/cbf.1754; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang HW, 2007, INT J CANCER, V120, P2019, DOI 10.1002/ijc.22402; Weaver DA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-18; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WOOD DP, 1993, MODERN PATHOL, V6, P33; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Xu YQ, 2014, J CELL BIOCHEM, V115, P1112, DOI 10.1002/jcb.24751; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Yu HM, 2012, FOOD CHEM TOXICOL, V50, P1226, DOI 10.1016/j.fct.2012.01.040; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200	70	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146256	10.1371/journal.pone.0146256	http://dx.doi.org/10.1371/journal.pone.0146256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799320	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300017
J	Bajwa, NM; Halavi, S; Hamer, M; Semple, BD; Noble-Haeusslein, LJ; Baghchechi, M; Hiroto, A; Hartman, RE; Obenaus, A				Bajwa, Nikita M.; Halavi, Shina; Hamer, Mary; Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Baghchechi, Mohsen; Hiroto, Alex; Hartman, Richard E.; Obenaus, Andre			Mild Concussion, but Not Moderate Traumatic Brain Injury, Is Associated with Long-Term Depression-Like Phenotype in Mice	PLOS ONE			English	Article							BEHAVIORAL DEFICITS; MOUSE MODEL; MOOD DISORDERS; ANIMAL-MODEL; IMPACT; BLAST; MOTOR; MAZE; RATS; NEUROINFLAMMATION	Mild traumatic brain injuries can lead to long-lasting cognitive and motor deficits, increasing the risk of future behavioral, neurological, and affective disorders. Our study focused on long-term behavioral deficits after repeated injury in which mice received either a single mild CHI (mCHI), a repeated mild CHI (rmCHI) consisting of one impact to each hemisphere separated by 3 days, or a moderate controlled cortical impact injury (CCI). Shams received only anesthesia. Behavioral tests were administered at 1, 3, 5, 7, and 90 days post-injury (dpi). CCI animals showed significant motor and sensory deficits in the early (1-7 dpi) and long-term (90 dpi) stages of testing. Interestingly, sensory and subtle motor deficits in rmCHI animals were found at 90 dpi. Most importantly, depression-like behaviors and social passiveness were observed in rmCHI animals at 90 dpi. These data suggest that mild concussive injuries lead to motor and sensory deficits and affective disorders that are not observed after moderate TBI.	[Bajwa, Nikita M.; Halavi, Shina; Hartman, Richard E.] Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA 92350 USA; [Hamer, Mary; Baghchechi, Mohsen; Hiroto, Alex; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Semple, Bridgette D.] Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Phys Therapy & Rehabil Sci, San Francisco, CA USA; [Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Sch Behav Hlth, Div Interdisciplinary Studies, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Royal Melbourne Hospital; University of Melbourne; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Riverside; Loma Linda University	Hartman, RE (corresponding author), Loma Linda Univ, Sch Behav Hlth, Dept Psychol, Loma Linda, CA 92350 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA.; Obenaus, A (corresponding author), Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Sch Behav Hlth, Div Interdisciplinary Studies, Loma Linda, CA 92350 USA.	behavioralneuroscience@gmail.com; aobenaus@llu.edu		Semple, Bridgette/0000-0002-2535-0491	School of Behavioral Health seed grant at Loma Linda University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077767] Funding Source: NIH RePORTER	School of Behavioral Health seed grant at Loma Linda University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by the School of Behavioral Health seed grant at Loma Linda University.; This work was supported by School of Behavioral Health seed grant at Loma Linda University. We are thankful to Chris Nishioka for his assistance in behavioral testing and CHI surgeries. Lastly, we would like to thank the Biomedical Undergraduate Research Program at University of California, Riverside for providing research students to assist in MRI analysis.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Arakawa H, 2009, BEHAV BRAIN RES, V205, P138, DOI 10.1016/j.bbr.2009.07.007; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; Craft TKS, 2006, BIOL PSYCHIAT, V60, P812, DOI 10.1016/j.biopsych.2006.03.011; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dulcich MS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/940830; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fenn AM, 2013, BIOL PSYCHIAT, P1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gerberding JL, 2003, REPORT TO CONGRESS O; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guley NH, 2015, J NEUROTRAUM, P1; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskowski RA., 2015, BRAIN NEUROTRAUMA MO; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Obenaus A, 2012, MILD TRAUMATIC BRAIN, P53; Obenaus A, 2015, ENCYCLOPEDIA OF MENT; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	76	36	36	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146886	10.1371/journal.pone.0146886	http://dx.doi.org/10.1371/journal.pone.0146886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796696	Green Published, gold			2022-12-27	WOS:000368530300014
J	Danner, SM; Krenn, M; Hofstoetter, US; Toth, A; Mayr, W; Minassian, K				Danner, Simon M.; Krenn, Matthias; Hofstoetter, Ursula S.; Toth, Andrea; Mayr, Winfried; Minassian, Karen			Body Position Influences Which Neural Structures Are Recruited by Lumbar Transcutaneous Spinal Cord Stimulation	PLOS ONE			English	Article							SOLEUS-H-REFLEX; TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR ROOT STIMULATION; POST-ACTIVATION DEPRESSION; HUMAN LUMBOSACRAL CORD; ELECTRICAL-STIMULATION; LEG MUSCLES; EPIDURAL STIMULATION; HUMANS; MODULATION	Transcutaneous stimulation of the human lumbosacral spinal cord is used to evoke spinal reflexes and to neuromodulate altered sensorimotor function following spinal cord injury. Both applications require the reliable stimulation of afferent posterior root fibers. Yet under certain circumstances, efferent anterior root fibers can be co-activated. We hypothesized that body position influences the preferential stimulation of sensory or motor fibers. Stimulus-triggered responses to transcutaneous spinal cord stimulation were recorded using surface-electromyography from quadriceps, hamstrings, tibialis anterior, and triceps surae muscles in 10 individuals with intact nervous systems in the supine, standing and prone positions. Single and paired (30-ms inter-stimulus intervals) biphasic stimulation pulses were applied through surface electrodes placed on the skin between the T11 and T12 interspinous processes referenced to electrodes on the abdomen. The paired stimulation was applied to evaluate the origin of the evoked electromyographic response; trans-synaptic responses would be suppressed whereas direct efferent responses would almost retain their amplitude. We found that responses to the second stimulus were decreased to 14% +/- 5% of the amplitude of the response to the initial pulse in the supine position across muscles, to 30%+/- 5% in the standing, and to only 80%+/- 5% in the prone position. Response thresholds were lowest during standing and highest in the prone position and response amplitudes were largest in the supine and smallest in the prone position. The responses obtained in the supine and standing positions likely resulted from selective stimulation of sensory fibers while concomitant motor-fiber stimulation occurred in the prone position. We assume that changes of root-fiber paths within the generated electric field when in the prone position increase the stimulation thresholds of posterior above those of anterior root fibers. Thus, we recommend conducting spinal reflex or neuromodulation studies with subjects lying supine or in an upright position, as in standing or stepping.	[Danner, Simon M.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Danner, Simon M.] Vienna Univ Technol, Inst Anal & Sci Comp, A-1040 Vienna, Austria; [Danner, Simon M.; Krenn, Matthias; Hofstoetter, Ursula S.; Toth, Andrea; Mayr, Winfried; Minassian, Karen] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	Drexel University; Technische Universitat Wien; Medical University of Vienna	Mayr, W (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	winfried.mayr@meduniwien.ac.at	Danner, Simon M./I-7944-2012	Danner, Simon M./0000-0002-4642-7064; Minassian, Karen/0000-0003-4197-6141; Krenn, Matthias J./0000-0002-3398-3627; Hofstoetter, Ursula S./0000-0002-3156-6483	Vienna Science and Technology Fund (WWTF) [LS11-057]; Wings for Life Spinal Cord Research Foundation [WFL-AT-007/11]	Vienna Science and Technology Fund (WWTF); Wings for Life Spinal Cord Research Foundation	This work was supported by the Vienna Science and Technology Fund (WWTF; Grant LS11-057; www.wwtf.at) and the Wings for Life Spinal Cord Research Foundation (Grant WFL-AT-007/11, http://www.wingsforlife.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese M, 1996, ELECTROMYOGR MOTOR C, V101, P339, DOI 10.1016/0924-980X(96)95682-9; Alrowayeh HN, 2005, J NEUROSCI METH, V144, P215, DOI 10.1016/j.jneumeth.2004.11.011; Andrews JC, 2015, J NEUROPHYSIOL, V114, P485, DOI 10.1152/jn.01007.2014; Andrews JC, 2015, NEUROSCI LETT, V589, P144, DOI 10.1016/j.neulet.2015.01.041; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; BROOKE JD, 1995, J NEUROPHYSIOL, V73, P102, DOI 10.1152/jn.1995.73.1.102; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRONE C, 1990, EXP BRAIN RES, V81, P35; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Danner SM, 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; DIMITRIJEVIC MR, 1983, SPINAL CORD RECONSTR, P465; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; HAYASHI R, 1992, NEUROSCI RES, V13, P227, DOI 10.1016/0168-0102(92)90062-H; Hofstoetter U. S., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4014; Hofstoetter U.S., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; Hofstoetter US, 2015, ARTIF ORGANS, V39, pE176, DOI 10.1111/aor.12615; Hofstoetter US, 2014, J SPINAL CORD MED, V37, P202, DOI 10.1179/2045772313Y.0000000149; Holsheimer J, 1998, NEUROMODULATION, V1, P57, DOI 10.1111/j.1525-1403.1998.tb00018.x; HOLSHEIMER J, 1994, AM J NEURORADIOL, V15, P951; Huang H, 2006, IEEE T NEUR SYS REH, V14, P14, DOI 10.1109/TNSRE.2005.862694; Kagamihara Y, 1998, MUSCLE NERVE, V21, P352, DOI 10.1002/(SICI)1097-4598(199803)21:3<352::AID-MUS9>3.0.CO;2-9; KATZ R, 1988, BRAIN, V111, P417, DOI 10.1093/brain/111.2.417; Kitano K, 2009, J NEUROSCI METH, V180, P111, DOI 10.1016/j.jneumeth.2009.03.006; Knikou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102313; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P630, DOI 10.1002/bem.21808; Knikou M, 2009, INT J NEUROSCI, V119, P2056, DOI 10.1080/00207450903139747; Krenn M., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4010; Krenn M, 2015, ARTIF ORGANS, V39, P834, DOI 10.1111/aor.12616; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; LLOYD DPC, 1957, J GEN PHYSIOL, V40, P409, DOI 10.1085/jgp.40.3.409; MERLETTI R, 1992, CRIT REV BIOMED ENG, V19, P293; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Minassian K, 2016, NEUROREHAB NEURAL RE, V30, P233, DOI 10.1177/1545968315591706; Pierrot-Deseilligny E, 2012, THE CIRCUITRY OF THE; Pinter MM, 2000, SPINAL CORD, V38, P524, DOI 10.1038/sj.sc.3101040; Ranger MRB, 2008, BRIT J ANAESTH, V101, P804, DOI 10.1093/bja/aen295; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Rattay F, 1990, ELECT NERVE STIMULAT; Rattay F., 2014, ENCY COMPUTATIONAL N, P1, DOI DOI 10.1007/978-1-4614-7320-6; Roy FD, 2014, EXP BRAIN RES, V232, P1717, DOI 10.1007/s00221-014-3864-6; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Sayenko DG, 2015, J APPL PHYSIOL, V118, P1364, DOI 10.1152/japplphysiol.01128.2014; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.3.CO;2-N; Troni W, 1996, MUSCLE NERVE, V19, P595, DOI 10.1002/(SICI)1097-4598(199605)19:5<595::AID-MUS7>3.3.CO;2-4; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P1025, DOI 10.1136/jnnp.52.9.1025; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053	56	43	50	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147479	10.1371/journal.pone.0147479	http://dx.doi.org/10.1371/journal.pone.0147479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797502	Green Submitted, gold, Green Published			2022-12-27	WOS:000368530300038
J	Pittman, HT; Krementz, DG				Pittman, H. Tyler; Krementz, David G.			Impacts of Short-Rotation Early-Growing Season Prescribed Fire on a Ground Nesting Bird in the Central Hardwoods Region of North America	PLOS ONE			English	Article							WILD TURKEY HENS; MELEAGRIS-GALLOPAVO SILVESTRIS; SITE SELECTION; REPRODUCTIVE ECOLOGY; FOREST STRUCTURE; SURVIVAL; POPULATION; DYNAMICS; ARKANSAS; SUCCESS	Landscape-scale short-rotation early-growing season prescribed fire, hereafter prescribed fire, in upland hardwood forests represents a recent shift in management strategies across eastern upland forests. Not only does this strategy depart from dormant season to growing season prescriptions, but the strategy also moves from stand-scale to landscape-scale implementation (>1,000 ha). This being so, agencies are making considerable commitments in terms of time and resources to this management strategy, but the effects on wildlife in upland forests, especially those dominated by hardwood canopy species, are relatively unknown. We initiated our study to assess whether this management strategy affects eastern wild turkey reproductive ecology on the Ozark-St. Francis National Forest. We marked 67 wild turkey hens with Global Positioning System (GPS) Platform Transmitting Terminals in 2012 and 2013 to document exposure to prescribed fire, and estimate daily nest survival, nest success, and nest-site selection. We estimated these reproductive parameters in forest units managed with prescribed fire (treated) and units absent of prescribed fire (untreated). Of 60 initial nest attempts monitored, none were destroyed or exposed to prescribed fire because a majority of fires occurred early than a majority of the nesting activity. We found nest success was greater in untreated units than treated units (36.4% versus 14.6%). We did not find any habitat characteristic differences between successful and unsuccessful nest-sites. We found that nest-site selection criteria differed between treated and untreated units. Visual concealment and woody ground cover were common selection criteria in both treated and untreated units. However, in treated units wild turkey selected nest-sites with fewer small shrubs (<5 cm ground diameter) and large trees (>20 cm DBH) but not in untreated units. In untreated units wild turkey selected nest-sites with more large shrubs (>= 5cm ground diameter) but did not select for small shrubs or large trees. Our findings suggest that wild turkey have not benefited from the reintroduction of prescribed fire to the WRERA.	[Pittman, H. Tyler] Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA; [Krementz, David G.] Univ Arkansas, Dept Biol Sci, Cooperat Fish & Wildlife Res Unit, US Geol Survey, Fayetteville, AR 72701 USA; [Pittman, H. Tyler] Florida Fish & Wildlife Commiss, Florida Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32601 USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of the Interior; United States Geological Survey; University of Arkansas System; University of Arkansas Fayetteville; Florida Fish & Wildlife Conservation Commission	Pittman, HT (corresponding author), Univ Arkansas, Dept Biol Sci, Arkansas Cooperat Fish & Wildlife Res Unit, Fayetteville, AR 72701 USA.; Pittman, HT (corresponding author), Florida Fish & Wildlife Commiss, Florida Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32601 USA.	H.T.Pittman@gmail.com			Arkansas Game and Fish Commission; USDA Forest Service Boson Mountain Ranger District; University of Arkansas; U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit; United States Department of Agriculture U.S. Forest Service; National Wild Turkey Federation	Arkansas Game and Fish Commission; USDA Forest Service Boson Mountain Ranger District; University of Arkansas; U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit; United States Department of Agriculture U.S. Forest Service; National Wild Turkey Federation	The authors received financial support from the Arkansas Game and Fish Commission for project implementation and logistics. The authors received support from the USDA Forest Service Boson Mountain Ranger District and the University of Arkansas, and the U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit to complete the project.; We received support from the United States Department of Agriculture U.S. Forest Service, Arkansas Game and Fish Commission, National Wild Turkey Federation, U.S. Geological Survey Arkansas Cooperative Fish and Wildlife Research Unit, and the University of Arkansas. We thank R. Whalen, B. Bowers, K. Lynch, J. Lindsay, J. Honey, J. Cothern, D. Magoulick, M. Douglas, and D. Moler for financial and logistical support. We thank C. Moorman, B. Collier, J. Cothern, D. Magoulick, M. Douglas, and two anonymous reviewers for comments to an early version of our manuscript. We also thank the Florida Fish and Wildlife Research Institute for allowing the work to be complete at the institute. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. All research was conducted under the approval of the Animal Care and Use Committee at the University of Arkansas (#11012).	Artman Vanessa L., 2005, Studies in Avian Biology, V30, P127; Artman VL, 2001, CONSERV BIOL, V15, P1423, DOI 10.1046/j.1523-1739.2001.00181.x; BADYAEV AV, 1995, CONDOR, V97, P221, DOI 10.2307/1368998; Badyaev AV, 1996, CONDOR, V98, P589, DOI 10.2307/1369571; Badyaev AV, 1994, THESIS U ARKANSAS; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne ME, 2013, AM MIDL NAT, V170, P95, DOI 10.1674/0003-0031-170.1.95; Chapman RA, 2006, FOREST ECOL MANAG, V236, P85, DOI 10.1016/j.foreco.2006.08.341; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Elliott KJ, 1999, FOREST ECOL MANAG, V114, P199, DOI 10.1016/S0378-1127(98)00351-X; Foti T. L., 2004, General Technical Report - Southern Research Station, USDA Forest Service, P21; Frank III., 2012, GEN TECH REP NRS P 1, P159; Franklin SB, 2003, FOREST ECOL MANAG, V184, P315, DOI 10.1016/S0378-1127(03)00153-1; Fryar RD, 2012, P 4 FIR E OAK FOR C, P292; Fuller AK, 2013, WILDLIFE BIOL, V19, P138, DOI 10.2981/11-121; Greenberg CH, 2007, J WILDLIFE MANAGE, V71, P1906, DOI 10.2193/2006-070; Greenberg CH, 2013, FOREST ECOL MANAG, V304, P80, DOI 10.1016/j.foreco.2013.04.035; Grubb TG, 1991, RM502 USDA FOR SERV; Guyette RP, 2006, FOREST ECOL MANAG, V234, P293, DOI 10.1016/j.foreco.2006.07.016; Kilburg EL, 2014, J WILDLIFE MANAGE, V78, P1033, DOI 10.1002/jwmg.751; Kiss BW, 2015, THESIS U MANITOBA; KURZEJESKI EW, 1987, J WILDLIFE MANAGE, V51, P188, DOI 10.2307/3801653; Lanham JD, 2006, FIRE E OAK FORESTS D, P303; Lehman CP, 2003, AM MIDL NAT, V149, P192, DOI 10.1674/0003-0031(2003)149[0192:COMCAN]2.0.CO;2; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Little AR, 2014, FOREST ECOL MANAG, V331, P180, DOI 10.1016/j.foreco.2014.07.030; Ludwig E, 2012, THESIS U DELAWARE; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; Miller DA, 1998, J WILDLIFE MANAGE, V62, P903, DOI 10.2307/3802541; Moore William F., 2010, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V64, P24; Nguyen LP, 2003, WILSON BULL, V115, P131, DOI 10.1676/02-123; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Paisley RN, 1998, J WILDLIFE MANAGE, V62, P911, DOI 10.2307/3802542; PALMER WE, 1993, J WILDLIFE MANAGE, V57, P783, DOI 10.2307/3809080; Peterson DW, 2001, ECOL APPL, V11, P914, DOI 10.1890/1051-0761(2001)011[0914:PFIOSF]2.0.CO;2; Pollentier CD, 2014, J WILDLIFE MANAGE, V78, P985, DOI 10.1002/jwmg.749; Reidy JL, 2014, FOREST ECOL MANAG, V313, P34, DOI 10.1016/j.foreco.2013.10.042; Thogmartin WE, 1999, AUK, V116, P912, DOI 10.2307/4089671; Thogmartin WE, 1998, THESIS U ARKANSAS; United States Department of Agriculture (USDA), 2005, US FOR SERV MAN B; VANGILDER LD, 1987, J WILDLIFE MANAGE, V51, P535, DOI 10.2307/3801265; Williams M, 2012, THESIS U GEORGIA; Wilson Walker B., 2005, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V59, P126	43	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147317	10.1371/journal.pone.0147317	http://dx.doi.org/10.1371/journal.pone.0147317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795913	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300029
J	Rebolj, M; Bonde, J; Preisler, S; Ejegod, D; Rygaard, C; Lynge, E				Rebolj, Matejka; Bonde, Jesper; Preisler, Sarah; Ejegod, Ditte; Rygaard, Carsten; Lynge, Elsebeth			Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MESSENGER-RNA ASSAY; INTRAEPITHELIAL NEOPLASIA; DNA TESTS; FOLLOW-UP; HPV TEST; CANCER; POPULATION; PERFORMANCE; PREVENTION	In women aged >= 30 years, Human Papillomavirus testing will replace cytology for primary cervical screening. We compared Hybrid Capture 2 (HC2), cobas, CLART, and APTIMA HPV assays with cytology on 2869 SurePath samples from women undergoing routine screening at 30-65 years in Copenhagen, Denmark. Women with cytological abnormalities were managed according to routine recommendations, with 92% completeness. Those with cytology-normal/HPV-positive samples (on any of the four assays) were invited for repeated cytology and HPV testing in 1.5 year, and 58% had additional testing. HPV testing detected more >= CIN3 than cytology (HC2: 35, cobas, CLART: 37, APTIMA: 34, cytology: 31), although statistically the differences were not significant. Cobas and CLART detected significantly more >= CIN2 than cytology (cobas, CLART: 49, cytology: 39). The proportion of women with false-positive test results (positive test results without >= CIN3) varied between 3.3% with cytology and 14.9% with cobas. All HPV assays led to significantly more false-positive tests, whereas compared to HC2 cobas and CLART were associated with a significantly higher and APTIMA with a significantly lower proportion. Detection of CIN1 was particularly increased for the three DNA assays. With APTIMA combined with cytological triage, about 20% more women were referred for colposcopy than with cytology screening. With the three DNA assays, the increase was >= 50%. The number of women with repeated testing was twice as high with APTIMA and almost five times as high with cobas compared to cytology. To our knowledge, Horizon was the only study set in routine practice that compared more than two HPV assays in the same women while also ascertaining the histological status of women with normal cytology/HPV-positive test results. HPV-based screening of Danish women aged 30-65 detected more high-grade CIN but decreased the screening specificity, and increased the demand for additional testing.	[Rebolj, Matejka; Lynge, Elsebeth] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bonde, Jesper; Preisler, Sarah; Ejegod, Ditte; Rygaard, Carsten] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark; [Rebolj, Matejka; Bonde, Jesper; Preisler, Sarah] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rebolj, M (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.; Rebolj, M (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark.	matejkarebolj@gmail.com	Bonde, Jesper/AAN-5930-2020; Bonde, Jesper H/F-1478-2013	Lynge, Elsebeth/0000-0003-4785-5236; Rebolj, Matejka/0000-0001-9597-645X; Bonde, Jesper/0000-0003-4853-6747	Danish Strategic Research Council [10092793]; Genomica; Hologic; Roche; QIAGEN	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Genomica; Hologic; Roche(Roche Holding); QIAGEN	Genomica, the manufacturer of the CLART HPV2 Assay; Hologic, the manufacturer of the APTIMA HPV Assay; Roche, the manufacturer of the cobas HPV Test; and QIAGEN, the manufacturer of the Hybrid Capture 2 Assay, provided tests, instrumentation, and limited co-funding for laboratory material. MR and SP were funded by the Danish Strategic Research Council (grant number: 10092793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers worked independently of the funders.	Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Bonde J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-413; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Castle PE, 2010, LANCET ONCOL, V11, P214, DOI 10.1016/S1470-2045(09)70385-7; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Goldman B, 2013, VACCINE, V31, P1604, DOI 10.1016/j.vaccine.2012.12.084; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Ingemann-Hansen O, 2008, BRIT J CANCER, V98, P1292, DOI 10.1038/sj.bjc.6604293; Kirschner B, 2011, GYNECOL ONCOL, V120, P68, DOI 10.1016/j.ygyno.2010.09.021; Lloveras B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058153; Lynge E, 2009, NAT REV CLIN ONCOL, V6, P699, DOI 10.1038/nrclinonc.2009.167; Monsonego J, 2011, INT J CANCER, V129, P691, DOI 10.1002/ijc.25726; Nieves L, 2013, INT J GYNECOL CANCER, V23, P513, DOI 10.1097/IGC.0b013e318280f3bc; Pista A, 2011, J MED VIROL, V83, P272, DOI 10.1002/jmv.21952; Poljak M, 2012, VACCINE, V30, pF100, DOI 10.1016/j.vaccine.2012.04.105; Preisler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059765; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Rebolj M, 2010, BRIT J CANCER, V103, P310, DOI 10.1038/sj.bjc.6605771; Rebolj M, 2007, INT J CANCER, V120, P806, DOI 10.1002/ijc.22167; Rebolj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086835; Rebolj M, 2013, J MOL DIAGN, V15, P670, DOI 10.1016/j.jmoldx.2013.04.002; Rebolj M, 2013, CURR PHARM DESIGN, V19, P1439; Rebolj M, 2012, EUR J CANCER PREV, V21, P73, DOI 10.1097/CEJ.0b013e3283498dbe; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076; Wu RF, 2010, INT J GYNECOL CANCER, V20, P1411, DOI 10.1111/IGC.0b013e3181f29547	31	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147326	10.1371/journal.pone.0147326	http://dx.doi.org/10.1371/journal.pone.0147326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789267	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100079
J	Chandrasekaran, S; Bonchev, D				Chandrasekaran, Sreedevi; Bonchev, Danail			Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; OXIDATIVE STRESS; NEUROFIBRILLARY TANGLES; GAMMA-SECRETASE; BETA; EXPRESSION; DYSFUNCTION; MECHANISMS; NEURODEGENERATION	Network-based approaches are powerful and beneficial tools to study complex systems in their entirety, elucidating the essential factors that turn the multitude of individual elements into a functional system. In this study we used critical network topology descriptors and guilt-by-association rule to explore and understand the significant molecular players, drug targets and underlying biological mechanisms of Alzheimer's disease. Analyzing two post-mortem brain gene microarrays (GSE4757 and GSE28146) with Pathway Studio software package we constructed and analyzed a set of protein-protein interaction, as well as miRNA-target networks. In a 4-step procedure the expression datasets were normalized using Robust Multi-array Average approach, while the modulation of gene expression by the disease was statistically evaluated by the empirical Bayes method from the limma Bioconductor package. Representative set of 214 seed-genes (p<0.01) common for the three brain sections of the two microarrays was thus created. The Pathway Studio analysis of the networks built identified 15 new potential AD-related genes and 17 novel AD-involved microRNAs. Using KEGG pathways relevant in Alzheimer's disease we built an integrated mechanistic network from the interactions between the overlapping genes in these pathways. Routes of possible disease initiation process were thus revealed through the CD4, DCN, and IL8 extracellular ligands. DAVID and IPA enrichment analysis uncovered a number of deregulated biological processes and pathways including neuron projection/differentiation, aging, oxidative stress, chemokine/neurotrophin signaling, long-term potentiation and others. The findings in this study offer information of interest for subsequent experimental studies.	[Chandrasekaran, Sreedevi; Bonchev, Danail] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University	Chandrasekaran, S (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA.	sreedevi.c@gmail.com						Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Auffret A, 2010, J ALZHEIMERS DIS, V19, P1021, DOI 10.3233/JAD-2010-1302; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Batagelj V., 1998, CONNECTIONS, V21, P1; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Cecarini V, 2012, BBA-MOL BASIS DIS, V1822, P1741, DOI 10.1016/j.bbadis.2012.07.015; Chandrasekaran S, 2013, COMPUT STRUCT BIOTEC, V7, DOI 10.5936/csbj.201304004; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Das P, 2006, J CLIN INVEST, V116, P2855, DOI 10.1172/JCI30284; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dunckley T, 2006, NEUROBIOL AGING, V27, P1359, DOI 10.1016/j.neurobiolaging.2005.08.013; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Estrada E, 2011, STRUCTURE COMPLEX NE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; GITTER BD, 1995, P NATL ACAD SCI USA, V92, P10738, DOI 10.1073/pnas.92.23.10738; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hertel M, 2002, EUR J NEUROSCI, V15, P1707, DOI 10.1046/j.1460-9568.2002.01992.x; Hippius Hanns, 2003, Dialogues Clin Neurosci, V5, P101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs HIL, 2013, NEUROSCI BIOBEHAV R, V37, P753, DOI 10.1016/j.neubiorev.2013.03.009; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Leuba G, 2004, NEUROPATH APPL NEURO, V30, P57, DOI 10.1046/j.0305-1846.2003.00511.x; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Manczak M, 2013, J ALZHEIMERS DIS, V36, P285, DOI 10.3233/JAD-130275; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Mateo I, 2009, ACTA NEUROL SCAND, V120, P130, DOI 10.1111/j.1600-0404.2008.01128.x; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; NCBI, NCHI GEO DAT GSE4757; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Pollak D, 2003, J NEURAL TRANSM-SUPP, P149; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Proctor CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-7; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Qin QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009999; Qin S, 2004, ACTA NEUROPATHOL, V107, P209, DOI 10.1007/s00401-003-0800-4; Raux G, 2005, J MED GENET, V42, P793, DOI 10.1136/jmg.2005.033456; Reddy PH, 2014, J ALZHEIMERS DIS, V40, P245, DOI 10.3233/JAD-132060; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P139, DOI 10.4137/GRSB.S13204; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serretti A, 2005, J ALZHEIMERS DIS, V7, P331; Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; Solerte SB, 1998, NEUROBIOL AGING, V19, P191, DOI 10.1016/S0197-4580(98)00050-5; Sonoda Y, 2010, NEUROSCI LETT, V471, P20, DOI 10.1016/j.neulet.2009.12.078; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Tichauer JE, 2012, J NEUROSCI RES, V90, P1970, DOI 10.1002/jnr.23082; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tsang SWY, 2008, NEUROBIOL AGING, V29, P1524, DOI 10.1016/j.neurobiolaging.2007.03.014; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Wolfe MS, 2013, NAT MED, V19, P22, DOI 10.1038/nm.3053; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia Jing, 2014, Int J Alzheimers Dis, V2014, P721453, DOI 10.1155/2014/721453; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Zambrano N, 2004, J BIOL CHEM, V279, P16161, DOI 10.1074/jbc.M311027200; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018	98	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144052	10.1371/journal.pone.0144052	http://dx.doi.org/10.1371/journal.pone.0144052			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784894	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400003
J	Gorst, SL; Gargon, E; Clarke, M; Blazeby, JM; Altman, DG; Williamson, PR				Gorst, Sarah L.; Gargon, Elizabeth; Clarke, Mike; Blazeby, Jane M.; Altman, Douglas G.; Williamson, Paula R.			Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey	PLOS ONE			English	Review							CLINICAL-TRIALS; WASTE; SETS	Background A COS represents an agreed minimum set of outcomes that should be measured and reported in all trials of a specific condition. The COMET (Core Outcome Measures in Effectiveness Trials) initiative aims to collate and stimulate the development and application of COS, by including data on relevant studies within a publically available internet-based resource. In recent years, there has been an interest in increasing the development of COS. Therefore, this study aimed to provide an update of a previous review, and examine the quality of development of COS. A further aim was to understand the reasons why individuals are searching the COMET database. Methods A multi-faceted search strategy was followed, in order to identify studies that sought to determine which outcomes/domains to measure in clinical trials of a specific condition. Additionally, a pop up survey was added to the COMET website, to ascertain why people were searching the COMET database. Results Thirty-two reports relating to 29 studies were eligible for inclusion in the review. There has been an improvement in the description of the scope of a COS and an increase in the proportion of studies using literature/systematic reviews and the Delphi technique. Clinical experts continue to be the most common group involved in developing COS, however patient and public involvement has increased. The pop-up survey revealed the most common reasons for visiting the COMET website to be thinking about developing a COS and planning a clinical trial. Conclusions This update demonstrates that recent studies appear to have adopted a more structured approach towards COS development and public representation has increased. However, there remains a need for developers to adequately describe details about the scope of COS, and for greater public engagement. The COMET database appears to be a useful resource for both COS developers and users of COS.	[Gorst, Sarah L.; Gargon, Elizabeth; Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Clarke, Mike] Queens Univ Belfast, Northern Ireland Network Trials Methodol Res, Belfast, Antrim, North Ireland; [Blazeby, Jane M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Blazeby, Jane M.] Univ Hosp NHS Fdn Trust, Div Surg Head & Neck, Bristol, Avon, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Liverpool; Queens University Belfast; University of Bristol; University of Oxford	Gorst, SL (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	sgorst@liverpool.ac.uk	Williamson, Paula R/B-6425-2016	Williamson, Paula R/0000-0001-9802-6636	NIHR (National Institute for Health Research) [NF-Sl_0513-10025]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/K025643/1, G0901530] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114, NF-SI-0513-10025, NF-SI-0513-10131] Funding Source: researchfish; MRC [G0901530, MR/K025643/1] Funding Source: UKRI	NIHR (National Institute for Health Research)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the NIHR (National Institute for Health Research), grant number NF-Sl_0513-10025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Gargon E, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0019-9; Gargon E, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-279; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Horsley T, 2011, COCHRANE DATABASER S, V8; INVOLVE, 2012, BRIEF NOT RES INV PU; Kirkham JJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0913-9; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	10	100	104	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146444	10.1371/journal.pone.0146444	http://dx.doi.org/10.1371/journal.pone.0146444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785121	gold, Green Published			2022-12-27	WOS:000368528400039
J	Kajubi, P; Whyte, SR; Kyaddondo, D; Katahoire, AR				Kajubi, Phoebe; Whyte, Susan Reynolds; Kyaddondo, David; Katahoire, Anne Ruhweza			Tensions in Communication between Children on Antiretroviral Therapy and Their Caregivers: A Qualitative Study in Jinja District, Uganda	PLOS ONE			English	Article							HIV STATUS; DISCLOSURE MODEL; DIAGNOSIS; ADOLESCENTS; CHILDHOODS; HIV/AIDS; ANTHROPOLOGY; DISTRESS; HEALTH	Introduction HIV treatment and disclosure guidelines emphasize the importance of communicating diagnosis and treatment to infected children in ways that are appropriate to children's developmental stage and age. Minimal attention, however, has been given to communication challenges confronted by HIV-infected children and their caregivers. This study examined the tensions between children and their caregivers arising from differing perspectives regarding when and what to communicate about antiretroviral therapy (ART). Methods This qualitative study was conducted between November 2011 and December 2012 and involved 29 HIV-infected children aged 8-17 years on ART and their caregivers. Data were collected through observations and in-depth interviews, which took place in homes, treatment centres and post-test clubs. Children and caregivers were sampled from among the 394 HIV-infected children and (their) 393 caregivers who participated in the cross-sectional survey that preceded the qualitative study. ATLAS.ti. Version 7 was used in the management of the qualitative data and in the coding of the emerging themes. The data were then analyzed using content thematic analysis. Results While the children felt that they were mature enough to know what they were suffering and what the medications were for, the caregivers wanted to delay discussions relating to the children's HIV diagnosis and medication until they felt that the children were mature enough to deal with the information and keep it a secret and this caused a lot of tension. The children employed different tactics including refusing to take the medicines, to find out what they were suffering from and what the medications were for. Children also had their own ideas about when, where and with whom to discuss their HIV condition, ideas that did not necessarily coincide with those of their caregivers, resulting in tensions. Conclusions Guidelines should take into consideration differing perceptions of maturity when recommending ages at which caregivers should communicate with their children about diagnosis and ART. Health care providers should also encourage caregivers to recognize and respect children's efforts to learn about and manage their condition. Children's questions and expressions of feelings should be treated as openings for communication on these issues.	[Kajubi, Phoebe; Kyaddondo, David; Katahoire, Anne Ruhweza] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Whyte, Susan Reynolds] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark	Makerere University; University of Copenhagen	Kajubi, P (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	phoebekajubi@yahoo.com		Whyte, Susan/0000-0001-7253-6478	Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)" [09-100KU]; ChildMed coordination team	Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)"; ChildMed coordination team	The study was funded by the Danish Ministry of Foreign Affairs, Uganda, through a project called "Quality Medicine Use for Children in Uganda (ChildMed)" project number: 09-100KU; website: http://childmed.ku.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the children and their caregivers who participated in the study and the health workers in all the study sites for their support. We acknowledge the support of the ChildMed coordination team.	Abadia-Barrero CE, 2006, AIDS PATIENT CARE ST, V20, P36, DOI 10.1089/apc.2006.20.36; Abebe W, 2012, AIDS CARE, V24, P1097, DOI 10.1080/09540121.2012.656565; [Anonymous], 2009, HIGH LOC GOV STAT AB; Aries P., 1962, CENTURIES CHILDHOOD; Arun S, 2009, INDIAN J PEDIATR, V76, P805, DOI 10.1007/s12098-009-0177-z; Baaroy JO, 1999, THESIS U OSLO NORWAY; Bernard H. R., 2017, RES METHODS ANTHR; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Bluebond-Langner M, 2007, AM ANTHROPOL, V109, P241, DOI 10.1525/AA.2007.109.2.241; Boyden J., 2003, CHILDREN YOUTH ENV, V13, P1; Brannen J, 2004, CHILDHOOD, V11, P409, DOI 10.1177/0907568204047104; Buhler-Niederberger D, 2008, CHILDHOOD, V15, P147, DOI 10.1177/0907568207088419; Campbell C, 2015, HEALTH PLACE, V31, P54, DOI 10.1016/j.healthplace.2014.09.008; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Hardman C, 2001, CHILDHOOD, V8, P501, DOI 10.1177/0907568201008004006; HARDY MS, 1994, J DEV BEHAV PEDIATR, V15, pS49; Heeren GA, 2011, INNOVATION-ABINGDON, V24, P199, DOI 10.1080/13511610.2011.553506; Instone S L, 2000, J Pediatr Health Care, V14, P235, DOI 10.1067/mph.2000.107338; Jenks C, 2004, CHILDHOOD, V11, P5, DOI 10.1177/0907568204040179; Kajubi P, 2014, CHILD YOUTH SERV REV, V45, P38, DOI 10.1016/j.childyouth.2014.03.036; Kajubi P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19012; Kalibala S, 2010, SITUATION ANAL VULNE, P2; Kidia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087322; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Lancy D. F., 2008, ANTHR CHILDHOOD CHER; Ledlie SW, 1999, NURS RES, V48, P141, DOI 10.1097/00006199-199905000-00004; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; LEE M, 1999, AIDS BEHAV, V3, P33, DOI DOI 10.1023/A:1025415418759; Lester P, 2002, JAIDS-J ACQ IMM DEF, V31, P309, DOI 10.1097/00126334-200211010-00006; LeVine RA, 2007, AM ANTHROPOL, V109, P247, DOI 10.1525/AA.2007.109.2.247; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Meinert L., 2009, HOPES FRICTION SCH H; Ministry of Health (MOH) [Uganda] and ICF International, 2011, UG AIDS IND SURV 201; MOH, 2009, UG NAT ANT TREATM GU; MOH, 2005, UG NAT POL HIV COUNS; Moodley K, 2008, S AFR MED J, V96, P201; Mupambireyi Z, 2014, CHILDREN YOUTH SERVI; Murphy DA, 2000, J ADOLESCENT HEALTH, V27, P391, DOI 10.1016/S1054-139X(00)00158-0; Myer L, 2006, J TROP PEDIATRICS, V52, P293, DOI 10.1093/tropej/fml004; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Onyango-Ouma W, 2001, CHILDREN HLTH COMMUN; Punch S, 2003, SOCIOLOGY, V37, P277, DOI 10.1177/0038038503037002004; Rushforth H, 1999, J CHILD PSYCHOL PSYC, V40, P683, DOI 10.1017/S0021963099003996; Rwemisisi J, 2008, HEALTH POLICY PLANN, V23, P36, DOI 10.1093/heapol/czm040; Siu GE, 2012, AIDS CARE, V24, P606, DOI 10.1080/09540121.2011.630346; Skovdal M, 2012, AJAR-AFR J AIDS RES, V11, P153, DOI 10.2989/16085906.2012.734975; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; The Government of the Republic of Uganda, 2010, NAT POL DIS PREP MAN; UAC, 2013, UG HIV AIDS COUNTR P; Vaz L, 2011, J DEV BEHAV PEDIAT J; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; WHO, 2013, GLOB UPD HIV TREATM; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2013, GUID HIV TEST COUNS	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147119	10.1371/journal.pone.0147119	http://dx.doi.org/10.1371/journal.pone.0147119			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784904	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400113
J	Kang, L; Zhang, S				Kang, Ling; Zhang, Song			Application of the Elitist-Mutated PSO and an Improved GSA to Estimate Parameters of Linear and Nonlinear Muskingum Flood Routing Models	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION	Heuristic search algorithms, which are characterized by faster convergence rates and can obtain better solutions than the traditional mathematical methods, are extensively used in engineering optimizations. In this paper, a newly developed elitist-mutated particle swarm optimization (EMPSO) technique and an improved gravitational search algorithm (IGSA) are successively applied to parameter estimation problems of Muskingum flood routing models. First, the global optimization performance of the EMPSO and IGSA are validated by nine standard benchmark functions. Then, to further analyse the applicability of the EMPSO and IGSA for various forms of Muskingum models, three typical structures are considered: the basic two-parameter linear Muskingum model (LMM), a three-parameter nonlinear Muskingum model (NLMM) and a four-parameter nonlinear Muskingum model which incorporates the lateral flow (NLMM-L). The problems are formulated as optimization procedures to minimize the sum of the squared deviations (SSQ) or the sum of the absolute deviations (SAD) between the observed and the estimated outflows. Comparative results of the selected numerical cases (Case 1-3) show that the EMPSO and IGSA not only rapidly converge but also obtain the same best optimal parameter vector in every run. The EMPSO and IGSA exhibit superior robustness and provide two efficient alternative approaches that can be confidently employed to estimate the parameters of both linear and nonlinear Muskingum models in engineering applications.	[Kang, Ling; Zhang, Song] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhang, S (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan 430074, Peoples R China.	zhangs@hust.edu.cn		Zhang, Song/0000-0002-6516-3965	Hubei Support Plan of Science and Technology of China [2015BCA291]; Wuhan Planning Project of Science and Technology of China [2014060101010062]	Hubei Support Plan of Science and Technology of China; Wuhan Planning Project of Science and Technology of China	This study was partly supported by the Hubei Support Plan of Science and Technology of China (No. 2015BCA291), and the Wuhan Planning Project of Science and Technology of China (No. 2014060101010062).	Al-Humoud JM, 2006, WATER RESOUR MANAG, V20, P979, DOI 10.1007/s11269-006-9018-2; [Anonymous], 1983, ENG HYDROLOGY; Barati R, 2011, J HYDROL ENG, V16, P946, DOI 10.1061/(ASCE)HE.1943-5584.0000379; Chen JJ, 2007, COMMUN NONLINEAR SCI, V12, P849, DOI 10.1016/j.cnsns.2005.06.005; Chow V. T., 1988, APPL HYDROLOGY; Chu HJ, 2009, J HYDROL ENG, V14, P1024, DOI 10.1061/(ASCE)HE.1943-5584.0000070; Clerc M., 1999, P C EV COMP, P1951, DOI DOI 10.1109/CEC.1999.785513; Das A, 2004, J IRRIG DRAIN ENG, V130, P140, DOI 10.1061/(ASCE)0733-9437(2004)130:2(140); Deb K, 2000, COMPUT METHOD APPL M, V186, P311, DOI 10.1016/S0045-7825(99)00389-8; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Geem ZW, 2006, J IRRIG DRAIN ENG, V132, P474, DOI 10.1061/(ASCE)0733-9437(2006)132:5(474); Geem ZW, 2014, ENG OPTIMIZ, V46, P328, DOI 10.1080/0305215X.2013.768242; GILL MA, 1978, J HYDROL, V36, P353, DOI 10.1016/0022-1694(78)90153-1; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Karahan H, 2015, ENG OPTIMIZ, V47, P737, DOI 10.1080/0305215X.2014.918115; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim JH, 2001, J AM WATER RESOUR AS, V37, P1131, DOI 10.1111/j.1752-1688.2001.tb03627.x; Kumar DN, 2007, J WATER RES PLAN MAN, V133, P192, DOI 10.1061/(ASCE)0733-9496(2007)133:3(192); Li CH, 2009, IEEE C EVOL COMPUTAT, P381, DOI 10.1109/CEC.2009.4982972; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Luo JG, 2010, J HYDROL ENG, V15, P844, DOI 10.1061/(ASCE)HE.1943-5584.0000244; [马细霞 MA Xixia], 2007, [郑州大学学报. 工学版, Journal of Zhengzhou University. Engineering Science], V28, P122; McCarthy GT., 1938, C N ATL DIV; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Mirjalili S., 2010, Proceedings of the 2010 International Conference on Computer and Information Application (ICCIA 2010), P374, DOI 10.1109/ICCIA.2010.6141614; ODONNELL T, 1985, HYDROLOG SCI J, V30, P479, DOI 10.1080/02626668509491013; Ouyang AJ, 2014, NEURAL COMPUT APPL, V25, P1785, DOI 10.1007/s00521-014-1669-y; Qu GJ, 1977, J HYDROL, V36, P40; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; TUNG YK, 1985, J HYDRAUL ENG-ASCE, V111, P1447, DOI 10.1061/(ASCE)0733-9429(1985)111:12(1447); Vesterstrom J, 2004, IEEE C EVOL COMPUTAT, P1980; Wang GG, 2014, ENG COMPUTATION, V31, P1198, DOI 10.1108/EC-10-2012-0232; Xu DM, 2012, J HYDROL ENG, V17, P348, DOI 10.1061/(ASCE)HE.1943-5584.0000432; Yang ZX, 2010, 2010 2ND IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND FINANCIAL ENGINEERING (ICIFE), P910, DOI 10.1109/ICIFE.2010.5609501; YOON JW, 1993, J WATER RES PL-ASCE, V119, P600, DOI 10.1061/(ASCE)0733-9496(1993)119:5(600)	38	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147338	10.1371/journal.pone.0147338	http://dx.doi.org/10.1371/journal.pone.0147338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784900	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400136
J	Khoory, J; Estanislau, J; Elkhal, A; Lazaar, A; Melhorn, MI; Brodsky, A; Illigens, B; Hamachi, I; Kurishita, Y; Ivanov, AR; Shevkoplyas, S; Shapiro, NI; Ghiran, IC				Khoory, Joseph; Estanislau, Jessica; Elkhal, Abdallah; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Illigens, Ben; Hamachi, Itaru; Kurishita, Yasutaka; Ivanov, Alexander R.; Shevkoplyas, Sergey; Shapiro, Nathan I.; Ghiran, Ionita C.			Ligation of Glycophorin A Generates Reactive Oxygen Species Leading to Decreased Red Blood Cell Function	PLOS ONE			English	Article							INDUCED ATP RELEASE; HUMAN ERYTHROCYTES; LUNG INJURY; RECEPTORS; PROTEIN; SEPSIS; DEFORMABILITY; PATHOGENESIS; DYSFUNCTION; APOPTOSIS	Acute, inflammatory conditions associated with dysregulated complement activation are characterized by significant increases in blood concentration of reactive oxygen species (ROS) and ATP. The mechanisms by which these molecules arise are not fully understood. In this study, using luminometric- and fluorescence-based methods, we show that ligation of glycophorin A (GPA) on human red blood cells (RBCs) results in a 2.1-fold, NADPH-oxidase-dependent increase in intracellular ROS that, in turn, trigger multiple downstream cascades leading to caspase-3 activation, ATP release, and increased band 3 phosphorylation. Functionally, using 2D microchannels to assess membrane deformability, GPS-ligated RBCs travel 33% slower than control RBCs, and lipid mobility was hindered by 10% using fluorescence recovery after photobleaching (FRAP). These outcomes were preventable by pretreating RBCs with cell-permeable ROS scavenger glutathione monoethyl ester (GSH-ME). Our results obtained in vitro using anti-GPA antibodies were validated using complement-altered RBCs isolated from control and septic patients. Our results suggest that during inflammatory conditions, circulating RBCs significantly contribute to capillary flow dysfunctions, and constitute an important but overlooked source of intravascular ROS and ATP, both critical mediators responsible for endothelial cell activation, microcirculation impairment, platelet activation, as well as long-term dysregulated adaptive and innate immune responses.	[Khoory, Joseph; Estanislau, Jessica; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Ghiran, Ionita C.] Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA; [Khoory, Joseph; Estanislau, Jessica; Elkhal, Abdallah; Lazaar, Asmae; Melhorn, Mark I.; Brodsky, Abigail; Illigens, Ben; Shapiro, Nathan I.; Ghiran, Ionita C.] Harvard Univ, Sch Med, Boston, MA USA; [Elkhal, Abdallah] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Illigens, Ben] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hamachi, Itaru; Kurishita, Yasutaka] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Ivanov, Alexander R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Shevkoplyas, Sergey] Univ Houston, Cullen Coll Engn, Dept Biomed Engn, Houston, TX USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Kyoto University; Northeastern University; University of Houston System; University of Houston; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Ghiran, IC (corresponding author), Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02215 USA.; Ghiran, IC (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	ighiran@bidmc.harvard.edu	Shapiro, Nathan/F-1718-2016	Shevkoplyas, Sergey/0000-0002-8203-8365	National Institutes of Health [R01 HL096795]; Bill and Melinda Gates Foundation [OPP1032683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health R01 HL096795 (ICG), and Bill and Melinda Gates Foundation award OPP1032683 (ICG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EH, 2001, BLOOD CELL MOL DIS, V27, P165, DOI 10.1006/bcmd.2000.0357; ABRAMSON SB, 1991, ANN INTERN MED, V114, P941, DOI 10.7326/0003-4819-114-11-941; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; [Anonymous], 2009, CHEST; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Bakhtiari N, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-9; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Bloomfield C D, 1976, Semin Oncol, V3, P297; Bohm R, 1996, BBA-BIOMEMBRANES, V1280, P238, DOI 10.1016/0005-2736(95)00303-7; Borschukova O, 2012, LUPUS, V21, P1294, DOI 10.1177/0961203312454342; Brain MC, 2002, BRIT J HAEMATOL, V118, P899, DOI 10.1046/j.1365-2141.2002.03657.x; Brandao-Burch Andrea, 2012, Front Endocrinol (Lausanne), V3, P41, DOI 10.3389/fendo.2012.00041; CHAPLIN H, 1983, BLOOD, V62, P965; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; COOPER NR, 1969, SCIENCE, V165, P396, DOI 10.1126/science.165.3891.396; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghiran IC, 2010, ARTHRITIS RHEUMATISM; Ghiran I, 2008, BLOOD, V112, P3465, DOI 10.1182/blood-2008-04-151845; Ghiran IC, 2011, ARTHRITIS RHEUM-US, V63, P503, DOI 10.1002/art.30143; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; HARRISON ML, 1994, J BIOL CHEM, V269, P955; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Howell MD, 2007, CRIT CARE MED, V35, P1422, DOI 10.1097/01.CCM.0000262933.08673.0C; HURD TC, 1988, ARCH SURG-CHICAGO, V123, P217; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; MACFARLANE GD, 1994, ORAL MICROBIOL IMMUN, V9, P180, DOI 10.1111/j.1399-302X.1994.tb00056.x; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Matsuyama H, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-79; McMullin MF, 1999, J CLIN PATHOL, V52, P245, DOI 10.1136/jcp.52.4.245; Melhorn MI, 2013, J BIOL CHEM, V288, P31139, DOI 10.1074/jbc.M113.486035; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Moutzouri AG, 2007, CLIN HEMORHEOL MICRO, V36, P291; Muroya T, 2014, CRIT CARE MED, V42, pE364, DOI 10.1097/CCM.0000000000000231; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nencioni A, 2009, INTERN EMERG MED; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; PIERCE KR, 1972, J AM VET MED ASSOC, V160, P323; PISANO A, 1993, GLYCOBIOLOGY, V3, P429, DOI 10.1093/glycob/3.5.429; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sinha A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09768; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vicas AE, 2005, AM J MED SCI, V329, P6, DOI 10.1097/00000441-200501000-00002; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Zhou G, 2012, AM J PHYSIOL-REG I, V302, pR409, DOI 10.1152/ajpregu.00153.2011	58	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0141206	10.1371/journal.pone.0141206	http://dx.doi.org/10.1371/journal.pone.0141206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784696	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400002
J	Shi, XC; Zhang, LF; Zhang, YQ; Zhou, BT; Liu, XQ				Shi, Xiaochun; Zhang, Lifan; Zhang, Yueqiu; Zhou, Baotong; Liu, Xiaoqing			Utility of T-Cell Interferon-gamma Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area - a pilot prospective cohort	PLOS ONE			English	Article							LATENT TUBERCULOSIS; INFECTION; CHINA	Background Tuberculosis (TB), especially extrapulmonary TB is still the leading cause of fever of unknown origin (FUO) in China. However, diagnosis of TB still remains a challenge. The aim of this study was to evaluate the diagnostic value of T-SPOT. TB for etiological diagnosis of classic FUO in adult patients in a high TB endemic area. Methods We prospectively enrolled patients presenting with classic FUO in a tertiary referral hospital in Beijing, China, to investigate the diagnostic sensitivity, specificity, predictive values and likelihood ratio of T-SPOT. TB. Clinical assessment and T-SPOT. TB were performed. Test results were compared with the final confirmed clinical diagnosis. Results 387 hospitalized patients (male n = 194, female n = 193; median age 46 (range 29-59) yrs) with classic FUO were prospectively enrolled into this study. These FUOs were caused by infection (n = 158, 40.8%), connective tissue disease (n = 82, 21.2%), malignancy (n = 41, 10.6%) and miscellaneous other causes (n = 31, 8.0%), and no cause was determined in 75 (19.4%) patients. 68 cases were diagnosed as active TB eventually. The sensitivity of T-SPOT. TB for the diagnosis of active TB was 70.6% (95% CI 58.9-80.1%), while specificity was 84.4% (95% CI 79.4-88.4%), positive predictive value was 55.8% (95% CI 45.3-65.8%), negative predictive value was 91.2%(95% CI 86.7-94.2%). Among these 68 active TB patients, 12 cases were culture or histology confirmed (11 cases with positive T-SPOT. TB, sensitivity was 91.7%) and 56 cases were clinically diagnosed (37 cases with positive T-SPOT. TB, sensitivity was 66.1%); 14 cases were pulmonary TB (13 cases with positive T-SPOT. TB, sensitivity was 92.9%) and 54 cases were extrapulmonary TB (35 cases with positive T-SPOT. TB, sensitivity was 64.8%). Conclusions For patients presenting with classic FUO in this TB endemic setting, T-SPOT. TB appears valuable for excluding active TB, with a high negative predictive value.	[Shi, Xiaochun; Zhang, Lifan; Zhang, Yueqiu; Zhou, Baotong; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Shi, Xiaochun; Zhang, Lifan; Zhang, Yueqiu; Zhou, Baotong; Liu, Xiaoqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Lifan; Liu, Xiaoqing] Peking Union Med Coll, Clin Epidemiol Unit, Int Clin Epidemiol Network, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.; Liu, XQ (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Liu, XQ (corresponding author), Peking Union Med Coll, Clin Epidemiol Unit, Int Clin Epidemiol Network, Beijing 100021, Peoples R China.	liuxqpumch@126.com			National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China [2014ZX10003003]; Health Fund Industry Research and Special Projects [201402001]	National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China; Health Fund Industry Research and Special Projects	This study was supported by grants from the National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China (2014ZX10003003) and the Health Fund Industry Research and Special Projects (201402001).	Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Cho OH, 2011, J INFECTION, V63, P362, DOI 10.1016/j.jinf.2011.06.010; Cho OH, 2010, J INFECTION, V61, P228, DOI 10.1016/j.jinf.2010.06.015; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Gasey R, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015619, DOI 10.1371/JOURNAL.PONE.0015619]; Horowitz HW, 2013, NEW ENGL J MED, V368, P197, DOI 10.1056/NEJMp1212725; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Li Y, 2012, J CROHNS COLITIS, V6, P317, DOI 10.1016/j.crohns.2011.09.002; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Ma JL, 2010, CHIN J DIF COMPL CAS, V9, P587; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Shi XC, 2013, CHINESE MED J-PEKING, V126, P808, DOI 10.3760/cma.j.issn.0366-6999.20121799; Shi Xiao-chun, 2010, Zhonghua Nei Ke Za Zhi, V49, P1002; TGGotFNTE Survey, 2012, CHINESE J ANTITUBERC, V34; [翟永志 ZHAI Yong-zhi], 2011, [中国全科医学, Chinese General Practice], V14, P2773	18	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146879	10.1371/journal.pone.0146879	http://dx.doi.org/10.1371/journal.pone.0146879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784112	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400076
J	Vallianou, I; Hadzopoulou-Cladaras, M				Vallianou, Ioanna; Hadzopoulou-Cladaras, Margarita			Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; TRIGLYCERIDE TRANSFER PROTEIN; HMG-COA REDUCTASE; ELEMENT-BINDING PROTEINS; CORONARY-HEART-DISEASE; FATTY-ACID SYNTHESIS; CHOLESTEROL-METABOLISM; CHEMICAL-COMPOSITION; STEROL REGULATION	The control of hyperlipidemia plays a central role in cardiovascular disease. Previously, we have shown that camphene, a constituent of mastic gum oil, lowers cholesterol and triglycerides (TG) in the plasma of hyperlipidemic rats without affecting HMG-CoA reductase activity, suggesting that its hypocholesterolemic and hypotriglyceridemic effects are associated with a mechanism of action different than that of statins. In the present study, we examine the mechanism by which camphene exerts its hypolipidemic action. We evaluated the effect of camphene on the de novo synthesis of cholesterol and TG from [C-14]-acetate in HepG2 cells, along with the statin mevinolin. Camphene inhibited the biosynthesis of cholesterol in a concentration-dependent manner, and a maximal inhibition of 39% was observed at 100 mu M while mevinolin nearly abolished cholesterol biosynthesis. Moreover, treatment with camphene reduced TG by 34% and increased apolipoprotein AI expression. In contrast, mevinolin increased TG by 26% and had a modest effect on apolipoprotein AI expression. To evaluate the mode of action of camphene, we examined its effects on the expression of SREBP-1, which affects TG biosynthesis and SREBP-2, which mostly affects sterol synthesis. Interestingly, camphene increased the nuclear translocation of the mature form of SREBP-1 while mevinolin was found to increase the amount of the mature form of SREBP-2. The effect of camphene is most likely regulated through SREBP-1 by affecting MTP levels in response to a decrease in the intracellular cholesterol. We propose that camphene upregulates SREBP-1 expression and MTP inhibition is likely to be a probable mechanism whereby camphene exerts its hypolipidemic effect.	[Vallianou, Ioanna; Hadzopoulou-Cladaras, Margarita] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece	Aristotle University of Thessaloniki	Hadzopoulou-Cladaras, M (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece.	cladaras@bio.auth.gr						Aggarwal Dimple, 2005, BMC Cardiovasc Disord, V5, P30, DOI 10.1186/1471-2261-5-30; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; ANDERSON KM, 1987, ATHEROSCLEROSIS, V68, P59, DOI 10.1016/0021-9150(87)90094-3; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; ASSMANN G, 1993, CIRCULATION, V87, P28; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BADIMON JJ, 1992, CIRCULATION, V86, P86; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Bergstrom JD, 1998, BBA-LIPID LIPID MET, V1389, P213, DOI 10.1016/S0005-2760(97)00182-3; BLANKENHORN DH, 1987, CONTROL CLIN TRIALS, V8, P354, DOI 10.1016/0197-2456(87)90156-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonn V, 2002, ATHEROSCLEROSIS, V163, P59; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Costet P, 2010, PHARMACOL THERAPEUT, V126, P263, DOI 10.1016/j.pharmthera.2010.02.006; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; DASHTI N, 1987, J LIPID RES, V28, P423; ENDO A, 1992, J LIPID RES, V33, P1569; Forte Trudy M., 1994, Current Opinion in Lipidology, V5, P354, DOI 10.1097/00041433-199410000-00007; Garcia-Pelayo MC, 2000, ANALYST, V125, P1583, DOI 10.1039/b004481o; GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Grassmann J, 2003, J AGR FOOD CHEM, V51, P7576, DOI 10.1021/jf030496e; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1998, CIRCULATION, V97, P1436; GRUNDY SM, 1977, AM J CLIN NUTR, V30, P985, DOI 10.1093/ajcn/30.6.985; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; Hajhosseiny R, 2014, CLIN PHARMACOL THER, V96, P64, DOI 10.1038/clpt.2014.76; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; Jactel H, 1996, J CHEM ECOL, V22, P1037, DOI 10.1007/BF02029953; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Jin FY, 1999, ARTERIOSCL THROM VAS, V19, P1051, DOI 10.1161/01.ATV.19.4.1051; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kim S, OBESITY SILVER SPRIN, V22, P408; KORNBRUST DJ, 1989, J PHARMACOL EXP THER, V248, P498; Koutsoudaki C, 2005, J AGR FOOD CHEM, V53, P7681, DOI 10.1021/jf050639s; KRAUSE BR, 1995, ATHEROSCLEROSIS, V117, P237, DOI 10.1016/0021-9150(95)05576-I; Lakusic D, 2013, NAT PROD COMMUN, V8, P131; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; Magiatis P, 1999, PLANTA MED, V65, P749, DOI 10.1055/s-2006-960856; Maki KC, 2012, J CLIN LIPIDOL, V6, P413, DOI 10.1016/j.jacl.2012.04.003; Marz W, 2001, CIRCULATION, V103, P1942; MASTERS BA, 1995, TOXICOL APPL PHARM, V131, P163, DOI 10.1006/taap.1995.1058; Maxia A, 2009, FITOTERAPIA, V80, P57, DOI 10.1016/j.fitote.2008.09.008; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; QIN W, 1992, BIOCHIM BIOPHYS ACTA, V1127, P57, DOI 10.1016/0005-2760(92)90201-6; Rached FH, 2014, CLIN PHARMACOL THER, V96, P57, DOI 10.1038/clpt.2014.85; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sawada M, 2001, EUR J PHARMACOL, V431, P11, DOI 10.1016/S0014-2999(01)01411-X; Scharnagl H, 2001, BIOCHEM PHARMACOL, V62, P1545, DOI 10.1016/S0006-2952(01)00790-0; Sebai H, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-189; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stein EA, 1998, AM J CARDIOL, V81, p66B, DOI 10.1016/S0002-9149(98)00041-1; TAM SP, 1985, J BIOL CHEM, V260, P1670; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Toth PP, 2004, CIRCULATION, V109, P1809, DOI 10.1161/01.CIR.0000126889.97626.B8; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; Vallianou I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020516; Venteclef N, 2005, BIOCHEM PHARMACOL, V69, P1041, DOI 10.1016/j.bcp.2005.01.005; Verdier C, 2013, ARCH CARDIOVASC DIS, V106, P601, DOI 10.1016/j.acvd.2013.06.052; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P270, DOI 10.1111/j.1742-1241.2011.02867.x; Wierzbicki Anthony S, 2003, Expert Opin Emerg Drugs, V8, P365, DOI 10.1517/14728214.8.2.365; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	82	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147117	10.1371/journal.pone.0147117	http://dx.doi.org/10.1371/journal.pone.0147117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784701	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400112
J	Saneei, P; Esmaillzadeh, A; Keshteli, AH; Roohafza, HR; Afshar, H; Feizi, A; Adibi, P				Saneei, Parvane; Esmaillzadeh, Ahmad; Keshteli, Ammar Hassanzadeh; Roohafza, Hamid Reza; Afshar, Hamid; Feizi, Awat; Adibi, Peyman			Combined Healthy Lifestyle Is Inversely Associated with Psychological Disorders among Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; QUALITY-OF-LIFE; MENTAL-HEALTH; PHYSICAL-ACTIVITY; DIETARY PATTERNS; RISK-FACTORS; WEIGHT-GAIN; DEPRESSION; ANXIETY; POPULATION	Background and Aims Joint association of lifestyle-related factors and mental health has been less studied in earlier studies, especially in Middle Eastern countries. This study aimed to examine how combinations of several lifestyle-related factors related to depression and anxiety in a large group of middle-age Iranian population. Methods In a cross-sectional study on 3363 Iranian adults, a healthy lifestyle score was constructed by the use of data from dietary intakes, physical activity, smoking status, psychological distress and obesity. A dish-based 106-item semi-quantitative validated food frequency questionnaire (FFQ), General Practice Physical Activity Questionnaire (GPPAQ), General Health Questionnaire (GHQ) and other pre-tested questionnaires were used to assess the components of healthy lifestyle score. The Hospital Anxiety and Depression Scale (HADS) was applied to screen for anxiety and depression. Results After adjustment for potential confounders, we found that individuals with the highest score of healthy lifestyle were 95% less likely to be anxious (OR: 0.05; 95% CI: 0.01-0.27) and 96% less likely to be depressed (OR: 0.04; 95% CI: 0.01-0.15), compared with those with the lowest score. In addition, non-smokers had lower odds of anxiety (OR: 0.64; 95% CI: 0.47-0.88) and depression (OR: 0.62; 95% CI: 0.48-0.81) compared with smokers. Individuals with low levels of psychological distress had expectedly lower odds of anxiety (OR: 0.13; 95% CI: 0.10-0.16) and depression (OR: 0.10; 95% CI: 0.08-0.12) than those with high levels. Individuals with a healthy diet had 29% lower odds of depression (OR: 0.71; 95% CI: 0.59-0.87) than those with a non-healthy diet. Conclusion We found evidence indicating that healthy lifestyle score was associated with lower odds of anxiety and depression in this group of Iranian adults. Healthy diet, psychological distress, and smoking status were independent predictors of mental disorders.	[Saneei, Parvane; Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran; [Saneei, Parvane] Isfahan Univ Med Sci, Students Res Comm, Esfahan, Iran; [Saneei, Parvane; Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Keshteli, Ammar Hassanzadeh] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Keshteli, Ammar Hassanzadeh; Feizi, Awat; Adibi, Peyman] Isfahan Univ Med Sci, Integrat Funct Gastroenterol Res Ctr, Esfahan, Iran; [Roohafza, Hamid Reza; Afshar, Hamid] Isfahan Univ Med Sci, Dept Psychiat, Psychosomat Res Ctr, Esfahan, Iran; [Feizi, Awat] Isfahan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Esfahan, Iran	Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science; Tehran University of Medical Sciences; University of Alberta; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science	Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.	esmaillzadeh@hlth.mui.ac.ir	Sedeh, Peyman Adibi/AAJ-4582-2020; afshar, hamid/AAC-7675-2020; Saneei, Parvane/T-5434-2019; Feizi, Awat/W-3409-2017; Keshteli, Ammar Hassanzadeh/K-7473-2012; Esmaillzadeh, Ahmad/N-5704-2014	Sedeh, Peyman Adibi/0000-0001-6411-5235; Saneei, Parvane/0000-0002-4605-7833; Feizi, Awat/0000-0002-1930-0340; Esmaillzadeh, Ahmad/0000-0002-8735-6047; Roohafza, Hamidreza/0000-0003-3582-0431; Hassanzadeh Keshteli, Ammar/0000-0001-7375-6210	Vice Chancellery for Research & Technology, Isfahan University of Medical Sciences, Islamic Republic of Iran; Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran	Vice Chancellery for Research & Technology, Isfahan University of Medical Sciences, Islamic Republic of Iran; Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran	This study was supported by a grant from the Vice Chancellery for Research & Technology, Isfahan University of Medical Sciences, Islamic Republic of Iran. The financial support for conception, design, data analysis and manuscript drafting comes from Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. This study was extracted from a PhD dissertation that was approved by Food Sciences, Isfahan University of Medical Sciences (No. 394292). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi P, 2012, J RES MED SCI, V17, pS292; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Bahreynian M, 2012, ARCH IRAN MED, V15, P648; Bakhshaie J, 2015, COMPR PSYCHIAT, V60, P142, DOI 10.1016/j.comppsych.2014.10.012; Bar-Sela G, 2015, SUPPORT CARE CANCER, V23, P1979, DOI 10.1007/s00520-014-2560-1; Barak F, 2015, MOL NUTR FOOD RES, V59, P315, DOI 10.1002/mnfr.201400333; Bhattacharya R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-10; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Cassidy K, 2004, AUST NZ J PSYCHIAT, V38, P940, DOI 10.1080/j.1440-1614.2004.01485.x; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Dias JA, 2015, ATHEROSCLEROSIS, V238, P38, DOI 10.1016/j.atherosclerosis.2014.11.006; Duivis HE, 2013, PSYCHONEUROENDOCRINO, V38, P1573, DOI 10.1016/j.psyneuen.2013.01.002; Esteghamati A, 2012, J HEALTH POPUL NUTR, V30, P66, DOI 10.3329/jhpn.v30i1.11278; Gentile M, 2010, EUR J CLIN NUTR, V64, P873, DOI 10.1038/ejcn.2010.69; Hossen MJ, 2015, PURE APPL GEOPHYS, V172, P969, DOI 10.1007/s00024-014-1014-5; Jacka FN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-149; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Keshteli AH, 2014, INT J PREVENTIVE MED, V5, P29; Kimura Y, 2012, J NUTR HEALTH AGING, V16, P728, DOI 10.1007/s12603-012-0067-3; Labad J, 2010, DIABETOLOGIA, V53, P467, DOI 10.1007/s00125-009-1628-9; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Loprinzi PD, 2014, J AFFECT DISORDERS, V165, P126, DOI 10.1016/j.jad.2014.04.073; Michal M, 2015, INT J CARDIOL, V187, P614, DOI 10.1016/j.ijcard.2015.03.374; Mojtabai R, 2013, AM J PUBLIC HEALTH, V103, P1656, DOI 10.2105/AJPH.2012.300911; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P66, DOI 10.1186/1477-7525-1-66; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Moylan S, 2013, MOL PSYCHIATR, V18, P595, DOI 10.1038/mp.2012.33; Murphy JM, 2009, INT J OBESITY, V33, P335, DOI 10.1038/ijo.2008.273; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Promoting N., 2006, PROM CREAT BUILT NAT; Quilty LC, 2003, J ANXIETY DISORD, V17, P405, DOI 10.1016/S0887-6185(02)00225-6; Ranasinghe CD, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-116; Salehi-Abargouei A, 2015, EUR J NUTR; Sallis A, 2014, J OCCUP REHABIL, V24, P469, DOI 10.1007/s10926-013-9481-6; Sanchez-Villegas A, 2012, PUBLIC HEALTH NUTR, V15, P424, DOI 10.1017/S1368980011001856; Saneei P, 2015, EUR J NUTR, V54, P421, DOI 10.1007/s00394-014-0723-y; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; Seligman F, 2015, ANN NY ACAD SCI, V1345, P25, DOI 10.1111/nyas.12738; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Silva LD, 2015, REV BRAS PSIQUIATR, V37, P21, DOI 10.1590/1516-4446-2014-1446; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Vallance JK, 2011, PREV MED, V53, P284, DOI 10.1016/j.ypmed.2011.07.013; Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077; Willett W., 2012, NUTR EPIDEMIOLOGY	48	29	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146888	10.1371/journal.pone.0146888	http://dx.doi.org/10.1371/journal.pone.0146888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771311	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300040
J	Wang, F; Wang, ZH; Kou, CL; Ma, ZH; Zhao, D				Wang, Fan; Wang, Zhaohui; Kou, Changlin; Ma, Zhenghua; Zhao, Dong			Responses of Wheat Yield, Macro- and Micro-Nutrients, and Heavy Metals in Soil and Wheat following the Application of Manure Compost on the North China Plain	PLOS ONE			English	Article							MICRONUTRIENT AVAILABILITY; NITROGEN-FERTILIZER; CROPPING SYSTEMS; WASTE-WATER; FOOD CROPS; IMPACT; MANAGEMENT; RESIDUES; CARBON; RISKS	The recycling of livestock manure in cropping systems is considered to enhance soil fertility and crop productivity. However, there have been no systematic long-term studies of the effects of manure application on soil and cropmacro- and micro-nutrients, heavy metals, and crop yields in China, despite their great importance for sustainable crop production and food safety. Thus, we conducted field experiments in a typical cereal crop production area of the North China Plain to investigate the effects of compost manure application rates on wheat yield, as well as on the macro-/micro-nutrients and heavy metals contents of soil and wheat. We found that compost application increased the soil total N and the available K, Fe, Zn, and Mn concentrations, whereas the available P in soil was not affected, and the available Cu decreased. In general, compost application had no significant effects on the grain yield, biomass, and harvest index of winter wheat. However, during 2012 and 2013, the N concentration decreased by 9% and 18% in straw, and by 16% and 12% in grain, respectively. With compost application, the straw P concentration only increased in 2012 but the grain P generally increased, while the straw K concentration tended to decrease and the grain K concentration increased in 2013. Compost application generally increased the Fe and Zn concentrations in straw and grain, whereas the Cu and Mn concentrations decreased significantly compared with the control. The heavy metal concentrations increased at some compost application rates, but they were still within the safe range. The balances of the macro-and micro-nutrients indicated that the removal of nutrients by wheat was compensated for by the addition of compost, whereas the level of N decreased without the application of compost. The daily intake levels of micronutrients via the consumption of wheat grain were still lower than the recommended levels when sheep manure compost was applied, except for that of Mn.	[Wang, Fan; Wang, Zhaohui] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Fan; Wang, Zhaohui] Northwest Agr & Forestry Univ, Key Lab Plant Nutr & Agri Environm Northwest Chin, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Wang, Fan; Kou, Changlin; Ma, Zhenghua] Henan Acad Agr Sci, Inst Plant Nutr & Resource Environm, Zhengzhou, Peoples R China; [Zhao, Dong] Minist Agr, Henan Acad Agr Sci, Key Lab Anim Immunol, Henan Prov Key Lab Anim Immunol, Zhengzhou, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, ZH (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Wang, ZH (corresponding author), Northwest Agr & Forestry Univ, Key Lab Plant Nutr & Agri Environm Northwest Chin, Minist Agr, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; Kou, CL (corresponding author), Henan Acad Agr Sci, Inst Plant Nutr & Resource Environm, Zhengzhou, Peoples R China.	w-zhaohui@263.net; koucl@126.com			National Key Basic Research Special Funds [2015CB150404]; Special Fund for Agro-scientific Research in the Public Interest [201103003]; China Agricultural Research System [CARS-3-1]	National Key Basic Research Special Funds(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; China Agricultural Research System	This study was supported by the National Key Basic Research Special Funds under grant 2015CB150404, the Special Fund for Agro-scientific Research in the Public Interest under grant 201103003, and the China Agricultural Research System (CARS-3-1).	Abbasi MK, 2012, AGRON J, V104, P169, DOI 10.2134/agronj2011.0264; Ahmad R, 2008, RENEW AGR FOOD SYST, V23, P243, DOI 10.1017/S1742170508002299; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Bao S.D., 2015, SOIL AGR CHEM ANAL, V3; Bastida F, 2008, MICROB ECOL, V55, P651, DOI 10.1007/s00248-007-9308-0; Berry PM, 2003, SOIL USE MANAGE, V19, P112, DOI 10.1079/SUM2003176; Bhattacharyya R, 2008, EUR J AGRON, V28, P33, DOI 10.1016/j.eja.2007.04.006; Campbell CR, 2009, SOUTHERN COOPERATIVE, V394; Chinese National Ministry of Health, 2012, 27622012 GB CHIN NAT; [崔崧 CUI Song], 2006, [华北农学报, Acta Agriculturae Boreali-Sinica], V21, P125; Dai XQ, 2013, FIELD CROP RES, V149, P141, DOI 10.1016/j.fcr.2013.04.027; Dong TongXi, 2014, Journal of Agricultural Resources and Environment, V31, P355; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; George S, 2013, SOIL TILL RES, V132, P47, DOI 10.1016/j.still.2013.05.004; Goni MA, 2014, B ENVIRON CONTAM TOX, V92, P726, DOI 10.1007/s00128-014-1264-z; Health and Human Services, 2010, DIET GUID AM; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Keshavarzi B, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4113-y; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Li BY, 2007, SOIL TILL RES, V96, P166, DOI 10.1016/j.still.2007.05.005; Li PJ, 2009, J HAZARD MATER, V161, P516, DOI 10.1016/j.jhazmat.2008.03.130; Li ShuTian, 2011, Scientia Agricultura Sinica, V44, P4207; Limon-Ortega A, 2009, AGRON J, V101, P600, DOI 10.2134/agronj2008.0036x; Ma W-Q, 1999, CHINESE J SOIL SCI, V30, P217; MacRae RJ., 1985, ADV SOIL SCI, V3, P71, DOI [10.1007/978-1-4612-5090-6_2, DOI 10.1007/978-1-4612-5090-6_2]; Majumdar B, 2005, INDIAN J AGR SCI, V75, P809; Marcussen H, 2009, ENVIRON SCI TECHNOL, V43, P1122, DOI 10.1021/es801970z; Ministry of Agriculture PRC, 2012, CHIN AGR STAT REP; NEPA (National Environmental Protection Agency), 1995, 156181995 NEPA GB; Ning Z.X., 2014, TIANJIN AGR SCI, V20, P30; Panwar NR, 2010, COMMUN SOIL SCI PLAN, V41, P1073, DOI 10.1080/00103621003687166; Paul GC, 2006, P INT S TECHN IMPR S, P108; Portch S., 1995, Fertiliser News, V40, P83; Qiu Huan-guang, 2013, Huanjing Kexue, V34, P2766; Rengel Z, 1999, FIELD CROP RES, V60, P27, DOI 10.1016/S0378-4290(98)00131-2; Rezig FAM, 2013, ARCH AGRON SOIL SCI, V59, P1245, DOI 10.1080/03650340.2012.709623; Rutkowska B, 2014, PLANT SOIL ENVIRON, V60, P198, DOI 10.17221/914/2013-PSE; Rutkowska B, 2009, J ELEM, V14, P349, DOI 10.5601/jelem.2009.14.2.15; Shah SA, 2009, INT J PLANT PROD, V3; Shen P, 2014, CATENA, V118, P20, DOI 10.1016/j.catena.2014.01.020; Singh A, 2010, ECOL ENG, V36, P1733, DOI 10.1016/j.ecoleng.2010.07.021; Wang JW, 2013, FIELD CROP RES, V150, P83, DOI 10.1016/j.fcr.2013.06.010; Yang HS, 1997, EUR J AGRON, V7, P211, DOI 10.1016/S1161-0301(97)00047-6; Ye YL, 2006, THEORY PRACTICE INTE, P180; Zhang F.S., 2003, PHOSPHATE COMPOUND F, V18, P1; Zhang SL, 2015, J PLANT NUTR, V38, P742, DOI 10.1080/01904167.2014.957390; Zhou LL, 2014, ENVIRON SCI POLLUT R, V21, P1360, DOI 10.1007/s11356-013-2023-0	48	90	95	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146453	10.1371/journal.pone.0146453	http://dx.doi.org/10.1371/journal.pone.0146453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771517	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300020
J	Wong, QWL; Vaz, C; Lee, QY; Zhao, TY; Luo, R; Archer, SK; Preiss, T; Tanavde, V; Vardy, LA				Wong, Queenie Wing-Lei; Vaz, Candida; Lee, Qian Yi; Zhao, Tian Yun; Luo, Raymond; Archer, Stuart K.; Preiss, Thomas; Tanavde, Vivek; Vardy, Leah A.			Embryonic Stem Cells Exhibit mRNA Isoform Specific Translational Regulation	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; 3' UNTRANSLATED REGIONS; NONCODING RNAS; PLURIPOTENCY; TRANSCRIPTION; PRECURSORS; EXPRESSION; MICRORNAS; INSIGHTS; REVEALS	The presence of multiple variants for many mRNAs is a major contributor to protein diversity. The processing of these variants is tightly controlled in a cell-type specific manner and has a significant impact on gene expression control. Here we investigate the differential translation rates of individual mRNA variants in embryonic stem cells (ESCs) and in ESC derived Neural Precursor Cells (NPCs) using polysome profiling coupled to RNA sequencing. We show that there are a significant number of detectable mRNA variants in ESCs and NPCs and that many of them show variant specific translation rates. This is correlated with differences in the UTRs of the variants with the 5'UTR playing a predominant role. We suggest that mRNA variants that contain alternate UTRs are under different post-transcriptional controls. This is likely due to the presence or absence of miRNA and protein binding sites that regulate translation rate. This highlights the importance of addressing translation rate when using mRNA levels as a read out of protein abundance. Additional analysis shows that many annotated non-coding mRNAs are present on the polysome fractions in ESCs and NPCs. We believe that the use of polysome fractionation coupled to RNA sequencing is a useful method for analysis of the translation state of many different RNAs in the cell.	[Wong, Queenie Wing-Lei; Zhao, Tian Yun; Tanavde, Vivek; Vardy, Leah A.] ASTAR, Inst Med Biol, Immunos, 8A Biomed Grove, Singapore 138648, Singapore; [Vaz, Candida; Lee, Qian Yi; Tanavde, Vivek] ASTAR, Bioinformat Inst, 30 Biopolis St, Singapore 138671, Singapore; [Luo, Raymond] Life Technol, 10 Biopolis Rd, Singapore 138670, Singapore; [Archer, Stuart K.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic, Australia; [Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res JCSMR, Dept Genome Sci, EMBL Australia Collaborating Grp, Canberra, ACT, Australia; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Vardy, Leah A.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Thermo Fisher Scientific; Monash University; Australian National University; John Curtin School of Medical Research; Victor Chang Cardiac Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Vardy, LA (corresponding author), ASTAR, Inst Med Biol, Immunos, 8A Biomed Grove, Singapore 138648, Singapore.; Vardy, LA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	leah.vardy@imb.a-star.edu.sg	Tanavde, Vivek/B-4758-2011; Vaz, Candida/HHZ-7196-2022; Preiss, Thomas/F-7355-2010	Tanavde, Vivek/0000-0001-7404-5568; Preiss, Thomas/0000-0001-6273-784X; Vaz, Candida/0000-0002-6650-7889; Lee, Qian Yi/0000-0001-9200-0910; Vardy, Leah/0000-0003-4186-684X; Archer, Stuart/0000-0003-0450-1243	Agency for Science, Technology and Research, Singapore; Australian Research Council [DP1300101928]; Agency for Science, Technology and Research	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Australian Research Council(Australian Research Council); Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	QWLW, CV, QYL, TYZ, VT and LAV were funded by the Agency for Science, Technology and Research, Singapore. Raymond Luo, a co-author in this study, is employed by Life Technologies, 10 Biopolis Road, Singapore 138670. The funder provided support in the form of salaries for authors [RL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RL was involved in data analysis. The specific roles of the author is articulated in the 'author contributions' section. TP acknowledges funding from the Australian Research Council (grant DP1300101928).; We thank the Agency for Science, Technology and Research for funding and Dr Austin Smith for the Sox1-GFP ESC cell line. We are grateful to the ACRF Biomolecular Resource Facility at Australian National University for the RNASeq library preparation and sequencing. TP acknowledges funding from the Australian Research Council (grant DP1300101928).	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen KN, 2015, WORLD J STEM CELLS, V7, P1, DOI 10.4252/wjsc.v7.i1.1; Clancy JL, 2011, RNA, V17, P1025, DOI 10.1261/rna.2567611; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hayashi R, 2014, GENE DEV, V28, P1772, DOI 10.1101/gad.245738.114; Hynes CJ, 2012, IUBMB LIFE, V64, P872, DOI 10.1002/iub.1082; Ibi M, 2011, J CELL SCI, V124, P857, DOI 10.1242/jcs.075705; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lu XY, 2013, NAT CELL BIOL, V15, P1141, DOI 10.1038/ncb2839; Malone CD, 2014, GENE DEV, V28, P1786, DOI 10.1101/gad.245829.114; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pollard SM, 2006, METHOD ENZYMOL, V418, P151, DOI 10.1016/S0076-6879(06)18010-6; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sterne-Weiler T, 2013, GENOME RES, V23, P1615, DOI 10.1101/gr.148585.112; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0143235	10.1371/journal.pone.0143235	http://dx.doi.org/10.1371/journal.pone.0143235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799392	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300002
J	Zhang, YT; Hodgson, NW; Trivedi, MS; Abdolmaleky, HM; Fournier, M; Cuenod, M; Do, KQ; Deth, RC				Zhang, Yiting; Hodgson, Nathaniel W.; Trivedi, Malav S.; Abdolmaleky, Hamid M.; Fournier, Margot; Cuenod, Michel; Do, Kim Quang; Deth, Richard C.			Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-METHYLATION; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; METABOLIC BIOMARKERS; CEREBROSPINAL-FLUID; SPECTRUM DISORDERS; GAMMA OSCILLATIONS; GLUTATHIONE	Many studies indicate a crucial role for the vitamin B-12 and folate-dependent enzyme methionine synthase (MS) in brain development and function, but vitamin B-12 status in the brain across the lifespan has not been previously investigated. Vitamin B-12 (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), serving as cofactors for MS and methylmalonylCoA mutase, respectively. We measured levels of five Cbl species in postmortem human frontal cortex of 43 control subjects, from 19 weeks of fetal development through 80 years of age, and 12 autistic and 9 schizophrenic subjects. Total Cbl was significantly lower in older control subjects (> 60 yrs of age), primarily reflecting a > 10-fold age-dependent decline in the level of MeCbl. Levels of inactive cyanocobalamin (CNCbl) were remarkably higher in fetal brain samples. In both autistic and schizophrenic subjects MeCbl and AdoCbl levels were more than 3-fold lower than age-matched controls. In autistic subjects lower MeCbl was associated with decreased MS activity and elevated levels of its substrate homocysteine (HCY). Low levels of the antioxidant glutathione (GSH) have been linked to both autism and schizophrenia, and both total Cbl and MeCbl levels were decreased in glutamate-cysteine ligase modulatory subunit knockout (GCLM-KO) mice, which exhibit low GSH levels. Thus our findings reveal a previously unrecognized decrease in brain vitamin B-12 status across the lifespan that may reflect an adaptation to increasing antioxidant demand, while accelerated deficits due to GSH deficiency may contribute to neurodevelopmental and neuropsychiatric disorders.	[Zhang, Yiting; Hodgson, Nathaniel W.; Trivedi, Malav S.; Deth, Richard C.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Hodgson, Nathaniel W.] Harvard Univ, Sch Med, Lab Nutr & Metab BIDMC, Dept Surg, Boston, MA 02215 USA; [Trivedi, Malav S.; Deth, Richard C.] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA; [Abdolmaleky, Hamid M.] Boston Univ, Sch Med, Dept Med Biomed Genet Sect Genet & Genom, Boston, MA 02118 USA; [Fournier, Margot; Cuenod, Michel; Do, Kim Quang] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland	Northeastern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Nova Southeastern University; Boston University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Deth, RC (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Deth, RC (corresponding author), Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA.	rdeth@nova.edu	Do, Kim Q./G-6694-2016; Deth, Richard/AFV-2608-2022	Do, Kim Q./0000-0003-1968-1646; Fournier, Margot/0000-0001-8906-1907; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174	Autism Research Institute; National Center of Competence in Research; Simons Foundation; Autism Speaks	Autism Research Institute; National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Simons Foundation; Autism Speaks	This work was supported by the Autism Research Institute (http://www.autism.com) to RD and the National Center of Competence in Research (http://www.snf.ch) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some tissue, biological specimens or data used in this research was obtained from Autism BrainNet that is sponsored by the Simons Foundation and Autism Speaks. The authors also acknowledge the Autism Tissue Program that was the predecessor to Autism BrainNet and the Australian Brain Bank Network (ABBN) for their assistance in providing samples.	Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Al-Farsi YM, 2013, NUTRITION, V29, P537, DOI 10.1016/j.nut.2012.09.014; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; [Anonymous], 2007, J PHYSL; Auta J, 2013, SCHIZOPHR RES, V150, P312, DOI 10.1016/j.schres.2013.07.030; BAKER H, 1984, J NEUROSCI RES, V11, P419, DOI 10.1002/jnr.490110409; Beyer K, 2003, NEUROREPORT, V14, P1391, DOI 10.1097/01.wnr.0000073683.00308.0e; Bosco P, 2004, J NEUROL NEUROSUR PS, V75, P1036, DOI 10.1136/jnnp.2003.025866; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089128; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; COHEN SM, 1974, BIOL PSYCHIAT, V8, P209; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Duarte JMD, 2012, BIOL PSYCHIAT, V71, P1006, DOI 10.1016/j.biopsych.2011.07.035; Eren E, 2010, CLIN LAB, V56, P513; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175; Gapp K, 2014, NEUROSCIENCE, V264, P99, DOI 10.1016/j.neuroscience.2012.11.040; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gille D, 2015, NUTR REV, V73, P106, DOI 10.1093/nutrit/nuu011; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Gueant JL, 2013, BIOCHIMIE, V95, P1033, DOI 10.1016/j.biochi.2013.01.020; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Haidemenos A, 2007, PROG NEURO-PSYCHOPH, V31, P1289, DOI 10.1016/j.pnpbp.2007.05.011; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; James SJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.87; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jensen LL, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12086; Kale A, 2010, PSYCHIAT RES, V175, P47, DOI 10.1016/j.psychres.2009.01.013; Kemperman RFJ, 2006, PROSTAG LEUKOTR ESS, V74, P75, DOI 10.1016/j.plefa.2005.11.004; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kirsch SH, 2013, CLIN CHEM LAB MED, V51, P139, DOI 10.1515/cclm-2012-0673; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Kulak A, 2012, BEHAV BRAIN RES, V226, P563, DOI 10.1016/j.bbr.2011.10.020; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Luder A S, 2008, J Inherit Metab Dis, V31 Suppl 3, P493, DOI 10.1007/s10545-007-0760-2; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Mitchell ES, 2014, NEUROSCI BIOBEHAV R, V47, P307, DOI 10.1016/j.neubiorev.2014.08.006; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Muntjewerff JW, 2006, MOL PSYCHIATR, V11, P143, DOI 10.1038/sj.mp.4001746; Muratore CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056927; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ooka S, 2003, ARTHRITIS RES THER, V5, pR174, DOI 10.1186/ar754; Park LK, 2012, P NUTR SOC, V71, P75, DOI 10.1017/S0029665111003302; Pasca SP, 2009, J CELL MOL MED, V13, P4229, DOI 10.1111/j.1582-4934.2008.00463.x; Pascale Crissey L, 2011, Fluids Barriers CNS, V8, P21, DOI 10.1186/2045-8118-8-21; Peerbooms OLJ, 2011, BRAIN BEHAV IMMUN, V25, P1530, DOI 10.1016/j.bbi.2010.12.006; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Pu DH, 2013, AUTISM RES, V6, P384, DOI 10.1002/aur.1300; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Saedisomeolia Ahmad, 2011, J Res Med Sci, V16 Suppl 1, pS437; Selhub J, 1999, ANN INTERN MED, V131, P331, DOI 10.7326/0003-4819-131-5-199909070-00003; Sharma A, 1999, MOL PSYCHIATR, V4, P235, DOI 10.1038/sj.mp.4000522; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Solomon LR, 2015, EUR J CLIN NUTR, V69, P687, DOI 10.1038/ejcn.2014.272; Spuch C, 2010, RECENT PATENTS ENDOC, V4, P190, DOI 10.2174/1872214811004030190; Ssonko Michael, 2014, BMC Res Notes, V7, P90, DOI 10.1186/1756-0500-7-90; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; STURMAN JA, 1970, J NEUROCHEM, V17, P1117, DOI 10.1111/j.1471-4159.1970.tb02268.x; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; TALLAN HH, 1958, J BIOL CHEM, V230, P707; Tarazi FI, 1999, MOL PSYCHIATR, V4, P529, DOI 10.1038/sj.mp.4000674; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476; Waly MI, 2011, ALCOHOL CLIN EXP RES, V35, P277, DOI 10.1111/j.1530-0277.2010.01343.x; WORMPETERSEN J, 1964, ACTA NEUROL SCAND, V40, P241; Wu YL, 2013, J NEUROL SCI, V335, P14, DOI 10.1016/j.jns.2013.09.006; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Zhang Y, OXID MED AND CELL LO; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	89	88	91	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146797	10.1371/journal.pone.0146797	http://dx.doi.org/10.1371/journal.pone.0146797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799654	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300037
J	Rakipovski, G; Lykkesfeldt, J; Raun, K				Rakipovski, Gunaj; Lykkesfeldt, Jens; Raun, Kirsten			Pulsatile Hyperglycaemia Induces Vascular Oxidative Stress and GLUT 1 Expression More Potently than Sustained Hyperglycaemia in Rats on High Fat Diet	PLOS ONE			English	Article							GLUCOSE ENHANCES APOPTOSIS; APOLIPOPROTEIN E-DEFICIENT; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; POSTPRANDIAL HYPERGLYCEMIA; DIABETIC-PATIENTS; LIVER; METABOLISM; ACTIVATION; MUSCLE	Introduction Pulsatile hyperglycaemia resulting in oxidative stress may play an important role in the development of macrovascular complications. We investigated the effects of sustained vs. pulsatile hyperglycaemia in insulin resistant rats on markers of oxidative stress, enzyme expression and glucose metabolism in liver and aorta. We hypothesized that liver's ability to regulate the glucose homeostasis under varying states of hyperglycaemia may indirectly affect oxidative stress status in aorta despite the amount of glucose challenged with. Methods Animals were infused with sustained high (SHG), low (SLG), pulsatile (PLG) glucose or saline (VEH) for 96 h. Oxidative stress status and key regulators of glucose metabolism in liver and aorta were investigated. Results Similar response in plasma lipid oxidation was observed in PLG as in SHG. Likewise, in aorta, PLG and SHG displayed increased expression of glucose transporter 1 (GLUT1), gp-91(PHOX) and super oxide dismutase (SOD), while only the PLG group showed increased accumulation of oxidative stress and oxidised low density lipoprotein (oxLDL) in aorta. Conclusion Pulsatile hyperglycaemia induced relatively higher levels of oxidative stress systemically and in aorta in particular than overt sustained hyperglycaemia thus supporting the clinical observations that pulsatile hyperglycaemia is an independent risk factor for diabetes related macrovascular complications.	[Rakipovski, Gunaj; Lykkesfeldt, Jens] Univ Copenhagen, Dept Expt Anim Models, Sect Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Rakipovski, Gunaj; Raun, Kirsten] Novo Nordisk AS, Global Res, Dept Diabet Pharmacol, Malov, Denmark	University of Copenhagen; Novo Nordisk	Rakipovski, G (corresponding author), Univ Copenhagen, Dept Expt Anim Models, Sect Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.; Rakipovski, G (corresponding author), Novo Nordisk AS, Global Res, Dept Diabet Pharmacol, Malov, Denmark.	GuRa@novonordisk.com	Lykkesfeldt, Jens/A-1072-2011	Lykkesfeldt, Jens/0000-0002-6514-8407	Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	Novo Nordisk A/S provided support in the form of salaries for authors KR and GR, and had an additional role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Aljada A, 2000, J CLIN ENDOCR METAB, V85, P2572, DOI 10.1210/jc.85.7.2572; Aljada A, 2001, J CLIN ENDOCR METAB, V86, P450, DOI 10.1210/jc.86.1.450; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Artwohl M, 2007, EUR J CLIN INVEST, V37, P643, DOI 10.1111/j.1365-2362.2007.01838.x; ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; BRICHARD SM, 1993, DIABETOLOGIA, V36, P292, DOI 10.1007/BF00400230; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Ceriello A, 2000, DIABETES, V49, P2170, DOI 10.2337/diabetes.49.12.2170; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Chen MY, 2001, BIOCHEM BIOPH RES CO, V287, P962, DOI 10.1006/bbrc.2001.5674; Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005; Ellger B, 2006, DIABETES, V55, P1096, DOI 10.2337/diabetes.55.04.06.db05-1434; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Harrison DG, 2003, J RENIN-ANGIO-ALDO S, V4, P51, DOI 10.3317/jraas.2003.014; Hodgkinson AD, 2003, DIABETES, V52, P846, DOI 10.2337/diabetes.52.3.846; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Horvath EM, 2009, DIABETOLOGIA, V52, P952, DOI 10.1007/s00125-009-1304-0; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Koo JR, 2003, KIDNEY INT, V63, P195, DOI 10.1046/j.1523-1755.2003.00728.x; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Ling PR, 2007, CRIT CARE MED, V35, P555, DOI 10.1097/01.CCM.0000253310.02180.C2; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P177; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Nawano M, 2000, AM J PHYSIOL-ENDOC M, V278, pE535, DOI 10.1152/ajpendo.2000.278.3.E535; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; OSCHRY Y, 1982, J LIPID RES, V23, P1099; Piarulli F, 2009, DIABETOLOGIA, V52, P1419, DOI 10.1007/s00125-009-1367-y; Sun Q, 2014, WORLD J DIABETES, V5, P89, DOI 10.4239/wjd.v5.i2.89; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Quagliaro L, 2007, NUTR METAB CARDIOVAS, V17, P257, DOI 10.1016/j.numecd.2006.01.007; Rakipovski G, 2011, DIABETES VASC DIS RE, V8, P295, DOI 10.1177/1479164111421033; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Sena CM, 2011, BRIT J PHARMACOL, V163, P424, DOI 10.1111/j.1476-5381.2011.01230.x; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Sugimoto R, 2005, LIVER INT, V25, P1018, DOI 10.1111/j.1478-3231.2005.01130.x; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Taskinen MR, 1996, ANN MED, V28, P335, DOI 10.3109/07853899608999090; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Zhao Y, 2008, J NUCL MED, V49, P1707, DOI 10.2967/jnumed.108.051847	56	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147412	10.1371/journal.pone.0147412	http://dx.doi.org/10.1371/journal.pone.0147412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790104	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100086
J	Arterbery, AS; Bogue, CW				Arterbery, Adam S.; Bogue, Clifford W.			Hhex Is Necessary for the Hepatic Differentiation of Mouse ES Cells and Acts via Vegf Signaling	PLOS ONE			English	Article							HOMEOBOX GENE HEX; LIVER DEVELOPMENT REQUIRES; ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA TRANSPORT; EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; IN-VITRO; HEPATOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN	Elucidating the molecular mechanisms involved in the differentiation of stem cells to hepatic cells is critical for both understanding normal developmental processes as well as for optimizing the generation of functional hepatic cells for therapy. We performed in vitro differentiation of mouse embryonic stem cells (mESCs) with a null mutation in the homeobox gene Hhex and show that Hhex(-/-) mESCs fail to differentiate from definitive endoderm (Sox17(+)/Foxa2(+)) to hepatic endoderm (Alb(+)/Dlk(+)). In addition, hepatic culture elicited a >7-fold increase in Vegfa mRNA expression in Hhex(-/-) cells compared to Hhex(+/+) cells. Furthermore, we identified VEGFR2(+)/ALB(+)/CD34(-) in early Hhex(+/+) hepatic cultures. These cells were absent in Hhex(-/-) cultures. Finally, through manipulation of Hhex and Vegfa expression, gain and loss of expression experiments revealed that Hhex shares an inverse relationship with the activity of the Vegf signaling pathway in supporting hepatic differentiation. In summary, our results suggest that Hhex represses Vegf signaling during hepatic differentiation of mouse ESCs allowing for cell-type autonomous regulation of Vegfr2 activity independent of endothelial cells.	[Arterbery, Adam S.; Bogue, Clifford W.] Yale Univ, Dept Pediat, Yale Sch Med, Sect Crit Care Med, New Haven, CT 06520 USA	Yale University	Arterbery, AS (corresponding author), Yale Univ, Dept Pediat, Yale Sch Med, Sect Crit Care Med, New Haven, CT 06520 USA.	adam.arterbery@yale.edu	Bogue, Clifford/AAD-3832-2019	Bogue, Clifford/0000-0002-2688-687X	NIH [DK061146-06A2, 5T32HL07272-32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061146, R56DK061146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by financial assistance from NIH Grants DK061146-06A2 to CWB and 5T32HL07272-32 to CWB/ASA.	Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bogue CW, 2003, P NATL ACAD SCI USA, V100, P556, DOI 10.1073/pnas.0236979100; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bossard P, 2000, DEVELOPMENT, V127, P4915; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Elia AV, 2002, J CLIN ENDOCR METAB, V87, P1376, DOI 10.1210/jc.87.3.1376; Delisle Juliette Cuvelier, 2008, BMC Res Notes, V1, P136, DOI 10.1186/1756-0500-1-136; Dufort D, 1998, DEVELOPMENT, V125, P3015; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Ghosh B, 2000, PEDIATR RES, V48, P634, DOI 10.1203/00006450-200011000-00014; Goldman O, 2013, CELL STEM CELL, V12, P748, DOI 10.1016/j.stem.2013.04.026; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; HOUSSAINT E, 1980, CELL DIFFER DEV, V9, P269, DOI 10.1016/0045-6039(80)90026-3; Hunter MP, 2007, DEV BIOL, V308, P355, DOI 10.1016/j.ydbio.2007.05.028; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jones EA, 2001, J ANAT, V198, P555, DOI 10.1046/j.1469-7580.2001.19850555.x; Jones EA, 2002, EXP CELL RES, V272, P15, DOI 10.1006/excr.2001.5396; Kallas A, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/298163; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kim Peter T W, 2012, Results Probl Cell Differ, V55, P303, DOI 10.1007/978-3-642-30406-4_17; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Kubo A, 2010, HEPATOLOGY, V51, P633, DOI 10.1002/hep.23293; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; Liu Y, 2014, STEM CELLS, V32, P1515, DOI 10.1002/stem.1695; Livigni A, 2009, CURR PROTOC STEM CEL, DOI [10.1002/9780470151808.sc01g03s10, DOI 10.1002/9780470151808.SCO1G03S10]; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Myint Z, 1999, J BIOCHEM-TOKYO, V125, P795, DOI 10.1093/oxfordjournals.jbchem.a022351; Nakagawa T, 2003, ARTERIOSCL THROM VAS, V23, P231, DOI 10.1161/01.ATV.0000052670.55321.87; Noy P, 2012, NUCLEIC ACIDS RES, V40, P9008, DOI 10.1093/nar/gks687; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Oh U, 2006, J INFECT DIS, V193, P1557, DOI 10.1086/503874; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pan YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017536; Pierreux CE, 2010, DEV BIOL, V347, P216, DOI 10.1016/j.ydbio.2010.08.024; Puppin C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-192; Schroeder Insa S., 2009, V530, P219, DOI 10.1007/978-1-59745-471-1_12; Shiraki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024228; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Soufi A, 2008, BIOCHEM J, V412, P399, DOI 10.1042/BJ20080035; Stanger BZ, 2009, TXB GASTROENTEROLOGY, P567; Tanaka T, 1999, BIOCHEM J, V339, P111, DOI 10.1042/0264-6021:3390111; Tanimizu N, 2004, J CELL SCI, V117, P6425, DOI 10.1242/jcs.01572; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003; Topisirovic I, 2003, EMBO J, V22, P689, DOI 10.1093/emboj/cdg069; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Williams H, 2008, J MOL BIOL, V383, P10, DOI 10.1016/j.jmb.2008.08.004; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	67	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146806	10.1371/journal.pone.0146806	http://dx.doi.org/10.1371/journal.pone.0146806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784346	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400066
J	Barbour, AG				Barbour, Alan G.			Multiple and Diverse vsp and vlp Sequences in Borrelia miyamotoi, a Hard Tick-Borne Zoonotic Pathogen	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ANTIGENIC VARIATION; LINEAR PLASMIDS; SURFACE PROTEIN; MOUSE MODEL; HERMSII; GENOME; EXPRESSION; VECTOR; GENES	Based on chromosome sequences, the human pathogen Borrelia miyamotoi phylogenetically clusters with species that cause relapsing fever. But atypically for relapsing fever agents, B. miyamotoi is transmitted not by soft ticks but by hard ticks, which also are vectors of Lyme disease Borrelia species. To further assess the relationships of B. miyamotoi to species that cause relapsing fever, I investigated extrachromosomal sequences of a North American strain with specific attention on plasmid-borne vsp and vlp genes, which are the underpinnings of antigenic variation during relapsing fever. For a hybrid approach to achieve assemblies that spanned more than one of the paralogous vsp and vlp genes, a database of short-reads from next-generation sequencing was supplemented with long-reads obtained with real-time DNA sequencing from single polymerase molecules. This yielded three contigs of 31, 16, and 11 kb, which each contained multiple and diverse sequences that were homologous to vsp and vlp genes of the relapsing fever agent B. hermsii. Two plasmid fragments had coding sequences for plasmid partition proteins that differed from each other from paralogous proteins for the megaplasmid and a small plasmid of B. miyamotoi. One of 4 vsp genes, vsp1, was present at two loci, one of which was downstream of a candiate prokaryotic promoter. A limited RNA-seq analysis of a population growing in the blood of mice indicated that of the 4 different vsp genes vsp1 was the one that was expressed. The findings indicate that B. miyamotoi has at least four types of plasmids, two or more of which bear vsp and vlp gene sequences that are as numerous and diverse as those of relapsing fever Borrelia. The database and insights from these findings provide a foundation for further investigations of the immune responses to this pathogen and of the capability of B. miyamotoi for antigenic variation.	[Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.; Barbour, AG (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	abarbour@uci.edu		Barbour, Alan/0000-0002-0719-5248	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI-100236, AI-114859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100236, R56AI114859] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grants AI-100236 and AI-114859 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to A.G.B.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbour A, 2005, TICK BORNE DIS HUMAN, P220; Barbour A.G., 2010, BORRELIA MOL BIOL HO, P333; Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Barbour AG, 2014, INFECT GENET EVOL, V27, P551, DOI 10.1016/j.meegid.2014.04.022; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaconas G, 2005, MOL MICROBIOL, V58, P625, DOI 10.1111/j.1365-2958.2005.04872.x; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fonville M, 2014, EMERG INFECT DIS, V20, P1244, DOI 10.3201/eid2007.131525; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hamase A, 1996, FEMS MICROBIOL LETT, V140, P131, DOI 10.1111/j.1574-6968.1996.tb08326.x; Hinnebusch BJ, 1998, INFECT IMMUN, V66, P432, DOI 10.1128/IAI.66.2.432-440.1998; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hue F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00713-13; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; KITTEN T, 1990, P NATL ACAD SCI USA, V87, P6077, DOI 10.1073/pnas.87.16.6077; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.MDNA3-0023-2014, DOI 10.1128/MICR0BI0LSPEC.MDNA3-0023-2014]; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; MARGOLIS N, 1994, J BACTERIOL, V176, P6427, DOI 10.1128/JB.176.21.6427-6432.1994; Margos G, 2015, TICKS TICK-BORNE DIS, V6, P181, DOI 10.1016/j.ttbdis.2014.12.001; MEIER JT, 1985, CELL, V41, P403, DOI 10.1016/S0092-8674(85)80013-1; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NORRIS SJ, 1995, INFECT IMMUN, V63, P2206, DOI 10.1128/IAI.63.6.2206-2212.1995; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Pennington PM, 1999, MOL MICROBIOL, V34, P1120, DOI 10.1046/j.1365-2958.1999.01675.x; Pennington PM, 1997, INFECT IMMUN, V65, P285, DOI 10.1128/IAI.65.1.285-292.1997; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; PLASTERK RHA, 1985, NATURE, V318, P257, DOI 10.1038/318257a0; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; RESTREPO BI, 1992, MOL MICROBIOL, V6, P3299, DOI 10.1111/j.1365-2958.1992.tb02198.x; Rich SM, 2001, P NATL ACAD SCI USA, V98, P15038, DOI 10.1073/pnas.071042098; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Sonenshine DE, 2014, BIOL TICKS; Wagemakers A, 2015, TRENDS PARASITOL, V31, P260, DOI 10.1016/j.pt.2015.03.008; Wagemakers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-418; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Zhong HM, 2006, J BACTERIOL, V188, P909, DOI 10.1128/JB.188.3.909-918.2006; Zhong JM, 2004, MOL MICROBIOL, V51, P729, DOI 10.1046/j.1365-2958.2003.03849.x	59	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146283	10.1371/journal.pone.0146283	http://dx.doi.org/10.1371/journal.pone.0146283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785134	gold, Green Published			2022-12-27	WOS:000368528400029
J	Chojenta, CL; Lucke, JC; Forder, PM; Loxton, DJ				Chojenta, Catherine L.; Lucke, Jayne C.; Forder, Peta M.; Loxton, Deborah J.			Maternal Health Factors as Risks for Postnatal Depression: A Prospective Longitudinal Study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; SOCIAL SUPPORT; SYMPTOMS; WOMEN; PREVALENCE; PREDICTORS; PREGNANCY; BIRTH	Purpose While previous studies have identified a range of potential risk factors for postnatal depression (PND), none have examined a comprehensive set of risk factors at a population-level using data collected prospectively. The aim of this study was to explore the relationship between a range of factors and PND and to construct a model of the predictors of PND. Methods Data came from 5219 women who completed Survey 5 of the Australian Longitudinal Study on Women's Health in 2009 and reported giving birth to a child. Results Over 15% of women reported experiencing PND with at least one of their children. The strongest positive associations were for postnatal anxiety (OR = 13.79, 95% CI = 10.48, 18.13) and antenatal depression (OR = 9.23, 95% CI = 6.10, 13.97). Positive associations were also found for history of depression and PND, low SF-36 Mental Health Index, emotional distress during labour, and breastfeeding for less than six months. Conclusions Results indicate that understanding a woman's mental health history plays an important role in the detection of those who are most vulnerable to PND. Treatment and management of depression and anxiety earlier in life and during pregnancy may have a positive impact on the incidence of PND.	[Chojenta, Catherine L.; Forder, Peta M.; Loxton, Deborah J.] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Callaghan, NSW 2308, Australia; [Lucke, Jayne C.] La Trobe Univ, Fac Hlth Sci, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of Newcastle; La Trobe University	Chojenta, CL (corresponding author), Univ Newcastle, Res Ctr Generat Hlth & Ageing, Callaghan, NSW 2308, Australia.	Catherine.Chojenta@newcastle.edu.au	Lucke, Jayne C/A-5538-2008; Chojenta, Catherine L/B-2521-2008	Lucke, Jayne C/0000-0002-2885-5292; Chojenta, Catherine L/0000-0002-2541-4491	Australian Government Department of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by the Australian Government Department of Health provides funding for the Australian Longitudinal Study on Women's Health.; The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health, the University of Newcastle and the University of Queensland. We are grateful to the Australian Government Department of Health for funding, to the staff of ALSWH and to the women who provided the survey data. Researchers in the Research Centre for Generational Health and Ageing at the University of Newcastle are members of the Hunter Medical Research Institute (HMRI).	Australian Institute of Health and Welfare. National Health Data Dictionary, NAT HLTH DAT DICT VE; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Boury JM, 2004, WOMEN HEALTH, V39, P19, DOI 10.1300/J013v39n03_02; Brown S, 1994, MISSING VOICES EXPER; Buist AE, 2008, AUST NZ J PSYCHIAT, V42, P66, DOI 10.1080/00048670701732749; Certain HE, 2008, JOGNN-J OBST GYN NEO, V37, P35, DOI [10.1111/j.1552-6909.2007.00200.x, 10.1111/J.1552-6909.2007.00200.x]; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; Dagher RK, 2012, ARCH WOMEN MENT HLTH, V15, P31, DOI 10.1007/s00737-011-0252-0; Davey HL, 2011, MATERN CHILD HLTH J, V15, P866, DOI 10.1007/s10995-008-0314-8; Dennis CL, 2012, CAN J PSYCHIAT, V57, P537, DOI 10.1177/070674371205700904; Dennis CLE, 2004, ACTA PSYCHIAT SCAND, V110, P338, DOI 10.1111/j.1600-0447.2004.00337.x; Eastwood JG, 2011, AUST NZ J PSYCHIAT, V45, P1040, DOI 10.3109/00048674.2011.619160; Haga SM, 2012, ARCH WOMEN MENT HLTH, V15, P175, DOI 10.1007/s00737-012-0274-2; IBM Corp, 2010, IBM SPSS STAT WIND V; LaCoursiere DY, 2010, BJOG-INT J OBSTET GY, V117, P1011, DOI 10.1111/j.1471-0528.2010.02569.x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Le Strat Y, 2011, J AFFECT DISORDERS, V135, P128, DOI 10.1016/j.jad.2011.07.004; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; National Health and Medical Research Council, 2000, POSTN DEPR SYST REV; NORBECK JS, 1984, RES NURS HEALTH, V7, P61, DOI 10.1002/nur.4770070110; O'Hara MW, 2013, POSTPARTUM DEPRESSIO, P379; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Price SK, 2009, J RURAL HEALTH, V25, P158, DOI 10.1111/j.1748-0361.2009.00212.x; Rosner B., 2006, FUNDAMENTALS BIOSTAT; SARASON IG, 1986, J PERS SOC PSYCHOL, V50, P845, DOI 10.1037/0022-3514.50.4.845; Sartorius N, 1996, BRIT J PSYCHIAT, V168, P38, DOI 10.1192/S0007125000298395; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tuohy Alan, 2008, Psychol Health Med, V13, P43, DOI 10.1080/13548500701294531; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White T, 2006, J REPROD INFANT PSYC, V24, P107, DOI 10.1080/02646830600643874; Wilton G, 2009, MCN-AM J MATERN-CHIL, V34, P297, DOI 10.1097/01.NMC.0000360422.06486.c4; Wu LL, 2001, J HUM RESOUR, V36, P520, DOI 10.2307/3069629; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426	36	26	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147246	10.1371/journal.pone.0147246	http://dx.doi.org/10.1371/journal.pone.0147246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785131	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400128
J	Cruz-Bermudez, A; Vicente-Blanco, RJ; Hernandez-Sierra, R; Montero, M; Alvarez, J; Manrique, MG; Blazquez, A; Martin, MA; Ayuso, C; Garesse, R; Fernandez-Moreno, MA				Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Montero, Mayte; Alvarez, Javier; Gonzalez Manrique, Mar; Blazquez, Alberto; Angel Martin, Miguel; Ayuso, Carmen; Garesse, Rafael; Fernandez-Moreno, Miguel A.			Functional Characterization of Three Concomitant MtDNA LHON Mutations Shows No Synergistic Effect on Mitochondrial Activity	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; COMPLEX I; DNA MUTATIONS; OXIDATIVE-PHOSPHORYLATION; CHINESE FAMILY; HUMAN-CELLS; DEFECTS; CHAIN; COMPLEMENTATION; HOMEOSTASIS	The presence of more than one non-severe pathogenic mutation in the same mitochondrial DNA (mtDNA) molecule is very rare. Moreover, it is unclear whether their co-occurrence results in an additive impact on mitochondrial function relative to single mutation effects. Here we describe the first example of a mtDNA molecule harboring three Leber's hereditary optic neuropathy (LHON)-associated mutations (m.11778G>A, m.14484T>C, m.11253T>C) and the analysis of its genetic, biochemical and molecular characterization in transmitochondrial cells (cybrids). Extensive characterization of cybrid cell lines harboring either the 3 mutations or the single classic m.11778G>A and m.14484T>C mutations revealed no differences in mitochondrial function, demonstrating the absence of a synergistic effect in this model system. These molecular results are in agreement with the ophthalmological characteristics found in the triple mutant patient, which were similar to those carrying single mtDNA LHON mutations.	[Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Blazquez, Alberto; Angel Martin, Miguel; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Hosp 12 Octubre i 12, Inst Invest Sanitaria, Madrid, Spain; [Cruz-Bermudez, Alberto; Vicente-Blanco, Ramiro J.; Hernandez-Sierra, Rosana; Blazquez, Alberto; Angel Martin, Miguel; Ayuso, Carmen; Garesse, Rafael; Fernandez-Moreno, Miguel A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Montero, Mayte; Alvarez, Javier] Univ Valladolid, Fac Med, Dept Bioquim Biol Mol & Fisiol, Valladolid, Spain; [Gonzalez Manrique, Mar] Univ Rey Juan Carlos, Hosp Mostoles, Madrid 28935, Spain; [Ayuso, Carmen] UAM, IIS Fdn Jimenez Diaz Univ Hosp IIS FJD, Dept Genet, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Universidad Rey Juan Carlos; Autonomous University of Madrid; Fundacion Jimenez Diaz	Garesse, R; Fernandez-Moreno, MA (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Hosp 12 Octubre i 12, Inst Invest Sanitaria, Madrid, Spain.; Garesse, R; Fernandez-Moreno, MA (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	rafael.garesse@uam.es; miguel.fernandez@uam.es	Garesse, Rafael/F-3836-2012; Bermúdez, Alberto Cruz/AAE-1341-2021; Blázquez Encinar, Alberto/S-4425-2018; Alvarez, Javier/K-8210-2014; Montero, Mayte/K-8212-2014; Fernandez-Moreno, Miguel Angel/K-4425-2017; Martin, Miguel A/S-2758-2018	Bermúdez, Alberto Cruz/0000-0001-5136-7011; Blázquez Encinar, Alberto/0000-0002-6479-3615; Alvarez, Javier/0000-0003-0636-5521; Montero, Mayte/0000-0001-7702-6653; Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Martin, Miguel A/0000-0003-4741-772X; Vicente-Blanco, Ramiro/0000-0002-8615-7417; Ayuso, Carmen/0000-0002-9242-7065	Instituto de Salud Carlos III [PI 04/1001, PI12/01683, PI13/00556]; Comunidad Autonoma de Madrid [S2010/BMD-2402]; Fundacion Mutua Madrilena [10.04.02.0064]; Spanish Ministry of Economy and Competitiveness [BFU2011-25763]; FEDER funds from the E.U	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds from the E.U	This work was supported by Instituto de Salud Carlos III, http://www.isciii.es/, PI 04/1001 to M.A.F.M.; Instituto de Salud Carlos III, http://www.isciii.es/, PI12/01683 to M.A.M.; Instituto de Salud Carlos III, http://www.isciii.es/, PI13/00556 to R.G.; Comunidad Autonoma de Madrid, http://www.madrid.org/cs/Satellite?pagename=ComunidadMadrid/Home, S2010/BMD-2402 to R.G.; Fundacion Mutua Madrilena, http://www.fundacionmutua.es/, 10.04.02.0064 to M.A.F.M.; The Spanish Ministry of Economy and Competitiveness, http://www.mineco.gob.es/, BFU2011-25763 to J.A.; FEDER funds from the E.U. to R.G., http://ec.europa.eu/regional_policy/es/funding/erdf/.	Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; CHOMYN A, 1994, AM J HUM GENET, V54, P966; Cruz-Bermudez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Drose S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128; Echevarria L, 2014, BIOCHEM J, V460, P91, DOI 10.1042/BJ20131107; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Gallardo ME, 2012, EUR HEART J, V33, P346, DOI 10.1093/eurheartj/ehr280; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117; HARDING AE, 1995, AM J HUM GENET, V57, P77; Haroon MF, 2007, NEUROBIOL DIS, V28, P237, DOI 10.1016/j.nbd.2007.07.021; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Khan NA, 2013, MOL VIS, V19, P1282; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Melberg A, 2009, EUR J MED GENET, V52, P47, DOI 10.1016/j.ejmg.2008.10.004; Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Qiao C, 2015, MOL MED REP, V12, P3067, DOI 10.3892/mmr.2015.3714; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Shu L, 2012, INT J OPHTHALMOL-CHI, V5, P28, DOI 10.3980/j.issn.2222-3959.2012.01.06; Tonska K, 2008, MITOCHONDRION, V8, P383, DOI 10.1016/j.mito.2008.08.002; Trevelyan AJ, 2010, BRAIN, V133, P787, DOI 10.1093/brain/awq023; Vallejo CG, 2013, BIOCHIMIE, V95, P1171, DOI 10.1016/j.biochi.2013.01.001; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wei QP, 2007, BIOCHEM BIOPH RES CO, V357, P910, DOI 10.1016/j.bbrc.2007.04.025; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zhang JJ, 2010, BIOCHEM BIOPH RES CO, V399, P647, DOI 10.1016/j.bbrc.2010.07.135; Zhang SR, 2008, MITOCHONDRION, V8, P205, DOI 10.1016/j.mito.2008.02.003; Zickermann V, 2008, J BIOENERG BIOMEMBR, V40, P475, DOI 10.1007/s10863-008-9171-9	60	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146816	10.1371/journal.pone.0146816	http://dx.doi.org/10.1371/journal.pone.0146816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784702	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400068
J	Ebrahim, S; Mndende, XK; Kharsany, ABM; Mbulawa, ZZA; Naranbhai, V; Frohlich, J; Werner, L; Samsunder, N; Karim, QA; Williamson, AL				Ebrahim, Sumayyah; Mndende, Xolani K.; Kharsany, Ayesha B. M.; Mbulawa, Zizipho Z. A.; Naranbhai, Vivek; Frohlich, Janet; Werner, Lise; Samsunder, Natasha; Karim, Quarraisha Abdool; Williamson, Anna-Lise			High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACQUISITION; PREVALENCE; EFFICACY; HIV; EPIDEMIOLOGY; VACCINATION; PERSISTENCE; PREVENTION; CONCURRENT; DURATION	Objectives HPV infection causes cervical cancer, yet information on prevalence and risk factors for HPV in Africa remain sparse. This study describes the prevalence of HPV genotypes and risk factors associated with HPV among young women <= 30 years of age in KwaZulu-Natal (KZN), South Africa. Methods Cervicovaginal lavage samples were tested for HPV genotypes in 224 women enrolled in a prospective cohort study. Clinical, behavioural and demographic data were collected. We measured prevalence of HPV genotypes and using logistic regression, examined for factors associated with HPV. Results Median age of participants was 21 years [interquartile range (IQR): 18-23]. The overall prevalence of HPV was 76.3%(171/224) with multiple and single genotypes prevalent in 56.3% and 20.1% of women respectively. Proportion of women with high-risk genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56 and 58) was 54.5%. Women not living with their partner [adjusted odds ratio (aOR)] = 3.42 95% CI1.22-9.60; p = 0.019), was significantly associated with HPV infection and high-risk HPV genotype infection. Conclusion The high burden of HPV and associated risk behaviours highlight the need to intensify behavioural interventions to prevent HPV acquisition in young women. The large scale delivery of HPV vaccine should be prioritised to prevent HPV acquisition and reduce HPV-related morbidity.	[Ebrahim, Sumayyah] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Surg, Durban, South Africa; [Mndende, Xolani K.; Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Mndende, Xolani K.; Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kharsany, Ayesha B. M.; Naranbhai, Vivek; Frohlich, Janet; Werner, Lise; Samsunder, Natasha; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Nelson R Mandela Sch Med, Durban, South Africa; [Mbulawa, Zizipho Z. A.] Groote Schuur Hosp, Natl Inst Communicable Dis, Ctr HIV & STIs, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Naranbhai, Vivek] Univ Oxford, Nuffield Dept Med, Oxford, England; [Karim, Quarraisha Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Cape Town; University of Cape Town; University of Kwazulu Natal; National Institute for Communicable Diseases (NICD); University of Cape Town; University of Oxford; Columbia University; University of Cape Town	Ebrahim, S (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Surg, Durban, South Africa.	ebrahims@ukzn.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Naranbhai, Vivek/0000-0003-4281-8882; Williamson, Anna-Lise/0000-0002-5467-1200; Ebrahim, Sumayyah/0000-0001-9822-6347	Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health [5 D43 TW000231-18]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Health Laboratory Service Research Trust; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER	Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Health Laboratory Service Research Trust; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Sumayyah Ebrahim was supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program (AITRP) through the Fogarty International Center, National Institutes of Health (grant# 5 D43 TW000231-18). Some of this work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Funding for the HPV laboratory work was also provided by the National Health Laboratory Service Research Trust and student (XKM) bursary by Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2013, J IMMUNOL TECH INFEC, V2, DOI [10.4172/2329-9541.1000106, DOI 10.4172/2329-9541.1000106]; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Campos NG, 2011, J INFECT DIS, V203, P823, DOI 10.1093/infdis/jiq131; Gattoc L, 2013, OBSTET GYN CLIN N AM, V40, P177, DOI 10.1016/j.ogc.2013.03.007; Giuliano AR, 2001, CANCER EPIDEM BIOMAR, V10, P1129; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; Longatto Filho A, 2010, GYNECOLOGIC OBSTET I, P1; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Marais DJ, 2008, J CLIN MICROBIOL, V46, P732, DOI 10.1128/JCM.01322-07; Marks M, 2011, INT J CANCER, V128, P2962, DOI 10.1002/ijc.25628; McDonald AC, 2014, FRONTIERS ONCOLOGY, V4, P1; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Morrison CS, 2009, BEST PRACT RES CL OB, V23, P263, DOI 10.1016/j.bpobgyn.2008.11.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Myer L, 2004, SEX TRANSM DIS, V31, P174, DOI 10.1097/01.OLQ.0000114942.41998.58; Richter K, 2013, SAMJ S AFR MED J, V103, P313, DOI 10.7196/SAMJ.6514; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Shisana O, 2014, S AFRICAN NATL HIV P; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; World Health Organization, 2007, HUM PAP HPV VACC TEC	32	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146603	10.1371/journal.pone.0146603	http://dx.doi.org/10.1371/journal.pone.0146603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785408	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400052
J	Gonzalez-Browne, C; Murua, MM; Navarro, L; Medel, R				Gonzalez-Browne, Catalina; Murua, Maureen M.; Navarro, Luis; Medel, Rodrigo			Does Plant Origin Influence the Fitness Impact of Flower Damage? A Meta-Analysis	PLOS ONE			English	Article							FEMALE REPRODUCTIVE SUCCESS; FLORAL HERBIVORY; ENEMY RELEASE; PERENNIAL HERB; HUMMINGBIRD POLLINATION; BIOTIC RESISTANCE; NECTAR-ROBBERS; SEX EXPRESSION; EXOTIC PLANTS; TOLERANCE	Herbivory has been long considered an important component of plant-animal interactions that influences the success of invasive species in novel habitats. One of the most important hypotheses linking herbivory and invasion processes is the enemy-release hypothesis, in which exotic plants are hypothesized to suffer less herbivory and fitness-costs in their novel ranges as they leave behind their enemies in the original range. Most evidence, however, comes from studies on leaf herbivory, and the importance of flower herbivory for the invasion process remains largely unknown. Here we present the results of a meta-analysis of the impact of flower herbivory on plant reproductive success, using as moderators the type of damage caused by floral herbivores and the residence status of the plant species. We found 51 papers that fulfilled our criteria. We also included 60 records from unpublished data of the laboratory, gathering a total of 143 case studies. The effects of florivory and nectar robbing were both negative on plant fitness. The methodology employed in studies of flower herbivory influenced substantially the outcome of flower damage. Experiments using natural herbivory imposed a higher fitness cost than simulated herbivory, such as clipping and petal removal, indicating that studies using artificial herbivory as surrogates of natural herbivory underestimate the real fitness impact of flower herbivory. Although the fitness cost of floral herbivory was high both in native and exotic plant species, floral herbivores had a three-fold stronger fitness impact on exotic than native plants, contravening a critical element of the enemy-release hypothesis. Our results suggest a critical but largely unrecognized role of floral herbivores in preventing the spread of introduced species into newly colonized areas.	[Gonzalez-Browne, Catalina; Murua, Maureen M.; Medel, Rodrigo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras 3425, Santiago, Chile; [Navarro, Luis] Univ Vigo, Dept Biol Vegetal, Vigo 36200, Spain	Universidad de Chile; Universidade de Vigo	Medel, R (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras 3425, Santiago, Chile.	rmedel@uchile.cl	Navarro, Luis/C-4175-2008	Navarro, Luis/0000-0002-8308-2237; Medel, Rodrigo/0000-0001-9955-764X; Murua Ibarra, Maureen/0000-0002-8777-9445	Fondo Nacional de Ciencia y Tecnologia [1120155, 1150112]	Fondo Nacional de Ciencia y Tecnologia	This research was supported by Fondo Nacional de Ciencia y Tecnologia, Grants 1120155 and 1150112, to RM ( http://www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Amsberry LK, 2006, PLANT ECOL, V187, P39, DOI 10.1007/s11258-006-9131-6; Ashman TL, 2004, ECOLOGY, V85, P2550, DOI 10.1890/03-0495; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Baron M, 2012, TERRESTRIAL PHOTOSYN, P331, DOI DOI 10.1017/CBO9781139051477.026; Borenstein M., 2009, INTRO METAANALYSIS; Botto-Mahan C, 2011, INT J PLANT SCI, V172, P1130, DOI 10.1086/662029; Burkle LA, 2007, AM J BOT, V94, P1935, DOI 10.3732/ajb.94.12.1935; Caballero P, 2013, PLANT ECOL, V214, P633, DOI 10.1007/s11258-013-0195-9; Cappuccino N, 2005, BIOL LETTERS, V1, P435, DOI 10.1098/rsbl.2005.0341; Cardel YJ, 2010, INT J PLANT SCI, V171, P283, DOI 10.1086/650154; Chun YJ, 2010, ECOL LETT, V13, P937, DOI 10.1111/j.1461-0248.2010.01498.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; de Waal C, 2012, AM J BOT, V99, P1096, DOI 10.3732/ajb.1100295; Deng XB, 2004, BIOTROPICA, V36, P633, DOI 10.1646/1603; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; FRITZ RS, 1981, OECOLOGIA, V50, P316, DOI 10.1007/BF00344969; Garcia MB, 2002, AM J BOT, V89, P1295, DOI 10.3732/ajb.89.8.1295; Gomez JM, 2005, OECOLOGIA, V143, P412, DOI 10.1007/s00442-004-1809-7; Gurevitch J, 2001, ADV ECOL RES, V32, P199, DOI 10.1016/S0065-2504(01)32013-5; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Heil M, 2010, EVOL ECOL, V24, P555, DOI 10.1007/s10682-009-9348-7; HENDRIX SD, 1981, OECOLOGIA, V49, P119, DOI 10.1007/BF00376908; HENDRIX SD, 1984, ECOLOGY, V65, P191, DOI 10.2307/1939470; HENDRIX SD, 1989, EVOLUTION, V43, P891, DOI [10.2307/2409316, 10.1111/j.1558-5646.1989.tb05186.x]; Herrera CM, 2000, ECOLOGY, V81, P2170, DOI 10.1890/0012-9658(2000)081[2170:MTEOPA]2.0.CO;2; Hill SB, 2010, BIOL INVASIONS, V12, P3333, DOI 10.1007/s10530-010-9726-7; Hillebrand H, 2008, META ANAL ECOLOGY EC; Hufbauer RA, 2002, AM MIDL NAT, V147, P204, DOI 10.1674/0003-0031(2002)147[0204:IEODTO]2.0.CO;2; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Irwin RE, 2011, OECOLOGIA, V166, P681, DOI 10.1007/s00442-010-1898-4; KARBAN R, 1993, ECOLOGY, V74, P39, DOI 10.2307/1939499; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Krupnick GA, 1998, PLANT ECOL, V134, P151, DOI 10.1023/A:1009762415520; Krupnick GA, 1999, ECOLOGY, V80, P125, DOI 10.1890/0012-9658(1999)080[0125:TCOFHF]2.0.CO;2; Krupnick GA, 1999, ECOLOGY, V80, P135, DOI 10.2307/176985; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maron JL, 2002, ECOLOGY, V83, P3382, DOI 10.1890/0012-9658(2002)083[3382:CDEOIA]2.0.CO;2; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; McCall AC, 2006, OIKOS, V112, P660, DOI 10.1111/j.0030-1299.2006.13981.x; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2; Mothershead K, 2000, ECOLOGY, V81, P30, DOI 10.2307/177131; Mutikainen P, 1996, OIKOS, V75, P353, DOI 10.2307/3545874; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Navarro L, 2001, PLANT ECOL, V152, P59, DOI 10.1023/A:1011463520398; NAVARRO L, 1993, FLORA, V188, P253; Navarro L, 2000, AM J BOT, V87, P980, DOI 10.2307/2656997; Newman DA, 2005, OIKOS, V110, P497, DOI 10.1111/j.0030-1299.2005.13885.x; Pohl N, 2006, OECOLOGIA, V149, P648, DOI 10.1007/s00442-006-0479-z; Quentin AG, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009096; R Core Team, 2021, R LANGUAGE ENV STAT; Riba-Hernandez P, 2005, BIOTROPICA, V37, P274, DOI 10.1111/j.1744-7429.2005.00037.x; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sowell DR, 2010, AM MIDL NAT, V163, P173, DOI 10.1674/0003-0031-163.1.173; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Strauss SY, 1996, AM NAT, V147, P1098, DOI 10.1086/285896; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sugiura S, 2010, J BIOGEOGR, V37, P237, DOI 10.1111/j.1365-2699.2009.02199.x; Temeles EJ, 2002, INT J PLANT SCI, V163, P803, DOI 10.1086/342033; Traveset A, 1998, FUNCT ECOL, V12, P459, DOI 10.1046/j.1365-2435.1998.00212.x; Utelli AB, 2001, OECOLOGIA, V127, P266, DOI 10.1007/s004420000580; Valdivia CE, 2005, NEW ZEAL J ECOL, V29, P321; van Kleunen M, 2009, J ECOL, V97; Wise MJ, 2008, EVOL ECOL, V22, P19, DOI 10.1007/s10682-007-9156-x; Zhang YW, 2007, PLANT ECOL, V193, P1, DOI 10.1007/s11258-006-9244-y; Zhang YW, 2009, ANN BOT-LONDON, V104, P33, DOI 10.1093/aob/mcp104	75	8	9	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146437	10.1371/journal.pone.0146437	http://dx.doi.org/10.1371/journal.pone.0146437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785039	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400038
J	Mahjabeen, I; Kayani, MA				Mahjabeen, Ishrat; Kayani, Mahmood Akhtar			Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study	PLOS ONE			English	Article							DOWN-REGULATION; ENHANCED PROLIFERATION; POOR-PROGNOSIS; SIRT3; METABOLISM; CANCER; REPAIR; DNA; INVASION; DAMAGE	Mitochondrial genes play important roles in cellular energy metabolism, free radical generation, and apoptosis. Dysregulation of these genes have long been suspected to contribute to the generation of reactive oxygen species (ROS), increased proliferation and progression of cancer. A family of orthologues of yeast silent information regulator 3 (SIRT3), 4 (SIRT4) and mitochondrial tumor suppressor 1 (MTUS1) are important mitochondrial tumor suppressor genes which play an important role in the progression of multiple cancers. However, their role in the development of oxidative stress, enhanced proliferation and progression of head and neck squamous cell carcinoma (HNSCC) has not yet been studied. In this study we aimed to test the association between reduced mitochondrial tumor suppressor genes' activities and enhancement in tissue oxidative stress and cell proliferation in HNSCC cases. The expression of mitochondrial tumor suppressor genes (SIRT3, SIRT4 and MTUS1), mitochondrial DNA repair gene (OGG1-2a) and a proliferation marker (Ki-67) was studied in a study cohort of 120 HNSCC patients and controls with reverse transcriptase polymerase chain reaction (RT-PCR) and real-time PCR (qPCR) in order to determine the potential prognostic significance of these genes. A statistically significant downregulation of SIRT3 (p<0.001), SIRT4 (p<0.0001), MTUS1 (p<0.002) and OGG1 (p<0.0001) was observed in HNSCC compared to control samples. Ki-67 was also overexpressed (p<0.0001) in HNSCC versus control samples. Additionally, to explore gene-gene relationship, we observed a positive spearmen correlation between SIRT3 versus SIRT4 (r = 0.523***, p<0.0001), SIRT3 versus MTUS1 (r = 0.273***, p<0.001), SIRT3 versus OGG1-2a (r = 0.213*, p<0.03), SIRT4 versus OGG1 (r = 0.338***, p<0.0001) and MTUS1 versus OGG1-2a (r = 0.215*, p<0.03) in HNSCC cases. A negative spearman correlation was observed between OGG1 versus Ki-67 (r = -0.224**, p<0.01) and OGG1-2a versus Ki-67 (r = -0.224**, p<0.01) in HNSCC cases. Here we report that the deregulation of mitochondrial tumor suppressor genes (SIRT3, SIRT4 and MTUS1) in relation to decreased expression of mitochondrial DNA repair gene OGG1-2a and increased proliferation (measured by proliferation marker Ki-67) may be considered important factors in the development of head and neck squamous cell carcinoma.	[Mahjabeen, Ishrat; Kayani, Mahmood Akhtar] COMSATS Inst Informat Technol, Dept Biosci, Canc Genet & Epigenet Res Grp, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Kayani, MA (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Canc Genet & Epigenet Res Grp, Islamabad, Pakistan.	mkayani@comsats.edu.pk	; Kayani, Mahmood/I-7760-2015	Mahjabeen, Ishrat/0000-0002-6392-672X; Kayani, Mahmood/0000-0001-9886-180X				Bacolod MD, 2010, J MOL DIAGN, V12, P552, DOI 10.2353/jmoldx.2010.100098; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Desouki MM, 2014, HUM PATHOL, V45, P1071, DOI 10.1016/j.humpath.2014.01.004; Ding XQ, 2012, MOL ONCOL, V6, P73, DOI 10.1016/j.molonc.2011.11.002; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Li HQ, 2013, INT J ONCOL, V43, P1420, DOI 10.3892/ijo.2013.2103; Louis SNS, 2010, PROSTATE, V70, P1563, DOI 10.1002/pros.21192; Mahjabeen I, 2014, TUMOR BIOL, V35, P5971, DOI 10.1007/s13277-014-1792-5; Mahjabeen I, 2013, MUTAGENESIS, V28, P213, DOI 10.1093/mutage/ges074; Mahjabeen I, 2012, MED ONCOL, V29, P3620, DOI 10.1007/s12032-012-0300-2; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Petruzzelli GJ, 2000, ORL J OTO-RHINO-LARY, V62, P178, DOI 10.1159/000027744; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sebastian C, 2010, CELL, V143, P667, DOI 10.1016/j.cell.2010.11.009; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Wang ZX, 2015, CANCER INFORM, V14, P1, DOI [10.4137/CIn.s13976, 10.4137/CIN.S13976]; Xiao K, 2013, ONCOL REP, V30, P1323, DOI 10.3892/or.2013.2604; Yu Jinsheng, 2009, BMC Res Notes, V2, P109, DOI 10.1186/1756-0500-2-109; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703; Zhao TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1209-x; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15; Zuern C, 2010, ONCOL REP, V23, P183, DOI 10.3892/or_00000621	28	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146948	10.1371/journal.pone.0146948	http://dx.doi.org/10.1371/journal.pone.0146948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785117	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400083
J	Nair, CB; Manjula, J; Subramani, PA; Nagendrappa, PB; Manoj, MN; Malpani, S; Pullela, PK; Subbarao, PV; Ramamoorthy, S; Ghosh, SK				Nair, Chandrasekhar Bhaskaran; Manjula, Jagannath; Subramani, Pradeep Annamalai; Nagendrappa, Prakash B.; Manoj, Mulakkapurath Narayanan; Malpani, Sukriti; Pullela, Phani Kumar; Subbarao, Pillarisetti Venkata; Ramamoorthy, Siva; Ghosh, Susanta K.			Differential Diagnosis of Malaria on Truelab Uno (R), a Portable, Real-Time, MicroPCR Device for Point-Of-Care Applications	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; HIGH PREVALENCE; FIELD SAMPLES; INFECTIONS; VIVAX; MICROSCOPY; PCR; TESTS	Background Sensitive and specific detection of malarial parasites is crucial in controlling the significant malaria burden in the developing world. Also important is being able to identify life threatening Plasmodium falciparum malaria quickly and accurately to reduce malaria related mortality. Existing methods such as microscopy and rapid diagnostic tests (RDTs) have major shortcomings. Here, we describe a new real-time PCR-based diagnostic test device at point-of-care service for resource-limited settings. Methods Truenat (R) Malaria, a chip-based microPCR test, was developed by bigtec Labs, Bangalore, India, for differential identification of Plasmodium falciparum and Plasmodium vivax parasites. The Truenat Malaria tests runs on bigtec's Truelab Uno (R) microPCR device, a handheld, battery operated, and easy-to-use real-time microPCR device. The performance of Truenat (R) Malaria was evaluated versus the WHO nested PCR protocol. The Truenat (R) Malaria was further evaluated in a triple-blinded study design using a sample panel of 281 specimens created from the clinical samples characterized by expert microscopy and a rapid diagnostic test kit by the National Institute of Malaria Research (NIMR). A comparative evaluation was done on the Truelab Uno (R) and a commercial real-time PCR system. Results The limit of detection of the Truenat Malaria assay was found to be <5 parasites/mu l for both P. falciparum and P. vivax. The Truenat (R) Malaria test was found to have sensitivity and specificity of 100% each, compared to the WHO nested PCR protocol based on the evaluation of 100 samples. The sensitivity using expert microscopy as the reference standard was determined to be around 99.3% (95% CI: 95.5-99.9) at the species level. Mixed infections were identified more accurately by Truenat Malaria (32 samples identified as mixed) versus expert microscopy and RDTs which detected 4 and 5 mixed samples, respectively. Conclusion The Truenat (R) Malaria microPCR test is a valuable diagnostic tool and implementation should be considered not only for malaria diagnosis but also for active surveillance and epidemiological intervention.	[Nair, Chandrasekhar Bhaskaran; Manjula, Jagannath; Manoj, Mulakkapurath Narayanan; Malpani, Sukriti; Pullela, Phani Kumar; Subbarao, Pillarisetti Venkata] Bigtec Private Ltd, 2nd Floor,59th C Cross,4th M Block, Bangalore 560010, Karnataka, India; [Subramani, Pradeep Annamalai; Ghosh, Susanta K.] Natl Inst Malaria Res, ICMR Complex, Bangalore 562110, Karnataka, India; [Nagendrappa, Prakash B.] Inst Trans Disciplinary Hlth Sci & Technol IHST, FRLHT 74-2,Via Yelahanka, Bangalore 560106, Karnataka, India; [Nair, Chandrasekhar Bhaskaran; Ramamoorthy, Siva] VIT Univ, Sch Adv Sci, Sch Bio Sci & Technol, Vellore 632014, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Vellore Institute of Technology	Ghosh, SK (corresponding author), Natl Inst Malaria Res, ICMR Complex, Bangalore 562110, Karnataka, India.	ghoshnimr@gmail.com	Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/D-7133-2019; Pullela, Phani Kumar/AAX-6259-2020	Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/0000-0001-7509-8602; Pullela, Phani Kumar/0000-0002-4462-4814; BN, Prakash/0000-0001-8575-9013; Annamalai Subramani, Pradeep/0000-0001-8685-0900	bigtec Private Limited	bigtec Private Limited	The study was funded by bigtec Private Limited. The funder provided support in the form of salaries for authors [CBN, JM, MNM, SM, PKP AND PVS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; [Anonymous], 1988, B WORLD HEALTH ORGAN, V66, P575; [Anonymous], 2009, MAL MICR QUAL ASS MA; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; BROWN AE, 1992, T ROY SOC TROP MED H, V86, P609, DOI 10.1016/0035-9203(92)90147-5; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kumar KK, 2008, U.S. Patent Application, Patent No. [12/682,555, 12682555]; Kumar KK, 2008, U.S. Patent Application, Patent No. [12/682,581, 12682581]; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Nikam C, 2014, INT J MYCOBACT, V3, P205, DOI 10.1016/j.ijmyco.2014.04.003; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; SATTABONGKOT J, 1991, PARASITOLOGY, V102, P27, DOI 10.1017/S0031182000060303; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2009, METH FIELD TRIALS MA; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2014, WHOHTMGMP20147	34	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146961	10.1371/journal.pone.0146961	http://dx.doi.org/10.1371/journal.pone.0146961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784111	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400087
J	Wei, C; Luo, SL; Ma, XC; Ren, H; Zhang, J; Pan, LM				Wei, Chao; Luo, Senlin; Ma, Xincheng; Ren, Hao; Zhang, Ji; Pan, Limin			Locally Embedding Autoencoders: A Semi-Supervised Manifold Learning Approach of Document Representation	PLOS ONE			English	Article							NETWORK	Topic models and neural networks can discover meaningful low-dimensional latent representations of text corpora; as such, they have become a key technology of document representation. However, such models presume all documents are non-discriminatory, resulting in latent representation dependent upon all other documents and an inability to provide discriminative document representation. To address this problem, we propose a semi-supervised manifold-inspired autoencoder to extract meaningful latent representations of documents, taking the local perspective that the latent representation of nearby documents should be correlative. We first determine the discriminative neighbors set with Euclidean distance in observation spaces. Then, the autoencoder is trained by joint minimization of the Bernoulli cross-entropy error between input and output and the sum of the square error between neighbors of input and output. The results of two widely used corpora show that our method yields at least a 15% improvement in document clustering and a nearly 7% improvement in classification tasks compared to comparative methods. The evidence demonstrates that our method can readily capture more discriminative latent representation of new documents. Moreover, some meaningful combinations of words can be efficiently discovered by activating features that promote the comprehensibility of latent representation.	[Wei, Chao; Luo, Senlin; Ma, Xincheng; Ren, Hao; Zhang, Ji; Pan, Limin] Beijing Inst Technol, Beijing 10081, Peoples R China	Beijing Institute of Technology	Pan, LM (corresponding author), Beijing Inst Technol, Beijing 10081, Peoples R China.	panlimin.bit@gmail.com			National Information Security 242 Project of China [2005C48]; Technology Innovation Program of Beijing Institute of Technology [2011CX01015]	National Information Security 242 Project of China; Technology Innovation Program of Beijing Institute of Technology	This work was supported in part by the National Information Security 242 Project of China under Grant No. 2005C48, and the Technology Innovation Program of Beijing Institute of Technology under Grant No. 2011CX01015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2002, ADV NEUR IN, V14, P585; Bengio Y., 2006, ADV NEURAL INFORM PR, V19; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bishop C.M., 2006, PATTERN RECOGN, V4, P12; Blei D. M., 2003, J MACHINE LEARNING R; Blei David M., 2007, P ANN C NEUR INF PRO, P121; Boyd-Graber J.L., 2009, ADV NEURAL INFORM PR, P185; Cai D., 2009, P 26 ANN INT C MACHI, P105; Cai D., 2008, P 17 ACM C INFORM KN, P911; Cao Z, 2015, NOVEL NEURAL TOPIC M; Chen XB, 2014, KNOWL-BASED SYST, V70, P154, DOI 10.1016/j.knosys.2014.06.020; Cheng XQ, 2014, IEEE T KNOWL DATA EN, V26, P2928, DOI 10.1109/TKDE.2014.2313872; Cui L, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P133; De Smet W, 2013, DATA MIN KNOWL DISC, V26, P533, DOI 10.1007/s10618-012-0270-1; Fan MY, 2014, IEEE T IMAGE PROCESS, V23, P2133, DOI 10.1109/TIP.2014.2312643; Hinton G.E., 2009, ADV NEURAL INFORM PR, P1607; Hofmann T., 1999, P 1999 INT C RES DEV; Huh S, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086740; Kausar N, 2011, COMM COM INF SC, V253, P24; Larochelle H., 2012, ADV NEURAL INFORM PR, P2708; Laszlo Lovasz MD, 2009, AM MATH SOC, P367; Luo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082119; Mountassir A, 2014, LECT NOTES ARTIF INT, V8556, P442, DOI 10.1007/978-3-319-08979-9_34; NARAYANAN H., 2010, ADV NEURAL INFORM PR, V2, P1786; Phan X., 2008, P 17 INT C WORLD WID, P91, DOI 10.1145/1367497.1367510; Ranzato M., 2008, P 25 INT C MACHINE L, P792, DOI DOI 10.1145/1390156.1390256; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shan HH, 2011, DATA MIN KNOWL DISC, V23, P1, DOI 10.1007/s10618-010-0198-2; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tu Loring W., 2011, INTRO MANIFOLDS, P47; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang W, 2014, IEEE COMPUT SOC CONF, P496, DOI 10.1109/CVPRW.2014.79; Wu H, 2012, PATTERN RECOGN, V45, P617, DOI 10.1016/j.patcog.2011.04.029; Wu S, 2013, MAYOCLINICNLP CORE S, P148; Zeng J, 2013, IEEE T PATTERN ANAL, V35, P1121, DOI 10.1109/TPAMI.2012.185; Zhang WN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0071511, 10.1371/journal.pone.0107941]; Zhu J, 2012, J MACH LEARN RES, V13, P2237	41	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146672	10.1371/journal.pone.0146672	http://dx.doi.org/10.1371/journal.pone.0146672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784692	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400057
J	Yang, L; Yan, J; Tang, XH; Xu, XL; Yu, W; Wu, HB				Yang, Li; Yan, Jing; Tang, Xinhua; Xu, Xiaoling; Yu, Wei; Wu, Haibin			Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013	PLOS ONE			English	Article							GLOBAL BURDEN; MANAGEMENT; POPULATION; COMMUNITY	To investigate the prevalence, awareness, treatment, control of hypertension and their associated factors in southern China. A cross-sectional survey was conducted in 5 cities of urban areas and 5 counties of rural areas in Southern China in 2013, a stratified multistage random sampling method was used to select a representative sample. Recruitment included a total of 19254 participants aged 15 or older. Socio-demographic profiles, examinations were administrated on each subject. Multilevel logistic regression models were used to identify the risk factors of hypertension, awareness, treatment, and control. Overall, the prevalence of hypertension and pre-hypertension are 24.59% and 32.11%, respectively in southern China. Among all the hypertensive patients, 67.43% were aware of their condition, 55.76% took anti-hypertension medication recent two weeks, and 30.79% had their blood pressure controlled. Compared with male, female hypertensive patients had higher rates of hypertension awareness, treatment and control. Age, gender, marital status, living areas, education, BMI, waist circumference, visceral adipose index (VAI), high body fat percentage (BFP) and family hypertension history correlated with the prevalence of hypertension. SBP/DBP increased with VAI and BFP increasing. There is an increasing prevalence of hypertension and high pre-hypertension in the general population in southern China, but levels of awareness, treatment, and control remain relatively low, especially for young and middle-aged population. Innovative strategies including of adopting appropriate anti-hypertensive medication therapy and healthy lifestyles should be taken.	[Yang, Li; Yan, Jing; Tang, Xinhua; Xu, Xiaoling; Yu, Wei] Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China; [Wu, Haibin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Yan, J; Tang, XH (corresponding author), Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China.	zjicu@vip.163.com; phoebe84331@163.com			National Key RAMP;D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology [2011BAI11B01]	National Key RAMP;D Program in the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology	This study was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology.r Sources of funding, this research was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BAI11B01) from the Chinese Ministry of Science and Technology.	Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bharucha NE, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-1; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; Cai L, 2012, CLIN EXP HYPERTENS, V34, P45, DOI 10.3109/10641963.2011.618206; Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension, 2005, CHIN J HYPERTENS, V134, P2; Diederichs C, 2014, J HYPERTENS, V32, P1405, DOI 10.1097/HJH.0000000000000211; Do HTP, 2015, AM J HYPERTENS, V28, P89, DOI 10.1093/ajh/hpu092; Fodor JG, 2008, CAN J CARDIOL, V24, P503, DOI 10.1016/S0828-282X(08)70626-3; Grucza RA, 2010, ARCH GEN PSYCHIAT, V67, P1301, DOI 10.1001/archgenpsychiatry.2010.155; Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Hazarika N C, 2003, J Assoc Physicians India, V51, P567; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Huang YL, 2014, AM HEART J, V167, P160, DOI 10.1016/j.ahj.2013.10.023; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khanam MA, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-015-1520-0, 10.1186/s12889-015-2471-1]; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lawes CM, 2000, J HYPERTENS, V2006, P423; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li Y., 2014, BIOMED RES IN, V2014, P14, DOI DOI 10.1186/1471-2458-14-903; Liang Ke, 2014, AM J HYPERTENS, V5, P1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malekzadeh MM, 2013, J HYPERTENS, V31, P1364, DOI 10.1097/HJH.0b013e3283613053; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Rahman MM, 2015, J HYPERTENS, V33, P465, DOI 10.1097/HJH.0000000000000421; Vigna-Taglianti F, 2009, J EPIDEMIOL COMMUN H, V63, P722, DOI 10.1136/jech.2008.081513; WanFen Yip, 2013, J HYPERTENSION, V31, P000; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang ZW, 2014, INT J CARDIOL, V174, P721, DOI 10.1016/j.ijcard.2014.03.117; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081	35	46	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146181	10.1371/journal.pone.0146181	http://dx.doi.org/10.1371/journal.pone.0146181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784948	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400027
J	Boughorbel, S; Al-Ali, R; Elkum, N				Boughorbel, Sabri; Al-Ali, Rashid; Elkum, Naser			Model Comparison for Breast Cancer Prognosis Based on Clinical Data	PLOS ONE			English	Article							STATISTICS	We compared the performance of several prediction techniques for breast cancer prognosis, based on AU-ROC performance (Area Under ROC) for different prognosis periods. The analyzed dataset contained 1,981 patients and from an initial 25 variables, the 11 most common clinical predictors were retained. We compared eight models from a wide spectrum of predictive models, namely; Generalized Linear Model (GLM), GLM-Net, Partial Least Square (PLS), Support Vector Machines (SVM), Random Forests (RF), Neural Networks, k-Nearest Neighbors (k-NN) and Boosted Trees. In order to compare these models, paired t-test was applied on the model performance differences obtained from data resampling. Random Forests, Boosted Trees, Partial Least Square and GLMNet have superior overall performance, however they are only slightly higher than the other models. The comparative analysis also allowed us to define a relative variable importance as the average of variable importance from the different models. Two sets of variables are identified from this analysis. The first includes number of positive lymph nodes, tumor size, cancer grade and estrogen receptor, all has an important influence on model predictability. The second set incudes variables related to histological parameters and treatment types. The short term vs long term contribution of the clinical variables are also analyzed from the comparative models. From the various cancer treatment plans, the combination of Chemo/Radio therapy leads to the largest impact on cancer prognosis.	[Boughorbel, Sabri; Al-Ali, Rashid] Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar; [Elkum, Naser] Sidra Med & Res Ctr, Div Clin Epidemiol, Doha, Qatar	Sidra Medical & Research Center; Sidra Medical & Research Center	Boughorbel, S (corresponding author), Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar.	sboughorbel@sidra.org	Elkum, Naser/AAU-5555-2020	Elkum, Naser/0000-0002-0457-0444; Boughorbel, Sabri/0000-0003-2734-3356				Ahmed A, 2012, BREAST CANC METASTAS, P1; Alteri R., 2013, BREAST CANC FACTS FI; Bishop C.M., 1995, NEURAL NETWORKS PATT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bridle John S, 1990, NEUROCOMPUTING, P227, DOI DOI 10.1007/978-3-642-76153-9_28; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burke H. B., 1995, Advances in Neural Information Processing Systems 7, P1063; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Eloranta S, 2013, CANCER CAUSE CONTROL, V24, P505, DOI 10.1007/s10552-012-0141-5; Endo A., 2008, INT J BIOMED SOFT CO, V13, P11, DOI DOI 10.24466/IJBSCHS.13.2_11; Eugster Manuel J.A., 2008, EXPLORATORY INFERENT; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Maglogiannis I, 2009, APPL INTELL, V30, P24, DOI 10.1007/s10489-007-0073-z; Max K., 2015, CARET MODEL TRAINING; Max K., 2015, VARIABLE IMPORTANCE; QUESENBERRY CP, 1989, AM J PUBLIC HEALTH, V79, P1643, DOI 10.2105/AJPH.79.12.1643; WOLD S, 1983, LECT NOTES MATH, V973, P286; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341	25	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146413	10.1371/journal.pone.0146413	http://dx.doi.org/10.1371/journal.pone.0146413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771838	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300017
J	Ohira, S; Inoue, T; Iwao, K; Takahashi, E; Tanihara, H				Ohira, Saori; Inoue, Toshihiro; Iwao, Keiichiro; Takahashi, Eri; Tanihara, Hidenobu			Factors Influencing Aqueous Proinflammatory Cytokines and Growth Factors in Uveitic Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MITOMYCIN-C; PSEUDOPHAKIC EYES; FACTOR-BETA; HUMOR; TRABECULECTOMY; PHACOEMULSIFICATION; CHEMOKINES; PROFILES; PHACOTRABECULECTOMY	Purpose To analyze the effects of factors on aqueous humor proinflammatory cytokine and growth factor levels in patients with uveitic glaucoma (UG). Methods In this cross-sectional study, we enrolled 143 participants: 1) UG patients (n = 39); 2) primary open-angle glaucoma (POAG) patients (n = 36); and 3) cataract surgery patients, as a comparative group (n = 68). Aqueous humor samples were obtained at the start of surgery. Aqueous cytokine levels were determined using a multiplex immunoassay (xMAP and the Human Cytokine/Chemokine Panel I). Results In UG cases, mean interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, tumor necrosis factor (TNF)-alpha, platelet-derived growth factor (PDGF)-AA, PDGF-AB/BB, and VEGF levels were 171.1, 214.5, 2791.7, 3.5, 23.9, 5.4, and 168.9 pg/mL, respectively, and were higher than those in cataract (non-glaucomatous) cases except PDGF. Levels of IL-6, MCP-1, and VEGF were higher in UG cases than in POAG cases. UG cases with a history of phacoemulsification displayed significantly higher levels of IL-6 (P = 0.0164), IL-8 (P = 0.0003), MCP-1 (P = 0.0465), and PDGF-AB/BB (P = 0.0062) compared to the phakic cases. The presence of cells in the anterior chamber was related to higher levels of IL-8 (P = 0.0002), TNF-alpha (P = 0.0037), and PDGF-AB/BB (P = 0.0009). The level of PDGF-AB/BB was higher in infectious uveitis than in non-infectious uveitis (P = 0.0211). The level of transforming growth factor (TGF)-beta 2 was negatively correlated with the levels of MCP-1 (adjusted R-2 = 0.28, t = -2.45, P = 0.031) and TNF-alpha (adjusted R-2 = 0.27, t = -2.43, P = 0.032). Conclusion A history of phacoemulsification, the presence of cells in the anterior chamber, and infectious uveitis were related to aqueous proinflammatory cytokine levels in patients with UG. TGF-beta 2 might be an anti-inflammatory factor in aqueous humor of UG patients.	[Ohira, Saori; Inoue, Toshihiro; Iwao, Keiichiro; Takahashi, Eri; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan	Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Iwao, Keiichiro/0000-0002-4102-9374; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [26293375, 15K15636, 26462664]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 26293375, 15K15636, and 26462664. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2012, CYTOKINE, V59, P377, DOI 10.1016/j.cyto.2012.04.030; Abu El-Asrar AM, 2011, IMMUNOBIOLOGY, V216, P1004, DOI 10.1016/j.imbio.2011.03.007; Abu El-Asrar AM, 2004, AM J OPHTHALMOL, V138, P401, DOI 10.1016/j.ajo.2004.04.046; Awai-Kasaoka N, 2012, J CATARACT REFR SURG, V38, P419, DOI 10.1016/j.jcrs.2011.09.035; BROADWAY DC, 1993, EYE, V7, P495, DOI 10.1038/eye.1993.108; Curnow SJ, 2006, CURR OPIN OPHTHALMOL, V17, P532, DOI 10.1097/ICU.0b013e32801094b5; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; DEBOER JH, 1994, INVEST OPHTH VIS SCI, V35, P3702; Howe LJ, 1996, CURR EYE RES, V15, P1149, DOI 10.3109/02713689608995149; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kaburaki T, 2009, EYE, V23, P1509, DOI [10.1038/eye.2009.117, 10.1038/eye.2009.117-cme]; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Kuiper JJW, 2011, AM J OPHTHALMOL, V152, P177, DOI 10.1016/j.ajo.2011.01.031; Landers J, 2012, OPHTHALMOLOGY, V119, P694, DOI 10.1016/j.ophtha.2011.09.043; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; NOROSE K, 1994, INVEST OPHTH VIS SCI, V35, P33; Ogata-Iwao M, 2013, ACTA OPHTHALMOL, V91, pe500, DOI 10.1111/aos.12133; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Park UC, 2006, AM J OPHTHALMOL, V142, P1005, DOI 10.1016/j.ajo.2006.07.018; Siddique SS, 2013, SURV OPHTHALMOL, V58, P1, DOI 10.1016/j.survophthal.2012.04.006; Sijssens KM, 2007, EXP EYE RES, V85, P443, DOI 10.1016/j.exer.2007.06.011; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Taylor AW, 2003, OCUL IMMUNOL INFLAMM, V11, P231, DOI 10.1076/ocii.11.4.231.18269; Valentincic NV, 2011, MOL VIS, V17, P2003; van Kooij B, 2006, AM J OPHTHALMOL, V142, P192, DOI 10.1016/j.ajo.2006.02.052; Verma MJ, 1997, CURR EYE RES, V16, P1202, DOI 10.1076/ceyr.16.12.1202.5034	34	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147080	10.1371/journal.pone.0147080	http://dx.doi.org/10.1371/journal.pone.0147080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771310	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300061
J	Tarnow, P; Hutzler, C; Grabiger, S; Schon, K; Tralau, T; Luch, A				Tarnow, Patrick; Hutzler, Christoph; Grabiger, Stefan; Schoen, Karsten; Tralau, Tewes; Luch, Andreas			Estrogenic Activity of Mineral Oil Aromatic Hydrocarbons Used in Printing Inks	PLOS ONE			English	Article							BREAST-CANCER-CELLS; GENE-EXPRESSION; RECEPTOR-ALPHA; RECYCLED PAPERBOARD; RESPONSIVE GENES; MCF-7 CELLS; CATHEPSIN-D; ACTIVATION; REPORTER; TOXICITY	The majority of printing inks are based on mineral oils (MOs) which contain complex mixtures of saturated and aromatic hydrocarbons. Consumer exposure to these oils occurs either through direct skin contacts or, more frequently, as a result of MO migration into the contents of food packaging that was made from recycled newspaper. Despite this ubiquitous and frequent exposure little is known about the potential toxicological effects, particularly with regard to the aromatic MO fractions. From a toxicological point of view the huge amount of alkylated and unsubstituted compounds therein is reason for concern as they can harbor genotoxicants as well as potential endocrine disruptors. The aim of this study was to assess both the genotoxic and estrogenic potential of MOs used in printing inks. Mineral oils with various aromatic hydrocarbon contents were tested using a battery of in vitro assays selected to address various endpoints such as estrogen-dependent cell proliferation, activation of estrogen receptor a or transcriptional induction of estrogenic target genes. In addition, the comet assay has been applied to test for genotoxicity. Out of 15 MOs tested, 10 were found to potentially act as xenoestrogens. For most of the oils the effects were clearly triggered by constituents of the aromatic hydrocarbon fraction. From 5 oils tested in the comet assay, 2 showed slight genotoxicity. Altogether it appears that MOs used in printing inks are potential endocrine disruptors and should thus be assessed carefully to what extent they might contribute to the total estrogenic burden in humans.	[Tarnow, Patrick; Hutzler, Christoph; Grabiger, Stefan; Schoen, Karsten; Tralau, Tewes; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Max Dohrn Str 8-10, D-10598 Berlin, Germany	Federal Institute for Risk Assessment	Tarnow, P (corresponding author), German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Max Dohrn Str 8-10, D-10598 Berlin, Germany.	Patrick.Tarnow@bfr.bund.de		Hutzler, Christoph/0000-0003-0299-8559; Tralau, Tewes/0000-0002-7857-4237	German Federal Institute for Risk Assessment [SFP1322-526]	German Federal Institute for Risk Assessment	This work was supported by an intramural grant at the German Federal Institute for Risk Assessment (SFP1322-526).	Ahmed S, 2009, TOXICOL SCI, V111, P254, DOI 10.1093/toxsci/kfp144; Beck S, 1997, INT J ONCOL, V10, P1051; Bergman A., 2012, STATE SCI ENDOCRINE; Biedermann M, 2013, FOOD ADDIT CONTAM A, V30, P885, DOI 10.1080/19440049.2013.786189; Biedermann M, 2012, J CHROMATOGR A, V1255, P56, DOI 10.1016/j.chroma.2012.05.095; Biedermann M, 2011, PACKAG TECHNOL SCI, V24, P61, DOI 10.1002/pts.914; Biedermann M, 2009, J AGR FOOD CHEM, V57, P8711, DOI 10.1021/jf901375e; Bohonowych JES, 2008, TOXICOL SCI, V102, P278, DOI 10.1093/toxsci/kfn011; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Brinkmann J, 2013, TOXICOL SCI, V131, P351, DOI 10.1093/toxsci/kfs316; CAVAILLES V, 1989, MOL ENDOCRINOL, V3, P552, DOI 10.1210/mend-3-3-552; Charles GD, 2000, TOXICOL SCI, V55, P320, DOI 10.1093/toxsci/55.2.320; COOMBS MM, 1976, CANCER RES, V36, P4525; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; EFSA, 2012, EFSA J, V10; EuPIA, 2013, CEPE ANN REP; Evans RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043606; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Genter MB, 2006, BIOCHEM BIOPH RES CO, V348, P120, DOI 10.1016/j.bbrc.2006.07.025; Gozgit JM, 2004, TOXICOL APPL PHARM, V196, P58, DOI 10.1016/j.taap.2003.12.003; Grob K., 1991, Journal of High Resolution Chromatography and Chromatography Communications, V14, P33, DOI 10.1002/jhrc.1240140109; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klinge CM, 1999, MOL CELL ENDOCRINOL, V157, P105, DOI 10.1016/S0303-7207(99)00165-3; Lorenzini R, 2013, FOOD ADDIT CONTAM A, V30, P760, DOI 10.1080/19440049.2013.766765; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; RICE JE, 1987, J TOXICOL ENV HEALTH, V21, P525, DOI 10.1080/15287398709531040; Safe S, 2003, CHEM RES TOXICOL, V16, P807, DOI 10.1021/tx034036r; Salaberria I, 2014, J TOXICOL ENV HEAL A, V77, P506, DOI 10.1080/15287394.2014.886983; Schreiner CA, 2003, J TOXICOL ENV HEAL B, V6, P161, DOI 10.1080/10937400306472; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sutter CH, 2009, P NATL ACAD SCI USA, V106, P4266, DOI 10.1073/pnas.0900874106; Tarnow P, 2013, TOXICOL IN VITRO, V27, P1467, DOI 10.1016/j.tiv.2013.03.003; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Vinggaard AM, 2000, CHEM RES TOXICOL, V13, P1214, DOI 10.1021/tx000146b; Vollmer A, 2011, EUR FOOD RES TECHNOL, V232, P175, DOI 10.1007/s00217-010-1376-6; Vondracek J, 2002, TOXICOL SCI, V70, P193, DOI 10.1093/toxsci/70.2.193; Vrabie CM, 2011, ENVIRON TOXICOL CHEM, V30, P973, DOI 10.1002/etc.463; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; ZACHAREWSKI TR, 1994, CANCER RES, V54, P2707	47	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147239	10.1371/journal.pone.0147239	http://dx.doi.org/10.1371/journal.pone.0147239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771904	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300073
J	Kinoshita, A; Kenez, A; Locher, L; Meyer, U; Danicke, S; Rehage, J; Huber, K				Kinoshita, Asako; Kenez, Akos; Locher, Lena; Meyer, Ulrich; Daenicke, Sven; Rehage, Juergen; Huber, Korinna			Insulin Signaling in Liver and Adipose Tissues in Periparturient Dairy Cows Supplemented with Dietary Nicotinic Acid	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; NIACIN SUPPLEMENTATION; GENE-EXPRESSION; GLUCOSE TRANSPORTERS; SKELETAL-MUSCLES; HOLSTEIN COWS; CATTLE; RECEPTOR; PHOSPHORYLATION; CONCENTRATE	The glucose homeostasis in dairy cattle is very well controlled, in line with the metabolic adaptation during the periparturient period. Former studies showed that nicotinic acid (NA) lowered plasma non-esterified fatty acids (NEFA) concentrations and increased insulin sensitivity in dairy cows. Thus, the purpose of this study was to investigate whether the expression of proteins involved in hepatic and adipose insulin signaling and protein expression of hepatic glucose transporter 2 (GLUT2) were affected by dietary NA and dietary concentrate intake in periparturient dairy cows. Twenty pluriparous German Holstein cows were fed with the same diet from about 21 days before the expected calving date (d-21) to calving. After calving, cows were randomly assigned in 4 groups and fed with diets different in concentrate proportion ("HC" with 60:40% or "LC" with 30:70% concentrate-to-roughage ratio) and supplemented with NA (24 g/day) (NA) or without (CON) until d21. Biopsy samples were taken from the liver, subcutaneous (SCAT) and retroperitoneal (RPAT) adipose tissues at d-21 and d21. Protein expression of insulin signaling molecules (insulin receptor (INSR), phosphatidylinositol-3-kinase (PI3K), protein kinase C zeta (PKC zeta)) and hepatic GLUT2 was measured by Western Blotting. The ratio of protein expression at d21/at d-21 was calculated and statistically evaluated for the effects of time and diet. Cows in HC had significantly higher dietary energy intake than cows in LC. In RPAT a decrease in PI3K and PKC zeta expression was found in all groups, irrespectively of diet. In the liver, the GLUT2 expression was significantly lower in cows in NA compared with cows in CON. In conclusion, insulin signaling might be decreased in RPAT over time without any effect of diet. NA was able to modulate hepatic GLUT2 expression, but its physiological role is unclear.	[Kinoshita, Asako] Univ Vet Med Hannover, Dept Physiol, Hannover, Germany; [Kenez, Akos; Huber, Korinna] Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany; [Locher, Lena] Univ Munich, Ctr Vet Clin Med, Clin Ruminants Ambulatory & Herd Hlth Serv, Munich, Germany; [Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University Hohenheim; University of Munich; Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation	Huber, K (corresponding author), Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany.	korinna.huber@uni-hohenheim.de	Kenéz, Ákos/AAX-4134-2020	Kenéz, Ákos/0000-0002-9041-3452	Deutsche Forschungsgemeinschaft (DFG) [DA 558/6-1, HU 838/12-1, RE 819/71]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/, grant nummers: DA 558/6-1, HU 838/12-1, RE 819/71). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the co-workers of the Institute of Animal Nutrition of the Friedrich-Loeffler-Institute (FLI) in Braunschweig Germany for performing the experiment. The valuable technical assistance of Kathrin Hansen is gratefully acknowledged. This study was supported by Deutsche Forschungsgemeinschaft (DFG).	[Anonymous], 1991, Journal of Animal Physiology and Animal Nutrition, V65, P229, DOI 10.1111/j.1439-0396.1991.tb00261.x; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Chilliard Y, 1995, J DAIRY SCI, V78, P2452, DOI 10.3168/jds.S0022-0302(95)76873-4; Choi S, 2011, METABOLISM, V60, P134, DOI 10.1016/j.metabol.2010.02.013; DLG, 1997, DLG FUTT WIED FEED V; Duehlmeier R, 2007, COMP BIOCHEM PHYS A, V146, P274, DOI 10.1016/j.cbpa.2006.10.029; Farese RV, 2010, AM J PHYSIOL-ENDOC M, V298, pE385, DOI 10.1152/ajpendo.00608.2009; Hammon HM, 2010, J DAIRY SCI, V93, P3007, DOI 10.3168/jds.2009-2931; Hayirli A, 2006, VET RES COMMUN, V30, P749, DOI 10.1007/s11259-006-3320-6; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Kang I, 2011, J CLIN ENDOCR METAB, V96, P3048, DOI 10.1210/jc.2011-1104; Karim S, 2012, WORLD J GASTROENTERO, V18, P6771, DOI 10.3748/wjg.v18.i46.6771; Kenez A, 2014, J DAIRY SCI, V97, P3626, DOI 10.3168/jds.2013-7662; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Khan M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-177; Komatsu T, 2005, J ANIM SCI, V83, P557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANHAM JK, 1992, J DAIRY SCI, V75, P184, DOI 10.3168/jds.S0022-0302(92)77752-2; Littell RC, 1998, J ANIM SCI, V76, P1216; Locher LF, 2011, J DAIRY SCI, V94, P4514, DOI 10.3168/jds.2011-4145; McGrattan PD, 2000, ANIM SCI, V71, P501, DOI 10.1017/S1357729800055466; Niehoff ID, 2009, ARCH ANIM NUTR, V63, P203, DOI 10.1080/17450390902863764; Niehoff ID, 2009, BRIT J NUTR, V101, P5, DOI 10.1017/S0007114508043377; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Pires JAA, 2007, J DAIRY SCI, V90, P4635, DOI 10.3168/jds.2007-0146; Rauls C, 2015, S AFR J ANIM SCI, V45, P395, DOI [10.4314/sajas.v45i4.6, 10.4314/SAJAS.V45I4.6]; Rukkwamsuk T, 1999, J DAIRY SCI, V82, P1164, DOI 10.3168/jds.S0022-0302(99)75339-7; Titgemeyer EC, 2011, J DAIRY SCI, V94, P4962, DOI 10.3168/jds.2011-4193; VDLUFA (Verband Deutscher Landwirtschaftlicher Untersuchungs- und Forschungsanstalten), 1997, VDLUFA METH; von Soosten D, 2011, J DAIRY SCI, V94, P2859, DOI 10.3168/jds.2010-3851; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhao FQ, 1996, J DAIRY SCI, V79, P1537, DOI 10.3168/jds.S0022-0302(96)76514-1	34	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147028	10.1371/journal.pone.0147028	http://dx.doi.org/10.1371/journal.pone.0147028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766039	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300058
J	Zhu, QB; Zhou, H; Zhang, AP; Gao, RF; Yang, SM; Zhao, CH; Wang, Y; Hu, JB; Goswami, R; Gong, LL; Li, QF				Zhu, Qibo; Zhou, Huang; Zhang, Aipin; Gao, Rufei; Yang, Shumin; Zhao, Changhong; Wang, Yue; Hu, Jinbo; Goswami, Richa; Gong, Lilin; Li, Qifu			Serum LBP Is Associated with Insulin Resistance in Women with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHRONIC INFLAMMATION; OBESITY; ENDOTOXEMIA; MARKER	Introduction Lipopolysaccharide-binding protein (LBP) is closely associated with many metabolic disorders. However, no study has been done to explore the relationship between LBP and polycystic ovary syndrome (PCOS). The objective of this study was to investigate whether the serum LBP level is elevated and associated with insulin resistance (IR) in PCOS. Participants and Design In this cross-sectional study, 117 PCOS patients and 121 age-matched controls were recruited. Hyperinsulinemic-euglycemic clamp was performed with an expression of M value for insulin sensitivity. Fasting serum samples were collected to detect LBP, lipids, insulin, sex hormones and high sensitive C reactive protein (hs-CRP). Pearson's correlation and multiple linear regression was used to analyze the associations between M value and LBP level. Settings The study was performed in a clinical research center. Results Compared with controls, PCOS subjects had a significantly higher LBP concentration (33.03 +/- 14.59 vs. 24.35 +/- 10.31 mu g/ml, p<0.001), and lower M value (8.21 +/- 3.06 vs. 12.31 +/- 1.72 mg/min/kg, p<0.001). Both in lean and overweight/obese individuals, serum LBP level was higher in PCOS subjects than that in controls. M value was negatively correlated with body mass index (BMI), fasting serum insulin, triglycerides, low-density lipoprotein cholesterol (LDL-c), free testosterone, high sensitive C reactive protein (hs-CRP) and LBP, whereas positively correlated with high-density lipoprotein cholesterol (HDL-c) and sex hormone binding globulin (SHBG). Serum LBP level was associated with M value after adjusting for BMI, fasting serum insulin, SHBG, as well as hs-CRP. Conclusion Serum LBP level significantly is elevated in PCOS, and is independently associated with IR in PCOS.	[Zhu, Qibo; Zhou, Huang; Zhang, Aipin; Gao, Rufei; Yang, Shumin; Zhao, Changhong; Wang, Yue; Hu, Jinbo; Goswami, Richa; Gong, Lilin; Li, Qifu] Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China	Chongqing Medical University	Li, QF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	liqifu@yeah.net	Hu, Jinbo/AAB-7109-2021	Li, Qifu/0000-0003-3904-410X	National Natural Science Foundation of China [81170751, 81370954]; National Key Clinical Specialties Construction Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Specialties Construction Program of China	This work was supported by National Natural Science Foundation of China, Grants 81170751 and 81370954 (to QFL), and the National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carmina E, 2012, Minerva Ginecol, V64, P501; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Ciampelli M, 2005, J CLIN ENDOCR METAB, V90, P1398, DOI 10.1210/jc.2004-0410; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fulghesu AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/389317; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; HERNANDEZ ER, 1988, ENDOCRINOLOGY, V122, P2034, DOI 10.1210/endo-122-5-2034; Hu WH, 2011, EUR J OBSTET GYN R B, V157, P53, DOI 10.1016/j.ejogrb.2011.03.015; Kaya C, 2010, FERTIL STERIL, V93, P1200, DOI 10.1016/j.fertnstert.2008.10.070; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kheirandish-Gozal L, 2014, J CLIN ENDOCR METAB, V99, P656, DOI 10.1210/jc.2013-3327; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Legro RS, 2004, OBSTET GYNECOL SURV, V59, P141, DOI 10.1097/01.OGX.0000109523.25076.E2; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Moreno-Navarrete JM, 2013, DIABETOLOGIA, V56, P2524, DOI 10.1007/s00125-013-3015-9; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Wang Y, 2006, FERTIL STERIL, V86, P223, DOI 10.1016/j.fertnstert.2005.12.037; Yang SM, 2011, FERTIL STERIL, V95, P1749, DOI 10.1016/j.fertnstert.2011.01.136; Yang SM, 2011, J CLIN ENDOCR METAB, V96, P831, DOI 10.1210/jc.2010-2140; Zhang YF, 2006, ENDOCRINE, V29, P419, DOI 10.1385/ENDO:29:3:419	26	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145337	10.1371/journal.pone.0145337	http://dx.doi.org/10.1371/journal.pone.0145337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799617	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300005
J	Lyu, IJ; Lee, JY; Kong, M; Park, KA; Oh, SY				Lyu, In Jeong; Lee, Ju-Yeun; Kong, Mingui; Park, Kyung-Ah; Oh, Sei Yeul			Surgical Responses of Medial Rectus Muscle Recession in Thyroid Eye Disease-Related Esotropia	PLOS ONE			English	Article							STRABISMUS SURGERY; GRAVES OPHTHALMOPATHY; ORBITAL DECOMPRESSION; ORBITOPATHY; MANAGEMENT; MYOPATHY; MOTILITY; OUTCOMES; SUBTYPE	We evaluate the surgical outcomes and surgical responses of medial rectus muscle (MR) recession patients with thyroid eye disease (TED)-related esotropia (ET). The surgical dose-response curves 1 week postoperatively and at the final visit were analyzed. Univariable and multivariable linear regression analyses were applied to investigate factors influencing surgical dose-response. A total of 43 patients with TED-related ET that underwent MR recession were included. The final success rate was 86.0% and the rate of undercorrection was 14.0%. The surgical dose-response curves of TED-related ET showed a gentle slope compared with those of standard surgical tables. In the univariable model, simultaneous vertical rectus muscle recession was the only significant factor influencing surgical dose-response of MR recession in TED-related ET (beta = -0.397, P = 0.044). In a model adjusted for age, sex, type of surgery, and preoperative horizontal angle of deviation, simultaneous vertical rectus muscle recession showed marginal significance (beta = -0.389, P = 0.064). The surgical dose-response curve of TED-related ET was unique. Simultaneous vertical rectus muscle recession was associated with increased surgical dose-response in TED-related ET.	[Lyu, In Jeong; Lee, Ju-Yeun; Kong, Mingui; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Lyu, In Jeong] Eulji Univ, Sch Med, Eulji Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Eulji University	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Ben Simon GJ, 2015, GRAEFES ARCH CLIN EX; Boergen K P, 1989, Dev Ophthalmol, V20, P159; Coats DK, 1999, OPHTHALMOLOGY, V106, P324, DOI 10.1016/S0161-6420(99)90071-4; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; Dal Canto AJ, 2006, OPHTHALMOLOGY, V113, P2324, DOI 10.1016/j.ophtha.2006.04.036; De Hoog J, 2010, EYE, V24, P1011, DOI 10.1038/eye.2009.267; DEWAARD R, 1983, DOC OPHTHALMOL, V56, P41, DOI 10.1007/BF00154707; DUNN WJ, 1986, OPHTHALMOLOGY, V93, P470; Dyer J.A., 1977, T AM OPHTHAL SOC, V74, P425; El-Kaissi S, 2004, INTERN MED J, V34, P482, DOI 10.1111/j.1445-5994.2004.00662.x; ELLIS FD, 1979, OPHTHALMOLOGY, V86, P2059; FORBES GS, 1982, RADIOLOGY, V142, P387, DOI 10.1148/radiology.142.2.7054827; GARDNER TA, 1990, OPHTHALMIC SURG LAS, V21, P519; Kaspar M, 2002, THYROID, V12, P187, DOI 10.1089/105072502753600115; KENDLER DL, 1993, ARCH OPHTHALMOL-CHIC, V111, P197, DOI 10.1001/archopht.1993.01090020051022; Kerr Natalie C, 2011, Trans Am Ophthalmol Soc, V109, P168; Kim MH, 2013, J AAPOS, V17, P188, DOI 10.1016/j.jaapos.2012.10.019; Kraus D J, 1993, Trans Am Ophthalmol Soc, V91, P67; Kuriyan AE, 2013, INVEST OPHTH VIS SCI, V54, P7370, DOI 10.1167/iovs.13-12741; LONG JC, 1966, ARCH OPHTHALMOL-CHIC, V75, P634; LUEDER GT, 1992, OPHTHALMOLOGY, V99, P993; Metz H S, 1984, J Pediatr Ophthalmol Strabismus, V21, P220; MILLER JE, 1965, ARCH OPHTHALMOL-CHIC, V74, P509; Mocan MC, 2007, J PEDIAT OPHTH STRAB, V44, P93, DOI 10.3928/01913913-20070301-02; NUGENT RA, 1990, RADIOLOGY, V177, P675, DOI 10.1148/radiology.177.3.2243967; NUNERY WR, 1993, OPHTHALMIC PLAST REC, V9, P77, DOI 10.1097/00002341-199306000-00001; Peragallo JH, 2013, STRABISMUS, V21, P23, DOI 10.3109/09273972.2012.762533; Prendiville P, 2000, OPHTHALMOLOGY, V107, P545, DOI 10.1016/S0161-6420(99)00145-1; Ruttum MS, 2000, J AAPOS, V4, P102, DOI 10.1067/mpa.2000.103872; SCOTT WE, 1981, OPHTHALMOLOGY, V88, P493; SKOV CMB, 1984, CAN J OPHTHALMOL, V19, P269; Tian S, 2007, ACTA OPHTHALMOL SCAN, V85, P431, DOI 10.1111/j.1600-0420.2007.00877.x; Volpe NJ, 2012, J AAPOS, V16, P518, DOI 10.1016/j.jaapos.2012.08.010	34	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146779	10.1371/journal.pone.0146779	http://dx.doi.org/10.1371/journal.pone.0146779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796354	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300012
J	Mukadi, P; Lejon, V; Barbe, B; Gillet, P; Nyembo, C; Lukuka, A; Likwela, J; Lumbala, C; Mbaruku, J; Vander Veken, W; Mumba, D; Lutumba, P; Muyembe, JJ; Jacobs, J				Mukadi, Pierre; Lejon, Veerle; Barbe, Barbara; Gillet, Philippe; Nyembo, Christophe; Lukuka, Albert; Likwela, Joris; Lumbala, Crispin; Mbaruku, Justin; Vander Veken, Wim; Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques; Jacobs, Jan			Performance of Microscopy for the Diagnosis of Malaria and Human African Trypanosomiasis by Diagnostic Laboratories in the Democratic Republic of the Congo: Results of a Nation-Wide External Quality Assessment	PLOS ONE			English	Article							SLEEPING SICKNESS; IMPACT; TESTS; FILMS	The present External Quality Assessment (EQA) assessed microscopy of blood parasites among diagnostic laboratories in the Democratic Republic of the Congo. The EQA addressed 445 participants in 10/11 provinces (October 2013-April 2014). Participants were sent a panel of five slides and asked to return a routinely stained slide which was assessed for quality of preparation and staining. Response rate was 89.9% (400/445). For slide 1 (no parasites), 30.6% participants reported malaria, mostly Plasmodium falciparum. Only 11.0% participants reported slide 2 (Plasmodium malariae) correctly, 71.0% reported "malaria" or "Plasmodium falciparum" (considered acceptable). Slide 3 contained Plasmodium falciparum (109/mu l) and Trypanosoma brucei brucei trypomastigotes: they were each reported by 32.5% and 16.5% participants respectively, 6.0% reported both. Slide 4 (Trypanosoma) was recognised by 44.9% participants. Slide 5 (Plasmodium ovale) was correctly reported by 6.2% participants, another 68.8% replied "malaria" or "Plasmodium falciparum" (considered acceptable). Only 13.6% of routine slides returned were correctly prepared and stained. The proportion of correct/acceptable scores for at least 4/5 slides was higher among EQA-experienced participants compared to first time participants (40.9% versus 22.4%, p = 0.001) and higher among those being trained < 2 years ago compared to those who were not (42.9% versus 26.3%, p = 0.01). Among diagnostic laboratories in Democratic Republic of the Congo, performance of blood parasite microscopy including non-falciparum species and Trypanosoma was poor. Recent training and previous EQA participation were associated with a better performance.	[Mukadi, Pierre; Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Mukadi, Pierre; Nyembo, Christophe; Lutumba, Pascal] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Lejon, Veerle] Inst Rech Dev, Montpellier, France; [Barbe, Barbara; Gillet, Philippe; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Lukuka, Albert; Likwela, Joris] Natl Malaria Control Program, Kinshasa, DEM REP CONGO; [Lumbala, Crispin; Mbaruku, Justin; Vander Veken, Wim] Natl Human African Trypanosomiasis Control Progra, Kinshasa, DEM REP CONGO; [Mumba, Dieudonne; Lutumba, Pascal; Muyembe, Jean-Jacques] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Institute Nacional de Recherche Biomedical; Institut de Recherche pour le Developpement (IRD); Institute of Tropical Medicine (ITM); Universite de Kinshasa; KU Leuven	Lejon, V (corresponding author), Inst Rech Dev, Montpellier, France.	veerle.lejon@ird.fr	Jacobs, Jan/GRX-7316-2022; Lejon, Veerle/AAG-4213-2020; Lejon, Veerle/AAG-5024-2020	Lejon, Veerle/0000-0002-6795-0962; gillet, philippe/0000-0001-5878-6446	Belgian Development Agency; National programme of sleeping sickness control in DRC; Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management) [3.21]	Belgian Development Agency; National programme of sleeping sickness control in DRC; Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management)	This study was funded by Directorate General of Development Cooperation of the Belgian Government through Trypano 4 project between Belgian Development Agency and the National programme of sleeping sickness control in DRC, and through the Institutional Collaboration INRB-ITM (Network Program on Laboratory Quality Management, Project 3.21). Pierre Mukadi has a scholarship of ITM through DGD Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MAL MICR QUAL ASS MA; Ayalew Freshwork, 2014, BMC Res Notes, V7, P839, DOI 10.1186/1756-0500-7-839; Central Intelligence Agency, WORLD FACTB 2013 201; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; Cooperation Technique Belge, 2008, DOSS TECHN FIN APP L; Dini L, 2003, T ROY SOC TROP MED H, V97, P675, DOI 10.1016/S0035-9203(03)80101-3; Hasker E, 2012, PLOS NEGLECT TROP D, V6, P1; Ishengoma DRS, 2010, ANN TROP MED PARASIT, V104, P123, DOI 10.1179/136485910X12607012373993; Kahama-Maro J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-332; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; Lejon V, 2013, B WORLD HEALTH ORGAN, V91, P718, DOI 10.2471/BLT.13.126474; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Maguire Jason D, 2006, Malar J, V5, P92; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; MIEZAN TW, 1994, B SOC PATHOL EXOT, V87, P101; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moura S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-437; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Mukadi P, 2013, B WORLD HEALTH ORGAN, V91, P441, DOI 10.2471/BLT.12.112706; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Obare P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-113; Programme National de Lutte contre la Trypanosomiase Humaine Africaine, 2014, RAPP ANN ACT LUTT TR; Programme National de Lutte contre le Paludisme, 2013, PLAN STRAT NAT LUTT; Programme National de Lutte contre le Paludisme, 2014, RAPP ANN ACT LUTT PA; Programme National de Lutte contre le Paludisme, 2010, MAN FORM DIAGN LAB P; Sarkinfada F, 2009, J INFECT DEV COUNTR, V3, P20, DOI 10.3855/jidc.101; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Thomson S, 2000, ARCH PATHOL LAB MED, V124, P57; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; Wafula R, 2014, AM J TROP MED HYG, V91, P481, DOI 10.4269/ajtmh.14-0133; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World-Health-Organization, 2005, MAL LIGHT MICR CREAT	35	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146450	10.1371/journal.pone.0146450	http://dx.doi.org/10.1371/journal.pone.0146450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788725	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100032
J	Trilling, DE				Trilling, David E.			The Surface Age of Sputnik Planum, Pluto, Must Be Less than 10 Million Years	PLOS ONE			English	Article							KUIPER-BELT OBJECTS; SIZE DISTRIBUTION	Data from the New Horizons mission to Pluto show no craters on Sputnik Planum down to the detection limit (2 km for low resolution data, 625 m for high resolution data). The number of small Kuiper Belt Objects that should be impacting Pluto is known to some degree from various astronomical surveys. We combine these geological and telescopic observations to make an order of magnitude estimate that the surface age of Sputnik Planum must be less than 10 million years. This maximum surface age is surprisingly young and implies that this area of Pluto must be undergoing active resurfacing, presumably through some cryo-geophysical process. We discuss three possible resurfacing mechanisms and the implications of each one for Pluto's physical properties.	[Trilling, David E.] No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA; [Trilling, David E.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA	Northern Arizona University	Trilling, DE (corresponding author), No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA.; Trilling, DE (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.	david.trilling@nau.edu						Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Bierhaus EB, 2015, ICARUS, V246, P165, DOI 10.1016/j.icarus.2014.05.044; de Elia GC, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014884; Fraser WC, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/100; Fraser WC, 2009, ASTROPHYS J, V706, P119, DOI 10.1088/0004-637X/706/1/119; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Melosh H.J., 2011, PLANETARY SURFACE PR, DOI 10.1017/CBO9780511977848; Parker AH, 2015, LUNAR PLANET SCI C; Schlichting HE, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/150; Scott T. A., 1976, Physics Reports. Physics Letters Section C, V27c, P89, DOI 10.1016/0370-1573(76)90032-6; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032	12	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147386	10.1371/journal.pone.0147386	http://dx.doi.org/10.1371/journal.pone.0147386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790001	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100085
J	Cantin, D; Djeddi, D; Carriere, V; Samson, N; Nault, S; Jia, WL; Beck, J; Praud, JP				Cantin, Danny; Djeddi, Djamal; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Beck, Jennifer; Praud, Jean-Paul			Inhibitory Effect of Nasal Intermittent Positive Pressure Ventilation on Gastroesophageal Reflux	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; NONSEDATED NEWBORN LAMBS; AIRWAY PRESSURE; MUSCLE-ACTIVITY; PRETERM LAMBS; INFANTS; APNEA	Non-invasive intermittent positive pressure ventilation can lead to esophageal insufflations and in turn to gastric distension. The fact that the latter induces transient relaxation of the lower esophageal sphincter implies that it may increase gastroesophageal refluxes. We previously reported that nasal Pressure Support Ventilation (nPSV), contrary to nasal Neurally-Adjusted Ventilatory Assist (nNAVA), triggers active inspiratory laryngeal closure. This suggests that esophageal insufflations are more frequent in nPSV than in nNAVA. The objectives of the present study were to test the hypotheses that: i) gastroesophageal refluxes are increased during nPSV compared to both control condition and nNAVA; ii) esophageal insufflations occur more frequently during nPSV than nNAVA. Polysomno-graphic recordings and esophageal multichannel intraluminal impedance pHmetry were performed in nine chronically instrumented newborn lambs to study gastroesophageal refluxes, esophageal insufflations, states of alertness, laryngeal closure and respiration. Recordings were repeated without sedation in control condition, nPSV (15/4 cmH(2)O) and nNAVA (similar to 15/4 cmH(2)O). The number of gastroesophageal refluxes recorded over six hours, expressed as median (interquartile range), decreased during both nPSV (1 (0, 3)) and nNAVA [1 (0, 3)] compared to control condition (5 (3, 10)), (p < 0.05). Meanwhile, the esophageal insufflation index did not differ between nPSV (40 (11, 61) h(-1)) and nNAVA (10 (9, 56) h(-1)) (p = 0.8). In conclusion, nPSV and nNAVA similarly inhibit gastroesophageal refluxes in healthy newborn lambs at pressures that do not lead to gastric distension. In addition, the occurrence of esophageal insufflations is not significantly different between nPSV and nNAVA. The strong inhibitory effect of nIPPV on gastroesophageal refluxes appears identical to that reported with nasal continuous positive airway pressure.	[Cantin, Danny; Djeddi, Djamal; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Praud, Jean-Paul] Univ Sherbrooke, Dept Pediat, Neonatal Resp Res Unit, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Danny; Carriere, Vincent; Samson, Nathalie; Nault, Stephanie; Jia, Wan Lu; Praud, Jean-Paul] Univ Sherbrooke, Dept Physiol, Sherbrooke, PQ J1K 2R1, Canada; [Djeddi, Djamal] Univ Picardie Jules Verne, Dept Pediat, Amiens, France; [Beck, Jennifer] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Beck, Jennifer] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Beck, Jennifer] Ryerson Univ, iBEST, Toronto, ON, Canada; [Beck, Jennifer] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Sherbrooke; University of Sherbrooke; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Praud, JP (corresponding author), Univ Sherbrooke, Dept Pediat, Neonatal Resp Res Unit, Sherbrooke, PQ J1K 2R1, Canada.; Praud, JP (corresponding author), Univ Sherbrooke, Dept Physiol, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Paul.Praud@USherbrooke.ca			Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke; Canadian Institutes of Health Research [RS-286032]; Canada Research Chair in Neonatal Respiratory Physiology; Fonds de la recherche Quebec - Sante	Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Neonatal Respiratory Physiology; Fonds de la recherche Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	DC was supported by a training scholarship from the Faculte de Medecine et des Sciences de la Sante of the Universite de Sherbrooke. JPP: The study was funded by an operating grant from the Canadian Institutes of Health Research (RS-286032) and the Canada Research Chair in Neonatal Respiratory Physiology. JPP is a member of the Sherbrooke University Hospital Research Center, which is funded by the Fonds de la recherche Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei A, 2008, GASTROENTEROLOGY, V134, P1322, DOI 10.1053/j.gastro.2008.02.031; Barwing J, 2009, INTENS CARE MED, V35, P1809, DOI 10.1007/s00134-009-1587-0; Boudaa N, 2013, J APPL PHYSIOL, V114, P637, DOI 10.1152/japplphysiol.00599.2012; Campanozzi A, 2009, PEDIATRICS, V123, P779, DOI 10.1542/peds.2007-3569; Carriere V, 2015, CRIT CARE MED, V43, pE296, DOI 10.1097/CCM.0000000000001080; Carron M, 2013, BRIT J ANAESTH, V110, P896, DOI 10.1093/bja/aet070; Czinn SJ, 2013, PEDIATR DRUGS, V15, P19, DOI 10.1007/s40272-012-0004-2; DeMauro SB, 2014, CURR OPIN PEDIATR, V26, P157, DOI 10.1097/MOP.0000000000000066; DiBlasi RM, 2011, RESP CARE, V56, P1273, DOI 10.4187/respcare.01376; Djeddi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107736; Djeddi D, 2012, J PEDIATR GASTR NUTR, V55, P745, DOI 10.1097/MPG.0b013e318263cae0; Hadj-Ahmed MA, 2015, NEONATOLOGY, V107, P199, DOI 10.1159/000369120; Hadj-Ahmed MA, 2012, J APPL PHYSIOL, V113, P63, DOI 10.1152/japplphysiol.01496.2011; Hershcovici T, 2011, NEUROGASTROENT MOTIL, V23, P819, DOI 10.1111/j.1365-2982.2011.01738.x; Hill NS, 1997, RESP CARE, V42, P432; Jadcherla SR, 2015, PEDIATR RES, V77, P99, DOI 10.1038/pr.2014.147; JOUNIEAUX V, 1995, J APPL PHYSIOL, V79, P186, DOI 10.1152/jappl.1995.79.1.186; KERR P, 1992, CHEST, V101, P1539, DOI 10.1378/chest.101.6.1539; KERR P, 1993, J CLIN GASTROENTEROL, V17, P276, DOI 10.1097/00004836-199312000-00002; Lagarde S, 2010, ANESTH ANALG, V110, P1676, DOI 10.1213/ANE.0b013e3181d8a14c; Lightdale JR, 2013, PEDIATRICS, V131, pE1684, DOI 10.1542/peds.2013-0421; Mathai Ss, 2012, Med J Armed Forces India, V68, P12, DOI 10.1016/S0377-1237(11)60123-8; Moreau-Bussiere F, 2007, J APPL PHYSIOL, V102, P2149, DOI 10.1152/japplphysiol.00891.2006; Pandolifino JE, 2006, GASTROENTEROLOGY, V131, P1725, DOI 10.1053/j.gastro.2006.09.009; Renolleau S, 1999, AM J RESP CRIT CARE, V159, P1396, DOI 10.1164/ajrccm.159.5.9807088; ROSEN CL, 1986, AM J DIS CHILD, V140, P547, DOI 10.1001/archpedi.1986.02140200057027; Samson N, 2005, J APPL PHYSIOL, V99, P1636, DOI 10.1152/japplphysiol.00464.2005; Samson N, 2011, RESP PHYSIOL NEUROBI, V179, P111, DOI 10.1016/j.resp.2011.09.008; Shepherd K, 2013, J CLIN SLEEP MED, V9, P13, DOI 10.5664/jcsm.2328; Shepherd KL, 2007, AM J PHYSIOL-GASTR L, V292, pG1200, DOI 10.1152/ajpgi.00476.2006; Tawk M, 2006, CHEST, V130, P1003, DOI 10.1378/chest.130.4.1003; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65	32	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146742	10.1371/journal.pone.0146742	http://dx.doi.org/10.1371/journal.pone.0146742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785264	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400062
J	Cashman, TJ; Josowitz, R; Johnson, BV; Gelb, BD; Costa, KD				Cashman, Timothy J.; Josowitz, Rebecca; Johnson, Bryce V.; Gelb, Bruce D.; Costa, Kevin D.			Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; GERMLINE BRAF; CARDIOMYOCYTES; MUTATIONS; DIVERSITY; LEOPARD; MODELS; GROWTH	Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death that often goes undetected in the general population. HCM is also prevalent in patients with cardio-facio-cutaneous syndrome (CFCS), which is a genetic disorder characterized by aberrant signaling in the RAS/MAPK signaling cascade. Understanding the mechanisms of HCM development in such RASopathies may lead to novel therapeutic strategies, but relevant experimental models of the human condition are lacking. Therefore, the objective of this study was to develop the first 3D human engineered cardiac tissue (hECT) model of HCM. The hECTs were created using human cardiomyocytes obtained by directed differentiation of induced pluripotent stem cells derived from a patient with CFCS due to an activating BRAF mutation. The mutant myocytes were directly conjugated at a 3:1 ratio with a stromal cell population to create a tissue of defined composition. Compared to healthy patient control hECTs, BRAF-hECTs displayed a hypertrophic phenotype by culture day 6, with significantly increased tissue size, twitch force, and atrial natriuretic peptide (ANP) gene expression. Twitch characteristics reflected increased contraction and relaxation rates and shorter twitch duration in BRAF-hECTs, which also had a significantly higher maximum capture rate and lower excitation threshold during electrical pacing, consistent with a more arrhythmogenic substrate. By culture day 11, twitch force was no longer different between BRAF and wild-type hECTs, revealing a temporal aspect of disease modeling with tissue engineering. Principal component analysis identified diastolic force as a key factor that changed from day 6 to day 11, supported by a higher passive stiffness in day 11 BRAF-hECTs. In summary, human engineered cardiac tissues created from BRAF mutant cells recapitulated, for the first time, key aspects of the HCM phenotype, offering a new in vitro model for studying intrinsic mechanisms and screening new therapeutic approaches for this lethal form of heart disease.	[Cashman, Timothy J.; Johnson, Bryce V.; Costa, Kevin D.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Josowitz, Rebecca; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Costa, KD (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	kevin.costa@mssm.edu	Cashman, Tim/M-7738-2019	Cashman, Timothy/0000-0001-6238-129X	NIH [F30 HL118923, R01 HL113499, T32 GM008553, T32 HD075735]; American Heart Association [12PRE12060254]; NIH/NHLBI PEN contract [HHSN268201000045C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113499, F30HL118923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH/NHLBI PEN contract; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH (F30 HL118923 to T.J.C. and R01 HL113499 to B.D.G.), the American Heart Association (12PRE12060254 to R.J.), funding to T.J.C. by NIH (T32 GM008553 and T32 HD075735), and to K.D.C by NIH/NHLBI PEN contract HHSN268201000045C.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Armour CM, 2008, J MED GENET, V45, P249, DOI 10.1136/jmg.2007.054460; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; de Lange WJ, 2011, CIRC RES, V109, P8, DOI 10.1161/CIRCRESAHA.111.242354; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Kirkton RD, 2012, EUROPACE, V14, pV40, DOI 10.1093/europace/eus269; Komae H, 2015, J TISSUE ENG REGEN M; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; Ma Z, 2014, BIOMATERIALS, V35, P1367, DOI 10.1016/j.biomaterials.2013.10.052; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Mortazavi Mohammed, 2013, Adv Pediatr, V60, P201, DOI 10.1016/j.yapd.2013.04.015; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nonaka M, 2014, WORLD J CARDIOL, V6, P1245, DOI 10.4330/wjc.v6.i12.1245; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Onan D, 2004, MOL ENDOCRINOL, V18, P2344, DOI 10.1210/me.2003-0309; Pakladok T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087457; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roberts A, 2006, J MED GENET, V43, P833, DOI 10.1136/jmg.2006.042796; Rodriguez-Viciana P, 2008, METHOD ENZYMOL, V438, P277, DOI 10.1016/S0076-6879(07)38019-1; Ruan HM, 2007, CIRCULATION, V116, P596, DOI 10.1161/CIRCULATIONAHA.106.682773; Sala V, 2012, MOL MED, V18, P938, DOI 10.2119/molmed.2011.00512; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Serrao GW, 2012, TISSUE ENG PT A, V18, P1322, DOI [10.1089/ten.tea.2011.0278, 10.1089/ten.TEA.2011.0278]; Shephard R, 2009, J CARDIOVASC TRANSL, V2, P471, DOI 10.1007/s12265-009-9120-y; Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang JX, 2013, BIOMATERIALS, V34, P8878, DOI 10.1016/j.biomaterials.2013.07.039; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yoon G, 2007, DEV MED CHILD NEUROL, V49, P894, DOI 10.1111/j.1469-8749.2007.00894.x; Zheng MZ, 2004, AM J PHYSIOL-HEART C, V286, pH424, DOI 10.1152/ajpheart.00110.2003	43	48	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146697	10.1371/journal.pone.0146697	http://dx.doi.org/10.1371/journal.pone.0146697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784941	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400059
J	Fekry, B; Esmaeilniakooshkghazi, A; Krupenko, SA; Krupenko, NI				Fekry, Baharan; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.			Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner	PLOS ONE			English	Article							CANCER-CELLS; SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; PHOTODYNAMIC THERAPY; THYMIDYLATE SYNTHASE; CARCINOMA-CELLS; DOWN-REGULATION; UP-REGULATION; TUMOR-CELLS	We previously reported that ceramide synthase 6 (CerS6) is elevated in response to folate stress in cancer cells, leading to enhanced production of C-16-ceramide and apoptosis. Antifolate methotrexate (MTX), a drug commonly used in chemotherapy of several types of cancer, is a strong inhibitor of folate metabolism. Here we investigated whether this drug targets CerS6. We observed that CerS6 protein was markedly elevated in several cancer cell lines treated with MTX. In agreement with the enzyme elevation, its product C-16-ceramide was also strongly elevated, so as several other ceramide species. The increase in C16-ceramide, however, was eliminated in MTX-treated cells lacking CerS6 through siRNA silencing, while the increase in other ceramides sustained. Furthermore, the siRNA silencing of CerS6 robustly protected A549 lung adenocarcinoma cells from MTX toxicity, while the silencing of another ceramide synthase, CerS4, which was also responsive to folate stress in our previous study, did not interfere with the MTX effect. The rescue effect of CerS6 silencing upon MTX treatment was further confirmed in HCT116 and HepG2 cell lines. Interestingly, CerS6 itself, but not CerS4, induced strong antiproliferative effect in several cancer cell lines if elevated by transient transfection. The effect of MTX on CerS6 elevation was likely p53 dependent, which is in agreement with the hypothesis that the protein is a transcriptional target of p53. In line with this notion, lometrexol, the antifolate inducing cytotoxicity through the p53-independent mechanism, did not affect CerS6 levels. We have also found that MTX induces the formation of ER aggregates, enriched with CerS6 protein. We further demonstrated that such aggregation requires CerS6 and suggests that it is an indication of ER stress. Overall, our study identified CerS6 and ceramide pathways as a novel MTX target.	[Fekry, Baharan; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA; [Krupenko, Sergey A.; Krupenko, Natalia I.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina; University of North Carolina Chapel Hill	Krupenko, NI (corresponding author), Univ N Carolina, Inst Nutr Res, Kannapolis, NC USA.; Krupenko, NI (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.	natalia_krupenko@unc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161	National Cancer Institute [CA193782, CA095030]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54388]; NATIONAL CANCER INSTITUTE [R01CA095030, R01CA193782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute grants CA193782 (to NIK) and CA095030 (to SAK), and National Institute of Diabetes and Digestive and Kidney Diseases grant DK54388 (to SAK). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bareford MD, 2012, CANCER BIOL THER, V13, P793, DOI 10.4161/cbt.20562; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Bronder JL, 2002, CANCER RES, V62, P5236; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; Cruickshanks N, 2015, CANCER BIOL THER, V16, P733, DOI 10.1080/15384047.2015.1026509; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Eberle M, 2014, BIOCHEM PHARMACOL, V92, P326, DOI 10.1016/j.bcp.2014.08.016; Edmond V, 2015, ONCOGENE, V34, P996, DOI 10.1038/onc.2014.55; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Floros KV, 2006, BIOL CHEM, V387, P1629, DOI 10.1515/BC.2006.203; Florou D, 2013, CANCER BIOL THER, V14, P587, DOI 10.4161/cbt.24591; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gibson RJ, 2005, CLIN EXP MED, V4, P188, DOI 10.1007/s10238-004-0055-y; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; Gurova KV, 2003, CANCER RES, V63, P2905; Hajj C, 2015, BIOL CHEM, V396, P669, DOI 10.1515/hsz-2014-0302; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harvald EB, 2015, APOPTOSIS, V20, P658, DOI 10.1007/s10495-015-1108-2; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; Hou Q, 2011, J LIPID RES, V52, P278, DOI 10.1194/jlr.M012161; Huang WY, 2011, BIOCHEM PHARMACOL, V81, P510, DOI 10.1016/j.bcp.2010.11.014; Jaffe N, 2014, ADV EXP MED BIOL, V804, P1, DOI 10.1007/978-3-319-04843-7_1; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Laethem RM, 1998, BLOOD, V91, P4350, DOI 10.1182/blood.V91.11.4350.411k27_4350_4360; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Nihal M, 2014, ARCH BIOCHEM BIOPHYS, V563, P101, DOI 10.1016/j.abb.2014.04.019; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Paci A, 2014, EUR J CANCER, V50, P2010, DOI 10.1016/j.ejca.2014.04.014; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Paschall AV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-24; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127558; Plant D, 2014, NAT REV RHEUMATOL, V10, P329, DOI 10.1038/nrrheum.2014.16; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schull S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.62; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Separovic D, 2012, ANTICANCER RES, V32, P753; Separovic D, 2011, BIOCHEM BIOPH RES CO, V409, P372, DOI 10.1016/j.bbrc.2011.04.091; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tirodkar TS, 2015, J BIOL CHEM, V290, P13157, DOI 10.1074/jbc.M114.631325; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Varadarajan S, 2012, CELL DEATH DIFFER, V19, P1896, DOI 10.1038/cdd.2012.108; Varadarajan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056603; Visentin M, 2012, HEMATOL ONCOL CLIN N, V26, P629, DOI 10.1016/j.hoc.2012.02.002; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Yacoub A, 2010, CANCER RES, V70, P1120, DOI 10.1158/0008-5472.CAN-09-4043	69	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146618	10.1371/journal.pone.0146618	http://dx.doi.org/10.1371/journal.pone.0146618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783755	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400053
J	Hayez, A; Roegiers, E; Malaisse, J; Balau, B; Sterpin, C; Achouri, Y; De Rouvroit, CL; Poumay, Y; Michiels, C; De Backer, O				Hayez, Aurelle; Roegiers, Edith; Malaisse, Jeremy; Balau, Benoit; Sterpin, Christiane; Achouri, Younes; De Rouvroit, Catherine Lambert; Poumay, Yves; Michiels, Carine; De Backer, Olivier			TMEM45A Is Dispensable for Epidermal Morphogenesis, Keratinization and Barrier Formation	PLOS ONE			English	Article							LAMELLAR GRANULES; DIFFERENTIATION; KERATINOCYTES; EXPRESSION	TMEM45A gene encodes an initially uncharacterized predicted transmembrane protein. We previously showed that this gene is highly expressed in keratinocytes where its expression correlates with keratinization, suggesting a role in normal epidermal physiology. To test this hypothesis, we generated TMEM45A knockout mice and found that these mice develop without any evident phenotype. The morphology of the epidermis assessed by histology and by labelling differentiation markers in immunofluorescence was not altered. Toluidine blue permeability assay showed that the epidermal barrier develops normally during embryonic development. We also showed that depletion of TMEM45A in human keratinocytes does not alter their potential to form in vitro 3D-reconstructed epidermis. Indeed, epidermis with normal morphogenesis were generated from TMEM45A-silenced keratinocytes. Their expression of differentiation markers quantified by RT-qPCR and evidenced by immunofluorescence labelling as well as their barrier function estimated by Lucifer yellow permeability were similar to the control epidermis. In summary, TMEM45A gene expression is dispensable for epidermal morphogenesis, keratinization and barrier formation. If this protein plays a role in the epidermis, its experimental depletion can possibly be compensated by other proteins in the two experimental models analyzed in this study.	[Hayez, Aurelle; Malaisse, Jeremy; Balau, Benoit; Sterpin, Christiane; De Rouvroit, Catherine Lambert; Poumay, Yves; De Backer, Olivier] Univ Namur, URPhyM NARILIS, Namur, Belgium; [Roegiers, Edith; Michiels, Carine] Univ Namur, URBC NARILIS, Namur, Belgium; [Achouri, Younes] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	University of Namur; University of Namur; Universite Catholique Louvain	Michiels, C (corresponding author), Univ Namur, URBC NARILIS, Namur, Belgium.	carine.michiels@unamur.be	Poumay, Yves/G-4525-2016	Poumay, Yves/0000-0001-5200-3367; ACHOURI, Younes/0000-0001-7409-1441	FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium); Televie grant (FNRS- National Funds for Scientific Research, Belgium)	FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Televie grant (FNRS- National Funds for Scientific Research, Belgium)	AH is a research fellow funded by FRIA (Fonds de la Recherche Industrielle et Agricole, FNRS, Belgium). ER is financed by Televie grant (FNRS- National Funds for Scientific Research, Belgium).	Akiyama M, 2011, DERM-ENDOCRINOL, V3, P107, DOI 10.4161/derm.3.2.15136; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Fartasch M, 2004, J INVEST DERMATOL, V122, pXI; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Frankart A, 2012, EXP DERMATOL, V21, P871, DOI 10.1111/exd.12020; Gerber PA, 2014, BIOL CHEM, V395, P577, DOI 10.1515/hsz-2013-0279; Gerber PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063949; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hayez A, 2014, EXP DERMATOL, V23, P339, DOI 10.1111/exd.12403; Inoue K, 2014, J INVEST DERMATOL, V134, P1465, DOI 10.1038/jid.2013.516; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Jarnik M, 2002, J INVEST DERMATOL, V118, P102, DOI 10.1046/j.0022-202x.2001.01661.x; Madison K C, 1998, J Investig Dermatol Symp Proc, V3, P80; Mattiuzzo NR, 2011, EXP DERMATOL, V20, P113, DOI 10.1111/j.1600-0625.2010.01188.x; Minner F, 2010, METHODS MOL BIOL, V585, P71, DOI 10.1007/978-1-60761-380-0_6; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Norlen L, 2001, J INVEST DERMATOL, V117, P830; Okada N, 2011, PROTEIN EXPRES PURIF, V77, P118, DOI 10.1016/j.pep.2011.01.011; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P1194, DOI 10.1038/jid.2014.15	22	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147069	10.1371/journal.pone.0147069	http://dx.doi.org/10.1371/journal.pone.0147069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785122	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400104
J	Kyte, D; Ives, J; Draper, H; Calvert, M				Kyte, Derek; Ives, Jonathan; Draper, Heather; Calvert, Melanie			Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE	Background Assessment of patient-reported outcomes (PROs) provides valuable information to inform patient-centered care, but may also reveal 'PRO alerts': psychological distress or physical symptoms that may require an immediate response. Ad-hoc management of PRO alerts in clinical trials may result in suboptimal patient care or potentially bias trial results. To gain greater understanding of current practice in PRO alert management we conducted a national survey of personnel involved in clinical trials with a PRO endpoint. Methods and Findings We conducted a national cross-sectional survey of 767 UK-based research nurses, data managers/coordinators, trial managers and chief/principal investigators involved in clinical trials using PROs. Respondents were self-selected volunteers from a non-randomised sample of eligible individuals recruited via 55 UK Clinical Research Collaboration Registered Clinical Trials Units and 19 Comprehensive Local Research Networks. Questions centred on the proportion of trial personnel encountering alerts, how staff responded to PRO alerts and whether current guidance was deemed sufficient to support research personnel. We undertook descriptive analyses of the quantitative data and directed thematic analysis of free-text comments. 20% of research nurses did not view completed PRO questionnaires and were not in a position to discover alerts, 39-50% of the remaining respondent group participants reported encountering PRO alerts. Of these, 83% of research nurses and 54% of data managers/trial coordinators reported taking action to assist the trial participant, but less than half were able to record the intervention in the trial documentation. Research personnel reported current PRO alert guidance/training was insufficient. Conclusions Research personnel are intermittently exposed to PRO alerts. Some intervene to help trial participants, but are not able to record this intervention in the trial documentation, risking cointervention bias. Other staff do not check PRO information during the trial, meaning alerts may remain undiscovered, or do not respond to alerts if they are inadvertently encountered; both of which may impact on patient safety. Guidance is needed to support PRO alert management that protects the interests of trial participants whilst avoiding potential bias.	[Kyte, Derek; Ives, Jonathan; Draper, Heather; Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	m.calvert@bham.ac.uk	Calvert, Melanie/F-7055-2011; Ives, Jonathan/ABE-4437-2020	Calvert, Melanie/0000-0002-1856-837X; Ives, Jonathan/0000-0002-5233-5000; kyte, Derek/0000-0002-7679-6741; Draper, Heather/0000-0002-0020-4252	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) studentship grant; National Institute for Health Research [SPCR-017] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) studentship grant(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by a National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) studentship grant. No other funding sources reported. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, MED CARE, V50, P1060, DOI 10.1097/MLR.0b013e318268aaff; Basch EM, 2011, VALUE HEALTH, V14, pA10, DOI 10.1016/j.jval.2011.02.060; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Brundage M, 2003, QUAL LIFE RES, V12, P395, DOI 10.1023/A:1023404731041; Calvert M, 2015, LANCET, V385, P1073, DOI 10.1016/S0140-6736(15)60599-2; Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114; Efficace F, 2014, EUR J CANCER, V50, P1925, DOI 10.1016/j.ejca.2014.04.005; EU (European Union), 2005, OFFICIAL J EUROPEAN; FDA, 2014, COD FED REG TITL 21; Food and Drug Administration U.S. Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; HSS, 2009, COD FED REG TITL 45; Kyte D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110229; Kyte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076625; Kyte D, 2013, JAMA-J AM MED ASSOC, V310, P1229, DOI 10.1001/jama.2013.277222; Kyte DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060684; Raboud JM, 1998, QUAL LIFE RES, V7, P487, DOI 10.1023/A:1008870223350; Sackett DL, 2011, CLIN TRIALS, V8, P440, DOI 10.1177/1740774511410995; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; The Institute of Clinical Research, 1996, INT C HARM TECHN REQ; WMA, 2013, WMA DECL HELS ETH PR	22	15	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144658	10.1371/journal.pone.0144658	http://dx.doi.org/10.1371/journal.pone.0144658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785084	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400006
J	Sheng, J; Yang, YP; Ma, YX; Qin, T; Hu, ZH; Hong, SD; Zhou, T; Huang, Y; Zhao, HY; Zhang, L				Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li			Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs	PLOS ONE			English	Article							CELL LUNG-CANCER; SYSTEMIC INFLAMMATORY RESPONSE; GROWTH-FACTOR RECEPTOR; PREDICTS; CHEMOTHERAPY; OUTCOMES; MULTICENTER; MUTATIONS; GEFITINIB; THERAPY	Objective This study was designed to demonstrate the prognostic value of prognostic nutritional index (PNI), a reflection systemic immunonutritional status, on the long-term survival of patients taking epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs). Methods In this retrospective study, eligible advanced NSCLC patients with sensitive EGFR mutations (exon 19 deletion or L858R in exon 21) were included to investigate the correlation between the PNI and overall survival (OS). The PNI was calculated as 10 x serum albumin value (g/dl) + 0.005 x peripheral lymphocyte count (per mm(3)). The prognostic significance of PNI and other clinicopathologic factors was identified by univariate and multivariate analysis. Results Finally, 144 patients met the inclusion criteria. The optimal cut-off value of PNI for survival stratification was 48.78. Compared with high PNI group (n = 81), low PNI (n = 63) was significantly associated with elevated C-reactive protein (CRP) level and non-response to TKIs. Overall survival was superior in the high PNI group (HR, 0.44, p = 0.004), especially for patient with L858R (HR, 0.37, p = 0.009) rather than 19 deletion (HR, 0.69, p = 0.401). The independent prognostic value of PNI was validated by multivariate analysis. Conclusion This pilot investigation demonstrated that low prognostic nutritional index correlates with worse survival for patients with advanced NSCLC and taking EGFR-TKIs. The assessment of a convenient index, known as PNI, worth attention in routine clinical practice for patients following EGFR-TKIs treatment.	[Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yun-Peng; Ma, Yu-Xiang; Qin, Tao; Hu, Zhi-Huang; Hong, Shao-Dong; Zhou, Ting; Huang, Yan; Zhao, Hong-Yun; Zhang, Li] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.; Zhang, L (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn			National Natural Science Foundation of China [81372502, 81201917]; National High Technology Research and Development Program of China [2012AA02A502]; Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library [2013ZX09401003-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library	This study was supported by: National Natural Science Foundation of China (Grant No. 81372502, and 81201917), National High Technology Research and Development Program of China (Grant No. 2012AA02A502) and Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library (Grant No. 2013ZX09401003-002). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preliminary result was present at the 16th World Conference on Lung Cancer, Denver, USA, September 6-9, 2015 (Oral, Abstract ID46: Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs). We thank the patients who participated in this study and their families; the medical, nursing, and research staffs at the study centers. This study was supported by: National Natural Science Foundation of China (Grant No. 81372502, and 81201917), National High Technology Research and Development Program of China (Grant No. 2012AA02A502) and Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library (Grant No. 2013ZX09401003-002).	Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Hofbauer Sebastian L, 2015, Urol Oncol, V33, DOI 10.1016/j.urolonc.2014.08.005; Hong S, 2014, TUMOUR BIOL; Hubbard TJE, 2011, BRIT J SURG, V98, P1032, DOI 10.1002/bjs.7608; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Maeda K, 2014, WORLD J SURG, V38, P1217, DOI 10.1007/s00268-013-2386-x; Masago K, 2010, ONCOLOGY-BASEL, V79, P355, DOI 10.1159/000323486; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Sachlova M, 2014, NUTR CANCER, V66, P1362, DOI 10.1080/01635581.2014.956261; Sagawa Masano, 2008, Gan To Kagaku Ryoho, V35, P2253; Sanchez-Lara K, 2012, NUTR CANCER, V64, P526, DOI 10.1080/01635581.2012.668744; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Wu KL, 2015, LUNG CANCER, V88, P187, DOI 10.1016/j.lungcan.2015.02.012; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang ZJ, 2014, TUMOR BIOL, V35, P12165, DOI 10.1007/s13277-014-2524-6; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yao ZH, 2013, J CANCER RES CLIN, V139, P2117, DOI 10.1007/s00432-013-1523-0; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; ZHANG Y, 2014, PLOS COMPUT BIOL, V10, DOI DOI 10.1371/JOURNAL.PONE.0107161; Zhang YX, 2015, CLIN LUNG CANCER, V16, P144, DOI 10.1016/j.cllc.2014.09.008; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	34	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147226	10.1371/journal.pone.0147226	http://dx.doi.org/10.1371/journal.pone.0147226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784943	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400126
J	Au, KY; Pong, JCH; Ling, WL; Li, JCB				Au, Kin Yi; Pong, John C. H.; Ling, Wai Lim; Li, James C. B.			MiR-1303 Regulates Mycobacteria Induced Autophagy by Targeting Atg2B	PLOS ONE			English	Article							MICRORNA BIOGENESIS; CELLS; TRANSLATION; MACROPHAGES; INITIATION; ELEGANS; DEFENSE; DISEASE; LIN-14; DECAY	MicroRNAs are emerging post-transcriptional regulators of gene expressions in both innate immunity and adaptive immunity. In mycobacteria infection, autophagy plays an important role in innate defense mechanism and is tightly regulated by the autophagy-related proteins. Here, we show that Atg2B is involved in the regulation of mycobacteria-induced autophagy. MiR-1303, which function is not defined yet, is found to negatively regulate mycobacteria-induced Atg2B protein production, ultimately down-regulate mycobacteria-induced autophagy. MiR-1303 production is shown to be upregulated during BCG infection and its production is regulated by PI3K and NF kappa B. It is also demonstrated that miR-1303 targets putative target sites on Atg2B and possibly represses its translation.	[Au, Kin Yi; Pong, John C. H.; Ling, Wai Lim; Li, James C. B.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, JCB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	jamesli@hkucc.hku.hk	Li, Chun Bong/C-4493-2009	Li, Chun Bong/0000-0002-7156-0318	Health and Medical Research Fund Hong Kong [13121172]	Health and Medical Research Fund Hong Kong	This work was supported by a grant from Health and Medical Research Fund Hong Kong (13121172), http://rfs1.fhb.gov.hk/english/welcome/welcome.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cecconi F, 2011, EMBO J, V30, P4517, DOI 10.1038/emboj.2011.387; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Kovaleva V, 2012, CANCER RES, V72, P1763, DOI 10.1158/0008-5472.CAN-11-3671; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	32	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146770	10.1371/journal.pone.0146770	http://dx.doi.org/10.1371/journal.pone.0146770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771516	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300034
J	Lin, JD; Lin, CF; Chung, WB; Chiou, MT; Lin, CN				Lin, Jung-Da; Lin, Chuen-Fu; Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan			Impact of Mated Female Nonproductive Days in Breeding Herd after Porcine Epidemic Diarrhea Virus Outbreak	PLOS ONE			English	Article							SUBSEQUENT REPRODUCTIVE-PERFORMANCE; UNITED-STATES; PRIMIPAROUS SOWS; FEED-INTAKE; LACTATION; STRAINS; PIGS; EMERGENCE; GERMANY; KOREA	Porcine epidemic diarrhea virus (PEDV) is an important pathogen that has a significant economic impact on the swine industry by imposing a high rate of mortality in suckling piglets. However, limited information on the productivity values of gilts and sows infected with PEDV is available. Here, we evaluate the productivity index in gilts and sows during the 1-year period before (19 January 2013 to 18 January 2014) and after (19 January 2014 to 18 January 2015) a PEDV outbreak from a 2000-sow breeding herd in Taiwan. The farrowing rate (FR), return rate (RR), total pigs born per litter (TB), pigs born alive per litter (BA), weaning pigs per litter (WPL), pre-weaning mortality, percentage of sows mated by 7 days after weaning, weaning to first service interval (WFSI), mated female nonproductive days (NPDs), replacement rate of sows and sow culling rate were compared using productive records. The FR (-9.6%), RR (+9.8%), TB (-1.6), BA (-1.1), WPL (-1.1), sows mated by 7 days after weaning (-6.9%), WFSI (+0.8 days), NPDs (+6.9 days) and sow culling rate (+7.2%) were significantly different between the 1-year pre-PEDV outbreak period and the post-PEDV outbreak period. Impacts of the PEDV infection on the reproductive performance were more severe in pregnant gilts than in sows. In conclusion, these findings indicate that the outbreak of PEDV caused an increase in the rate of NPDs in breeding herds.	[Lin, Jung-Da] Natl Chung Cheng Univ, Dept Business Adm, Chiayi 621, Taiwan; [Lin, Chuen-Fu] Natl Chiayi Univ, Dept Vet Med, Chiayi 60004, Taiwan; [Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan; [Chung, Wen-Bin; Chiou, Ming-Tang; Lin, Chao-Nan] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Anim Dis Diagnost Ctr, Pingtung 91201, Taiwan	National Chung Cheng University; National Chiayi University; National Pingtung University Science & Technology; National Pingtung University Science & Technology	Chiou, MT; Lin, CN (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan.; Chiou, MT; Lin, CN (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Anim Dis Diagnost Ctr, Pingtung 91201, Taiwan.	mtchiou@mail.npust.edu.tw; cnlin6@mail.npust.edu.tw						Almond GW., 2006, DIS SWINE, V9, P113; Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; Chiou MT, 2014, AUSTIN VIROL RETROVI, V1, P4; Choi JC, 2014, INFECT GENET EVOL, V26, P348, DOI 10.1016/j.meegid.2014.06.005; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; King VL, 1998, PREV VET MED, V35, P255, DOI 10.1016/S0167-5877(98)00068-3; Koketsu Y, 1996, J ANIM SCI, V74, P2875; Koketsu Y, 2005, J ANIM SCI, V83, P1406; Koketsu Y, 1998, ANIM REPROD SCI, V52, P153, DOI 10.1016/S0378-4320(98)00093-1; Koketsu Y, 2009, J VET MED SCI, V71, P263, DOI 10.1292/jvms.71.263; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Lin CN, 2014, J VET MED SCI; Mejia-Guadarrama CA, 2002, J ANIM SCI, V80, P3286; Olanratmanee EO, 2010, ANIM REPROD SCI, V122, P42, DOI 10.1016/j.anireprosci.2010.07.004; Oldham J, 1972, PIG FARMING, V10, P72; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PIJPERS A, 1993, VET REC, V132, P129, DOI 10.1136/vr.132.6.129; Puranaveja S, 2009, EMERG INFECT DIS, V15, P1112, DOI 10.3201/eid1507.081256; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2016, J VET MED SCI, V78, P355, DOI 10.1292/jvms.15-0446; Suzuki T, 2015, INFECT GENET EVOL, V36, P363, DOI 10.1016/j.meegid.2015.10.017; SVAJGR AJ, 1974, J ANIM SCI, V38, P100, DOI 10.2527/jas1974.381100x; Taylor D.J., 1999, DIS SWINE, P1029; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Yang H, 2000, J ANIM SCI, V78, P993	27	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147316	10.1371/journal.pone.0147316	http://dx.doi.org/10.1371/journal.pone.0147316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771383	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300075
J	Lorenz, T; Frischling, C; Cuadros, R; Heinitz, K				Lorenz, Timo; Frischling, Cora; Cuadros, Raphael; Heinitz, Kathrin			Autism and Overcoming Job Barriers: Comparing Job-Related Barriers and Possible Solutions in and outside of Autism-Specific Employment	PLOS ONE			English	Article							COMPUTER SELF-EFFICACY; SPECTRUM DISORDERS; COPING STRATEGIES; SOCIAL SUPPORT; GENDER; ADULTS; SATISFACTION; PERFORMANCE; RESILIENCE; WORK	The aim of this study was to discover how individuals with autism succeed in entering the job market. We therefore sought to identify expected and occurred barriers, keeping them from taking up and staying in employment as well as to identify the solutions used to overcome these barriers. Sixty-six employed individuals with autism-17 of them with autism-specific employment-participated in an online survey. Results showed a variety of possible barriers. Individuals in autism-specific employment named formality problems-problems with organizational and practical process-related aspects of the job entry-most frequently while individuals in non-autism-specific employment mentioned social problems-obstacles concerning communication and human interaction-most. In terms of solutions, both groups used their own resources as much as external help, but differed in their specific strategies. In addition, correlations of an autism-specific employment with general and occupational self-efficacy as well as life and job satisfaction were examined. Possible implications of the results are discussed with regard to problem solving behavior and the use of strengths.	[Lorenz, Timo; Frischling, Cora; Cuadros, Raphael; Heinitz, Kathrin] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany	Free University of Berlin	Lorenz, T (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.	timo.lorenz@fu-berlin.de	Lorenz, Timo/AAC-2249-2022	Lorenz, Timo/0000-0002-3830-489X				Alcantara JI, 2004, J CHILD PSYCHOL PSYC, V45, P1107, DOI 10.1111/j.1469-7610.2004.t01-1-00303.x; Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; American Psychiatric Association, 2013, DSM 5 AUT SPECTR DIS; Anger C, 2011, MINT TRENDREPORT 201; [Anonymous], 2014, OECD ED GLANCE OECD; [Anonymous], 2003, POSITIVE ORG SCHOLAR; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Attwood A., 1998, ASPERGERS SYNDROME G; Avey JB, 2010, J OCCUP HEALTH PSYCH, V15, P17, DOI 10.1037/a0016998; Baath R., 2014, P USER, V2014, P2; Bakker A. B., 2011, OXFORD HDB POSITIVE, P178, DOI 10.13140/2.1.1145.472.3; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Billstedt E, 2011, AUTISM, V15, P7, DOI 10.1177/1362361309346066; Bolte S, 2011, AUTISM; BRETZ RD, 1994, J VOCAT BEHAV, V44, P32; Bundesagentur fur Arbeit, 2020, KLASS BER 2010 UB FA; Buxbaum JD, 2013, NEUROSCIENCE OF AUTISM SPECTRUM DISORDERS, P3, DOI 10.1016/B978-0-12-391924-3.00001-6; Camarena PM, 2009, FOCUS AUTISM DEV DIS, V24, P115, DOI 10.1177/1088357609332675; Capo Leisa C., 2001, Work, V16, P201; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chown N, 2012, J FURTH HIGH EDUC, V36, P477, DOI 10.1080/0309877X.2011.643771; Danoff-Burg S., 2004, J BLACK PSYCHOL, V30, P208, DOI [10.1177/0095798403260725, DOI 10.1177/0095798403260725]; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dumont M, 1999, J YOUTH ADOLESCENCE, V28, P343, DOI 10.1023/A:1021637011732; Dunson DB, 2000, J ROY STAT SOC B, V62, P355, DOI 10.1111/1467-9868.00236; Durndell A, 2000, PERS INDIV DIFFER, V28, P1037, DOI 10.1016/S0191-8869(99)00155-5; Durndell A, 2002, COMPUT HUM BEHAV, V18, P521, DOI 10.1016/S0747-5632(02)00006-7; Garcia-Villamisar D, 2007, J INTELL DISABIL RES, V51, P142, DOI 10.1111/j.1365-2788.2006.00854.x; Garcuia-Villamisar D., 2002, J VOCATIONAL REHABIL, V17, P309; Geffken GR, 2006, J ANXIETY DISORD, V20, P614, DOI 10.1016/j.janxdis.2005.07.001; Gerhardt PF., 2011, J CONT PSYCH, V41, P37, DOI [10.1007/s10879-010-9160-2, DOI 10.1007/S10879-010-9160-2]; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hagner D., 2005, FOCUS AUTISM OTHER D, V20, P91, DOI [10.1177/10883576050200020501, DOI 10.1177/10883576050200020501]; Hattier MA, 2011, RES DEV DISABIL, V32, P2346, DOI 10.1016/j.ridd.2011.07.028; He J, 2009, J INFORM SYSTEMS ED, V21, P202; Hendricks D, 2010, J VOCAT REHABIL, V32, P125, DOI 10.3233/JVR-2010-0502; HOLDEN G, 1991, SOC WORK HEALTH CARE, V16, P53; Howlin P, 2005, AUTISM, V9, P533, DOI 10.1177/1362361305057871; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Inzlicht M, 2006, PSYCHOL SCI, V17, P262, DOI 10.1111/j.1467-9280.2006.01695.x; Jex SM, 2001, J APPL PSYCHOL, V86, P401, DOI 10.1037//0021-9010.86.3.401; Jiang Z, 2015, PERS INDIV DIFFER, V75, P68, DOI 10.1016/j.paid.2014.11.013; JUDGE TA, 1994, J APPL PSYCHOL, V79, P767, DOI 10.1037/0021-9010.79.5.767; Judge TA, 2001, J APPL PSYCHOL, V86, P80, DOI 10.1037/0021-9010.86.1.80; K-m Ban, 2015, SECRETARY GEN MESSAG; Kanner L, 1943, NERV CHILD, V2, P217; Kleim B, 2008, J MENT HEALTH, V17, P482, DOI 10.1080/09638230701506283; Kristof-Brown AL, 2005, PERS PSYCHOL, V58, P281, DOI 10.1111/j.1744-6570.2005.00672.x; Kruschke JK, 2012, ORGAN RES METHODS, V15, P722, DOI 10.1177/1094428112457829; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Lorenz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100358; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luszczynska A, 2005, INT J PSYCHOL, V40, P80, DOI 10.1080/00207590444000041; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165; Luthans F., 2015, PSYCHOL CAPITAL; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Maddi S. R., 1999, CONSULT PSYCH J, V51, P83, DOI [10.1037/1061-4087.51.2.83, DOI 10.1037/1061-4087.51.2.83]; Magaletta PR, 1999, J CLIN PSYCHOL, V55, P539, DOI 10.1002/(SICI)1097-4679(199905)55:5<539::AID-JCLP2>3.3.CO;2-7; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Mawhood L., 1999, AUTISM, V3, P229, DOI [DOI 10.1177/1362361399003003003, 10.1177/1362361399003003003]; Mayring P, 2014, QUALITATIVE CONTENT; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Montgomery C, 2005, CAN J EDUC, V28, P458, DOI [DOI 10.2307/4126479, 10.2307/4126479]; Muller E., 2003, J VOCAT REHABIL, V18, P163; Nes LS, 2006, PERS SOC PSYCHOL REV, V10, P235, DOI 10.1207/s15327957pspr1003_3; Pinquart M, 2003, J VOCAT BEHAV, V63, P329, DOI 10.1016/S0001-8791(02)00031-3; R Core Team, 2021, R LANGUAGE ENV STAT; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Russo N, 2009, J AUTISM DEV DISORD, V39, P1185, DOI 10.1007/s10803-009-0737-0; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R, 2015, GENERAL SELF EFFICAC; Schyns B, 2012, BERUFLICHE SELBSTWIR; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spychala A, 2009, THESIS; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Standifer S., 2011, FACT SHEET AUTISM EM; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Talay-Ongan A., 2000, INT J DISABIL DEV ED, V47, P201, DOI [10.1080/713671112, DOI 10.1080/713671112]; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Vekiri I, 2008, COMPUT EDUC, V51, P1392, DOI 10.1016/j.compedu.2008.01.003; von Eye A, 2006, EUR PSYCHOL, V11, P12, DOI 10.1027/1016-9040.11.1.12; Weber M, 2013, PERS INDIV DIFFER, V55, P322, DOI 10.1016/j.paid.2013.03.006; Wehman PH, 2014, J AUTISM DEV DISORD, V44, P487, DOI 10.1007/s10803-013-1892-x; WOOD R, 1989, ACAD MANAGE REV, V14, P361, DOI 10.2307/258173; Zyphur MJ, 2015, J MANAGE, V41, P390, DOI 10.1177/0149206313501200	93	61	62	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147040	10.1371/journal.pone.0147040	http://dx.doi.org/10.1371/journal.pone.0147040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26766183	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300059
J	Suzuki, K; Inoue, S; Morita, S; Watanabe, N; Shintani, A; Inokuchi, S; Ogura, S				Suzuki, Kodai; Inoue, Shigeaki; Morita, Seiji; Watanabe, Nobuo; Shintani, Ayumi; Inokuchi, Sadaki; Ogura, Shinji			Comparative Effectiveness of Emergency Resuscitative Thoracotomy versus Closed Chest Compressions among Patients with Critical Blunt Trauma: A Nationwide Cohort Study in Japan	PLOS ONE			English	Article							ROOM THORACOTOMY; CARDIOPULMONARY-RESUSCITATION; DEPARTMENT THORACOTOMY; CARDIAC-ARREST; SURVIVAL; CARE; DETERMINANTS; UTILITY; TIME	Background Although emergency resuscitative thoracotomy is performed as a salvage maneuver for critical blunt trauma patients, evidence supporting superior effectiveness of emergency resuscitative thoracotomy compared to conventional closed-chest compressions remains insufficient. The objective of this study was to investigate whether emergency resuscitative thoracotomy at the emergency department or in the operating room was associated with favourable outcomes after blunt trauma and to compare its effectiveness with that of closed-chest compressions. Methods This was a retrospective nationwide cohort study. Data were obtained from the Japan Trauma Data Bank for the period between 2004 and 2012. The primary and secondary outcomes were patient survival rates 24 h and 28 d after emergency department arrival. Statistical analyses were performed using multivariable generalized mixed-effects regression analysis. We adjusted for the effects of different hospitals by introducing random intercepts in regression analysis to account for the differential quality of emergency resuscitative thoracotomy at hospitals where patients in cardiac arrest were treated. Sensitivity analyses were performed using propensity score matching. Results In total, 1,377 consecutive, critical blunt trauma patients who received cardiopulmonary resuscitation in the emergency department or operating room were included in the study. Of these patients, 484 (35.1%) underwent emergency resuscitative thoracotomy and 893 (64.9%) received closed-chest compressions. Compared to closed-chest compressions, emergency resuscitative thoracotomy was associated with lower survival rate 24 h after emergency department arrival (4.5% vs. 17.5%, respectively, P < 0.001) and 28 d after arrival (1.2% vs. 6.0%, respectively, P < 0.001). Multivariable generalized mixed-effects regression analysis with and without a propensity score-matched dataset revealed that the odds ratio for an unfavorable survival rate after 24 h was lower for emergency resuscitative thoracotomy than for closed-chest compressions (P < 0.001). Conclusions Emergency resuscitative thoracotomy was independently associated with decreased odds of a favorable survival rate compared to closed-chest compressions.	[Suzuki, Kodai; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Inoue, Shigeaki; Morita, Seiji; Watanabe, Nobuo; Inokuchi, Sadaki] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 25911, Japan; [Shintani, Ayumi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan	Gifu University; Tokai University; Osaka University	Suzuki, K (corresponding author), Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan.	koudysir@gifu-u.ac.jp		Ogura, Shinji/0000-0001-7686-6001				[Anonymous], 2010, INJURIES VIOLENCE FA; Arreola-Risa C, 2000, J TRAUMA, V48, P119, DOI 10.1097/00005373-200001000-00020; Asensio JA, 2001, J AM COLL SURGEONS, V193, P303; BAXTER BT, 1988, WORLD J SURG, V12, P671; BRAUTIGAN MW, 1991, RESUSCITATION, V22, P103, DOI 10.1016/0300-9572(91)90069-B; Brown SE, 1996, AM SURGEON, V62, P530; Brown TB, 2007, J TRAUMA, V62, P1180, DOI 10.1097/01.ta.0000235951.21584.a0; CHAMPION HR, 1986, ARCH EMERG MED, V3, P95; CLEVENGER FW, 1988, J TRAUMA, V28, P441, DOI 10.1097/00005373-198804000-00004; COGBILL TH, 1983, J TRAUMA, V23, P453, DOI 10.1097/00005373-198306000-00002; Dabrowska Agata, 2011, Wiad Lek, V64, P127; Edens JW, 2009, J AM COLL SURGEONS, V209, P188, DOI 10.1016/j.jamcollsurg.2009.03.023; ESPOSITO TJ, 1991, J TRAUMA, V31, P881, DOI 10.1097/00005373-199107000-00001; FELICIANO DV, 1986, AM J SURG, V152, P654; Fialka C, 2004, J TRAUMA, V57, P809, DOI 10.1097/01.TA.0000124266.39529.6E; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; FINGERHUT LA, 1997, INJURY CHARTBOOK HLT; Frezza EE, 1999, J CARDIOVASC SURG, V40, P147; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Hunt PA, 2006, INJURY, V37, P1, DOI 10.1016/j.injury.2005.02.014; IVATURY RR, 1991, J TRAUMA, V31, P1076, DOI 10.1097/00005373-199131080-00005; KAVOLIUS J, 1993, ARCH SURG-CHICAGO, V128, P1158; KEMMERER W T, 1961, J Trauma, V1, P595, DOI 10.1097/00005373-196101060-00006; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; LEWIS G, 1991, INJURY, V22, P5, DOI 10.1016/0020-1383(91)90149-9; LOCICERO J, 1989, SURG CLIN N AM, V69, P15; LORENZ HP, 1992, J TRAUMA, V32, P780, DOI 10.1097/00005373-199206000-00020; MAZZORANA V, 1994, AM SURGEON, V60, P516; MILLHAM FH, 1993, J TRAUMA, V34, P332, DOI 10.1097/00005373-199303000-00004; Morrison JJ, 2013, J TRAUMA ACUTE CARE, V74, P825, DOI 10.1097/TA.0b013e31827e1d26; Pahle AS, 2010, J TRAUMA, V68, P599, DOI 10.1097/TA.0b013e3181a5ec54; Passos EM, 2012, J AM COLL SURGEONS, V214, P18, DOI 10.1016/j.jamcollsurg.2011.09.020; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; SANDERS AB, 1985, CRIT CARE MED, V13, P897, DOI 10.1097/00003246-198511000-00008; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Sikka R, 2004, J TRAUMA, V56, P867, DOI 10.1097/01.TA.0000082686.93669.10; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Stephen Westaby, 1999, CARDIOTHORACIC TRAUM; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145963	10.1371/journal.pone.0145963	http://dx.doi.org/10.1371/journal.pone.0145963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766574	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300012
J	Belstrom, D; Holmstrup, P; Bardow, A; Kokaras, A; Fiehn, NE; Paster, BJ				Belstrom, Daniel; Holmstrup, Palle; Bardow, Allan; Kokaras, Alexis; Fiehn, Nils-Erik; Paster, Bruce J.			Temporal Stability of the Salivary Microbiota in Oral Health	PLOS ONE			English	Article							PERIODONTAL-DISEASE; BIOMARKERS; PATTERNS; INDIVIDUALS; DIVERSITY; ANALYTES; LESIONS; RNA	Objectives Saliva is a biological fluid suitable for biomarker analysis, and differences in the salivary microbiota in oral health and disease have been reported. For such comparative analyses, time of sampling is critical since the bacterial composition may vary throughout the day, i.e., diurnal variation. The purpose of this study is to compare the salivary microbiome over time to determine the optimal time for sampling. Design Stimulated saliva samples were collected from 5 orally healthy individuals in 4 h intervals for 24 h, and collection was repeated 7 days later (number of samples per person, n = 12, total number of samples, n = 60). Salivary microbiota was analyzed using the Human Oral Microbe Identification using Next Generation Sequencing (HOMINGS), and statistical analysis was performed using the Kruskal-Wallis test with Benjamini-Hochberg's correction for multiple comparisons, cluster analysis, principal component analysis and correspondence analysis. Results From a total of 60 saliva samples, 477 probe targets were collectively identified with a mean number of probes per sample of 207 (range: 153-307). Little or no variation in microbial profiles within subjects was observed over time. Conclusions Although there was considerable variation between subjects, microbial profiles within subjects were stable throughout a 24 hour period and after 1 week. Since there is little or no evidence of diurnal variation of the salivary microbiome, time of sampling of saliva is not critical for perturbation or other microbial studies.	[Belstrom, Daniel; Holmstrup, Palle] Univ Copenhagen, Sect Periodontol Microbiol & Community Dent, Fac Hlth & Med Sci, Sch Dent, Copenhagen, Denmark; [Bardow, Allan] Univ Copenhagen, Sch Dent, Dept Oral Med, Copenhagen, Denmark; [Kokaras, Alexis; Paster, Bruce J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Fiehn, Nils-Erik] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Paster, Bruce J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA	University of Copenhagen; University of Copenhagen; Harvard University; Forsyth Institute; University of Copenhagen; Harvard University; Harvard School of Dental Medicine	Belstrom, D (corresponding author), Univ Copenhagen, Sect Periodontol Microbiol & Community Dent, Fac Hlth & Med Sci, Sch Dent, Copenhagen, Denmark.	dbel@sund.ku.dk	Paster, Bruce J/AAP-8559-2021		Danish Dental Association; Danish Foundation of Mutual Efforts in Dental Care; Trygfonden; Simon Spies Foundation; NIH [DE021565]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021565] Funding Source: NIH RePORTER	Danish Dental Association; Danish Foundation of Mutual Efforts in Dental Care; Trygfonden; Simon Spies Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by external financial support by: the Danish Dental Association, the Danish Foundation of Mutual Efforts in Dental Care, Trygfonden, and the Simon Spies Foundation. It was also funded in part from NIH grant DE021565 (BJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; Belstrom D., 2014, J ORAL MICROBIOL, V4, P1; Belstrom D, 2015, J ORAL MICROBIOL, P1; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Ebersole JL, 2013, J CLIN IMMUNOL, V33, P271, DOI 10.1007/s10875-012-9771-3; Giannobile W V, 2011, Adv Dent Res, V23, P375, DOI 10.1177/0022034511420434; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Gomes BPFA, 2015, J ENDODONT, V41, P1975, DOI 10.1016/j.joen.2015.08.022; Gursoy UK, 2013, J CLIN PERIODONTOL, V40, P18, DOI 10.1111/jcpe.12020; Gursoy UK, 2011, DIS MARKERS, V30, P299, DOI [10.3233/DMA-2011-0788, 10.1155/2011/621484]; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Kongstad J, 2013, ACTA ODONTOL SCAND, V71, P1560, DOI 10.3109/00016357.2013.776701; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Meschiari CA, 2013, CLIN CHIM ACTA, V421, P140, DOI 10.1016/j.cca.2013.03.008; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Spear GT, 2005, FEMS IMMUNOL MED MIC, V45, P129, DOI 10.1016/j.femsim.2005.03.002; Teles RP, 2009, J PERIODONTAL RES, V44, P411, DOI 10.1111/j.1600-0765.2008.01119.x; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; Tobon-Arroyave SI, 2008, ARCH ORAL BIOL, V53, P346, DOI 10.1016/j.archoralbio.2007.11.005; Yakob Maha, 2014, Curr Oral Health Rep, V1, P133; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010	35	83	83	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147472	10.1371/journal.pone.0147472	http://dx.doi.org/10.1371/journal.pone.0147472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799067	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300111
J	Solanki, A; Mohanty, P; Shukla, P; Rao, A; Ghosh, K; Vundinti, BR				Solanki, Avani; Mohanty, Purvi; Shukla, Pallavi; Rao, Anita; Ghosh, Kanjaksha; Vundinti, Babu Rao			FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients	PLOS ONE			English	Article							COMPLEMENTATION GROUP; IDENTIFICATION; SPECTRUM; DELETION	Fanconi anemia (FA), a rare heterogeneous genetic disorder, is known to be associated with 19 genes and a spectrum of clinical features. We studied FANCA molecular changes in 34 unrelated and 2 siblings of Indian patients with FA and have identified 26 different molecular changes of FANCA gene, of which 8 were novel mutations (a small deletion c.2500delC, 4 non-sense mutations c. 2182C>T, c.2630C>G, c.3677C>G, c.3189G>A; and 3 missense mutations; c.1273G>C, c.3679G>C, and c.3992T>C). Among these only 16 patients could be assigned FA-A complementation group, because we could not confirm single exon deletions detected by MLPA or cDNA amplification by secondary confirmation method and due to presence of heterozygous non-pathogenic variations or heterozygous pathogenic mutations. An effective molecular screening strategy should be developed for confirmation of these mutations and determining the breakpoints for single exon deletions.	[Solanki, Avani; Mohanty, Purvi; Shukla, Pallavi; Rao, Anita; Ghosh, Kanjaksha; Vundinti, Babu Rao] Natl Inst Immunohaematol ICMR, Dept Cytogenet, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Vundinti, BR (corresponding author), Natl Inst Immunohaematol ICMR, Dept Cytogenet, Mumbai, Maharashtra, India.	vbaburao@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Indian Council of Medical Research [56/1/2009-BMS]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by 56/1/2009-BMS from the Indian Council of Medical Research, http://icmr.nic.in/.	Adachi D, 2002, HUM MOL GENET, V11, P3125, DOI 10.1093/hmg/11.25.3125; Ameziane N, 2008, HUM MUTAT, V29, P159, DOI 10.1002/humu.20625; Arthur NBJ, 2014, 56 ASH ANN M EXP, P508; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; Castella M, 2011, BLOOD, V117, P3759, DOI 10.1182/blood-2010-08-299917; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Faivre L, 2000, BLOOD, V96, P4064; Flynn EK, 2014, HUM MUTAT, V35, P1342, DOI 10.1002/humu.22680; Gille JJP, 2012, ANEMIA, V2012, DOI 10.1155/2012/603253; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; Levran O, 2005, HUM MUTAT, V25, P142, DOI 10.1002/humu.20125; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moghrabi NN, 2009, GENET MED, V11, P183, DOI 10.1097/GIM.0b013e318193ba67; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Neveling K, 2009, MUTAT RES-FUND MOL M, V668, P73, DOI 10.1016/j.mrfmmm.2009.05.006; Oostra AB, 2012, ANEMIA, V2012, DOI 10.1155/2012/238731; SASAKI MS, 1973, CANCER RES, V33, P1829; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002; Shukla P, 2013, GENE, V518, P470, DOI 10.1016/j.gene.2013.01.016; Solomon PJ, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0142-6; Tachibana A, 1999, HUM MUTAT, V13, P237, DOI 10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.3.CO;2-6; Tamary H, 2000, BRIT J HAEMATOL, V111, P338, DOI 10.1046/j.1365-2141.2000.02323.x; Tipping AJ, 2001, P NATL ACAD SCI USA, V98, P5734, DOI 10.1073/pnas.091402398; Wijker M, 1999, EUR J HUM GENET, V7, P52, DOI 10.1038/sj.ejhg.5200248; Yagasaki H, 2004, HUM MUTAT, V24, P481, DOI 10.1002/humu.20099	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147016	10.1371/journal.pone.0147016	http://dx.doi.org/10.1371/journal.pone.0147016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799702	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300054
J	Harkenrider, M; Sharma, R; De Vleesschauwer, D; Tsao, L; Zhang, XT; Chern, M; Canlas, P; Zuo, SM; Ronald, PC				Harkenrider, Mitch; Sharma, Rita; De Vleesschauwer, David; Tsao, Li; Zhang, Xuting; Chern, Mawsheng; Canlas, Patrick; Zuo, Shimin; Ronald, Pamela C.			Overexpression of Rice Wall-Associated Kinase 25 (OsWAK25) Alters Resistance to Bacterial and Fungal Pathogens	PLOS ONE			English	Article							GUANYLYL CYCLASE ACTIVITY; ARABIDOPSIS-THALIANA; SYSTEMIC RESISTANCE; DISEASE-RESISTANCE; MAGNAPORTHE-GRISEA; GENE; RECEPTOR; EXPRESSION; EXPANSION; INTERACTS	Wall-associated kinases comprise a sub-family of receptor-like kinases that function in plant growth and stress responses. Previous studies have shown that the rice wall-associated kinase, OsWAK25, interacts with a diverse set of proteins associated with both biotic and abiotic stress responses. Here, we show that wounding and BTH treatments induce OsWAK25 transcript expression in rice. We generated OsWAK25 overexpression lines and show that these lines exhibit a lesion mimic phenotype and enhanced expression of rice NH1 (NPR1 homolog 1), OsPAL2, PBZ1 and PR10. Furthermore, these lines show resistance to the hemibiotrophic pathogens, Xanthomonas oryzae pv. oryzae (Xoo) and Magnaporthe oryzae, yet display increased susceptibility to necrotrophic fungal pathogens, Rhizoctonia solani and Cochliobolus miyabeanus.	[Harkenrider, Mitch; Sharma, Rita; Tsao, Li; Chern, Mawsheng; Canlas, Patrick; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sharma, Rita; Chern, Mawsheng; Ronald, Pamela C.] Joint BioEnergy Inst, Emeryville, CA USA; [De Vleesschauwer, David] Univ Ghent, Lab Phytopathol, B-9000 Ghent, Belgium; [Zhang, Xuting; Zuo, Shimin] Yangzhou Univ, Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol & Coinnovat, Yangzhou 225009, Jiangsu, Peoples R China	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ghent University; Yangzhou University	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.; Ronald, PC (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	pcronald@ucdavis.edu	Sharma, Rita/G-2425-2017; Ronald, Pamela/AAK-7664-2020		NSF CREATE-IGERT program at UC Davis [DGE-0653984]; Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [GM55962]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	NSF CREATE-IGERT program at UC Davis; Joint BioEnergy Institute - Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Partial funding for this research was provided to MH by the NSF CREATE-IGERT program at UC Davis (Award Number DGE-0653984). Additional funding was through the Joint BioEnergy Institute supported by the Office of Science, Office of Biological and Environmental Research of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Additional support was given by NIH GM55962 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon DI, 1938, AM J BOT, V25, P322, DOI 10.2307/2436754; Ashton AR, 2011, P NATL ACAD SCI USA, V108, pE96, DOI 10.1073/pnas.1101007108; Berkowitz GA, 2011, P NATL ACAD SCI USA, V108, pE97, DOI 10.1073/pnas.1103313108; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; De Vleesschauwer D, 2008, PLANT PHYSIOL, V148, P1996, DOI 10.1104/pp.108.127878; De Vleesschauwer D, 2006, MOL PLANT MICROBE IN, V19, P1406, DOI 10.1094/MPMI-19-1406; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Feng JX, 2011, EUR J PLANT PATHOL, V131, P221, DOI 10.1007/s10658-011-9801-7; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; Hu W, 2014, PLANT SOIL, V384, P335, DOI 10.1007/s11104-014-2204-8; Jo Y, 2011, PROTOPLASMA, V248, P191, DOI 10.1007/s00709-010-0251-4; Kohorn BD, 2012, MOL PLANT, V5, P841, DOI 10.1093/mp/ssr096; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Meier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008904; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Qi M, 2002, PHYTOPATHOLOGY, V92, P870, DOI 10.1094/PHYTO.2002.92.8.870; Qi Z, 2010, P NATL ACAD SCI USA, V107, P21193, DOI 10.1073/pnas.1000191107; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schweizer P, 1997, PLANT PHYSIOL, V114, P79, DOI 10.1104/pp.114.1.79; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Thuan NTN, 2006, EUR J PLANT PATHOL, V114, P381, DOI 10.1007/s10658-006-0002-8; Tocquard K, 2014, TREE GENET GENOMES, V10, P1135, DOI 10.1007/s11295-014-0748-7; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Wong A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-48; Yang K, 2014, CROP J, V2, P255, DOI 10.1016/j.cj.2014.04.010; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zuo SM, 2013, THEOR APPL GENET, V126, P1257, DOI 10.1007/s00122-013-2051-7	36	41	46	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147310	10.1371/journal.pone.0147310	http://dx.doi.org/10.1371/journal.pone.0147310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795719	gold, Green Submitted, Green Published			2022-12-27	WOS:000368530300028
J	van den Akker, GGH; Surtel, DAM; Cremers, A; Richardson, SM; Hoyland, JA; van Rhijn, LW; Voncken, JW; Welting, TJM				van den Akker, Guus G. H.; Surtel, Don A. M.; Cremers, Andy; Richardson, Stephen M.; Hoyland, Judith A.; van Rhijn, Lodewijk W.; Voncken, Jan Willem; Welting, Tim J. M.			Novel Immortal Cell Lines Support Cellular Heterogeneity in the Human Annulus Fibrosus	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; GENE-EXPRESSION; NUCLEUS PULPOSUS; ARTICULAR CHONDROCYTES; MOUSE IMPLICATIONS; ASCORBIC-ACID; DEGENERATION; COLLAGEN; PHENOTYPE; IDENTIFICATION	Introduction Loss of annulus fibrosus (AF) integrity predisposes to disc herniation and is associated with IVD degeneration. Successful implementation of biomedical intervention therapy requires in-depth knowledge of IVD cell biology. We recently generated unique clonal human nucleus pulposus (NP) cell lines. Recurring functional cellular phenotypes from independent donors provided pivotal evidence for cell heterogeneity in the mature human NP. In this study we aimed to generate and characterize immortal cell lines for the human AF from matched donors. Methods Non-degenerate healthy disc material was obtained as surplus surgical material. AF cells were immortalized by simian virus Large T antigen (SV40LTAg) and human telomerase (hTERT) expression. Early passage cells and immortalized cell clones were characterized based on marker gene expression under standardized culturing and in the presence of Transforming Growth factor beta (TGF beta). Results The AF-specific expression signature included COL1A1, COL5A1, COL12A1, SFRP2 and was largely maintained in immortal AF cell lines. Remarkably, TGF beta induced rapid 3D sheet formation in a subgroup of AF clones. This phenotype was associated with inherent differences in Procollagen type I processing and maturation, and correlated with differential mRNA expression of Prolyl 4-hydroxylase alpha polypeptide 1 and 3 (P4HA1,3) and Lysyl oxidase (LOX) between clones and differential P4HA3 protein expression between AF cells in histological sections. Conclusion We report for the first time the generation of representative human AF cell lines. Gene expression profile analysis and functional comparison of AF clones revealed variation between immortalized cells and suggests phenotypic heterogeneity in the human AF. Future characterization of AF cellular (sub-)populations aims to combine identification of additional specific AF marker genes and their biological relevance. Ultimately this knowledge will contribute to clinical application of cell-based technology in IVD repair.	[van den Akker, Guus G. H.; Surtel, Don A. M.; Cremers, Andy; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Med Ctr, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands; [van den Akker, Guus G. H.; Voncken, Jan Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Richardson, Stephen M.; Hoyland, Judith A.] Univ Manchester, Inst Inflammat & Repair, Ctr Tissue Injury & Repair, Manchester, Lancs, England	Maastricht University; Maastricht University; University of Manchester	Welting, TJM (corresponding author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.; Voncken, JW (corresponding author), Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl; t.welting@maastrichtuniversity.nl	Richardson, Stephen/A-4124-2009; van den Akker, Guus/A-1642-2016; van den Akker, Guus/AAD-9536-2019	Richardson, Stephen/0000-0002-7637-4135; van den Akker, Guus/0000-0002-7071-1487; 	Project P2.01 IDiDAS; Dutch Arthritis Foundation [LLP14]; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia; Apifarma, Portugal	Project P2.01 IDiDAS; Dutch Arthritis Foundation; Programme for Advanced Medical Education; Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Apifarma, Portugal	This study was supported by Project P2.01 IDiDAS (LWvR, TJMW); LLP14 Grant Dutch Arthritis Foundation (JWV, LWvR); Programme for Advanced Medical Education, Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude, Fundacao para a Ciencia e Tecnologia and Apifarma, Portugal. None of the funding sources had any role in study design, data collection, analysis and interpretation, writing of the manuscript or the decision to submit the manuscript for publication.; Approval for all experimental sections of the current study and informed consent for publication of patient details and accompanying images in this manuscript was obtained as an integral part of the MUMC-MERC approval 08-4-028. For immunohistochemical studies informed consent was obtained from the donor's relatives and approval for the study was granted by the North West Research Ethics Committee. The approvals are held by the authors and are available for review by the Editor-in-Chief. The authors thank R. Bernards (NKI Amsterdam, the Netherlands) for hTERT (human telomerase) cDNA, R. Bank (University of Groningen, Netherlands) for useful discussions and suggestions on Collagen detection and P. Willems (MUMC, Netherlands) for medical ethical reflections. Funding: Project P2.01 IDiDAS (LWvR, TJMW); LLP14 Grant Dutch Arthritis Foundation (JWV, LWvR); Programme for Advanced Medical Education, Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude, Fundacao para a Ciencia e Tecnologia and Apifarma, Portugal. None of the funding sources had any role in study design, data collection, analysis and interpretation, writing of the manuscript or the decision to submit the manuscript for publication.	Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Brayda-Bruno M, 2014, EUR SPINE J, V23, pS315, DOI 10.1007/s00586-013-2960-9; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Chou AI, 2008, TISSUE ENG PT A, V14, P2079, DOI 10.1089/ten.tea.2007.0337; CHRIST B, 1992, ANN ANAT, V174, P23, DOI 10.1016/S0940-9602(11)80337-7; Clouet J, 2009, JOINT BONE SPINE, V76, P614, DOI 10.1016/j.jbspin.2009.07.002; Clouet J, 2009, RHEUMATOLOGY, V48, P1447, DOI 10.1093/rheumatology/kep262; DECLERCK YA, 1980, BIOCHEM J, V186, P217, DOI 10.1042/bj1860217; ESTERVIG DN, 1990, J CELL PHYSIOL, V142, P552, DOI 10.1002/jcp.1041420314; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Gilbert HTJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3229; Gruber HE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-63; Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012; Gruber HE, 2010, SPINE J, V10, P721, DOI 10.1016/j.spinee.2010.05.014; Guillaume O, 2014, ACTA BIOMATER, V10, P1985, DOI 10.1016/j.actbio.2013.12.037; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Hayes AJ, 2011, EUR CELLS MATER, V21, P1; Hayes AJ, 2011, EUR CELLS MATER, V22, P226, DOI 10.22203/eCM.v022a18; Hayes AJ, 2011, HISTOCHEM CELL BIOL, V136, P163, DOI 10.1007/s00418-011-0835-x; Ivanov V, 2005, J CARDIOVASC PHARM, V46, P570, DOI 10.1097/01.fjc.0000179432.73007.45; Jin L, 2013, EUR SPINE J, V22, P1090, DOI 10.1007/s00586-013-2663-2; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Kroemer KE, 2010, SKELETAL STRUCTURES, P1; Lama P, 2013, BONE JOINT J, V95B, P1127, DOI [10.1302/0301-620X.95B8.31660, 10.1302/0301-620X.95138.31660]; Lampot JD, 2015, CELL TRANSPLANT, V24, P1053, DOI 10.3727/096368914X681054; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971; Lui PPY, 2014, AM J SPORT MED, V42, P681, DOI 10.1177/0363546513517539; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Minogue BM, 2010, ARTHRITIS RHEUM-US, V62, P3695, DOI 10.1002/art.27710; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nosikova YS, 2012, J ANAT, V221, P577, DOI 10.1111/j.1469-7580.2012.01537.x; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Prickaerts P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-12; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; ROBERTSON WV, 1953, J BIOL CHEM, V201, P689; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; SCHWARZ RI, 1981, MOL CELL BIOL, V1, P843, DOI 10.1128/MCB.1.9.843; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; TAKEZAWA T, 1993, EXP CELL RES, V208, P430, DOI 10.1006/excr.1993.1265; van den Akker GGH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4597; Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015	56	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144497	10.1371/journal.pone.0144497	http://dx.doi.org/10.1371/journal.pone.0144497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794306	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300001
J	Henriques, J; Pazart, L; Grigoryeva, L; Muzard, E; Beaussant, Y; Haffen, E; Moulin, T; Aubry, R; Ortega, JP; Gabriel, D				Henriques, Julie; Pazart, Lionel; Grigoryeva, Lyudmila; Muzard, Emelyne; Beaussant, Yvan; Haffen, Emmanuel; Moulin, Thierry; Aubry, Regis; Ortega, Juan-Pablo; Gabriel, Damien			Bedside Evaluation of the Functional Organization of the Auditory Cortex in Patients with Disorders of Consciousness	PLOS ONE			English	Article							PATIENTS OWN NAME; VEGETATIVE STATE; TONOTOPIC ORGANIZATION; TOPOGRAPHY; POTENTIALS; AREAS; COMA; N100	To measure the level of residual cognitive function in patients with disorders of consciousness, the use of electrophysiological and neuroimaging protocols of increasing complexity is recommended. This work presents an EEG-based method capable of assessing at an individual level the integrity of the auditory cortex at the bedside of patients and can be seen as the first cortical stage of this hierarchical approach. The method is based on two features: first, the possibility of automatically detecting the presence of a N100 wave and second, in showing evidence of frequency processing in the auditory cortex with a machine learning based classification of the EEG signals associated with different frequencies and auditory stimulation modalities. In the control group of twelve healthy volunteers, cortical frequency processing was clearly demonstrated. EEG recordings from two patients with disorders of consciousness showed evidence of partially preserved cortical processing in the first patient and none in the second patient. From these results, it appears that the classification method presented here reliably detects signal differences in the encoding of frequencies and is a useful tool in the evaluation of the integrity of the auditory cortex. Even though the classification method presented in this work was designed for patients with disorders of consciousness, it can also be applied to other pathological populations.	[Henriques, Julie; Grigoryeva, Lyudmila; Ortega, Juan-Pablo] Lab Math Besancon, Besancon, France; [Henriques, Julie] Cegos Deployment, Besancon, France; [Pazart, Lionel; Haffen, Emmanuel; Moulin, Thierry; Aubry, Regis; Gabriel, Damien] CHU Besancon, INSERM, Ctr Invest Clin Innovat Technol, CIC 1431, F-25030 Besancon, France; [Pazart, Lionel; Haffen, Emmanuel; Moulin, Thierry; Aubry, Regis; Gabriel, Damien] Lab Neurosci Besancon, EA 481, Besancon, France; [Muzard, Emelyne; Moulin, Thierry] CHU Besancon, Serv Neurol, F-25030 Besancon, France; [Beaussant, Yvan; Aubry, Regis] CHU Besancon, Dept Douleur Soins Palliatifs, F-25030 Besancon, France; [Muzard, Emelyne] CHU Besancon, Serv Psychiat Adulte, F-25030 Besancon, France; [Ortega, Juan-Pablo] CNRS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS)	Gabriel, D (corresponding author), CHU Besancon, INSERM, Ctr Invest Clin Innovat Technol, CIC 1431, F-25030 Besancon, France.; Gabriel, D (corresponding author), Lab Neurosci Besancon, EA 481, Besancon, France.	dgabriel@chu-besancon.fr	haffen, emmanuel/R-2765-2017; Pazart, Lionel/GYU-1917-2022	haffen, emmanuel/0000-0002-4091-518X; gabriel, damien/0000-0001-5413-3640; Moulin, thierry/0000-0002-6639-8117; Aubry, Regis/0000-0001-7580-567X	Translational clinical research program from the French Ministry of Health; Inserm	Translational clinical research program from the French Ministry of Health; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the 2011 Translational clinical research program from the French Ministry of Health and Inserm. Recipient: RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAND O, 1991, ACTA OTO-LARYNGOL, P116; Bostanov V, 2006, CLIN NEUROPHYSIOL, V117, P2627, DOI 10.1016/j.clinph.2006.08.012; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Gabriel D, 2015, NEUROSCIENCE, V290, P435, DOI 10.1016/j.neuroscience.2015.01.053; Glass I, 1998, CLIN ELECTROENCEPHAL, V29, P19, DOI 10.1177/155005949802900109; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Iramina K, 1996, BRAIN TOPOGR, V8, P297, DOI 10.1007/BF01184788; Langers DRM, 2012, CEREB CORTEX, V22, P2024, DOI 10.1093/cercor/bhr282; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Lutkenhoner B, 2003, NEUROIMAGE, V19, P935, DOI 10.1016/S1053-8119(03)00172-1; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Moerel M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00225; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2005, PROG BRAIN RES, V150, P457, DOI 10.1016/S0079-6123(05)50032-3; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Rojas DC, 2002, BIOL PSYCHIAT, V52, P32, DOI 10.1016/S0006-3223(01)01365-8; Saenz M, 2014, HEARING RES, V307, P42, DOI 10.1016/j.heares.2013.07.016; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Tecchio F, 2000, HUM BRAIN MAPP, V10, P28, DOI 10.1002/(SICI)1097-0193(200005)10:1<28::AID-HBM40>3.0.CO;2-G; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; VERKINDT C, 1995, EVOKED POTENTIAL, V96, P143, DOI 10.1016/0168-5597(94)00242-7	24	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146788	10.1371/journal.pone.0146788	http://dx.doi.org/10.1371/journal.pone.0146788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789734	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100041
J	Tochitani, S; Ikeno, T; Ito, T; Sakurai, A; Yamauchi, T; Matsuzaki, H				Tochitani, Shiro; Ikeno, Takahiro; Ito, Tatsuhito; Sakurai, Asuka; Yamauchi, Tomoki; Matsuzaki, Hideo			Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PERINATAL UNDERNUTRITION; BRAIN-DEVELOPMENT; RESTRICTION; HEALTH; STRESS; IMPACT; MODEL; ABNORMALITIES; MALTREATMENT	There is increasing evidence that the gut microbiota plays a major role in host health and disease. In this study, we examined whether perturbation of the maternal gut microbiota during pregnancy, induced by administration of non-absorbable antibiotics to pregnant dams, influences the behavior of offspring. Terminal restriction fragment length polymorphism analyses of fecal bacterial composition showed that the relative abundance of the bacterial order Lactobacillales was lower in offspring born from antibiotic-treated dams (20.7 +/- 3.4%) than in control offspring (42.1 +/- 6.2%) at P24, while the relative abundance of the bacterial family Clostridium subcluster XIVa was higher in offspring born from antibiotic-treated dams (34.2 +/- 5.0%) than in control offspring (16.4 +/- 3.3%). Offspring born from antibiotic-treated dams exhibited low locomotor activity in both familiar and novel environments, and preferred to explore in the peripheral area of an unfamiliar field at postnatal week 4. At postnatal weeks 7-8, no difference was observed in the level of locomotor activity between control offspring and offspring from antibiotic-treated dams, while the tendency for the offspring from antibiotic-treated dams to be less engaged in exploring the inside area was still observed. The behavioral phenotypes of the offspring from antibiotic-treated dams at postnatal week 4 could be rescued to a considerable extent through fostering of these offspring by normal dams from postnatal day 1. Although the detailed underlying mechanisms are not fully elucidated, the present results suggest that administration of non-absorbable antibiotics to pregnant dams to perturb the maternal gut microbiota during pregnancy leads to alterations in the behavior of their offspring.	[Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Div Dev Mental Funct, Res Ctr Child Mental Dev, Fukui 9101193, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Osaka Univ, Div Dev Higher Brain Funct, Dept Child Dev, United Grad Sch Child Dev, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Kanazawa Univ, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Chiba Univ, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Suita, Osaka 5650871, Japan; [Tochitani, Shiro; Matsuzaki, Hideo] Univ Fukui, Res & Educ Program Life Sci, Fukui 9108507, Japan; [Ikeno, Takahiro; Ito, Tatsuhito; Sakurai, Asuka; Yamauchi, Tomoki; Matsuzaki, Hideo] Univ Fukui, Sch Med, Fac Med Sci, Fukui 9101193, Japan	University of Fukui; Osaka University; Kanazawa University; Hamamatsu University School of Medicine; Chiba University; University of Fukui; University of Fukui; University of Fukui	Tochitani, S (corresponding author), Univ Fukui, Div Dev Mental Funct, Res Ctr Child Mental Dev, Fukui 9101193, Japan.; Tochitani, S (corresponding author), Osaka Univ, Div Dev Higher Brain Funct, Dept Child Dev, United Grad Sch Child Dev, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Kanazawa Univ, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 5650871, Japan.; Tochitani, S (corresponding author), Chiba Univ, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Univ Fukui, Suita, Osaka 5650871, Japan.; Tochitani, S (corresponding author), Univ Fukui, Res & Educ Program Life Sci, Fukui 9108507, Japan.	tochitani.shiro@gmail.com	MATSUZAKI, HIDEO/AAE-5246-2020	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tochitani, Shiro/0000-0001-5765-3668	Research and Education Program for Life Science at University of Fukui; Yakult Bio-Science Foundation	Research and Education Program for Life Science at University of Fukui; Yakult Bio-Science Foundation	This work was supported by a grant for exploratory research from the Research and Education Program for Life Science at University of Fukui (to ST) and a grant for general scientific research from the Yakult Bio-Science Foundation (to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Blevins CR, 2015, EVOLUTION MED PUBLIC, DOI [10.1093/emph/eov007, DOI 10.1093/EMPH/E0V007]; Aomatsu T, 2012, DIGESTION, V86, P129, DOI 10.1159/000339777; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blaze J, 2013, DEV NEUROSCI-BASEL, V35, P306, DOI 10.1159/000350716; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Borre YE, 2014, ADV EXP MED BIOL, V817, P373, DOI 10.1007/978-1-4939-0897-4_17; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Cicchetti D, 2005, ANNU REV CLIN PSYCHO, V1, P409, DOI 10.1146/annurev.clinpsy.1.102803.144029; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins SM, 2013, CURR OPIN MICROBIOL, V16, P240, DOI 10.1016/j.mib.2013.06.004; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Ghosh SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108577; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groer MW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-38; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hinde K, 2015, SCIENCE, V348, P1427, DOI 10.1126/science.aac7436; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Imaeda H, 2012, DIGESTION, V86, P250, DOI 10.1159/000341508; Ishikawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100627; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jasarevic E, 2015, NEUROBIOL STRESS, V1, P81, DOI 10.1016/j.ynstr.2014.10.005; Kohata Y, 2015, DIGEST DIS SCI, V60, P2654, DOI 10.1007/s10620-015-3662-4; Leonhardt M, 2003, BIOL REPROD, V68, P390, DOI 10.1095/biolreprod.102.003269; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lopatina O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00133; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mikami K, 2012, PHARMACEUTICALS-BASE, V5, P629, DOI 10.3390/ph5060629; Miyazawa K, 2015, MICROBIOL IMMUNOL, V59, P99, DOI 10.1111/1348-0421.12226; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Oda Y, 2011, BIOFACTORS, V37, P31, DOI 10.1002/biof.132; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374; Silverman JL, 2013, NEUROPHARMACOLOGY, V64, P268, DOI 10.1016/j.neuropharm.2012.07.013; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Tochitani S, 2008, BIOCHEM BIOPH RES CO, V372, P691, DOI 10.1016/j.bbrc.2008.05.127; Tochitani S, 2010, NEUROSCI LETT, V472, P128, DOI 10.1016/j.neulet.2010.01.071; Toth SL, 2013, DEV PSYCHOPATHOL, V25, P1601, DOI 10.1017/S0954579413000795; Tousen Y, 2011, METABOLISM, V60, P1425, DOI 10.1016/j.metabol.2011.02.009; Trujillo V, 2016, STRESS, V19, P91, DOI 10.3109/10253890.2015.1105958; Unno T, 2015, J AGR FOOD CHEM, V63, P7952, DOI 10.1021/acs.jafc.5b02649; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Vieau D, 2007, PSYCHONEUROENDOCRINO, V32, pS16, DOI 10.1016/j.psyneuen.2007.03.014; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang T, 2015, BENEF MICROBES, V6, P707, DOI 10.3920/BM2014.0177; Wattez JS, 2014, J DEV ORIG HLTH DIS, V5, P109, DOI 10.1017/S2040174413000548; Yoda K, 2012, J APPL MICROBIOL, V113, P155, DOI 10.1111/j.1365-2672.2012.05316.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	70	87	88	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0138293	10.1371/journal.pone.0138293	http://dx.doi.org/10.1371/journal.pone.0138293			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789865	gold, Green Published			2022-12-27	WOS:000368529100001
J	Milner, AN; George, BJ; Allison, DB				Milner, Adrienne N.; George, Brandon J.; Allison, David B.			Black and Hispanic Men Perceived to Be Large Are at Increased Risk for Police Frisk, Search, and Force	PLOS ONE			English	Article							BODY-WEIGHT; OBESITY; PERCEPTIONS; STIGMA; RACE; DISCRIMINATION; JUDGMENTS; ATTITUDES; MATTER	Social justice issues remain some of the most pressing problems in the United States. One aspect of social justice involves the differential treatment of demographic groups in the criminal justice system. While data consistently show that Blacks and Hispanics are often treated differently than Whites, one understudied aspect of these disparities is how police officers' assessments of suspects' size affects their decisions. Using over 3 million cases from the New York Police Department (NYPD) Stop, Question, and Frisk (SQF) Database, 2006-2013, this study is the first to explore suspects' race, perceived size, and police treatment. Results indicate that tall and heavy black and Hispanic men are at the greatest risk for frisk or search. Tall and heavy suspects are at increased risk for experiencing police force, with black and Hispanic men being more likely to experience force than white men across size categories.	[Milner, Adrienne N.] Univ Alabama Birmingham, Dept Sociol, Birmingham, AL 35294 USA; [Milner, Adrienne N.; George, Brandon J.; Allison, David B.] Univ Alabama Birmingham, Nutrician Obes Res Ctr, Birmingham, AL 35294 USA; [Milner, Adrienne N.] Univ Alabama Birmingham, Minor Hlth & Hlth Dispar Res Ctr, Birmingham, AL 35294 USA; [Milner, Adrienne N.] Univ Alabama Birmingham, Ctr Study Community Hlth, Birmingham, AL 35294 USA; [George, Brandon J.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [George, Brandon J.; Allison, David B.] Univ Alabama Birmingham, Off Energet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Milner, AN (corresponding author), Univ Alabama Birmingham, Dept Sociol, Birmingham, AL 35294 USA.; Milner, AN; Allison, DB (corresponding author), Univ Alabama Birmingham, Nutrician Obes Res Ctr, Birmingham, AL 35294 USA.; Milner, AN (corresponding author), Univ Alabama Birmingham, Minor Hlth & Hlth Dispar Res Ctr, Birmingham, AL 35294 USA.; Milner, AN (corresponding author), Univ Alabama Birmingham, Ctr Study Community Hlth, Birmingham, AL 35294 USA.; Allison, DB (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA.; Allison, DB (corresponding author), Univ Alabama Birmingham, Off Energet, Birmingham, AL 35294 USA.	amilner@uab.edu; dallison@uab.edu		Milner, Adrienne/0000-0003-3209-6185	National Institutes of Health [P30DK056336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DBA reports grants from National Institutes of Health grant P30DK056336. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, STOP AND FRISK 2011; [Anonymous], 2015, STOP AND FRISK DAT; [Anonymous], 2014, HESPERIA STAR   1022; [Anonymous], 2015, GUARDIAN; Balcetis E, 2010, PSYCHOL SCI, V21, P147, DOI 10.1177/0956797609356283; BIERNAT M, 1991, J PERS SOC PSYCHOL, V60, P485, DOI 10.1037/0022-3514.60.4.485; Bobo Lawrence., 1997, RACIAL ATTITUDE 1990, P15; Bonilla-Silva E., 2006, RACISM RACISTS COLOR; Bosewell F, 2014, NATL PUBLIC RADIO; Bouie J., 2014, SLATE; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Chan Sewell, 2007, NY TIMES; Cullinane DM, 2009, MED SCI LAW, V49, P200, DOI 10.1258/rsmmsl.49.3.200; Desmond-Harris J, 2014, THE ROOT        0721; Fagan JA, 2010, RACE ETHNICITY POLIC, P264; Feagin J.R., 2006, SYSTEMIC RACISM THEO; Freedman DS, 2015, AM J CLIN NUTR, V102, P1000, DOI 10.3945/ajcn.115.115576; Gabrielson R, 2014, PROPUBLICA      1010; Geller A, 2010, J EMPIR LEGAL STUD, V7, P591, DOI 10.1111/j.1740-1461.2010.01190.x; Gelman A, 2006, ANAL NYPDS STOP AND, DOI [10.2139/ssrn.846365, DOI 10.2139/SSRN.846365]; Golub Andrew, 2007, Criminol Public Policy, V6, P131, DOI 10.1111/j.1745-9133.2007.00426.x; Herbozo Sylvia, 2004, Eat Disord, V12, P21; Howard SC, 2014, HUFFINGTON POST; Kalist DE, 2013, ECON HUM BIOL, V11, P8, DOI 10.1016/j.ehb.2012.02.001; Kapp T, 2015, READ MEMO STOP AND F; Khruakham S., 2012, LAW ENFORCEMENT EXEC, V12, P122; KINDER DR, 1981, J PERS SOC PSYCHOL, V40, P414, DOI 10.1037/0022-3514.40.3.414; Maddana S, 2008, SOC SCI J, V45, P330, DOI 10.1016/j.soscij.2008.03.009; Masicampo EJ, 2014, J EXP PSYCHOL GEN, V143, P2135, DOI 10.1037/a0037831; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Preston J, 2014, HUFFINGTON POST; Price GN, 2009, ECON LETT, V103, P149, DOI 10.1016/j.econlet.2009.03.009; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2013, J HEALTH COMMUN, V18, P686, DOI 10.1080/10810730.2012.743631; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Ridgeway G., 2007, ANAL RACIAL DISPARIT; Rivera R, 2010, FEW BLOCKS 4 YEARS 5; Roblesand F, 2014, NY TIMES; Sandberg H, 2007, COMMUNICATIONS-GER, V32, P447, DOI 10.1515/COMMUN.2007.018; Schvey NA, 2013, INT J OBESITY, V37, P1275, DOI 10.1038/ijo.2012.211; Sheldon W. H., 1940, VARIETIES HUMAN PHYS; Solis C, 2009, ANN AM ACAD POLIT SS, V623, P39, DOI 10.1177/0002716208330487; Vartanian LR, 2010, INT J OBESITY, V34, P1302, DOI 10.1038/ijo.2010.45; Waytz A, 2014, WASHINGTON POST; Waytz A, 2015, SOC PSYCHOL PERS SCI, V6, P352, DOI 10.1177/1948550614553642; Wear D, 2006, ACAD MED, V81, P454, DOI 10.1097/01.ACM.0000222277.21200.a1; Wee CC, 2015, J GEN INTERN MED, V30, P229, DOI 10.1007/s11606-014-3041-4; White DE, 2014, OBES RES CLIN PRACT, V8, pE599, DOI 10.1016/j.orcp.2013.11.003; Wigton RS, 2001, J GEN INTERN MED, V16, P262, DOI 10.1046/j.1525-1497.2001.016004262.x; Wing, 2014, HUFFINGTON POST; Zirin Dave, 2015, NATION	53	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147158	10.1371/journal.pone.0147158	http://dx.doi.org/10.1371/journal.pone.0147158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26785118	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400116
J	Alberto, AVP; Faria, RX; de Menezes, JRL; Surrage, A; da Rocha, NC; Ferreira, LGB; Frutuoso, VD; Martins, MA; Alves, LA				Pinto Alberto, Anael Viana; Faria, Robson Xavier; Lacerda de Menezes, Joao Ricardo; Surrage, Andrea; da Rocha, Natasha Cristina; Braga Ferreira, Leonardo Gomes; Frutuoso, Valber da Silva; Martins, Marco Aurelio; Alves, Luiz Anastacio			Role of P2 Receptors as Modulators of Rat Eosinophil Recruitment in Allergic Inflammation	PLOS ONE			English	Article							OXYGEN RADICAL PRODUCTION; ANTIGEN-PRESENTING CELLS; EXTRACELLULAR ATP; PHARMACOLOGICAL CHARACTERIZATION; ALVEOLAR MACROPHAGES; PURINERGIC RECEPTORS; INTRACELLULAR CA2+; LUNG INFLAMMATION; DENDRITIC CELLS; NUCLEOTIDES	ATP and other nucleotides are released from cells through regulated pathways or following the loss of plasma membrane integrity. Once outside the cell, these compounds can activate P2 receptors: P2X ionotropic receptors and G protein-coupled P2Y receptors. Eosinophils represent major effector cells in the allergic inflammatory response and they are, in fact, associated with several physiological and pathological processes. Here we investigate the expression of P2 receptors and roles of those receptors in murine eosinophils. In this context, our first step was to investigate the expression and functionality of the P2X receptors by patch clamping, our results showed a potency ranking order of ATP>ATP gamma S>2meSATP>ADP>alpha beta meATP>beta gamma meATP>BzATP>UTP>UDP>cAMP. This data suggest the presence of P2X1, P2X2 and P2X7. Next we evaluate by microfluorimetry the expression of P2Y receptors, our results based in the ranking order of potency (UTP>ATP gamma S>ATP>UDP>ADP>2meSATP>alpha beta meATP) suggests the presence of P2Y2, P2Y4, P2Y6 and P2Y11. Moreover, we confirmed our findings by immunofluorescence assays. We also did chemotaxis assays to verify whether nucleotides could induce migration. After 1 or 2 hours of incubation, ATP increased migration of eosinophils, as well as ATP gamma S, a less hydrolysable analogue of ATP, while suramin a P2 blocker abolished migration. In keeping with this idea, we tested whether these receptors are implicated in the migration of eosinophils to an inflammation site in vivo, using a model of rat allergic pleurisy. In fact, migration of eosinophils has increased when ATP or ATP gamma S were applied in the pleural cavity, and once more suramin blocked this effect. We have demonstrated that rat eosinophils express P2X and P2Y receptors. In addition, the activation of P2 receptors can increase migration of eosinophils in vitro and in vivo, an effect blocked by suramin.	[Pinto Alberto, Anael Viana; Faria, Robson Xavier; da Rocha, Natasha Cristina; Braga Ferreira, Leonardo Gomes; Alves, Luiz Anastacio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comunicacao Celular, Rio De Janeiro, Brazil; [Martins, Marco Aurelio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Inflamacao, Rio De Janeiro, Brazil; [Lacerda de Menezes, Joao Ricardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Neuroanat Celular, Rio De Janeiro, Brazil; [Surrage, Andrea; Frutuoso, Valber da Silva] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Alves, LA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comunicacao Celular, Rio De Janeiro, Brazil.	alveslaa@ioc.fiocruz.br	Menezes, João R. L./D-5668-2012		Instituto Oswaldo Cruz; CAPES	Instituto Oswaldo Cruz; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Instituto Oswaldo Cruz and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; BRUIJNZEEL PLB, 1994, ANN NY ACAD SCI, V725, P259, DOI 10.1111/j.1749-6632.1994.tb39808.x; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 1995, Pharm Acta Helv, V69, P231, DOI 10.1016/0031-6865(94)00043-U; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Desreumaux P, 1996, CURR OPIN IMMUNOL, V8, P790, DOI 10.1016/S0952-7915(96)80006-9; Dichmann S, 2000, BLOOD, V95, P973, DOI 10.1182/blood.V95.3.973.003k47_973_978; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2001, J CELL PHYSIOL, V188, P329, DOI 10.1002/jcp.1129; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V305, pC1050, DOI 10.1152/ajpcell.00138.2013; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Legrand Fanny, 2008, V415, P215, DOI 10.1007/978-1-59745-570-1_13; MARTINS MA, 1993, J LEUKOCYTE BIOL, V53, P104, DOI 10.1002/jlb.53.1.104; MARTINS MA, 1989, BRAZ J MED BIOL RES, V22, P1151; Mohanty JG, 2001, J ALLERGY CLIN IMMUN, V107, P849, DOI 10.1067/mai.2001.114658; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181; Neves JS, 2010, J ALLERGY CLIN IMMUN, V125, P477, DOI 10.1016/j.jaci.2009.11.029; Padigel UM, 2006, INFECT IMMUN, V74, P3232, DOI 10.1128/IAI.02067-05; Ralevic V, 1998, PHARMACOL REV, V50, P413; Shi HZ, 2004, J LEUKOCYTE BIOL, V76, P520, DOI 10.1189/jlb.0404228; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; WALKER C, 1991, INT ARCH ALLER A IMM, V94, P248, DOI 10.1159/000235373; WEINSTOCK JV, 1988, J IMMUNOL, V141, P961; WELLER PF, 1991, P NATL ACAD SCI USA, V88, P7430, DOI 10.1073/pnas.88.16.7430; Zosky GR, 2008, CLIN EXP ALLERGY, V38, P829, DOI 10.1111/j.1365-2222.2007.02884.x; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	41	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145392	10.1371/journal.pone.0145392	http://dx.doi.org/10.1371/journal.pone.0145392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784445	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400012
J	Hsu, HC; Chang, WM; Wu, JY; Huang, CC; Lu, FJ; Chuang, YW; Chang, PJ; Chen, KH; Hong, CZ; Yeh, RH; Liu, TZ; Chen, CH				Hsu, Hung-Chih; Chang, Wen-Ming; Wu, Jin-Yi; Huang, Chin-Chin; Lu, Fung-Jou; Chuang, Yi-Wen; Chang, Pey-Jium; Chen, Kai-Hua; Hong, Chang-Zern; Yeh, Rang-Hui; Liu, Tsan-Zon; Chen, Ching-Hsein			Folate Deficiency Triggered Apoptosis of Synoviocytes: Role of Overproduction of Reactive Oxygen Species Generated via NADPH Oxidase/Mitochondrial Complex II and Calcium Perturbation	PLOS ONE			English	Article							NF-KAPPA-B; FIBROBLAST-LIKE SYNOVIOCYTES; FOLIC-ACID SUPPLEMENTATION; INCREASED OXIDATIVE STRESS; NEURAL-TUBE DEFECTS; PLASMA HOMOCYSTEINE; PROTEIN-EXTRACT; CELLS; OSTEOARTHRITIS; DISEASE	Despite a plethora of literature has documented that osteoarthritis (OA) is veritably associated with oxidative stress-mediated chondrocyte death and matrix degradation, yet the possible involvement of synoviocyte abnormality as causative factor of OA has not been thoroughly investigated. For this reason, we conduct the current studies to insight into how synoviocytes could respond to an episode of folate-deprived (FD) condition. First, when HIG-82 synoviocytes were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature mediated through FD-evoked overproduction of reactive oxygen species (ROS) and drastically released of cytosolic calcium (Ca2+) concentrations. Next, we uncovered that FD-evoked ROS overproduction could only be strongly suppressed by either mitochondrial complex II inhibitors (TTFA and carboxin) or NADPH oxidase (NOX) inhibitors (AEBSF and apocynin), but not by mitochondrial complex I inhibitor (rotenone) and mitochondrial complex III inhibitor (antimycin A). Interestingly, this selective inhibition of FD-evoked ROS by mitochondrial complex II and NOX inhibitors was found to correlate excellently with the suppression of cytosolic Ca2+ release and reduced the magnitude of the apoptotic TUNEL-positive cells. Taken together, we present the first evidence here that FD-triggered ROS overproduction in synoviocytes is originated from mitochondrial complex II and NOX. Both elevated ROS in tandem with cytosolic Ca2+ overload serve as final arbitrators for apoptotic lethality of synoviocytes cultivated under FD condition. Thus, folate supplementation may be beneficial to patients with OA.	[Hsu, Hung-Chih; Chang, Wen-Ming; Chuang, Yi-Wen; Chen, Kai-Hua; Yeh, Rang-Hui] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsu, Hung-Chih; Chang, Wen-Ming; Chuang, Yi-Wen; Chen, Kai-Hua] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Hsu, Hung-Chih; Chang, Pey-Jium] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Ctr Adv Integrat Sports Med, Chiayi, Taiwan; [Wu, Jin-Yi; Huang, Chin-Chin; Chen, Ching-Hsein] Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi 60004, Taiwan; [Lu, Fung-Jou] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hong, Chang-Zern] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan; [Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University; Chang Gung Memorial Hospital; National Chiayi University; Chung Shan Medical University; Hungkuang University; Taipei Medical University; Taipei Medical University Hospital	Chen, CH (corresponding author), Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi 60004, Taiwan.; Liu, TZ (corresponding author), Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan.	tzliu@tmuh.org.tw; chench@mail.ncyu.edu.tw		Chang, Pey-Jium/0000-0002-6492-0346	Chang Gung Memorial Hospital, R.O.C. [CMRPG6B0471]; National Science Council, Taiwan (National Science Council's) [NSC 102-2320-B-415-005-MY3]	Chang Gung Memorial Hospital, R.O.C.(Chang Gung Memorial Hospital); National Science Council, Taiwan (National Science Council's)	This study was supported by Chang Gung Memorial Hospital, R.O.C. (CMRPG6B0471, W.M.C.) and in part by National Science Council, Taiwan (NSC 102-2320-B-415-005-MY3; National Science Council's, C.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Buckwalter JA, 2013, CARTILAGE, V4, P286, DOI 10.1177/1947603513495889; Chen CH, 2011, FOOD CHEM TOXICOL, V49, P494, DOI 10.1016/j.fct.2010.11.031; Chern CL, 2001, BIOMED PHARMACOTHER, V55, P434, DOI 10.1016/S0753-3322(01)00095-6; Clarke R, 2004, AGE AGEING, V33, P34, DOI 10.1093/ageing/afg109; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Cutolo M, 2001, ANN RHEUM DIS, V60, P729, DOI 10.1136/ard.60.8.729; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Ding XQ, 2015, INT IMMUNOPHARMACOL, V26, P153, DOI 10.1016/j.intimp.2015.03.024; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; GEORGESCU HI, 1988, IN VITRO CELL DEV B, V24, P1015; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; HARRISON RJ, 1971, BRIT J HAEMATOL, V20, P623, DOI 10.1111/j.1365-2141.1971.tb00800.x; Hsieh TJ, 2006, FOOD CHEM TOXICOL, V44, P344, DOI 10.1016/j.fct.2005.08.005; Hsu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077931; Hwang SY, 2011, AM J PHYSIOL-RENAL, V300, pF189, DOI 10.1152/ajprenal.00272.2010; Iwanaga T, 2000, ARCH HISTOL CYTOL, V63, P17, DOI 10.1679/aohc.63.17; Kao TT, 2014, NEUROBIOL DIS, V71, P234, DOI 10.1016/j.nbd.2014.08.004; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lebiedzinska A, 2008, TOXICOL MECH METHOD, V18, P463, DOI 10.1080/15376510701623870; Li D, 2012, AM J MED SCI, V344, P486, DOI 10.1097/MAJ.0b013e3182579dc6; Lindenbaum J., 1995, FOLATE HLTH DIS, P43; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; Lopez HL, 2012, PM&R, V4, pS155, DOI 10.1016/j.pmrj.2012.02.023; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Ong PL, 2008, FOOD CHEM TOXICOL, V46, P1535, DOI 10.1016/j.fct.2007.12.015; Ovey IS, 2015, NEUROSCIENCE, V284, P225, DOI 10.1016/j.neuroscience.2014.09.078; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rogers EJ, 2007, NEW ENGL J MED, V357, P421, DOI 10.1056/NEJMc066569; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Tjiattas L, 2004, AGING CELL, V3, P71, DOI 10.1111/j.1474-9728.2004.00086.x; UELAND PM, 1989, J LAB CLIN MED, V114, P473; Vacek TP, 2013, CLIN CHEM LAB MED, V51, P579, DOI 10.1515/cclm-2012-0605; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Yang CR, 2014, J MOL MED, V92, P1147, DOI 10.1007/s00109-014-1192-8; Yang JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094180; Yeh CH, 2011, PROCESS BIOCHEM, V46, P1599, DOI 10.1016/j.procbio.2011.04.015; Yu DH, 2012, EXP MOL MED, V44, P529, DOI 10.3858/emm.2012.44.9.060; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	46	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146440	10.1371/journal.pone.0146440	http://dx.doi.org/10.1371/journal.pone.0146440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771387	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300019
J	Arbillaga-Etxarri, A; Torrent-Pallicer, J; Gimeno-Santos, E; Barberan-Garcia, A; Delgado, A; Balcells, E; Rodriguez, DA; Vilaro, J; Vall-Casas, P; Irurtia, A; Rodriguez-Roisin, R; Garcia-Aymerich, J				Arbillaga-Etxarri, Ane; Torrent-Pallicer, Jaume; Gimeno-Santos, Elena; Barberan-Garcia, Anael; Delgado, Anna; Balcells, Eva; Rodriguez, Diego A.; Vilaro, Jordi; Vall-Casas, Pere; Irurtia, Alfredo; Rodriguez-Roisin, Robert; Garcia-Aymerich, Judith		Urban Training Study Grp	Validation of Walking Trails for the Urban Training (TM) of Chronic Obstructive Pulmonary Disease Patients	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE CAPACITY; COPD; ENVIRONMENT; PEOPLE; ADULTS; SOCIETY	Purpose Accessible interventions to train patients with chronic obstructive pulmonary disease (COPD) are needed. We designed urban trails of different intensities (low, moderate and high) in different types of public spaces (boulevard, beach and park). We aimed to validate the trails' design by assessing the physiological response to unsupervised walking trails of: (1) different intensities in COPD patients, and (2) same intensity from different public spaces in healthy adults. Methods On different days and under standardized conditions, 10 COPD patients walked the three intensity trails designed in a boulevard space, and 10 healthy subjects walked the three intensity trails in three different spaces. We measured physiological response and energy expenditure using a gas analyzer. We compared outcomes across trails intensity and/or spaces using mixed-effects linear regression. Results In COPD patients, physiological response and energy expenditure increased significantly according to the trails intensity: mean (SD) peak (V) over dotO(2) 15.9 (3.5), 17.4 (4.7), and 17.7 (4.4) mL/min/kg (p-trend = 0.02), and MET-min 60 (23), 64 (26), 72 (31) (p-trend<0.01) in low, moderate and high intensity trails, respectively. In healthy subjects there were no differences in physiological response to walking trails of the same intensity across different spaces. Conclusions We validated the trails design for the training of COPD patients by showing that the physiological response to and energy expenditure on unsupervised walking these trails increased according to the predefined trails' intensity and did not change across trails of the same intensity in different public space. Walkable public spaces allow the design of trails that could be used for the training of COPD patients in the community.	[Arbillaga-Etxarri, Ane; Torrent-Pallicer, Jaume; Gimeno-Santos, Elena; Delgado, Anna; Garcia-Aymerich, Judith] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Arbillaga-Etxarri, Ane; Torrent-Pallicer, Jaume; Gimeno-Santos, Elena; Delgado, Anna; Balcells, Eva; Garcia-Aymerich, Judith] UPF, Barcelona, Spain; [Arbillaga-Etxarri, Ane; Torrent-Pallicer, Jaume; Gimeno-Santos, Elena; Delgado, Anna; Garcia-Aymerich, Judith] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Gimeno-Santos, Elena] Ramon Llull Univ, Res Grp Phys Act & Hlth SAFE, FCS Blanquerna, Barcelona, Spain; [Barberan-Garcia, Anael; Rodriguez-Roisin, Robert] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain; [Barberan-Garcia, Anael; Rodriguez-Roisin, Robert] Univ Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Barberan-Garcia, Anael; Balcells, Eva; Rodriguez, Diego A.; Rodriguez-Roisin, Robert] CIBER Resp Dis CIBERES, Bunyola, Illes Balears, Spain; [Delgado, Anna; Balcells, Eva; Rodriguez, Diego A.] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Balcells, Eva; Rodriguez, Diego A.] Hosp del Mar, Dept Pneumol, Barcelona, Spain; [Vall-Casas, Pere] Univ Int Catalunya, Barcelona, Spain; [Irurtia, Alfredo] Catalan Natl Inst Phys Educ INEFC, Barcelona, Spain	Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat Ramon Llull; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat Internacional de Catalunya (UIC)	Garcia-Aymerich, J (corresponding author), Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.	jgarcia@creal.cat	Martin Cantera, Carlos/D-2693-2011; J, Garcia-Aymerich/G-6867-2014; IRURTIA, ALFREDO/R-3360-2019	Martin Cantera, Carlos/0000-0003-0656-8126; J, Garcia-Aymerich/0000-0002-7097-4586; Arbillaga-Etxarri, Ane/0000-0003-3565-0751; Marin, Alicia/0000-0002-9358-2120; Barberan-Garcia, Anael/0000-0002-0378-4467; Benet Mora, Marta/0000-0001-9600-3510; Rodriguez Chiaradia, Diego A./0000-0002-8566-4011; Irurtia, Alfredo/0000-0002-3463-6643; Simonet, Pere J/0000-0002-4978-1747	Fondo de Investigacion Sanitaria, Ministry of Health, Spain [FIS PI11/01283]; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Society of Pneumology and Thoracic Surgery [SEPAR 147/2011, 201/2011]; Catalan Society of Pneumology (SOCAP Fisioterapia); Agaur, Catalan Government [2014-SGR-661]	Fondo de Investigacion Sanitaria, Ministry of Health, Spain(Spanish GovernmentInstituto de Salud Carlos III); ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Spanish Society of Pneumology and Thoracic Surgery; Catalan Society of Pneumology (SOCAP Fisioterapia); Agaur, Catalan Government(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	The study was funded by grants from Supported by Fondo de Investigacion Sanitaria, Ministry of Health, Spain (FIS PI11/01283), integrated into Plan Estatal I+D+I 2013-2016 and co-funded by ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion and Fondo Europeo de Desarrollo Regional (FEDER); Spanish Society of Pneumology and Thoracic Surgery (SEPAR 147/2011 and 201/2011), and Catalan Society of Pneumology (SOCAP Fisioterapia 2013). Anael Barberan-Garcia had personal funding from Agaur 2014-SGR-661, Catalan Government. There was no involvement of any funding source in study design, in the collection, analysis and interpretation of data, in the writing of the report, nor in the decision to submit the article for publication.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Barberan-Garcia A, 2015, RESPIRATION, V89, P221, DOI 10.1159/000371356; Breyer MK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-112; Castro AAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079727; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Darter BJ, 2013, RES Q EXERCISE SPORT, V84, P223, DOI 10.1080/02701367.2013.784720; Edwards P., 2006, PROMOTING PHYS ACTIV, P9; Gimeno-Santos E, 2014, THORAX, V69, P731, DOI 10.1136/thoraxjnl-2013-204763; Inoue S, 2011, J EPIDEMIOL, V21, P481, DOI 10.2188/jea.JE20110044; Jeng C, 2003, HEART LUNG, V32, P121, DOI 10.1067/mhl.2003.20; Leung RWM, 2010, J PHYSIOTHER, V56, P105, DOI 10.1016/S1836-9553(10)70040-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marrugat J, 1998, MED CLIN-BARCELONA, V111, P267; Moran M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-79; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Pleguezuelos E, 2013, RESP MED, V107, P1948, DOI 10.1016/j.rmed.2013.07.008; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ries Andrew L, 2005, COPD, V2, P105; Roman-Vinas B, 2007, PUBLIC HLTH NUTR, V10; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Starnes HA, 2011, J PHYS ACT HEALTH, V8, P1160, DOI 10.1123/jpah.8.8.1160; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Wootton SL, 2014, EUR RESPIR J, V44, P885, DOI 10.1183/09031936.00078014; World Health Organization, 2009, INT DIET PHYS ACT WH; Zainuldin R, 2015, J CARDIOPULM REHABIL, V35, P65, DOI 10.1097/HCR.0000000000000074	28	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146705	10.1371/journal.pone.0146705	http://dx.doi.org/10.1371/journal.pone.0146705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766184	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300035
J	Modi, P; Glavis-Bloom, J; Nasrin, S; Guy, A; Chowa, EP; Dvor, N; Dworkis, DA; Oh, M; Silvestri, DM; Strasberg, S; Rege, S; Noble, VE; Alam, NH; Levine, AC				Modi, Payal; Glavis-Bloom, Justin; Nasrin, Sabiha; Guy, Allysia; Chowa, Erika P.; Dvor, Nathan; Dworkis, Daniel A.; Oh, Michael; Silvestri, David M.; Strasberg, Stephen; Rege, Soham; Noble, Vicki E.; Alam, Nur H.; Levine, Adam C.			Accuracy of Inferior Vena Cava Ultrasound for Predicting Dehydration in Children with Acute Diarrhea in Resource-Limited Settings	PLOS ONE			English	Article							INTRAVASCULAR VOLUME; GASTROENTERITIS; METAANALYSIS	Introduction Although dehydration from diarrhea is a leading cause of morbidity and mortality in children under five, existing methods of assessing dehydration status in children have limited accuracy. Objective To assess the accuracy of point-of-care ultrasound measurement of the aorta-to-IVC ratio as a predictor of dehydration in children. Methods A prospective cohort study of children under five years with acute diarrhea was conducted in the rehydration unit of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). Ultrasound measurements of aorta-to-IVC ratio and dehydrated weight were obtained on patient arrival. Percent weight change was monitored during rehydration to classify children as having "some dehydration" with weight change 3-9% or "severe dehydration" with weight change > 9%. Logistic regression analysis and Receiver-Operator Characteristic (ROC) curves were used to evaluate the accuracy of aorta-to-IVC ratio as a predictor of dehydration severity. Results 850 children were enrolled, of which 771 were included in the final analysis. Aorta to IVC ratio was a significant predictor of the percent dehydration in children with acute diarrhea, with each 1-point increase in the aorta to IVC ratio predicting a 1.1% increase in the percent dehydration of the child. However, the area under the ROC curve (0.60), sensitivity (67%), and specificity (49%), for predicting severe dehydration were all poor. Conclusions Point-of-care ultrasound of the aorta-to-IVC ratio was statistically associated with volume status, but was not accurate enough to be used as an independent screening tool for dehydration in children under five years presenting with acute diarrhea in a resource-limited setting.	[Modi, Payal; Glavis-Bloom, Justin; Rege, Soham; Levine, Adam C.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Nasrin, Sabiha; Alam, Nur H.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Guy, Allysia; Dvor, Nathan; Oh, Michael; Strasberg, Stephen] Lincoln Med & Mental Hlth Ctr, Dept Emergency Med, Bronx, NY 10451 USA; [Chowa, Erika P.; Dworkis, Daniel A.; Silvestri, David M.; Noble, Vicki E.] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA	Brown University; International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard Medical School	Levine, AC (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA.	adam_levine@brown.edu	; Levine, Adam/F-1813-2016	Glavis-Bloom, Justin/0000-0002-4879-1572; Levine, Adam/0000-0003-3982-3824; Dworkis, Daniel/0000-0003-0706-5117	US National Institutes of Health Fogarty International Center [1K01TW009208-01A1]; University Emergency Medicine Foundation; FOGARTY INTERNATIONAL CENTER [K01TW009208] Funding Source: NIH RePORTER	US National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University Emergency Medicine Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was funded by the US National Institutes of Health Fogarty International Center (grant number 1K01TW009208-01A1) and the University Emergency Medicine Foundation (http://www.uemf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardhan P., 2012, ANN STAT DHAKA HOSP; Blehar DJ, 2014, J CRIT CARE, V29, P486, DOI 10.1016/j.jcrc.2014.03.025; Chen L, 2010, ACAD EMERG MED, V17, P1042, DOI 10.1111/j.1553-2712.2010.00873.x; De Lorenzo RA, 2014, ADV EMERG NURS J, V36, P271, DOI 10.1097/TME.0000000000000025; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Enright K, 2010, EMERG MED J, V27, P731, DOI 10.1136/emj.2008.063271; Fonseca BK, 2004, ARCH PEDIAT ADOL MED, V158, P483, DOI 10.1001/archpedi.158.5.483; Freedman SB, 2015, J PEDIATR-US, V166, P908, DOI 10.1016/j.jpeds.2014.12.029; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; Jauregui J, 2014, CRIT ULTRASOUND J, V6, DOI 10.1186/s13089-014-0015-z; Levine AC, 2010, ACAD EMERG MED, V17, P1035, DOI 10.1111/j.1553-2712.2010.00830.x; Mindel S, 1997, LANCET, V350, P426, DOI 10.1016/S0140-6736(97)03340-0; Ng L, 2013, PEDIATR EMERG CARE, V29, P337, DOI 10.1097/PEC.0b013e31828512a5; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Richter J, 2003, LANCET, V362, P900, DOI 10.1016/S0140-6736(03)14334-6; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220	18	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146859	10.1371/journal.pone.0146859	http://dx.doi.org/10.1371/journal.pone.0146859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766306	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300047
J	Demberg, V; Sayeed, A				Demberg, Vera; Sayeed, Asad			The Frequency of Rapid Pupil Dilations as a Measure of Linguistic Processing Difficulty	PLOS ONE			English	Article							LOCUS-COERULEUS; LOAD; MODULATION; RESPONSES; STATE	While it has long been known that the pupil reacts to cognitive load, pupil size has received little attention in cognitive research because of its long latency and the difficulty of separating effects of cognitive load from the light reflex or effects due to eye movements. A novel measure, the Index of Cognitive Activity (ICA), relates cognitive effort to the frequency of small rapid dilations of the pupil. We report here on a total of seven experiments which test whether the ICA reliably indexes linguistically induced cognitive load: three experiments in reading (a manipulation of grammatical gender match / mismatch, an experiment of semantic fit, and an experiment comparing locally ambiguous subject versus object relative clauses, all in German), three dual-task experiments with simultaneous driving and spoken language comprehension (using the same manipulations as in the single-task reading experiments), and a visual world experiment comparing the processing of causal versus concessive discourse markers. These experiments are the first to investigate the effect and time course of the ICA in language processing. All of our experiments support the idea that the ICA indexes linguistic processing difficulty. The effects of our linguistic manipulations on the ICA are consistent for reading and auditory presentation. Furthermore, our experiments show that the ICA allows for usage within a multi-task paradigm. Its robustness with respect to eye movements means that it is a valid measure of processing difficulty for usage within the visual world paradigm, which will allow researchers to assess both visual attention and processing difficulty at the same time, using an eye-tracker. We argue that the ICA is indicative of activity in the locus caeruleus area of the brain stem, which has recently also been linked to P600 effects observed in psycholinguistic EEG experiments.	[Demberg, Vera; Sayeed, Asad] Univ Saarland, Cluster Excellence MMCI, D-66123 Saarbrucken, Germany	Saarland University	Demberg, V (corresponding author), Univ Saarland, Cluster Excellence MMCI, D-66123 Saarbrucken, Germany.	vera@coli.uni-saarland.de	Demberg, Vera/AAL-3992-2021	Demberg, Vera/0000-0002-8834-0020	German Research Foundation (DFG); Cluster of Excellence Multimodal Computing and Interaction [EXC284]	German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Multimodal Computing and Interaction	This work was supported by German Research Foundation (DFG); both authors were supported by the Cluster of Excellence Multimodal Computing and Interaction EXC284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, HUMAN FACTORS ASSIST; [Anonymous], 2013, LINEAR MIXED EFFECTS; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bader M, 1999, J PSYCHOLINGUIST RES, V28, P121, DOI 10.1023/A:1023206208142; Bartels M., 2012, P S EYE TRACK RES AP, P161, DOI [10.1145/2168556.2168582, DOI 10.1145/2168556.2168582]; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Demberg V., 2013, P ANN M COGN SCI SOC, V35, P2154; Drenhaus H., 2014, P 36 ANN M COGN SCI; Engelhardt PE, 2010, Q J EXP PSYCHOL, V63, P639, DOI 10.1080/17470210903469864; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Frank S., 2012, P 34 ANN C COGN SCI, P1554; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Klingner J, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P69, DOI 10.1145/1344471.1344489; Koehne J., 2013, P 35 ANN M COGN SCI, P2760, DOI DOI 10.1016/J.BRAINRES.2007.05.079; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; LOEWENFELD I. E., 1993, PUPIL ANATOMY PHYSL, VII; Mahr A, 2012, ADJ P 4 INT C AUT US, P88; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Marshall S. P., 2002, New Century, New Trends. Proceedings of the 2002 IEEE 7th Conference on Human Factors and Power Plants (Cat. No.02CH37355), P7, DOI 10.1109/HFPP.2002.1042860; Marshall S. P., 2000, US Patent, Patent No. [US-6090051-A, 6090051, 6,090,051]; Marshall SP, 2007, AVIAT SPACE ENVIR MD, V78, pB165; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sassenhagen J, 2014, BRAIN LANG, V137, P29, DOI 10.1016/j.bandl.2014.07.010; SCHLUROFF M, 1982, BRAIN LANG, V17, P133, DOI 10.1016/0093-934X(82)90010-4; Schroder M., 2003, International Journal of Speech Technology, V6, P365, DOI 10.1023/A:1025708916924; Schwalm M, 2008, PUPILLOMETRIE METHOD; Tromp J, 2016, Q J EXP PSYCHOL, V69, P1093, DOI 10.1080/17470218.2015.1065282; VIVIANI P, 1990, J MOTOR BEHAV, V22, P407; Wood S., 2014, GAMM4 GEN ADDITIVE M; Wood S.N., 2001, R R NEWS, V1, P20; Xiang M, 2014, LANGUAGE COGNITION N; Zellin M, 2011, INT J PSYCHOPHYSIOL, V81, P133, DOI 10.1016/j.ijpsycho.2011.05.009	40	39	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146194	10.1371/journal.pone.0146194	http://dx.doi.org/10.1371/journal.pone.0146194			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6WB	26799065	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300015
J	Ye, XL; Qian, Y; Wang, Q; Yuan, WZ; Mo, XY; Li, YQ; Jiang, ZG; Xu, W; Deng, Y; Wan, YQ; Fan, XW; Wu, XS; Wang, YQ				Ye, Xiangli; Qian, Yu; Wang, Qian; Yuan, Wuzhou; Mo, Xiaoyang; Li, Yongqing; Jiang, Zhigang; Xu, Wei; Deng, Yun; Wan, Yongqi; Fan, Xiongwei; Wu, Xiushan; Wang, Yuequn			SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTOR; GROWTH-FACTOR; TARGET; DIFFERENTIATION; ACTIVATION; PROTEIN; T(8/21); BOP	Previous studies have demonstrated that Smyd1 plays a critical role in cardiomyocyte differentiation, cardiac morphogenesis and myofibril organization. In this study, we uncovered a novel function of Smyd1 in the regulation of endothelial cells (ECs). Our data showed that Smyd1 is expressed in vascular endothelial cells, and knockdown of SMYD1 in endothelial cells impairs EC migration and tube formation. Furthermore, Co-IP and GST pull-down assays demonstrated that SMYD1 is associated with the Serum Response Factor (SRF). EMSA assays further showed that SMYD1 forms a complex with SRF and enhances SRF DNA binding activity. Our studies indicate that SMYD1 serves as an SRF-interacting protein, enhances SRF DNA binding activity, and is required for EC migration and tube formation to regulate angiogenesis.	[Ye, Xiangli; Yuan, Wuzhou; Mo, Xiaoyang; Li, Yongqing; Jiang, Zhigang; Xu, Wei; Deng, Yun; Wan, Yongqi; Fan, Xiongwei; Wu, Xiushan; Wang, Yuequn] Hunan Normal Univ, Coll Life Sci, Key Lab MOE Dev Biol & Prot Chem, Ctr Heart Dev, Changsha 410081, Hunan, Peoples R China; [Ye, Xiangli; Qian, Yu; Wang, Qian] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Ye, Xiangli; Qian, Yu; Wang, Qian] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Ye, Xiangli] Hunan Normal Univ, Coll Med, Changsha 410013, Hunan, Peoples R China	Hunan Normal University; East China Normal University; East China Normal University; Hunan Normal University	Fan, XW; Wu, XS; Wang, YQ (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab MOE Dev Biol & Prot Chem, Ctr Heart Dev, Changsha 410081, Hunan, Peoples R China.	fansha1234@aliyun.com; xiushanwu2003@aliyun.com; yuequnwang@yahoo.com		Xu, Wei/0000-0003-1549-4237	National Natural Science Foundation of China [81270291, 31572349, 31171318, 30930054, 81170229, 31171402, 81170088, 31172044, 31071999, 30970425, 31272396, 81270156, 81370451, 81400304, 31472060, 81470377, 81470449]; Hunan Provincial Natural Science Foundation of China [12JJ3117, 2015JJ3087]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [2013-448-6]; Scientific Research Fund of Hunan Provincial Education Department [14A093]; Construct Program of the Key Discipline of Basic Medicine in Hunan Province; Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University [2012LRB02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Construct Program of the Key Discipline of Basic Medicine in Hunan Province; Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University	This study was supported in part by grants from the National Natural Science Foundation of China (Nos. 81270291, 31572349, 31171318, 30930054, 81170229, 31171402, 81170088, 31172044, 31071999, 30970425, 31272396, 81270156, 81370451, 81400304, 31472060, 81470377, 81470449), Hunan Provincial Natural Science Foundation of China (Nos. 12JJ3117, 2015JJ3087), the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (No. 2013-448-6), the Scientific Research Fund of Hunan Provincial Education Department (No. 14A093), the Construct Program of the Key Discipline of Basic Medicine in Hunan Province, and the Open Research Fund Program of Shanghai Key Laboratory of Regulatory Biology and Institute of Biomedical Sciences of East China Normal University (No. 2012LRB02).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Del Carratore R, 2012, BIOMED PHARMACOTHER, V66, P312, DOI 10.1016/j.biopha.2011.11.004; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Franco CA, 2009, CELL ADHES MIGR, V3, P264, DOI 10.4161/cam.3.3.8291; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Glinskii OV, 2008, CELL CYCLE, V7, P1385, DOI 10.4161/cc.7.10.5819; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088143; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; MOHUN TJ, 1991, EMBO J, V10, P933, DOI 10.1002/j.1460-2075.1991.tb08027.x; Mohun TJ, 1993, MOL CELL BIOL, V13, P6907; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; PHILLIPS GD, 1993, J SUBMICR CYTOL PATH, V25, P149; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860	31	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146468	10.1371/journal.pone.0146468	http://dx.doi.org/10.1371/journal.pone.0146468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799706	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300022
J	Kiat, Y; Izhaki, I				Kiat, Yosef; Izhaki, Ido			Moult Strategies Affect Age Differences in Autumn Migration Timing in East Mediterranean Migratory Passerines	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; WING MOLT; SYLVIIDAE; MIGRANTS; DURATION; RANGE; BIRDS; MASS	Adult passerines renew their flight feathers at least once every year. This complete moult occurs either in the breeding areas, just after breeding (summer moult), or, in some long-distance migratory species, at the non-breeding areas, after arrival to the southern wintering area at the end of autumn migration (winter moult). The aim of this study was to relate moult strategies with the DMD, the difference in median migration date, through Israel, between juveniles and adults. Our data on autumn migration timing in juveniles and adults was based on ringing data of 49,125 individuals belonging to 23 passerine species that breed in Europe and Western Asia and migrate through Israel. We found that DMD was associated with moult timing. In all species that perform a winter moult, adults preceded juveniles during autumn. Among migrants who perform a summer moult, we found evidence of both migration timing patterns: juveniles preceding adults or adults preceding juveniles. In addition, in summer moulters, we found a significant, positive correlation between mean breeding latitude and DMD. Although previous studies described that moult duration and extent can be affected by migration, we suggest that moult strategies affect both migration timing and migration strategy. These two moult strategies (summer or winter moult) also represent two unique migration strategies. Our findings highlight the evolutionary interplay between moult and migration strategies.	[Kiat, Yosef] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Movement Ecol Lab, Edmond J Safra Campus, Jerusalem, Israel; [Izhaki, Ido] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	Hebrew University of Jerusalem; University of Haifa	Kiat, Y (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Movement Ecol Lab, Edmond J Safra Campus, Jerusalem, Israel.	yosefkiat@gmail.com	Izhaki, Ido/I-9712-2019	Izhaki, Ido/0000-0002-4525-4683; Kiat, Yosef/0000-0002-3485-3517				ALERSTAM T, 1982, ORNIS SCAND, V13, P25, DOI 10.2307/3675970; [Anonymous], 2014, R LANG ENV STAT COMP; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; Benson AM, 2001, AUK, V118, P513, DOI 10.1642/0004-8038(2001)118[0513:TOBROA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler LK, 2002, AUK, V119, P1010, DOI 10.1642/0004-8038(2002)119[1010:MMIWTP]2.0.CO;2; Carlisle JD, 2005, AUK, V122, P1070, DOI 10.1642/0004-8038(2005)122[1070:MSAADI]2.0.CO;2; Cramp S., 1994, BIRDS W PALEARCTIC; de la Hera I, 2012, AUK, V129, P222, DOI 10.1525/auk.2012.11212; de la Hera I, 2010, J AVIAN BIOL, V41, P609, DOI 10.1111/j.1600-048X.2010.05075.x; ELLEGREN H, 1991, ORNIS SCAND, V22, P340, DOI 10.2307/3676506; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; FRUMKIN R, 1995, J ORNITHOL, V136, P127, DOI 10.1007/BF01651235; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Hall KSS, 2004, EVOL ECOL, V18, P85, DOI 10.1023/B:EVEC.0000017848.20735.8b; Hall KSS, 2001, IBIS, V143, P580; HOLMGREN N, 1995, EVOL ECOL, V9, P354, DOI 10.1007/BF01237759; Jakubas D, 2010, NATURWISSENSCHAFTEN, V97, P505, DOI 10.1007/s00114-010-0666-y; Jenni L., 2011, MOULT AGEING EUROPEA; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Neto JM, 2008, BIRD STUDY, V55, P78, DOI 10.1080/00063650809461507; Newton I, 2010, MIGRATION ECOLOGY BI; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; Newton Ian, 2009, Ringing & Migration, V24, P220; NIKOLAUS G, 1991, Ringing and Migration, V12, P46; Norman SC, 1997, IBIS, V139, P617, DOI 10.1111/j.1474-919X.1997.tb04684.x; Orme D., 2013, CAPER PACKAGE COMP A; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PRICE T, 1981, IBIS, V123, P131, DOI 10.1111/j.1474-919X.1981.tb00920.x; Rguibi-Idrissi H, 2003, IBIS, V145, P650, DOI 10.1046/j.1474-919X.2003.00208.x; Rohwer Sievert, 2005, P87; Rubolini D, 2015, CURR ZOOL, V61, P959, DOI 10.1093/czoolo/61.6.959; Shirihai H., 2001, SYLVIA WARBLERS IDEN; Shirihai H., 1996, BIRDS ISRAEL; SNOW DW, 1967, GUIDE MOULT BRIT BIR; Svensson E, 1999, BIOL J LINN SOC, V67, P263, DOI 10.1006/bijl.1998.0302; Svensson L., 1992, IDENTIFICATION GUIDE; THOMAS D K, 1977, Ringing and Migration, V1, P125; UNDERHILL LG, 1992, IBIS, V134, P286, DOI 10.1111/j.1474-919X.1992.tb03811.x; Voelker G, 1998, AUK JSTOR, P142; Yom-Tov Y, 1988, ZOOGEOGRAPHY ISRAEL	42	9	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147471	10.1371/journal.pone.0147471	http://dx.doi.org/10.1371/journal.pone.0147471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797292	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300037
J	Ravishankar, S; Ambady, A; Swetha, RG; Anbarasu, A; Ramaiah, S; Sambandamurthy, VK				Ravishankar, Sudha; Ambady, Anisha; Swetha, Rayapadi G.; Anbarasu, Anand; Ramaiah, Sudha; Sambandamurthy, Vasan K.			Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN STRUCTURES; EDITING DOMAIN; YBAK PROTEIN; YADB GENE; I-TASSER; INHIBITORS; TUBERCULOSIS; MYCOTHIOL; TRANSLATION	Discovery of mupirocin, an antibiotic that targets isoleucyl-tRNA synthetase, established aminoacyl-tRNA synthetase as an attractive target for the discovery of novel antibacterial agents. Despite a high degree of similarity between the bacterial and human aminoacyl-tRNA synthetases, the selectivity observed with mupirocin triggered the possibility of targeting other aminoacyl-tRNA synthetases as potential drug targets. These enzymes catalyse the condensation of a specific amino acid to its cognate tRNA in an energy-dependent reaction. Therefore, each organism is expected to encode at least twenty aminoacyl-tRNA synthetases, one for each amino acid. However, a bioinformatics search for genes encoding aminoacyl-tRNA synthetases from Mycobacterium smegmatis returned multiple genes for glutamyl (GluRS), cysteinyl (CysRS), prolyl (ProRS) and lysyl (LysRS) tRNA synthetases. The pathogenic mycobacteria, namely, Mycobacterium tuberculosis and Mycobacterium leprae, were also found to possess two genes each for CysRS and LysRS. A similar search indicated the presence of additional genes for LysRS in gram negative bacteria as well. Herein, we describe sequence and structural analysis of the additional aminoacyl-tRNA synthetase genes found in M. smegmatis. Characterization of conditional expression strains of Cysteinyl and Lysyl-tRNA synthetases generated in M. smegmatis revealed that the canonical aminoacyl-tRNA synthetase are essential, while the additional ones are not essential for the growth of M. smegmatis.	[Ravishankar, Sudha; Ambady, Anisha; Sambandamurthy, Vasan K.] AstraZeneca India Pvt Ltd, Bellary Rd, Bengaluru 560024, Karnataka, India; [Ravishankar, Sudha; Swetha, Rayapadi G.; Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Ambady, Anisha] Gangagen Biotechnol Pvt Ltd, Bengaluru, Karnataka, India; [Sambandamurthy, Vasan K.] Mazumdar Shaw Med Ctr, MSCTR, Bengaluru, Karnataka, India	AstraZeneca; Vellore Institute of Technology	Ravishankar, S (corresponding author), AstraZeneca India Pvt Ltd, Bellary Rd, Bengaluru 560024, Karnataka, India.; Ravishankar, S (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India.	mailsuravi01@gmail.com	Anbarasu, Anand/U-6323-2019; Ramaiah, Sudha/T-3682-2019	, Rayapadi G Swetha/0000-0002-6299-7825	AstraZeneca India Pvt Ltd.	AstraZeneca India Pvt Ltd.	The authors received no specific funding for this work. AstraZeneca India Pvt Ltd. provided support in the form of salaries for authors SR, AA and VKS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bartholow TG, 2014, BIOCHEMISTRY-US, V53, P1059, DOI 10.1021/bi401279r; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Blaise M, 2005, BIOCHIMIE, V87, P847, DOI 10.1016/j.biochi.2005.03.007; Blaise M, 2004, NUCLEIC ACIDS RES, V32, P2768, DOI 10.1093/nar/gkh608; Blaise M, 2008, J MOL BIOL, V381, P1224, DOI 10.1016/j.jmb.2008.06.053; Blanchard SC, 2010, CHEM BIOL, V17, P633, DOI 10.1016/j.chembiol.2010.06.003; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; BRETON R, 1986, J BIOL CHEM, V261, P610; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dubois DY, 2004, P NATL ACAD SCI USA, V101, P7530, DOI 10.1073/pnas.0401634101; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ernst CM, 2015, MBIO, V6, DOI 10.1128/mBio.02340-14; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gurcha SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113568; Hoffmann M, 2009, J MOL MODEL, V15, P665, DOI 10.1007/s00894-008-0421-x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu QH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02475; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maloney E, 2009, 2 DOMAIN LYSX PROTEI, V5; Martinis SA, 2010, FEBS LETT, V584, P455, DOI 10.1016/j.febslet.2009.11.071; Nam SH, 2015, ONCOTARGET, V6, P21655, DOI 10.18632/oncotarget.4130; Ochsner UA, 2007, EXPERT OPIN INV DRUG, V16, P1599; Oka M, 2015, ARCH BIOCHEM BIOPHYS, V579, P33, DOI 10.1016/j.abb.2015.05.014; Oku Y, 2004, MICROBIOL-SGM, V150, P45, DOI 10.1099/mic.0.26706-0; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; PARENTI MA, 1987, CLIN PHARMACY, V6, P761; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Raghunand TR, 2006, INT J ANTIMICROB AG, V28, P36, DOI 10.1016/j.ijantimicag.2006.01.012; Ravishankar S, 2015, TUBERCULOSIS, V95, P589, DOI 10.1016/j.tube.2015.05.004; Ravishankar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134562; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Reddy BKK, 2014, ANTIMICROB AGENTS CH, V58, P3312, DOI 10.1128/AAC.00140-14; Robinson A, 2013, NAT REV MICROBIOL, V11, P303, DOI 10.1038/nrmicro2994; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Salazar JC, 2004, P NATL ACAD SCI USA, V101, P7536, DOI 10.1073/pnas.0401982101; Salowe SP, 2009, J BIOL CHEM, V284, P9656, DOI 10.1074/jbc.M809013200; Sareen D, 2003, J BACTERIOL, V185, P6736, DOI 10.1228/JB.185.22.6736-6740.2003; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Stefanska AL, 2000, J ANTIBIOT, V53, P345, DOI 10.7164/antibiotics.53.345; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Suzuki T, 2010, FEBS LETT, V584, P272, DOI 10.1016/j.febslet.2009.11.085; Tandon M, 2004, BIOORG MED CHEM LETT, V14, P1909, DOI 10.1016/j.bmcl.2004.01.094; Teng M, 2013, J MED CHEM, V56, P1748, DOI 10.1021/jm301756m; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P13326, DOI 10.1021/bi801708f; Tshori S, 2013, AMINOACY TRNA SYNTHE; Wards BJ, 1996, FEMS MICROBIOL LETT, V145, P101, DOI 10.1016/0378-1097(96)00394-1; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Wright M, 2014, BIOORG MED CHEM LETT, V24, P2346, DOI 10.1016/j.bmcl.2014.03.064; Yanagisawa T, NATURE STRU MOL BIOL, V17, P1136; Yu XY, 2004, BIOORG MED CHEM LETT, V14, P1343, DOI 10.1016/j.bmcl.2003.11.082; Yu XY, 2001, BIOORG MED CHEM LETT, V11, P541, DOI 10.1016/S0960-894X(00)00697-1; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YX, 2014, INT J MOL SCI, V15, P1358, DOI 10.3390/ijms15011358	68	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147188	10.1371/journal.pone.0147188	http://dx.doi.org/10.1371/journal.pone.0147188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794499	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300022
J	Sheen, YS; Liao, YH; Lin, MH; Chiu, HC; Jee, SH; Liau, JY; Chang, YL; Chu, CY				Sheen, Yi-Shuan; Liao, Yi-Hua; Lin, Ming-Hsien; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Liau, Jau-Yu; Chang, Yih-Leong; Chu, Chia-Yu			Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; IMP-3 EXPRESSION; MELANOGENESIS; CELLS; HMGA2; IDENTIFICATION; PROGRESSION; QUEENSLAND; MUTATIONS	Insulin-like growth factor-II mRNA-binding protein 3 (IMP-3) is an RNA-binding protein expressed in multiple cancers, including melanomas. However, the expression of IMP-3 has not been investigated in acral lentiginous melanoma (ALM). This study sought to elucidate its prognostic value in ALMs. IMP-3 expression was studied in 93 patients diagnosed with ALM via immunohistochemistry. Univariate and multivariate analyses for survival were performed, according to clinical and histologic parameters, using the Cox proportional hazard model. Survival curves were graphed using the Kaplan-Meier method. IMP-3 was over-expressed in 70 out of 93 tumors (75.3%). IMP-3 expression correlated with thick and high-stage tumor and predicted poorer overall, melanoma-specific, recurrence-free and distant metastasis-free survivals (P = 0.002, 0.006, 0.008 and 0.012, respectively). Further analysis showed that patients with tumor thickness <= 4.0 mm and positive IMP-3 expression had a significantly worse melanoma-specific survival than those without IMP-3 expression (P = 0.048). IMP-3 (hazard ratio 3.67, 95% confidence intervals 1.35-9.97, P = 0.011) was confirmed to be an independent prognostic factor for melanoma-specific survival in multivariate survival analysis. Positive IMP-3 expression was an important prognostic factor for ALMs.	[Sheen, Yi-Shuan; Liao, Yi-Hua; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Chu, Chia-Yu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chiu, Hsien-Ching; Jee, Shiou-Hwa; Chu, Chia-Yu] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Sheen, Yi-Shuan; Liau, Jau-Yu; Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Surg, Hisn Chu, Taiwan; [Liau, Jau-Yu; Chang, Yih-Leong] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chu, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	chiayu@ntu.edu.tw	Sheen, Yi-Shuan/HGA-1172-2022	CHANG, YIH-LEONG/0000-0001-5309-0554; LIAO, YI-HUA/0000-0002-4434-3780; Sheen, Yi-Shuan/0000-0002-8743-7496; CHIU, HSIEN-CHING/0000-0002-1409-8470; JEE, SHIOU-HWA/0000-0001-6737-6297; LIAU, JAU-YU/0000-0002-1336-3850	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-065-MY3]; National Taiwan University Hospital [NTUH 101-N1950, NTUH 102-N2274, NTUH 103-N2597, NTUH 104-M2835]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This project was supported by an unrestricted Grant No. MOST 103-2314-B-002-065-MY3 (CYC) from the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/en/public) and by unrestricted Grants No. NTUH 101-N1950, NTUH 102-N2274, NTUH 103-N2597 and NTUH 104-M2835 (YSS) from the National Taiwan University Hospital (http://www.ntuh.gov.tw/en/default_P.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chang John Wen-Cheng, 2010, Chang Gung Med J, V33, P602; Chen YJ, 1999, J AM ACAD DERMATOL, V41, P945, DOI 10.1016/S0190-9622(99)70251-3; Chi ZH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-85; Chokoeva AA, 2015, J BIOL REG HOMEOS AG, V29, P695; Chraybi M, 2013, HUM PATHOL, V44, P1902, DOI 10.1016/j.humpath.2013.01.025; Egger ME, 2012, AM J SURG, V204, P874, DOI 10.1016/j.amjsurg.2012.05.013; Gao Tian-wen, 2004, Beijing Da Xue Xue Bao Yi Xue Ban, V36, P469; Garbe C, 2000, CANCER-AM CANCER SOC, V89, P1269, DOI 10.1002/1097-0142(20000915)89:6<1269::AID-CNCR11>3.0.CO;2-C; Geller AC, 2013, J CLIN ONCOL, V31, P4172, DOI 10.1200/JCO.2012.47.3728; Jeng YM, 2009, BRIT J SURG, V96, P66, DOI 10.1002/bjs.6438; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Jonson L, 2014, CELL REP, V7, P539, DOI 10.1016/j.celrep.2014.03.015; KREMENTZ ET, 1982, ANN SURG, V195, P632, DOI 10.1097/00000658-198205000-00013; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lin SA, 2013, J INVEST DERMATOL, V133, P579, DOI 10.1038/jid.2012.338; Luk NM, 2004, CLIN EXP DERMATOL, V29, P600, DOI 10.1111/j.1365-2230.2004.01644.x; Mayer JE, 2014, J AM ACAD DERMATOL, V71, DOI [10.1016/j.jaad.2014.05.045, 10.1016/j.jaad.2014.05.046]; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Owen SA, 2001, CANCER-AM CANCER SOC, V91, P983, DOI 10.1002/1097-0142(20010301)91:5<983::AID-CNCR1088>3.0.CO;2-J; Pryor JG, 2008, MODERN PATHOL, V21, P431, DOI 10.1038/modpathol.3801016; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; REINTGEN DS, 1982, JAMA-J AM MED ASSOC, V248, P1856, DOI 10.1001/jama.248.15.1856; Sheen YS, 2015, J INVEST DERMATOL, V135, P1065, DOI 10.1038/jid.2014.480; SLINGLUFF CL, 1990, J SURG ONCOL, V45, P91, DOI 10.1002/jso.2930450207; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Sng J, 2009, J AM ACAD DERMATOL, V61, P426, DOI 10.1016/j.jaad.2009.03.031; Tanaka H, 1999, J Epidemiol, V9, pS129; Wu CE, 2015, J FORMOS MED ASSOC, V114, P415, DOI 10.1016/j.jfma.2013.06.018; Yamazaki N, 2015, MELANOMA RES, V25, P9, DOI 10.1097/CMR.0000000000000091; Youl PH, 2013, BRIT J DERMATOL, V168, P136, DOI 10.1111/j.1365-2133.2012.11064.x; Yu LM, 2010, J CUTAN PATHOL, V37, P316, DOI 10.1111/j.1600-0560.2009.01428.x; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147431	10.1371/journal.pone.0147431	http://dx.doi.org/10.1371/journal.pone.0147431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796627	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300033
J	Saadi, Y; Yanto, ITR; Herawan, T; Balakrishnan, V; Chiroma, H; Risnumawan, A				Saadi, Younes; Yanto, Iwan Tri Riyadi; Herawan, Tutut; Balakrishnan, Vimala; Chiroma, Haruna; Risnumawan, Anhar			Ringed Seal Search for Global Optimization via a Sensitive Search Model	PLOS ONE			English	Article							GENETIC ALGORITHMS; BROWNIAN-MOTION; LEVY; EXPLORATION; EXPLOITATION; METAHEURISTICS; DIVERSITY; PATTERNS; BEHAVIOR; BALANCE	The efficiency of a metaheuristic algorithm for global optimization is based on its ability to search and find the global optimum. However, a good search often requires to be balanced between exploration and exploitation of the search space. In this paper, a new metaheuristic algorithm called Ringed Seal Search (RSS) is introduced. It is inspired by the natural behavior of the seal pup. This algorithm mimics the seal pup movement behavior and its ability to search and choose the best lair to escape predators. The scenario starts once the seal mother gives birth to a new pup in a birthing lair that is constructed for this purpose. The seal pup strategy consists of searching and selecting the best lair by performing a random walk to find a new lair. Affected by the sensitive nature of seals against external noise emitted by predators, the random walk of the seal pup takes two different search states, normal state and urgent state. In the normal state, the pup performs an intensive search between closely adjacent lairs; this movement is modeled via a Brownian walk. In an urgent state, the pup leaves the proximity area and performs an extensive search to find a new lair from sparse targets; this movement is modeled via a Levy walk. The switch between these two states is realized by the random noise emitted by predators. The algorithm keeps switching between normal and urgent states until the global optimum is reached. Tests and validations were performed using fifteen benchmark test functions to compare the performance of RSS with other baseline algorithms. The results show that RSS is more efficient than Genetic Algorithm, Particles Swarm Optimization and Cuckoo Search in terms of convergence rate to the global optimum. The RSS shows an improvement in terms of balance between exploration (extensive) and exploitation (intensive) of the search space. The RSS can efficiently mimic seal pups behavior to find best lair and provide a new algorithm to be used in global optimization problems.	[Saadi, Younes; Herawan, Tutut; Balakrishnan, Vimala; Risnumawan, Anhar] Univ Malaya, Dept Informat Syst, Kuala Lumpur 50603, Malaysia; [Yanto, Iwan Tri Riyadi] Univ Ahmad Dahlan, Dept Comp Sci, Jalan Kapas 9, Yogyakarta 55165, Indonesia; [Chiroma, Haruna] Fed Coll Educ, Dept Comp Sci, Gombe, Nigeria	Universiti Malaya; Universitas Ahmad Dahlan	Saadi, Y (corresponding author), Univ Malaya, Dept Informat Syst, Kuala Lumpur 50603, Malaysia.	younes@siswa.um.edu.my	Balakrishnan, Vimala/F-4037-2011; Risnumawan, Anhar/GQZ-7674-2022; Herawan, Tutut/AAB-6534-2021; Risnumawan, Anhar/GRJ-1061-2022	Balakrishnan, Vimala/0000-0002-6859-4488; Herawan, Tutut/0000-0001-9262-9137; Tri Riyadi Yanto, Iwan/0000-0001-6477-1697	University of Malaya High Impact Research [UM.C/625/HIR/MOHE/SC/13/2]; University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia [UM.C/625/HIR/MOHE/SC/13/2]	University of Malaya High Impact Research; University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia	This work was funded by University of Malaya High Impact Research (Grant number: UM.C/625/HIR/MOHE/SC/13/2). The fund support for this research includes data collection and analysis, decision to publish and preparation of the manuscript.; This work is supported by University of Malaya High Impact Research Grant no vote UM.C/625/HIR/MOHE/SC/13/2 from Ministry of Higher Education Malaysia. We are grateful to Kirsten Durward for the valuable comments on an early draft of the manuscript.	Adra SF, 2011, IEEE T EVOLUT COMPUT, V15, P183, DOI 10.1109/TEVC.2010.2058117; Alba E, 2005, IEEE T EVOLUT COMPUT, V9, P126, DOI 10.1109/TEVC.2005.843751; Alok AK, 1701, SOFT COMPUT, P1; Alok AK, 2015, APPL INTELL, P1; Arani BO, 2013, SWARM EVOL COMPUT, V11, P1, DOI 10.1016/j.swevo.2012.12.004; Araujo L, 2011, IEEE T EVOLUT COMPUT, V15, P456, DOI 10.1109/TEVC.2010.2064322; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Bandyopadhyay S, 2008, IEEE T EVOLUT COMPUT, V12, P269, DOI 10.1109/TEVC.2007.900837; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106373; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Blackwell T., 2007, EVOLUTIONARY COMPUTA, V51, P29, DOI DOI 10.1007/978-3-540-49774-5_2; Blum C, 2003, ACM COMPUT SURV, V35, P268, DOI 10.1145/937503.937505; Blum C, 2011, APPL SOFT COMPUT, V11, P4135, DOI 10.1016/j.asoc.2011.02.032; Bogon Tjorben, 2012, Multiagent System Technologies. Proceedings 10th German Conference, MATES 2012, P30, DOI 10.1007/978-3-642-33690-4_5; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Chelouah R, 2000, EUR J OPER RES, V123, P256, DOI 10.1016/S0377-2217(99)00255-6; Chen G, 2009, IEEE T EVOLUT COMPUT, V13, P661, DOI 10.1109/TEVC.2008.2011742; Chifu VR, 2011, STUD COMPUT INTELL, V382, P93; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Crepinsek M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2480741.2480752; Cuevas E, 2014, APPL INTELL, V40, P256, DOI 10.1007/s10489-013-0458-0; Dees ND, 2009, ROLE STOCHASTIC RESO; Doctor S, 2004, IEEE C EVOL COMPUTAT, P1390, DOI 10.1109/CEC.2004.1331059; Duman E, 2008, INT REV COMPUTERS SO; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fernandes CM, 2013, APPL INTELL, V39, P279, DOI 10.1007/s10489-012-0413-5; Fogel L. J., 1966, ARTIF INTELL; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P89, DOI 10.1016/j.cnsns.2012.06.009; Gandomi AH, 2012, COMPUT MATH APPL, V63, P191, DOI 10.1016/j.camwa.2011.11.010; Gautestad AO, 2012, J R SOC INTERFACE, V9, P2332, DOI 10.1098/rsif.2012.0059; Ghauri SA, 2012, INT CONF INTERNET, P175; GJERTZ I, 1986, Polar Research, V4, P65; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gwak J, 2013, APPL INTELL, V38, P384, DOI 10.1007/s10489-012-0378-4; HAMMILL MO, 1991, MAR MAMMAL SCI, V7, P123, DOI 10.1111/j.1748-7692.1991.tb00559.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Ito H, 2013, J ETHOL, V31, P23, DOI 10.1007/s10164-012-0344-y; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Jong D., 1975, ANAL BEHAV CLASS GEN; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knysh DS, 2010, J COMPUT SYS SC INT+, V49, P579, DOI 10.1134/S1064230710040088; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Koza J.R, 1990, TECHNICAL REPORT STA; Kumar A, 2011, DESIGN OPTIMIZATION, P264; Kunnasranta M, 2001, POLAR BIOL, V24, P171, DOI 10.1007/s003000000192; Le Boeuf BJ, 2000, J EXP BIOL, V203, P3265; Li X., 2013, GENE, V7, P8; Liang J, 2013, 201212 ZHENGZHOU U; Liu SH, 2013, APPL SOFT COMPUT, V13, P3792, DOI 10.1016/j.asoc.2013.05.010; Liu SH, 2009, INT J KNOWL-BASED IN, V13, P185, DOI 10.3233/KES-2009-0184; Liu SH, 2007, APPLIED COMPUTING 2007, VOL 1 AND 2, P738; LYDERSEN C, 1986, Polar Research, V4, P57; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Paenke I, 2009, ADAPT BEHAV, V17, P153, DOI 10.1177/1059712309103566; Pilfold NW, 2014, POPUL ECOL, V56, P129, DOI 10.1007/s10144-013-0396-z; Pilfold NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041429; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Rajabioun R, 2011, APPL SOFT COMPUT, V11, P5508, DOI 10.1016/j.asoc.2011.05.008; Rardin RL, 2001, J HEURISTICS, V7, P261, DOI 10.1023/A:1011319115230; Reynolds AM, 2009, PHYSICA A, V388, P561, DOI 10.1016/j.physa.2008.11.007; Robert UG-A, 2007, ROBERT RINGED SEAL P; Rochat Y., 1995, Journal of Heuristics, V1, P147, DOI 10.1007/BF02430370; Saha S, 2015, USE SEMISUPERVISED C; Sati Dayal C., 2011, International Journal of Applied Engineering Research, V2, P52; Schulte T, 2014, BALANCING EXPLORATIO; Senthilnath J, 2013, CLUSTERING USING LEV, P65; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Singh G, 2015, ROLE PARTICLE SWARM, P255; SRINIVAS M, 1994, COMPUTER, V27, P17, DOI 10.1109/2.294849; Tan KC, 2009, EUR J OPER RES, V197, P701, DOI 10.1016/j.ejor.2008.07.025; Vidal T, 2012, OPER RES, V60, P611, DOI 10.1287/opre.1120.1048; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Williams Michael T., 2006, Aquatic Mammals, V32, P311, DOI 10.1578/AM.32.3.2006.311; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Yanagida T, 2007, BIOSYSTEMS, V88, P228, DOI 10.1016/j.biosystems.2006.08.012; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2014, APPL MATH INFORM SCI, V8, P977, DOI 10.12785/amis/080306; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Yang XS, 2012, ENG COMPUTATION, V29, P464, DOI 10.1108/02644401211235834; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Yang XS, 2010, STUD COMPUT INTELL, V284, P101; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14	92	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144371	10.1371/journal.pone.0144371	http://dx.doi.org/10.1371/journal.pone.0144371			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790131	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000368529100003
J	Cripps, JK; Martin, JK; Coulson, G				Cripps, Jemma K.; Martin, Jennifer K.; Coulson, Graeme			Anthelmintic Treatment Does Not Change Foraging Strategies of Female Eastern Grey Kangaroos, Macropus giganteus	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE; TRADE-OFFS; HELMINTH INFECTIONS; SOCIAL-ORGANIZATION; GRAZING BEHAVIOR; FECAL AVOIDANCE; PARASITE RISK; RED; RUMINANTS; HERBIVORE	Large mammalian herbivores are commonly infected with gastrointestinal helminths. Heavily parasitised hosts are likely to have increased nutritional requirements and would be predicted to increase their food intake to compensate for costs of being parasitised, but experimental tests of the impacts of these parasites on the foraging efficiency of hosts are lacking, particularly in free-ranging wildlife. We conducted a field experiment on a population of free-ranging eastern grey kangaroos (Macropus giganteus) to test this prediction, removing nematodes from one group of adult females using an anthelmintic treatment. We then carried out observations before and following treatment to assess the influence of parasites on foraging behaviour. Contrary to our predictions, the manipulation of parasite burdens did not result in changes in any of the key foraging variables we measured. Our results suggest that despite carrying large burdens of gastrointestinal parasites, the foraging strategy of female kangaroos is likely be driven by factors unrelated to parasitism, and that kangaroos in high nutritional environments may be able acquire sufficient nutrients to offset the costs of parasitism. We conclude that the drivers of forage intake likely differ between domesticated and free-ranging herbivores, and that free-ranging hosts are likely more resilient to parasitism.	[Cripps, Jemma K.; Martin, Jennifer K.; Coulson, Graeme] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Cripps, Jemma K.] Univ Melbourne, Ctr Vet Clin, Fac Vet Sci, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Cripps, JK (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.; Cripps, JK (corresponding author), Univ Melbourne, Ctr Vet Clin, Fac Vet Sci, Werribee, Vic, Australia.	crippsj@unimelb.edu.au	Cripps, Jemma/V-2293-2019		Holsworth Wildlife Research Endowment; University of Melbourne's Animal Ethics Committee [1011709]	Holsworth Wildlife Research Endowment; University of Melbourne's Animal Ethics Committee	This work was supported by the Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx) through a grant to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Holsworth Wildlife Research Endowment. We thank Rachel Kane and staff at Anglesea Golf Club for logistic support, and the many volunteers who assisted with fieldwork. Special thanks to Ian Beveridge, Michelle Wilson and Sarah Garnick for perceptive comments on early drafts of the manuscript. Thanks to Mark Elgar for discussions around experimental design, Christine Andersen for technical assistance and Rachel Sore for statistical advice. This research was carried out with approval from The University of Melbourne's Animal Ethics Committee (project 1011709) and the Department of Sustainability and Environment (research permit 10005557).	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; Arneberg P, 1996, PARASITOLOGY, V112, P213, DOI 10.1017/S003118200008478X; ARUNDEL JH, 1990, AUST WILDLIFE RES, V17, P39; Ayele WY, 2001, VET MED-CZECH, V46, P205, DOI 10.17221/7878-VETMED; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Balic A, 2000, ADV PARASIT, V45, P181, DOI 10.1016/S0065-308X(00)45005-0; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; BEVERIDGE I, 1978, INT J PARASITOL, V8, P379, DOI 10.1016/0020-7519(78)90036-X; BEVERIDGE I, 1979, AUST WILDLIFE RES, V6, P69; Beveridge I, 2001, INT J PARASITOL, V31, P976, DOI 10.1016/S0020-7519(01)00200-4; Blumstein DT, 2000, JWATCHER V 1 0 INTRO; Brambilla A, 2013, ANIM BEHAV, V86, P153, DOI 10.1016/j.anbehav.2013.05.006; Cameron A., 2003, RESO EXCEL V 4 0 FAE; CLARKE J, 1985, J ZOOL, V207, P537; CLARKE JL, 1995, AUST J ZOOL, V43, P519, DOI 10.1071/ZO9950519; CLARKE JL, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P611; Colditz IG, 2008, PARASITE IMMUNOL, V30, P63, DOI 10.1111/j.1365-3024.2007.00964.x; Colditz IG, 1996, INT J PARASITOL, V26, P869, DOI 10.1016/S0020-7519(96)80058-0; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; Cooper J, 2000, APPL ANIM BEHAV SCI, V69, P15, DOI 10.1016/S0168-1591(00)00116-7; Coulson Graeme, 2014, Animals, V4, P272, DOI 10.3390/ani4020272; Coulson G, 2009, WILDLIFE RES, V36, P57, DOI 10.1071/WR08038; Cripps J, 2015, AUST J ZOOL, V63, P163, DOI 10.1071/ZO15003; Cripps J, 2013, J WILDLIFE DIS, V49, P535, DOI 10.7589/2012-06-151; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; Downes B.J., 2002, MONITORING ECOLOGICA; FABIYI JP, 1987, INT J PARASITOL, V17, P435, DOI 10.1016/0020-7519(87)90119-6; Fleurance G, 2007, APPL ANIM BEHAV SCI, V108, P288, DOI 10.1016/j.applanim.2006.11.019; Forbes AB, 2000, VET PARASITOL, V90, P111, DOI 10.1016/S0304-4017(00)00218-1; Fox MT, 1997, VET PARASITOL, V72, P285, DOI 10.1016/S0304-4017(97)00102-7; FREELAND WJ, 1980, ECOLOGY, V61, P1297, DOI 10.2307/1939037; Garnick SW, 2010, BEHAV ECOL, V21, P129, DOI 10.1093/beheco/arp162; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; Gooderham K, 2011, BEHAV ECOL, V22, P1195, DOI 10.1093/beheco/arr112; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; Gunn A, 2003, WILDLIFE SOC B, V31, P117; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Hughes, 1993, DIET SELECTION INTER; Hutchings MR, 1999, J ANIM ECOL, V68, P310, DOI 10.1046/j.1365-2656.1999.00287.x; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Hutchings MR, 2002, OECOLOGIA, V132, P453, DOI 10.1007/s00442-002-0971-z; Inwood D, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P1; Irvine RJ, 2006, PARASITOLOGY, V133, P465, DOI 10.1017/S0031182006000606; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JARMAN PJ, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P527; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P133; JOHNSTON JT, 1984, NEW ZEAL VET J, V32, P177, DOI 10.1080/00480169.1984.35114; Jones OR, 2006, CAN J ZOOL, V84, P685, DOI 10.1139/Z06-045; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; King W. J., 2011, Australian Mammalogy, V33, P47, DOI 10.1071/AM10029; Kirmani SN, 2010, OECOLOGIA, V164, P349, DOI 10.1007/s00442-010-1717-y; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu SM, 2003, AUST J EXP AGR, V43, P1409, DOI 10.1071/EA03017; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loyacano AF, 2002, VET PARASITOL, V107, P227, DOI 10.1016/S0304-4017(02)00130-9; LOZANO GA, 1991, OIKOS, V60, P391, DOI 10.2307/3545084; Maguire G, 2006, J ZOOL, V268, P261, DOI 10.1111/j.1469-7998.2005.00026.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mercer JG, 2000, PARASITOLOGY, V120, P641, DOI 10.1017/S0031182099005922; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Moe SR, 2010, RANGIFER, V19, P55; Mulder RA, 2010, WILDLIFE RES, V37, P440, DOI 10.1071/WR10007; Newey S, 2004, P ROY SOC B-BIOL SCI, V271, pS413, DOI 10.1098/rsbl.2004.0202; O'Connor LJ, 2006, VET PARASITOL, V142, P1, DOI 10.1016/j.vetpar.2006.08.035; OKELLY JC, 1988, ANIM REPROD SCI, V16, P177, DOI 10.1016/0378-4320(88)90011-5; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; POOLE WE, 1982, AUST WILDLIFE RES, V9, P9; POPPI DP, 1990, PROC NEW ZEAL SOC AN, V50, P237; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Ruckstuhl KE, 2003, BEHAV ECOL SOCIOBIOL, V54, P167, DOI 10.1007/s00265-003-0615-2; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smith LA, 2006, BEHAV ECOL, V17, P591, DOI 10.1093/beheco/ark004; SOUTHWELL C, 1987, MAMMALIA, V51, P211, DOI 10.1515/mamm.1987.51.2.211; Sykes A. R., 1987, The nutrition of herbivores., P211; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; van der Wal R, 2000, OECOLOGIA, V124, P19, DOI 10.1007/s004420050020; vanHoutert MFJ, 1996, INT J PARASITOL, V26, P1151, DOI 10.1016/S0020-7519(96)00120-8; WATSON DM, 1993, WILDLIFE RES, V20, P785, DOI 10.1071/WR9930785; Watson Maggie J., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P190, DOI 10.1016/j.ijppaw.2013.05.001; Wilson ME, 2013, WILDLIFE RES, V40, P403, DOI 10.1071/WR13050; WOOD IB, 1995, VET PARASITOL, V58, P181, DOI 10.1016/0304-4017(95)00806-2; Worsley-Tonks KEL, 2015, ANIM BEHAV, V108, P47, DOI 10.1016/j.anbehav.2015.07.018	90	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147384	10.1371/journal.pone.0147384	http://dx.doi.org/10.1371/journal.pone.0147384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784582	Green Published, gold			2022-12-27	WOS:000368528400145
J	Das, R; Khalil, S; Mirdha, BR; Makharia, GK; Dattagupta, S; Chaudhry, R				Das, Rojaleen; Khalil, Shehla; Mirdha, B. R.; Makharia, Govind K.; Dattagupta, Siddharta; Chaudhry, Rama			Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PREVALENCE; HOMINIS; HOSTS; INFECTION; DIAGNOSIS; ANIMALS; HUMANS	Blastocystis species has been extensively studied in recent few years to establish its pathogenecity. Present study was designed to identify and examine the association of Blastocystis sp. and its subtypes with Irritable Bowel Syndrome (IBS). Blastocystis sp. detected using wet-mount microscopy, trichrome staining, in-vitro culture and Polymerase Chain Reaction (PCR) assay in a cohort of IBS patients (n = 150) and healthy controls (n = 100). Isolates of Blastocystis sp. were subtyped using Sequence Tagged Site and representative samples were sequenced at SSUrRNA locus. A total of sixty five isolates of Blastocystis sp. were identified [IBS (n = 50); Controls (n = 15)] of which 91% belonged to ST3 and 9% belonged to ST1. No other subtypes could be identified. Statistically significant association was observed between Blastocystis sp. and IBS patients; however no particular subtype could be ascertained to any particular clinical type of IBS. The frequency of occurrence of Blastocystis sp. was more in IBS patients as compared to the controls and ST3 being the most prevalent subtype. The genetic polymorphism of SSU-rRNA gene amongst the different Blastocystis sp. isolates found in this study reinforces the fact that these organisms are genetically highly divergent.	[Das, Rojaleen; Khalil, Shehla; Mirdha, B. R.; Chaudhry, Rama] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Makharia, Govind K.] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Dattagupta, Siddharta] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mirdha, BR (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	mirdhabr2078@gmail.com			All India Institute of Medical sciences	All India Institute of Medical sciences	The work was supported by All India Institute of Medical sciences as a part of MD thesis of Dr. Rojaleen Das.	Abe N, 2004, VET PARASITOL, V120, P235, DOI 10.1016/j.vetpar.2004.01.003; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Arisue N, 2003, PARASITOLOGY, V126, P1, DOI 10.1017/S0031182002002640; Armentia A, 1993, Allergol Immunopathol (Madr), V21, P149; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; CASEMORE DP, 1985, J CLIN PATHOL, V38, P1337, DOI 10.1136/jcp.38.12.1337; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Dogruman-Al F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015484; Dogruman-Al F, 2009, MEM I OSWALDO CRUZ, V104, P724, DOI 10.1590/S0074-02762009000500011; Drossman DA, 2006, AM J GASTROENTEROL, V101, P1172, DOI 10.1111/j.1572-0241.2006.00592.x; El Safadi D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-164; Ramirez-Miranda ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-96; Ghoshal Uday C, 2008, Indian J Gastroenterol, V27, P22; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Gupta R, 2006, AUSTRALAS J DERMATOL, V47, P117, DOI 10.1111/j.1440-0960.2006.00244.x; Makharia GK, 2011, J NEUROGASTROENTEROL, V17, P82, DOI 10.5056/jnm.2011.17.1.82; Noel C, 2003, MOL BIOCHEM PARASIT, V126, P119, DOI 10.1016/S0166-6851(02)00246-3; Nourrisson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111868; Pandey PK, 2015, INFECT GENET EVOL, V31, P296, DOI 10.1016/j.meegid.2015.02.012; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Stensvold Christen Rune, 2013, Trop Parasitol, V3, P26, DOI 10.4103/2229-5070.113896; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Surangsrirat Surapon, 2010, J Med Assoc Thai, V93 Suppl 6, pS119; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; WHEATLEY WB, 1951, AM J CLIN PATHOL, V21, P990, DOI 10.1093/ajcp/21.10_ts.990; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yoshikawa H, 2003, J PARASITOL, V89, P585, DOI 10.1645/0022-3395(2003)089[0585:MCSABI]2.0.CO;2; Yoshikawa H, 2011, PARASITOL RES, V109, P1045, DOI 10.1007/s00436-011-2342-3	30	18	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147055	10.1371/journal.pone.0147055	http://dx.doi.org/10.1371/journal.pone.0147055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784888	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400102
J	Glaser, L; Carstensen, M; Shaw, S; Robbe-Austerman, S; Wunschmann, A; Grear, D; Stuber, T; Thomsen, B				Glaser, Linda; Carstensen, Michelle; Shaw, Sheryl; Robbe-Austerman, Suelee; Wunschmann, Arno; Grear, Dan; Stuber, Tod; Thomsen, Bruce			Descriptive Epidemiology and Whole Genome Sequencing Analysis for an Outbreak of Bovine Tuberculosis in Beef Cattle and White-Tailed Deer in Northwestern Minnesota	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; DIAGNOSIS	Bovine tuberculosis (bTB) was discovered in a Minnesota cow through routine slaughter surveillance in 2005 and the resulting epidemiological investigation led to the discovery of infection in both cattle and white-tailed deer in the state. From 2005 through 2009, a total of 12 beef cattle herds and 27 free-ranging white-tailed deer (Odocoileus virginianus) were found infected in a small geographic region of northwestern Minnesota. Genotyping of isolates determined both cattle and deer shared the same strain of bTB, and it was similar to types found in cattle in the southwestern United States and Mexico. Whole genomic sequencing confirmed the introduction of this infection into Minnesota was recent, with little genetic divergence. Aggressive surveillance and management efforts in both cattle and deer continued from 2010-2012; no additional infections were discovered. Over 10,000 deer were tested and 705 whole herd cattle tests performed in the investigation of this outbreak.	[Glaser, Linda] Minnesota Board Anim Hlth, St Paul, MN USA; [Carstensen, Michelle] Minnesota Dept Nat Resources, Wildlife Hlth Program, Forest Lake, MN USA; [Shaw, Sheryl] Anim & Plant Hlth Inspect Serv, Vet Serv, USDA, Madison, WI USA; [Robbe-Austerman, Suelee; Stuber, Tod; Thomsen, Bruce] Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Vet Serv, USDA, Ames, IA USA; [Wunschmann, Arno] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Grear, Dan] Anim & Plant Hlth Inspect Serv, Ctr Epidemiol, Vet Serv, USDA, Ft Collins, CO USA; [Grear, Dan] Anim & Plant Hlth Inspect Serv, Ctr Anim Hlth, Vet Serv, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Glaser, L (corresponding author), Minnesota Board Anim Hlth, St Paul, MN USA.	Linda.Glaser@state.mn.us		Grear, Daniel/0000-0002-5478-1549	Minnesota State Legislature; Department of Natural Resources (DNR); state funds, the U.S. Department of Agriculture; U.S Dept. of Agriculture; state funding through the University of Minnesota; Commodity Credit Corporation; federal government funding	Minnesota State Legislature; Department of Natural Resources (DNR); state funds, the U.S. Department of Agriculture; U.S Dept. of Agriculture(United States Department of Agriculture (USDA)); state funding through the University of Minnesota; Commodity Credit Corporation; federal government funding	This data was collected during the control and eradication effort by state and federal animal health regulatory authorities. State funding sources used during this control program included general fund dollars and additional disease control funds appropriated by the Minnesota State Legislature to the Board of Animal Health (BAH) and Department of Natural Resources (DNR). In addition to state funds, the U.S. Department of Agriculture provided funding to these two agencies (BAH, DNR) to assist in the increased program activities for this control effort. The U.S Dept. of Agriculture funding sources included funding appropriated through Congress as well as from the Commodity Credit Corporation. The additional funds provided indemnity for infected herds, contracting accredited veterinarians for live animal cattle testing, and paying federal animal health staff for temporary duty assignments to work in Minnesota on the control effort. Funding for laboratory work performed at the Minnesota Veterinary Diagnostic Laboratory was provided by state funding through the University of Minnesota. Funding for the laboratory at the National Veterinary Services Laboratory is provided by federal government funding to the US Dept. Agriculture, Animal Plant Health Inspection Service, Veterinary Services. The US Dept. Agriculture along with all state animal health agencies cooperatively developed the guidelines and requirements for the bovine tuberculosis eradication program. These requirements and guidelines were used for this disease eradication effort in Minnesota and guided the live animal testing, cattle movement data collection, and wildlife surveillance requirements. The data reported in this article was generated during this eradication effort.	[Anonymous], 2014, TRACER V1 6; [Anonymous], 2005, 9145011 USDA APHIS; [Anonymous], 2008, ASS RISK ASS MINN PR; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Driscoll JR, 2009, METHODS MOL BIOL, V551, P117, DOI 10.1007/978-1-60327-999-4_10; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Martinez LR, 2008, J VET DIAGN INVEST, V20, P707, DOI 10.1177/104063870802000601; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304; Norby B, 2004, J VET DIAGN INVEST, V16, P126, DOI 10.1177/104063870401600206; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Rambaut A., 2014, FIGTREE V1 4 2 TREE; Robbe-Austerman S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-74; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thacker TC, 2015, VET MICROBIOL, V180, P75, DOI 10.1016/j.vetmic.2015.07.006	22	29	30	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145735	10.1371/journal.pone.0145735	http://dx.doi.org/10.1371/journal.pone.0145735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785113	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400018
J	Hajek, A; Konig, HH				Hajek, Andre; Koenig, Hans-Helmut			Longitudinal Predictors of Functional Impairment in Older Adults in Europe - Evidence from the Survey of Health, Ageing and Retirement in Europe	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; INSTRUMENTAL ACTIVITIES; ALCOHOL-CONSUMPTION; RISK-FACTORS; DISABILITY; DECLINE; PEOPLE; ADL; TRANSITIONS	Objective To examine time-dependent predictors of functional impairment in older adults in Europe longitudinally. Methods Data were derived from the Survey of Health Ageing, and Retirement in Europe (20042013). Functional impairment was assessed by using activities of daily living (ADL) and instrumental activities of daily living (IADL) indices. Fixed effects regressions were used to estimate the effects of sociodemographic factors (age, marital status, living situation, and income deciles (median split)), lifestyle factors (smoking status and alcohol consumption per week), depression, cognitive function and chronic diseases on the outcome variables. Results Longitudinal regressions revealed that functional impairment increased significantly with age, the occurrence of depression, cognitive impairment, the number of chronic conditions, and less than daily alcohol consumption in the total sample and in both sexes. Moreover, the onset of smoking and living without a spouse/partner in household increased functional impairment in the total sample. The effect of depression on functional impairment was significantly more pronounced in men. Conclusion Our findings highlight the relevance of changes in age, depression, cognitive function, smoking and chronic diseases for functional impairment. Since particularly depression and smoking may be avoidable, developing strategies to prevent depression or stop smoking might be useful approaches to postpone functional impairment in older adults.	[Hajek, Andre; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de	König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745	European Commission [QLK6-CT-2001-00360, RII-CT-2006-062193, CIT5- CT-2005-028857, CIT4-CT-2006-028812, 211909, 227822, 261982]; U.S. National Institute on Aging [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, OGHA 04-064]; German Ministry of Education and Research; NATIONAL INSTITUTE ON AGING [P30AG012815, U01AG009740, R21AG025169, P01AG008291, P01AG005842] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982). Additional funding from the US National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064) and the German Ministry of Education and Research, as well as from various national sources, is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper uses data from SHARE Wave 5 release 1.0.0, as of March 31st 2015 (DOI: 10.6103/SHARE.w5.100) or SHARE Wave 4 release 1.1.1, as of March 28th 2013 (DOI: 10.6103/SHARE.w4.111) or SHARE Waves 1 and 2 release 2.6.0, as of November 29th 2013 (DOI:10.6103/SHARE. w1.260 and 10.6103/SHARE.w2.260) or SHARELIFE release 1.0.0, as of November 24th 2010 (DOI: 10.6103/SHARE.w3.100). The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982). Additional funding from the U.S. National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064) and the German Ministry of Education and Research as well as from various national sources is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Borsch-Supan A., 2008, STARTING LONGITUDINA; BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28; Burdick DJ, 2005, J GERONTOL A-BIOL, V60, P258, DOI 10.1093/gerona/60.2.258; Cameron A.C., 2009, MICROECONOMETRICS US; Cameron C., 2005, MICROECONOMETRICS US, P1056; Castro-Costa E, 2007, BRIT J PSYCHIAT, V191, P393, DOI 10.1192/bjp.bp.107.036772; Chan KS, 2012, J GERONTOL B-PSYCHOL, V67, P121, DOI 10.1093/geronb/gbr133; Chen CM, 2012, J GERONTOL A-BIOL, V67, P1059, DOI 10.1093/gerona/gls074; Chiu HC, 2005, INT J GERIATR PSYCH, V20, P635, DOI 10.1002/gps.1292; Dunlop DD, 2005, ARTHRITIS RHEUM-US, V52, P1274, DOI 10.1002/art.20968; Friedman B, 2005, J AM GERIATR SOC, V53, P1570, DOI 10.1111/j.1532-5415.2005.53461.x; Fujiwara Y, 2008, GERONTOLOGY, V54, P373, DOI 10.1159/000151221; Geerlings SW, 2001, PSYCHOL MED, V31, P1361, DOI 10.1017/S0033291701004639; Gill TM, 1997, J AM GERIATR SOC, V45, P441, DOI 10.1111/j.1532-5415.1997.tb05168.x; Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74; Greene W.H., 2012, ECONOMETRIC ANAL; Hajek A, 2016, J NUTR HEALTH AGING, V20, P952, DOI 10.1007/s12603-015-0634-5; Hajek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144203; Hajek A, 2015, QUAL LIFE RES, V24, P2713, DOI 10.1007/s11136-015-1005-8; Hendrie HC, 1996, J AM GERIATR SOC, V44, P1158, DOI 10.1111/j.1532-5415.1996.tb01364.x; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Iwasa H, 2009, INT J GERIATR PSYCH, V24, P1192, DOI 10.1002/gps.2245; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LIU X, 1995, J GERONTOL B-PSYCHOL, V50, pS383, DOI 10.1093/geronb/50B.6.S383; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; McGuire LC, 2006, AM J GERIAT PSYCHIAT, V14, P36, DOI 10.1097/01.JGP.0000192502.10692.d6; Moore AA, 2003, J AM GERIATR SOC, V51, P44, DOI 10.1034/j.1601-5215.2002.51008.x; Palgi Y, 2015, QUAL LIFE RES, V24, P1835, DOI 10.1007/s11136-015-0918-6; Penninx BWJH, 1999, AM J PUBLIC HEALTH, V89, P1346, DOI 10.2105/AJPH.89.9.1346; Perreira KM, 2002, ADDICTION, V97, P301, DOI 10.1046/j.1360-0443.2002.00067.x; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Rodgers W, 1997, J GERONTOL B-PSYCHOL, V52, P21, DOI 10.1093/geronb/52B.Special_Issue.21; Lopez SR, 2014, GERIATR GERONTOL INT, V14, P403, DOI 10.1111/ggi.12115; Shinkai S., 2003, GERIATR GERONTOL INT, V3, pS31, DOI [10.1111/j.1444-0594.2003.00094.x, DOI 10.1111/J.1444-0594.2003.00094.X]; Solon G, 2015, J HUM RESOUR, V50, P301, DOI 10.3368/jhr.50.2.301; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Stuck S, 2013, REL GUID 1 1 1 SHARE; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; Wallace RB, 1995, J HUM RESOUR, V30, pS84, DOI 10.2307/146279; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Xue QL, 2008, AM J EPIDEMIOL, V167, P240, DOI 10.1093/aje/kwm270; Yang Y, 2005, J AGING HEALTH, V17, P263, DOI 10.1177/0898264305276295	50	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146967	10.1371/journal.pone.0146967	http://dx.doi.org/10.1371/journal.pone.0146967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784698	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400090
J	Jia, LF; Song, Q; Zhou, CY; Li, XM; Pi, LH; Ma, XR; Li, H; Lu, XY; Shen, YP				Jia, Lifeng; Song, Qi; Zhou, Chenyang; Li, Xiaoming; Pi, Lihong; Ma, Xiuru; Li, Hui; Lu, Xiuying; Shen, Yupeng			Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling	PLOS ONE			English	Article							CANCER-CELLS; TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; CONSTITUTIVE ACTIVATION; ANTITUMOR-ACTIVITY; IN-VITRO; PATHWAY; TRANSDUCER; TRANSCRIPTION-3; APOPTOSIS	Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study, we investigated the potential of dihydroartemisinin (DHA) as a putative STAT3 inhibitor and its antitumor activities in head and neck squamous cell carcinoma (HNSCC). The inhibitory effects of DHA on STAT3 activation along with its underlying mechanisms were studied in HNSCC cells. The antitumor effects of DHA against HNSCC cells were explored both in vitro and in vivo. An investigation on cooperative effects of DHA with cisplatin in killing HNSCC cells was also implemented. DHA exhibited remarkable and specific inhibitory effects on STAT3 activation via selectively blocking Jak2/STAT3 signaling. Besides, DHA significantly inhibited HNSCC growth both in vitro and in vivo possibly through induction of apoptosis and attenuation of cell migration. DHA also synergized with cisplatin in tumor inhibition in HNSCC cells. Our findings demonstrate that DHA is a putative STAT3 inhibitor that may represent a new and effective drug for cancer treatment and therapeutic sensitization in HNSCC patients.	[Jia, Lifeng; Zhou, Chenyang; Lu, Xiuying; Shen, Yupeng] Third Med Mil Univ, Postgrad Sch, Chongqing 400038, Peoples R China; [Jia, Lifeng; Song, Qi; Zhou, Chenyang; Li, Xiaoming] Bethune Int Peace Hosp, Dept Otolaryngol Head & Neck Surg, Shijiazhuang 050081, Hebei Province, Peoples R China; [Song, Qi] Med Coll PLA, Postgrad Sch, Beijing 100700, Peoples R China; [Pi, Lihong] Hebei Gen Hosp, Dept Otolaryngol, Shijiazhuang 050051, Hebei Province, Peoples R China; [Ma, Xiuru] Hebei Coll Tradit Chinese Med, Dept Basic Sci, Shijiazhuang 050061, Hebei Province, Peoples R China; [Li, Hui] Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang 050081, Hebei Province, Peoples R China	Army Medical University	Li, XM (corresponding author), Bethune Int Peace Hosp, Dept Otolaryngol Head & Neck Surg, Shijiazhuang 050081, Hebei Province, Peoples R China.	xmlmo@126.com			Key Projects for Applied Basic Research of Hebei Province, China [14967721D]	Key Projects for Applied Basic Research of Hebei Province, China	This work was supported by Key Projects for Applied Basic Research of Hebei Province, China, Grant No. 14967721D to XML.; This work was supported by Key Projects for Applied Basic Research of Hebei Province, China, Grant No. 14967721D to X Li.	Adachi M, 2012, ORAL ONCOL, V48, P1220, DOI 10.1016/j.oraloncology.2012.06.006; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cognetti DM, 2008, CANCER-AM CANCER SOC, V113, P1911, DOI 10.1002/cncr.23654; Flobinus A, 2014, J ANTIMICROB CHEMOTH, V69, P34, DOI 10.1093/jac/dkt346; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Gu F, 2010, ONCOL REP, V23, P671, DOI 10.3892/or_00000683; Handrick R, 2010, MOL CANCER THER, V9, P2497, DOI 10.1158/1535-7163.MCT-10-0051; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li CY, 2009, MOL CANCER THER, V8, P2211, DOI 10.1158/1535-7163.MCT-09-0327; Li T, 2012, INT IMMUNOPHARMACOL, V12, P144, DOI 10.1016/j.intimp.2011.11.004; Li XM, 2010, EXP THER MED, V1, P947, DOI 10.3892/etm.2010.156; Liu JW, 2012, PLANTA MED, V78, P1568, DOI 10.1055/s-0032-1315121; Lu JJ, 2011, INVEST NEW DRUG, V29, P1276, DOI 10.1007/s10637-010-9481-8; Lu JJ, 2010, BIOCHEM PHARMACOL, V80, P22, DOI 10.1016/j.bcp.2010.02.016; Masuda M, 2002, CANCER RES, V62, P3351; Nam S, 2012, MOL ONCOL, V6, P484, DOI 10.1016/j.molonc.2012.05.002; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Onimoe GI, 2012, INVEST NEW DRUG, V30, P916, DOI 10.1007/s10637-011-9645-1; Pi LH, 2014, ONCOL LETT, V7, P685, DOI 10.3892/ol.2013.1753; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Song X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-114; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wong AL, 2015, ANN ONCOL, V26, P998, DOI 10.1093/annonc/mdv026; Wu C, 2013, MOLECULES, V18, P6866, DOI 10.3390/molecules18066866; Yokogami K, 2013, BRAIN TUMOR PATHOL, V30, P135, DOI 10.1007/s10014-012-0122-0; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002; Zhang XL, 2013, CANCER RES, V73, P1922, DOI 10.1158/0008-5472.CAN-12-3175; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	43	39	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147157	10.1371/journal.pone.0147157	http://dx.doi.org/10.1371/journal.pone.0147157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784960	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400115
J	Jin, X; Li, SS; Bondy, B; Zhong, WW; Oginsky, MF; Wu, Y; Johnson, CM; Zhang, S; Cui, NR; Jiang, C				Jin, Xin; Li, Shanshan; Bondy, Brian; Zhong, Weiwei; Oginsky, Max F.; Wu, Yang; Johnson, Christopher M.; Zhang, Shuang; Cui, Ningren; Jiang, Chun			Identification of a Group of GABAergic Neurons in the Dorsomedial Area of the Locus Coeruleus	PLOS ONE			English	Article							NORADRENERGIC NEURONS; MECP2-NULL MICE; CERULEUS; CORTEX; GABA; MODULATION; NUCLEUS; SYSTEM; SLEEP	The locus coeruleus (LC)-norepinephrine (NE) system in the brainstem plays a critical role in a variety of behaviors is an important target of pharmacological intervention to several neurological disorders. Although GABA is the major inhibitory neurotransmitter of LC neurons, the modulation of LC neuronal firing activity by local GABAergic interneurons remains poorly understood with respect to their precise location, intrinsic membrane properties and synaptic modulation. Here, we took an optogenetic approach to address these questions. Channelrhodopsin (ChR2) in a tandem with the yellow fluorescent protein (YFP) was expressed in GABAergic neurons under the control of glutamic acid decarboxylase 2 (GAD2) promoter. Immediately dorsomedial to the LC nucleus, a group of GABAergic neurons was observed. They had small soma and were densely packed in a small area, which we named the dorsomedial LC or dmLC nucleus. These GABAergic neurons showed fast firing activity, strong inward rectification and spike frequency adaptation. Lateral inhibition among these GABAergic neurons was observed. Optostimulation of the dmLC area drastically inhibited LC neuronal firing frequency, expanded the spike intervals, and reset their pacemaking activity. Analysis of the light evoked inhibitory postsynaptic currents (IPSCs) indicated that they were monosynaptic. Such light evoked IPSCs were not seen in slices where this group of GABAergic neurons was absent. Thus, an isolated group of GABAergic neurons is demonstrated in the LC area, whose location, somatic morphology and intrinsic membrane properties are clearly distinguishable from adjacent LC neurons. They interact with each and may inhibit LC neurons as well as a part of local neuronal circuitry in the LC.	[Jin, Xin; Li, Shanshan; Bondy, Brian; Zhong, Weiwei; Oginsky, Max F.; Wu, Yang; Johnson, Christopher M.; Zhang, Shuang; Cui, Ningren; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Jin, Xin] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Li, Shanshan] Harbin Med Univ, Sch Pharm, Harbin, Heilongjiang, Peoples R China	University System of Georgia; Georgia State University; Yale University; Harbin Medical University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA USA.	cjiang@gsu.edu			NIH [NS073875]; International Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (NS073875) and the International Rett Syndrome Research Foundation.	Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Blanco L, 2013, NEUROSCIENCE, V247, P351, DOI 10.1016/j.neuroscience.2013.05.047; Cui NR, 2011, J NEUROPHYSIOL, V105, P2791, DOI 10.1152/jn.00759.2010; Dimitrov EL, 2013, J COMP NEUROL, V521, P2373, DOI 10.1002/cne.23291; ENNIS M, 1989, J NEUROSCI, V9, P2973; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Howells FM, 2012, METAB BRAIN DIS, V27, P267, DOI 10.1007/s11011-012-9287-9; Jin X, 2013, AM J PHYSIOL-CELL PH, V305, pC1151, DOI 10.1152/ajpcell.00195.2013; Jin X, 2013, AM J PHYSIOL-CELL PH, V304, pC844, DOI 10.1152/ajpcell.00399.2012; Kaur S, 1997, NEUROSCI LETT, V223, P105, DOI 10.1016/S0304-3940(97)13410-3; KISVARDAY ZF, 1993, J COMP NEUROL, V327, P398, DOI 10.1002/cne.903270307; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; MASUKO S, 1986, J NEUROSCI, V6, P3229; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026	16	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146470	10.1371/journal.pone.0146470	http://dx.doi.org/10.1371/journal.pone.0146470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785258	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400040
J	Namjoshi, DR; Cheng, WH; Carr, M; Martens, KM; Zareyan, S; Wilkinson, A; McInnes, KA; Cripton, PA; Wellington, CL				Namjoshi, Dhananjay R.; Cheng, Wai Hang; Carr, Michael; Martens, Kris M.; Zareyan, Shahab; Wilkinson, Anna; McInnes, Kurt A.; Cripton, Peter A.; Wellington, Cheryl L.			Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; RECEPTOR MESSENGER-RNA; NATIONAL-FOOTBALL-LEAGUE; BRAIN-INJURY; HEAD-INJURY; POSTCONCUSSION SYNDROME; PROTEIN-TAU; MALE-MICE; SEROTONIN; IMPACT	Concussion is a serious health concern. Concussion in athletes is of particular interest with respect to the relationship of concussion exposure to risk of chronic traumatic encephalopathy (CTE), a neurodegenerative condition associated with altered cognitive and psychiatric functions and profound tauopathy. However, much remains to be learned about factors other than cumulative exposure that could influence concussion pathogenesis. Approximately 20% of CTE cases report a history of substance use including androgenic-anabolic steroids (AAS). How acute, chronic, or historical AAS use may affect the vulnerability of the brain to concussion is unknown. We therefore tested whether antecedent AAS exposure in young, male C57BI/6 mice affects acute behavioral and neuropathological responses to mild traumatic brain injury (TBI) induced with the CHIMERA (Closed Head Impact Model of Engineered Rotational Acceleration) platform. Male C57Bl/6 mice received either vehicle or a cocktail of three AAS (testosterone, nandrolone and 17 alpha-methyltestosterone) from 8-16 weeks of age. At the end of the 7th week of treatment, mice underwent two closed-head TBI or sham procedures spaced 24 h apart using CHIMERA. Post-repetitive TBI (rTBI) behavior was assessed for 7 d followed by tissue collection. AAS treatment induced the expected physiological changes including increased body weight, testicular atrophy, aggression and downregulation of brain 5-HT1B receptor expression. rTBI induced behavioral deficits, widespread axonal injury and white matter microgliosis. While AAS treatment did not worsen post-rTBI behavioral changes, AAS-treated mice exhibited significantly exacerbated axonal injury and microgliosis, indicating that AAS exposure can alter neuronal and innate immune responses to concussive TBI.	[Namjoshi, Dhananjay R.; Cheng, Wai Hang; Carr, Michael; Martens, Kris M.; Zareyan, Shahab; Wilkinson, Anna; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [McInnes, Kurt A.; Cripton, Peter A.] Univ British Columbia, Dept Biomech Engn, Vancouver, BC V5Z 1M9, Canada; [Cripton, Peter A.; Wellington, Cheryl L.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Wellington, CL (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.; Wellington, CL (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada.	wcheryl@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020; Meijer, Anna/K-5118-2016	Cripton, Peter Alec/0000-0002-5067-0833; Cheng, Wai Hang/0000-0002-3408-9184; McInnes, Kurt/0000-0001-5931-2963	Canadian Institutes of Health Research [MOP 123461]; Alzheimer Society Research Program Doctoral award; Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Research Program Doctoral award; Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao	This work was supported by operating funding from the Canadian Institutes of Health Research (MOP 123461) to CLW (http://www.cihrirsc.gc.ca/e/193.htm). WHC is supported by Alzheimer Society Research Program Doctoral award (http://www.alzheimer.ca/en/Research/Alzheimer-Society-Research-Program) and Comissao Technica de Atribuicao de Bolsas para Estudos Pos-Graduados Macao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambar G, 2009, GENES BRAIN BEHAV, V8, P161, DOI 10.1111/j.1601-183X.2008.00458.x; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bonaventure P, 1998, NEUROSCIENCE, V82, P469; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Clark AS, 2003, NEUROSCI BIOBEHAV R, V27, P413, DOI 10.1016/S0149-7634(03)00064-2; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Cunningham RL, 2013, HORM BEHAV, V64, P350, DOI 10.1016/j.yhbeh.2012.12.009; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gerberding JL, 2003, THE REPORT TO CONGRE; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grimes JM, 2002, PHARMACOL BIOCHEM BE, V73, P713, DOI 10.1016/S0091-3057(02)00880-8; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hoffman JR, 2006, J SPORT SCI MED, V5, P182; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kindlundh AMS, 2003, NEUROSCIENCE, V119, P113, DOI 10.1016/S0306-4522(03)00120-9; Kubala KH, 2008, BRAIN RES, V1232, P21, DOI 10.1016/j.brainres.2008.07.065; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levin B, 2014, NEUROCRIT CARE, V20, P334, DOI 10.1007/s12028-013-9931-1; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Marshall-Gradisnik S, 2009, CENT EUR J BIOL, V4, P19, DOI 10.2478/s11535-008-0058-x; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mills JD, 2012, NEUROSURGERY, V70, P205, DOI 10.1227/NEU.0b013e3182250918; Millspaugh J, 1937, US NAVAL MED B, V35, P297; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Penatti CAA, 2009, J NEUROSCI, V29, P12484, DOI 10.1523/JNEUROSCI.3108-09.2009; Popova N K, 2008, Neurosci Behav Physiol, V38, P471, DOI 10.1007/s11055-008-9004-7; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Robinson S, 2012, HORM BEHAV, V61, P67, DOI 10.1016/j.yhbeh.2011.10.004; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Turillazzi E, 2011, MINI-REV MED CHEM, V11, P374, DOI 10.2174/138955711795445925; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Varnas K, 2005, SYNAPSE, V56, P21, DOI 10.1002/syn.20128; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271	66	30	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146540	10.1371/journal.pone.0146540	http://dx.doi.org/10.1371/journal.pone.0146540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784694	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400046
J	Schimming, O; Schmitt, I; Bode, HB				Schimming, Olivia; Schmitt, Imke; Bode, Helge B.			Identification of the Sfp-Type PPTase EppA from the Lichenized Fungus Evernia prunastri	PLOS ONE			English	Article							PHOSPHOPANTETHEINYL TRANSFERASE; BACILLUS-SUBTILIS; 4'-PHOSPHOPANTETHEINYL TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; XANTHORIA-PARIETINA; SECONDARY-PRODUCT; NATURAL-PRODUCT; BLUE PIGMENT; FATTY-ACID; POLYKETIDE	In the last decades, natural products from lichens have gained more interest for pharmaceutical application due to the broad range of their biological activity. However, isolation of the compounds of interest directly from the lichen is neither feasible nor sustainable due to slow growth of many lichens. In order to develop a pipeline for heterologous expression of lichen biosynthesis gene clusters and thus the sustainable production of their bioactive compounds we have identified and characterized the phosphopantheteinyl transferase (PPTase) EppA from the lichen Evernia prunastri. The Sfp-type PPTase EppA was functionally characterized through heterologous expression in E. coli using the production of the blue pigment indigoidine as readout and by complementation of a lys5 deletion in S. cerevisiae.	[Schimming, Olivia; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Schmitt, Imke] Senckenberg Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Bode, HB (corresponding author), Goethe Univ Frankfurt, Fachbereich Biowissensch, Max von Laue Str 9, D-60438 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909	Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)"	Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)"	This work was supported by the Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)".; This work was supported by the Hessian Ministry of Science and Art via the LOEWE research focus "Integrative fungal research (IPF)". The authors thank Eckhard Boles for useful discussions regarding all aspects of yeast molecular biology, and Anjuli Meiser, Francesco Dal Grande and Jurgen Otte for providing the draft genome of E. prunastri.	Ahmadjian V, 1993, THE LICHEN SYMBIOSIS; [Anonymous], 2006, COLD SPRING HARB PRO, DOI [10.1101/pdb.rec8190, DOI 10.1101/PDB.REC8190]; [Anonymous], 2006, COLD SPRING HARBOR P, V2006; Basile A, 2015, INT J MOL SCI, V16, P7861, DOI 10.3390/ijms16047861; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; BORELL CW, 1988, CURR GENET, V13, P299, DOI 10.1007/BF00424423; Boustie Joel, 2005, Plant Genetic Resources Characterization and Utilization, V3, P273, DOI 10.1079/PGR200572; Brachmann AO, 2012, J BIOTECHNOL, V157, P96, DOI 10.1016/j.jbiotec.2011.10.002; Burkholder PR, 1944, P NATL ACAD SCI USA, V30, P250, DOI 10.1073/pnas.30.9.250; Clarke KM, 2005, J AM CHEM SOC, V127, P11234, DOI 10.1021/ja052911k; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; CULBERSON CF, 1992, EXP MYCOL, V16, P52, DOI 10.1016/0147-5975(92)90041-O; EMMERICH R, 1993, PHYTOCHEMISTRY, V33, P1389, DOI 10.1016/0031-9422(93)85097-B; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Gagunashvili AN, 2009, MYCOL RES, V113, P354, DOI 10.1016/j.mycres.2008.11.011; Gaitatzis N, 2001, J BIOCHEM, V129, P119, DOI 10.1093/oxfordjournals.jbchem.a002821; Gibson D., 2009, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2009.77, DOI 10.1038/NPROT.2009.77]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hamada N, 1996, BRYOLOGIST, V99, P71, DOI 10.2307/3244441; Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676; Kealey JT, 1998, P NATL ACAD SCI USA, V95, P505, DOI 10.1073/pnas.95.2.505; Kegler C, 2014, CHEMBIOCHEM, V15, P826, DOI 10.1002/cbic.201300602; Keszenman-Pereyra D, 2003, CURR GENET, V43, P186, DOI 10.1007/s00294-003-0382-7; Nguyen KH, 2013, NAT PROD REP, V30, P1490, DOI 10.1039/c3np70064j; Knop W., 1844, LIEBIGS ANN CHEM, V49, P103, DOI [10.1002/jlac.18440490202, DOI 10.1002/JLAC.18440490202]; La Clair, 2004, CHEM BIOL, V11, P195, DOI [10.1016/j.chembiol.2004.02.010, DOI 10.1016/J.CHEMBIOL.2004.02.010]; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAUTERWEIN M, 1995, ANTIMICROB AGENTS CH, V39, P2541, DOI 10.1128/AAC.39.11.2541; Miao V, 2001, TRENDS BIOTECHNOL, V19, P349, DOI 10.1016/S0167-7799(01)01700-0; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Muller M, 2012, METAB ENG, V14, P325, DOI 10.1016/j.ymben.2012.04.002; Muggia L, 2009, SIM NEWS, P85; Muller K, 2001, APPL MICROBIOL BIOT, V56, P9, DOI 10.1007/s002530100684; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Myers JA, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-4; Park SH, 2014, APPL ENVIRON MICROB, V80, P2645, DOI 10.1128/AEM.00470-14; Park SY, 2013, ANTIMICROB AGENTS CH, V57, P5536, DOI 10.1128/AAC.01137-13; Park SY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00357-14; Park SY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00695-13; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Schimming O, 2014, CHEMBIOCHEM, V15, P1290, DOI 10.1002/cbic.201402065; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Siewers V, 2009, METAB ENG, V11, P391, DOI 10.1016/j.ymben.2009.08.002; Sinnemann SJ, 2000, CURR GENET, V37, P333, DOI 10.1007/s002940050536; Solhaug KA, 1996, OECOLOGIA, V108, P412, DOI 10.1007/BF00333715; Stack D, 2007, MICROBIOL-SGM, V153, P1297, DOI 10.1099/mic.0.2006/006908-0; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Vijayakumar C. S., 2000, Fitoterapia, V71, P564, DOI 10.1016/S0367-326X(00)00209-4; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Wang YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-34; Yeast extract-peptone-dextrose growth medium (YEPD), 2010, COLD SPRING HARBOR P, V2010, DOI [10.1101/pdb.rec12161, DOI 10.1101/PDB.REC12161]; Yu DY, 2013, J IND MICROBIOL BIOT, V40, P159, DOI 10.1007/s10295-012-1207-9	60	1	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145624	10.1371/journal.pone.0145624	http://dx.doi.org/10.1371/journal.pone.0145624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784935	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400016
J	Willkomm, S; Deerberg, A; Heidemann, J; Flugge, F; Meine, J; Hu, R; Far, RKK; Restle, T				Willkomm, Sarah; Deerberg, Andrea; Heidemann, Johannes; Fluegge, Friedemann; Meine, Janica; Hu, Rui; Far, Rosel Kretschmer-Kazemi; Restle, Tobias			Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage In Vitro	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; RISC-LOADING COMPLEX; BINDING PROTEIN; HUMAN ARGONAUTE2; TRBP; PACT; DICER; INTERFERENCE; RECOGNITION	The human TAR RNA-binding protein (hTRBP) and protein activator of protein kinase R (hPACT) are important players in RNA interference (RNAi). Together with hArgonaute2 (hAgo2) and hDicer they have been reported to form the RISC-loading complex (RLC). Among other functions, hTRBP was suggested to assist the loading of hAgo2 with small interfering RNAs (siRNAs) within the RLC. Although several studies have been conducted to evaluate the specific functions of hTRBP and hPACT in RNAi, exact mechanisms and modes of action are still unknown. Here, we present a biochemical study further evaluating the role of hTRBP and hPACT in hAgo2-loading. We found that both proteins enhance hAgo2-mediated RNA cleavage significantly; even a hAgo2 mutant impaired in siRNA binding shows full cleavage activity in the presence of hTRBP or hPACT. Pre-steady state binding studies reveal that the assembly of wildtype-hAgo2 (wt-hAgo2) and siRNAs remains largely unaffected, whereas the binding of mutant hAgo2-PAZ9 to siRNA is restored by adding either hTRBP or hPACT. We conclude that both proteins assist in positioning the siRNA within hAgo2 to ensure optimal binding and cleavage. Overall, our data indicate that hTRBP and hPACT are part of a regulative system of RNAi that is important for efficient target RNA cleavage.	[Willkomm, Sarah] Univ Regensburg, Single Mol Biochem Lab, Inst Microbiol, D-93053 Regensburg, Germany; [Willkomm, Sarah; Deerberg, Andrea; Heidemann, Johannes; Fluegge, Friedemann; Meine, Janica; Hu, Rui; Far, Rosel Kretschmer-Kazemi; Restle, Tobias] Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany	University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck	Restle, T (corresponding author), Med Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Mol Med, D-23538 Lubeck, Germany.	restle@imm.uni-luebeck.de	Fluegge, Friedemann/AAA-5987-2020	Kretschmer-Kazemi Far, Rosel/0000-0002-2363-7499	Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck; German National Academic Foundation	Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck; German National Academic Foundation	S.W. acknowledges funding by the Graduate School for Computing in Medicine and Life Sciences at the University of Lubeck and A.D. by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9899; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Deerberg A, 2013, P NATL ACAD SCI USA, V110, P17850, DOI 10.1073/pnas.1217838110; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gredell JA, 2010, BIOCHEMISTRY-US, V49, P3148, DOI 10.1021/bi902189s; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/BJ20020204; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Noland CL, 2013, RNA, V19, P639, DOI 10.1261/rna.037424.112; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063434; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146814	10.1371/journal.pone.0146814	http://dx.doi.org/10.1371/journal.pone.0146814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784517	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400067
J	Li, YJ; Wang, YG; An, B; Xu, H; Liu, Y; Zhang, LC; Ma, HY; Wang, WM				Li, Y. J.; Wang, Y. G.; An, B.; Xu, H.; Liu, Y.; Zhang, L. C.; Ma, H. Y.; Wang, W. M.			A Practical Anodic and Cathodic Curve Intersection Model to Understand Multiple Corrosion Potentials of Fe-Based Glassy Alloys in OH- Contained Solutions	PLOS ONE			English	Article							ALKALINE AQUEOUS-ELECTROLYTES; BULK METALLIC GLASSES; SOFT-MAGNETIC-ALLOYS; ELECTROCHEMICAL-BEHAVIOR; FERROSILICIDES FEXSI; STAINLESS-STEEL; PHOSPHORIC-ACID; FILM GROWTH; SCAN RATE; PASSIVATION	A practical anodic and cathodic curve intersection model, which consisted of an apparent anodic curve and an imaginary cathodic line, was proposed to explain multiple corrosion potentials occurred in potentiodynamic polarization curves of Fe-based glassy alloys in alkaline solution. The apparent anodic curve was selected from the measured anodic curves. The imaginary cathodic line was obtained by linearly fitting the differences of anodic curves and can be moved evenly or rotated to predict the number and value of corrosion potentials.	[Li, Y. J.; Wang, Y. G.; An, B.; Xu, H.; Liu, Y.; Wang, W. M.] Shandong Univ, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China; [Zhang, L. C.] Edith Cowan Univ, Sch Engn, 270 Joondalup Dr, Perth, WA 6027, Australia; [Ma, H. Y.] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Shandong, Peoples R China	Shandong University; Edith Cowan University; Shandong University	Wang, WM (corresponding author), Shandong Univ, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China.	weiminw@sdu.edu.cn	Wang, Weimin/AAC-4153-2020; zhang, lai/GVS-4725-2022; Zhang, Lai-Chang/B-9769-2011	Wang, Weimin/0000-0002-4789-6399; Zhang, Lai-Chang/0000-0003-0661-2051	National Natural Science Foundation of China [51171091, 51471099]; National Basic Research Program of China (973 Program) [2012CB825702]; Excellent Youth Project of Shandong Natural Science Foundation [JQ201012]; Australian Research Council (ARC) Discovery Projects [DP130103592]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Excellent Youth Project of Shandong Natural Science Foundation; Australian Research Council (ARC) Discovery Projects(Australian Research Council)	The work is supported by the National Natural Science Foundation of China (No. 51171091 and No. 51471099), the National Basic Research Program of China (973 Program) (No. 2012CB825702), the Excellent Youth Project of Shandong Natural Science Foundation (No. JQ201012) and the Australian Research Council (ARC) Discovery Projects (DP130103592).	Almeida CMVB, 2001, MATER CHEM PHYS, V69, P261, DOI 10.1016/S0254-0584(00)00458-2; Amaral ST, 1999, CORROS SCI, V41, P759, DOI 10.1016/S0010-938X(98)00149-8; An B, 2014, J ALLOY COMPD, V593, P16, DOI 10.1016/j.jallcom.2014.01.086; An B, 2014, EFFECTS COOLING RATE; CALANDRA AJ, 1974, ELECTROCHIM ACTA, V19, P901, DOI 10.1016/0013-4686(74)85041-3; Casella IG, 2002, J ELECTROANAL CHEM, V534, P31, DOI 10.1016/S0022-0728(02)01100-2; Cekerevac M, 2012, CORROS SCI, V64, P204, DOI 10.1016/j.corsci.2012.07.019; Escriva-Cerdan C, 2012, CORROS SCI, V56, P114, DOI 10.1016/j.corsci.2011.11.014; Green ML, 2001, J APPL PHYS, V90, P2057, DOI 10.1063/1.1385803; Guenbour A, 2006, APPL SURF SCI, V253, P2362, DOI 10.1016/j.apsusc.2006.05.005; Gui Q, 2012, COMPOSITION TECHNOLO; Han Y, 2015, J MATER RES, V30, P547, DOI 10.1557/jmr.2014.389; Inoue A, 2006, INTERMETALLICS, V14, P936, DOI 10.1016/j.intermet.2006.01.038; Kelly RG., 2002, ELECTROCHEM TECHNOL, DOI DOI 10.1201/9780203909133; KELSALL GH, 1991, J ELECTROCHEM SOC, V138, P941, DOI 10.1149/1.2085751; KELSALL GH, 1991, J ELECTROCHEM SOC, V138, P931, DOI 10.1149/1.2085750; LEE TS, 1971, J ELECTROCHEM SOC, V118, P1278, DOI 10.1149/1.2408305; Li YJ, 2014, J NON-CRYST SOLIDS, V392, P51, DOI 10.1016/j.jnoncrysol.2014.03.030; Lu ZP, 2006, CORROS SCI, V48, P3049, DOI 10.1016/j.corsci.2005.11.014; MANNING PE, 1980, CORROSION, V36, P468, DOI 10.5006/0010-9312-36.9.468; Meng GZ, 2014, J MATER SCI TECHNOL, V30, P253, DOI [10.1016/j.jmst.2013.07.810, 10.1016/j.jmst.2013.07.010]; Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201; Naumkin AV, 2012, POWELL CJ NIST STAND; Pan C, 2012, J ELECTROCHEM SOC, V159, pC453, DOI 10.1149/2.034211jes; Pan C, 2011, ELECTROCHIM ACTA, V56, P7740, DOI 10.1016/j.electacta.2011.05.106; Pang SJ, 2002, ACTA MATER, V50, P489, DOI 10.1016/S1359-6454(01)00366-4; Pyun SI, 2000, J SOLID STATE ELECTR, V4, P267, DOI 10.1007/s100080050203; Qiao YX, 2009, ELECTROCHIM ACTA, V54, P2298, DOI 10.1016/j.electacta.2008.10.038; Qiao YX, 2009, CORROS SCI, V51, P979, DOI 10.1016/j.corsci.2009.02.026; Refaey SAM, 2006, ELECTROCHIM ACTA, V51, P2942, DOI 10.1016/j.electacta.2005.09.033; Sato K, 2003, APPL SURF SCI, V216, P376, DOI 10.1016/S0169-4332(03)00445-8; Shi MJ, 2015, INTERMETALLICS, V61, P16, DOI 10.1016/j.intermet.2015.02.010; Srinivasan S., 1966, ELECTROCHIM ACTA, V11, P321; URQUIDIMACDONALD M, 1987, J ELECTROCHEM SOC, V134, P41, DOI 10.1149/1.2100433; Wang ZB, 2014, ELECTROCHIM ACTA, V135, P526, DOI 10.1016/j.electacta.2014.05.055; Xu Y, 2011, APPL MECH MATER, V66-68, P1094, DOI 10.4028/www.scientific.net/AMM.66-68.1094; Ye SL, 2013, J ALLOY COMPD, V562, P143, DOI 10.1016/j.jallcom.2013.02.006; Ye W, 2006, ELECTROCHIM ACTA, V51, P4426, DOI 10.1016/j.electacta.2005.12.034; Yi Y, 2013, CORROS SCI, V74, P92, DOI 10.1016/j.corsci.2013.04.028; Yim CD, 2015, CORROS SCI, V90, P597, DOI 10.1016/j.corsci.2014.11.003; YOSHIZAWA Y, 1988, J APPL PHYS, V64, P6044, DOI 10.1063/1.342149; Zarrouk A, 2015, CORROS SCI, V90, P572, DOI 10.1016/j.corsci.2014.10.052; Zhang XL, 2009, CORROS SCI, V51, P581, DOI 10.1016/j.corsci.2008.12.005; Zhang YC, 2012, ELECTROCHIM ACTA, V69, P12, DOI 10.1016/j.electacta.2012.01.023	44	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146421	10.1371/journal.pone.0146421	http://dx.doi.org/10.1371/journal.pone.0146421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771194	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300018
J	Wang, XY; Li, CQ; Guo, DH; Wang, XY; Wei, S; Geng, YF; Wang, EY; Wang, ZH; Zhao, XW; Su, MJ; Liu, QJ; Zhang, SY; Feng, L; Sun, DB				Wang, Xinyu; Li, Chunqiu; Guo, Donghua; Wang, Xinyu; Wei, Shan; Geng, Yufei; Wang, Enyu; Wang, Zhihui; Zhao, Xiwen; Su, Mingjun; Liu, Qiujin; Zhang, Siyao; Feng, Li; Sun, Dongbo			Co-Circulation of Canine Coronavirus I and IIa/b with High Prevalence and Genetic Diversity in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DIARRHEIC DOGS; FECAL SAMPLES; IDENTIFICATION; GENOTYPE; RNA	To trace the evolution of canine coronavirus (CCoV), 201 stool samples from diarrheic dogs in northeast China were subjected to reverse transcription-polymerase chain reactions (RT-PCRs) targeting the partial M and S genes of CCoV, followed by an epidemiological analysis. M gene RT-PCRs showed that 28.36% (57/201) of the samples were positive for CCoV; of the 57 positive samples, CCoV-I and CCoV-II accounted for 15.79% (9/57) and 84.21% (48/57), respectively. A sequence comparison of the partial M gene revealed nucleotide homologies of 88.4%-100% among the 57 CCoV strains, and 88.7%-96.2% identity between the 57 CCoV strains and the Chinese reference strain HF3. The CCoV-I and CCoV-II strains exhibited genetic diversity when compared with reference strains from China and other countries. The 57 CCoV strains exhibited high co-infection rates with canine kobuvirus (CaKV) (33.33%) and canine parvovirus-2 (CPV-2) (31.58%). The CCoV prevalence in diarrheic dogs differed significantly with immunization status, regions, seasons, and ages. Moreover, 28 S genes were amplified from the 57 CCoV-positive samples, including 26 CCoV-IIa strains, one CCoV-IIb strain, and one CCoV-I strain. A sequence comparison of the partial S gene revealed 86.3%-100% nucleotide identity among the 26 CCoV-IIa strains, and 89.6%-92.2% identity between the 26 CCoV-IIa strains and the Chinese reference strain V1. The 26 CCoV-IIa strains showed genetic diversity when compared with reference strains from China and other countries. Our data provide evidence that CCoV-I, CCoV-IIa, and CCoV-IIb strains co-circulate in the diarrhoetic dogs in northeast China, high co-infection rates with CaKV and CPV-2 were observed, and the CCoV-II strains exhibited high prevalence and genetic diversity.	[Wang, Xinyu; Li, Chunqiu; Guo, Donghua; Wang, Xinyu; Wei, Shan; Geng, Yufei; Wang, Enyu; Wang, Zhihui; Zhao, Xiwen; Su, Mingjun; Liu, Qiujin; Zhang, Siyao; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 5 Xinfeng Rd, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 5 Xinfeng Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022; Feng, Li/GQQ-3764-2022	Wang, Xin/0000-0002-4457-7376; 	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]; National Natural Science Foundation of China [31472209]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016), and the National Natural Science Foundation of China (grant no. 31472209).	Bandai C, 1999, J VET MED SCI, V61, P731, DOI 10.1292/jvms.61.731; Binn L N, 1974, Proc Annu Meet U S Anim Health Assoc, P359; Buonavoglia C, 2006, EMERG INFECT DIS, V12, P492, DOI 10.3201/eid1203.050839; Buonavoglia D, 2000, MICROBIOLOGICA, V23, P93; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Choi S, 2014, J VET MED SCI, V76, P1141, DOI 10.1292/jvms.13-0585; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2015, VIRUS RES, V210, P100, DOI 10.1016/j.virusres.2015.07.018; Decaro N, 2013, J CLIN MICROBIOL, V51, P83, DOI 10.1128/JCM.02466-12; Decaro N, 2011, VET CLIN N AM-SMALL, V41, P1121, DOI 10.1016/j.cvsm.2011.07.005; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Decaro N, 2009, J VIROL, V83, P15332, DOI 10.1128/JVI.01937-08; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Erles K, 2009, VIRUS RES, V141, P21, DOI 10.1016/j.virusres.2008.12.009; Gao FS, 2009, J VET SCI, V10, P261, DOI 10.4142/jvs.2009.10.3.261; Geng YF, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131886, 10.1371/journal.pone.0137288]; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Jeoung SY, 2014, J VET SCI, V15, P495, DOI 10.4142/jvs.2014.15.4.495; King A. M., 2012, VIRUS TAXONOMY CLASS; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Le Poder S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/609465; Li C, 2015, J VET MED SCI; Licitra BN, 2014, VIRUSES-BASEL, V6, P3363, DOI 10.3390/v6083363; Ma GG, 2008, VIRUS GENES, V36, P491, DOI 10.1007/s11262-008-0214-4; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Ntafis V, 2011, VET MICROBIOL, V151, P238, DOI 10.1016/j.vetmic.2011.03.008; Ntafis V, 2013, INFECT GENET EVOL, V16, P129, DOI 10.1016/j.meegid.2013.01.014; Pinto LD, 2014, VET J, V202, P659, DOI 10.1016/j.tvjl.2014.09.006; Pratelli A, 2004, J CLIN MICROBIOL, V42, P1797, DOI 10.1128/JCM.42.4.1797-1799.2004; Pratelli A, 2004, VET MICROBIOL, V99, P43, DOI 10.1016/j.vetmic.2003.07.009; Pratelli A, 2003, MICROBIOLOGICA, V26, P151; Pratelli A, 2003, J VIROL METHODS, V107, P213, DOI 10.1016/S0166-0934(02)00246-X; Pratelli A, 1999, J VIROL METHODS, V80, P11, DOI 10.1016/S0166-0934(99)00017-8; Regan AD, 2012, VIROLOGY, V430, P90, DOI 10.1016/j.virol.2012.04.013; Soma T, 2011, RES VET SCI, V90, P205, DOI 10.1016/j.rvsc.2010.05.027; Stavisky J, 2012, INFECT GENET EVOL, V12, P1419, DOI 10.1016/j.meegid.2012.04.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106534; Wang Y, 2006, BERL MUNCH TIERARZTL, V119, P35	41	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146975	10.1371/journal.pone.0146975	http://dx.doi.org/10.1371/journal.pone.0146975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771312	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300047
J	Lange, M; Di Marco, LY; Lekadir, K; Lassila, T; Frangi, AF				Lange, Matthias; Di Marco, Luigi Yuri; Lekadir, Karim; Lassila, Toni; Frangi, Alejandro F.			Protective Role of False Tendon in Subjects with Left Bundle Branch Block: A Virtual Population Study	PLOS ONE			English	Article							LEFT-VENTRICULAR BANDS; TWO-DIMENSIONAL ECHOCARDIOGRAPHY; APPARENTLY HEALTHY-SUBJECTS; CARDIAC CONDUCTION SYSTEM; NORMAL HUMAN HEARTS; PAPILLARY-MUSCLES; CLINICAL IMPORTANCE; GENERAL-POPULATION; PURKINJE-FIBERS; PREVALENCE	False tendons (FTs) are fibrous or fibromuscular bands that can be found in both the normal and abnormal human heart in various anatomical forms depending on their attachment points, tissue types, and geometrical properties. While FTs are widely considered to affect the function of the heart, their specific roles remain largely unclear and unexplored. In this paper, we present an in silico study of the ventricular activation time of the human heart in the presence of FTs. This study presents the first computational model of the human heart that includes a FT, Purkinje network, and papillary muscles. Based on this model, we perform simulations to investigate the effect of different types of FTs on hearts with the electrical conduction abnormality of a left bundle branch block (LBBB). We employ a virtual population of 70 human hearts derived from a statistical atlas, and run a total of 560 simulations to assess ventricular activation time with different FT configurations. The obtained results indicate that, in the presence of a LBBB, the FT reduces the total activation time that is abnormally augmented due to a branch block, to such an extent that surgical implant of cardiac resynchronisation devices might not be recommended by international guidelines. Specifically, the simulation results show that FTs reduce the QRS duration at least 10 ms in 80% of hearts, and up to 45 ms for FTs connecting to the ventricular free wall, suggesting a significant reduction of cardiovascular mortality risk. In further simulation studies we show the reduction in the QRS duration is more sensitive to the shape of the heart then the size of the heart or the exact location of the FT. Finally, the model suggests that FTs may contribute to reducing the activation time difference between the left and right ventricles from 12 ms to 4 ms. We conclude that FTs may provide an alternative conduction pathway that compensates for the propagation delay caused by the LBBB. Further investigation is needed to quantify the clinical impact of FTs on cardiovascular mortality risk.	[Lange, Matthias; Di Marco, Luigi Yuri; Lassila, Toni; Frangi, Alejandro F.] Univ Sheffield, Ctr Computat Imaging & Simulat Technol Biomed, Sheffield, S Yorkshire, England; [Lekadir, Karim] Univ Pompeu Fabra, Ctr Computat Imaging & Simulat Technol Biomed, Barcelona, Spain	University of Sheffield; Pompeu Fabra University	Lange, M (corresponding author), Univ Sheffield, Ctr Computat Imaging & Simulat Technol Biomed, Sheffield, S Yorkshire, England.	m.lange@sheffield.ac.uk	Frangi, Alejandro F/C-6500-2008	Frangi, Alejandro F/0000-0002-2675-528X; Lange, Matthias/0000-0001-5635-3444; Lassila, Toni/0000-0001-8947-1447				ABDULLA AK, 1990, CHEST, V98, P129, DOI 10.1378/chest.98.1.129; Abouezzeddine O, 2010, J CARDIOVASC ELECTR, V21, P245, DOI 10.1111/j.1540-8167.2009.01621.x; Aktas EO, 2004, SAUDI MED J, V25, P1176; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Badheka AO, 2013, AM J CARDIOL, V112, P671, DOI 10.1016/j.amjcard.2013.04.040; Bathe K.-J., 2006, FINITE ELEMENT PROCE; Betsuyaku T, 2012, PACE, V35, pE341, DOI 10.1111/j.1540-8159.2011.03160.x; Bhatt MR, 2009, J THORAC CARDIOV SUR, V138, P1123, DOI 10.1016/j.jtcvs.2008.10.056; Bordas R, 2011, PROG BIOPHYS MOL BIO, V107, P90, DOI 10.1016/j.pbiomolbio.2011.05.002; Borg AN, 2012, EUR HEART J-CARD IMG, V13, P795, DOI 10.1093/ehjci/jes062; BOYD MT, 1987, J AM COLL CARDIOL, V9, P323, DOI 10.1016/S0735-1097(87)80383-2; BRENNER JI, 1984, J AM COLL CARDIOL, V3, P1515, DOI 10.1016/S0735-1097(84)80291-0; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cangelosi M M, 1992, Ann Ital Med Int, V7, P102; CASTA A, 1986, AM HEART J, V111, P321, DOI 10.1016/0002-8703(86)90147-X; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Cherry EM, 2012, NONLINEAR DYNAM, V68, P365, DOI 10.1007/s11071-011-0221-1; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Clements CJ, 2005, P ANN INT IEEE EMBS, P4235, DOI 10.1109/IEMBS.2005.1615399; Cocchieri M, 1992, Minerva Cardioangiol, V40, P353; Colli Franzone P, 1998, MATH BIOSCI, V2, P131, DOI [10.1016/S0025-5564(97)00093-X, DOI 10.1016/S0025-5564(97)00093-X]; Colli-Franzone P, 2004, MATH MOD METH APPL S, V14, P883, DOI 10.1142/S0218202504003489; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; ESTES EH, 1966, AM HEART J, V71, P356, DOI 10.1016/0002-8703(66)90475-3; Gao Mingchen, 2013, Inf Process Med Imaging, V23, P184, DOI 10.1007/978-3-642-38868-2_16; GERLIS LM, 1984, BRIT HEART J, V52, P641; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Grzybiak M, 1996, Folia Morphol (Warsz), V55, P89; Haataja P, 2013, INT J CARDIOL, V167, P1953, DOI 10.1016/j.ijcard.2012.05.024; Hoogendoorn C, 2013, IEEE T MED IMAGING, V32, P28, DOI 10.1109/TMI.2012.2230015; Hosapatna M, 2014, IBNOSINA J MED BIOME, V6, P168, DOI [10.4103/1947-489X.210379, DOI 10.4103/1947-489X.210379]; Ijiri T, 2008, J PHYSIOL SCI, V58, P481, DOI 10.2170/physiolsci.RP003208; Irie T, 2015, J ARRYTHM, V31, P163, DOI 10.1016/j.joa.2014.09.002; Keener J., 2009, INTERDISCIPLINARY AP, V8/I; Ker J, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-13; Kervancioglu M, 2003, CLIN ANAT, V16, P389, DOI 10.1002/ca.10152; Krishnamoorthi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114494; Kucuk U, 2012, ECHOCARDIOGR-J CARD, V29, pE178, DOI 10.1111/j.1540-8175.2012.01692.x; Lee Sang Hyuk, 2012, J Cardiovasc Ultrasound, V20, P97, DOI 10.4250/jcu.2012.20.2.97; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125173; Loukas M, 2007, CLIN ANAT, V20, P163, DOI 10.1002/ca.20347; Loukas M, 2010, CLIN ANAT, V23, P443, DOI 10.1002/ca.20968; LUETMER PH, 1986, J AM COLL CARDIOL, V8, P179, DOI 10.1016/S0735-1097(86)80110-3; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; MALOUF J, 1986, BRIT HEART J, V55, P587; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Nigri GR, 2001, SURG RADIOL ANAT, V23, P45, DOI 10.1007/s00276-001-0045-7; Nishimura T, 1981, J Cardiogr, V11, P253; Oetgen WJ, 2013, J AM COLL CARDIOL, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Okada JI, 2013, PACE, V36, P309, DOI 10.1111/pace.12057; Okamoto M, 1981, J Cardiogr, V11, P265; Ozbag D, 2005, INT J CLIN PRACT, V59, P529, DOI [10.1111/j.1742-1241.2004.00345.x, 10.1111/j.1368-5031.2005.00345.x]; Pashaei A, 2010, COMPUT CARDIOL CONF, V37, P871; Pashaei A, 2011, IEEE T BIO-MED ENG, V58, P2956, DOI 10.1109/TBME.2011.2162841; PERRY LW, 1983, AM J CARDIOL, V52, P1264, DOI 10.1016/0002-9149(83)90584-2; Philip S, 2011, PEDIATR NEONATOL, V52, P279, DOI 10.1016/j.pedneo.2011.06.007; RAWLING DA, 1987, CIRC RES, V60, P580, DOI 10.1161/01.RES.60.4.580; Remme EW, 2004, IEEE T BIO-MED ENG, V51, P1923, DOI 10.1109/TBME.2004.834283; Sachse FB, 2004, P ANN INT IEEE EMBS, V26, P3593; Salazar J, 1997, PEDIATR CARDIOL, V18, P434, DOI 10.1007/s002469900223; Sebastian R, 2013, IEEE T MED IMAGING, V32, P45, DOI 10.1109/TMI.2012.2221474; Sermesant M, 2007, LECT NOTES COMPUT SC, V4466, P160; SETHURAMAN KR, 1984, INT J CARDIOL, V6, P385, DOI 10.1016/0167-5273(84)90201-8; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; SUTTON MGS, 1994, BRIT HEART J, V71, P187; SUWA M, 1988, J AM COLL CARDIOL, V12, P910, DOI 10.1016/0735-1097(88)90453-6; SUWA M, 1984, CIRCULATION, V70, P793, DOI 10.1161/01.CIR.70.5.793; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; VEENSTRA RD, 1984, CIRC RES, V54, P500, DOI 10.1161/01.RES.54.5.500; VERED Z, 1984, AM J CARDIOL, V53, P330, DOI 10.1016/0002-9149(84)90450-8; Vigmond EJ, 2007, IEEE T BIO-MED ENG, V54, P389, DOI 10.1109/TBME.2006.888817; Wiedmann RT, 1996, AM J PHYSIOL-HEART C, V271, pH1507, DOI 10.1152/ajpheart.1996.271.4.H1507	72	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146477	10.1371/journal.pone.0146477	http://dx.doi.org/10.1371/journal.pone.0146477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766041	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300021
J	Choe, E; Drnevich, J; Williams, MM				Choe, Eunsoo; Drnevich, Jenny; Williams, Martin M., II			Identification of Crowding Stress Tolerance Co-Expression Networks Involved in Sweet Corn Yield	PLOS ONE			English	Article							PLANT-POPULATION; GENE-EXPRESSION; DROUGHT TOLERANCE; CYANOBACTERIAL FLAVODOXIN; TRANSCRIPTION FACTOR; TRANSGENIC TOBACCO; DYNAMIC CHANGES; USE EFFICIENCY; AFFECTS GROWTH; DRY-MATTER	Tolerance to crowding stress has played a crucial role in improving agronomic productivity in field corn; however, commercial sweet corn hybrids vary greatly in crowding stress tolerance. The objectives were to 1) explore transcriptional changes among sweet corn hybrids with differential yield under crowding stress, 2) identify relationships between phenotypic responses and gene expression patterns, and 3) identify groups of genes associated with yield and crowding stress tolerance. Under conditions of crowding stress, three high-yielding and three low-yielding sweet corn hybrids were grouped for transcriptional and phenotypic analyses. Transcriptional analyses identified from 372 to 859 common differentially expressed genes (DEGs) for each hybrid. Large gene expression pattern variation among hybrids and only 26 common DEGs across all hybrid comparisons were identified, suggesting each hybrid has a unique response to crowding stress. Over-represented biological functions of DEGs also differed among hybrids. Strong correlation was observed between: 1) modules with up-regulation in high-yielding hybrids and yield traits, and 2) modules with up-regulation in low-yielding hybrids and plant/ear traits. Modules linked with yield traits may be important crowding stress response mechanisms influencing crop yield. Functional analysis of the modules and common DEGs identified candidate crowding stress tolerant processes in photosynthesis, glycolysis, cell wall, carbohydrate/nitrogen metabolic process, chromatin, and transcription regulation. Moreover, these biological functions were greatly inter-connected, indicating the importance of improving the mechanisms as a network.	[Choe, Eunsoo; Williams, Martin M., II] USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL USA; [Drnevich, Jenny] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Williams, MM (corresponding author), USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL USA.	martin.williams@ars.usda.gov		Williams, Martin/0000-0002-6302-7724				Allison JCS, 1997, ANN APPL BIOL, V131, P339, DOI [10.1111/j.1744-7348.1997.tb05160.x, 10.1111/j.1744-7348.1969.tb05474.x]; BAENZIGER PS, 1980, CROP SCI, V20, P444, DOI 10.2135/cropsci1980.0011183X002000040005x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco NE, 2011, PLANT J, V65, P922, DOI 10.1111/j.1365-313X.2010.04479.x; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; BOYLE MG, 1991, CROP SCI, V31, P1246, DOI 10.2135/cropsci1991.0011183X003100050033x; BUNTING ES, 1973, J AGR SCI-CAMBRIDGE, V81, P455, DOI 10.1017/S0021859600086512; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cox WJ, 1996, AGRON J, V88, P489, DOI 10.2134/agronj1996.00021962008800030022x; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; Doyle SM, 2010, J EXP BOT, V61, P473, DOI 10.1093/jxb/erp320; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duvick DN, 2005, MAYDICA, V50, P193; Duvick D.N., 1997, DEV DROUGHT LOW N TO, P332; DWYER LM, 1991, CAN J PLANT SCI, V71, P1, DOI 10.4141/cjps91-001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; FRY SC, 1989, PHYSIOL PLANTARUM, V75, P532, DOI 10.1111/j.1399-3054.1989.tb05620.x; Fu JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-63; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Gopalakrishna R, 2001, BIOCHEM BIOPH RES CO, V284, P574, DOI 10.1006/bbrc.2001.4992; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; HASLETT BG, 1973, BIOCHEM J, V136, P697, DOI 10.1042/bj1360697; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Holtgrefe S, 2003, PLANT PHYSIOL, V133, P1768, DOI 10.1104/pp.103.026013; Huebert DJ, 2012, MOL CELL BIOL, V32, P1645, DOI 10.1128/MCB.06170-11; Humbert S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-3; IREMIREN GO, 1980, EXP AGR, V16, P321, DOI 10.1017/S001447970001108X; Jan A, 2004, PLANT PHYSIOL, V136, P3670, DOI 10.1104/pp.104.052274; Kakkar RK, 2002, PHYSIOL PLANTARUM, V116, P281, DOI 10.1034/j.1399-3054.2002.1160302.x; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 1997, TRENDS PLANT SCI, V2, P124, DOI 10.1016/S1360-1385(97)01013-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; LI ZC, 1993, PLANTA, V191, P349, DOI 10.1007/BF00195692; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu W, 2015, PLANT PHYSIOL, V168, P343, DOI 10.1104/pp.15.00030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansfield BD, 2014, CROP SCI, V54, P157, DOI 10.2135/cropsci2013.04.0252; MCCULLOUGH DE, 1994, CAN J PLANT SCI, V74, P479, DOI 10.4141/cjps94-088; MERTENS E, 1990, PLANT PHYSIOL, V93, P584, DOI 10.1104/pp.93.2.584; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Neter J., 1996, APPL LINEAR STAT MOD; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Scheibe R, 2012, PLANT CELL ENVIRON, V35, P202, DOI 10.1111/j.1365-3040.2011.02319.x; Schluter U, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-442; SCHRAUDNER M, 1992, PLANT PHYSIOL, V99, P1321, DOI 10.1104/pp.99.4.1321; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw R. H., 1977, World Meteorological Organization: Agrometeorology of the maize (corn) crop., P119; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Smith AM, 2008, PLANT J, V54, P546, DOI 10.1111/j.1365-313X.2008.03468.x; Smith KT, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001371; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; St Pierre S, 2011, PLANT GENOME-US, V4, P47, DOI 10.3835/plantgenome2010.08.0020; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tardieu F, 2003, TRENDS PLANT SCI, V8, P9, DOI 10.1016/S1360-1385(02)00008-0; Tardieu F, 2010, CURR OPIN PLANT BIOL, V13, P206, DOI 10.1016/j.pbi.2009.12.012; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; Urano K, 2004, BIOCHEM BIOPH RES CO, V313, P369, DOI 10.1016/j.bbrc.2003.11.119; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Voss I, 2008, PHYSIOL PLANTARUM, V133, P584, DOI 10.1111/j.1399-3054.2008.01112.x; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Wang BQ, 2011, BIOCHEM BIOPH RES CO, V413, P10, DOI 10.1016/j.bbrc.2011.08.015; Weiste C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4883; Weston DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-16; Williams MM, 2015, AGRON J, V107, P1782, DOI 10.2134/agronj15.0011; Williams MM, 2012, FIELD CROP RES, V128, P55, DOI 10.1016/j.fcr.2011.12.007; Xu P, 2014, J EXP BOT, V65, P4285, DOI 10.1093/jxb/eru202; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9	87	12	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147418	10.1371/journal.pone.0147418	http://dx.doi.org/10.1371/journal.pone.0147418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796516	Green Submitted, gold, Green Published			2022-12-27	WOS:000368530300032
J	Rainone, V; Martelli, C; Ottobrini, L; Biasin, M; Borelli, M; Lucignani, G; Trabattoni, D; Clerici, M				Rainone, Veronica; Martelli, Cristina; Ottobrini, Luisa; Biasin, Mara; Borelli, Manuela; Lucignani, Giovanni; Trabattoni, Daria; Clerici, Mario			Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy	PLOS ONE			English	Article							IMMUNE-RESPONSES; EXPRESSION; MELANOMA; ANTIGENS; SUBSETS; CD4(+)	Introduction Dendritic cells play a key role as initiators of T-cell responses, and even if tumour antigen-loaded dendritic cells can induce anti-tumour responses, their efficacy has been questioned, suggesting a need to enhance immunization strategies. Matherials & Methods We focused on the characterization of bone marrow-derived dendritic cells pulsed with whole tumour lysate (TAA-DC), as a source of known and unknown antigens, in a mouse model of breast cancer (MMTV-Ras). Dendritic cells were evaluated for antigen uptake and for the expression of MHC class I/II and costimulatory molecules and markers associated with maturation. Results Results showed that antigen-loaded dendritic cells are characterized by a phenotypically semi-mature/mature profile and by the upregulation of genes involved in antigen presentation and T-cell priming. Activated dendritic cells stimulated T-cell proliferation and induced the production of high concentrations of IL-12p70 and IFN-gamma but only low levels of IL-10, indicating their ability to elicit a T(H)1-immune response. Furthermore, administration of Antigen loaded-Dendritic Cells in MMTV-Ras mice evoked a strong anti-tumour response in vivo as demonstrated by a general activation of immunocompetent cells and the release of T(H)1 cytokines. Conclusion Data herein could be useful in the design of antitumoral DC-based therapies, showing a specific activation of immune system against breast cancer.	[Rainone, Veronica; Biasin, Mara; Borelli, Manuela; Trabattoni, Daria] Univ Milan, Chair Immunol, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Martelli, Cristina; Ottobrini, Luisa; Clerici, Mario] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Martelli, Cristina; Ottobrini, Luisa; Lucignani, Giovanni] Univ Milan, Ctr Mol & Cellular Imaging IMAGO, Milan, Italy; [Ottobrini, Luisa] Natl Res Council CNR, Inst Mol Bioimaging & Physiol IBFM, Milan, Italy; [Lucignani, Giovanni] Univ Milan, Dept Hlth Sci, Milan, Italy; [Lucignani, Giovanni] San Paolo Hosp, Nucl Med Unit, Dept Diagnost Serv, Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn IRCCS, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Milan; San Paolo-Polo Universitaria Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus	Clerici, M (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.; Clerici, M (corresponding author), Don C Gnocchi Fdn IRCCS, Milan, Italy.	mario.clerici@unimi.it	Trabattoni, Daria/G-7424-2012; Lucignani, Giovanni/C-6773-2008; Ottobrini, Luisa/K-7608-2016; Martelli, Cristina/P-4426-2017; biasin, mara/G-7426-2012	Trabattoni, Daria/0000-0001-9535-3359; Lucignani, Giovanni/0000-0002-9674-8958; Ottobrini, Luisa/0000-0002-5002-6845; Martelli, Cristina/0000-0003-0023-9110; biasin, mara/0000-0003-3671-4235	PRIN (Progetti di Rilevante Interesse Nazionale, Health Ministry) [20082NHWH9_001]; AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-9311]; Italian program PRIN [20082NHWH9_001]	PRIN (Progetti di Rilevante Interesse Nazionale, Health Ministry)(Ministry of Education, Universities and Research (MIUR)); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian program PRIN	This work was supported by PRIN 2008 (Progetti di Rilevante Interesse Nazionale, Health Ministry, project no. 20082NHWH9_001) received by MC and AIRC (Associazione Italiana per la Ricerca sul Cancro; funded project no IG-9311) received by MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Italian program PRIN 2008 (project no. 20082NHWH9_001) and by AIRC (Associazione Italiana per la Ricerca sul Cancro) funded project no IG-9311. All the authors have read the manuscript and approve the final version herein attached.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Ahmad M, 2004, CANCER IMMUNOL IMMUN, V53, P844, DOI 10.1007/s00262-004-0540-x; Bai L, 2002, INT J ONCOL, V20, P247; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Caux C, 2002, TRANSPLANTATION, V73, pS7, DOI 10.1097/00007890-200201151-00005; Chiang CLL, 2010, SEMIN IMMUNOL, V22, P132, DOI 10.1016/j.smim.2010.02.004; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; De Vries IJ, 2008, CANCER RES, V63, P12; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Gunn MD, 2003, SEMIN IMMUNOL, V15, P271, DOI 10.1016/j.smim.2003.08.004; Hart JP, 2004, J IMMUNOL, V172, P70, DOI 10.4049/jimmunol.172.1.70; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Mackensen A, 2000, INT J CANCER, V86, P385, DOI 10.1002/(SICI)1097-0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T; Malumbres M, 2003, NAT REV CANCER, V3, P708, DOI 10.1038/nrc1193; Martelli C, 2012, MOL IMAGING BIOL, V14, P183, DOI 10.1007/s11307-011-0496-0; Melero I, 2000, GENE THER, V7, P1167, DOI 10.1038/sj.gt.3301234; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Ridolfi Ruggero, 2004, J Transl Med, V2, P27; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satthaporn S, 2001, J ROY COLL SURG EDIN, V46, P9; Shumway NM, 2009, BIODRUGS, V23, P277, DOI 10.2165/11313490-000000000-00000; Sogn JA, 1998, IMMUNITY, V9, P757, DOI 10.1016/S1074-7613(00)80641-X; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; Zanetti M, 2003, ANN NY ACAD SCI, V987, P249, DOI 10.1111/j.1749-6632.2003.tb06056.x; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhang XS, 2005, J IMMUNOL, V175, P2931, DOI 10.4049/jimmunol.175.5.2931	43	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146622	10.1371/journal.pone.0146622	http://dx.doi.org/10.1371/journal.pone.0146622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795765	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300009
J	Deshpande, A; Toshniwal, H; Joshi, S; Jani, RH				Deshpande, Alka; Toshniwal, Harsh; Joshi, Shashank; Jani, Rajendrakumar H.			A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy	PLOS ONE			English	Article							INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK; FENOFIBRATE; DYSLIPIDEMIA; GEMFIBROZIL; ATORVASTATIN; LIPOPROTEIN; METABOLISM; MANAGEMENT	Objective This study was designed to explore the efficacy and safety of saroglitazar 4 mg on hypertri-glyceridemia in patients with HIV associated lipodystrophy. Methods During this 12-week prospective, multi-centric, open-label, single arm exploratory study, 50 patients were enrolled to receive saroglitazar 4 mg orally once daily in the morning before breakfast. The primary efficacy endpoint was the percent change in triglyceride (TG) levels from baseline to Week 6 and Week 12. The secondary efficacy endpoints were assessment of low-density-lipoprotein (LDL), very-low-density-lipoprotein (VLDL), high-density-lipoprotein (HDL), non-HDL cholesterol, total cholesterol, apo-lipoprotein (Apo) A1, Apo B, and C-peptide and fasting insulin for HOMA beta and HOMA IR. Safety assessment was performed during the study. Results Saroglitazar 4 mg significantly decreased the serum TG levels from baseline at Week 6 (percent change: -40.98; 95% CI: -50.82, -31.15) and Week 12 (percent change -45.11; 95% CI: -52.37, -37.86). Reduction in VLDL cholesterol (percent change: -46.33; 95% CI: -52.89, -39.76) and total cholesterol (percent change: 7.37; 95% CI: 1.96, 12.78) was observed at week 12 from baseline. Saroglitazar increased HDL cholesterol (percent change: 34.56, 95% CI: 22.22, 46.90), Apo A1 (percent change: 33.16; 95% CI: 18.69, 47.63) and Apo B (percent change: 10.55, 95% CI: 2.86, 18.25) levels at week 12 from baseline. Saroglitazar treatment led to increase in the C-peptide (percent change: 59.42, 95% CI: 48.78, 70.06), fasting insulin levels (percent change: 47.10; 95% CI: 38.63, 55.57), HOMA of beta cell function for C-peptide (percent change: 71.67; 95% CI: 39.09, 104.26) and HOMA of insulin resistance for C-peptide (percent change: 58.29, 95% CI: 46.74, 69.83) at week 12 from baseline. Saroglitazar treatment was safe and well tolerated in this study. Conclusion Overall, the observed changes in lipid profile after 12 weeks of saroglitazar treatment were in the direction of improvement in patients with HIV associated lipodystrophy.	[Deshpande, Alka] Grant Med Coll & Sir JJ Grp Hosp, Bombay, Maharashtra, India; [Toshniwal, Harsh] IDTM Clin, Ahmadabad, Gujarat, India; [Joshi, Shashank] Joshi Clin, 12,Golden Palace,Turner Rd,Bandra West, Bombay, Maharashtra, India; [Jani, Rajendrakumar H.] Cadila Healthcare Ltd, Clin R&D, Zydus Res Ctr, Sarkhej Bavla NH 8A, Ahmadabad, Gujarat, India	Zydus Cadila	Jani, RH (corresponding author), Cadila Healthcare Ltd, Clin R&D, Zydus Res Ctr, Sarkhej Bavla NH 8A, Ahmadabad, Gujarat, India.	rhjani@zyduscadila.com		Jani, Rajendrakumar/0000-0002-7077-8024	Cadila Healthcare Limited	Cadila Healthcare Limited	Study sponsored by Cadila Healthcare Limited and in collaboration with the investigators, the Sponsor of trial contributed to the design of the study, collection of data, statistical analysis and interpretation and reporting of the results.	Aberg JA, 2005, AIDS RES HUM RETROV, V21, P757, DOI 10.1089/aid.2005.21.757; Anuurad E, 2008, ATHEROSCLEROSIS, V198, P192, DOI 10.1016/j.atherosclerosis.2007.09.042; Badiou S, 2004, ATHEROSCLEROSIS, V172, P273, DOI 10.1016/j.atherosclerosis.2003.10.006; Balasubramanyam A, 2004, CURR OPIN LIPIDOL, V15, P59, DOI 10.1097/00041433-200402000-00011; Baril L, 2001, AIDS, V15, P415, DOI 10.1097/00002030-200102160-00016; Bennett MT, 2008, FUTURE LIPIDOL, V3, P175, DOI 10.2217/17460875.3.2.175; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Bonnet F, 2004, HIV MED, V5, P133, DOI 10.1111/j.1468-1293.2004.00200.x; Calza L, 2002, INFECTION, V30, P26, DOI 10.1007/s15010-001-2052-3; Caramelli B, 2001, Braz J Infect Dis, V5, P332; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; Hewitt RG, 1999, AIDS, V13, P868, DOI 10.1097/00002030-199905070-00023; Jani RH, 2013, CLIN DRUG INVEST, V33, P809, DOI 10.1007/s40261-013-0128-3; Jani RH, 2014, DIABETES TECHNOL THE, V16, P63, DOI 10.1089/dia.2013.0253; Kramer AS, 2009, ARQ BRAS CARDIOL, V93, P519; Leonard EG, 2003, PEDIATR INFECT DIS J, V22, P77, DOI 10.1097/00006454-200301000-00018; Manfredi R, 2001, J INFECTION, V42, P181, DOI 10.1053/jinf.2001.0829; McGoldrick C, 2007, HIV MED, V8, P325, DOI 10.1111/j.1468-1293.2007.00480.x; Michael LG, 2002, J GEN INTERN MED, V17, P797; Miller J, 2002, AIDS, V16, P2195, DOI 10.1097/00002030-200211080-00012; Pai Vikas, 2014, J Diabetes Sci Technol, V8, P132; Palacios R, 2002, JAIDS-J ACQ IMM DEF, V31, P251, DOI 10.1097/00126334-200210010-00018; Periard D, 1999, CIRCULATION, V100, P700, DOI 10.1161/01.CIR.100.7.700; Rao A, 2004, AM J MED SCI, V327, P315, DOI 10.1097/00000441-200406000-00003; Reeds DN, 2003, AM J PHYSIOL-ENDOC M, V285, pE490, DOI 10.1152/ajpendo.00118.2003; Schmitz M, 2001, J ACQ IMMUN DEF SYND, V26, P225, DOI 10.1097/00126334-200103010-00004; Shahmanesh M, 2005, J CLIN ENDOCR METAB, V90, P755, DOI 10.1210/jc.2004-1273; Smith Jr SC, 2013, CIRCULATION; Sutinen J, 2009, PPAR RES, V2009, DOI 10.1155/2009/373524; Troll JG, 2011, CURR ATHEROSCLER REP, V13, P51, DOI 10.1007/s11883-010-0152-1; Yiqing S, 2007, DIABETES CARE, V30, P1747; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146222	10.1371/journal.pone.0146222	http://dx.doi.org/10.1371/journal.pone.0146222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789842	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100028
J	Aerts, L; Craessaerts, K; De Strooper, B; Morais, VA				Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.			In Vitro Comparison of the Activity Requirements and Substrate Specificity of Human and Triboleum castaneum PINK1 Orthologues	PLOS ONE			English	Article							PARKINSONS-DISEASE; CATALYTIC-ACTIVITY; INSULIN-RECEPTOR; PHOSPHORYLATION; MUTATIONS; PROTEIN; UBIQUITIN; ACTIVATION	Mutations in the gene encoding the mitochondrial kinase PINK1 cause early-onset familial Parkinson's disease. To understand the biological function of PINK1 and its role in the pathogenesis of Parkinson's disease, it is useful to study its kinase activity towards substrates both in vivo and in vitro. For in vitro kinase assays, a purified Triboleum castaneum PINK1 insect orthologue is often employed, because it displays higher levels of activity when compared to human PINK1. We show, however, that the activity requirements, and more importantly the substrate specificity, differ between both orthologues. While Triboleum castaneum PINK1 readily phosphorylates the PINKtide peptide and Histone H1 in vitro, neither of these non-physiological substrates is phosphorylated by human PINK1. Nonetheless, both Tc and human PINK1 phosphorylate Parkin and Ubiquitin, two physiological substrates of PINK1. Our results show that the substrate selectivity differs among PINK1 orthologues, an important consideration that should be taken into account when extrapolating findings back to human PINK1.	[Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Flemish Inst Biotechnol VIB, Ctr Biol Dis, Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London, England; [Morais, Vanessa A.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; University of London; University College London; Universidade de Lisboa	De Strooper, B; Morais, VA (corresponding author), Flemish Inst Biotechnol VIB, Ctr Biol Dis, Leuven, Belgium.; De Strooper, B; Morais, VA (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, Leuven, Belgium.; De Strooper, B; Morais, VA (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium.; De Strooper, B (corresponding author), UCL, Inst Neurol, London, England.; Morais, VA (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	Bart.DeStrooper@cme.vib-kuleuven.be; vmorais@medicina.ulisboa.pt	de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Aerts, Liesbeth/0000-0002-7981-8176; Morais, Vanessa/0000-0002-0830-0548	Flemish agency for Innovation by Science and Technology (IWT); Fund for Scientific Research Flanders (FWO); Hercules Foundation; Federal Office for Scientific Affairs [IAP P7/16]; VIB; IWT doctoral grant; Fundacao para a Ciencia e a Tecnologia (FCT) [IF/01693/2014]; Alzheimer's disease research program at Janssen Pharmaceutica; Alzheimer's disease research program at Envivo; Alzheimer's disease research program at Remynd NV; Methusalem grant of the Flemish Government; research fund KU Leuven	Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Hercules Foundation; Federal Office for Scientific Affairs; VIB; IWT doctoral grant; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Alzheimer's disease research program at Janssen Pharmaceutica; Alzheimer's disease research program at Envivo; Alzheimer's disease research program at Remynd NV; Methusalem grant of the Flemish Government; research fund KU Leuven(KU Leuven)	This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), the Fund for Scientific Research Flanders (FWO), research fund KU Leuven, the Hercules Foundation, the Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, and VIB. LA is supported by an IWT doctoral grant. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. VAM is supported by the Fundacao para a Ciencia e a Tecnologia (FCT) for the FCT Investigator Grant (IF/01693/2014). BDS is a paid consultant for the Alzheimer's disease research programs at Janssen Pharmaceutica, Envivo, and Remynd NV. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), the Fund for Scientific Research Flanders (FWO), research fund KU Leuven, the Hercules Foundation, the Federal Office for Scientific Affairs (IAP P7/16), a Methusalem grant of the Flemish Government, and VIB. LA is supported by an IWT doctoral grant. BDS is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2015, BIOCHEM SOC T, V43, P280, DOI 10.1042/BST20150002; Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; MASSAGUE J, 1982, J BIOL CHEM, V257, P6729; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Sim CH, 2012, HUM MUTAT, V33, P1408, DOI 10.1002/humu.22127; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012	29	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146083	10.1371/journal.pone.0146083	http://dx.doi.org/10.1371/journal.pone.0146083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784449	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400023
J	McCullough, SJ; O'Donoghue, L; Saunders, KJ				McCullough, Sara J.; O'Donoghue, Lisa; Saunders, Kathryn J.			Six Year Refractive Change among White Children and Young Adults: Evidence for Significant Increase in Myopia among White UK Children	PLOS ONE			English	Article							SCHOOL-CHILDREN; CLINICAL-EVALUATION; ACCOMMODATIVE LAG; PARENTAL HISTORY; OCULAR BIOMETRY; RISK-FACTORS; ERROR; PREVALENCE; CHILDHOOD; SCHOOLCHILDREN	Objective To determine six-year spherical refractive error change among white children and young adults in the UK and evaluate differences in refractive profiles between contemporary Australian children and historical UK data. Design Population-based prospective study. Participants The Northern Ireland Childhood Errors of Refraction (NICER) study Phase 1 examined 1068 children in two cohorts aged 6-7 years and 12-13 years. Prospective data for six-year follow-up (Phase 3) are available for 212 12-13 year olds and 226 18-20 year olds in each cohort respectively. Methods Cycloplegic refractive error was determined using binocular open-field autorefraction (Shin-Nippon NVision-K 5001, cyclopentolate 1%). Participants were defined by spherical equivalent refraction (SER) as myopic SER <=-0.50D, emmetropic -0.50D< SER<+ 2.00 or hyperopic SER >=+ 2.00D. Main Outcome Measures Proportion and incidence of myopia. Results The proportion of myopes significantly increased between 6-7 years (1.9%) and 12-13 years (14.6%) (p<0.001) but not between 12-13 and 18-20 years (16.4% to 18.6%, p = 0.51). The estimated annual incidence of myopia was 2.2% and 0.7% for the younger and older cohorts respectively. There were significantly more myopic children in the UK at age 12-13 years in the NICER study (16.4%) than reported in Australia (4.4%) (p<0.001). However by 17 years the proportion of myopia neared equivalence in the two populations (NICER 18.6%, Australia 17.7%, p = 0.75). The proportion of myopic children aged 12-13 years in the present study (2006-2008) was 16.4%, significantly greater than that reported for children aged 10-16 years in the 1960' s (7.2%, p = 0.01). The proportion of hyperopes in the younger NICER cohort decreased significantly over the six year period (from 21.7% to 14.2%, p = 0.04). Hyperopes with SER >=+ 3.50D in both NICER age cohorts demonstrated persistent hyperopia. Conclusions The incidence and proportion of myopia are relatively low in this contemporary white UK population in comparison to other worldwide studies. The proportion of myopes in the UK has more than doubled over the last 50 years in children aged between 10-16 years and children are becoming myopic at a younger age. Differences between the proportion of myopes in the UK and in Australia apparent at 12-13 years were eliminated by 17 years of age.	[McCullough, Sara J.; O'Donoghue, Lisa; Saunders, Kathryn J.] Univ Ulster, Sch Biomed Sci, Biomed Sci Res Inst, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	McCullough, SJ (corresponding author), Univ Ulster, Sch Biomed Sci, Biomed Sci Res Inst, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	sj.mccullough@ulster.ac.uk	Saunders, Kathryn/C-2328-2013	Saunders, Kathryn/0000-0002-9289-5731; McCullough, Sara/0000-0002-4438-1154	College of Optometrists, London, UK; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803] Funding Source: NIH RePORTER	College of Optometrists, London, UK; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by The College of Optometrists, London, UK Grant name: The Northern Ireland Childhood Errors of Refraction Study - Phase 3 Refractive development in childhood and early adulthood. http://www.college-optometrists.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, GEOGR DISTR POP; Breslin KMM, 2013, INVEST OPHTH VIS SCI, V54, P4843, DOI 10.1167/iovs.13-11813; Candy TR, 2012, INVEST OPHTH VIS SCI, V53, P143, DOI 10.1167/iovs.11-8174; Castagno VD, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-163; Czepita Damian, 2008, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V54, P17; Davies LN, 2003, OPTOMETRY VISION SCI, V80, P320, DOI 10.1097/00006324-200304000-00011; DOBSON V, 1989, INVEST OPHTH VIS SCI, V30, P1146; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; French AN, 2013, OPHTHAL PHYSL OPT, V33, P318, DOI 10.1111/opo.12045; French AN, 2012, INVEST OPHTH VIS SCI, V53, P4021, DOI 10.1167/iovs.12-9556; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Horwood AM, 2011, BRIT J OPHTHALMOL, V95, P231, DOI 10.1136/bjo.2009.177378; INGRAM RM, 1979, BRIT J OPHTHALMOL, V63, P339, DOI 10.1136/bjo.63.5.339; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Kulp MT, 2012, AM J OPHTHALMOL, V154, P297, DOI 10.1016/j.ajo.2012.02.035; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Logan NS, 2011, OPHTHAL PHYSL OPT, V31, P550, DOI 10.1111/j.1475-1313.2011.00862.x; Mallen EAH, 2015, OPHTHAL PHYSL OPT, V35, P622, DOI 10.1111/opo.12254; McCullough SJ, 2014, OPHTHAL PHYSL OPT, V34, P685; Mcknight CM, 2014, AM J OPHTHALMOL, V158, P1079, DOI 10.1016/j.ajo.2014.07.033; Mezer E, 2015, GRAEF ARCH CLIN EXP, V253, P1013, DOI 10.1007/s00417-015-3033-z; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P324; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P666, DOI 10.1097/OPX.0b013e3181a6174f; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Northern Ireland Statistics and Research Agency, 2013, POP MIGR EST NO STAT; Northern Ireland Statistics and Research Agency, 2011, CENS 2011 KEY STAT N; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1150, DOI 10.1136/bjo.2009.167965; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; O'Donoghue L, 2015, INVEST OPHTH VIS SCI, V56, P1524, DOI 10.1167/iovs.14-15549; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Sleszynski P, 2014, GEOGR POL, V87, P61, DOI 10.7163/GPol.2014.4; SORSBY A, 1961, Memo Med Res Counc, V301(Special), P1; Tang WC, 2014, OPHTHAL PHYSL OPT, V34, P89, DOI 10.1111/opo.12098; Tarczy-Hornoch K, 2012, J AAPOS, V16, P112, DOI 10.1016/j.jaapos.2011.10.015; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI DOI 10.1001/ARCH0PHTHALM0L.2009.303; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1936; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	49	54	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146332	10.1371/journal.pone.0146332	http://dx.doi.org/10.1371/journal.pone.0146332			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783753	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400031
J	Yang, N; Moermond, TC; Lloyd, H; Xu, Y; Dou, L; Zhang, K; Yue, BS; Ran, JH				Yang, Nan; Moermond, Timothy C.; Lloyd, Huw; Xu, Yu; Dou, Liang; Zhang, Kai; Yue, Bisong; Ran, Jianghong			Effects of Supplementary Feeding on the Breeding Ecology of the Buff-Throated Partridge in a Tibetan Sacred Site, China	PLOS ONE			English	Article							AVES GALLIFORMES PHASIANIDAE; FLORIDA SCRUB-JAYS; FOOD SUPPLEMENTATION; TETRAOPHASIS-SZECHENYII; REPRODUCTIVE SUCCESS; SEASONAL DECLINE; BODY CONDITION; TIME; POPULATION; SURVIVAL	Our goal was to document effects of year-round supplemental feeding on breeding ecology of the Buff-throated Partridge, Tetraophasis szechenyii, within a Tibetan sacred site. We evaluated effects of supplemental feeding used as religious/cultural practices which could potentially aid conservation of endangered phasianids. We compared fed breeding groups to neighboring nonfed groups. Fed groups initiated first clutches significantly earlier than nonfed groups. Earlier laying groups within fed and nonfed groups showed significantly lower hatching rates than later groups; however, fed groups showed significantly higher hatching rates than nonfed groups laying in the same period. Earlier laying increased opportunities to renest. All six fed groups with clutch failures renested compared to only one of five nonfed groups with clutch failures. Fed female breeders showed significantly greater investment in their young with larger clutches and larger eggs, which likely increased survivability of early hatchlings. We observed no predation on birds at feeding sites and recorded only four cases of predation on incubating females, which showed no detectable difference between fed and nonfed groups. Ground-nesting birds typically face high risks of predation. Ten of the 48 groups nested in trees, which occurs in few phasianid species. Tree nests showed significantly higher hatching rates compared to ground nests; however, we found no significant difference in tree nesting between fed and nonfed groups. This partridge is one of four gallinaceous species with cooperative breeding. Breeding groups with helpers had significantly greater reproductive success than single pairs, and fed female breeders with helpers laid bigger eggs than single pairs. Comparing annual reproductive output per group, fed groups not only produced significantly more independent young (>= 150 days post-hatching), their young hatched significantly earlier, which likely have greater reproductive value over later hatched young of nonfed groups. Supplemental feeding year-round is likely what enabled the successes of the fed partridges.	[Yang, Nan; Moermond, Timothy C.; Xu, Yu; Dou, Liang; Zhang, Kai; Yue, Bisong; Ran, Jianghong] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China; [Lloyd, Huw] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Sch Sci & Environm, Chester St, Manchester M15 6BH, Lancs, England	Sichuan University; Manchester Metropolitan University	Ran, JH (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China.	rjhong-01@163.com		Yue, Bisong/0000-0001-6731-538X; Xu, Yu/0000-0002-9437-3267	National Natural Sciences Foundation of China [31172105]; Rufford Small Grant Foundation (UK)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Rufford Small Grant Foundation (UK)	This study was funded by the National Natural Sciences Foundation of China (No. 31172105, http://www.nsfc.gov.cn) to JR. Nan Yang was supported in part by the Rufford Small Grant Foundation (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Will Stein for useful comments, Zhang Man for her help in remaking Fig 1, Beibei Du and Wen Lin for office work, and Pinjia Que and Pengfei Yu for their help in the field work. We thank Richard Van Koningsveld for his valuable advice and generous assistance with application of new statistical analyses. This study was funded by the National Natural Sciences Foundation of China (No. 31172105, http://www.nsfc.gov.cn) to JR. Nan Yang was supported in part by the Rufford Small Grant Foundation (UK).	Anderson DM, 2005, BIODIVERS CONSERV, V14, P3065, DOI 10.1007/s10531-004-0316-9; Aparicio JM, 2002, ECOLOGY, V83, P873, DOI 10.1890/0012-9658(2002)083[0873:EOFSAH]2.0.CO;2; ARCESE P, 1985, J ANIM ECOL, V54, P817, DOI 10.2307/4380; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Bortolotti GR, 2009, AUK, V126, P831, DOI 10.1525/auk.2009.08197; Bourgault P, 2009, J FIELD ORNITHOL, V80, P127, DOI 10.1111/j.1557-9263.2009.00214.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BRITTINGHAM MC, 1988, ECOLOGY, V69, P581, DOI 10.2307/1941007; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Castro I, 2003, BIOL CONSERV, V114, P271, DOI 10.1016/S0006-3207(03)00046-6; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Daan S., 1988, P392; De Neve L, 2004, J AVIAN BIOL, V35, P246, DOI 10.1111/j.0908-8857.2004.03162.x; De Neve L, 2002, ANIM BEHAV, V63, P975, DOI 10.1006/anbe.2001.1989; Deng WH, 2005, ORYX, V39, P158, DOI 10.1017/S0030605305000396; DHINDSA MS, 1990, IBIS, V132, P595, DOI 10.1111/j.1474-919X.1990.tb00283.x; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Draycott RAH, 1998, J WILDLIFE MANAGE, V62, P557, DOI 10.2307/3802329; Du Plessis MA, 1998, ECOLOGY EVOLUTION CO, P117; Dunn E.H., 1999, BIRDS YOUR FEEDER GU; DUNN EH, 1994, J FIELD ORNITHOL, V65, P8; Ekman J, 2006, J AVIAN BIOL, V37, P289, DOI 10.1111/j.2006.0908-8857.03666.x; Fleischer AL, 2003, CONDOR, V105, P515, DOI 10.1650/7224; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Hale AM, 2006, CONDOR, V108, P107, DOI 10.1650/0010-5422(2006)108[0107:GLITBW]2.0.CO;2; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Heffner RA, 1996, ECOLOGY, V77, P2558, DOI 10.2307/2265754; HOCHACHKA W, 1990, ECOLOGY, V71, P1279, DOI 10.2307/1938265; HOGSTEDT G, 1981, J ANIM ECOL, V50, P219, DOI 10.2307/4041; Hoodless AN, 1999, J APPL ECOL, V36, P147, DOI 10.1046/j.1365-2664.1999.00388.x; JANSSON C, 1981, OIKOS, V37, P313, DOI 10.2307/3544122; Johnsgard Paul A, 1999, PHEASANTS WORLD BIOL; Kelly JF, 1997, ECOLOGY, V78, P2504; Klaus S, 2003, J ORNITHOL, V144, P197, DOI 10.1007/BF02465647; Ligon J. David, 2004, P5, DOI 10.1017/CBO9780511606816.002; Liu FW, 2014, ZOOL SCI, V31, P160, DOI 10.2108/zsj.31.160; Long CR, 2007, THESIS W VIRGINIA U; Lu TC, 2006, CHINA ENDEMIC BIRDS, P54; Lu X, 2005, ARDEA, V93, P17; Lu X, 2003, IBIS, V145, P657, DOI 10.1046/j.1474-919X.2003.00204.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Meng Y, 2010, J NAT HIST, V44, P2955, DOI 10.1080/00222933.2010.502596; Miehe G, 2003, MT RES DEV, V23, P324, DOI 10.1659/0276-4741(2003)023[0324:SFIT]2.0.CO;2; Millan J, 2003, WILDLIFE BIOL, V9, P229, DOI 10.2981/wlb.2003.055; Murray BG, 2000, CONDOR, V102, P470, DOI 10.1650/0010-5422(2000)102[0470:MARSIB]2.0.CO;2; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nan W. Y, 2001, NATL RES QINGHAI, V12, P23; Newton I., 1998, POPULATION LIMITATIO; NILSSON JA, 1994, J ANIM ECOL, V63, P200, DOI 10.2307/5595; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Nilsson JA, 2000, OIKOS, V88, P351, DOI 10.1034/j.1600-0706.2000.880214.x; Ridley AR, 2008, J AVIAN BIOL, V39, P389, DOI 10.1111/j.2008.0908-8857.04479.x; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; ROBB LA, 1992, J ANIM ECOL, V61, P215, DOI 10.2307/5524; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Salick J, 2007, BIODIVERS CONSERV, V16, P693, DOI 10.1007/s10531-005-4381-5; Schoech SJ, 2003, AUK, V120, P1114, DOI 10.1642/0004-8038(2003)120[1114:DDATPI]2.0.CO;2; Schoech SJ, 2007, J ORNITHOL, V148, pS625, DOI 10.1007/s10336-007-0177-6; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Shen XL, 2008, THESIS PEKING U; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; SVENSSON E, 1995, ECOLOGY, V76, P1804, DOI 10.2307/1940712; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; Townsend DE, 1999, WILDLIFE SOC B, V27, P1074; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; VONBROMSSEN A, 1980, ORNIS SCAND, V11, P173, DOI 10.2307/3676121; Wang S., 2004, CHINA SPECIES RED LI; Wright J, 2001, P ROY SOC B-BIOL SCI, V268, P821, DOI 10.1098/rspb.2000.1574; Xu Y, 2013, ETHOL ECOL EVOL, V25, P289, DOI 10.1080/03949370.2013.800161; Xu Y, 2011, J ORNITHOL, V152, P695, DOI 10.1007/s10336-011-0651-z; Xu Y, 2010, ZOOL STUD, V49, P461; Xu Y, 2008, ORNIS FENNICA, V85, P126; Yang N, 2011, ARDEA, V99, P199, DOI 10.5253/078.099.0210; Yang Nan, 2009, Chinese Journal of Zoology, V44, P48; Yu PF, 2010, SICHUAN J ZOOL, V30, P74; Zeng LJ, 2014, THESIS U CALIFORNIA; Zhang Baiping, 2002, Journal of Geographical Sciences, V12, P135; Zhang K, 2011, WILSON J ORNITHOL, V123, P93, DOI 10.1676/10-035.1; Zhang Zheng-Wang, 2003, Shengwu Duoyangxing, V11, P414; Zheng GM, 1998, CHINA RED DATA BOOK, P104	83	5	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146568	10.1371/journal.pone.0146568	http://dx.doi.org/10.1371/journal.pone.0146568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784961	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400048
J	Kim, CS; Vanture, S; Cho, M; Klapperich, CM; Wang, C; Huang, FW				Kim, Chloe S.; Vanture, Sarah; Cho, Margaret; Klapperich, Catherine M.; Wang, Catharine; Huang, Franklin W.			Awareness, Interest, and Preferences of Primary Care Providers in Using Point-of-Care Cancer Screening Technology	PLOS ONE			English	Article							BREAST; PREVENTION; BARRIERS	Well-developed point-of-care (POC) cancer screening tools have the potential to provide better cancer care to patients in both developed and developing countries. However, new medical technology will not be adopted by medical providers unless it addresses a population's existing needs and end-users' preferences. The goals of our study were to assess primary care providers' level of awareness, interest, and preferences in using POC cancer screening technology in their practice and to provide guidelines to biomedical engineers for future POC technology development. A total of 350 primary care providers completed a one-time self-administered online survey, which took approximately 10 minutes to complete. A $50 Amazon gift card was given as an honorarium for the first 100 respondents to encourage participation. The description of POC cancer screening technology was provided in the beginning of the survey to ensure all participants had a basic understanding of what constitutes POC technology. More than half of the participants (57%) stated that they heard of the term "POC technology" for the first time when they took the survey. However, almost all of the participants (97%) stated they were either "very interested" (68%) or "some-what interested" (29%) in using POC cancer screening technology in their practice. Demographic characteristics such as the length of being in the practice of medicine, the percentage of patients on Medicaid, and the average number of patients per day were not shown to be associated with the level of interest in using POC. These data show that there is a great interest in POC cancer screening technology utilization among this population of primary care providers and vast room for future investigations to further understand the interest and preferences in using POC cancer technology in practice. Ensuring that the benefits of new technology outweigh the costs will maximize the likelihood it will be used by medical providers and patients.	[Kim, Chloe S.; Vanture, Sarah; Cho, Margaret; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wang, Catharine] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Huang, Franklin W.] Harvard Univ, Sch Med, Boston, MA USA; [Huang, Franklin W.] Dana Farber Canc Inst, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Klapperich, CM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Huang, FW (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Huang, FW (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	catherin@bu.edu; Franklin_Huang@dfci.harvard.edu	Wang, Catharine/AHB-4212-2022	Wang, Catharine/0000-0001-8584-2781	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) [5-U54-EB015403]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES014562] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Research reported in this paper was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) under the grant number: 5-U54-EB015403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Mangione for his helpful comments during the survey design phase. Research reported in this paper was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIBIB-NIH) under the grant number: 5-U54-EB015403.	Arvey SR, 2012, HEALTH EDUC BEHAV, V39, P352, DOI 10.1177/1090198111418110; Bender JL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2661; Chan CPY, 2013, ANNU REV ANAL CHEM, V6, P191, DOI 10.1146/annurev-anchem-062012-092641; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Garrett Paula, 2006, Perspect Health Inf Manag, V3, P9; Long SY, 2013, ARCH GYNECOL OBSTET, V288, P113, DOI 10.1007/s00404-012-2697-4; Louie RF, 2000, LAB MED, V31, P402, DOI 10.1309/0Y5F-B7NP-5Y67-GW7T; Martin JL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-74; Matteucci E, 2011, MINI-REV MED CHEM, V11, P178, DOI 10.2174/138955711794519474; Meissner HI, 2012, AM J PREV MED, V43, P584, DOI 10.1016/j.amepre.2012.08.016; Obort Aniebietabasi S, 2013, Rev Urol, V15, P97; Panayi ND, 2013, FUTURE ONCOL, V9, P613, DOI [10.2217/FON.13.42, 10.2217/fon.13.42]; Philip EJ, 2010, CANCER CAUSE CONTROL, V21, P1685, DOI 10.1007/s10552-010-9597-3; Phillips M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090226; Price CP, 2001, BMJ-BRIT MED J, V322, P1285, DOI 10.1136/bmj.322.7297.1285; Roth RG, 2014, RADIOGRAPHICS, V34, pE89, DOI 10.1148/rg.344130087; Tejeda S, 2013, J WOMENS HEALTH, V22, P507, DOI 10.1089/jwh.2012.3590; Wallner Paul E, 2008, J Am Coll Radiol, V5, P1125, DOI 10.1016/j.jacr.2008.06.008; Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c; Weinstein RS, 2014, AM J MED, P127; Wiwanitkit V, 2011, OTOLARYNG HEAD NECK, V145, P880, DOI 10.1177/0194599811420804	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0145215	10.1371/journal.pone.0145215	http://dx.doi.org/10.1371/journal.pone.0145215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771309	gold, Green Published			2022-12-27	WOS:000368628300005
J	Fan, W; Zong, J; Luo, ZJ; Chen, MJ; Zhao, XX; Zhang, DB; Qi, YP; Yuan, Z				Fan, Wei; Zong, Jie; Luo, Zhijing; Chen, Mingjiao; Zhao, Xiangxiang; Zhang, Dabing; Qi, Yiping; Yuan, Zheng			Development of a RAD-Seq Based DNA Polymorphism Identification Software, AgroMarker Finder, and Its Application in Rice Marker-Assisted Breeding	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; MOLECULAR MARKERS; READ ALIGNMENT; GENOME; RESISTANCE; DISCOVERY; SELECTION; CONSTRUCTION; DIVERSITY; CULTIVARS	Rapid and accurate genome-wide marker detection is essential to the marker-assisted breeding and functional genomics studies. In this work, we developed an integrated software, AgroMarker Finder (AMF: http://erp.novelbio.com/AMF), for providing graphical user interface (GUI) to facilitate the recently developed restriction-site associated DNA (RAD) sequencing data analysis in rice. By application of AMF, a total of 90,743 high-quality markers (82,878 SNPs and 7,865 InDels) were detected between rice varieties JP69 and Jiaoyuan5A. The density of the identified markers is 0.2 per Kb for SNP markers, and 0.02 per Kb for InDel markers. Sequencing validation revealed that the accuracy of genome-wide marker detection by AMF is 93%. In addition, a validated subset of 82 SNPs and 31 InDels were found to be closely linked to 117 important agronomic trait genes, providing a basis for subsequent marker-assisted selection (MAS) and variety identification. Furthermore, we selected 12 markers from 31 validated InDel markers to identify seed authenticity of variety Jiaoyuanyou69, and we also identified 10 markers closely linked to the fragrant gene BADH2 to minimize linkage drag for Wuxiang075 (BADH2 donor)/Jiachang1 recombinants selection. Therefore, this software provides an efficient approach for marker identification from RAD-seq data, and it would be a valuable tool for plant MAS and variety protection.	[Fan, Wei; Luo, Zhijing; Chen, Mingjiao; Zhang, Dabing; Yuan, Zheng] Shanghai Jiao Tong Univ, State Key Lab Hybrid Rice, Shanghai Jiao Tong Univ Univ Adelaide Joint Ctr A, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zong, Jie] Novel Bioinformat Co, Shanghai, Peoples R China; [Zhao, Xiangxiang; Zhang, Dabing; Yuan, Zheng] Huaiyin Normal Univ, Key Lab Crop Marker Assisted Breeding Huaian Muni, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Nanjing, Jiangsu, Peoples R China; [Zhang, Dabing] Univ Adelaide, Sch Agr Food & Wine, Plant Genom Ctr, Waite Campus, Urrbrae, SA, Australia; [Qi, Yiping] E Carolina Univ, Dept Biol, Greenville, NC USA	Shanghai Jiao Tong University; Huaiyin Normal University; University of Adelaide; University of North Carolina; East Carolina University	Yuan, Z (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Hybrid Rice, Shanghai Jiao Tong Univ Univ Adelaide Joint Ctr A, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.; Yuan, Z (corresponding author), Huaiyin Normal Univ, Key Lab Crop Marker Assisted Breeding Huaian Muni, Jiangsu Collaborat Innovat Ctr Reg Modern Agr & E, Nanjing, Jiangsu, Peoples R China.	zyuan@sjtu.edu.cn	Zhang, Dabing/AAR-6473-2020; Yuan, Zheng/M-9223-2015; Qi, Yiping/AAZ-3976-2020	Yuan, Zheng/0000-0003-1254-0410; Qi, Yiping/0000-0002-9556-6706; Zong, Jie/0000-0001-6107-3228	EU FP7 project (DECATHLON) [613908]; Project on Breeding from Agriculture Commission of Shanghai [2013-13, 2014-1-3]; National Natural Science Foundation of China [31470397, 31270222, 31230051, 31110103915]; Key Project on Basic Research from Science and Technology Commission of Shanghai [14JC1403900, 14391917100]; China Talents of Discipline to Universities (111 Project) [B14016]; Novel Bioinformatics Company	EU FP7 project (DECATHLON); Project on Breeding from Agriculture Commission of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project on Basic Research from Science and Technology Commission of Shanghai; China Talents of Discipline to Universities (111 Project); Novel Bioinformatics Company	This work was supported by the Funds from the EU FP7 project (DECATHLON, 613908), Project on Breeding from Agriculture Commission of Shanghai (2013-13, 2014-1-3), National Natural Science Foundation of China (31470397, 31270222, 31230051 and 31110103915), Key Project on Basic Research from Science and Technology Commission of Shanghai (14JC1403900, 14391917100), and China Talents of Discipline to Universities (111 Project, B14016). Novel Bioinformatics Company provided support in the form of salaries for authors [JZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai-Kichise Y, 2011, PLANT CELL PHYSIOL, V52, P274, DOI 10.1093/pcp/pcr003; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cervera MT, 1996, THEOR APPL GENET, V93, P733, DOI 10.1007/BF00224069; Chakravarthi BK, 2006, AFR J BIOTECHNOL, V5, P684; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; Cheung F, 2014, NATURE, V514, pS60, DOI 10.1038/514S60a; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Dokku P, 2013, EUPHYTICA, V192, P87, DOI 10.1007/s10681-013-0878-2; Dwivedi S, 2008, PLANT BIOTECHNOL J, V6, P529, DOI 10.1111/j.1467-7652.2008.00343.x; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Edwards M., 2012, Molecular markers in plants, P21; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Hegarty M, 2013, PLANT BIOTECHNOL J, V11, P572, DOI 10.1111/pbi.12045; Henrique R., 2012, EVOLUTION DNA MARKER, P1; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Huang JK, 2002, NATURE, V418, P678, DOI 10.1038/nature01015; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jain M, 2014, PLANT BIOTECHNOL J, V12, P253, DOI 10.1111/pbi.12133; Jeong IS, 2013, RICE, V6, DOI 10.1186/1939-8433-6-6; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kumar A, 2014, J EXP BOT, V65, P6265, DOI 10.1093/jxb/eru363; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; LANDER ES, 1989, GENETICS, V121, P185; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau WCP, 2016, CRIT REV BIOTECHNOL, V36, P87, DOI 10.3109/07388551.2014.923987; Li G, 2012, GENET MOL RES, V11, P4157, DOI 10.4238/2012.September.10.4; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Lu H, 2005, CROP SCI, V45, P66, DOI 10.2135/cropsci2005.0066; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCouch SR, 1997, PLANT MOL BIOL, V35, P89, DOI 10.1023/A:1005711431474; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Ophir R, 2013, ISR J CHEM, V53, P173, DOI 10.1002/ijch.201200090; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Qu Jingtao, 2013, BMC Res Notes, V6, P403, DOI 10.1186/1756-0500-6-403; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Ravn K, 2014, NATURE, V514, pS64, DOI 10.1038/514S64a; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Rozen S, 1998, PRIMER3; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Slater AT, 2014, THEOR APPL GENET, V127, P2279, DOI 10.1007/s00122-014-2386-8; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Takano-Kai N, 2011, BREEDING SCI, V61, P244, DOI 10.1270/jsbbs.61.244; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Via LE, 1993, BIOTECHNIQUES, V14, P748; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waldmuller S, 2008, CLIN CHEM, V54, P682, DOI 10.1373/clinchem.2007.099119; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang L, 2009, J EVOLUTION BIOL, V22, P751, DOI 10.1111/j.1420-9101.2009.01698.x; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Xie CQ, 1998, HEREDITY, V80, P489, DOI 10.1046/j.1365-2540.1998.00308.x; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Zhou L, 2013, BREEDING SCI, V63, P347, DOI 10.1270/jsbbs.63.347	71	15	15	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147187	10.1371/journal.pone.0147187	http://dx.doi.org/10.1371/journal.pone.0147187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799713	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300070
J	Olshefsky, A; Shehata, L; Kuldell, N				Olshefsky, Audrey; Shehata, Laila; Kuldell, Natalie			Site-Directed Mutagenesis to Improve Sensitivity of a Synthetic Two-Component Signaling System	PLOS ONE			English	Article							LIGHT	Two-component signaling (2CS) systems enable bacterial cells to respond to changes in their local environment, often using a membrane-bound sensor protein and a cytoplasmic responder protein to regulate gene expression. Previous work has shown that Escherichia coli's natural EnvZ/OmpR 2CS could be modified to construct a light-sensing bacterial photography system. The resulting bacterial photographs, or "co/iroids," rely on a phosphotransfer reaction between Cph8, a synthetic version of EnvZ that senses red light, and OmpR. Gene expression changes can be visualized through upregulation of a LacZ reporter gene by phosphorylated OmpR. Unfortunately, basal LacZ expression leads to a detectable reporter signal even when cells are grown in the light, diminishing the contrast of the co/iroids. We performed site-directed mutagenesis near the phosphotransfer site of Cph8 to isolate mutants with potentially improved image contrast. Five mutants were examined, but only one of the mutants, T541S, increased the ratio of dark/light gene expression, as measured by P-galactosidase activity. The ratio changed from 2.57 fold in the starting strain to 5.59 in the T541S mutant. The ratio decreased in the four other mutant strains we examined. The phenotype observed in the T541S mutant strain may arise because the serene sidechain is chemically similar but physically smaller than the threonine sidechain. This may minimally change the protein's local structure, but may be less sterically constrained when compared to threonine, resulting in a higher probability of a phosphotransfer event. Our initial success pairing synthetic biology and site-directed mutagenesis to optimize the bacterial photography system's performance encourages us to imagine further improvements to the performance of this and other synthetic systems, especially those based on 2CS signaling.	[Olshefsky, Audrey; Shehata, Laila; Kuldell, Natalie] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kuldell, Natalie] BioBuilder Educ Fdn, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Kuldell, N (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kuldell, N (corresponding author), BioBuilder Educ Fdn, Cambridge, MA USA.	nkuldell@mit.edu						Chu T, 2015, APPL ENV MICROBOL, V81; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Gardner L, 2012, CURR OPIN CHEM BIOL, V16, P292, DOI 10.1016/j.cbpa.2012.04.010; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Rodrigo G, 2007, BMC SYSTEMS BIOL S1, V1, P1; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	9	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147494	10.1371/journal.pone.0147494	http://dx.doi.org/10.1371/journal.pone.0147494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799494	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300115
J	Brown, LR; Komoroske, LM; Wagner, RW; Morgan-King, T; May, JT; Connon, RE; Fangue, NA				Brown, Larry R.; Komoroske, Lisa M.; Wagner, R. Wayne; Morgan-King, Tara; May, Jason T.; Connon, Richard E.; Fangue, Nann A.			Coupled Downscaled Climate Models and Ecophysiological Metrics Forecast Habitat Compression for an Endangered Estuarine Fish	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; CHANGE IMPACTS; CHANGE SCENARIOS; THERMAL TOLERANCE; DELTA SMELT; MARINE; COASTAL; STRESS; CALIFORNIA; PERFORMANCE	Climate change is driving rapid changes in environmental conditions and affecting population and species' persistence across spatial and temporal scales. Integrating climate change assessments into biological resource management, such as conserving endangered species, is a substantial challenge, partly due to a mismatch between global climate forecasts and local or regional conservation planning. Here, we demonstrate how outputs of global climate change models can be downscaled to the watershed scale, and then coupled with ecophysiological metrics to assess climate change effects on organisms of conservation concern. We employed models to estimate future water temperatures (2010-2099) under several climate change scenarios within the large heterogeneous San Francisco Estuary. We then assessed the warming effects on the endangered, endemic Delta Smelt, Hypomesus transpacificus, by integrating localized projected water temperatures with thermal sensitivity metrics (tolerance, spawning and maturation windows, and sublethal stress thresholds) across life stages. Lethal temperatures occurred under several scenarios, but sublethal effects resulting from chronic stressful temperatures were more common across the estuary (median > 60 days above threshold for > 50% locations by the end of the century). Behavioral avoidance of such stressful temperatures would make a large portion of the potential range of Delta Smelt unavailable during the summer and fall. Since Delta Smelt are not likely to migrate to other estuaries, these changes are likely to result in substantial habitat compression. Additionally, the Delta Smelt maturation window was shortened by 18-85 days, revealing cumulative effects of stressful summer and fall temperatures with early initiation of spring spawning that may negatively impact fitness. Our findings highlight the value of integrating sublethal thresholds, life history, and in situ thermal heterogeneity into global change impact assessments. As downscaled climate models are becoming widely available, we conclude that similar assessments at management-relevant scales will improve the scientific basis for resource management decisions.	[Brown, Larry R.; Morgan-King, Tara; May, Jason T.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA; [Komoroske, Lisa M.] NOAA, Natl Res Council, Natl Marine Fisheries Serv, La Jolla, CA USA; [Komoroske, Lisa M.; Fangue, Nann A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Wagner, R. Wayne] Univ Texas Austin, Dept Geol Sci, Austin, TX USA; [Connon, Richard E.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA	United States Department of the Interior; United States Geological Survey; National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; University of Texas System; University of Texas Austin; University of California System; University of California Davis	Brown, LR (corresponding author), US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA.	lrbrown@usgs.gov		Wagner, Wayne/0000-0002-3978-2025	Priority Ecosystem Science Programs of the U.S. Geological Survey; Delta Stewardship Council through the Delta Science Program; University of California Agricultural Experiment Station [2098-H]; United States Department of Interior, Bureau of Reclamation [R12AP20018]; State and Federal Contractors Water Agency [201301957]; California Delta Stewardship Council [201015533]; California Sea Grant Delta Science Doctoral Fellowship [R/SF-56]; National Academies, National Research Council post-doctoral research fellowship	Priority Ecosystem Science Programs of the U.S. Geological Survey; Delta Stewardship Council through the Delta Science Program; University of California Agricultural Experiment Station(University of California System); United States Department of Interior, Bureau of Reclamation; State and Federal Contractors Water Agency; California Delta Stewardship Council; California Sea Grant Delta Science Doctoral Fellowship; National Academies, National Research Council post-doctoral research fellowship	Funding to LRB, TM-K, and JTM was provided by the Priority Ecosystem Science Programs of the U.S. Geological Survey, and by a grant from the Delta Stewardship Council through the Delta Science Program. This work represents contribution 69 of the "CASCaDE: Computational Assessments of Scenarios of Change for the Delta Ecosystem" project. This work was supported by the University of California Agricultural Experiment Station [grant number 2098-H to NAF], the United States Department of Interior, Bureau of Reclamation [contract number R12AP20018 to REC and NAF], the State and Federal Contractors Water Agency [grant number 201301957 to REC] and the California Delta Stewardship Council [contract number 201015533 to REC and NAF]. Partial funding was provided to LMK by the California Sea Grant Delta Science Doctoral Fellowship R/SF-56 and the National Academies, National Research Council post-doctoral research fellowship. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenal T.B., 1978, P75; Baxter R, 2015, AN UPDATED CONCEPTUA; Bennett WA, 2015, ESTUAR COAST, V38, P826, DOI 10.1007/s12237-014-9877-3; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Bennett WA, 1997, COPEIA, P77; Bennett WA, 1997, T AM FISH SOC, V126, P841, DOI 10.1577/1548-8659(1997)126<0841:CTAPOO>2.3.CO;2; Bennett WA, 2008, INTERPLAY OF ENVIRON; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brekke LD, 2004, J AM WATER RESOUR AS, V40, P149, DOI 10.1111/j.1752-1688.2004.tb01016.x; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Brown LR, 2013, ESTUAR COAST, V36, P754, DOI 10.1007/s12237-013-9585-4; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Cavanaugh KC, 2015, GLOBAL CHANGE BIOL, V21, P1928, DOI 10.1111/gcb.12843; Cayan D, 2009, CLIMATE CHANGE SCENA; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cloern JE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044774; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Dege M, 2004, AM FISH S S, V39, P49; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dettinger M.D., 2005, SAN FRANCISCO ESTUAR, V3; Dettinger MD, 2013, CLIMATIC CHANGE, V116, P17, DOI 10.1007/s10584-012-0501-x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Feyrer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067829; FIELDS R, 1987, T AM FISH SOC, V116, P856, DOI 10.1577/1548-8659(1987)116<856:CACTMO>2.0.CO;2; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Fry F.E.J., 1971, P1; Groot C., 1995, PACIFIC SALMON LIFE; Gustafson EJ, 2015, GLOBAL CHANGE BIOL, V21, P843, DOI 10.1111/gcb.12713; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hasenbein M, 2013, INTEGR COMP BIOL, V53, P620, DOI 10.1093/icb/ict082; Helsel D. R., 2002, 4A3 USGS, V4, pA3, DOI DOI 10.3133/TWRI04A3; Hidalgo HG, 2008, DOWNSCALING WITH CON; Hochachka P., 2002, BIOCH ADAPTATION MEC; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann G, 2009, ANNU REV PHYSIOL, V404, P16, DOI DOI 10.1146/ANNUREV-PHYSI0L-021909-135900; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; IPCC (Intergovernmental Panel on Climate Change), 2014, WORKING GROUP II CON; IPCC (Intergovernmental Panel on Climate Change), 2007, CONTRIBUTION WORKING, P793; Kimmerer W., 2004, ESTUARY WATERSHED SC, V2, DOI 10.15447/sfews.2004v2iss1art1; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Komoroske LM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou008; Komoroske LM, 2015, MOL ECOL, V24, P4960, DOI 10.1111/mec.13373; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lawrence DJ, 2015, J ANIM ECOL, V84, P879, DOI 10.1111/1365-2656.12332; Lawrence DJ, 2014, ECOL APPL, V24, P895, DOI 10.1890/13-0753.1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Luoma Samuel N., 2015, San Francisco Estuary & Watershed Science, V13, P7; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; Maurer EP, 2010, HYDROL EARTH SYST SC, V14, P1125, DOI 10.5194/hess-14-1125-2010; McCormick SD, 2013, FISH PHYSIOL, V32, P1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Nakicenovic N, 2000, SPECIAL REPORT EMISS; Nobriga Matthew L., 2008, San Francisco Estuary & Watershed Science, V6, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Schulte PM, 2014, J EXP BIOL, V217, P23, DOI 10.1242/jeb.089722; Snover AK, 2013, CONSERV BIOL, V27, P1147, DOI 10.1111/cobi.12163; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sommer T, SAN FRANCISCO ESTUAR, V11, P2; Sommer T, 2011, SAN FRANCISCO ESTUAR, V9, P2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Swanson C, 1998, J EXP BIOL, V201, P333; Thomson J.R., 2010, ECOLOGICAL APPL, V20, P181, DOI DOI 10.1890/09-0998.1; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Wagner RW, 2011, ESTUAR COAST, V34, P544, DOI 10.1007/s12237-010-9369-z; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Yates D, 2008, CLIMATIC CHANGE, V91, P335, DOI 10.1007/s10584-008-9427-8	79	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146724	10.1371/journal.pone.0146724	http://dx.doi.org/10.1371/journal.pone.0146724			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796147	Green Published, Green Submitted, gold			2022-12-27	WOS:000368530300011
J	Ciach, K; Niedoszytko, M; Abacjew-Chmylko, A; Pabin, I; Adamski, P; Leszczynska, K; Preis, K; Olszewska, H; Wydra, DG; Hansdorfer-Korzon, R				Ciach, Katarzyna; Niedoszytko, Marek; Abacjew-Chmylko, Anna; Pabin, Izabela; Adamski, Przemyslaw; Leszczynska, Katarzyna; Preis, Krzysztof; Olszewska, Hanna; Wydra, Dariusz G.; Hansdorfer-Korzon, Rita			Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM)	PLOS ONE			English	Article							INDOLENT SYSTEMIC MASTOCYTOSIS; COMPLICATING PREGNANCY; CUTANEOUS MASTOCYTOSIS; ANESTHETIC MANAGEMENT; URTICARIA PIGMENTOSA; MAST-CELLS; C-KIT; MUTATION; ANAPHYLAXIS; MECHANISMS	Objective To present current guidelines regarding treatment of mastocytosis in pregnancy on the example of observed patients. Design Case control national study. Setting Polish Center of the European Competence Network on Mastocytosis (ECNM). Population or Sample 23 singleton spontaneous pregnancies in 17 women diagnosed with mastocytosis in years 1999-2014, before becoming pregnant. Methods Prospective analysis outcomes of pregnancies and deliveries. Main Outcome Measures Survey developed in cooperation with the Spanish Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Red Espanola de Mastocitosis (REMA), Spain. Results All 23 pregnancies resulted from natural conception. Obstetrical complications recorded in the first trimester included spontaneous miscarriage (5 pregnancies). Four patients delivered preterm, including one delivery due to preeclampsia at 26 weeks which resulted with neonate death due to extreme prematurity. Five women delivered via cesarean: four due to obstetrical indications and one due to mastocytosis, during which no anesthesia related complications were recorded. Of patients delivering vaginally, two received extradural anesthesia, three required oxytocin infusion due to uterine hypotonia. No labor complications were recorded. In one woman with pregnancy-induced hypertension, early puerperium was complicated by the presence of persistent arterial hypertension. One neonate was born with the signs of cutaneous mastocytosis. Another neonate was diagnosed with Patau syndrome. Four women were treated for mastocytosis prior to conception and continued therapy after becoming pregnant. One patient was put on medications in the first trimester due to worsening of her symptoms. Pregnancy exerted only a slight effect on the intensity and frequency of mastocytosis-related symptoms observed. Worsening of the disease-related symptoms was documented in only four patients (23%). None of the patients showed the signs of anaphylaxis, either before becoming pregnant, or during pregnancy and puerperium. Conclusions There is no contraindication to pregnancy when mastocystosis-related pathologies are under appropriate medical control.	[Ciach, Katarzyna; Pabin, Izabela; Adamski, Przemyslaw; Leszczynska, Katarzyna; Preis, Krzysztof] Med Univ Gdansk, Dept Obstet, Gdansk, Poland; [Niedoszytko, Marek] Med Univ Gdansk, Dept Allergol, Gdansk, Poland; [Abacjew-Chmylko, Anna; Olszewska, Hanna; Wydra, Dariusz G.] Med Univ Gdansk, Dept Gynecol Gynecol Oncol & Gynecol Endocrinol, Gdansk, Poland; [Hansdorfer-Korzon, Rita] Med Univ Gdansk, Dept Physiotherapy, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Ciach, K (corresponding author), Med Univ Gdansk, Dept Obstet, Gdansk, Poland.	kciach@wp.pl	Hansdorfer-Korzon, Rita/U-2883-2018; Wydra, Dariusz G/F-5186-2016; Wydra, Dariusz/ABD-1189-2020; Niedoszytko, Marek/U-1250-2018	Hansdorfer-Korzon, Rita/0000-0003-3777-9153; Wydra, Dariusz G/0000-0002-6755-1478; Niedoszytko, Marek/0000-0003-1089-1911; Wydra, Dariusz/0000-0002-4510-9558				Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; *AM COLL RAD, 2007, PRACT GUID TECHN STA, P73; Bruns S. B., 2003, Journal of Allergy and Clinical Immunology, V111, pS323, DOI 10.1016/S0091-6749(03)81179-X; Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33; Ciach K, 2014, ALERGOL POL, V1, P166, DOI 10.1016/j.alergo.2014.11.003; COLLADA JCG, 2000, REV ESP ANESTESIOL R, V47, P326; Cunningham FG, 1997, WILLIAMS OBSTET, P261; DONAHUE JG, 1995, OBSTET GYNECOL, V85, P813, DOI 10.1016/0029-7844(94)00305-W; Einarson A, 1997, ANN ALLERG ASTHMA IM, V78, P183, DOI 10.1016/S1081-1206(10)63385-6; Garfield RE, 2006, AM J OBSTET GYNECOL, V194, P261, DOI 10.1016/j.ajog.2005.05.011; Greenhawt M, 2007, CURR OPIN ALLERGY CL, V7, P387, DOI 10.1097/ACI.0b013e3282a6443e; Gupta S, 1998, INT J OBSTET ANESTH, V7, P261, DOI 10.1016/S0959-289X(98)80049-6; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Kehoe SL, 2006, OBSTET GYNECOL, V107, P514, DOI 10.1097/01.AOG.0000174579.44885.db; Kristensen T, 2014, AM J HEMATOL, V89, P493, DOI 10.1002/ajh.23672; Lange M, 2016, ACTA DERM-VENEREOL, V96, P292, DOI 10.2340/00015555-2210; Maatouk A, 2013, J GYNECOL OBST BIO R, V42, P117, DOI 10.1016/j.jgyn.2011.11.010; Madendag IC, 2010, TAIWAN J OBSTET GYNE, V49, P192, DOI 10.1016/S1028-4559(10)60040-X; Matito A, 2011, INT ARCH ALLERGY IMM, V156, P104, DOI 10.1159/000321954; Metcalfe DD, 2001, LEUKEMIA RES, V25, P577, DOI 10.1016/S0145-2126(01)00046-7; MULLINS RJ, 1991, LANCET, V338, P1279, DOI 10.1016/0140-6736(91)92152-R; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Notter A, 1969, Bull Fed Soc Gynecol Obstet Lang Fr, V21, P455; Rausz E, 2013, BRIT J HAEMATOL, V160, P216, DOI 10.1111/bjh.12086; RUDOLPH MI, 1993, BRIT J OBSTET GYNAEC, V100, P1125, DOI 10.1111/j.1471-0528.1993.tb15178.x; Schwarz EB, 2008, DRUG SAFETY, V31, P775, DOI 10.2165/00002018-200831090-00006; Shank JJ, 2009, OBSTET GYNECOL, V114, P415, DOI 10.1097/AOG.0b013e3181a20721; SOTER NA, 1991, J INVEST DERMATOL, V96, pS32, DOI 10.1111/1523-1747.ep12468973; Ulbrich F, 2013, INT J OBSTET ANESTH, V22, P243, DOI 10.1016/j.ijoa.2013.03.011; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; van Doormaal JJ, 2013, J ALLERGY CLIN IMMUN, V131, P1429, DOI 10.1016/j.jaci.2012.10.015; Villeneuve V, 2006, CAN J ANAESTH, V53, P380, DOI 10.1007/BF03022503; Wasag B, 2011, EXP HEMATOL, V39, P859, DOI 10.1016/j.exphem.2011.05.009; Watson KD, 2012, OBSTET GYNECOL, V119, P486, DOI 10.1097/AOG.0b013e318242d3c5; Wolbing F, 2013, ALLERGY, V68, P1085, DOI 10.1111/all.12193; Woidacki K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00231; Worobec AS, 2000, OBSTET GYNECOL, V95, P391, DOI 10.1016/S0029-7844(99)00591-8	37	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146924	10.1371/journal.pone.0146924	http://dx.doi.org/10.1371/journal.pone.0146924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796887	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300015
J	Loe, H; Nes, BM; Wisloff, U				Loe, Henrik; Nes, Bjarne M.; Wisloff, Ulrik			Predicting VO2peak from Submaximal- and Peak Exercise Models: The HUNT 3 Fitness Study, Norway	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; CARDIORESPIRATORY FITNESS; HEART-RATE; AEROBIC CAPACITY; ALL-CAUSE; TREADMILL; MORTALITY; EQUATIONS; WALKING; VO2MAX	Purpose Peak oxygen uptake (VO2peak) is seldom assessed in health care settings although being inversely linked to cardiovascular risk and all-cause mortality. The aim of this study was to develop VO2peak prediction models for men and women based on directly measured VO2peak from a large healthy population Methods VO2peak prediction models based on submaximal- and peak performance treadmill work were derived from multiple regression analysis. 4637 healthy men and women aged 20-90 years were included. Data splitting was used to generate validation and cross-validation samples. Results The accuracy for the peak performance models were 10.5% (SEE = 4.63 mL.kg(-1).min(-1)) and 11.5% (SEE = 4.11 mL.kg(-1).min(-1)) for men and women, respectively, with 75% and 72% of the variance explained. For the submaximal performance models accuracy were 14.1% (SEE = 6.24 mL.kg(-1).min(-1)) and 14.4% (SEE = 5.17 mL.kg(-1).min(-1)) for men and women, respectively, with 55% and 56% of the variance explained. The validation and cross-validation samples displayed SEE and variance explained in agreement with the total sample. Cross-classification between measured and predicted VO2peak accurately classified 91% of the participants within the correct or nearest quintile of measured VO2peak. Conclusion Judicious use of the exercise prediction models presented in this study offers valuable information in providing a fairly accurate assessment of VO2peak, which may be beneficial for risk stratification in health care settings.	[Loe, Henrik; Nes, Bjarne M.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Loe, Henrik] Valnesfjord Rehabil Ctr, Valnesfjord, Norway	Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	Ulrik.wisloff@ntnu.no	Nes, Bjarne Martens/I-2903-2016	Nes, Bjarne Martens/0000-0002-9958-8179; Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on cardiovascular Disease; Research Council of Norway; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	K.G. Jebsen Foundation; Norwegian Council on cardiovascular Disease; Research Council of Norway(Research Council of Norway); Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	This study was funded by K.G. Jebsen Foundation, The Norwegian Council on cardiovascular Disease, The Research Council of Norway, Foundation for Cardiovascular Research at St. Olav's Hospital, Norwegian State Railways, Roche Norway Incorporated and Valnesfjord Rehabilitation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, ACSMS GUIDELINES FOR; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Astrand PO, 2003, PHYSIOLOGICAL BASES; Billinger SA, 2012, MED SCI SPORT EXER, V44, P1539, DOI 10.1249/MSS.0b013e31824f5be4; Cao ZB, 2013, J PHYS ACT HEALTH, V10, P280, DOI 10.1123/jpah.10.2.280; Cao ZB, 2010, MED SCI SPORT EXER, V42, P179, DOI 10.1249/MSS.0b013e3181af238d; Cao ZB, 2009, EUR J APPL PHYSIOL, V105, P289, DOI 10.1007/s00421-008-0902-8; Cink R E, 1981, Br J Sports Med, V15, P182; Coquart JBJ, 2010, EUR J APPL PHYSIOL, V110, P645, DOI 10.1007/s00421-010-1524-5; Esco MR, 2012, J STRENGTH COND RES, V26, P1920, DOI 10.1519/JSC.0b013e318238e863; Evans HJL, 2015, J SCI MED SPORT, V18, P183, DOI 10.1016/j.jsams.2014.03.006; FAULKNER JA, 1971, J APPL PHYSIOL, V30, P457, DOI 10.1152/jappl.1971.30.4.457; Faulkner J, 2007, EUR J APPL PHYSIOL, V101, P397, DOI 10.1007/s00421-007-0508-6; Guazzi M, 2012, CIRCULATION, V126, P2261, DOI 10.1161/CIR.0b013e31826fb946; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; HEIL DP, 1995, MED SCI SPORT EXER, V27, P599; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Kendall KL, 2012, J STRENGTH COND RES, V26, P733, DOI 10.1519/JSC.0b013e318225f3ac; Kilding AE, 2006, J SPORT MED PHYS FIT, V46, P366; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koutlianos N, 2013, HIPPOKRATIA, V17, P136; Lamberts RP, 2014, INT J SPORTS MED, V35, P217, DOI 10.1055/s-0033-1349139; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Magrani P, 2010, ARQ BRAS CARDIOL, V94, P763, DOI 10.1590/S0066-782X2010005000054; Malek MH, 2005, J STRENGTH COND RES, V19, P559; Malek MH, 2004, MED SCI SPORT EXER, V36, P1427, DOI 10.1249/01.MSS.0000135795.60449.CE; Marsh CE, 2012, J STRENGTH COND RES, V26, P548, DOI 10.1519/JSC.0b013e3181bac56e; MILES DS, 1980, MED SCI SPORT EXER, V12, P14; MIYAMURA M, 1972, J APPL PHYSIOL, V32, P185, DOI 10.1152/jappl.1972.32.2.185; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nes BM, 2011, MED SCI SPORT EXER, V43, P2024, DOI 10.1249/MSS.0b013e31821d3f6f; OJA P, 1991, INT J SPORTS MED, V12, P356, DOI 10.1055/s-2007-1024694; Okura Tomohiro, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P255, DOI 10.2114/jpa.20.255; Roca J, 1997, EUR RESPIR J, V10, P2662; ROSNER B., 2006, FUNDAMENTALS OF BIOS; Rotstein A, 2005, MED SCI SPORT EXER, V37, P1864, DOI 10.1249/01.mss.0000177217.12977.2f; ROWELL LB, 1964, J APPL PHYSIOL, V19, P919, DOI 10.1152/jappl.1964.19.5.919; Skalski J, 2012, CIRCULATION, V126, P2465, DOI 10.1161/CIRCULATIONAHA.112.110460; Stamatakis E, 2013, EUR HEART J, V34, P750, DOI 10.1093/eurheartj/ehs097; Swain DP, 1997, MED SCI SPORT EXER, V29, P1104, DOI 10.1097/00005768-199708000-00017; Tsiaras V, 2010, PEDIATR EXERC SCI, V22, P624, DOI 10.1123/pes.22.4.624; Turvey MT, 1999, J MOTOR BEHAV, V31, P265, DOI 10.1080/00222899909600993; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; Wier LT, 2006, MED SCI SPORT EXER, V38, P555, DOI 10.1249/01.mss.0000193561.64152	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144873	10.1371/journal.pone.0144873	http://dx.doi.org/10.1371/journal.pone.0144873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794677	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300003
J	Masiye, F; Kaonga, O; Kirigia, JM				Masiye, Felix; Kaonga, Oliver; Kirigia, Joses M.			Does User Fee Removal Policy Provide Financial Protection from Catastrophic Health Care Payments? Evidence from Zambia	PLOS ONE			English	Article							AFRICA; INSURANCE; EXEMPTIONS; COUNTRIES; SERVICES; BARRIERS; ACCESS; UGANDA; IMPACT; MALI	Background Out-of-pocket payments in health care have been shown to impose significant burden on households in Sub-Saharan Africa, leading to constrained access to health care and impoverishment. In an effort to reduce the financial burden imposed on households by user fees, some countries in Sub-Saharan Africa have abolished user fees in the health sector. Zambia is one of few countries in Sub-Saharan Africa to abolish user fees in primary health care facilities with a view to alleviating financial burden of out-of-pocket payments among the poor. The main aim of this paper was to examine the extent and patterns of financial protection from fees following the decision to abolish user fees in public primary health facilities. Methods Our analysis is based on a nationally representative health expenditure and utilization survey conducted in 2014. We calculated the incidence and intensity of catastrophic health expenditure based on households' out-of-pocket payments during a visit as a percentage of total household consumption expenditure. We further show the intensity of the problem of catastrophic health expenditure (CHE) experienced by households. Results Our analysis show that following the removal of user fees, a majority of patients who visited public health facilities benefitted from free care at the point of use. Further, seeking care at public primary health facilities is associated with a reduced likelihood of incurring CHE after controlling for economic wellbeing and other covariates. However, 10% of households are shown to suffer financial catastrophe as a result of out-of-pocket payments. Further, there is considerable inequality in the incidence of CHE whereby the poorest expenditure quintile experienced a much higher incidence. Conclusion Despite the removal of user fees at primary health care level, CHE is high among the poorest sections of the population. This study also shows that cost of transportation is mainly responsible for limiting the protective effectiveness of user fee removal on CHE among particularly poorest households.	[Masiye, Felix; Kaonga, Oliver] Univ Zambia, Sch Humanities & Social Sci, Dept Econ, Lusaka, Zambia; [Kirigia, Joses M.] WHO, Reg Off Africa WHO AFRO, Brazzaville, Rep Congo	University of Zambia; World Health Organization	Masiye, F (corresponding author), Univ Zambia, Sch Humanities & Social Sci, Dept Econ, Lusaka, Zambia.	fmasiye@yahoo.com		KIRIGIA, Joses Muthuri/0000-0002-2317-4666; Kaonga, Oliver/0000-0001-8256-2717	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Central Statistics Office, 2012, LIVING CONDITIONS MO; Central Statistics Office, 2014, ZAMB HOUS EXP UT SUR; Chuma J, 2012, BMC HLTH SERVICES RE; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Government of Zambia, 2006, NATIONAL HEALTH ACCO; Hatt LE, 2013, J HEALTH POPUL NUTR, V31, P67; Hjortsberg C, 2003, HEALTH ECON, V12, P755, DOI 10.1002/hec.839; Kwesiga B, 2015, BMC HLTH SERVICES RE, V15; Lagarde M, 2012, J HEALTH SERV RES PO, V17, P30, DOI 10.1258/jhsrp.2011.010166; Laokri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056752; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Masiye FC, 2008, 57 EQ; Masiye F, 2010, SOC SCI MED, V71, P743, DOI 10.1016/j.socscimed.2010.04.029; McLaren ZM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0541-1; Mwabu G, 1996, APPL ECON LETT, V3, P213, DOI 10.1080/758520866; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Orem JN, 2011, HEALTH POLICY PLANN, V26, pII41, DOI 10.1093/heapol/czr065; Parkhurst JO, 2009, HEALTH POLICY PLANN, V24, P377, DOI 10.1093/heapol/czp023; Ponsar F, 2011, INT HEALTH, V3, P91, DOI 10.1016/j.inhe.2011.01.002; Ridde V, 2011, HEALTH POLICY PLANN, V26, pII30, DOI 10.1093/heapol/czr060; Saksena P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001701; Sambo LG, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0028-5; Sambo Luis Gomes, 2013, Int Arch Med, V6, P10, DOI 10.1186/1755-7682-6-10; Spaan E, 2012, B WORLD HEALTH ORGAN, V90, P685, DOI 10.2471/BLT.12.102301; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; WHO, 2010, WOR HEALT REP, P1; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Xu K, 2005, TECHNICAL BRIEFS FOR	35	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146508	10.1371/journal.pone.0146508	http://dx.doi.org/10.1371/journal.pone.0146508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5CE	26795620	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300008
J	Prins-van Ginkel, AC; Berbers, GAM; Grundeken, LH; Tcherniaeva, I; Wittenberns, JI; Elberse, K; Mollema, L; de Melker, HE; Knol, MJ				Prins-van Ginkel, Annemarijn C.; Berbers, Guy A. M.; Grundeken, Lucienne H.; Tcherniaeva, Irina; Wittenberns, Jelle I.; Elberse, Karin; Mollema, Liesbeth; de Melker, Hester E.; Knol, Mirjam J.			Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era	PLOS ONE			English	Article							7-VALENT CONJUGATE VACCINE; COMMUNITY-LEVEL PREDICTORS; STREPTOCOCCUS-PNEUMONIAE; RISK-FACTORS; NASOPHARYNGEAL CARRIAGE; YOUNG-CHILDREN; DISEASE; NETHERLANDS; POPULATION; POLYSACCHARIDES	Introduction Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumococcal disease (IPD), while non-vaccine serotype IPD increased. To fully understand this serotype replacement, knowledge about serotype dynamics in the pre-vaccine era is needed. In addition to IPD surveillance and carriage studies, the serotype replacement can be investigated by serosurveillance studies. The current study compared the results of two Dutch serosurveillance studies conducted in 1995-1996 (PIENTER1) and 2006-2007 (PIENTER2). Methods Participants in these studies donated a blood sample and completed a questionnaire. Pneumococcal antibodies of serotypes included in PCV13 were measured with a fluorescent-bead based multiplex immunoassay. Geometric mean antibody concentrations (GMCs) and determinants of pneumococcal antibody levels were investigated. Results GMCs were higher in PIENTER2 for serotypes 1, 6A, 6B, 9V, 18C, 19F and 23F and lower for 3 and 5. Age, day care attendance, household size, vaccination coverage, and urbanisation rate were associated with pneumococcal antibodies in children. Education level, ethnicity, age, low vaccination coverage sample, urbanisation rate, and asthma/COPD were associated with pneumococcal antibodies in elderly. The determinants significantly associated with pneumococcal IgG were slightly different for the elderly in PIENTER1 compared to the elderly in PIENTER2. Conclusion Although most of the serotype antibody levels remained stable, some of the serotype-specific antibody levels varied during the pre-vaccine era, indicating that exposure of certain serotypes changes without interference of PCVs.	[Prins-van Ginkel, Annemarijn C.; Berbers, Guy A. M.; Grundeken, Lucienne H.; Tcherniaeva, Irina; Wittenberns, Jelle I.; Elberse, Karin; Mollema, Liesbeth; de Melker, Hester E.; Knol, Mirjam J.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Prins-van Ginkel, AC (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	annemarijn.van.ginkel@rivm.nl		Prins-van Ginkel, Annemarijn/0000-0002-0767-736X	Ministry of Health, Welfare and Sports (VWS)	Ministry of Health, Welfare and Sports (VWS)	The PIENTER-studies were financed by the Ministry of Health, Welfare and Sports (VWS).	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Balmer P, 2007, CLIN VACCINE IMMUNOL, V14, P1442, DOI 10.1128/CVI.00264-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Cekmez Ferhat, 2009, Int J Biomed Sci, V5, P101; Ciruela P, 2013, VACCINE, V31, P960, DOI 10.1016/j.vaccine.2012.11.102; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; Elberse KEM, 2011, VACCINE, V29, P1029, DOI 10.1016/j.vaccine.2010.11.054; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; Helferty M, 2013, INT J CIRCUMPOL HEAL, V72, P666, DOI 10.3402/ijch.v72i0.21606; Hsieh YC, 2012, PEDIATR INFECT DIS J, V31, pE163, DOI 10.1097/INF.0b013e31825cb9f9; Hsu KK, 2014, EPIDEMIOL INFECT, V142, P379, DOI 10.1017/S0950268813000794; Huang SS, 2004, AM J EPIDEMIOL, V159, P645, DOI 10.1093/aje/kwh088; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jung JA, 2010, POSTGRAD MED, V122, P116, DOI 10.3810/pgm.2010.09.2208; Keck JW, 2014, VACCINE, V32, P6478, DOI 10.1016/j.vaccine.2014.09.037; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Mollema L, 2009, PIENTER 2 PROJECT 2; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; Roche A, 2007, ARCH DIS CHILD, V92, P1073, DOI 10.1136/adc.2007.126359; Sankilampi U, 1997, INT J EPIDEMIOL, V26, P420, DOI 10.1093/ije/26.2.420; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Ueno M, 2013, JPN J INFECT DIS, V66, P22, DOI 10.7883/yoken.66.22; van der Klis FRM, 2009, NETH J MED, V67, P301; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147437	10.1371/journal.pone.0147437	http://dx.doi.org/10.1371/journal.pone.0147437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796783	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300034
J	Singh, R; Nawale, L; Sarkar, D; Suresh, CG				Singh, Ruby; Nawale, Laxman; Sarkar, Dhiman; Suresh, C. G.			Two Chitotriose-Specific Lectins Show Anti-Angiogenesis, Induces Caspase-9-Mediated Apoptosis and Early Arrest of Pancreatic Tumor Cell Cycle	PLOS ONE			English	Article							CONCANAVALIN-A; CANCER; PROLIFERATION; ACTIVATION; AUTOPHAGY; GROWTH	The antiproliferative activity of two chito-specific agglutinins purified from Benincasa hispida (BhL) and Datura innoxia (DiL9) of different plant family origin was investigated on various cancer cell lines. Both lectins showed chitotriose specificity, by inhibiting lectin hemagglutinating activity. On further studies, it was revealed that these agglutinins caused remarkable concentration-dependent antiproliferative effect on human pancreatic cancerous cells but not on the normal human umbilical vein endothelial cells even at higher doses determined using MTT assay. The GI(50) values were approximately 8.4 mu g ml(-1) (0.247 mu M) and 142 mu g ml(-1) (14.8 mu M) for BhL and DiL9, respectively, against PANC-1 cells. The growth inhibitory effect of these lectins on pancreatic cancer cells were shown to be a consequence of lectin cell surface binding and triggering G(0)/G(1) arrest, mitochondrial membrane depolarization, sustained increase of the intracellular calcium release and the apoptotic signal is amplified by activation of caspases executing cell death. Interestingly, these lectins also showed anti-angiogenic activity by disrupting the endothelial tubulogenesis. Therefore, we report for the first time two chito-specific lectins specifically binding to tumor glycans; they can be considered to be a class of molecules with antitumor activity against pancreatic cancer cells mediated through caspase dependent mitochondrial apoptotic pathway.	[Singh, Ruby; Suresh, C. G.] CSIR Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India; [Nawale, Laxman; Sarkar, Dhiman] CSIR Natl Chem Lab, Combichem Bioresource Ctr, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Suresh, CG (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Pune, Maharashtra, India.; Sarkar, D (corresponding author), CSIR Natl Chem Lab, Combichem Bioresource Ctr, Pune, Maharashtra, India.	d.sarkar@ncl.res.in; cg.suresh@ncl.res.in	Sarkar, Dhiman/AAK-7481-2020	Sarkar, Dhiman/0000-0002-3912-1104; Nawale, Laxman/0000-0002-9538-6561	CSIR, New Delhi, India	CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	RS received Senior Research Fellowship of CSIR, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RS received Senior Research Fellowship of CSIR, New Delhi, India. RS is a registered PhD student of AcSIR and DS & CGS are faculty of AcSIR.	AUB JC, 1965, P NATL ACAD SCI USA, V54, P400, DOI 10.1073/pnas.54.2.400; Belotti D, 1996, CLIN CANCER RES, V2, P1843; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23; Folkman J, 1992, Semin Cancer Biol, V3, P65; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gastman B, 2004, BIOCHEM BIOPH RES CO, V316, P263, DOI 10.1016/j.bbrc.2004.02.043; Han SJ, 2009, J GYNECOL ONCOL, V20, P113, DOI 10.3802/jgo.2009.20.2.113; Haugland RP, 1996, HDB FLUORESCENT PROB, P266; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang TB, 2007, J BIOCHEM MOL BIOL, V40, P959; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li WW, 2011, BIOCHEM BIOPH RES CO, V414, P282, DOI 10.1016/j.bbrc.2011.09.072; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Lyu SY, 2002, ARCH PHARM RES, V25, P93, DOI 10.1007/BF02975269; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; McCarter C, 2015, PROTEOM CLIN APPL, V7, P632; McLane Mary Ann, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P327, DOI 10.2174/1568006043335880; Minamiguchi K, 2001, INT J CANCER, V93, P307, DOI 10.1002/ijc.1321; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; Pujari R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079311; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Roukos V, 2015, NAT PROTOC, V10, P334, DOI 10.1038/nprot.2015.016; Savanur MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110107; Shiratsuchi A, 1998, BIOCHEM BIOPH RES CO, V246, P549, DOI 10.1006/bbrc.1998.8663; Singh R, 2015, INT J BIOCH RES REV, V9, P1; Suen YK, 2000, APOPTOSIS, V5, P369, DOI 10.1023/A:1009691727077; Tatsuta T, 2013, INT J ONCOL, V43, P1402, DOI 10.3892/ijo.2013.2092; Valentiner U, 2003, ANTICANCER RES, V23, P1197; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146110	10.1371/journal.pone.0146110	http://dx.doi.org/10.1371/journal.pone.0146110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795117	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300005
J	Cartwright, R; Newton, C; West, KM; Rice, J; Niemeyer, M; Burek, K; Wilson, A; Wall, AN; Remonida-Bennett, J; Tejeda, A; Messi, S; Marcial-Hernandez, L				Cartwright, Rachel; Newton, Cori; West, Kristi M.; Rice, Jim; Niemeyer, Misty; Burek, Kathryn; Wilson, Andrew; Wall, Alison N.; Remonida-Bennett, Jean; Tejeda, Areli; Messi, Sarah; Marcial-Hernandez, Lila			Tracking the Development of Muscular Myoglobin Stores in Mysticete Calves	PLOS ONE			English	Article							WHALES MEGAPTERA-NOVAEANGLIAE; BODY OXYGEN STORES; ESCHRICHTIUS-ROBUSTUS; SKELETAL-MUSCLES; DIVING BEHAVIOR; HUMPBACK WHALE; LOCOMOTORY MUSCLES; BAJA-CALIFORNIA; MARINE MAMMALS; ONTOGENY	For marine mammals, the ability to tolerate apnea and make extended dives is a defining adaptive trait, facilitating the exploitation of marine food resources. Elevated levels of myoglobin within the muscles are a consistent hallmark of this trait, allowing oxygen collected at the surface to be stored in the muscles and subsequently used to support extended dives. In mysticetes, the largest of marine predators, details on muscular myoglobin levels are limited. The developmental trajectory of muscular myoglobin stores has yet to be documented and any physiological links between early behavior and the development of muscular myoglobin stores remain unknown. In this study, we used muscle tissue samples from stranded mysticetes to investigate these issues. Samples from three different age cohorts and three species of mysticetes were included (total sample size = 18). Results indicate that in mysticete calves, muscle myoglobin stores comprise only a small percentage (17-23%) of con-specific adult myoglobin complements. Development of elevated myoglobin levels is protracted over the course of extended maturation in mysticetes. Additionally, comparisons of myoglobin levels between and within muscles, along with details of interspecific differences in rates of accumulation of myoglobin in very young mysticetes, suggest that levels of exercise may influence the rate of development of myoglobin stores in young mysticetes. This new information infers a close interplay between the physiology, ontogeny and early life history of young mysticetes and provides new insight into the pressures that may shape adaptive strategies in migratory mysticetes. Furthermore, the study highlights the vulnerability of specific age cohorts to impending changes in the availability of foraging habitat and marine resources.	[Cartwright, Rachel; Newton, Cori; Wilson, Andrew; Wall, Alison N.; Remonida-Bennett, Jean; Tejeda, Areli; Messi, Sarah; Marcial-Hernandez, Lila] Calif State Univ Channel Isl, Camarillo, CA USA; [Cartwright, Rachel] Keiki Kohola Project, Lahaina, HI USA; [West, Kristi M.] Hawaii Pacific Univ, Hawaii Pacific Univ Stranding Program, Coll Nat & Computat Sci, Kaneohe, HI USA; [Rice, Jim] Oregon State Univ, Oregon Marine Mammal Stranding Network, Marine Mammal Inst, Newport, OR USA; [Niemeyer, Misty] Int Fund Anim Welf, Yarmouth Port, MA USA; [Burek, Kathryn] Alaska Vet Pathol Serv, Eagle River, AK USA	California State University System; California State University Channel Islands; Oregon State University	Cartwright, R (corresponding author), Calif State Univ Channel Isl, Camarillo, CA USA.; Cartwright, R (corresponding author), Keiki Kohola Project, Lahaina, HI USA.	rachel.cartwright@csuci.edu			John H. Prescott Marine Mammal Rescue Assistance Grant Program; Provost's Faculty Resource Fund; California State University Channel Islands; Biology Department; Project Acceso, California State University Channel Islands	John H. Prescott Marine Mammal Rescue Assistance Grant Program; Provost's Faculty Resource Fund; California State University Channel Islands; Biology Department; Project Acceso, California State University Channel Islands	Funds to support the work of Oregon Marine Mammal Stranding Network and Hawaii Pacific University Stranding Program are provided by the John H. Prescott Marine Mammal Rescue Assistance Grant Program. Funds to cover laboratory work were provided through a grant from the Provost's Faculty Resource Fund, California State University Channel Islands, with additional supplies provided by the Biology department of the university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful for support provided by the Biology Department, the Provost's Faculty Resource Fund and Project Acceso, California State University Channel Islands. Additional thanks to Michael Mahoney and Catherine Hutchinson for their assistance during laboratory work, to Blake Gillespie, for assistance at the out-set of this study and to Phil Clapham, for support in the final stages of this study. We would also like to thank the many volunteers of the Hawaii Pacific University Stranding Program, the Oregon Marine Mammal Stranding Network, the International Fund for Animal Welfare and the Alaska Stranding Network for the provision of tissue samples used in the study. Additionally, thanks go to Michelle Berman, Santa Barbara Natural History Museum, for the provision of additional tissue samples for use as controls in the study.	ARKOWITZ R, 1985, MAR MAMMAL SCI, V1, P203, DOI 10.1111/j.1748-7692.1985.tb00009.x; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Best P. B., 1982, Report, International Whaling Commission, V32, P759; BLAKE RW, 1983, J MAR BIOL ASSOC UK, V63, P61, DOI 10.1017/S0025315400049808; Boyd PW, 2015, NAT CLIM CHANGE, V5, P71, DOI [10.1038/NCLIMATE2441, 10.1038/nclimate2441]; Calambokidis J, 2010, PAPER SC 62 BRG32 PR; Cartwright R., 2005, THESIS; Cartwright R, 2009, MAR MAMMAL SCI, V25, P659, DOI 10.1111/j.1748-7692.2009.00286.x; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; CHITTLEBOROUGH R. G., 1958, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V9, P1; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; De Miranda MA, 2012, J EXP BIOL, V215, P806, DOI 10.1242/jeb.060681; Dolar MLL, 1999, J EXP BIOL, V202, P227; EDEL RK, 1978, MAR BIOL, V48, P279, DOI 10.1007/BF00397155; Etnier SA, 2004, P ROY SOC B-BIOL SCI, V271, P909, DOI 10.1098/rspb.2004.2683; FISH FE, 1991, MAMMAL REV, V21, P181, DOI 10.1111/j.1365-2907.1991.tb00292.x; Ford JKB, 2005, MAR MAMMAL SCI, V21, P603, DOI 10.1111/j.1748-7692.2005.tb01254.x; Ford JKB, 2008, MAMMAL REV, V38, P50, DOI 10.1111/j.1365-2907.2008.00118.x; Geiseler SJ, 2013, J EXP BIOL, V216, P1793, DOI 10.1242/jeb.082099; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Helbo S, 2012, J EXP BIOL, V215, P3403, DOI 10.1242/jeb.073726; Hertel H., 1966, STRUCTURE FORM MOVEM; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Horwood JW, 1989, BIOLOGY AND EXPLOITA; Kanatous SB, 2008, J EXP BIOL, V211, P2559, DOI 10.1242/jeb.018119; Kanatous SB, 2002, J EXP BIOL, V205, P3601; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Kooyman GL, 1989, DIVERSE DIVERS PHYSI; LAWRIE RA, 1952, NATURE, V170, P122, DOI 10.1038/170122a0; Lestyk KC, 2009, J COMP PHYSIOL B, V179, P985, DOI 10.1007/s00360-009-0378-9; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; MACARTHUR RA, 1990, J COMP PHYSIOL B, V160, P593; McIntyre IW, 2002, J EXP BIOL, V205, P45; Millikan GA, 1939, PHYSIOL REV, V19, P503, DOI 10.1152/physrev.1939.19.4.503; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Noren SR, 2008, FUNCT ECOL, V22, P278, DOI 10.1111/j.1365-2435.2007.01353.x; Noren SR, 2014, J COMP PHYSIOL B, V184, P1065, DOI 10.1007/s00360-014-0854-8; Noren SR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P482, DOI 10.1086/430228; Noren SR, 2002, J ZOOL, V258, P105, DOI 10.1017/S0952836902001243; Noren SR, 2001, J COMP PHYSIOL B, V171, P127, DOI 10.1007/s003600000161; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; NORRIS KS, 1977, FISH B-NOAA, V75, P159; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; PABST DA, 1993, J ZOOL, V230, P159, DOI 10.1111/j.1469-7998.1993.tb02679.x; Pacheco AS, 2013, REV BIOL MAR OCEANOG, V48, P185, DOI 10.4067/S0718-19572013000100016; Polasek LK, 2001, J EXP BIOL, V204, P209; Ponganis PJ, 2010, J EXP BIOL, V213, P1901, DOI 10.1242/jeb.042093; Ponganis PJ, 2011, COMPR PHYSIOL, V1, P447, DOI 10.1002/cphy.c091003; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Prewitt JS, 2010, J COMP PHYSIOL B, V180, P757, DOI 10.1007/s00360-010-0448-z; REED JZ, 1994, J EXP BIOL, V194, P33; REYNAFARJE B, 1963, J LAB CLIN MED, V61, P138; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; Rice DW, 1971, THE LIFE HISTORY AND; Richmond JP, 2006, J COMP PHYSIOL B, V176, P535, DOI 10.1007/s00360-006-0076-9; de la Gala-Hernandez SR, 2008, CAN J ZOOL, V86, P307, DOI 10.1139/Z07-141; Schlater AE, 2014, J APPL PHYSIOL, V117, P307, DOI 10.1152/japplphysiol.00973.2013; Scholander P. F., 1940, Hvalradets Skrifter, Vno. 22, P1; SNYDER GK, 1983, RESP PHYSIOL, V54, P269, DOI 10.1016/0034-5687(83)90072-5; Stelle LL, 2008, MAR MAMMAL SCI, V24, P462, DOI 10.1111/j.1748-7692.2008.00205.x; STEPHENSON R, 1989, J EXP BIOL, V141, P265; Stevick PT, 1999, MAR MAMMAL SCI, V15, P725, DOI 10.1111/j.1748-7692.1999.tb00839.x; SUMICH JL, 1986, MAR MAMMAL SCI, V2, P145, DOI 10.1111/j.1748-7692.1986.tb00035.x; Swartz S.L., 1983, International Whaling Commission Report of the Commission, V33, P503; Szabo A, 2008, ANIM BEHAV, V75, P1085, DOI 10.1016/j.anbehav.2007.08.019; TAWARA T, 1949, YAKUGAKU ZASSHI, V69, P539, DOI 10.1248/yakushi1947.69.12_539; Thiemann GW, 2008, MAR MAMMAL SCI, V24, P91, DOI 10.1111/j.1748-7692.2007.00165.x; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; Thorson P., 1994, ELEPHANT SEALS POPUL; Tyson RB, 2012, MAR ECOL PROG SER, V457, P209, DOI 10.3354/meps09708; Verrier D, 2011, FUNCT ECOL, V25, P818, DOI 10.1111/j.1365-2435.2011.01846.x; VIDELER J, 1985, J EXP BIOL, V119, P265; WHITEHEAD H, 1985, Investigations on Cetacea, V17, P117; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Wittenberg BA, 2009, AM J PHYSIOL-CELL PH, V296, pC390, DOI 10.1152/ajpcell.00002.2009	78	14	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145893	10.1371/journal.pone.0145893	http://dx.doi.org/10.1371/journal.pone.0145893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788728	Green Published, gold			2022-12-27	WOS:000368529100018
J	Jiang, ZH; Wang, XH; Tan, XM; Fan, ZN				Jiang, ZhongHua; Wang, XiaoHong; Tan, XueMing; Fan, ZhiNing			Effect of Age on Survival Outcome in Operated and Non-Operated Patients with Colon Cancer: A Population-Based Study	PLOS ONE			English	Article							ONSET COLORECTAL-CANCER; YOUNG-PATIENTS; CLINICOPATHOLOGICAL CHARACTERISTICS; POORER PROGNOSIS; OLDER PATIENTS; TERM OUTCOMES; IMPACT; RATES; ADENOCARCINOMA; OXALIPLATIN	Objective To know the effect of age on survival outcome in operated and non-operated patients with colon cancer. Methods From the Surveillance, Epidemiology, and End Results database, we identified 123,356 patients with colon cancer who were diagnosed between 1996 and 2005, grouped them as older or younger than 40 years and analyzed their 5-year cancer-specific survival (CSS) data, along with some risk factors, using Kaplan-Meier methods and multivariable Cox regression models. Results The younger group had significantly higher pathological grades (P<0.001), more mucinous and signet-ring histology (P<0.001), advanced AJCC stage (P<0.001), and were more likely to undergo surgery (P<0.001). For surgically treated patients, age did not significantly affect 5-year CSS (younger: 66.7%; older: 67.3%; P = 0.86). Further analysis showed that age was an independent prognostic factor in stage I-IV disease (stage I: P = 0.001; P<0.001 for stages II-IV, in both uni- and multivariate analyses), but not for patients with unknown disease stage (P = 0.52). For non-surgically treated patients, age significantly affected 5-year CSS (younger: 16.2%; older: 12.9%; P<0.001) in univariate analysis; and was an independent prognostic factor (P<0.001) in multivariate analysis. Conclusion The CSS rate for younger CC patients was at least as high as for older patients, although they presented with higher proportions of unfavorable factors and more advanced disease.	[Jiang, ZhongHua; Wang, XiaoHong; Tan, XueMing] Nanjing Med Univ, Affiliated Hosp 2, Dept Digest Endoscopy, Nanjing, Jiangsu, Peoples R China; [Jiang, ZhongHua; Wang, XiaoHong; Tan, XueMing] Nanjing Med Univ, Affiliated Hosp 2, Med Ctr Digest Dis, Nanjing, Jiangsu, Peoples R China; [Jiang, ZhongHua] 1 Peoples Hosp Yancheng, Dept Gastroenterol, Yancheng, Jiangsu, Peoples R China; [Wang, XiaoHong] Xuzhou Med Coll, Affiliated Hosp 2, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China; [Fan, ZhiNing] Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University	Fan, ZN (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Digest Endoscopy, Nanjing, Jiangsu, Peoples R China.	13815586912@163.com			National Natural Science Foundation of China [81172266]; Jiangsu Province Social Development Fund [BL2012031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Social Development Fund	This study was supported by grants from the National Natural Science Foundation of China (no. 81172266), The Jiangsu Province Social Development Fund (no. BL2012031). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atrkar-Roushan Z, 2013, ASIAN PAC J CANCER P, V14, P7587, DOI 10.7314/APJCP.2013.14.12.7587; Austin H, 2014, CANCER CAUSE CONTROL, V25, P191, DOI 10.1007/s10552-013-0321-y; Ben-Ishay O, 2013, ISR MED ASSOC J, V15, P284; Benmoussa A, 2013, PATHOL BIOL, V61, P117, DOI 10.1016/j.patbio.2012.01.003; Blanke CD, 2011, J CLIN ONCOL, V29, P2781, DOI 10.1200/JCO.2010.33.5281; Bouassida M, 2012, PAN AFR MED J, V12; Chan KK, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-82; Chew MH, 2009, INT J COLORECTAL DIS, V24, P1075, DOI 10.1007/s00384-009-0701-7; Dozois EJ, 2008, MEDICINE, V87, P259, DOI 10.1097/MD.0b013e3181881354; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Eheman C, 2012, CANCER-AM CANCER SOC, V118, P2338, DOI 10.1002/cncr.27514; Fu JF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000135; Ganapathi S, 2011, INT J COLORECTAL DIS, V26, P927, DOI 10.1007/s00384-011-1174-z; Goodwin Rachel A, 2009, Clin Colon Rectal Surg, V22, P251, DOI 10.1055/s-0029-1242465; Grothey A, 2004, EXPERT OPIN PHARMACO, V5, P2159, DOI 10.1517/14656566.5.10.2159; Hubbard JM, 2013, J NATL COMPR CANC NE, V11, P1219, DOI 10.6004/jnccn.2013.0144; Jones HG, 2015, INT J COLORECTAL DIS, V30, P483, DOI 10.1007/s00384-015-2166-1; Kang BW, 2009, MED ONCOL, V26, P32, DOI 10.1007/s12032-008-9077-8; Keswani SG, 2002, AM SURGEON, V68, P871; Kirzin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103159; Laskar RS, 2014, INDIAN J MED RES, V139, P314; Lemmens VEPP, 2005, BRIT J SURG, V92, P615, DOI 10.1002/bjs.4913; Li J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1071-x; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; Makela JT, 2010, INT J COLORECTAL DIS, V25, P823, DOI 10.1007/s00384-010-0914-9; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Neufeld D, 2009, TECH COLOPROCTOL, V13, P201, DOI 10.1007/s10151-009-0501-7; Nitsche U, 2014, INT J COLORECTAL DIS, V29, P971, DOI 10.1007/s00384-014-1914-y; O'Connell JB, 2003, AM SURGEON, V69, P866; Ohtani Hiroshi, 2008, Gan To Kagaku Ryoho, V35, P1769; Plunkett M, 2014, ANZ J SURG, V84, P371, DOI 10.1111/ans.12380; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Steele SR, 2014, DIS COLON RECTUM, V57, P303, DOI 10.1097/DCR.0b013e3182a586e7; Stillwell AP, 2010, WORLD J SURG, V34, P797, DOI 10.1007/s00268-009-0366-y; Taggarshe D, 2013, AM J SURG, V205, P312, DOI 10.1016/j.amjsurg.2012.10.016; Warren JL, 2002, MED CARE, V40, P3; Yang ZL, 2014, SURG TODAY, V44, P115, DOI 10.1007/s00595-013-0507-7; Yeo SA, 2013, TECH COLOPROCTOL, V17, P653, DOI 10.1007/s10151-013-0977-z; You YN, 2012, ARCH INTERN MED, V172, P287, DOI 10.1001/archinternmed.2011.602; Zahir Muhammad Nauman, 2014, ISRN Oncol, V2014, P461570, DOI 10.1155/2014/461570	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147383	10.1371/journal.pone.0147383	http://dx.doi.org/10.1371/journal.pone.0147383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789841	Green Published, gold			2022-12-27	WOS:000368529100084
J	Li, Y; Mendiratta, S; Ehrhardt, K; Kashyap, N; White, MA; Bleris, L				Li, Yi; Mendiratta, Saurabh; Ehrhardt, Kristina; Kashyap, Neha; White, Michael A.; Bleris, Leonidas			Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions	PLOS ONE			English	Article							DUAL-RNA; GENOME; TRANSCRIPTION; ENDONUCLEASE; EFFECTORS; CAS9	CRISPR/Cas9 is an enabling RNA-guided technology for genome targeting and engineering. An acute DNA binding constraint of the Cas9 protein is the Protospacer Adjacent Motif (PAM). Here we demonstrate that the PAM requirement can be exploited to specifically target single-nucleotide heterozygous mutations while exerting no aberrant effects on the wild-type alleles. Specifically, we target the heterozygous G13A activating mutation of KRAS in colorectal cancer cells and we show reversal of drug resistance to a MEK small-molecule inhibitor. Our study introduces a new paradigm in genome editing and therapeutic targeting via the use of gRNA to guide Cas9 to a desired protospacer adjacent motif.	[Li, Yi; Ehrhardt, Kristina; Kashyap, Neha; Bleris, Leonidas] Univ Texas Dallas, Dept Bioengn, 800 West Campbell Rd, Richardson, TX 75080 USA; [Li, Yi; Ehrhardt, Kristina; Kashyap, Neha; Bleris, Leonidas] Univ Texas Dallas, Ctr Syst Biol, 800 West Campbell Rd, Richardson, TX 75080 USA; [Mendiratta, Saurabh; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bleris, Leonidas] Univ Texas Dallas, Dept Elect Engn, 800 West Campbell Rd, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Bleris, L (corresponding author), Univ Texas Dallas, Dept Bioengn, 800 West Campbell Rd, Richardson, TX 75080 USA.; Bleris, L (corresponding author), Univ Texas Dallas, Ctr Syst Biol, 800 West Campbell Rd, Richardson, TX 75080 USA.; Bleris, L (corresponding author), Univ Texas Dallas, Dept Elect Engn, 800 West Campbell Rd, Richardson, TX 75080 USA.	bleris@utdallas.edu			US National Institutes of Health (NIH) [GM096271, CA170018]; US National Science Foundation (NSF) CAREER grant [1351354]; University of Texas at Dallas; Robert Welch Foundation [I-1414]; Directorate For Engineering [1351354] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA170018, R35CA197717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096271] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF) CAREER grant(National Science Foundation (NSF)); University of Texas at Dallas; Robert Welch Foundation(The Welch Foundation); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grants GM096271, CA170018, the US National Science Foundation (NSF) CAREER grant 1351354, the University of Texas at Dallas, and Robert Welch Foundation (I-1414).	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2015, GENE THER; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton I. B., 2015, NAT BIOTECHNOL; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kleinstiver B. P., 2015, NATURE; Kuscu C, 2014, NAT BIOTECHNOL; Li Y, 2014, ASSEMBLY VALIDATION, V4; Li Y, 2012, TRANSCRIPTION ACTIVA, V2; Liao J, 2015, NAT GENET; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moore R, 2015, NUCLEIC ACIDS RES, V43, P1297, DOI 10.1093/nar/gku1326; Moore R, 2014, ACS SYNTH BIOL, V3, P708, DOI 10.1021/sb400137b; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schreiber T, 2014, NUCLEIC ACIDS RES, V42, P7160, DOI 10.1093/nar/gku341; Taylor DW, 2015, SCIENCE; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Yang LH, 2014, METHODS MOL BIOL, V1114, P245, DOI 10.1007/978-1-62703-761-7_16; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240	27	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144970	10.1371/journal.pone.0144970	http://dx.doi.org/10.1371/journal.pone.0144970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788852	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100005
J	Ruiz-Casares, M; Cleveland, J; Oulhote, Y; Dunkley-Hickin, C; Rousseau, C				Ruiz-Casares, Monica; Cleveland, Janet; Oulhote, Youssef; Dunkley-Hickin, Catherine; Rousseau, Cecile			Knowledge of Healthcare Coverage for Refugee Claimants: Results from a Survey of Health Service Providers in Montreal	PLOS ONE			English	Article							IMMIGRANTS; BARRIERS; CHILDREN; CANADA; ACCESS; WOMEN	Following changes to the Interim Federal Health (IFH) program in Canada in 2012, this study investigates health service providers' knowledge of the healthcare coverage for refugee claimants living in Quebec. An online questionnaire was completed by 1,772 staff and physicians from five hospitals and two primary care centres in Montreal. Low levels of knowledge and significant associations between knowledge and occupational group, age, and contact with refugees were documented. Social workers, respondents aged 40-49 years, and those who reported previous contact with refugee claimants seeking healthcare were significantly more likely to have 2 or more correct responses. Rapid and multiple changes to the complex IFH policy have generated a high level of confusion among healthcare providers. Simplification of the system and a knowledge transfer strategy aimed at improving healthcare delivery for IFH patients are urgently needed, proposing easy avenues to access rapidly updated information and emphasizing ethical and clinical issues.	[Ruiz-Casares, Monica; Rousseau, Cecile] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Ruiz-Casares, Monica; Cleveland, Janet; Rousseau, Cecile] SHERPA Inst Univ, Ctr Integre Univ Sante & Serv Sociaux, Ctr Ouest Ile Montreal, Montreal, PQ, Canada; [Oulhote, Youssef] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Dunkley-Hickin, Catherine] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada	McGill University; Harvard University; Harvard T.H. Chan School of Public Health; McGill University	Ruiz-Casares, M (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Ruiz-Casares, M (corresponding author), SHERPA Inst Univ, Ctr Integre Univ Sante & Serv Sociaux, Ctr Ouest Ile Montreal, Montreal, PQ, Canada.	monica.ruizcasares@mcgill.ca		oulhote, youssef/0000-0002-2323-1982	Canadian Institutes of Health Research [MOP-130451]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by a grant from the Canadian Institutes of Health Research (MOP-130451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LANCET, V370, P2; [Anonymous], 2014, 651T35613 FC CAN DOC; Arya N, 2012, CAN MED ASSOC J, V184, P1875, DOI 10.1503/cmaj.120938; Barnes S, 2012, REAL COST CUTTING RE; Campbell RM, 2014, J IMMIGR MINOR HEALT, V16, P165, DOI 10.1007/s10903-012-9740-1; CIC, 2015, CAN FACTS FIG 2014 I; Edberg M, 2011, J IMMIGR MINOR HEALT, V13, P576, DOI 10.1007/s10903-010-9337-5; Evans A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096902; Gagnon AJ, 2013, SOC SCI MED, V76, P197, DOI 10.1016/j.socscimed.2012.11.001; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Kirmayer LJ, 2012, J PSYCHIAT, V57, P1; Marwah Sonal, 2014, REFUGEE HLTH CARE CU; McKeary M, 2010, J REFUG STUD, V23, P523, DOI 10.1093/jrs/feq038; Merry LA, 2011, CAN J PUBLIC HEALTH, V102, P286, DOI 10.1007/BF03404050; Pottie K, 2011, CANADIAN MED ASS J, V183; Pottie K, 2008, CAN J PUBLIC HEALTH, V99, P505, DOI 10.1007/BF03403786; R Core Team, 2021, R LANGUAGE ENV STAT; Rousseau C, 2013, PAED CHILD HEALT-CAN, V18, P465, DOI 10.1093/pch/18.9.465; Ruiz-Casares M, 2013, MATERN CHILD HLTH J, V17, P292, DOI 10.1007/s10995-012-0973-3; Simich L, 2007, CAN J PUBLIC HEALTH, V98, P369, DOI 10.1007/BF03405421; Stanbrook MB, 2014, CAN MED ASSOC J, V186, P91, DOI 10.1503/cmaj.131861; ter Kuile S, 2007, INT J MIGR HEALTH SO, V3, P15, DOI 10.1108/17479894200700003; Willen SS, 2011, MED ANTHROPOL Q, V25, P303, DOI 10.1111/j.1548-1387.2011.01163.x	25	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146798	10.1371/journal.pone.0146798	http://dx.doi.org/10.1371/journal.pone.0146798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26789844	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100042
J	Niederkrotenthaler, T; Tinghog, P; Goldman-Mellor, S; Wilcox, HC; Gould, M; Mittendorfer-Rutz, E				Niederkrotenthaler, Thomas; Tinghog, Petter; Goldman-Mellor, Sidra; Wilcox, Holly C.; Gould, Madelyn; Mittendorfer-Rutz, Ellenor			Medical and Social Determinants of Subsequent Labour Market Marginalization in Young Hospitalized Suicide Attempters	PLOS ONE			English	Article							SICKNESS ABSENCE; RISK-FACTORS; HEALTH; WORK	Background Individuals with a history of suicide attempt have a high risk for subsequent labour market marginalization. This study aimed at assessing the effect of individual and parental factors on different measures of marginalization. Methods Prospective cohort study based on register linkage of 5 649 individuals who in 1994 were 16-30 years old, lived in Sweden and were treated in inpatient care for suicide attempt during 1992-1994. Hazard ratios (HRs) for labour market marginalization defined as long-term unemployment (>180 days), sickness absence (>90 days), or disability pension in 19952010 were calculated with Cox regression. Results Medical risk factors, particularly any earlier diagnosed specific mental disorders (e.g., schizophrenia: HR 5.4 (95% CI: 4.2, 7.0), personality disorders: HR 3.9, 95% CI: 3.1, 4.9), repetitive suicide attempts (HR 1.6, 95% CI: 1.4, 1.9) were associated with a higher relative risk of disability pension. Individual medical factors were of smaller importance for long-term sickness absence, and of only marginal relevance to long-term unemployment. Country of birth outside Europe had an opposite effect on disability pension (HR 0.6, 95% CI: 0.4, 0.8) and long-term unemployment (HR 1.5, 95% CI: 1.3, 1.8). Female sex was positively correlated with long-term sickness absence (HR 1.6, 95% CI: 1.4, 1.7), and negatively associated with long-term unemployment (HR: 0.8, 95% CI: 0.7, 0.9). Conclusions As compared to disability pension, long-term sickness absence and unemployment was more strongly related to socio-economic variables. Marginalization pathways seemed to vary with migration status and sex. These findings may contribute to the development of intervention strategies which take the individual risk for marginalization into account.	[Niederkrotenthaler, Thomas] Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Suicide Res Unit, A-1090 Vienna, Austria; [Tinghog, Petter; Mittendorfer-Rutz, Ellenor] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, S-17177 Stockholm, Sweden; [Tinghog, Petter] Swedish Red Cross Univ Coll, Stockholm, Sweden; [Goldman-Mellor, Sidra] Univ Calif Merced, Merced, CA 95343 USA; [Wilcox, Holly C.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; [Gould, Madelyn] Columbia Univ, NYS Psychiat Inst, New York, NY 10032 USA	Medical University of Vienna; Karolinska Institutet; University of California System; University of California Merced; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; New York State Psychiatry Institute	Niederkrotenthaler, T (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Suicide Res Unit, A-1090 Vienna, Austria.	thomas.niederkrotenthaler@meduniwien.ac.at		Niederkrotenthaler, Thomas/0000-0001-9550-628X; Wilcox, Holly/0000-0003-2624-0654; Gould, Madelyn/0000-0002-2881-9152	Swedish Research Council-Vetenskaspsradet [2014-3335]	Swedish Research Council-Vetenskaspsradet	This work was funded by the Swedish Research Council-Vetenskaspsradet, (grant number 2014-3335, see http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; Azmat G, 2004, 4307 CEPR; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bynner J., 1996, RISKS OUTCOMES SOCIA; Claussen B, 2009, SCAND J PUBLIC HEALT, V37, P395, DOI 10.1177/1403494809104220; Eurofound, 2012, NEETS YOUNG PEOPL EM; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Henderson M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2256; Ishtiak-Ahmed K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-805; Klasen S., 2001, EUROPEAN SOC, V3, P413, DOI [10.1080/14616690120112208, DOI 10.1080/14616690120112208]; Kokkevi A, 2012, J CHILD PSYCHOL PSYC, V53, P381, DOI 10.1111/j.1469-7610.2011.02457.x; Krug GE, 2002, WORLD REPORT HLTH VI; Lager A, 2012, SCAND J PUBLIC HEALT, V40, P42, DOI 10.1177/1403494812459459; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Meershoek A, 2011, SOC SCI MED, V72, P15, DOI 10.1016/j.socscimed.2010.10.022; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mittendorfer-Rutz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099869; Mittendorfer-Rutz E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-75; National Board of Health and Welfare, 2009, DOD PAT; National Board of Health and Welfare, 2010, SOC REP 2010; Niederkrotenthaler T, 2014, INT J EPIDEMIOL, V43, P1520, DOI 10.1093/ije/dyu155; Niederkrotenthaler T, 2014, AM J PREV MED, V47, pS235, DOI 10.1016/j.amepre.2014.06.010; Nordic Social Insurance Portal, 2015, UN BEN; O'Higgins N., 2010, WORKING PAPER; OECD, 2013, MENT HLTH WORK SWED; OECD, 2003, TRANSF DIS AB POL PR; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Ostby KA, 2014, SOC PSYCH PSYCH EPID, V49, P2003, DOI 10.1007/s00127-014-0878-0; OTTO U, 1972, ACTA PSYCHIAT SCAND, P1; Schmidtke A, 2004, SUICIDAL BEHAVIOUR IN EUROPE: RESULTS FROM THE WHO/EURO MULTICENTRE STUDY ON SUICIDAL BEHAVIOUR, P15; Social Insurance Agency, 2014, SOC INS FIG; Statistics Sweden, 2003, REG IND SVER 1 JAN 1; Waddell G., 2006, IS WORK GOOD YOUR HL	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146130	10.1371/journal.pone.0146130	http://dx.doi.org/10.1371/journal.pone.0146130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784886	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400025
J	Passey, SL; Bozinovski, S; Vlahos, R; Anderson, GP; Hansen, MJ				Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.; Hansen, Michelle J.			Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes	PLOS ONE			English	Article							PEPTIDE RECEPTOR; PROTEIN BREAKDOWN; MYOBLAST MODELS; MESSENGER-RNA; IGF-I; COPD; MORTALITY; EXACERBATIONS; DYSFUNCTION; ACTIVATION	Background Skeletal muscle wasting is an important comorbidity of Chronic Obstructive Pulmonary Disease (COPD) and is strongly correlated with morbidity and mortality. Patients who experience frequent acute exacerbations of COPD (AECOPD) have more severe muscle wasting and reduced recovery of muscle mass and function after each exacerbation. Serum levels of the pro-inflammatory acute phase protein Serum Amyloid A (SAA) can rise more than 1000-fold in AECOPD and are predictively correlated with exacerbation severity. The direct effects of SAA on skeletal muscle are poorly understood. Here we have examined SAA effects on pro-inflammatory cachectic cytokine expression (IL-6 and TNF alpha) and atrophy in C2C12 myotubes. Results SAA increased IL-6 (31-fold) and TNF alpha (6.5-fold) mRNA levels compared to control untreated cells after 3h of SAA treatment, and increased secreted IL-6 protein at 24h. OxPAPC, a dual TLR2 and TLR4 inhibitor, reduced the response to SAA by approximately 84% compared to SAA alone, and the TLR2 neutralising antibody T2.5 abolished SAA-induced expression of IL-6, indicating that SAA signalling in C2C12 myotubes is primarily via TLR2. SAA also reduced myotube width by 10-13% and induced a 2.5-fold increase in the expression of the muscle atrophy gene Atrogin-1, suggesting direct effects of SAA on muscle wasting. Blocking of TLR2 inhibited the SAA-induced decrease in myotube width and Atrogin-1 gene expression, indicating that SAA induces atrophy through TLR2. Conclusions These data demonstrate that SAA stimulates a robust pro-inflammatory response in skeletal muscle myotubes via the TLR2-dependent release of IL-6 and TNF alpha. Furthermore, the observed atrophy effects indicate that SAA could also be directly contributing to the wasting and poor recovery of muscle mass. Therapeutic strategies targeting this SAA-TLR2 axis may therefore ameliorate muscle wasting in AECOPD and a range of other inflammatory conditions associated with loss of muscle mass.	[Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross; Anderson, Gary P.; Hansen, Michelle J.] Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia; [Passey, Samantha L.; Bozinovski, Steven; Vlahos, Ross] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Passey, SL; Hansen, MJ (corresponding author), Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia.; Passey, SL (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Samantha.Passey@rmit.edu.au; mjhansen@unimelb.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071; Bozinovski, Steven/0000-0001-6533-8641; Anderson, Gary/0000-0001-6580-3398; Passey, Samantha/0000-0002-9782-3032	National Health and Medical Research Council of Australia [628492]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a National Health and Medical Research Council of Australia project grant to MJH (grant number 628492, www.nhmrc.gov.au). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari K, 2012, POSTGRAD MED J, V88, P372, DOI 10.1136/postgradmedj-2011-130293; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KQ, 2008, J LEUKOCYTE BIOL, V83, P1467, DOI 10.1189/jlb.0907607; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hughes DC, 2016, BIOGERONTOLOGY, V17, P619, DOI 10.1007/s10522-015-9621-9; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Koga T, 2008, FEBS LETT, V582, P579, DOI 10.1016/j.febslet.2008.01.022; Kumon Y, 1999, J RHEUMATOL, V26, P785; Lakota K, 2013, MICROVASC RES, V90, P55, DOI 10.1016/j.mvr.2013.07.011; Langhans C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; O'Reilly S, 2014, IMMUNOLOGY, V143, P331, DOI 10.1111/imm.12260; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Player DJ, 2014, BIOTECHNOL LETT, V36, P1113, DOI 10.1007/s10529-014-1464-y; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Sharples AP, 2011, CURR OPIN CLIN NUTR, V14, P230, DOI 10.1097/MCO.0b013e3283457ade; Sharples AP, 2010, J CELL PHYSIOL, V225, P240, DOI 10.1002/jcp.22252; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; Spruit MA, 2003, THORAX, V58, P752, DOI 10.1136/thorax.58.9.752; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tamamoto T, 2013, VET IMMUNOL IMMUNOP, V155, P190, DOI 10.1016/j.vetimm.2013.06.010; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; Vilaro J, 2010, RESP MED, V104, P1896, DOI 10.1016/j.rmed.2010.05.001; Waechter V, 2012, J IMMUNOL, V188, P1856, DOI 10.4049/jimmunol.1101788; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	53	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146882	10.1371/journal.pone.0146882	http://dx.doi.org/10.1371/journal.pone.0146882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784349	gold, Green Published			2022-12-27	WOS:000368528400077
J	Boccaccio, A; Uva, AE; Fiorentino, M; Mori, G; Monno, G				Boccaccio, Antonio; Uva, Antonio Emmanuele; Fiorentino, Michele; Mori, Giorgio; Monno, Giuseppe			Geometry Design Optimization of Functionally Graded Scaffolds for Bone Tissue Engineering: A Mechanobiological Approach	PLOS ONE			English	Article							MANDIBULAR DISTRACTION OSTEOGENESIS; MECHANO-REGULATION MODEL; HYDROXYAPATITE CERAMICS; DIFFERENTIATION; FABRICATION; POROSITY; REGENERATION; ANGIOGENESIS; SIMULATION; BODIES	Functionally Graded Scaffolds (FGSs) are porous biomaterials where porosity changes in space with a specific gradient. In spite of their wide use in bone tissue engineering, possible models that relate the scaffold gradient to the mechanical and biological requirements for the regeneration of the bony tissue are currently missing. In this study we attempt to bridge the gap by developing a mechanobiology-based optimization algorithm aimed to determine the optimal graded porosity distribution in FGSs. The algorithm combines the parametric finite element model of a FGS, a computational mechano-regulation model and a numerical optimization routine. For assigned boundary and loading conditions, the algorithm builds iteratively different scaffold geometry configurations with different porosity distributions until the best microstructure geometry is reached, i.e. the geometry that allows the amount of bone formation to be maximized. We tested different porosity distribution laws, loading conditions and scaffold Young's modulus values. For each combination of these variables, the explicit equation of the porosity distribution law-i.e the law that describes the pore dimensions in function of the spatial coordinates-was determined that allows the highest amounts of bone to be generated. The results show that the loading conditions affect significantly the optimal porosity distribution. For a pure compression loading, it was found that the pore dimensions are almost constant throughout the entire scaffold and using a FGS allows the formation of amounts of bone slightly larger than those obtainable with a homogeneous porosity scaffold. For a pure shear loading, instead, FGSs allow to significantly increase the bone formation compared to a homogeneous porosity scaffolds. Although experimental data is still necessary to properly relate the mechanical/biological environment to the scaffold microstructure, this model represents an important step towards optimizing geometry of functionally graded scaffolds based on mechanobiological criteria.	[Boccaccio, Antonio; Uva, Antonio Emmanuele; Fiorentino, Michele; Monno, Giuseppe] Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy; [Mori, Giorgio] Univ Foggia, Dipartimento Med Clin & Sperimentale, I-71122 Foggia, Italy	Politecnico di Bari; University of Foggia	Boccaccio, A (corresponding author), Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy.	a.boccaccio@poliba.it	Uva, Antonio Emmanuele/A-9673-2012; Fiorentino, Michele/M-6976-2015; Mori, Giorgio/P-1370-2014	Fiorentino, Michele/0000-0003-2197-6574; Mori, Giorgio/0000-0001-6731-0247; BOCCACCIO, ANTONIO/0000-0002-9623-7189; Uva, Antonio/0000-0001-7271-6137				Bailey BM, 2013, ACTA BIOMATER, V9, P8254, DOI 10.1016/j.actbio.2013.05.012; Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1; Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x; Boccaccio A, 2012, MED BIOL ENG COMPUT, V50, P947, DOI 10.1007/s11517-012-0937-1; Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112; Boccaccio A, 2008, J MECH MED BIOL, V8, P203, DOI 10.1142/S0219519408002644; Boccaccio A, 2016, INT J BIOL SCI, V12, P1, DOI 10.7150/ijbs.13158; Boccaccio A, 2011, J ORTHOP RES, V29, P433, DOI 10.1002/jor.21231; Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003; Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9; Chua CK, 2011, MRS BULL, V36, P1006, DOI 10.1557/mrs.2011.271; Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004; Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010; Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955; Giannitelli SM, 2015, MAT SCI ENG C-MATER, V51, P329, DOI 10.1016/j.msec.2015.03.002; Guyot Y, 2014, BIOMECH MODEL MECHAN, V13, P1361, DOI 10.1007/s10237-014-0577-5; Hendrikson WJ, 2014, BIOTECHNOL BIOENG, V111, P1864, DOI 10.1002/bit.25231; Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Lee BT, 2006, J EUR CERAM SOC, V26, P3525, DOI 10.1016/j.jeurceramsoc.2005.12.017; Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002; Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e; Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Miao XG, 2010, MATERIALS, V3, P26, DOI 10.3390/ma3010026; Muthutantri A, 2008, J R SOC INTERFACE, V5, P1459, DOI 10.1098/rsif.2008.0092; Pan Z, 2015, REGEN BIOMATER, V2, P9, DOI 10.1093/rb/rbv001; Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4; Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063; Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8; Wieding J, 2014, J MECH BEHAV BIOMED, V37, P56, DOI 10.1016/j.jmbbm.2014.05.002; Yang JW, 2015, J CRANIOFAC SURG, V26, pE148, DOI 10.1097/SCS.0000000000001383; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yavari SA, 2014, J BIOMECH, V47, P2700, DOI 10.1016/j.jbiomech.2014.05.006; Zadpoor AA, 2015, BIOMATER SCI-UK, V3, P231, DOI 10.1039/c4bm00291a	42	67	70	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146935	10.1371/journal.pone.0146935	http://dx.doi.org/10.1371/journal.pone.0146935			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771746	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300044
J	Indrakanti, S; Mikler, AR; O'Neill, M; Tiwari, C				Indrakanti, Saratchandra; Mikler, Armin R.; O'Neill, Martin, II; Tiwari, Chetan			Quantifying Access Disparities in Response Plans	PLOS ONE			English	Article							PUBLIC-HEALTH; VULNERABILITY; FRAMEWORK; MODEL	Effective response planning and preparedness are critical to the health and well-being of communities in the face of biological emergencies. Response plans involving mass prophylaxis may seem feasible when considering the choice of dispensing points within a region, overall population density, and estimated traffic demands. However, the plan may fail to serve particular vulnerable subpopulations, resulting in access disparities during emergency response. For a response plan to be effective, sufficient mitigation resources must be made accessible to target populations within short, federally-mandated time frames. A major challenge in response plan design is to establish a balance between the allocation of available resources and the provision of equal access to PODs for all individuals in a given geographic region. Limitations on the availability, granularity, and currency of data to identify vulnerable populations further complicate the planning process. To address these challenges and limitations, data driven methods to quantify vulnerabilities in the context of response plans have been developed and are explored in this article.	[Indrakanti, Saratchandra; Mikler, Armin R.; O'Neill, Martin, II; Tiwari, Chetan] Univ N Texas, Ctr Computat Epidemiol & Response Anal CeCERA, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Indrakanti, S (corresponding author), Univ N Texas, Ctr Computat Epidemiol & Response Anal CeCERA, Denton, TX 76203 USA.	saratchandraindrakanti@my.unt.edu		Mikler, Armin/0000-0002-5253-144X	National Institutes of Health [NIH1R01LM011647-01, NIH1R15LM010804-01]; NATIONAL LIBRARY OF MEDICINE [R01LM011647, R15LM010804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project described was supported by the National Institutes of Health through the following grants: grant number NIH1R01LM011647-01 and grant number NIH1R15LM010804-01 (http://www.nih.gov/).	Adger W.N., 2010, KLIMAWANDEL, P327, DOI [10.1007/978-3-531-92258-4_19, DOI 10.1007/978-3-531-92258-4_19]; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Andrulis DP, 2007, HEALTH AFFAIR, V26, P1269, DOI 10.1377/hlthaff.26.5.1269; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response, 2010, PUBL HLTH WORKB DEF; Cervero R, 2006, J AM PLANN ASSOC, V72, P285, DOI 10.1080/01944360608976751; Cervero R, 2010, TRANSP RES RECORD, P1, DOI 10.3141/2145-01; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Eisenman David P, 2007, Am J Public Health, V97 Suppl 1, pS109, DOI 10.2105/AJPH.2005.084335; Fernandez Lauren S, 2002, Prehosp Disaster Med, V17, P67; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Jimenez T, 2012, IEEE T SYST MAN CY A, V42, P1194, DOI 10.1109/TSMCA.2012.2183360; Joyce M, 2010, ITE 2010 ANN M EXH; Koh HK, 2008, DISASTER MED PUBLIC, V2, P40, DOI 10.1097/DMP.0b013e318164f440; Lee EK, 2009, INTERFACES, V39, P476, DOI 10.1287/inte.1090.0463; Lombardi M, 2012, CONSTRAINTS, V17, P51, DOI 10.1007/s10601-011-9115-6; Loucks D., 2005, WATER RESOURCES SYST; Lurie N, 2006, HEALTH AFFAIR, V25, P935, DOI 10.1377/hlthaff.25.4.935; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Murray AT, 1998, TRANSPORT RES D-TR E, V3, P319, DOI 10.1016/S1361-9209(98)00010-8; O'Neill M, 2014, IEEE T SYST MAN CY-S, V44, P1569, DOI 10.1109/TSMC.2014.2332137; Oak Ridge Institute for Science and Education, BIOL ATT COMM CHALL; Phillips B.D., 2007, NAT HAZARDS REV, V8, P61, DOI [10.1061/(ASCE)1527-6988(2007)8:3(61), DOI 10.1061/(ASCE)1527-6988(2007)8:3(61)]; Richter A, 2009, INTERFACES, V39, P228, DOI 10.1287/inte.1080.0427; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schneider T, 2009, P 2009 INT C DIS MAN; Shan SQ, 2012, INFORM TECHNOL MANAG, V13, P411, DOI 10.1007/s10799-012-0130-0; Smith L., 1995, TRANSIMS TRANSPORTAT; The White House, 2005, EX ORD IND DIS EM PR; The White House, 2006, FED RESP HURR KATR L, V12, P2009; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; U. S. Department of Health and Human Services, 2012, STRAT NAT STOCKP SNS; Urban Design 4 Health, SAN DIEG REG HLTH IM; US Department of Health and Human Services and others, 2005, REC DISTR DISP STRAT	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146350	10.1371/journal.pone.0146350	http://dx.doi.org/10.1371/journal.pone.0146350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771551	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300015
J	Li, ESS; Cheung, PY; O'Reilly, M; LaBossiere, J; Lee, TF; Cowan, S; Bigam, DL; Schmolzer, GM				Li, Elliott Shang-shun; Cheung, Po-Yin; O'Reilly, Megan; LaBossiere, Joseph; Lee, Tze-Fun; Cowan, Shaun; Bigam, David L.; Schmoelzer, Georg Marcus			Exhaled CO2 Parameters as a Tool to Assess Ventilation-Perfusion Mismatching during Neonatal Resuscitation in a Swine Model of Neonatal Asphyxia	PLOS ONE			English	Article							TIDAL CARBON-DIOXIDE; CARDIOPULMONARY-RESUSCITATION; CARDIAC-OUTPUT; PORCINE MODEL; DELIVERY ROOM; BLOOD-FLOW; GUIDE; BIRTH; NEWBORN; PIGLETS	Background End-tidal CO2 (ETCO2), partial pressure of exhaled CO2 (PECO2), and volume of expired CO2 (VCO2) can be continuously monitored non-invasively to reflect pulmonary ventilation and perfusion status. Although ETCO2 >= 14mmHg has been shown to be associated with return of an adequate heart rate in neonatal resuscitation and quantifying the PECO2 has the potential to serve as an indicator of resuscitation quality, there is little information regarding capnometric measurement of PECO2 and ETCO2 in detecting return of spontaneous circulation (ROSC) and survivability in asphyxiated neonates receiving cardiopulmonary resuscitation (CPR). Methods Seventeen newborn piglets were anesthetized, intubated, instrumented, and exposed to 45-minute normocapnic hypoxia followed by apnea to induce asphyxia. Protocolized resuscitation was initiated when heart rate decreased to 25% of baseline. Respiratory and hemo-dynamic parameters including ETCO2, PECO2, VCO2, heart rate, cardiac output, and carotid artery flow were continuously measured and analyzed. Results There were no differences in respiratory and hemodynamic parameters between surviving and non-surviving piglets prior to CPR. Surviving piglets had significantly higher ETCO2, PECO2, VCO2, cardiac index, and carotid artery flow values during CPR compared to non-surviving piglets. Conclusion Surviving piglets had significantly better respiratory and hemodynamic parameters during resuscitation compared to non-surviving piglets. In addition to optimizing resuscitation efforts, capnometry can assist by predicting outcomes of newborns requiring chest compressions.	[Li, Elliott Shang-shun] McGill Univ, Fac Sci, Montreal, PQ, Canada; [Li, Elliott Shang-shun; Cheung, Po-Yin; O'Reilly, Megan; Lee, Tze-Fun; Schmoelzer, Georg Marcus] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Cheung, Po-Yin; O'Reilly, Megan; Cowan, Shaun; Schmoelzer, Georg Marcus] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Cheung, Po-Yin; LaBossiere, Joseph; Bigam, David L.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Cowan, Shaun] Univ Alberta, Fac Sci, Edmonton, AB, Canada	McGill University; University of Alberta; Royal Alexandra Hospital; University of Alberta; University of Alberta	Schmolzer, GM (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013	Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523	Laerdal Foundation for Acute Medicine, Norway; Northern Alberta Clinical Trials and Research Centre, Faculty of Medicine and Dentistry, University of Alberta; Molly Towell Perinatal Research Foundation, Edmonton, Alberta, Canada; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Foundation Canada Research Scholarship; Neonatal Research Fund; Northern Alberta Neonatal Program; Alberta Health Services	Laerdal Foundation for Acute Medicine, Norway; Northern Alberta Clinical Trials and Research Centre, Faculty of Medicine and Dentistry, University of Alberta; Molly Towell Perinatal Research Foundation, Edmonton, Alberta, Canada; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Foundation Canada Research Scholarship; Neonatal Research Fund; Northern Alberta Neonatal Program; Alberta Health Services	The authors would like to thank the Laerdal Foundation for Acute Medicine, Norway, (http://www.laerdalfoundation.org) for their support of the current study. ESL was supported in part by the Northern Alberta Clinical Trials and Research Centre, Faculty of Medicine and Dentistry, University of Alberta, and Neonatal Research Fund, Northern Alberta Neonatal Program, Alberta Health Services. MOR is supported by a Fellowship of Molly Towell Perinatal Research Foundation, Edmonton, Alberta, Canada. GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation and a Heart and Stroke Foundation Canada Research Scholarship. No relation with industry exists. Respironics (Philips, Wallingford, CT) and Fisher & Paykel (Auckland, New Zealand) provided a respiratory function monitor and Neopuff T-pieces for the study, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHRMAN RE, 1970, AM J OBSTET GYNECOL, V108, P956, DOI 10.1016/0002-9378(70)90341-8; CALLAHAM M, 1990, CRIT CARE MED, V18, P358, DOI 10.1097/00003246-199004000-00002; Chalak LF, 2011, PEDIATR RES, V69, P401, DOI 10.1203/PDR.0b013e3182125f7f; COHN HE, 1974, AM J OBSTET GYNECOL, V120, P817, DOI 10.1016/0002-9378(74)90587-0; Dawson JA, 2010, ARCH DIS CHILD-FETAL, V95, pF177, DOI 10.1136/adc.2009.169102; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; DOMSKY M, 1995, CRIT CARE MED, V23, P1497, DOI 10.1097/00003246-199509000-00009; FALK JL, 1988, NEW ENGL J MED, V318, P607, DOI 10.1056/NEJM198803103181005; GARNETT AR, 1987, JAMA-J AM MED ASSOC, V257, P512, DOI 10.1001/jama.257.4.512; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hansen JE, 2007, CHEST, V132, P977, DOI 10.1378/chest.07-0619; Hooper SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070895; Kang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102729; KERN KB, 1989, J AM COLL CARDIOL, V13, P1184, DOI 10.1016/0735-1097(89)90282-9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LaValle T L, 1995, Dimens Crit Care Nurs, V14, P70, DOI 10.1097/00003465-199503000-00002; LEFFLER CW, 1986, PROSTAGLANDINS, V31, P183, DOI 10.1016/0090-6980(86)90045-6; Li ES, 2014, NEONATOLOGY, V105, P200, DOI 10.1159/000357609; Nicoll J, 2013, RESUSCITATION, V84, P1439, DOI 10.1016/j.resuscitation.2013.05.004; PALMEKILANDER C, 1993, ARCH DIS CHILD-FETAL, V68, P11, DOI 10.1136/adc.68.1_Spec_No.11; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Rabi Y, 2013, SEMIN FETAL NEONAT M, V18, P330, DOI 10.1016/j.siny.2013.08.007; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Schmolzer GM, 2013, CIRCULATION, V128, P2495, DOI 10.1161/CIRCULATIONAHA.113.002289; STEEDMAN DJ, 1990, ARCH EMERG MED, V7, P129; TREVINO RP, 1985, CRIT CARE MED, V13, P910, DOI 10.1097/00003246-198511000-00012; van Os S, 2014, ACTA PAEDIATR, V103, P796, DOI 10.1111/apa.12650; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011; Wyckoff M, 2000, PEDIATRICS, V106, P618, DOI 10.1542/peds.106.3.618	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146524	10.1371/journal.pone.0146524	http://dx.doi.org/10.1371/journal.pone.0146524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766424	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300023
J	Zheng, W; Suzuki, K; Tanaka, T; Kohama, M; Yamagata, Z				Zheng, Wei; Suzuki, Kohta; Tanaka, Taichiro; Kohama, Moriyasu; Yamagata, Zentaro		Okinawa Child Hlth Study Grp	Association between Maternal Smoking during Pregnancy and Low Birthweight: Effects by Maternal Age	PLOS ONE			English	Article							UNITED-STATES; WOMEN; PREVALENCE; DETERMINANTS; AMERICAN; OUTCOMES; JAPAN	Background Maternal smoking during pregnancy has been consistently related to low birthweight. However, older mothers, who are already at risk of giving birth to low birthweight infants, might be even more susceptible to the effects of maternal smoking. Therefore, this study aimed to examine the modified association between maternal smoking and low birthweight by maternal age. Methods Data were obtained from a questionnaire survey of all mothers of children born between 2004 and 2010 in Okinawa, Japan who underwent medical check-ups at age 3 months. Variables assessed were maternal smoking during pregnancy, maternal age, gestational age, parity, birth year, and complications during pregnancy. Stratified analyses were performed using a logistic regression model. Results In total, 92641 participants provided complete information on all variables. Over the 7 years studied, the proportion of mothers smoking during pregnancy decreased from 10.6% to 5.0%, while the prevalence of low birthweight did not change remarkably (around 10%). Maternal smoking was significantly associated with low birthweight in all age groups. The strength of the association increased with maternal age, both in crude and adjusted models. Conclusions Consistent with previous studies conducted in Western countries, this study demonstrates that maternal age has a modifying effect on the association between maternal smoking and birthweight. This finding suggests that specific education and health care programs for older smoking mothers are important to improve their foetal growth.	[Zheng, Wei] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; [Zheng, Wei; Suzuki, Kohta; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan; [Tanaka, Taichiro] Toho Univ, Fac Med, Dept Social Med, Ohta Ward, Tokyo, Japan; [Kohama, Moriyasu] Okinawa Prefectural Chubu Hosp, Dept Pediat, Okinawa, Okinawa, Japan	Peking University; University of Yamanashi; Toho University	Yamagata, Z (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Chuo Ku, Yamanashi, Japan.	zenymgt@yamanashi.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [23390173]; Health Labour Sciences Research Grant (Health Research on Children, Youth and Families)	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant (Health Research on Children, Youth and Families)	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) (23390173) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Health Labour Sciences Research Grant (Health Research on Children, Youth and Families).	Abel EL, 2002, AM J PERINAT, V19, P49, DOI 10.1055/s-2002-20173; Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Catt J W, 2000, Hum Reprod, V15 Suppl 2, P199; Chiolero A, 2005, SWISS MED WKLY, V135, P525; Cooper AR, 2008, SEMIN REPROD MED, V26, P204, DOI 10.1055/s-2008-1042959; Dahly DL, INT J OBES LOND, V34, P751; FOX SH, 1994, AM J EPIDEMIOL, V139, P1008, DOI 10.1093/oxfordjournals.aje.a116940; GODFREY KM, 1999, FETAL PROGRAMMING IN, P283; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Kaneita Y, 2007, PREV MED, V45, P15, DOI 10.1016/j.ypmed.2007.04.009; Kim D, 2013, INT J ENV RES PUB HE, V10, P2296, DOI 10.3390/ijerph10062296; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Ministry of Health Labour and Welfare of Japan, 2014, CHILDR CHILDR 2014; Ministry of Health Labour and Welfare of Japan, MOTH CHILD HLTH HDB; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; O'Connor RJ, 2006, AM J EPIDEMIOL, V164, P750, DOI 10.1093/aje/kwj263; Pierce JP, 2011, JAMA-J AM MED ASSOC, V305, P1106, DOI 10.1001/jama.2011.334; Reichman NE, 1997, FAM PLANN PERSPECT, V29, P268, DOI 10.2307/2953415; Savitz DA, 2001, EPIDEMIOLOGY, V12, P636, DOI 10.1097/00001648-200111000-00010; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; SIMPSON WJ, 1957, AM J OBSTET GYNECOL, V73, P808, DOI 10.1016/0002-9378(57)90391-5; Suzuki K, 2008, J EPIDEMIOL, V18, P89, DOI 10.2188/jea.JE2007415; Suzuki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118538; Suzuki K, 2014, J EPIDEMIOL, V24, P60, DOI 10.2188/jea.JE20130083; Suzuki K, 2010, J OBSTET GYNAECOL RE, V36, P745, DOI 10.1111/j.1447-0756.2010.01206.x; The Okinawa Society of Child Health, 2 REP HLTH EX INF OK; Yamamoto Y, 2008, J EPIDEMIOL, V18, P173, DOI 10.2188/jea.JE2007419	30	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146241	10.1371/journal.pone.0146241	http://dx.doi.org/10.1371/journal.pone.0146241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795494	Green Published, Green Submitted, gold			2022-12-27	WOS:000368530300007
J	Koole, O; Denison, JA; Menten, J; Tsui, S; Wabwire-Mangen, F; Kwesigabo, G; Mulenga, M; Auld, A; Agolory, S; Mukadi, YD; van Praag, E; Torpey, K; Williams, S; Kaplan, J; Zee, A; Bangsberg, DR; Colebunders, R				Koole, Olivier; Denison, Julie A.; Menten, Joris; Tsui, Sharon; Wabwire-Mangen, Fred; Kwesigabo, Gideon; Mulenga, Modest; Auld, Andrew; Agolory, Simon; Mukadi, Ya Diul; van Praag, Eric; Torpey, Kwasi; Williams, Seymour; Kaplan, Jonathan; Zee, Aaron; Bangsberg, David R.; Colebunders, Robert			Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia	PLOS ONE			English	Article							HIV PATIENTS; REPORTED ADHERENCE; FOOD INSECURITY; SUPPORT; AFRICA; ADULTS; HAART; QUESTIONNAIRE; DETERMINANTS; METAANALYSIS	Objectives To identify the reasons patients miss taking their antiretroviral therapy (ART) and the proportion who miss their ART because of symptoms; and to explore the association between symptoms and incomplete adherence. Methods Secondary analysis of data collected during a cross-sectional study that examined ART adherence among adults from 18 purposefully selected sites in Tanzania, Uganda, and Zambia. We interviewed 250 systematically selected patients per facility (>= 18 years) on reasons for missing ART and symptoms they had experienced (using the HIV Symptom Index). We abstracted clinical data from the patients' medical, pharmacy, and laboratory records. Incomplete adherence was defined as having missed ART for at least 48 consecutive hours during the past 3 months. Results Twenty-nine percent of participants reported at least one reason for having ever missed ART (1278/4425). The most frequent reason was simply forgetting (681/1278 or 53%), followed by ART-related hunger or not having enough food (30%), and symptoms (12%). The median number of symptoms reported by participants was 4 (IQR: 2-7). Every additional symptom increased the odds of incomplete adherence by 12% (OR: 1.1, 95% CI: 1.1-1.2). Female participants and participants initiated on a regimen containing stavudine were more likely to report greater numbers of symptoms. Conclusions Symptoms were a common reason for missing ART, together with simply forgetting and food insecurity. A combination of ART regimens with fewer side effects, use of mobile phone text message reminders, and integration of food supplementation and livelihood programmes into HIV programmes, have the potential to decrease missed ART and hence to improve adherence and the outcomes of ART programmes.	[Koole, Olivier] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Koole, Olivier; Menten, Joris; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Denison, Julie A.; Tsui, Sharon; Mukadi, Ya Diul; van Praag, Eric; Torpey, Kwasi] FHI 360, Social & Behav Hlth Sci, Durham, NC USA; [Denison, Julie A.; Tsui, Sharon] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Wabwire-Mangen, Fred] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Kwesigabo, Gideon] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia; [Auld, Andrew; Agolory, Simon; Williams, Seymour; Kaplan, Jonathan; Zee, Aaron] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Colebunders, Robert] Univ Antwerp, Epidemiol & Social Med, B-2020 Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); FHI 360; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Muhimbili University of Health & Allied Sciences; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Antwerp	Koole, O (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.; Koole, O (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	olivier.koole@lshtm.ac.uk	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Torpey, Kwasi/0000-0003-1628-2922; Koole, Olivier/0000-0002-1122-5382; Denison, Julie/0000-0002-4670-093X; Colebunders, Robert/0000-0002-1919-1340; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC); Health Resources&Services Administration (HRSA) [2006-N-08428, FHI 360]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Health Resources&Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) and the Health Resources&Services Administration (HRSA) under the terms of the contract no. 2006-N-08428 with FHI 360. The CDC provided technical input into the study design, data collection, data analysis, data interpretation, and writing of the manuscript.	Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Barfod TS, 2006, HIV MED, V7, P285, DOI 10.1111/j.1468-1293.2006.00387.x; Bhat VG, 2010, EUR J CLIN MICROBIOL, V29, P947, DOI 10.1007/s10096-010-0949-4; Bonfanti P, 2000, J ACQ IMMUN DEF SYND, V23, P236; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Denison JA, 2015, AIDS, V29, P361, DOI 10.1097/QAD.0000000000000543; Duran S, 2001, HIV Clin Trials, V2, P38; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Genberg BL, 2012, AIDS, V26, P1415, DOI 10.1097/QAD.0b013e328354bed6; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Martinez P, 2014, JAIDS-J ACQ IMM DEF, V65, P456, DOI 10.1097/QAI.0000000000000062; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Nachega Jean B, 2009, Curr HIV/AIDS Rep, V6, P121, DOI 10.1007/s11904-009-0017-9; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Rodrigues R, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19036; Sacktor N, 2009, NEUROLOGY, V72, P165, DOI 10.1212/01.wnl.0000339042.96109.86; Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860; Sarna A, 2008, INDIAN J MED RES, V127, P28; Singer AW, 2014, AIDS BEHAV      0806; Sithinamsuwan P, 2008, JAIDS-J ACQ IMM DEF, V49, P456, DOI 10.1097/QAI.0b013e318186eb03; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2014, AMB TREATM TARG WRIT; UNAIDS, 2014, GAP REP 2014; UNAIDS, 2014, CIT REP; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; WHO, 2008, MHGAP MENTAL HLTH GA; Yager JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026117	53	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147309	10.1371/journal.pone.0147309	http://dx.doi.org/10.1371/journal.pone.0147309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26788919	Green Accepted, Green Published, gold			2022-12-27	WOS:000368529100076
J	Randall, CJ; Jordan-Garza, AG; Muller, EM; van Woesik, R				Randall, Carly J.; Jordan-Garza, Adan G.; Muller, Erinn M.; van Woesik, Robert			Does Dark-Spot Syndrome Experimentally Transmit among Caribbean Corals?	PLOS ONE			English	Article							BLACK-BAND DISEASE; TEMPERATURE ANOMALIES; MONTASTRAEA-FAVEOLATA; REEF SYSTEM; PREVALENCE; SUSCEPTIBILITY; PATHOGEN; INFECTION; STRESS	Over the last half-century, coral diseases have contributed to the rapid decline of coral populations throughout the Caribbean region. Some coral diseases appear to be potentially infectious, yet little is known about their modes of transmission. This study experimentally tested whether dark-spot syndrome on Siderastrea siderea was directly or indirectly transmissible to neighboring coral colonies. We also tested whether open wounds were necessary to facilitate disease transmission. At the completion of the experiments, we sampled bacterial communities on diseased, exposed, and healthy coral colonies to determine whether bacterial pathogens had transmitted to the susceptible colonies. We saw no evidence of either direct or waterborne transmission of dark-spot syndrome, and corals that received lesions by direct contact with diseased tissue, healed and showed no signs of infection. There were no significant differences among bacterial communities on healthy, exposed, and diseased colonies, although nine individual ribotypes were significantly higher in diseased corals compared with healthy and exposed corals, indicating a lack of transmission. Although our experiments do not fully refute the possibility that dark-spot syndrome is infectious and transmissible, our results suggest that in situ macroscopic signs of dark-spot syndrome are not always contagious.	[Randall, Carly J.; Jordan-Garza, Adan G.; van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL USA; [Muller, Erinn M.] Mote Marine Lab, Sarasota, FL 34236 USA; [Jordan-Garza, Adan G.] Univ Veracruzana, Tuxpan, Veracruz, Mexico	Florida Institute of Technology; Mote Marine Laboratory & Aquarium; Universidad Veracruzana	Randall, CJ (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL USA.	crandall2012@my.fit.edu	Jordán-Garza, Adán Guillermo/ABE-4089-2021; Randall, Carly J./H-4195-2019	Jordán-Garza, Adán Guillermo/0000-0002-9856-2276; Randall, Carly J./0000-0001-8112-3552	National Science Foundation [OCE-1219804]; Directorate For Geosciences [1219804] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study was provided by the National Science Foundation award #OCE-1219804 awarded to RvW.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; [Anonymous], 2014, R LANG ENV STAT COMP; Antonius A, 1999, CORAL REEFS, V18, P300, DOI 10.1007/s003380050199; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruckner AW, 1997, B MAR SCI, V61, P919; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Carricart-Ganivet JP, 2011, DIS AQUAT ORGAN, V95, P181, DOI 10.3354/dao02359; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Clemens E, 2015, CORAL REEFS, P1; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fox J., 2019, R COMPANION APPL REG, V.; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GARZONFERREIRA J, 1998, REEF ENCOUNTER, V24, P10; Gignoux-Wolfsohn SA, 2012, SCI REP, V2, P1; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; Gil-Agudelo DL, 2001, B MAR SCI, V69, P619; Gochfeld DJ, 2006, DIS AQUAT ORGAN, V69, P53, DOI 10.3354/dao069053; Hall ER, 2012, P 12 INT COR REEF S, P1; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Jordan-Garza AG, 2011, DIS AQUAT ORGAN, V96, P83, DOI 10.3354/dao02368; Kellogg CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108767; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kooperman N, 2007, FEMS MICROBIOL LETT, V276, P106, DOI 10.1111/j.1574-6968.2007.00921.x; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Oksanen J., **DATA OBJECT**; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Peters G, 2011, USERFRIENDLYSCIENCE; Porter JW, 2011, J EXP MAR BIOL ECOL, V408, P79, DOI 10.1016/j.jembe.2011.07.027; PORTER JW, 2001, HYDROBIOLOGIA, V1, P24; Pratte ZA, 2015, J INVERTEBR PATHOL, V125, P42, DOI 10.1016/j.jip.2014.12.009; Randall CJ, 2014, ECOLOGY, V95, P1981, DOI 10.1890/13-0774.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Renegar D.A., 2008, P 11 INT COR REEF S, P185; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rodriguez S, 2009, CORAL REEFS, V28, P67, DOI 10.1007/s00338-008-0419-y; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Santavy D.L., 1997, P607; Smith GW, 1998, REV BIOL TROP, V46, P205; Stedman T.L, 1976, STEDMANS MED DICT; Sudek M, 2015, DIS AQUAT ORGAN, V113, P59, DOI 10.3354/dao02828; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2009, CARIBB J SCI, V45, P221; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	64	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147493	10.1371/journal.pone.0147493	http://dx.doi.org/10.1371/journal.pone.0147493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788918	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100090
J	Hu, ML; Yang, SL; Yang, L; Cheng, YZ; Zhang, H				Hu, Minling; Yang, Shuangli; Yang, Li; Cheng, Yanzhen; Zhang, Hua			Interleukin-22 Alleviated Palmitate-Induced Endoplasmic Reticulum Stress in INS-1 Cells through Activation of Autophagy	PLOS ONE			English	Article							OXIDATIVE STRESS; HOMEOSTASIS; EXPRESSION; IMMUNITY; IL-22; MASS	Objective Stimulation with saturated fatty acids has been shown to induce oxidative stress and endoplasmic reticulum (ER) stress in beta cells and has been recognized as an important component of the pathogenesis of type 2 diabetes (T2D). Interleukin-22 (IL-22) plays a critical role in preventing beta cells from oxidative and ER stress, and autophagy is associated with the survival and function of beta cells. However, whether IL-22 alleviates cellular stress through activation of autophagy is unclear. In this study, we investigated the effects of IL-22 on rat insulin-secreting cells and the mechanisms underlying IL-22 and lipotoxicity-induced oxidative and ER stress in vitro. Methods The levels of reactive oxygen species (ROS) were detected by flow cytometry and fluorescence microscopy. The protein expression of glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), microtubule-associated protein light chain 3B (LC3B) and Bcl-2-interacting myosin-like coiled-coil protein (Beclin-1) were evaluated by western blot. Transmission electron microscopy was utilized to observe the process of autophagy. Results Palmitate induced increased levels of ROS and the overexpression of GRP78 and CHOP, whereas these effects were partly reversed by treatment with IL-22. Furthermore, IL-22 upregulated the protein expression of Beclin-1 and the conversion of LC3B-I to LC3B-II. Moreover, the aforementioned effects were partly suppressed by treating cells with 3-methyladenine (3-MA), an autophagy inhibitor. Conclusions Our results suggest that IL-22 alleviated the oxidative and ER stress induced by palmitate, which was likely mediated by autophagy. These findings could facilitate the development of novel therapeutic strategies to suppress the progression of T2D.	[Hu, Minling; Yang, Shuangli; Yang, Li; Cheng, Yanzhen; Zhang, Hua] Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhang, H (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China.	jimzhua123@163.com			Guangzhou Science Technology and Innovation Commission; special grant for diabetic research in Guangzhou [2014J4100129]	Guangzhou Science Technology and Innovation Commission; special grant for diabetic research in Guangzhou	This work was supported by Guangzhou Science Technology and Innovation Commission and a special grant for diabetic research in Guangzhou (No. 2014J4100129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Avitabile S, 2015, J INVEST DERMATOL, V135, P2862, DOI 10.1038/jid.2015.278; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bikopoulos G, 2008, J ENDOCRINOL, V196, P455, DOI 10.1677/JOE-07-0174; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen YY, 2013, INT J MOL MED, V32, P1401, DOI 10.3892/ijmm.2013.1530; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hill Thomas, 2013, Cell Regen, V2, P2, DOI 10.1186/2045-9769-2-2; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Yin JJ, 2013, INT J ENDOCRINOL MET, V11, P184, DOI 10.5812/ijem.8088	41	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146818	10.1371/journal.pone.0146818	http://dx.doi.org/10.1371/journal.pone.0146818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784895	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400069
J	Wang, MR; Zheng, WK; Zhu, XH; Xu, J; Cai, BG; Zhang, YQ; Zheng, F; Zhou, LF; Yang, ZG; Zhang, X; Wang, CJ; Nie, SN; Zhu, J				Wang, Maorong; Zheng, Wenkai; Zhu, Xuhui; Xu, Jing; Cai, Binggang; Zhang, Yiqing; Zheng, Feng; Zhou, Linfu; Yang, Zhiguo; Zhang, Xin; Wang, Changjun; Nie, Shinan; Zhu, Jin			A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages	PLOS ONE			English	Article							NEGATIVE REGULATION; HEPATIC-FIBROSIS; STELLATE CELLS; RECOGNITION; TLR4; ACTIVATION; ENDOTOXIN	The results of clinical and experimental studies suggest that endotoxin/toll-like receptor 4 (TLR4)-mediated proinflammatory and profibrotic signaling activation is critical in the development of hepatic fibrosis. However, studies examining the role of specific TLR4 inhibitor are still lacking. The present study was aimed to prepare a human anti-TLR4 Fab fragment, named hTLR4-Fab01, and to explore its immune activity. We screened the positive clone of anti-human TLR4 phagemid from a human phage-display antibody library using recombinant TLR4 protein, which was used as template cDNA for the amplification of variable regions of the heavy (V-H) chain and light chain (V-L), then coupled with highly conserved regions of the heavy chain domain 1 (CH1) and the light chain (CL), respectively. Thus, the prokaryotic expression vector pETDuet-1 of hTLR4-Fab01 was constructed and transformed into Escherichia coli (E. coli) BL21. The characteristic of hTLR4-Fab01 was examined by SDS-PAGE, Western blotting, ELISA, affinity and kinetics assay. Further, our data demonstrate that hTLR4-Fab01 could specifically bind to TLR4, and its treatment obviously attenuated the proinflammatory effect, characterized by less LPS-induced TNF-alpha, IL-1, IL-6 and IL-8 production in human macrophages. In conclusion, we have successfully prepared the hTLR4-Fab01 with efficient activity for blocking LPS-induced proinflammatory cytokines production, suggesting that the hTLR4-Fab01 may be a potential candidate for the treatment of hepatic fibrosis.	[Wang, Maorong; Zheng, Wenkai; Xu, Jing; Zhang, Yiqing; Yang, Zhiguo; Zhang, Xin] Nanjing Jingdu Hosp, Inst Liver Dis, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Xuhui; Zheng, Feng; Wang, Changjun; Zhu, Jin] Huadong Med Inst Biotech, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Jin] NJMU, Dept Pathol, Key Lab Antibody Tech, Minist Hlth, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Maorong; Cai, Binggang] Anhui Med Univ, Bayi Clin Coll, Nanjing 210002, Jiangsu, Peoples R China; [Zhu, Xuhui; Nie, Shinan] Nanjing Univ, Jinling Hosp, Dept Emergency Med, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Zhou, Linfu] Nanjing Med Univ, Dept Resp Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Anhui Medical University; Nanjing University; Nanjing Medical University	Wang, MR (corresponding author), Nanjing Jingdu Hosp, Inst Liver Dis, Nanjing 210002, Jiangsu, Peoples R China.; Zhu, J (corresponding author), Huadong Med Inst Biotech, Nanjing 210002, Jiangsu, Peoples R China.; Zhu, J (corresponding author), NJMU, Dept Pathol, Key Lab Antibody Tech, Minist Hlth, Nanjing 210029, Jiangsu, Peoples R China.; Wang, MR (corresponding author), Anhui Med Univ, Bayi Clin Coll, Nanjing 210002, Jiangsu, Peoples R China.	maorongwang@126.com; zhujin1968@njmu.edu.cn			Chinese National Twelfth Five-year Plan Project [2013ZX09J13110-05B]; Eleventh Five-year Plan Project of PLA [08G023]; Social development project of Jiangsu Province [BE2015651]; Jiangsu Province Science Foundation for Youths [SBK2014041529]	Chinese National Twelfth Five-year Plan Project; Eleventh Five-year Plan Project of PLA; Social development project of Jiangsu Province; Jiangsu Province Science Foundation for Youths	This work was supported by the Grant (2013ZX09J13110-05B) from Chinese National Twelfth Five-year Plan Project, the Grant (08G023) from Eleventh Five-year Plan Project of PLA, the Grant (BE2015651) from Social development project of Jiangsu Province and the Grant (SBK2014041529) Jiangsu Province Science Foundation for Youths. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai BG, 2015, INT J MOL SCI, V16, P25502, DOI 10.3390/ijms161025502; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Cong M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/158547; Ding GP, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475809; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463; Huang JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10660; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Li JD, 2007, J IMMUNOL METHODS, V318, P113, DOI 10.1016/j.jim.2006.10.010; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Liang YH, 2012, CLIN BIOCHEM, V45, P1689, DOI 10.1016/j.clinbiochem.2012.09.001; Liao YJ, 2005, MOL BIOTECHNOL, V31, P41, DOI 10.1385/MB:31:1:041; Lin H, 2014, INT J CANCER, V134, P1239, DOI 10.1002/ijc.28451; Liu J, 2012, CELL MOL IMMUNOL, V9, P197, DOI 10.1038/cmi.2012.12; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Pol Ewa, 2010, J Vis Exp, DOI 10.3791/1746; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Trebicka J, 2011, EUR J GASTROEN HEPAT, V23, P1218, DOI 10.1097/MEG.0b013e32834a75dc; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	31	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146856	10.1371/journal.pone.0146856	http://dx.doi.org/10.1371/journal.pone.0146856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785354	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400074
J	Janssenswillen, S; Bossuyt, F				Janssenswillen, Sunita; Bossuyt, Franky			Male Courtship Pheromones Induce Cloacal Gaping in Female Newts (Salamandridae)	PLOS ONE			English	Article							SEX-PHEROMONE; CHEMICAL CUES; CRESTED NEWT; COMMUNICATION; ATTRACTANTS; RECEPTIVITY; PHYLOGENY; AMPHIBIA; SODEFRIN; BEHAVIOR	Pheromones are an important component of sexual communication in courting salamanders, but the number of species in which their use has been demonstrated with behavioral evidence remains limited. Here we developed a behavioral assay for demonstrating courtship pheromone use in the aquatically courting Iberian ribbed newt Pleurodeles waltl. By performing an in-depth study of the courtship behavior, we show that females invariably open their cloaca (cloacal gaping) before engaging in pinwheel behavior, the circling movement that is the prelude to spermatophore uptake. In contrast, cloacal gaping was not observed in failed courtships, where females escaped or displayed thanatosis. Since gaping mainly occurred during male amplexus and cloacal imposition, which is the obvious period of pheromone transfer, we next investigated whether male courtship water (i.e., water holding courtship pheromones) alone was able to induce this reaction in females. These tests showed that courtship water induced cloacal gaping significantly more than water, even in the absence of a male. Cloacal gaping thus provides a simple and robust test for demonstrating courtship pheromone use in the Iberian ribbed newt. Since opening the cloaca is an essential prerequisite for spermatophore pick-up in all internally fertilizing salamanders, we hypothesize that variations on this assay will also be useful in several other species.	[Janssenswillen, Sunita; Bossuyt, Franky] Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium	Vrije Universiteit Brussel	Bossuyt, F (corresponding author), Vrije Univ Brussel, Dept Biol, Amphibian Evolut Lab, Brussels, Belgium.	fbossuyt@vub.ac.be		Bossuyt, Franky/0000-0001-6804-9271	European Research Council starting grant (project TAPAS) [ERC 204509]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G013308, G026715N]; Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen [093428]; SRP Growth Funding Program of Vrije Universiteit Brussel	European Research Council starting grant (project TAPAS); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen; SRP Growth Funding Program of Vrije Universiteit Brussel	This work was supported by a European Research Council starting grant (http://erc.europa.eu/) (ERC 204509, project TAPAS) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (http://www.fwo.be/) (grant nos. G013308 and G026715N). SJ is supported by the Agentschap voor Innovatie door Wetenschap en Technologie Vlaanderen (http://www.iwt.be/) (grant no. 093428) and the SRP Growth Funding Program of the Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold S.J., 1977, P141; Arnold SJ., 1982, BIOCH ASP EVOL BIOL, P173; ARNOLD SJ, 1972, THESIS U MICHIGAN AN; BELVEDERE P, 1988, MONIT ZOOL ITAL, V22, P397; BRODIE ED, 1977, COPEIA, P523, DOI 10.2307/1443271; CARPENTER CC, 1977, AM ZOOL, V17, P217; Cummins SF, 2012, NAT PROD REP, V29, P642, DOI 10.1039/c2np00102k; DAWLEY EM, 1984, HERPETOLOGICA, V40, P101; DENNIS D S, 1976, Journal of the Kansas Entomological Society, V49, P48; DOLE JW, 1974, COPEIA, P230, DOI 10.2307/1443028; Dytham C., 2011, CHOOSING USING STAT; Gallien L, 1952, B SOC ZOOL FR, V97, P456; GILLINGHAM J C, 1987, P184; Greene MJ, 2000, HERPETOLOGICA, V56, P166; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Halliday T.R., 1977, P185; Halliday T.R., 1990, Advances in the Study of Behavior, V19, P137, DOI 10.1016/S0065-3454(08)60202-8; Hansen LS, 2008, BEHAV ECOL, V19, P546, DOI 10.1093/beheco/arm165; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Iwata T, 1999, FEBS LETT, V457, P400, DOI 10.1016/S0014-5793(99)01062-5; Janssenswillen S, 2015, MOL BIOL EVOL, V32, P472, DOI 10.1093/molbev/msu316; Kikuyama S, 1999, REV REPROD, V4, P1; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; MALACARNE G, 1984, MONIT ZOOL ITAL, V18, P33; MALACARNE G, 1987, COPEIA, P245; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; Noble GK, 1937, B AM MUS NAT HIST, V73, P673; Osikowski A, 2008, ZOOL SCI, V25, P587, DOI 10.2108/zsj.25.587; Poschadel JR, 2007, ACTA ETHOL, V10, P35, DOI 10.1007/s10211-007-0025-y; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; SALTHE SN, 1967, COPEIA, P100; Salvador A., 1999, HDB REPTILIEN AMPHIB, P209; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secondi J, 2005, ETHOLOGY, V111, P726, DOI 10.1111/j.1439-0310.2005.01096.x; SEVER DM, 1981, HERPETOLOGICA, V37, P142; SEVER DM, 1992, ANAT REC, V233, P229, DOI 10.1002/ar.1092330206; Shine R, 2005, EVOLUTION, V59, P2426; Sparreboom Max, 2014, P9; *SPSS INC, 2005, SPSS WIND REL 14 0 0; TOYODA F, 1994, PHYSIOL BEHAV, V55, P569, DOI 10.1016/0031-9384(94)90118-X; Treer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056538; VERRELL P, 1982, ANIM BEHAV, V30, P1224, DOI 10.1016/S0003-3472(82)80215-7; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Woodley SK, 2010, J COMP PHYSIOL A, V196, P713, DOI 10.1007/s00359-010-0540-6; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	47	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0144985	10.1371/journal.pone.0144985	http://dx.doi.org/10.1371/journal.pone.0144985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771882	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300003
J	Wiendl, H; Butzkueven, H; Kappos, L; Trojano, M; Pellegrini, F; Paes, D; Zhang, AN; Belachew, S				Wiendl, Heinz; Butzkueven, Helmut; Kappos, Ludwig; Trojano, Maria; Pellegrini, Fabio; Paes, Dominic; Zhang, Annie; Belachew, Shibeshih		Tysabri Observational Program TOP	Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; CRITICAL-APPRAISAL; READERS GUIDE; NATALIZUMAB; EFFICACY; COHORT	Objective To evaluate the effect of natalizumab on disability progression beyond 2 years of treatment in clinical practice. Methods Analyses included the 496 relapsing-remitting multiple sclerosis (RRMS) patients among 5122 patients in the Tysabri Observational Program (TOP) who had completed 4 continuous years of natalizumab treatment and had baseline (study enrollment) and postbaseline Expanded Disability Status Scale (EDSS) assessments. Proportions of patients with 6-month or 12-month confirmed >= 1.0-point EDSS progression relative to baseline were compared in treatment months 1-24 and 25-48. Sensitivity analyses compared progression rates in months 13-24 and 25-36. Results Baseline characteristics appeared similar between the overall TOP population (N = 5122), patients who had completed 4 years of natalizumab treatment (n = 469), and patients eligible to complete 4 years in TOP who had discontinued natalizumab after 2 years of treatment (n = 514). Among 4-year completers, the proportion of patients with 6-month and 12-month confirmed EDSS progression decreased between months 1-24 and 25-48 of natalizumab treatment by 42% (from 10.9% to 6.3%; p < 0.01) and 52% (from 9.5% to 4.6%; p < 0.01), respectively. Few patients had 6-month or 12-month confirmed EDSS progression in both epochs (0.6% and 0.2%, respectively). Between months 13-24 and 25-36 of treatment, the proportion of patients with 6-month and 12-month confirmed EDSS progression decreased by 60% (from 7.5% to 3.0%; p < 0.01) and 58% (from 6.7% to 2.8%; p < 0.01), respectively. Significant reductions in disability progression events between months 13-24 and 25-36 were also observed in relapse-free patients. Conclusion In this observational study, the disability progression rate decreased further beyond 2 years of natalizumab treatment. Patients who responded well and remained on continuous natalizumab therapy for over 4 years had sustained and potentially enhanced reductions in EDSS progression over time.	[Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, D-48149 Munster, Germany; [Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut] Monash Univ, Box Hill Hosp, Dept Neurol, Clayton, Vic 3800, Australia; [Kappos, Ludwig] Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland; [Trojano, Maria] Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy; [Pellegrini, Fabio; Paes, Dominic; Zhang, Annie; Belachew, Shibeshih] Biogen, Cambridge, MA USA	University of Munster; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Monash University; University of Basel; University of Basel; University of Basel; Universita degli Studi di Bari Aldo Moro; Biogen	Wiendl, H (corresponding author), Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, D-48149 Munster, Germany.	heinz.wiendl@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Belachew, Shibeshih/V-9185-2019	Belachew, Shibeshih/0000-0003-3976-1950; Butzkueven, Helmut/0000-0003-3940-8727; Wiendl, Heinz/0000-0003-4310-3432; Trojano, Maria/0000-0002-6329-8946	Biogen	Biogen(Biogen)	The TOP study is funded by Biogen (www.biogen.com); Biogen employees had a role in study design, data collection, and analysis. Biogen reviewed and provided feedback on the manuscript to the authors. Biogen also provided funding for editorial support in the development of this manuscript (provided by Nolan Campbell of Biogen and Joshua Safran and Melissa Austin of Infusion Communications, listed in the Acknowledgments). All Biogen employees listed as authors meet ICMJE authorship criteria. All authors have contributed sufficiently to the project to be included as authors and have read and approved the manuscript.	Butzkueven H, 2014, J NEUROL NEUROSUR PS, V85, P1190, DOI 10.1136/jnnp-2013-306936; Fernandez O, 2011, MULT SCLER, V17, P192, DOI 10.1177/1352458510385507; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Hutchinson M, 2009, J NEUROL, V256, P405, DOI 10.1007/s00415-009-0093-1; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Lanzillo R, 2012, ACTA NEUROL SCAND, V126, P306, DOI 10.1111/j.1600-0404.2011.01622.x; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Lublin FD, 2014, MULT SCLER RELAT DIS, V3, P705, DOI 10.1016/j.msard.2014.08.005; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Phillips JT, 2011, MULT SCLER J, V17, P970, DOI 10.1177/1352458511399611; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2; Putzki N, 2010, EUR J NEUROL, V17, P31, DOI 10.1111/j.1468-1331.2009.02728.x; Rochon PA, 2005, BMJ-BRIT MED J, V330, P895, DOI 10.1136/bmj.330.7496.895; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick Richard A, 2004, Expert Rev Neurother, V4, P571, DOI 10.1586/14737175.4.4.571	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0144834	10.1371/journal.pone.0144834	http://dx.doi.org/10.1371/journal.pone.0144834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771747	Green Published, gold			2022-12-27	WOS:000368628300002
J	Vernet, N; Mahadevaiah, SK; Decarpentrie, F; Longepied, G; de Rooij, DG; Burgoyne, PS; Mitchell, MJ				Vernet, Nadege; Mahadevaiah, Shantha K.; Decarpentrie, Fanny; Longepied, Guy; de Rooij, Dirk G.; Burgoyne, Paul S.; Mitchell, Michael J.			Mouse Y-Encoded Transcription Factor Zfy2 Is Essential for Sperm Head Remodelling and Sperm Tail Development	PLOS ONE			English	Article							SEX-DETERMINING REGION; ZINC-FINGER PROTEIN; MALE-MICE; ACIDIC DOMAIN; CHROMOSOME; GENE; DELETION; EXPRESSION; ZFX; REARRANGEMENT	A previous study indicated that genetic information encoded on the mouse Y chromosome short arm (Yp) is required for efficient completion of the second meiotic division (that generates haploid round spermatids), restructuring of the sperm head, and development of the sperm tail. Using mouse models lacking a Y chromosome but with varying Yp gene complements provided by Yp chromosomal derivatives or transgenes, we recently identified the Y-encoded zinc finger transcription factors Zfy1 and Zfy2 as the Yp genes promoting the second meiotic division. Using the same mouse models we here show that Zfy2 (but not Zfy1) contributes to the restructuring of the sperm head and is required for the development of the sperm tail. The preferential involvement of Zfy2 is consistent with the presence of an additional strong spermatid-specific promotor that has been acquired by this gene. This is further supported by the fact that promotion of sperm morphogenesis is also seen in one of the two markedly Yp gene deficient models in which a Yp deletion has created a Zfy2/1 fusion gene that is driven by the strong Zfy2 spermatid-specific promotor, but encodes a protein almost identical to that encoded by Zfy1. Our results point to there being further genetic information on Yp that also has a role in restructuring the sperm head.	[Vernet, Nadege; Mahadevaiah, Shantha K.; Decarpentrie, Fanny; Burgoyne, Paul S.] Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; [Vernet, Nadege] Inst Genet & Biol Mol & Cellulaire, Dept Funct Genom & Canc, Illkirch Graffenstaden, France; [Mahadevaiah, Shantha K.; Decarpentrie, Fanny] Mill Hill Lab, Francis Crick Inst, London, England; [de Rooij, Dirk G.] Univ Utrecht, Fac Sci, Dept Biol, Reprod Biol Grp,Div Dev Biol, Utrecht, Netherlands; [de Rooij, Dirk G.] Univ Amsterdam, Amsterdam Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Longepied, Guy; Mitchell, Michael J.] Aix Marseille Univ, GMGF, Marseille, France; [Longepied, Guy; Mitchell, Michael J.] INSERM, UMR S 910, F-13258 Marseille, France	MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Francis Crick Institute; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Vernet, N (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England.	vernet@igbmc.fr	, vernet/P-2217-2015; de Rooij, D.G./AAW-1195-2021; Mitchell, Michael/I-3987-2016	, vernet/0000-0002-1308-2469; Mitchell, Michael/0000-0003-2052-7347; de Rooij, Dirk/0000-0003-3932-4419	Medical Research Council United Kingdom [U117532009]; Medical Research Council United Kingdom Career Development Fellowships [2007-458, N00399-1]; Journal of the European Molecular Biology Organization Long-Term Fellowships [282-2008]	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council United Kingdom Career Development Fellowships(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Journal of the European Molecular Biology Organization Long-Term Fellowships	The work was funded by the Medical Research Council United Kingdom (PSB: U117532009) http://www.mrc.ac.uk/funding/; the Medical Research Council United Kingdom Career Development Fellowships (NV: 2007-458, FD: N00399-1) http://www.mrc.ac.uk/skills-careers/fellowships/non-clinical-fellowships/career-development-award-cda-transition-to-independence/; and the Journal of the European Molecular Biology Organization Long-Term Fellowships (NV: 282-2008) http://www.embo.org/funding-awards/fellowships/long-term-fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Bachtrog D, 2014, CELL, V159, P715, DOI 10.1016/j.cell.2014.10.036; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; Burgoyne PS, 1998, CYTOGENET CELL GENET, V80, P37, DOI 10.1159/000014954; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Decarpentrie F, 2012, HUM MOL GENET, V21, P2631, DOI 10.1093/hmg/dds088; EICHER EM, 1991, CYTOGENET CELL GENET, V57, P221, DOI 10.1159/000133152; Ellis PJI, 2011, HUM MOL GENET, V20, P3010, DOI 10.1093/hmg/ddr204; Grants J, 2010, BIOCHEMISTRY-US, V49, P679, DOI 10.1021/bi9018626; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HALE DW, 1991, CYTOGENET CELL GENET, V57, P231, DOI 10.1159/000133153; Hansen MA, 2006, MOL REPROD DEV, V73, P568, DOI 10.1002/mrd.20463; Itoh Yuichiro, 2015, BMC Res Notes, V8, P69, DOI 10.1186/s13104-015-0986-2; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; LHaridon M, 1996, NUCLEIC ACIDS RES, V24, P1928, DOI 10.1093/nar/24.10.1928; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; MARDON G, 1990, MOL CELL BIOL, V10, P681, DOI 10.1128/MCB.10.2.681; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; MARDON G, 1989, SCIENCE, V243, P78, DOI 10.1126/science.2563173; Matsubara Y, 2015, STEM CELLS DEV, V24, P1164, DOI 10.1089/scd.2014.0466; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; NAGAMINE CM, 1990, GENE DEV, V4, P63, DOI 10.1101/gad.4.1.63; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; Rodriguez TA, 2001, CHROMOSOMA, V110, P124, DOI 10.1007/s004120100134; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHIMMIN LC, 1994, J MOL EVOL, V39, P569, DOI 10.1007/BF00160402; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052; TAYLORHARRIS P, 1995, FEBS LETT, V360, P315, DOI 10.1016/0014-5793(95)00141-U; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Tucker PK, 2003, MOL BIOL EVOL, V20, P999, DOI 10.1093/molbev/msg112; van Rheede T, 2006, MOL BIOL EVOL, V23, P587, DOI 10.1093/molbev/msj064; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Vernet N, 2014, PLOS GENET IN PRESS; Vernet N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004444; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamauchi Y, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r66; Yamauchi Y, 2009, BIOL REPROD, V81, P353, DOI 10.1095/biolreprod.109.076307	46	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145398	10.1371/journal.pone.0145398	http://dx.doi.org/10.1371/journal.pone.0145398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765744	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300007
J	Rogans, SJ; Rey, C				Rogans, Sarah Jane; Rey, Chrissie			Unveiling the Micronome of Cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNAS; TARGET GENES; SIRNA BIOGENESIS; SMALL RNAS; FUNCTIONAL DIVERSIFICATION; ARABIDOPSIS; MIRNA; BINDING; EVOLUTION	MicroRNAs (miRNAs) are an important class of endogenous non-coding single-stranded small RNAs (21-24 nt in length), which serve as post-transcriptional negative regulators of gene expression in plants. Despite the economic importance of Manihot esculenta Crantz (cassava) only 153 putative cassava miRNAs (from multiple germplasm) are available to date in miRBase (Version 21), and identification of a number of miRNAs from the cassava EST database have been limited to comparisons with Arabidopsis. In this study, mature sequences of all known plant miRNAs were used as a query for homologous searches against cassava EST and GSS databases, and additional identification of novel and conserved miRNAs were gleaned from next generation sequencing (NGS) of two cassava landraces (T200 from southern Africa and TME3 from West Africa) at three different stages post explant transplantation and acclimatization. EST and GSS derived data revealed 259 and 32 miRNAs in cassava, and one of the miRNA families (miR2118) from previous studies has not been reported in cassava. NGS data collectively displayed expression of 289 conserved miRNAs in leaf tissue, of which 230 had not been reported previously. Of the 289 conserved miRNAs identified in T200 and TME3, 208 were isomiRs. Thirty-nine novel cassava-specific miRNAs of low abundance, belonging to 29 families, were identified. Thirty-eight (98.6%) of the putative new miRNAs identified by NGS have not been previously reported in cassava. Several miRNA targets were identified in T200 and TME3, highlighting differential temporal miRNA expression between the two cassava landraces. This study contributes to the expanding knowledge base of the micronome of this important crop.	[Rogans, Sarah Jane; Rey, Chrissie] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa	University of Witwatersrand	Rey, C (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	chrissie.rey@wits.ac.za			National Research Foundation (ZA) [93467, 73895]	National Research Foundation (ZA)	This work was supported by National Research Foundation (ZA) Grant number: 93467; National Research Foundation (ZA) Grant Number: 73895. www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Amiteye S, 2011, AFR J BIOTECHNOL, V10, P2562; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Ballen-Taborda C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/857986; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; CARTER SE, 1993, APPL GEOGR, V13, P353, DOI 10.1016/0143-6228(93)90037-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dhandapani V, 2011, MOL CELLS, V32, P21, DOI 10.1007/s10059-011-2313-7; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; FAO, 2013, SAV GROW CASS GUID S; Frazier TP, 2011, METHODS MOL BIOL, V678, P13, DOI 10.1007/978-1-60761-682-5_2; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gehrig HH, 2000, PLANT MOL BIOL REP, V18, P369, DOI 10.1007/BF02825065; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hwang DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064238; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Lakhotia N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-6; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Panda D, 2014, GENE, V537, P333, DOI 10.1016/j.gene.2014.01.010; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Patanun O, 2013, MOL BIOTECHNOL, V53, P257, DOI 10.1007/s12033-012-9521-z; Perez-Quintero AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-29; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Unver T., 2009, INT J PLANT GENOMICS, V2009, P1, DOI [10.1155/2009/198680, DOI 10.1155/2009/198680]; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JY, 2012, GENE, V505, P300, DOI 10.1016/j.gene.2012.06.002; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Yu B, 2008, P NATL ACAD SCI USA, V105, P10073, DOI 10.1073/pnas.0804218105; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	102	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147251	10.1371/journal.pone.0147251	http://dx.doi.org/10.1371/journal.pone.0147251			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799216	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300080
J	Xu, YQ; Zhang, ZH; Chen, XY; Li, RX; Li, D; Feng, SQ				Xu, Yunqiang; Zhang, Zhenhui; Chen, Xuyi; Li, Ruixin; Li, Dong; Feng, Shiqing			A Silk Fibroin/Collagen Nerve Scaffold Seeded with a Co-Culture of Schwann Cells and Adipose-Derived Stem Cells for Sciatic Nerve Regeneration	PLOS ONE			English	Article							PERIPHERAL-NERVES; REPAIR; FIBROIN; AXON; DIFFERENTIATION; RECOVERY; CONDUIT; GAP	As a promising alternative to autologous nerve grafts, tissue-engineered nerve grafts have been extensively studied as a way to bridge peripheral nerve defects and guide nerve regeneration. The main difference between autogenous nerve grafts and tissue-engineered nerve grafts is the regenerative microenvironment formed by the grafts. If an appropriate regenerative microenvironment is provided, the repair of a peripheral nerve is feasible. In this study, to mimic the body's natural regenerative microenvironment closely, we co-cultured Schwann cells (SCs) and adipose-derived stem cells (ADSCs) as seed cells and introduced them into a silk fibroin (SF)/collagen scaffold to construct a tissue-engineered nerve conduit (TENC). Twelve weeks after the three different grafts (plain SF/collagen scaffold, TENC, and autograft) were transplanted to bridge 1-cm long sciatic nerve defects in rats, a series of electrophysiological examinations and morphological analyses were performed to evaluate the effect of the tissue-engineered nerve grafts on peripheral nerve regeneration. The regenerative outcomes showed that the effect of treatment with TENCs was similar to that with autologous nerve grafts but superior to that with plain SF/collagen scaffolds. Meanwhile, no experimental animals had inflammation around the grafts. Based on this evidence, our findings suggest that the TENC we developed could improve the regenerative microenvironment and accelerate nerve regeneration compared to plain SF/collagen and may serve as a promising strategy for peripheral nerve repair.	[Xu, Yunqiang; Zhang, Zhenhui; Li, Dong; Feng, Shiqing] Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China; [Chen, Xuyi] Affiliated Brain Hosp Armed Logist, Dept Neurosurg, Tianjin, Peoples R China; [Li, Ruixin] Acad Mil & Med Sci, Inst Med Equipment, Tianjin, Peoples R China	Tianjin Medical University; Academy of Military Medical Sciences - China	Xu, YQ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China.	docxu@sina.com			National Natural Science Foundation of China [81101362, 11102235]; Special Projects of National Science and Technology Cooperation with Russia [2014DFR31210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Projects of National Science and Technology Cooperation with Russia	This study was funded by the National Natural Science Foundation of China (Grant 81101362, Grant 11102235.), the Special Projects of National Science and Technology Cooperation with Russia (2014DFR31210).	Alberti KA, 2014, BIOMATERIALS, V35, P3551, DOI 10.1016/j.biomaterials.2013.12.082; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.tea.2011.0496, 10.1089/ten.TEA.2011.0496]; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Goto E, 2010, J BIOSCI BIOENG, V109, P512, DOI 10.1016/j.jbiosc.2009.11.002; Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002; Honkanen H, 2007, EUR J NEUROSCI, V26, P953, DOI 10.1111/j.1460-9568.2007.05726.x; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Jaing TH, 2014, CELL TRANSPLANT, V23, P493, DOI 10.3727/096368914X678300; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Koeppen AH, 2004, J NEUROL SCI, V220, P115, DOI 10.1016/j.jns.2004.03.008; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Lehmann HC, 2016, BRAIN RES, V1638, P97, DOI 10.1016/j.brainres.2015.10.040; Liao DP, 2010, ARCH MED SCI, V6, P145, DOI 10.5114/aoms.2010.13885; MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4; Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3; Nagase T, 2007, J CRANIOFAC SURG, V18, P49, DOI 10.1097/01.scs.0000249357.66720.d2; Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052; Ruan Y, 2005, MACROMOL BIOSCI, V1, P419; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.TEC.2011.0201, 10.1089/ten.tec.2011.0201]; Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2; Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799; Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060; Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028; Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004; Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]; Zurita M, 2007, NEUROREPORT, V18, P1713, DOI 10.1097/WNR.0b013e3282f0d3b0	34	73	77	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147184	10.1371/journal.pone.0147184	http://dx.doi.org/10.1371/journal.pone.0147184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799619	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300069
J	Agebratt, C; Strom, E; Romu, T; Dahlqvist-Leinhard, O; Borga, M; Leandersson, P; Nystrom, FH				Agebratt, Christian; Strom, Edvin; Romu, Thobias; Dahlqvist-Leinhard, Olof; Borga, Magnus; Leandersson, Per; Nystrom, Fredrik H.			A Randomized Study of the Effects of Additional Fruit and Nuts Consumption on Hepatic Fat Content, Cardiovascular Risk Factors and Basal Metabolic Rate	PLOS ONE			English	Article							LIVER-DISEASE; ENERGY-INTAKE; CANCER; FRUCTOSE; WATER; SUPPLEMENTATION; PREVENTION; MORTALITY; PEANUTS; HEALTH	Background Fruit has since long been advocated as a healthy source of many nutrients, however, the high content of sugars in fruit might be a concern. Objectives To study effects of an increased fruit intake compared with similar amount of extra calories from nuts in humans. Methods Thirty healthy non-obese participants were randomized to either supplement the diet with fruits or nuts, each at +7 kcal/kg bodyweight/day for two months. Major endpoints were change of hepatic fat content (HFC, by magnetic resonance imaging, MRI), basal metabolic rate (BMR, with indirect calorimetry) and cardiovascular risk markers. Results Weight gain was numerically similar in both groups although only statistically significant in the group randomized to nuts (fruit: from 22.15+/-1.61 kg/m(2) to 22.30+/-1.7 kg/m(2), p = 0.24 nuts: from 22.54+/-2.26 kg/m(2) to 22.73+/-2.28 kg/m(2), p = 0.045). On the other hand BMR increased in the nut group only (p = 0.028). Only the nut group reported a net increase of calories (from 2519+/-721 kcal/day to 2763+/-595 kcal/day, p = 0.035) according to 3-day food registrations. Despite an almost three-fold reported increased fructose-intake in the fruit group (from 9.1+/-6.0 gram/day to 25.6+/-9.6 gram/day, p<0.0001, nuts: from 12.4+/-5.7 gram/day to 6.5+/-5.3 gram/day, p = 0.007) there was no change of HFC. The numerical increase in fasting insulin was statistical significant only in the fruit group (from 7.73+/-3.1 pmol/l to 8.81+/-2.9 pmol/l, p = 0.018, nuts: from 7.29+/-2.9 pmol/l to 8.62+/-3.0 pmol/l, p = 0.14). Levels of vitamin C increased in both groups while alpha-tocopherol/cholesterol-ratio increased only in the fruit group. Conclusions Although BMR increased in the nut-group only this was not linked with differences in weight gain between groups which potentially could be explained by the lack of reported net caloric increase in the fruit group. In healthy non-obese individuals an increased fruit intake seems safe from cardiovascular risk perspective, including measurement of HFC by MRI.	[Agebratt, Christian; Strom, Edvin; Dahlqvist-Leinhard, Olof; Nystrom, Fredrik H.] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Romu, Thobias; Dahlqvist-Leinhard, Olof; Borga, Magnus] Linkoping Univ, Fac Med & Hlth Sci, Ctr Med Image Sci & Visualizat, Linkoping, Sweden; [Leandersson, Per] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Romu, Thobias; Borga, Magnus] Linkoping Univ, Dept Biomed Engn, Fac Med & Hlth Sci, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nystrom, FH (corresponding author), Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden.	fredrik.h.nystrom@liu.se		Romu, Thobias/0000-0003-0607-9795; Strom, Edvin/0000-0002-9292-1055; Leanderson, Per/0000-0001-6724-7305; Nystrom, Fredrik/0000-0002-1680-1000	County Council of Ostergotland; Linkoping University, Department of Medical and Health Sciences	County Council of Ostergotland; Linkoping University, Department of Medical and Health Sciences	The County Council of Ostergotland and Linkoping University, Department of Medical and Health Sciences, supported the trial with grants and other resources. The funders had no role in the design or completion of the trial.	Angelopoulos TJ, 2009, J NUTR, V139, pS1242, DOI 10.3945/jn.108.098194; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Claesson AL, 2009, SCAND J CLIN LAB INV, V69, P598, DOI 10.1080/00365510902912754; Dahlen EM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-55; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Edefonti V, 2015, INT J CANCER, V137, P448, DOI 10.1002/ijc.29388; Emond JA, 2014, INT J OBESITY, V38, P603, DOI 10.1038/ijo.2013.130; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Hagfors L, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-5; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Karlsson A, 2015, J MAGN RESON IMAGING, V41, P1558, DOI 10.1002/jmri.24726; Kechagias S, 2008, GUT, V57, P649, DOI 10.1136/gut.2007.131797; Kechagias S, 2008, GUT; Kechagias S, 2011, ANN MED, V43, P545, DOI 10.3109/07853890.2011.588246; Keller C, 2007, THER APHER DIAL, V11, P2, DOI 10.1111/j.1744-9987.2007.00449.x; Kim NH, 2014, HEART, V100, P938, DOI 10.1136/heartjnl-2013-305099; Lamprecht M, 2012, MED SPORT SCI, V59, P70, DOI 10.1159/000341960; Lazzeroni M, 2011, BREAST, V20, pS36, DOI 10.1016/S0960-9776(11)70292-2; Lecoultre V, 2013, OBESITY, V21, P782, DOI 10.1002/oby.20377; Leinhard OD, 2008, 19 INT C PATT REC TA; Lidebjer C, 2007, NUTR METAB CARDIOVAS, V17, P448, DOI 10.1016/j.numecd.2006.02.006; Lof M, 2004, J HUM NUTR DIET, V17, P471, DOI 10.1111/j.1365-277X.2004.00554.x; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Moeller SM, 2009, J AM COLL NUTR, V28, P619, DOI 10.1080/07315724.2009.10719794; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Alves RDM, 2014, NUTR HOSP, V29, P1024, DOI 10.3305/nh.2014.29.5.7235; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Souza RGM, 2015, NUTR REV, V73, P335, DOI 10.1093/nutrit/nuu008; Stice E, 2014, APPETITE, V81, P84, DOI 10.1016/j.appet.2014.06.012; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Wallhuss A, 2010, SCAND J CLIN LAB INV, V70, P334, DOI 10.3109/00365513.2010.491125; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737	34	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147149	10.1371/journal.pone.0147149	http://dx.doi.org/10.1371/journal.pone.0147149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788923	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100062
J	Cheney, KL; White, A; Mudianta, IW; Winters, AE; Quezada, M; Capon, RJ; Mollo, E; Garson, MJ				Cheney, Karen L.; White, Andrew; Mudianta, I. Wayan; Winters, Anne E.; Quezada, Michelle; Capon, Robert J.; Mollo, Ernesto; Garson, Mary J.			Choose Your Weaponry: Selective Storage of a Single Toxic Compound, Latrunculin A, by Closely Related Nudibranch Molluscs	PLOS ONE			English	Article							MARINE SPONGE; OPISTHOBRANCH MOLLUSKS; SECONDARY METABOLITES; CHEMICAL DEFENSE; DORID NUDIBRANCH; NATURAL-PRODUCTS; DITERPENES; SEQUESTRATION; CONSTITUENTS; MACROLIDES	Natural products play an invaluable role as a starting point in the drug discovery process, and plants and animals use many interesting biologically active natural products as a chemical defense mechanism against predators. Among marine organisms, many nudibranch gastropods are known to derive defensive metabolites from the sponges they eat. Here we investigated the putative sequestration of the toxic compound latrunculin A-a 16-membered macrolide that prevents actin polymerization within cellular processes-which has been identified from sponge sources, by five closely related nudibranch molluscs of the genus Chromodoris. Only latrunculin A was present in the rim of the mantle of these species, where storage reservoirs containing secondary metabolites are located, whilst a variety of secondary metabolites were found in their viscera. The species studied thus selectively accumulate latrunculin A in the part of the mantle that is more exposed to potential predators. This study also demonstrates that latrunculin-containing sponges are not their sole food source. Latrunculin A was found to be several times more potent than other compounds present in these species of nudibranchs when tested by in vitro and in vivo toxicity assays. Anti-feedant assays also indicated that latrunculin A was unpalatable to rock pool shrimps, in a dose-dependent manner. These findings led us to propose that this group of nudibranchs has evolved means both to protect themselves from the toxicity of latrunculin A, and to accumulate this compound in the mantle rim for defensive purposes. The precise mechanism by which the nudibranchs sequester such a potent compound from sponges without disrupting their own key physiological processes is unclear, but this work paves the way for future studies in this direction. Finally, the possible occurrence of both visual and chemosensory Mllerian mimicry in the studied species is discussed.	[Cheney, Karen L.; White, Andrew; Winters, Anne E.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [White, Andrew; Mudianta, I. Wayan; Garson, Mary J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Quezada, Michelle; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Mollo, Ernesto] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Mudianta, I. Wayan] Ganesha Univ Educ, Jl Udayana 11, Singaraja 81116, Bali, Indonesia	University of Queensland; University of Queensland; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Ganesha University of Education	Cheney, KL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	k.cheney@uq.edu.au	Mudianta, I Wayan/AAN-5829-2020; Cheney, Karen/L-3427-2018; Capon, Robert/G-9238-2012; Mollo, Ernesto/F-7842-2013; Cheney, Karen L/A-6827-2013; White, Andrew/C-8001-2017	Mudianta, I Wayan/0000-0002-0388-3828; Cheney, Karen/0000-0001-5622-9494; Capon, Robert/0000-0002-8341-7754; Mollo, Ernesto/0000-0001-7379-1788; Cheney, Karen L/0000-0001-5622-9494; Winters, Anne/0000-0003-2840-6267; White, Andrew/0000-0002-9481-1079	Australian and Pacific Science Foundation (APSF); Australia Research Council (ARC); University of Queensland; University of Queensland from the Institute for Molecular Bioscience; Australian Government	Australian and Pacific Science Foundation (APSF); Australia Research Council (ARC)(Australian Research Council); University of Queensland(University of Queensland); University of Queensland from the Institute for Molecular Bioscience; Australian Government(Australian GovernmentCGIAR)	The authors thank the Australian and Pacific Science Foundation (APSF); the Australia Research Council (ARC); and The University of Queensland (Promoting Women Fellowship to K.L.C., a UQ International Postgraduate Award to I.W.M., and support from the Institute for Molecular Bioscience to R.J.C.). A.E.W. was supported by a Postgraduate Endeavour Award from the Australian Government. M.Q. acknowledges the Mexican Council for Science and Technology (CONACYT).	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Avila C, 1995, OCEANOGR MAR BIOL, V33, P487; Avila C, 1997, MAR ECOL PROG SER, V150, P171, DOI 10.3354/meps150171; Benkendorff K, 2010, BIOL REV, V85, P757, DOI 10.1111/j.1469-185X.2010.00124.x; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; BOBZIN SC, 1989, J ORG CHEM, V54, P3902, DOI 10.1021/jo00277a029; BOBZIN SC, 1989, J ORG CHEM, V54, P5727, DOI 10.1021/jo00285a019; CAMBIE RC, 1987, J NAT PROD, V50, P948, DOI 10.1021/np50053a033; Carbone M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062075; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cheney KL, 2014, J EVOLUTION BIOL, V27, P676, DOI 10.1111/jeb.12348; Cimino Guido, 2009, Proceedings of the California Academy of Sciences, V60, P175; CORLEY DG, 1988, J ORG CHEM, V53, P3644, DOI 10.1021/jo00250a053; Cortesi F, 2010, J EVOLUTION BIOL, V23, P1509, DOI 10.1111/j.1420-9101.2010.02018.x; de Cook S.C., 2002, SYSTEMA PORIFERA GUI, P1028, DOI [10.1007/978-1-4615-0747-5, DOI 10.1007/978-1-4615-0747-5]; EISNER T, 1981, SCIENCE, V213, P476, DOI 10.1126/science.7244647; FAULKNER DJ, 1983, MAR ECOL PROG SER, V13, P295, DOI 10.3354/meps013295; Ferreira M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00266; FONTANA A, 1994, EXPERIENTIA, V50, P510, DOI 10.1007/BF01920760; Garson MJ, 2004, CHEM AUSTR, V71, P16; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Gohli J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005779; Gordaliza M, 2010, MAR DRUGS, V8, P2849, DOI 10.3390/md8122849; Graham SK, 2010, J CHEM CRYSTALLOGR, V40, P468, DOI 10.1007/s10870-009-9679-9; Haber M, 2010, BIOL BULL-US, V218, P181, DOI 10.1086/BBLv218n2p181; Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+; HAMANN MT, 1993, J ORG CHEM, V58, P6565, DOI 10.1021/jo00076a012; HAMBLEY TW, 1986, TETRAHEDRON LETT, V27, P3281, DOI 10.1016/S0040-4039(00)84775-9; Hartmann T, 1997, PHYTOCHEMISTRY, V45, P489, DOI 10.1016/S0031-9422(97)00009-5; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Hirayama Y, 2016, AUST J CHEM, V69, P136, DOI 10.1071/CH15203; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; JOHNSON S, 1983, PAC SCI, V37, P251; KAKOU Y, 1987, J NAT PROD, V50, P482, DOI 10.1021/np50051a023; KARUSO P, 1986, AUST J CHEM, V39, P1629, DOI 10.1071/CH9861629; KASHMAN Y, 1980, TETRAHEDRON LETT, V21, P3629, DOI 10.1016/0040-4039(80)80255-3; Konishi H, 2009, ANTICANCER RES, V29, P2091; Marin A, 1997, J MOLLUS STUD, V63, P431, DOI 10.1093/mollus/63.3.431; Martin-Algarra S, 2009, EUR J CANCER, V45, P732, DOI 10.1016/j.ejca.2008.12.005; McPhail K, 1997, TETRAHEDRON, V53, P4655, DOI 10.1016/S0040-4020(97)00198-1; MEBS D, 1985, J CHEM ECOL, V11, P713, DOI 10.1007/BF00988300; Mollo E, 2005, CHEMOECOLOGY, V15, P31, DOI 10.1007/s00049-005-0289-5; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092; Mudianta IW, 2014, PURE APPL CHEM, V86, P995, DOI 10.1515/pac-2013-1111; NEEMAN I, 1975, MAR BIOL, V30, P293, DOI 10.1007/BF00390634; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; OKUDA RK, 1985, EXPERIENTIA, V41, P1355, DOI 10.1007/BF01952094; PAWLIK JR, 1988, J EXP MAR BIOL ECOL, V119, P99, DOI 10.1016/0022-0981(88)90225-0; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; PIKA J, 1995, TETRAHEDRON, V51, P8189, DOI 10.1016/0040-4020(95)00440-J; Rudman WB, 2007, MOLLUSCAN RES, V27, P60; RUDMAN WB, 1981, ZOOL J LINN SOC-LOND, V72, P219, DOI 10.1111/j.1096-3642.1981.tb01571.x; RUDMAN WB, 1991, J MOLLUS STUD, V57, P167, DOI 10.1093/mollus/57.2.167; Salazar R, 2013, CANCER CHEMOTH PHARM, V72, P75, DOI 10.1007/s00280-013-2170-5; Sanders Miranda L., 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V66, P117; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Slattery M, 1998, J EXP MAR BIOL ECOL, V226, P33, DOI 10.1016/S0022-0981(97)00240-2; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Suciati, 2011, AUST J CHEM, V64, P757, DOI 10.1071/CH11036; Uddin MH, 2009, CHEM PHARM BULL, V57, P885, DOI 10.1248/cpb.57.885; Wagele H, 2006, OCEANOGR MAR BIOL, V44, P197; WALKER RP, 1981, J ORG CHEM, V46, P1098, DOI 10.1021/jo00319a012; Weldon PJ, 2013, CHEMOECOLOGY, V23, P201, DOI 10.1007/s00049-013-0140-3	64	43	43	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145134	10.1371/journal.pone.0145134	http://dx.doi.org/10.1371/journal.pone.0145134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788920	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100006
J	Li, SS; Zhang, Y; Wang, JH; Yang, YF; Miao, C; Guo, YF; Zhang, ZD; Cao, QC; Shui, WQ				Li, Shanshan; Zhang, Yong; Wang, Jihua; Yang, Yunfei; Miao, Chen; Guo, Yufeng; Zhang, Zhidan; Cao, Qichen; Shui, Wenqing			Combining Untargeted and Targeted Proteomic Strategies for Discrimination and Quantification of Cashmere Fibers	PLOS ONE			English	Article							KERATIN; IDENTIFICATION; WOOL; HAIR	Cashmere is regarded as a specialty and luxury fiber due to its scarcity and high economic value. For fiber quality assessment, it is technically very challenging to distinguish and quantify the cashmere fiber from yak or wool fibers because of their highly similar physical appearance and substantial protein sequence homology. To address this issue, we propose a workflow combining untargeted and targeted proteomics strategies for selecting, verifying and quantifying biomarkers for cashmere textile authentication. Untargeted proteomic surveys were first applied to identify 174, 157, and 156 proteins from cashmere, wool and yak fibers, respectively. After marker selection at different levels, peptides turned out to afford much higher selectivity than proteins for fiber species discrimination. Subsequently, parallel reaction monitoring (PRM) methods were developed for ten selected peptide markers. The PRM-based targeted analysis of peptide markers enabled accurate determination of fiber species and cashmere percentages in different fiber mixtures. Furthermore, collective use of these peptide makers allowed us to discriminate and quantify cashmere fibers in commercial finished fabrics that have undergone heavy chemical treatments. Cashmere proportion measurement in fabric samples using our proteomic approach was in good agreement with results from traditional light microscopy, yet our method can be more readily standardized to become an objective and robust assay for assessing authenticity of fibers and textiles. We anticipate that the proteomic strategies presented in our study could be further implicated in discovery of quality trait markers for other products containing highly homologous proteomes.	[Li, Shanshan; Miao, Chen; Guo, Yufeng; Zhang, Zhidan; Cao, Qichen; Shui, Wenqing] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Zhang, Yong; Yang, Yunfei] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Jihua] Tianjin Text Engn Res Inst, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Nankai University	Cao, QC; Shui, WQ (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China.	cao_qc@tib.cas.cn; shui_wq@tib.cas.cn	Zhang, Yong/X-5075-2019	Zhang, Yong/0000-0003-0513-8941	National Natural Science Foundation of China [31401150, 21505151]; Key Projects in the Tianjin Science & Technology Pillar Program [14ZCZDSY00062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program	This work was supported by (WQS) the National Natural Science Foundation of China (No. 31401150), http://www.nsfc.gov.cn; (QCC) the National Natural Science Foundation of China (No. 21505151), http://www.nsfc.gov.cn; (WQS) the Key Projects in the Tianjin Science & Technology Pillar Program (No. 14ZCZDSY00062), http://http://www.tstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2014, J PROTEOMICS, V103, P170, DOI 10.1016/j.jprot.2014.03.036; Ancheng W, 1987, J CHINA TEXTILE U, V13, P8; Baek JH, 2009, J PROTEOME RES, V8, P3625, DOI 10.1021/pr800853k; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Clerens S, 2010, J PROTEOMICS, V73, P1722, DOI 10.1016/j.jprot.2010.05.005; Gong H, 2012, DNA CELL BIOL, V31, P366, DOI 10.1089/dna.2011.1346; Gong H, 2011, EXP DERMATOL, V20, P815, DOI 10.1111/j.1600-0625.2011.01333.x; Gong H, 2011, MOL BIOL REP, V38, P5429, DOI 10.1007/s11033-011-0697-2; Gong H, 2010, ELECTROPHORESIS, V31, P3545, DOI 10.1002/elps.201000301; Hamlyn PF, 1998, J SOC DYERS COLOUR, V114, P78; Ji W, 2011, FORENSIC SCI INT, V208, P139, DOI 10.1016/j.forsciint.2010.11.017; Kerkhoff K, 2009, TEXT RES J, V79, P69, DOI 10.1177/0040517508090488; Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m; Koehn H, 2009, J PROTEOMICS, V73, P323, DOI 10.1016/j.jprot.2009.09.017; Langbein L, INT REV CYTOLOGY SUR, V243; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; LANGLEY KD, 1981, TEXT RES J, V51, P703, DOI 10.1177/004051758105101104; Lewin M., 2006, HDB FIBER CHEM; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McLaren RJ, 1997, MAMM GENOME, V8, P938, DOI 10.1007/s003359900616; Paolella S, 2013, J MASS SPECTROM, V48, P919, DOI 10.1002/jms.3222; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Phan K-H, 1987, SCHRIFTENREIHE DWI, V101, P4; Phan K-H, 2004, 3 INT S SPEC FIBR DW; Plowman JE, 2012, J PROTEOMICS, V75, P4315, DOI 10.1016/j.jprot.2012.03.027; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Robotti E, 2013, J PROTEOM BIOINFORM, V3, DOI [10.4172/jpb.S3-003, DOI 10.4172/JPB.S3-003]; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Tonetti C, 2012, TEXT RES J, V82, P766, DOI 10.1177/0040517511433146; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Tucker DJ, 1990, P 2 INT S SPEC AN FI; Vineis C, 2014, TEXT RES J, V84, P953, DOI 10.1177/0040517513512394; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; WORTMANN FJ, 1986, TEXT RES J, V56, P442, DOI 10.1177/004051758605600708	35	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147044	10.1371/journal.pone.0147044	http://dx.doi.org/10.1371/journal.pone.0147044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789629	gold, Green Published			2022-12-27	WOS:000368529100054
J	Broeders, EPM; Vijgen, GHEJ; Havekes, B; Bouvy, ND; Mottaghy, FM; Kars, M; Schaper, NC; Schrauwen, P; Brans, B; Lichtenbelt, WDV				Broeders, Evie P. M.; Vijgen, Guy H. E. J.; Havekes, Bas; Bouvy, Nicole D.; Mottaghy, Felix M.; Kars, Marleen; Schaper, Nicolaas C.; Schrauwen, Patrick; Brans, Boudewijn; Lichtenbelt, Wouter D. van Marken			Thyroid Hormone Activates Brown Adipose Tissue and Increases Non-Shivering Thermogenesis - A Cohort Study in a Group of Thyroid Carcinoma Patients	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; BLOOD-PRESSURE; COLD; HYPERTHYROIDISM; FAT; METABOLISM; RECEPTOR; SERUM	Background/Objectives Thyroid hormone receptors are present on brown adipose tissue (BAT), indicating a role for thyroid hormone in the regulation of BAT activation. The objective of this study was to examine the effect of thyroid hormone withdrawal followed by thyroid hormone in TSH-suppressive dosages, on energy expenditure and brown adipose tissue activity. Subjects/Methods This study was a longitudinal study in an academic center, with a follow-up period of 6 months. Ten patients with well-differentiated thyroid carcinoma eligible for surgical treatment and subsequent radioactive iodine ablation therapy were studied in a hypothyroid state after thyroidectomy and in a subclinical hyperthyroid state (TSH-suppression according to treatment protocol). Paired two-tailed t-tests and linear regression analyses were used. Results Basal metabolic rate (BMR) was significantly higher after treatment with synthetic thyroid hormone (levothyroxine) than in the hypothyroid state (BMR 3.8 +/- 0.5 kJ/min versus 4.4 +/- 0.6 kJ/min, P = 0.012), and non-shivering thermogenesis (NST) significantly increased from 15 +/- 10% to 25 +/- 6% (P = 0.009). Mean BAT activity was significantly higher in the subclinical hyperthyroid state than in the hypothyroid state (BAT standard uptake value (SUVMean) 4.0 +/- 2.9 versus 2.4 +/- 1.8, P = 0.039). Conclusions Our study shows that higher levels of thyroid hormone are associated with a higher level of cold-activated BAT.	[Broeders, Evie P. M.; Vijgen, Guy H. E. J.; Schrauwen, Patrick; Lichtenbelt, Wouter D. van Marken] MUMC, Dept Human Biol, Maastricht, Netherlands; [Vijgen, Guy H. E. J.] St Franciscus Gasthuis, Dept Surg, Rotterdam, Netherlands; [Mottaghy, Felix M.; Brans, Boudewijn] MUMC, Dept Nucl Med, Maastricht, Netherlands; [Mottaghy, Felix M.] Univ Hosp RWTH Aachen Univ, Dept Nucl Med, Aachen, Germany; [Havekes, Bas; Kars, Marleen; Schaper, Nicolaas C.] MUMC, Dept Endocrinol, Maastricht, Netherlands; [Broeders, Evie P. M.; Vijgen, Guy H. E. J.; Bouvy, Nicole D.] MUMC, Dept Gen Surg, Maastricht, Netherlands	Maastricht University; Franciscus Gasthuis; Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Maastricht University	Lichtenbelt, WDV (corresponding author), MUMC, Dept Human Biol, Maastricht, Netherlands.	markenlichtenbelt@maastrichtuniversity.nl	Mottaghy, Felix/AAU-2673-2020; Bouvy, Nicole/AAD-2844-2021; Schaper, Nicolaas C/E-7112-2014	Mottaghy, Felix/0000-0002-7212-6521; Vijgen, Guy/0000-0002-6011-753X; schaper, nicolaas/0000-0002-2128-8029; schrauwen, patrick/0000-0002-0973-847X	Netherlands Organization for Scientific Research [TOP 91209037]; EU FP7 project DIABAT [HEALTH-F2-2011-278373]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU FP7 project DIABAT	This work is partly financed by the Netherlands Organization for Scientific Research (TOP 91209037 to W.D.v.M.L.), and by the EU FP7 project DIABAT (HEALTH-F2-2011-278373).	Andersen S, 2012, EUR J ENDOCRINOL, V166, P433, DOI 10.1530/EJE-11-0888; BARKER SB, 1952, AM J PHYSIOL, V170, P81, DOI 10.1152/ajplegacy.1952.170.1.81; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, NAT MED, V16, P965, DOI 10.1038/nm0910-965; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581, DOI 10.1016/S0300-595X(84)80039-0; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Endo T, 2008, AM J PHYSIOL-ENDOC M, V295, pE514, DOI 10.1152/ajpendo.90433.2008; Gagnon A, 2010, METABOLISM, V59, P547, DOI 10.1016/j.metabol.2009.08.018; Goglia F, 2002, BIOSCIENCE REP, V22, P17, DOI 10.1023/A:1016056905347; Johannsen DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040837; Kim MS, 2014, J CLIN ENDOCR METAB, V99, pE1686, DOI 10.1210/jc.2014-1343; Kingma BRM, 2011, ACTA PHYSIOL, V203, P419, DOI 10.1111/j.1748-1716.2011.02336.x; Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312; Lee JY, 2011, AM J PHYSL CELL PHYS; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu D, 2010, J HUM HYPERTENS, V24, P134, DOI 10.1038/jhh.2009.44; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Louzada RA, 2014, AM J PHYSIOL-ENDOC M, V307, pE1020, DOI 10.1152/ajpendo.00637.2013; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; NIELSEN HV, 1987, CLIN PHYSIOL, V7, P297, DOI 10.1111/j.1475-097X.1987.tb00172.x; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; TATA JR, 1962, NATURE, V193, P1058, DOI 10.1038/1931058a0; Thrush AB, 2012, HORM METAB RES, V44, P825, DOI 10.1055/s-0032-1316332; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Volzke H, 2006, J HYPERTENS, V24, P1947; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; WEISS M, 1993, J CLIN ENDOCR METAB, V76, P680, DOI 10.1210/jc.76.3.680	38	54	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145049	10.1371/journal.pone.0145049	http://dx.doi.org/10.1371/journal.pone.0145049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784028	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400010
J	Kaliszewski, K; Diakowska, D; Wojtczak, B; Strutynska-Karpinska, M; Domoslawski, P; Sutkowski, K; Glod, M; Balcerzak, W; Forkasiewicz, Z; Lukienczuk, T				Kaliszewski, Krzysztof; Diakowska, Dorota; Wojtczak, Beata; Strutynska-Karpinska, Marta; Domoslawski, Pawel; Sutkowski, Krzysztof; Glod, Mateusz; Balcerzak, Waldemar; Forkasiewicz, Zdzislaw; Lukienczuk, Tadeusz			Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules	PLOS ONE			English	Article							BENIGN MULTINODULAR GOITER; ENDEMIC GOITER; ULTRASOUND; RISK; FEATURES; DIFFERENTIATION; POPULATION; PREVALENCE; CARCINOMA; PAPILLARY	Background Fine-needle aspiration biopsy (FNAB) is a recognized technique for the basic, preoperative cytological diagnosis of thyroid nodules. Aim of the Study To analyze the accuracy of FNAB in the diagnosis of thyroid cancer in patients with solitary and multiple thyroid nodules and to compare the demographic, clinical and pathological characteristics of patients with thyroid carcinoma in solitary and multiple tumors. Materials and Methods The case records of 2,403 patients with solitary and multiple thyroid tumors treated consecutively between 2008 and 2013 were analyzed retrospectively. We selected 1,645 for further analysis. A solitary thyroid nodule was observed in 493 patients, and multiple nodules were detected in 1,152 patients. Further classification of the patients in these two groups was performed on the basis of the FNAB results, type of surgery performed and histopathology. TC was histopathologically confirmed in 166 patients, and benign disease was found in 1,479. The TC patients were assigned to the study group, and those with benign thyroid disease were placed into the control group. The study group was divided into two subgroups according to the presence of cancer in a single thyroid nodule or in multiple nodules. Malignancy in a solitary thyroid nodule was diagnosed in 98 (59.0%) patients, and cancer in multiple nodules was diagnosed in 68 (41.0%). Comparative analyses of the demographic, clinical and histopathological characteristics were performed for both subgroups. The following statistical analyses were performed: comparative characteristic of subgroups, ROC analysis for study group and subgroup of patients, and multivariable logistic regression analysis for study group. Results The rate of prediction of TC by FNAB was three times higher in the patients with a solitary thyroid nodule compared with those with multiple thyroid nodules and it was statistically significant (p<0.001). The rate of total thyroid resection and lack of necessity for reoperation were also significantly higher in the TC patients with a solitary nodule. The histopathological results showed that significantly more patients with a solitary nodule had advanced-stage TC (stage III or IV) and tumor progression (pT3 or pT4) (p = 0.002 for both). ROC analysis demonstrated that the overall accuracy of FNAB as a predictor of thyroid cancer presence was high, especially for the subgroup of patients with a solitary thyroid nodule (AUC = 0.958, p<0.0001). Multivariable logistic regression analysis confirmed that a positive FNAB result was the sole predictor of the performance of total resection in the TC study group (p<0.0001), while a negative FNAB result and the presence of a papillary cancer type were independent predictors of the risk of reoperation (p<0.0001 and p = 0.002, respectively). Conclusions FNAB often produces false-negative results in patients with multiple malignant thyroid tumors, which results in reoperation in many cases. False-negative FNAB results are rare in patients with a solitary tumor. Because of the low predictive capacity of FNAB for thyroid cancer in patients with multiple thyroid tumors, total thyroid excision should be considered in most cases despite a "negative" (no malignant) FNAB result.	[Kaliszewski, Krzysztof; Wojtczak, Beata; Strutynska-Karpinska, Marta; Domoslawski, Pawel; Sutkowski, Krzysztof; Glod, Mateusz; Balcerzak, Waldemar; Forkasiewicz, Zdzislaw; Lukienczuk, Tadeusz] Wroclaw Med Univ, Dept 1, Wroclaw, Poland; [Kaliszewski, Krzysztof; Wojtczak, Beata; Strutynska-Karpinska, Marta; Domoslawski, Pawel; Sutkowski, Krzysztof; Glod, Mateusz; Balcerzak, Waldemar; Forkasiewicz, Zdzislaw; Lukienczuk, Tadeusz] Wroclaw Med Univ, Clin Gen Gastroenterol & Endocrine Surg, Wroclaw, Poland; [Diakowska, Dorota] Wroclaw Med Univ, Dept & Clin Gastrointestinal & Gen Surg, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University	Kaliszewski, K (corresponding author), Wroclaw Med Univ, Dept 1, Wroclaw, Poland.; Kaliszewski, K (corresponding author), Wroclaw Med Univ, Clin Gen Gastroenterol & Endocrine Surg, Wroclaw, Poland.	krzysztofkali@wp.pl		Domoslawski, Pawel/0000-0003-1903-0843; Kaliszewski, Krzysztof/0000-0002-3291-5294; Wojtczak, Beata/0000-0002-9953-0460; Diakowska, Dorota/0000-0002-1377-5601				Agarwal G, 2008, WORLD J SURG, V32, P1313, DOI 10.1007/s00268-008-9579-8; AGHINILOMBARDI F, 1993, ACTA ENDOCRINOL-COP, V129, P497, DOI 10.1530/acta.0.1290497; Algin O, 2010, KOREAN J RADIOL, V11, P594, DOI 10.3348/kjr.2010.11.6.594; Barczynski M, 2010, WORLD J SURG, V34, P1203, DOI 10.1007/s00268-010-0491-7; Boger MS, 2004, SURG CLIN N AM, V84, P849, DOI 10.1016/j.suc.2004.01.006; Cappelli C, 2006, EUR J ENDOCRINOL, V155, P27, DOI 10.1530/eje.1.02177; Coorough N, 2013, J SURG RES, V184, P746, DOI 10.1016/j.jss.2013.02.018; Garcia RC, 2008, RADIOLOGIA-MADRID, V50, P471, DOI 10.1016/S0033-8338(08)76334-3; Delbridge L, 1999, ARCH SURG-CHICAGO, V134, P1389, DOI 10.1001/archsurg.134.12.1389; Efremidou EI, 2009, CAN J SURG, V52, P39; Ersoz C, 2004, CANCER CYTOPATHOL, V102, P302, DOI 10.1002/cncr.20610; Eszlinger M, 2014, THYROID, V24, P305, DOI 10.1089/thy.2013.0278; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; HINTZE G, 1991, ACTA ENDOCRINOL-COP, V124, P12, DOI 10.1530/acta.0.1240012; Ho TWT, 2011, AM J SURG, V201, P569, DOI 10.1016/j.amjsurg.2010.12.006; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Koike E, 2001, ARCH SURG-CHICAGO, V136, P334, DOI 10.1001/archsurg.136.3.334; KONDE M, 1994, LANCET, V344, P1675, DOI 10.1016/S0140-6736(94)90461-8; Kovacevic O, 2007, J CLIN ULTRASOUND, V35, P63, DOI 10.1002/jcu.20287; MARTINO E, 1994, J ENDOCRINOL INVEST, V17, P653, DOI 10.1007/BF03349681; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Palas Cesar, 2014, Rev Fac Cien Med Univ Nac Cordoba, V71, P127; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Popowicz B, 2009, EUR J ENDOCRINOL, V161, P103, DOI 10.1530/EJE-09-0022; Puzziello A, 2011, BMC GERIATRICS S1, pA49; RALLISON ML, 1991, AM J MED, V91, P363, DOI 10.1016/0002-9343(91)90153-O; Ravetto C, 2000, CANCER CYTOPATHOL, V90, P357, DOI 10.1002/1097-0142(20001225)90:6<357::AID-CNCR6>3.0.CO;2-4; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; Suen KC, 1996, MODERN PATHOL, V9, P710; SUEN KC, 1983, J CLIN PATHOL, V36, P1036, DOI 10.1136/jcp.36.9.1036; SUEN KC, 1985, ACTA CYTOL, V29, P488; Tollin SR, 2000, THYROID, V10, P235, DOI 10.1089/thy.2000.10.235; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377; Ucar AE, 2014, TURK J MED SCI, V44, P1002, DOI 10.3906/sag-1312-56; Ugurlu S, 2008, INTERNAL MED, V47, P205, DOI 10.2169/internalmedicine.47.0608; Yoldas T, 2015, INT SURG, V100, P9, DOI 10.9738/INTSURG-D-13-00275.1	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146883	10.1371/journal.pone.0146883	http://dx.doi.org/10.1371/journal.pone.0146883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784518	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400078
J	Oosterman, JE; Belsham, DD				Oosterman, Johanneke E.; Belsham, Denise D.			Glucose Alters Per2 Rhythmicity Independent of AMPK, Whereas AMPK Inhibitor Compound C Causes Profound Repression of Clock Genes and AgRP in mHypoE-37 Hypothalamic Neurons	PLOS ONE			English	Article							O-GLCNAC TRANSFERASE; MESSENGER-RNA LEVELS; CIRCADIAN CLOCK; CELL MODELS; METABOLISM; BRAIN; PHOSPHORYLATION; INTEGRATION; EXPRESSION; PALMITATE	Specific neurons in the hypothalamus are regulated by peripheral hormones and nutrients to maintain proper metabolic control. It is unclear if nutrients can directly control clock gene expression. We have therefore utilized the immortalized, hypothalamic cell line mHypoE-37, which exhibits robust circadian rhythms of core clock genes. mHypoE-37 neurons were exposed to 0.5 or 5.5 mM glucose, comparable to physiological levels in the brain. Per2 and Bmal1 mRNAs were assessed every 3 hours over 36 hours. Incubation with 5.5 mM glucose significantly shortened the period and delayed the phase of Per2 mRNA levels, but had no effect on Bmal1. Glucose had no significant effect on phospho-GSK3 beta, whereas AMPK phosphorylation was altered. Thus, the AMPK inhibitor Compound C was utilized, and mRNA levels of Per2, Bmal1, Cryptochrome1 (Cry1), agouti-related peptide (AgRP), carnitine palmitoyltransferase 1C (Cpt1c), and O-linked N-acetylglucosamine transferase (Ogt) were measured. Remarkably, Compound C dramatically reduced transcript levels of Per2, Bmal1, Cry1, and AgRP, but not Cpt1c or Ogt. Because AMPK was not inhibited at the same time or concentrations as the clock genes, we suggest that the effect of Compound C on gene expression occurs through an AMPK-independent mechanism. The consequences of inhibition of the rhythmic expression of clock genes, and in turn downstream metabolic mediators, such as AgRP, could have detrimental effects on overall metabolic processes. Importantly, the effects of the most commonly used AMPK inhibitor Compound C should be interpreted with caution, considering its role in AMPK-independent repression of specific genes, and especially clock gene rhythm dysregulation.	[Oosterman, Johanneke E.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Oosterman, Johanneke E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Belsham, Denise D.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Amsterdam; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Belsham, DD (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Belsham, DD (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation; Canada Research Chairs Program; AMC PhD Scholarship	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); AMC PhD Scholarship	This work was supported by the Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program (DDB). AMC PhD Scholarship (JEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding from the Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation and Canada Research Chairs Program (DDB). JEO was supported by an AMC PhD Scholarship. The authors thank Jennifer Chalmers, Alice Treen and Dean Tran for their generous support with the experiments. Many thanks to Dr. Leigh Wellhauser for invaluable insight and technical assistance.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASCHOFF J, 1984, ANN NY ACAD SCI, V423, P442, DOI 10.1111/j.1749-6632.1984.tb23452.x; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balsalobre A, 2002, CELL TISSUE RES, V309, P193, DOI 10.1007/s00441-002-0585-0; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Chalmers JA, 2014, MOL CELL ENDOCRINOL, V382, P262, DOI 10.1016/j.mce.2013.10.013; Dai RY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.419; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Fick LJ, 2011, BIOCHEM BIOPH RES CO, V413, P414, DOI 10.1016/j.bbrc.2011.08.103; Foster RG, 2007, CURR BIOL, V17, pR746, DOI 10.1016/j.cub.2007.07.007; Greco JA, 2014, AM J PHYSIOL-REG I, V307, pR1049, DOI 10.1152/ajpregu.00100.2014; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Jordan SD, 2013, MOL CELL ENDOCRINOL, V366, P163, DOI 10.1016/j.mce.2012.06.017; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kaladchibachi Sevag A, 2007, J Circadian Rhythms, V5, P3, DOI 10.1186/1740-3391-5-3; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Oosterman JE, 2015, AM J PHYSIOL-REG I, V308, pR337, DOI 10.1152/ajpregu.00322.2014; Panda S, 2007, NEURON, V53, P619, DOI 10.1016/j.neuron.2007.02.017; Paul JR, 2012, NEUROSCIENCE, V226, P1, DOI 10.1016/j.neuroscience.2012.08.047; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schwartz GJ, 2000, NATURE, V404, P661; SILVER IA, 1994, J NEUROSCI, V14, P5068; Talamantes F., 1988, P2093; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	50	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146969	10.1371/journal.pone.0146969	http://dx.doi.org/10.1371/journal.pone.0146969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784927	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400091
J	Sun, P; Yan, H; Ranadive, SM; Lane, AD; Kappus, RM; Bunsawat, K; Baynard, T; Hu, M; Li, SC; Fernhall, B				Sun, Peng; Yan, Huimin; Ranadive, Sushant M.; Lane, Abbi D.; Kappus, Rebecca M.; Bunsawat, Kanokwan; Baynard, Tracy; Hu, Min; Li, Shichang; Fernhall, Bo			Autonomic Recovery Is Delayed in Chinese Compared with Caucasian following Treadmill Exercise	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BAROREFLEX SENSITIVITY; PHYSICAL-ACTIVITY; RELIABILITY; BOUTS	Caucasian populations have a higher prevalence of cardiovascular disease (CVD) when compared with their Chinese counterparts and CVD is associated with autonomic function. It is unknown whether autonomic function during exercise recovery differs between Caucasians and Chinese. The present study investigated autonomic recovery following an acute bout of treadmill exercise in healthy Caucasians and Chinese. Sixty-two participants (30 Caucasian and 32 Chinese, 50% male) performed an acute bout of treadmill exercise at 70% of heart rate reserve. Heart rate variability (HRV) and baroreflex sensitivity (BRS) were obtained during 5-min epochs at pre-exercise, 30-min, and 60-min post-exercise. HRV was assessed using frequency [natural logarithm of high (LnHF) and low frequency (LnLF) powers, normalized high (nHF) and low frequency (nLF) powers, and LF/HF ratio] and time domains [Root mean square of successive differences (RMSSD), natural logarithm of RMSSD (LnRMSSD) and R-R interval (RRI)]. Spontaneous BRS included both up-up and down-down sequences. At pre-exercise, no group differences were observed for any HR, HRV and BRS parameters. During exercise recovery, significant race-by-time interactions were observed for LnHF, nHF, nLF, LF/HF, LnRMSSD, RRI, HR, and BRS (up-up). The declines in LnHF, nHF, RMSSD, RRI and BRS (up-up) and the increases in LF/HF, nLF and HR were blunted in Chinese when compared to Caucasians from pre-exercise to 30-min to 60-min post-exercise. Chinese exhibited delayed autonomic recovery following an acute bout of treadmill exercise. This delayed autonomic recovery may result from greater sympathetic dominance and extended vagal withdrawal in Chinese.	[Sun, Peng; Li, Shichang] E China Normal Univ, Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai 200062, Peoples R China; [Lane, Abbi D.; Kappus, Rebecca M.; Bunsawat, Kanokwan; Baynard, Tracy; Fernhall, Bo] Univ Illinois, Coll Appl Hlth Sci, Chicago, IL USA; [Sun, Peng; Yan, Huimin; Ranadive, Sushant M.; Lane, Abbi D.; Kappus, Rebecca M.; Bunsawat, Kanokwan; Baynard, Tracy; Fernhall, Bo] Univ Illinois, Dept Kinesiol & Community Hlth, Exercise & Cardiovasc Res Lab, Urbana, IL 61801 USA; [Hu, Min] Guangzhou Inst Phys Educ, Guangzhou, Guangdong, Peoples R China	East China Normal University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; Guangzhou Sport University	Sun, P (corresponding author), E China Normal Univ, Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai 200062, Peoples R China.; Fernhall, B (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Chicago, IL USA.; Sun, P; Fernhall, B (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Exercise & Cardiovasc Res Lab, Urbana, IL 61801 USA.	psun@tyxx.ecnu.edu.cn; fernhall@uic.edu	Bunsawat, Kanokwan (Mandy)/ABH-5880-2020; hu, min/AAI-9797-2020; Ranadive, Sushant/AAN-4098-2021; Baynard, Tracy/AAN-8711-2021	Ranadive, Sushant/0000-0003-1674-4285; Bunsawat, Kanokwan/0000-0002-5950-6634; Hu, Min/0000-0001-9433-9547; Sun, Peng/0000-0002-0615-2510; Yan, Huimin/0000-0003-0907-1246; Baynard, Tracy/0000-0002-5150-4095	National Institute of Health [1R01HL093249-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093249] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Institute of Health, 1R01HL093249-01A1, awarded to Bo Fernhall. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Al Haddad H, 2011, INT J SPORTS MED, V32, P598, DOI 10.1055/s-0031-1275356; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BRUCE RA, 1974, AM J CARDIOL, V33, P715, DOI 10.1016/0002-9149(74)90211-2; Camm AJ, 1996, CIRCULATION, V93, P1043; Cole CR, 2000, HERZ KREISLAUF, V32, P156; dos Santos MR, 2013, INT J SPORTS MED, V34, P931, DOI 10.1055/s-0032-1331741; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Galetta F, 2013, INTERN EMERG MED, V8, pS27, DOI 10.1007/s11739-013-0919-9; Gladwell VF, 2010, CLIN PHYSIOL FUNCT I, V30, P17, DOI 10.1111/j.1475-097X.2009.00899.x; GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305; Hall MH, 2013, PSYCHOSOM MED, V75, P783, DOI 10.1097/PSY.0b013e3182a7ec5c; Heffernan KS, 2007, INT J SPORTS MED, V28, P197, DOI 10.1055/s-2006-924290; Heffernan KS, 2009, AM J PHYSIOL-REG I, V296, pR1098, DOI 10.1152/ajpregu.90936.2008; Heffernan KS, 2005, MED SCI SPORT EXER, V37, P2026, DOI 10.1249/01.mss.0000179217.59831.41; Javorka M, 2002, BRAZ J MED BIOL RES, V35, P991, DOI 10.1590/S0100-879X2002000800018; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lehrer F, 2006, CHEST, V129, P278, DOI 10.1378/chest.129.2.278; Leti T, 2013, AUTON NEUROSCI-BASIC, V173, P14, DOI 10.1016/j.autneu.2012.10.007; MCCONNELL TR, 1988, SPORTS MED, V5, P57, DOI 10.2165/00007256-198805010-00005; Mendonca GV, 2011, J SPORT SCI, V29, P879, DOI 10.1080/02640414.2011.572991; Menicucci D, 2013, ARCH ITAL BIOL, V151, P126, DOI 10.4449/aib.v151i3.1523; Murray NP, 2012, APPL PSYCHOPHYS BIOF, V37, P219, DOI 10.1007/s10484-012-9196-z; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Ohuchi H, 2000, PEDIATR RES, V47, P329, DOI 10.1203/00006450-200003000-00008; Parekh A, 2005, MED SCI SPORT EXER, V37, P599, DOI 10.1249/01.MSS.0000159139.29220.9A; PERINI R, 1989, EUR J APPL PHYSIOL, V58, P879, DOI 10.1007/BF02332222; Piotrowicz E, 2009, PACE, V32, pS113, DOI 10.1111/j.1540-8159.2008.02266.x; Pober DM, 2004, MED SCI SPORT EXER, V36, P1140, DOI 10.1249/01.MSS.0000132273.30827.9A; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Santos AM, 2014, ARQ BRAS CARDIOL, V102, P579, DOI 10.5935/abc.20140066; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Terziotti P, 2001, EUR J APPL PHYSIOL, V84, P187, DOI 10.1007/s004210170003; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Vanoli E, 2008, HEART RHYTHM, V5, P300, DOI 10.1016/j.hrthm.2007.10.021; White DW, 2014, J PHYSIOL-LONDON, V592, P2491, DOI 10.1113/jphysiol.2014.271858; Zheng YX, 2009, CLIN CARDIOL, V32, P491, DOI 10.1002/clc.20605	39	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147104	10.1371/journal.pone.0147104	http://dx.doi.org/10.1371/journal.pone.0147104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784109	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400109
J	Taylor, I; Wang, Y; Seitz, K; Baer, J; Bennewitz, S; Mooney, BP; Walker, JC				Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Mooney, Brian P.; Walker, John C.			Analysis of Phosphorylation of the Receptor-Like Protein Kinase HAESA during Arabidopsis Floral Abscission	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; ORGAN ABSCISSION; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; INNATE IMMUNITY; IN-VITRO; INFLORESCENCE-DEFICIENT; ACTIVATION; BRI1; AUTOPHOSPHORYLATION	Receptor-like protein kinases (RLKs) are the largest family of plant transmembrane signaling proteins. Here we present functional analysis of HAESA, an RLK that regulates floral organ abscission in Arabidopsis. Through in vitro and in vivo analysis of HAE phosphorylation, we provide evidence that a conserved phosphorylation site on a region of the HAE protein kinase domain known as the activation segment positively regulates HAE activity. Additional analysis has identified another putative activation segment phosphorylation site common to multiple RLKs that potentially modulates HAE activity. Comparative analysis suggests that phosphorylation of this second activation segment residue is an RLK specific adaptation that may regulate protein kinase activity and substrate specificity. A growing number of RLKs have been shown to exhibit biologically relevant dual specificity toward serine/threonine and tyrosine residues, but the mechanisms underlying dual specificity of RLKs are not well understood. We show that a phospho-mimetic mutant of both HAE activation segment residues exhibits enhanced tyrosine auto-phosphorylation in vitro, indicating phosphorylation of this residue may contribute to dual specificity of HAE. These results add to an emerging framework for understanding the mechanisms and evolution of regulation of RLK activity and substrate specificity.	[Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Walker, John C.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Taylor, Isaiah; Wang, Ying; Seitz, Kati; Baer, John; Bennewitz, Stefan; Mooney, Brian P.; Walker, John C.] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Charles W Gehrke Prote Ctr, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Bond Life Sci Ctr, Div Biochem, Columbia, MO USA; [Wang, Ying] Rutgers State Univ, Dept Food Sci, POB 231, New Brunswick, NJ 08903 USA; [Seitz, Kati] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI USA; [Seitz, Kati] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Bennewitz, Stefan] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Rutgers State University New Brunswick; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Leibniz Institut fur Pflanzenbiochemie	Walker, JC (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.; Walker, JC (corresponding author), Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA.	walkerj@missouri.edu			National Science Foundation [MCB0743955]; National Institute of General Medical Sciences [5T32GM008396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation grant MCB0743955 to JW (NSF.gov). IT was supported by National Institute of General Medical Sciences grant 5T32GM008396 (NIGMS.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; BHATTACHARYYA MK, 1994, PLANT J, V6, P957, DOI 10.1046/j.1365-313X.1994.6060957.x; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; Boller T, 2012, PEPTIDES DANGER SIGN, P163; Bryan A, 2012, RECEPTOR LIKE KINASE, P41; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cao YR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003313; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubin MJ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-3; Gama L, 1999, BIOTECHNIQUES, V26, P814, DOI 10.2144/99265bm03; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HORN MA, 1994, BBA-PROTEIN STRUCT M, V1208, P65, DOI 10.1016/0167-4838(94)90160-0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jinn TL, 2000, GENE DEV, V14, P108; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Khan M, 2013, J BIOL CHEM, V288, P7519, DOI 10.1074/jbc.M112.384453; Kim BH, 2013, MOL CELLS, V35, P7, DOI 10.1007/s10059-013-2255-3; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Lease KA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-2; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Meyer MR, 2011, BIOCHEMISTRY-US, V50, P2170, DOI 10.1021/bi101935x; Mitra SK, 2015, PLANT J; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Niederhuth CE, 2013, J INTEGR PLANT BIOL, V55, P1251, DOI 10.1111/jipb.12116; Niederhuth CE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-37; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Sessa G, 2000, EUR J BIOCHEM, V267, P171, DOI 10.1046/j.1432-1327.2000.00979.x; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Somssich M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0598; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Taylor I, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-22; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wang J, 2014, CELL RES, V24, P1328, DOI 10.1038/cr.2014.132; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Xu JH, 2013, PROTEIN CELL, V4, P771, DOI 10.1007/s13238-013-3053-6; Yan LM, 2012, CELL RES, V22, P1304, DOI 10.1038/cr.2012.74; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	75	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147203	10.1371/journal.pone.0147203	http://dx.doi.org/10.1371/journal.pone.0147203			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784444	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400122
J	Yokochi, K; Kennington, WJ; Bencini, R				Yokochi, Kaori; Kennington, Winn Jason; Bencini, Roberta			An Endangered Arboreal Specialist, the Western Ringtail Possum (Pseudocheirus occidentalis), Shows a Greater Genetic Divergence across a Narrow Artificial Waterway than a Major Road	PLOS ONE			English	Article							RED-BACKED SALAMANDERS; HABITAT FRAGMENTATION; POPULATION; DISPERSAL; FLOW; CONSERVATION; PHILOPATRY; SOFTWARE; PATTERNS; DISTANCE	The fragmentation of habitats by roads and other artificial linear structures can have a profound effect on the movement of arboreal species due to their strong fidelity to canopies. Here, we used 12 microsatellite DNA loci to investigate the fine-scale spatial genetic structure and the effects of a major road and a narrow artificial waterway on a population of the endangered western ringtail possum (Pseudocheirus occidentalis) in Busselton, Western Australia. Using spatial autocorrelation analysis, we found positive genetic structure in continuous habitat over distances up to 600 m. These patterns are consistent with the sedentary nature of P. occidentalis and highlight their vulnerability to the effects of habitat fragmentation. Pairwise relatedness values and Bayesian cluster analysis also revealed significant genetic divergences across an artificial waterway, suggesting that it was a barrier to gene flow. By contrast, no genetic divergences were detected across the major road. While studies often focus on roads when assessing the effects of artificial linear structures on wildlife, this study provides an example of an often overlooked artificial linear structure other than a road that has a significant impact on wildlife dispersal leading to genetic subdivision.	[Yokochi, Kaori; Kennington, Winn Jason; Bencini, Roberta] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Western Australia	Yokochi, K (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	yokochi.kaori@gmail.com	Kennington, Winn J/H-5182-2014; Bencini, Roberta/A-1426-2013	Kennington, Winn J/0000-0001-6100-6543; Bencini, Roberta/0000-0002-6927-5198; Yokochi, kaori/0000-0002-8474-9590	School of Animal Biology at The University of Western Australia; Main Roads Western Australia; Western Australian Department of Parks and Wildlife; Western Power; Satterley Property Group via Western Australian Department of Parks and Wildlife; Holsworth Wildlife Research Endowment [RA/1/411/330]; City of Busselton; Peppermint Park Eco Village; Camp Geographe; Abundant Life Centre; Christian Brethren Campsites; Legacy Camp; Possum Centre Busselton Inc.	School of Animal Biology at The University of Western Australia; Main Roads Western Australia; Western Australian Department of Parks and Wildlife; Western Power; Satterley Property Group via Western Australian Department of Parks and Wildlife; Holsworth Wildlife Research Endowment; City of Busselton; Peppermint Park Eco Village; Camp Geographe; Abundant Life Centre; Christian Brethren Campsites; Legacy Camp; Possum Centre Busselton Inc.	This work was conducted with funding from the School of Animal Biology at The University of Western Australia to KY (http://www.animals.uwa.edu.au), Main Roads Western Australia to RB (https://www.mainroads.wa.gov.au), the Western Australian Department of Parks and Wildlife to RB (http://www.dpaw.wa.gov.au), Western Power to RB (http://www.westernpower.com.au), the Satterley Property Group (http://satterley.com.au) to RB via Western Australian Department of Parks and Wildlife and the Holsworth Wildlife Research Endowment to KY (RA/1/411/330, http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the School of Animal Biology at The University of Western Australia, Main Roads Western Australia, and the Western Australian Department of Parks and Wildlife for providing technical support for this project. We gratefully acknowledge Mr. Paul J. de Tores and Dr. Judy Clarke for providing valuable advice, support and training for the fieldwork. Yvette Hitchen at Helix Molecular Solutions Pty Ltd provided technical assistance with DNA extractions and conducted PCR and scoring of genotypes for this project. We would also like to thank the City of Busselton, Peppermint Park Eco Village, Camp Geographe, Abundant Life Centre, Christian Brethren Campsites, Legacy Camp and Possum Centre Busselton Inc. for their support and over 100 volunteers who helped us in the field. We thank Dr Miriam Goosem, Prof. Darryl Jones, and Adj/ Prof. Jeff Bowman for their invaluable comments on this manuscript as a part of a thesis review. We also would like to thank the academic reviewers of PLOS ONE for their comments.	Australian Bureau of Statistics, 2014, 3218 0 REG POP GROWT; Broquet T, 2006, MOL ECOL, V15, P1689, DOI 10.1111/j.1365-294X.2006.02878.x; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Clarke J., 2011, THESIS MURDOCH U; CLOUT MN, 1984, J ANIM ECOL, V53, P737, DOI 10.2307/4656; de Tores PJ, 2010, WILDLIFE RES, V37, P512, DOI 10.1071/WR10090; Dique DS, 2003, WILDLIFE RES, V30, P281, DOI 10.1071/WR02043; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Estes-Zumpe WA, 2010, J MAMMAL, V91, P208, DOI 10.1644/09-MAMM-A-032R.1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Goldingay RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080383; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harring-Harris K, 2014, THESIS U W AUSTR; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES BA, 1994, WILDLIFE RES, V21, P175, DOI 10.1071/WR9940175; JONES BA, 1994, WILDLIFE RES, V21, P189, DOI 10.1071/WR9940189; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; Lee T, 2010, WILDLIFE RES, V37, P156, DOI 10.1071/WR09134; Main Roads Western Australia, 2009, STAT TRAFF DIG 2003; Marsh DM, 2007, CAN J ZOOL, V85, P319, DOI 10.1139/Z07-008; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Molloy SW, 2014, ENVIRON CONSERV, V41, P176, DOI 10.1017/S0376892913000337; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; NEI M, 1974, GENETICS, V76, P379; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; R Development Core Team, 2013, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Stow AJ, 2006, WILDLIFE RES, V33, P409, DOI 10.1071/WR06019; Taylor AM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017069, 10.1371/journal.pone.0026651]; Trimming E, 2009, SEM 55 M AUSTR MAMM, P24; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker FM, 2008, MOL ECOL, V17, P1674, DOI 10.1111/j.1365-294X.2008.03701.x; Wilson K, 2009, CONSERV GENET RESOUR, V1, P123, DOI 10.1007/s12686-009-9030-y; Wilson KJ, 2009, THESIS MURDOCH U; Yokochi K, 2015, J MAMMAL, V96, P1284, DOI 10.1093/jmammal/gyv137	53	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146167	10.1371/journal.pone.0146167	http://dx.doi.org/10.1371/journal.pone.0146167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784921	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400026
J	Zhong, X; Song, YJ; Yang, P; Wang, Y; Jiang, SY; Zhang, X; Li, CY				Zhong, Xue; Song, Yunjia; Yang, Peng; Wang, Yao; Jiang, Shaoyun; Zhang, Xu; Li, Changyi			Titanium Surface Priming with Phase-Transited Lysozyme to Establish a Silver Nanoparticle-Loaded Chitosan/Hyaluronic Acid Antibacterial Multilayer via Layer-by-Layer Self-Assembly	PLOS ONE			English	Article							IN-VITRO; CYTOTOXICITY; IMPLANTS	Objectives The formation of biofilm around implants, which is induced by immediate bacterial colonization after installation, is the primary cause of post-operation infection. Initial surface modification is usually required to incorporate antibacterial agents on titanium (Ti) surfaces to inhibit biofilm formation. However, simple and effective priming methods are still lacking for the development of an initial functional layer as a base for subsequent coatings on titanium surfaces. The purpose of our work was to establish a novel initial layer on Ti surfaces using phase-transited lysozyme (PTL), on which multilayer coatings can incorporate silver nanoparticles (AgNP) using chitosan (CS) and hyaluronic acid (HA) via a layer-by-layer (LbL) self-assembly technique. Methods In this study, the surfaces of Ti substrates were primed by dipping into a mixture of lysozyme and tris(2-carboxyethyl)phosphine (TCEP) to obtain PTL-functionalized Ti substrates. The subsequent alternating coatings of HA and chitosan loaded with AgNP onto the precursor layer of PTL were carried out via LbL self-assembly to construct multilayer coatings on Ti substrates. Results The results of SEM and XPS indicated that the necklace-like PTL and self-assembled multilayer were successfully immobilized on the Ti substrates. The multilayer coatings loaded with AgNP can kill planktonic and adherent bacteria to 100% during the first 4 days. The antibacterial efficacy of the samples against planktonic and adherent bacteria achieved 65%-90% after 14 days. The sustained release of Ag over 14 days can prevent bacterial invasion until mucosa healing. Although the AgNP-containing structure showed some cytotoxicity, the toxicity can be reduced by controlling the Ag release rate and concentration. Conclusions The PTL priming method provides a promising strategy for fabricating long-term antibacterial multilayer coatings on titanium surfaces via the LbL self-assembly technique, which is effective in preventing implant-associated infections in the early stage.	[Zhong, Xue; Song, Yunjia; Wang, Yao; Jiang, Shaoyun; Zhang, Xu; Li, Changyi] Tianjin Med Univ, Hosp Stomatol, Sch Dent, Tianjin, Peoples R China; [Yang, Peng] Shaanxi Normal Univ, Coll Chem & Chem Engn, Minist Educ, Key Lab Appl Surface & Colloid Chem, Xian, Peoples R China	Tianjin Medical University; Shaanxi Normal University	Zhang, X; Li, CY (corresponding author), Tianjin Med Univ, Hosp Stomatol, Sch Dent, Tianjin, Peoples R China.	zhxden@gmail.com; cli02@tmu.edu.cn	Li, Changyi/GVS-6654-2022; YANG, Peng/F-5519-2010; gao, qiuying/AAO-3696-2021; Yang, Peng/J-8099-2019	YANG, Peng/0000-0002-0463-1024; 	National Natural Science Foundation of China [31470920, 21374057, 51303100]; Tianjin Research Program of Application Foundation and Advanced Technology [12JCZDJC22700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	This work was funded by: 1) National Natural Science Foundation of China (Grant No: 31470920), http://www.nsfc.gov.cn/; 2) National Natural Science Foundation of China (Grant No: 21374057,51303100), http://www.nsfc.gov.cn/; 3) Tianjin Research Program of Application Foundation and Advanced Technology (Grant No: 12JCZDJC22700), http://www.tstc.gov.cn/.	Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092; Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078; Camargo Igor Batista, 2015, Dent Clin North Am, V59, P57, DOI 10.1016/j.cden.2014.08.003; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033; He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169; Huang R, 2015, BIOMATERIALS, V53, P58, DOI 10.1016/j.biomaterials.2015.02.076; Jeon S, 2015, COLLOID SURFACE B, V129, P7, DOI 10.1016/j.colsurfb.2015.03.018; Koseki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107588; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Lv HB, 2014, J DENT, V42, P1464, DOI 10.1016/j.jdent.2014.06.003; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018; Noda K, 2015, J PROSTHODONT RES, V59, P178, DOI 10.1016/j.jpor.2015.04.003; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Qiao SC, 2015, INT J NANOMED, V10, P653, DOI 10.2147/IJN.S73467; Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040; Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004; Song W, 2015, INT J NANOMED, V10, P2335, DOI 10.2147/IJN.S76513; Wu ZF, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201400401; Yeo In-Sung, 2014, Open Biomed Eng J, V8, P114, DOI 10.2174/1874120701408010114; Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010; Zhang X, 2008, MAT SCI ENG C-BIO S, V28, P237, DOI 10.1016/j.msec.2006.12.007; Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhao Y, 2014, INT J NANOMED, V9, P5177, DOI 10.2147/IJN.S65386	29	54	57	6	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146957	10.1371/journal.pone.0146957	http://dx.doi.org/10.1371/journal.pone.0146957			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783746	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400086
J	Okamoto, T; Ozawa, Y; Kamoshita, M; Osada, H; Toda, E; Kurihara, T; Nagai, N; Umezawa, K; Tsubota, K				Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Osada, Hideto; Toda, Eriko; Kurihara, Toshihide; Nagai, Norihiro; Umezawa, Kazuo; Tsubota, Kazuo			The Neuroprotective Effect of Rapamycin as a Modulator of the mTOR-NF-kappa B Axis during Retinal Inflammation	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; II TYPE-1 RECEPTOR; DIABETIC MACULAR EDEMA; OCULAR INFLAMMATION; SUPPRESSION; MECHANISM; PATHWAY; DEGRADATION; RHODOPSIN; SIROLIMUS	Purpose The determination of the molecular mechanism underlying retinal pathogenesis and visual dysfunction during innate inflammation, and the treatment effect of rapamycin thereon. Methods The endotoxin-induced uveitis and retinitis mouse model was established by injecting lipopolysaccharide. The mice were subsequently treated with rapamycin, a mammalian target of rapamycin (mTOR) inhibitor. The rhodopsin mRNA and protein expression level in the retina and the photoreceptor outer segment (OS) length in immunohistochemical stainings were measured, and visual function was recorded by electroretinography. Inflammatory cytokines, their related molecules, mTOR, and LC3 levels were measured by real-time PCR and/or immunoblotting. Leukocyte adhesion during inflammation was analyzed using concanavalin A lectin. Results The post-transcriptional reduction in the visual pigment of rod photoreceptor cells, rhodopsin, OS shortening, and rod photoreceptor cell dysfunction during inflammation were suppressed by rapamycin. Activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) and induction of inflammatory cytokines, such as interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), and the activation of the downstream signaling protein, signal transducer and activator of transcription 3 (STAT3), which reduces rhodopsin in the retina during inflammation, were attenuated by rapamycin. Increased leukocyte adhesion was also attenuated by rapamycin. Interestingly, although mTOR activation was observed after NF-kappa B activation, mTOR inhibition suppressed NF-kappa B activation at the early phase, indicating that the basal level of activated mTOR was sufficient to activate NF-kappa B in the retina. In addition, the inhibition of NF-kappa B suppressed mTOR activation, suggesting a positive feedback loop of mTOR and NF-kappa B during inflammation. The ratio of LC3II to LC3I, which reflects autophagy induction, was not changed by inflammation but was increased by rapamycin. Conclusions Our results propose the potential use of rapamycin as a neuroprotective therapy to suppress local activated mTOR levels, related inflammatory molecules, and the subsequent visual dysfunction during retinal inflammation.	[Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Osada, Hideto; Toda, Eriko; Kurihara, Toshihide; Nagai, Norihiro] Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Okamoto, Tomohiro; Ozawa, Yoko; Kamoshita, Mamoru; Kurihara, Toshihide; Nagai, Norihiro; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 4801195, Japan	Keio University; Keio University; Aichi Medical University	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.; Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020; Kurihara, Toshihide/ABA-7058-2020	Kurihara, Toshihide/0000-0002-5457-2720; Osada, Hideto/0000-0001-9971-8992	JSPS KAKENHI [24592647]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research, JSPS KAKENHI to Y.O. (24592647).	Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Chen Y, 2013, J BIOL CHEM, V288, P7506, DOI 10.1074/jbc.M112.439935; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Frosali S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/489821; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038; Kamoshita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103013; Kubota S, 2011, INVEST OPHTH VIS SCI, V52, P9142, DOI 10.1167/iovs.11-8041; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Nagai N, 2009, FREE RADICAL BIO MED, V47, P300, DOI 10.1016/j.freeradbiomed.2009.04.033; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh IK, 2010, CURR EYE RES, V35, P1116, DOI 10.3109/02713683.2010.510257; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Ozawa Y, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/506137; Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Nguyen QD, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-32; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Satofuka S, 2006, INVEST OPHTH VIS SCI, V47, P2686, DOI 10.1167/iovs.05-1458; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Sen ES, 2015, NAT REV RHEUMATOL, V11, P338, DOI 10.1038/nrrheum.2015.20; Suzuki M, 2010, MOL VIS, V16, P1382; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yoshida S, 2015, BRIT J OPHTHALMOL, V99, P960, DOI 10.1136/bjophthalmol-2014-306366	43	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146517	10.1371/journal.pone.0146517	http://dx.doi.org/10.1371/journal.pone.0146517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771918	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300024
J	Vermeij, GJ				Vermeij, Geerat J.			Gigantism and Its Implications for the History of Life	PLOS ONE			English	Article							DINOSAUR BODY TEMPERATURES; ATMOSPHERIC OXYGEN; SAUROPOD DINOSAURS; SIZE EVOLUTION; SEA-TURTLE; COPES RULE; GIANT; FOSSIL; PHYSIOLOGY; INCREASE	Gigantism-very large body size-is an ecologically important trait associated with competitive superiority. Although it has been studied in particular cases, the general conditions for the evolution and maintenance of gigantism remain obscure. I compiled sizes and dates for the largest species in 3 terrestrial and 7 marine trophic and habitat categories of animals from throughout the Phanerozoic. The largest species (global giants) in all categories are of post-Paleozoic age. Gigantism at this level appeared tens to hundreds of millions of years after mass extinctions and long after the origins of clades in which it evolved. Marine gigantism correlates with high planktic or seafloor productivity, but on land the correspondence between productivity and gigantism is weak at best. All global giants are aerobically active animals, not gentle giants with low metabolic demands. Oxygen concentration in the atmosphere correlates with gigantism in the Paleozoic but not thereafter, likely because of the elaboration of efficient gas-exchange systems in clades containing giants. Although temperature and habitat size are important in the evolution of very large size in some cases, the most important (and rare) enabling circumstance is a highly developed ecological infrastructure in which essential resources are abundant and effectively recycled and reused, permitting activity levels to increase and setting the stage for gigantic animals to evolve. Gigantism as a hallmark of competitive superiority appears to have lost its luster on land after the Mesozoic in favor of alternative means of achieving dominance, especially including social organization and coordinated food-gathering.	[Vermeij, Geerat J.] Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	Vermeij, GJ (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA.	gjvermeij@ucdavis.edu						Abbott I.A., 1992, MARINE ALGAE CALIFOR; Allmon WD, 2014, PALEOBIOLOGY, V40, P256, DOI 10.1666/13065; ALTMANN SA, 1987, J ZOOL, V211, P215, DOI 10.1111/j.1469-7998.1987.tb01530.x; Amano K, 2011, NAUTILUS, V125, P29; Anderson PSL, 2007, BIOL LETTERS, V3, P76, DOI 10.1098/rsbl.2006.0569; Anderson RP, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0412; Arnaud P.M., 1974, TETHYS, V6, P567; Ausich W.I., 1985, Echinoderms, V1984, P3; Azzaroli A., 1958, Palaeontographia Italica, V52, P1; Bakker R. T., 1980, COLD LOOK WARM BLOOD, P351; Bates KT, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0215; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Beu AG., 2007, PALAEONTOL Z, V81, P267; Boyce CK, 2012, INT J PLANT SCI, V173, P561, DOI 10.1086/665820; Boyce CK, 2010, P ROY SOC B-BIOL SCI, V277, P3437, DOI 10.1098/rspb.2010.0485; Braddy SJ, 2008, BIOL LETTERS, V4, P106, DOI 10.1098/rsbl.2007.0491; Brink KS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4269; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Butler Mark J., 2006, P263, DOI 10.1002/9780470995969.ch8; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; CHEN JY, 1994, SCIENCE, V264, P1304, DOI 10.1126/science.264.5163.1304; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; Cieri RL, 2014, P NATL ACAD SCI USA, V111, P17218, DOI 10.1073/pnas.1405088111; Clapham ME, 2012, P NATL ACAD SCI USA, V109, P10927, DOI 10.1073/pnas.1204026109; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Clauset A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053967; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Compagno LJV, 1925, FAO FISHERIES SYNOPS, V125, P1; Cristoffer C, 2003, J BIOGEOGR, V30, P1357, DOI 10.1046/j.1365-2699.2003.00926.x; CROWLEY TJ, 1989, GEOLOGY, V17, P457, DOI 10.1130/0091-7613(1989)017<0457:SCVOTS>2.3.CO;2; Damsgaard C, 2013, J EXP BIOL, V216, P1616, DOI 10.1242/jeb.080861; Day MO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0834; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Denison R, 1978, PLACODERMS HDB PA AO, V2; Denny M. W., 1993, AIR WATER BIOL PHYS; Diamond J.M., 1984, P824; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Droser ML, 2014, J PALEONTOL, V88, P145, DOI 10.1666/12-158; Dudley R, 1998, J EXP BIOL, V201, P1043; Dudley R., 2000, BIOMECHANICS INSECT; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Falcon-Lang HJ, 2004, GEOLOGY, V32, P417, DOI 10.1130/G20371.1; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; FORTELIUS M, 1993, ZOOL J LINN SOC-LOND, V108, P85, DOI 10.1006/zjls.1993.1018; Friedman M, 2012, P ROY SOC B-BIOL SCI, V279, P944, DOI 10.1098/rspb.2011.1381; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Ghisalberti M, 2014, CURR BIOL, V24, P305, DOI 10.1016/j.cub.2013.12.017; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Green WA, 2010, P ROY SOC B-BIOL SCI, V277, P2257, DOI 10.1098/rspb.2010.0224; Greene H. W., 1997, SNAKES EVOLUTION MYS; Greer A.E., 1974, Journal Herpet, V8, P381, DOI 10.2307/1562913; Gutierrez-Marco JC, 2009, GEOLOGY, V37, P443, DOI 10.1130/G25513A.1; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Harzhauser M, 2008, PALAEONTOLOGY, V51, P199, DOI 10.1111/j.1475-4983.2007.00742.x; Harzhauser M, 2014, ACTA PALAEONTOL POL, V59, P367, DOI 10.4202/app.2011.0196; Hayami I, 1980, PALAEONTOLOGY, V23, P789; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Heeren T, 1997, MAR FRESHWATER RES, V48, P7, DOI 10.1071/MF96026; Heim NA, 2015, SCIENCE, V347, P867, DOI 10.1126/science.1260065; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Hennemann FH, 2008, ZOOTAXA, P1; HOLLAND CH, 1987, J GEOL SOC LONDON, V144, P1, DOI 10.1144/gsjgs.144.1.0001; Houssaye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076741; Houssaye A, 2013, PALAEONTOLOGY, V56, P647, DOI 10.1111/pala.12008; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Inuzuka Norihisa, 1996, Journal of the Geological Society of Japan, V102, P816; Isozaki Y, 2009, PALAEOGEOGR PALAEOCL, V284, P11, DOI 10.1016/j.palaeo.2009.08.022; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaeger Peter, 2001, Zoosystema, V23, P461; Jaffe AL, 2011, BIOL LETTERS, V7, P558, DOI 10.1098/rsbl.2010.1084; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Kauffman EG, 2007, J PALEONTOL, V81, P64, DOI 10.1666/0022-3360(2007)81[64:POGIPO]2.0.CO;2; Kear BP, 2006, BIOL LETT-UK, V2, P116, DOI 10.1098/rsbl.2005.0406; Kelly SRA, 2000, GEOL SOC SPEC PUBL, V177, P227, DOI 10.1144/GSL.SP.2000.177.01.13; Kemp T.S, 1982, MAMMAL LIKE REPTILES; Kiel S, 2010, TOP GEOBIOL, V33, P255, DOI 10.1007/978-90-481-9572-5_8; Kingsolver JG, 2004, EVOLUTION, V58; Klug C, 2015, LETHAIA, V48, P267, DOI 10.1111/let.12104; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Kollmann HA, 2014, GEODIVERSITAS, V36, P349, DOI 10.5252/g2014n3a2; Kozhov M., 1963, LAKE BAIKAL ITS LIFE, DOI 10.1007/978-94-015-7388-7; Ksepka DT, 2014, P NATL ACAD SCI USA, V111, P10624, DOI 10.1073/pnas.1320297111; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Larjavaara M, 2014, NEW PHYTOL, V202, P344, DOI 10.1111/nph.12656; Larjavaara M, 2012, GLOBAL ECOL BIOGEOGR, V21, P998, DOI 10.1111/j.1466-8238.2011.00740.x; LEIGH EG, 2008, TROPICAL FOREST COMM, P121; Lindberg DR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P67; Liu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07142; Long J.A., 2001, P52, DOI 10.1002/9780470999295.ch10; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Mazzetta GV, 2004, HIST BIOL, V17, P1; MCCAMMON HM, 1973, J PALEONTOL, V47, P266; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Menin Marcelo, 2005, Phyllomedusa, V4, P39; Meyer-Berthaud B, 2007, NATURE, V446, P861, DOI 10.1038/446861a; Moran AL, 2012, J EXP BIOL, V215, P1995, DOI 10.1242/jeb.067066; MORGAN G J, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P189; Motani R, 2015, NATURE, V517, P485, DOI 10.1038/nature13866; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muir-Wood H. M., 1960, Memoirs Geological Society of America, V81, P1; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Novack-Gottshall PM, 2008, PALEOBIOLOGY, V34, P210, DOI 10.1666/0094-8373(2008)034[0210:EBTICM]2.0.CO;2; Novack-Gottshall PM, 2008, P NATL ACAD SCI USA, V105, P5430, DOI 10.1073/pnas.0709645105; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Osborne CP, 2002, PALAEOGEOGR PALAEOCL, V182, P15, DOI 10.1016/S0031-0182(01)00450-3; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parsons Michael J., 1992, Tropical Lepidoptera, V3, P33; Payne JL, 2005, PALEOBIOLOGY, V31, P269, DOI 10.1666/0094-8373(2005)031[0269:EDOGSA]2.0.CO;2; Payne JL, 2013, EVOLUTION, V67, P816, DOI 10.1111/j.1558-5646.2012.01807.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; PEEL JS, 1984, LETHAIA, V17, P211, DOI 10.1111/j.1502-3931.1984.tb01619.x; Pimiento C, 2015, PALAEONTOLOGY, V41, P469; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Polis G.A., 1990, P247; Poulsen CJ, 2015, SCIENCE, V348, P1238, DOI 10.1126/science.1260670; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; RICHARDS AM, 1973, J ZOOL, V169, P195; Richards PW, 1952, TROPICAL RAIN FOREST; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Robinson J.M., 1990, HIST BIOL, V3, P189, DOI DOI 10.1080/08912969009386521; Rosa R, 2010, J MAR BIOL ASSOC UK, V90, P1375, DOI 10.1017/S0025315409991494; ROSEWATER JOSEPH, 1965, INDO PACIFIC MOLLUSCA, V1, P347; Rudkin DM, 2003, J PALEONTOL, V77, P99, DOI 10.1017/S0022336000043456; Ruxton G, 2014, J EXP BIOL, V217, P2627, DOI 10.1242/jeb.104919; Saarinen JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2049; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sarko DK, 2010, MAR MAMMAL SCI, V26, P937, DOI 10.1111/j.1748-7692.2010.00384.x; Scarabino Victor, 1995, Memoires du Museum National d'Histoire Naturelle, V167, P189; Schoch RR, 2002, LETHAIA, V35, P309, DOI 10.1080/002411602320790634; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seilacher Adolf, 1998, P423; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Shelley RM, 2000, TROP ZOOL, V13, P159, DOI 10.1080/03946975.2000.10531129; Shimada K, 2012, J VERTEBR PALEONTOL, V32, P1271, DOI 10.1080/02724634.2012.707997; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Soibelzon LH, 2011, J PALEONTOL, V85, P69, DOI 10.1666/10-037.1; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Sperling EA, 2015, NATURE, V523, P451, DOI 10.1038/nature14589; Stein WE, 2007, NATURE, V446, P904, DOI 10.1038/nature05705; Stilwell J.D., 1992, ANTARCT RES SER, V55, P1, DOI DOI 10.1029/AR055; STRAATMAN R, 1975, Journal of the Lepidopterists' Society, V29, P85; Tamburello N, 2015, AM NAT, V186, P196, DOI 10.1086/682070; Taylor JD, 2010, TOP GEOBIOL, V33, P107, DOI 10.1007/978-90-481-9572-5_5; Taylor JD, 2009, PALAEONTOLOGY, V52, P95, DOI 10.1111/j.1475-4983.2008.00839.x; TEICHERT CURT, 1960, BREVIORA MUS COMP ZOOL [HARVARD], V128, P1; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; Tng DYP, 2012, NEW PHYTOL, V196, P1001, DOI 10.1111/j.1469-8137.2012.04359.x; Van Roy P, 2015, NATURE, V522, P77, DOI 10.1038/nature14256; Van Valkenburgh Blaire, 2002, Paleontological Society Papers, V8, P267; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Vermeij GJ, 2008, ECOLOGY, V89, pS39, DOI 10.1890/07-0663.1; Vermeij GJ, 2013, ANNU REV EARTH PL SC, V41, P1, DOI 10.1146/annurev-earth-050212-124123; Vermeij GJ, 2013, BIOL J LINN SOC, V109, P497, DOI 10.1111/bij.12095; Vermeij GJ, 2012, BIOL J LINN SOC, V106, P776, DOI 10.1111/j.1095-8312.2012.01897.x; Vermeij GJ, 2012, EVOLUTION, V66, P2007, DOI 10.1111/j.1558-5646.2012.01592.x; Vermeij GJ, 2011, P ROY SOC B-BIOL SCI, V278, P2362, DOI 10.1098/rspb.2010.2362; Vermeij GJ, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P239; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; Ware JL, 2014, J BIOGEOGR, V41, P1291, DOI 10.1111/jbi.12273; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; Wesselingh FP, 1999, VELIGER, V42, P67; Wilkinson DM, 2013, FUNCT ECOL, V27, P131, DOI 10.1111/1365-2435.12033; Witton MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013982; Worthy T. H., 2002, LOST WORLD MOA PREHI; Xiao SH, 2014, CURR BIOL, V24, pR120, DOI 10.1016/j.cub.2013.12.035; YANCEY TE, 1983, PALAEONTOLOGY, V26, P497; Yuan XL, 2002, GEOLOGY, V30, P363, DOI 10.1130/0091-7613(2002)030<0363:TSIAEC>2.0.CO;2	190	55	56	4	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146092	10.1371/journal.pone.0146092	http://dx.doi.org/10.1371/journal.pone.0146092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771527	Green Published, gold			2022-12-27	WOS:000368628300007
J	Weiss, SJ; Mansell, TJ; Mortazavi, P; Knight, R; Gill, RT				Weiss, Sophie J.; Mansell, Thomas J.; Mortazavi, Pooneh; Knight, Rob; Gill, Ryan T.			Parallel Mapping of Antibiotic Resistance Alleles in Escherichia coli	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SUPERVISED CLASSIFICATION; MULTIDRUG-RESISTANCE; CHROMOSOMAL GENES; DRUG-RESISTANCE; GENOME; COMMUNITY; SEQUENCE; EVOLUTION; ABUNDANCE	Chemical genomics expands our understanding of microbial tolerance to inhibitory chemicals, but its scope is often limited by the throughput of genome-scale library construction and genotype-phenotype mapping. Here we report a method for rapid, parallel, and deep characterization of the response to antibiotics in Escherichia coli using a barcoded genome-scale library, next-generation sequencing, and streamlined bioinformatics software. The method provides quantitative growth data (over 200,000 measurements) and identifies contributing antimicrobial resistance and susceptibility alleles. Using multivariate analysis, we also find that subtle differences in the population responses resonate across multiple levels of functional hierarchy. Finally, we use machine learning to identify a unique allelic and proteomic fingerprint for each antibiotic. The method can be broadly applied to tolerance for any chemical from toxic metabolites to next-generation biofuels and antibiotics.	[Weiss, Sophie J.; Mansell, Thomas J.; Gill, Ryan T.] Univ Colorado, Dept Chem & Biol Engn, 3415 Colorado Ave, Boulder, CO 80303 USA; [Mortazavi, Pooneh] Univ Colorado, Dept Comp Sci, 1111 Engn Dr ECOT 717, Boulder, CO 80303 USA; [Knight, Rob] Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr,MC 0602, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, 9500 Gilman Dr,MC 0404, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of California System; University of California San Diego	Gill, RT (corresponding author), Univ Colorado, Dept Chem & Biol Engn, 3415 Colorado Ave, Boulder, CO 80303 USA.	rtg@colorado.edu		MANSELL, THOMAS/0000-0001-8807-4570; Knight, Rob/0000-0002-0975-9019	NIH/CU Molecular Biophysics Training Scholarship [T32 GM-065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	NIH/CU Molecular Biophysics Training Scholarship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SJW was funded by the NIH/CU Molecular Biophysics Training Scholarship (T32 GM-065103).	Aitchison J, 1986, STAT ANAL COMPOSITIO; Amirkia VD, 2011, BIOINFORMATION, V5, P365, DOI 10.6026/97320630005365; Andersson DI, 2012, DRUG RESIST UPDATE, V15, P162, DOI 10.1016/j.drup.2012.03.005; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; HURLEY JR, 1962, BEHAV SCI, V7, P258, DOI 10.1002/bs.3830070216; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kadrmas JL, 1998, J BIOL CHEM, V273, P2799, DOI 10.1074/jbc.273.5.2799; Kaldalu M, 2004, ANTIMICROB AGENTS CH, V48, P890, DOI 10.1128/AAC.48.3.890-896.2004; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon DH, 2003, ANTIMICROB AGENTS CH, V47, P2169, DOI 10.1128/AAC.47.7.2169-2178.2003; Lawhorn BG, 2004, J BIOL CHEM, V279, P43555, DOI 10.1074/jbc.M404284200; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Martin RG, 2004, MOL MICROBIOL, V53, P183, DOI 10.1111/j.1365-2958.2004.04080.x; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Piras C, 2012, MOL BIOSYST, V8, P1060, DOI 10.1039/c1mb05385j; Robinson DG, 2014, G3-GENES GENOM GENET, V4, P11, DOI 10.1534/g3.113.008565; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz C, 2010, ANTIMICROB AGENTS CH, V54, P2125, DOI 10.1128/AAC.01420-09; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thorsing M, 2015, MICROBIOL-SGM, V161, P1999, DOI 10.1099/mic.0.000152; Toprak E, 2013, NAT PROTOC, V8, P555, DOI [10.1038/nprot.2013.021, 10.1038/nprot.nprot.2013.021]; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219	69	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146916	10.1371/journal.pone.0146916	http://dx.doi.org/10.1371/journal.pone.0146916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771672	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300043
J	Deng, TX; Pang, CY; Lu, XR; Zhu, P; Duan, AQ; Tan, ZZ; Huang, J; Li, H; Chen, MT; Liang, XW				Deng, Tingxian; Pang, Chunying; Lu, Xingrong; Zhu, Peng; Duan, Anqin; Tan, Zhengzhun; Huang, Jian; Li, Hui; Chen, Mingtan; Liang, Xianwei			De Novo Transcriptome Assembly of the Chinese Swamp Buffalo by RNA Sequencing and SSR Marker Discovery	PLOS ONE			English	Article							WATER-BUFFALO; SEQ DATA; GENETIC DIVERSITY; BUBALUS-BUBALIS; RIVER BUFFALO; GENOME; IDENTIFICATION; CATTLE; POPULATIONS; ANNOTATION	The Chinese swamp buffalo (Bubalis bubalis) is vital to the lives of small farmers and has tremendous economic importance. However, a lack of genomic information has hampered research on augmenting marker assisted breeding programs in this species. Thus, a high-throughput transcriptomic sequencing of B. bubalis was conducted to generate transcriptomic sequence dataset for gene discovery and molecular marker development. Illumina paired-end sequencing generated a total of 54,109,173 raw reads. After trimming, de novo assembly was performed, which yielded 86,017 unigenes, with an average length of 972.41 bp, an N50 of 1,505 bp, and an average GC content of 49.92%. A total of 62,337 unigenes were successfully annotated. Among the annotated unigenes, 27,025 (43.35%) and 23,232 (37.27%) unigenes showed significant similarity to known proteins in NCBI non-redundant protein and Swiss-Prot databases (E-value < 1.0E-5), respectively. Of these annotated unigenes, 14,439 and 15,813 unigenes were assigned to the Gene Ontology (GO) categories and EuKaryotic Ortholog Group (KOG) cluster, respectively. In addition, a total of 14,167 unigenes were assigned to 331 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Furthermore, 17,401 simple sequence repeats (SSRs) were identified as potential molecular markers. One hundred and fifteen primer pairs were randomly selected for amplification to detect polymorphisms. The results revealed that 110 primer pairs (95.65%) yielded PCR amplicons and 69 primer pairs (60.00%) presented polymorphisms in 35 individual buffaloes. A phylogenetic analysis showed that the five swamp buffalo populations were clustered together, whereas two river buffalo breeds clustered separately. In the present study, the Illumina RNA-seq technology was utilized to perform transcriptome analysis and SSR marker discovery in the swamp buffalo without using a reference genome. Our findings will enrich the current SSR markers resources and help spearhead molecular genetic research studies on the swamp buffalo.	[Deng, Tingxian; Pang, Chunying; Lu, Xingrong; Zhu, Peng; Duan, Anqin; Tan, Zhengzhun; Huang, Jian; Li, Hui; Chen, Mingtan; Liang, Xianwei] Chinese Acad Agr Sci, Buffalo Res Inst, Minist Agr, Key Lab Buffalo Genet Breeding & Reprod Technol, Nanning, Guangxi, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liang, XW (corresponding author), Chinese Acad Agr Sci, Buffalo Res Inst, Minist Agr, Key Lab Buffalo Genet Breeding & Reprod Technol, Nanning, Guangxi, Peoples R China.	liangbri@126.com			National International Technology Cooperation Project [2014DFA31970]; Key Program of Natural Science of Guangxi [2014GXNSFDA118017]; Scientific Project of Guangxi Aquatic Animal Husbandry and Veterinary Bureau [1304512]	National International Technology Cooperation Project; Key Program of Natural Science of Guangxi; Scientific Project of Guangxi Aquatic Animal Husbandry and Veterinary Bureau	1. National International Technology Cooperation Project: No. 2014DFA31970; http://www.istcp.org.cn/; received by XWL. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Key Program of Natural Science of Guangxi: No. 2014GXNSFDA118017; http://www.gxsti.net/; received by XWL. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3. Scientific Project of Guangxi Aquatic Animal Husbandry and Veterinary Bureau: No. 1304512; http://www.gxfa.gov.cn/; received by TXD. The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Magd M, 2014, GENE, V540, P133, DOI 10.1016/j.gene.2014.02.059; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker JSF, 1997, ANIM GENET, V28, P103, DOI 10.1111/j.1365-2052.1997.00085.x; Bonfatti V, 2012, J DAIRY SCI, V95, P3435, DOI 10.3168/jds.2011-4901; Borghese A, 2013, BUFFALO LIVESTOCK PR; Borghese A, 2013, BUFFALO BULL, V32, P50; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chen HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120170; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Lorenzis G, 2013, MOL BIOTECHNOL, V54, P634, DOI 10.1007/s12033-012-9605-9; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Drost M, 2007, THERIOGENOLOGY, V68, P450, DOI 10.1016/j.theriogenology.2007.04.013; El Nahas Soheir M, 2014, J Genet, V93, pe94; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; FAO, 2000, WAT BUFF ASS UND F R; Farrell JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103567; Finseth FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108550; Gargani M, 2010, ANIM GENET, V41, P93, DOI 10.1111/j.1365-2052.2009.01954.x; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Iamartino D, 2013, BUFFALO BULL, V32, P151; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Jiang ZH, 2009, INT J BIOL SCI, V5, P298; Jung WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111982; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koringa PG, 2013, GENE, V530, P119, DOI 10.1016/j.gene.2013.07.061; Kumar S, 2006, MOL ECOL, V15, P593, DOI 10.1111/j.1365-294X.2006.02837.x; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; le Roex N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048792; Lei CZ, 2011, ANIM GENET, V42, P432, DOI 10.1111/j.1365-2052.2011.02174.x; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Liu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077062; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Long Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115805; Long Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1111; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Michelizzi VN, 2010, INT J BIOL SCI, V6, P333; Nanda Amarjit Singh, 2003, Animal Science Journal, V74, P443, DOI 10.1046/j.1344-3941.2003.00138.x; Nie QH, 2011, DNA RES, V18, P343, DOI 10.1093/dnares/dsr021; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Paraguison RC, 2012, BIOCHEM GENET, V50, P579, DOI 10.1007/s10528-012-9502-8; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Patzak J, 2012, GENOME, V55, P647, DOI [10.1139/g2012-054, 10.1139/G2012-054]; Pauciullo A, 2012, J DAIRY RES, V79, P429, DOI 10.1017/S0022029912000507; QIU H, 1986, BOVINE BREEDS CHINA; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Ropka-Molik K, 2014, ANIM GENET, V45, P674, DOI 10.1111/age.12184; Roth J, BUBALUS BUBALIS; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Sarika, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-43; Savage SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116941; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Sraphet S, 2008, ASIAN AUSTRAL J ANIM, V21, P177, DOI 10.5713/ajas.2008.70327; Thiruvenkadan AK, 2013, BUFFALO BULL, V32, P227; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vidal NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112654; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Warriach HM, 2015, ASIAN AUSTRAL J ANIM, V28, P451, DOI 10.5713/ajas.14.0259; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan QL, 2008, J GENET GENOMICS, V35, P261, DOI 10.1016/S1673-8527(08)60037-5; Yang BZ, 2013, BUFFALO BULL, V32, P111; Yue XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056552; Zhang C., 2000, SCI TECHNOLOGY CHINE; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang Y, 2011, ANIM GENET, V42, P366, DOI 10.1111/j.1365-2052.2010.02166.x; Zhang Y, 2008, ASIAN AUSTRAL J ANIM, V21, P1238, DOI 10.5713/ajas.2008.70746; Zimin A.V., 2015, BUBALUS BUBALIS WHOL; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	79	25	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147132	10.1371/journal.pone.0147132	http://dx.doi.org/10.1371/journal.pone.0147132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766209	gold, Green Submitted, Green Published			2022-12-27	WOS:000368459300070
J	Kongkavitoon, P; Tangkijvanich, P; Hirankarn, N; Palaga, T				Kongkavitoon, Pornrat; Tangkijvanich, Pisit; Hirankarn, Nattiya; Palaga, Tanapat			Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma	PLOS ONE			English	Article							X-PROTEIN; TUMOR ANGIOGENESIS; PATHWAY; CANCER; CELLS; PATHOGENESIS; PROMOTES	Hepatitis virus B (HBV) infection is one of the major causes of hepatocellular carcinomas (HCC). HBx protein encoded in HBV genome is one of the key viral factors leading to malignant transformation of infected cells. HBx functions by interfering with cellular functions, causing aberration in cellular behaviour and transformation. Notch signalling is a well-conserved pathway involved in cellular differentiation, cell survival and cell death operating in various types of cells. Aberration in the Notch signalling pathways is linked to various tumors, including HCC. The role of HBx on the Notch signalling in HCC, however, is still controversial. In this study, we reported that HBV genome-containing HCC cell line HepG2 (HepG2.2.15) expressed higher Notch1 and Delta-like 4 (Dll4), compared to the control HepG2 without HBV genome. This upregulation coincided with increased appearance of the cleavage of Notch1, indicating constitutively activated Notch signalling. Silencing of HBx specifically reduced the level of Dll4 and cleaved Notch1. The increase in Dll4 level was confirmed in clinical specimens of HCC lesion, in comparison with non-tumor lesions. Using specific signalling pathway inhibitors, we found that MEK1/2, PI3K/AKT and NF-kappa B pathways are critical for HBx-mediated Dll4 upregulation. Silencing of HBx clearly decreased the level of phosphorylation of Akt and Erk1/2. Upon silencing of Dll4 in HepG2.2.15, decreased cleaved Notch1, increased apoptosis and cell cycle arrest were observed, suggesting a critical role of HBx-Dll4-Notch1 axis in regulating cell survival in HCC. Furthermore, clonogenic assay confirmed the important role of Dll4 in regulating cell survival of HBV-genome containing HCC cell line. Taken together, we reported a link between HBx and the Notch signalling in HCC that affects cell survival of HCC, which can be a potential target for therapy.	[Kongkavitoon, Pornrat; Hirankarn, Nattiya; Palaga, Tanapat] Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Kongkavitoon, Pornrat; Hirankarn, Nattiya; Palaga, Tanapat] Chulalongkorn Univ, Grad Sch, Interdisciplinary Grad Program Med Microbiol, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok 10330, Thailand; [Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok 10330, Thailand; [Palaga, Tanapat] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Hirankarn, N (corresponding author), Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	nattiyap@gmail.com; tanapat.p@chula.ac.th		Hirankarn, Nattiya/0000-0003-2224-6856	National Research Council of Thailand (NRCT); Ratchadaphiseksomphot Endowment Fund from Faculty of Medicine; 90th Anniversary of Chulalongkorn University Fund from Chulalongkorn University Graduate School; Thai Government Stimulus Package 2 under the Project for the Establishment of Innovative Food and Health Products and Agriculture [TKK2555]; Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) [PHD/0349/2550]	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Ratchadaphiseksomphot Endowment Fund from Faculty of Medicine; 90th Anniversary of Chulalongkorn University Fund from Chulalongkorn University Graduate School; Thai Government Stimulus Package 2 under the Project for the Establishment of Innovative Food and Health Products and Agriculture; Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF)	This work was supported by the National Research Council of Thailand (NRCT) 2013 and the Ratchadaphiseksomphot Endowment Fund from Faculty of Medicine and the 90th Anniversary of Chulalongkorn University Fund from Chulalongkorn University Graduate School. The equipment used in this study was purchased with funds from the Thai Government Stimulus Package 2 (TKK2555) under the Project for the Establishment of Innovative Food and Health Products and Agriculture. PK was sponsored by a Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant No. PHD/0349/2550.; This work was supported by the National Research Council of Thailand (NRCT) and the Ratchadaphiseksomphot Endowment Fund from Faculty of Medicine and the 90th Anniversary of Chulalongkorn University Fund from Chulalongkorn University Graduate School. The equipment used in this study was purchased with funds from the Thai Government Stimulus Package 2 (TKK2555) under the Project for the Establishment of Innovative Food and Health Products and Agriculture. PK was sponsored by a Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant No. PHD/0349/2550.	Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bharadwaj M, 2013, CANCER METAST REV, V32, P229, DOI 10.1007/s10555-012-9412-6; Flores AN, 2014, NAT REV UROL, V11, P499, DOI 10.1038/nrurol.2014.195; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; Gao J, 2007, BIOCHEM BIOPH RES CO, V356, P341, DOI 10.1016/j.bbrc.2007.02.130; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Han QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027931; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Liu YR, 2015, BIOMATERIALS, V42, P161, DOI 10.1016/j.biomaterials.2014.11.039; Liu ZG, 2014, J CANCER RES CLIN, V140, P525, DOI 10.1007/s00432-013-1534-x; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Luo J, 2013, INT J ONCOL, V42, P1636, DOI 10.3892/ijo.2013.1842; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Malmstrom S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036349; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sun Q, 2014, INT J ONCOL, V45, P1638, DOI 10.3892/ijo.2014.2537; Wang F, 2013, BIOTECHNOL LETT, V35, P29, DOI 10.1007/s10529-012-1048-7; Wang F, 2012, ONCOL REP, V27, P1170, DOI 10.3892/or.2012.1620; Wang F, 2010, CANCER LETT, V298, P64, DOI 10.1016/j.canlet.2010.06.003; Yamamoto S, 2014, METHODS MOL BIOL, V1187, P1, DOI 10.1007/978-1-4939-1139-4_1; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393	24	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146696	10.1371/journal.pone.0146696	http://dx.doi.org/10.1371/journal.pone.0146696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766040	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300034
J	Degl'Innocenti, A; Parrilla, M; Harr, B; Teschke, M				Degl'Innocenti, Andrea; Parrilla, Marta; Harr, Bettina; Teschke, Meike			The Mouse Solitary Odorant Receptor Gene Promoters as Models for the Study of Odorant Receptor Gene Choice	PLOS ONE			English	Article							PUTATIVE PHEROMONE RECEPTORS; OLFACTORY SENSORY NEURONS; MULTIPLE SEQUENCE ALIGNMENT; MULTIGENE FAMILY; LABORATORY MOUSE; EXPRESSION; MICE; MAMMALS; GLOMERULI; GENOME	Background In vertebrates, several anatomical regions located within the nasal cavity mediate olfaction. Among these, the main olfactory epithelium detects most conventional odorants. Olfactory sensory neurons, provided with cilia exposed to the air, detect volatile chemicals via an extremely large family of seven-transmembrane chemoreceptors named odorant receptors. Their genes are expressed in a monogenic and monoallelic fashion: a single allele of a single odorant receptor gene is transcribed in a given mature neuron, through a still uncharacterized molecular mechanism known as odorant receptor gene choice. Aim Odorant receptor genes are typically arranged in genomic clusters, but a few are isolated (we call them solitary) from the others within a region broader than 1 Mb upstream and downstream with respect to their transcript's coordinates. The study of clustered genes is problematic, because of redundancy and ambiguities in their regulatory elements: we propose to use the solitary genes as simplified models to understand odorant receptor gene choice. Procedures Here we define number and identity of the solitary genes in the mouse genome (C57BL/6J), and assess the conservation of the solitary status in some mammalian orthologs. Furthermore, we locate their putative promoters, predict their homeodomain binding sites (commonly present in the promoters of odorant receptor genes) and compare candidate promoter sequences with those of wild-caught mice. We also provide expression data from histological sections. Results In the mouse genome there are eight intact solitary genes: Olfr19 (M12), Olfr49, Olfr266, Olfr267, Olfr370, Olfr371, Olfr466, Olfr1402; five are conserved as solitary in rat. These genes are all expressed in the main olfactory epithelium of three-day-old mice. The C57BL/6J candidate promoter of Olfr370 has considerably varied compared to its wild-type counterpart. Within the putative promoter for Olfr266 a homeodomain binding site is predicted. As a whole, our findings favor Olfr266 as a model gene to investigate odorant receptor gene choice.	[Degl'Innocenti, Andrea; Parrilla, Marta] Max Planck Inst Biophys, Frankfurt, Germany; [Degl'Innocenti, Andrea] Univ Pisa, Dipartimento Biol, Unita Biol Cellulare & Sviluppo, Pisa, Italy; [Harr, Bettina; Teschke, Meike] Max Planck Inst Evolut Biol, Abt Evolut Genet, D-24306 Plon, Germany	Max Planck Society; University of Pisa; Max Planck Society	Degl'Innocenti, A (corresponding author), Max Planck Inst Biophys, Frankfurt, Germany.; Degl'Innocenti, A (corresponding author), Univ Pisa, Dipartimento Biol, Unita Biol Cellulare & Sviluppo, Pisa, Italy.	adeglinno@yahoo.com			Max Planck Society	Max Planck Society(Max Planck Society)	The study was generously funded by the Max Planck Society.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; Bressel OC, 2016, J COMP NEUROL, V524, P199, DOI 10.1002/cne.23835; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Hoppe R, 2006, GENOMICS, V87, P711, DOI 10.1016/j.ygeno.2006.02.005; Ibarra-Soria X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004593; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Kaluza JF, 2004, J NEUROSCI RES, V76, P442, DOI 10.1002/jnr.20083; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan M, 2013, MOL CELL NEUROSCI, V57, P120, DOI 10.1016/j.mcn.2013.08.001; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Logan DW, 2012, CURR BIOL, V22, P1998, DOI 10.1016/j.cub.2012.08.041; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Plessy C, 2012, GENOME RES, V22, P486, DOI 10.1101/gr.126201.111; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Royal SJ, 1999, J NEUROSCI, V19, P9856; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shum EY, 2015, NUCL ACIDS RES; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72; Yalcin B, 2012, MAMM GENOME, V23, P490, DOI 10.1007/s00335-012-9402-6; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Young JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-561; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	85	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0144698	10.1371/journal.pone.0144698	http://dx.doi.org/10.1371/journal.pone.0144698			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794459	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300002
J	Huang, LJ; Zhou, GF; Liu, ZG; Dang, XB; Yang, ZT; Kong, XZ; Wang, X; Song, YY; Zhen, ZL; Liu, J				Huang, Lijie; Zhou, Guangfu; Liu, Zhaoguo; Dang, Xiaobin; Yang, Zetian; Kong, Xiang-Zhen; Wang, Xu; Song, Yiying; Zhen, Zonglei; Liu, Jia			A Multi-Atlas Labeling Approach for Identifying Subject-Specific Functional Regions of Interest	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; VENTRAL TEMPORAL CORTEX; BRAIN IMAGES; PROBABILITY MAPS; SEGMENTATION; VARIABILITY; LOCALIZERS; SELECTION; MIND; PROPAGATION	The functional region of interest (fROI) approach has increasingly become a favored methodology in functional magnetic resonance imaging (fMRI) because it can circumvent inter-subject anatomical and functional variability, and thus increase the sensitivity and functional resolution of fMRI analyses. The standard fROI method requires human experts to meticulously examine and identify subject-specific fROIs within activation clusters. This process is time-consuming and heavily dependent on experts' knowledge. Several algorithmic approaches have been proposed for identifying subject-specific fROIs; however, these approaches cannot easily incorporate prior knowledge of inter-subject variability. In the present study, we improved the multi-atlas labeling approach for defining subject-specific fROIs. In particular, we used a classifier-based atlas-encoding scheme and an atlas selection procedure to account for the large spatial variability across subjects. Using a functional atlas database for face recognition, we showed that with these two features, our approach efficiently circumvented inter-subject anatomical and functional variability and thus improved labeling accuracy. Moreover, in comparison with a single-atlas approach, our multi-atlas labeling approach showed better performance in identifying subject-specific fROIs.	[Huang, Lijie; Zhou, Guangfu; Liu, Zhaoguo; Dang, Xiaobin; Yang, Zetian; Kong, Xiang-Zhen; Wang, Xu; Song, Yiying; Zhen, Zonglei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Huang, Lijie; Zhou, Guangfu; Liu, Zhaoguo; Dang, Xiaobin; Yang, Zetian; Kong, Xiang-Zhen; Wang, Xu; Song, Yiying; Zhen, Zonglei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University	Zhen, ZL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Zhen, ZL (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.; Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	zhenzonglei@bnu.edu.cn; liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022	Liu, Jia/0000-0003-0383-0934	National Natural Science Foundation of China [31230031, 31221003, 31470055, 31471067]; National Basic Research Program of China [2014CB846101]; National Social Science Foundation of China [13ZD073, 14ZDB160]; Changjiang Scholars Programme of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Social Science Foundation of China; Changjiang Scholars Programme of China	This study was funded by the National Natural Science Foundation of China (31230031), the National Basic Research Program of China (2014CB846101), the National Natural Science Foundation of China (31221003, 31470055, and 31471067), the National Social Science Foundation of China (13&ZD073, 14ZDB160), and Changjiang Scholars Programme of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China (31230031), the National Basic Research Program of China (2014CB846101), the National Natural Science Foundation of China (31221003, 31470055, and 31471067), the National Social Science Foundation of China (13&ZD073, 14ZDB160), and Changjiang Scholars Programme of China. The authors declare no conflict of interest.	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Asman AJ, 2011, IEEE T MED IMAGING, V30, P1779, DOI 10.1109/TMI.2011.2147795; Berman MG, 2010, NEUROIMAGE, V50, P56, DOI 10.1016/j.neuroimage.2009.12.024; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Coulon O, 2000, NEUROIMAGE, V11, P767, DOI 10.1006/nimg.2000.0580; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Gholipour A, 2007, IEEE T MED IMAGING, V26, P427, DOI 10.1109/TMI.2007.892508; Hassan S, 2011, RESTING STATE FMRI T; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Hickok G, 2009, J NEUROPHYSIOL, V101, P2725, DOI 10.1152/jn.91099.2008; Julian JB, 2012, NEUROIMAGE, V60, P2357, DOI 10.1016/j.neuroimage.2012.02.055; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Keraudren K, 2014, NEUROIMAGE, V101, P633, DOI 10.1016/j.neuroimage.2014.07.023; Klein Arno, 2005, BMC Med Imaging, V5, P7, DOI 10.1186/1471-2342-5-7; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Lu YL, 2003, NEUROIMAGE, V20, P455, DOI 10.1016/S1053-8119(03)00352-5; Miller MB, 2002, J COGNITIVE NEUROSCI, V14, P1200, DOI 10.1162/089892902760807203; Monir SMG, 2011, COMM SIGN PROC ICICS, P1; Nieto-Castanon A, 2003, NEUROIMAGE, V19, P1303, DOI 10.1016/S1053-8119(03)00188-5; Nieto-Castanon A, 2012, NEUROIMAGE, V63, P1646, DOI 10.1016/j.neuroimage.2012.06.065; Pinel P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-91; Pitcher D, 2011, NEUROIMAGE; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Rohlfing T, 2005, PATTERN RECOGN LETT, V26, P2070, DOI 10.1016/j.patrec.2005.03.017; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rousseau F, 2011, IEEE T MED IMAGING, V30, P1852, DOI 10.1109/TMI.2011.2156806; Sabuncu MR, 2010, CEREB CORTEX, V20, P130, DOI 10.1093/cercor/bhp085; Sanroma G, 2014, IEEE T MED IMAGING, V33, P1939, DOI 10.1109/TMI.2014.2327516; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Thirion B, 2007, LECT NOTES COMPUT SC, V4584, P482; Thirion B, 2007, IEEE T MED IMAGING, V26, P1256, DOI 10.1109/TMI.2007.903226; Thirion B, 2010, LECT NOTES COMPUT SC, V6362, P241; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wohlschlager AM, 2005, NEUROIMAGE, V26, P73, DOI 10.1016/j.neuroimage.2005.01.021; Wu MJ, 2007, NEUROIMAGE, V34, P1612, DOI 10.1016/j.neuroimage.2006.07.050; Xu L, 2009, BIOMETRICS, V65, P1041, DOI 10.1111/j.1541-0420.2008.01190.x; Zhen ZL, 2015, NEUROIMAGE, V113, P13, DOI 10.1016/j.neuroimage.2015.03.010; Zikic D, 2014, MED IMAGE ANAL, V18, P1262, DOI 10.1016/j.media.2014.06.010	54	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146868	10.1371/journal.pone.0146868	http://dx.doi.org/10.1371/journal.pone.0146868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796546	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300013
J	Alt, KW; Zesch, S; Garrido-Pena, R; Knipper, C; Szecsenyi-Nagy, A; Roth, C; Tejedor-Rodriguez, C; Held, P; Garcia-Martinez-de-Lagran, I; Navitainuck, D; Magallon, HA; Rojo-Guerra, MA				Alt, Kurt W.; Zesch, Stephanie; Garrido-Pena, Rafael; Knipper, Corina; Szecsenyi-Nagy, Anna; Roth, Christina; Tejedor-Rodriguez, Cristina; Held, Petra; Garcia-Martinez-de-Lagran, Inigo; Navitainuck, Denise; Arcusa Magallon, Hector; Rojo-Guerra, Manuel A.			A Community in Life and Death: The Late Neolithic Megalithic Tomb at Alto de Reinoso (Burgos, Spain)	PLOS ONE			English	Article							ANCIENT DNA; STRONTIUM ISOTOPES; BONE-COLLAGEN; NITROGEN ISOTOPES; STABLE CARBON; SKELETAL AGE; LONG BONES; POPULATIONS; DIET; AGRICULTURE	The analysis of the human remains from the megalithic tomb at Alto de Reinoso represents the widest integrative study of a Neolithic collective burial in Spain. Combining archaeology, osteology, molecular genetics and stable isotope analysis (Sr-87/Sr-86, delta N-15, delta C-13) it provides a wealth of information on the minimum number of individuals, age, sex, body height, pathologies, mitochondrial DNA profiles, kinship relations, mobility, and diet. The grave was in use for approximately one hundred years around 3700 cal BC, thus dating from the Late Neolithic of the Iberian chronology. At the bottom of the collective tomb, six complete and six partial skeletons lay in anatomically correct positions. Above them, further bodies represented a subsequent and different use of the tomb, with almost all of the skeletons exhibiting signs of manipulation such as missing skeletal parts, especially skulls. The megalithic monument comprised at least 47 individuals, including males, females, and subadults, although children aged 0-6 years were underrepresented. The skeletal remains exhibited a moderate number of pathologies, such as degenerative joint diseases, healed fractures, cranial trauma, and a low intensity of caries. The mitochondrial DNA profiles revealed a pattern pointing to a closely related local community with matrilineal kinship patterns. In some cases adjacent individuals in the bottom layer showed familial relationships. According to their strontium isotope ratios, only a few individuals were likely to have spent their early childhood in a different geological environment, whilst the majority of individuals grew up locally. Carbon and nitrogen isotope analysis, which was undertaken to reconstruct the dietary habits, indicated that this was a homogeneous group with egalitarian access to food. Cereals and small ruminants were the principal sources of nutrition. These data fit in well with a lifestyle typical of sedentary farming populations in the Spanish Meseta during this period of the Neolithic.	[Alt, Kurt W.] Danube Private Univ, Krems, Austria; [Alt, Kurt W.] Univ Basel, Inst Prehistory & Archaeol Sci, Basel, Switzerland; [Alt, Kurt W.] Univ Basel, Hightech Res Ctr, Basel, Switzerland; [Alt, Kurt W.] State Off Heritage Management & Archaeol Saxony A, Halle, Germany; [Alt, Kurt W.] State Museum Prehistory, Halle, Germany; [Zesch, Stephanie] Reiss Engelhorn Museen, German Mummy Project, Mannheim, Germany; [Garrido-Pena, Rafael] Autonomous Univ Madrid, Fac Philosophy & Letters, Dept Prehistory & Archaeol, E-28049 Madrid, Spain; [Knipper, Corina] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Szecsenyi-Nagy, Anna] Hungarian Acad Sci, Lab Archaeogenet, Inst Archaeol, Res Ctr Humanities, Budapest, Hungary; [Roth, Christina; Navitainuck, Denise] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Tejedor-Rodriguez, Cristina] Univ Valladolid, Arcadia Gen Fdn, Valladolid, Spain; [Held, Petra] Johannes Gutenberg Univ Mainz, Dept Appl & Analyt Paleontol, D-55122 Mainz, Germany; [Garcia-Martinez-de-Lagran, Inigo] Univ Basque Govt, Dept Prehist, Vitoria, Spain; [Garcia-Martinez-de-Lagran, Inigo] Univ Toulouse, Lab TRACES UMR5608, Toulouse, France; [Rojo-Guerra, Manuel A.] Univ Valladolid, Dept Prehist & Archaeol, Valladolid, Spain	University of Basel; University of Basel; Autonomous University of Madrid; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Johannes Gutenberg University of Mainz; Universidad de Valladolid; Johannes Gutenberg University of Mainz; Basque Government; University of Basque Country; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universidad de Valladolid	Alt, KW (corresponding author), Danube Private Univ, Krems, Austria.; Alt, KW (corresponding author), Univ Basel, Inst Prehistory & Archaeol Sci, Basel, Switzerland.; Alt, KW (corresponding author), Univ Basel, Hightech Res Ctr, Basel, Switzerland.; Alt, KW (corresponding author), State Off Heritage Management & Archaeol Saxony A, Halle, Germany.; Alt, KW (corresponding author), State Museum Prehistory, Halle, Germany.	kurt.alt@unibas.ch	Garrido Pena, Rafael/E-8788-2013; Rojo-Guerra, Manuel Ángel/AAB-6968-2019; Rodrigez, Cristina/AAD-1218-2019; García-Martínez de Lagrán, Iñigo/J-2803-2015	Garrido Pena, Rafael/0000-0001-8263-2949; Rojo-Guerra, Manuel Ángel/0000-0002-9317-8654; Rodrigez, Cristina/0000-0002-3156-0866; García-Martínez de Lagrán, Iñigo/0000-0002-2411-8228; Navitainuck, Denise/0000-0002-6082-0778; Zesch, Stephanie/0000-0003-4529-0366; Szecsenyi-Nagy, Anna/0000-0003-2095-738X	Junta de Castilla y Leon (Spain); German Research Foundation [Al 287/14-1]; Johannes Gutenberg University of Mainz, Germany; Danube Private University, Krems, Austria	Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); German Research Foundation(German Research Foundation (DFG)); Johannes Gutenberg University of Mainz, Germany; Danube Private University, Krems, Austria	The archaeological research was supported and financed by the Junta de Castilla y Leon (Spain), the anthropological analyses by the German Research Foundation Al 287/14-1, the Johannes Gutenberg University of Mainz, Germany (no grant number), and the Danube Private University, Krems, Austria (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S. C., 2011, SOCIAL BIOARCHAEOLOG; Aguilera M, 2008, RAPID COMMUN MASS SP, V22, P1653, DOI 10.1002/rcm.3501; ALBERT AM, 1995, J FORENSIC SCI, V40, P623; Alt K.W, 2012, KONIGIN EDITHA IHRE, P105; Alt KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110793; Alt KW, 2013, LANDESAMT DENKMALPFL, P38; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; An CB, 2015, J ARCHAEOL SCI, V53, P316, DOI 10.1016/j.jas.2014.11.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ortega LA, 2013, QUATERN INT, V303, P54, DOI 10.1016/j.quaint.2013.02.008; [Anonymous], 1980, J HUM EVOL, V9, P517; Araus JL, 1997, J ARCHAEOL SCI, V24, P729, DOI 10.1006/jasc.1997.0154; Arias P., 2007, P BRIT ACAD, P53, DOI DOI 10.5871/BACAD/9780197264140.003.0004; Bach A., 1978, WEIMARER MONOGRAPHIE, V1; Bach H, 1965, ANTHROPOL ANZ, V29, P12; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bienert H. D., 1991, J PREHISTORIC RELIG, V5, P9; Boaventura R, 2014, ANTHROPOLOGIE, V12, P183; BocquetAppel JP, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P1, DOI 10.1007/978-1-4020-6424-1; Bogaard A, 2013, P NATL ACAD SCI USA, V110, P12589, DOI 10.1073/pnas.1305918110; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Bonogofsky M., 2001, PALEORIENT, V27, P141; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G., 2014, EARLY FARMERS VIEW A, P95, DOI DOI 10.5871/BACAD/9780197265758.003.0006; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Breitinger E., 1938, ANTHROPOL ANZ, V14, P249; Bueno P., 1999, TRABAJOS PREHIST, V56, P141; Bueno RamYrez P., 2002, TRABAJOS PREHIST, V59, P65, DOI [DOI 10.3989/TP.2002.V59.I2.198, 10.3989/tp.2002.v59.i2.198]; Buikstra J.E., 1994, FAYETTEVILLE ARKANSA, V44; Buikstra J.E, 2006, BIOARCHAEOLOGY CONTE; CarlieThiele P., 1996, SPUREN MANGELERKRANK; Caselitz P, 1998, DENTAL ANTHROPOLOGY, P203; Casta?os P, 2004, SALDUIE, V4, P125; Chandler H., 2005, ACTAS 3 CONGRESSO NE, VVol. 1, P781; Chandler H., 2003, THESIS U OXFORD; Darvill T, 2003, MEGALITHS ANTIQUITY; de-la-Rua C, 2015, QUATERN INT, V364, P306, DOI 10.1016/j.quaint.2015.01.035; Delibes de Castro G., 1995, SERIE CRUSOS C, V3, P61; Delibes G, 2002, ARCH ESPAN ARQUEOL, V75, P1; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Donat P, 1971, Z ARCHAOL, V5, P234; Doppler T, 2015, LANDSCAPE OPENING HE; Doppler Thomas, 2012, ANTIQUA, V51; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; Eshed V, 2010, AM J PHYS ANTHROPOL, V143, P121, DOI 10.1002/ajpa.21301; Fernandez-Crespo T., 2007, EAA SUMMER SCH EBOOK, V1, P55; Fernandez-Crespo T, 2015, J ARCHAEOL SCI, V53, P604, DOI 10.1016/j.jas.2014.11.015; Fischer A, 2007, J ARCHAEOL SCI, V34, P2125, DOI 10.1016/j.jas.2007.02.028; Formicola V, 1996, AM J PHYS ANTHROPOL, V100, P83; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Furholt M., 2012, TIME GOES MONUMENTAL TIME GOES MONUMENTAL, P13; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Guixe EG, 2006, CURR ANTHROPOL, V47, P549, DOI 10.1086/504170; Gibaja J.F, 2004, CURR ANTHROPOL, V45, P679, DOI DOI 10.1086/425634; Gibaja J.F., 2012, NEOLTICO PENNSULA IB, P333; Gomez-Sanchez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105105; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Haberle S, 2016, ENVIRON ARCHAEOL, V21, P119, DOI 10.1179/1749631414Y.0000000042; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Herrscher E, 2010, AM J PHYS ANTHROPOL, V141, P259, DOI 10.1002/ajpa.21141; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Hillson S., 2008, BIOL ANTHR HUMAN SKE, V2, P301; Jorkov MLS, 2007, J ARCHAEOL SCI, V34, P1824, DOI 10.1016/j.jas.2006.12.020; Katzenberg M.A., 2000, BIOL ANTHR HUMAN SKE, P305, DOI DOI 10.1002/9780470245842.CH13; Knipper C., 2012, POPULATION DYNAMICS; Knipper C, 2012, ANTIQUA, V51, P188; Knipper C, 2014, J ARCHAEOL SCI, V41, P818, DOI 10.1016/j.jas.2013.09.019; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lee EJ, 2014, J ARCHAEOL SCI, V51, P174, DOI 10.1016/j.jas.2012.08.037; Lee E, 2014, ARCHAEOL ANTHROP SCI, V6, P199, DOI 10.1007/s12520-013-0173-0; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; Lewis ME, 2007, CAM S BIO EVOL ANTHR, V50, P1; Lohrke B, 2002, STUDIA ARCHAEOLOGICA, V91, P83; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; LOVELL NC, 1986, ARCHAEOMETRY, V28, P51, DOI 10.1111/j.1475-4754.1986.tb00373.x; LUBELL D, 1994, J ARCHAEOL SCI, V21, P201, DOI 10.1006/jasc.1994.1022; MARSHALL F, 1993, AM ANTIQUITY, V58, P261, DOI 10.2307/281968; Martin Rudolf, 1928, LEHRBUCH ANTHR SYSTE; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; McClure SB, 2011, J ARCHAEOL SCI, V38, P420, DOI 10.1016/j.jas.2010.09.023; Meiklejohn C., 1984, PALEOPATHOLOGY ORIGI, P75; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Meller H, 2013, LANDESAMT DENKMALPFL, P349; Meyer C, 2013, ARCHAOLOGIE DEUTSCHL, V5, P30; Meyer C, 2008, TOTENHUTTE BENZINGER, V7, P107; Meyer C.H., 2012, SPREITENBACH MOOSWEG, V51, P104; Miles A.E.W., 1963, DENT ANTHR, P191, DOI DOI 10.1016/B978-0-08-009823-4.50015-X; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Molnar P, 2006, AM J PHYS ANTHROPOL, V129, P12, DOI 10.1002/ajpa.20234; Montero Ruiz I., 1999, TRABAJOS PREHISTORIA, V56, P119; Muller J., 2011, ARCHAOLOGIE EURASIEN, V24; Nicklisch N, 2005, DESAFIO ETERNIDAD TU, V14, P323; Nicklisch N., 2014, THESIS U MAINZ; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Oross K, 2012, ACAD SCI, V63, P257, DOI [10.1556/AArch.63.2012.2.1, DOI 10.1556/AARCH.63.2012.2.1]; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Papathanasiou A, 2005, AM J PHYS ANTHROPOL, V126, P377, DOI 10.1002/ajpa.20140; Pearson K, 1899, PHIL T R SOC LOND A, V192, P169, DOI [DOI 10.1098/RSTA.1899.0004, 10.1098/rsta.1899.0004]; Perez Ripoll M., 1999, ACT 2 C NEOL PEN IB, V2, P95; Perez-Obiol R, 2011, HOLOCENE, V21, P75, DOI 10.1177/0959683610384161; Prevedorou E., 2010, DENT ANTHR, V23, P42, DOI DOI 10.26575/daj.v23i2.74; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Robson HK, 2016, ENVIRON ARCHAEOL, V21, P105, DOI 10.1179/1749631415Y.0000000014; Rojo Guerra M, 2005, MEMORIAS ARQUEOLOGIA, V14; Rojo-Guerra MA, 2008, ASENTAMIENTOS NEOLIT; Rojo-Guerra MA, 2012, BAR INT SERIES, V2417, P21; ROSING F. W., 1988, ANTHROPOLOGIE, V1, P586; Salazar-Garcia DC, 2009, MONOGRAFIES PREHISTO, V8, P411; Salazar-Garcia DC, 2014, J ARCHAEOL SCI, V42, P231, DOI 10.1016/j.jas.2013.11.006; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Scarre C, 2003, STONES BONES FORMAL, V1201, P65; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schonenberger R, 1997, EINFUHRUNG GEOLOGIE; Schulting R., 2012, STICKS STONES BROKEN; SjOvold T, 1990, HUM EVOL, V5, P431, DOI [DOI 10.1007/%2FBF02435593, 10.1007/BF02435593, DOI 10.1007/BF02435593]; Solari Giachino A., 2010, THESIS U GRANADA; Steckel R.H., 2002, BACKBONE HIST HLTH N, DOI DOI 10.1017/CBO9780511549953.004; STLOUKAL M, 1978, HOMO, V29, P53; Subira ME, 2016, INT J OSTEOARCHAEOL, V26, P104, DOI 10.1002/oa.2400; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Trotter M., 1970, PERSONAL IDENTIFICAT, P71; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; Valaitis R, 2000, CAN J PUBLIC HEALTH, V91, P411, DOI 10.1007/BF03404819; van der Merwe N.J., 1986, Palaeoecology of Africa and the Surrounding Islands, V17, P123; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; van Klinken GJ, 2000, BIOGEOCHEMICAL APPRO, P39, DOI DOI 10.1007/0-306-47194-9_3; Veit U., 1996, TUBINGER STUDIEN UR, V1; Velasco Vazquez X., 2005, ARQUEOLOGIA CASTILLA, V14, P340; Waterman A.J., 2012, THESIS U IOWA; Waterman AJ, 2014, J ARCHAEOL SCI, V42, P119, DOI 10.1016/j.jas.2013.11.004; Waterman AJ, 2011, OXFORD J ARCHAEOL, V30, P165, DOI 10.1111/j.1468-0092.2011.00363.x; White T.D., 2000, HUMAN OSTEOLOGY; Zapata L, 2004, J WORLD PREHIST, V18, P283, DOI 10.1007/s10963-004-5621-4; Zeeb-Lanz A., 2011, SCHADELKULT KOPF SCH, P47; ZilhAo J, 2000, EUROPES 1 FARMERS, P144, DOI DOI 10.1017/CBO9780511607851.007	148	38	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146176	10.1371/journal.pone.0146176	http://dx.doi.org/10.1371/journal.pone.0146176			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DB5BW	26789731	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100027
J	An, YY; Qi, L; Wang, LJ				An, Yuyan; Qi, Lin; Wang, Liangju			ALA Pretreatment Improves Waterlogging Tolerance of Fig Plants	PLOS ONE			English	Article							PHOTOSYNTHETIC GAS-EXCHANGE; 5-AMINOLEVULINIC ACID; FICUS-CARICA; GENE-EXPRESSION; PROLINE ACCUMULATION; OXYGEN DEFICIENCY; INDUCED INCREASE; SALINITY STRESS; BRASSICA-NAPUS; SEEDLINGS	5-aminolevulinic acid (ALA), a natural and environmentally friendly plant growth regulator, can improve plant tolerance to various environmental stresses. However, whether ALA can improve plant waterlogging tolerance is unknown. Here, we investigated the effects of ALA pretreatment on the waterlogging-induced damage of fig (Ficus carica Linn.) plants, which often suffer from waterlogging stress. ALA pretreatment significantly alleviated stress-induced morphological damage, increased leaf relative water content (RWC), and reduced leaf superoxide anion (O-2 (radical anion)) production rate and malonaldehyde (MDA) content in fig leaves, indicating ALA mitigates waterlogging stress of fig plants. We further demonstrated that ALA pretreatment largely promoted leaf chlorophyll content, photosynthetic electron transfer ability, and photosynthetic performance index, indicating ALA significantly improves plant photosynthetic efficiency under waterlogging stress. Moreover, ALA pretreatment significantly increased activities of leaf superoxide dismutase (SOD) and peroxidase (POD), root vigor, and activities of root alcohol dehydrogenase (ADH), and lactate dehydrogenase (LDH), indicating ALA also significantly improves antioxidant ability and root function of fig plants under waterlogging stress. Taken together, ALA pretreatment improves waterlogging tolerance of fig plants significantly, and the promoted root respiration, leaf photosynthesis, and antioxidant ability may contribute greatly to this improvement. Our data firstly shows that ALA can improve plant waterlogging tolerance.	[An, Yuyan; Qi, Lin; Wang, Liangju] Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, LJ (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing 210095, Jiangsu, Peoples R China.	wlj@njau.edu.cn			Agricultural Key Science and Technology project of Jiangsu Province, China [BE2012339, BE2013327]; Fundamental Research Funds for the Central Universities [KJQN201538]; National Natural Science Foundation of China [31401820]; Natural Science Foundation of Jiangsu Province, China [BK20140702]	Agricultural Key Science and Technology project of Jiangsu Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This research was supported by the Agricultural Key Science and Technology project of Jiangsu Province, China (BE2012339, BE2013327; LW), the Fundamental Research Funds for the Central Universities (KJQN201538; YA), the National Natural Science Foundation of China (31401820; YA) and the Natural Science Foundation of Jiangsu Province, China (BK20140702; YA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2002, PLANT SCI, V163, P117, DOI 10.1016/S0168-9452(02)00080-8; Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; An YY, 2011, S AFR J BOT, V77, P446, DOI 10.1016/j.sajb.2010.11.003; An YY, 2013, ACTA PHYSIOL PLANT, V35, P959, DOI 10.1007/s11738-012-1139-z; [Anonymous], 2003, FUNCT PLANT BIOL; Ashraf M. A., 2012, African Journal of Agricultural Research, V7, P1976; Badgujar SB, 2014, PHARM BIOL, V52, P1487, DOI 10.3109/13880209.2014.892515; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Balestrasse KB, 2010, PHYTOCHEMISTRY, V71, P2038, DOI 10.1016/j.phytochem.2010.07.012; Banti V, 2013, INT J MOL SCI, V14, P4734, DOI 10.3390/ijms14034734; Barolo MI, 2014, FOOD CHEM, V164, P119, DOI 10.1016/j.foodchem.2014.04.112; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bertolde FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108705; Bindu RC, 1998, PLANT GROWTH REGUL, V26, P15, DOI 10.1023/A:1006098005335; Borella J, 2014, SCI AGR, V71, P499, DOI 10.1590/0103-9016-2014-0044; Ciarmiello LF, 2015, S AFR J BOT, V97, P40, DOI 10.1016/j.sajb.2014.11.012; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Czarnecki O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00236; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Dennis ES, 2000, J EXP BOT, V51, P89, DOI 10.1093/jexbot/51.342.89; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hotta Y, 1998, J PESTIC SCI, V23, P29; Hotta Y, 1997, PLANT GROWTH REGUL, V22, P109, DOI 10.1023/A:1005883930727; Irfan M, 2010, PROTOPLASMA, V241, P3, DOI 10.1007/s00709-009-0098-8; Juntawong P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00658; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Kreuzwieser J, 2014, PLANT CELL ENVIRON, V37, P2245, DOI 10.1111/pce.12310; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Limami AM, 2014, PLANTA, V239, P531, DOI 10.1007/s00425-013-2015-9; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Mustroph A, 2003, PHYSIOL PLANTARUM, V117, P508, DOI 10.1034/j.1399-3054.2003.00051.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Naeem MS, 2010, PLANT SOIL, V332, P405, DOI 10.1007/s11104-010-0306-5; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; SASIKALA C, 1994, BIOTECHNOL PROGR, V10, P451, DOI 10.1021/bp00029a001; Shabala S, 2014, PLANT CELL ENVIRON, V37, P2216, DOI 10.1111/pce.12339; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Vemmos SN, 2013, SCI HORTIC-AMSTERDAM, V160, P198, DOI 10.1016/j.scienta.2013.05.036; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Wang LJ, 2004, PHYSIOL PLANTARUM, V121, P258, DOI 10.1111/j.0031-9317.2004.00319.x; Watanabe K, 2000, PLANT GROWTH REGUL, V32, P99, DOI 10.1023/A:1006369404273; WATERS I, 1991, J EXP BOT, V42, P1437, DOI 10.1093/jxb/42.11.1437; Xu XW, 2014, SCI HORTIC-AMSTERDAM, V179, P388, DOI 10.1016/j.scienta.2014.10.001; Yang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116283; Yiu JC, 2009, PLANT PHYSIOL BIOCH, V47, P710, DOI 10.1016/j.plaphy.2009.03.007; Yiu JC, 2009, SCI HORTIC-AMSTERDAM, V120, P306, DOI 10.1016/j.scienta.2008.11.020; Youssef T, 2008, J PLANT GROWTH REGUL, V27, P1, DOI 10.1007/s00344-007-9025-4; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127982; Zhang ZJ, 2006, PLANT GROWTH REGUL, V49, P27, DOI 10.1007/s10725-006-0011-9; Zhen A, 2012, BIOL PLANTARUM, V56, P566, DOI 10.1007/s10535-012-0118-y; Zhou J, 2003, ECON FOR RES, V21, P90	62	33	38	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147202	10.1371/journal.pone.0147202	http://dx.doi.org/10.1371/journal.pone.0147202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789407	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100066
J	Bowers, CA; Kundu, B; Rosenbluth, J; Hawryluk, GWJ				Bowers, Christian A.; Kundu, Bornali; Rosenbluth, Jeffrey; Hawryluk, Gregory W. J.			Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone	PLOS ONE			English	Article							PHARMACOLOGICAL THERAPY; PRIORITIES; NEUROPROSTHESIS; TRIALS; LEVEL	Methylprednisolone sodium succinate (MPSS) for treatment of acute spinal cord injury (SCI) has been associated with both benefits and adverse events. MPSS administration was the standard of care for acute SCI until recently when its use has become controversial. Patients with SCI have had little input in the debate, thus we sought to learn their opinions regarding administration of MPSS. A summary of the published literature to date on MPSS use for acute SCI was created and adjudicated by 28 SCI experts. This summary was then emailed to 384 chronic SCI patients along with a survey that interrogated the patients' neurological deficits, communication with physicians and their views on MPSS administration. 77 out of 384 patients completed the survey. 28 respondents indicated being able to speak early after injury and of these 24 reported arriving at the hospital within 8 hours of injury. One recalled a physician speaking to them about MPSS and one patient reported choosing whether or not to receive MPSS. 59.4% felt that the small neurological benefits associated with MPSS were 'very important' to them (p<0.0001). Patients had ` little concern' for potential side-effects of MPSS (p = 0.001). Only 1.4% felt that MPSS should not be given to SCI patients regardless of degree of injury (p<0.0001). This is the first study to report SCI patients' preferences regarding MPSS treatment for acute SCI. Patients favor the administration of MPSS for acute SCI, however few had input into whether or not it was administered. Conscious patients should be given greater opportunity to decide their treatment. These results also provide some guidance regarding MPSS administration in patients unable to communicate.	[Bowers, Christian A.; Kundu, Bornali; Hawryluk, Gregory W. J.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Rosenbluth, Jeffrey] Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Hawryluk, GWJ (corresponding author), Univ Utah, Dept Neurosurg, Salt Lake City, UT USA.	gregory.hawryluk@hsc.utah.edu	Kundu, Bornali/AAR-1705-2021					Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.251.1.45; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Brown-Triolo DL, 2002, J REHABIL RES DEV, V39, P659; Chappell ET, 2002, NEUROSURGERY, V51, P855, DOI 10.1097/00006123-200209000-00062; Fehlings MG, 2001, SPINE, V26, pS55, DOI 10.1097/00007632-200112151-00011; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; French JS, 2010, NEUROMODULATION, V13, P229, DOI 10.1111/j.1525-1403.2009.00252.x; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Hurlbert RJ, 2001, SPINE, V26, pS39, DOI 10.1097/00007632-200112151-00009; Inc. G, RES METH GARTN HYP C; Johnson AT, 2015, IEEE PULSE, V6, P50, DOI 10.1109/MPUL.2014.2386491; Kaplowitz MD, 2004, PUBLIC OPIN QUART, V68, P94, DOI 10.1093/poq/nfh006; Mason C, 2009, REGEN MED, V4, P329, DOI 10.2217/RME.09.20; Munce SEP, 2016, SPINAL CORD, V54, P29, DOI 10.1038/sc.2015.91; Munce SEP, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0209-9; OTANI K, 1994, SEKITSUI SEKIZUI J, V7, P633; Petitjean ME, 1998, ANN FR ANESTH, V17, P114, DOI 10.1016/S0750-7658(98)80058-0; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Politi MC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7066; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Yilmaz B, 2014, SPINAL CORD, V52, P826, DOI 10.1038/sc.2014.134	27	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145991	10.1371/journal.pone.0145991	http://dx.doi.org/10.1371/journal.pone.0145991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789007	gold, Green Published			2022-12-27	WOS:000368529100021
J	Brunoldi, M; Bozzini, G; Casale, A; Corvisiero, P; Grosso, D; Magnoli, N; Alessi, J; Bianchi, CN; Mandich, A; Morri, C; Povero, P; Wurtz, M; Melchiorre, C; Viano, G; Cappanera, V; Fanciulli, G; Bei, M; Stasi, N; Taiuti, M				Brunoldi, Marco; Bozzini, Giorgio; Casale, Alessandra; Corvisiero, Pietro; Grosso, Daniele; Magnoli, Nicodemo; Alessi, Jessica; Bianchi, Carlo Nike; Mandich, Alberta; Morri, Carla; Povero, Paolo; Wurtz, Maurizio; Melchiorre, Christian; Viano, Gianni; Cappanera, Valentina; Fanciulli, Giorgio; Bei, Massimiliano; Stasi, Nicola; Taiuti, Mauro			A Permanent Automated Real-Time Passive Acoustic Monitoring System for Bottlenose Dolphin Conservation in the Mediterranean Sea	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; WHISTLE CHARACTERISTICS; TOUR BOATS; CLASSIFICATION; DISTURBANCE; EXTRACTION; RESPONSES; PATTERNS; NOISE; OCEAN	Within the framework of the EU Life+ project named LIFE09 NAT/IT/000190 ARION, a permanent automated real-time passive acoustic monitoring system for the improvement of the conservation status of the transient and resident population of bottlenose dolphin (Tursiops truncatus) has been implemented and installed in the Portofino Marine Protected Area (MPA), Ligurian Sea. The system is able to detect the simultaneous presence of dolphins and boats in the area and to give their position in real time. This information is used to prevent collisions by diffusing warning messages to all the categories involved (tourists, professional fishermen and so on). The system consists of two gps-synchronized acoustic units, based on a particular type of marine buoy (elastic beacon), deployed about 1 km off the Portofino headland. Each one is equipped with a four-hydrophone array and an onboard acquisition system which can record the typical social communication whistles emitted by the dolphins and the sound emitted by boat engines. Signals are pre-filtered, digitized and then broadcast to the ground station via wi-fi. The raw data are elaborated to get the direction of the acoustic target to each unit, and hence the position of dolphins and boats in real time by triangulation.	[Brunoldi, Marco; Bozzini, Giorgio; Casale, Alessandra; Corvisiero, Pietro; Grosso, Daniele; Magnoli, Nicodemo; Taiuti, Mauro] Univ Genoa, Dept Phys, Genoa, Italy; [Alessi, Jessica; Bianchi, Carlo Nike; Mandich, Alberta; Morri, Carla; Povero, Paolo; Wurtz, Maurizio] Univ Genoa, Dept Earth Environm & Life Sci, Genoa, Italy; [Melchiorre, Christian; Viano, Gianni] SOFTECO Sismat Srl, Genoa, Italy; [Cappanera, Valentina; Fanciulli, Giorgio] Minist Environm & Protect Terr & Sea, Area Marina Protetta Portofino, Santa Margherita Ligure, Genoa, Italy; [Bei, Massimiliano; Stasi, Nicola] Minist Infrastruct & Transport, Direz Marittima Genova, Genoa, Italy	University of Genoa; University of Genoa	Brunoldi, M (corresponding author), Univ Genoa, Dept Phys, Genoa, Italy.	brunoldi@fisica.unige.it	Grosso, Daniele/R-4212-2016; Grosso, Daniele/GXM-9039-2022; Alessi, Jessica/S-4350-2018	Grosso, Daniele/0000-0002-0699-3459; Alessi, Jessica/0000-0002-3814-702X; Magnoli, Nicodemo/0000-0001-5372-4836; Bianchi, Carlo Nike/0000-0003-1071-3285; Morri, Carla/0000-0003-4520-2741; Casale, Alessandra/0000-0001-9090-1002	European Commission [LIFE09 NAT/IT/000190 ARION]; European Union (EU)	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union (EU)(CGIAREuropean Commission)	This work has been entirely funded by the European Commission within the framework of the ARION project (grant number: LIFE09 NAT/IT/000190 ARION). The funding organization did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials. The authors Christian Melchiorre (C. Melchiorre) and Gianni Viano (GV) are employed by the commercial IT company named Softeco Sismat S.r.l. Softeco Sismat S.r.l. is one of the four beneficiaries of the project: 1. University of Genova (coordinating beneficiary) 2. Direzione Marittima di Genova (associated beneficiary) 3. Portofino Marine Protected Area (associated beneficiary) 4. Softeco Sismat S.r.l. (associated beneficiary) The funder provided support in the form of salaries for authors C. Melchiorre and GV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; This study received financial support by European Union (EU). We wish to thank Massimiliano (Capo) Bei for both logistical and technical support at the Portofino lighthouse. Thanks to P. Campodonico, G. Mastrocola and S. Venturini (Portofino MPA) for the great availability in boat transport to the detection units. A special thank to W.M.X. Zimmer and G. Pavan for their support in detection and tracking algorithms development.	Ainslie MA, 1998, J ACOUST SOC AM, V103, P1671, DOI 10.1121/1.421258; Alessi J, 2014, J COAST CONSERV, V18, P449, DOI 10.1007/s11852-014-0330-3; Allen MC, 2000, MAR MAMMAL SCI, V16, P815, DOI 10.1111/j.1748-7692.2000.tb00974.x; AU WWL, 1974, J ACOUST SOC AM, V56, P1280, DOI 10.1121/1.1903419; Bazua-Duran C, 2004, AN ACAD BRAS CIENC, V76, P386, DOI 10.1590/S0001-37652004000200030; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Branstetter BK, 2012, J ACOUST SOC AM, V131, P1613, DOI 10.1121/1.3676694; BUCK JR, 1993, J ACOUST SOC AM, V94, P2497, DOI 10.1121/1.407385; Chung KW, 2011, ADV ACOUS VIB, V2011, DOI 10.1155/2011/952798; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Esfahanian Mahdi, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P6038, DOI 10.1109/ICASSP.2014.6854763; Esfahanian M, 2013, J ACOUST SOC AM, V134, pEL105, DOI 10.1121/1.4811162; EU, 2007, DIAB DIR; FREITAG LE, 1993, J ACOUST SOC AM, V93, P2197, DOI 10.1121/1.406681; Gannier A, 2010, APPL ACOUST, V71, P1063, DOI 10.1016/j.apacoust.2010.05.019; Gnone Guido, 2005, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V146, P39; Gubbins Cara, 2002, Aquatic Mammals, V28, P24; Halkias XC, 2006, APPL ACOUST, V67, P1164, DOI 10.1016/j.apacoust.2006.05.006; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; Jensen FH, 2012, J ACOUST SOC AM, V131, P582, DOI 10.1121/1.3662067; Ketten DR, 2004, MARINE MAMMAL AUDITO; Lemon M, 2006, BIOL CONSERV, V127, P363, DOI 10.1016/j.biocon.2005.08.016; Lopez BD, 2011, MAMM BIOL, V76, P180, DOI 10.1016/j.mambio.2010.06.006; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Marini C, 2015, J ENVIRON MANAGE, V150, P9, DOI 10.1016/j.jenvman.2014.11.008; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mohammad B, 2011, IEEE J OCEANIC ENG, V36, P431, DOI 10.1109/JOE.2010.2060790; Morri C, 1988, B MUS I BIOL U GEN S, V52, P213; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Ou H, 2013, J ACOUST SOC AM, V133, P301, DOI 10.1121/1.4770251; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Pirotta E, 2015, BIOL CONSERV, V181, P82, DOI 10.1016/j.biocon.2014.11.003; Richardson WJ, 1996, J MAR BIOL ASSOC UK, V76, P550; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Salmona P, 2001, OCEAN COAST MANAGE, V44, P39, DOI 10.1016/S0964-5691(00)00084-3; Seekings PJ, 2010, OC 10 IEEE SYDN NSW, P1, DOI DOI 10.1109/OCEANSSYD.2010.5603596; Simmonds M., 2002, CETACEAN HABITAT LOS; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Zimmer W. M. X., 2011, PASSIVE ACOUSTIC MON, DOI [10.1017/CBO9780511977107, DOI 10.1017/CB09780511977107]	50	15	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145362	10.1371/journal.pone.0145362	http://dx.doi.org/10.1371/journal.pone.0145362			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789265	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100009
J	Ezewuiro, O; Grushko, TA; Kocherginsky, M; Habis, M; Hurteau, JA; Mills, KA; Hunn, J; Olopade, OI; Fleming, GF; Romero, IL				Ezewuiro, Obiageli; Grushko, Tatyana A.; Kocherginsky, Masha; Habis, Mohammed; Hurteau, Jean A.; Mills, Kathryn A.; Hunn, Jessica; Olopade, Olufunmilayo I.; Fleming, Gini F.; Romero, Iris L.			Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy	PLOS ONE			English	Article							MORTALITY; PROLIFERATION; OVERWEIGHT; OBESITY; CELLS; RISK	There is increasing evidence that metformin, a commonly used treatment for diabetes, might have the potential to be repurposed as an economical and safe cancer therapeutic. The aim of this study was to determine whether stage III-IV or recurrent endometrial cancer patients who are using metformin during treatment with chemotherapy have improved survival. To test this we analyzed a retrospective cohort of subjects at two independent institutions who received chemotherapy for stage III-IV or recurrent endometrial cancer from 1992 to 2011. Diagnosis of diabetes, metformin use, demographics, endometrial cancer clinicopathologic parameters, and survival duration were abstracted. The primary outcome was overall survival. The final cohort included 349 patients, 31 (8.9%) had diabetes and used metformin, 28 (8.0%) had diabetes but did not use metformin, and 291 (83.4%) did not have diabetes. The results demonstrate that the median overall survival was 45.6 months for patients with diabetes who used metformin compared to 12.5 months for patients with diabetes who did not use metformin and 28.5 months for patients without diabetes (log-rank test comparing the three groups P = 0.006). In a model adjusted for confounders, the difference in survival between the three groups remained statistically significant (P = 0.023). The improvement in survival among metformin users was not explained by better baseline health status or more aggressive use of chemotherapy. Overall, the findings in this retrospective cohort of endometrial cancer patients with stage III-IV or recurrent disease treated with chemotherapy indicate that patients with diabetes who were concurrently treated with metformin survived longer than patients with diabetes who did not use metformin.	[Ezewuiro, Obiageli; Grushko, Tatyana A.; Olopade, Olufunmilayo I.; Fleming, Gini F.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kocherginsky, Masha] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Habis, Mohammed; Mills, Kathryn A.; Hunn, Jessica; Romero, Iris L.] Univ Chicago, Dept Obstet & Gynecol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Hurteau, Jean A.] NorthShore Univ Hlth Syst, Dept Obstet & Gynecol, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; NorthShore University Health System	Romero, IL (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA.	iromero@uchicago.edu	Romero, Iris/N-8451-2018	Romero, Iris/0000-0001-5849-5024	National Cancer Institute [NCI P50 CA136393, NCI T32 CA009566, NCI K12 CA139160]; CTSA-ITM CS [UL1 RR024999]; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [2K12HD000849-26]; Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center [NCI CA014599]; Entertainment Industry Foundation National Women's Cancer Research Alliance Program; American Board of Obstetrics and Gynecology; Biological Sciences Division; Institute for Translational Medicine, CTSA from the National Institutes of Health [UL1 TR000430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014599, P50CA136393, T32CA009566, K12CA139160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA-ITM CS; National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center; Entertainment Industry Foundation National Women's Cancer Research Alliance Program; American Board of Obstetrics and Gynecology; Biological Sciences Division; Institute for Translational Medicine, CTSA from the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is supported by grants from the National Cancer Institute NCI P50 CA136393 (GF and ILR), NCI T32 CA009566 (OE), NCI K12 CA139160 (TAG), CTSA-ITM CS UL1 RR024999 (TAG), National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (2K12HD000849-26) (ILR), Biostatistics Core Facility of the University of Chicago Medicine Comprehensive Cancer Center (NCI CA014599), Entertainment Industry Foundation National Women's Cancer Research Alliance Program (OIO), and American Board of Obstetrics and Gynecology (ILR). The REDCap project at the University of Chicago is hosted and managed by the Center for Research Informatics and funded by the Biological Sciences Division and by the Institute for Translational Medicine, CTSA grant number UL1 TR000430 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Febbraro T, 2014, GYNECOL ONCOL, V135, P614, DOI 10.1016/j.ygyno.2014.10.011; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Iglesias DA, 2013, MOL CANCER THER, V12, P2847, DOI 10.1158/1535-7163.MCT-13-0439; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Liao CY, 2014, GYNECOL ONCOL, V135, P163, DOI 10.1016/j.ygyno.2014.07.095; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Rutanen EM, 1998, GYNECOL ENDOCRINOL, V12, P399, DOI 10.3109/09513599809012842; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Schrauwen S, 2015, GYNECOL ONCOL, V138, P378, DOI 10.1016/j.ygyno.2015.06.006; Schuler KM, 2013, J CLIN ONCOL, V31; Soliman PT, 2013, SOC GYNECOLOGIC S15; Sterne J, 1957, MAROC MED, V36, P1295; Stine JE, 2014, OBSTET GYNECOL SURV, V69, P477, DOI 10.1097/OGX.0000000000000092; Zhang YY, 2014, INT J BIOL MARKER, V29, pE21, DOI 10.5301/jbm.5000047; Zhang ZB, 2011, INT J GYNECOL CANCER, V21, P213, DOI 10.1097/IGC.0b013e318207dac7	32	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147145	10.1371/journal.pone.0147145	http://dx.doi.org/10.1371/journal.pone.0147145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788855	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100061
J	Lal, D; Neubauer, BA; Toliat, MR; Altmuller, J; Thiele, H; Nurnberg, P; Kamrath, C; Schaenzer, A; Sander, T; Hahn, A; Nothnagel, M				Lal, Dennis; Neubauer, Bernd A.; Toliat, Mohammad R.; Altmueller, Janine; Thiele, Holger; Nuernberg, Peter; Kamrath, Clemens; Schaenzer, Anne; Sander, Thomas; Hahn, Andreas; Nothnagel, Michael			Increased Probability of Co-Occurrence of Two Rare Diseases in Consanguineous Families and Resolution of a Complex Phenotype by Next Generation Sequencing	PLOS ONE			English	Article							SELENOPROTEIN-N GENE; HYPOPHOSPHATEMIC RICKETS; CYSTIC-FIBROSIS; MUSCULAR-DYSTROPHY; LINKAGE ANALYSIS; MUTATIONS; MYOPATHIES; DISORDERS; SEPN1; HYPERCALCIURIA	Massively parallel sequencing of whole genomes and exomes has facilitated a direct assessment of causative genetic variation, now enabling the identification of genetic factors involved in rare diseases (RD) with Mendelian inheritance patterns on an almost routine basis. Here, we describe the illustrative case of a single consanguineous family where this strategy suffered from the difficulty to distinguish between two etiologically distinct disorders, namely the co-occurrence of hereditary hypophosphatemic rickets (HRR) and congenital myopathies (CM), by their phenotypic manifestation alone. We used parametric linkage analysis, homozygosity mapping and whole exome-sequencing to identify mutations underlying HRR and CM. We also present an approximate approach for assessing the probability of co-occurrence of two unlinked recessive RD in a single family as a function of the degree of consanguinity and the frequency of the disease-causing alleles. Linkage analysis and homozygosity mapping yielded elusive results when assuming a single RD, but whole-exome sequencing helped to identify two mutations in two genes, namely SLC34A3 and SEPN1, that segregated independently in this family and that have previously been linked to two etiologically different diseases. We assess the increase in chance co-occurrence of rare diseases due to consanguinity, i.e. under circumstances that generally favor linkage mapping of recessive disease, and show that this probability can increase by several orders of magnitudes. We conclude that such potential co-occurrence represents an underestimated risk when analyzing rare or undefined diseases in consanguineous families and should be given more consideration in the clinical and genetic evaluation.	[Lal, Dennis; Toliat, Mohammad R.; Altmueller, Janine; Thiele, Holger; Nuernberg, Peter; Sander, Thomas; Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Lal, Dennis; Neubauer, Bernd A.; Hahn, Andreas] Univ Med Fac Giessen & Marburg, Dept Neuropediat, D-35392 Giessen, Germany; [Lal, Dennis; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kamrath, Clemens] Univ Med Fac Giessen, Dept Pediat, D-35392 Giessen, Germany; [Schaenzer, Anne] Univ Med Fac Giessen & Marburg, Inst Neuropathol, D-35392 Giessen, Germany	University of Cologne; University Hospital of Giessen & Marburg; University of Cologne; University of Cologne; University Hospital of Giessen & Marburg	Lal, D; Nothnagel, M (corresponding author), Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany.; Lal, D (corresponding author), Univ Med Fac Giessen & Marburg, Dept Neuropediat, D-35392 Giessen, Germany.; Lal, D (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	Dennis.Lal@uni-koeln.de; michael.nothnagel@uni-koeln.de	Nothnagel, Michael/L-7187-2019; Kamrath, Clemens/GWR-0507-2022; Nothnagel, Michael/G-6545-2014; Thiele, Holger/ABE-6792-2020; Neubauer, Bernd/AAZ-9391-2020	Nothnagel, Michael/0000-0001-8305-7114; Kamrath, Clemens/0000-0002-8241-4105; Thiele, Holger/0000-0002-0169-998X; Altmuller, Janine/0000-0003-4372-1521				Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Benayoun L, 2009, AM J MED GENET A, V149A, P650, DOI 10.1002/ajmg.a.32634; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Clarke NF, 2006, ANN NEUROL, V59, P546, DOI 10.1002/ana.20761; Ferreiro A, 2004, ANN NEUROL, V55, P676, DOI 10.1002/ana.20077; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Frishberg Y, 2007, GENET MED, V9, P180, DOI 10.1097/GIM.0b013e318031c7de; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Hoefsloot LH, 2014, CLIN GENET, V85, P514, DOI 10.1111/cge.12339; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Jungbluth H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-31; Kremke B, 2009, EXP CLIN ENDOCR DIAB, V117, P49, DOI 10.1055/s-2008-1076716; Laing NG, 2012, CRIT REV CL LAB SCI, V49, P33, DOI 10.3109/10408363.2012.658906; Lezirovitz K, 2008, EUR J HUM GENET, V16, P89, DOI 10.1038/sj.ejhg.5201917; Marin S, 2012, HORM RES PAEDIAT, V77, P63, DOI 10.1159/000335235; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Nigro V, 2011, CURR OPIN NEUROL, V24, P429, DOI 10.1097/WCO.0b013e32834aa38d; OBER C, 1987, AM J HUM GENET, V41, P1145; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schara U, 2008, EUR J PAEDIATR NEURO, V12, P224, DOI 10.1016/j.ejpn.2007.08.011; SCHMIDTKE J, 1987, HUM GENET, V76, P337, DOI 10.1007/BF00272441; Scoto M, 2011, NEUROLOGY, V76, P2073, DOI 10.1212/WNL.0b013e31821f467c; Seelow D, 2012, NUCLEIC ACIDS RES, V40, pW516, DOI 10.1093/nar/gks487; Silberstein M, 2013, BIOINFORMATICS, V29, P197, DOI 10.1093/bioinformatics/bts658; Tajsharghi H, 2005, NEUROMUSCULAR DISORD, V15, P299, DOI 10.1016/j.nmd.2004.11.004; Veilleux LN, 2012, J CLIN ENDOCR METAB, V97, pE1492, DOI 10.1210/jc.2012-1336; Ward LM, 2004, BONE, V34, P905, DOI 10.1016/j.bone.2003.12.025; WATKINS PC, 1986, AM J HUM GENET, V39, P735; Weeks DE, 1998, AM J HUM GENET, V62, P728; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	38	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146040	10.1371/journal.pone.0146040	http://dx.doi.org/10.1371/journal.pone.0146040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789268	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100023
J	Reisland, MA; Lambert, JE				Reisland, Melissa Ann; Lambert, Joanna E.			Sympatric Apes in Sacred Forests: Shared Space and Habitat Use by Humans and Endangered Javan Gibbons (Hylobates moloch)	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; PREDATION RISK; GORILLA GROUP; DISTURBANCE; ECOTOURISM; CONSEQUENCES; CONSERVATION; POPULATION; IMPACTS; ECOLOGY	In this research, we use a combination of ethnographic observation and GIS analysis to explore the use of space by humans and gibbons (Hylobates moloch) to determine areas of potential space competition in the sacred forest and nature reserve Cagar Alam Leuweung Sancang in West Java, Indonesia. More specifically, we test whether gibbons respond to the presence of humans in a manner consistent with predator-avoidance and predicted that the gibbon study subjects would avoid areas visited by humans (Risk-Disturbance Hypothesis). Data were collected August 2010-June 2011. We collected GPS locations and behavioral data on both the humans (6,652 hours) and the gibbons (1,253 hours) in the forest using 10 minute instantaneous sampling. Results indicate that humans preferentially assemble at the most sacred spot in the forest (Cikajayaan waterfall). Two gibbon groups' home ranges encompassed most of the sacred areas. Group B avoided areas of high human use, as high human use areas and high gibbon use areas did not overlap. Group C, though, continued to use areas that were heavily visited by humans. We thus found partial support for the Risk-Disturbance Hypothesis, although the variation in gibbon response to human disturbance indicates behavioral flexibility. We suggest that understanding the effects of shared space on wildlife is necessary for informing conservation policy in human-visited forests.	[Reisland, Melissa Ann] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Reisland, Melissa Ann; Lambert, Joanna E.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder	Reisland, MA (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA.; Reisland, MA (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.	melissa.reisland@colorado.edu			Fulbright Institute of International Education; Primate Conservation, Inc. (PCI) [879]; International Primatological Society	Fulbright Institute of International Education; Primate Conservation, Inc. (PCI); International Primatological Society	This study was funded by a fellowship from the Fulbright Institute of International Education (http://www.iie.org/fulbright), a conservation grant from Primate Conservation, Inc. (PCI #879; http://www.primate.org), and a conservation grant from International Primatological Society (http://www.internationalprimatologicalsociety.org). All funds were awarded to MAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; ARCGis Help, 2012, ARCGIS DESKT HELP ME; Brown Joel S., 2007, P437; Buckley R., 2004, Environmental impacts of ecotourism, P211, DOI 10.1079/9780851998107.0211; Cipolletta C, 2003, INT J PRIMATOL, V24, P1207, DOI 10.1023/B:IJOP.0000005988.52177.45; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Constantine R, 2001, MAR MAMMAL SCI, V17, P689, DOI 10.1111/j.1748-7692.2001.tb01293.x; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P1, DOI 10.1007/978-4-431-87771-4; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P65, DOI 10.1007/978-4-431-87771-4_4; de la Torre S, 2000, BIOL CONSERV, V94, P153, DOI 10.1016/S0006-3207(99)00183-4; DORRANCE MJ, 1975, J WILDLIFE MANAGE, V39, P563, DOI 10.2307/3800399; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Dudek G., 2000, COMPUTATIONAL PRINCI; EDWARDS J, 1983, OECOLOGIA, V60, P185, DOI 10.1007/BF00379520; Frid A, 2002, CONSERV ECOL, V6; Fuentes A, 2012, ANNU REV ANTHROPOL, V41, P101, DOI 10.1146/annurev-anthro-092611-145808; Gander H, 1997, BIOL CONSERV, V79, P107, DOI 10.1016/S0006-3207(96)00102-4; Geertz Cliffod, 1963, AGR INVOLUTION; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gill Jennifer A., 2000, Conservation Biology Series (Cambridge), V2, P51; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Grossberg R, 2003, ENVIRON CONSERV, V30, P40, DOI 10.1017/S0376892903000031; Guillemain M, 2007, BIODIVERS CONSERV, V16, P3633, DOI 10.1007/s10531-007-9160-z; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurmaya KJ, 1995, PRIMATE SURV POPULAT, P1; HAINESYOUNG R, 1993, LANDSCAPE ECOLOGY GE; Higginbottom K., 2004, WILDLIFE TOURISM IMP; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; HUNSAKER C, 2001, SPATIAL UNCERTAINTY; Kappeler M., 1984, P19; Kappeler M., 1981, THESIS U BASEL BASEL; Kim S, 2011, AM J PRIMATOL, V73, P270, DOI 10.1002/ajp.20893; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; KOOL K M, 1992, Oryx, V26, P29; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Lafferty KD, 2001, BIOL CONSERV, V101, P315, DOI 10.1016/S0006-3207(01)00075-1; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindquist G., 2000, NATURAL ENEMIES PEOP, P170; Lord A, 1997, BIOL CONSERV, V82, P15, DOI 10.1016/S0006-3207(97)00013-X; LOTT DF, 1995, BIOL CONSERV, V73, P23, DOI 10.1016/0006-3207(95)90053-5; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Malone N.M., 2007, THESIS U OREGON EUGE; Malone N, 2012, AM J PHYS ANTHROPOL, V147, P202; Malone Nicholas, 2009, P241, DOI 10.1007/978-0-387-88604-6_12; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; Norman A, 2012, LIT AESTHET, V22, P20; Paterson J. D., 2005, COMMENSALISM CONFLIC, V4; Pelletier F., 2006, Ibex Journal of Mountain Ecology, V8, P15; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reimers E, 2009, J WILDLIFE MANAGE, V73, P844, DOI 10.2193/2008-133; Reisland MAR, 2013, THESIS U WISCONSIN M; Rinaldi D, 1999, THESIS U GEORG AUGUS; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; Strier KB, 2010, AM J PRIMATOL, V72, P772, DOI 10.1002/ajp.20830; Supriatna Jatna, 2006, Primate Conservation, V21, P155, DOI 10.1896/0898-6207.21.1.155; Supriatna J, 2010, DEV PRIMATOL-PROG PR, P57, DOI 10.1007/978-1-4419-1560-3_5; Tabacow FP, 2009, AM ANTHROPOL, V111, P238, DOI 10.1111/j.1548-1433.2009.01116.x; Tilman David, 1997, Monographs in Population Biology, V30, P233; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Treves A., 2005, COMMENSALISM CONFLIC, P146; WESSING R, 1993, J SOUTHE ASIAN STUD, V24, P1, DOI 10.1017/S002246340000148X; Wolf ID, 2010, APPL ANIM BEHAV SCI, V126, P75, DOI 10.1016/j.applanim.2010.06.001	67	12	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146891	10.1371/journal.pone.0146891	http://dx.doi.org/10.1371/journal.pone.0146891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790025	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100043
J	Belgrad, BA; Griffen, BD				Belgrad, Benjamin A.; Griffen, Blaine D.			The Influence of Diet Composition on Fitness of the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; CHASMAGNATHUS-GRANULATA DANA; ULVA-LACTUCA L; ESTUARINE CRAB; POPULATION-DYNAMICS; PREY-SIZE; EGG SIZE; PREDATOR; RATHBUN; PESTICIDES	The physiological condition and fecundity of an organism is frequently controlled by diet. As changes in environmental conditions often cause organisms to alter their foraging behavior, a comprehensive understanding of how diet influences the fitness of an individual is central to predicting the effect of environmental change on population dynamics. We experimentally manipulated the diet of the economically and ecologically important blue crab, Callinectes sapidus, to approximate the effects of a dietary shift from primarily animal to plant tissue, a phenomenon commonly documented in crabs. Crabs whose diet consisted exclusively of animal tissue had markedly lower mortality and consumed substantially more food than crabs whose diet consisted exclusively of seaweed. The quantity of food consumed had a significant positive influence on reproductive effort and long-term energy stores. Additionally, seaweed diets produced a three-fold decrease in hepatopancreas lipid content and a simultaneous two-fold increase in crab aggression when compared to an animal diet. Our results reveal that the consumption of animal tissue substantially enhanced C. sapidus fitness, and suggest that a dietary shift to plant tissue may reduce crab population growth by decreasing fecundity as well as increasing mortality. This study has implications for C. sapidus fisheries.	[Belgrad, Benjamin A.; Griffen, Blaine D.] Univ S Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA; [Griffen, Blaine D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Belgrad, BA (corresponding author), Univ S Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA.	babelgra@eckerd.edu	Belgrad, Benjamin/AAH-2153-2021; Griffen, Blaine/AAC-6384-2021	Belgrad, Benjamin/0000-0003-2032-2210; 	National Science Foundation grant (NSF) [OCE-1129166]; University of South Carolina fellowship; Ohio Mayflower Society scholarship	National Science Foundation grant (NSF)(National Science Foundation (NSF)); University of South Carolina fellowship; Ohio Mayflower Society scholarship	This work was supported by a National Science Foundation grant to BG (NSF # OCE-1129166), a University of South Carolina fellowship to BB, and an Ohio Mayflower Society scholarship to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD WS, 1984, J EXP MAR BIOL ECOL, V80, P207, DOI 10.1016/0022-0981(84)90150-3; BAGENAL TB, 1969, J FISH BIOL, V1, P349, DOI 10.1111/j.1095-8649.1969.tb03882.x; Bergen BJ, 2001, ENVIRON TOXICOL CHEM, V20, P575, DOI 10.1002/etc.5620200317; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P47, DOI 10.1016/0022-0981(82)90175-7; Boucard CGV, 2004, AQUACULTURE, V236, P523, DOI 10.1016/j.aquaculture.2003.09.048; CAREW LB, 1964, J NUTR, V83, P300, DOI 10.1093/jn/83.4.300; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Darnell MZ, 2009, MAR ECOL PROG SER, V394, P153, DOI 10.3354/meps08295; Davis AM, 2011, J FISH BIOL, V78, P265, DOI 10.1111/j.1095-8649.2010.02862.x; Decker Mary Beth, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P425; Dickinson GH, 2006, B MAR SCI, V79, P273; Dissanayake A, 2010, MAR ENVIRON RES, V70, P368, DOI 10.1016/j.marenvres.2010.07.004; Dittel AI, 2006, HYDROBIOLOGIA, V568, P379, DOI 10.1007/s10750-006-0204-2; Doughty P, 1997, OECOLOGIA, V110, P508, DOI 10.1007/s004420050187; DUNN EH, 1975, AUK, V92, P553, DOI 10.2307/4084609; Duquesne S, 2010, ISR J ECOL EVOL, V56, P433, DOI 10.1560/IJEE.56.3-4.433; Eagles-Smith CA, 2008, ECOL APPL, V18, pA213, DOI 10.1890/06-1415.1; Fiorenza M., 1999, ECOL MONOGR, V67, P203; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Gimenez L, 2001, J EXP MAR BIOL ECOL, V260, P241, DOI 10.1016/S0022-0981(01)00258-1; Gimenez L, 2003, MAR ECOL PROG SER, V249, P251, DOI 10.3354/meps249251; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Griffen BD, 2015, BIOL INVASIONS, V17, P2533, DOI 10.1007/s10530-015-0890-7; Griffen BD, 2015, ECOL EVOL, V5, P1474, DOI 10.1002/ece3.1427; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; Griffen BD, 2011, J ANIM ECOL, V80, P854, DOI 10.1111/j.1365-2656.2011.01832.x; GUTHRIE RK, 1979, B ENVIRON CONTAM TOX, V21, P53, DOI 10.1007/BF01685385; Hanlon SM, 2013, COPEIA, P691, DOI 10.1643/CE-13-019; Hartnoll RG, 2006, HYDROBIOLOGIA, V557, P31, DOI 10.1007/s10750-005-9305-6; HAZLETT B. A., 1975, CRUSTACEANA, V28, P11, DOI DOI 10.1163/156854075X00801; Herbreteau F, 1997, BOT MAR, V40, P25, DOI 10.1515/botm.1997.40.1-6.25; Hines AH, 2007, BLUE CRAB CALLINECTE, P565; JOHNSON DA, 1985, J EXP MAR BIOL ECOL, V86, P73, DOI 10.1016/0022-0981(85)90043-7; Jorgensen HB, 1997, PEDOBIOLOGIA, V41, P307; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kelly DW, 2005, FRESHWATER BIOL, V50, P127, DOI 10.1111/j.1365-2427.2004.01315.x; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; KUCHARSKI LCR, 1991, COMP BIOCHEM PHYS A, V99, P215, DOI 10.1016/0300-9629(91)90261-A; LAUGHLIN RA, 1982, B MAR SCI, V32, P807; Leopoldo J, 2010, AQUACULTURE, V310, P84, DOI 10.1016/j.aquaculture.2010.09.038; Linton SM, 2007, J COMP PHYSIOL B, V177, P269, DOI 10.1007/s00360-006-0138-z; LITTLE EE, 1990, ARCH ENVIRON CON TOX, V19, P380, DOI 10.1007/BF01054982; Lucifora LO, 2009, ECOL RES, V24, P109, DOI 10.1007/s11284-008-0487-z; Macneale KH, 2010, FRONT ECOL ENVIRON, V8, P475, DOI 10.1890/090142; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McBride MM, 2014, ICES J MAR SCI, V71, P1934, DOI 10.1093/icesjms/fsu002; McKinney RA, 2004, WILDLIFE BIOL, V10, P241, DOI 10.2981/wlb.2004.029; MICHELI F, 1995, J ANIM ECOL, V64, P63, DOI 10.2307/5827; Millikin MR, 1984, FAO FISH SYNOP, V138, P1; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Montevecchi WA, 1997, ICES J MAR SCI, V54, P608, DOI 10.1006/jmsc.1997.0265; NMFS, 2013, FISH US 2012; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; PARVATHY K, 1971, MAR BIOL, V10, P82, DOI 10.1007/BF02026770; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pickova J, 1997, CAN J FISH AQUAT SCI, V54, P2410, DOI 10.1139/cjfas-54-10-2410; Rathbun R., 1884, FISHERIES FISHERY 5, P775; Rathbun R., 1887, FISHERIES FISHERY IN, VII, P629; Reichmuth JM, 2011, HYDROBIOLOGIA, V658, P173, DOI 10.1007/s10750-010-0460-z; Reichmuth JM, 2009, ESTUAR COAST, V32, P298, DOI 10.1007/s12237-008-9130-z; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; Rosalino LM, 2005, MAMM BIOL, V70, P12, DOI 10.1078/1616-5047-00172; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Saric MM, 2002, BIOMETALS, V15, P175, DOI 10.1023/A:1015212929481; Shields JD, 2011, J INVERTEBR PATHOL, V106, P79, DOI 10.1016/j.jip.2010.09.015; Shpigel M, 1999, J SHELLFISH RES, V18, P227; Simpson S.J., 1990, P111; Simpson S.J., 1995, P251; Sinn DL, 2010, BEHAV ECOL SOCIOBIOL, V64, P693, DOI 10.1007/s00265-009-0887-2; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stocker AM, 2001, ETHOLOGY, V107, P727, DOI 10.1046/j.1439-0310.2001.00705.x; Undeland I, 1998, FOOD CHEM, V61, P355, DOI 10.1016/S0308-8146(97)00053-8; Vinoj Kumar V., 2007, J MAR BIOL ASSOC IND, V49, P35; VIRNSTEIN RW, 1977, ECOLOGY, V58, P1199, DOI 10.2307/1935076; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Weis JS, 2001, BIOSCIENCE, V51, P209, DOI 10.1641/0006-3568(2001)051[0209:EOCOBB]2.0.CO;2; WILLIAMS AB, 1974, FISH B-NOAA, V72, P685; WOLCOTT DL, 1992, AM ZOOL, V32, P370; XU XL, 1994, AQUACULTURE, V119, P359, DOI 10.1016/0044-8486(94)90300-X; Zhang L, 2009, BBA-MOL BASIS DIS, V1792, P417, DOI 10.1016/j.bbadis.2008.09.006; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012	87	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145481	10.1371/journal.pone.0145481	http://dx.doi.org/10.1371/journal.pone.0145481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784581	Green Published, gold			2022-12-27	WOS:000368528400013
J	Kang, SH; Choi, EW; Park, JW; Cho, KH; Do, JY				Kang, Seok Hui; Choi, Eun Woo; Park, Jong Won; Cho, Kyu Hyang; Do, Jun Young			Clinical Significance of the Edema Index in Incident Peritoneal Dialysis Patients	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; EXTRACELLULAR FLUID VOLUME; HEMODIALYSIS-PATIENTS; BODY-COMPOSITION; SODIUM REMOVAL; BLOOD-PRESSURE; ULTRAFILTRATION; DECLINE; CAPD; PREDICTORS	Background Proper monitoring for volume overload is important to improve prognosis in peritoneal dialysis (PD) patients. The association between volume status and residual renal function (RRF) remains an unresolved issue. The aim of the present study was to evaluate the association between the edema index and survival or RRF in incident PD patients. Patients and Methods We identified all adults who underwent PD. The edema index was defined as the ratio of extracellular fluid to total body fluid. Participants with available data regarding survivorship or non-survivorship during the first year after PD initiation were included in the area under the receiver operating characteristic curve analysis. The cutoff value of the edema index for 1-year mortality was >0.371 in men and >0.372 in women. Participants were divided into two groups according to the cutoff value of their baseline edema indices: High (>cutoff value) and Low (<= cutoff value). Survivors during the first year after PD initiation were divided into two groups according to the initial and 1-year edema index: Non-improvement (maintenance of criteria in the initial Low group during the year) and Other (all participants except those in the Non-improvement group). Results In total, 631 patients were enrolled in the present study. The cutoff value of the edema index for 1-year mortality was >0.371 in men and >0.372 in women. The respective mean initial RRF values (mL.min(-1).1.73 m(-2)) in the Low and High groups, respectively, were 4.88 +/- 4.09 and 4.21 +/- 3.28 in men (P = 0.108), and 3.19 +/- 2.57 and 2.98 +/- 2.70 in women (P = 0.531). There were no significant differences between groups in either sex. The respective mean RRF values at 1 year after PD initiation in the Low and High groups, respectively, were 3.56 +/- 4.35 and 2.73 +/- 2.53 in men, and 2.80 +/- 2.36 and 1.85 +/- 1.51 in women. RRF at 1 year after PD initiation was higher in the Low group than in the High group (men: P = 0.027; women: P = 0.001). In men, the cumulative 5-year survival rates were 78.7% and 46.2% in the Low and High groups, respectively, whereas in women, rates were 77.2% and 58.8% in the Low and High groups, respectively. For survivors during the first year after PD initiation, the Non-improvement group was associated with a poor survival rate compared with the Other group for both sexes. Conclusion A high edema index was associated with mortality in incident PD patients at baseline and follow-up. The edema index may be used as a new marker for predicting mortality in PD patients.	[Kang, Seok Hui; Choi, Eun Woo; Park, Jong Won; Cho, Kyu Hyang; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr	Barretti, Pasqual/AAK-7934-2021; Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Barretti, Pasqual/0000-0003-4979-4836	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asci G, 2006, PERITON DIALYSIS INT, V26, P85; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Castillo AA, 2002, AM J KIDNEY DIS, V40, P1301, DOI 10.1053/ajkd.2002.36907; Chamney PW, 2002, KIDNEY INT, V61, P2250, DOI 10.1046/j.1523-1755.2002.00377.x; Charra B, 1996, AM J NEPHROL, V16, P35, DOI 10.1159/000168968; Cheng LT, 2008, PERITON DIALYSIS INT, V28, P397; Cheng LT, 2005, AM J KIDNEY DIS, V45, P891, DOI 10.1053/j.ajkd.2005.01.037; Davies SJ, 2002, NEPHROL DIAL TRANSPL, V17, P1085, DOI 10.1093/ndt/17.6.1085; Dou YN, 2012, SEMIN DIALYSIS, V25, P377, DOI 10.1111/j.1525-139X.2012.01095.x; Dumler F, 2003, ASAIO J, V49, P282, DOI 10.1097/01.MAT.0000065465.52748.BB; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Gao N, 2011, CLIN NEPHROL, V76, P16, DOI 10.5414/CN106896; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gunal AI, 2001, AM J KIDNEY DIS, V37, P588, DOI 10.1053/ajkd.2001.22085; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Hufnagel C, 1999, NEPHROL DIAL TRANSPL, V14, P1224, DOI 10.1093/ndt/14.5.1224; Hur SM, 2014, KOREAN J INTERN MED, V29, P489, DOI 10.3904/kjim.2014.29.4.489; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Jones CH, 2002, AM J KIDNEY DIS, V39, P872, DOI 10.1053/ajkd.2002.32010; Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Kawaguchi Y, 1997, KIDNEY INT, V52, pS105; Koc M, 2002, NEPHROL DIAL TRANSPL, V17, P1661, DOI 10.1093/ndt/17.9.1661; Koh ES, 2015, AM J NEPHROL, V42, P91, DOI 10.1159/000439060; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Lee SW, 2003, AM J KIDNEY DIS, V41, P1257, DOI 10.1016/S0272-6386(03)00358-5; Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Lu YH, 2015, PERITON DIALYSIS INT, V35, P172, DOI 10.3747/pdi.2013.00060; Lysaght M J, 1991, ASAIO Trans, V37, P598; Mandelbaum A, 1996, NEPHROL DIAL TRANSPL, V11, P24; Mujais S, 2000, PERITON DIALYSIS INT, V20, pS5; Mujais S., 2009, NOLPH GOKALS TXB PER, V3, P505, DOI [10.1007/978-0-387-78940-8_17, DOI 10.1007/978-0-387-78940-8_17]; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Papakrivopoulou E, 2012, NEPHROL DIAL TRANSPL, V27, P396, DOI 10.1093/ndt/gfr338; *PER DIAL AD WORK, 2006, AM J KIDNEY DIS S, V48, pS98; Rodriguez-Carmona A, 2004, AM J KIDNEY DIS, V44, P132, DOI 10.1053/j.ajkd.2004.03.035; Rodriguez-Carmona A, 2002, PERITON DIALYSIS INT, V22, P705; Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049; Smit W, 2004, PERITON DIALYSIS INT, V24, P562; US Renal Data System, 2013, USRDS 2013 ANN DAT R; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Wilson B, 2004, HEMODIAL INT, V11, P263; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS143; Wright S, 2010, CLIN J AM SOC NEPHRO, V5, P1828, DOI 10.2215/CJN.06230909; Yonova C, 2004, Minerva Urol Nefrol, V56, P367	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147070	10.1371/journal.pone.0147070	http://dx.doi.org/10.1371/journal.pone.0147070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785259	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400105
J	Li, L; Jiang, YX; Lao, SH; Yang, BY; Yu, SF; Zhang, YN; Wu, CY				Li, Li; Jiang, Yuxia; Lao, Suihua; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou			Mycobacterium tuberculosis-Specific IL-21(+)IFN-gamma(+)CD4(+) T Cells Are Regulated by IL-12	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; FOLLICULAR HELPER; IL-21 RECEPTOR; NKT CELLS; B-CELLS; DIFFERENTIATION; INTERLEUKIN-21; MECHANISMS; RESPONSES; CD4(+)	In the current study of Mycobacterium tuberculosis (MTB)-specific T and B cells, we found that MTB-specific peptides from early secreted antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) induced the expression of IL-21 predominantly in CD4(+) T cells. A fraction of IL-21-expressing CD4(+) T cells simultaneously expressed Th1 cytokines but did not secrete Th2 or Th17 cytokines, suggesting that MTB-specific IL-21-expressing CD4(+) T cells were different from Th1, Th2 and Th17 subpopulations. The majority of MTB-specific IL-21-expressing CD4+ T cells co-expressed IFN-gamma and IL-21+ IFN-gamma(+) CD4(+) T cells exhibited obviously polyfunctionality. In addition, MTB-specific IL-21-expressing CD4(+) T cells displayed a CD45RO(+)CD62L(low)CCR7(low)CD40L(high)ICOS(high) phenotype. Bcl-6-expression was significantly higher in IL-21-expressing CD4(+) T cells than IL-21-CD4(+) T cells. Moreover, IL12 could up-regulate MTB-specific IL-21 expression, especially the frequency of IL-21+ IFN-gamma(+) CD4(+) T cells. Taken together, our results demonstrated that MTB-specific IL-21+ IFN-gamma(+)CD4(+) T cells from local sites of tuberculosis (TB) infection could be enhanced by IL-12, which have the features of both Tfh and Th1 cells and may have an important role in local immune responses against TB infection.	[Li, Li; Jiang, Yuxia; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou] Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Li, Li] Wuhan Pulm Hosp, Wuhan Inst TB Control, Wuhan, Peoples R China; [Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Natural Science Foundation of China [31270942]; Natural Science Foundation of Guangdong Province [S2012010009159]; Hubei Provincial Natural Science Foundation of China [2015CFB255]; Program of China during the Twelfth Five-Year Plan Period [2013ZX10003007-002-003]	Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of China during the Twelfth Five-Year Plan Period	This study was funded by grants from Guangdong Recruitment Program of Creative Research Groups (no. 2009010058), the National Natural Science Foundation of China (no. 31270942), the Natural Science Foundation of Guangdong Province (no. S2012010009159), Hubei Provincial Natural Science Foundation of China (no. 2015CFB255), and the Program of China during the Twelfth Five-Year Plan Period (no. 2013ZX10003007-002-003).	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chen MG, 2012, CELL MOL IMMUNOL, V9, P375, DOI 10.1038/cmi.2012.18; Collins M, 2003, IMMUNOL RES, V28, P131, DOI 10.1385/IR:28:2:131; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cummings KJ, 2007, PUBLIC HEALTH REP, V122, P683, DOI 10.1177/003335490712200517; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Habib T, 2003, J ALLERGY CLIN IMMUN, V112, P1033, DOI 10.1016/j.jaci.2003.08.039; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Iannello A, 2010, J IMMUNOL, V184, P114, DOI 10.4049/jimmunol.0901967; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111098; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082196; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Qiao D, 2011, INFECT IMMUN, V79, P3358, DOI 10.1128/IAI.00014-11; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Williams LD, 2014, J VIROL, V88, P10259, DOI 10.1128/JVI.00764-14; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Wu CY, 2015, ONCOTARGET, V6, P28633, DOI 10.18632/oncotarget.5764; Xiao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12781; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	47	20	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147356	10.1371/journal.pone.0147356	http://dx.doi.org/10.1371/journal.pone.0147356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785168	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400140
J	Tseliou, E; Kanazawa, H; Dawkins, J; Gallet, R; Kreke, M; Smith, R; Middleton, R; Valle, J; Marban, L; Kar, S; Makkar, R; Marban, E				Tseliou, Eleni; Kanazawa, Hideaki; Dawkins, James; Gallet, Romain; Kreke, Michelle; Smith, Rachel; Middleton, Ryan; Valle, Jackelyn; Marban, Linda; Kar, Saibal; Makkar, Rajendra; Marban, Eduardo			Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology	PLOS ONE			English	Article							INTRAMYOCARDIAL INJECTION; CARDIAC REPAIR; INFARCTION; THERAPY; REGENERATION; TRANSPLANTATION; CARDIOSPHERES; ELEVATION; BIOMARKERS; EFFICACY	Single-vessel, intracoronary infusion of stem cells under stop-flow conditions has proven safe but achieves only limited myocardial coverage. Continuous flow intracoronary delivery to one or more coronary vessels may achieve broader coverage for treating cardiomyopathy, but has not been investigated. Using nonocclusive coronary guiding catheters, we infused allogeneic cardiosphere-derived cells (CDCs) either in a single vessel or sequentially in all three coronary arteries in porcine ischemic cardiomyopathy and used magnetic resonance imaging (MRI) to assess structural and physiological outcomes. Vehicle-infused animals served as controls. Single-vessel stop-flow and continuous-flow intracoronary infusion revealed equivalent effects on scar size and function. Sequential infusion into each of the three major coronary vessels under stop-flow or continuous-flow conditions revealed equal efficacy, but less elevation of necrotic biomarkers with continuous-flow delivery. In addition, multi-vessel delivery resulted in enhanced global and regional tissue function compared to a triple-vessel placebo-treated group. The functional benefits after global cell infusion were accompanied histologically by minimal inflammatory cellular infiltration, attenuated regional fibrosis and enhanced vessel density in the heart. Sequential multi-vessel non-occlusive delivery of CDCs is safe and provides enhanced preservation of left ventricular function and structure. The current findings provide preclinical validation of the delivery method currently undergoing clinical testing in the Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trial of CDCs in heart failure patients.	[Tseliou, Eleni; Dawkins, James; Gallet, Romain; Smith, Rachel; Middleton, Ryan; Valle, Jackelyn; Marban, Linda; Kar, Saibal; Makkar, Rajendra; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Kanazawa, Hideaki] Keio Univ, Sch Med, Tokyo, Japan; [Kreke, Michelle; Smith, Rachel; Marban, Linda; Marban, Eduardo] Capricor Inc, Los Angeles, CA USA	Cedars Sinai Medical Center; Keio University	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA USA.; Marban, E (corresponding author), Capricor Inc, Los Angeles, CA USA.	Eduardo.Marban@csmc.edu	Marban, Eduardo/GWC-8514-2022	Gallet, Romain/0000-0003-4595-509X	Cedars-Sinai Board of Governors Heart Stem Cell Center	Cedars-Sinai Board of Governors Heart Stem Cell Center	This work was supported by the Cedars-Sinai Board of Governors Heart Stem Cell Center. The Cedars-Sinai Board of Governors Heart Stem Cell Center provided support in the form of salaries for authors ET, HK, JD, JV, RM, RM, SK and EM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. RS, LM and MK are employed by Capricor Inc but did not participate in the funding of this study nor did they play a role in the study design, data collection, decision to publish, or preparation of the manuscript.	Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; Aminzadeh MA, 2015, EUR HEART J, V36, P751, DOI 10.1093/eurheartj/ehu196; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Baldazzi F, 2008, EUR HEART J, V29, P1819, DOI 10.1093/eurheartj/ehn233; Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9; Byrne MJ, 2007, J AM COLL CARDIOL, V50, P1484, DOI 10.1016/j.jacc.2007.07.011; Castillo E, 2005, J CARDIOVASC MAGN R, V7, P783, DOI 10.1080/10976640500295417; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Fasanaro P, 2015, CURR VASC PHARMACOL, V13, P305, DOI 10.2174/15701611113119990011; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Herbots L, 2009, EUR HEART J, V30, P662, DOI 10.1093/eurheartj/ehn532; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Houtgraaf JH, 2013, CIRC RES, V113, P153, DOI 10.1161/CIRCRESAHA.112.300730; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kali A, 2014, CIRC-CARDIOVASC IMAG, V7, P471, DOI 10.1161/CIRCIMAGING.113.001541; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Lara-Pezzi E, 2015, J CARDIOVASC TRANSL, V8, P3, DOI 10.1007/s12265-015-9606-8; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2014, EMBO MOL MED, V6, P760, DOI 10.1002/emmm.201303626; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2014, STEM CELL TRANSL MED, V3, P2, DOI 10.5966/sctm.2013-0104; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Povsic TJ, 2012, AM HEART J, V164, P689, DOI 10.1016/j.ahj.2012.06.022; Rasmussen TL, 2011, CIRCULATION, V123, P1771, DOI 10.1161/CIRCULATIONAHA.109.858019; Rosen MR, 2014, J AM COLL CARDIOL, V64, P922, DOI 10.1016/j.jacc.2014.06.1175; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Traverse JH, 2011, AM HEART J, V162, P671, DOI 10.1016/j.ahj.2011.06.019; Tseliou E, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0443-8; Tseliou E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088590; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805	48	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144523	10.1371/journal.pone.0144523	http://dx.doi.org/10.1371/journal.pone.0144523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784932	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400004
J	Xu, QQ; Jiang, YS; Wangkahart, E; Zou, J; Chang, MX; Yang, DQ; Secombes, CJ; Nie, P; Wang, TH				Xu, Qiaoqing; Jiang, Yousheng; Wangkahart, Eakapol; Zou, Jun; Chang, Mingxian; Yang, Daiqin; Secombes, Chris J.; Nie, Pin; Wang, Tiehui			Sequence and Expression Analysis of Interferon Regulatory Factor 10 (IRF10) in Three Diverse Teleost Fish Reveals Its Role in Antiviral Defense	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; IMMUNE-RESPONSES; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; GENE; BIOACTIVITY; MODULATION; PARALOGUES	Background Interferon regulatory factor (IRF) 10 was first found in birds and is present in the genome of other tetrapods (but not humans and mice), as well as in teleost fish. The functional role of IRF10 in vertebrate immunity is relatively unknown compared to IRF1-9. The target of this research was to clone and characterize the IRF10 genes in three economically important fish species that will facilitate future evaluation of this molecule in fish innate and adaptive immunity. Molecular Characterization of IRF10 in Three Fish Species In the present study, a single IRF10 gene was cloned in grass carp Ctenopharyngodon idella and Asian swamp eel Monopterus albus, and two, named IRF10a and IRF10b, in rain-bow trout Oncorhynchus mykiss. The fish IRF10 molecules share highest identities to other vertebrate IRF10s, and have a well conserved DNA binding domain, IRF-associated domain, and an 8 exon/7 intron structure with conserved intron phase. The presence of an upstream ATG or open reading frame (ORF) in the 5'-untranslated region of different fish IRF10 cDNA sequences suggests potential regulation at the translational level, and this has been verified by in vitro transcription/translation experiments of the trout IRF10a cDNA, but would still need to be validated in fish cells. Expression Analysis of IRF10 In Vivo and In Vitro Both trout IRF10 paralogues are highly expressed in thymus, blood and spleen but are relatively low in head kidney and caudal kidney. Trout IRF10b expression is significantly higher than IRF10a in integumentary tissues i.e. gills, scales, skin, intestine, adipose fin and tail fins, suggesting that IRF10b may be more important in mucosal immunity. The expression of both trout IRF10 paralogues is up-regulated by recombinant IFN-gamma. The expression of the IRF10 genes is highly induced by Poly I:C in vitro and in vivo, and by viral infection, but is less responsive to peptidoglycan and bacterial infection, suggesting an important role of fish IRF10 in antiviral defense.	[Xu, Qiaoqing; Yang, Daiqin] Yangtze Univ, Sch Anim Sci, Jingzhou 434025, Hubei Prov, Peoples R China; [Xu, Qiaoqing; Jiang, Yousheng; Wangkahart, Eakapol; Zou, Jun; Secombes, Chris J.; Wang, Tiehui] Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland; [Xu, Qiaoqing; Chang, Mingxian; Nie, Pin] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei Province, Peoples R China; [Jiang, Yousheng] Shanghai Ocean Univ, Coll Fishery & Life Sci, Shanghai 201306, Peoples R China	Yangtze University; University of Aberdeen; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Shanghai Ocean University	Wang, TH (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Scottish Fish Immunol Res Ctr, Aberdeen AB24 2TZ, Scotland.; Nie, P (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei Province, Peoples R China.	pinnie@ihb.ac.cn; t.h.wang@abdn.ac.uk	Wangkahart, Eakapol/AAM-5099-2020	nie, pin/0000-0002-9492-2940; Wang, Tiehui/0000-0002-1148-8959	National Natural Science Foundation of China [31101928]; National Science and Technology Support Program of China [2013BAD20B06]; State Key Laboratory of Freshwater Ecology and Biotechnology [2010FB02]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council [HR09011]; National Scholarship Council of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) - Scottish Funding Council; National Scholarship Council of China	This research was supported financially by the National Natural Science Foundation of China (31101928), the National Science and Technology Support Program of China (2013BAD20B06), the State Key Laboratory of Freshwater Ecology and Biotechnology (2010FB02) and the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) funded by the Scottish Funding Council (grant reference HR09011). Q.X. and Y.J. were supported financially by the National Scholarship Council of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported financially by the National Natural Science Foundation of China (31101928), the National Science and Technology Support Program of China (2013BAD20B06), the State Key Laboratory of Freshwater Ecology and Biotechnology (2010FB02) and the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) funded by the Scottish Funding Council (grant reference HR09011). Q.X. and Y.J. were supported financially by the National Scholarship Council of China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cain KD, 2000, FISH SHELLFISH IMMUN, V10, P651, DOI 10.1006/fsim.2000.0280; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Campbell S, 2009, DIS AQUAT ORGAN, V86, P205, DOI 10.3354/dao02127; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collet B, 2014, DEV COMP IMMUNOL, V43, P160, DOI 10.1016/j.dci.2013.08.017; Costa MM, 2011, MOL IMMUNOL, V48, P1903, DOI 10.1016/j.molimm.2011.05.027; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harun NO, 2011, FISH SHELLFISH IMMUN, V31, P107, DOI 10.1016/j.fsi.2011.04.010; Hill JE, 2007, N AM J AQUACULT, V69, P139, DOI 10.1577/A05-070.1; Hong S, 2001, VET IMMUNOL IMMUNOP, V81, P1, DOI 10.1016/S0165-2427(01)00328-2; Hong S, 2013, J IMMUNOL, V191, P5959, DOI 10.4049/jimmunol.1301584; Huang B, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-22; Husain M, 2012, DEV COMP IMMUNOL, V38, P431, DOI 10.1016/j.dci.2012.07.010; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li J, 1997, DIS AQUAT ORGAN, V29, P7, DOI 10.3354/dao029007; Li S, 2014, J IMMUNOL, V193, P1100, DOI 10.4049/jimmunol.1400253; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Maehr T, 2014, MOL IMMUNOL, V62, P186, DOI 10.1016/j.molimm.2014.06.021; Nehyba J, 2002, MOL CELL BIOL, V22, P3942, DOI 10.1128/MCB.22.11.3942-3957.2002; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; *OFF INT EP, 2000, DIAGN MAN AQ AN DIS, P74; Roca FJ, 2007, MOL IMMUNOL, V44, P472, DOI 10.1016/j.molimm.2006.02.015; Shi Y, 2010, MOL BIOL REP, V37, P1483, DOI 10.1007/s11033-009-9544-0; Skall HF, 2005, J FISH DIS, V28, P509, DOI 10.1111/j.1365-2761.2005.00654.x; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Suzuki Y, 2011, FISH SHELLFISH IMMUN, V30, P67, DOI 10.1016/j.fsi.2010.09.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wang T, 2003, IMMUNOGENETICS, V55, P615, DOI 10.1007/s00251-003-0622-5; Wang TH, 2014, DEV COMP IMMUNOL, V46, P194, DOI 10.1016/j.dci.2014.04.008; Wang TH, 2014, EUR J IMMUNOL, V44, P1541, DOI 10.1002/eji.201344273; Wang TH, 2011, IMMUNOGENETICS, V63, P235, DOI 10.1007/s00251-010-0508-2; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Xu QQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-25; Xu QQ, 2010, VET IMMUNOL IMMUNOP, V134, P269, DOI 10.1016/j.vetimm.2009.10.020; Xu QQ, 2014, DEV COMP IMMUNOL, V45, P201, DOI 10.1016/j.dci.2014.03.002; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	46	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147181	10.1371/journal.pone.0147181	http://dx.doi.org/10.1371/journal.pone.0147181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783745	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400119
J	Chen, WL; Xie, H; Wang, HX; Chen, L; Sun, Y; Chen, ZC; Li, QB				Chen, Wenlan; Xie, Hui; Wang, Hongxiang; Chen, Li; Sun, Yi; Chen, Zhichao; Li, Qiubai			Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; C-KIT; GENETIC LESIONS; FLT3 MUTATIONS; IMPACT; AML; INV(16); T(8/21); EXPRESSION; DIAGNOSIS	The prognostic significance of KIT mutations in core-binding factor acute myeloid leukemia (CBF-AML), including inv(16) and t(8;21) AML, is uncertain. We performed a systematic review and meta-analysis of the effect of KIT mutations on the complete remission (CR) and relapse rates and overall survival (OS) of CBF-AML. PubMed, Embase, Web of Science, and the Cochrane Library were searched and relevant studies were included. Negative effect was indicated on relapse risk of CBF-AML (RR [relative risk], 1.43; 95% CI [confidence interval], 1.20-1.70) and t(8;21) AML (RR, 1.70; 95% CI, 1.31-2.21), not on OS of CBF-AML (RR, 1.09; 95% CI, 0.97-1.23), CR (OR [odds ratio], 0.95; 95% CI, 0.52-1.74), relapse risk (RR, 1.12; 95% CI, 0.90-1.41) or OS (RR, 1.03; 95% CI, 0.90-1.18) of inv(16) AML. Subgroup analysis of t(8,21) AML showed negative effect of KIT mutations on CR (OR, 2.03; 95% CI: 1.02-4.05), relapse risk (RR, 1.89; 95% CI: 1.51-2.37) and OS (RR, 2.26; 95% CI: 1.35-3,78) of non-Caucasians, not on CR (OR, 0.61; 95% CI: 0.19-1.95) or OS (RR, 1.12; 95% CI: 0.90-1.40) of Caucasians. This study indicates KIT mutations in CBF-AML to be included in the initial routine diagnostic workup and stratification system of t (8,21) AML. Prospective large-scale clinical trials are warranted to evaluate these findings.	[Chen, Wenlan; Xie, Hui; Chen, Zhichao; Li, Qiubai] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Wang, Hongxiang; Chen, Li] Wuhan Cent Hosp, Dept Hematol, Wuhan 430000, Peoples R China; [Sun, Yi] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Social Med, Tongji Med Coll, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, ZC; Li, QB (corresponding author), Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	chenzhichao@hust.edu.cn; qiubaili@hust.edu.cn	Li, Qiubai/GWQ-9911-2022		National Natural Science Foundation of China [81272624, 81071943, 81470330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China to QBL (No. 81272624 and No. 81071943) and to ZCC (No. 81470330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2013, LEUKEMIA, V27, P1891, DOI 10.1038/leu.2013.186; Beghini A, 1998, BLOOD CELL MOL DIS, V24, P262, DOI 10.1006/bcmd.1998.0191; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Cairoli R, 2003, LEUKEMIA, V17, P471, DOI 10.1038/sj.leu.2402795; Cairoli R, 2013, AM J HEMATOL, V88, P594, DOI 10.1002/ajh.23461; Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x; CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huh J, 2011, BLOOD, V118, P1499; Iwanaga E, 2009, HAEMATOL-HEMATOL J, V94, P433, DOI 10.3324/haematol.13283; Jones D, 2010, GENE CHROMOSOME CANC, V49, P182, DOI 10.1002/gcc.20732; Jourdan E, 2013, BLOOD, V121, P2213, DOI 10.1182/blood-2012-10-462879; Jung HA, 2014, ANTICANCER RES, V34, P1037; Kim HJ, 2013, ANN HEMATOL, V92, P163, DOI 10.1007/s00277-012-1580-5; Kok CH, 2013, BRIT J HAEMATOL, V160, P557, DOI 10.1111/bjh.12131; Krauth MT, 2014, LEUKEMIA, V28, P1449, DOI 10.1038/leu.2014.4; Kurosawa S, 2013, HAEMATOLOGICA, V98, P1525, DOI 10.3324/haematol.2012.078030; Luck SC, 2010, BRIT J HAEMATOL, V148, P925, DOI 10.1111/j.1365-2141.2009.08035.x; Manara E, 2014, LEUKEMIA, V28, P1132, DOI 10.1038/leu.2013.339; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Markova J, 2009, LEUKEMIA LYMPHOMA, V50, P1448, DOI 10.1080/10428190903085951; National Comprehensive Cancer, 2015, NETW CLIN PRACT GUID; Park SH, 2013, LEUKEMIA RES, V37, P784, DOI 10.1016/j.leukres.2013.02.010; Park SH, 2011, LEUKEMIA RES, V35, P1376, DOI 10.1016/j.leukres.2011.06.003; Paschka P, 2008, SEMIN ONCOL, V35, P410, DOI 10.1053/j.seminoncol.2008.04.011; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; Paschka P, 2013, HEMATOL-AM SOC HEMAT, P209, DOI 10.1182/asheducation-2013.1.209; Paschka P, 2013, BLOOD, V121, P170, DOI 10.1182/blood-2012-05-431486; Pollard JA, 2010, BLOOD, V115, P2372, DOI 10.1182/blood-2009-09-241075; Qin YZ, 2014, LEUKEMIA RES, V38, P1435, DOI 10.1016/j.leukres.2014.09.017; Riera L, 2013, ONCOL REP, V29, P1867, DOI 10.3892/or.2013.2328; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Schwind S, 2013, BLOOD, V121, P385, DOI 10.1182/blood-2012-07-442772; Shih LY, 2008, LEUKEMIA, V22, P303, DOI 10.1038/sj.leu.2404995; Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408; Shimada A, 2007, INT J HEMATOL, V86, P289, DOI 10.1007/BF03006937; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Wakita S, 2011, LEUKEMIA, V25, P1423, DOI 10.1038/leu.2011.104; Wang D, 2012, BIOCHEM BIOPH RES CO, V428, P411, DOI 10.1016/j.bbrc.2012.10.069; Zhu HH, 2013, BLOOD, V121, P4056, DOI 10.1182/blood-2012-11-468348	48	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146614	10.1371/journal.pone.0146614	http://dx.doi.org/10.1371/journal.pone.0146614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771376	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300026
J	Jung, HW; Kim, JW; Han, JW; Kim, K; Kim, JH; Kim, KI; Kim, CH; Kim, KW				Jung, Hee-Won; Kim, Jin Won; Han, Ji Won; Kim, Kayoung; Kim, Jee Hyun; Kim, Kwang-Il; Kim, Cheol-Ho; Kim, Ki Woong			Multidimensional Geriatric Prognostic Index, Based on a Geriatric Assessment, for Long-Term Survival in Older Adults in Korea	PLOS ONE			English	Article							LIFE EXPECTANCY; FRAILTY; COMORBIDITY; MORTALITY; VALIDATION; BURDEN	The patient's survival estimate is important for clinical decision-making, especially in frail patients with multimorbidities. We aimed to develop a multidimensional geriatric prognosis index (GPI) for 3- and 5-year mortality in community-dwelling elderly and to validate the GPI in a separate hospital-based population. The GPI was constructed using data for 988 participants in the Korean Longitudinal Study on Health and Aging (KLoSHA) and cross-validated with 1109 patients who underwent a geriatric assessment at the Seoul National University Bundang Hospital (SNUBH). The GPI, with a total possible score of 8, included age, gender, activities of daily living, instrumental activities of daily living, comorbidities, mood, cognitive function, and nutritional status. During the 5-year observation period, 179 KLoSHA participants (18.1%) and 340 SNUBH patients (30.7%) died. The c-indices for 3-and 5-year mortality were 0.78 and 0.80, respectively, in the KLoSHA group and 0.73 and 0.80, respectively, in the SNUBH group. Positive linear trends were observed for GPI scores and both 3-and 5-year mortality in both groups. In conclusions, using common components of a geriatric assessment, the GPI can stratify the risk of 3-and 5-year mortality in Korean elderly people both in the community and hospital.	[Jung, Hee-Won; Kim, Kwang-Il; Kim, Cheol-Ho] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Geriatr,Dept Internal Med, Songnam, South Korea; [Kim, Jin Won; Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Hematol & Med Oncol,Dept Internal Med, Songnam, South Korea; [Han, Ji Won; Kim, Kayoung; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Div Hematol & Med Oncol,Dept Internal Med, Songnam, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea.	jwkim@snubh.org; kwkimmd@snu.ac.kr	Kim, Kwang-il/D-8024-2012; Jung, Hee-Won/B-4269-2015; Kim, Kwang-il/AAP-7315-2021	Kim, Kwang-il/0000-0002-6658-047X; Jung, Hee-Won/0000-0002-2583-3354; Kim, Kwang-il/0000-0002-6658-047X	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320370]; Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092077]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was supported by grants from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (study no: 1320370) and from the Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (grant No. A092077). The funding organizations had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Beloosesky Y, 2011, DRUG AGING, V28, P1007, DOI 10.2165/11597040-000000000-00000; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Evans SJ, 2014, AGE AGEING, V43, P127, DOI 10.1093/ageing/aft156; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Jung HW, 2014, ANN GERIATR MED RES, V18, P65, DOI 10.4235/jkgs.2014.18.2.65; Jung HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087958; Jung IK, 1997, J KOREAN NEUROPSYCHI, V1, P61; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kim JW, 2014, SUPPORT CARE CANCER, V22, P773, DOI 10.1007/s00520-013-2033-y; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; MAHONEY F I, 1965, Md State Med J, V14, P61; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mittal S, 2014, CLIN GASTROENTEROL H, V12, P443, DOI 10.1016/j.cgh.2013.08.021; OECD, 2012, OECD EC SURV KOR 201, P17; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Won CW, 2002, J KOREAN GERIATR SOC, V6, P107, DOI DOI 10.1037/T06803-000]; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147032	10.1371/journal.pone.0147032	http://dx.doi.org/10.1371/journal.pone.0147032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771562	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300056
J	Laudy, AE; Mrowka, A; Krajewska, J; Tyski, S				Laudy, Agnieszka E.; Mrowka, Agnieszka; Krajewska, Joanna; Tyski, Stefan			The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; HELICOBACTER-PYLORI; STENOTROPHOMONAS-MALTOPHILIA; FLUOROQUINOLONE RESISTANCE; ACINETOBACTER-BAUMANNII	Background Most patients with bacterial infections suffer from fever and various pains that require complex treatments with antibiotics, antipyretics, and analgaesics. The most common drugs used to relieve these symptoms are non-steroidal anti-inflammatory drugs (NSAIDs), which are not typically considered antibiotics. Here, we investigate the effects of NSAIDs on bacterial susceptibility to antibiotics and the modulation of bacterial efflux pumps. Methodology The activity of 12 NSAID active substances, paracetamol (acetaminophen), and eight relevant medicinal products was analyzed with or without pump inhibitors against 89 strains of Gram-negative rods by determining the MICs. Furthermore, the effects of NSAIDs on the susceptibility of clinical strains to antimicrobial agents with or without PA beta N (Phe-Arg-beta-naphtylamide) were measured. Results The MICs of diclofenac, mefenamic acid, ibuprofen, and naproxen, in the presence of PA beta N, were significantly (>= 4-fold) reduced, decreasing to 25-1600 mg/L, against the majority of the studied strains. In the case of acetylsalicylic acid only for 5 and 7 out of 12 strains of P. mirabilis and E. coli, respectively, a 4-fold increase in susceptibility in the presence of PA beta N was observed. The presence of Aspirin resulted in a 4-fold increase in the MIC of ofloxacin against only two strains of E. coli among 48 tested clinical strains, which included species such as E. coli, K. pneumoniae, P. aeruginosa, and S. maltophilia. Besides, the medicinal products containing the following NSAIDs, diclofenac, mefenamic acid, ibuprofen, and naproxen, did not cause the decrease of clinical strains' susceptibility to antibiotics. Conclusions The effects of PA beta N on the susceptibility of bacteria to NSAIDs indicate that some NSAIDs are substrates for efflux pumps in Gram-negative rods. Morever, Aspirin probably induced efflux-mediated resistance to fluoroquinolones in a few E. coli strains.	[Laudy, Agnieszka E.; Krajewska, Joanna; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Oczki 3 Str, PL-02007 Warsaw, Poland; [Mrowka, Agnieszka; Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Chelmska 30-34 Str, PL-00725 Warsaw, Poland	Medical University of Warsaw; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Oczki 3 Str, PL-02007 Warsaw, Poland.	alaudy@wp.pl	Laudy, Agnieszka/M-4930-2018; Laudy, Agnieszka/AAC-1000-2022; Tyski, Stefan/W-5271-2018; Krajewska, Joanna/ACL-3842-2022	Laudy, Agnieszka/0000-0002-5989-4462; Tyski, Stefan/0000-0003-3352-038X; Kociszewska, Agnieszka/0000-0002-2055-2588; Krajewska, Joanna/0000-0002-4963-9521	Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland [REGON: 006220910, NIP: 5262173856, KRS: 0000195643]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"	The study was supported by the Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland (REGON: 006220910, NIP: 5262173856, KRS: 0000195643; foundation of some reagents). Research was carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabi M, 2015, INFECT CHEMOTHER, V47, P98, DOI 10.3947/ic.2015.47.2.98; Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Axon J. M. C., 1992, P295; Baucheron S, 2002, MICROB DRUG RESIST, V8, P281, DOI 10.1089/10766290260469543; Bazyleu A, 2014, FEMS MICROBIOL LETT, V357, P136, DOI 10.1111/1574-6968.12530; Bown RL, 2002, INT J CLIN PRACT, V56, P132; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; Dastidar SG, 2000, INT J ANTIMICROB AG, V14, P249, DOI 10.1016/S0924-8579(99)00159-4; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Dutta NK, 2007, INT J ANTIMICROB AG, V30, P242, DOI 10.1016/j.ijantimicag.2007.04.018; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Hartog E, 2010, J ANTIMICROB CHEMOTH, V65, P888, DOI 10.1093/jac/dkq077; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Huang YW, 2013, J ANTIMICROB CHEMOTH, V68, P2498, DOI 10.1093/jac/dkt250; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Kristiansen JE, 2010, IN VIVO, V24, P751; Kruszewska H, 2012, ACTA POL PHARM, V69, P1368; Kruszewska H, 2010, ACTA POL PHARM, V67, P733; Kruszewska H, 2008, ACTA POL PHARM, V65, P779; Kruszewska Hanna, 2006, Acta Pol Pharm, V63, P457; Laudy AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119997; Lode HM, 2014, INT J ANTIMICROB AG, V43, P497, DOI 10.1016/j.ijantimicag.2014.02.014; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mallea M, 2002, BIOCHEM BIOPH RES CO, V293, P1370, DOI 10.1016/S0006-291X(02)00404-7; Marquez B, 2005, BIOCHIMIE, V87, P1137, DOI 10.1016/j.biochi.2005.04.012; Martins M, 2008, INT J ANTIMICROB AG, V31, P198, DOI 10.1016/j.ijantimicag.2007.10.025; Mazumdar K, 2010, INT J ANTIMICROB AG, V36, P295, DOI 10.1016/j.ijantimicag.2010.05.003; Mazumdar K, 2006, IN VIVO, V20, P613; Nair BM, 2004, J CLIN INVEST, V113, P464, DOI 10.1172/JCi200419710; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Opperman TJ, 2014, ANTIMICROB AGENTS CH, V58, P722, DOI 10.1128/AAC.01866-13; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Piddock LJV, 2010, J ANTIMICROB CHEMOTH, V65, P1215, DOI 10.1093/jac/dkq079; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Ribera A, 2002, J ANTIMICROB CHEMOTH, V49, P697, DOI 10.1093/jac/49.4.697; ROSNER JL, 1991, J BACTERIOL, V173, P5631, DOI 10.1128/jb.173.18.5631-5638.1991; ROSNER JL, 1985, P NATL ACAD SCI USA, V82, P8771, DOI 10.1073/pnas.82.24.8771; Saenz Y, 2004, J ANTIMICROB CHEMOTH, V53, P544, DOI 10.1093/jac/dkh117; Sanchez P, 2003, J ANTIMICROB CHEMOTH, V51, P1042, DOI 10.1093/jac/dkg181; Sedef Gocmen J, 2008, J DERMATOL TREAT, V19, P351, DOI 10.1080/09546630802050498; Shen ZQ, 2011, APPL ENVIRON MICROB, V77, P7128, DOI 10.1128/AEM.00763-11; Shirin H, 2006, J GASTROEN HEPATOL, V21, P1388, DOI 10.1111/j.1440-1746.2006.04194.x; Sonnet P, 2012, INT J ANTIMICROB AG, V39, P77, DOI 10.1016/j.ijantimicag.2011.08.005; Tamanai-Shacoori Z, 2004, CAN J ANAESTH, V51, P911, DOI 10.1007/BF03018889; Tamanai-Shacoori Z, 2007, ANESTH ANALG, V105, P524, DOI 10.1213/01.ane.0000267525.51017.b8; Tanabe H, 1997, J GEN APPL MICROBIOL, V43, P257, DOI 10.2323/jgam.43.257; Wang WH, 2003, GUT, V52, P490, DOI 10.1136/gut.52.4.490; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84; Wu KK, 2000, CIRCULATION, V102, P2022, DOI 10.1161/01.CIR.102.17.2022; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Yin Z, 2014, CHEM BIOL, V21, P481, DOI 10.1016/j.chembiol.2014.02.009; Zechini Barbara, 2009, Recent Pat Antiinfect Drug Discov, V4, P37; Zhang XP, 2009, WORLD J GASTROENTERO, V15, P919, DOI 10.3748/wjg.15.919	61	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147131	10.1371/journal.pone.0147131	http://dx.doi.org/10.1371/journal.pone.0147131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771525	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300063
J	Stockslager, MA; Samuels, BC; Allingham, RR; Klesmith, ZA; Schwaner, SA; Forest, CR; Ethier, CR				Stockslager, Max A.; Samuels, Brian C.; Allingham, R. Rand; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross			System for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial Pressure	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE HEAD; OUTFLOW FACILITY; OCULAR RIGIDITY; LUMBAR PUNCTURE; GOLDMANN APPLANATION; UVEOSCLERAL OUTFLOW; GLAUCOMA; PULSATION; EYE	Pathologic changes in intracranial pressure (ICP) are commonly observed in a variety of medical conditions, including traumatic brain injury, stroke, brain tumors, and glaucoma. However, current ICP measurement techniques are invasive, requiring a lumbar puncture or surgical insertion of a cannula into the cerebrospinal fluid (CSF)-filled ventricles of the brain. A potential alternative approach to ICP measurement leverages the unique anatomy of the central retinal vein, which is exposed to both intraocular pressure (IOP) and ICP as it travels inside the eye and through the optic nerve; manipulating IOP while observing changes in the natural pulsations of the central retinal vein could potentially provide an accurate, indirect measure of ICP. As a step toward implementing this technique, we describe the design, fabrication, and characterization of a system that is capable of manipulating IOP in vivo with <0.1 mmHg resolution and settling times less than 2 seconds. In vitro tests were carried out to characterize system performance. Then, as a proof of concept, we used the system to manipulate IOP in tree shrews (Tupaia belangeri) while video of the retinal vessels was recorded and the caliber of a selected vein was quantified. Modulating IOP using our system elicited a rapid change in the appearance of the retinal vein of interest: IOP was lowered from 10 to 3 mmHg, and retinal vein caliber sharply increased as IOP decreased from 7 to 5 mmHg. Another important feature of this technology is its capability to measure ocular compliance and outflow facility in vivo, as demonstrated in tree shrews. Collectively, these proof-of-concept demonstrations support the utility of this system to manipulate IOP for a variety of useful applications in ocular biomechanics, and provide a framework for further study of the mechanisms of retinal venous pulsation.	[Stockslager, Max A.; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Allingham, R. Rand] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Ethier, C. Ross] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University of Alabama System; University of Alabama Birmingham; Duke University; University System of Georgia; Georgia Institute of Technology; Emory University	Ethier, CR (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Ethier, CR (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	ross.ethier@bme.gatech.edu		Samuels, Brian/0000-0003-3860-6879; Ethier, Ross/0000-0001-6110-3052	National Institute of Health BRAIN Initiative Grant (NEI) [1-U01-MH106027-01]; National Institute of Health BRAIN Initiative Grant (NIMH) [1-U01-MH106027-01]; National Institutes of Health Single Cell Grant [1 R01 EY023173]; NATIONAL EYE INSTITUTE [R01EY023173, T32EY007092, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106027] Funding Source: NIH RePORTER	National Institute of Health BRAIN Initiative Grant (NEI); National Institute of Health BRAIN Initiative Grant (NIMH); National Institutes of Health Single Cell Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CRE acknowledges the Georgia Research Alliance (gra.org). CRF acknowledges the National Institutes of Health BRAIN Initiative Grant (NEI and NIMH 1-U01-MH106027-01; nih.gov) and National Institutes of Health Single Cell Grant (1 R01 EY023173; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SV, 2006, POSTGRAD MED J, V82, P713, DOI 10.1136/pgmj.2006.044792; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Boussommier-Calleja A, 2012, INVEST OPHTH VIS SCI, V53, P5838, DOI 10.1167/iovs.12-9923; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Brubaker RF, 2001, J GLAUCOMA, V10, pS45, DOI 10.1097/00061198-200110001-00017; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chen W, P 2009 2 INT C BIOM, DOI [10.1109/BMEI.2009.5305808, DOI 10.1109/BMEI.2009.5305808]; Cheung CMG, 2004, BRIT J OPHTHALMOL, V88, P582, DOI 10.1136/bjo.2003.027219; Cioboata M, 2014, J Med Life, V7 Spec No. 2, P5; De Moraes CGV, 2008, J OPTOM, V01, P43; Eilaghi A, 2010, ANN BIOMED ENG, V38, P1586, DOI 10.1007/s10439-009-9879-7; EISENLOHR JE, 1962, INVEST OPHTH VISUAL, V1, P63; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Golzan SM, 2012, ANN BIOMED ENG, V40, P1940, DOI 10.1007/s10439-012-0563-y; GRANT WM, 1950, ARCH OPHTHALMOL-CHIC, V44, P204; GRANT WM, 1951, AMA ARCH OPHTHALMOL, V46, P113; Gurol ME, 2008, CURR ATHEROSCLER REP, V10, P324, DOI 10.1007/s11883-008-0050-y; Harder B, 2007, BR J OPHTHALMOL, V91, P399; HARRINGTON H, 1982, J NEUROSURG, V57, P703, DOI 10.3171/jns.1982.57.5.0703; Heimann H., 2010, ESSENTIALS OPHTHALMO, P67; Honjo M., 2011, ARCH OPHTHALMOL-CHIC, V119, P1171; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Kahook MY, 2013, CHANDLER AND GRANT'S GLAUCOMA, FIFTH EDITION, P1; KAST R, 1985, J NEUROL, V232, P260, DOI 10.1007/BF00313790; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kymionis GD, 2008, J REFRACT SURG, V24, P173, DOI 10.3928/1081597X-20080201-08; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Morgan WH, 1999, THESIS U W AUSTR; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ramulu PY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1335, DOI 10.1001/archophthalmol.2010.224; RUBEN JB, 1985, INVEST OPHTH VIS SCI, V26, P153; Sherwood JM, 2015, PLOS ONE UNPUB; Shetty AK, 1999, PEDIATRICS, V103, P1284, DOI 10.1542/peds.103.6.1284; Villamarin A, 2012, INVEST OPHTH VIS SCI, V53, P2831, DOI 10.1167/iovs.11-8752; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wang AS, 2013, J GLAUCOMA, V22, P127, DOI 10.1097/IJG.0b013e3182254ba3; Wang J, 2013, INVEST OPHTH VIS SCI, V54, P1706, DOI 10.1167/iovs.12-9841	44	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147020	10.1371/journal.pone.0147020	http://dx.doi.org/10.1371/journal.pone.0147020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771837	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300052
J	Geddes, RI; Peterson, BL; Stein, DG; Sayeed, I				Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal			Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; WATER-MAZE; GENDER-DIFFERENCES; IMPROVED OUTCOMES; PREGNANT-WOMEN; CLINICAL-TRIAL; IMMATURE RATS; RECOVERY; NEUROPROTECTION	Purpose We recently showed that progesterone treatment can reduce lesion size and behavioral deficits after moderate-to-severe bilateral injury to the medial prefrontal cortex in immature male rats. Whether there are important sex differences in response to injury and progesterone treatment in very young subjects has not been given sufficient attention. Here we investigated progesterone's effects in the same model of brain injury but with pre-pubescent females. Methods Twenty-eight-day-old female Sprague-Dawley rats received sham (n = 14) or controlled cortical impact (CCI) (n = 21) injury, were given progesterone (8 mg/kg body weight) or vehicle injections on post-injury days (PID) 1-7, and underwent behavioral testing from PID 9-27. Brains were evaluated for lesion size at PID 28. Results Lesion size in vehicle-treated female rats with CCI injury was smaller than that previously reported for similarly treated age-matched male rats. Treatment with progesterone reduced the effect of CCI on extent of damage and behavioral deficits. Conclusion Pre-pubescent female rats with midline CCI injury to the frontal cortex have reduced morphological and functional deficits following progesterone treatment. While gender differences in susceptibility to this injury were observed, progesterone treatment produced beneficial effects in young rats of both sexes following CCI.	[Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020	Geddes, Rastafa/0000-0002-7313-761X	Emory Center for Injury Control, National Institutes of Health [R49CE001494-04]; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of Health [R49CE001494-04]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE001494] Funding Source: NIH RePORTER	Emory Center for Injury Control, National Institutes of Health; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, the Emory University Summer Undergraduate Research Experience (SURE) program, and by unrestricted gifts to the Brain Research Laboratory from BHR Pharma and Allen and Company. There were no employer/employee relationships with either of the companies although DGS had a consulting agreement with BHR to provide pre-clinical information on the use of progesterone for the treatment of TBI. None of the authors currently participate in any licensing agreement or receive any royalties from BHR Pharma. Allen and Company is an investment firm with no commercial interests in pharmacology or any other matter relating to the authors' research. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of this or any other manuscript.; This work was supported by unrestricted gifts in support of research from BHR Pharma, Allen and Company, the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, and the Emory University Summer Undergraduate Research Experience (SURE) program. The authors would like to acknowledge the contributions of our undergraduate research trainees (William Godwin, Maydda Qureshi, Leea Richardson, and Noah Rosen) towards the completion of this work.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P929; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berry C, 2012, AM J SURG, V204, P558, DOI 10.1016/j.amjsurg.2011.07.012; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Frye CA, 2011, J PSYCHOPHARMACOL, V25, P421, DOI 10.1177/0269881109349836; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haider AH, 2007, ARCH SURG-CHICAGO, V142, P875, DOI 10.1001/archsurg.142.9.875; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; HULL EM, 1981, PHYSIOL BEHAV, V26, P401, DOI 10.1016/0031-9384(81)90166-9; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kolb B, 2000, NEUROPHARMACOLOGY, V39, P756, DOI 10.1016/S0028-3908(99)00260-9; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2011, DEV MED CHILD NEUROL, V53, P4, DOI 10.1111/j.1469-8749.2011.04054.x; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mueller SC, 2009, J CHILD PSYCHOL PSYC, V50, P1227, DOI 10.1111/j.1469-7610.2009.02112.x; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; PARKER V, 1986, NEUROPHARMACOLOGY, V25, P663, DOI 10.1016/0028-3908(86)90224-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reddy DS, 2010, NEUROPHARMACOLOGY, V59, P573, DOI 10.1016/j.neuropharm.2010.08.017; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2014, J BIOENERG BIOMEMBR; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Schieb LJ, 2013, MMWR-MORBID MORTAL W, V62, P721; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2012, AM J SURG, V204, P803, DOI 10.1016/j.amjsurg.2011.05.002; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	81	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146419	10.1371/journal.pone.0146419	http://dx.doi.org/10.1371/journal.pone.0146419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799561	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300020
J	Girerd-Genessay, I; Baratin, D; Ferry, T; Chidiac, C; Ronin, V; Vanhems, P				Girerd-Genessay, Isabelle; Baratin, Dominique; Ferry, Tristan; Chidiac, Christian; Ronin, Vincent; Vanhems, Philippe			Higher HIV RNA Viral Load in Recent Patients with Symptomatic Acute HIV Infection in Lyon University Hospitals	PLOS ONE			English	Article							CAPTURE-RECAPTURE ESTIMATION; CD4 CELL COUNT; DISEASE PROGRESSION; PROGNOSTIC MARKERS; TRANSMISSION; FRANCE; COHORT; VIRULENCE; SURVIVAL; TYPE-1	Introduction Increased human immunodeficiency virus (HIV) virulence at infection has been suggested by a meta-analysis based on viral load and CD4 T lymphocytes (CD4) count during acute infection. This result was obtained after secondary analyses of large databases, facilitating the detection of differences. Similar finding in cohorts of more modest sample size would indicate that the effect could be more substantial. Methods Change from initial CD4 count and HIV viral load after acute HIV infection by calendar year was explored in patients treated at Lyon University hospitals. All patients admitted to our hospitals with acute HIV infection between 1996 and 2013 were included in our study. Initial CD4 count and viral load before the start of anti-retroviral treatment were analyzed. Trends over time were assessed in linear models. Results Initial CD4 count remained similar over time. However, in 2006-2013, initial viral load rose significantly (+1.12 log(10)/ml/year, p = 0.01). Conclusion Our data, obtained from a single hospital cohort, confirmed findings from a large meta-analysis, showed increased initial viremia at acute HIV infection since 2006 and suggesting potentially higher HIV virulence in recent years.	[Girerd-Genessay, Isabelle; Baratin, Dominique; Vanhems, Philippe] Hosp Civils Lyon, Hop Edouard Herriot, Infect Control & Epidemiol Unit, Lyon, France; [Ferry, Tristan; Chidiac, Christian] Hosp Civils Lyon, Dept Infect Dis, Lyon, France; [Ronin, Vincent] Hosp Civils Lyon, Hop Croix Rousse, Infect Control & Epidemiol Unit, Lyon, France; [Vanhems, Philippe] ENS Lyon, Emerging Pathogens Lab, Ctr Int Rech Infectiol, Fondat Merieux,CNRS,INSERM,U1111,UMR5308, F-69007 Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanhems, P (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Infect Control & Epidemiol Unit, Lyon, France.	philippe.vanhems@chu-lyon.fr	Ferry, Tristan/M-5108-2014	ferry, tristan/0000-0003-3082-7001				Bernillon P, 2000, INT J EPIDEMIOL, V29, P168, DOI 10.1093/ije/29.1.168; Cazein F, 2014, B EPIDEMIOLOGIQUE HE, V9-10, P154; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hoen B, 2007, MALADIES INFECTIEUSE, P468; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Institut de Veille Sanitaire, 2013, INC INF VIH; Lewden C, 2006, EPIDEMIOL INFECT, V134, P1345, DOI 10.1017/S095026880600639X; Marzel A, 2015, CLIN INFECT DIS; Matheron S, 2003, AIDS, V17, P2593, DOI 10.1097/00002030-200312050-00006; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Pantazis N, 2014, LANCET HIV, V1, pE119, DOI 10.1016/S2352-3018(14)00002-2; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Philippe Morlat, 2013, PRISE CHARGE MED PER; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Tassie JM, 1999, AIDS, V13, P1881, DOI 10.1097/00002030-199910010-00010; Toure A, 2012, AIDS CARE, V24, P1272, DOI 10.1080/09540121.2012.656574	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146978	10.1371/journal.pone.0146978	http://dx.doi.org/10.1371/journal.pone.0146978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799390	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300050
J	Li, GY; Hayward, IN; Jenkins, BR; Rothfuss, HM; Young, CH; Nevalainen, MT; Muth, A; Thompson, PR; Navratil, AM; Cherrington, BD				Li, Guangyuan; Hayward, Isaac N.; Jenkins, Brittany R.; Rothfuss, Heather M.; Young, Coleman H.; Nevalainen, Marja T.; Muth, Aaron; Thompson, Paul R.; Navratil, Amy M.; Cherrington, Brian D.			Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID 9 Cells and Expressed in the Lactating Mouse Mammary Gland	PLOS ONE			English	Article							BREAST-CANCER CELLS; CASEIN GENE-TRANSCRIPTION; GLUCOCORTICOID-RECEPTOR; IN-VITRO; PROTEIN; STAT5; BETA; ACTIVATION; DIFFERENTIATION; CITRULLINATION	Peptidylarginine deiminases (PADs) post-translationally convert arginine into neutral citrulline residues. Our past work shows that PADs are expressed in the canine and murine mammary glands; however, the mechanisms regulating PAD expression and the function of citrullination in the normal mammary gland are unclear. Therefore, the first objective herein was to investigate regulation of PAD expression in mammary epithelial cells. We first examined PAD levels in CID-9 cells, which were derived from the mammary gland of mid-pregnant mice. PAD3 expression is significantly higher than all other PAD isoforms and mediates protein citrullination in CID-9 cells. We next hypothesized that prolactin regulates PAD3 expression. To test this, CID-9 cells were stimulated with 5 pg/mL of prolactin for 48 hours which significantly increases PAD3 mRNA and protein expression. Use of a JAK2 inhibitor and a dominant negative (DN)-STAT5 adenovirus indicate that prolactin stimulation of PAD3 expression is mediated by the JAK2/STAT5 signaling pathway in CID-9 cells. In addition, the human PAD3 gene promoter is prolactin responsive in CID-9 cells. Our second objective was to investigate the expression and activity of PAD3 in the lactating mouse mammary gland. PAD3 expression in the mammary gland is highest on lactation day 9 and coincident with citrullinated proteins such as histones. Use of the PAD3 specific inhibitor, C14-amidine, indicates that PAD3, in part, can citrullinate proteins in L9 mammary glands. Collectively, our results show that upregulation of PAD3 is mediated by prolactin induction of the JAK2/STAT5 signaling pathway, and that PAD3 appears to citrullinate proteins during lactation.	[Li, Guangyuan; Hayward, Isaac N.; Jenkins, Brittany R.; Rothfuss, Heather M.; Young, Coleman H.; Navratil, Amy M.; Cherrington, Brian D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Nevalainen, Marja T.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Muth, Aaron; Thompson, Paul R.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA	University of Wyoming; Medical College of Wisconsin; University of Massachusetts System; University of Massachusetts Worcester	Cherrington, BD (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	bcherrin@uwyo.edu	Li, Guangyuan/AAO-9049-2021	Li, Guangyuan/0000-0002-8241-4965; Cherrington, Brian/0000-0001-5847-2295; Young, Coleman/0000-0002-1109-2057	National Institute of General Medical Sciences from National Institutes of Health [2P20GM103432]; Wyoming Agricultural Experiment Station through National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch [232473]; NATIONAL CANCER INSTITUTE [R01CA113580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432, R01GM079357] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from National Institutes of Health; Wyoming Agricultural Experiment Station through National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BDC: This project is supported in part by a grant from the National Institute of General Medical Sciences (2P20GM103432) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BDC: This material is based upon work that is supported by Wyoming Agricultural Experiment Station by funding provided through the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch under #232473. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; AKIYAMA K, 1989, ENDOCRINOLOGY, V125, P1121, DOI 10.1210/endo-125-3-1121; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Cherrington BD, 2012, J COMP PATHOL, V147, P139, DOI 10.1016/j.jcpa.2012.01.021; Cherrington BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041242; Cherrington BD, 2010, PLOS ONE, V5, DOI [10.1371/journal/pone.0011768, 10.1371/journal.pone.0011768]; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Horibata S, 2012, J REPROD DEVELOP, V58, P274, DOI 10.1262/jrd.2011-040; INAGAKI M, 1989, J BIOL CHEM, V264, P18119; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kavarthapu R, 2014, ONCOTARGET, V5, P9079, DOI 10.18632/oncotarget.2376; Keilhoff G, 2008, DEV NEUROBIOL, V68, P101, DOI 10.1002/dneu.20578; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Lange S, 2011, DEV BIOL, V355, P205, DOI 10.1016/j.ydbio.2011.04.015; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; McElwee JL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-500; O'Leary KA, 2013, ENDOCRINOLOGY, V154, P4483, DOI 10.1210/en.2013-1533; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Raijmakers R, 2007, J MOL BIOL, V367, P1118, DOI 10.1016/j.jmb.2007.01.054; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; Shen Q, 2011, J BIOL CHEM, V286, P14554, DOI 10.1074/jbc.M110.165704; Shi J, 2013, ANN RHEUM DIS, V72, P148, DOI 10.1136/annrheumdis-2012-201559; Stadler SC, 2013, P NATL ACAD SCI USA, V110, P11851, DOI 10.1073/pnas.1308362110; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; U KP, 2014, BBA-MOL CELL RES, V1843, P1162, DOI 10.1016/j.bbamcr.2014.02.018; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Wyszomierski SL, 2001, MOL ENDOCRINOL, V15, P228, DOI 10.1210/me.15.2.228; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112	39	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147503	10.1371/journal.pone.0147503	http://dx.doi.org/10.1371/journal.pone.0147503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799659	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300117
J	Elnakady, YA; Chatterjee, I; Bischoff, M; Rohde, M; Josten, M; Sahl, HG; Herrmann, M; Muller, R				Elnakady, Yasser A.; Chatterjee, Indranil; Bischoff, Markus; Rohde, Manfred; Josten, Michaele; Sahl, Hans-Georg; Herrmann, Mathias; Mueller, Rolf			Investigations to the Antibacterial Mechanism of Action of Kendomycin	PLOS ONE			English	Article							CELL-WALL SYNTHESIS; STAPHYLOCOCCUS-AUREUS; NATURAL-PRODUCTS; DRUG DISCOVERY; STRESS RESISTANCE; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; ESCHERICHIA-COLI; CLP PROTEASE	Purpose The emergence of bacteria that are resistant to many currently used drugs emphasizes the need to discover and develop new antibiotics that are effective against such multi-resistant strains. Kendomycin is a novel polyketide that has a unique quinone methide ansa structure and various biological properties. This compound exhibits strong antibacterial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Despite the promise of kendomycinin in several therapeutic areas, its mode of action has yet to be identified. Methods In this study, we used a multidisciplinary approach to gain insight into the antibacterial mechanism of this compound. Results The antibacterial activity of kendomycin appears to be bacteriostatic rather than bactericidal. Kendomycin inhibited the growth of the MRSA strain COL at a low concentration (MIC of 5 mu g/mL). Proteomic analysis and gene transcription profiling of kendomycin-treated cells indicated that this compound affected the regulation of numerous proteins and genes involved in central metabolic pathways, such as the tricarboxylic acid (TCA) cycle (SdhA) and gluconeogenesis (PckA and GapB), cell wall biosynthesis and cell division (FtsA, FtsZ, and MurAA), capsule production (Cap5A and Cap5C), bacterial programmed cell death (LrgA and CidA), the cellular stress response (ClpB, ClpC, ClpP, GroEL, DnaK, and GrpE), and oxidative stress (AhpC and KatA). Electron microscopy revealed that kendomycin strongly affected septum formation during cell division. Most kendomycin-treated cells displayed incomplete septa with abnormal morphology. Conclusions Kendomycin might directly or indirectly affect the cell division machinery, protein stability, and programmed cell death in S. aureus. Additional studies are still needed to obtain deeper insight into the mode of action of kendomycin.	[Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany; [Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Elnakady, Yasser A.] King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia; [Chatterjee, Indranil; Bischoff, Markus; Herrmann, Mathias] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Dept Med Microbiol, Bonn, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; King Saud University; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn	Muller, R (corresponding author), Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany.; Muller, R (corresponding author), Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany.	rolf.mueller@helmholtz-hzi.de	Elnakady, Yasser Abbass/GYJ-1602-2022; Müller, Rolf/B-1559-2008; Bischoff, Markus/D-2130-2014; Herrmann, Mathias/B-6475-2013; Elnakady, Yasser A./N-6882-2019	Müller, Rolf/0000-0002-1042-5665; Bischoff, Markus/0000-0001-6734-2732; Herrmann, Mathias/0000-0003-2638-2257; 	Deutsche Forschungsgemeinschaft [Bi 1350/1-2, He1850/8-1]; King Saud University, Deanship of Scientific Research, College of Science Research Centre	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); King Saud University, Deanship of Scientific Research, College of Science Research Centre(King Saud University)	This work was supported in part by the Deutsche Forschungsgemeinschaft (Bi 1350/1-2 and He1850/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by King Saud University, Deanship of Scientific Research, College of Science Research Centre, and in part by the Deutsche Forschungsgemeinschaft (Bi 1350/1-2 and He1850/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Bayles KW, 2003, TRENDS MICROBIOL, V11, P306, DOI 10.1016/S0966-842X(03)00144-6; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bode HB, 2000, J CHEM SOC PERK T 1, P323, DOI 10.1039/a908387a; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Cebrian G, 2009, J APPL MICROBIOL, V107, P187, DOI 10.1111/j.1365-2672.2009.04194.x; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chatterjee I, 2011, INT J MED MICROBIOL, V301, P341, DOI 10.1016/j.ijmm.2010.10.002; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Du WS, 2000, J BACTERIOL, V182, P4146, DOI 10.1128/JB.182.15.4146-4152.2000; Duggal P, 2011, LARYNGOSCOPE, V121, P51, DOI 10.1002/lary.21214; Elnakady YA, 2007, CHEMBIOCHEM, V8, P1261, DOI 10.1002/cbic.200700050; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gray Alexander I, 2012, Methods Mol Biol, V864, P515, DOI 10.1007/978-1-61779-624-1_20; Harvey A, 2010, IDRUGS, V13, P70; Harvey AL, 2010, EXPERT OPIN DRUG DIS, V5, P559, DOI 10.1517/17460441.2010.488263; Hesje CK, 2011, CURR EYE RES, V36, P94, DOI 10.3109/02713683.2010.534229; HIGHTON PJ, 1972, J BACTERIOL, V109, P1181, DOI 10.1128/JB.109.3.1181-1190.1972; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Lowe JT, 2008, ORG LETT, V10, P3813, DOI 10.1021/ol801499s; Malachowa N, 2011, INFECT IMMUN, V79, P342, DOI 10.1128/IAI.00736-10; Martin HJ, 2010, ANGEW CHEM INT EDIT, V49, P5614, DOI 10.1002/anie.201000227; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; MIYAKAWA Y, 1980, J BACTERIOL, V141, P502, DOI 10.1128/JB.141.2.502-507.1980; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Patwardhan B, 2010, INDIAN J EXP BIOL, V48, P220; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pohlit AM, 2013, MOLECULES, V18, P9219, DOI 10.3390/molecules18089219; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Scovill WH, 1996, J BACTERIOL, V178, P3362, DOI 10.1128/jb.178.11.3362-3364.1996; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Tanaka K, 2010, ORG LETT, V12, P1700, DOI 10.1021/ol100229f; Tattevin P, 2011, MED MALADIES INFECT, V41, P167, DOI 10.1016/j.medmal.2010.11.017; Vasilevich NI, 2012, J MED CHEM, V55, P7003, DOI 10.1021/jm300344v; Veiga H, 2011, MOL MICROBIOL, V80, P1366, DOI 10.1111/j.1365-2958.2011.07651.x; Walther J, 2009, FEMS MICROBIOL LETT, V290, P156, DOI 10.1111/j.1574-6968.2008.01413.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Williams DR, 2005, ORG LETT, V7, P4161, DOI 10.1021/ol051512r; WILLIAMSON R, 1985, EUR J BIOCHEM, V151, P475, DOI 10.1111/j.1432-1033.1985.tb09126.x; Wolz C, 2002, INFECT IMMUN, V70, P2758, DOI 10.1128/IAI.70.6.2758-2762.2002; WYLIE EB, 1962, BIOCHIM BIOPHYS ACTA, V59, P450, DOI 10.1016/0006-3002(62)90195-6; Yan K, 2001, BIOCHEM BIOPH RES CO, V284, P515, DOI 10.1006/bbrc.2001.5008; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Yuan Y, 2004, J AM CHEM SOC, V126, P14720, DOI 10.1021/ja0447154; Zhanel GG, 2012, CLIN INFECT DIS, V54, pS214, DOI 10.1093/cid/cir920; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	69	14	14	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146165	10.1371/journal.pone.0146165	http://dx.doi.org/10.1371/journal.pone.0146165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795276	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300006
J	Yang, CY; Yu, K; Wang, Y; Chen, SA; Liu, DD; Wang, ZY; Su, YN; Yang, SZ; Chen, TT; Livnat, I; Vilim, FS; Cropper, EC; Weiss, KR; Sweedler, JV; Jing, J				Yang, Chao-Yu; Yu, Ke; Wang, Ye; Chen, Song-An; Liu, Dan-Dan; Wang, Zheng-Yang; Su, Yan-Nan; Yang, Shao-Zhong; Chen, Ting-Ting; Livnat, Itamar; Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Sweedler, Jonathan V.; Jing, Jian			Aplysia Locomotion: Network and Behavioral Actions of GdFFD, a D-Amino Acid-Containing Neuropeptide	PLOS ONE			English	Article							GASTRIC MILL ACTIVITY; ACHATINA-FULICA; MOTOR PROGRAMS; PEDAL PEPTIDE; SYNAPTIC CONNECTIONS; NEURAL CIRCUIT; VIDEO-TRACKING; NEURONS; GANGLIA; CALIFORNICA	One emerging principle is that neuromodulators, such as neuropeptides, regulate multiple behaviors, particularly motivated behaviors, e.g., feeding and locomotion. However, how neuromodulators act on multiple neural networks to exert their actions remains poorly understood. These actions depend on the chemical form of the peptide, e.g., an alternation of L-to D-form of an amino acid can endow the peptide with bioactivity, as is the case for the Aplysia peptide GdFFD (where dF indicates D-phenylalanine). GdFFD has been shown to act as an extrinsic neuromodulator in the feeding network, while the all L-amino acid form, GFFD, was not bioactive. Given that both GdFFD/GFFD are also present in pedal neurons that mediate locomotion, we sought to determine whether they impact locomotion. We first examined effects of both peptides on isolated ganglia, and monitored fictive programs using the parapedal commissural nerve (PPCN). Indeed, GdFFD was bioactive and GFFD was not. GdFFD increased the frequency with which neural activity was observed in the PPCN. In part, there was an increase in bursting spiking activity that resembled fictive locomotion. Additionally, there was significant activity between bursts. To determine how the peptide-induced activity in the isolated CNS is translated into behavior, we recorded animal movements, and developed a computer program to automatically track the animal and calculate the path of movement and velocity of locomotion. We found that GdFFD significantly reduced locomotion and induced a foot curl. These data suggest that the increase in PPCN activity observed in the isolated CNS during GdFFD application corresponds to a reduction, rather than an increase, in locomotion. In contrast, GFFD had no effect. Thus, our study suggests that GdFFD may act as an intrinsic neuromodulator in the Aplysia locomotor network. More generally, our study indicates that physiological and behavioral analyses should be combined to evaluate peptide actions.	[Yang, Chao-Yu; Yu, Ke; Wang, Ye; Chen, Song-An; Liu, Dan-Dan; Wang, Zheng-Yang; Su, Yan-Nan; Yang, Shao-Zhong; Chen, Ting-Ting; Jing, Jian] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Collaborat Innovat Ctr Chem Life Sci,Sch Life Sci, State Key Lab Pharmaceut,Biotechnol Adv Inst Life, Nanjing 210008, Jiangsu, Peoples R China; [Livnat, Itamar; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Livnat, Itamar; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL USA; [Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Vilim, Ferdinand S.; Cropper, Elizabeth C.; Weiss, Klaudiusz R.; Jing, Jian] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA	Nanjing University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Jing, J (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Collaborat Innovat Ctr Chem Life Sci,Sch Life Sci, State Key Lab Pharmaceut,Biotechnol Adv Inst Life, Nanjing 210008, Jiangsu, Peoples R China.; Jing, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Jing, J (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	jingj01@live.com	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Jing, Jian/0000-0003-1422-143X	National Natural Science Foundation of China [31371104, J1103512, J1210026]; National Institutes of Health [NS066587, NS070583, NS031609, MH051393]; National Undergraduate Innovation Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609, R01NS066587, R01NS070583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA037654] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Undergraduate Innovation Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Natural Science Foundation of China (Grant 31371104), the National Institutes of Health (Grants NS066587, NS070583, NS031609 and MH051393) and the National Undergraduate Innovation Program and National Natural Science Foundation of China (Grants J1103512 and J1210026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TW, 2012, CURR BIOL, V22, pR705, DOI 10.1016/j.cub.2012.08.011; Aguiar P, 2007, J NEUROSCI METH, V166, P66, DOI 10.1016/j.jneumeth.2007.06.020; Aguzzi J, 2009, SCI MAR, V73, P773, DOI 10.3989/scimar.2009.73n4773; Bai L, 2013, J BIOL CHEM, V288, P32837, DOI 10.1074/jbc.M113.486670; Bai Lu, 2009, Bioanal Rev, V1, P7; BERNHEIM SM, 1995, J COMP PHYSIOL A, V176, P131; Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Bruno AM, 2015, NEURON, V86, P304, DOI 10.1016/j.neuron.2015.03.005; Crispim CF, 2012, COMPUT BIOL MED, V42, P257, DOI 10.1016/j.compbiomed.2011.12.002; FREDMAN SM, 1980, BRAIN RES BULL, V5, P179, DOI 10.1016/0361-9230(80)90191-4; FREDMAN SM, 1983, J NEUROPHYSIOL, V49, P1092, DOI 10.1152/jn.1983.49.5.1092; FUJIMOTO K, 1991, BIOCHEM BIOPH RES CO, V177, P847, DOI 10.1016/0006-291X(91)91867-C; FUJISAWA Y, 1992, COMP BIOCHEM PHYS C, V102, P91, DOI 10.1016/0742-8413(92)90049-D; Gruninger TR, 2007, MOL NEUROBIOL, V35, P1; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P528, DOI 10.1152/jn.1988.59.2.528; HEINZEL HG, 1988, J NEUROPHYSIOL, V59, P551, DOI 10.1152/jn.1988.59.2.551; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Horn CC, 2004, J NEUROPHYSIOL, V92, P157, DOI 10.1152/jn.01190.2003; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; JACKLET JW, 1984, INT REV CYTOL, V89, P251, DOI 10.1016/S0074-7696(08)61305-4; JAHANPARWAR B, 1980, BRAIN RES BULL, V5, P169, DOI 10.1016/0361-9230(80)90190-2; JAHANPARWAR B, 1978, J NEUROPHYSIOL, V41, P600, DOI 10.1152/jn.1978.41.3.600; JAHANPARWAR B, 1979, BEHAV NEURAL BIOL, V27, P39, DOI 10.1016/S0163-1047(79)92744-4; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2015, J NEUROSCI, V35, P9137, DOI 10.1523/JNEUROSCI.0180-15.2015; Jing J, 2009, REV NEUROSCIENCE, V20, P405; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz PS, 1996, TRENDS NEUROSCI, V19, P54, DOI 10.1016/0166-2236(96)89621-4; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; KUPFERMA.I, 1974, BEHAV BIOL, V12, P317, DOI 10.1016/S0091-6773(74)91503-X; LLOYD PE, 1989, J NEUROSCI, V9, P312; Lum CS, 2005, J NEUROPHYSIOL, V94, P2427, DOI 10.1152/jn.00280.2005; MACKEY S, 1983, J NEUROSCI, V3, P1469; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nusbaum MP, 2012, CURR OPIN NEUROBIOL, V22, P592, DOI 10.1016/j.conb.2012.01.003; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R; PEARSON WL, 1990, J NEUROBIOL, V21, P883, DOI 10.1002/neu.480210606; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; Sieling F, 2014, CURR BIOL, V24, P941, DOI 10.1016/j.cub.2014.03.004; Strand FL, 1999, NEUROPEPTIDES REGULA; Thorsell A, 2010, EXP BIOL MED, V235, P1163, DOI 10.1258/ebm.2010.009331; VONDERPORTEN K, 1982, BEHAV NEURAL BIOL, V36, P1; Vorster APA, 2014, SLEEP, V37, P1453, DOI 10.5665/sleep.3992; Watts AG, 2002, STEVENS HDB EXPT PSY, V3, P563, DOI DOI 10.1002/0471214426.PAS0314; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wu JS, 2014, J NEUROSCI, V34, P6510, DOI 10.1523/JNEUROSCI.5094-13.2014; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9; Zhang YL, 2012, NAT NEUROSCI, V15, P294, DOI 10.1038/nn.2990; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	63	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147335	10.1371/journal.pone.0147335	http://dx.doi.org/10.1371/journal.pone.0147335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796097	Green Submitted, gold, Green Published			2022-12-27	WOS:000368530300030
J	Frade, PR; Roll, K; Bergauer, K; Herndl, GJ				Frade, Pedro R.; Roll, Katharina; Bergauer, Kristin; Herndl, Gerhard J.			Archaeal and Bacterial Communities Associated with the Surface Mucus of Caribbean Corals Differ in Their Degree of Host Specificity and Community Turnover Over Reefs	PLOS ONE			English	Article							MICROBIAL DIVERSITY; BIOGEOGRAPHY; VARIABILITY; HEALTHY; TISSUE; SEA	Comparative studies on the distribution of archaeal versus bacterial communities associated with the surface mucus layer of corals have rarely taken place. It has therefore remained enigmatic whether mucus-associated archaeal and bacterial communities exhibit a similar specificity towards coral hosts and whether they vary in the same fashion over spatial gradients and between reef locations. We used microbial community profiling (terminal-restriction fragment length polymorphism, T-RFLP) and clone library sequencing of the 16S rRNA gene to compare the diversity and community structure of dominant archaeal and bacterial communities associating with the mucus of three common reef-building coral species (Porites astreoides, Siderastrea siderea and Orbicella annularis) over different spatial scales on a Caribbean fringing reef. Sampling locations included three reef sites, three reef patches within each site and two depths. Reference sediment samples and ambient water were also taken for each of the 18 sampling locations resulting in a total of 239 samples. While only 41% of the bacterial operational taxonomic units (OTUs) characterized by T-RFLP were shared between mucus and the ambient water or sediment, for archaeal OTUs this percentage was 2-fold higher (78%). About half of the mucus-associated OTUs (44% and 58% of bacterial and archaeal OTUs, respectively) were shared between the three coral species. Our multivariate statistical analysis (ANOSIM, PERMANOVA and CCA) showed that while the bacterial community composition was determined by habitat (mucus, sediment or seawater), host coral species, location and spatial distance, the archaeal community composition was solely determined by the habitat. This study highlights that mucus-associated archaeal and bacterial communities differ in their degree of community turnover over reefs and in their host-specificity.	[Frade, Pedro R.; Roll, Katharina; Bergauer, Kristin; Herndl, Gerhard J.] Univ Vienna, Dept Limnol & Biooceanog, Ctr Ecol, Althanstr 14, A-1090 Vienna, Austria; [Frade, Pedro R.] Caribbean Res & Management Biodivers CARMABI Fdn, POB 2090, Willemstad, Curacao, Netherlands; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands	University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Frade, PR (corresponding author), Univ Vienna, Dept Limnol & Biooceanog, Ctr Ecol, Althanstr 14, A-1090 Vienna, Austria.; Frade, PR (corresponding author), Caribbean Res & Management Biodivers CARMABI Fdn, POB 2090, Willemstad, Curacao, Netherlands.	pedro.rodrigues.frade@univie.ac.at	Bergauer, Kristin/AAG-3050-2021; Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Bergauer, Kristin/0000-0003-3018-0711; Rodrigues Frade, Pedro/0000-0002-4010-255X	Marie Curie fellowship (Seventh Framework Programme) from the Lise Meitner Program of the Austrian Science Fund (FWF) [FP7-299320]; Lise Meitner Program of the Austrian Science Fund (FWF) [M1363-B20]; Austrian Science Fund (FWF) [I486-B09, P23234-B11]; FWF [I486-B09, P23234-B11]; Austrian Science Fund (FWF) [I 486] Funding Source: researchfish	Marie Curie fellowship (Seventh Framework Programme) from the Lise Meitner Program of the Austrian Science Fund (FWF); Lise Meitner Program of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Financial support was provided by Marie Curie fellowship (Seventh Framework Programme) FP7-299320 and fellowship M1363-B20 from the Lise Meitner Program of the Austrian Science Fund (FWF) to PRF. Additional support by the Austrian Science Fund (FWF) projects I486-B09 and P23234-B11 to GJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Thanks to Christian Baranyi for lab assistance at the University of Vienna. Financial support for fieldwork, lab consumables and sequencing costs was provided by Marie Curie fellowship FP7-299320 and fellowship M1363-B20 from the Lise Meitner Program of the Austrian Science Fund (FWF) to PRF, and the FWF projects I486-B09 and P23234-B11 to GJH. We are grateful to one anonymous reviewer for comments that greatly improved the manuscript.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bourne DG, 2013, ISME J, V7, P1452, DOI 10.1038/ismej.2012.172; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Ceh J, 2013, MICROB ECOL, V65, P227, DOI 10.1007/s00248-012-0105-z; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Daniels CA, 2011, MAR ECOL PROG SER, V426, P29, DOI 10.3354/meps09024; de la Fuente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101435; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Frade PR, 2016, ENVIRON CHEM, V13, P252, DOI 10.1071/EN15023; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gast GJ, 1999, B MAR SCI, V65, P523; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hewson I, 2006, MAR ECOL PROG SER, V306, P79, DOI 10.3354/meps306079; Kellogg CA, 2004, MAR ECOL PROG SER, V273, P81, DOI 10.3354/meps273081; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Pantos O, 2015, ISME J, V9, P1916, DOI 10.1038/ismej.2015.3; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rodriguez-Lanetty M, 2013, MOL ECOL, V22, P4349, DOI 10.1111/mec.12392; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Siboni N, 2008, ENVIRON MICROBIOL, V10, P2979, DOI 10.1111/j.1462-2920.2008.01718.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Tout J, 2014, MICROB ECOL, V67, P540, DOI 10.1007/s00248-013-0362-5; Tremblay P, 2011, J MAR BIOL ASSOC UK, V91, P649, DOI 10.1017/S002531541000130X; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344	47	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144702	10.1371/journal.pone.0144702	http://dx.doi.org/10.1371/journal.pone.0144702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788724	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100004
J	Ouyang, B; Jiang, LR; Teng, ZS				Ouyang, Bo; Jiang, Lurong; Teng, Zhaosheng			A Noise-Filtering Method for Link Prediction in Complex Networks	PLOS ONE			English	Article							CASCADING FAILURES; OPTIMIZATION; MODEL; RISK	Link prediction plays an important role in both finding missing links in networked systems and complementing our understanding of the evolution of networks. Much attention from the network science community are paid to figure out how to efficiently predict the missing/future links based on the observed topology. Real-world information always contain noise, which is also the case in an observed network. This problem is rarely considered in existing methods. In this paper, we treat the existence of observed links as known information. By filtering out noises in this information, the underlying regularity of the connection information is retrieved and then used to predict missing or future links. Experiments on various empirical networks show that our method performs noticeably better than baseline algorithms.	[Ouyang, Bo; Teng, Zhaosheng] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China; [Jiang, Lurong] Zhejiang Sci Tech Univ, Sch Informat Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Hunan University; Zhejiang Sci-Tech University	Ouyang, B (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China.	ouyangbo@hnu.edu.cn			Fundamental Research Funds for the Central Universities of China [531107040852]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by Fundamental Research Funds for the Central Universities of China, Grant No. 531107040852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge B. Y. Zhu, for his helpful suggestions. This work is supported by the Fundamental Research Funds for the Central Universities of China, Grant No. 531107040852.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; BURT RS, 1976, SOC FORCES, V55, P93, DOI 10.2307/2577097; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Chung F., 1997, SPECTRAL GRAPH THEOR; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Horn RA., 1985, MATRIX ANAL; Huang XQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01219; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2015, P NATL ACAD SCI USA, V112, P2325, DOI 10.1073/pnas.1424644112; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Scott J., 2012, SOCIAL NETWORK ANAL; Spring N, 2002, ACM SIGCOMM COMP COM, V32, P133, DOI 10.1145/964725.633039; Tan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107056; Ulanowicz R.E., 2005, US GEOL SURV PROGRAM, V114, P45; Vladimir B, PAJEK DATASETS; Vladimir B, 2006, PAJEK DATASETS; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang Peng, 2015, [Science China. Information Science, 中国科学. 信息科学], V58, P011101; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westermarck J, 2013, MOL CELL PROTEOMICS, V12, P1752, DOI 10.1074/mcp.R113.027771; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhang QM, 2014, ARXIV14103519; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8; Zhu BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13707	45	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146925	10.1371/journal.pone.0146925	http://dx.doi.org/10.1371/journal.pone.0146925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788737	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100046
J	Rewatkar, PV; Parekh, HS; Parat, MO				Rewatkar, Prarthana V.; Parekh, Harendra S.; Parat, Marie-Odile			Molecular Determinants of the Cellular Entry of Asymmetric Peptide Dendrimers and Role of Caveolae	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; SURFACE-CHARGE; ANIONIC SITES; DIFFERENTIATED MICRODOMAINS; TRANSLOCATION MECHANISMS; CAPILLARY ENDOTHELIUM; PAMAM DENDRIMERS; LUMINAL SURFACE; DELIVERY; MEMBRANE	Caveolae are flask-shaped plasma membrane subdomains abundant in most cell types that participate in endocytosis. Caveola formation and functions require membrane proteins of the caveolin family, and cytoplasmic proteins of the cavin family. Cationic peptide dendrimers are non-vesicular chemical carriers that can transport pharmacological agents or genetic material across the plasma membrane. We prepared a panel of cationic dendrimers and investigated whether they require caveolae to enter into cells. Cell-based studies were performed using wild type or caveola-deficient i.e. caveolin-1 or PTRF gene-disrupted cells. There was a statistically significant difference in entry of cationic dendrimers between wild type and caveola-deficient cells. We further unveiled differences between dendrimers with varying charge density and head groups. Our results show, using a molecular approach, that (i) expression of caveola-forming proteins promotes cellular entry of cationic dendrimers and (ii) dendrimer structure can be modified to promote endocytosis in caveola-forming cells.	[Rewatkar, Prarthana V.; Parekh, Harendra S.; Parat, Marie-Odile] Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia	University of Queensland	Parekh, HS; Parat, MO (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia.	h.parekh@uq.edu.au; m.parat@uq.edu.au	Parekh, Harendra S/D-6846-2011; Parekh, Harendra/P-3964-2019; Parat, Marie-Odile/G-4410-2010	Parekh, Harendra S/0000-0001-8792-4318; Parekh, Harendra/0000-0001-8792-4318; Parat, Marie-Odile/0000-0003-4895-7381	School of Pharmacy	School of Pharmacy	This study was entirely funded by internal funds from the School of Pharmacy to MOP and HSP.	Albertazzi L, 2012, BIOMACROMOLECULES, V13, P4089, DOI 10.1021/bm301384y; Billiet L, 2012, BIOMATERIALS, V33, P2980, DOI 10.1016/j.biomaterials.2011.12.027; Biswas S, 2013, PHARMACEUTICALS-BASE, V6, P161, DOI 10.3390/ph6020161; Buczkowski A, 2011, INT J PHARMACEUT, V408, P266, DOI 10.1016/j.ijpharm.2011.02.014; Bugno J, 2015, BIOMATER SCI-UK, V3, P1025, DOI 10.1039/c4bm00351a; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Cordes H, 2007, BIOMACROMOLECULES, V8, P3578, DOI 10.1021/bm7006168; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Futaki S, 2002, INT J PHARM, V245, P1, DOI 10.1016/S0378-5173(02)00337-X; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Kaneshiro TL, 2009, BIOMATERIALS, V30, P5660, DOI 10.1016/j.biomaterials.2009.06.026; Kim TI, 2007, BIOMATERIALS, V28, P2061, DOI 10.1016/j.biomaterials.2006.12.013; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu XX, 2015, NANOSCALE, V7, P3867, DOI 10.1039/c4nr04759a; Maiti PK, 2004, MACROMOLECULES, V37, P6236, DOI 10.1021/ma035629b; Naka K, 2012, POLYM J, V44, P353, DOI 10.1038/pj.2011.145; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Parat MO, 2001, J BIOL CHEM, V276, P15776, DOI 10.1074/jbc.M006722200; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Perumal OP, 2008, BIOMATERIALS, V29, P3469, DOI 10.1016/j.biomaterials.2008.04.038; Rewatkar PV, 2015, ADV DRUG DELIVER REV, V91, P92, DOI 10.1016/j.addr.2015.01.003; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Schlormann W, 2010, HISTOCHEM CELL BIOL, V133, P223, DOI 10.1007/s00418-009-0651-8; Shah N, 2011, J PEPT SCI, V17, P470, DOI 10.1002/psc.1347; Shah ND, 2014, PHARM RES-DORDR, V31, P3150, DOI 10.1007/s11095-014-1408-1; SIMIONESCU D, 1983, MICROVASC RES, V25, P85, DOI 10.1016/0026-2862(83)90045-6; SIMIONESCU M, 1981, J CELL BIOL, V90, P614, DOI 10.1083/jcb.90.3.614; SIMIONESCU N, 1981, J CELL BIOL, V90, P605, DOI 10.1083/jcb.90.3.605; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Topp A, 1999, MACROMOLECULES, V32, P7232, DOI 10.1021/ma9901240; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147491	10.1371/journal.pone.0147491	http://dx.doi.org/10.1371/journal.pone.0147491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788849	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100089
J	Besada, D; Kerber, K; Leon, N; Sanders, D; Daviaud, E; Rohde, S; Rohde, J; van Damme, W; Kinney, M; Manda, S; Oliphant, NP; Hachimou, F; Ouedraogo, A; Ghali, AY; Doherty, T				Besada, Donela; Kerber, Kate; Leon, Natalie; Sanders, David; Daviaud, Emmanuelle; Rohde, Sarah; Rohde, Jon; van Damme, Wim; Kinney, Mary; Manda, Samuel; Oliphant, Nicholas P.; Hachimou, Fatima; Ouedraogo, Adama; Ghali, Asma Yaroh; Doherty, Tanya			Niger's Child Survival Success, Contributing Factors and Challenges to Sustainability: A Retrospective Analysis	PLOS ONE			English	Article							LIVES SAVED TOOL; CASE-MANAGEMENT; INTERVENTIONS; MORTALITY; MODEL	Background Household surveys undertaken in Niger since 1998 have revealed steady declines in under-5 mortality which have placed the country 'on track' to reach the fourth Millennium Development goal (MDG). This paper explores Niger's mortality and health coverage data for children under-5 years of age up to 2012 to describe trends in high impact interventions and the resulting impact on childhood deaths averted. The sustainability of these trends are also considered. Methods and Findings Estimates of child mortality using the 2012 Demographic and Health Survey were developed and maternal and child health coverage indicators were calculated over four time periods. Child survival policies and programmes were documented through a review of documents and key informant interviews. The Lives Saved Tool (LiST) was used to estimate the number of child lives saved and identify which interventions had the largest impact on deaths averted. The national mortality rate in children under-5 decreased from 286 child deaths per 1000 live births (95% confidence interval 177 to 394) in the period 1989-1990 to 128 child deaths per 1000 live births in the period 2011-2012 (101 to 155), corresponding to an annual rate of decline of 3.6%, with significant declines taking place after 1998. Improvements in the coverage of maternal and child health interventions between 2006 and 2012 include one and four or more antenatal visits, maternal Fansidar and tetanus toxoid vaccination, measles and DPT3 vaccinations, early and exclusive breastfeeding, oral rehydration salts (ORS) and proportion of children sleeping under an insecticide-treated bed net (ITN). Approximately 26,000 deaths of children under-5 were averted in 2012 due to decreases in stunting rates (27%), increases in ORS (14%), the Hib vaccine (14%), and breastfeeding (11%). Increases in wasting and decreases in vitamin A supplementation negated some of those gains. Care seeking at the community level was responsible for an estimated 7,800 additional deaths averted in 2012. A major policy change occurred in 2006 enabling free health care provision for women and children, and in 2008 the establishment of a community health worker programme. Conclusion Increases in access and coverage of care for mothers and children have averted a considerable number of childhood deaths. The 2006 free health care policy and health post expansion were paramount in reducing barriers to care. However the sustainability of this policy and health service provision is precarious in light of persistently high fertility rates, unpredictable GDP growth, a high dependence on donor support and increasing pressures on government funding.	[Besada, Donela; Leon, Natalie; Daviaud, Emmanuelle; Rohde, Sarah; Rohde, Jon; Doherty, Tanya] South African Med Res Council, Hlth Syst Res Unit, Francie Zijl Dr, ZA-7535 Cape Town, South Africa; [Kerber, Kate; Kinney, Mary] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Sanders, David; van Damme, Wim; Doherty, Tanya] Univ Western Cape, Sch Publ Hlth, Robert Sobukwe Rd, ZA-7535 Cape Town, South Africa; [van Damme, Wim] Inst Trop Med, Sint Rochusstr 2, B-2000 Antwerp, Belgium; [Manda, Samuel] South African Med Res Council, Biostat Res Unit, 1 Soutpansberg Rd, ZA-0001 Pretoria, South Africa; [Oliphant, Nicholas P.] UNICEF Head Off, 125 Maiden Lane,11th Floor, New York, NY 10038 USA; [Hachimou, Fatima] UNICEF Niger, 2 Rue Oasis Quartier Ancien Plateau, Niamey, Niger; [Ouedraogo, Adama] UNICEF Benin, 01 BP 2289 Cotonou Blvd CEN SAD, Cotonou, Benin; [Ghali, Asma Yaroh] Minist Hlth, BP 613, Niamey, Niger; [Sanders, David] Univ Cape Town, Fac Hlth Sci, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Manda, Samuel] Univ Kwazulu Natal, Sch Math Stat & Comp Sci, King George V Ave, ZA-4041 Durban, South Africa	South African Medical Research Council; Save the Children; University of the Western Cape; Institute of Tropical Medicine (ITM); South African Medical Research Council; UNICEF; University of Cape Town; University of Kwazulu Natal	Doherty, T (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Francie Zijl Dr, ZA-7535 Cape Town, South Africa.; Doherty, T (corresponding author), Univ Western Cape, Sch Publ Hlth, Robert Sobukwe Rd, ZA-7535 Cape Town, South Africa.	tanya.doherty@mrc.ac.za	Van Damme, Wim/F-7404-2011; Kinney, Mary V/M-6952-2013	Van Damme, Wim/0000-0002-6344-3007; Kinney, Mary V/0000-0002-2903-0161; Besada, Donela/0000-0002-2020-5244; Manda, Samuel/0000-0002-9672-3312	Catalytic Initiative - Department of Foreign Affairs, Trade and Development Canada (DFATD); South African Medical Research Council; UNICEF [43126165]; National Research Foundation, South Africa; Save the Children's Saving Newborn Lives program - Bill & Melinda Gates Foundation	Catalytic Initiative - Department of Foreign Affairs, Trade and Development Canada (DFATD); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UNICEF; National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council); Save the Children's Saving Newborn Lives program - Bill & Melinda Gates Foundation	This evaluation was supported through Catalytic Initiative funding by the Department of Foreign Affairs, Trade and Development Canada (DFATD), the South African Medical Research Council and UNICEF (contract number 43126165). TD and DS are supported by the National Research Foundation, South Africa. KK and MK are supported by Save the Children's Saving Newborn Lives program, which is funded by a grant from the Bill & Melinda Gates Foundation. The sponsors of the study had no role in the study design, data collection, data analysis, data interpretation or in the decision to submit the paper for publication. The evaluation team had full access to all study data and had final responsibility for the decision to submit for publication.; This evaluation was supported through Catalytic Initiative funding by the Department of Foreign Affairs, Trade and Development Canada (DFATD), the South African Medical Research Council and UNICEF. We thank the Niger Ministry of Health and UNICEF country office for their assistance with the field visit. TD and DS are supported by the National Research Foundation, South Africa. KK and MK are supported by Save the Children's Saving Newborn Lives program, which is funded by a grant from the Bill & Melinda Gates Foundation. We acknowledge the role of Dr David Hercot in the development of the protocol for this evaluation. We would also like to acknowledge the comments received from Dr Theresa Diaz, Prof Debra Jackson and Mr Christian Salazar on the manuscript draft which helped to strengthen the paper.	Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], 2010, LANCET, V376, P1274, DOI 10.1016/S0140-6736(10)61897-1; [Anonymous], 2000, NIG REC US 890 MILL; [Anonymous], 2011, STATEMENT IMF MANAGI; Boschi-Pinto C, 2011, INT J EPIDEMIOL, V40, P520, DOI 10.1093/ije/dyq171; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Bureau of African Affairs US Department of State, 2013, US REL NIG FACT SHEE; Canadian International Development Agency, CAT IN SAV MILL LIV; Central Intelligence Agency, POP POV LIN 2014; Cornia GA, 2008, NIGERS 2005 FOOD CRI; Doherty T, 2014, REPORT SUMMATIVE EXT; Flynn D, 2014, SPECIAL REPORT AREVA; Friberg IK, 2014, J GLOB HEALTH, V4, P186, DOI 10.7189/jogh.04.020412; Guenther T, 2012, AM J TROP MED HYG, V87, P77, DOI 10.4269/ajtmh.2012.11-0747; Index Mundi, NIG POP GROWTH RAT 2; Institut National de la Statistique Ministere de l'Economie et des Finances, 2011, ENQ NAT SURV ENF 0 5; Institut National de la Statistique Ministere de l'Economie et des Finances Macro International Inc, 2007, ENQ DEM SANT IND MUL; Institut National de la Statistique Ministere de l'Economie et des Finances Macro International Inc, 2013, ENQ DEM SANT IND MUL; International Monetary Fund, 2007, NIG 5 REV 3 YEAR ARR; Leon N, 2014, REPORT SUMMATIVE EXT; Leon N, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27214; Liu L, 2014, LANCET; LOUTAN L, 1984, LANCET, V1, P945; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Oliphant NP, 2014, J GLOB HEALTH, V4, P140, DOI 10.7189/jogh.04.020408; Olivier de Sardan JP, 2012, JOINT COMM PRACT WOR; Pedersen J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001289; Republique du Niger UNICEF, 2000, ENQ IND MULT FIN DEC; Rutstein SO, 2006, GUIDE DHS STAT; Storo C, 2010, FOOD INSECURITY NIGE; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; The World Data Bank, 2014, OUT OF POCK HLTH EXP; The World Data Bank, 2014, HLTH EXP PUBL GOV EX; Thurston A, 2011, UPDATE FLOOD REFUGEE; Trading Economics, 2015, RUR POP TOT POP NIG; UNHCR, UNHCR ADDR NEEDS 200; UNICEF, 2014, UNICEF FIN REP CIDA; UNICEF, 2013, AT A GLANC; UNICEF, 2014, GEN 2030 AFR; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; United Nations High Comissioner for Refugees, 2014, 2014 UNHCR COUNTR OP; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Bank, WORLD DEV IND 2015	44	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146945	10.1371/journal.pone.0146945	http://dx.doi.org/10.1371/journal.pone.0146945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784993	gold, Green Published			2022-12-27	WOS:000368528400082
J	Biondo, AE; Giarlotta, A; Pluchino, A; Rapisarda, A				Biondo, Alessio Emanuele; Giarlotta, Alfio; Pluchino, Alessandro; Rapisarda, Andrea			Perfect Information vs Random Investigation: Safety Guidelines for a Consumer in the Jungle of Product Differentiation	PLOS ONE			English	Article							CHOICE; ENVIRONMENT; STRATEGIES; MODELS	We present a graph-theoretic model of consumer choice, where final decisions are shown to be influenced by information and knowledge, in the form of individual awareness, discriminating ability, and perception of market structure. Building upon the distance-based Hotelling's differentiation idea, we describe the behavioral experience of several prototypes of consumers, who walk a hypothetical cognitive path in an attempt to maximize their satisfaction. Our simulations show that even consumers endowed with a small amount of information and knowledge may reach a very high level of utility. On the other hand, complete ignorance negatively affects the whole consumption process. In addition, rather unexpectedly, a random walk on the graph reveals to be a winning strategy, below a minimal threshold of information and knowledge.	[Biondo, Alessio Emanuele; Giarlotta, Alfio] Univ Catania, Dept Econ & Business, Corso Italia 55, I-95129 Catania, Italy; [Pluchino, Alessandro; Rapisarda, Andrea] Univ Catania, Dept Phys & Astron, Via S Sofia 64, I-95123 Catania, Italy; [Pluchino, Alessandro; Rapisarda, Andrea] Ist Nazl Fis Nucl, Sect Catania, Via S Sofia 64, I-95123 Catania, Italy	University of Catania; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN)	Biondo, AE (corresponding author), Univ Catania, Dept Econ & Business, Corso Italia 55, I-95129 Catania, Italy.	ae.biondo@unict.it	Rapisarda, Andrea/S-2758-2019; Rapisarda, Andrea/D-2453-2014; Biondo, Alessio Emanuele/C-3951-2015	Rapisarda, Andrea/0000-0001-8290-8183; Rapisarda, Andrea/0000-0001-8290-8183; Biondo, Alessio Emanuele/0000-0002-1421-3707; Giarlotta, Alfio/0000-0002-2109-1381	FIR Research Project of the University of Catania [2014 N.ABDD94]	FIR Research Project of the University of Catania	This work was partially supported by the FIR Research Project 2014 N.ABDD94 of the University of Catania.	AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Arana JE, 2009, ECOL ECON, V68, P2316, DOI 10.1016/j.ecolecon.2009.03.003; Ariel Rubinstein, 1998, MODELING BOUNDED RAT, V1; Balasubramanian S, 2005, J INTERACT MARK, V19, P12, DOI 10.1002/dir.20032; Bela Bollobas, 1998, MODERN GRAPH THEORY, V184; Berkowitsch NAJ, 2014, J EXP PSYCHOL GEN, V143, P1331, DOI 10.1037/a0035159; Bernard Roy, 1985, ECONOMICA; Bettman James R., 1979, J MARKETING; Bettman JR, 1998, J CONSUM RES, V25, P187, DOI 10.1086/209535; Biondo AE, 2014, CONTEMP PHYS, V55, P318, DOI 10.1080/00107514.2014.929308; Biondo AE, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062814; Biondo AE, 2014, AGROECOL SUST FOOD, V38, P230, DOI 10.1080/21683565.2013.841609; Biondo AE, 2013, J STAT PHYS, V151, P607, DOI 10.1007/s10955-013-0691-2; Bridges Douglas S, 2013, REPRESENTATIONS PREF, V422; Broder A, 2010, JUDGM DECIS MAK, V5, P326; Cellini Roberto, 2015, KNOW NOT KNOW ENDOGE; Chamberlin Edward Hastings, 1962, THEORY MONOPOLISTIC, V38; Chartrand TL, 2008, J CONSUM RES, V35, P189, DOI 10.1086/588685; CREMER H, 1991, J IND ECON, V39, P383, DOI 10.2307/2098438; DEPALMA A, 1994, AM ECON REV, V84, P419; DIXIT AK, 1977, AM ECON REV, V67, P297; Emanuele Biondo Alessio, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068344, DOI 10.1371/J0URNAL.P0NE.0068344]; Fuad Aleskerov, 2007, UTILITY MAXIMIZATION, V16; GABSZEWICZ JJ, 1980, J ECON THEORY, V22, P327; GABSZEWICZ JJ, 1979, J ECON THEORY, V20, P340; Gilboa I, 2001, SOC CHOICE WELFARE, V18, P269, DOI 10.1007/s003550100103; GROSSMAN GM, 1984, REV ECON STUD, V51, P63, DOI 10.2307/2297705; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kahn BE., 1995, J RETAIL CONSUM SERV, V2, P139, DOI DOI 10.1016/0969-6989(95)00038-0; Keeney Ralph L, 1993, DECISIONS MULTIPLE O; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; LIPMAN BL, 1995, CAN J ECON, V28, P42, DOI 10.2307/136022; Nosofsky RM, 2000, PSYCHON B REV, V7, P375; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Payne J., 1991, HDB CONSUMER BEHAV, P50; Pluchino A, 2011, PHYSICA A, V390, P3944, DOI 10.1016/j.physa.2011.06.028; Pluchino A, 2011, PHYSICA A, V390, P3496, DOI 10.1016/j.physa.2011.05.021; Pluchino A, 2010, PHYSICA A, V389, P467, DOI 10.1016/j.physa.2009.09.045; Riley JG, 2001, J ECON LIT, V39, P432, DOI 10.1257/jel.39.2.432; SALOP SC, 1979, BELL J ECON, V10, P141, DOI 10.2307/3003323; Scheibehenne B, 2015, J ECON PSYCHOL, V46, P39, DOI 10.1016/j.joep.2014.11.006; Scheibehenne B, 2013, PSYCHOL REV, V120, P39, DOI 10.1037/a0030777; Schwartz B, 2004, SCI AM, V290, P70, DOI 10.1038/scientificamerican0404-70; SELTEN R, 1978, THEOR DECIS, V9, P127, DOI 10.1007/BF00131770; SHAKED A, 1983, ECONOMETRICA, V51, P1469, DOI 10.2307/1912285; SHAKED A, 1982, REV ECON STUD, V49, P3, DOI 10.2307/2297136; Simon H. A., 1976, 25 YEARS EC THEORY, P65, DOI DOI 10.1007/978-1-4613-4367-7_6; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sirieix L, 2013, INT J CONSUM STUD, V37, P143, DOI 10.1111/j.1470-6431.2012.01109.x; Sivaramakrishnan S, 2007, J INTERACT MARK, V21, P60, DOI 10.1002/dir.20075; SPENCE M, 1976, REV ECON STUD, V43, P217, DOI 10.2307/2297319; Swait J, 2001, ORGAN BEHAV HUM DEC, V86, P141, DOI 10.1006/obhd.2000.2941; Zaccaria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113770	54	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146389	10.1371/journal.pone.0146389	http://dx.doi.org/10.1371/journal.pone.0146389			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784700	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400035
J	Fernandez-Murga, ML; Sanz, Y				Leonor Fernandez-Murga, M.; Sanz, Yolanda			Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROBIOTIC STRAINS; GENE-EXPRESSION; OBESITY; COLONIZATION; COMMENSAL; RISK; ACID; FOOD	Background Bacteroides uniformis CECT 7771 is a potential probiotic strain, originally isolated from the stools of healthy breast-feed infants. The strain showed pre-clinical efficacy in a mouse obesity model. The objective of this study was to evaluate its potential toxicity and translocation ability after acute oral administration to mice. Methods and Findings A safety study was conducted in immunocompetent and immunosuppressed C57BL-6 mice. Both mouse groups (n = 10 per group) were fed orally 2 x 10(9) colony forming units (cfu)/day of B. uniformis CECT 7771 or placebo by gavage for 6 days. Throughout this time, feed and water intake and body weight were monitored. Afterwards, mice were sacrificed and biological samples were collected to analyze blood and urine biochemistry, inflammatory and immune markers; gut mucosal histology and bacterial translocation to peripheral tissues. The results demonstrated that acute ingestion of this Bacteroides strain had no adverse effects on the animals' general health status or food intake, nor did it affect biochemical indicators of liver, kidney and pancreatic function or gut mucosal histology. Findings also demonstrated that administration did not lead to bacterial translocation to blood, liver or mesenteric lymph nodes. B. uniformis CECT 7771 also downregulated gene and protein expression (iNOS and PPAR-gamma) and inflammatory cytokines induced by immunosuppression. Conclusions The findings indicate that the acute oral consumption of B. uniformis CECT 7771 does not raise safety concerns in mice. Further studies in humans should be conducted.	[Leonor Fernandez-Murga, M.; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia, Spain.	yolsanz@iata.csic.es	Fernández-Murga, Leonor/N-3532-2019; Sanz, Yolanda/H-5498-2012	Fernández-Murga, Leonor/0000-0001-7123-9834; Sanz, Yolanda/0000-0002-1615-1976	EU [613979]	EU(European Commission)	This study was supported by the EU Project no 613979 (MyNewGut) from the 7th Framework Program.	Andreoletti O, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3938; Ank N, 2015, INT J ANTIMICROB AG, V46, P117, DOI 10.1016/j.ijantimicag.2015.02.024; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Chenoll E, 2011, APPL ENVIRON MICROB, V77, P1335, DOI 10.1128/AEM.01820-10; Collins JK, 1998, INT DAIRY J, V8, P487, DOI 10.1016/S0958-6946(98)00073-9; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Davis RL, 2005, NITRIC OXIDE-BIOL CH, V12, P200, DOI 10.1016/j.niox.2005.04.005; de Kivit S, 2014, FRONT IMMUNOL, V18, P5; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ford HR, 1996, J PEDIATR SURG, V31, P486, DOI 10.1016/S0022-3468(96)90480-7; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Hong PY, 2008, APPL ENVIRON MICROB, V74, P2882, DOI 10.1128/AEM.02568-07; Jang BC, 2004, BIOCHEM PHARMACOL, V68, P2167, DOI 10.1016/j.bcp.2004.08.008; Kadowaki S, 2004, MOL CELL BIOCHEM, V262, P51, DOI 10.1023/B:MCBI.0000038215.89821.7f; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kumar H, 2015, CURR OPIN BIOTECH, V32, P99, DOI 10.1016/j.copbio.2014.11.021; Lara-Villoslada F, 2007, J DAIRY SCI, V90, P3583, DOI 10.3168/jds.2006-685; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA L, 1990, CURR MICROBIOL, V20, P177, DOI 10.1007/BF02091994; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; Meile L, 2008, INT J FOOD MICROBIOL, V126, P316, DOI 10.1016/j.ijfoodmicro.2007.08.019; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Munoz JAM, 2011, APPL ENVIRON MICROB, V77, P8775, DOI 10.1128/AEM.05548-11; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; Neef A, 2013, CURR OPIN CLIN NUTR, V16, P679, DOI 10.1097/MCO.0b013e328365c258; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Playne M., 1994, FOOD AUSTR, P46; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Stine KE, 1996, PRINCIPLES TOXICOLOG, P1; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhou JS, 2000, INT J FOOD MICROBIOL, V56, P87, DOI 10.1016/S0168-1605(00)00219-1; [No title captured]	39	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145503	10.1371/journal.pone.0145503	http://dx.doi.org/10.1371/journal.pone.0145503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784747	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400014
J	Pampalona, J; Roscioli, E; Silkworth, WT; Bowden, B; Genesca, A; Tusell, L; Cimini, D				Pampalona, Judit; Roscioli, Emanuele; Silkworth, William T.; Bowden, Brent; Genesca, Anna; Tusell, Laura; Cimini, Daniela			Chromosome Bridges Maintain Kinetochore-Microtubule Attachment throughout Mitosis and Rarely Break during Anaphase	PLOS ONE			English	Article							TOPOISOMERASE-II INHIBITION; SISTER-CHROMATID COHESION; MAMMARY EPITHELIAL-CELLS; DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; TELOMERE DYSFUNCTION; DNA-DAMAGE; MITOTIC INSTABILITY; SEGREGATION ERRORS; SPINDLE MECHANICS	Accurate chromosome segregation during cell division is essential to maintain genome stability, and chromosome segregation errors are causally linked to genetic disorders and cancer. An anaphase chromosome bridge is a particular chromosome segregation error observed in cells that enter mitosis with fused chromosomes/sister chromatids. The widely accepted Breakage/Fusion/Bridge cycle model proposes that anaphase chromosome bridges break during mitosis to generate chromosome ends that will fuse during the following cell cycle, thus forming new bridges that will break, and so on. However, various studies have also shown a link between chromosome bridges and aneuploidy and/or polyploidy. In this study, we investigated the behavior and properties of chromosome bridges during mitosis, with the idea to gain insight into the potential mechanism underlying chromosome bridge-induced aneuploidy. We find that only a small number of chromosome bridges break during anaphase, whereas the rest persist through mitosis into the subsequent cell cycle. We also find that the microtubule bundles (k-fibers) bound to bridge kinetochores are not prone to breakage/detachment, thus supporting the conclusion that k-fiber detachment is not the cause of chromosome bridge-induced aneuploidy. Instead, our data suggest that while the microtubules bound to the kinetochores of normally segregating chromosomes shorten substantially during anaphase, the k-fibers bound to bridge kinetochores shorten only slightly, and may even lengthen, during anaphase. This causes some of the bridge kinetochores/chromosomes to lag behind in a position that is proximal to the cell/spindle equator and may cause the bridged chromosomes to be segregated into the same daughter nucleus or to form a micronucleus.	[Pampalona, Judit; Roscioli, Emanuele; Silkworth, William T.; Bowden, Brent; Cimini, Daniela] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Pampalona, Judit; Genesca, Anna; Tusell, Laura] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Bellaterra, Spain; [Roscioli, Emanuele] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Pampalona, Judit] Inst Res Biomed Barcelona, Cell Div Grp, C Baldiri Reixac 10-12, E-08028 Barcelona, Spain; [Roscioli, Emanuele] Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Mechanochem Cell Biol Bldg, Coventry CV4 7AL, W Midlands, England; [Silkworth, William T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bowden, Brent] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Autonomous University of Barcelona; Virginia Polytechnic Institute & State University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Warwick; University of California System; University of California Los Angeles; Virginia Polytechnic Institute & State University	Cimini, D (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cimini@vt.edu	Cimini, Daniela/A-3039-2016; Tusell, Laura/H-8699-2017; Genesca, Anna/J-4195-2017	Cimini, Daniela/0000-0002-4082-4894; Tusell, Laura/0000-0002-2848-345X; Pampalona, Judit/0000-0001-9454-0734; Genesca, Anna/0000-0002-0509-956X	Commonwealth Research Initiative; Fralin Research Institute; NSF [MCB-0842551, MCB-1517506]; HFSP grant [RGY0069/2010]; EURATOM grant [Dark. Risk GA 323216]; Ministerio de Economia y Competitividad grant [SAF2013-43801-P]; Instituto de Salud Carlos III [RD06/0020/1020]; Generalitat de Catalunya [2009 SGR-282, 2014 SGR-524, 2007FIC-00642, 2008BE100443];  [CSN2012-0001]; Direct For Biological Sciences [1517506] Funding Source: National Science Foundation	Commonwealth Research Initiative; Fralin Research Institute; NSF(National Science Foundation (NSF)); HFSP grant; EURATOM grant; Ministerio de Economia y Competitividad grant(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partly funded by the Commonwealth Research Initiative and the Fralin Research Institute. Additional funding was provided by: NSF grants MCB-0842551 and MCB-1517506 and HFSP grant RGY0069/2010 to DC; EURATOM grant Dark. Risk GA 323216 and CSN2012-0001 grant to AG; Ministerio de Economia y Competitividad grant SAF2013-43801-P to LT; Instituto de Salud Carlos III grant RD06/0020/1020 and Generalitat de Catalunya grants 2009 SGR-282 and 2014 SGR-524 to AG and LT. JP was supported by Generalitat de Catalunya (grants 2007FIC-00642 and 2008BE100443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJER A, 1958, CHROMOSOMA, V9, P319; BAJER A, 1963, HEREDITAS, V50, P179; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 1997, CYTOGENET CELL GENET, V76, P61, DOI 10.1159/000134517; CLARKE DJ, 1993, J CELL SCI, V105, P563; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895; Falck GCM, 2002, MUTAGENESIS, V17, P111, DOI 10.1093/mutage/17.2.111; Fouladi B, 2000, RADIAT RES, V153, P795, DOI 10.1667/0033-7587(2000)153[0795:CORODD]2.0.CO;2; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2005, CELL CYCLE, V4, P1007, DOI 10.4161/cc.4.8.1884; Glanz C, 2007, NEUROPATH APPL NEURO, V33, P440, DOI 10.1111/j.1365-2990.2007.00832.x; GORBSKY GJ, 1994, CANCER RES, V54, P1042; GROTE SJ, 1981, INT J RADIAT BIOL, V39, P395, DOI 10.1080/09553008114550491; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Houchmandzadeh B, 1997, J CELL BIOL, V139, P1, DOI 10.1083/jcb.139.1.1; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; Ladouceur AM, 2011, CURR BIOL, V21, pR388, DOI 10.1016/j.cub.2011.04.009; LaFountain JR, 2002, CELL MOTIL CYTOSKEL, V51, P16, DOI 10.1002/cm.10011; LaFountain JR, 2001, MOL BIOL CELL, V12, P4054, DOI 10.1091/mbc.12.12.4054; Lo AWI, 2002, MOL CELL BIOL, V22, P4836, DOI 10.1128/MCB.22.13.4836-4850.2002; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; McClintock B, 1944, GENETICS, V29, P478; McClintock B, 1941, GENETICS, V26, P234; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Montgomery E, 2003, CANCER BIOL THER, V2, P248, DOI 10.4161/cbt.2.3.362; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Pampalona J, 2012, PLOS GENET, V8, P601, DOI 10.1371/journal.pgen.1002679; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Poirier M, 2000, MOL BIOL CELL, V11, P269, DOI 10.1091/mbc.11.1.269; Quevedo O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002509; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Samoshkin A, 2012, CHROMOSOMA, V121, P191, DOI 10.1007/s00412-011-0353-6; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Sun MX, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015003; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tusell L, 2008, CYTOGENET GENOME RES, V122, P315, DOI 10.1159/000167818; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	68	37	38	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147420	10.1371/journal.pone.0147420	http://dx.doi.org/10.1371/journal.pone.0147420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784746	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400146
J	Shu, M; Zai, XL; Zhang, BN; Wang, R; Lin, ZH				Shu, Mao; Zai, Xiaoli; Zhang, Beina; Wang, Rui; Lin, Zhihua			Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ADVERSE DRUG-REACTIONS; RETINOID-X-RECEPTOR; THYROID-HORMONE; CANCER-PATIENTS; TRANSIENT HYPOTHYROIDISM; CELL; ASSOCIATION; ACID; PHARMACOLOGY	Tyrosine kinase inhibitors (TKIs) provide more effective targeted treatments for cancer, but are subject to a variety of adverse effects, such as hypothyroidism. TKI-induced hypothyroidism is a highly complicated issue, because of not only the unrealized toxicological mechanisms, but also different incidences of individual TKI drugs. While sunitinib is suspected for causing thyroid dysfunction more often than other TKIs, sorafenib is believed to be less risky. Here we integrated clinical data and in silico drug-protein interactions to examine the pharmacological distinction between sunitinib and sorafenib. Statistical analysis on the FDA Adverse Event Reporting System (FAERS) confirmed that sunitinib is more concurrent with hypothyroidism than sorafenib, which was observed in both female and male patients. Then, we used docking method and identified 3 proteins specifically binding to sunitinib but not sorafenib, i.e., retinoid X receptor alpha, retinoic acid receptors beta and gamma. As potential off-targets of sunitinib, these proteins are well known to assemble with thyroid hormone receptors, which can explain the profound impact of sunitinib on thyroid function. Taken together, we established a strategy of integrated analysis on clinical records and drug off-targets, which can be applied to explore the molecular basis of various adverse drug reactions.	[Shu, Mao; Zai, Xiaoli; Zhang, Beina; Wang, Rui; Lin, Zhihua] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400054, Peoples R China; [Lin, Zhihua] Chongqing Univ, Sch Chem & Chem Engn, Chongqing 400044, Peoples R China	Chongqing University of Technology; Chongqing University	Shu, M; Lin, ZH (corresponding author), Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400054, Peoples R China.; Lin, ZH (corresponding author), Chongqing Univ, Sch Chem & Chem Engn, Chongqing 400044, Peoples R China.	sm7507@126.com; zhlin@cqut.edu.cn			National Natural Science Foundation of China [31170747, 81171508]; Key Project of Natural Science Foundation of Chong Qing [CSTC 2013JJB10004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Chong Qing	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 31170747, 81171508), Key Project of Natural Science Foundation of Chong Qing (CSTC 2013JJB10004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31170747, 81171508), Key Project of Natural Science Foundation of Chong Qing (CSTC 2013JJB10004).	Ahmadieh H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/725410; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Bauer M, 2014, BIPOLAR DISORD, V16, P58, DOI 10.1111/bdi.12150; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; Boomsma MJ, 2011, RADIOTHER ONCOL, V99, P1, DOI 10.1016/j.radonc.2011.03.002; Chen H, 2014, MOL MED REP, V10, P2130, DOI 10.3892/mmr.2014.2399; Daimon M, 2012, JPN J CLIN ONCOL, V42, P742, DOI 10.1093/jjco/hys076; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Fujiwara Y, 2012, INVEST NEW DRUG, V30, P1055, DOI 10.1007/s10637-011-9637-1; Ganguly D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004247; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Grossmann M, 2008, CLIN ENDOCRINOL, V69, P669, DOI 10.1111/j.1365-2265.2008.03253.x; Hadj-Kacem H, 2009, INT J IMMUNOGENET, V36, P85, DOI 10.1111/j.1744-313X.2009.00830.x; Hartmann JT, 2009, CURR DRUG METAB, V10, P470, DOI 10.2174/138920009788897975; Haugen BR, 2009, BEST PRACT RES CL EN, V23, P793, DOI 10.1016/j.beem.2009.08.003; Huang SC, 2009, THYROID, V19, P13, DOI 10.1089/thy.2008.0002; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee S, 2005, MOL ENDOCRINOL, V19, P863, DOI 10.1210/me.2004-0210; Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2; Luboshitzky R, 1996, ISRAEL J MED SCI, V32, P60; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Mannavola D, 2007, J CLIN ENDOCR METAB, V92, P3531, DOI 10.1210/jc.2007-0586; Morganti S, 2005, J Endocrinol Invest, V28, P101; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Papaetis GS, 2009, BIODRUGS, V23, P377, DOI 10.2165/11318860-000000000-00000; Parks JS, 2010, PEDIATRICS, V125, pS54, DOI 10.1542/peds.2009-1975F; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Rezaeian S, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.13946; Riesenbeck LM, 2011, WORLD J UROL, V29, P807, DOI 10.1007/s00345-010-0627-2; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Schmidinger M, 2011, CANCER-AM CANCER SOC, V117, P534, DOI 10.1002/cncr.25422; Sun LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060598; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; SURKS MI, 1995, NEW ENGL J MED, V333, P1688, DOI 10.1056/NEJM199512213332507; Torino F, 2009, NAT REV CLIN ONCOL, V6, P219, DOI 10.1038/nrclinonc.2009.4; Torino F, 2009, THYROID, V19, P539, DOI 10.1089/thy.2008.0367; Wang GJ, 2015, BIOCHEM BIOPH RES CO, V457, P249, DOI 10.1016/j.bbrc.2014.12.096; Wang KJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003315; Weng ZQ, 2015, ONCOTARGET, V6, P17031, DOI 10.18632/oncotarget.4400; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wolter P, 2008, BRIT J CANCER, V99, P448, DOI 10.1038/sj.bjc.6604497; Wong E, 2007, THYROID, V17, P351, DOI 10.1089/thy.2006.0308; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110; Yang L, 2013, J FUDAN U NATURAL SC, V2013, P6; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang L, 2011, INTERDISCIP SCI, V3, P22, DOI 10.1007/s12539-011-0051-8; Yang L, 2010, PLOS ONE, V5, pA71, DOI 10.1371/journal.pone.0009568; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747	54	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147048	10.1371/journal.pone.0147048	http://dx.doi.org/10.1371/journal.pone.0147048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784451	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400100
J	Fang, LL; Yu, J; Jiang, Z; Guo, XJ				Fang, Linlin; Yu, Jia; Jiang, Zhen; Guo, Xingjie			Preparation of a beta-Cyclodextrin-Based Open-Tubular Capillary Electrochromatography Column and Application for Enantioseparations of Ten Basic Drugs	PLOS ONE			English	Article							ALKYLTHIOL GOLD NANOPARTICLES; ELECTROMIGRATION TECHNIQUES; LIQUID-CHROMATOGRAPHY; SEPARATION; TRENDS	An open-tubular capillary electrochromatography column was prepared by chemically immobilized beta-cyclodextrin modified gold nanoparticles onto new surface with the prederivatization of (3-mercaptopropyl)-trimethoxysilane. The synthesized nanoparticles and the prepared column were characterized by transmission electron microscopy, scanning electron microscopy, infrared spectroscopy and ultraviolet visible spectroscopy. When the column was employed as the chiral stationary phase, no enantioselectivity was observed for ten model basic drugs. So beta-cyclodextrin was added to the background electrolyte as chiral additive to expect a possible synergistic effect occurring and resulting in a better separation. Fortunately, significant improvement in enantioselectivity was obtained for ten pairs of drug enantiomers. Then, the effects of beta-cyclodextrin concentration and background electrolyte pH on the chiral separation were investigated. With the developed separation mode, all the enantiomers (except for venlafaxine) were baseline separated in resolutions of 4.49, 1.68, 1.88, 1.57, 2.52, 2.33, 3.24, 1.63 and 3.90 for zopiclone, chlorphenamine maleate, brompheniramine maleate, dioxopromethazine hydrochloride, carvedilol, homatropine hydrobromide, homatropine methylbromide, venlafaxine, sibutramine hydrochloride and terbutaline sulfate, respectively. Further, the possible separation mechanism involved was discussed.	[Fang, Linlin; Yu, Jia; Jiang, Zhen; Guo, Xingjie] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut Anal, Minist Educ, Shenyang, Liaoning Provin, Peoples R China	Shenyang Pharmaceutical University	Guo, XJ (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut Anal, Minist Educ, Shenyang, Liaoning Provin, Peoples R China.	syykdx410@163.com			National Natural Science Foundation of China [81473178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No.81473178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammazzalorso A, 2005, J CHROMATOGR A, V1088, P110, DOI 10.1016/j.chroma.2005.04.079; Aturki Z, 2014, ELECTROPHORESIS, V35, P3242, DOI 10.1002/elps.201400085; Cheong WJ, 2013, J CHROMATOGR A, V1308, P1, DOI 10.1016/j.chroma.2013.07.107; Davis BA, 2008, J CHROMATOGR B, V875, P102; Gubitz G, 2008, J CHROMATOGR A, V1204, P140, DOI 10.1016/j.chroma.2008.07.071; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Kapnissi-Christodoulou CP, 2003, ELECTROPHORESIS, V24, P3917, DOI 10.1002/elps.200305640; LEBELLE MJ, 1995, FORENSIC SCI INT, V71, P215, DOI 10.1016/0379-0738(94)01669-0; Li M, 2013, TALANTA, V109, P1, DOI 10.1016/j.talanta.2013.03.035; Liang RP, 2012, J CHROMATOGR A, V1266, P95, DOI 10.1016/j.chroma.2012.09.101; Liu FK, 2005, J CHROMATOGR A, V1083, P205, DOI 10.1016/j.chroma.2005.06.035; Liu Z, 2003, ELECTROPHORESIS, V24, P3917; Mangelings D, 2011, ELECTROPHORESIS, V32, P2583, DOI 10.1002/elps.201100009; MATHYS K, 1992, J CHROMATOGR, V593, P79, DOI 10.1016/0021-9673(92)80270-5; Matyska MT, 2001, J CHROMATOGR A, V924, P211, DOI 10.1016/S0021-9673(01)00830-5; Misl'anova C, 2003, J CHROMATOGR B, V797, P91, DOI 10.1016/j.jchromb.2003.07.018; O'Mahony T, 2003, J CHROMATOGR A, V1004, P181, DOI 10.1016/S0021-9673(03)00856-2; Scriba GKE, 2002, J PHARMACEUT BIOMED, V27, P373, DOI 10.1016/S0731-7085(01)00653-7; Wille K, 2012, TRAC-TREND ANAL CHEM, V35, P87, DOI 10.1016/j.trac.2011.12.003; Xue Y, 2015, ELECTROPHORESIS, V36, P124, DOI 10.1002/elps.201400312; Yang L, 2005, J SEP SCI, V28, P757, DOI 10.1002/jssc.200400075; Yang L, 2005, ANAL CHEM, V77, P1840, DOI 10.1021/ac048544x; Yu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120216; Zhao M, 2014, J SEP SCI, V37, P151, DOI 10.1002/jssc.201300831	24	16	17	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146292	10.1371/journal.pone.0146292	http://dx.doi.org/10.1371/journal.pone.0146292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771454	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300013
J	Mellem, D; Fischer, F; Jaspers, S; Wenck, H; Rubhausen, M				Mellem, Daniel; Fischer, Frank; Jaspers, Soeren; Wenck, Horst; Ruebhausen, Michael			Quality Saving Mechanisms of Mitochondria during Aging in a Fully Time-Dependent Computational Biophysical Model	PLOS ONE			English	Article							OXIDATIVE STRESS; RAT HEPATOCYTES; FUSION; FISSION; CELLS; DNA; TURNOVER; HYPERFUSION; DEGRADATION; BIOGENESIS	Mitochondria are essential for the energy production of eukaryotic cells. During aging mitochondria run through various processes which change their quality in terms of activity, health and metabolic supply. In recent years, many of these processes such as fission and fusion of mitochondria, mitophagy, mitochondrial biogenesis and energy consumption have been subject of research. Based on numerous experimental insights, it was possible to qualify mitochondrial behaviour in computational simulations. Here, we present a new biophysical model based on the approach of Figge et al. in 2012. We introduce exponential decay and growth laws for each mitochondrial process to derive its time-dependent probability during the aging of cells. All mitochondrial processes of the original model are mathematically and biophysically redefined and additional processes are implemented: Mitochondrial fission and fusion is separated into a metabolic outer-membrane part and a protein-related inner-membrane part, a quality-dependent threshold for mitophagy and mitochondrial biogenesis is introduced and processes for activity-dependent internal oxidative stress as well as mitochondrial repair mechanisms are newly included. Our findings reveal a decrease of mitochondrial quality and a fragmentation of the mitochondrial network during aging. Additionally, the model discloses a quality increasing mechanism due to the interplay of the mitophagy and biogenesis cycle and the fission and fusion cycle of mitochondria. It is revealed that decreased mitochondrial repair can be a quality saving process in aged cells. Furthermore, the model finds strategies to sustain the quality of the mitochondrial network in cells with high production rates of reactive oxygen species due to large energy demands. Hence, the model adds new insights to biophysical mechanisms of mitochondrial aging and provides novel understandings of the interdependency of mitochondrial processes.	[Mellem, Daniel; Ruebhausen, Michael] Univ Hamburg, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Mellem, Daniel; Fischer, Frank; Jaspers, Soeren; Wenck, Horst] Beiersdorf AG, Appl Biophys, Hamburg, Germany	University of Hamburg; Beiersdorf AG	Fischer, F (corresponding author), Beiersdorf AG, Appl Biophys, Hamburg, Germany.	frank.fischer@beiersdorf.com	Fischer, Frank/AFO-7637-2022	Fischer, Frank/0000-0002-7932-7174	Foundation of German Business; Beiersdorf AG	Foundation of German Business; Beiersdorf AG	This work was supported by Foundation of German Business: DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beiersdorf AG provided support in the form of salaries for authors DM, SJ, HW, FF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berndt N, 2013, CELL BIOCHEM BIOPHYS, V67, P527, DOI 10.1007/s12013-013-9538-3; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442; Cervinkova Z, 2007, ATLA-ALTERN LAB ANIM, V35, P353, DOI 10.1177/026119290703500303; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Hill A.V, 1910, J PHYSL, V40; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kampen NGv, 2007, STOCHASTIC PROCESSES; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lodish H., 2004, MOL CELL BIOL; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Winter M.E., 2009, BASIC CLIN PHARMACOK; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	41	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146973	10.1371/journal.pone.0146973	http://dx.doi.org/10.1371/journal.pone.0146973			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771181	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300046
J	Schinagl, CW; Vrabl, P; Burgstaller, W				Schinagl, Christoph W.; Vrabl, Pamela; Burgstaller, Wolfgang			Adapting High-Resolution Respirometry to Glucose-Limited Steady State Mycelium of the Filamentous Fungus Penicillium ochrochloron: Method Development and Standardisation	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; CEPHALOSPORIN-C PRODUCTION; ELECTRON-TRANSPORT CHAIN; ASPERGILLUS-NIGER; ALTERNATIVE OXIDASE; NEUROSPORA-CRASSA; RESPIRATORY-CHAIN; CYANIDE-RESISTANT; ACREMONIUM-CHRYSOGENUM; CHEMOSTAT CULTURES	Fungal electron transport systems (ETS) are branched, involving alternative NADH dehydrogenases and an alternative terminal oxidase. These alternative respiratory enzymes were reported to play a role in pathogenesis, production of antibiotics and excretion of organic acids. The activity of these alternative respiratory enzymes strongly depends on environmental conditions. Functional analysis of fungal ETS under highly standardised conditions for cultivation, sample processing and respirometric assay are still lacking. We developed a highly standardised protocol to explore in vivo the ETS-and in particular the alternative oxidase-in Penicillium ochrochloron. This included cultivation in glucose-limited chemostat (to achieve a defined and reproducible physiological state), direct transfer without any manipulation of a broth sample to the respirometer (to maintain the physiological state in the respirometer as close as possible to that in the chemostat), and high-resolution respirometry (small sample volume and high measuring accuracy). This protocol was aimed at avoiding any changes in the physiological phenotype due to the high phenotypic plasticity of filamentous fungi. A stable oxygen consumption (< 5% change in 20 minutes) was only possible with glucose limited chemostat mycelium and a direct transfer of a broth sample into the respirometer. Steady state respiration was 29% below its maximum respiratory capacity. Additionally to a rotenone-sensitive complex I and most probably a functioning complex III, the ETS of P. ochrochloron also contained a cyanide-sensitive terminal oxidase (complex IV). Activity of alternative oxidase was present constitutively. The degree of inhibition strongly depended on the sequence of inhibitor addition. This suggested, as postulated for plants, that the alternative terminal oxidase was in dynamic equilibrium with complex IV-independent of the rate of electron flux. This means that the onset of activity does not depend on a complete saturation or inhibition of the cytochrome pathway.	[Schinagl, Christoph W.; Vrabl, Pamela; Burgstaller, Wolfgang] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck	Schinagl, CW (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	christoph.schinagl@uibk.ac.at		Vrabl, Pamela/0000-0002-8104-8684	Austrian Science Fund (FWF) [P22220-B11]; University of Innsbruck; Austrian Science Fund (FWF) [P 22220] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF; www.fwf.ac.at) project P22220-B11 and a research fellowship of the University of Innsbruck (www.uibk.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZH, 2004, ENZYME MICROB TECH, V34, P10, DOI 10.1016/j.enzmictec.2003.07.008; Carneiro P, 2007, J MOL BIOL, V368, P1114, DOI 10.1016/j.jmb.2007.02.080; Costa C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00197; de Jonge LP, 2012, METABOLOMICS, V8, P727, DOI 10.1007/s11306-011-0367-3; Descheneau AT, 2005, GENETICS, V169, P123, DOI 10.1534/genetics.104.034017; Egli T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00287; Foster JW., 1949, CHEM ACTIVITIES FUNG; FRANZ A, 1991, APPL ENVIRON MICROB, V57, P769, DOI 10.1128/AEM.57.3.769-774.1991; Gallmetzer M, 2001, ANTON LEEUW INT J G, V79, P81, DOI 10.1023/A:1010295924549; Ganzera M, 2006, ANAL BIOCHEM, V359, P132, DOI 10.1016/j.ab.2006.09.012; Gibbs PA, 2000, CRIT REV BIOTECHNOL, V20, P17, DOI 10.1080/07388550091144177; Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x; GRIFFIN DH, 1994, FUNGAL PHYSL; Hattori T, 2008, J BIOSCI BIOENG, V105, P55, DOI 10.1263/jbb.105.55; Joseph-Horne T, 2000, PEST MANAG SCI, V56, P24, DOI 10.1002/(SICI)1526-4998(200001)56:1<24::AID-PS71>3.0.CO;2-Y; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Karaffa L, 1996, BIOTECHNOL LETT, V18, P701, DOI 10.1007/BF00130769; KIRIMURA K, 1987, AGR BIOL CHEM TOKYO, V51, P1299, DOI 10.1080/00021369.1987.10868216; Kirimura K, 2000, BIOSCI BIOTECH BIOCH, V64, P2034, DOI 10.1271/bbb.64.2034; Kirimura K, 1996, FEMS MICROBIOL LETT, V141, P251, DOI 10.1016/0378-1097(96)00230-3; Kozma J, 1996, J BIOTECHNOL, V48, P59, DOI 10.1016/0168-1656(96)01400-9; KUBICEK CP, 1980, EUR J APPL MICROBIOL, V9, P101, DOI 10.1007/BF00503505; LAMBOWIT.AM, 1971, J BACTERIOL, V108, P1087, DOI 10.1128/JB.108.3.1087-1096.1971; Magnani T, 2008, J BIOENERG BIOMEMBR, V40, P631, DOI 10.1007/s10863-008-9191-5; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; Nargang FE, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P155; Nielsen J, 2007, TOPICS CURRENT GENET, P1, DOI DOI 10.1007/978-3-540-74719-2; PARRISH DJ, 1978, PLANT PHYSIOL, V62, P470, DOI 10.1104/pp.62.3.470; PROMPER C, 1993, EUR J BIOCHEM, V216, P223, DOI 10.1111/j.1432-1033.1993.tb18136.x; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; SIEDOW JN, 1980, PLANT PHYSIOL, V65, P669, DOI 10.1104/pp.65.4.669; Siedow JN, 2000, BBA-BIOENERGETICS, V1459, P432, DOI 10.1016/S0005-2728(00)00181-X; Slepecky RA, 2009, MYCOLOGIA, V101, P823, DOI 10.3852/08-197; Tanton LL, 2003, FUNGAL GENET BIOL, V39, P176, DOI 10.1016/S1087-1845(03)00002-1; Tudella VG, 2004, INT J BIOCHEM CELL B, V36, P162, DOI 10.1016/S1357-2725(03)00194-8; Uribe D, 2008, CAN J MICROBIOL, V54, P119, DOI 10.1139/w07-127; van Gulik WM, 2013, SAMPLING SAMPLE PREP, P1; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Vrabl P, 2008, FUNGAL GENET BIOL, V45, P1380, DOI 10.1016/j.fgb.2008.07.017; WALLRATH J, 1991, APPL MICROBIOL BIOT, V36, P76, DOI 10.1007/BF00164702; Yukioka H, 1997, FUNGAL GENET BIOL, V22, P221, DOI 10.1006/fgbi.1997.1016; ZEHENTGRUBER O, 1980, FEMS MICROBIOL LETT, V8, P71, DOI 10.1016/0378-1097(80)90071-3; Zivic M, 2009, ANTON LEEUW INT J G, V95, P207, DOI 10.1007/s10482-008-9304-5	43	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146878	10.1371/journal.pone.0146878	http://dx.doi.org/10.1371/journal.pone.0146878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771937	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300038
J	Yang, LB; Geng, ZH; Nickel, T; Johnson, C; Gao, L; Dutton, J; Hou, C; Zhang, JY				Yang, Libang; Geng, Zhaohui; Nickel, Thomas; Johnson, Caitlin; Gao, Lin; Dutton, James; Hou, Cody; Zhang, Jianyi			Differentiation of Human Induced-Pluripotent Stem Cells into Smooth-Muscle Cells: Two Novel Protocols	PLOS ONE			English	Article							VASCULAR TISSUE; MOLECULAR REGULATION; EPIGENETIC MEMORY; MODEL; GENERATION; ORIGIN; HEART	Conventional protocols for differentiating human induced-pluripotent stem cells (hiPSCs) into smooth-muscle cells (SMCs) can be inefficient and generally fail to yield cells with a specific SMC phenotype (i.e., contractile or synthetic SMCs). Here, we present two novel hiPSC-SMC differentiation protocols that yield SMCs with predominantly contractile or synthetic phenotypes. Flow cytometry analyses of smooth-muscle actin (SMA) expression indicated that similar to 45% of the cells obtained with each protocol assumed an SMC phenotype, and that the populations could be purified to similar to 95% via metabolic selection. Assessments of cellular mRNA and/or protein levels indicated that SMA, myosin heavy chain II, collagen 1, calponin, transgelin, connexin 43, and vimentin expression in the SMCs obtained via the Contractile SMC protocol and in SMCs differentiated via a traditional protocol were similar, while SMCs produced via the Sythetic SMC protocol expressed less calponin, more collagen 1, and more connexin 43. Differences were also observed in functional assessments of the two SMC populations: the two-dimensional surface area of Contractile SMCs declined more extensively (to 12% versus 44% of original size) in response to carbachol treatment, while quantification of cell migration and proliferation were greater in Synthetic SMCs. Collectively, these data demonstrate that our novel differentiation protocols can efficiently generate SMCs from hiPSCs.	[Yang, Libang; Nickel, Thomas; Johnson, Caitlin; Gao, Lin; Hou, Cody; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA; [Geng, Zhaohui; Dutton, James; Zhang, Jianyi] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Zhang, Jianyi] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Johnson, Caitlin; Zhang, Jianyi] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Zhang, Jianyi] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Sch Engn, Birmingham, AL 35294 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham	Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA.; Zhang, JY (corresponding author), Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA.; Zhang, JY (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA.; Zhang, JY (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA.; Zhang, JY (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Sch Engn, Birmingham, AL 35294 USA.	jayzhang@uab.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Hou, Cody/0000-0001-8692-6768	National Institute of Health [RO1 HL67828, RO1 HL95077, RO1 HL114120, UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828, U01HL100407, R01HL114120, R01HL095077] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health RO1 HL67828; National Institute of Health RO1 HL95077; National Institute of Health RO1 HL114120; and National Institute of Health UO1 HL100407.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Christen T, 2001, CIRCULATION, V103, P882, DOI 10.1161/01.CIR.103.6.882; Christen T, 1999, CIRC RES, V85, P99; Dash BC, 2015, BIOCHEM J, V465, P185, DOI 10.1042/BJ20141078; Fernandez CE, 2014, CURR OPIN CHEM ENG, V3, P83, DOI 10.1016/j.coche.2013.12.001; Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237; Hill KL, 2010, EXP HEMATOL, V38, P246, DOI 10.1016/j.exphem.2010.01.001; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Marchand M, 2014, STEM CELL TRANSL MED, V3, P91, DOI 10.5966/sctm.2013-0124; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Sundaram S, 2014, STEM CELL TRANSL MED, V3, P1535, DOI 10.5966/sctm.2014-0065; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Wang YY, 2014, BIOMATERIALS, V35, P8960, DOI 10.1016/j.biomaterials.2014.07.011; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wong MM, 2015, JOVE-J VIS EXP, DOI 10.3791/52565; Ye L, 2015, METHODS MOL BIOL, V1299, P103, DOI 10.1007/978-1-4939-2572-8_8; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Zhang LY, 2015, CIRC-HEART FAIL, V8, P156, DOI 10.1161/CIRCHEARTFAILURE.114.001317; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	27	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147155	10.1371/journal.pone.0147155	http://dx.doi.org/10.1371/journal.pone.0147155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771193	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300067
J	Koo, LW; Horowitz, AM; Radice, SD; Wang, MQ; Kleinman, DV				Koo, Laura W.; Horowitz, Alice M.; Radice, Sarah D.; Wang, Min Q.; Kleinman, Dushanka V.			Nurse Practitioners' Use of Communication Techniques: Results of a Maryland Oral Health Literacy Survey	PLOS ONE			English	Article							TEACH-BACK; CARE; PHYSICIANS; STRATEGIES; KNOWLEDGE; OUTCOMES; IMPACT	Objectives We examined nurse practitioners' use and opinions of recommended communication techniques for the promotion of oral health as part of a Maryland state-wide oral health literacy assessment. Use of recommended health-literate and patient-centered communication techniques have demonstrated improved health outcomes. Methods A 27-item self-report survey, containing 17 communication technique items, across 5 domains, was mailed to 1,410 licensed nurse practitioners (NPs) in Maryland in 2010. Use of communication techniques and opinions about their effectiveness were analyzed using descriptive statistics. General linear models explored provider and practice characteristics to predict differences in the total number and the mean number of communication techniques routinely used in a week. Results More than 80% of NPs (N = 194) routinely used 3 of the 7 basic communication techniques: simple language, limiting teaching to 2-3 concepts, and speaking slowly. More than 75% of respondents believed that 6 of the 7 basic communication techniques are effective. Socio-demographic provider characteristics and practice characteristics were not significant predictors of the mean number or the total number of communication techniques routinely used by NPs in a week. Potential predictors for using more of the 7 basic communication techniques, demonstrating significance in one general linear model each, were: assessing the office for user-friendliness and ever taking a communication course in addition to nursing school. Conclusions NPs in Maryland self-reported routinely using some recommended health-literate communication techniques, with belief in their effectiveness. Our findings suggest that NPs who had assessed the office for patient-friendliness or who had taken a communication course beyond their initial education may be predictors for using more of the 7 basic communication techniques. These self-reported findings should be validated with observational studies. Graduate and continuing education for NPs should increase emphasis on health-literate and patient-centered communication techniques to increase patient understanding of dental caries prevention. Non-dental healthcare providers, such as NPs, are uniquely positioned to contribute to preventing early childhood dental caries through health-literate and patient-centered communication.	[Koo, Laura W.] Univ Maryland, Sch Nursing, Dept Org Syst & Adult Hlth, Baltimore, MD 21201 USA; [Horowitz, Alice M.; Wang, Min Q.] Univ Maryland, Sch Publ Hlth, Dept Behav & Community Hlth, College Pk, MD 20742 USA; [Radice, Sarah D.] Univ Maryland, Sch Publ Hlth, Off Dean, College Pk, MD 20742 USA; [Kleinman, Dushanka V.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Koo, LW (corresponding author), Univ Maryland, Sch Nursing, Dept Org Syst & Adult Hlth, Baltimore, MD 21201 USA.	lkoo@son.umaryland.edu	Horowitz, Alice/AAU-6750-2020		DentaQuest Foundation	DentaQuest Foundation	The study was funded by DentaQuest Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Nurse Practitioners, 2013, SCOP PRACT NURS PRAC; American Academy of Pediatrics, 2015, MARYLAND MEDICAID FA; American Academy on Pediatric Dentistry Council on Clinical Affairs, 2008, Pediatr Dent, V30, P22; [Anonymous], 2012, WILL AFFORDABLE CARE; Berkman N. D, 2011, HLTH LITERACY INTERV, P1; Berry JA, 2009, J NURSE PRACT, V5, pP508, DOI [10.1016/j.nurpra.2009.02.019, DOI 10.1016/J.NURPRA.2009.02.019]; Brach C., 2012, ATTRIBUTES A HLTH LI, DOI [10.31478/201201f, DOI 10.31478/201201F]; Brega AG., 2015, PREPARED COLORADO HL, V15-0023EF; Charlton CR, 2008, J AM ACAD NURSE PRAC, V20, P382, DOI 10.1111/j.1745-7599.2008.00336.x; Clovis Joanne B, 2012, J Dent Hyg, V86, P292; Cook JV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-160; Forrest J L, 2000, J Dent Hyg, V74, P183; GIFT HC, 1992, AM J PUBLIC HEALTH, V82, P1663, DOI 10.2105/AJPH.82.12.1663; Gilbert DA, 2009, NURS RES, V58, P283, DOI 10.1097/NNR.0b013e3181ac1413; Hart V. A., 2010, PATIENTPROVIDER COMM, P1; Horowitz AM, 2014, AM J PUBLIC HEALTH, V104, pE85, DOI 10.2105/AJPH.2014.302036; Horowitz Alice M, 2013, J Dent Hyg, V87, P212; Horowitz AM, 2013, AM J PUBLIC HEALTH, V103, pE69, DOI 10.2105/AJPH.2012.301038; Hudon C, 2011, ANN FAM MED, V9, P155, DOI 10.1370/afm.1226; Institute of Medicine, 2011, ADV OR HLTH AM; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Koh HK, 2012, HEALTH AFFAIR, V31, P434, DOI 10.1377/hlthaff.2011.1169; Loupe M J, 1988, J Dent Educ, V52, P149; Maybury C, 2013, J AM DENT ASSOC, V144, P1386, DOI 10.14219/jada.archive.2013.0075; National Quality Forum, 2010, SAF PRACT BETT HEALT; Negarandeh R, 2013, PRIM CARE DIABETES, V7, P111, DOI 10.1016/j.pcd.2012.11.001; Otto M, 2007, WASHINGTON POST; Paterniti DA, 2010, ARCH INTERN MED, V170, P381, DOI 10.1001/archinternmed.2009.533; Plain Language Action and Information Network (PLAIN), 2004, PLAINLANGUAGE GOV IM; Rozier RG, 2011, J AM DENT ASSOC, V142, P518, DOI 10.14219/jada.archive.2011.0222; Rudd R. E., 2006, HLTH LITERACY ENV HO; Sanders B, DENT CRISIS AM NEED; Satcher DS, 2000, PUBLIC HEALTH REP, V115, P489, DOI 10.1093/phr/115.5.489; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Schwartzberg JG, 2007, AM J HEALTH BEHAV, V31, pS96; Smith William, 2015, J Dent Hyg, V89 Suppl 1, P36; The Joint Commission, 2010, ADV EFF COMM CULT CO; U.S. Department of Health and Human Services, 2005, J PUBLIC HLTH DENT, V65, P174; U.S. Department of Health and Human Services [HHS]. Office of Disease Prevention and Health Promotion, 2010, HLTH COMM HLTH INF T; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Weatherspoon DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119855; Weinstein RS, 2013, AM J MED, V126, P1029, DOI 10.1016/j.amjmed.2013.06.030; Weiss PA, 2003, PEDIATRICS, V111, P1113; White M, 2013, J CARDIOVASC NURS, V28, P137, DOI 10.1097/JCN.0b013e31824987bd; Williams DM, 2010, PERS SOC PSYCHOL REV, V14, P417, DOI 10.1177/1088868310368802; Wilson FL, 2008, COMPR CHILD ADOLES N, V31, P7, DOI 10.1080/01460860701877142	46	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146545	10.1371/journal.pone.0146545	http://dx.doi.org/10.1371/journal.pone.0146545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26766557	Green Published, gold			2022-12-27	WOS:000368459300024
J	Khodaparast, L; Khodaparast, L; Shahrooei, M; Stijlemans, B; Merckx, R; Baatsen, P; O'Gara, JP; Waters, E; Van Mellaert, L; Van Eldere, J				Khodaparast, Laleh; Khodaparast, Ladan; Shahrooei, Mohammad; Stijlemans, Benoit; Merckx, Rita; Baatsen, Pieter; O'Gara, James P.; Waters, Elaine; Van Mellaert, Lieve; Van Eldere, Johan			The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; FIBRONECTIN-BINDING PROTEINS; FOREIGN-BODY INFECTIONS; AUREUS; MATRIX; ICA; POLYSACCHARIDE; MECHANISMS; FIBRINOGEN; SORTASES	Staphylococcus epidermidis is the most common cause of device-associated infections. It has been shown that active and passive immunization in an animal model against protein SesC significantly reduces S. epidermidis biofilm-associated infections. In order to elucidate its role, knock-out of sesC or isolation of S. epidermidis sesC-negative mutants were attempted, however, without success. As an alternative strategy, sesC was introduced into Staphylococcus aureus 8325-4 and its isogenic icaADBC and srtA mutants, into the clinical methicillin-sensitive S. aureus isolate MSSA4 and the MRSA S. aureus isolate BH1CC, which all lack sesC. Transformation of these strains with sesC i) changed the biofilm phenotype of strains 8325-4 and MSSA4 from PIA-dependent to proteinaceous even though PIA synthesis was not affected, ii) converted the non-biofilm-forming strain 8325-4 ica::tet to a proteinaceous biofilm-forming strain, iii) impaired PIA-dependent biofilm formation by 8325-4 srtA::tet, iv) had no impact on protein-mediated biofilm formation of BH1CC and v) increased in vivo catheter and organ colonization by strain 8325-4. Furthermore, treatment with anti-SesC antibodies significantly reduced in vitro biofilm formation and in vivo colonization by these transformants expressing sesC. These findings strongly suggest that SesC is involved in S. epidermidis attachment to and subsequent biofilm formation on a substrate.	[Khodaparast, Laleh; Khodaparast, Ladan; Shahrooei, Mohammad; Merckx, Rita; Van Eldere, Johan] KU Leuven Univ Leuven, Univ Leuven, Lab Clin Bacteriol & Mycol, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Stijlemans, Benoit] Vrije Univ Brussel, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium; [Stijlemans, Benoit] VIB, Dept Myeloid Cell Immunol, B-1050 Brussels, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, Univ Leuven, Ctr Human Genet, Electron Microscopy Facil,VIB Bio Imaging Core, B-3000 Leuven, Belgium; [O'Gara, James P.] Natl Univ Ireland, Sch Nat Sci, Dept Microbiol, Galway, Ireland; [Waters, Elaine] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Van Mellaert, Lieve] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Bacteriol, B-3000 Leuven, Belgium; [Van Eldere, Johan] Katholieke Univ Leuven, Univ Leuven, Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium	KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; Ollscoil na Gaillimhe-University of Galway; University of Liverpool; KU Leuven; KU Leuven; University Hospital Leuven	Khodaparast, L; Van Eldere, J (corresponding author), KU Leuven Univ Leuven, Univ Leuven, Lab Clin Bacteriol & Mycol, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.; Van Eldere, J (corresponding author), Katholieke Univ Leuven, Univ Leuven, Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium.	Laleh.khodaparast@switch.vib-kuleuven.be; Johan.vaneldere@uzleuven.be	O'Gara, James/GXG-4818-2022; Van Mellaert, Lieve/Q-4975-2017; Van Eldere, Johan/AAI-8965-2020; O'Gara, James/U-5641-2019; Stijlemans, Benoit/AAD-9122-2021; Waters, Elaine/C-8460-2018	Van Mellaert, Lieve/0000-0002-8584-8160; O'Gara, James/0000-0003-3866-7161; Stijlemans, Benoit/0000-0003-0082-9751; Khodaparast, Laleh/0000-0002-5865-7748; Waters, Elaine/0000-0002-6573-3462; Khodaparast, ladan/0000-0001-6373-8019				Arrecubieta C, 2009, PLOS PATHOG, P5, DOI DOI 10.1371/J0URNAL.PPAT.1000411; Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lazzell AL, 2009, J ANTIMICROB CHEMOTH, V64, P567, DOI 10.1093/jac/dkp242; Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Oosterlinck W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/281312; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pereira M, 2002, J CELL SCI, V115, P609; Pintens V, 2008, MICROBIOL-SGM, V154, P2827, DOI 10.1099/mic.0.2007/015768-0; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285; Rawlinson LAB, 2011, J MED MICROBIOL, V60, P968, DOI 10.1099/jmm.0.025619-0; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shahrooei M, 2012, INFECT IMMUN, V80, P3660, DOI 10.1128/IAI.00104-12; Shahrooei M, 2009, INFECT IMMUN, V77, P3670, DOI 10.1128/IAI.01464-08; Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Van Wijngaerden E, 1999, J ANTIMICROB CHEMOTH, V44, P669, DOI 10.1093/jac/44.5.669; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146704	10.1371/journal.pone.0146704	http://dx.doi.org/10.1371/journal.pone.0146704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799073	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300031
J	Lovati, AB; Romano, CL; Bottagisio, M; Monti, L; De Vecchi, E; Previdi, S; Accetta, R; Drago, L				Lovati, Arianna Barbara; Romano, Carlo Luca; Bottagisio, Marta; Monti, Lorenzo; De Vecchi, Elena; Previdi, Sara; Accetta, Riccardo; Drago, Lorenzo			Modeling Staphylococcus epidermidis-Induced Non-Unions: Subclinical and Clinical Evidence in Rats	PLOS ONE			English	Article							STABILIZED SEGMENTAL DEFECT; COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM FORMATION; IN-VIVO; GRAFT INFECTION; OSTEOMYELITIS; FRACTURE; DEBRIDEMENT; AUTOLYSIN; AUREUS	S. epidermidis is one of the leading causes of orthopaedic infections associated with biofilm formation on implant devices. Open fractures are at risk of S. epidermidis transcutaneous contamination leading to higher non-union development compared to closed fractures. Although the role of infection in delaying fracture healing is well recognized, no in vivo models investigated the impact of subclinical low-grade infections on bone repair and non-union. We hypothesized that the non-union rate is directly related to the load of this commonly retrieved pathogen and that a low-grade contamination delays the fracture healing without clinically detectable infection. Rat femurs were osteotomized and stabilized with plates. Fractures were infected with a characterized clinical-derived methicillin-resistant S. epidermidis (103, 105, 108 colony forming units) and compared to uninfected controls. After 56 days, bone healing and osteomyelitis were clinically assessed and further evaluated by micro-CT, microbiological and histological analyses. The biofilm formation was visualized by scanning electron microscopy. The control group showed no signs of infection and a complete bone healing. The 103 group displayed variable response to infection with a 67% of altered bone healing and positive bacterial cultures, despite no clinical signs of infection present. The 105 and 108 groups showed severe signs of osteomyelitis and a non-union rate of 83-100%, respectively. The cortical bone reaction related to the periosteal elevation in the control group and the metal scattering detected by micro-CT represented limitations of this study. Ourmodel showed that an intraoperative low-grade S. epidermidis contamination might prevent the bone healing, even in the absence of infectious signs. Our findings also pointed out a dose-dependent effect between the S. epidermidis inoculum and non-union rate. This pilot study identifies a relevant preclinical model to assess the role of subclinical infections in orthopaedic and trauma surgery and to test specifically designed diagnostic, prevention and therapeutic strategies.	[Lovati, Arianna Barbara; Bottagisio, Marta] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Romano, Carlo Luca] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurgia Ricostrutt & Infez Osteoar, Milan, Italy; [Monti, Lorenzo; Accetta, Riccardo] IRCCS Galeazzi Orthopaed Inst, Orthopaed & Traumatol, Milan, Italy; [De Vecchi, Elena; Drago, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Previdi, Sara] Mario Negri Inst Pharmacol Res, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Via Eritrea 62, Milan, Italy; [Drago, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Bottagisio, Marta] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	De Vecchi, Elena/B-8209-2017; Bottagisio, Marta/J-8212-2016; Monti, Lorenzo/AAB-2967-2020; Lovati, Arianna Barbara/J-8213-2016; ROMANO, CARLO LUCA/C-4310-2017	De Vecchi, Elena/0000-0001-9781-8607; Bottagisio, Marta/0000-0001-8105-5959; Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593	Italian Ministry of Health (RC, Research Line 4) [62]	Italian Ministry of Health (RC, Research Line 4)	The financial support for this study was provided by the Italian Ministry of Health (RC 2014, Research Line 4, # 62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalar C, 2006, ANZ J SURG, V76, P387, DOI 10.1111/j.1445-2197.2006.03728.x; Alt V, 2011, BONE, V48, P1146, DOI 10.1016/j.bone.2011.01.018; ANDRIOLE VT, 1973, J BONE JOINT SURG AM, VA 55, P1511, DOI 10.2106/00004623-197355070-00019; Bracho DO, 2009, ACAD EMERG MED, V16, P656, DOI 10.1111/j.1553-2712.2009.00439.x; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037281; Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91; Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136; Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479; Del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P4064, DOI 10.1128/AAC.00432-09; Drago L, 2012, CLIN ORTHOP RELAT R, V470, P2915, DOI 10.1007/s11999-012-2415-3; Esteban J, 2012, Open Orthop J, V6, P255, DOI 10.2174/1874325001206010255; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Garcia P, 2013, EUR CELLS MATER, V26, P1; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hirschfeld J, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.26102; Horst SA, 2012, AM J PATHOL, V181, P1206, DOI 10.1016/j.ajpath.2012.07.005; Hou Z, 2013, ANTIMICROB AGENTS CH, V57, P5045, DOI 10.1128/AAC.00504-13; Jonasson J, 2007, APMIS, V115, P668; Kim PH, 2012, CLIN ORTHOP RELAT R, V470, P3270, DOI 10.1007/s11999-012-2376-6; Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7; Lima ALL, 2014, BRAZ J INFECT DIS, V18, P526, DOI 10.1016/j.bjid.2013.12.005; Lovati AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067628; LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834; Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Odekerken JCE, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-38; OSTERMANN PAW, 1994, ORTHOPEDICS, V17, P397; Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Romano CL, 2012, HIP INT, V22, pS19, DOI 10.5301/HIP.2012.9566; Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Sacar M, 2007, J SURG RES, V139, P170, DOI 10.1016/j.jss.2006.10.003; Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026; Seligson D, 1999, CLIN ORTHOP RELAT R, P30; Southwood LL, 2004, J ORTHOP RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Trampuz Andrej, 2008, Curr Infect Dis Rep, V10, P394, DOI 10.1007/s11908-008-0064-1; Van Praagh ADG, 2011, ANTIMICROB AGENTS CH, V55, P4081, DOI 10.1128/AAC.00147-11; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; WORLOCK P, 1988, BRIT J EXP PATHOL, V69, P235; Zhai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102760	45	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147447	10.1371/journal.pone.0147447	http://dx.doi.org/10.1371/journal.pone.0147447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796958	gold, Green Submitted, Green Published			2022-12-27	WOS:000368530300035
J	Cruz, FF; Horta, LFB; Maia, LD; Lopes-Pacheco, M; da Silva, AB; Morales, MM; Goncalves-de-Albuquerque, CF; Takiya, CM; de Castro-Faria-Neto, HC; Rocco, PRM				Cruz, Fernanda Ferreira; Bastos Horta, Lucas Felipe; Maia, Ligia de Albuquerque; Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Morales, Marcelo Marco; Goncalves-de-Albuquerque, Cassiano Felippe; Takiya, Christina Maeda; de Castro-Faria-Neto, Hugo Caire; Macedo Rocco, Patricia Rieken			Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis	PLOS ONE			English	Article							TYROSINE-KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; IN-VITRO; MACROPHAGE POLARIZATION; KAPPA-B; ACTIVATION; VIVO; MECHANISMS; COLLAGEN; DISEASE	Silicosis is an occupational lung disease with no effective treatment. We hypothesized that dasatinib, a tyrosine kinase inhibitor, might exhibit therapeutic efficacy in silica-induced pulmonary fibrosis. Silicosis was induced in C57BL/6 mice by a single intratracheal administration of silica particles, whereas the control group received saline. After 14 days, when the disease was already established, animals were randomly assigned to receive DMSO or dasatinib (1 mg/kg) by oral gavage, twice daily, for 14 days. On day 28, lung morphofunction, inflammation, and remodeling were investigated. RAW 264.7 cells (a macrophage cell line) were incubated with silica particles, followed by treatment or not with dasatinib, and evaluated for macrophage polarization. On day 28, dasatinib improved lung mechanics, increased M2 macrophage counts in lung parenchyma and granuloma, and was associated with reduction of fraction area of granuloma, fraction area of collapsed alveoli, protein levels of tumor necrosis factor-alpha, interleukin-1 beta, transforming growth factor-beta, and reduced neutrophils, M1 macrophages, and collagen fiber content in lung tissue and granuloma in silicotic animals. Additionally, dasatinib reduced expression of iNOS and increased expression of arginase and metalloproteinase-9 in silicotic macrophages. Dasatinib was effective at inducing macrophage polarization toward the M2 phenotype and reducing lung inflammation and fibrosis, thus improving lung mechanics in a murine model of acute silicosis.	[Cruz, Fernanda Ferreira; Bastos Horta, Lucas Felipe; Maia, Ligia de Albuquerque; Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Macedo Rocco, Patricia Rieken] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, BR-21941 Rio De Janeiro, Brazil; [Lopes-Pacheco, Miqueias; da Silva, Andre Benedito; Morales, Marcelo Marco] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Cellular & Mol Physiol, BR-21941 Rio De Janeiro, Brazil; [Goncalves-de-Albuquerque, Cassiano Felippe; de Castro-Faria-Neto, Hugo Caire] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunopharmacol, BR-21045900 Rio De Janeiro, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Cellular Pathol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Pulm Invest, BR-21941 Rio De Janeiro, Brazil.	prmrocco@biof.ufrj.br	Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Lopes-Pacheco, Miquéias/I-1290-2017; Rocco, Patricia/I-7460-2012; Takiya, Christina/AAU-5959-2021; Cruz, Fernanda F/P-1193-2016; Lopes-Pacheco, Miquéias/AAM-7432-2020	Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Rocco, Patricia/0000-0003-1412-7136; Takiya, Christina/0000-0002-8019-628X; Cruz, Fernanda F/0000-0001-9443-3648; Lopes-Pacheco, Miquéias/0000-0002-7444-9359	European Community [HEALTH-F4-2011-282095]; Brazilian Council for Scientific and Technological Development (CNPq); Rio de Janeiro State Research Foundation (FAPERJ) (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	European Community(European Commission); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ) (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement no. HEALTH-F4-2011-282095 (HCCFN, PRMR), Brazilian Council for Scientific and Technological Development (CNPq) (MMM, CMT, HCCFN, PRMR), the Rio de Janeiro State Research Foundation (FAPERJ) (CNPq) (MMM, CMT, HCCFN, PRMR) and Coordination for the Improvement of Higher Level Personnel (CAPES) (MMM, CMT, HCCFN, PRMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MA, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0118-x; BATES JHT, 1985, J APPL PHYSIOL, V59, P732, DOI 10.1152/jappl.1985.59.3.732; Blake SJ, 2008, BLOOD, V111, P4415, DOI 10.1182/blood-2008-02-138701; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; Borges VM, 2002, AM J RESP CELL MOL, V27, P78, DOI 10.1165/ajrcmb.27.1.4717; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Chen C, 2013, ADV EXP MED BIOL, V765, P47, DOI 10.1007/978-1-4614-4989-8_7; Cowie RL, 2010, MURRAY NADELS TXB RE; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Endo M, 2003, AM J PHYSIOL-LUNG C, V285, pL313, DOI 10.1152/ajplung.00434.2002; Faffe DS, 2001, J APPL PHYSIOL, V90, P1400, DOI 10.1152/jappl.2001.90.4.1400; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fraser CK, 2009, EXP HEMATOL, V37, P1435, DOI 10.1016/j.exphem.2009.09.007; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Gratacap MP, 2009, BLOOD, V114, P1884, DOI 10.1182/blood-2009-02-205328; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Kang JL, 2006, TOXICOL SCI, V90, P470, DOI 10.1093/toxsci/kfj096; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Lopes-Pacheco M, 2013, CELL PHYSIOL BIOCHEM, V32, P1681, DOI 10.1159/000356603; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Maron-Gutierrez T, 2011, EUR RESPIR J, V37, P1217, DOI 10.1183/09031936.00205009; Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rabenau KE, 2014, CANCER GENET-NY, V207, P109, DOI 10.1016/j.cancergen.2014.02.006; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weibel ER., 1990, MODELS LUNG DIS MICR, P199; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Weng SY, 2014, J HEPATOL, V60, pS279, DOI 10.1016/S0168-8278(14)60795-9; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009	42	47	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147005	10.1371/journal.pone.0147005	http://dx.doi.org/10.1371/journal.pone.0147005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789403	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100052
J	Xu, JT; Lowe, RJ; Ivey, GN; Jones, NL; Zhang, ZL				Xu, Jiangtao; Lowe, Ryan J.; Ivey, Gregory N.; Jones, Nicole L.; Zhang, Zhenlin			Ocean Transport Pathways to a World Heritage Fringing Coral Reef: Ningaloo Reef, Western Australia	PLOS ONE			English	Article							LEEUWIN CURRENT; SHELF CIRCULATION; BUOYANCY ARREST; DYNAMICS; PARTICLES; MESOSCALE; SIMULATE; MODEL	A Lagrangian particle tracking model driven by a regional ocean circulation model was used to investigate the seasonally varying connectivity patterns within the shelf circulation surrounding the 300 km long Ningaloo Reef in Western Australia (WA) during 2009-2010. Forward-in-time simulations revealed that surface water was transported equatorward and offshore in summer due to the upwelling-favorable winds. In winter, however, water was transported polewards down the WA coast due to the seasonally strong Leeuwin Current. Using backward-in-time simulations, the subsurface transport pathways revealed two main source regions of shelf water reaching Ningaloo Reef: (1) a year-round source to the northeast in the upper 100 m of water column; and (2) during the summer, an additional source offshore and to the west of Ningaloo in depths between similar to 30 and similar to 150 m. Transient wind-driven coastal upwelling, onshore geostrophic transport and stirring by offshore eddies were identified as the important mechanisms influencing the source water origins. The identification of these highly time-dependent transport pathways and source water locations is an essential step towards quantifying how key material (e.g., nutrients, larvae, contaminants, etc.) is exchanged between Ningaloo Reef and the surrounding shelf ocean, and how this is mechanistically coupled to the complex ocean dynamics in this region.	[Xu, Jiangtao; Ivey, Gregory N.; Jones, Nicole L.] Univ Western Australia, Sch Civil Environm & Min Engn, Crawley, Australia; [Xu, Jiangtao; Lowe, Ryan J.; Ivey, Gregory N.; Jones, Nicole L.; Zhang, Zhenlin] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [Lowe, Ryan J.; Zhang, Zhenlin] Univ Western Australia, Sch Earth & Environm, Crawley, Australia; [Lowe, Ryan J.] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Crawley, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Xu, JT (corresponding author), Univ Western Australia, Sch Civil Environm & Min Engn, Crawley, Australia.; Xu, JT (corresponding author), Univ Western Australia, UWA Oceans Inst, Crawley, Australia.	jiangtao.xu@uwa.edu.au	Jones, Nicole/A-3549-2009; Ivey, Gregory N/K-5299-2012; Lowe, Ryan/A-5032-2012	Jones, Nicole/0000-0003-2550-4590; Ivey, Gregory N/0000-0003-2469-2470; Lowe, Ryan/0000-0002-7080-8406	Scholarship for International Research Fees at the University of Western Australia; Australian Research Council [DP120103036, DP0985221]; Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund; Australian Research Council Centre of Excellence for Coral Reef Studies [CE140100020]	Scholarship for International Research Fees at the University of Western Australia; Australian Research Council(Australian Research Council); Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	JX acknowledges support from a Scholarship for International Research Fees at the University of Western Australia. This work was supported by Australian Research Council Discovery Project grants (DP120103036 and DP0985221) with additional support provided by the Pilbara Marine Conservation Program as part of the State of Western Australia's Net Conservation Benefits Fund. RL also acknowledges support through the Australian Research Council Centre of Excellence for Coral Reef Studies (CE140100020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassin CJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023017; Batchelder HP, 2006, J ATMOS OCEAN TECH, V23, P727, DOI 10.1175/JTECH1874.1; Beardsley RC, 1985, INTRODUCTION TO THE; Brink KH, 2012, J PHYS OCEANOGR, V42, P644, DOI 10.1175/JPO-D-11-0143.1; Brink KH, 2010, J PHYS OCEANOGR, V40, P636, DOI 10.1175/2009JPO4267.1; Brink KH, 2010, J PHYS OCEANOGR, V40, P621, DOI 10.1175/2009JPO4266.1; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; CRESSWELL GR, 1980, DEEP-SEA RES, V27, P449, DOI 10.1016/0198-0149(80)90055-2; Cushman-Roisin B, 2010, INTRODUCTION TO GEOP; Domingues CM, 2007, DEEP-SEA RES PT II, V54, P797, DOI 10.1016/j.dsr2.2006.10.003; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Feng M, 2005, J PHYS OCEANOGR, V35, P964, DOI 10.1175/JPO2730.1; GARRETT C, 1993, ANNU REV FLUID MECH, V25, P291, DOI 10.1146/annurev.fl.25.010193.001451; GODFREY JS, 1985, J PHYS OCEANOGR, V15, P481, DOI 10.1175/1520-0485(1985)015<0481:TLSEOT>2.0.CO;2; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Hanson CE, 2005, CONT SHELF RES, V25, P1561, DOI 10.1016/j.csr.2005.04.003; HOLLOWAY PE, 1995, DEEP-SEA RES PT I, V42, P285, DOI 10.1016/0967-0637(95)00004-P; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Lowe RJ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007653; MACCREADY P, 1991, J FLUID MECH, V223, P631, DOI 10.1017/S0022112091001581; Marchesiello P, 2010, J MAR RES, V68, P37, DOI 10.1357/002224010793079004; Meuleners MJ, 2008, DEEP-SEA RES PT I, V55, P261, DOI 10.1016/j.dsr.2007.12.004; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; North EW, 2006, J MARINE SYST, V60, P365, DOI 10.1016/j.jmarsys.2005.08.003; North EW, 2011, GEOPHYS MONOGR SER, V195, P217, DOI 10.1029/2011GM001102; Ridgway KR, 2015, J GEOPHYS RES-OCEANS, V120, P6843, DOI 10.1002/2015JC011049; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rivas D, 2011, J PHYS OCEANOGR, V41, P88, DOI 10.1175/2010JPO4327.1; Rossi V, 2013, J GEOPHYS RES-OCEANS, V118, P3608, DOI 10.1002/jgrc.20242; Rossi V, 2013, J GEOPHYS RES-OCEANS, V118, P1211, DOI 10.1002/jgrc.20110; Roughan M, 2003, J PHYS OCEANOGR, V33, P2551, DOI 10.1175/1520-0485(2003)033<2551:AMSOTC>2.0.CO;2; Schlag Z, 2012, REPORT; SMITH RL, 1991, J PHYS OCEANOGR, V21, P323, DOI 10.1175/1520-0485(1991)021<0323:TLCOWA>2.0.CO;2; THOMPSON RORY, 1984, J PHYS OCEANOGR, V14, P623, DOI 10.1175/1520-0485(1984)014<0623:OOTLCO>2.0.CO;2; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Wyatt ASJ, 2012, LIMNOL OCEANOGR, V57, P401, DOI 10.4319/lo.2012.57.2.0401; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Xu J, 2014, OCEAN DYNAMICS AND C; Xu JT, 2015, CONT SHELF RES, V95, P54, DOI 10.1016/j.csr.2014.12.013; Xu JT, 2013, J GEOPHYS RES-OCEANS, V118, P1099, DOI 10.1002/jgrc.20098	41	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145822	10.1371/journal.pone.0145822	http://dx.doi.org/10.1371/journal.pone.0145822			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790154	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100017
J	Bavi, R; Kumar, R; Choi, L; Lee, KW				Bavi, Rohit; Kumar, Raj; Choi, Light; Lee, Keun Woo			Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; B-CELL MALIGNANCIES; POTENT INHIBITOR; BINDING PROTEIN; BTK; DOMAIN; LFM-A13; FAMILY; IDENTIFICATION; GENERATION	Bruton's tyrosine kinase (BTK) is a cytoplasmic, non-receptor tyrosine kinase which is expressed in most of the hematopoietic cells and plays an important role in many cellular signaling pathways. B cell malignancies are dependent on BCR signaling, thus making BTK an efficient therapeutic target. Over the last few years, significant efforts have been made in order to develop BTK inhibitors to treat B-cell malignancies, and autoimmunity or allergy/hypersensitivity but limited success has been achieved. Here in this study, 3D QSAR pharmacophore models were generated for Btk based on known IC50 values and experimental energy scores with extensive validations. The five features pharmacophore model, Hypo1, includes one hydrogen bond acceptor lipid, one hydrogen bond donor, and three hydrophobic features, which has the highest correlation coefficient (0.98), cost difference (112.87), and low RMS (1.68). It was further validated by the Fisher's randomization method and test set. The well validated Hypo1 was used as a 3D query to search novel Btk inhibitors with different chemical scaffold using high throughput virtual screening technique. The screened compounds were further sorted by applying ADMET properties, Lipinski's rule of five and molecular docking studies to refine the retrieved hits. Furthermore, molecular dynamic simulation was employed to study the stability of docked conformation and to investigate the binding interactions in detail. Several important hydrogen bonds with Btk were revealed, which includes the gatekeeper residues Glu475 and Met 477 at the hinge region. Overall, this study suggests that the proposed hits may be more effective inhibitors for cancer and autoimmune therapy.	[Bavi, Rohit; Kumar, Raj; Choi, Light; Lee, Keun Woo] GNU, RINS, PMBBRC, Div Appl Life Sci,Plus Program BK21,SSAC, 501 Jinju Daero, Jinju 52828, South Korea		Lee, KW (corresponding author), GNU, RINS, PMBBRC, Div Appl Life Sci,Plus Program BK21,SSAC, 501 Jinju Daero, Jinju 52828, South Korea.	kwlee@gnu.ac.kr	Bavi, Rohit/X-9173-2019; Kumar, Raj/C-4022-2016	Bavi, Rohit/0000-0003-3167-4131; Kumar, Raj/0000-0003-2328-8521	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea; Pioneer Research Center Program through the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015M3C1A3023028]; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ01106202]	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea; Pioneer Research Center Program through the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	Dr. Rohit S. Bavi was financially supported by a postdoctoral fellowship from BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea. This research was supported by the Pioneer Research Center Program through the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2015M3C1A3023028). This work was also supported by the Next-Generation BioGreen 21 Program (PJ01106202) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalipour A, 2013, BRIT J HAEMATOL, V163, P436, DOI 10.1111/bjh.12573; Barf T, 2012, J MED CHEM, V55, P6243, DOI 10.1021/jm3003203; Bonnet P, 2004, PROTEIN SCI, V13, P946, DOI 10.1110/ps.03129704; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; CONLEY ME, 1985, J IMMUNOL, V134, P3070; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debnath AK, 2002, J MED CHEM, V45, P41, DOI 10.1021/jm010360c; Di Paolo JA, NOVEL SPECIFIC BTK I; Fischer R, 1966, THE PRINCIPLE OF EXP; Goldberg DR, 2003, J MED CHEM, V46, P1337, DOI 10.1021/jm020446l; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S4; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S28; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kang SW, 2001, EMBO J, V20, P5692, DOI 10.1093/emboj/20.20.5692; Kersseboom R, 2006, J IMMUNOL, V176, P4543, DOI 10.4049/jimmunol.176.8.4543; Kim KH, 2011, BIOORG MED CHEM LETT, V21, P6258, DOI 10.1016/j.bmcl.2011.09.008; Leandro MJ, 2009, CLIN EXP IMMUNOL, V157, P191, DOI 10.1111/j.1365-2249.2009.03978.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Lou Y, 2012, J MED CHEM, V55, P4539, DOI 10.1021/jm300035p; Maas A, 2001, Dev Immunol, V8, P171, DOI 10.1155/2001/28962; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Sakkiah S, 2010, EUR J MED CHEM, V45, P2132, DOI 10.1016/j.ejmech.2010.01.016; Sonawane KD, 2015, AMINO ACIDS, V47, P543, DOI 10.1007/s00726-014-1887-8; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Steindl T, 2004, J CHEM INF COMP SCI, V44, P1849, DOI 10.1021/ci049844i; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 2007, BIOORGAN MED CHEM, V15, P800, DOI 10.1016/j.bmc.2006.10.050; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; van den Akker E, 2004, BIOL CHEM, V385, P409; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1994, FEBS LETT, V350, P263, DOI 10.1016/0014-5793(94)00783-7; Vorontsov II, 2011, J COMPUT CHEM, V32, P1043, DOI 10.1002/jcc.21683; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wiestner A, 2013, J CLIN ONCOL, V31, P128, DOI 10.1200/JCO.2012.44.4281; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	51	21	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147190	10.1371/journal.pone.0147190	http://dx.doi.org/10.1371/journal.pone.0147190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784025	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400120
J	Bumdelger, B; Kokubo, H; Kamata, R; Fujii, M; Yoshimura, K; Aoki, H; Orita, Y; Ishida, T; Ohtaki, M; Nagao, M; Ishida, M; Yoshizumi, M				Bumdelger, Batmunkh; Kokubo, Hiroki; Kamata, Ryo; Fujii, Masayuki; Yoshimura, Koichi; Aoki, Hiroki; Orita, Yuichi; Ishida, Takafumi; Ohtaki, Megu; Nagao, Masataka; Ishida, Mari; Yoshizumi, Masao			Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; MATRIX METALLOPROTEINASES; SERUM OSTEOPROTEGERIN; VASCULAR CALCIFICATION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; ATHEROSCLEROSIS; PROLIFERATION; PATHOGENESIS	Abdominal aortic aneurysms (AAAs), which commonly occur among elderly individuals, are accompanied by a risk of rupture and subsequent high mortality. Establishment of medical therapies for the prevention of AAAs requires further understanding of the molecular pathogenesis of this condition. This report details the possible involvement of Osteoprotegerin (OPG) in the prevention of AAAs through inhibition of Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). In CaCl2-induced AAA models, both internal and external diameters were significantly increased with destruction of elastic fibers in the media in Opg knockout (KO) mice, as compared to wild-type mice. Moreover, up-regulation of TRAIL expression was observed in the media by immunohistochemical analyses. Using a culture system, both the TRAIL-induced expression of matrix metalloproteinase-9 in smooth muscle cells (SMCs) and the chemoattractive effect of TRAIL on SMCs were inhibited by OPG. These data suggest that Opg may play a preventive role in the development of AAA through its antagonistic effect on Trail.	[Bumdelger, Batmunkh; Kokubo, Hiroki; Kamata, Ryo; Fujii, Masayuki; Ishida, Mari; Yoshizumi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Orita, Yuichi; Ishida, Takafumi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Ohtaki, Megu] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Environmetr & Biometr, Hiroshima, Japan; [Nagao, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Forens Med, Hiroshima, Japan	Hiroshima University; Yamaguchi University; Kurume University; Hiroshima University; Hiroshima University; Hiroshima University	Yoshizumi, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan.	yoshizum-tky@umin.ac.jp	Ohtaki, Megu/S-9927-2018; Ishida, Mari/L-8208-2016	Kamata, Ryo/0000-0001-6970-9657	Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology in Japan.; The authors would like to thank Ms. Kumi Hashida, Ms. Yukiko Yoritsune, Mr. Hidemichi Miyahara, Mr. Masayoshi Takatani, and Ms. Chiho Taniguchi for their technical guidance. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Bobryshev YV, 1998, CARDIOVASC SURG, V6, P240, DOI 10.1016/S0967-2109(97)00168-3; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bumdelger Batmunkh, 2013, Hiroshima Journal of Medical Sciences, V62, P63; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Eskandari MK, 2005, J SURG RES, V123, P289, DOI 10.1016/j.jss.2004.07.247; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Jono S, 2010, J THROMB HAEMOST, V8, P1170, DOI 10.1111/j.1538-7836.2010.03833.x; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Koole D, 2012, ARTERIOSCL THROM VAS, V32, P1497, DOI 10.1161/ATVBAHA.111.243592; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Moran CS, 2014, ARTERIOSCL THROM VAS, V34, P2609, DOI 10.1161/ATVBAHA.114.304587; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Muhlenbeck F, 1998, J BIOL CHEM, V273, P33091, DOI 10.1074/jbc.273.49.33091; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Olesen P, 2005, DIABETOLOGIA, V48, P561, DOI 10.1007/s00125-004-1652-8; Orita Y, 2007, ARTERIOSCL THROM VAS, V27, P2058, DOI 10.1161/ATVBAHA.107.147868; Ovchinnikova O, 2009, ARTERIOSCL THROM VAS, V29, P1478, DOI 10.1161/ATVBAHA.109.188185; Papalambros E, 2003, INT J MOL MED, V12, P965; Pearce WH, 1996, ANN NY ACAD SCI, V800, P175; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Soe NN, 2009, J ATHEROSCLER THROMB, V16, P230, DOI 10.5551/jat.E422; THOMPSON EW, 1995, J ANDROL, V16, P28; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Uzui H, 2014, J CARDIOVASC PHARM T, V19, P304, DOI 10.1177/1074248413511692; Wei W, 2010, MOL IMMUNOL, V47, P2475, DOI 10.1016/j.molimm.2010.06.004; Yamashita A, 2001, WORLD J SURG, V25, P259, DOI 10.1007/s002680020062; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147088	10.1371/journal.pone.0147088	http://dx.doi.org/10.1371/journal.pone.0147088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783750	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400108
J	Gao, XJ; Zhang, GL; Shan, SG; Shang, YL; Chi, LF; Li, HJ; Cao, YF; Zhu, XQ; Zhang, MB; Yang, J				Gao, Xiangjing; Zhang, Guanglin; Shan, Shigang; Shang, Yunlong; Chi, Linfeng; Li, Hongjuan; Cao, Yifei; Zhu, Xinqiang; Zhang, Meibian; Yang, Jun			Depletion of Paraspeckle Protein 1 Enhances Methyl Methanesulfonate-Induced Apoptosis through Mitotic Catastrophe	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE; CELLS; MITOSIS; REPAIR; DEATH; KINASES; ARREST; GROWTH; AGENTS	Previously, we have shown that paraspeckle protein 1 (PSPC1), a protein component of paraspeckles that was involved in cisplatin-induced DNA damage response (DDR), probably functions at the G1/S checkpoint. In the current study, we further examined the role of PSPC1 in another DNA-damaging agent, methyl methanesulfonate (MMS)-induced DDR, in particular, focusing on MMS-induced apoptosis in HeLa cells. First, it was found that MMS treatment induced the expression of PSPC1. While MMS treatment alone can induce apoptosis, depletion of PSPC1 expression using siRNA significantly increased the level of apoptosis following MMS exposure. In contrast, overexpressing PSPC1 decreased the number of apoptotic cells. Interestingly, morphological observation revealed that many of the MMS-treated PSPC1-knockdown cells contained two or more nuclei, indicating the occurrence of mitotic catastrophe. Cell cycle analysis further showed that depletion of PSPC1 caused more cells entering the G2/M phase, a prerequisite of mitosis catastrophe. On the other hand, over-expressing PSPC1 led to more cells accumulating in the G1/S phase. Taken together, these observations suggest an important role for PSPC1 in MMS-induced DDR, and in particular, depletion of PSPC1 can enhance MMS-induced apoptosis through mitotic catastrophe.	[Gao, Xiangjing; Zhang, Meibian] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Gao, Xiangjing; Zhang, Guanglin; Shan, Shigang; Chi, Linfeng; Zhu, Xinqiang; Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Shang, Yunlong] Zhejiang CONBA Pharmaceut Co Ltd, Hangzhou 310058, Zhejiang, Peoples R China; [Chi, Linfeng] Zhejiang Univ, Sch Med, Affiliated Stomatol Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Hongjuan; Cao, Yifei; Yang, Jun] Hangzhou Normal Univ, Sch Med, Dept Toxicol, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Hangzhou Normal University	Zhang, MB (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.; Yang, J (corresponding author), Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.; Yang, J (corresponding author), Hangzhou Normal Univ, Sch Med, Dept Toxicol, Hangzhou 310016, Zhejiang, Peoples R China.	mbzhang@cdc.zj.cn; gastate@zju.edu.cn		zhang, meibian/0000-0002-6839-737X	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; National Natural Science Foundation of China [81172692, 81373036, 81472961, 81302398, 81502752]; Zhejiang Provincial Department of Science and Technology [2013C14016]; Zhejiang Provincial Department of Education [Y201328971]; Hangzhou City Commission of Science and Technology [20130633B27]; Ministry of Science and Technology of the People's Republic of China [2009DFB30390]; National Health and Family Planning Commission of China [WKJ2014-ZJ-0]; Postdoctoral Science Foundation of China [520000-X91504]; Fundamental Research Funds for the Central Universities [2014QNA7021]; Zhejiang CONBA Pharmaceutical Co. Ltd.	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Science and Technology; Zhejiang Provincial Department of Education; Hangzhou City Commission of Science and Technology; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang CONBA Pharmaceutical Co. Ltd.	JY is a recipient of the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. This work was funded by National Natural Science Foundation of China (Nos. 81172692, 81373036, 81472961, 81302398, 81502752, http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action), Zhejiang Provincial Department of Science and Technology (2013C14016, http://www.zjkjt.gov.cn/news/node01/detail0101/2013/0101_47060.htm), Zhejiang Provincial Department of Education (Y201328971), Hangzhou City Commission of Science and Technology (20130633B27, http://220.191.210.97:8080/WebHall/WebIndex.aspx), Ministry of Science and Technology of the People's Republic of China (2009DFB30390, http://finance.most.gov.cn/), National Health and Family Planning Commission of China (No. WKJ2014-ZJ-0, http://www.zjmed.org.cn/previewerlet.do?id=D4A9C5F17379B886F94E42A9BF39BB32), Postdoctoral Science Foundation of China (520000-X91504, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx) and Fundamental Research Funds for the Central Universities (2014QNA7021). The funder (Zhejiang CONBA Pharmaceutical Co. Ltd.) provided support in the form of salaries for author YLS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of YLS are articulated in the 'author contributions' section.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; AYSCOUGH K, 1992, MOL GEN GENET, V232, P344, DOI 10.1007/BF00266236; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen CA, 2013, J MED FOOD, V16, P869, DOI 10.1089/jmf.2012.2617; Cogswell JP, 2000, CELL GROWTH DIFFER, V11, P615; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gao XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097174; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Hosseinimehr SJ, 2011, TOXICOL IND HEALTH, V27, P363, DOI 10.1177/0748233710387010; Hsu MH, 2012, TOXICOL APPL PHARM, V259, P219, DOI 10.1016/j.taap.2011.12.026; Jordan MA, 1996, CANCER RES, V56, P816; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liang Xiaogong, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P549; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lock RB, 1996, CANCER RES, V56, P4006; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MCINTOSH JR, 1984, NATURE, V312, P196, DOI 10.1038/312196b0; MOLZ L, 1989, GENETICS, V122, P773; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Waxman DJ, 2003, CANCER RES, V63, P8563; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yu YK, 2006, TOXICOL IN VITRO, V20, P959, DOI 10.1016/j.tiv.2006.01.004	43	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146952	10.1371/journal.pone.0146952	http://dx.doi.org/10.1371/journal.pone.0146952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785254	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400084
J	Meijer, MF; Velleman, T; Boerboom, AL; Bulstra, SK; Otten, E; Stevens, M; Reininga, IHF				Meijer, Marrigje F.; Velleman, Ton; Boerboom, Alexander L.; Bulstra, Sjoerd K.; Otten, Egbert; Stevens, Martin; Reininga, Inge H. F.			The Validity of a New Low-Dose Stereoradiography System to Perform 2D and 3D Knee Prosthetic Alignment Measurements	PLOS ONE			English	Article							RELIABILITY; ROTATION	Introduction The EOS stereoradiography system has shown to provide reliable varus/valgus (VV) measurements of the lower limb in 2D (VV2D) and 3D (VV3D) after total knee arthroplasty (TKA). Validity of these measurements has not been investigated yet, therefore the purpose of this study was to determine validity of EOS VV2D and VV3D. Methods EOS images were made of a lower limb phantom containing a knee prosthesis, while varying VV angle from 15 degrees varus to 15 degrees valgus and flexion angle from 0 degrees to 20 degrees, and changing rotation from 20 degrees internal to 20 degrees external rotation. Differences between the actual VV position of the lower limb phantom and its position as measured on EOS 2D and 3D images were investigated. Results Rotation, flexion or VV angle alone had no major impact on VV2D or VV3D. Combination of VV angle and rotation with full extension did not show major differences in VV2D measurements either. Combination of flexion and rotation with a neutral VV angle showed variation of up to 7.4 degrees for VV2D; maximum variation for VV3D was only 1.5 degrees. A combination of the three variables showed an even greater distortion of VV2D, while VV3D stayed relatively constant. Maximum measurement difference between preset VV angle and VV2D was 9.8 degrees, while the difference with VV3D was only 1.9 degrees. The largest differences between the preset VV angle and VV2D were found when installing the leg in extreme angles, for example 15 degrees valgus, 20 degrees flexion and 20 degrees internal rotation. Conclusions After TKA, EOS VV3D were more valid than VV2D, indicating that 3D measurements compensate for malpositioning during acquisition. Caution is warranted when measuring VV angle on a conventional radiograph of a knee with a flexion contracture, varus or valgus angle and/or rotation of the knee joint during acquisition.	[Meijer, Marrigje F.; Boerboom, Alexander L.; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Velleman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Otten, Egbert] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Meijer, MF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.	m.f.meijer@umcg.nl	Reininga, Inge H.F./H-4250-2013; Stevens, Martin/A-5196-2013	Reininga, Inge H.F./0000-0003-1341-845X; Stevens, Martin/0000-0001-8183-6894	Zimmer (Warsaw, IN, USA)	Zimmer (Warsaw, IN, USA)	The authors of this manuscript have the following competing interests: One of the authors will be and has been paid as a consultant by Zimmer (Warsaw, IN, USA) for purposes of education and training in knee arthroplasty. The department receives research institutional support from Inspine (Schiedam, NL) and Stryker (Kalamazoo, Mich. USA). Nevertheless there has not been any direct funding related to this study.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouwer R W, 2007, J Knee Surg, V20, P210; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gheno R, 2012, EUR RADIOL, V22, P765, DOI 10.1007/s00330-011-2308-y; Guenoun B, 2012, ORTHOP TRAUMATOL-SUR, V98, P506, DOI 10.1016/j.otsr.2012.03.014; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709, DOI 10.1302/0301-620X.73B5.1894655; Kalifa G, 1998, PEDIATR RADIOL, V28, P557, DOI 10.1007/s002470050413; Lonner JH, 1996, CLIN ORTHOP RELAT R, P102; LOTKE PA, 1977, J BONE JOINT SURG AM, V59, P77, DOI 10.2106/00004623-197759010-00013; Meijer MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104613; Parratte S, 2010, J BONE JOINT SURG AM, V92A, P2143, DOI 10.2106/JBJS.I.01398; Radtke K, 2010, ARCH ORTHOP TRAUM SU, V130, P451, DOI 10.1007/s00402-009-0999-1; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; RITTER MA, 1994, CLIN ORTHOP RELAT R, P153; Ritter MA, 2011, J BONE JOINT SURG AM, V93A, P1588, DOI 10.2106/JBJS.J.00772; Swanson KE, 2000, CLIN ORTHOP RELAT R, P246; Thelen P, 2012, SKELETAL RADIOL, V41, P1287, DOI 10.1007/s00256-012-1438-x	18	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146187	10.1371/journal.pone.0146187	http://dx.doi.org/10.1371/journal.pone.0146187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771177	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300011
J	Chen, QW; Li, HJ; Chen, YN; Ning, ZY; Gao, S; Shen, YH; Meng, ZQ; Vargulick, S; Wang, BY; Chen, H				Chen, Qi-wen; Li, Hai-jin; Chen, Ya-nan; Ning, Zhou-yu; Gao, Song; Shen, Ye-hua; Meng, Zhi-qiang; Vargulick, Sonya; Wang, Bi-yun; Chen, Hao			Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma	PLOS ONE			English	Article							B-VIRUS REACTIVATION; HBV REACTIVATION; PRIMARY TUMORS; WOMEN; LYMPHOMA; BRCA1; RISK	Purpose Liver metastasis is a common phenomenon in breast cancer patients. Hepatic lesions detected in breast cancer patients may be easily misdiagnosed as metastatic sites, rather than being treated as primary foci. This descriptive study aims to investigate the clinicopathological characteristics of second primary hepatocellular carcinoma in breast cancer patients and to infer in which circumstances liver biopsy is needed. Methods Eighty-one consecutive breast cancer patients with hepatic lesions admitted to our department were retrospectively studied and analyzed from January 2009 to March 2014 according to Warren and Gates' criteria for second primary cancers. Results Second primary hepatocellular carcinoma was observed in sixteen of seventy eight patients with breast cancer. There was a significant difference in HBV status between the second HCC group and liver metastases group (P<0.0001). There was no significant difference in age (P=0.2254) and family history (P=0.1160) between second primary HCC and metastases group. Two of these patients had synchronous second primary hepatocellular carcinoma and the remaining fourteen patients had metachronous second primary HCC. All sixteen patients were infected with hepatitis, including hepatitis virus B and C, or resolved HBV infection. Conclusions Breast cancer patients with either HBV infection or resolved HBV infection, regardless of an elevated AFP level, may receive liver biopsy to avoid unnecessary and inappropriate treatments for metastasis. Awareness of second primary HCC in breast cancer patients needs to be emphasized.	[Chen, Qi-wen; Ning, Zhou-yu; Gao, Song; Shen, Ye-hua; Meng, Zhi-qiang; Chen, Hao] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Oncol, Shanghai 200433, Peoples R China; [Chen, Qi-wen; Ning, Zhou-yu; Gao, Song; Shen, Ye-hua; Meng, Zhi-qiang; Wang, Bi-yun; Chen, Hao] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Li, Hai-jin; Chen, Ya-nan] China Med Univ, Shaoxing Hosp, Dept Med Oncol, Shaoxing, Peoples R China; [Wang, Bi-yun] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Vargulick, Sonya] Albany Coll Pharm & Hlth Sci, Dept Pharm, Albany, NY USA	Fudan University; Fudan University; Fudan University; Albany College of Pharmacy & Health Sciences	Wang, BY (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	pro_wangbiyun@163.com; chenhao19720627@hotmail.com			National science foundation of China [81102685]	National science foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National science foundation of China (81102685).	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Brown LC, 2015, INT J WOMENS HEALTH, V7, P449, DOI 10.2147/IJWH.S55552; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buyukasik O, 2010, RADIOL ONCOL, V44, P239, DOI 10.2478/v10019-010-0048-2; Chen QW, 2014, PLOS ONE, V29, P9; Fraumeni J. F., 2006, NEW MALIGNANCIES CAN; Grantzau T, 2014, RADIOTHER ONCOL, V111, P366, DOI 10.1016/j.radonc.2014.05.004; Iqbal J, 2012, BRIT J CANCER, V107, P2005, DOI 10.1038/bjc.2012.483; Kanatas A, 2012, TUMORI, V98, P678, DOI 10.1700/1217.13489; Kim SJ, 2013, EUR J CANCER, V49, P3486, DOI 10.1016/j.ejca.2013.07.006; Lao XM, 2013, LIVER INT, V33, P595, DOI 10.1111/liv.12112; Liu WP, 2014, WORLD J GASTROENTERO, V20, P5165, DOI 10.3748/wjg.v20.i17.5165; Mariotto AB, 2007, CANCER EPIDEM BIOMAR, V16, P566, DOI 10.1158/1055-9965.EPI-06-0782; Matsui T, 2013, J MED VIROL, V85, P1900, DOI 10.1002/jmv.23694; McGlynn KA, 2015, CLIN LIVER DIS, V19, P223, DOI 10.1016/j.cld.2015.01.001; Mellemkjaer L, 2006, INT J CANCER, V118, P2285, DOI 10.1002/ijc.21651; Papaconstantinou I, 2015, J BUON, V20, P332; Raymond JS, 2006, BRIT J CANCER, V94, P1745, DOI 10.1038/sj.bjc.6603172; Sharma P, 2014, BREAST CANCER RES TR, V145, P707, DOI 10.1007/s10549-014-2980-0; Sighoko D, 2014, ONCOLOGIST, V19, P592, DOI 10.1634/theoncologist.2013-0427; Silverman Paul M, 2005, Cancer Imaging, V5, P178, DOI 10.1102/1470-7330.2005.0105; Singal AK, 2013, ALIMENT PHARM THER, V38, P98, DOI 10.1111/apt.12344; Sisti G, 2014, GYNECOL ONCOL, V134, P90, DOI 10.1016/j.ygyno.2014.05.004; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tang CM, 2014, WORLD J GASTROENTERO, V20, P6262, DOI 10.3748/wjg.v20.i20.6262; Tubiana M, 2009, RADIOTHER ONCOL, V91, P4, DOI 10.1016/j.radonc.2008.12.016; Xu L, 2014, MOL MED REP, V9, P1345, DOI 10.3892/mmr.2014.1973	27	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0139782	10.1371/journal.pone.0139782	http://dx.doi.org/10.1371/journal.pone.0139782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766567	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300001
J	Saraf, R; Huang, T; Mahmood, F; Owais, K; Bardia, A; Khabbaz, KR; Liu, D; Senthilnathan, V; Lassaletta, AD; Sellke, F; Matyal, R				Saraf, Rabya; Huang, Thomas; Mahmood, Feroze; Owais, Khurram; Bardia, Amit; Khabbaz, Kamal R.; Liu, David; Senthilnathan, Venkatachalam; Lassaletta, Antonio D.; Sellke, Frank; Matyal, Robina			Early Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic Syndrome	PLOS ONE			English	Article							ARTERIAL STIFFNESS; OXIDATIVE STRESS; NEUROPEPTIDE-Y; NITRIC-OXIDE; HYPERTENSION; APOPTOSIS; INFLAMMATION; MECHANISMS; PRESSURE; FIBROSIS	Background Metabolic syndrome is associated with pathological remodeling of the heart and adjacent vessels. The early biochemical and cellular changes underlying the vascular damage are not fully understood. In this study, we sought to establish the nature, extent, and initial time-line of cytochemical derangements underlying reduced ventriculo-arterial compliance in a swine model of metabolic syndrome. Methods Yorkshire swine (n = 8 per group) were fed a normal diet (ND) or a high-cholesterol (HCD) for 12 weeks. Myocardial function and blood flow was assessed before harvesting the heart. Immuno-blotting and immuno-histochemical staining were used to assess the cellular changes in the myocardium, ascending aorta and left anterior descending artery (LAD). Results There was significant increase in body mass index, blood glucose and mean arterial pressures (p = 0.002, p = 0.001 and p = 0.024 respectively) in HCD group. At the cellular level there was significant increase in anti-apoptotic factors p-Akt (p = 0.007 and p = 0.002) and Bcl-xL (p = 0.05 and p = 0.01) in the HCD aorta and myocardium, respectively. Pro-fibrotic markers TGF-beta (p = 0.01), pSmad1/5 (p = 0.03) and MMP-9 (p = 0.005) were significantly increased in the HCD aorta. The levels of pro-apoptotic p38MAPK, Apaf-1 and cleaved Caspase3 were significantly increased in aorta of HCD (p = 0.03, p = 0.04 and p = 0.007 respectively). Similar changes in coronary arteries were not observed in either group. Functionally, the high cholesterol diet resulted in significant increase in ventricular end systolic pressure and-dp/dt (p = 0.05 and p = 0.007 respectively) in the HCD group. Conclusion Preclinical metabolic syndrome initiates pro-apoptosis and pro-fibrosis pathways in the heart and ascending aorta, while sparing coronary arteries at this early stage of dietary modification.	[Saraf, Rabya; Khabbaz, Kamal R.; Liu, David; Senthilnathan, Venkatachalam; Lassaletta, Antonio D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Cardiac Surg, Boston, MA 02215 USA; [Huang, Thomas; Mahmood, Feroze; Owais, Khurram; Bardia, Amit; Matyal, Robina] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Lassaletta, Antonio D.; Sellke, Frank] Rhode Isl Hosp, Brown Alpert Sch Med, Dept Surg, Providence, RI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Matyal, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	rmatyal1@bidmc.harvard.edu	Mahmood, Feroze/B-1383-2008; Liu, David R./HCH-3132-2022	Mahmood, Feroze/0000-0002-7071-0476; Huang, Thomas/0000-0001-7257-1134	Department of Anesthesia at Beth Israel Deaconess Medical Center; Ronald M. Weintraub Family Research Fund; NIH [R01 HL069024, RO1 HL46716]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046716, R01HL069024] Funding Source: NIH RePORTER	Department of Anesthesia at Beth Israel Deaconess Medical Center; Ronald M. Weintraub Family Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Department of Anesthesia at Beth Israel Deaconess Medical Center, the Ronald M. Weintraub Family Research Fund, and NIH grants R01 HL069024 and RO1 HL46716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Asrih M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370715; Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Czernichow S, 2005, AM J HYPERTENS, V18, P1154, DOI 10.1016/j.amjhyper.2005.04.006; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Ghigliotti G, 2014, INFLAMMATION, V37, P1337, DOI 10.1007/s10753-014-9914-1; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hamasaki S, 2000, J AM COLL CARDIOL, V35, P1654, DOI 10.1016/S0735-1097(00)00594-5; Hay I, 2005, AM J PHYSIOL-HEART C, V288, pH1203, DOI 10.1152/ajpheart.00681.2004; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jain S, 2014, ATHEROSCLEROSIS, V237, P381, DOI 10.1016/j.atherosclerosis.2014.09.011; Kangas P, 2013, METABOLISM, V62, P1114, DOI 10.1016/j.metabol.2013.02.009; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Laursen JB, 2001, FREE RADICAL RES, V35, P387, DOI 10.1080/10715760100300901; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Matyal R, 2013, EUR J PHARMACOL, V718, P261, DOI 10.1016/j.ejphar.2013.08.023; Matyal R, 2011, EUR J PHARMACOL, V665, P19, DOI 10.1016/j.ejphar.2011.04.039; RAMSEY MW, 1995, CIRCULATION, V92, P3212, DOI 10.1161/01.CIR.92.11.3212; Robich MP, 2011, EUR J PHARMACOL, V664, P45, DOI 10.1016/j.ejphar.2011.04.059; Robich MP, 2010, J MOL CELL CARDIOL, V49, P1022, DOI 10.1016/j.yjmcc.2010.08.022; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Safar ME, 2006, J AM COLL CARDIOL, V47, P72, DOI 10.1016/j.jacc.2005.08.052; Schillaci G, 2005, HYPERTENSION, V45, P1078, DOI 10.1161/01.HYP.0000165313.84007.7d; Singleton JR, 2003, DIABETES, V52, P2867, DOI 10.2337/diabetes.52.12.2867; Spitler KM, 2014, HYPERTENSION, V63, pE40, DOI 10.1161/HYPERTENSIONAHA.113.02558; Trask AJ, 2012, J APPL PHYSIOL, V113, P1128, DOI 10.1152/japplphysiol.00604.2012; UUSITUPA MIJ, 1990, ANN MED, V22, P377, DOI 10.3109/07853899009147274; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Yiu KH, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-94; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146481	10.1371/journal.pone.0146481	http://dx.doi.org/10.1371/journal.pone.0146481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766185	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300022
J	Sayyad, WA; Fabris, P; Torre, V				Sayyad, Wasim A.; Fabris, Paolo; Torre, Vincent			The Role of Rac1 in the Growth Cone Dynamics and Force Generation of DRG Neurons	PLOS ONE			English	Article							ARP2/3 COMPLEX; RHO-GTPASES; MYOSIN-II; ACTIN; LAMELLIPODIA; FILOPODIA; FAMILY; BINDING; INHIBITORS; PROTEINS	We used optical tweezers, video imaging, immunocytochemistry and a variety of inhibitors to analyze the role of Rac1 in the motility and force generation of lamellipodia and filopodia from developing growth cones of isolated Dorsal Root Ganglia neurons. When the activity of Rac1 was inhibited by the drug EHop-016, the period of lamellipodia protrusion/retraction cycles increased and the lamellipodia retrograde flow rate decreased; moreover, the axial force exerted by lamellipodia was reduced dramatically. Inhibition of Arp2/3 by a moderate amount of the drug CK-548 caused a transient retraction of lamellipodia followed by a complete recovery of their usual motility. This recovery was abolished by the concomitant inhibition of Rac1. The filopodia length increased upon inhibition of both Rac1 and Arp2/3, but the speed of filopodia protrusion increased when Rac1 was inhibited and decreased instead when Arp2/3 was inhibited. These results suggest that Rac1 acts as a switch that activates upon inhibition of Arp2/3. Rac1 also controls the filopodia dynamics necessary to explore the environment.	[Sayyad, Wasim A.; Fabris, Paolo; Torre, Vincent] Int Sch Adv Studies SISSA, Neurosci Area, Trieste, Italy	International School for Advanced Studies (SISSA)	Torre, V (corresponding author), Int Sch Adv Studies SISSA, Neurosci Area, Trieste, Italy.	torre@sissa.it	Sayyad, Wasim/AAL-4403-2020	Sayyad, Wasim/0000-0002-6064-2860	Seventh Framework Programme for Research of the European Commission: the FOCUS Project [FP7-ICT-270483]; 'ICTP TRIL Programme', Trieste, Italy; Seventh Framework Programme for Research of the European Commission: the NEUROSCAFFOLDS Project [604263]; Seventh Framework Programme for Research of the European Commission: the SI-CODE Project FET-Open grant, VT [FP7-284553]	Seventh Framework Programme for Research of the European Commission: the FOCUS Project; 'ICTP TRIL Programme', Trieste, Italy; Seventh Framework Programme for Research of the European Commission: the NEUROSCAFFOLDS Project; Seventh Framework Programme for Research of the European Commission: the SI-CODE Project FET-Open grant, VT	The authors acknowledge the financial support of the following projects within the Seventh Framework Programme for Research of the European Commission: the FOCUS Project n. FP7-ICT-270483, the NEUROSCAFFOLDS Project n. 604263, the SI-CODE Project FET-Open grant n. FP7-284553, VT. Wasim A. Sayyad undertook this work with the support of 'ICTP TRIL Programme', Trieste, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support of the following projects within the Seventh Framework Programme for Research of the European Commission: the FOCUS Project n. FP7-ICT-270483, the NEUROSCAFFOLDS Project n. 604263. The author, Wasim A. Sayyad undertook this work with the support of 'ICTP TRIL Programme', Trieste, Italy. We thank M. Lough for editing the paper, Andrea Raffin for developing the LabView based algorithm and Priyadharishini V. for helping in protein estimation.	Agero U, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051904; Amin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073025; Amin L, 2012, BIOPHYS J, V102, P2451, DOI 10.1016/j.bpj.2012.04.036; Amin L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00153; Beckham Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100943; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ILLC D, 1995, NATURE, V377, P539; Jacquemet G, 2013, J CELL SCI, V126, P4121, DOI 10.1242/jcs.121988; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Lopez-Munoz F, 2006, BRAIN RES BULL, V70, P391, DOI 10.1016/j.brainresbull.2006.07.010; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Marthon Ph., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V595, P318, DOI 10.1117/12.952277; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Montalvo-Ortiz BL, 2012, J BIOL CHEM, V287, P13228, DOI 10.1074/jbc.M111.334524; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Sayyad WA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07842; Shahapure R, 2010, BIOPHYS J, V98, P979, DOI 10.1016/j.bpj.2009.11.041; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stavenger RA, 2007, J MED CHEM, V50, P2, DOI 10.1021/jm060873p; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Thies E, 2002, INDEPENDENT ROLES RH, P358; Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Zhang W., 2012, INT J PHOTOENERGY, V2012, P1, DOI DOI 10.1109/JSTSP.2013.2285520; Zhuravlev PI, 2012, P NATL ACAD SCI USA, V109, P10849, DOI 10.1073/pnas.1200160109; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106	56	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146842	10.1371/journal.pone.0146842	http://dx.doi.org/10.1371/journal.pone.0146842			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766136	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300046
J	Fu, HL; Mueller, JL; Whitley, MJ; Cardona, DM; Willett, RM; Kirsch, DG; Brown, JQ; Ramanujam, N				Fu, Henry L.; Mueller, Jenna L.; Whitley, Melodi J.; Cardona, Diana M.; Willett, Rebecca M.; Kirsch, David G.; Brown, J. Quincy; Ramanujam, Nimmi			Structured Illumination Microscopy and a Quantitative Image Analysis for the Detection of Positive Margins in a Pre-Clinical Genetically Engineered Mouse Model of Sarcoma	PLOS ONE			English	Article							BREAST-CONSERVING SURGERY; FROZEN-SECTION ANALYSIS; LUMPECTOMY MARGINS; ACRIDINE-ORANGE; CONSERVATION; CANCER; TISSUE; RATES; STATISTICS; REEXCISION	Intraoperative assessment of surgical margins is critical to ensuring residual tumor does not remain in a patient. Previously, we developed a fluorescence structured illumination microscope (SIM) system with a single-shot field of view (FOV) of 2.1x1.6 mm (3.4 mm(2)) and sub-cellular resolution (4.4 mu m). The goal of this study was to test the utility of this technology for the detection of residual disease in a genetically engineered mouse model of sarcoma. Primary soft tissue sarcomas were generated in the hindlimb and after the tumor was surgically removed, the relevant margin was stained with acridine orange (AO), a vital stain that brightly stains cell nuclei and fibrous tissues. The tissues were imaged with the SIM system with the primary goal of visualizing fluorescent features from tumor nuclei. Given the heterogeneity of the background tissue (presence of adipose tissue and muscle), an algorithm known as maximally stable extremal regions (MSER) was optimized and applied to the images to specifically segment nuclear features. A logistic regression model was used to classify a tissue site as positive or negative by calculating area fraction and shape of the segmented features that were present and the resulting receiver operator curve (ROC) was generated by varying the probability threshold. Based on the ROC curves, the model was able to classify tumor and normal tissue with 77% sensitivity and 81% specificity (Youden's index). For an unbiased measure of the model performance, it was applied to a separate validation dataset that resulted in 73% sensitivity and 80% specificity. When this approach was applied to representative whole margins, for a tumor probability threshold of 50%, only 1.2% of all regions from the negative margin exceeded this threshold, while over 14.8% of all regions from the positive margin exceeded this threshold.	[Fu, Henry L.; Mueller, Jenna L.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Whitley, Melodi J.; Kirsch, David G.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cardona, Diana M.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Willett, Rebecca M.] Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA; [Kirsch, David G.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC USA; [Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Duke University; Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; Duke University; Tulane University	Fu, HL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	henry.fu@duke.edu		Whitley, Melodi/0000-0002-8163-6881; Cardona, Diana/0000-0002-6877-2280	National Institutes of Health [R21 CA159936, BRP 1R01EB011574-01]; NATIONAL CANCER INSTITUTE [R21CA159936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health grant award R21 CA159936 and BRP 1R01EB011574-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATL CANC DATA BASE; Cabioglu N, 2007, ANN SURG ONCOL, V14, P1458, DOI 10.1245/s10434-006-9236-0; Chagpar AB, 2004, AM J SURG, V188, P399, DOI 10.1016/j.amjsurg.2004.06.020; D'Halluin F, 2009, BREAST, V18, P248, DOI 10.1016/j.breast.2009.05.002; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dillon MF, 2008, MODERN PATHOL, V21, P39, DOI 10.1038/modpathol.3800975; Dillon MF, 2007, ANN SURG ONCOL, V14, P1618, DOI 10.1245/s10434-006-9246-y; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Fu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068868; Gareau DS, 2009, OPT LETT, V34, P3235, DOI 10.1364/OL.34.003235; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Ikeda, 1999, Breast Cancer, V6, P93, DOI 10.1007/BF02966914; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Jorns JM, 2012, AM J CLIN PATHOL, V138, P657, DOI 10.1309/AJCP4IEMXCJ1GDTS; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Krolenko SA, 2006, CELL BIOL INT, V30, P933, DOI 10.1016/j.cellbi.2006.06.017; Kurniawan ED, 2008, ANN SURG ONCOL, V15, P2542, DOI 10.1245/s10434-008-0054-4; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Mito JK, 2013, J PATHOL, V229, P132, DOI 10.1002/path.4099; Mueller JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066198; Mueller JL, 2015, RAPID MICROSCOPIC AP; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Muldoon TJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3406386; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Pisters PWT, 1996, J CLIN ONCOL, V14, P859, DOI 10.1200/JCO.1996.14.3.859; Riedl O, 2009, EJSO-EUR J SURG ONC, V35, P264, DOI 10.1016/j.ejso.2008.05.007; Sabolch A, 2012, AM J CLIN ONCOL-CANC, V35, P151, DOI 10.1097/COC.0b013e318209cd72; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srivastava S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907167; Tanbakuchi AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.027; Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207139; Tartter PI, 2000, AM J SURG, V179, P81, DOI 10.1016/S0002-9610(00)00272-5; Thill M, 2014, J SURG ONCOL, V110, P15, DOI 10.1002/jso.23634; Udovich JA, 2009, J MICROSC-OXFORD, V234, P124, DOI 10.1111/j.1365-2818.2009.03153.x	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147006	10.1371/journal.pone.0147006	http://dx.doi.org/10.1371/journal.pone.0147006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799613	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300053
J	Gundlach, E; Hoffmann, MM; Prasse, A; Heinzelmann, S; Ness, T				Gundlach, Enken; Hoffmann, Michael Marcus; Prasse, Antje; Heinzelmann, Sonja; Ness, Thomas			Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis	PLOS ONE			English	Article							TNF-ALPHA RELEASE; T-CELL-ACTIVATION; BRONCHOALVEOLAR LAVAGE; MEDICAL PROGRESS; SERUM MARKERS; RECEPTOR; PARAMETERS; UVEITIS; MANIFESTATION; EXPRESSION	Purpose To study the impact of soluble IL2 receptor (sIL2R), chest x-ray (CxR), and angiotensin-converting enzyme (ACE) as markers for sarcoidosis in uveitis patients. Design Retrospective study. Methods Serum concentrations of sIL2R and ACE were measured in patients with active uveitis. Those with elevated sIL2R and/or ACE values were examined for suspected systemic sarcoidosis. Main Outcome Measure Our main outcome parameters were the specificity and sensitivity of sIL2R, CxR and ACE in screening for ocular sarcoidosis. Results We measured 261 patients with uveitis for sarcoidosis using sIL2R and ACE between January 2008 and November 2011; sarcoidosis was been diagnosed using other tests (e.g. computer tomography, brochoalveolar lavage, biopsy) in 41 of 53 patients with elevated sIL2R values (>639 U/ml) and in one patient with normal sIL2R (582 U/ml). Their mean sIL2R value was 1310 U/ml, extending from 582 to 8659 U/ml. Only 9 patients, however, presented elevated ACE (>82 U/l). Their mean ACE value was 116.4 U/l, ranging from 84.1 to 175.5 U/l. IL2R specificity was 94% with 98% sensitivity. In contrast, ACE had a specificity of 99.5%, but a sensitivity of only 22%; the chest x-ray had a specificity of 100% with 50% sensitivity in detecting sarcoidosis. We observed the entire spectrum of uveitis: sixteen patients suffered from anterior, 8 from intermediate, 16 from posterior, and 2 from panuveitis. Conclusions An elevated level of soluble IL2R suggests sarcoidosis with uveitis more convincingly than ACE, making sIL2R a more effective marker parameter for sarcoidosis than ACE or chest x-ray in uveitis patients.	[Gundlach, Enken] Univ Eye Hosp Charite, Berlin, Germany; [Gundlach, Enken; Heinzelmann, Sonja; Ness, Thomas] Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany; [Hoffmann, Michael Marcus] Univ Hosp Freiburg, Inst Clin Chem & Lab Med, Freiburg, Germany; [Prasse, Antje] Univ Hosp Freiburg, Dept Pneumol, Freiburg, Germany; [Prasse, Antje] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Prasse, Antje] Fraunhofer ITEM, Clin Res Ctr, Hannover, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Hannover Medical School	Ness, T (corresponding author), Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany.	thomas.ness@uniklinik-freiburg.de	Prasse, Antje/AAY-6279-2020; Hoffmann, Michael M/D-4074-2015; Prasse, Antje/AAM-7521-2021; Heinzelmann, Sonja/AAN-5823-2021	Hoffmann, Michael M/0000-0001-8459-6080; Prasse, Antje/0000-0002-7336-7458; 				Abad S, 2009, REV MED INTERNE, V30, P492, DOI 10.1016/j.revmed.2008.08.011; Adan A, 2004, MED CLIN-BARCELONA, V122, P748, DOI 10.1157/13062195; AROCKERMETTINGER E, 1990, CURR EYE RES, V9, P25, DOI 10.3109/02713689008999415; Authier FJ, 1997, NEUROPATH APPL NEURO, V23, P132, DOI 10.1046/j.1365-2990.1997.d01-169.x; Baughman RP, 2012, SARCOIDOSIS VASC DIF, V29, P26; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; BAUGHMAN RP, 1984, AM REV RESPIR DIS, V129, P676, DOI 10.1164/arrd.1984.129.5.676; BENEZRA D, 1993, AM J OPHTHALMOL, V115, P26, DOI 10.1016/S0002-9394(14)73520-2; Beste C, 2014, BRAIN BEHAV IMMUN, V41, P126, DOI 10.1016/j.bbi.2014.05.005; Bezo C, 2013, J FR OPHTALMOL, DOI [10.1016/j.jfo.2012.06.029, DOI 10.1016/J.JF0.2012.06.029]; Biller H, 2009, SARCOIDOSIS VASC DIF, V26, P139; Birnbaum AD, 2011, ARCH OPHTHALMOL-CHIC, V129, P409, DOI 10.1001/archophthalmol.2011.52; CAMPEN DH, 1988, ARTHRITIS RHEUM, V31, P1358, DOI 10.1002/art.1780311103; Caspers LE, 2014, OCUL IMMUNOL INFLAMM, V22, P102, DOI 10.3109/09273948.2013.820836; Cremers J, 2012, EUR J GASTROEN HEPAT, V24, P17, DOI 10.1097/MEG.0b013e32834c7b71; CUMMINGS M M, 1956, Postgrad Med, V19, P437; Cunningham ET, 2014, OCUL IMMUNOL INFLAMM, V22, P253, DOI 10.3109/09273948.2014.941235; Evans M, 2007, OPHTHALMOLOGY, V114, P325, DOI 10.1016/j.ophtha.2006.05.074; Febvay C, 2015, BRIT J OPHTHALMOL, V99, P1372, DOI 10.1136/bjophthalmol-2014-306353; GILBERT S, 1993, AM REV RESPIR DIS, V148, P483, DOI 10.1164/ajrccm/148.2.483; Grutters JC, 2003, CHEST, V124, P186, DOI 10.1378/chest.124.1.186; GUNDELFINGER B, 1961, AM REV RESPIR DIS, V84, P109; Gungor S, 2015, INT IMMUNOPHARMACOL, V25, P174, DOI 10.1016/j.intimp.2015.01.015; Heiligenhaus A, 2011, OPHTHALMIC RES, V46, P9, DOI 10.1159/000321947; Heinle R, 2014, AUTOIMMUN REV, V13, P383, DOI 10.1016/j.autrev.2014.01.035; Herbort CP, 2009, OCUL IMMUNOL INFLAMM, V17, P160, DOI 10.1080/09273940902818861; Hunninghake GW, 1999, SARCOIDOSIS VASC DIF, V16, P149; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; Kawaguchi T, 2007, JPN J OPHTHALMOL, V51, P121, DOI 10.1007/s10384-006-0413-2; KUMAR A, 1987, J IMMUNOL, V139, P3680; LAWRENCE EC, 1988, AM REV RESPIR DIS, V137, P759, DOI 10.1164/ajrccm/137.4.759; MANGGE H, 1995, ARTHRITIS RHEUM, V38, P211, DOI 10.1002/art.1780380209; Martin CM, 2000, CURR EYE RES, V20, P287, DOI 10.1076/0271-3683(200004)20:4;1-5;FT287; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Mostard RLM, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-57; Muller W, 1983, Prax Klin Pneumol, V37 Suppl 1, P553; MULLERQUERNHEIM J, 1991, AM REV RESPIR DIS, V144, P1322; MURRAY PI, 1992, CURR EYE RES, V11, P193, DOI 10.3109/02713689208999532; Ness T, SOLUBLE INTERLEUKIN; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Papadaki T, 2010, ACTA OPHTHALMOL, V88, pe28, DOI 10.1111/j.1755-3768.2008.01422.x; Petereit HF, 2010, J NEUROL, V257, P1855, DOI 10.1007/s00415-010-5623-3; Power WJ, 1995, OPHTHALMOLOGY, V102, P2007, DOI 10.1016/S0161-6420(95)30763-4; Prasse A, 2008, AM J RESP CRIT CARE, V177, P330, DOI 10.1164/rccm.200705-742OC; RICKER W, 1949, AM J CLIN PATHOL, V19, P725; Rossman Milton D, 2007, Proc Am Thorac Soc, V4, P453, DOI 10.1513/pats.200607-138MS; Rothova A, 2000, BRIT J OPHTHALMOL, V84, P110, DOI 10.1136/bjo.84.1.110; Rufer F, 2014, ACTA OPHTHALMOL, V92, P249, DOI [10.1111/aos.12248, 10.1111/aos.12051]; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; STEGEMAN CA, 1993, CLIN EXP IMMUNOL, V91, P415; STUDDY PR, 1989, ANN CLIN BIOCHEM, V26, P13, DOI 10.1177/000456328902600102; Thorne JE, 2000, RETINA-J RET VIT DIS, V20, P8, DOI 10.1097/00006982-200001000-00002; Torun N, 2005, OPHTHALMIC RES, V37, P112, DOI 10.1159/000084271; Varron L, 2011, REV MED INTERNE, V32, P86, DOI 10.1016/j.revmed.2010.09.003; VINK A, 1990, EUR J IMMUNOL, V20, P1, DOI 10.1002/eji.1830200102; Wakefield D, 2010, OCUL IMMUNOL INFLAMM, V18, P5, DOI 10.3109/09273941003597276; WIGFALL DR, 1988, CLIN IMMUNOL IMMUNOP, V47, P354, DOI 10.1016/S0090-1229(88)80012-6; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZHENG L, 1995, AM J RESP CRIT CARE, V152, P1061, DOI 10.1164/ajrccm.152.3.7663784; Ziegenhagen MW, 2003, EUR RESPIR J, V21, P407, DOI 10.1183/09031936.03.00010403; Ziegenhagen MW, 1997, AM J RESP CRIT CARE, V156, P1586, DOI 10.1164/ajrccm.156.5.97-02050	63	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147258	10.1371/journal.pone.0147258	http://dx.doi.org/10.1371/journal.pone.0147258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799486	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300083
J	Roy, S; Tripathi, AM; Yadav, A; Mishra, P; Nautiyal, CS				Roy, Sribash; Tripathi, Abhinandan Mani; Yadav, Amrita; Mishra, Parneeta; Nautiyal, Chandra Shekhar			Identification and Expression Analyses of miRNAs from Two Contrasting Flower Color Cultivars of Canna by Deep Sequencing	PLOS ONE			English	Article							SMALL RNA; TRANSCRIPTION FACTORS; FLORAL DEVELOPMENT; MICRORNA; ARABIDOPSIS; GENES; BIOGENESIS; TIME; BIOSYNTHESIS; BOUNDARY	miRNAs are endogenous small RNA (sRNA) that play critical roles in plant development processes. Canna is an ornamental plant belonging to family Cannaceae. Here, we report for the first time the identification and differential expression of miRNAs in two contrasting flower color cultivars of Canna, Tropical sunrise and Red president. A total of 313 known miRNAs belonging to 78 miRNA families were identified from both the cultivars. Thirty one miRNAs (17 miRNA families) were specific to Tropical sunrise and 43 miRNAs (10 miRNA families) were specific to Red president. Thirty two and 18 putative new miRNAs were identified from Tropical sunrise and Red president, respectively. One hundred and nine miRNAs were differentially expressed in the two cultivars targeting 1343 genes. Among these, 16 miRNAs families targeting60 genes were involved in flower development related traits and five miRNA families targeting five genes were involved in phenyl propanoid and pigment metabolic processes. We further validated the expression analysis of a few miRNA and their target genes by qRT-PCR. Transcription factors were the major miRNA targets identified. Target validation of a few randomly selected miRNAs by RLM-RACE was performed but was successful with only miR162. These findings will help in understanding flower development processes, particularly the color development in Canna.	[Roy, Sribash; Tripathi, Abhinandan Mani; Yadav, Amrita; Mishra, Parneeta] Natl Bot Res Inst, Div Genet & Mol Biol, CSIR, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India; [Roy, Sribash; Tripathi, Abhinandan Mani; Mishra, Parneeta] CSIR, Acad Sci & Innovat Res AcSIR, Natl Bot Res Inst Campus,Rana Pratap Marg, Lucknow, Uttar Pradesh, India; [Nautiyal, Chandra Shekhar] Natl Bot Res Inst, CSIR, Div Plant Microbe Interact, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Nautiyal, CS (corresponding author), Natl Bot Res Inst, CSIR, Div Plant Microbe Interact, Lucknow 226001, Uttar Pradesh, India.	nautiyalnbri@lycas.com	Tripathi, Abhinandan/ABF-2608-2020	Nautiyal, Chandra/0000-0003-3899-5034; MISHRA, PARNEETA/0000-0002-1047-3544	Council of Scientific and Industrial Research, New Delhi, India; University Grant Commission, New Delhi; Council for Scientific and Industrial Research (CSIR), New Delhi [OLP-088]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, New Delhi(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge University Grant Commission, New Delhi, for fellowship to AMT and PM. The work was supported by Council for Scientific and Industrial Research (CSIR), New Delhi granted project,OLP-088.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Biswabijayinee Patra, 2008, International Journal of Integrative Biology, V2, P129; Bocs S, 2014, PLANT AN GEN 22 C PL; Brousse C, 2014, NUCLEIC ACIDS RES, V42, P5270, DOI 10.1093/nar/gku157; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; CHEN BH, 1992, FOOD CHEM, V44, P61, DOI 10.1016/0308-8146(92)90259-5; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Dong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075978; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Glazinska P, 2009, J PLANT PHYSIOL, V166, P1801, DOI 10.1016/j.jplph.2009.05.011; Glinos E, 2011, PLANT SYST EVOL, V291, P49, DOI 10.1007/s00606-010-0379-x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan X, 2014, NATURE COMMUNICATION, P5; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Korbes AP, 2012, IDENTIFYING CONSERVE; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lakhotia N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-6; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lee WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127526; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; MANCINELLI AL, 1984, PLANT CELL PHYSIOL, V25, P93; Mangrauthia SK, 2013, SALT STRESS PLANTS, P15, DOI [10.1007/978-1-4614-6108-1_2, DOI 10.1007/978-1-4614-6108-1_2]; May P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3145; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mishra T., 2012, FREE RADICALS ANTIOX, V2, P13, DOI DOI 10.5530/AX.2012.2.5; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nishihara M, 2011, BIOTECHNOL LETT, V33, P433, DOI 10.1007/s10529-010-0461-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shen D, 2014, NEW PHYTOL, V204, P577, DOI 10.1111/nph.12934; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Vankar PS, 2008, INT J FOOD ENG, V4; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Weir I, 2004, DEVELOPMENT, V131, P915, DOI 10.1242/dev.00993; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	70	13	14	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147499	10.1371/journal.pone.0147499	http://dx.doi.org/10.1371/journal.pone.0147499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799570	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300116
J	Tang, XL; Perez-Cruzado, C; Fehrmann, L; Alvarez-Gonzalez, JG; Lu, YC; Kleinn, C				Tang, Xiaolu; Perez-Cruzado, Cesar; Fehrmann, Lutz; Gabriel Alvarez-Gonzalez, Juan; Lu, Yuanchang; Kleinn, Christoph			Development of a Compatible Taper Function and Stand-Level Merchantable Volume Model for Chinese Fir Plantations	PLOS ONE			English	Article							STEM TAPER; CARBON STORAGE; PINE; EQUATIONS; NORTHERN; SYSTEM	Chinese fir (Cunninghamia lanceolata [Lamb.] Hook) is one of the most important plantation tree species in China with good timber quality and fast growth. It covers an area of 8.54 million hectare, which corresponds to 21% of the total plantation area and 32% of total plantation volume in China. With the increasing market demand, an accurate estimation and prediction of merchantable volume at tree-and stand-level is becoming important for plantation owners. Although there are many studies on the total tree volume estimation from allometric models, these allometric models cannot predict tree-and stand-level merchantable volume at any merchantable height, and the stand-level merchantable volume model was not seen yet in Chinese fir plantations. This study aimed to develop (1) a compatible taper function for tree-level merchantable volume estimation, and (2) a stand-level merchantable volume model for Chinese fir plantations. This "taper function system" consisted in a taper function, a merchantable volume equation and a total tree volume equation. 46 Chinese fir trees were felled to develop the taper function in Shitai County, Anhui province, China. A second-order continuous autoregressive error structure corrected the inherent serial autocorrelation of different observations in one tree. The taper function and volume equations were fitted simultaneously after autocorrelation correction. The compatible taper function fitted well to our data and had very good performances in diameter and total tree volume prediction. The stand-level merchantable volume equation based on the ratio approach was developed using basal area, dominant height, quadratic mean diameter and top diameter (ranging from 0 to 30 cm) as independent variables. At last, a total stand-level volume table using stand basal area and dominant height as variables was proposed for local forest managers to simplify the stand volume estimation.	[Tang, Xiaolu; Perez-Cruzado, Cesar; Fehrmann, Lutz; Kleinn, Christoph] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany; [Gabriel Alvarez-Gonzalez, Juan] Univ Santiago de Compostela, Dept Ingn Agroforestal, Lugo, Spain; [Lu, Yuanchang] Chinese Acad Forestry, Inst Forest Resource Informat Tech, Dept Forest Management & Stat, Beijing, Peoples R China; [Tang, Xiaolu] Int Ctr Bamboo & Rattan, State Key Lab Bamboo & Rattan Sci, Beijing, Peoples R China	University of Gottingen; Universidade de Santiago de Compostela; Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; International Centre for Bamboo & Rattan	Tang, XL (corresponding author), Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany.; Tang, XL (corresponding author), Int Ctr Bamboo & Rattan, State Key Lab Bamboo & Rattan Sci, Beijing, Peoples R China.	lxtt2010@163.com	Kleinn, Christoph/AAG-1768-2020; Alvarez, Juan/GSD-7155-2022; Pérez-Cruzado, César/E-4011-2012; Tang, Xiaolu/C-3675-2014	Pérez-Cruzado, César/0000-0002-9878-7678; Tang, Xiaolu/0000-0001-5079-7650; Alvarez-Gonzalez, Juan Gabriel/0000-0002-5206-9128	Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value) - Federal Ministry of Education and Research (BMBF) [033L049-CAFYBB2012013]; Chinese Academy of Forestry	Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value) - Federal Ministry of Education and Research (BMBF); Chinese Academy of Forestry	This work was supported by Sino-German Cooperation on Innovative Technologies and Service Capacities of Multifunctional Forest Management (Lin2Value 033L049-CAFYBB2012013), funded by the Federal Ministry of Education and Research (BMBF) and the Chinese Academy of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alder D, 1980, ESTUDIO FAO MONTES, V22, P80; Anta MB, 2007, ANN FOREST SCI, V64, P511, DOI 10.1051/forest:2007028; Barrio-Anta M, 2008, FOREST ECOL MANAG, V255, P1167, DOI 10.1016/j.foreco.2007.10.022; Bi HuiQuan, 1998, Australian Forestry, V61, P275; CAO Q V, 1980, Southern Journal of Applied Forestry, V4, P166; CAO QV, 1980, FOREST SCI, V26, P71; Chen GS, 2013, FOREST ECOL MANAG, V300, P68, DOI 10.1016/j.foreco.2012.07.046; CLUTTER JL, 1980, FOREST SCI, V26, P117; Cutini A., 2013, iForest, V6, P331; DEMAERSCHALK JP, 1972, FOREST SCI, V18, P241, DOI 10.1093/forestscience/18.3.241; Deusen P. C. van, 1981, Southern Journal of Applied Forestry, V5, P186; Dieguez-Aranda U, 2006, CAN J FOREST RES, V36, P1190, DOI 10.1139/X06-008; Fang ZX, 2000, FOREST SCI, V46, P1; FURNIVAL GEORGE M., 1961, FOREST SCI, V7, P337; Geng T.S., 2011, J ANHUI AGR SCI, V39, P482; Geng T. S., 2011, J ANHUI AGR SCI, V39, P451; Gregoire TG, 1996, J APPL STAT, V23, P257, DOI 10.1080/02664769624233; Hui GY, 1997, FORSTWISS CENTRALBL, V116, P315, DOI 10.1007/BF02766907; Jia Z, 2009, REPORT CHINESE FORES; Kozak A, 2004, FOREST CHRON, V80, P507, DOI 10.5558/tfc80507-4; KOZAK A, 1988, CAN J FOREST RES, V18, P1363, DOI 10.1139/x88-213; Lu C.M., 2010, GEOL ANHUI, V20, P120; Menendez-Miguelez M, 2014, ANN FOREST SCI, V71, P761, DOI 10.1007/s13595-014-0372-6; Navar J, 2013, ANN FOR RES, V56, P165; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; REED DD, 1984, FOREST SCI, V30, P977; Rojo A, 2005, EUR J FOREST RES, V124, P177, DOI 10.1007/s10342-005-0066-6; SAS Institute Inc, 2007, SAS US GUID VERS 9 2; Tasissa G., 1997, Southern Journal of Applied Forestry, V21, P146; Teshome T, 2005, FOREST ECOL MANAG, V204, P171, DOI 10.1016/j.foreco.2004.07.064; Turski M, 2008, FOREST ECOL MANAG, V255, P2678, DOI 10.1016/j.foreco.2008.01.028; Wu ZL, 1984, CHINESE FIR BEIJING; Zhao MF, 2009, FOREST ECOL MANAG, V257, P1520, DOI 10.1016/j.foreco.2008.12.025	34	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147610	10.1371/journal.pone.0147610	http://dx.doi.org/10.1371/journal.pone.0147610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799399	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300130
J	Wang, TF; Zhao, M; Rotgans, BA; Strong, A; Liang, D; Ni, GY; Limpanont, Y; Ramasoota, P; McManus, DP; Cummins, SF				Wang, Tianfang; Zhao, Min; Rotgans, Bronwyn A.; Strong, April; Liang, Di; Ni, Guoying; Limpanont, Yanin; Ramasoota, Pongrama; McManus, Donald P.; Cummins, Scott F.			Proteomic Analysis of the Schistosoma mansoni Miracidium	PLOS ONE			English	Article							OPEN READING FRAME; HEAT-SHOCK-PROTEIN; COMPATIBILITY POLYMORPHISM; MOLECULAR CHARACTERIZATION; EXPRESSION PATTERNS; ECHINOSTOMA-CAPRONI; FASCIOLA-HEPATICA; SIGNAL PEPTIDES; GENOME; MODEL	Despite extensive control efforts, schistosomiasis continues to be a major public health problem in developing nations in the tropics and sub-tropics. The miracidium, along with the cercaria, both of which are water-borne and free-living, are the only two stages in the life-cycle of Schistosoma mansoni which are involved in host invasion. Miracidia penetrate intermediate host snails and develop into sporocysts, which lead to cercariae that can infect humans. Infection of the snail host by the miracidium represents an ideal point at which to interrupt the parasite's life-cycle. This research focuses on an analysis of the miracidium proteome, including those proteins that are secreted. We have identified a repertoire of proteins in the S. mansoni miracidium at 2 hours post-hatch, including proteases, venom allergen-like proteins, receptors and HSP70, which might play roles in snail-parasite interplay. Proteins involved in energy production and conservation were prevalent, as were proteins predicted to be associated with defence. This study also provides a strong foundation for further understanding the roles that neurohormones play in host-seeking by schistosomes, with the potential for development of novel anthelmintics that interfere with its various lifecycle stages.	[Wang, Tianfang; Zhao, Min; Rotgans, Bronwyn A.; Strong, April; Liang, Di; Ni, Guoying; Cummins, Scott F.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Ni, Guoying] Griffith Univ, Griffith Hlth Inst, Sch Med Sci, Gold Coast, Qld 4222, Australia; [Limpanont, Yanin; Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [McManus, Donald P.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia	University of the Sunshine Coast; Griffith University; Menzies Health Institute Queensland; Mahidol University; QIMR Berghofer Medical Research Institute	Cummins, SF (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	Wang, Tianfang/L-5192-2016; Wang, Tianfang/AAG-4290-2020; Zhao, Min/J-6588-2019; Wang, Tianfang/GRO-0844-2022; McManus, Don/AAC-5394-2020; Ramasoota, Pongrama/W-3503-2019; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Wang, Tianfang/0000-0002-4876-7767; McManus, Don/0000-0001-6443-1449; Cummins, Scott/0000-0002-1454-2076	University of the Sunshine Coast internal grant; Australian Research Council [FT110100990]; University of the Sunshine Coast [URG 13/11]; Australian government	University of the Sunshine Coast internal grant; Australian Research Council(Australian Research Council); University of the Sunshine Coast; Australian government(Australian GovernmentCGIAR)	The authors thank the following for support for this work: University of the Sunshine Coast internal grant and Australian Research Council (FT110100990); University of the Sunshine Coast, URG 13/11. This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson KJ, 2015, PEPTIDES; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Aly HF, 2013, PARASITOL INT, V62, P380, DOI 10.1016/j.parint.2013.04.002; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Araujo-Montoya BO, 2011, EXP PARASITOL, V129, P284, DOI 10.1016/j.exppara.2011.07.008; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Ballen D, 2002, EXP PARASITOL, V101, P164, DOI 10.1016/S0014-4894(02)00104-2; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Benitez L, 1998, PARASITOL RES, V84, P423, DOI 10.1007/s004360050422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; CHIANG CP, 1989, AM J PATHOL, V135, P1015; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosseau C, 2010, OIKOS, V119, P669, DOI 10.1111/j.1600-0706.2009.18040.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curwen RS, 2004, MOL BIOCHEM PARASIT, V138, P57, DOI 10.1016/j.molbiopara.2004.06.016; Pitta MGD, 2013, MINI-REV MED CHEM, V13, P493; Dalton JP, 1997, PARASITOLOGY, V115, P29, DOI 10.1017/S0031182097001091; Danso-Appiah A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000528.pub2; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Don TA, 2008, INT J INFECT DIS, V12, pE39, DOI 10.1016/j.ijid.2007.10.007; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; El Aswad BEW, 2011, IMMUNOBIOLOGY, V216, P379, DOI 10.1016/j.imbio.2010.06.014; ElRidi R, 1996, INFECT IMMUN, V64, P4700, DOI 10.1128/IAI.64.11.4700-4705.1996; Espino AM, 2003, J PARASITOL, V89, P545, DOI 10.1645/GE-3113; Farias LP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001510; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Haberl B, 2000, PARASITOLOGY, V120, P479, DOI 10.1017/S0031182099005697; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hernandez HJ, 1999, J IMMUNOL, V163, P3877; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Hrckova G, 2004, INT J PARASITOL, V34, P83, DOI 10.1016/j.ijpara.2003.10.007; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Kalbe M, 1997, PARASITOL RES, V83, P806, DOI 10.1007/s004360050344; Kappe G, 2004, PROTEINS, V57, P109, DOI 10.1002/prot.20220; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Koehler JW, 2007, MEM I OSWALDO CRUZ, V102, P83, DOI 10.1590/S0074-02762007000100014; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lee JY, 2002, BIOCHEM BIOPH RES CO, V296, P1238, DOI 10.1016/S0006-291X(02)02062-4; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Luo QL, 2009, ACTA TROP, V112, P91, DOI 10.1016/j.actatropica.2009.06.011; MALDONADO JF, 1948, AM J TROP MED, V28, P645, DOI 10.4269/ajtmh.1948.s1-28.645; Martins VP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/962538; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; McVeigh P, 2011, INT J PARASITOL, V41, P905, DOI 10.1016/j.ijpara.2011.03.010; McVeigh P, 2009, INT J PARASITOL, V39, P1243, DOI 10.1016/j.ijpara.2009.03.005; Merckelbach A, 2003, PARASITOL RES, V90, P493, DOI 10.1007/s00436-003-0888-4; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Mone Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000813; Morales ME, 2008, MOL BIOCHEM PARASIT, V157, P160, DOI 10.1016/j.molbiopara.2007.10.009; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Odegaard JI, 2014, PARASITE IMMUNOL, V36, P428, DOI 10.1111/pim.12084; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinheiro CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/503068; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Quandt A., 2014, EUPA OPEN PROTEOMICS, V5, P21; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rofatto HK, 2012, INT J PARASITOL, V42, P613, DOI 10.1016/j.ijpara.2012.04.008; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P205, DOI 10.1016/j.molbiopara.2007.11.003; Roger E, 2008, MOL BIOCHEM PARASIT, V157, P217, DOI 10.1016/j.molbiopara.2007.11.015; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2009, MOL BIOCHEM PARASIT, V166, P4, DOI 10.1016/j.molbiopara.2009.02.003; SCHREIBER FG, 1949, J PARASITOL, V35, P91, DOI 10.2307/3273392; Sharma M, 2009, J MOL GRAPH MODEL, V27, P665, DOI 10.1016/j.jmgm.2008.10.009; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Stack C, 2011, ADV EXP MED BIOL, V712, P116, DOI 10.1007/978-1-4419-8414-2_8; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van de Vijver KK, 2006, GLYCOBIOLOGY, V16, P237, DOI 10.1093/glycob/cwj058; Vassilaki N, 2008, J VIROL, V82, P11503, DOI 10.1128/JVI.01640-08; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wu XJ, 2009, MOL BIOCHEM PARASIT, V164, P32, DOI 10.1016/j.molbiopara.2008.11.005; Yoshino TP, 2014, INT J PARASITOL, V44, P551, DOI 10.1016/j.ijpara.2014.04.002; YOSHINO TP, 1993, J PARASITOL, V79, P23, DOI 10.2307/3283272; Zerlotini A, 2013, NUCLEIC ACIDS RES, V41, pD728, DOI 10.1093/nar/gks1087; Zhang SM, 2008, INNATE IMMUN-LONDON, V14, P175, DOI 10.1177/1753425908093800; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	101	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147247	10.1371/journal.pone.0147247	http://dx.doi.org/10.1371/journal.pone.0147247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799066	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300079
J	Madenjian, CP; Jensen, OP; Rediske, RR; O'Keefe, JP; Vastano, AR; Pothoven, SA				Madenjian, Charles P.; Jensen, Olaf P.; Rediske, Richard R.; O'Keefe, James P.; Vastano, Anthony R.; Pothoven, Steven A.			Differences in Energy Expenditures and Growth Dilution Explain Higher PCB Concentrations in Male Summer Flounder	PLOS ONE			English	Article							TROUT SALVELINUS-NAMAYCUSH; POLYCHLORINATED BIPHENYL CONCENTRATIONS; SEXUAL DIFFERENCE; LAKE TROUT; PARALICHTHYS-DENTATUS; CONGENER DISTRIBUTIONS; OXYGEN-CONSUMPTION; STABLE-ISOTOPES; DIETARY UPTAKE; FISH	Comparison of polychlorinated biphenyl (PCB) concentrations between the sexes of mature fish may reveal important behavioral and physiological differences between the sexes. We determined whole-fish PCB concentrations in 23 female summer flounder Paralichthys dentatus and 27 male summer flounder from New Jersey coastal waters. To investigate the potential for differences in diet or habitat utilization between the sexes, carbon and nitrogen stable isotope ratios were also determined. In 5 of the 23 female summer flounder, PCB concentrations in the somatic tissue and ovaries were determined. In addition, we used bioenergetics modeling to assess the contribution of the growth dilution effect to the observed difference in PCB concentrations between the sexes. Whole-fish PCB concentrations for females and males averaged 87 and 124 ng/g, respectively; thus males were 43% higher in PCB concentration compared with females. Carbon and nitrogen stable isotope ratios did not significantly differ between the sexes, suggesting that diet composition and habitat utilization did not vary between the sexes. Based on PCB determinations in the somatic tissue and ovaries, we predicted that PCB concentration of females would increase by 0.6%, on average, immediately after spawning due to release of eggs. Thus, the change in PCB concentration due to release of eggs did not explain the higher PCB concentrations observed in males. Bioenergetics modeling results indicated that the growth dilution effect could account for males being 19% higher in PCB concentration compared with females. Thus, the bulk of the observed difference in PCB concentrations between the sexes was not explained by growth dilution. We concluded that a higher rate of energy expenditure in males, stemming from greater activity and a greater resting metabolic rate, was most likely the primary driver for the observed difference in PCB concentrations between the sexes.	[Madenjian, Charles P.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA; [Jensen, Olaf P.; Vastano, Anthony R.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Rediske, Richard R.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA; [O'Keefe, James P.] Michigan Dept Hlth & Human Serv, Bur Labs, Lansing, MI USA; [Pothoven, Steven A.] Natl Ocean & Atmospher Adm, Great Lakes Environm Res Lab, Lake Michigan Field Stn, Muskegon, MI USA	United States Department of the Interior; United States Geological Survey; Rutgers State University New Brunswick; Grand Valley State University; MDHHS - Michigan Department of Health & Human Services; National Oceanic Atmospheric Admin (NOAA) - USA	Madenjian, CP (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA.	cmadenjian@usgs.gov		Rediske, Richard/0000-0002-5048-1063	U. S. Geological Survey Great Lakes Science Center; Rutgers University	U. S. Geological Survey Great Lakes Science Center(United States Geological Survey); Rutgers University	This work was supported by the U. S. Geological Survey Great Lakes Science Center to CPM and Rutgers University to OPJ.	BALLSCHMITER K, 1992, HRC-J HIGH RES CHROM, V15, P260; BEAMISH FWH, 1964, CAN J ZOOLOG, V42, P189, DOI 10.1139/z64-017; Bodiguel X, 2009, SCI TOTAL ENVIRON, V408, P304, DOI 10.1016/j.scitotenv.2009.10.004; Booij K, 2003, ENVIRON SCI TECHNOL, V37, P4213, DOI 10.1021/es034147c; BORGMANN U, 1992, CAN J FISH AQUAT SCI, V49, P1086, DOI 10.1139/f92-120; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Burgess RM, 1999, ENVIRON POLLUT, V104, P373, DOI 10.1016/S0269-7491(98)00194-8; Burke BJ, 2002, T AM FISH SOC, V131, P120, DOI 10.1577/1548-8659(2002)131&lt;0120:ALFABM&gt;2.0.CO;2; Capossela KM, 2013, FISH B-NOAA, V111, P189, DOI 10.7755/FB.111.2.6; Carlson DL, 2010, ENVIRON SCI TECHNOL, V44, P2004, DOI 10.1021/es903191u; Carlson DL, 2005, ENVIRON SCI TECHNOL, V39, P7389, DOI 10.1021/es048023r; Cooke SJ, 2004, FUNCT ECOL, V18, P398, DOI 10.1111/j.0269-8463.2004.00878.x; Darnaude AM, 2004, OECOLOGIA, V138, P325, DOI 10.1007/s00442-003-1457-3; Frame G.M., 1996, J HIGH RES CHROMATOG, V19, P657, DOI DOI 10.1002/JHRC.1240191202; Gewurtz SB, 2011, ENVIRON INT, V37, P425, DOI 10.1016/j.envint.2010.11.005; HARTMAN KJ, 1995, CAN J FISH AQUAT SCI, V52, P1667, DOI 10.1139/f95-760; HESSELBERG RJ, 1990, J GREAT LAKES RES, V16, P121, DOI 10.1016/S0380-1330(90)71403-7; International Union of Pure and Applied Chemistry (IUPAC), 2012, REC ORG BIOCH NOM SY; Jude DJ, 2010, J GREAT LAKES RES, V36, P267, DOI 10.1016/j.jglr.2010.03.002; KAMMANN U, 1993, MAR POLLUT BULL, V26, P629, DOI 10.1016/0025-326X(93)90502-B; Kennish Michael J., 2005, Bulletin New Jersey Academy of Science, V50, P1; Kimbrough K.L., 2008, 74 NOAA NOS NCCOS; LOZAN JL, 1992, NETH J SEA RES, V29, P223, DOI 10.1016/0077-7579(92)90022-7; Madenjian CP, 2014, ARCH ENVIRON CON TOX, V66, P529, DOI 10.1007/s00244-014-0015-9; Madenjian CP, 2013, ARCH ENVIRON CON TOX, V65, P693, DOI 10.1007/s00244-013-9936-y; Madenjian CP, 2015, J GREAT LAKES RES, V41, P1185, DOI 10.1016/j.jglr.2015.09.010; Madenjian CP, 2014, SCI TOTAL ENVIRON, V493, P377, DOI 10.1016/j.scitotenv.2014.06.007; Madenjian CP, 2013, J GREAT LAKES RES, V39, P358, DOI 10.1016/j.jglr.2013.03.011; Madenjian CP, 2011, FISH FISH, V12, P451, DOI 10.1111/j.1467-2979.2011.00414.x; Madenjian CP, 2010, SCI TOTAL ENVIRON, V408, P1725, DOI 10.1016/j.scitotenv.2009.12.024; Madenjian CP, 2010, SCI TOTAL ENVIRON, V408, P1719, DOI 10.1016/j.scitotenv.2009.12.023; Madenjian CP, 2009, SCI TOTAL ENVIRON, V407, P4526, DOI 10.1016/j.scitotenv.2009.04.031; MADENJIAN CP, 1993, CAN J FISH AQUAT SCI, V50, P97, DOI 10.1139/f93-012; Madenjian CP, 2000, CAN J FISH AQUAT SCI, V57, P1025, DOI 10.1139/cjfas-57-5-1025; Madenjian CP, 1998, CAN J FISH AQUAT SCI, V55, P1085, DOI 10.1139/cjfas-55-5-1085; MALLOY KD, 1994, T AM FISH SOC, V123, P182, DOI 10.1577/1548-8659(1994)123<0182:EORLAL>2.3.CO;2; MARTHINSEN I, 1991, ARCH ENVIRON CON TOX, V20, P353, DOI 10.1007/BF01064402; Morgan EJ, 2010, ENVIRON SCI TECHNOL, V44, P5444, DOI 10.1021/es100450f; MORSE WW, 1981, J FISH BIOL, V19, P189, DOI 10.1111/j.1095-8649.1981.tb05823.x; Morson JM, 2015, MAR COAST FISH, V7, P393, DOI 10.1080/19425120.2015.1067261; Morson JM, 2012, N AM J FISH MANAGE, V32, P1201, DOI 10.1080/02755947.2012.728174; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Narvaez DA, 2015, J MARINE SYST, V141, P136, DOI 10.1016/j.jmarsys.2014.08.007; NIIMI AJ, 1983, CAN J FISH AQUAT SCI, V40, P306, DOI 10.1139/f83-045; Pearson RF, 1996, ENVIRON SCI TECHNOL, V30, P1429, DOI 10.1021/es940626n; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pothoven SA, 2012, T AM FISH SOC, V141, P772, DOI 10.1080/00028487.2012.675911; Qiao P, 2000, ARCH ENVIRON CON TOX, V39, P369; RUDSTAM LG, 1989, J PLANKTON RES, V11, P971, DOI 10.1093/plankt/11.5.971; Rypel AL, 2007, CHEMOSPHERE, V68, P1707, DOI 10.1016/j.chemosphere.2007.03.046; Sackett DK, 2008, MAR ECOL PROG SER, V364, P199, DOI 10.3354/meps07391; Sackett DK, 2007, ESTUAR COAST SHELF S, V74, P119, DOI 10.1016/j.ecss.2007.03.027; SCHMIDT LJ, 1992, ARCH ENVIRON CON TOX, V23, P37, DOI 10.1007/BF00225993; Schulz-Bull DE, 1998, MAR CHEM, V61, P101, DOI 10.1016/S0304-4203(98)00010-3; SMITH KL, 1983, MAR BIOL, V76, P325, DOI 10.1007/BF00393036; Stapanian MA, 2014, ENVIRON TOXICOL CHEM, V33, P2448, DOI 10.1002/etc.2703; Stapanian MA, 2013, CHEMOSPHERE, V93, P1615, DOI 10.1016/j.chemosphere.2013.08.016; STEIMLE F W JR, 1985, Journal of Northwest Atlantic Fishery Science, V6, P117; Terceiro M, 2001, REV FISH BIOL FISHER, V11, P125, DOI 10.1023/A:1015260005887; Terceiro M, 2011, REV FISH BIOL FISHER, V21, P681, DOI 10.1007/s11160-011-9207-9; THAYER GW, 1973, FISH B-NOAA, V71, P289; U. S. Army Corps of Engineers U. S. Environmental Protection Agency, 2010, SIT MAN MON PLAN HIS; WEININGER D, 1978, THESIS U WISCONSIN M; Wuenschel M, 2010, 12 FLATF BIOL C 2010; Wuenschel MJ, 2013, FISH B-NOAA, V111, P352, DOI 10.7755/FB.111.4.5	66	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147223	10.1371/journal.pone.0147223	http://dx.doi.org/10.1371/journal.pone.0147223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794728	Green Published, Green Submitted, gold			2022-12-27	WOS:000368530300023
J	Mills, CA; Godley, BJ; Hodgson, DJ				Mills, Cheryl A.; Godley, Brendan J.; Hodgson, David J.			Take Only Photographs, Leave Only Footprints: Novel Applications of Non-Invasive Survey Methods for Rapid Detection of Small, Arboreal Animals	PLOS ONE			English	Article							STOATS MUSTELA-ERMINEA; CAMERA TRAPS; TRACKING TUNNELS; ECOLOGY; POPULATIONS; AGREEMENT; DORMOUSE; MAMMALS; SITES	The development of appropriate wildlife survey techniques is essential to promote effective and efficient monitoring of species of conservation concern. Here, we demonstrate the utility of two rapid-assessment, non-invasive methods to detect the presence of elusive, small, arboreal animals. We use the hazel dormouse, Muscardinus avellanarius, a rodent of conservation concern, as our focal species. Prevailing hazel dormouse survey methods are prolonged (often taking months to years to detect dormice), dependent on season and habitat, and/or have low detection rates. Alternatives would be of great use to ecologists who undertake dormouse surveys, especially those assessing the need for mitigation measures, as legally required for building development projects. Camera traps and footprint tracking are well-established tools for monitoring elusive large terrestrial mammals, but are rarely used for small species such as rodents, or in arboreal habitats. In trials of these adapted methods, hazel dormice visited bait stations and were successfully detected by both camera traps and tracking equipment at each of two woodland study sites, within days to weeks of installation. Camera trap images and footprints were of adequate quality to allow discrimination between two sympatric small mammal species (hazel dormouse and wood mouse, Apodemus sylvaticus). We discuss the relative merits of these methods with respect to research aims, funds, time available and habitat.	[Mills, Cheryl A.; Godley, Brendan J.; Hodgson, David J.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England; [Mills, Cheryl A.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England	University of Exeter; Keele University	Hodgson, DJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.	D.J.Hodgson@exeter.ac.uk	godley, brendan/O-1959-2019	godley, brendan/0000-0003-3845-0034				Alibhai Sky K., 2008, Endangered Species Research, V4, P205, DOI 10.3354/esr00067; Bright P.W., 2006, DORMOUSE CONSERVATIO; BRIGHT PW, 1994, J APPL ECOL, V31, P329, DOI 10.2307/2404547; Brown NP, 1996, NZ J ECOLOGY, V20, P271; Capizzi D, 2002, ITAL J ZOOL, V69, P25, DOI 10.1080/11250000209356434; CAREY AB, 1991, J MAMMAL, V72, P192, DOI 10.2307/1381996; Chanin P, 2003, 524 ENGL NAT; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Glennon MJ, 2002, J MAMMAL, V83, P734, DOI 10.1644/1545-1542(2002)083<0734:AAFTFE>2.0.CO;2; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; Huijser MP, 2000, BIOL CONSERV, V95, P111, DOI 10.1016/S0006-3207(00)00006-9; Jarvie S, 2014, NEW ZEAL J ZOOL, V41, P210, DOI 10.1080/03014223.2014.911753; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x; KING CM, 1977, NEW ZEAL J ZOOL, V4, P193, DOI 10.1080/03014223.1977.9517953; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x; Mayer W. V., 1957, Journal of Mammalogy, V38, P531, DOI 10.2307/1376421; Mccallum J, 2013, MAMMAL REV, V43, P196, DOI 10.1111/j.1365-2907.2012.00216.x; Meek PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110832; National Dormouse Database, 2014, NAT DORM DAT; Palma ART, 2007, REV BRAS ZOOL, V24, P333, DOI 10.1590/S0101-81752007000200011; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Ratz H, 2000, NEW ZEAL J ZOOL, V27, P57, DOI 10.1080/03014223.2000.9518210; Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592; Reynolds JC, 2004, BIOL CONSERV, V120, P533, DOI 10.1016/j.biocon.2004.03.026; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Russell JC, 2009, ECOLOGY, V90, P2007, DOI 10.1890/08-1069.1; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Treweek J, 1996, J APPL ECOL, V33, P191, DOI 10.2307/2404742; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; VANAPELDOORN R, 1993, MAMMALIA, V57, P407, DOI 10.1515/mamm.1993.57.3.407; Watts CH, 2008, NEW ZEAL J ECOL, V32, P92	39	23	25	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146142	10.1371/journal.pone.0146142	http://dx.doi.org/10.1371/journal.pone.0146142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789632	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100026
J	Showmaker, KC; Bednarova, A; Gresham, C; Hsu, CY; Peterson, DG; Krishnan, N				Showmaker, Kurt C.; Bednarova, Andrea; Gresham, Cathy; Hsu, Chuan-Yu; Peterson, Daniel G.; Krishnan, Natraj			Insight into the Salivary Gland Transcriptome of Lygus lineolaris (Palisot de Beauvois)	PLOS ONE			English	Article							TARNISHED PLANT BUG; RNA-SEQ DATA; HEMIPTERA-MIRIDAE THRESHOLDS; XANTHINE DEHYDROGENASE; PROTEIN FAMILIES; GENOME SEQUENCE; GLUCOSE-OXIDASE; GENE-EXPRESSION; HOST PLANTS; ROSY LOCUS	The tarnished plant bug (TPB), Lygus lineolaris (Palisot de Beauvois) is a polyphagous, phytophagous insect that has emerged as a major pest of cotton, alfalfa, fruits, and vegetable crops in the eastern United States and Canada. Using its piercing-sucking mouthparts, TPB employs a "lacerate and flush" feeding strategy in which saliva injected into plant tissue degrades cell wall components and lyses cells whose contents are subsequently imbibed by the TPB. It is known that a major component of TPB saliva is the polygalacturonase enzymes that degrade the pectin in the cell walls. However, not much is known about the other components of the saliva of this important pest. In this study, we explored the salivary gland transcriptome of TPB using Illumina sequencing. After in silico conversion of RNA sequences into corresponding polypeptides, 25,767 putative proteins were discovered. Of these, 19,540 (78.83%) showed significant similarity to known proteins in the either the NCBI nr or Uniprot databases. Gene ontology (GO) terms were assigned to 7,512 proteins, and 791 proteins in the sialotranscriptome of TPB were found to collectively map to 107 Kyoto Encyclopedia of Genes and Genomes (KEGG) database pathways. A total of 3,653 Pfam domains were identified in 10,421 sialotranscriptome predicted proteins resulting in 12,814 Pfam annotations; some proteins had more than one Pfam domain. Functional annotation revealed a number of salivary gland proteins that potentially facilitate degradation of host plant tissues and mitigation of the host plant defense response. These transcripts/proteins and their potential roles in TPB establishment are described.	[Showmaker, Kurt C.; Gresham, Cathy; Hsu, Chuan-Yu; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Showmaker, Kurt C.; Bednarova, Andrea; Krishnan, Natraj] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Bednarova, Andrea] Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budeaejovice 37005, Czech Republic; [Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Mississippi State University	Krishnan, N (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	nk260@msstate.edu	Krishnan, Natraj/H-2937-2019; KRISHNAN, NATRAJ/B-4856-2012; Bednarova, Andrea/C-5249-2016; Bednarova, Andrea/T-1874-2019	Krishnan, Natraj/0000-0001-6832-259X; KRISHNAN, NATRAJ/0000-0001-6832-259X; Bednarova, Andrea/0000-0002-6822-6351; Bednarova, Andrea/0000-0002-6822-6351; Peterson, Daniel/0000-0002-0274-5968; Showmaker, Kurt/0000-0002-6317-9402	Mississippi State University from National Science Foundation [269110-151250]; Experimental Program to Stimulate Competitive Research; Mississippi State University Schillig special teaching grant [365082]; United States Department of Agriculture, Agricultural Research Service from the Grant Agency of the University of South Bohemia [6402-21310-003-24S, 6402-21310-003-18S, 038/2014/P]; American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT [LH 14047]	Mississippi State University from National Science Foundation; Experimental Program to Stimulate Competitive Research(National Science Foundation (NSF)NSF - Office of the Director (OD)); Mississippi State University Schillig special teaching grant; United States Department of Agriculture, Agricultural Research Service from the Grant Agency of the University of South Bohemia; American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT	This research was supported by the start-up funds from Mississippi State University No. 269110-151250 from National Science Foundation, Experimental Program to Stimulate Competitive Research, and the Mississippi State University Schillig special teaching grant 365082 (N.K.), and in part through funding from United States Department of Agriculture, Agricultural Research Service awards 6402-21310-003-24S and 6402-21310-003-18S (D. G.P), Grant No. 038/2014/P from the Grant Agency of the University of South Bohemia (A.B.). The stay of A.B. in the lab of N.K. was partially covered from the American Science Information Center, Czech-American Science and Technology Cooperative grant KONTAKT No. LH 14047. The funding authorities had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Allen ML, 2007, GENET MOL RES, V6, P206; Allen ML, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2701; Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourland F. M., 1999, Journal of Cotton Science, V3, P171; Bourland F, 2015, AGRON MONOGR, V57, P205, DOI 10.2134/agronmonogr57.2013.0025; Bourland FM, 2015, J PLANT REGIST, V9, P94, DOI 10.3198/jpr2014.05.0033crg; Bourland FM, 2013, J PLANT REGIST, V7, P135, DOI 10.3198/jpr2012.07.0011crc; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Celorio-Mancera MD, 2008, ARTHROPOD-PLANT INTE, V2, P215, DOI 10.1007/s11829-008-9050-7; Chivasa S, 2009, PLANT SIGNAL BEHAV, V4, P1078, DOI 10.4161/psb.4.11.9784; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Choi JK, 2004, PROTEINS, V55, P22, DOI 10.1002/prot.10434; Cohen AC, 2000, J ENTOMOL SCI, V35, P301, DOI 10.18474/0749-8004-35.3.301; Cooper WR, 2013, ANN ENTOMOL SOC AM, V106, P86, DOI 10.1603/AN12096; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Doyle WA, 1996, EUR J BIOCHEM, V239, P782, DOI 10.1111/j.1432-1033.1996.0782u.x; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gore J, 2012, J ECON ENTOMOL, V105, P2007, DOI 10.1603/EC12079; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAY M, 1991, GENETICS, V127, P139; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HANNY BW, 1977, ENVIRON ENTOMOL, V6, P460, DOI 10.1093/ee/6.3.460; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; HAYASHI Y, 1961, NATURE, V192, P756, DOI 10.1038/192756b0; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hori K., 1992, P157; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Ji R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079612; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KEITH TP, 1987, GENETICS, V116, P67; Kirsch R, 2014, INSECT BIOCHEM MOLEC, V52, P33, DOI 10.1016/j.ibmb.2014.06.008; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Komoto N, 1999, INSECT MOL BIOL, V8, P73, DOI 10.1046/j.1365-2583.1999.810073.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Layton MB, 2000, SOUTHWEST ENTOMOL, P7; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lim MH, 2014, PLANT PHYSIOL, V164, P2054, DOI 10.1104/pp.113.233429; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Magalhaes LC, 2013, ENTOMOL EXP APPL, V146, P364, DOI 10.1111/eea.12035; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MAREDIA KM, 1994, SOUTHWEST ENTOMOL, V19, P63; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; Musser FR, 2009, J ECON ENTOMOL, V102, P2109, DOI 10.1603/029.102.0614; Musser FR, 2009, J ECON ENTOMOL, V102, P1827, DOI 10.1603/029.102.0513; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; Oates ME, 2015, NUCLEIC ACIDS RES, V43, pD227, DOI 10.1093/nar/gku1041; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oviedo MN, 2009, INSECT BIOCHEM MOLEC, V39, P382, DOI 10.1016/j.ibmb.2009.03.001; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pauchet Y, 2014, INSECT BIOCHEM MOLEC, V49, P1, DOI 10.1016/j.ibmb.2014.03.004; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Perera OP, 2007, MOL ECOL NOTES, V7, P987, DOI 10.1111/j.1471-8286.2007.01747.x; Perera OP, 2015, ANN ENTOMOL SOC AM, V108, P181, DOI 10.1093/aesa/sau016; Perera OP, 2012, J INVERTEBR PATHOL, V109, P11, DOI 10.1016/j.jip.2011.08.004; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ribeiro J.M.C., 1995, P74; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; Shelby Kent S., 2013, Insects, V4, P712, DOI 10.3390/insects4040712; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Singh H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25615; Smith Thomas M, 2006, Purinergic Signal, V2, P327, DOI 10.1007/s11302-005-5300-7; Snodgrass GL, 2009, J ECON ENTOMOL, V102, P699, DOI 10.1603/029.102.0231; Snodgrass GL, 2003, ENVIRON ENTOMOL, V32, P945, DOI 10.1603/0046-225X-32.5.945; Snodgrass GL, 2003, J ECON ENTOMOL, V96, P902, DOI 10.1603/0022-0493-96.3.902; Snodgrass GL, 1996, J ECON ENTOMOL, V89, P783, DOI 10.1093/jee/89.4.783; Snodgrass GL, 2000, J ECON ENTOMOL, V93, P441, DOI 10.1603/0022-0493-93.2.441; SNODGRASS GL, 1984, ENVIRON ENTOMOL, V13, P110, DOI 10.1093/ee/13.1.110; Snodgrass GL, 2008, SOUTHWEST ENTOMOL, V33, P173, DOI 10.3958/0147-1724-33.3.173; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; STRONG FE, 1970, J ECON ENTOMOL, V63, P808, DOI 10.1093/jee/63.3.808; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Walker WB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14133; Wheeler Alfred G. Jr., 2001, pi; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; WILLIAMS L, 1987, J ECON ENTOMOL, V80, P527, DOI 10.1093/jee/80.2.527; Williams L, 2000, J ENTOMOL SCI, V35, P187, DOI 10.18474/0749-8004-35.2.187; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747; Zhang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126391; Zhu Yu Cheng, 2012, PLoS One, V7, pe37586, DOI 10.1371/journal.pone.0037586; Zhu YC, 2015, PEST MANAG SCI, V71, P40, DOI 10.1002/ps.3761	135	16	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147197	10.1371/journal.pone.0147197	http://dx.doi.org/10.1371/journal.pone.0147197			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789269	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100065
J	Yesudhas, D; Anwar, MA; Panneerselvam, S; Durai, P; Shah, M; Choi, S				Yesudhas, Dhanusha; Anwar, Muhammad Ayaz; Panneerselvam, Suresh; Durai, Prasannavenkatesh; Shah, Masaud; Choi, Sangdun			Structural Mechanism behind Distinct Efficiency of Oct4/Sox2 Proteins in Differentially Spaced DNA Complexes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; HIGH-THROUGHPUT; BINDING DOMAIN; FORCE-FIELD; OCT4; SOX2; PLURIPOTENCY; CORE	The octamer-binding transcription factor 4 (Oct4) and sex-determining region Y (SRY)box 2 (Sox2) proteins induce various transcriptional regulators to maintain cellular pluripotency. Most Oct4/Sox2 complexes have either 0 base pairs (Oct4/Sox20bp) or 3 base pairs (Oct4/Sox23bp) separation between their DNA-binding sites. Results from previous biochemical studies have shown that the complexes separated by 0 base pairs are associated with a higher pluripotency rate than those separated by 3 base pairs. Here, we performed molecular dynamics (MD) simulations and calculations to determine the binding free energy and per-residue free energy for the Oct4/Sox20bp and Oct4/Sox23bp complexes to identify structural differences that contribute to differences in induction rate. Our MD simulation results showed substantial differences in Oct4/Sox2 domain movements, as well as secondary-structure changes in the Oct4 linker region, suggesting a potential reason underlying the distinct efficiencies of these complexes during reprogramming. Moreover, we identified key residues and hydrogen bonds that potentially facilitate protein-protein and protein-DNA interactions, in agreement with previous experimental findings. Consequently, our results confess that differential spacing of the Oct4/Sox2 DNA binding sites can determine the magnitude of transcription of the targeted genes during reprogramming.	[Yesudhas, Dhanusha; Anwar, Muhammad Ayaz; Panneerselvam, Suresh; Durai, Prasannavenkatesh; Shah, Masaud; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea	Ajou University	Choi, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.	sangdunchoi@ajou.ac.kr	Panneerselvam, Suresh/K-3994-2019; Anwar, Muhammad Ayaz/ABC-8104-2021; Shah, Masaud/K-8748-2016; Durai, Prasannavenkatesh/AAU-4782-2021	Panneerselvam, Suresh/0000-0001-9341-2861; Anwar, Muhammad Ayaz/0000-0002-8794-5589; Durai, Prasannavenkatesh/0000-0002-1538-8349	Korea Health Technology R&D Project through the Korea Health Industry Development Institute [HI14C1992]; Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2015R1A2A2A09001059]; Priority Research Centers Program [NRF 2012-0006687]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Priority Research Centers Program	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI14C1992). This work was also partially supported by the Mid-Career Researcher Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A09001059) and a grant from the Priority Research Centers Program (NRF 2012-0006687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bredenberg J, 2002, PROTEINS, V49, P24, DOI 10.1002/prot.10195; Chen L, 2015, PHYS CHEM CHEM PHYS, V17, P5704, DOI 10.1039/c4cp05413j; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Govindaraj RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012713; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hays FA, 2005, P NATL ACAD SCI USA, V102, P7157, DOI 10.1073/pnas.0409455102; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jauch R, 2011, STEM CELLS, V29, P940, DOI 10.1002/stem.639; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lambrughi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00435; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Maisuradze GG, 2009, J MOL BIOL, V385, P312, DOI 10.1016/j.jmb.2008.10.018; Manavalan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106542; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Merino F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004287; Merino F, 2014, STRUCTURE, V22, P1274, DOI 10.1016/j.str.2014.06.014; Mesentean S, 2006, PROTEINS, V64, P210, DOI 10.1002/prot.20981; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan YP, 2008, J PHYS CHEM B, V112, P6716, DOI 10.1021/jp800680w; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIVE GG, 1991, J MOL BIOL, V217, P177, DOI 10.1016/0022-2836(91)90619-H; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; Schmidt R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-251; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Upadhyay SK, 2014, MOL BIOSYST, V10, P3120, DOI 10.1039/c4mb00371c; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	59	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147240	10.1371/journal.pone.0147240	http://dx.doi.org/10.1371/journal.pone.0147240			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790000	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100071
J	Andersen, NJ; Boguslawski, EA; Naidu, AS; Szot, C; Bromberg-White, JL; Kits, K; Kuk, CY; Holton, LE; St Croix, B; Chambers, CM; Duesbery, NS				Andersen, N. J.; Boguslawski, E. A.; Naidu, A. S.; Szot, C.; Bromberg-White, J. L.; Kits, K.; Kuk, C. Y.; Holton, L. E.; St Croix, B.; Chambers, C. M.; Duesbery, N. S.			Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GROWTH; INFLAMMATION; EXPRESSION; PROLIFERATION; VENULES; CELLS	Anthrax toxin receptor 1/tumor endothelial marker 8 (Antxr1 or TEM8) is up-regulated in tumor vasculature and serves as a receptor for anthrax toxin, but its physiologic function is unclear. The objective of this study was to evaluate the role of Antxr1 in arteriogenesis. The role of Antxr1 in arteriogenesis was tested by measuring gene expression and immunohistochemistry in a mouse model of hindlimb ischemia using wild-type and ANTXR1(-/-)mice. Additional tests were performed by measuring gene expression in in vitro models of fluid shear stress and hypoxia, as well as in human muscle tissues obtained from patients having peripheral artery disease. We observed that Antxr1 expression transiently increased in ischemic tissues following femoral artery ligation and that its expression was necessary for arteriogenesis. In the absence of Antxr1, the mean arterial lumen area in ischemic tissues decreased. Antxr1 mRNA and protein expression was positively regulated by fluid shear stress, but not by hypoxia. Furthermore, Antxr1 expression was elevated in human peripheral artery disease requiring lower extremity bypass surgery. These findings demonstrate an essential physiologic role for Antxr1 in arteriogenesis and peripheral artery disease, with important implications for managing ischemia and other arteriogenesis-dependent vascular diseases.	[Andersen, N. J.; Holton, L. E.; Chambers, C. M.] Spectrum Hosp, Frederik Meijer Heart & Vasc Inst, 100 Michigan St NE, Grand Rapids, MI 49503 USA; [Andersen, N. J.; Boguslawski, E. A.; Naidu, A. S.; Bromberg-White, J. L.; Kits, K.; Kuk, C. Y.; Chambers, C. M.; Duesbery, N. S.] Van Andel Res Inst, Ctr Canc Cell Biol, Lab Canc & Dev Cell Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA; [Szot, C.; St Croix, B.] NCI, Tumor Angiogenesis Sect, Ctr Canc Res, Bldg 560, Frederick, MD 21702 USA; [Kits, K.] Van Andel Educ Inst, Partners Sci Program, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA	Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Duesbery, NS (corresponding author), Van Andel Res Inst, Ctr Canc Cell Biol, Lab Canc & Dev Cell Biol, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	duesbery@vai.org		Andersen, Nicholas/0000-0001-5958-3210; Duesbery, Nicholas/0000-0002-5708-4984; Kuk, ChiuYing/0000-0001-9413-7830; DUESBERY, NICK/0000-0002-4258-5655	Van Andel Institute; Frederic Meijer Heart and Vascular Institute; intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS); NATIONAL CANCER INSTITUTE [ZIABC010484] Funding Source: NIH RePORTER	Van Andel Institute; Frederic Meijer Heart and Vascular Institute; intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was funded by the Van Andel Institute, the Frederic Meijer Heart and Vascular Institute, and the intramural research program of the NCI, NIH, Department of Health and Social Services (DHSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA N, 1993, J BIOL CHEM, V268, P3334; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; Ezaki T, 2001, AM J PATHOL, V158, P2043, DOI 10.1016/S0002-9440(10)64676-7; Felicetti P, 2007, CYTOTHERAPY, V9, P23, DOI 10.1080/14653240601048369; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; McDonald Donald M, 2011, Proc Am Thorac Soc, V8, P504, DOI 10.1513/pats.201102-022MW; Meehan B, 2015, NEOPLASMA; Murphy TJ, 1999, AM J PATHOL, V155, P93, DOI 10.1016/S0002-9440(10)65104-8; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Niiyama H., 2009, J VIS EXP; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; Pipp F, 2004, ARTERIOSCL THROM VAS, V24, P1664, DOI 10.1161/01.ATV.0000138028.14390.e4; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; Wu WX, 2009, J IMMUNOL, V183, P5799, DOI 10.4049/jimmunol.0803406; Yang XM, 2010, VACCINE, V28, P7130, DOI 10.1016/j.vaccine.2010.07.014; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573; Zheng QP, 2013, GENE, V523, P195, DOI 10.1016/j.gene.2013.02.053	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146586	10.1371/journal.pone.0146586	http://dx.doi.org/10.1371/journal.pone.0146586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785120	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400049
J	Jaramillo-Ruiz, D; De La Mata, FJ; Gomez, R; Correa-Rocha, R; Munoz-Fernandez, MA				Jaramillo-Ruiz, Didiana; Javier De La Mata, Francisco; Gomez, Rafael; Correa-Rocha, Rafael; Angeles Munoz-Fernandez, Ma			Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CARBOSILANE DENDRIMERS; EXPRESSION; CHEMISTRY; PROFILE; MODEL	Background HIV-1 has proved to infect regulatory T cells (Treg) modifying their phenotype and impairing their suppressive capacity. As Treg cells are a crucial component in the preservation of the immune homeostasis, we researched that the antiviral capacity of carboxilan dendrimers prevents the HIV-1 infection of Treg and their effects. The phenotype and suppressive capacity of Treg treated or non-treated with carbosilane dendrimers were studied by flow cytometry. Treated and non-treated Treg from healthy donors were infected with HIV-1(NL4.3). The infection of Treg cells by HIV-1, and protective effect of two dendrimers were determined by measuring antigen p24(gag) in the supernatant of the culture and intracellular. Results The Treg cells were treated with cationic and anionic carbosilane dendrimers. The results showed that both dendrimers did not modify the phenotype and functionality of Treg cells compared with non-treated Treg cells. Anionic dendrimers showed high biocompatibility with normal activity of the Treg cells and in antiviral assays. These dendrimers were highly active against HIV-1 preventing the infection of Treg, and were able to protect the Treg from the Foxp3 downregulation induced by the HIV-1 infection. Conclusions This is the first work showing that the in vitro use of anionic dendrimers prevent the HIV-1 replication and the infection of expanded Treg cells in culture, which raises the possibility to use Treg cells therapeutically in HIV-1-infected subjects.	[Jaramillo-Ruiz, Didiana; Correa-Rocha, Rafael; Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Spanish HIV HGM BioBank, Inst Invest Sanitaria Gregorio Maranon,Lab Inmuno, Madrid, Spain; [Javier De La Mata, Francisco; Gomez, Rafael] Univ Alcala de Henares, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Quim Inorgan & Quim Organ, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala	Munoz-Fernandez, MA (corresponding author), Hosp Gen Univ Gregorio Maranon, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Spanish HIV HGM BioBank, Inst Invest Sanitaria Gregorio Maranon,Lab Inmuno, Madrid, Spain.	mmunoz.hgugm@gmail.com	Correa-Rocha, Rafael/C-8213-2011; Ramírez, Rafael Gómez/K-1216-2014	Correa-Rocha, Rafael/0000-0003-3456-9986; Ramírez, Rafael Gómez/0000-0001-6448-2414; Jaramillo, Didiana/0000-0003-0898-1723; Munoz-Fernandez/0000-0002-0813-4500	Plan Nacional R+D+I [RD12/0017/0037]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [RETIC PT13/0010/0028]; Fondo de Investigacion Sanitaria (FIS) [PI12-00934, PI13/02016]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid [S-2010/BMD-2351, S-2010/BMD-2332]; grant of "Miguel Servet II" Program [CPII13/00033]; VI National RDi Plan; Consolider Program; CIBER Actions; Instituto de Salud Carlos III; European Regional Development Fund; ISC III [PT13/0010/0028]; FIPSE; IniciativaIngenio; MIMECO [CTQ2011-23245]; CYTED [214RT0482]	Plan Nacional R+D+I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid; grant of "Miguel Servet II" Program; VI National RDi Plan; Consolider Program(Spanish Government); CIBER Actions; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); ISC III(Instituto de Salud Carlos III); FIPSE; IniciativaIngenio(Spanish Government); MIMECO; CYTED	This work has been (partially) funded by the RD12/0017/0037, project as part of the Plan Nacional R+D+I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), RETIC PT13/0010/0028, Fondo de Investigacion Sanitaria (FIS) (grant numbers PI12-00934, PI13/02016), CTQ2011-23245 (MIMECO), "Fundacion para la Investigacion y la Prevencion del Sida en Espana" (FIPSE), Comunidad de Madrid (grant numbers S-2010/BMD-2351 and S-2010/BMD-2332], CYTED 214RT0482, and R.C-R is supported by a grant of "Miguel Servet II" Program (CPII13/00033). CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, IniciativaIngenio 2010, the Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. Also, the authors thank Dr Maribel Clemente Mayoral for her technical assistance and advice as cell culture technician (CA10/01274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Centre of Transfusion of Madrid for the buffy coats and the Spanish HIV HGM BioBank supported by ISC III (Grant no PT13/0010/0028) and FIPSE. Also, we thank Dr Maribel Clemente Mayoral for her technical assistance and advice as cell culture technician (CA10/01274).	Angin M, 2014, J INFECT DIS, V210, P899, DOI 10.1093/infdis/jiu188; Angin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086920; Angin M, 2013, JOVE-J VIS EXP, DOI 10.3791/50244; Angin M, 2012, AIDS, V26, P2112, DOI 10.1097/QAD.0b013e328358cc75; Bermejo JF, 2007, CHEM-EUR J, V13, P483, DOI 10.1002/chem.200600594; Canavan JB, 2012, BLOOD, V119, pE57, DOI 10.1182/blood-2011-09-380048; Card CM, 2012, JAIDS-J ACQ IMM DEF, V59, P427, DOI 10.1097/QAI.0b013e3182454fcd; Chonco L, 2012, J CONTROL RELEASE, V161, P949, DOI 10.1016/j.jconrel.2012.04.050; Cordoba E. V., 2013, AIDS, DOI 10.1097/QAD.0b013e328361fa4a; Cordoba EV, 2013, NANOMED-NANOTECHNOL, V9, P972, DOI 10.1016/j.nano.2013.03.004; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Galan M, 2014, ORG BIOMOL CHEM, V12, P3222, DOI 10.1039/c4ob00162a; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gonzalo T, 2010, CHEMMEDCHEM, V5, P921, DOI 10.1002/cmdc.201000029; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Clemente MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085230; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Mendez-Lagares G, 2014, JAIDS-J ACQ IMM DEF, V65, P278, DOI 10.1097/QAI.0000000000000092; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Pion M, 2010, BIOMATERIALS, V31, P8749, DOI 10.1016/j.biomaterials.2010.07.093; Rasines B, 2012, DALTON T, V41, P12733, DOI 10.1039/c2dt31099f; Rittner K, 2002, MOL THER, V5, P104, DOI 10.1006/mthe.2002.0523; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schaier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034208; Sepulveda-Crespo D, 2014, NANOMED-NANOTECHNOL, V10, P609, DOI 10.1016/j.nano.2013.10.002; Simonetta F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00215; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; Weber N, 2008, J CONTROL RELEASE, V132, P55, DOI 10.1016/j.jconrel.2008.07.035	36	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145760	10.1371/journal.pone.0145760	http://dx.doi.org/10.1371/journal.pone.0145760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785250	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400019
J	Montufar-Solis, D; Klein, JR				Montufar-Solis, Dina; Klein, John R.			Splenic Leukocytes Traffic to the Thyroid and Produce a Novel TSH beta Isoform during Acute Listeria monocytogenes Infection in Mice	PLOS ONE			English	Article							PERIPHERAL-BLOOD LEUKOCYTES; SPLICE VARIANT; IMMUNE-SYSTEM; THYROTROPIN; MONOCYTES; REGULATOR; EXPRESSION; SUBSETS; SUBUNIT; DISEASE	The thyroid stimulating hormone beta-subunit (TSH beta) with TSH alpha form a glycoprotein hormone that is produced by the anterior pituitary in the hypothalamus-pituitary-thyroid (HPT) axis. Although TSH beta has been known for many years to be made by cells of the immune system, the role of immune system TSH has remained unclear. Recent studies demonstrated that cells of the immune system produce a novel splice variant isoform of TSH beta (TSH beta v), but little if any native TSH beta. Here, we show that within three days of systemic infection of mice with Listeria monocytogenes, splenic leukocytes synthesized elevated levels of TSH beta v. This was accompanied by an influx of CD14(+), Ly6C(+), Ly6G(+) cells into the thyroid of infected mice, and increased levels of intrathyroidal TSH beta v gene expression. Adoptive transfer of carboxyfluorescein succinimidyl ester (CFSE)-labeled splenic leukocytes from infected mice into non-infected mice migrated into the thyroid as early as forty-eight hours post-cell transfer, whereas CFSE-labeled cells from non-infected mice failed to traffic to the thyroid. These findings demonstrate for the first time that during bacterial infection peripheral leukocytes produce elevated levels of TSH beta v, and that spleen cells traffic to the thyroid where they produce TSH beta v intrathyroidally.	[Montufar-Solis, Dina; Klein, John R.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77054 USA	University of Texas System; University of Texas Health Science Center Houston	Klein, JR (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77054 USA.	john.r.klein@uth.tmc.edu			Public Health Service from the National Institute of Digestion, Diabetes, and Kidney Disease [DK035566]; National Institute of Allergy and Infectious Diseases [AI100159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI100159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035566, R23DK035566] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Digestion, Diabetes, and Kidney Disease; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grant DK035566 from the National Institute of Digestion, Diabetes, and Kidney Disease and AI100159 from the National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baliram R, 2013, ENDOCRINOLOGY, V154, P4919, DOI 10.1210/en.2012-2234; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GORDON DF, 1988, DNA-J MOLEC CELL BIO, V7, P17, DOI 10.1089/dna.1988.7.17; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Kernbauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065007; Klein JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00155; Klein JR, 2006, EXP BIOL MED, V231, P229; KRUGER TE, 1989, J IMMUNOL, V142, P744; Lindback T, 2011, APPL ENVIRON MICROB, V77, P3478, DOI 10.1128/AEM.02708-10; Liu CR, 2012, MOL BIOL REP, V39, P10019, DOI 10.1007/s11033-012-1871-x; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schaefer JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056436; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schaefer JS, 2011, FASEB J, V25, P29, DOI 10.1096/fj.10-168203; Schaefer JS, 2009, GEN COMP ENDOCR, V162, P241, DOI 10.1016/j.ygcen.2009.04.006; SMITH EM, 1983, P NATL ACAD SCI-BIOL, V80, P6010, DOI 10.1073/pnas.80.19.6010; Song JS, 2015, IMMUNOL LETT, V167, P41, DOI 10.1016/j.imlet.2015.07.002; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vincent BH, 2009, GENES IMMUN, V10, P18, DOI 10.1038/gene.2008.69; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhou Q, 2002, HYBRIDOMA HYBRIDOM, V21, P75, DOI 10.1089/15368590252917674	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146111	10.1371/journal.pone.0146111	http://dx.doi.org/10.1371/journal.pone.0146111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771831	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300010
J	Orii, M; Kono, K; Wen, HI; Nakanishi, M				Orii, Minami; Kono, Keiko; Wen, Hsin-I; Nakanishi, Makoto			PP1-Dependent Formin Bnr1 Dephosphorylation and Delocalization from a Cell Division Site	PLOS ONE			English	Article							PROTEIN PHOSPHATASE; BNI1P; LOCALIZATION; CYTOKINESIS; MECHANISM; TYPE-1; CYCLE	Cell cycle ends with cytokinesis that is the physical separation of a cell into two daughter cells. For faithful cytokinesis, cells integrate multiple processes, such as actomyosin ring formation, contraction and plasma membrane closure, into coherent responses. Linear actin assembly by formins is essential for formation and maintenance of actomyosin ring. Although budding yeast's two formins, Bni1 and Bnr1, are known to switch their subcellular localization at the division site prior to cytokinesis, the underlying mechanisms were not completely understood. Here, we provide evidence showing that Bnr1 is dephosphorylated concomitant with its release from the division site. Impaired PP1/Glc7 activity delayed Bnr1 release and dephosphorylation, Bni1 recruitment and actomyosin ring formation at the division site. These results suggest the involvement of Glc7 in this regulation. Further, we identified Ref2 as the PP1 regulatory subunit responsible for this regulation. Taken together, Glc7 and Ref2 may have a role in actomyosin ring formation by modulating the localization of formins during cytokinesis.	[Orii, Minami; Kono, Keiko; Wen, Hsin-I; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan	Nagoya City University	Kono, K; Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mkt-naka@med.nagoya-cu.ac.jp; kono@med.nagoya-cu.ac.jp		Kono, Keiko/0000-0003-4057-8790				Andrews PD, 2000, J CELL SCI, V113, P507; Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Bloom J, 2011, J BIOL CHEM, V286, P5434, DOI 10.1074/jbc.M110.205054; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Desai A, 2008, SCIENCE, P1543, DOI [10.1126/science.1163086, DOI 10.1126/SCIENCE.1163086]; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Ferrer-Dalmau J, 2010, BIOCHEM J, V426, P355, DOI 10.1042/BJ20091909; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Kono K, 2012, CELL, V150, P151, DOI 10.1016/j.cell.2012.05.030; Mishra M, 2014, FEMS MICROBIOL REV, V38, P213, DOI 10.1111/1574-6976.12064; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Nigavekar SS, 2002, ARCH BIOCHEM BIOPHYS, V404, P71, DOI 10.1016/S0003-9861(02)00231-X; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146941	10.1371/journal.pone.0146941	http://dx.doi.org/10.1371/journal.pone.0146941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771880	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300045
J	Sekhon, BK; Roubin, RH; Li, YM; Devi, PB; Nammi, S; Fan, K; Sze, DMY				Sekhon, Bhagwant Kaur; Roubin, Rebecca Heidi; Li, Yiming; Devi, Parimala B.; Nammi, Srinivas; Fan, Kei; Sze, Daniel Man-yuen			Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; B-CELLS; THERAPY; THALIDOMIDE; VACCINE; BLOOD	Polysaccharopeptide (PSP), from Coriolus versicolor, has been used widely as an adjuvant to chemotherapy with demonstrated anti-tumor and broad immunomodulating effects. While PSP's mechanism of action still remains unknown, its enhanced immunomodulatory potential with acacia gum is of great interest. Acacia gum, which also contains polysaccharides and glycoproteins, has been demonstrated to be immunopotentiating. To elucidate whether PSP directly activates T-cell-dependent B-cell responses in vivo, we used a well-established hapten carrier system (Nitrophenyl-chicken gamma globulin (NP-CGG)). 6-week C57BL/6 male mice were immunised with 50 mu g of NP25-CGG alum precipitate intraperitoneally. Mice were gavaged daily with 50mg/kg PSP in a vehicle containing acacia gum and sacrificed at days 0, 4, 7, 10, 14 and 21. ELISA was used to measure the total and relative hapten-specific anti-NP IgA, IgM and IgG titre levels compared to the controls. It was found that PSP, combined with acacia gum, significantly increased total IgG titre levels at day 4 (P<0.05), decreased IgM titre levels at days 4 and 21 (P<0.05) with no alterations observed in the IgA or IgE titre levels at any of the time points measured. Our results suggest that while PSP combined with acacia gum appears to exert weak immunological effects through specific T-cell dependent B-cell responses, they are likely to be broad and non-specific which supports the current literature on PSP. We report for the first time the application of a well-established hapten-carrier system that can be used to characterise and delineate specific T-cell dependent B-cell responses of potential immunomodulatory glyco-protein-based herbal medicines combinations in vivo.	[Sekhon, Bhagwant Kaur; Roubin, Rebecca Heidi; Li, Yiming; Devi, Parimala B.; Nammi, Srinivas; Fan, Kei; Sze, Daniel Man-yuen] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Sze, Daniel Man-yuen] RMIT Univ, Sch Med Sci, Melbourne, Vic 3000, Australia; [Sze, Daniel Man-yuen] RMIT Univ, HIRi, Melbourne, Vic 3000, Australia; [Nammi, Srinivas] Univ Western Sydney, Sch Med Sci, Campbelltown, NSW 2560, Australia	University of Sydney; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Western Sydney University	Sze, DMY (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	bhagwant.sekhon@sydney.edu.au; daniel.sze@rmit.edu.au	Roubin, Rebecca/E-8133-2010; Nammi, Srinivas/I-2983-2013; Roubin, Rebecca/GQQ-0980-2022	Roubin, Rebecca/0000-0002-7444-8145; Nammi, Srinivas/0000-0002-4735-2789; Roubin, Rebecca/0000-0002-7444-8145	Cancer Institute NSW: DMS; National Institute of Complementary Medicines	Cancer Institute NSW: DMS; National Institute of Complementary Medicines	This work was supported by Cancer Institute NSW: DMS; National Institute of Complementary Medicines. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UH, 2013, CLIN PHARMACOL-ADV A, V5, P21, DOI 10.2147/CPAA.S45884; Anguille S, 2014, LANCET ONCOL, V15, pE257, DOI 10.1016/S1470-2045(13)70585-0; Ballal A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-139; Bertrand F, 2015, CANCER RES, V75, P2619, DOI 10.1158/0008-5472.CAN-14-2524; Brown RD, 2009, LEUKEMIA LYMPHOMA, V50, P1860, DOI 10.3109/10428190903216804; Cui T, 2003, BIOTECHNOL ADV, V21, P109, DOI 10.1016/S0734-9750(03)00002-8; Doi Y, 2006, FOOD CHEM TOXICOL, V44, P560, DOI 10.1016/j.fct.2005.09.002; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eliza WLY, 2012, RECENT PATENTS INFLA, V6, P78, DOI [10.2174/187221312798889275, 10.2174/187221312798889310]; Engel AL, 2013, IMMUNOBIOLOGY, V218, P1468, DOI 10.1016/j.imbio.2013.05.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanzly M, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2014.02.005; Hong F, 2011, PLANTA MED, V77, P817, DOI 10.1055/s-0030-1250574; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kallberg E, 2014, SCAND J IMMUNOL, V79, P237, DOI 10.1111/sji.12152; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lee CL, 2006, ENZYME MICROB TECH, V38, P14, DOI 10.1016/j.enzmictec.2004.10.009; Lee Kuo-Hsiung, 2012, J Tradit Complement Med, V2, P84; Li J, 2010, BLOOD, V115, P3580, DOI 10.1182/blood-2009-10-246991; Liao M, 1993, P PSP INT S, P243; LIVINGSTON PO, 1994, VACCINE, V12, P1275, DOI 10.1016/S0264-410X(94)80052-2; Mamalis A, 2014, ARCH DERMATOL RES, V306, P511, DOI 10.1007/s00403-014-1457-7; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Naslund TI, 2013, J IMMUNOL, V190, P2712, DOI 10.4049/jimmunol.1203082; Nesher L, 2014, INFECTION, V42, P5, DOI 10.1007/s15010-013-0525-9; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Ouyang Hua-Qiang, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P655; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Ribatti D, 2014, IMMUNOL LETT, V161, P96, DOI 10.1016/j.imlet.2014.05.010; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sekhon BK, 2013, FOOD CHEM, V138, P2201, DOI 10.1016/j.foodchem.2012.11.009; STROBEL S, 1982, TOXICOL LETT, V14, P247, DOI 10.1016/0378-4274(82)90059-5; STROBEL S, 1986, FOOD ADDIT CONTAM, V3, P43; Sze DMY, 2006, CURR CANCER DRUG TAR, V6, P325, DOI 10.2174/156800906777441762; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tanaka T, 1999, CARCINOGENESIS, V20, P1471, DOI 10.1093/carcin/20.8.1471; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Vannucci L, 2013, INT J ONCOL, V43, P357, DOI 10.3892/ijo.2013.1974; Xuan NT, 2010, CELL PHYSIOL BIOCHEM, V25, P641, DOI 10.1159/000315083; Yang Q.Y., 1999, ADV RES PSP 1999, V1999', P5; YANG QY, 1992, EOS-RIV IMMUNOL, V12, P29; Zhang LY, 1999, ADV RES PSP 1999, P328; Zhu ZQ, 2015, J IMMUNOL, V195, P3482, DOI 10.4049/jimmunol.1401571	45	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146881	10.1371/journal.pone.0146881	http://dx.doi.org/10.1371/journal.pone.0146881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799072	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300047
J	Yang, J; Zhang, F; Li, J; Chen, JP; Zhang, HM				Yang, Jian; Zhang, Fen; Li, Jing; Chen, Jian-Ping; Zhang, Heng-Mu			Integrative Analysis of the microRNAome and Transcriptome Illuminates the Response of Susceptible Rice Plants to Rice Stripe Virus	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR FAMILY; ARABIDOPSIS; RESISTANCE; SYMPTOM; IDENTIFICATION; MOVEMENT; BIOLOGY; PROTEIN; NSVC4	Rice stripe virus (RSV) is one of the most serious rice viruses in East Asia. To investigate how rice responds to RSV infection, we integrated miRNA expression with parallel mRNA transcription profiling by deep sequencing. A total of 570 miRNAs were identified of which 69 miRNAs (56 up-regulated and 13 down-regulated) were significantly modified by RSV infection. Digital gene expression (DGE) analysis showed that 1274 mRNAs (431 up-regulated and 843 down-regulated genes) were differentially expressed as a result of RSV infection. The differential expression of selected miRNAs and mRNAs was confirmed by qRT-PCR. Gene ontology (GO) and pathway enrichment analysis showed that a complex set of miRNA and mRNA networks were selectively regulated by RSV infection. In particular, 63 differentially expressed miRNAs were found to be significantly and negatively correlated with 160 target mRNAs. Interestingly, 22 up-regulated miRNAs were negatively correlated with 24 down-regulated mRNAs encoding disease resistance-related proteins, indicating that the host defense responses were selectively suppressed by RSV infection. The suppression of both osa-miR1423-5p- and osa-miR1870-5p-mediated resistance pathways was further confirmed by qRT-PCR. Chloroplast functions were also targeted by RSV, especially the zeaxanthin cycle, which would affect the stability of thylakoid membranes and the biosynthesis of ABA. All these modifications may contribute to viral symptom development and provide new insights into the pathogenicity mechanisms of RSV.	[Yang, Jian; Zhang, Fen; Li, Jing; Chen, Jian-Ping; Zhang, Heng-Mu] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect MOA & Zhejiang P, Inst Virol & Biotechnol, Hangzhou 310021, Zhejiang, Peoples R China; [Zhang, Fen] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University	Zhang, HM (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect MOA & Zhejiang P, Inst Virol & Biotechnol, Hangzhou 310021, Zhejiang, Peoples R China.	jpchen2001@yahoo.com.cn; zhhengmu@tsinghua.org.cn			National Science and Technology Support Program [2012BAD19B03]; China 973 Program [2010CB126203, 2014CB160309]; Zhejiang Provincial Foundation for Natural Science [LQ14C14003]	National Science and Technology Support Program; China 973 Program(National Basic Research Program of China); Zhejiang Provincial Foundation for Natural Science(Natural Science Foundation of Zhejiang Province)	This work was funded by National Science and Technology Support Program (2012BAD19B03), the China 973 Program (2010CB126203 and 2014CB160309), and the Zhejiang Provincial Foundation for Natural Science (LQ14C14003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2001, PLANT PHYSIOL, V125, P1248, DOI 10.1104/pp.125.3.1248; Amano E., 1933, J PLANT PROT JPN, V20, P634; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZH, 2015, PLANT CELL REP, V34, P767, DOI 10.1007/s00299-015-1740-x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; [丁新伦 Ding Xinlun], 2013, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V42, P466; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fang XP, 2015, PROTEOMICS, V15, P1525, DOI 10.1002/pmic.201400384; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim K, 2012, MOL PLANT MICROBE IN, V25, P534, DOI 10.1094/MPMI-11-11-0282; Kong LF, 2014, MOL PLANT, V7, P691, DOI 10.1093/mp/sst158; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KURIBAYASHI K., 1931, Journal of Plant Protection, V18, P565; Lewsey M, 2007, PLANT J, V50, P240, DOI 10.1111/j.1365-313X.2007.03042.x; Liang DL, 2005, VIRUS GENES, V31, P211, DOI 10.1007/s11262-005-1798-6; Liu LiHua, 2000, Acta Phytopathologica Sinica, V30, P306; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Ruan YL, 1984, PLANT PROT, V10, P22; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; SHINKAI A., 1962, Bull. natn. Inst. agric. Sci., Tokyo, V14, P1; Shirako Y., 2012, VIRUS TAXONOMY, P771; Sun F, 2011, J PHYTOPATHOL, V159, P767, DOI 10.1111/j.1439-0434.2011.01840.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Wang BA, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0328-y; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5768; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wu WQ, 2013, PLANT DIS, V97, P1181, DOI 10.1094/PDIS-02-12-0207-RE; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00269; Yang J, 2014, GENE, V548, P285, DOI 10.1016/j.gene.2014.07.048; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; [袁正杰 Yuan Zhengjie], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P45; Zhang C, 2012, VIROLOGY, V425, P113, DOI 10.1016/j.virol.2012.01.007; Zhang HengMu, 2007, Acta Phytophylacica Sinica, V34, P436; [张晓婷 ZHANG Xiaoting], 2008, [激光生物学报, Acta Laser Biology Sinica], V17, P620; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zheng WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082126; Zhou Tong, 2009, Scientia Agricultura Sinica, V42, P103	66	55	63	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146946	10.1371/journal.pone.0146946	http://dx.doi.org/10.1371/journal.pone.0146946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799317	Green Submitted, Green Published, gold			2022-12-27	WOS:000368655300049
J	Melckenbeeck, I; Audenaert, P; Michoel, T; Colle, D; Pickavet, M				Melckenbeeck, Ine; Audenaert, Pieter; Michoel, Tom; Colle, Didier; Pickavet, Mario			An Algorithm to Automatically Generate the Combinatorial Orbit Counting Equations	PLOS ONE			English	Article								Graphlets are small subgraphs, usually containing up to five vertices, that can be found in a larger graph. Identification of the graphlets that a vertex in an explored graph touches can provide useful information about the local structure of the graph around that vertex. Actually finding all graphlets in a large graph can be time-consuming, however. As the graphlets grow in size, more different graphlets emerge and the time needed to find each graphlet also scales up. If it is not needed to find each instance of each graphlet, but knowing the number of graphlets touching each node of the graph suffices, the problem is less hard. Previous research shows a way to simplify counting the graphlets: instead of looking for the graphlets needed, smaller graphlets are searched, as well as the number of common neighbors of vertices. Solving a system of equations then gives the number of times a vertex is part of each graphlet of the desired size. However, until now, equations only exist to count graphlets with 4 or 5 nodes. In this paper, two new techniques are presented. The first allows to generate the equations needed in an automatic way. This eliminates the tedious work needed to do so manually each time an extra node is added to the graphlets. The technique is independent on the number of nodes in the graphlets and can thus be used to count larger graphlets than previously possible. The second technique gives all graphlets a unique ordering which is easily extended to name graphlets of any size. Both techniques were used to generate equations to count graphlets with 4, 5 and 6 vertices, which extends all previous results. Code can be found at https://github.com/IneMelckenbeeck/equation-generator and https://github.com/IneMelckenbeeck/graphlet-naming.	[Melckenbeeck, Ine; Audenaert, Pieter; Colle, Didier; Pickavet, Mario] Univ Ghent, iMinds, Dept Informat Technol INTEC, B-9000 Ghent, Belgium; [Michoel, Tom] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland	Ghent University; IMEC; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Melckenbeeck, I (corresponding author), Univ Ghent, iMinds, Dept Informat Technol INTEC, B-9000 Ghent, Belgium.	ine.melckenbeeck@intec.ugent.be	Pickavet, Mario J/E-9530-2019	Pickavet, Mario J/0000-0001-5817-7886; Melckenbeeck, Ine/0000-0003-0733-089X; Michoel, Tom/0000-0003-4749-4725	UGhent - iMinds; Roslin Institute Strategic Grant from the BBSRC [BB/J004235/1, BB/M020053/1]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211552, BB/M020053/1, BBS/E/D/20211551] Funding Source: researchfish; BBSRC [BBS/E/D/20211551, BBS/E/D/20211552, BB/M020053/1] Funding Source: UKRI	UGhent - iMinds; Roslin Institute Strategic Grant from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IM, PA, DC and MP are funded by UGhent - iMinds. TM is supported by Roslin Institute Strategic Grant funding from the BBSRC (BB/J004235/1 and BB/M020053/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demeyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061183; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; Houbraken M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097896; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301	5	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147078	10.1371/journal.pone.0147078	http://dx.doi.org/10.1371/journal.pone.0147078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797021	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300016
J	Simon, A; Subra, JF; Guilpain, P; Jeannin, P; Pignon, P; Blanchard, S; Garo, E; Jaillon, S; Chevailler, A; Renier, G; Puechal, X; Bottazzi, B; Mantovani, A; Delneste, Y; Augusto, JF				Simon, Amelie; Subra, Jean-Francois; Guilpain, Philippe; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Renier, Gilles; Puechal, Xavier; Bottazzi, Barbara; Mantovani, Alberto; Delneste, Yves; Augusto, Jean-Francois			Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis	PLOS ONE			English	Article							LONG PENTRAXIN PTX3; C-REACTIVE PROTEIN; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; DISEASE-ACTIVITY; RECOGNITION; NEUTROPHILS; CELLS; MYELOPEROXIDASE; PATHOGENESIS; GRANULES	Objectives Pentraxin 3 (PTX3), in common with myeloperoxidase and proteinase 3, is stored in human neutrophil granules and is expressed on apoptotic neutrophil surface. We therefore investigated the presence of anti-PTX3 autoantibodies (aAbs) in the sera of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients. Methods Presence of anti-PTX3 autoantibodies was analysed by a specific enzyme-linked immunosorbent assay in sera from 150 patients with microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA), and in sera of 227 healthy subjects (HS), 40 systemic sclerosis (SSc) patients, and 25 giant cell arteritis patients (GCA). Using indirect immunofluorescence on fixed human neutrophils, we also analyzed the staining pattern associated with the presence of anti-PTX3 aAbs. Results Anti-PTX3 aAbs were detected in 56 of 150 (37.3%) of the AAV patients (versus 12 of 227 (5.3%) of HS, p<0.001) and, interestingly, in 7 of 14 MPO and PR3 ANCA negative AAV patients. Moreover, by indirect immunofluorescence on fixed neutrophils, anti-PTX3 aAbs gave rise to a specific cytoplasmic fluorescence pattern distinct from the classical cytoplasmic (c-ANCA), perinuclear (p-ANCA), and atypical (a-ANCA) pattern. Anti-PTX3 aAbs levels were higher in patients with active AAV as compared to patients with inactive disease. Conclusion Our work suggests that PTX3 is as a novel ANCA antigen. Anti-PTX3 aAbs appear thus as a promising novel biomarker in the diagnosis of AAV, including in patients without detectable MPO and PR3 ANCA.	[Simon, Amelie; Subra, Jean-Francois; Augusto, Jean-Francois] Univ Hosp Angers, Dept Nephrol, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] Univ Angers, Canc Res Ctr Nantes Angers, LUNAM Univ, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] INSERM, UMR 892, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] CNRS, UMR 6299, Angers, France; [Simon, Amelie; Subra, Jean-Francois; Jeannin, Pascale; Pignon, Pascale; Blanchard, Simon; Garo, Erwan; Jaillon, Sebastien; Chevailler, Alain; Delneste, Yves; Augusto, Jean-Francois] LabEx IGO, Angers, France; [Guilpain, Philippe] Univ Hosp Montpellier, Dept Internal Med, Monptellier, France; [Jeannin, Pascale; Blanchard, Simon; Chevailler, Alain; Renier, Gilles; Delneste, Yves] Univ Hosp Angers, Immunol & Allergol Lab, Angers, France; [Puechal, Xavier] Hop Cochin, AP HP, Dept Internal Med, Natl Referral Ctr Rare System Autoimmune Dis, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas, Immunol & Inflammat Res Lab, Milan, Italy	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite de Montpellier; CHU de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Humanitas Research Hospital	Augusto, JF (corresponding author), Univ Hosp Angers, Dept Nephrol, Angers, France.; Augusto, JF (corresponding author), Univ Angers, Canc Res Ctr Nantes Angers, LUNAM Univ, Angers, France.; Augusto, JF (corresponding author), INSERM, UMR 892, Angers, France.; Augusto, JF (corresponding author), CNRS, UMR 6299, Angers, France.; Augusto, JF (corresponding author), LabEx IGO, Angers, France.	jfaugusto@chu-angers.fr	Jean-François, Augusto/L-2887-2015; DELNESTE, Yves/K-7367-2015; JEANNIN, Pascale/K-8656-2015; Puéchal, Xavier/P-1555-2017; Mantovani, Alberto/HCI-7449-2022; Delneste, Yves/O-3956-2016; bottazzi, barbara/ABH-9274-2020; JAILLON, Sebastien/A-7537-2015	Jean-François, Augusto/0000-0003-1498-2132; DELNESTE, Yves/0000-0002-2142-596X; Puéchal, Xavier/0000-0003-3573-9203; Mantovani, Alberto/0000-0001-5578-236X; bottazzi, barbara/0000-0002-1930-9257; JAILLON, Sebastien/0000-0002-5600-855X; JEANNIN, Pascale/0000-0002-3666-3856; Garo, Erwan/0000-0003-4411-9161	Institut National de la Sante et de la Recherche Medicale, France; University of Angers; Agence Nationale de la Recherche (project Pentraximmune); Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche); Conseil General du Maine et Loire	Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Angers; Agence Nationale de la Recherche (project Pentraximmune)(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche); Conseil General du Maine et Loire(Region Pays de la Loire)	This work was supported by institutional grants from Institut National de la Sante et de la Recherche Medicale, France and the University of Angers and by a grant from the Agence Nationale de la Recherche (project Pentraximmune). Amelie Simon and Sebastien Jaillon were supported by grants from the Ministere de la Recherche et de l'Enseignement superieur (Bourse annee-recherche) and the Conseil General du Maine et Loire, respectively.	ALLES VV, 1994, BLOOD, V84, P3483; Augusto JF, 2009, RHEUMATOLOGY, V48, P442, DOI 10.1093/rheumatology/ken507; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; Basu N, 2010, ANN RHEUM DIS, V69, P1744, DOI 10.1136/ard.2009.119032; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Falk RJ, 2010, J AM SOC NEPHROL, V21, P745, DOI 10.1681/ASN.2009121238; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Gilligan HM, 1996, J EXP MED, V184, P2231, DOI 10.1084/jem.184.6.2231; Gomez-Puerta JA, 2009, AM J PATHOL, V175, P1790, DOI 10.2353/ajpath.2009.090533; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Hu N, 2011, AUTOIMMUN REV, V10, P536, DOI 10.1016/j.autrev.2011.04.004; Jaillon S, 2009, CELL DEATH DIFFER, V16, P465, DOI 10.1038/cdd.2008.173; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Knight JS, 2012, CURR OPIN RHEUMATOL, V24, P441, DOI 10.1097/BOR.0b013e3283546703; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Roth AJ, 2013, J CLIN INVEST, V123, P1773, DOI 10.1172/JCI65292; Sangaletti S, 2012, BLOOD, V120, P3007, DOI 10.1182/blood-2012-03-416156; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sjowall C, 2002, J AUTOIMMUN, V19, P155, DOI 10.1006/jaut.2002.0608; Stegeman CA, 2002, NEPHROL DIAL TRANSPL, V17, P2077, DOI 10.1093/ndt/17.12.2077; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; Tan Y, 2011, CLIN J AM SOC NEPHRO, V6, P93, DOI 10.2215/CJN.09051209; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Zandman-Goddard G, 2005, ANN RHEUM DIS, V64, P1698, DOI 10.1136/ard.2005.035832	40	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147091	10.1371/journal.pone.0147091	http://dx.doi.org/10.1371/journal.pone.0147091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26797217	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300017
J	Benson, KA; Maxwell, AP; McKnight, AJ				Benson, Katherine Angela; Maxwell, Alexander Peter; McKnight, Amy Jayne			A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; BODY-MASS INDEX; 2 TCF7L2 GENE; RISK-FACTORS; MELLITUS; POLYMORPHISMS; ADIPONECTIN; VARIANT; CDKAL1; RECIPIENTS	Purpose New onset diabetes after transplantation (NODAT) is a serious complication following solid organ transplantation. There is a genetic contribution to NODAT and we have conducted comprehensive meta-analysis of available genetic data in kidney transplant populations. Methods Relevant articles investigating the association between genetic markers and NODAT were identified by searching PubMed, Web of Science and Google Scholar. SNPs described in a minimum of three studies were included for analysis using a random effects model. The association between identified variants and NODAT was calculated at the per-study level to generate overall significance values and effect sizes. Results Searching the literature returned 4,147 citations. Within the 36 eligible articles identified, 18 genetic variants from 12 genes were considered for analysis. Of these, three were significantly associated with NODAT by meta-analysis at the 5% level of significance; CDKAL1 rs10946398 p = 0.006 OR = 1.43, 95% CI = 1.11-1.85 (n = 696 individuals), KCNQ1 rs2237892 p = 0.007 OR = 1.43, 95% CI = 1.10-1.86 (n = 1,270 individuals), and TCF7L2 rs7903146 p = 0.01 OR = 1.41, 95% CI = 1.07-1.85 (n = 2,967 individuals). Conclusion Evaluating cumulative evidence for SNPs associated with NODAT in kidney transplant recipients has revealed three SNPs associated with NODAT. An adequately powered, dense genome-wide association study will provide more information using a carefully defined NODAT phenotype.	[Benson, Katherine Angela; Maxwell, Alexander Peter; McKnight, Amy Jayne] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Maxwell, Alexander Peter] Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland	Queens University Belfast; Belfast City Hospital	Benson, KA (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	kbenson04@qub.ac.uk	McKnight, Amy Jayne/ABF-4492-2020	McKnight, Amy Jayne/0000-0002-7482-709X; Benson, Katherine/0000-0003-3529-315X; Maxwell, Alexander P./0000-0002-6110-7253	Queen's University Belfast, School of Medicine Dentistry and Biomedical Sciences; Northern Ireland Kidney Research Fund; Public Health Agency [STL/3714/07, STL/4760/13] Funding Source: researchfish	Queen's University Belfast, School of Medicine Dentistry and Biomedical Sciences; Northern Ireland Kidney Research Fund; Public Health Agency	KAB is supported by a Queen's University Belfast, School of Medicine Dentistry and Biomedical Sciences (http://www.qub.ac.uk/schools/mdbs/) international studentship and the Northern Ireland Kidney Research Fund, a local charity (http://www.kidneyresearchni.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot GW, 2015, GENE, p[S0378, 01168]; Ao D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128901; Babel N, 2004, KIDNEY INT, V66, P428, DOI 10.1111/j.1523-1755.2004.00749.x; Bazzi MD, 2014, GENET MOL RES, V13, P10194, DOI 10.4238/2014.December.4.14; Brambillasca S, 2012, J BIOL CHEM, V287, P41808, DOI 10.1074/jbc.M112.376558; Cattaneo D, 2009, J AM SOC NEPHROL, V20, P1404, DOI 10.1681/ASN.2008080819; Chakkera HA, 2012, TRANSPL P, V41, P4172; Chang HR, 2011, CLIN CHIM ACTA, V412, P322, DOI 10.1016/j.cca.2010.10.029; Chen Y, 2012, TRANSPLANTATION, V93, P325, DOI 10.1097/TP.0b013e31823f7f26; Chudek J, 2013, ANN TRANSPL, V18, P593, DOI 10.12659/AOT.884022; Davidson JA, 2004, DIABETES CARE, V27, P805, DOI 10.2337/diacare.27.3.805; Dehwah MAS, 2010, GENET MOL RES, V9, P1109, DOI 10.4238/vol9-2gmr802; Dutkiewicz G, 2010, ARCH MED RES, V41, P350, DOI 10.1016/j.arcmed.2010.06.006; Elens L, 2013, PHARMACOGENET GENOM, V23, P649, DOI 10.1097/FPC.0000000000000001; Ergun I, 2011, INT UROL NEPHROL, V43, P543, DOI 10.1007/s11255-010-9786-8; Fougeray S, 2011, TRANSPL P, V43, P3418, DOI 10.1016/j.transproceed.2011.09.022; Gaynor JJ, 2015, CLIN TRANSPLANT, V29, P301, DOI 10.1111/ctr.12510; Ghisdal L, 2009, J AM SOC NEPHROL, V20, P2459, DOI 10.1681/ASN.2008121314; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hattersley AT, 2007, NEPHROLOGY, V117, P6; Hecking M, 2013, NEPHROL DIAL TRANSPL, V28, P550, DOI 10.1093/ndt/gfs583; Huerta-Chagoya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126408; Jeong KH, 2010, AM J NEPHROL, V32, P356, DOI 10.1159/000319704; Kang ES, 2008, DIABETES CARE, V31, P63, DOI 10.2337/dc07-1005; Kang ES, 2008, DIABETES, V57, P1043, DOI 10.2337/db07-0761; Kang ES, 2012, J CLIN ENDOCR METAB, V97, pE129, DOI 10.1210/jc.2011-1796; Kang ES, 2009, TRANSPLANTATION, V88, P693, DOI 10.1097/TP.0b013e3181b29c41; Kao CC, 2010, TRANSPL P, V42, P3559, DOI 10.1016/j.transproceed.2010.06.032; Kesiraju S, 2014, TRANSPL IMMUNOL, V30, P52, DOI 10.1016/j.trim.2013.10.006; Khan Imran Ullah, 2015, 2015 International Conference on Energy Economics and Environment (ICEEE), P1, DOI 10.1109/EnergyEconomics.2015.7235096; Kim YG, 2012, TRANSPLANTATION, V93, P900, DOI 10.1097/TP.0b013e3182497534; Kurzawski M, 2014, PHARMACOGENET GENOM, V24, P397, DOI 10.1097/FPC.0000000000000067; Kurzawski M, 2012, EUR J CLIN PHARMACOL, V68, P1587, DOI 10.1007/s00228-012-1292-8; Kurzawski M, 2011, PHARMACOL REP, V63, P826, DOI 10.1016/S1734-1140(11)70595-3; Kurzawski M, 2010, PHARMACOGENOMICS J, V10, P120, DOI 10.1038/tpj.2009.44; Lee SR, 2013, KIDNEY BLOOD PRESS R, V37, P95, DOI 10.1159/000343404; Liu LJ, 2014, ISLETS, V6, DOI 10.4161/19382014.2014.962386; Luan FL, 2011, TRANSPLANTATION, V91, P334, DOI 10.1097/TP.0b013e318203c25f; McCaughan JA, 2014, J AM SOC NEPHROL, V25, P1037, DOI 10.1681/ASN.2013040383; Menzaghi C, 2004, PHYSIOL GENOMICS, V19, P170, DOI 10.1152/physiolgenomics.00122.2004; Mora PF, 2010, J INVEST MED, V58, P755, DOI 10.231/JIM.0b013e3181e61a64; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nicod N, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-41; Nicoletto BB, 2013, TRANSPLANTATION, V96, P1059, DOI 10.1097/TP.0b013e3182a45283; Ozdemir BH, 2011, TRANSPL P, V43, P572, DOI 10.1016/j.transproceed.2011.01.046; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Schultz BM, 2015, NUCLEIC ACIDS RES, V43, P745, DOI 10.1093/nar/gku1324; Sgariglia F, 2015, BONE, V72, P123, DOI 10.1016/j.bone.2014.11.024; Shabir S, 2013, TRANSPL INT, V26, P315, DOI 10.1111/tri.12042; Sharif A, 2014, AM J TRANSPLANT, V14, P1992, DOI 10.1111/ajt.12850; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Szuszkiewicz M, 2011, METAB SYNDR RELAT D, V9, P25, DOI 10.1089/met.2010.0041; Tavira B, 2012, MOL GENET METAB, V105, P525, DOI 10.1016/j.ymgme.2011.12.020; Tavira B, 2011, CLIN TRANSPLANT, V25, pE284, DOI 10.1111/j.1399-0012.2011.01417.x; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; The Cochrane Collaboration, 2014, REV MAN REVMAN COMP; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Tsai JP, 2011, J CLIN LAB ANAL, V25, P432, DOI 10.1002/jcla.20498; Vattam K., 2013, OPEN J NEPHROLOGY, V3, P104; Wang P, 2011, ARCH PATHOL LAB MED, V135, P1581, DOI 10.5858/arpa.2011-0160-OA; Weng SC, 2012, TRANSPL P, V44, P667, DOI 10.1016/j.transproceed.2011.11.011; Yang J, 2011, TRANSPLANTATION, V91, P1114, DOI 10.1097/TP.0b013e31821620f9; Yao B, 2013, TRANSPL P, V45, P194, DOI 10.1016/j.transproceed.2012.08.019; Yu AR, 2011, TRANSPL P, V43, P1607, DOI 10.1016/j.transproceed.2011.02.057; Zhou B, 2014, HUM MOL GENET, V23, P4639, DOI 10.1093/hmg/ddu184	66	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147323	10.1371/journal.pone.0147323	http://dx.doi.org/10.1371/journal.pone.0147323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789123	gold, Green Submitted, Green Published			2022-12-27	WOS:000368529100078
J	Gerwing, TG; Drolet, D; Hamilton, DJ; Barbeau, MA				Gerwing, Travis G.; Drolet, David; Hamilton, Diana J.; Barbeau, Myriam A.			Relative Importance of Biotic and Abiotic Forces on the Composition and Dynamics of a Soft-Sediment Intertidal Community	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; ILYANASSA-OBSOLETA SAY; BOTTOM-UP CONTROL; TOP-DOWN; UPPER BAY; SUBSTRATE SELECTION; SPATIAL-PATTERNS; MUD SNAIL; MARINE-INVERTEBRATES; POPULATION-DYNAMICS	Top-down, bottom-up, middle-out and abiotic factors are usually viewed as main forces structuring biological communities, although assessment of their relative importance, in a single study, is rarely done. We quantified, using multivariate methods, associations between abiotic and biotic (top-down, bottom-up and middle-out) variables and infaunal population/community variation on intertidal mudflats in the Bay of Fundy, Canada, over two years. Our analysis indicated that spatial structural factors like site and plot accounted for most of the community and population variation. Although we observed a significant relationship between the community/populations and the biotic and abiotic variables, most were of minor importance relative to the structural factors. We suggest that community and population structure were relatively uncoupled from the structuring influences of biotic and abiotic factors in this system because of high concentrations of resources that sustain high densities of infauna and limit exploitative competition. Furthermore, we hypothesize that the infaunal community primarily reflects stochastic spatial events, namely a "first come, first served" process.	[Gerwing, Travis G.; Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, POB 4400, Fredericton, NB E3B 5A3, Canada; [Drolet, David; Hamilton, Diana J.] Mt Allison Univ, Dept Biol, Sackville, NB E4L 1G7, Canada	University of New Brunswick; Mount Allison University	Gerwing, TG (corresponding author), Univ New Brunswick, Dept Biol, POB 4400, Fredericton, NB E3B 5A3, Canada.	t.g.gerwing@gmail.com	Gerwing, Travis/AAU-6569-2020	Gerwing, Travis/0000-0002-4433-1843	Natural Sciences and Engineering Research Council of Canada [365130, 227554, 327321]; New Brunswick Wildlife Trust Fund [B231-016, B232-016]; Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences); Science Horizons Internship Program (Environment Canada); Canada Summer Job Program; Marguerite and Murray Vaughan Fellowships in Marine Sciences; UNB	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Wildlife Trust Fund; Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences); Science Horizons Internship Program (Environment Canada); Canada Summer Job Program; Marguerite and Murray Vaughan Fellowships in Marine Sciences; UNB	This study was funded by the Natural Sciences and Engineering Research Council of Canada (a Strategic Project Grant (365130) and Discovery grants to MAB (227554) and DJH (327321)), New Brunswick Wildlife Trust Fund grants to MAB (B231-016 and B232-016), Mprime (a Canadian Network of Centres of Excellence for the mathematical sciences), Science Horizons Internship Program (Environment Canada), and the Canada Summer Job Program. TGG received support from Marguerite and Murray Vaughan Fellowships in Marine Sciences, and UNB (including a President's Doctoral Tuition award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; AMBROSE WG, 1984, J MAR RES, V42, P633; AMBROSE WG, 1991, AM ZOOL, V31, P849; AMBROSE WG, 1984, J EXP MAR BIOL ECOL, V81, P115, DOI 10.1016/0022-0981(84)90002-9; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bertness M.D., 2007, ATLANTIC SHORELINES; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; Bracken MES, 2014, ECOLOGY, V95, P1458, DOI 10.1890/13-2094.1; Bringloe TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069091; Caliman A, 2013, ECOLOGY, V94, P1977, DOI 10.1890/12-1385.1; Cheverie AV, 2014, J SEA RES, V92, P102, DOI 10.1016/j.seares.2014.03.011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Coffin MRS, 2008, J EXP MAR BIOL ECOL, V364, P110, DOI 10.1016/j.jembe.2008.07.030; Coffin MRS, 2012, J EXP MAR BIOL ECOL, V418, P12, DOI 10.1016/j.jembe.2012.03.002; COMMITO JA, 1985, MAR ECOL PROG SER, V26, P289, DOI 10.3354/meps026289; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; CONNOLLY RM, 1994, J EXP MAR BIOL ECOL, V180, P39; Coulthard ME, 2011, J EXP MAR BIOL ECOL, V397, P161, DOI 10.1016/j.jembe.2010.12.001; CRANFORD PJ, 1985, NETH J SEA RES, V19, P135, DOI 10.1016/0077-7579(85)90018-3; Crewe TL, 2001, ESTUAR COAST SHELF S, V53, P151, DOI 10.1006/ecss.2001.0795; Currie DJ, 2007, J BIOGEOGR, V34, P2009, DOI 10.1111/j.1365-2699.2007.01808.x; Davis B, 2014, MAR ECOL PROG SER, V500, P175, DOI 10.3354/meps10671; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DEWITT TH, 1985, J EXP MAR BIOL ECOL, V92, P97, DOI 10.1016/0022-0981(85)90024-3; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Drolet D., 2013, ESTUAR COAST, V36, P1; Drolet D, 2013, J EXP MAR BIOL ECOL, V441, P126, DOI 10.1016/j.jembe.2013.01.023; Drolet D, 2012, MAR ECOL PROG SER, V449, P197, DOI 10.3354/meps09495; Drolet D, 2011, MAR ECOL PROG SER, V431, P255, DOI 10.3354/meps09121; Dyer KR, 2000, CONT SHELF RES, V20, P1039, DOI 10.1016/S0278-4343(00)00011-X; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Ferguson N, 2013, ECOLOGY, V94, P126, DOI 10.1890/12-0795.1; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; FLACH EC, 1992, NETH J SEA RES, V30, P81, DOI 10.1016/0077-7579(92)90048-J; FLACH EC, 1992, NETH J SEA RES, V29, P379, DOI 10.1016/0077-7579(92)90077-R; Flach EC, 1995, OCEANOGRAPHIC LIT RE, V42; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; Gerwing TG, 2015, NORTHEAST NAT, V22, P1, DOI 10.1656/045.022.m1201; Gerwing TG, 2015, J SEA RES, V97, P40, DOI 10.1016/j.seares.2015.01.001; Gerwing TG, 2015, INT J SEDIMENT RES, V30, P74, DOI 10.1016/S1001-6279(15)60008-7; Gerwing TG, 2013, MAR ECOL PROG SER, V487, P7, DOI 10.3354/meps10407; Ghasemi AF, 2014, J GREAT LAKES RES, V40, P692, DOI 10.1016/j.jglr.2014.05.004; GORDON DC, 1986, NETH J SEA RES, V20, P325, DOI 10.1016/0077-7579(86)90054-2; Gorley C.K., 2006, GETTING STARTED PRIM; Greenville AC, 2014, OECOLOGIA, V175, P1349, DOI 10.1007/s00442-014-2977-8; Hamilton DJ, 2006, HYDROBIOLOGIA, V567, P285, DOI 10.1007/s10750-006-0062-y; Hamilton DJ, 2003, CAN J ZOOL, V81, P1358, DOI 10.1139/Z03-130; Hamilton DJ, 2000, ECOL MONOGR, V70, P21, DOI 10.1890/0012-9615(2000)070[0021:DAIEOP]2.0.CO;2; HARGRAVE BT, 1983, CAN J FISH AQUAT SCI, V40, P229; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; HICKLIN PW, 1987, WILSON BULL, V99, P540; Hughes JM, 2014, J EXP MAR BIOL ECOL, V459, P190, DOI 10.1016/j.jembe.2014.05.026; Johnson KD, 2014, MAR ECOL PROG SER, V507, P197, DOI 10.3354/meps10815; Jumars P. A., 2014, ANNU REV MAR SCI, V7, P1; Kelaher BP, 2001, J MAR BIOL ASSOC UK, V81, P917, DOI 10.1017/S0025315401004842; Kennedy K., 2012, THESIS U NEW BRUNSWI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Levinton J, 2004, J EXP MAR BIOL ECOL, V300, P65, DOI 10.1016/j.jembe.2003.12.008; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Lu L, 2008, ESTUAR COAST, V31, P994, DOI 10.1007/s12237-008-9097-9; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCurdy DG, 2005, J CRUSTACEAN BIOL, V25, P558, DOI 10.1651/C-2539.1; MEADOWS PS, 1964, J EXP BIOL, V41, P499; MEADOWS PS, 1964, J ANIM ECOL, V33, P387, DOI 10.2307/2560; MEADOWS PS, 1967, J EXP BIOL, V47, P553; MEADOWS PS, 1964, J EXP BIOL, V41, P677; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1991, J EXP MAR BIOL ECOL, V146, P69, DOI 10.1016/0022-0981(91)90255-U; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Murray F, 2014, MAR ECOL PROG SER, V516, P23, DOI 10.3354/meps11020; Nybakken J., 2005, MARINE BIOL ECOLOGIC; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; Pagliosa PR, 2005, MAR ECOL-EVOL PERSP, V26, P246, DOI 10.1111/j.1439-0485.2005.00065.x; PETERSON CH, 1991, AM SCI, V79, P236; Pilditch CA, 2015, NEW ZEAL J MAR FRESH, V49, P224, DOI 10.1080/00288330.2014.995678; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; Poysa H, 2004, OIKOS, V104, P612, DOI 10.1111/j.0030-1299.2004.12788.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Quijon PA, 2008, MAR ECOL PROG SER, V371, P85, DOI 10.3354/meps07691; RISK MJ, 1976, J SEDIMENT PETROL, V46, P411; Robar NDP, 2007, WATERBIRDS, V30, P116, DOI 10.1675/1524-4695(2007)030[0116:AMFEHU]2.0.CO;2; ROSE GA, 1989, CAN J FISH AQUAT SCI, V46, P1904, DOI 10.1139/f89-240; ROSEMOND AD, 1993, ECOLOGY, V74, P1264, DOI 10.2307/1940495; Scholz B, 2012, EUR J PHYCOL, V47, P120, DOI 10.1080/09670262.2012.665251; Schuldt A, 2014, OECOLOGIA, V176, P171, DOI 10.1007/s00442-014-3006-7; Searle SR., 1992, VARIANCE COMPONENTS; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; STUART V, 1985, J EXP MAR BIOL ECOL, V88, P243, DOI 10.1016/0022-0981(85)90233-3; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Trites M, 2005, HYDROBIOLOGIA, V544, P299, DOI 10.1007/s10750-005-1696-x; Underwood, 1996, EXPT ECOLOGY THEIR L; van den Hoff J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2842; Vinueza LR, 2014, ECOL MONOGR, V84, P411, DOI 10.1890/13-0169.1; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391	104	28	28	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147098	10.1371/journal.pone.0147098	http://dx.doi.org/10.1371/journal.pone.0147098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790098	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100058
J	Honig, G; Mader, S; Chen, HY; Porat, A; Ochani, M; Wang, P; Volpe, BT; Diamond, B				Honig, Gerard; Mader, Simone; Chen, Huiyi; Porat, Amit; Ochani, Mahendar; Wang, Ping; Volpe, Bruce T.; Diamond, Betty			Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; SYSTEMIC INFLAMMATION; SUBDIAPHRAGMATIC VAGOTOMY; PERIVASCULAR MACROPHAGES; NEUTROPHIL RECRUITMENT; LEUKOCYTE INFILTRATION; UP-REGULATION; SEPTIC SHOCK	Systemic infection can initiate or exacerbate central nervous system (CNS) pathology, even in the absence of overt invasion of bacteria into the CNS. Recent epidemiological studies have demonstrated that human survivors of sepsis have an increased risk of long-term neurocognitive decline. There is thus a need for improved understanding of the physiological mechanisms whereby acute sepsis affects the CNS. In particular, MyD88-dependent activation of brain microvascular endothelial cells and a resulting loss of blood-brain barrier integrity have been proposed to play an important role in the effects of systemic inflammation on the CNS. Signaling through the vagus nerve has also been considered to be an important component of CNS responses to systemic infection. Here, we demonstrate that blood-brain barrier permeabilization and hippocampal transcriptional responses during polymicrobial sepsis occur even in the absence of MyD88-dependent signaling in cerebrovascular endothelial cells. We further demonstrate that these transcriptional responses can occur without vagus nerve input. These results suggest that redundant signals mediate CNS responses in sepsis. Either endothelial or vagus nerve activation may be individually sufficient to transmit systemic inflammation to the central nervous system. Transcriptional activation in the forebrain in sepsis may be mediated by MyD88-independent endothelial mechanisms or by non-vagal neuronal pathways.	[Honig, Gerard; Mader, Simone; Chen, Huiyi; Porat, Amit; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA; [Ochani, Mahendar; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA; [Volpe, Bruce T.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA; [Honig, Gerard] Symbiot Hlth Inc, Roslyn Hts, NY USA	Northwell Health; Northwell Health; Northwell Health	Diamond, B (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	bdiamond@nshs.edu	Honig, Gerard/ABB-5333-2020; volpe, b/U-8409-2019	Mader, Simone/0000-0002-2844-9091; Wang, Ping/0000-0002-1557-0394; Volpe, Bruce/0000-0002-1098-1848; Honig, Gerard/0000-0001-9147-7450	National Institute for Allergy and Infectious Diseases [3P01AI073693-02S1]; S.L.E. Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073693] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); S.L.E. Lupus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institute for Allergy and Infectious Diseases (grant 3P01AI073693-02S1). Simone Mader's work was supported by the S.L.E. Lupus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; [Anonymous], 2006, ENDOCRINOLOGY, V147, P4445, DOI [10.1210/en.2006-0465, DOI 10.1210/EN.2006-0465]; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Belevych N, 2010, BRAIN BEHAV IMMUN, V24, P1137, DOI 10.1016/j.bbi.2010.05.007; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Braun TP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-229; BRETDIBAT JL, 1995, BRAIN BEHAV IMMUN, V9, P242, DOI 10.1006/brbi.1995.1023; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Chung DW, 2010, CELL MOL NEUROBIOL, V30, P531, DOI 10.1007/s10571-009-9477-0; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Di Filippo M, 2013, NEUROBIOL DIS, V52, P229, DOI 10.1016/j.nbd.2012.12.009; Ding JQ, 2009, J IMMUNOL, V183, P4031, DOI 10.4049/jimmunol.0900105; Ebong S, 1999, INFECT IMMUN, V67, P6603; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Esen F, 2012, CRIT CARE MED, V40, P1214, DOI 10.1097/CCM.0b013e31823779ca; Fil D, 2011, METAB BRAIN DIS, V26, P49, DOI 10.1007/s11011-010-9231-9; Flierl MA, 2010, CRIT CARE, V14, DOI 10.1186/cc9035; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Hiraki S, 2012, SURGERY, V151, P313, DOI 10.1016/j.surg.2011.07.019; Hofer S, 2008, J SURG RES, V146, P276, DOI 10.1016/j.jss.2007.07.021; Honig G, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-82; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Imamura Y, 2011, NEUROSCIENCE, V187, P63, DOI 10.1016/j.neuroscience.2011.04.063; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jin AY, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-12; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; LAYE S, 1995, AM J PHYSIOL-REG I, V268, pR1327, DOI 10.1152/ajpregu.1995.268.5.R1327; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Naert G, 2009, J INNATE IMMUN, V1, P480, DOI 10.1159/000225990; NIIJIMA A, 1995, J AUTONOM NERV SYST, V54, P137, DOI 10.1016/0165-1838(95)00003-G; Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Pan WH, 2008, AM J PHYSIOL-CELL PH, V294, pC1436, DOI 10.1152/ajpcell.00489.2007; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Saper CB, 2010, NEURON, V65, P4, DOI 10.1016/j.neuron.2009.12.029; Scheiermann P, 2011, INT IMMUNOPHARMACOL, V11, P719, DOI 10.1016/j.intimp.2011.01.020; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Secor D, 2010, INTENS CARE MED, V36, P1928, DOI 10.1007/s00134-010-1969-3; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Serrats J, 2009, BRAIN BEHAV IMMUN, V23, P1038, DOI 10.1016/j.bbi.2009.06.004; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Sharkey KA, 2014, AUTON NEUROSCI-BASIC, V182, P70, DOI 10.1016/j.autneu.2014.03.004; Sharshar T, 2005, CRIT CARE, V9, P37, DOI 10.1186/cc2951; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Vachharjani V, 2005, MICROCIRCULATION, V12, P183, DOI 10.1080/10739680590904982; Vandenbroucke RE, 2012, J NEUROSCI, V32, P9805, DOI 10.1523/JNEUROSCI.0967-12.2012; Verant P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870083; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang P, 2014, INT J MOL SCI, V15, P10101, DOI 10.3390/ijms150610101; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Wiersinga WJ, 2011, CURR OPIN CRIT CARE, V17, P480, DOI 10.1097/MCC.0b013e32834a4aeb; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wuchert F, 2008, J NEUROIMMUNOL, V204, P66, DOI 10.1016/j.jneuroim.2008.07.017; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yokoo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051539; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309; Zielinski MR, 2013, SLEEP, V36, P1227, DOI 10.5665/sleep.2892	110	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0144215	10.1371/journal.pone.0144215	http://dx.doi.org/10.1371/journal.pone.0144215			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790027	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100002
J	Royer, A; Montuire, S; Legendre, S; Discamps, E; Jeannet, M; Lecuyer, C				Royer, Aurelien; Montuire, Sophie; Legendre, Serge; Discamps, Emmanuel; Jeannet, Marcel; Lecuyer, Christophe			Investigating the Influence of Climate Changes on Rodent Communities at a Regional-Scale (MIS 1-3, Southwestern France)	PLOS ONE			English	Article							SMALL-MAMMAL DIVERSITY; LAST GLACIAL PERIOD; LATE-PLEISTOCENE; QUATERNARY HISTORY; WESTERN-EUROPE; VARIABILITY; RESPONSES; REFUGIA; COLONIZATION; FLUCTUATIONS	Terrestrial ecosystems have continuously evolved throughout the Late Pleistocene and the Holocene, deeply affected by both progressive environmental and climatic modifications, as well as by abrupt and large climatic changes such as the Heinrich or Dansgaard-Oeschger events. Yet, the impacts of these different events on terrestrial mammalian communities are poorly known, as is the role played by potential refugia on geographical species distributions. This study examines community changes in rodents of southwestern France between 50 and 10 ky BP by integrating 94 dated faunal assemblages coming from 37 archaeological sites. This work reveals that faunal distributions were modified in response to abrupt and brief climatic events, such as Heinrich events, without actually modifying the rodent community on a regional scale. However, the succession of events which operated between the Late Pleistocene and the Holocene gradually led to establishing a new rodent community at the regional scale, with intermediate communities occurring between the Bolling and the Allerod.	[Royer, Aurelien; Discamps, Emmanuel] Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France; [Royer, Aurelien; Legendre, Serge; Lecuyer, Christophe] Univ Lyon 1, F-69622 Villeurbanne, France; [Royer, Aurelien; Legendre, Serge; Lecuyer, Christophe] Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, UMR 5276, F-69622 Villeurbanne, France; [Montuire, Sophie] Univ Bourgogne, Biogeosci, CNRS, UMR 6282, 6 Blvd Gabriel, F-21000 Dijon, France; [Discamps, Emmanuel] Univ Bergen, AHKR Inst, Oysteinsgate 1,POB 7805, N-5020 Bergen, Norway; [Jeannet, Marcel] Aix Marseille Univ, LAMPEA, CNRS, UMR 7269,MMSH, 5 Rue Chateau Horloge,BP 647, F-13094 Aix En Provence 2, France; [Montuire, Sophie] Ecole Prat Hautes Etud, Lab EPHE PALEVO, F-21000 Dijon, France; [Lecuyer, Christophe] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Bergen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Bourgogne; Institut Universitaire de France	Royer, A (corresponding author), Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France.; Royer, A (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.; Royer, A (corresponding author), Ecole Normale Super Lyon, Lab Geol Lyon, CNRS, UMR 5276, F-69622 Villeurbanne, France.	aurelien_royer@hotmail.com	Lecuyer, Christophe/AAO-8154-2021; Legendre, Serge/B-4042-2008; Royer, Aurélien/L-4641-2018	Legendre, Serge/0000-0003-4867-6790; Royer, Aurélien/0000-0002-0139-8765; Discamps, Emmanuel/0000-0002-2464-0761	Conseil General du departement de la Charente [CG16]; department of Charente (France) [CG16]	Conseil General du departement de la Charente; department of Charente (France)	This work was supported by funding from Conseil General du departement de la Charente (CG16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author of this study was granted by the department of Charente (CG16; France). Authors are grateful to Veronique Laroulandie, Mathieu Langlais and Marie Soressi for giving access to the material and for inviting A.R to study Peyrazet (Lot) and Les Cottes (Vienne). The authors also acknowledge the insightful comments made by Trenton Holliday. The authors would like to thank M. Hernandez Fernandez and an anonymous reviewer for their constructive remarks that greatly improved this paper.	Aguilar JP, 2008, CR PALEVOL, V7, P217, DOI 10.1016/j.crpv.2008.02.004; Allain J., 1985, GALLIA PR HIST, V28, P37; Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Auffray Jean-Christophe, 2009, Kasetsart Journal Natural Sciences, V43, P83; Belmaker M, 2011, QUATERNARY SCI REV, V30, P3196, DOI 10.1016/j.quascirev.2011.08.001; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Bertran P, 2014, BOREAS, V43, P699, DOI 10.1111/bor.12025; Bertran P, 2013, J ARCHAEOL SCI, V40, P2274, DOI 10.1016/j.jas.2013.01.012; Bertran P, 2009, J QUATERNARY SCI, V24, P259, DOI 10.1002/jqs.1220; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Bouchud J., 1968, GALLIA PREHISTOIRE, V11, P113; Bouchud J, 1952, B SOC PREHISTORIQUE, V49, P267; Bouchud J., 1975, EXCAVATION ABRI PATA, P69; Bouchud P, 1957, B STE ETUDES RECHERC, V7, P13; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Brugal Jean Philip, 2004, BAR International Series, V1271, P39; BRUNETLECOMTE P, 1989, MAMMALIA, V53, P605, DOI 10.1515/mamm.1989.53.4.605; CHALINE J, 1995, PALAEOGEOGR PALAEOCL, V117, P229, DOI 10.1016/0031-0182(94)00137-W; Chaline J, 1974, PROIES RAPACES; Chaline J, 1965, B ASS FRANCAISE ETUD, V3-4, P243; Chaline J., 1972, CAHIERS PALEONTOLOGI; Chaline J, 1977, APPROCHE ECOLOGIQUE, P77; Champagne F., 1981, PIAGE SITE PREHISTOR; Clements F. E., 1916, PLANT SUCCESSION; Clot A., 1984, Munibe, V36, P33; Clot A, 1979, B SOC PREHISTORIQUE, V76, P324; Costamagno S., 2009, ELS PIRINEUS AREES C, P185; Costamagno S, 2001, MODE VIE MAGDALENIEN, P73; Coulonges L., 1963, GALL PREHIST, V7, P1; Cuenca-Bescos G, 1999, J HUM EVOL, V37, P353, DOI 10.1006/jhev.1999.0306; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Delluc B, 1981, GALLIA PREHISTOIRE, V24, P1; Delpech F., 1989, TEMPS PREHISTOIRE, P48; DELPECH F., 1983, B LINSTITUT G OLOGIE, V34, P165; Delpech F., 2000, PALEO, V12, P97; Delpech F., 1999, PALEO, V11, P19, DOI DOI 10.3406/PAL.1999.1169; Desclaux E, 2003, PREHISTOIRE, P222; Discamps E, 2014, QUATERN INT, V337, P64, DOI 10.1016/j.quaint.2013.07.046; Discamps E, 2011, QUATERNARY SCI REV, V30, P2755, DOI 10.1016/j.quascirev.2011.06.009; Eastham A, 1995, MEMOIRE SOC PREHISTO, V22, P235; Eastham A., 1999, GALLIA PREHISTOIRE, V41, P113; Escarguel G, 2008, CR GEOSCI, V340, P602, DOI 10.1016/j.crte.2007.11.005; Fernandez MH, 2006, QUATERNARY RES, V65, P308, DOI 10.1016/j.yqres.2005.08.022; Fernandez-Garcia M, C R PALEVOL; Fletcher WJ, 2010, QUATERNARY SCI REV, V29, P2839, DOI 10.1016/j.quascirev.2009.11.015; Flojgaard C, 2009, J BIOGEOGR, V36, P1152, DOI 10.1111/j.1365-2699.2009.02089.x; Forcino FL, 2012, PALAEOGEOGR PALAEOCL, V365, P48, DOI 10.1016/j.palaeo.2012.09.011; Genty D, 2003, NATURE, V421, P833, DOI 10.1038/nature01391; Genty D, 2010, QUATERNARY SCI REV, V29, P2799, DOI 10.1016/j.quascirev.2010.06.035; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Graham RW, 1996, SCIENCE, V272, P1601; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harle Edouard, 1906, Bulletin de la Societe Geologique Ser 4, V6; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Fernandez MH, 2015, PALAEOBIO PALAEOENV, V95, P387, DOI 10.1007/s12549-015-0196-x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jackson ST, 2015, P NATL ACAD SCI USA, V112, P4915, DOI 10.1073/pnas.1403664111; Jeannet M, 2009, GROTTE TAILLIS COTEA, P105; Jeannet M, 2009, B PREHISTOIRE SUD OU, V17, P179; Jeannet M, 2001, REGION POITOU CHAREN, P304; Jeannet M, 2009, REV ARCHEOLOGIE LEST, V58, P5; Jeannet M., 2010, PREHISTORIES MEDITER, V1, P11; Kowalski K., 2001, PLEISTOCENE RODENTS; Kowalski Kazimierz, 1995, Acta Zoologica Cracoviensia, V38, P85; Langlais M, 2012, QUATERN INT, V272, P138, DOI 10.1016/j.quaint.2012.02.053; Le Louarn H., 2003, RONGEURS FRANCE FAUN; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Magri D, 2010, QUATERN INT, V219, P145, DOI 10.1016/j.quaint.2009.10.032; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Lopez-Garcia JM, 2015, PALAEOGEOGR PALAEOCL, V435, P244, DOI 10.1016/j.palaeo.2015.06.022; Lopez-Garcia JM, 2013, GEOLOGY, V41, P267, DOI 10.1130/G33744.1; Lopez-Garcia JM, 2010, PALAEOGEOGR PALAEOCL, V292, P453, DOI 10.1016/j.palaeo.2010.04.006; Markova AK, 2010, QUATERN INT, V212, P149, DOI 10.1016/j.quaint.2009.02.010; Marquet J-C, 1973, CAHIERS CLAISE S2; Marquet J-C, 2005, GROTTE BOIS RAGOT GO, P373; Marquet JC, 1989, THESIS U DIJON; Mistrot V, 2001, THESIS U PARIS 1 PAN; Montuire S, 1997, BOREAS, V26, P355; O'Neill R. V., 1986, HIERARCHICAL CONCEPT; Oppliger J, 2008, THESIS U GENEVE FREN; PAILHAUGUE N, 2003, GROTTE VACHE ARIEGE, P73; PERRY DA, 1990, CONSERV BIOL, V4, P266, DOI 10.1111/j.1523-1739.1990.tb00288.x; Prevost MC, 1842, ANN SCI GEOL, P3; Prost S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010447; Rasmussen SO, QUAT SCI REV, V106, P14; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rofes J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14219; Royer A, 2013, THESIS ECOLE PRATIQU; Royer A, 2014, QUATERNARY RES, V82, P420, DOI 10.1016/j.yqres.2014.06.006; Royer A, 2013, QUATERNARY RES, V80, P113, DOI 10.1016/j.yqres.2013.03.007; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Saint Girons, 1973, MAMMIFERES FRANCE B; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Schmitt T, 2008, MOL ECOL, V17, P2194, DOI 10.1111/j.1365-294X.2007.03687.x; SIMARD S, 1968, Naturaliste Canadien (Quebec), V95, P1435; Sitzia L, 2014, THESIS U BORDEAUX 1; Sokal R.R., 2012, BIOMETRY; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Sommer RS, 2009, MAMMAL REV, V39, P1, DOI 10.1111/j.1365-2907.2008.00137.x; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Talamo S, 2012, J ARCHAEOL SCI, V39, P175, DOI 10.1016/j.jas.2011.09.019; Tougard C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003532; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; Van Kolfschoten Thijs, 1995, Acta Zoologica Cracoviensia, V38, P73; Villa P, 2010, J ARCHAEOL SCI, V37, P919, DOI 10.1016/j.jas.2009.11.025; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wohlfarth B, 2008, GEOLOGY, V36, P407, DOI 10.1130/G24600A.1; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; [No title captured]	123	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145600	10.1371/journal.pone.0145600	http://dx.doi.org/10.1371/journal.pone.0145600			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789523	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100011
J	Wessel, J; Gupta, J; de Groot, M				Wessel, Jennifer; Gupta, Jyoti; de Groot, Mary			Factors Motivating Individuals to Consider Genetic Testing for Type 2 Diabetes Risk Prediction	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES	The purpose of this study was to identify attitudes and perceptions of willingness to participate in genetic testing for type 2 diabetes (T2D) risk prediction in the general population. Adults (n = 598) were surveyed on attitudes about utilizing genetic testing to predict future risk of T2D. Participants were recruited from public libraries (53%), online registry (37%) and a safety net hospital emergency department (10%). Respondents were 37+/-11 years old, primarily White (54%), female (69%), college educated (46%), with an annual income >=$25,000 (56%). Half of participants were interested in genetic testing for T2D (52%) and 81% agreed/strongly agreed genetic testing should be available to the public. Only 57% of individuals knew T2D is preventable. A multivariate model to predict interest in genetic testing was adjusted for age, gender, recruitment location and BMI; significant predictors were motivation (high perceived personal risk of T2D [OR = 4.38 (1.76, 10.9)]; family history [OR = 2.56 (1.46, 4.48)]; desire to know risk prior to disease onset [OR = 3.25 (1.94, 5.42)]; and knowing T2D is preventable [OR = 2.11 (1.24, 3.60)], intention (if the cost is free [OR = 10.2 (4.27, 24.6)]; and learning T2D is preventable [OR = 5.18 (1.95, 13.7)]) and trust of genetic testing results [OR = 0.03 (0.003, 0.30)]. Individuals are interested in genetic testing for T2D risk which offers unique information that is personalized. Financial accessibility, validity of the test and availability of diabetes prevention programs were identified as predictors of interest in T2D testing.	[Wessel, Jennifer; Gupta, Jyoti] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Wessel, Jennifer; de Groot, Mary] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Wessel, J (corresponding author), Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA.; Wessel, J (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	wesselj@iu.edu		de Groot, Mary/0000-0003-4021-8824; Wessel, Jennifer/0000-0002-7031-0085	Center for Urban Health - Indiana University-Purdue University Indianapolis (IUPUI) Signature Center Initiative; Research Support Funds Grant; Indiana Clinical Translational Sciences Institute [TR000006]; National Institutes of Health [R18DK092765]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000006, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R18DK092765] Funding Source: NIH RePORTER	Center for Urban Health - Indiana University-Purdue University Indianapolis (IUPUI) Signature Center Initiative; Research Support Funds Grant; Indiana Clinical Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by the Center for Urban Health, supported by Indiana University-Purdue University Indianapolis (IUPUI) Signature Center Initiative (http://research.iupui.edu/centers/signaturecenters.html) (JW) and Research Support Funds Grant (http://research.iupui.edu/funding) (JW); the Indiana Clinical Translational Sciences Institute (TR000006) (http://www.ncats.nih.gov/ctsa) (JW) and the National Institutes of Health (R18DK092765) (http://www.niddk.nih.gov/Pages/default.aspx) (MdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates Mekeshia D, 2011, J Natl Black Nurses Assoc, V22, P1; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Botoseneanu A, 2011, HEALTH EDUC BEHAV, V38, P617, DOI 10.1177/1090198110389711; Calsbeek Hiske, 2007, J Genet Couns, V16, P493, DOI 10.1007/s10897-006-9085-9; DeVellis R. F., 2012, SCALE DEV THEORY APP; Furr LA, 1999, GENET TEST, V3, P193, DOI 10.1089/gte.1999.3.193; Glanz K., 2008, HLTH BEHAV HLTH ED T; Grant RW, 2009, DIABETOLOGIA, V52, P2299, DOI 10.1007/s00125-009-1512-7; Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884; Henderson G, 2008, GENET MED, V10, P193, DOI 10.1097/GIM.0b013e318164e4f5; Kaphingst KA, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1587; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Liljestrom B, 2005, DIABETOLOGIA, V48, P242, DOI 10.1007/s00125-004-1629-7; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Markowitz SM, 2011, DIABETES CARE, V34, P568, DOI 10.2337/dc10-1960; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McBride CM, 2009, GENET MED, V11, P582, DOI 10.1097/GIM.0b013e3181b22c3a; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Molster C, 2009, PUBLIC HEALTH GENOMI, V12, P84, DOI 10.1159/000164684; Morren M, 2007, PATIENT EDUC COUNS, V65, P197, DOI 10.1016/j.pec.2006.07.005; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Turner-Bowker DM, 2002, HLTH SURVEY SF BIBLI; Vassy JL, 2014, DIABETES, V63, P2172, DOI 10.2337/db13-1663; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147071	10.1371/journal.pone.0147071	http://dx.doi.org/10.1371/journal.pone.0147071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789839	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100056
J	Xiao, J; Shen, C; Chu, MJ; Gao, YX; Xu, GF; Huang, JP; Xu, QQ; Cai, H				Xiao, Jing; Shen, Chong; Chu, Min J.; Gao, Yue X.; Xu, Guang F.; Huang, Jian P.; Xu, Qiong Q.; Cai, Hui			Physical Activity and Sedentary Behavior Associated with Components of Metabolic Syndrome among People in Rural China	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARDIORESPIRATORY FITNESS; AEROBIC FITNESS; LIFE-STYLE; TIME; OBESITY; RISK; 2-H; CONSUMPTION; POPULATION	Background Metabolic syndrome is prevalent worldwide and its prevalence is related to physical activity, race, and lifestyle. Little data is available for people living in rural areas of China. In this study we examined associations of physical activity and sedentary behaviors with metabolic syndrome components among people in rural China. Methods The Nantong Metabolic Syndrome Study recruited 13,505 female and 6,997 male participants between 2007 and 2008. Data of socio-demographic characteristics and lifestyle were collected. The associations of physical activity and sedentary behaviors with metabolic syndrome components were analyzed. Results Prevalence of metabolic syndrome was 21.6%. It was significantly lower in men than in women. Low risks of metabolic syndrome were observed in those who did less sitting and engaged in more vigorous physical activity. The highest tertile of vigorous physical activity was associated with 15-40% decreased odds of metabolic syndrome and all of its components, except for low high-density lipoprotein cholesterol in men. Women with the highest tertile of moderate physical activity had 15-30% lower odds of central obesity, high glucose, and high triglycerides compared with those in the lowest tertile. Sitting time >42 hours per week had a 4%-12% attributable risk of metabolic syndrome, central obesity, and high triglycerides in both genders, and abnormal glucose and diastolic blood pressure in women. Sleeping for more than 8 hours per day was associated with risk of high serum glucose and lipids. Conclusions Our data suggested that physical activity has a preventive effect against metabolic syndrome and all its abnormal components, and that longer sitting time and sleep duration are associated with an increased risk of metabolic syndrome components, including central obesity and high triglycerides, glucose, and diastolic blood pressure. This study could provide information for future investigation into these associations. Also, recommendations are developed to reduce prevalence of metabolic syndrome and its components in rural Chinese populations.	[Xiao, Jing; Chu, Min J.; Gao, Yue X.; Xu, Guang F.; Xu, Qiong Q.; Cai, Hui] Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Nantong 226019, Jiangsu, Peoples R China; [Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 210029, Jiangsu, Peoples R China; [Huang, Jian P.] Ctr Dis Control & Prevent Nantong, Dept Chron Dis & Prevent, Nantong 226007, Jiangsu, Peoples R China	Nantong University; Nanjing Medical University	Cai, H (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Nantong 226019, Jiangsu, Peoples R China.	huicai2012@yahoo.com			National Natural Science Foundation of China [31000539]; Ministry of Science and Technology of China [2006 BA1 01A 01]; Health Department of Preventive Medicine of Jiangsu Province [Y2013031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Health Department of Preventive Medicine of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (31000539), the Ministry of Science and Technology of China (2006 BA1 01A 01), and the Health Department of Preventive Medicine of Jiangsu Province (Y2013031). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Committee IR, GUID DAT PROCSS AN I; Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Esteghamati A, 2009, METABOLISM, V58, P1347, DOI 10.1016/j.metabol.2009.04.019; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Ghosh A, 2014, AM J HUM BIOL, V26, P427, DOI 10.1002/ajhb.22536; Hamasaki H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/526201; Hastert TA, 2015, PREV MED, V70, P39, DOI 10.1016/j.ypmed.2014.11.006; He D, 2014, ENDOCRINE, V46, P231, DOI 10.1007/s12020-013-0110-0; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2006, DIABETES CARE, V29, P2598, DOI 10.2337/dc06-0313; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Huffman KM, 2014, METABOLISM, V63, P554, DOI 10.1016/j.metabol.2014.01.002; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Li CL, 2007, PUBLIC HEALTH, V121, P83, DOI 10.1016/j.puhe.2006.08.004; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Mkhonto Seth S, 2012, BMC Res Notes, V5, P118, DOI 10.1186/1756-0500-5-118; Mohan V, 2005, DIABETIC MED, V22, P1206, DOI 10.1111/j.1464-5491.2005.01616.x; Parsons TJ, 2008, EUR J CLIN NUTR, V62, P1355, DOI 10.1038/sj.ejcn.1602884; Perez LG, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130032; Pinheiro AR, 2007, NUTR METAB CARDIOVAS, V17, P365, DOI 10.1016/j.numecd.2006.01.009; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rampal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046365; Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005; Shuval K, 2014, MAYO CLIN PROC, V89, P1052, DOI 10.1016/j.mayocp.2014.04.026; Simmons RK, 2008, DIABETOLOGIA, V51, P787, DOI 10.1007/s00125-008-0949-4; Wang X, 2015, CHINESE MED J-PEKING, V128, P1989, DOI 10.4103/0366-6999.161337; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xiao J, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0007-4; Yoon JH, 2013, SALUD PUBLICA MEXICO, V55, P492; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147062	10.1371/journal.pone.0147062	http://dx.doi.org/10.1371/journal.pone.0147062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789723	Green Published, gold			2022-12-27	WOS:000368529100055
J	Chang, HY; Chen, CT; Lih, TM; Lynn, KS; Juo, CG; Hsu, WL; Sung, TY				Chang, Hui-Yin; Chen, Ching-Tai; Lih, T. Mamie; Lynn, Ke-Shiuan; Juo, Chiun-Gung; Hsu, Wen-Lian; Sung, Ting-Yi			iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination	PLOS ONE			English	Article							MASS-SPECTROMETRY DATA; OPEN-SOURCE SOFTWARE; LC-MS; IDENTIFICATION; METABOLITES; ANNOTATION; EXTRACTION; PROTEOMICS; ALIGNMENT; PROFILE	Efficient and accurate quantitation of metabolites from LC-MS data has become an important topic. Here we present an automated tool, called iMet-Q (intelligent Metabolomic Quantitation), for label-free metabolomics quantitation from high-throughput MS1 data. By performing peak detection and peak alignment, iMet-Q provides a summary of quantitation results and reports ion abundance at both replicate level and sample level. Furthermore, it gives the charge states and isotope ratios of detected metabolite peaks to facilitate metabolite identification. An in-house standard mixture and a public Arabidopsis metabolome data set were analyzed by iMet-Q. Three public quantitation tools, including XCMS, MetAlign, and MZmine 2, were used for performance comparison. From the mixture data set, seven standard metabolites were detected by the four quantitation tools, for which iMet-Q had a smaller quantitation error of 12% in both profile and centroid data sets. Our tool also correctly determined the charge states of seven standard metabolites. By searching the mass values for those standard metabolites against Human Metabolome Database, we obtained a total of 183 metabolite candidates. With the isotope ratios calculated by iMet-Q, 49%(89 out of 183) metabolite candidates were filtered out. From the public Arabidopsis data set reported with two internal standards and 167 elucidated metabolites, iMet-Q detected all of the peaks corresponding to the internal standards and 167 metabolites. Meanwhile, our tool had small abundance variation (<= 0.19) when quantifying the two internal standards and had higher abundance correlation (>= 0.92) when quantifying the 167 metabolites. iMet-Q provides user-friendly interfaces and is publicly available for download at http://ms.iis.sinica.edu.tw/comics/Software_iMet-Q.html.	[Chang, Hui-Yin; Lih, T. Mamie] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei 11529, Taiwan; [Chang, Hui-Yin; Lih, T. Mamie] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 11221, Taiwan; [Chang, Hui-Yin; Chen, Ching-Tai; Lih, T. Mamie; Hsu, Wen-Lian; Sung, Ting-Yi] Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan; [Lynn, Ke-Shiuan] Fu Jen Catholic Univ, Dept Math, New Taipei 24205, Taiwan; [Juo, Chiun-Gung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Fu Jen Catholic University; Chang Gung University	Sung, TY (corresponding author), Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan.	tsung@iis.sinica.edu.tw	Sung, Ting-Yi/AAQ-5413-2021; Hsu, Wen-Lian/ABB-2851-2020	Sung, Ting-Yi/0000-0002-6028-0409; Hsu, Wen-Lian/0000-0001-7061-3513	Ministry of Science and Technology of Taiwan [MOST103-2221-E-001-037]; Taiwan International Graduate Program; Academia Sinica	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan International Graduate Program; Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Ministry of Science and Technology of Taiwan (MOST103-2221-E-001-037), and Taiwan International Graduate Program.; We thank the support from Academia Sinica, Ministry of Science and Technology of Taiwan (MOST 103-2221-E-001-037), and Taiwan International Graduate Program. We also thank Wai-Kok Choong and Thejkiran Pitti for fruitful discussion on the manuscript.	Aberg KM, 2008, J CHROMATOGR A, V1192, P139, DOI 10.1016/j.chroma.2008.03.033; Baker M, 2011, NAT METHODS, V8, P117, DOI 10.1038/nmeth0211-117; Bedair M, 2008, TRAC-TREND ANAL CHEM, V27, P238, DOI 10.1016/j.trac.2008.01.006; Blekherman G, 2011, METABOLOMICS, V7, P329, DOI 10.1007/s11306-010-0270-3; Cleveland W.S., 1981, T AM STAT, V35, P54, DOI DOI 10.2307/2683591; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Katajamaa M, 2007, J CHROMATOGR A, V1158, P318, DOI 10.1016/j.chroma.2007.04.021; Keller BO, 2008, ANAL CHIM ACTA, V627, P71, DOI 10.1016/j.aca.2008.04.043; Kenar E, 2014, MOL CELL PROTEOMICS, V13, P348, DOI 10.1074/mcp.M113.031278; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lynn KS, 2015, ANAL CHEM, V87, P2143, DOI 10.1021/ac503325c; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Nagao T, 2014, ANAL CHIM ACTA, V813, P70, DOI 10.1016/j.aca.2014.01.032; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sugimoto M, 2012, CURR BIOINFORM, V7, P96, DOI 10.2174/157489312799304431; Sugimoto M, 2010, METABOLOMICS, V6, P27, DOI 10.1007/s11306-009-0175-1; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Tolstikov VV, 2003, ANAL CHEM, V75, P6737, DOI 10.1021/ac034716z; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Werner E, 2008, J CHROMATOGR B, V871, P143, DOI 10.1016/j.jchromb.2008.07.004; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	37	14	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146112	10.1371/journal.pone.0146112	http://dx.doi.org/10.1371/journal.pone.0146112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784691	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400024
J	Minatani, N; Waraya, M; Yamashita, K; Kikuchi, M; Ushiku, H; Kojo, K; Ema, A; Nishimiya, H; Kosaka, Y; Katoh, H; Sengoku, N; Tanino, H; Sidransky, D; Watanabe, M				Minatani, Naoko; Waraya, Mina; Yamashita, Keishi; Kikuchi, Mariko; Ushiku, Hideki; Kojo, Ken; Ema, Akira; Nishimiya, Hiroshi; Kosaka, Yoshimasa; Katoh, Hiroshi; Sengoku, Norihiko; Tanino, Hirokazu; Sidransky, David; Watanabe, Masahiko			Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer	PLOS ONE			English	Article							CYSTEINE DIOXYGENASE; METHYLATION; SYSTEM; CELLS; ANTIPORTER; SUBTYPES; GROWTH; TUMORS	Using pharmacological unmasking microarray, we identified promoter DNA methylation of cysteine dioxygenase 1 (CDO1) gene in human cancer. In this study, we assessed the clinicopathological significance of CDO1 methylation in primary breast cancer (BC) with no prior chemotherapy. The CDO1 DNA methylation was quantified by TaqMan methylation specific PCR (Q-MSP) in 7 BC cell lines and 172 primary BC patients with no prior chemotherapy. Promoter DNA of the CDO1 gene was hypermethylated in 6 BC cell lines except SK-BR3, and CDO1 gene expression was all silenced at mRNA level in the 7 BC cell lines. Quantification of CDO1 methylation was developed using Q-MSP, and assessed in primary BC. Among the clinicopathologic factors, CDO1 methylation level was not statistically significantly associated with any prognostic factors. The log-rank plot analysis elucidated that the higher methylation the tumors harbored, the poorer prognosis the patients exhibited. Using the median value of 58.0 as a cut-off one, disease specific survival in BC patients with CDO1 hypermethylation showed significantly poorer prognosis than those with hypomethylation (p = 0.004). Multivariate Cox proportional hazards model identified that CDO1 hypermethylation was prognostic factor as well as Ki-67 and hormone receptor status. The most intriguingly, CDO1 hypermethylation was of robust prognostic relevance in triple negative BC (p = 0.007). Promoter DNA methylation of CDO1 gene was robust prognostic indicator in primary BC patients with no prior chemotherapy. Prognostic relevance of the CDO1 promoter DNA methylation is worthy of being paid attention in triple negative BC cancer.	[Minatani, Naoko; Waraya, Mina; Yamashita, Keishi; Kikuchi, Mariko; Ushiku, Hideki; Kojo, Ken; Ema, Akira; Kosaka, Yoshimasa; Katoh, Hiroshi; Sengoku, Norihiko; Tanino, Hirokazu; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Sidransky, David] Johns Hopkins Univ, Dept Otolaryngol, Baltimore, MD USA; [Nishimiya, Hiroshi] Yamato Municipal Hosp, Dept Surg, Yamato, Kanagawa, Japan	Kitasato University; Johns Hopkins University	Watanabe, M (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan.	gekaw@med.kitasato-u.ac.jp	Tanino, Hirokazu/AAN-4455-2021					Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Dawson S J, 2009, Eur J Cancer, V45 Suppl 1, P27, DOI 10.1016/S0959-8049(09)70013-9; Dietrich D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-247; Friedrich K, 2008, CELL ONCOL, V30, P39; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joseph CA, 2007, CHEM COMMUN, P3338, DOI 10.1039/b702158e; Kataoka A, 2001, CLIN CANCER RES, V7, P2815; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Nishimiya H, 2014, ANTICANCER RES, V34, P259; Oien DB, 2007, BIOCHEM BIOPH RES CO, V352, P556, DOI 10.1016/j.bbrc.2006.11.063; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Sotgia F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2892; Stefansson OA, 2014, MOL ONCOL; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Ueo H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12080; Wang F, 2014, BREAST CANCER RES TR, V147, P203, DOI 10.1007/s10549-014-3068-6; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546	33	22	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144862	10.1371/journal.pone.0144862	http://dx.doi.org/10.1371/journal.pone.0144862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785325	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400008
J	Sallaberry, A; Fu, YC; Ho, HC; Ma, KL				Sallaberry, Arnaud; Fu, Yang-chih; Ho, Hwai-Chung; Ma, Kwan-Liu			Contact Trees: Network Visualization beyond Nodes and Edges	PLOS ONE			English	Article							SCALE GRAPH VISUALIZATION; EXPLORATION	Node-Link diagrams make it possible to take a quick glance at how nodes (or actors) in a network are connected by edges (or ties). A conventional network diagram of a "contact tree" maps out a root and branches that represent the structure of nodes and edges, often without further specifying leaves or fruits that would have grown from small branches. By furnishing such a network structure with leaves and fruits, we reveal details about "contacts" in our ContactTrees upon which ties and relationships are constructed. Our elegant design employs a bottom-up approach that resembles a recent attempt to understand subjective well-being by means of a series of emotions. Such a bottom-up approach to social-network studies decomposes each tie into a series of interactions or contacts, which can help deepen our understanding of the complexity embedded in a network structure. Unlike previous network visualizations, ContactTrees highlight how relationships form and change based upon interactions among actors, as well as how relationships and networks vary by contact attributes. Based on a botanical tree metaphor, the design is easy to construct and the resulting tree-like visualization can display many properties at both tie and contact levels, thus recapturing a key ingredient missing from conventional techniques of network visualization. We demonstrate ContactTrees using data sets consisting of up to three waves of 3-month contact diaries over the 2004-2012 period, and discuss how this design can be applied to other types of datasets.	[Sallaberry, Arnaud] Univ Montpellier 3, Montpellier Lab Informat Robot & Microelect, F-34032 Montpellier, France; [Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Ho, Hwai-Chung] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Ma, Kwan-Liu] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Universite de Montpellier; Universite Paul-Valery; Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of California System; University of California Davis	Fu, YC (corresponding author), Acad Sinica, Inst Sociol, Taipei 115, Taiwan.	fuyc@sinica.edu.tw	Sallaberry, Arnaud/AAK-2830-2021	Sallaberry, Arnaud/0000-0001-7068-176X	Ministry of Science and Technology, Taiwan [MOST 103-2410-H-001-068-MY3]; Academia Sinica, Taiwan [AS-100-TP2-C01]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan (MOST 103-2410-H-001-068-MY3) (www.most.gov.tw, YCF) and Academia Sinica, Taiwan (AS-100-TP2-C01) (www.sinica.edu.tw, YCF, HCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello J, 2006, IEEE T VIS COMPUT GR, V12, P669, DOI 10.1109/TVCG.2006.120; Andrews K, 1998, P IEEE S INF VIS INF, P9; [Anonymous], GRAPH VIS SOFTW; Archambault D, 2007, IEEE T VIS COMPUT GR, V13, P305, DOI 10.1109/TVCG.2007.46; Auber D, 2003, MATH VISUALIZATION S; Auber D, 2013, IEEE T VIS COMPUT GR, V19, P1820, DOI 10.1109/TVCG.2013.91; Battista G. D., 1999, GRAPH DRAWING ALGORI; Baur M, 2001, GRAPH DRAWING, P463; Bezerianos A, 2010, IEEE T VIS COMPUT GR, V16, P1073, DOI 10.1109/TVCG.2010.159; Borgatti SP, UCINET SOFTWARE SOCI; Chlan EB, 2004, P JOINT EUR IEEE VGT, P231; David B, 2016, SOC NETWORKS, V44, P253, DOI 10.1016/j.socnet.2015.10.001; Fisher D, 2005, IEEE INTERNET COMPUT, V9, P20, DOI 10.1109/MIC.2005.114; Fisher Danyel, 2004, P SIGCHI C HUM FACT, P551, DOI [10.1145/985692.985762, DOI 10.1145/985692.985762]; Freeman L. C., 2000, J SOCIAL STRUCTURE, V1, P4; Fu YC, 2007, FIELD METHOD, V19, P194, DOI 10.1177/1525822X06298590; Fu YC, 2013, SOC NETWORKS, V35, P279, DOI 10.1016/j.socnet.2013.02.004; Gomez JA, 2012, HCIL201204 U MAR; Heer J, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P33; Henry N, 2007, IEEE T VIS COMPUT GR, V13, P1302, DOI 10.1109/TVCG.2007.70582; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Holten D, 2009, COMPUT GRAPH FORUM, V28, P983, DOI 10.1111/j.1467-8659.2009.01450.x; HONDA H, 1971, J THEOR BIOL, V31, P331, DOI 10.1016/0022-5193(71)90191-3; Jurgensmann S, 2010, IEEE VISWEEK 2010; Kadushin C., 2012, UNDERSTANDING SOCIAL; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kaufmann M., 2001, LNCS, V2025; Kleiberg E, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P87, DOI 10.1109/INFVIS.2001.963285; KRUSKAL JB, 1983, AM STAT, V37, P162, DOI 10.2307/2685881; Lee B, 2006, IEEE T VIS COMPUT GR, V12, P1414, DOI 10.1109/TVCG.2006.106; Lin N., 2014, SOCIAL CAPITAL ITS I, P3; Lonkila M, 1999, SOCIAL NETWORKS POST; Ma KL, 2013, COMPUTER, V46, P39, DOI 10.1109/MC.2013.242; MacLean D., 2011, P 16 INT C INT US IN, P83; McGuffin MJ, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P17; Muelder C, 2008, IEEE T VIS COMPUT GR, V14, P1301, DOI 10.1109/TVCG.2008.158; Palubicki W, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531364; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Sallaberry Arnaud, 2013, Graph Drawing. 20th International Symposium, GD 2012. Revised Selected Papers, P487, DOI 10.1007/978-3-642-36763-2_43; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shneiderman B, 2009, TREEMAPS SPACE CONST; Stasko J, 2000, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2000, P57, DOI 10.1109/INFVIS.2000.885091; Stefaner M, 2010, NOTABILIA VISUALIZIN; Tuttle C, 2010, IEEE T VIS COMPUT GR, V16, P1063, DOI 10.1109/TVCG.2010.185; Ulam S, 1962, P S APPL MATH, V14, P215, DOI DOI 10.1090/PSAPM/014/9947; van Ham F, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P199, DOI 10.1109/INFVIS.2004.43; van Ham F, 2009, IEEE T VIS COMPUT GR, V15, P953, DOI 10.1109/TVCG.2009.108; von Landesberger T, 2011, COMPUT GRAPH FORUM, V30, P1719, DOI 10.1111/j.1467-8659.2011.01898.x; Wang SM, 2015, IEEE COMPUT GRAPH, V35, P82, DOI 10.1109/MCG.2015.74; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts D. J., 2004, 6 DEGREES SCI CONNEC; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Whittaker S., 2004, ACM T COMPUT-HUM INT, V11, P445, DOI DOI 10.1145/1035575.1035580; Xiong R., 1999, 99 UIST. Proceedings of the 12th Annual ACM Symposium on User Interface Software and Technology, P37, DOI 10.1145/320719.322581; Yee KP, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P43	55	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146368	10.1371/journal.pone.0146368	http://dx.doi.org/10.1371/journal.pone.0146368			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784350	gold, Green Published, Green Submitted			2022-12-27	WOS:000368528400033
J	Basu, A; Cajigas-Du Ross, CK; Rios-Colon, L; Mediavilla-Varela, M; Daniels-Wells, TR; Leoh, LS; Rojas, H; Banerjee, H; Martinez, SR; Acevedo-Martinez, S; Casiano, CA				Basu, Anamika; Cajigas-Du Ross, Christina K.; Rios-Colon, Leslimar; Mediavilla-Varela, Melanie; Daniels-Wells, Tracy R.; Leoh, Lai Sum; Rojas, Heather; Banerjee, Hiya; Martinez, Shannalee R.; Acevedo-Martinez, Stephanny; Casiano, Carlos A.			LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEOMIC ANALYSIS; HEAT-SHOCK; TRANSCRIPTIONAL REGULATION; LENTIVIRAL INTEGRATION; LYSOSOMAL PATHWAYS; PROTEIN EXPRESSION; PROGNOSTIC MARKER; CELL-DEATH; ERP57	Prostate cancer (PCa) mortality is driven by highly aggressive tumors characterized by metastasis and resistance to therapy, and this aggressiveness is mediated by numerous factors, including activation of stress survival pathways in the pro-inflammatory tumor micro-environment. LEDGF/p75, also known as the DFS70 autoantigen, is a stress transcription co-activator implicated in cancer, HIV-AIDS, and autoimmunity. This protein is targeted by autoantibodies in certain subsets of patients with PCa and inflammatory conditions, as well as in some apparently healthy individuals. LEDGF/p75 is overexpressed in PCa and other cancers, and promotes resistance to chemotherapy-induced cell death via the transactivation of survival proteins. We report in this study that overexpression of LEDGF/p75 in PCa cells attenuates oxidative stress-induced necrosis but not staurosporine-induced apoptosis. This finding was consistent with the observation that while LEDGF/p75 was robustly cleaved in apoptotic cells into a p65 fragment that lacks stress survival activity, it remained relatively intact in necrotic cells. Overexpression of LEDGF/p75 in PCa cells led to the upregulation of transcript and protein levels of the thiol-oxidoreductase ERp57 (also known as GRP58 and PDIA3), whereas its depletion led to ERp57 transcript downregulation. Chromatin immunoprecipitation and transcription reporter assays showed LEDGF/p75 binding to and transactivating the ERp57 promoter, respectively. Immunohistochemical analysis revealed significantly elevated co-expression of these two proteins in clinical prostate tumor tissues. Our results suggest that LEDGF/p75 is not an inhibitor of apoptosis but rather an antagonist of oxidative stress-induced necrosis, and that its overexpression in PCa leads to ERp57 upregulation. These findings are of significance in clarifying the role of the LEDGF/p75 stress survival pathway in PCa.	[Basu, Anamika; Cajigas-Du Ross, Christina K.; Rios-Colon, Leslimar; Mediavilla-Varela, Melanie; Daniels-Wells, Tracy R.; Leoh, Lai Sum; Martinez, Shannalee R.; Acevedo-Martinez, Stephanny; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Rojas, Heather] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA; [Banerjee, Hiya] Novartis Pharmaceut Oncol, E Hanover, NJ 08807 USA; [Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92350 USA; [Daniels-Wells, Tracy R.; Leoh, Lai Sum] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA; [Mediavilla-Varela, Melanie] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Acevedo-Martinez, Stephanny] Univ Puerto Rico, Hosp Dr Federico Trilla, Dept Emergency Med, Carolina, PR 00924 USA	Loma Linda University; Loma Linda University; Novartis; Loma Linda University; University of California System; University of California Los Angeles; H Lee Moffitt Cancer Center & Research Institute; University of Puerto Rico; University of Puerto Rico at Carolina	Basu, A (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	abasu@llu.edu		Daniels-Wells, Tracy/0000-0002-8277-9702; Martinez, Shannalee/0000-0002-9682-0227	NIH [5R25GM060507, 5P20MD001632, 5P20MD006988]; Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine; medical research training internship [5P20MD006988]; NIH; Novartis;  [R25GM060507]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine; medical research training internship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); ; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grants 5R25GM060507, 5P20MD001632 and 5P20MD006988, and by Loma Linda University School of Medicine Center for Health Disparities and Molecular Medicine. CKCD, MMV, LRC, and SRM were supported by graduate training fellowships under grant R25GM060507. SAM was supported by a medical research training internship under grant 5P20MD006988. HB is employed by a commercial company-Novartis Pharmaceutical Oncology. The funders (NIH, Novartis) provided support in the form of salaries for authors (CAC, CKCD, MMV, LRC, SRM, SAM, HB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albany C, 2014, ASIAN J ANDROL, V16, P359, DOI 10.4103/1008-682X.126400; Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Basu A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00116; Basu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030132; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bhargavan B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.57; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Cesen MH, 2012, EXP CELL RES, V318, P1245, DOI 10.1016/j.yexcr.2012.03.005; Chay D, 2010, INT J ONCOL, V37, P399, DOI 10.3892/ijo_00000688; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Choe MH, 2015, ONCOTARGET, V6, P2654, DOI 10.18632/oncotarget.3042; Chowdhury SKR, 2007, FREE RADICAL RES, V41, P1116, DOI 10.1080/10715760701579314; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Cicchillitti L, 2009, J PROTEOME RES, V8, P1902, DOI 10.1021/pr800856b; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Cohen B, 2009, NEOPLASIA, V11, P921, DOI 10.1593/neo.09636; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Hanus J, 2015, INVEST OPHTH VIS SCI, V56, P5048, DOI 10.1167/iovs.15-16401; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Kalinichenko SV, 2008, LUNG CANCER, V62, P173, DOI 10.1016/j.lungcan.2008.03.022; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Leitz J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003957; Leoh LS, 2012, MOL CANCER RES, V10, P378, DOI 10.1158/1541-7786.MCR-11-0314; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Liao CJ, 2011, CANCER SCI, V102, P2255, DOI 10.1111/j.1349-7006.2011.02102.x; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Long AC, 2004, EXP BIOL MED, V229, P1072, DOI 10.1177/153537020422901012; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Menoret A, 2014, MOL CARCINOGEN, V53, pE11, DOI 10.1002/mc.21986; Mereau H, 2013, LEUKEMIA, V27, P1245, DOI 10.1038/leu.2013.10; Ochs RL, 2015, CLIN EXP ME IN PRESS; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Pacheco FJ, 2014, INFLAMM RES, V63, P859, DOI 10.1007/s00011-014-0760-2; Pacheco FJ, 2005, ARTHRITIS RHEUM-US, V52, P2133, DOI 10.1002/art.21147; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Pelech S, METHODS MOL BIOL, V218, P99; Pressinotti NC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-130; Santana-Codina N, 2013, MOL CELL PROTEOMICS, V12, P2111, DOI 10.1074/mcp.M112.022772; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sardao VA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-11; Seliger B, 2010, CANCER IMMUNOL IMMUN, V59, P529, DOI 10.1007/s00262-009-0769-5; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shin JH, 2008, NEUROSCI LETT, V435, P131, DOI 10.1016/j.neulet.2008.02.029; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Shiota M, 2011, FREE RADICAL BIO MED, V51, P1320, DOI 10.1016/j.freeradbiomed.2011.07.011; Shishkin SS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1415, DOI 10.1134/S000629791313004X; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Ummanni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016833; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Wu XW, 2001, ARTHRITIS RHEUM, V44, P2642, DOI 10.1002/1529-0131(200111)44:11<2642::AID-ART444>3.0.CO;2-8; Xu X, 2014, MOL CARCINOGEN, V53, P300, DOI 10.1002/mc.21977; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	73	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146549	10.1371/journal.pone.0146549	http://dx.doi.org/10.1371/journal.pone.0146549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771192	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300025
J	Kaur, S; Dhugga, KS; Gill, K; Singh, J				Kaur, Simerjeet; Dhugga, Kanwarpal S.; Gill, Kulvinder; Singh, Jaswinder			Novel Structural and Functional Motifs in cellulose synthase (CesA) Genes of Bread Wheat (Triticum aestivum, L.)	PLOS ONE			English	Article							EXPRESSION ANALYSIS; WALL; COMPLEXES; GROWTH; MAIZE; ORGANIZATION; BIOSYNTHESIS; SUPERFAMILY; EUCALYPTUS; SEQUENCE	Cellulose is the primary determinant of mechanical strength in plant tissues. Late-season lodging is inversely related to the amount of cellulose in a unit length of the stem. Wheat is the most widely grown of all the crops globally, yet information on its CesA gene family is limited. We have identified 22 CesA genes from bread wheat, which include homoeologs from each of the three genomes, and named them as TaCesAXA, TaCesAXB or TaCesAXD, where X denotes the gene number and the last suffix stands for the respective genome. Sequence analyses of the CESA proteins from wheat and their orthologs from barley, maize, rice, and several dicot species (Arabidopsis, beet, cotton, poplar, potato, rose gum and soybean) revealed motifs unique to monocots (Poales) or dicots. Novel structural motifs CQIC and SVICEXWFA were identified, which distinguished the CESAs involved in the formation of primary and secondary cell wall (PCW and SCW) in all the species. We also identified several new motifs specific to monocots or dicots. The conserved motifs identified in this study possibly play functional roles specific to PCW or SCW formation. The new insights from this study advance our knowledge about the structure, function and evolution of the CesA family in plants in general and wheat in particular. This information will be useful in improving culm strength to reduce lodging or alter wall composition to improve biofuel production.	[Kaur, Simerjeet; Singh, Jaswinder] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Dhugga, Kanwarpal S.] DuPont Pioneer, Genet Discovery, 7300 NW 62nd Ave, Johnston, IA USA; [Gill, Kulvinder] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Dhugga, Kanwarpal S.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Estado De Mexic, Mexico	McGill University; DuPont; Pioneer Hi-Bred International, Inc.; Washington State University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Singh, J (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	jaswinder.singh@mcgill.ca		Dhugga, Kanwarpal/0000-0003-2477-3422	BIOFUEL NET CANADA	BIOFUEL NET CANADA	This study was supported by BIOFUEL NET CANADA (http://www.biofuelnet.ca/). The funders had no role in study design, data collection and analysis.	Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray N, 2015, ARXIV150502710; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dhugga KS, 2007, CROP SCI, V47, P2211, DOI 10.2135/cropsci2007.05.0299; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Endo T, 2002, MOL BIOL EVOL, V19, P521, DOI 10.1093/oxfordjournals.molbev.a004107; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamann T, 2004, CELLULOSE, V11, P279, DOI 10.1023/B:CELL.0000046340.99925.57; Hill JL, 2014, PLANT CELL; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Houston K, 2015, PLOS ONE, V10; Kaur R, 2013, FUNCT INTEGR GENOMIC, V13, P167, DOI 10.1007/s10142-013-0310-y; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Li Shundai, 2014, Arabidopsis Book, V12, pe0169, DOI 10.1199/tab.0169; Lin Y, 2014, J PLANT BIOCHEM BIOT, V23, P199, DOI 10.1007/s13562-013-0202-1; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079329; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Mochida K., 2003, MGG Molecular Genetics and Genomics, V270, P371, DOI 10.1007/s00438-003-0939-7; Mochida K, 2013, PLANT CELL PHYSIOL, V54, P1931, DOI 10.1093/pcp/pct163; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Ranik M, 2006, TREE PHYSIOL, V26, P545, DOI 10.1093/treephys/26.5.545; Rayon C, 2014, REDESIGNING CELLULOS, P183; Richmond T., 2000, GENOME BIOL, V1, DOI 10.1186/GB-2000-1-4-REVIEWS3001; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110; Slabaugh E, 2014, TRENDS PLANT SCI, V19, P99, DOI 10.1016/j.tplants.2013.09.009; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Takata N, 2015, PLANTA, V241, P29, DOI 10.1007/s00425-014-2217-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tian JX, 2014, MOL GENET GENOMICS, V289, P439, DOI 10.1007/s00438-014-0824-6; Trapp SC, 2001, GENETICS, V158, P811; Wang DF, 2012, PLANT SCI, V196, P117, DOI 10.1016/j.plantsci.2012.08.002; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang Y, 2013, NUCLEIC ACIDS RES, V41, pD1159, DOI 10.1093/nar/gks1109; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	52	18	24	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147046	10.1371/journal.pone.0147046	http://dx.doi.org/10.1371/journal.pone.0147046			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771740	Green Submitted, gold, Green Published			2022-12-27	WOS:000368628300058
J	Kvac, M; Havrdova, N; Hlaskova, L; Dankova, T; Kandera, J; Jezkova, J; Vitovec, J; Sak, B; Ortega, Y; Xiao, LH; Modry, D; Chelladurai, JRJJ; Prantlova, V; McEvoy, J				Kvac, Martin; Havrdova, Nikola; Hlaskova, Lenka; Dankova, Tereza; Kandera, Jiri; Jezkova, Jana; Vitovec, Jiri; Sak, Bohumil; Ortega, Ynes; Xiao, Lihua; Modry, David; Chelladurai, Jeba Rose Jennifer Jesudoss; Prantlova, Veronika; McEvoy, John			Cryptosporidium proliferans n. sp (Apicomplexa: Cryptosporidiidae): Molecular and Biological Evidence of Cryptic Species within Gastric Cryptosporidium of Mammals	PLOS ONE			English	Article							JAPANESE FIELD MICE; GENETIC DIVERSITY; MURIS INFECTION; ABOMASAL CRYPTOSPORIDIOSIS; PHYLOGENETIC ANALYSIS; GIARDIA-DUODENALIS; NATURAL INFECTION; GENOTYPES; PARVUM; PREVALENCE	The morphological, biological, and molecular characteristics of Cryptosporidium muris strain TS03 are described, and the species name Cryptosporidium proliferans n. sp. is proposed. Cryptosporidium proliferans obtained from a naturally infected East African mole rat (Tachyoryctes splendens) in Kenya was propagated under laboratory conditions in rodents (SCID mice and southern multimammate mice, Mastomys coucha) and used in experiments to examine oocyst morphology and transmission. DNA from the propagated C. proliferans isolate, and C. proliferans DNA isolated from the feces of an African buffalo (Syncerus caffer) in Central African Republic, a donkey (Equus africanus) in Algeria, and a domestic horse (Equus caballus) in the Czech Republic were used for phylogenetic analyses. Oocysts of C. proliferans are morphologically distinguishable from C. parvum and C. muris HZ206, measuring 6.8-8.8 (mean = 7.7 mu m) x 4.8-6.2 mu m (mean = 5.3) with a length to width ratio of 1.48 (n = 100). Experimental studies using an isolate originated from T. splendens have shown that the course of C. proliferans infection in rodent hosts differs from that of C. muris and C. andersoni. The prepatent period of 18-21 days post infection (DPI) for C. proliferans in southern multimammate mice (Mastomys coucha) was similar to that of C. andersoni and longer than the 6-8 DPI prepatent period for C. muris RN66 and HZ206 in the same host. Histopatologicaly, stomach glands of southern multimammate mice infected with C. proliferans were markedly dilated and filled with necrotic material, mucus, and numerous Cryptosporidium developmental stages. Epithelial cells of infected glands were atrophic, exhibited cuboidal or squamous metaplasia, and significantly proliferated into the lumen of the stomach, forming papillary structures. The epithelial height and stomach weight were six-fold greater than in non-infected controls. Phylogenetic analyses based on small subunit rRNA, Cryptosporidium oocyst wall protein, thrombospondin-related adhesive protein of Cryptosporidium-1, heat shock protein 70, actin, heat shock protein 90 (MS2), MS1, MS3, and M16 gene sequences revealed that C. proliferans is genetically distinct from C. muris and other previously described Cryptosporidium species.	[Kvac, Martin; Hlaskova, Lenka; Sak, Bohumil; Modry, David; Prantlova, Veronika] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Kvac, Martin; Havrdova, Nikola; Vitovec, Jiri; Prantlova, Veronika] Univ South Bohemia, Fac Agr, Ceske Budejovice, Czech Republic; [Dankova, Tereza; Kandera, Jiri] Grammar Sch, Vimperk, Czech Republic; [Dankova, Tereza; Kandera, Jiri] High Sch Econ, Vimperk, Czech Republic; [Jezkova, Jana] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Ortega, Ynes] Univ Georgia, Dept Food Sci & Technol, Ctr Food Safety, Griffin, GA 30223 USA; [Xiao, Lihua] Ctr Dis Control & Prevent, Atlanta, GA USA; [Modry, David] Univ Vet & Pharmaceut Sci, Dept Pathol & Parasitol, Brno, Czech Republic; [Modry, David] CEITEC VFU, Brno, Czech Republic; [Chelladurai, Jeba Rose Jennifer Jesudoss; McEvoy, John] N Dakota State Univ, Vet & Microbiol Sci Dept, Fargo, ND 58105 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University of Veterinary Sciences Brno; North Dakota State University Fargo	Kvac, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Kvac, M (corresponding author), Univ South Bohemia, Fac Agr, Ceske Budejovice, Czech Republic.	kvac@paru.cas.cz	Sak, Bohumil/G-9262-2014; Chelladurai, Jeba Jesudoss/AAJ-8621-2020; Chelladurai, Jeba R J Jesudoss/C-3813-2018; Modry, David/G-7815-2014; Prantlová, Veronika/ABE-8837-2021; Kvac, Martin/AAT-9533-2020; Xiao, Lihua/B-1704-2013; Kvac, Martin/G-7299-2014	Chelladurai, Jeba Jesudoss/0000-0003-3077-0201; Chelladurai, Jeba R J Jesudoss/0000-0003-3077-0201; Modry, David/0000-0001-9649-6255; Xiao, Lihua/0000-0001-8532-2727; Kvac, Martin/0000-0003-0013-6090; McEvoy, John/0000-0001-6843-5551	Ministry of Education, Youth and Sports of the Czech Republic [LH11061]; Czech Science Foundation [15-01090S]; Grant Agency of University of South Bohemia [011/2013/Z]; NIH [1R15AI067284-01A1]; CEITEC-Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.100/02.0068]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of University of South Bohemia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEITEC-Central European Institute of Technology from European Regional Development Fund	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (LH11061, to MK); the Czech Science Foundation (15-01090S, to MK); the Grant Agency of University of South Bohemia (011/2013/Z, to MK); the NIH (1R15AI067284-01A1, to JM); and CEITEC-Central European Institute of Technology (CZ.1.05/1.100/02.0068) from European Regional Development Fund (to DM).	ANDERSON BC, 1987, VET PATHOL, V24, P235, DOI 10.1177/030098588702400307; Anderson BC, 1998, J DAIRY SCI, V81, P3036, DOI 10.3168/jds.S0022-0302(98)75868-0; ANDERSON BC, 1991, J PROTOZOOL, V38, pS16; ARROWOOD MJ, 1987, J PARASITOL, V73, P314, DOI 10.2307/3282084; Aydin Y, 1996, VET PARASITOL, V66, P257, DOI 10.1016/S0304-4017(96)01007-2; CASEMORE DP, 1991, J CLIN PATHOL, V44, P445, DOI 10.1136/jcp.44.6.445; Chalmers RM, 1997, PARASITOL RES, V83, P478, DOI 10.1007/s004360050283; Crawshaw G.J., 1987, Erkrankungen der Zootiere, P353; Deng MQ, 1999, PARASITOL RES, V85, P733, DOI 10.1007/s004360050623; Dixon BR, 2008, J PARASITOL, V94, P1161, DOI 10.1645/GE-1485.1; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; ESTEBAN E, 1995, J DAIRY SCI, V78, P1068, DOI 10.3168/jds.S0022-0302(95)76723-6; Fayer R, 2001, J PARASITOL, V87, P1415, DOI 10.1645/0022-3395(2001)087[1415:CCNSFD]2.0.CO;2; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; Fayer R, 2009, VET PARASITOL, V164, P192, DOI 10.1016/j.vetpar.2009.05.011; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Graczyk TK, 1996, J PARASITOL, V82, P748, DOI 10.2307/3283886; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyot K, 2001, J CLIN MICROBIOL, V39, P3472, DOI 10.1128/JCM.39.10.3472-3480.2001; Hikosaka K, 2005, PARASITOL RES, V97, P373, DOI 10.1007/s00436-005-1459-7; Hurkova L, 2003, J WILDLIFE DIS, V39, P441; ISEKI M, 1989, PARASITOL RES, V75, P218, DOI 10.1007/BF00931279; Jalovecka M, 2010, PARASITOL RES, V106, P1159, DOI 10.1007/s00436-010-1785-2; Jenkins MB, 2010, APPL ENVIRON MICROB, V76, P5757, DOI 10.1128/AEM.00434-10; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; KILANI RT, 1987, AM J TROP MED HYG, V36, P505, DOI 10.4269/ajtmh.1987.36.505; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Koudela B, 1998, VET PARASITOL, V76, P181, DOI 10.1016/S0304-4017(97)00217-3; Koyama Y, 2005, VET PARASITOL, V130, P323, DOI 10.1016/j.vetpar.2005.03.014; Kvac M, 2011, PARASITE IMMUNOL, V33, P210, DOI 10.1111/j.1365-3024.2010.01271.x; Kvac M, 2003, J VET MED B, V50, P451, DOI 10.1046/j.0931-1793.2003.00701.x; Kvac M, 2008, VET PARASITOL, V153, P363, DOI 10.1016/j.vetpar.2008.01.033; Kvac M, 2007, VET PARASITOL, V143, P229, DOI 10.1016/j.vetpar.2006.08.031; Kvac M, 2014, VET PARASITOL, V201, P9, DOI 10.1016/j.vetpar.2014.01.014; Kvac M, 2013, INT J PARASITOL, V43, P805, DOI 10.1016/j.ijpara.2013.04.007; Kvac M, 2013, EXP PARASITOL, V134, P438, DOI 10.1016/j.exppara.2013.04.007; Kvac M, 2012, EXP PARASITOL, V131, P107, DOI 10.1016/j.exppara.2012.03.016; Kvac M, 2009, VET PARASITOL, V163, P33, DOI 10.1016/j.vetpar.2009.03.047; Kvac M, 2009, VET PARASITOL, V160, P319, DOI 10.1016/j.vetpar.2008.11.007; Laatamna A, 2015, VET PARASITOL, V208, P135, DOI 10.1016/j.vetpar.2015.01.007; Lindsay DS, 2000, J EUKARYOT MICROBIOL, V47, P91, DOI 10.1111/j.1550-7408.2000.tb00016.x; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Matsui T, 2001, J VET MED SCI, V63, P319, DOI 10.1292/jvms.63.319; MCDONALD V, 1992, INFECT IMMUN, V60, P3325, DOI 10.1128/IAI.60.8.3325-3331.1992; Melicherova J, 2014, PARASITOLOGY, V141, P287, DOI 10.1017/S0031182013001637; MILACEK P, 1985, FOLIA PARASIT, V32, P50; Modry D, 2012, PARASITOL RES, V111, P471, DOI 10.1007/s00436-012-2821-1; Morgan UM, 1999, J PARASITOL, V85, P525, DOI 10.2307/3285789; Morgan UM, 1998, PARASITOLOGY, V117, P31, DOI 10.1017/S0031182098002765; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Murakoshi F, 2013, VET PARASITOL, V196, P184, DOI 10.1016/j.vetpar.2013.02.011; Nakai Y, 2004, J VET MED SCI, V66, P983, DOI 10.1292/jvms.66.983; Neumayerova H, 2008, VET PARASITOL, V153, P197, DOI 10.1016/j.vetpar.2008.02.009; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Ng-Hublin JSY, 2013, INFECT GENET EVOL, V16, P5, DOI 10.1016/j.meegid.2013.01.011; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; OZKUL IA, 1994, VET PARASITOL, V55, P129, DOI 10.1016/0304-4017(94)90062-0; PAVLASEK I, 1995, VET MED-CZECH, V40, P261; Pedraza-Diaz S, 2009, VET PARASITOL, V160, P204, DOI 10.1016/j.vetpar.2008.11.003; POSPISCHIL A, 1987, VET REC, V121, P379, DOI 10.1136/vr.121.16.379; Qi M, 2014, VET PARASITOL, V205, P518, DOI 10.1016/j.vetpar.2014.06.035; Qin SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-230; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Rhee Jae Ku, 1999, Korean Journal of Parasitology, V37, P33, DOI 10.3347/kjp.1999.37.1.33; Rhee Jae Ku, 1995, Korean Journal of Parasitology, V33, P377, DOI 10.3347/kjp.1995.33.4.377; Rhee Jae Ku, 1998, Korean Journal of Parasitology, V36, P171, DOI 10.3347/kjp.1998.36.3.171; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Ryan UM, 2005, APPL ENVIRON MICROB, V71, P4992, DOI 10.1128/AEM.71.9.4992-4997.2005; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Satoh M, 2003, APPL ENVIRON MICROB, V69, P691, DOI 10.1128/AEM.69.1.691-692.2003; SAUCH JF, 1991, APPL ENVIRON MICROB, V57, P3243, DOI 10.1128/AEM.57.11.3243-3247.1991; Siefker C, 2002, J PARASITOL, V88, P213, DOI 10.1645/0022-3395(2002)088[0213:MCOCSI]2.0.CO;2; Sreter T, 2000, J PARASITOL, V86, P1244, DOI 10.1645/0022-3395(2000)086[1244:MHSAGC]2.0.CO;2; Sulaiman IM, 2002, J PARASITOL, V88, P388, DOI 10.1645/0022-3395(2002)088[0388:MPAERO]2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MA, 1999, VET PARASITOL, V86, P41, DOI 10.1016/S0304-4017(99)00114-4; TILLEY M, 1991, CAN J MICROBIOL, V37, P949, DOI 10.1139/m91-163; Traversa D, 2008, MOL CELL PROBE, V22, P122, DOI 10.1016/j.mcp.2007.11.001; Trout JM, 2006, J ZOO WILDLIFE MED, V37, P141, DOI 10.1638/05-06TYM-123005.1; Tyzzer E., 1907, P SOC EXP BIOL MED, V5, P12; Tyzzer E. E., 1912, Archiv fuer Protistenkunde Jena, V26; Tyzzer EE, 1910, J MED RES, V23, P487; UPTON SJ, 1989, J WILDLIFE DIS, V25, P20, DOI 10.7589/0090-3558-25.1.20; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Vitovec J, 2006, J VET MED B, V53, P239, DOI 10.1111/j.1439-0450.2006.00950.x; Wagnerova P, 2015, PARASITOL RES, V114, P1619, DOI 10.1007/s00436-015-4353-y; Warren KS, 2003, AUST VET J, V81, P739, DOI 10.1111/j.1751-0813.2003.tb14602.x; Xiao LH, 2006, APPL ENVIRON MICROB, V72, P4461, DOI 10.1128/AEM.00370-06; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2004, APPL ENVIRON MICROB, V70, P891, DOI 10.1128/AEM.70.2.891-899.2004; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	96	50	52	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147090	10.1371/journal.pone.0147090	http://dx.doi.org/10.1371/journal.pone.0147090			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771460	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300062
J	Vafaei, A; Ahmed, T; Freire, ADF; Zunzunegui, MV; Guerra, RO				Vafaei, Afshin; Ahmed, Tamer; Falcao Freire, Aline do N.; Zunzunegui, Maria Victoria; Guerra, Ricardo O.			Depression, Sex and Gender Roles in Older Adult Populations: The International Mobility in Aging Study (IMIAS)	PLOS ONE			English	Article							SELF-RATED HEALTH; CES-D; MASCULINITY; FEMININITY; SYMPTOMS; EPIDEMIOLOGY; SATISFACTION; PREVALENCE; INEQUALITY; DISORDERS	Objectives To assess the associations between gender roles and depression in older men and women and whether gender roles are independent risk factors for depression. Methods International cross-sectional study of adults between 65 and 74 years old (n = 1,967). Depression was defined by a score of 16 or over in the Center for Epidemiologic Studies Depression Scale (CES-D). A validated 12-item Bem Sex Role Inventory (BSRI) was used to classify participants in gender roles (Masculine, Feminine, Androgynous, and Undifferentiated) using research site medians of femininity and masculinity as cut-off points. Poisson regressions were fitted to estimate the prevalence ratios (PR) of depression for each gender role compared to the masculine role, adjusting for sex, sufficiency of income, education, marital status, self-rated health, and chronic conditions. Results Among men, 31.2% were androgynous, 26% were masculine, 14.4% were feminine, and 28.4% were undifferentiated; among women, the corresponding percentages were 32.7%, 14.9%, 27%, and 25.4%. Both in men and in women, depressive symptoms (CES-D >= 16) were more prevalent in those endorsing the undifferentiated type, compared to masculine, feminine or androgynous groups. However, after adjusting for potential confounders, compared to the masculine group only those endorsing the androgynous role were 28% less likely to suffer from depression: PR of 0.72 (95% CI: 0.55-0.93). In fully adjusted models, prevalence rates of depression were not different from masculine participants in the two other gender groups of feminine and undifferentiated. Conclusions Androgynous roles were associated with lower rates of depression in older adults, independently of being a man or a woman.	[Vafaei, Afshin] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Ahmed, Tamer; Zunzunegui, Maria Victoria] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Falcao Freire, Aline do N.; Guerra, Ricardo O.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil	Queens University - Canada; Universite de Montreal; Universidade Federal do Rio Grande do Norte	Vafaei, A (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	5av14@queensu.ca	GUERRA, Ricardo/J-7586-2015	GUERRA, Ricardo/0000-0003-3824-3713; Ahmed, Tamer/0000-0002-5708-0270; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team [AAM 108751]	International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team(Canadian Institutes of Health Research (CIHR))	Data collection for this study was funded by the International Mobility in Aging Study (IMIAS) project: Canadian Institutes of Health Research (CIHR), Institute of Aging, New Emerging Team; gender differences in immobility; reference number AAM 108751. No other funds were received for analysis and preparing the manuscript.	Ahmed T, 2015, CANADIAN J IN PRESS; Almeida N, 2004, SOC SCI MED, V59, P1339, DOI 10.1016/j.socscimed.2003.11.037; Alvarado BE, 2007, J GERONTOL B-PSYCHOL, V62, pS226; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bassoff ES, 1982, COUNS PSYCHOL, V10, P7; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BEM SL, 1977, J CONSULT CLIN PSYCH, V45, P196, DOI 10.1037//0022-006X.45.2.196; Blakely TA, 2002, SOC SCI MED, V54, P65, DOI 10.1016/S0277-9536(01)00007-7; Brown D, 1997, SEX ROLE IDENTITY DE; Carver LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076356; Connell R. W., 1995, MASCULINITIES; Connell R, 2011, S AFR REV SOCIOL, V42, P103, DOI 10.1080/21528586.2011.621242; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Costa E, 2007, AM J GERIAT PSYCHIAT, V15, P17, DOI 10.1097/01.JGP.0000230659.72417.a0; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; DOWNEY AM, 1984, PSYCHOL REP, V54, P811, DOI 10.2466/pr0.1984.54.3.811; FAVA GA, 1983, J CLIN PSYCHOL, V39, P249, DOI 10.1002/1097-4679(198303)39:2<249::AID-JCLP2270390218>3.0.CO;2-Y; Gale-Ross R, 2009, CAN J AGING, V28, P135, DOI 10.1017/S0714980809090187; Hunt K, 2007, INT J EPIDEMIOL, V36, P612, DOI 10.1093/ije/dym022; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KRAMES L, 1988, SEX ROLES, V19, P713, DOI 10.1007/BF00288987; Lee C., 2002, PSYCHOL MENS HLTH; Lefkowitz ES, 2006, J PERS ASSESS, V87, P95, DOI 10.1207/s15327752jpa8701_08; Lehmann V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-109; Li CE, 2006, ADOLESCENCE, V41, P409; Maciel ACC, 2008, REV ASSOC MED BRAS, V54, P6; Mansdotter A, 2009, J EPIDEMIOL COMMUN H, V63, P408, DOI 10.1136/jech.2008.082628; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; Morin AJS, 2011, REV EPIDEMIOL SANTE, V59, P327, DOI 10.1016/j.respe.2011.03.061; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Oquendo MA, 2004, ACTA PSYCHIAT SCAND, V110, P446, DOI 10.1111/j.1600-0447.2004.00404.x; Patten SB, 2015, CAN J PSYCHIAT, V60, P23, DOI 10.1177/070674371506000106; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ried LD, 2002, J WOMEN HEALTH GEN-B, V11, P813, DOI 10.1089/15409990260430963; Rosenfiled S, 2012, HDB SOCIOLOGY MENTAL, P277; Ruiz-Grosso P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045413; Sachs-Ericsson N, 2000, SEX ROLES, V43, P605, DOI 10.1023/A:1007148407005; Sanchez-Santos M, 2011, EUR J AGEING, V8, P9; Shifren K, 1996, SEX ROLES, V34, P841, DOI 10.1007/BF01544319; Silva MT, 2014, REV BRAS PSIQUIATR, V36, P262, DOI 10.1590/1516-4446-2013-1294; Sinnott JD, 2011, HDB PSYCHOL AGING, P454; Subramanian SV, 2001, SOC SCI MED, V53, P9, DOI 10.1016/S0277-9536(00)00309-9; Sweeting H, 2014, SOC PSYCH PSYCH EPID, V49, P791, DOI 10.1007/s00127-013-0730-y; Szklo M, 2014, EPIDEMIOLOGY BASICS; Batistoni SST, 2007, REV SAUDE PUBL, V41, P598, DOI 10.1590/S0034-89102007000400014; Thomas JL, 2001, INT J PSYCHIAT MED, V31, P25, DOI 10.2190/FUFR-PK9F-6U10-JXRK; Twenge JM, 1997, SEX ROLES, V36, P305, DOI 10.1007/BF02766650; UNDP, 2014, HUM DEV REP; Vafaei A, 2014, ARCH GERONTOL GERIAT; Williams J.E., 1990, MEASURING SEX STEREO, VVol. 6; World Health Organization, 2008, The global burden of disease: 2004 update; Wrightsman L.S., 1991, MEASURES PERSONALITY, P573, DOI DOI 10.1016/B978-0-12-590241-0.50015-0	54	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146867	10.1371/journal.pone.0146867	http://dx.doi.org/10.1371/journal.pone.0146867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771828	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300037
J	Vaz, S; Cordier, R; Boyes, M; Parsons, R; Joosten, A; Ciccarelli, M; Falkmer, M; Falkmer, T				Vaz, Sharmila; Cordier, Reinie; Boyes, Mark; Parsons, Richard; Joosten, Annette; Ciccarelli, Marina; Falkmer, Marita; Falkmer, Torbjorn			Is Using the Strengths and Difficulties Questionnaire in a Community Sample the Optimal Way to Assess Mental Health Functioning?	PLOS ONE			English	Article							CROSS-INFORMANT CORRELATIONS; CHILD PSYCHIATRIC-DISORDERS; NORMATIVE DATA; YOUNG-PEOPLE; HELP-SEEKING; PRIMARY-CARE; SDQ; TEACHER; PARENT; AGREEMENT	An important characteristic of a screening tool is its discriminant ability or the measure's accuracy to distinguish between those with and without mental health problems. The current study examined the inter-rater agreement and screening concordance of the parent and teacher versions of SDQ at scale, subscale and item-levels, with the view of identifying the items that have the most informant discrepancies; and determining whether the concordance between parent and teacher reports on some items has the potential to influence decision making. Cross-sectional data from parent and teacher reports of the mental health functioning of a community sample of 299 students with and without disabilities from 75 different primary schools in Perth, Western Australia were analysed. The study found that: a) Intraclass correlations between parent and teacher ratings of children's mental health using the SDQ at person level was fair on individual child level; b) The SDQ only demonstrated clinical utility when there was agreement between teacher and parent reports using the possible or 90% dichotomisation system; and c) Three individual items had positive likelihood ratio scores indicating clinical utility. Of note was the finding that the negative likelihood ratio or likelihood of disregarding the absence of a condition when both parents and teachers rate the item as absent was not significant. Taken together, these findings suggest that the SDQ is not optimised for use in community samples and that further psychometric evaluation of the SDQ in this context is clearly warranted.	[Vaz, Sharmila; Cordier, Reinie; Parsons, Richard; Joosten, Annette; Ciccarelli, Marina; Falkmer, Marita; Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Boyes, Mark] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Rehabil Med, Linkoping, Sweden; [Falkmer, Torbjorn] UHL, Pain & Rehabil Ctr, Cty Council, Linkoping, Sweden	Curtin University; Curtin University; Curtin University; Jonkoping University; Linkoping University	Vaz, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	s.vaz@curtin.edu.au	Ciccarelli, Michele/K-2824-2016; Boyes, Mark/G-9680-2014; Cordier, Reinie/AAH-6290-2019; Ciccarelli, Michele/ABC-2826-2021	Ciccarelli, Michele/0000-0003-2379-1960; Boyes, Mark/0000-0001-5420-8606; Cordier, Reinie/0000-0002-9906-5300; Ciccarelli, Michele/0000-0003-2379-1960; Joosten, Annette/0000-0003-4722-1081; Vaz, Sharmila/0000-0003-1003-9593	Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	This project was funded by a Doctoral scholarship provided by the Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia. It was part of a larger study that was awarded the 2007 Social Determinants for Health Research award by Healthway Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2006, CURR DIR PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2006.00414.x; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1992, INT CLASS DIS CLASS; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Attia J, 2003, AUSTR PRESCRIBER; Australian Bureau of Statistics, 2011, 2033 0 55 001 CENS P; Australian Bureau of Statistics [ABS], 2001, ABS 2001 CENS DICT; Babor TF, 2004, AM J PREV MED, V27, P42, DOI 10.1016/j.amepre.2004.04.018; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Bond TG., 2020, APPL RASCH MODEL FUN; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Bricker D, 2004, INFANT YOUNG CHILD, V17, P129, DOI 10.1097/00001163-200404000-00005; Brondbo P, 2011, CHILD ADOLESCENT PSY, V5, P1; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; De Los Reyes A, 2004, PSYCHOL ASSESSMENT, V16, P330, DOI 10.1037/1040-3590.16.3.330; De los Reyes A, 2006, PSYCHOL REV, V113, P554, DOI 10.1037/0033-295X.113.3.554; De Los Reyes A, 2009, J ABNORM CHILD PSYCH, V37, P637, DOI 10.1007/s10802-009-9307-3; Enders C. K., 2010, APPL MISSING DATA AN; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Fleming Michael F, 2002, Subst Abus, V23, P47; Glover TA, 2007, J SCHOOL PSYCHOL, V45, P117, DOI 10.1016/j.jsp.2006.05.005; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2004, EUR CHILD ADOLES PSY, V13, P25, DOI 10.1007/s00787-004-2005-3; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Hamilton Cody, 2007, J Clin Monit Comput, V21, P331, DOI 10.1007/s10877-007-9092-x; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; Hickie I, 2004, INVESTING AUSTR FUTU; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koenig K, 2009, J AUTISM DEV DISORD, V39, P1163, DOI 10.1007/s10803-009-0728-1; Lane LK, 2007, J EMOTIONAL BEHAV DI, V15, P209; Levitt JM, 2007, J SCHOOL PSYCHOL, V45, P163, DOI 10.1016/j.jsp.2006.11.005; Linacre JM, 2009, WINSTEPS PROGRAMME V; Loades ME, 2010, CHILD ADOL MENT H-UK, V15, P150, DOI 10.1111/j.1475-3588.2009.00551.x; LOEBER R, 1990, J CLIN CHILD PSYCHOL, V19, P136, DOI 10.1207/s15374424jccp1902_5; Marzocchi GM, 2004, EUR CHILD ADOLES PSY, V13, P40, DOI 10.1007/s00787-004-2007-1; Mash EJ, 2005, J CLIN CHILD ADOLESC, V34, P362, DOI 10.1207/s15374424jccp3403_1; Mathai J, 2004, AUST NZ J PSYCHIAT, V38, P639, DOI 10.1111/j.1440-1614.2004.01428.x; Mathai J, 2002, AEJAMH, V1, P235, DOI [DOI 10.5172/JAMH.1.3.235, 10.5172/jamh.1.3.235]; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; Meyers L. S., 2006, APPL MULTIVARIATE RE; NGUYEN N, 1994, J AM ACAD CHILD PSY, V33, P1275, DOI 10.1097/00004583-199411000-00008; Obel C, 2004, EUR CHILD ADOLES PSY, V13, P32, DOI 10.1007/s00787-004-2006-2; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Reinke WM, 2011, SCHOOL PSYCHOL QUART, V26, P1, DOI 10.1037/a0022714; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Rothi DM, 2006, PASTOR CARE EDUC, V24, P4, DOI 10.1111/j.1468-0122.2006.00373.x; Rothi DM, 2008, TEACH TEACH EDUC, V24, P1217, DOI 10.1016/j.tate.2007.09.011; Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x; Sayal K, 2010, BRIT J PSYCHIAT, V197, P476, DOI 10.1192/bjp.bp.110.081448; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Strickland J, 2012, J ABNORM CHILD PSYCH, V40, P933, DOI 10.1007/s10802-012-9622-y; Suelto MD, 1999, ANESTHESIOLOGY; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Vaz S, 2010, FACTORS AFFECTING ST; Vaz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089874; Verhulst FC, 1997, ACTA PSYCHIAT SCAND, V96, P75, DOI 10.1111/j.1600-0447.1997.tb09909.x; Vostanis P, 2006, CURR OPIN PSYCHIATR, V19, P367, DOI 10.1097/01.yco.0000228755.72366.05; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-2002-6; Youngstrom E, 2000, J CONSULT CLIN PSYCH, V68, P1038, DOI 10.1037/0022-006X.68.6.1038	66	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0144039	10.1371/journal.pone.0144039	http://dx.doi.org/10.1371/journal.pone.0144039			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771673	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000368628300001
J	Kullenberg, C; Kasperowski, D				Kullenberg, Christopher; Kasperowski, Dick			What Is Citizen Science? - A Scientometric Meta-Analysis	PLOS ONE			English	Article							TOOL; PARTICIPATION	Context The concept of citizen science (CS) is currently referred to by many actors inside and outside science and research. Several descriptions of this purportedly new approach of science are often heard in connection with large datasets and the possibilities of mobilizing crowds outside science to assists with observations and classifications. However, other accounts refer to CS as a way of democratizing science, aiding concerned communities in creating data to influence policy and as a way of promoting political decision processes involving environment and health. Objective In this study we analyse two datasets (N = 1935, N = 633) retrieved from the Web of Science (WoS) with the aim of giving a scientometric description of what the concept of CS entails. We account for its development over time, and what strands of research that has adopted CS and give an assessment of what scientific output has been achieved in CS-related projects. To attain this, scientometric methods have been combined with qualitative approaches to render more precise search terms. Results Results indicate that there are three main focal points of CS. The largest is composed of research on biology, conservation and ecology, and utilizes CS mainly as a methodology of collecting and classifying data. A second strand of research has emerged through geographic information research, where citizens participate in the collection of geographic data. Thirdly, there is a line of research relating to the social sciences and epidemiology, which studies and facilitates public participation in relation to environmental issues and health. In terms of scientific output, the largest body of articles are to be found in biology and conservation research. In absolute numbers, the amount of publications generated by CS is low (N = 1935), but over the past decade a new and very productive line of CS based on digital platforms has emerged for the collection and classification of data.	[Kullenberg, Christopher; Kasperowski, Dick] Univ Gothenburg, Dept Philosophy Linguist & Theory Sci, Gothenburg, Sweden	University of Gothenburg	Kullenberg, C (corresponding author), Univ Gothenburg, Dept Philosophy Linguist & Theory Sci, Gothenburg, Sweden.	christopher.kullenberg@gu.se	Kullenberg, Christopher/AAF-4577-2019	Kullenberg, Christopher/0000-0002-1577-3570	Marianne and Marcus Wallenberg Foundation [MMW 2013.00.20]	Marianne and Marcus Wallenberg Foundation	This research was supported by the Marianne and Marcus Wallenberg Foundation (MMW 2013.00.20) in the research project "Taking Science to the Crowd: Researchers, Programmers and Volunteer Contributors Transforming Science Online (https://www.wallenberg.com/mmw/projektanslag-2013).	Alexis C, 2014, SEMANTIC ANAL CITIZE; [Anonymous], 2015, NATURE, V524, P265, DOI 10.1038/524265a; Ashcroft MB, 2012, BIOL INVASIONS, V14, P515, DOI 10.1007/s10530-011-0092-x; Belter CW, 2013, SCIENTOMETRICS, V95, P629, DOI 10.1007/s11192-012-0836-0; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; BROWN P, 1992, J HEALTH SOC BEHAV, V33, P267, DOI 10.2307/2137356; Brulle RJ, 2006, ANNU REV PUBL HEALTH, V27, P103, DOI 10.1146/annurev.publhealth.27.021405.102124; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2007, ECOL SOC, V12; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Corburn Jason, 2005, STREET SCIENCE COMMU; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; GARFIELD E, 1993, J AM SOC INFORM SCI, V44, P298, DOI 10.1002/(SICI)1097-4571(199306)44:5<298::AID-ASI5>3.0.CO;2-A; Haklay M, 2013, CROWDSOURCING GEOGRA, P105, DOI [10.1007/978-94-007-4587-2_7, DOI 10.1007/978-94-007-4587-2_7]; Holocher-Ertl T, 2013, GREEN PAPER; Irwin A., 1995, CITIZEN SCI STUDY PE, pxi; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Kruger LE, 2000, SOC NATUR RESOUR, V13, P461, DOI 10.1080/089419200403866; Kullenberg C., 2015, J RESIST STUD, V1, P50; Leung MW, 2004, INT J EPIDEMIOL, V33, P499, DOI 10.1093/ije/dyh010; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; Nascimento S, 2014, FROM CITIZEN SCIENCE; O'Rourke D, 2003, J POLICY ANAL MANAG, V22, P383, DOI 10.1002/pam.10138; Martinez M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045006; Ottinger G, 2010, SCI TECHNOL HUM VAL, V35, P244, DOI 10.1177/0162243909337121; Polymath DHJ, 2014, ALGEBR NUMBER THEORY, V8, P2067, DOI 10.2140/ant.2014.8.2067; Raddick M. J., 2013, ARXIV13036886ASTROPH; Rowl, 2012, NATURE, V25, P1070, DOI [10.1038/nature.2012.10054, DOI 10.1038/NATURE.2012.10054]; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Tattersall PJ, 2010, FUTURES, V42, P466, DOI 10.1016/j.futures.2009.11.031; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Wylie SA, 2014, INFORM SOC, V30, P116, DOI 10.1080/01972243.2014.875783	41	256	260	9	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147152	10.1371/journal.pone.0147152	http://dx.doi.org/10.1371/journal.pone.0147152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB4CC	26766577	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300073
J	Bui, DC; Son, H; Shin, JY; Kim, JC; Kim, H; Choi, GJ; Lee, YW				Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Kim, Jin-Cheol; Kim, Hun; Choi, Gyung Ja; Lee, Yin-Won			The FgNot3 Subunit of the Ccr4-Not Complex Regulates Vegetative Growth, Sporulation, and Virulence in Fusarium graminearum	PLOS ONE			English	Article							GIBBERELLA-ZEAE; GENE-EXPRESSION; FUNCTIONAL ANALYSES; EUKARYOTIC CELLS; IN-VIVO; YEAST; PROTEIN; MODULE; WHEAT; NOT5	The Ccr4-Not complex is evolutionarily conserved and important for multiple cellular functions in eukaryotic cells. In this study, the biological roles of the FgNot3 subunit of this complex were investigated in the plant pathogenic fungus Fusarium graminearum. Deletion of Fg NOT3 resulted in retarded vegetative growth, retarded spore germination, swollen hyphae, and hyper -branching. The Delta Fgnot3 mutants also showed impaired sexual and asexual sporulation, decreased virulence, and reduced expression of genes related to conidiogenesis. Fgnot3 deletion mutants were sensitive to thermal stress, whereas NOT3 orthologs in other model eukaryotes are known to be required for cell wall integrity. We found that FgNot3 functions as a negative regulator of the production of secondary metabolites, including trichothecenes and zearalenone. Further functional characterization of other components of the Not module of the Ccr4-Not complex demonstrated that the module is conserved. Each subunit primarily functions within the context of a complex and might have distinct roles outside of the complex in F. graminearum. This is the first study to functionally characterize the Not module in filamentous fungi and provides novel insights into signal transduction pathways in fungal development.	[Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Lee, Yin-Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Bui, Duc-Cuong; Son, Hokyoung; Shin, Ji Young; Lee, Yin-Won] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea; [Son, Hokyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Kim, Jin-Cheol] Chonnam Natl Univ, Div Appl Biosci & Biotechnol, Inst Environm Friendly Agr, Coll Agr & Life Sci, Gwangju, South Korea; [Kim, Hun; Choi, Gyung Ja] Korea Res Inst Chem Technol, Ecofriendly New Mat Res Grp, Res Ctr Biobased Chem, Div Convergence Chem, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chonnam National University; Korea Research Institute of Chemical Technology (KRICT)	Lee, YW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Lee, YW (corresponding author), Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea.	lee2443@snu.ac.kr	Bui, Duc Cuong/J-9740-2019	Bui, Duc Cuong/0000-0001-5366-6103; Son, Hokyoung/0000-0001-5080-7951	National Research Foundation of Korea (NRF) - Korean government [2013R1A6A3A04059121]; Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea [PJ01085602]	National Research Foundation of Korea (NRF) - Korean government; Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (2013R1A6A3A04059121) and the Cooperative Research Program for Agricultural Science and Technology Development (Project PJ01085602), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Bhaskar V, 2013, NAT STRUCT MOL BIOL, V20, P1281, DOI 10.1038/nsmb.2686; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Boland A, 2013, NAT STRUCT MOL BIOL, V20, P1289, DOI 10.1038/nsmb.2681; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; CAPPELLINI R, 1965, MYCOLOGIA, P962; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Cheng SJ, 2005, INFECT IMMUN, V73, P7190, DOI 10.1128/IAI.73.11.7190-7197.2005; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2013, CELL SIGNAL, V25, P743, DOI 10.1016/j.cellsig.2012.12.018; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; DENIS CL, 1984, GENETICS, V108, P833; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Han YK, 2007, MOL MICROBIOL, V63, P768, DOI 10.1111/j.1365-2958.2006.05557.x; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Hong SY, 2010, FUNGAL GENET BIOL, V47, P364, DOI 10.1016/j.fgb.2010.01.005; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Jonkers W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002724; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Leslie J. F., 2006, FUSARIUM LAB MANUAL, V10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Morita M, 2011, EMBO J, V30, P4678, DOI 10.1038/emboj.2011.320; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Ohara T, 2004, GENETICS, V166, P113, DOI 10.1534/genetics.166.1.113; Panepinto John C., 2013, Frontiers in Genetics, V4, P302, DOI 10.3389/fgene.2013.00302; Park AR, 2012, FUNGAL GENET BIOL, V49, P511, DOI 10.1016/j.fgb.2012.05.006; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sambrook J., 2001, MOL CLONING LAB MANU; Seo JA, 1996, MYCOPATHOLOGIA, V134, P31, DOI 10.1007/BF00437050; Son H, 2014, EUKARYOT CELL, V13, P87, DOI 10.1128/EC.00220-13; Son H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072915; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Son H, 2011, FUNGAL GENET BIOL, V48, P408, DOI 10.1016/j.fgb.2011.01.002; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Venturini G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003040; Villanyi Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004569; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yu J, 2014, CURR GENET, V60, P35, DOI 10.1007/s00294-013-0409-7; Zheng WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045432	57	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147481	10.1371/journal.pone.0147481	http://dx.doi.org/10.1371/journal.pone.0147481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799401	gold, Green Published, Green Submitted			2022-12-27	WOS:000368655300114
J	Damm, T; Spiegel, H; Barth, S; Fischer, R; Naehring, J				Damm, Tatjana; Spiegel, Holger; Barth, Stefan; Fischer, Rainer; Naehring, Joerg			Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GLOMERULAR-FILTRATION-RATE; ACUTE KIDNEY INJURY; SERUM CREATININE; PROTEIN; MARKER; CELLS; GFR; ANTIBODIES; ANTIGEN	Human cystatin C (hCC), a cysteine protease inhibitor, has been proposed as a diagnostic marker because its serum levels correlate with certain cardiovascular and kidney diseases. All current hCC assays are based on ex vivo detection. Here we describe the generation and evaluation of antibodies that allow the repetitive binding and release of hCC and hCC-fusion proteins, a prerequisite for long-term measurement, which is required for compatibility with implantable biochip devices and for the development of innovative antibody-based assays suitable for continuous in vivo and in vitro monitoring. Recombinant hCC and hCC-fusion proteins were produced in Escherichia coli and HEK293T cells and were used to generate antibodies by hybridoma technology. After screening by indirect and sandwich ELI-SAs, 12 monoclonal hybridoma cell lines producing hCC-specific monoclonal antibodies were identified. To determine their hCC association and dissociation properties, the antibodies were analysed by surface plasmon resonance spectroscopy, revealing three with the desired fast binding and moderate-to-fast release characteristics. The analysis of binding and dissociation in the presence of hCC and hCC-fusion proteins using fluorescence-based replacement assays showed that mAb CyDI-4 was the most suitable for further analysis. The results showed that repetitive replacement on mAb CyDI-4 was possible and that most of the change in signal intensity occurred after 20-30 min. Furthermore, the suitability of mAb CyDI-4 for serum hCC measurement was confirmed by a fluorescence-based replacement assay using serially-diluted reference serum from the Institute for Reference Materials and Measurements (ERM-DA471/IFCC). Our results suggest that the assay covers the physiological and pathological ranges of hCC.	[Damm, Tatjana; Spiegel, Holger; Fischer, Rainer; Naehring, Joerg] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Barth, Stefan; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biol, Aachen, Germany; [Barth, Stefan] Rhein Westfal TH Aachen, Inst Appl Med Engn, Aachen, Germany; [Damm, Tatjana] Rhein Westfal TH Aachen, IBMG, Aachen, Germany; [Barth, Stefan] Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	Fraunhofer Gesellschaft; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Cape Town	Naehring, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	joerg.naehring@ime.fraunhofer.de	Barth, Stefan/F-7301-2012	Barth, Stefan/0000-0001-9589-653X	German Bundesministerium fur Bildung und Forschung [16SV5461]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	German Bundesministerium fur Bildung und Forschung funding (16SV5461).	Ataei N, 2014, PEDIATR NEPHROL, V29, P133, DOI 10.1007/s00467-013-2586-5; Bel-Ochi NC, 2013, CLIN VACCINE IMMUNOL, V20, P468, DOI 10.1128/CVI.00512-12; Bhasin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082028; BUTLER EA, 1961, J CLIN PATHOL, V14, P172, DOI 10.1136/jcp.14.2.172; Conti M, 2006, CLIN CHEM LAB MED, V44, P288, DOI 10.1515/CCLM.2006.050; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-9; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Feller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079920; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Finney H, 2000, ANN CLIN BIOCHEM, V37, P49, DOI 10.1258/0004563001901524; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hamed HM, 2013, INDIAN J CRIT CARE M, V17, P92, DOI 10.4103/0972-5229.114829; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; IEDB, 2011, IMM EP DAT AN RES; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; JACOBSSON B, 1995, HISTOPATHOLOGY, V26, P559, DOI 10.1111/j.1365-2559.1995.tb00275.x; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson A, 2008, CHRONOBIOL INT, V25, P1047, DOI 10.1080/07420520802553614; Lei JH, 2011, AM J TROP MED HYG, V85, P1054, DOI 10.4269/ajtmh.2011.11-0051; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Li X, 2013, J GERIATR CARDIOL, V10, P286, DOI 10.3969/j.issn.1671-5411.2013.03.001; LOFBERG H, 1979, SCAND J CLIN LAB INV, V39, P619, DOI 10.3109/00365517909108866; Mack ET, 2011, J AM CHEM SOC, V133, P11701, DOI 10.1021/ja2038084; Muntner P, 2009, KIDNEY INT, V76, P81, DOI 10.1038/ki.2009.76; Peuscher A, 2013, J IMMUNOASS IMMUNOCH, V35, P322; Polzikov MA, 2012, HYBRIDOMA, V31, P48, DOI 10.1089/hyb.2011.0078; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Rule AD, 2013, KIDNEY INT, V83, P1169, DOI 10.1038/ki.2013.7; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; SIMONSEN O, 1985, SCAND J CLIN LAB INV, V45, P97, DOI 10.3109/00365518509160980; Stocker M, 2003, PROTEIN EXPRES PURIF, V28, P211, DOI 10.1016/S1046-5928(02)00709-X; Thakkar H, 1998, KIDNEY INT, V54, P1197, DOI 10.1046/j.1523-1755.1998.00098.x; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V216, P440, DOI 10.1016/j.atherosclerosis.2011.02.016; Waters WR, 2011, CLIN VACCINE IMMUNOL, V18, P1882, DOI 10.1128/CVI.05343-11; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086066; Xiong FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088777; Yu KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050438	46	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147177	10.1371/journal.pone.0147177	http://dx.doi.org/10.1371/journal.pone.0147177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799562	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300068
J	Syed, MA; Choo-Wing, R; Homer, RJ; Bhandari, V				Syed, Mansoor A.; Choo-Wing, Rayman; Homer, Robert J.; Bhandari, Vineet			Role of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice Lungs	PLOS ONE			English	Article							VEGF RECEPTOR INHIBITOR; COLLAGEN-IV CONTRIBUTES; BRONCHOPULMONARY DYSPLASIA; PULMONARY-HYPERTENSION; INDUCED ANGIOGENESIS; PREVENTS ALVEOLAR; ANIMAL-MODELS; MOUSE MODEL; HYPEROXIA; RATS	Background The role of vascular endothelial growth factor (VEGF)-induced 3 different nitric oxide synthase (NOS) isoforms in lung development and injury in the newborn (NB) lung are not known. We hypothesized that VEGF-induced specific NOS pathways are critical regulators of lung development and injury. Methodology We studied NB wild type (WT), lung epithelial cell-targeted VEGF165 doxycycline-inducible overexpressing transgenic (VEGFTG), VEGFTG treated with a NOS1 inhibitor (L-NIO), VEGFTG x NOS2(-/-) and VEGFTG x NOS3(+/-) mice in room air (RA) for 7 postnatal (PN) days. Lung morphometry (chord length), vascular markers (Ang1, Ang2, Notch2, vWF, CD31 and VE-cadherin), cell proliferation (Ki67), vascular permeability, injury and oxidative stress markers (hemosiderin, nitrotyrosine and 8-OHdG) were evaluated. Results VEGF overexpression in RA led to increased chord length and vascular markers at PN7, which were significantly decreased to control values in VEGFTG x NOS2(-/-) and VEGFTG x NOS3(+/-) lungs. However, we found no noticeable effect on chord length and vascular markers in the VEGFTG/NOS1 inhibited group. In the NB VEGFTG mouse model, we found VEGF-induced vascular permeability in the NB murine lung was partially dependent on NOS2 and NOS3-signaling pathways. In addition, the inhibition of NOS2 and NOS3 resulted in a significant decrease in VEGF-induced hemosiderin, nitrotyrosine-and 8-OHdG positive cells at PN7. NOS1 inhibition had no significant effect. Conclusion Our data showed that the complete absence of NOS2 and partial deficiency of NOS3 confers protection against VEGF-induced pathologic lung vascular and alveolar developmental changes, as well as injury markers. Inhibition of NOS1 does not have any modulating role on VEGF-induced changes in the NB lung. Overall, our data suggests that there is a significant differential regulation in the NOS-mediated effects of VEGF overexpression in the developing mouse lung.	[Syed, Mansoor A.; Choo-Wing, Rayman; Bhandari, Vineet] Yale Univ, Dept Pediat, Div Perinatal Med, Sch Med, 333 Cedar St, New Haven, CT 06520 USA; [Homer, Robert J.] Yale Univ, Dept Pathol, Sch Med, 310 Cedar St, New Haven, CT 06520 USA; [Syed, Mansoor A.; Bhandari, Vineet] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Choo-Wing, Rayman] Novartis Inst BioMed Res, Cambridge, MA USA	Yale University; Yale University; Drexel University; Novartis	Bhandari, V (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	vineet.bhandari@drexelmed.edu	syed, mansoor ali/I-6957-2018; Bhandari, Vineet/AAS-3365-2020; homer, robert/P-3884-2019; syed, Mansoor ali/G-8986-2013	homer, robert/0000-0002-2055-5885; syed, Mansoor ali/0000-0003-2697-7832	NHLBI of the National Institutes of Health, USA [HL85103]; department of pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085103] Funding Source: NIH RePORTER	NHLBI of the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); department of pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant HL85103 (V.B.) from the NHLBI of the National Institutes of Health, USA. Additional funding from department of pediatrics (internal).	Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V290, pL1111, DOI 10.1152/ajplung.00431.2005; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; Bhandari V, 2008, AM J RESP CELL MOL, V39, P420, DOI 10.1165/rcmb.2007-0024OC; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Bhandari V, 2012, AM J RESP CELL MOL, V46, P668, DOI 10.1165/rcmb.2011-0074OC; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Choo-Wing R, 2013, AM J RESP CELL MOL, V48, P749, DOI 10.1165/rcmb.2012-0381OC; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Demchenko IT, 2008, AM J PHYSIOL-LUNG C, V294, pL984, DOI 10.1152/ajplung.00420.2007; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; Grisafi D, 2012, LUNG, V190, P419, DOI 10.1007/s00408-012-9382-z; Harijith A, 2011, AM J RESP CELL MOL, V44, P621, DOI 10.1165/rcmb.2010-0058OC; Knaapi J, 2015, PEDIATR PULM, V50, P164, DOI 10.1002/ppul.23011; Knaapi J, 2011, EXP LUNG RES, V37, P408, DOI 10.3109/01902148.2011.581738; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Li Z, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-54; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Lopez E, 2006, AM J RESP CELL MOL, V34, P738, DOI 10.1165/rcmb.2005-0254OC; Lu JI, 2007, J BIOL CHEM, V282, P22176, DOI 10.1074/jbc.M700063200; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Meller S, 2012, EXP LUNG RES, V38, P192, DOI 10.3109/01902148.2012.663454; O'Reilly MA, 2008, AM J RESP CRIT CARE, V177, P1103, DOI 10.1164/rccm.200712-1839OC; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Persson HL, 2011, CHEST, V139, P361, DOI 10.1378/chest.10-0818; Stewart JA, 2011, AM J PHYSIOL-CELL PH, V300, pC968, DOI 10.1152/ajpcell.00059.2011; Sun HX, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-27; Sureshbabu A, 2015, RESP RES, V16, DOI 10.1186/s12931-014-0162-6; Syed MA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/457189; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Wang HF, 2011, AM J PHYSIOL-CELL PH, V300, pC979, DOI 10.1152/ajpcell.00368.2010; Yuba T, 2007, RESP MED, V101, P793, DOI 10.1016/j.rmed.2006.08.001; Zhang XF, 2010, CHINESE MED J-PEKING, V123, P929, DOI 10.3760/cma.j.issn.0366-6999.2010.07.030	40	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147588	10.1371/journal.pone.0147588	http://dx.doi.org/10.1371/journal.pone.0147588			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799210	Green Submitted, gold, Green Published			2022-12-27	WOS:000368655300128
J	Beurskens, R; Haeger, M; Kliegl, R; Roecker, K; Granacher, U				Beurskens, Rainer; Haeger, Matthias; Kliegl, Reinhold; Roecker, Kai; Granacher, Urs			Postural Control in Dual-Task Situations: Does Whole-Body Fatigue Matter?	PLOS ONE			English	Article							MUSCLE FATIGUE; COGNITIVE TASK; ATTENTIONAL DEMANDS; BALANCE CONTROL; EXERCISE; GAIT; INTERFERENCE; POSITION; ANKLE; SWAY	Postural control is important to cope with demands of everyday life. It has been shown that both attentional demand (i.e., cognitive processing) and fatigue affect postural control in young adults. However, their combined effect is still unresolved. Therefore, we investigated the effects of fatigue on single-(ST) and dual-task (DT) postural control. Twenty young subjects (age: 23.7 +/- 2.7) performed an all-out incremental treadmill protocol. After each completed stage, one-legged-stance performance on a force platform under ST (i.e., one-legged-stance only) and DT conditions (i.e., one-legged-stance while subtracting serial 3s) was registered. On a second test day, subjects conducted the same balance tasks for the control condition (i.e., non-fatigued). Results showed that heart rate, lactate, and ventilation increased following fatigue (all p < 0.001; d = 4.2-21). Postural sway and sway velocity increased during DT compared to ST (all p < 0.001; d = 1.9-2.0) and fatigued compared to non-fatigued condition (all p < 0.001; d = 3.3-4.2). In addition, postural control deteriorated with each completed stage during the treadmill protocol (all p < 0.01; d = 1.9-3.3). The addition of an attention-demanding interference task did not further impede one-legged-stance performance. Although both additional attentional demand and physical fatigue affected postural control in healthy young adults, there was no evidence for an overadditive effect (i.e., fatigue-related performance decrements in postural control were similar under ST and DT conditions). Thus, attentional resources were sufficient to cope with the DT situations in the fatigue condition of this experiment.	[Beurskens, Rainer; Haeger, Matthias; Granacher, Urs] Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany; [Kliegl, Reinhold] Univ Potsdam, Dept Psychol, Div Cognit Psychol, Potsdam, Germany; [Roecker, Kai] Univ Furtwangen, Fac Appl Publ Hlth, Furtwangen, Germany; [Beurskens, Rainer] Heidelberg Univ, Agaples Bethanien Hosp Heidelberg, Geriatr Ctr, Heidelberg, Germany	University of Potsdam; University of Potsdam; Ruprecht Karls University Heidelberg	Beurskens, R (corresponding author), Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany.; Beurskens, R (corresponding author), Heidelberg Univ, Agaples Bethanien Hosp Heidelberg, Geriatr Ctr, Heidelberg, Germany.	rbeurskens@posteo.de	Kliegl, Reinhold/A-1276-2009; Kliegl, Reinhold/AAD-3463-2019; Granacher, Urs/GXM-3858-2022; Roecker, Kai/GOP-3245-2022; Meijer, Anna/K-5118-2016; Granacher, Urs/T-9900-2017; Granacher, Urs/N-1963-2019	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Granacher, Urs/0000-0002-7095-813X; Roecker, Kai/0000-0003-1133-2548; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Haeger, Mathias/0000-0001-9915-7478				Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bisson EJ, 2011, GAIT POSTURE, V33, P83, DOI 10.1016/j.gaitpost.2010.10.001; Boyas S., 2011, Annals of Physical and Rehabilitation Medicine, V54, P88, DOI 10.1016/j.rehab.2011.01.001; Bredin SSD, 2013, CAN FAM PHYSICIAN, V59, P273; Brickenkamp R., 1981, HDB PSYCHOL PADAGOGI, P270; Chong RKY, 2010, NEUROPSYCHOLOGIA, V48, P2709, DOI 10.1016/j.neuropsychologia.2010.05.018; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Douris PC, 2011, J STRENGTH COND RES, V25, P3299, DOI 10.1519/JSC.0b013e318215fa07; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Evans Daniel R, 2016, Pers Soc Psychol Rev, V20, P291, DOI 10.1177/1088868315597841; Finsterer J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-218; Fitts RH, 2006, ACSMS ADV EXERCISE P, P178; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Frey I., 2002, EUR J SPORT SCI, V2, P1, DOI [DOI 10.1080/17461390200072406, 10.1080/17461390200072406]; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Granacher U, 2011, GERONTOLOGY, V57, P247, DOI 10.1159/000322196; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; HUNTER IW, 1981, NEUROSCI LETT, V25, P155, DOI 10.1016/0304-3940(81)90324-4; Hwang JH, 2013, ANN REHABIL MED-ARM, V37, P347, DOI 10.5535/arm.2013.37.3.347; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Moore RD, 2012, J SPORT SCI, V30, P841, DOI 10.1080/02640414.2012.675083; Muehlbauer T, 2011, J STRENGTH COND RES, V25, P2228, DOI 10.1519/JSC.0b013e3181fb393b; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Prettin S, 2011, J SPORT MED PHYS FIT, V51, P179; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Reimer RC, 2010, J SCI MED SPORT, V13, P161, DOI 10.1016/j.jsams.2009.01.001; Schubert P, 2014, GAIT POSTURE, V39, P518, DOI 10.1016/j.gaitpost.2013.09.001; Simoneau M, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-22; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Stensdotter AK, 2013, J MOTOR BEHAV, V45, P279, DOI 10.1080/00222895.2013.791241; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Vuillerme N, 2002, MED SCI SPORT EXER, V34, P1907, DOI 10.1097/00005768-200212000-00008; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zech A, 2012, J STRENGTH COND RES, V26, P1162, DOI 10.1519/JSC.0b013e31822dfbbb; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147392	10.1371/journal.pone.0147392	http://dx.doi.org/10.1371/journal.pone.0147392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26796320	Green Published, Green Submitted, gold			2022-12-27	WOS:000368530300031
J	Foditsch, C; Oikonomou, G; Machado, VS; Bicalho, ML; Ganda, EK; Lima, SF; Rossi, R; Ribeiro, BL; Kussler, A; Bicalho, RC				Foditsch, Carla; Oikonomou, Georgios; Machado, Vinicius Silva; Bicalho, Marcela Luccas; Ganda, Erika Korzune; Lima, Svetlana Ferreira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Kussler, Arieli; Bicalho, Rodrigo Carvalho			Lameness Prevalence and Risk Factors in Large Dairy Farms in Upstate New York. Model Development for the Prediction of Claw Horn Disruption Lesions	PLOS ONE			English	Article							WHITE LINE DISEASE; COW-LEVEL PREVALENCE; BODY CONDITION; SOLE ULCERS; MILK-YIELD; DIGITAL DERMATITIS; STALL SURFACE; TIME BUDGETS; FOOT LESIONS; HERD-LEVEL	The main objectives of this prospective cohort study were a) to describe lameness prevalence at drying off in large high producing New York State herds based on visual locomotion score (VLS) and identify potential cow and herd level risk factors, and b) to develop a model that will predict the probability of a cow developing claw horn disruption lesions (CHDL) in the subsequent lactation using cow level variables collected at drying off and/or available from farm management software. Data were collected from 23 large commercial dairy farms located in upstate New York. A total of 7,687 dry cows, that were less than 265 days in gestation, were enrolled in the study. Farms were visited between May 2012 and March 2013, and cows were assessed for body condition score (BCS) and VLS. Data on the CHDL events recorded by the farm employees were extracted from the Dairy-Comp 305 database, as well as information regarding the studied cows' health events, milk production, and reproductive records throughout the previous and subsequent lactation period. Univariable analyses and mixed multivariable logistic regression models were used to analyse the data at the cow level. The overall average prevalence of lameness (VLS > 2) at drying off was 14%. Lactation group, previous CHDL, mature equivalent 305-d milk yield (ME305), season, BCS at drying off and sire PTA for strength were all significantly associated with lameness at the drying off (cow-level). Lameness at drying off was associated with CHDL incidence in the subsequent lactation, as well as lactation group, previous CHDL and ME305. These risk factors for CHDL in the subsequent lactation were included in our predictive model and adjusted predicted probabilities for CHDL were calculated for all studied cows. ROC analysis identified an optimum cut-off point for these probabilities and using this cut-off point we could predict CHDL incidence in the subsequent lactation with an overall specificity of 75% and sensitivity of 59%. Using this approach, we would have detected 33% of the studied population as being at risk, eventually identifying 59% of future CHDL cases. Our predictive model could help dairy producers focusing their efforts on CHDL reduction by implementing aggressive preventive measures for high risk cows.	[Foditsch, Carla; Oikonomou, Georgios; Machado, Vinicius Silva; Bicalho, Marcela Luccas; Ganda, Erika Korzune; Lima, Svetlana Ferreira; Rossi, Rodolfo; Ribeiro, Bruno Leonardo; Kussler, Arieli; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Oikonomou, Georgios] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Warrington, Cheshire, England	Cornell University; University of Liverpool	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ribeiro, Bruno Leonardo Mendonça/W-2138-2019; Ganda, Erika/AAD-6286-2020	Ribeiro, Bruno Leonardo Mendonça/0000-0002-4303-0504; Ganda, Erika/0000-0002-8735-0753; Rossi, Rodolfo/0000-0002-4776-1232	Elanco Animal Health; USDA/NIFA Federal Formula Funds project [NYC-478438]	Elanco Animal Health; USDA/NIFA Federal Formula Funds project	This study was supported by Elanco Animal Health (https://www.elanco.com), RCB received the grant; USDA/NIFA Federal Formula Funds project NYC-478438, RCB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the dairy producers who participated in this study for granting us access to their facilities, cows and herd records, and Peter Hausser who helped identify cooperator farms. This project was funded by Elanco Animal Health and by the USDA/NIFA Federal Formula Funds project NYC-478438.	Alawneh JI, 2014, PREV VET MED, V113, P72, DOI 10.1016/j.prevetmed.2013.10.010; Amory JR, 2008, PREV VET MED, V83, P381, DOI 10.1016/j.prevetmed.2007.09.007; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; BENNETT R., 2003, EC ASSESSMENT LIVEST; Bicalho RC, 2008, J DAIRY SCI, V91, P2653, DOI 10.3168/jds.2007-0744; Bicalho RC, 2007, J DAIRY SCI, V90, P3294, DOI 10.3168/jds.2007-0076; Bicalho RC, 2013, LIVEST SCI, V156, P96, DOI 10.1016/j.livsci.2013.06.007; Caixeta LS, 2011, CAN J VET RES, V75, P233; Calderon DF, 2011, J DAIRY SCI, V94, P2883, DOI 10.3168/jds.2010-3855; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; Chapinal N, 2014, J DAIRY SCI, V97, P4309, DOI 10.3168/jds.2014-8089; Chapinal N, 2013, J DAIRY SCI, V96, P318, DOI 10.3168/jds.2012-5940; Clarkson MJ, 1996, VET REC, V138, P563, DOI 10.1136/vr.138.23.563; Cook NB, 2007, J DAIRY SCI, V90, P1674, DOI 10.3168/jds.2006-634; Cook NB, 2004, J DAIRY SCI, V87, P2912, DOI 10.3168/jds.S0022-0302(04)73422-0; Cook NB, 2003, J AM VET MED ASSOC, V223, P1324, DOI 10.2460/javma.2003.223.1324; Cramer G, 2008, J DAIRY SCI, V91, P3888, DOI 10.3168/jds.2008-1135; de Vries M, 2015, PREV VET MED, V118, P80, DOI 10.1016/j.prevetmed.2014.11.016; Domecq JJ, 1997, J DAIRY SCI, V80, P101, DOI 10.3168/jds.S0022-0302(97)75917-4; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Eicher SD, 2013, J DAIRY SCI, V96, P3639, DOI 10.3168/jds.2012-6049; Fjeldaas T, 2011, J DAIRY SCI, V94, P1243, DOI 10.3168/jds.2010-3173; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Gomez A, 2010, J DAIRY SCI, V93, P5772, DOI 10.3168/jds.2010-3436; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Green LE, 2014, PREV VET MED, V113, P63, DOI 10.1016/j.prevetmed.2013.10.009; Hirst WM, 2002, PREV VET MED, V54, P191, DOI 10.1016/S0167-5877(02)00021-1; Holzhauer M, 2008, PREV VET MED, V85, P125, DOI 10.1016/j.prevetmed.2008.01.004; Husfeldt AW, 2012, J DAIRY SCI, V95, P5626, DOI 10.3168/jds.2011-5075; Huxley JN, 2004, VET REC, V155, P237, DOI 10.1136/vr.155.8.237; Huzzey JM, 2006, J DAIRY SCI, V89, P126, DOI 10.3168/jds.S0022-0302(06)72075-6; Linden TC, 2009, J DAIRY SCI, V92, P2580, DOI [10.3168/jds.2008-1603, 10.3168/jds.2008-1827]; Lischer CJ, 2002, VET REC, V151, P694; Machado VS, 2010, J DAIRY SCI, V93, P4071, DOI 10.3168/jds.2010-3177; Machado VS, 2011, AM J VET RES, V72, P1338, DOI 10.2460/ajvr.72.10.1338; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Oberbauer AM, 2013, J DAIRY SCI, V96, P605, DOI 10.3168/jds.2012-5485; Oikonomou G, 2013, J DAIRY SCI, V96, P3713, DOI 10.3168/jds.2012-6308; Raber M, 2004, VET J, V167, P258, DOI 10.1016/S1090-0233(03)00053-4; Tarlton JF, 2002, VET J, V163, P196, DOI 10.1053/tvjl.2001.0651; Telezhenko E, 2007, J DAIRY SCI, V90, P3716, DOI 10.3168/jds.2006-876; U.S. Department of Agriculture (USDA), 2010, OV US DAIR IND; Vanegas J, 2006, J DAIRY SCI, V89, P4251, DOI 10.3168/jds.S0022-0302(06)72471-7; Vergara CF, 2014, J DAIRY SCI, V97, P4127, DOI 10.3168/jds.2012-6440; von Keyserlingk MAG, 2012, J DAIRY SCI, V95, P7399, DOI 10.3168/jds.2012-5807; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Whay HR, 2003, VET REC, V153, P197, DOI 10.1136/vr.153.7.197	48	30	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0146718	10.1371/journal.pone.0146718	http://dx.doi.org/10.1371/journal.pone.0146718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795970	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300010
J	Albers, HJ; Busby, GM; Hamaide, B; Ando, AW; Polasky, S				Albers, Heidi J.; Busby, Gwenlyn M.; Hamaide, Bertrand; Ando, Amy W.; Polasky, Stephen			Spatially-Correlated Risk in Nature Reserve Site Selection	PLOS ONE			English	Article							BIOLOGICAL RESERVES; CONSERVATION; EXTINCTION; ALGORITHMS; MODELS; LANDSCAPES; COVERAGE; DESIGN	Establishing nature reserves protects species from land cover conversion and the resulting loss of habitat. Even within a reserve, however, many factors such as fires and defoliating insects still threaten habitat and the survival of species. To address the risk to species survival after reserve establishment, reserve networks can be created that allow some redundancy of species coverage to maximize the expected number of species that survive in the presence of threats. In some regions, however, the threats to species within a reserve may be spatially correlated. As examples, fires, diseases, and pest infestations can spread from a starting point and threaten neighboring parcels' habitats, in addition to damage caused at the initial location. This paper develops a reserve site selection optimization framework that compares the optimal reserve networks in cases where risks do and do not reflect spatial correlation. By exploring the impact of spatially-correlated risk on reserve networks on a stylized landscape and on an Oregon landscape, this analysis demonstrates an appropriate and feasible method for incorporating such post-reserve establishment risks in the reserve site selection literature as an additional tool to be further developed for future conservation planning.	[Albers, Heidi J.] Univ Wyoming, Haub Sch Environm & Nat Resources, Dept Econ & Finance, Laramie, WY 82072 USA; [Busby, Gwenlyn M.] GreenWood Resources, Portland, OR 97201 USA; [Hamaide, Bertrand] St Louis Univ, Dept Econ Social & Polit Sci, Brussels, Belgium; [Ando, Amy W.] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Wyoming; University Saint-Louis - Bruxelles; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities	Hamaide, B (corresponding author), St Louis Univ, Dept Econ Social & Polit Sci, Brussels, Belgium.	bertrand.hamaide@usaintlouis.be	Polasky, Stephen/AAC-5341-2019	Ando, Amy/0000-0002-3279-8075; Albers, Heidi J/0000-0002-3775-7870; Hamaide, Bertrand/0000-0002-1240-8367	GreenWood Resources	GreenWood Resources	The authors received no specific funding for this work. GreenWood Resources provided support in the form of salaries for authors [GB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arthur JL, 2004, ECOL APPL, V14, P1936, DOI 10.1890/02-5360; Bettinger P, 2002, SILVA FENN, V36, P561, DOI 10.14214/sf.545; Boston K, 1999, FOREST SCI, V45, P292; Camm JD, 1996, BIOL CONSERV, V78, P353, DOI 10.1016/0006-3207(95)00132-8; Camm JD, 2002, OPER RES, V50, P946, DOI 10.1287/opre.50.6.946.351; CBD (Convention on Biological Diversity), 2010, REV UPD STRAT PLAN T; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; Cohon J.L., 2004, MULTIOBJECTIVE PROGR; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Dissanayake S, 2014, HDB EC BIODIVERSITY; Dissanayake STM, 2011, ECOL ECON, V70, P2225, DOI 10.1016/j.ecolecon.2011.06.015; Drechsler M, 2004, BIODIVERS CONSERV, V13, P141, DOI 10.1023/B:BIOC.0000004316.91025.8c; Fischer DT, 2005, ENVIRON MODEL ASSESS, V10, P215, DOI 10.1007/s10666-005-9005-7; Flowers R, 2011, FOREST HLTH HIGHLIGH; Haight RG, 2000, OPER RES, V48, P697, DOI 10.1287/opre.48.5.697.12411; Hamaide B, 2006, ECOL ECON, V56, P570, DOI 10.1016/j.ecolecon.2005.03.009; Hamaide B, 2014, SOCIO-ECON PLAN SCI, V48, P158, DOI 10.1016/j.seps.2014.03.003; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; Hiebeler DE, 2007, J THEOR BIOL, V246, P136, DOI 10.1016/j.jtbi.2006.12.024; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Horan R, 2005, REV AGR ECON, V27, P483, DOI 10.1111/j.1467-9353.2005.00248.x; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Liu GL, 2006, ECOL MODEL, V194, P421, DOI 10.1016/j.ecolmodel.2005.10.028; McCarthy MA, 2000, BIODIVERS CONSERV, V9, P47, DOI 10.1023/A:1008953426795; McCarthy MA, 2011, ECOL LETT, V14, P470, DOI 10.1111/j.1461-0248.2011.01608.x; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moilanen A, 2002, ECOL APPL, V12, P913, DOI 10.1890/1051-0761(2002)012[0913:SSDSS]2.0.CO;2; Moilanen A., 2009, SPATIAL CONSERVATION; MURRAY AT, 1995, OR SPEKTRUM, V17, P193, DOI 10.1007/BF01719265; Nalle DJ, 2002, ENVIRON MODEL ASSESS, V7, P99, DOI 10.1023/A:1015697632040; Onal H, 2006, OPER RES, V54, P379, DOI 10.1287/opre.1060.0272; Onal H, 2003, P ROY SOC B-BIOL SCI, V270, P1487, DOI 10.1098/rspb.2003.2393; Parkhurst GM, 2007, ECOL ECON, V64, P344, DOI 10.1016/j.ecolecon.2007.07.009; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; ReVelle CS, 2002, ENVIRON MODEL ASSESS, V7, P71, DOI 10.1023/A:1015641514293; Shaw DC, 2011, J FOREST, V109, P109; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams JC, 2008, COMPUT OPER RES, V35, P488, DOI 10.1016/j.cor.2006.03.012; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; Ying X., 2012, THESIS VIRGINIA TECH	47	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146023	10.1371/journal.pone.0146023	http://dx.doi.org/10.1371/journal.pone.0146023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789127	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100022
J	Borucki, MK; Lao, V; Hwang, M; Gardner, S; Adney, D; Munster, V; Bowen, R; Allen, JE				Borucki, Monica K.; Lao, Victoria; Hwang, Mona; Gardner, Shea; Adney, Danielle; Munster, Vincent; Bowen, Richard; Allen, Jonathan E.			Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants	PLOS ONE			English	Article							DROMEDARY CAMELS; MERS-COV; NUCLEOCAPSID PROTEIN; ANTIBODIES; EMERGENCE	Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging human pathogen related to SARS virus. In vitro studies indicate this virus may have a broad host range suggesting an increased pandemic potential. Genetic and epidemiological evidence indicate camels serve as a reservoir for MERS virus but the mechanism of cross species transmission is unclear and many questions remain regarding the susceptibility of humans to infection. Deep sequencing data was obtained from the nasal samples of three camels that had been experimentally infected with a human MERS-CoV isolate. A majority of the genome was covered and average coverage was greater than 12,000x depth. Although only 5 mutations were detected in the consensus sequences, 473 intrahost single nucleotide variants were identified. Many of these variants were present at high frequencies and could potentially influence viral phenotype and the sensitivity of detection assays that target these regions for primer or probe binding.	[Borucki, Monica K.; Lao, Victoria; Hwang, Mona; Gardner, Shea; Allen, Jonathan E.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Adney, Danielle; Bowen, Richard] Colorado State Univ, Ft Collins, CO 80523 USA; [Munster, Vincent] NIH, Rocky Mt Labs, Hamilton, MT USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Colorado State University; National Institutes of Health (NIH) - USA	Borucki, MK (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	borucki2@llnl.gov	Munster, Vincent/I-7607-2018	Munster, Vincent/0000-0002-2288-3196; Allen, Jonathan/0000-0002-4359-8263	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NIH S10 Instrumentation Grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609; Aronesty E., 2011, EA UTILS COMMAND LIN; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Borucki MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052752; Bouvet M, 2014, J BIOL CHEM, V289, P25783, DOI 10.1074/jbc.M114.577353; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chen Y, 2013, J VIROL, V87, P6296, DOI 10.1128/JVI.00061-13; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Chen-Harris H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-96; Corman V, ASSAYS LAB CONFIRMAT; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Frey KG, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00324-14; Gardner Shea N., 2014, Advances in Bioinformatics, V2014, P101894, DOI 10.1155/2014/101894; Gitlin L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004529; Goh GKM, 2012, J PATHOG, V2012, DOI 10.1155/2012/738590; Goh GK-M, 2013, PLOS CURRENTS, V5; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Holtgrewe M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-210; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; LU L, 2014, NAT COMMUN, V5; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Mackay IM, VIRUS RES; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; ROUX L, 1991, ADV VIRUS RES, V40, P181; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; Timm C, 2014, J VIROL, V88, P2623, DOI 10.1128/JVI.02675-13; Vabret A, 2006, J GEN VIROL, V87, P3349, DOI 10.1099/vir.0.82065-0; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Xu DP, 2004, NEW ENGL J MED, V350, P1366, DOI 10.1056/NEJMc032421; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146251	10.1371/journal.pone.0146251	http://dx.doi.org/10.1371/journal.pone.0146251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790002	gold, Green Published, Green Submitted			2022-12-27	WOS:000368529100029
J	Holstein, DM; Smith, TB; Paris, CB				Holstein, Daniel M.; Smith, Tyler B.; Paris, Claire B.			Depth-Independent Reproduction in the Reef Coral Porites astreoides from Shallow to Mesophotic Zones	PLOS ONE			English	Article							US VIRGIN-ISLANDS; STYLOPHORA-PISTILLATA; CARIBBEAN REEF; SEXUAL REPRODUCTION; RED-SEA; GROWTH; DEEP; VARIABILITY; SKELETONS; FECUNDITY	Mesophotic coral ecosystems between 30-150 m may be important refugia habitat for coral reefs and associated benthic communities from climate change and coastal development. However, reduced light at mesophotic depths may present an energetic challenge to the successful reproduction of light-dependent coral organisms, and limit this refugia potential. Here, the relationship of depth and fecundity was investigated in a brooding depth-generalist scleractinian coral, Porites astreoides from 5-37 m in the U.S. Virgin Islands (USVI) using paraffin tissue histology. Despite a trend of increasing planulae production with depth, no significant differences were found in mean peak planulae density between shallow, mid-depth and mesophotic sites. Differential planulae production over depth is thus controlled by P. astreoides coral cover, which peaks at 10 m and similar to 35 m in the USVI. These results suggest that mesophotic ecosystems are reproductive refuge for P. astreoides in the USVI, and may behave as refugia for P. astreoides metapopulations providing that vertical larval exchanges are viable.	[Holstein, Daniel M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Holstein, Daniel M.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Ocean Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of Miami; University of the Virgin Islands; University of Miami	Holstein, DM (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.; Holstein, DM (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	daniel.holstein@uvi.edu	Holstein, Daniel/ABA-6674-2020	Holstein, Daniel/0000-0002-9933-833X; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research; Black Coral Penalty Fund; Natural Environment Research Council; European Union Future of Reefs in a Changing Environment project; National Science Foundation [OCE-0928423]; EU FORCE project	US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research; Black Coral Penalty Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Union Future of Reefs in a Changing Environment project; National Science Foundation(National Science Foundation (NSF)); EU FORCE project	Research was supported by the US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research (to TBS, CBP and DMH) and the Black Coral Penalty Fund (TBS). Further support was provided through the Natural Environment Research Council, European Union Future of Reefs in a Changing Environment project and the National Science Foundation OCE-0928423 (to CBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the US National Science Foundation-Virgin Islands Experimental Program to Stimulate Competitive Research (to TBS, CBP and DMH) and the Black Coral Penalty Fund (TBS). Further support was provided through the Natural Environment Research Council and EU FORCE project and the National Science Foundation OCE-0928423 (to CBP). V. Brandtneris contributed to field operations, and A. Moulding and D.A. Renegar provided expertise in coral histology. P. Ruiz and S. Philip provided the Olympus VS120-S5 digital slide scanner. The research herein reflects the views of the authors and does not necessarily reflect the views of the funding agencies.	Armstrong RA, 2007, CORAL REEFS, V26, P945, DOI 10.1007/s00338-007-0286-y; Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; BOSSCHER H, 1993, CORAL REEFS, V12, P97, DOI 10.1007/BF00302109; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V351, P27, DOI 10.1016/j.jembe.2007.05.038; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; GATTUSO JP, 1993, MAR ECOL PROG SER, V92, P267, DOI 10.3354/meps092267; GLEASON DF, 1995, MAR BIOL, V123, P693, DOI 10.1007/BF00349112; GOREAU TF, 1967, B MAR SCI, V17, P442; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Holstein DM, 2016, CORAL REEFS, V35, P23, DOI 10.1007/s00338-015-1339-2; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Menza C, 2008, REV BIOL TROP, V56, P11; Prasetia R, 2016, CORAL REEFS, V35, P53, DOI 10.1007/s00338-015-1348-1; RICHMOND RH, 1987, B MAR SCI, V41, P594; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serrano X., 2013, THESIS; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Smith TB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00107.1; Smith TB, 2010, CORAL REEFS, V29, P289, DOI 10.1007/s00338-009-0575-8; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Smith TB, 2011, ANN REPORT; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Villinski JT, 2003, MAR BIOL, V142, P1043, DOI 10.1007/s00227-002-0997-0; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; WOLGAST LJ, 1983, BOT GAZ, V144, P260, DOI 10.1086/337371; Xu DR, 2009, MAGN RESON IMAGING, V27, P311, DOI 10.1016/j.mri.2008.07.018	42	39	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146068	10.1371/journal.pone.0146068	http://dx.doi.org/10.1371/journal.pone.0146068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789408	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100024
J	Lopes, FB; da Silva, MC; Magnabosco, CU; Narciso, MG; Sainz, RD				Lopes, Fernando Brito; da Silva, Marcelo Correa; Magnabosco, Claudio Ulhoa; Narciso, Marcelo Goncalves; Sainz, Roberto Daniel			Selection Indices and Multivariate Analysis Show Similar Results in the Evaluation of Growth and Carcass Traits in Beef Cattle	PLOS ONE			English	Article							GENETIC-PARAMETERS; BREEDING VALUES; PERFORMANCE TESTS; BAYESIAN-ANALYSIS; MULTIPLE TRAITS; BULL SELECTION; NELLORE CATTLE; WEIGHT; COMPONENTS; VARIANCE	This research evaluated a multivariate approach as an alternative tool for the purpose of selection regarding expected progeny differences (EPDs). Data were fitted using a multi-trait model and consisted of growth traits (birth weight and weights at 120, 210, 365 and 450 days of age) and carcass traits (longissimus muscle area (LMA), back-fat thickness (BF), and rump fat thickness (RF)), registered over 21 years in extensive breeding systems of Polled Nellore cattle in Brazil. Multivariate analyses were performed using standardized (zero mean and unit variance) EPDs. The k mean method revealed that the best fit of data occurred using three clusters (k = 3) (P < 0.001). Estimates of genetic correlation among growth and carcass traits and the estimates of heritability were moderate to high, suggesting that a correlated response approach is suitable for practical decision making. Estimates of correlation between selection indices and the multivariate index (LD1) were moderate to high, ranging from 0.48 to 0.97. This reveals that both types of indices give similar results and that the multivariate approach is reliable for the purpose of selection. The alternative tool seems very handy when economic weights are not available or in cases where more rapid identification of the best animals is desired. Interestingly, multivariate analysis allowed forecasting information based on the relationships among breeding values (EPDs). Also, it enabled fine discrimination, rapid data summarization after genetic evaluation, and permitted accounting for maternal ability and the genetic direct potential of the animals. In addition, we recommend the use of longissimus muscle area and subcutaneous fat thickness as selection criteria, to allow estimation of breeding values before the first mating season in order to accelerate the response to individual selection.	[Lopes, Fernando Brito] Univ Wisconsin, Coll Agr & Life Sci, Anim Sci Bldg,1675 Observ Dr, Madison, WI 53706 USA; [da Silva, Marcelo Correa] Univ Fed Goias, Programa Pos Grad Ciencia Anim, Escola Vet & Zootecnia, Campus 2, BR-74001970 Goiania, Go, Brazil; [Magnabosco, Claudio Ulhoa] Embrapa Cerrados CNPq, BR 020 Km 18,POB 08223, BR-73310970 Planaltina, DF, Brazil; [Narciso, Marcelo Goncalves] Embrapa Rice & Beans, Rodovia GO 462,Km 12, BR-75375000 Santo Antonio De Goias, Go, Brazil; [Sainz, Roberto Daniel] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; Universidade Federal de Goias; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of California System; University of California Davis	Lopes, FB (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Anim Sci Bldg,1675 Observ Dr, Madison, WI 53706 USA.	camult@gmail.com	Silva, Marcelo/AAE-4532-2021; Magnabosco, Cláudio Ulhoa/ABC-4494-2021	Silva, Marcelo/0000-0002-7599-1967; Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; Daniel Sainz Gonzalez, Roberto/0000-0002-4925-8614	CNPq (National Council of Technological and Scientific Development)	CNPq (National Council of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CNPq (National Council of Technological and Scientific Development) provided post-doctoral and doctoral scholarships for the first and second author.	Neto FRA, 2011, GENET MOL RES, V10, P3127, DOI 10.4238/2011.December.19.1; Baath R., 2014, TEST FUNCTIONS R P U, V2014, P2; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertazzo RP, 2004, REV BRAS ZOOTECN, V33, P1118, DOI 10.1590/S1516-35982004000500003; Boligon AA, 2009, REV BRAS ZOOTECN, V38, P2320, DOI 10.1590/S1516-35982009001200005; Buzanskas ME, 2013, REPROD FERT DEVELOP, V25, P775, DOI 10.1071/RD12132; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Coffey MP, 2006, J DAIRY SCI, V89, P322, DOI 10.3168/jds.S0022-0302(06)72097-5; de Faria CU, 2015, CIENC RURAL, V45, P317, DOI 10.1590/0103-8478cr20140331; Santos Geneíldes Cristina de Jesus, 2012, Acta Sci., Anim. Sci., V34, P97, DOI 10.4025/actascianimsci.v34i1.12172; Lira Thaymisson Santos de, 2013, Ciênc. anim. bras., V14, P23, DOI 10.5216/cab.v14i1.16785; de Sousa JER, 2008, PESQUI AGROPECU BRAS, V43, P1725, DOI 10.1590/S0100-204X2008001200012; Dias LT, 2005, REV BRAS ZOOTECN, V34, P1914, DOI 10.1590/S1516-35982005000600015; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Eler JP, 2000, REV BRAS ZOOTECN, V29, P1642, DOI 10.1590/S1516-35982000000600007; Faria CU, 2009, ARQ BRAS MED VET ZOO, V61, P949, DOI 10.1590/S0102-09352009000400025; FAS, 2015, BEEF VEAL SEL COUNTR, P1; GELFAND AE, 1992, J AM STAT ASSOC, V87, P523, DOI 10.2307/2290286; GROEN AF, 1995, LIVEST PROD SCI, V41, P201, DOI 10.1016/0301-6226(94)00062-C; Guidolin DGF, 2012, ANIM PROD SCI, V52, P975, DOI 10.1071/AN11037; Hazel LN, 1943, GENETICS, V28, P476; Hazel LN, 1942, J HERED, V33, P393, DOI 10.1093/oxfordjournals.jhered.a105102; Heydarpour M, 2008, J ANIM BREED GENET, V125, P89, DOI 10.1111/j.1439-0388.2007.00703.x; Kluyts JF, 2007, S AFR J ANIM SCI, V37, P122; LIN CY, 1990, J ANIM BREED GENET, V107, P311, DOI 10.1111/j.1439-0388.1990.tb00040.x; Lopes F. B., 2011, Revista Brasileira de Saude e Producao Animal, V12, P607; Lopes FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075423; Lopes FB, 2013, TROP ANIM HEALTH PRO, V45, P1375, DOI 10.1007/s11250-013-0373-8; Marques EG, 2013, BIOSCI J, V29, P159; Lima PRM, 2013, TROP ANIM HEALTH PRO, V45, P1627, DOI 10.1007/s11250-013-0408-1; Meyer K, 1997, LIVEST PROD SCI, V52, P187, DOI 10.1016/S0301-6226(97)00144-9; MISZTAL I., 2015, MANUAL BLUPF90 FAMIL, P125; Osorio-Avalos J, 2015, LIVEST SCI, V176, P54, DOI 10.1016/j.livsci.2015.03.029; R CORE TEAM, 2014, R LANG ENV STAT COMP, P1; Ribeiro MN, 2001, REV BRAS ZOOTECN, V30, P1224, DOI 10.1590/S1516-35982001000500014; Robinson DL, 1997, LIVEST PROD SCI, V47, P277, DOI 10.1016/S0301-6226(96)01396-6; SAS Institute Inc, 2009, SAS STAT 9 2 US GUID, P7886; Savegnago RP, 2011, POULTRY SCI, V90, P2174, DOI 10.3382/ps.2011-01474; SCHNEEBERGER M, 1992, J ANIM BREED GENET, V109, P180, DOI 10.1111/j.1439-0388.1992.tb00395.x; Searle SR., 1992, VARIANCE COMPONENTS; Silva JAI, 2006, LIVEST SCI, V99, P51, DOI 10.1016/j.livprodsci.2005.05.022; Souza JC, 2005, ARCH LATINOAM PROD A, V11, P94, DOI [10.1590/S1516-35982011000300014, DOI 10.1590/S1516-35982011000300014]; TOSH JJ, 1994, J ANIM SCI, V72, P1184, DOI 10.2527/1994.7251184x; Val JE, 2008, ARQ BRAS MED VET ZOO, V60, P705, DOI 10.1590/S0102-09352008000300027; WILLHAM RL, 1972, J ANIM SCI, V35, P1288; Yokoo MJ, 2010, J ANIM SCI, V88, P52, DOI 10.2527/jas.2008-1028; Yokoo MJ, 2007, REV BRAS ZOOTECN, V36, P1761, DOI 10.1590/S1516-35982007000800008; Zuin RG, 2012, MEAT SCI, V91, P352, DOI 10.1016/j.meatsci.2012.02.018	48	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147180	10.1371/journal.pone.0147180	http://dx.doi.org/10.1371/journal.pone.0147180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789008	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100063
J	Wiener, DJ; Doherr, MG; Muller, EJ; Welle, MM				Wiener, Dominique J.; Doherr, Marcus G.; Mueller, Eliane J.; Welle, Monika M.			Spatial Distribution of Stem Cell-Like Keratinocytes in Dissected Compound Hair Follicles of the Dog	PLOS ONE			English	Article							BULGE CELLS; EXISTENCE; LOCATION; ALOPECIA; RESIDE; NICHE; GUIDE; CYCLE; SKIN	Hair cycle disturbances are common in dogs and comparable to some alopecic disorders in humans. A normal hair cycle is maintained by follicular stem cells which are predominately found in an area known as the bulge. Due to similar morphological characteristics of the bulge area in humans and dogs, the shared particularity of compound hair follicles as well as similarities in follicular biomarker expression, the dog is a promising model to study human hair cycle and stem cell disorders. To gain insight into the spatial distribution of follicular keratinocytes with stem cell potential in canine compound follicles, we microdissected hair follicles in anagen and telogen from skin samples of freshly euthanized dogs. The keratinocytes isolated from different locations were investigated for their colony forming efficiency, growth and differentiation potential as well as clonal growth. Our results indicate that i) compound and single hair follicles exhibit a comparable spatial distribution pattern with respect to cells with high growth potential and stem cell-like characteristics, ii) the lower isthmus (comprising the bulge) harbors most cells with high growth potential in both, the anagen and the telogen hair cycle stage, iii) unlike in other species, colonies with highest growth potential are rather small with an irregular perimeter and iv) the keratinocytes derived from the bulbar region exhibit characteristics of actively dividing transit amplifying cells. Our results now provide the basis to conduct comparative studies of normal dogs and those with hair cycle disorders with the possibility to extend relevant findings to human patients.	[Wiener, Dominique J.; Mueller, Eliane J.; Welle, Monika M.] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland; [Wiener, Dominique J.; Mueller, Eliane J.; Welle, Monika M.] Univ Hosp Bern, Inselspital, Vetsuisse Fac, Dermfocus, CH-3010 Bern, Switzerland; [Doherr, Marcus G.] Free Univ Berlin, Dept Vet Med, Inst Vet Epidemiol & Biostat, Berlin, Germany; [Mueller, Eliane J.] Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; Free University of Berlin; University of Bern; University Hospital of Bern	Wiener, DJ (corresponding author), Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland.; Wiener, DJ (corresponding author), Univ Hosp Bern, Inselspital, Vetsuisse Fac, Dermfocus, CH-3010 Bern, Switzerland.	dominique.wiener@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Wiener, Dominique Judith/AAN-3313-2021	Doherr, Marcus/0000-0003-0064-1708				BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Gerhards NM, 2016, J HISTOCHEM CYTOCHEM, V64, P190, DOI 10.1369/0022155415627679; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; Kobayashi T, 2010, J INVEST DERMATOL, V130, P1988, DOI 10.1038/jid.2010.68; Kobayashi T, 2009, VET DERMATOL, V20, P338, DOI 10.1111/j.1365-3164.2009.00815.x; LAVKER RM, 1983, J INVEST DERMATOL, V81, pS121, DOI 10.1111/1523-1747.ep12540880; Lyle S, 1998, J CELL SCI, V111, P3179; Muntener T, 2012, VET DERMATOL, V23, P206, DOI 10.1111/j.1365-3164.2012.01049.x; Muntener T, 2011, VET DERMATOL, V22, P383, DOI 10.1111/j.1365-3164.2011.00963.x; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Purba TS, 2014, BIOESSAYS, V36, P513, DOI 10.1002/bies.201300166; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rompolas P, 2014, SEMIN CELL DEV BIOL, V25, P34, DOI 10.1016/j.semcdb.2013.12.005; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wiener DJ, 2015, VET DERMATOL, V26, P198, DOI 10.1111/vde.12192	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146937	10.1371/journal.pone.0146937	http://dx.doi.org/10.1371/journal.pone.0146937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788850	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100047
J	Hald, T; Aspinall, W; Devleesschauwer, B; Cooke, R; Corrigan, T; Havelaar, AH; Gibb, HJ; Torgerson, PR; Kirk, MD; Angulo, FJ; Lake, RJ; Speybroeck, N; Hoffmann, S				Hald, Tine; Aspinall, Willy; Devleesschauwer, Brecht; Cooke, Roger; Corrigan, Tim; Havelaar, Arie H.; Gibb, Herman J.; Torgerson, Paul R.; Kirk, Martyn D.; Angulo, Fred J.; Lake, Robin J.; Speybroeck, Niko; Hoffmann, Sandra			World Health Organization Estimates of the Relative Contributions of Food to the Burden of Disease Due to Selected Foodborne Hazards: A Structured Expert Elicitation	PLOS ONE			English	Article							SOURCE ATTRIBUTION; HUMAN SALMONELLOSIS; PUBLIC-HEALTH; UNITED-STATES; HUMAN CAMPYLOBACTERIOSIS; RISK-ASSESSMENT; CLIMATE-CHANGE; OUTBREAK DATA; NEW-ZEALAND; JUDGMENT	Background The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in 2007 by the World Health Organization (WHO) to estimate the global burden of foodborne diseases (FBDs). This estimation is complicated because most of the hazards causing FBD are not transmitted solely by food; most have several potential exposure routes consisting of transmission from animals, by humans, and via environmental routes including water. This paper describes an expert elicitation study conducted by the FERG Source Attribution Task Force to estimate the relative contribution of food to the global burden of diseases commonly transmitted through the consumption of food. Methods and Findings We applied structured expert judgment using Cooke's Classical Model to obtain estimates for 14 subregions for the relative contributions of different transmission pathways for eleven diarrheal diseases, seven other infectious diseases and one chemical (lead). Experts were identified through international networks followed by social network sampling. Final selection of experts was based on their experience including international working experience. Enrolled experts were scored on their ability to judge uncertainty accurately and informatively using a series of subject-matter specific 'seed' questions whose answers are unknown to the experts at the time they are interviewed. Trained facilitators elicited the 5th, and 50th and 95th percentile responses to seed questions through telephone interviews. Cooke's Classical Model uses responses to the seed questions to weigh and aggregate expert responses. After this interview, the experts were asked to provide 5th, 50th, and 95th percentile estimates for the 'target' questions regarding disease transmission routes. A total of 72 experts were enrolled in the study. Ten panels were global, meaning that the experts should provide estimates for all 14 subregions, whereas the nine panels were subregional, with experts providing estimates for one or more subregions, depending on their experience in the region. The size of the 19 hazard-specific panels ranged from 6 to 15 persons with several experts serving on more than one panel. Pathogens with animal reservoirs (e.g. non-typhoidal Salmonella spp. and Toxoplasma gondii) were in general assessed by the experts to have a higher proportion of illnesses attributable to food than pathogens with mainly a human reservoir, where human-to-human transmission (e.g. Shigella spp. and Norovirus) or waterborne transmission (e.g. Salmonella Typhi and Vibrio cholerae) were judged to dominate. For many pathogens, the foodborne route was assessed relatively more important in developed subregions than in developing subregions. The main exposure routes for lead varied across subregions, with the foodborne route being assessed most important only in two subregions of the European region. Conclusions For the first time, we present worldwide estimates of the proportion of specific diseases attributable to food and other major transmission routes. These findings are essential for global burden of FBD estimates. While gaps exist, we believe the estimates presented here are the best current source of guidance to support decision makers when allocating resources for control and intervention, and for future research initiatives.	[Hald, Tine] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Aspinall, Willy] Aspinall & Associates, Tisbury, England; [Aspinall, Willy] Univ Bristol, Bristol, England; [Devleesschauwer, Brecht] Univ Ghent, Merelbeke, Belgium; [Devleesschauwer, Brecht; Speybroeck, Niko] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, B-2000 Antwerp, Belgium; [Cooke, Roger] Resources Future Inc, Washington, DC USA; [Cooke, Roger] Delft Univ Technol, Delft, Netherlands; [Corrigan, Tim] WHO, CH-1211 Geneva, Switzerland; [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Havelaar, Arie H.] Univ Florida, Gainesville, FL USA; [Havelaar, Arie H.] Univ Utrecht, Utrecht, Netherlands; [Gibb, Herman J.] Gibb Epidemiol Consulting LLC, Arlington, VA USA; [Torgerson, Paul R.] Univ Zurich, Zurich, Switzerland; [Kirk, Martyn D.] Australian Natl Univ, Canberra, ACT, Australia; [Angulo, Fred J.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Hoffmann, Sandra] Econ Res Serv, USDA, Washington, DC USA	Technical University of Denmark; University of Bristol; Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Resources for the Future; Delft University of Technology; World Health Organization; Netherlands National Institute for Public Health & the Environment; State University System of Florida; University of Florida; Utrecht University; University of Zurich; Australian National University; Centers for Disease Control & Prevention - USA; Institute of Environmental Science & Research (ESR) - New Zealand; United States Department of Agriculture (USDA)	Hald, T (corresponding author), Tech Univ Denmark, DK-2800 Lyngby, Denmark.	tiha@food.dtu.dk	Torgerson, Paul R/A-7510-2010; Torgerson, Paul R/M-4447-2013; Havelaar, Arie H./P-8495-2014; Devleesschauwer, Brecht/G-9895-2018; Hald, Tine/B-5477-2016; Aspinall, Willy/AAW-1022-2020	Torgerson, Paul R/0000-0003-4277-9983; Torgerson, Paul R/0000-0003-4277-9983; Havelaar, Arie H./0000-0002-6456-5460; Devleesschauwer, Brecht/0000-0002-2867-6892; Hald, Tine/0000-0002-1115-9792; Aspinall, Willy/0000-0001-6014-6042; Speybroeck, Niko/0000-0003-3322-3502; Hoffmann, Sandra/0000-0003-2537-8731; Kirk, Martyn/0000-0001-5432-5984	Aspinall Associate; Gibb Epidemiology Consulting LLC; United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE)] [NE/J017450/1]; Natural Environment Research Council [NE/J017450/1] Funding Source: researchfish; NERC [NE/J017450/1] Funding Source: UKRI	Aspinall Associate; Gibb Epidemiology Consulting LLC; United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE)]; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was commissioned and paid for by the World Health Organization. Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. Aspinall & Associate and Gibb Epidemiology Consulting LLC provided support in the form of salaries for authors [WA, HJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The work by WPA was further supported by the United Kingdom Natural Environment Research Council [Consortium on Risk in the Environment: Diagnostics, Integration, Benchmarking, Learning and Elicitation (CREDIBLE); grant number NE/J017450/1]. This Council provided support in form of salary, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.764; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3502; [Anonymous], 2014, R LANG ENV STAT COMP; Arnell NW, 2005, RISK ANAL, V25, P1419, DOI 10.1111/j.1539-6924.2005.00689.x; Aspinall W, 1998, PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4, P2113; Aspinall WP, 2006, STATISTICS IN VOLCANOLOGY, P15; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Aspinall WP, 2015, PLOS ONE IN PRESS; Bamber JL, 2013, NAT CLIM CHANGE, V3, P424, DOI [10.1038/nclimate1778, 10.1038/NCLIMATE1778]; Baxter PJ, 2008, J VOLCANOL GEOTH RES, V178, P454, DOI 10.1016/j.jvolgeores.2008.08.015; Boysen L, 2014, EPIDEMIOL INFECT, V142, P1599, DOI 10.1017/S0950268813002719; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chan M, 2014, LANCET, V384, P1910, DOI 10.1016/S0140-6736(14)62037-7; Cooke R.M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2004, J RISK RES, V7, P643, DOI 10.1080/1366987042000192237; Cooke RM, 2000, RADIAT PROT DOSIM, V90, P303, DOI 10.1093/oxfordjournals.rpd.a033152; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P657, DOI 10.1016/j.ress.2007.03.005; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P745, DOI 10.1016/j.ress.2007.03.017; Cooke RM, 2006, RELIAB ENG SYST SAFE, V91, P1364, DOI 10.1016/j.ress.2005.11.054; Cooke RM, 2015, NAT CLIM CHANGE, V5, P8, DOI 10.1038/nclimate2466; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; De Knegt LV, 2015, EPIDEMIOL INFECT, V143, P1175, DOI 10.1017/S0950268814001903; Devleesschauwer B, 2015, PLOS ONE IN PRESS; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172; Evers E. G., 2008, International Journal of Risk Assessment & Management, V8, P174, DOI 10.1504/IJRAM.2008.016151; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flandoli F, 2011, RELIAB ENG SYST SAFE, V96, P1292, DOI 10.1016/j.ress.2011.05.012; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Gibb H, 2015, PLOS MED UNPUB; Gkogka E, 2011, EMERG INFECT DIS, V17, P1581, DOI 10.3201/eid1709.101766; Guo CF, 2011, FOODBORNE PATHOG DIS, V8, P509, DOI 10.1089/fpd.2010.0714; Hald T, 2004, RISK ANAL, V24, P255, DOI 10.1111/j.0272-4332.2004.00427.x; Havelaar AH, 2007, ZOONOSES PUBLIC HLTH, V54, P103, DOI 10.1111/j.1863-2378.2007.01036.x; Havelaar AH, 2015, PLOS MED IN PRESS; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Kirk MD, 2015, PLOS MED IN PRESS; Lake RJ, 2010, RISK ANAL, V30, P743, DOI 10.1111/j.1539-6924.2009.01269.x; Lempert R, 2004, CLIMATIC CHANGE, V65, P1, DOI 10.1023/B:CLIM.0000037561.75281.b3; Little CL, 2010, FOODBORNE PATHOG DIS, V7, P749, DOI 10.1089/fpd.2009.0439; Mangen MJJ, 2010, RISK ANAL, V30, P782, DOI 10.1111/j.1539-6924.2009.01291.x; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Neri A, 2008, J VOLCANOL GEOTH RES, V178, P397, DOI 10.1016/j.jvolgeores.2008.05.014; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pires SM, 2014, FOODBORNE PATHOG DIS, V11, P667, DOI 10.1089/fpd.2014.1744; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Pires SM, 2012, INT J FOOD MICROBIOL, V152, P129, DOI 10.1016/j.ijfoodmicro.2011.04.018; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P1463, DOI 10.1089/fpd.2010.0582; Rice J, 2007, MATH STAT DATA ANAL, P353; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Tauxe RV, 2010, INT J FOOD MICROBIOL, V139, pS16, DOI 10.1016/j.ijfoodmicro.2009.10.014; Torgerson PR, 2015, PLOS MED IN PRESS; Tyshenko M.G., 2012, INT J RISK ASSESS MA, V16, P48, DOI [10.1504/ijram.2012.047552, DOI 10.1504/IJRAM.2012.047552, 10.1504/IJRAM.2012.047552.]; Tyshenko MG, 2011, J TOXICOL ENV HEAL A, V74, P261, DOI 10.1080/15287394.2011.529783; Vally H, 2014, FOODBORNE PATHOG DIS, V11, P727, DOI 10.1089/fpd.2014.1746; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; von Krauss MPK, 2004, RISK ANAL, V24, P1515, DOI 10.1111/j.0272-4332.2004.00546.x; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	63	118	119	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145839	10.1371/journal.pone.0145839	http://dx.doi.org/10.1371/journal.pone.0145839			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784029	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000368528400021
J	Jiang, DH; Xiao, XQ; Fu, TS; Mashaghi, A; Liu, QH; Hong, JX				Jiang, Donghong; Xiao, Xiangqian; Fu, Tongsheng; Mashaghi, Alireza; Liu, Qinghuai; Hong, Jiaxu			Transient Tear Film Dysfunction after Cataract Surgery in Diabetic Patients	PLOS ONE			English	Article							DRY EYE DISEASE; PHACOEMULSIFICATION; PREVALENCE; SENSATION; OUTCOMES; CHINA	Purpose Diabetes mellitus is an increasingly common systemic disease. Many diabetic patients seek cataract surgery for a better visual acuity. Unlike in the general population, the influence of cataract surgery on tear film function in diabetic patients remains elusive. The aim of this study was to evaluate the tear function in diabetic and nondiabetic patients following cataract surgery. Methods In this prospective, interventional case series, 174 diabetic patients without dry eye syndrome (DES) and 474 age-matched nondiabetic patients as control who underwent phacoemulsification were enrolled at two different eye centers between January 2011 and January 2013. Patients were followed up at baseline and at 7 days, 1 month, and 3 months postoperatively. Ocular symptom scores (Ocular Surface Disease Index, OSDI) and tear film function including tear film stability (tear film break-up time, TBUT), corneal epithelium integrity (corneal fluorescein staining, CFS), and tear secretion (Schirmer's I test, SIT) were evaluated. Results In total, 83.9% of the diabetic patients (146 cases with 185 eyes) and 89.0% of the nondiabetic patients (422 cases with 463 eyes) completed all check-ups after the interventions (P = 0.095). The incidence of DES was 17.1% in the diabetic patients and 8.1% in the nondiabetic patients at 7 days after cataract surgery. In the diabetic patients, the incidence of DES remained 4.8% at 1 month postoperatively and decreased to zero at 3 months after surgery. No DES was diagnosed in nondiabetic patients at either the 1-month or 3-month follow-up. Compared with the baseline, the diabetic patients had worse symptom scores and lower TBUT values at 7 days and 1 month but not at 3 months postoperatively. In the nondiabetic patients, symptom scores and TBUT values had returned to preoperative levels at 1-month check-up. CFS scores and SIT values did not change significantly postoperatively in either group (P = 0.916 and P = 0.964, respectively). Conclusions Diabetic patients undergoing cataract surgery are prone to DES. Ocular symptoms and tear film stability are transiently worsened in diabetic patients and are restored more slowly than those in nondiabetic patients.	[Jiang, Donghong; Xiao, Xiangqian] Second People Hosp, Dept Ophthalmol, Taixing, Peoples R China; [Fu, Tongsheng] People Hosp, Dept Ophthalmol, Yangzhong, Peoples R China; [Hong, Jiaxu] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai 200433, Peoples R China; [Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Mashaghi, Alireza; Hong, Jiaxu] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA; [Hong, Jiaxu] State Hlth Minist, Key Lab Myopia, Shangha, Peoples R China; [Hong, Jiaxu] Key Lab Visual Impairment & Restorat Shanghai, Shangha, Peoples R China; [Hong, Jiaxu] Xiamen Univ, Sch Life Sci, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China	Fudan University; Nanjing Medical University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Xiamen University	Hong, JX (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai 200433, Peoples R China.; Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.; Hong, JX (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA.; Hong, JX (corresponding author), State Hlth Minist, Key Lab Myopia, Shangha, Peoples R China.; Hong, JX (corresponding author), Key Lab Visual Impairment & Restorat Shanghai, Shangha, Peoples R China.; Hong, JX (corresponding author), Xiamen Univ, Sch Life Sci, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China.	liuqh0545@126.com; jiaxu_hong@163.com	Mashaghi, Alireza/Q-8218-2017	Mashaghi, Alireza/0000-0002-2157-1211; Liu, Qinghuai/0000-0003-1605-1964	Key Clinic Medicine Research Program, the Ministry of Health, China [201302015]; National Science and Technology Research Program, the Ministry of Science and Technology, China [2012BAI08B01]; National Natural Science Foundation of China [81170817, 81200658, 81300735, 81270978, U1205025, 81330022]; Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai [13441900900, 13430720400]; Chinese Postdoctoral Fund [XMU135890]; New Technology Joint Research Project in Shanghai Hospitals [SHDC12014114]	Key Clinic Medicine Research Program, the Ministry of Health, China; National Science and Technology Research Program, the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Postdoctoral Fund; New Technology Joint Research Project in Shanghai Hospitals	The authors were supported by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (201302015); the National Science and Technology Research Program, the Ministry of Science and Technology, China (2012BAI08B01); the National Natural Science Foundation of China (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); the Scientific Research Program, Science and Technology Commission of Shanghai Municipality, Shanghai (13441900900, 13430720400); the Chinese Postdoctoral Fund (XMU135890); and the New Technology Joint Research Project in Shanghai Hospitals (SHDC12014114). The sponsor or funding organization had no role in the design or conduct of this research.	Alves MD, 2008, ARQ BRAS OFTALMOL, V71, P96, DOI 10.1590/S0004-27492008000700018; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Cetinkaya S, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0058-3; Chan JCN, 2014, LANCET DIABETES ENDO, V2, P969, DOI 10.1016/S2213-8587(14)70144-5; Cho Yang Kyeung, 2009, Korean J Ophthalmol, V23, P65, DOI 10.3341/kjo.2009.23.2.65; Chung Yeon Woong, 2013, Korean J Ophthalmol, V27, P167, DOI 10.3341/kjo.2013.27.3.167; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Dogru M, 2001, OPHTHALMOLOGY, V108, P586, DOI 10.1016/S0161-6420(00)00599-6; Esquenazi S, 2007, CLIN EXP OPHTHALMOL, V35, P545, DOI 10.1111/j.1442-9071.2007.01543.x; Gao SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107370; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Gemensky-Metzler AJ, 2015, VET OPHTHALMOL, V18, P472, DOI 10.1111/vop.12238; Han KE, 2014, AM J OPHTHALMOL, V157, P1144, DOI 10.1016/j.ajo.2014.02.036; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Kanellopoulos AJ, 2014, J REFRACT SURG, V30, P348, DOI 10.3928/1081597X-20140416-04; Kasetsuwan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078657; Kohlhaas M, 1998, J CATARACT REFR SURG, V24, P1399, DOI 10.1016/S0886-3350(98)80237-X; Kymionis GD, 2006, J REFRACT SURG, V22, P511; Li XM, 2007, CORNEA, V26, pS16, DOI 10.1097/ICO.0b013e31812f67ca; Liang Qingfeng, 2014, Zhonghua Yan Ke Za Zhi, V50, P244; Liu NN, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/748654; Liu X, 2008, J ZHEJIANG UNIV-SC B, V9, P324, DOI 10.1631/jzus.B0710359; Lv HB, 2014, ACTA OPHTHALMOL, V92, pE96, DOI 10.1111/aos.12063; Misra SL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/848659; Moon H, 2014, CORNEA, V33, P373, DOI 10.1097/ICO.0000000000000072; Murakami Y, 2012, OPHTHALMOLOGY, V119, P2220, DOI 10.1016/j.ophtha.2012.06.013; Najafi L, 2013, J DIABETES COMPLICAT, V27, P459, DOI 10.1016/j.jdiacomp.2013.04.006; Oh T, 2012, JPN J OPHTHALMOL, V56, P113, DOI 10.1007/s10384-012-0117-8; Ram J, 1998, J CATARACT REFR SURG, V24, P1119, DOI 10.1016/S0886-3350(98)80107-7; Ram J, 2002, J CATARACT REFR SURG, V28, P1386, DOI 10.1016/S0886-3350(02)01387-1; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Tomkins-Netzer O, 2015, PROG RETIN EYE RES, V48, P119, DOI 10.1016/j.preteyeres.2015.05.002; Xu XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132616; Yoon Kyung-Chul, 2004, Korean J Ophthalmol, V18, P168	34	25	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146752	10.1371/journal.pone.0146752	http://dx.doi.org/10.1371/journal.pone.0146752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771186	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300032
J	Luo, SY; Chen, S; Qin, YD; Chen, ZW				Luo, Sheng-Yong; Chen, Shuo; Qin, Yi-De; Chen, Zhi-Wu			Urotensin-II Receptor Antagonist SB-710411 Protects Rat Heart against IschemiaReperfusion Injury via RhoA/ROCK Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; RHO-KINASE; DYSFUNCTION; PEPTIDE; ATHEROSCLEROSIS; HYPERTROPHY; APOPTOSIS; PRESSURE; CELLS	Aim SB-710411 is a rat selective urotensin-II (U-II) receptor antagonist, which can block U-II-induced contraction of the aorta and inhibit U-II-induced myocardial fibrosis in rats. However, the effect of SB-710411 on myocardial ischemia-reperfusion (I/R) injury is unclear. The present study was designed to investigate whether SB-710411 has a protective effect on myocardial I/R injury in rats and the possible mechanisms. Methods and Results Myocardial I/R injury was induced by occluding the left anterior descending coronary artery in adult male Sprague-Dawley rats. Hemodynamic parameters, electrocardiogram (ECG), infarct size, histological alteration, lactate dehydrogenase (LDH), creatine phosphokinase-MB (CK-MB), cardiac troponin I (cTnI), RhoA, and the protein expressions of U-II receptor (UTR), ROCK1 and ROCK2 were evaluated. Cardiac I/R injury significantly up-regulated the expressions of UTR, ROCK1 and ROCK2 proteins in rat myocardium. SB-710411 1.0 and 2.0 mu g/kg significantly reduced cardiac I/R-induced the infarct size and histological damage in rat myocardium, markedly inhibited the changes of hemodynamic parameters and the increases of ST-segment in ECG, the serum LDH and CK-MB activities and cTnI level in rats subjected to myocardial I/R injury. Furthermore, SB-710411 obviously prevented myocardial I/R-increased RhoA activity and UTR, ROCK1 and ROCK2 protein expressions. Conclusions Our results indicate that cardiac I/R injury increases myocardial UTR expression, and SB-710411 has a potent protective effect on myocardial I/R injury in rats. The cardioprotection may be associated with the inhibition of UTR-RhoA/ROCK pathway.	[Luo, Sheng-Yong; Chen, Zhi-Wu] Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China; [Luo, Sheng-Yong] Anhui Acad Med Sci, Hefei, Anhui, Peoples R China; [Chen, Shuo] Liaoning Univ Tradit Chinese Med, Xinglin Coll, Shenyang, Liaoning, Peoples R China; [Qin, Yi-De] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China	Anhui Medical University; Liaoning University of Traditional Chinese Medicine; Anhui Medical University	Chen, ZW (corresponding author), Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China.; Qin, YD (corresponding author), Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China.	qinyide@hotmail.com; chpharmzw@163.com			National Natural Science Foundation of China [81374002, 30840104, 81173596]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81374002 (ZWC, No. 30840104 (ZWC) and No. 81173596 (ZWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Behm DJ, 2010, BRIT J PHARMACOL, V161, P207, DOI 10.1111/j.1476-5381.2010.00889.x; Behm DJ, 2004, EUR J PHARMACOL, V492, P113, DOI 10.1016/j.ejphar.2004.03.059; Behm DJ, 2002, BRIT J PHARMACOL, V137, P449, DOI 10.1038/sj.bjp.0704887; Bousette N, 2006, J MOL CELL CARDIOL, V41, P285, DOI 10.1016/j.yjmcc.2006.05.008; Chiu CZ, 2014, J ENDOCRINOL, V220, P233, DOI 10.1530/JOE-13-0261; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Fan J, 2014, BIOMED ENVIRON SCI, V27, P162, DOI 10.3967/bes2014.037; Forty EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083317; Gao S, 2012, PEPTIDES, V36, P199, DOI 10.1016/j.peptides.2012.05.004; Gonzalez J, 2014, WORLD J CARDIOL, V6, P353, DOI 10.4330/wjc.v6.i6.353; Grisk O, 2014, J HYPERTENS, V32, P2199, DOI 10.1097/HJH.0000000000000326; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Jani PP, 2013, PEPTIDES, V40, P72, DOI 10.1016/j.peptides.2012.12.014; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Liu Y, 2014, APOPTOSIS, V19, P1254, DOI 10.1007/s10495-014-1001-4; Ma LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103628; Ma LN, 2014, LAB INVEST, V94, P1083, DOI 10.1038/labinvest.2014.95; Matsubara M, 2010, ANN THORAC SURG, V89, P1532, DOI 10.1016/j.athoracsur.2010.01.065; Pakala R, 2008, CARDIOVASC REVASCULA, V9, P166, DOI 10.1016/j.carrev.2008.02.001; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Prosser HCG, 2008, PEPTIDES, V29, P770, DOI 10.1016/j.peptides.2007.08.013; Proulx CD, 2008, PEPTIDES, V29, P691, DOI 10.1016/j.peptides.2007.10.027; Riches K, 2014, CARDIOVASC REVASCULA, V15, P141, DOI 10.1016/j.carrev.2014.02.005; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Shah SV, 2015, J RENAL NUTR, V25, P205, DOI 10.1053/j.jrn.2014.10.024; Sivaraman V, 2014, J CARDIOVASC PHARM T, V19, P83, DOI 10.1177/1074248413499973; Tolle M, 2008, PEPTIDES, V29, P743, DOI 10.1016/j.peptides.2007.08.029; Townsend PA, 2007, AM J PHYSIOL-HEART C, V293, pH928, DOI 10.1152/ajpheart.01135.2006; Tran L, 2010, AM J PHYSIOL-HEART C, V298, pH608, DOI 10.1152/ajpheart.00942.2009; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Xu SK, 2009, TOHOKU J EXP MED, V219, P283, DOI 10.1620/tjem.219.283; Xue L, 2014, ASIAN PAC J TROP MED, V7, P280, DOI 10.1016/S1995-7645(14)60038-9; You ZP, 2012, ARTERIOSCL THROM VAS, V32, P1809, DOI 10.1161/ATVBAHA.112.252973; Yu ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099024; Zhang JY, 2012, CAN J PHYSIOL PHARM, V90, P637, DOI [10.1139/Y2012-048, 10.1139/y2012-048]; Zhao J, 2013, REGUL PEPTIDES, V182, P53, DOI 10.1016/j.regpep.2012.12.006; Zhou Ping, 2003, Shengli Xuebao, V55, P442	39	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146094	10.1371/journal.pone.0146094	http://dx.doi.org/10.1371/journal.pone.0146094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771557	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300008
J	Santermans, E; Robesyn, E; Ganyani, T; Sudre, B; Faes, C; Quinten, C; Van Bortel, W; Haber, T; Kovac, T; Van Reeth, F; Testa, M; Hens, N; Plachouras, D				Santermans, Eva; Robesyn, Emmanuel; Ganyani, Tapiwa; Sudre, Bertrand; Faes, Christel; Quinten, Chantal; Van Bortel, Wim; Haber, Tom; Kovac, Thomas; Van Reeth, Frank; Testa, Marco; Hens, Niel; Plachouras, Diamantis			Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness	PLOS ONE			English	Article							TRANSMISSION; LIBERIA	Background The Ebola outbreak in West Africa has infected at least 27,443 individuals and killed 11,207, based on data until 24 June, 2015, released by the World Health Organization (WHO). This outbreak has been characterised by extensive geographic spread across the affected countries Guinea, Liberia and Sierra Leone, and by localized hotspots within these countries. The rapid recognition and quantitative assessment of localised areas of higher transmission can inform the optimal deployment of public health resources. Methods A variety of mathematical models have been used to estimate the evolution of this epidemic, and some have pointed out the importance of the spatial heterogeneity apparent from incidence maps. However, little is known about the district-level transmission. Given that many response decisions are taken at sub-national level, the current study aimed to investigate the spatial heterogeneity by using a different modelling framework, built on publicly available data at district level. Furthermore, we assessed whether this model could quantify the effect of intervention measures and provide predictions at a local level to guide public health action. We used a two-stage modelling approach: a) a flexible spatiotemporal growth model across all affected districts and b) a deterministic SEIR compartmental model per district whenever deemed appropriate. Findings Our estimates show substantial differences in the evolution of the outbreak in the various regions of Guinea, Liberia and Sierra Leone, illustrating the importance of monitoring the outbreak at district level. We also provide an estimate of the time-dependent district-specific effective reproduction number, as a quantitative measure to compare transmission between different districts and give input for informed decisions on control measures and resource allocation. Prediction and assessing the impact of control measures proved to be difficult without more accurate data. In conclusion, this study provides us a useful tool at district level for public health, and illustrates the importance of collecting and sharing data.	[Santermans, Eva; Ganyani, Tapiwa; Faes, Christel; Kovac, Thomas; Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Robesyn, Emmanuel; Sudre, Bertrand; Quinten, Chantal; Van Bortel, Wim; Testa, Marco; Plachouras, Diamantis] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Haber, Tom; Kovac, Thomas; Van Reeth, Frank] tUL, iMinds, Expertise Ctr Digital Media, Diepenbeek, Belgium; [Testa, Marco] Univ Turin, Dept Publ Hlth, Turin, Italy; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium	Hasselt University; European Centre for Disease Prevention & Control; IMEC; University of Turin	Santermans, E (corresponding author), Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium.	eva.santermans@uhasselt.be	Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021; Hens, Niel/M-4445-2017; Faes, Christel/E-1384-2017; Plachouras, Diamantis/AAA-9109-2020	Van Bortel, Wim/0000-0002-6644-518X; Hens, Niel/0000-0003-1881-0637; Faes, Christel/0000-0002-1878-9869; Plachouras, Diamantis/0000-0001-9637-7803; Ganyani, Tapiwa/0000-0002-9116-3117; VAN REETH, Frank/0000-0002-3705-7807	Methusalem research grant from the Flemish government; Antwerp University scientific chair in Evidence-Based Vaccinology; Hercules Foundation; Flemish Government-department EWI	Methusalem research grant from the Flemish government; Antwerp University scientific chair in Evidence-Based Vaccinology; Hercules Foundation; Flemish Government-department EWI	ES acknowledges support from a Methusalem research grant from the Flemish government awarded to Herman Goossens (Antwerpen University) en Geert Molenberghs (Hasselt University). NH acknowledges support from the Antwerp University scientific chair in Evidence-Based Vaccinology, financed in 2009-2015 by an unrestricted gift from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors further acknowledge Valeria Pelosi, for contribution in data collection and Yvan Hutin, for editorial support. The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Hercules Foundation and the Flemish Government-department EWI.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Azmon A, 2014, STAT MED, V33, P1176, DOI 10.1002/sim.6015; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Chowell G, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002057, 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261]; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5089; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Liberia MoHaSWRo, FACTS EB VIR DIS; Liu HN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106839, 10.1371/currents.outbreaks.b4690859d91684da963dc40e00f3da81]; Majumder Maimuna S, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Moha Sanitation, EB SIT REP; National Ebola Response Centre (NERC), 2014, EVD DAIL MOHS UPD; Nations U., W AFR EB OUTBR 2014; Nishiura H, 2014, EUROSURVEILLANCE, V19; Roberts GO, 2009, J COMPUT GRAPH STAT, V18, P349, DOI 10.1198/jcgs.2009.06134; Rosenthal JS, 2007, COMPUT STAT DATA AN, V51, P5467, DOI 10.1016/j.csda.2007.02.021; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sane J., 2015, OVERCOMING BARRIERS; WHO, 2015, EB OUTBR LIB IS; World Health Organization, 2014, CAS DEF REC EB MARB; World Health Organization, 2015, EB SIT REP 24 JUN 20; World Health Organization, 2015, EB SIT REP 18 MARCH	25	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147172	10.1371/journal.pone.0147172	http://dx.doi.org/10.1371/journal.pone.0147172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771513	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300069
J	Sun, Y; Li, S; Bonini, N; Liu, Y				Sun, Yan; Li, Shu; Bonini, Nicolao; Liu, Yang			Effect of Graph Scale on Risky Choice: Evidence from Preference and Process in Decision-Making	PLOS ONE			English	Article							SIMILARITY JUDGMENTS; REPRESENTATION; UNCERTAINTY; INFORMATION; PSYCHOLOGY; MAGNITUDE; ANOMALIES; NUMBERS; BRAIN	We investigate the effect of graph scale on risky choices. By (de) compressing the scale, we manipulate the relative physical distance between options on a given attribute in a coordinate graphical context. In Experiment 1, the risky choice changes as a function of the scale in the graph. In Experiment 2, we show that the type of graph scale also affects decision times. In Experiment 3, we examine the graph scale effect by using real money among students who have taken statistics courses. Consequently, the scale effects still appear even when we control the variations in calculation ability and increase the gravity with which participants view the consequence of their decisions. This finding is inconsistent with descriptive invariance of preference. The theoretical implications and practical applications of the findings are discussed.	[Sun, Yan; Li, Shu; Liu, Yang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Bonini, Nicolao] Univ Trento, Dept Econ & Management, Trento, Italy; [Liu, Yang] Univ Chinese Acad Sci, Coll Humanities & Social Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Trento; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, S (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	lishu@psych.ac.cn		Bonini, Nicolao/0000-0001-8871-0936; li, shu/0000-0003-4402-1674	National Natural Science Foundation of China [31170976]; Supervisor of Beijing Excellent Doctoral Dissertation [20138012501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supervisor of Beijing Excellent Doctoral Dissertation	The present study is supported by the National Natural Science Foundation of China (No. 31170976) and the Supervisor of Beijing Excellent Doctoral Dissertation (20138012501), which Shu Li received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini N, 2004, J BEHAV DECIS MAKING, V17, P139, DOI 10.1002/bdm.466; Coulter KS, 2009, J CONSUM PSYCHOL, V19, P144, DOI 10.1016/j.jcps.2009.02.008; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hevia MD, 2008, Q J EXPT PSYCHOL, V61, P1496; Huang W., 2006, AS PAC FIC S INF VIS, P207; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; Law Anna S, 2005, J Clin Monit Comput, V19, P183, DOI 10.1007/s10877-005-0879-3; Leland JW, 1998, MANAGE SCI, V44, P659, DOI 10.1287/mnsc.44.5.659; Leland JW, 2002, ECON INQ, V40, P574, DOI 10.1093/ei/40.4.574; LELAND JW, 1994, J RISK UNCERTAINTY, V9, P151, DOI 10.1007/BF01064183; LEVIN IP, 1988, J CONSUM RES, V15, P374, DOI 10.1086/209174; LEVIN IP, 1987, B PSYCHONOMIC SOC, V25, P85; Li S, 2003, EUR J OPER RES, V148, P65, DOI 10.1016/S0377-2217(02)00367-3; PAYNE JW, 1992, ACTA PSYCHOL, V80, P107, DOI 10.1016/0001-6918(92)90043-D; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Rubinstein A, 2003, INT ECON REV, V44, P1207, DOI 10.1111/1468-2354.t01-1-00106; RUBINSTEIN M, 1985, J FINANC, V40, P455, DOI 10.2307/2327895; Seron X, 2006, CORTEX, V42, P406, DOI 10.1016/S0010-9452(08)70370-8; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Sun Y, 2012, J BEHAV DECIS MAKING, V25, P491, DOI 10.1002/bdm.749; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1994, PSYCHOL REV, V101, P547, DOI 10.1037/0033-295X.101.4.547; WEBER M, 1988, MANAGE SCI, V34, P431, DOI 10.1287/mnsc.34.4.431	28	2	2	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146914	10.1371/journal.pone.0146914	http://dx.doi.org/10.1371/journal.pone.0146914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771530	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300042
J	Yang, Y; Yang, YF; Hou, JW; Ding, Y; Zhang, T; Zhang, Y; Wang, JY; Shi, CC; Fu, WW; Cai, ZZ				Yang, Yang; Yang, Yifu; Hou, Jianwei; Ding, Yue; Zhang, Tong; Zhang, Yong; Wang, Jianying; Shi, Chenchen; Fu, Wenwei; Cai, Zhenzhen			The Hydroxyl at Position C1 of Genipin Is the Active Inhibitory Group that Affects Mitochondrial Uncoupling Protein 2 in Panc-1 Cells	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; CANCER-CELLS; APOPTOSIS; GENIPOSIDE; EXPRESSION; CARCINOMA; ANTIGEN	Genipin (GNP) effectively inhibits uncoupling protein 2 (UCP2), which regulates the leakage of protons across the inner mitochondrial membrane. UCP2 inhibition may induce pancreatic adenocarcinoma cell death by increasing reactive oxygen species (ROS) levels. In this study, the hydroxyls at positions C10 (10-OH) and C1 (1-OH) of GNP were hypothesized to be the active groups that cause these inhibitory effects. Four GNP derivatives in which the hydroxyl at position C10 or C1 was replaced with other chemical groups were synthesized and isolated. Differences in the inhibitory effects of GNP and its four derivatives on pancreatic carcinoma cell (Panc-1) proliferation were assessed. The effects of GNP and its derivatives on apoptosis, UCP2 inhibition and ROS production were also studied to explore the relationship between GNP's activity and its structure. The derivatives with 1-OH substitutions, geniposide (1-GNP1) and 1-ethyl-genipin (1-GNP2) lacked cytotoxic effects, while the other derivatives that retained 1-OH, 10-piv-genipin (10-GNP1) and 10-acetic acid-genipin (10-GNP2) exerted biological effects similar to those of GNP, even in the absence of 10-OH. Thus, 1-OH is the key functional group in the structure of GNP that is responsible for GNP's apoptotic effects. These cytotoxic effects involve the induction of Panc-1 cell apoptosis through UCP2 inhibition and subsequent ROS production.	[Yang, Yang; Yang, Yifu; Shi, Chenchen; Cai, Zhenzhen] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Expt Ctr Sci & Technol, Shanghai, Peoples R China; [Hou, Jianwei; Ding, Yue; Zhang, Tong; Zhang, Yong; Wang, Jianying] Shanghai Univ Tradit Chinese Med, Expt Ctr Teaching & Learning, Shanghai, Peoples R China; [Fu, Wenwei] Shanghai Univ Tradit Chinese Med, Innovat Tradit Chinese Med Lab, Coll Tradit Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Ding, Y; Zhang, T (corresponding author), Shanghai Univ Tradit Chinese Med, Expt Ctr Teaching & Learning, Shanghai, Peoples R China.	dingyue-2001@hotmail.com; zhangtongshutcm@hotmail.com	Fu, Wenwei/AAD-6756-2020		National Natural Science Foundation of China [81173561, 81274200, 81403175]; Shanghai Municipal Commission of Health and Family planning [20134Y053]; Youth Talent Sail Plan from Shanghai Committee of Science and Technology [14YF1411300]; Shanghai Committee of Science and Technology [13401900301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family planning; Youth Talent Sail Plan from Shanghai Committee of Science and Technology; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the following sources of funding: 1. National Natural Science Foundation of China [Grant No.81173561, TZ] and Project from Shanghai Municipal Commission of Health and Family planning [Grant No. 20134Y053, TZ]; 2. National Natural Science Foundation of China [81274200, ZZC]; and 3. National Natural Science Foundation of China [Grant No.81403175, YD], Youth Talent Sail Plan from Shanghai Committee of Science and Technology [Grant No. 14YF1411300, YD] and Project from Shanghai Committee of Science and Technology [Grant No. 13401900301, YD].	AKAO T, 1994, BIOL PHARM BULL, V17, P1573; Cao HL, 2010, BIOL PHARM BULL, V33, P1343, DOI 10.1248/bpb.33.1343; Chang YC, 2004, TOXICOL APPL PHARM, V198, P11, DOI 10.1016/j.taap.2004.03.004; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; DARLINGTON GJ, 1987, IN VITRO CELL DEV B, V23, P349; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Ding Y, 2011, ZHONG YAO CAI, V34, P1448; Ding Yue, 2011, Zhong Yao Cai, V34, P623; Donadelli M, 2015, WORLD J GASTROENTERO, V21, P3232, DOI 10.3748/wjg.v21.i11.3232; Feng QA, 2011, ACTA PHARMACOL SIN, V32, P519, DOI 10.1038/aps.2010.158; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7; Hwa JS, 2011, KOREAN J PHYSIOL PHA, V15, P157, DOI 10.4196/kjpp.2011.15.3.157; Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016; Jina HO, 2008, LUNG CANCER, V61, P317, DOI 10.1016/j.lungcan.2008.01.002; Kang K, 2010, BIOTECHNOL LETT, V32, P1045, DOI 10.1007/s10529-010-0277-x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LAN MS, 1990, CANCER RES, V50, P2997; Li CC, 2012, FOOD CHEM TOXICOL, V50, P2978, DOI 10.1016/j.fct.2012.05.054; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lin Lin, 2010, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V27, P1327; Liu LM, 2014, ANTIOXID REDOX SIGN, V21, P1571, DOI 10.1089/ars.2013.5519; Lu Y, 2008, ACTA U TRAD MED SINE, V22, P76; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006; OSHIMA T, 1988, J CHROMATOGR, V455, P410, DOI 10.1016/S0021-9673(01)82148-8; Qiu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041391; Soltany-Rezaee-Rad M, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/185035; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571; Yang X, 2013, J PHARMACOL SCI, V121, P272, DOI 10.1254/jphs.12234FP; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	38	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147026	10.1371/journal.pone.0147026	http://dx.doi.org/10.1371/journal.pone.0147026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771380	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300054
J	Hu, DY; Zhang, DG; Zheng, SZ; Guo, MD; Lin, XX; Jiang, Y				Hu, Dingyuan; Zhang, Daguan; Zheng, Shuzi; Guo, Maodong; Lin, Xinxin; Jiang, Yi			Association of Ulcerative Colitis with FUT2 and FUT3 Polymorphisms in Patients from Southeast China	PLOS ONE			English	Article							HISTO-BLOOD GROUP; INFLAMMATORY-BOWEL-DISEASE; MOLECULAR-GENETIC ANALYSIS; CROHNS-DISEASE; NONSENSE MUTATION; GROUP ANTIGENS; GROUP SYSTEM; LEWIS-A; PHENOTYPE; MICROBIOTA	Objectives Dysbiosis of intestinal microbiota has been implicated in ulcerative colitis (UC). Fucosyltransferase (FUT) 2 and FUT3 determine expression of histo-blood group antigens in the gut and may affect the intestinal microbiota. We investigated the association between FUT2 and FUT3 polymorphisms and UC in Chinese patients. Methods We genotyped FUT2 (rs281377, rs1047781 and rs601338) and FUT3 (rs28362459, rs3745635 and rs3894326) in 485 UC patients and 580 healthy controls using SNaPshot. We also evaluated expression of Lewis a and b antigens in the sigmoid colon of 7 UC patients and 7 patients with benign colonic polyps. Results The frequencies of mutant allele (A) and genotype (GA+AA) in FUT3 (rs3745635) were higher in UC patients than controls (P = 0.016, 95% CI: 1.339-1.699; P = 0.038, 95% CI: 1.330-1.742, respectively). Stratified analyses revealed that the frequencies of mutant allele (G) and genotype (TG+GG) of FUT3 (rs28362459) were significantly lower in patients with extensive colitis than those with distal colitis (P<0.001, 95% CI: 0.503-0.742; P = 0.001, 95% CI: 0.567-0.786, respectively). Similar conclusions were drawn for the mutant allele (A) and genotype (GA+AA) of FUT3 (rs3745635) in patients with extensive colitis compared to those with distal colitis (P = 0.006, 95% CI: 0.553-0.845; P = 0.011, 95% CI: 0.621-0.900, respectively). Although expression of Lewis b antigen in the sigmoid colon did not differ between UC patients and controls, Lewis a antigen expression was higher in the cryptic epithelium of both inflammatory and non-inflammatory sigmoid colon of UC patients than controls (P = 0.028). Conclusions Our findings indicated that polymorphisms in FUT3 and its intestinal expression might be associated with UC pathogenesis.	[Hu, Dingyuan; Zhang, Daguan; Zheng, Shuzi; Guo, Maodong; Lin, Xinxin; Jiang, Yi] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou, Peoples R China	Wenzhou Medical University	Jiang, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou, Peoples R China.	wzjiangyi@yeah.net		Hu, Dingyuan/0000-0002-7149-5501	Natural Science Foundation of Zhejiang Province [LY14H030012]; Zhejiang Provincial Health Bureau [2014KYB157, 2012KYA132]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Health Bureau	The study project was supported by grants from Natural Science Foundation of Zhejiang Province (Grant number: LY14H030012, http://www.zjnsf.gov.cn/; recipient: YJ) and Zhejiang Provincial Health Bureau (Grant number: 2014KYB157 and 2012KYA132, http://www.zjwst.gov.cn/; recipient: YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheman A, 2012, WORLD J GASTROENTERO, V18, P4758, DOI 10.3748/wjg.v18.i34.4758; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Duell EJ, 2015, INT J CANCER, V136, P880, DOI 10.1002/ijc.29034; Ellison RC, 1999, AM J CARDIOL, V83, P345, DOI 10.1016/S0002-9149(98)00866-2; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Forni D, 2014, J CROHNS COLITIS, V8, P489, DOI 10.1016/j.crohns.2013.10.014; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Fujitani N, 2000, GLYCOCONJUGATE J, V17, P331, DOI 10.1023/A:1007173722426; Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; KODA Y, 1993, BLOOD, V82, P2915; Kudo T, 1996, J BIOL CHEM, V271, P9830, DOI 10.1074/jbc.271.16.9830; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu YH, 1999, J HUM GENET, V44, P181, DOI 10.1007/s100380050138; Liu YH, 1999, J FORENSIC SCI, V44, P82; Magalhaes A, 2010, BRAZ J MED BIOL RES, V43, P611, DOI 10.1590/S0100-879X2010007500049; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; NISHIHARA S, 1994, J BIOL CHEM, V269, P29271; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Petit JM, 1997, DIABETES METAB, V23, P202; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083523; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yip SP, 2007, TRANSFUSION, V47, P1369, DOI 10.1111/j.1537-2995.2007.01280.x; YUAN M, 1985, CANCER RES, V45, P4499	37	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146557	10.1371/journal.pone.0146557	http://dx.doi.org/10.1371/journal.pone.0146557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766790	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300025
J	Yu, Y; Xu, ML; Sun, JD; Li, RY; Li, ML; Wang, JG; Zhang, DF; Xu, AQ				Yu, Yang; Xu, Minglei; Sun, Jiandong; Li, Ruiying; Li, Meilan; Wang, Jianguang; Zhang, Dongfeng; Xu, Aiqiang			Human Papillomavirus Infection and Vaccination: Awareness and Knowledge of HPV and Acceptability of HPV Vaccine among Mothers of Teenage Daughters in Weihai, Shandong, China	PLOS ONE			English	Article							PREVENT CERVICAL-CANCER; ADOLESCENTS AWARENESS; PARENTAL ACCEPTANCE; GENITAL WARTS; ATTITUDES; WOMEN; BELIEFS	In preparation for the introduction of human papillomavirus (HPV) vaccine, we investigated awareness and knowledge of HPV/HPV vaccine and potential acceptability to HPV vaccine among mothers with a teenage daughter in Weihai, Shandong, China. A cross-sectional survey was conducted in 2013 with a sample of 1850 mothers who had a daughter (aged 9-17 years) attending primary, junior and senior high schools. In the final sample (N = 1578, response rate 85.30%), awareness of HPV was reported by 305 (19.32%) mothers. Awareness varied significantly by daughter's age (P<0.01), mother's education level (P<0.01), mother's occupation (P<0.01), household income (P<0.01) and residence type (P<0.01). Knowledge about HPV/HPV vaccine was poor with a mean total score of 3.56 (SD = 2.40) out of a possible score of 13. Mothers with a higher education level reported higher levels of knowledge (P = 0.02). Slightly more than one-fourth (26.49%) of mothers expressed their potential acceptability of HPV vaccine for their daughters. Acceptability increased along with increased daughters' age (P<0.01), household income (P<0.01) and knowledge level (P<0.01). House wives and unemployed mothers had the highest acceptability (P<0.01). The most common reasons for not accepting HPV vaccination were "My daughter is too young to have risk of cervical cancer (30.95%)", "The vaccine has not been widely used, and the decision will be made after it is widely used (24.91%)", "Worry about the safety of the vaccine (22.85%)". Awareness and knowledge of HPV/HPV vaccines are poor and HPV vaccine acceptability is low among these Chinese mothers. These results may help inform appropriate health education programs in this population.	[Yu, Yang; Li, Ruiying; Li, Meilan; Wang, Jianguang] Weihai Ctr Dis Control & Prevent, Weihai, Shandong, Peoples R China; [Xu, Minglei; Zhang, Dongfeng] Qingdao Univ, Coll Med, Qingdao 266071, Shandong, Peoples R China; [Sun, Jiandong] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Xu, Aiqiang] Shandong Univ, Acad Prevent Med, Jinan 250100, Shandong, Peoples R China; [Xu, Aiqiang] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Shandong, Peoples R China	Qingdao University; Queensland University of Technology (QUT); Shandong University	Zhang, DF (corresponding author), Qingdao Univ, Coll Med, Qingdao 266071, Shandong, Peoples R China.	zhangdf1961@126.com; aqxuepi@163.com			Taishan Scholar Program of Shandong Province	Taishan Scholar Program of Shandong Province	This study was supported by a grant from Taishan Scholar Program of Shandong Province.	Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038; Bryan JT, 2007, VACCINE, V25, P3001, DOI 10.1016/j.vaccine.2007.01.013; Centers for Disease Control and Prevention, 2013, NAT REG STAT SEL LOC; Centers for Disease Control and Prevention, 2012, NAT STAT VACC COV AD; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P1100; Cheaper HPV, 2008, LANCET, V3719625, DOI [10.1016/S0140-6736(08)60701-1, DOI 10.1016/S0140-6736(08)60701-1]; Chen B, 2015, VACCINE, V33, P1780, DOI 10.1016/j.vaccine.2015.02.046; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Dochez C, 2014, VACCINE, V32, P1595, DOI 10.1016/j.vaccine.2013.10.081; European Centers for Disease Control and Prevention, INTR HPV VACC EUR UN; Franco EL, 2005, VACCINE, V23, P2388, DOI 10.1016/j.vaccine.2005.01.016; Hausdorf K, 2007, AUST NZ J PUBL HEAL, V31, P288, DOI 10.1111/j.1467-842X.2007.00066.x; Jaspers L, 2011, VACCINE, V29, P7785, DOI 10.1016/j.vaccine.2011.07.107; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Marek E, 2012, VACCINE, V30, P6824, DOI 10.1016/j.vaccine.2012.09.012; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; Marlow LAV, 2007, HUM VACCINES, V3, P171, DOI 10.4161/hv.3.5.4310; Marlow LAV, 2013, VACCINE, V31, P763, DOI 10.1016/j.vaccine.2012.11.083; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Qiao YL, 2007, 24 INT PAP C CLIN WO; Rosenthal SL, 2008, J ADOLESCENT HEALTH, V43, P239, DOI 10.1016/j.jadohealth.2008.06.009; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Wei Min-xi, 2009, Chinese Journal of Virology, V25, P245; World Health Organization, 2013, COMPR CERV CANC PREV; World Health Organization (WHO), 2014, HUM PAP VACC WHO POS; Xie Minghui, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P1082; Zhang SK, 2013, VACCINE, V31, P3244, DOI 10.1016/j.vaccine.2013.05.046; Zhao FH, 2012, CANCER EPIDEMIOL, V36, P384, DOI 10.1016/j.canep.2012.01.009	31	32	35	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146741	10.1371/journal.pone.0146741	http://dx.doi.org/10.1371/journal.pone.0146741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766565	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300037
J	Kim, J; Medicherla, CB; Ma, CL; Feher, A; Kukar, N; Geevarghese, A; Goyal, P; Horn, E; Devereux, RB; Weinsaft, JW				Kim, Jiwon; Medicherla, Chaitanya B.; Ma, Claudia L.; Feher, Attila; Kukar, Nina; Geevarghese, Alexi; Goyal, Parag; Horn, Evelyn; Devereux, Richard B.; Weinsaft, Jonathan W.			Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; ARTERY SYSTOLIC PRESSURE; PULMONARY-HYPERTENSION; DILATED CARDIOMYOPATHY; WALL STRESS; MASS; MORTALITY; PATTERN	Background Non-ischemic fibrosis (NIF) on cardiac magnetic resonance (CMR) has been linked to poor prognosis, but its association with adverse right ventricular (RV) remodeling is unknown. This study examined a broad cohort of patients with RV dysfunction, so as to identify relationships between NIF and RV remodeling indices, including RV pressure load, volume and wall stress. Methods and Results The population comprised patients with RV dysfunction (EF<50%) undergoing CMR and transthoracic echo within a 14 day (5 3) interval. Cardiac structure, function, and NIF were assessed on CMR. Pulmonary artery systolic pressure (PASP) was measured on echo. 118 patients with RV dysfunction were studied, among whom 47% had NIF. Patients with NIF had lower RVEF (34 +/- 10 vs. 39 +/- 9%; p = 0.01) but similar LVEF (40 +/- 21 vs. 39 +/- 8%; p = 0.7) and LV volumes (p = NS). RV wall stress was higher with NIF (17 +/- 7 vs. 12 +/- 6 kPa; p<0.001) corresponding to increased RV end-systolic volume (143 +/- 79 vs. 110 +/- 36 ml; p = 0.006), myocardial mass (60 +/- 21 vs. 53 +/- 17 gm; p = 0.04), and PASP (52 +/- 18 vs. 41 +/- 18 mmHg; p = 0.001). NIF was associated with increased wall stress among subgroups with isolated RV (p = 0.005) and both RV and LV dysfunction (p = 0.003). In multivariable analysis, NIF was independently associated with RV volume (OR = 1.17 per 10 ml, [CI 1.041.32]; p = 0.01) and PASP (OR = 1.43 per 10 mmHg, [1.14-1.81]; p = 0.002) but not RV mass (OR = 0.91 per 10 gm, [0.69-1.20]; p = 0.5) [model x2 = 21; p<0.001]. NIF prevalence was higher in relation to PA pressure and RV dilation and was > 6-fold more common in the highest, vs. the lowest, common tertile of PASP and RV size (p<0.001). Conclusion Among wall stress components, NIF was independently associated with RV chamber dilation and afterload, supporting the concept that NIF is linked to adverse RV chamber remodeling.	[Kim, Jiwon; Medicherla, Chaitanya B.; Ma, Claudia L.; Feher, Attila; Geevarghese, Alexi; Goyal, Parag; Horn, Evelyn; Devereux, Richard B.; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY USA; [Kim, Jiwon; Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Kukar, Nina; Weinsaft, Jonathan W.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY USA.; Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY USA.; Weinsaft, JW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	jik9027@med.cornell.edu			United States National Institutes of Health [K23 HL102249-01]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102249] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was conducted with salary support as provided by the United States National Institutes of Health (grant number K23 HL102249-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter P, 2011, EUR J HEART FAIL, V13, P937, DOI 10.1093/eurjhf/hfr082; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727; Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328; Codella NCF, 2008, RADIOLOGY, V248, P1004, DOI 10.1148/radiol.2482072016; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kim J, 2014, INT J CARDIOVAS IMAG, V30, P1559, DOI 10.1007/s10554-014-0487-8; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Mauritz GJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-5; MCKENZIE JC, 1994, J MOL CELL CARDIOL, V26, P753, DOI 10.1006/jmcc.1994.1090; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065; Otto C., 2012, PRACTICE CLIN ECHOCA; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Swift AJ, 2014, JACC-CARDIOVASC IMAG, V7, P1209, DOI 10.1016/j.jcmg.2014.08.014; Tandri H, 2006, AM J CARDIOL, V98, P1660, DOI 10.1016/j.amjcard.2006.07.049; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477	25	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147349	10.1371/journal.pone.0147349	http://dx.doi.org/10.1371/journal.pone.0147349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799498	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300099
J	Berdej, SM; Armitage, DR				Berdej, Samantha M.; Armitage, Derek R.			Bridging Organizations Drive Effective Governance Outcomes for Conservation of Indonesia's Marine Systems	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; PROTECTED AREA NETWORKS; CORAL-REEF MANAGEMENT; ADAPTIVE COMANAGEMENT; KNOWLEDGE GENERATION; TRADE-OFFS; CHALLENGES; INSTITUTIONS; LANDSCAPE; DECLINE	This study empirically investigates the influence of bridging organizations on governance outcomes for marine conservation in Indonesia. Conservation challenges require ways of governing that are collaborative and adaptive across boundaries, and where conservation actions are better coordinated, information flows improved, and knowledge better integrated and mobilized. We combine quantitative social network analysis and qualitative data to analyze bridging organizations and their networks, and to understand their contributions and constraints in two case studies in Bali, Indonesia. The analysis shows 1) bridging organizations help to navigate the 'messiness' inherent in conservation settings by compensating for sparse linkages, 2) the particular structure and function of bridging organizations influence governing processes (i.e., collaboration, knowledge sharing) and subsequent conservation outcomes, 3) 'bridging' is accomplished using different strategies and platforms for collaboration and social learning, and 4) bridging organizations enhance flexibility to adjust to changing marine conservation contexts and needs. Understanding the organizations that occupy bridging positions, and how they utilize their positionality in a governance network is emerging as an important determinant of successful conservation outcomes. Our findings contribute to a relatively new body of literature on bridging organizations in marine conservation contexts, and add needed empirical investigation into their value to governance and conservation in Coral Triangle nations and beyond.	[Berdej, Samantha M.] Univ Waterloo, Environm Change & Governance Grp, Dept Geog & Environm Management, Waterloo, ON N2L 3G1, Canada; [Armitage, Derek R.] Univ Waterloo, Environm Change & Governance Grp, Sch Environm Resources & Sustainabil, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Berdej, SM (corresponding author), Univ Waterloo, Environm Change & Governance Grp, Dept Geog & Environm Management, Waterloo, ON N2L 3G1, Canada.	smberdej@uwaterloo.ca	Lobo, Diele/I-9106-2012; Armitage, Derek/ABE-6315-2020		International Development Research Centre of Canada [107473-99906075-011]; Social Sciences and Humanities Research Council of Canada [752-2014-1793, 410-2010-1109]; Social Sciences and Humanities - Research Council of Canada Partnership Grant for the Community Conservation Research Network [895-2011-1017]	International Development Research Centre of Canada(CGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Social Sciences and Humanities - Research Council of Canada Partnership Grant for the Community Conservation Research Network	This research was supported by an International Development Research Centre of Canada Award (no. 107473-99906075-011) to SB, Social Sciences and Humanities Research Council of Canada Awards to SB (no. 752-2014-1793) and DA (no. 410-2010-1109), as well as a Social Sciences and Humanities Funded by Research Council of Canada Partnership Grant for the Community Conservation Research Network (no. 895-2011-1017) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2014, SOCIAL RELATIONAL NE; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Armitage D, 2008, INT J COMMONS, V2, P2; Armitage D, 2008, GLOBAL ENVIRON CHANG, V18, P86, DOI 10.1016/j.gloenvcha.2007.07.002; Armitage D, 2012, CONSERV LETT, V5, P245, DOI 10.1111/j.1755-263X.2012.00238.x; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Berdej S, 2015, CONSERVATIO IN PRESS; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; BPS: Bandan Pusat Statistic Kabupaten Buleleng, 2014, STAT DAER KEC TEJ 20; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Campbell SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050074; Cinner J, 2006, ECOL SOC, V11; Clifton J, 2012, SOC NATUR RESOUR, V25, P716, DOI 10.1080/08941920.2011.618487; Cohen PJ, 2012, CONSERV LETT, V5, P376, DOI 10.1111/j.1755-263X.2012.00255.x; Coral Triangle Initiative Secretariat, 2009, REG PLAN ACT COR TRI; Crona BI, 2012, ECOL SOC, V17, DOI 10.5751/ES-04534-170132; Crona BI, 2006, ECOL SOC, V11; Cros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096332; CTC, 2014, NUS PEN EST MPA LEAR; CTC: Coral Triangle Center, 2015, US VIS MISS; CTI Leaders Declaration, 2009, COR TRIANGL IN LEAD; De Meo P, 2012, KNOWL-BASED SYST, V30, P136, DOI 10.1016/j.knosys.2012.01.007; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dougill AJ, 2010, ECOL SOC, V15; Erviani N., 2014, JAKARTA POST; Evans LS, 2011, ECOL SOC, V16; Fidelman P, 2014, OCEAN COAST MANAGE, V95, P117, DOI 10.1016/j.ocecoaman.2014.04.001; Fidelman P, 2012, MAR POLICY, V36, P42, DOI 10.1016/j.marpol.2011.03.007; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Frey JB, 2014, INT J COMMONS, V8, P26; Green S. J., 2011, Conservation and Society, V9, P173, DOI 10.4103/0972-4923.86986; Hahn T, 2006, HUM ECOL, V34, P573, DOI 10.1007/s10745-006-9035-z; Hay I., 2010, QUALITATIVE RES METH, VThird; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Horigue V, 2012, OCEAN COAST MANAGE, V64, P15, DOI 10.1016/j.ocecoaman.2012.04.012; Jacobson Cynthia, 2012, Human Dimensions of Wildlife, V17, P333, DOI 10.1080/10871209.2012.709310; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; LINI: Indonesian Nature Foundation, AB US; Lowry GT, 2009, COASTAL MANAGEMENT, V37, P335; Majors C, 2008, BIODIVERSITY AND HUMAN LIVELIHOODS IN PROTECTED AREAS: CASE STUDIES FROM THE MALAY ARCHIPELAGO, P241; Marin A, 2010, MAR POLICY, V34, P851, DOI 10.1016/j.marpol.2010.01.007; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mills M, 2010, CONSERV LETT, V3, P291, DOI 10.1111/j.1755-263X.2010.00134.x; Mustika PL, 2013, RAP B BIOL ASSESSMEN, V64; Newig J, 2010, ECOL SOC, V15; Olsson P, 2007, ECOL SOC, V12; Patlis JM, 2005, OCEAN COAST MANAGE, V48, P450, DOI 10.1016/j.ocecoaman.2005.04.005; Prell Christina., 2011, SOCIAL NETWORK ANAL; RC-I: Reef Check Indonesia, WHO WE ARE; Rosen F, 2013, MAR POLICY, V38, P195, DOI 10.1016/j.marpol.2012.05.036; Satria Arif, 2006, Environment Development and Sustainability, V8, P99, DOI 10.1007/s10668-005-0909-9; Schultz L, 2011, ENVIRON EDUC RES, V16, P645; von Heland F, 2014, GLOBAL ENVIRON CHANG, V29, P53, DOI 10.1016/j.gloenvcha.2014.08.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Weeks Rebecca, 2014, F1000Res, V3, P91, DOI 10.12688/f1000research.3886.3; Weeks R, 2014, COAST MANAGE, V42, P183, DOI 10.1080/08920753.2014.877768; Welly M, 2009, LOCAL COMMUNITY LEMB	62	45	46	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147142	10.1371/journal.pone.0147142	http://dx.doi.org/10.1371/journal.pone.0147142			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5CE	26794003	Green Published, gold, Green Submitted			2022-12-27	WOS:000368530300019
J	Koga, T; Minamizato, T; Kawai, Y; Miura, K; Takashi, I; Nakatani, Y; Sumita, Y; Asahina, I				Koga, Takamitsu; Minamizato, Tokutaro; Kawai, Yosuke; Miura, Kei-ichiro; Takashi, I; Nakatani, Yuya; Sumita, Yoshinori; Asahina, Izumi			Bone Regeneration Using Dentin Matrix Depends on the Degree of Demineralization and Particle Size	PLOS ONE			English	Article							FREEZE-DRIED BONE; RIDGE; ALLOGRAFTS; GRAFTS	Objectives This study aimed to examine the influence of particle size and extent of demineralization of dentin matrix on bone regeneration. Materials and Methods Extracted human teeth were pulverized and divided into 3 groups according to particle size; 200, 500, and 1000 mu m. Each group was divided into 3 groups depending on the extent of demineralization; undemineralized dentin (UDD), partially demineralized dentin matrix (PDDM), and completely demineralized dentin matrix (CDDM). The dentin sample was implanted into rat calvarial bone defects. After 4 and 8 weeks, the bone regeneration was evaluated with micro-CT images, histomorphometric and immunohistochemical analyses. Osteoblasts were cultured on UDD and DDM to evaluate the cell attachment using electron microscope. Results Micro-CT images and histological observation revealed that CDDM had largely resorbed but UDD had not, and both of them induced little bone formation, whereas all particle sizes of PDDM induced more new bone, especially the 1000 mu m. Electron microscopic observation showed osteoblasts attached to DDM but not to UDD. Conclusions PDDM with larger particle size induced prominent bone regeneration, probably because PDDM possessed a suitable surface for cell attachment. There might be an exquisite balance between its resorption and bone formation on it. PDDM could be considered as a potential bone substitute.	[Koga, Takamitsu; Minamizato, Tokutaro; Kawai, Yosuke; Miura, Kei-ichiro; Takashi, I; Nakatani, Yuya; Sumita, Yoshinori; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, Nagasaki 852, Japan	Nagasaki University	Asahina, I (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, Nagasaki 852, Japan.	asahina@nagasaki-u.ac.jp	Kawai, Yosuke/S-4496-2019	Kawai, Yosuke/0000-0003-0666-1224; I, Takashi/0000-0001-5167-5268; Nakatani, Yuya/0000-0002-1289-3921	Japan Society for Promotion of Science [25293413, 2643017]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (25293413, 2643017) from the Japan Society for Promotion of Science.	AMES JR, 1981, ORAL SURG ORAL MED O, V51, P588, DOI 10.1016/S0030-4220(81)80005-9; Artzi Z, 2003, INT J ORAL MAX IMPL, V18, P440; Bath M., 2006, ILLUSTRATED DENT EMB, P49; BUTLER WT, 1977, J DENT RES, V56, P228, DOI 10.1177/00220345770560030601; Cammack GV, 2005, INT J PERIODONT REST, V25, P231; Endoh T, 1990, JPN SOC ORAL MAXILLO, V36, P898; FINKELMAN RD, 1990, J BONE MINER RES, V5, P717; FONSECA RJ, 1983, J ORAL MAXIL SURG, V41, P153, DOI 10.1016/0278-2391(83)90073-3; FUCINI SE, 1993, J PERIODONTOL, V64, P844, DOI 10.1902/jop.1993.64.9.844; Fugazzotto P A, 1986, Quintessence Int, V17, P461; GLOWACKI J, 1981, LANCET, V1, P959; Glowacki J, 2015, J ORAL MAXIL SURG, V73, pS126, DOI 10.1016/j.joms.2015.04.009; Gomes Mônica Fernandes, 2006, Braz. oral res., V20, P324, DOI 10.1590/S1806-83242006000400008; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1; HOLMES R, 1984, CLIN ORTHOP RELAT R, P252; Ihoki M, 1991, JPN SOC ORAL MAXILLO, V37, P1923; INOUE T, 1986, J PERIODONTAL RES, V21, P243, DOI 10.1111/j.1600-0765.1986.tb01456.x; Ito k, 2008, ARCH BIOCERAM RES, V8, P166; KAWAI T, 1989, J DENT RES, V68, P1069, DOI 10.1177/00220345890680060301; KENT JN, 1983, J ORAL MAXIL SURG, V41, P629, DOI 10.1016/0278-2391(83)90016-2; Kim SG, 2001, J CRANIO MAXILL SURG, V29, P282, DOI 10.1054/jcms.2001.0236; Kim YK, 2010, ORAL SURG ORAL MED O, V109, P496, DOI 10.1016/j.tripleo.2009.10.017; Kluppel LE, 2013, J CRANIOFAC SURG, V24, P1074, DOI 10.1097/SCS.0b013e318286a0a3; Kon K, 2009, CLIN ORAL IMPLAN RES, V20, P1240, DOI 10.1111/j.1600-0501.2009.01798.x; Lee JY, 2013, J KOR ASSOC ORAL MAX, V39, P156, DOI 10.5125/jkaoms.2013.39.4.156; Li R, 2011, BIOMATERIALS, V32, P4525, DOI 10.1016/j.biomaterials.2011.03.008; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Murata M, 2012, J KOR ASSOC ORAL MAX, V38, P321, DOI 10.5125/jkaoms.2012.38.6.321; Piattelli A, 1996, BIOMATERIALS, V17, P1127, DOI 10.1016/0142-9612(96)85915-1; Scheven BAA, 2002, CELL BIOL INT, V26, P337, DOI 10.1006/cbir.2002.0860; SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625; Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8; Turonis James W, 2006, J Oral Implantol, V32, P55, DOI 10.1563/780.1; von Arx T, 1996, Int J Oral Maxillofac Implants, V11, P387; Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x; YAMASHITA F, 1985, CLIN ORTHOP RELAT R, P43; Yoshida T, 1998, J ENDODONT, V24, P581, DOI 10.1016/S0099-2399(98)80114-3; Young C, 1999, INT J ORAL MAX IMPL, V14, P72	39	51	60	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147235	10.1371/journal.pone.0147235	http://dx.doi.org/10.1371/journal.pone.0147235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26795024	gold, Green Published, Green Submitted			2022-12-27	WOS:000368530300024
J	Niella, T; Stier-Moses, N; Sigman, M				Niella, Tamara; Stier-Moses, Nicolas; Sigman, Mariano			Nudging Cooperation in a Crowd Experiment	PLOS ONE			English	Article							TRUST GAME; EXPECTATIONS; BEHAVIOR; WORLD	We examine the hypothesis that driven by a competition heuristic, people don't even reflect or consider whether a cooperation strategy may be better. As a paradigmatic example of this behavior we propose the zero-sum game fallacy, according to which people believe that resources are fixed even when they are not. We demonstrate that people only cooperate if the competitive heuristic is explicitly overridden in an experiment in which participants play two rounds of a game in which competition is suboptimal. The observed spontaneous behavior for most players was to compete. Then participants were explicitly reminded that the competing strategy may not be optimal. This minor intervention boosted cooperation, implying that competition does not result from lack of trust or willingness to cooperate but instead from the inability to inhibit the competition bias. This activity was performed in a controlled laboratory setting and also as a crowd experiment. Understanding the psychological underpinnings of these behaviors may help us improve cooperation and thus may have vast practical consequences to our society.	[Niella, Tamara; Stier-Moses, Nicolas; Sigman, Mariano] Univ Torcuato Tella, C1428BIJ, Buenos Aires, DF, Argentina; [Stier-Moses, Nicolas; Sigman, Mariano] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Stier-Moses, Nicolas] Facebook Data Sci, San Francisco, CA USA	Universidad Torcuato Di Tella; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Facebook Inc	Sigman, M (corresponding author), Univ Torcuato Tella, C1428BIJ, Buenos Aires, DF, Argentina.; Sigman, M (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	sigman@utdt.edu	Stier-Moses, Nicolas/R-5236-2018	Stier-Moses, Nicolas/0000-0001-6380-1516	CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina [PIP 112-201201-00450CO]; FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina [PICT 2012-1324]; CONICET; FONCYT Argentina [PICT-2013-1653]; James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award	CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina; FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT Argentina(FONCyT); James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award	Financial support from CONICET (El Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina Grant PIP 112-201201-00450CO and FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina Grant PICT 2012-1324. M.S. is sponsored by CONICET, FONCYT Argentina Grant PICT-2013-1653 and the James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition - Scholar Award.; We gratefully acknowledge financial support from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) Argentina Grant PIP 112-201201-00450CO and FONCYT (Fondo para la Investigacion Cientifica y Tecnologica) Argentina Grant PICT 2012-1324. M.S. is sponsored by CONICET, FONCYT Argentina Grant PICT-2013-1653 and the James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition-Scholar Award. We would like to thank Gerry Garbulsky, Mariano Bergman, Jimena Jiterman, Gisela Braier, Belen Zanoni, Hermes Mazali, Gustavo Contreras Dvorak, Hernan Berdichevsky and Diego Golombek for substantial help in the development of this project.	Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Branas-Garza P, 2011, J ECON BEHAV ORGAN, V78, P25, DOI 10.1016/j.jebo.2010.12.005; Camera G, 2013, P NATL ACAD SCI USA, V110, P14889, DOI 10.1073/pnas.1301888110; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Eriksson K, 2014, JUDGM DECIS MAK, V9, P360; Exadaktylos F, 2013, NATURE SCI REPORTS; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fiske ST, 2010, SOCIAL BEINGS CORE M, P531; Hayes BK, 2010, WIRES COGN SCI, V1, P278, DOI 10.1002/wcs.44; Heit E, 2000, PSYCHON B REV, V7, P569, DOI 10.3758/BF03212996; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Jousten A, 2010, EFFECTS EARLY RETIRE, P47; Kivikangas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100318; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; MCCLINTOCK CG, 1972, BEHAV SCI, V17, P438, DOI 10.1002/bs.3830170505; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Ortega J, 2000, ECON J, V110, P92, DOI 10.1111/1468-0297.00492; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Van Lange P. A. M., 2000, EUROPEAN REV SOCIAL, V11, P297, DOI DOI 10.1080/14792772043000068; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202; Yamagishi T, 2013, ORGAN BEHAV HUM DEC, V120, P260, DOI 10.1016/j.obhdp.2012.06.002	30	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147125	10.1371/journal.pone.0147125	http://dx.doi.org/10.1371/journal.pone.0147125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5CE	26797425	gold, Green Submitted, Green Published			2022-12-27	WOS:000368530300018
J	Idris, NS; Cheung, MMH; Grobbee, DE; Burgner, D; Kurniati, N; Uiterwaal, CSPM				Idris, Nikmah S.; Cheung, Michael M. H.; Grobbee, Diederick E.; Burgner, David; Kurniati, Nia; Uiterwaal, Cuno S. P. M.			Cardiac Effects of Antiretroviral-Naive versus Antiretroviral-Exposed HIV Infection in Children	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; THERAPY; MULTICENTER; DISEASE; ECHOCARDIOGRAPHY; INVOLVEMENT; CHILDHOOD; MORTALITY; INFANTS; MOTHERS	Background Cardiac involvement in HIV infected children has been frequently reported, but whether this is due to HIV infection itself or to antiretroviral treatment (ART) is unknown. Methods This cross sectional study involved 114 vertically-acquired HIV-infected (56 ART-naive, 58 ART-exposed) and 51 healthy children in Jakarta, Indonesia. Echocardiography was performed to measure dimensions of the left ventricle (LV) and systolic functions. We applied general linear modeling to evaluate the associations between HIV infection/treatment status and cardiac parameters with further adjustment for potential confounders or explanatory variables. Findings are presented as (adjusted) mean differences between each of the two HIV groups and healthy children, with 95% confidence intervals and p values. Results Compared to healthy children, ART-naive HIV-infected children did not show significant differences in age-and-height adjusted cardiac dimensions apart from larger LV internal diameter (difference 2.0 mm, 95% CI 0.2 to 3.7), whereas ART exposed HIV infection showed thicker LV posterior walls (difference = 1.1 mm, 95% CI 0.5 to 1.6), larger LV internal diameter (difference = 1.7 mm, 95% CI 0.2 to 3.2) and higher LV mass (difference = 14.0 g, 7.4 to 20.5). With respect to systolic function, reduced LV ejection fraction was seen in both ART-naive HIV infected (adjusted difference = -6.7%, -11.4 to -2.0) and, to a lesser extent, in ART-exposed HIV infected children (difference = -4.5%, -8.5 to -0.4). Inflammation level seemed to be involved in most associations in ART-exposed HIV-infected, but few, if any, for decreased function in the ART-naive ones, whereas lower hemoglobin appeared to partially mediate chamber dilation in both groups and reduced function, mainly in ART-exposed children. Conclusions ART-naive HIV infected children have a substantial decrease in cardiac systolic function, whereas the ART-exposed have thicker ventricular walls with larger internal diameter and higher mass, but less functional impairment.	[Idris, Nikmah S.; Kurniati, Nia] Univ Indonesia, Fac Med, Dept Child Hlth, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia; [Idris, Nikmah S.; Grobbee, Diederick E.; Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Idris, Nikmah S.; Cheung, Michael M. H.; Burgner, David] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Idris, Nikmah S.; Cheung, Michael M. H.; Burgner, David] Royal Childrens Hosp, Heart Res Grp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	University of Indonesia; Utrecht University; Utrecht University Medical Center; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Idris, NS (corresponding author), Univ Indonesia, Fac Med, Dept Child Hlth, Cipto Mangunkusumo Natl Gen Hosp, Jakarta, Indonesia.; Idris, NS (corresponding author), Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.; Idris, NS (corresponding author), Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia.; Idris, NS (corresponding author), Royal Childrens Hosp, Heart Res Grp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	nikmah@ikafkui.org		Burgner, David/0000-0002-8304-4302; Idris, Nikmah Salamia/0000-0001-5890-1934				[Anonymous], 2012, GLOB REP UNAIDS REP; Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6; Chanthong P, 2014, AIDS, V28, P2071, DOI 10.1097/QAD.0000000000000376; Currie PF, 2003, AIDS, V17, pS21, DOI 10.1097/00002030-200304001-00004; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; GRAHAM TP, 1971, CIRCULATION, V43, P895, DOI 10.1161/01.CIR.43.6.895; Kearney DL, 2003, CARDIOVASC PATHOL, V12, P140, DOI 10.1016/S1054-8807(03)00035-8; Lipshultz SE, 2000, CIRCULATION, V102, P1542, DOI 10.1161/01.CIR.102.13.1542; Lipshultz SE, 1998, CIRCULATION, V97, P1246, DOI 10.1161/01.CIR.97.13.1246; Lipshultz SE, 2002, LANCET, V360, P368, DOI 10.1016/S0140-6736(02)09607-1; LIPSHULTZ SE, 2009, CIRCULATION S2, V120, pS909; Lipshultz SE, 2015, AIDS, V29, P91, DOI 10.1097/QAD.0000000000000499; Lipshultz SE, 2013, JAMA PEDIATR, V167, P520, DOI 10.1001/jamapediatrics.2013.1206; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Lorell BH, 2000, CIRCULATION, V102, P470; LUGINBUHL LM, 1993, JAMA-J AM MED ASSOC, V269, P2869, DOI 10.1001/jama.269.22.2869; National Health and Nutrition Examination Survey (NHANES), 2007, ANTHR PROC MAN; Plebani A, 2004, PEDIATR INFECT DIS J, V23, P559, DOI 10.1097/01.inf.0000130073.48745.a6; Sims A, 2012, J AM SOC ECHOCARDIOG, V25, P741, DOI 10.1016/j.echo.2012.04.004; Cunha MDSA, 2008, ARQ BRAS CARDIOL, V90, P11, DOI 10.1590/S0066-782X2008000100003; Starc TJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e14; World Health Organisation, 2007, WHO CAS DEF HIV SURV	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146753	10.1371/journal.pone.0146753	http://dx.doi.org/10.1371/journal.pone.0146753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789522	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100039
J	Urasaki, Y; Pizzorno, G; Le, TT				Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.			Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice	PLOS ONE			English	Article							LIPID-ACCUMULATION; INSULIN-RESISTANCE; PHOSPHORYLASE; DISEASE; PROTEIN; ACID; GENE; SUPPLEMENTATION; BIOSYNTHESIS; NUCLEOTIDES	Uridine is a pyrimidine nucleoside that exerts restorative functions in tissues under stress. Short-term co-administration of uridine with multiple unrelated drugs prevents drug-induced liver lipid accumulation. Uridine has the ability to modulate liver metabolism; however, the precise mechanism has not been delineated. In this study, long-term effects of uridine on liver metabolism were examined in both HepG2 cell cultures and C57BL/6J mice. We report that uridine administration was associated with O-GlcNAc modification of FOXO1, increased gluconeogenesis, reduced insulin signaling activity, and reduced expression of a liver-specific fatty acid binding protein FABP1. Long-term uridine feeding induced systemic glucose intolerance and severe liver lipid accumulation in mice. Our findings suggest that the therapeutic potentials of uridine should be designed for short-term acute administration.	[Urasaki, Yasuyo; Le, Thuc T.] Roseman Univ Hlth Sci, Coll Med, Dept Biomed Sci, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Pizzorno, Giuseppe] Desert Res Inst, 10530 Discovery Dr, Las Vegas, NV 89135 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Le, TT (corresponding author), Roseman Univ Hlth Sci, Coll Med, Dept Biomed Sci, 10530 Discovery Dr, Las Vegas, NV 89135 USA.	tle5@roseman.edu			Roseman University of Health Sciences	Roseman University of Health Sciences	This study is supported by start-up funds from Roseman University of Health Sciences to TTL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; BLAKE WL, 1990, BIOCHEM BIOPH RES CO, V173, P87, DOI 10.1016/S0006-291X(05)81025-3; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Dudzinska W, 2013, PHYSIOL RES, V62, P163, DOI 10.33549/physiolres.932355; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; GALLAI V, 1992, ACTA NEUROL SCAND, V86, P3, DOI 10.1111/j.1600-0404.1992.tb08045.x; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; HRESKO RC, 1990, J BIOL CHEM, V265, P21075; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Le TT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-27; Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; McComsey GA, 2010, AIDS, V24, P2503, DOI 10.1097/QAD.0b013e32833ea9bc; McEvilly M, 2011, AM J HEALTH-SYST PH, V68, P1806, DOI 10.2146/ajhp100434; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Roosild TP, 2011, J STRUCT BIOL, V176, P229, DOI 10.1016/j.jsb.2011.08.002; Urasaki Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038418, DOI 10.1371/J0URNAL.P0NE.0038418]; Urasaki Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099728, DOI 10.1371/J0URNAL.P0NE.0099728]; VANGROENINGEN CJ, 1991, J NATL CANCER I, V83, P437; Wurtman RJ, 2014, NUTRIENTS, V6, P1701, DOI 10.3390/nu6041701; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6; Yamamoto T, 2010, NUCLEOS NUCLEOT NUCL, V29, P504, DOI 10.1080/15257771003740986; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zhang W, 2015, NAT COMMUN, V6, P7079, DOI [10.1038/ncomms8079, DOI 10.1038/NC0MMS8079]; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	37	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146994	10.1371/journal.pone.0146994	http://dx.doi.org/10.1371/journal.pone.0146994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789264	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100051
J	Cong, HR; Jiang, HQ; Peng, JT; Cui, SL; Liu, LJ; Wang, JW; Zhang, XJ				Cong, Hengri; Jiang, Hanqiu; Peng, Jingting; Cui, Shilei; Liu, Lijuan; Wang, Jiawei; Zhang, Xiaojun			Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; NEUROMYELITIS-OPTICA; GM-CSF; INDUCTION; IL-17; CYTOKINE; MEMORY; NERVE; BETA	Background Typical and atypical optic neuritis (ON) are two clinical types of autoimmune inflammatory diseases of the optic nerve that causes acute vision loss, and are difficult to distinguish in their early stages. The disturbance in the balance of Th17 and Treg lymphocytes is thought to play an essential role in these autoimmune inflammatory diseases. Objectives To detect the clinical relevance of Th17 and Treg in peripheral blood and the ratio of Treg/Th17 in patients with typical and atypical ON. To determine whether analysis of Th17 and Treg lymphocytes will provides insights into the different disease phenotypes of typical and atypical ON. Methods We studied a consecutive series of patients aged 14-70 years who presented to our neurological department with typical ON (n = 30) or atypical ON (n = 33) within 4 weeks of their acute attacks. Routine clinical tests and ophthalmological examination were performed in all patients. Blood samples were collected from untreated patients and from gender-and age-matched healthy controls (n = 30). The proportion of peripheral blood Th17 cells and Treg cells was determined by flow cytometry. Results Patients with atypical ON had a higher proportion of Th17 cells than patients with typical ON (3.61 +/- 1.56 vs 2.55 +/- 1.74, P<0.01) or controls (1.45 +/- 0.86, P<0.01). The proportion of Th17 cells in patients with typical ON was also markedly higher than in controls (P<0.01). The mean percentage of Treg cells in atypical ON (6.31 +/- 2.11) and typical ON (6.80 +/- 2.00) were significantly lower when compared to controls (8.29 +/- 2.32, both P<0.01). No significant difference in Treg frequency was observed between typical ON and atypical ON (p>0.05). Conclusions The frequency of Th17 cells is higher in atypical ON than typical ON, and patients with atypical ON have a greater imbalance of pro-inflammatory and regulatory cells than patients with typical ON when compared with controls. These changes are indicative of distinct pathological mechanisms and may provide useful information to distinguish typical and atypical ON.	[Cong, Hengri; Jiang, Hanqiu; Peng, Jingting; Cui, Shilei; Wang, Jiawei; Zhang, Xiaojun] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Liu, Lijuan] Capital Med Univ, Beijing Tongren Hosp, Ctr Eye, Beijing 100730, Peoples R China	Capital Medical University; Capital Medical University	Zhang, XJ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Beijing 100730, Peoples R China.	zxjune@gmail.com	zhang, jin/GXV-9154-2022		Beijing Education Commission technology development program project Grant [SQKM201210025016]; Chinese National Science-tech Supporting Plan [2012BAI08B06]	Beijing Education Commission technology development program project Grant; Chinese National Science-tech Supporting Plan	This work was supported by Beijing Education Commission technology development program project Grant No. SQKM201210025016 and Chinese National Science-tech Supporting Plan, Grant No. 2012BAI08B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Babaloo Z, 2015, IMMUNOL LETT, V164, P76, DOI 10.1016/j.imlet.2015.01.001; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gaudreau S, 2010, CELL IMMUNOL, V265, P31, DOI 10.1016/j.cellimm.2010.06.010; Hua FL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/571302; Kale N, 2012, CURR OPIN OPHTHALMOL, V23, P472, DOI 10.1097/ICU.0b013e328358b202; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Knier B, 2015, J AUTOIMMUN, V56, P34, DOI 10.1016/j.jaut.2014.09.003; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krumbholz M, 2014, SEMIN IMMUNOPATHOL, V36, P339, DOI 10.1007/s00281-014-0424-x; Lai CT, 2011, J NEURO-OPHTHALMOL, V31, P16, DOI 10.1097/WNO.0b013e3181f8a693; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lau PPK, 2015, INT OPHTHALMOL, V35, P303, DOI 10.1007/s10792-014-9945-5; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li B, 2013, EXP NEUROL, V250, P239, DOI 10.1016/j.expneurol.2013.10.002; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; Malik A, 2014, INDIAN J OPHTHALMOL, V62, P982, DOI 10.4103/0301-4738.145986; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mitsdoerffer M, 2013, ANN NY ACAD SCI, V1283, P57, DOI 10.1111/nyas.12118; Peng JT, 2015, J NEUROL SCI, V349, P94, DOI 10.1016/j.jns.2014.12.031; Quan C, 2015, J NEUROIMMUNOL, V282, P45, DOI 10.1016/j.jneuroim.2015.03.016; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Tian AY, 2010, INT J MOL MED, V25, P869, DOI 10.3892/ijmm_00000416; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	39	4	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146270	10.1371/journal.pone.0146270	http://dx.doi.org/10.1371/journal.pone.0146270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785053	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400028
J	Crook, ED; Kroeker, KJ; Potts, DC; Rebolledo-Vieyra, M; Hernandez-Terrones, LM; Paytan, A				Crook, Elizabeth Derse; Kroeker, Kristy J.; Potts, Donald C.; Rebolledo-Vieyra, Mario; Hernandez-Terrones, Laura M.; Paytan, Adina			Recruitment and Succession in a Tropical Benthic Community in Response to In-Situ Ocean Acidification	PLOS ONE			English	Article							FILAMENTOUS TURF ALGAE; CORAL-REEFS; NUTRIENT ENRICHMENT; CARBONIC-ACID; CALCIFICATION; SETTLEMENT; SEAWATER; DISSOCIATION; THRESHOLDS; CONSTANTS	Ocean acidification is a pervasive threat to coral reef ecosystems, and our understanding of the ecological processes driving patterns in tropical benthic community development in conditions of acidification is limited. We deployed limestone recruitment tiles in low aragonite saturation (Omega(arag)) waters during an in-situ field experiment at Puerto Morelos, Mexico, and compared them to tiles placed in control zones over a 14-month investigation. The early stages of succession showed relatively little difference in coverage of calcifying organisms between the low Omega(arag) and control zones. However, after 14 months of development, tiles from the low Omega(arag) zones had up to 70% less cover of calcifying organisms coincident with 42% more fleshy algae than the controls. The percent cover of biofilm and turf algae was also significantly greater in the low Omega(arag) zones, while the number of key grazing taxa remained constant. We hypothesize that fleshy algae have a competitive edge over the primary calcified space holders, coralline algae, and that acidification leads to altered competitive dynamics between various taxa. We suggest that as acidification impacts reefs in the future, there will be a shift in community assemblages away from upright and crustose coralline algae toward more fleshy algae and turf, established in the early stages of succession.	[Crook, Elizabeth Derse] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Crook, Elizabeth Derse; Paytan, Adina] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kroeker, Kristy J.; Potts, Donald C.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Rebolledo-Vieyra, Mario; Hernandez-Terrones, Laura M.] Ctr Invest Cient Yucatan AC, Unidad Ciencias Agua UCIA, Cancun, Quintana Roo, Mexico	University of California System; University of California Irvine; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Centro de Investigacion Cientifica de Yucatan	Crook, ED (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA.; Crook, ED (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	e.crook@uci.edu		Kroeker, Kristy/0000-0002-5766-1999	National Science Foundation [1040952]; Environmental Protection Agency-Science to Achieve Results	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency-Science to Achieve Results	This work was supported by the National Science Foundation-1040952 (AP) (nsf.gov) and the Environmental Protection Agency-Science to Achieve Results (EDC) (epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1973, PHYCOLOGIA, V2, P111; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Beddows PA, 2007, J HYDROL, V346, P18, DOI 10.1016/j.jhydrol.2007.08.013; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falkenberg LJ, 2013, MAR ECOL PROG SER, V492, P85, DOI 10.3354/meps10491; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; HILL AS, 1991, J MAR BIOL ASSOC UK, V71, P403, DOI 10.1017/S0025315400051675; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Johnson VR, 2013, MAR BIOL, V160, P1813, DOI 10.1007/s00227-011-1840-2; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; LITTLER MM, 1984, J EXP MAR BIOL ECOL, V74, P13, DOI 10.1016/0022-0981(84)90035-2; Littler MM, 1972, ANN REV OCEANOG MAR, V10, P31; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; MEADOWS PS, 1963, NATURE, V198, P610, DOI 10.1038/198610b0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pandolfi JM, 2011, SCIENCE, V334, P1495, DOI 10.1126/science.334.6062.1495; Paytan A, 2014, P NATL ACAD SCI USA, V111, pE302, DOI 10.1073/pnas.1319572111; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; SEBENS KP, 1986, ECOL MONOGR, V56, P73, DOI 10.2307/2937271; Short J, 2014, J EXP MAR BIOL ECOL, V456, P70, DOI 10.1016/j.jembe.2014.03.014; Solomon S., 2007, PHYS SCI BASIS WORKI; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Thacker RW, 2001, CORAL REEFS, V19, P318, DOI 10.1007/s003380000122; Thompson RC, 2004, ECOLOGY, V85, P1372, DOI 10.1890/03-0279; Thompson RC, 1998, HYDROBIOLOGIA, V375-76, P203, DOI 10.1023/A:1017036301082; Wallace D, 2006, MS EXCEL PROGRAM DEV; WILLIAMS SL, 1990, J PHYCOL, V26, P36, DOI 10.1111/j.0022-3646.1990.00036.x	57	18	18	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146707	10.1371/journal.pone.0146707	http://dx.doi.org/10.1371/journal.pone.0146707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784986	Green Published, gold			2022-12-27	WOS:000368528400060
J	Melchiorre, MG; Di Rosa, M; Lamura, G; Torres-Gonzales, F; Lindert, J; Stankunas, M; Ioannidi-Kapolou, E; Barros, H; Macassa, G; Soares, JJF				Melchiorre, Maria Gabriella; Di Rosa, Mirko; Lamura, Giovanni; Torres-Gonzales, Francisco; Lindert, Jutta; Stankunas, Mindaugas; Ioannidi-Kapolou, Elisabeth; Barros, Henrique; Macassa, Gloria; Soares, Joaquim J. F.			Abuse of Older Men in Seven European Countries: A Multilevel Approach in the Framework of an Ecological Model	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; ELDER ABUSE; SOCIAL SUPPORT; RISK-FACTORS; SOMATIC SYMPTOMS; FINANCIAL EXPLOITATION; PEOPLES PERCEPTIONS; PSYCHOLOGICAL ABUSE; AFRICAN-AMERICANS; FORGOTTEN VICTIMS	Background Several studies on elder abuse indicate that a large number of victims are women, but others report that men in later life are also significantly abused, especially when they show symptoms of disability and poor health, and require help for their daily activities as a result. This study focused on the prevalence of different types of abuse experienced by men and on a comparison of male victims and non-victims concerning demographic/socio-economic characteristics, lifestyle/health variables, social support and quality of life. Additionally, the study identified factors associated with different types of abuse experienced by men and characteristics associated with the victims. Methods The cross-sectional data concerning abuse in the past 12 months were collected by means of interviews and self-response during January-July 2009, from a sample of 4,467 not demented individuals aged between 60-84 years living in seven European countries (Germany, Greece, Italy, Lithuania, Portugal, Spain and Sweden). We used a multilevel approach, within the framework of an Ecological Model, to explore the phenomenon of abuse against males as the complex result of factors from multiple levels: individual, relational, community and societal. Results Multivariate analyses showed that older men educated to higher levels, blue-collar workers and men living in a rented accommodation were more often victims than those educated to lower levels, low-rank white-collar workers and home owners, respectively. In addition, high scores for factors such as somatic and anxiety symptoms seemed linked with an increased probability of being abused. Conversely, factors such as increased age, worries about daily expenses (financial strain) and greater social support seemed linked with a decreased probability of being abused. Conclusions Male elder abuse is under-recognized, under-detected and under-reported, mainly due to the vulnerability of older men and to social/cultural norms supporting traditional male characteristics of stoicism and strength. Further specific research on the topic is necessary in the light of the present findings. Such research should focus, in particular, on societal/community aspects, as well as individual and family ones, as allowed by the framework of the Ecological Model, which in turn could represent a useful method also for developing prevention strategies for elder abuse.	[Melchiorre, Maria Gabriella; Lamura, Giovanni] INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy; [Di Rosa, Mirko] INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Sci Direct, Ancona, Italy; [Torres-Gonzales, Francisco] Univ Granada, Ctr Invest Biomed Red Salud Mental CIBERSAM, Granada, Spain; [Lindert, Jutta] Univ Emden, Dept Publ Hlth, Emden, Germany; [Lindert, Jutta] Brandeis Univ, Womens Studies Res Ctr, Waltham, MA USA; [Stankunas, Mindaugas] Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania; [Stankunas, Mindaugas] Griffith Univ, Sch Med, Ctr Hlth Innovat, Hlth Serv Management Dept, Gold Coast, Qld, Australia; [Ioannidi-Kapolou, Elisabeth] Natl Sch Publ Hlth, Dept Sociol, Athens, Greece; [Barros, Henrique] Univ Porto, Sch Med, Dept Hyg & Epidemiol, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Macassa, Gloria] Univ Gavle, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Macassa, Gloria] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Soares, Joaquim J. F.] Mid Sweden Univ, Sect Publ Hlth Sci, Dept Hlth Sci, Sundsvall, Sweden	IRCCS INRCA; IRCCS INRCA; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; Brandeis University; Lithuanian University of Health Sciences; Griffith University; National & Kapodistrian University of Athens; Universidade do Porto; University of Gavle; Karolinska Institutet; Mid-Sweden University	Melchiorre, MG (corresponding author), INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy.	g.melchiorre@inrca.it	Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019; Melchiorre, Maria Gabriella/K-4625-2016; Di Rosa, Mirko/J-5974-2016; Stankunas, Mindaugas/B-1770-2019	Barros, Henrique/0000-0003-4699-6571; Melchiorre, Maria Gabriella/0000-0002-4428-3749; Di Rosa, Mirko/0000-0002-1862-4159; Fernandes Soares, Joaquim Jorge/0000-0001-5221-9504	European Commission, through the Executive Agency for Health and Consumers (EAHC) (Public Health Programme) [2007123]	European Commission, through the Executive Agency for Health and Consumers (EAHC) (Public Health Programme)	This research was funded by grant support from the European Commission, through the Executive Agency for Health and Consumers (EAHC) (Public Health Programme 2008-2010), Grant Agreement n. 2007123, which made possible the realisation of the ABUEL Project, "Elder Abuse: A multinational prevalence survey." EAHC is currently named CHAFEA (since January 2014). Thus the related URL http://ec.europa.eu/chafea/index.html includes the name CHAFEA instead of EAHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 2013, GSA SCI ANN M 20 24; Amstadter AB, 2010, J ELDER ABUSE NEGL, V23, P43, DOI 10.1080/08946566.2011.534707; ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Astrom S, 2002, SCAND J CARING SCI, V16, P66, DOI 10.1046/j.1471-6712.2002.00052.x; Austin PC, 2001, CAN J PUBLIC HEALTH, V92, P150, DOI 10.1007/BF03404950; Band-Winterstein T, 2012, J AGING STUD, V26, P504, DOI 10.1016/j.jaging.2012.07.003; Beach SR, 2010, GERONTOLOGIST, V50, P744, DOI 10.1093/geront/gnq053; Beaulieu M, 1999, OLDER ADULTS PERSONA; Beehr T. A., 2001, RES OCCUPATIONAL STR, P97, DOI DOI 10.1016/S1479-3555; Biggs S, 2009, J ELDER ABUSE NEGL, V21, P1, DOI 10.1080/08946560802571870; Blundo R, 2007, J ELDER ABUSE NEGL, V19, P173, DOI 10.1300/J084v19n01_11; Bonnie R. J., 2003, ELDER MISTREATMENT A; Borg T, 2013, MENS HLTH       0319; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brahler E, 1995, HANDBUCH 2 ERGANZTE; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U., 1997, FDN SPECIAL ED, P49; Buri H, 2006, RES AGING, V28, P562, DOI 10.1177/0164027506289722; Burnes D., 2014, THESIS COLUMBIA U; CHAPPELL D., 2000, VIOLENCE WORK; Cheung M, 2009, J FAM VIOLENCE, V24, P447, DOI 10.1007/s10896-009-9240-9; Choi NG, 1999, J ELDER ABUSE NEGL, V10, P39, DOI 10.1300/J084v10n03_03; Choi NG, 2000, J GERONTOL SOC WORK, V33, P5, DOI 10.1300/J083v33n02_02; Cooney C, 1995, INT J SOC PSYCHIATR, V41, P276, DOI 10.1177/002076409504100405; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Crowell N. A., 1996, UNDERSTANDING VIOLEN; Dahlberg L. L., 2002, WORLD REPORT VIOLENC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Daskalopoulos MD, 2006, J ELDER ABUSE NEGL, V18, P67, DOI 10.1300/J084v18n02_05; Deem DL, 2000, J ELDER ABUSE NEGL, V12, P33, DOI 10.1300/J084v12n02_05; Dessin C. L., 2000, IDAHO LAW R, V36, P203; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Dimah A, 2002, J BLACK STUD, V32, P557, DOI 10.1177/002193470203200504; Dong XQ, 2008, GERONTOLOGY, V54, P381, DOI 10.1159/000143228; Dong XQ, 2012, GENERATIONS, V36, P40; Dong XQ, 2010, ARCH GERONTOL GERIAT, V50, P202, DOI 10.1016/j.archger.2009.03.011; Drayer RA, 2005, INT J GERIATR PSYCH, V20, P973, DOI 10.1002/gps.1389; DUHART DT, 2001, VIOLENCE WORKPLACE 1; Edelson J., 1992, INTERVENTION MEN WHO; Fanslow J., 2005, ZERO TOLERANCE KEY I; Folkhalsorapport, 2007, STOCKH COUNT COUNC S; Fuhrer R, 2002, SOC SCI MED, V54, P811, DOI 10.1016/S0277-9536(01)00111-3; Fulmer T, 2005, GERONTOLOGIST, V45, P525, DOI 10.1093/geront/45.4.525; Garre-Olmo J, 2009, J AM GERIATR SOC, V57, P815, DOI 10.1111/j.1532-5415.2009.02221.x; Gorbien MJ, 2005, CLIN GERIATR MED, V21, P279, DOI 10.1016/j.cger.2004.12.001; Hafemeister TL, 2003, ELDER MISTREATMENT A; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Health in Aging Foundation, 2015, PREV ELD AB NEGL OLD; HealthLink British Columbia, 2014, ELD AB PREV SER C, V93c, P1; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Helmes E, 2007, AUSTRALAS J AGEING, V26, P120, DOI 10.1111/j.1741-6612.2007.00235.x; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hox J. J., 1998, CLASSIFICATION DATA, P147, DOI [DOI 10.1007/978-3-642-72087-1_17, 10.1007/978-3-642-72087-1_17]; Hwang M M, 1996, J Long Term Home Health Care, V15, P13; Juklestad O., 2001, J ADULT PROTECT, V3, P32; Killick C, 2015, J ELDER ABUSE NEGL, V27, P100, DOI 10.1080/08946566.2014.997374; Kosberg J. I., 2007, ABUSE OF OLDER MEN; Kosberg JI, 1998, J ELDER ABUSE NEGL, V9, P69, DOI 10.1300/J084v09n03_04; Kosberg JI., 2002, GERONTOL GERIATR EDU, V22, P27, DOI DOI 10.1300/J021V22N04_03; Kosberg JI, 2014, J ELDER ABUSE NEGL, V26, P207, DOI 10.1080/08946566.2014.898442; Krienert JL, 2009, J ELDER ABUSE NEGL, V21, P325, DOI 10.1080/08946560903005042; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; LACHS MS, 1994, J AM GERIATR SOC, V42, P169, DOI 10.1111/j.1532-5415.1994.tb04947.x; Lai DWL, 2011, J ELDER ABUSE NEGL, V23, P326, DOI 10.1080/08946566.2011.584047; Langan J, 1996, AGEING SOC, V16, P287, DOI 10.1017/S0144686X00003433; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; Leung KK, 2007, ARCH GERONTOL GERIAT, V44, P203, DOI 10.1016/j.archger.2006.05.001; Lindert J, 2013, INT J PUBLIC HEALTH, V58, P121, DOI 10.1007/s00038-012-0388-3; Lindert J, 2012, EUR J PUBLIC HEALTH, V22, P662, DOI 10.1093/eurpub/ckr079; Litwin H, 2010, J GERONTOL B-PSYCHOL, V65, P599, DOI 10.1093/geronb/gbp104; Lovestad S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-945; Lowenstein A, 2007, J GERONTOL B-PSYCHOL, V62, pS100, DOI 10.1093/geronb/62.2.S100; Lowenstein A, 2009, J ELDER ABUSE NEGL, V21, P253, DOI 10.1080/08946560902997629; Macassa G, 2013, J AGGRESS CONFL PEAC, V5, P16, DOI 10.1108/17596591311290722; MacDonald D.K., 2015, ASSESSING ELDER ABUS; MACINTYRE S, 2000, SOCIAL EPIDEMIOLOGY; Malmedal W, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/902515; ManKind Initiative Helpline, 2014, MAL VICT DOM PARTN A; Marmolejo I.I., 2008, ELDER ABUSE FAMILY S; Gil APM, 2015, J ELDER ABUSE NEGL, V27, P174, DOI 10.1080/08946566.2014.953659; McNeely RL, 2007, J ELDER ABUSE NEGL, V19, P99, DOI 10.1300/J084v19n01_07; Melchiorre MG, 2014, EDUC GERONTOL, V40, P909, DOI 10.1080/03601277.2014.912839; Melchiorre MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054856; Melchiorre MG, 2007, INT J AGEING LATER L, V7, pIX; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Moon A, 2000, GENERATIONS, V24, P75; Mouton CP, 2001, CLIN GERONTOL, V24, P15; Mowlam A., 2007, UK STUDY ABUSE NEGLE; Munoz J, 2004, PERSONAS MAYORES MAL; National Committee for the Prevention of Elder Abuse (NCPEA), 2001, ELD AB FIN AB; National Research Council (NRC), 2003, PAN REV RISK PREV EL; Naughton C, 2010, ABUSE NEGLECT OLDER; Naughton C, 2014, J ELDER ABUSE NEGL, V26, P300, DOI 10.1080/08946566.2013.867242; Nerenberg L, 2000, J ELDER ABUSE NEGL, V12, P49, DOI 10.1300/J084v12n02_06; O'Brien M, 2001, TOTAL INDIFFERENCE O; O'Keeffe M, 2007, NURSING OLDER PEOPLE, DOI DOI 10.7748/NOP2007.10.19.8.24.C6268; Penhale B, 1999, ELDER ABUSE OLDER ME; Perel-Levin S., 2008, DISCUSSING SCREENING; Phelan A, 2013, INT PERSPECTIVES ELD; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; Poole C, 2012, J ELDER ABUSE NEGL, V24, P120, DOI 10.1080/08946566.2011.646503; Power M, 2005, QUAL LIFE RES, V14, P1651; Powers LE, 2008, J REHABIL, V74, P41; Pritchard J, 2001, MALE VICTIMS ELDER A; Reeves KA, 2007, J ELDER ABUSE NEGL, V19, P7, DOI 10.1300/J084v19n01_02; Reilly JM, 2012, FAM MED, V44, P332; Roberto KA, 2013, J ELDER ABUSE NEGL, V25, P230, DOI 10.1080/08946566.2012.751825; ROSS CE, 1989, J HEALTH SOC BEHAV, V30, P206, DOI 10.2307/2137014; Safran D.A., 1996, VIOLENCE JOB IDENTIF, P207, DOI [10.1037/10215-010, DOI 10.1037/10215-010]; Schiamberg LB, 2000, INT J AGING HUM DEV, V50, P329, DOI 10.2190/DXAX-8TJ9-RG5K-MPU5; Sethi D., 2011, EUROPEAN REPORT PREV; Singleton N., 2003, BETTER WORSE LONGITU; Skirbekk V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-336; Soares JJ, 2010, ABUSE HLTH ELDERLY E; Soares JJF, 2007, INT J SOC WELF, V16, P269, DOI 10.1111/j.1468-2397.2006.00461.x; Soares JJF, 2014, J ADULT PROT, V16, P213, DOI 10.1108/JAP-08-2013-0034; Spencer C., 1998, GRC NEWS, V17, P6; Stratton DC, 2007, J ELDER ABUSE NEGL, V19, P75, DOI 10.1300/J084v19n01_06; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus MA, 2011, AGGRESS VIOLENT BEH, V16, P279, DOI 10.1016/j.avb.2011.04.010; Teaster PB, 2007, J ELDER ABUSE NEGL, V19, P29, DOI 10.1300/J084v19n01_03; Teaster PB, 2013, PROMISE PERIL CONCEP; The National Elder Abuse Incidence Study (NEAIS), 1998, FIN REP; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; Thomas PA, 2011, SOC SCI MED, V73, P1428, DOI 10.1016/j.socscimed.2011.07.035; Thompson EH, 2007, J ELDER ABUSE NEGL, V19, P129, DOI 10.1300/J084v19n01_09; Tsukada N, 2001, J ELDER ABUSE NEGL, V13, P71, DOI 10.1300/J084v13n01_04; Werner P, 2005, J ELDER ABUSE NEGL, V17, P63, DOI 10.1300/J084v17n02_04; Wolf RS, 1997, J GERIATR PSYCHIAT, V30, P153; WOLF RS, 1989, HELPING ELDERLY VICT; World Health Organization, 2002, WORLD REPORT VIOLENC; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	135	18	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146425	10.1371/journal.pone.0146425	http://dx.doi.org/10.1371/journal.pone.0146425			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784897	Green Published, gold, Green Submitted			2022-12-27	WOS:000368528400036
J	Ndege, S; Washington, S; Kaaria, A; Prudhomme-O'Meara, W; Were, E; Nyambura, M; Keter, AK; Wachira, J; Braitstein, P				Ndege, Samson; Washington, Sierra; Kaaria, Alice; Prudhomme-O'Meara, Wendy; Were, Edwin; Nyambura, Monica; Keter, Alfred K.; Wachira, Juddy; Braitstein, Paula			HIV Prevalence and Antenatal Care Attendance among Pregnant Women in a Large Home-Based HIV Counseling and Testing Program in Western Kenya	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SERVICES; AFRICA	Objective To describe the uptake of and factors associated with HIV prevalence among pregnant women in a large-scale home-based HIV counseling and testing (HBCT) program in western Kenya. Methods In 2007, the Academic Model Providing Access to Healthcare Program (AMPATH) initiated HBCT to all individuals aged >= 13 years and high-risk children <13 years. Included in this analysis were females aged 13-50 years, from 6 catchment areas (11/08-01/12). We used descriptive statistics and logistic regression to describe factors associated with HIV prevalence. Results There were 119,678 women eligible for analysis; median age 25 (interquartile range, IQR: 18-34) years. Of these, 7,396 (6.2%) were pregnant at the time of HBCT; 4,599 (62%) had ever previously tested for HIV and 2,995 (40.5%) had not yet attended ANC for their current pregnancy. Testing uptake among pregnant women was high (97%). HBCT newly identified 241 (3.3%) pregnant HIV-positive women and overall HIV prevalence among all pregnant women was 6.9%. HIV prevalence among those who had attended ANC in this pregnancy was 5.4% compared to 9.0% among those who had not. Pregnant women were more likely to newly test HIV-positive in HBCT if they had not attended ANC in the current pregnancy (AOR: 6.85, 95% CI: 4.49-10.44). Conclusions Pregnant women who had never attended ANC were about 6 times more likely to newly test HIV-positive compared to those who had attended ANC, suggesting that the cascade of services for prevention of mother-to-child HIV transmission should optimally begin at the home and village level if elimination of perinatal HIV transmission is to be achieved.	[Ndege, Samson; Kaaria, Alice; Prudhomme-O'Meara, Wendy; Were, Edwin; Nyambura, Monica; Keter, Alfred K.; Wachira, Juddy; Braitstein, Paula] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Ndege, Samson; Prudhomme-O'Meara, Wendy] Moi Univ, Sch Publ Hlth, Coll Hlth Sci, Eldoret, Kenya; [Washington, Sierra] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Kaaria, Alice] Moi Teaching & Referral Hosp, Eldoret, Kenya; [Prudhomme-O'Meara, Wendy] Duke Univ, Sch Med, Durham, NC USA; [Prudhomme-O'Meara, Wendy] Duke Global Hlth Inst, Durham, NC USA; [Were, Edwin; Wachira, Juddy; Braitstein, Paula] Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Indiana University System; Indiana University Bloomington; Duke University; Duke University; Moi University; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Braitstein, P (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Braitstein, P (corresponding author), Moi Univ, Sch Med, Coll Hlth Sci, Eldoret, Kenya.; Braitstein, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Braitstein, P (corresponding author), Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA.; Braitstein, P (corresponding author), Regenstrief Inst Inc, Indianapolis, IN USA.	paula.braitstein@utoronto.ca		Were, Edwin/0000-0002-4783-0795; Kaaria, Alice/0000-0003-3830-6497	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], 2014, WORLD AIDS DAY 2014; Delva W, 2010, TROP MED INT HEALTH, V15, P584, DOI 10.1111/j.1365-3156.2010.02499.x; Druce N, 2007, REPROD HEALTH MATTER, V15, P190, DOI 10.1016/S0968-8080(07)30337-6; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Government of Kenya, 2010, DEM HLTH SURV 2008 2; Government of Kenya, 2015, KEN DEM HLTH SURV 20; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Kenya Demographic & Health Survey, 2011, KEN DEM HLTH SURV 20; Kimaiyo S, 2010, East Afr Med J, V87, P100; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; O'Meara WP, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-55; Operario D, 2013, HEALTH PSYCHOL, V32, P932, DOI 10.1037/a0032760; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Suthar AB, 2013, B WORLD HEALTH ORGAN, V91, P46, DOI 10.2471/BLT.12.107003; Turan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044181; UNAIDS, 2014, PROGR REP GLOB PLAN; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Wachira J, 1999, J ACQUIRED IMMUNE DE; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; World Health Organization, 2012, PLANN IMPL MON HOM B; World Health Organization, 2013, CONS GUID US ANT TRE; World Health Organization, 2012, SERV DEL APPR HIV TE	28	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0144618	10.1371/journal.pone.0144618	http://dx.doi.org/10.1371/journal.pone.0144618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784957	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400005
J	Sullivan, K; Cramer-Morales, K; McElroy, DL; Ostrov, DA; Haas, K; Childers, W; Hromas, R; Skorski, T				Sullivan, Katherine; Cramer-Morales, Kimberly; McElroy, Daniel L.; Ostrov, David A.; Haas, Kimberly; Childers, Wayne; Hromas, Robert; Skorski, Tomasz			Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection	PLOS ONE			English	Article							ENRICHED FRAGMENT LIBRARIES; DRUG DISCOVERY; PROTEIN; CELLS; REPAIR; KINASE; CANCER; DOMAIN; LETHAL; BREAKS	It has been reported that inhibition of RAD52 either by specific shRNA or a small peptide aptamer induced synthetic lethality in tumor cell lines carrying BRCA1 and BRCA2 inactivating mutations. Molecular docking was used to screen two chemical libraries: 1) 1,217 FDA approved drugs, and 2) 139,735 drug-like compounds to identify candidates for interacting with DNA binding domain of human RAD52. Thirty six lead candidate compounds were identified that were predicted to interfere with RAD52 -DNA binding. Further biological testing confirmed that 9 of 36 candidate compounds were able to inhibit the binding of RAD52 to single-stranded DNA in vitro. Based on molecular binding combined with functional assays, we propose a model in which the active compounds bind to a critical "hotspot" in RAD52 DNA binding domain 1. In addition, one of the 9 active compounds, adenosine 5'-monophosphate (A5MP), and also its mimic 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) 5' phosphate (ZMP) inhibited RAD52 activity in vivo and exerted synthetic lethality against BRCA1 and BRCA2-mutated carcinomas. These data suggest that active, inhibitory RAD52 binding compounds could be further refined for efficacy and safety to develop drugs inducing synthetic lethality in tumors displaying deficiencies in BRCA1/2-mediated homologous recombination.	[Sullivan, Katherine; Cramer-Morales, Kimberly; Skorski, Tomasz] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Sullivan, Katherine; Cramer-Morales, Kimberly; Skorski, Tomasz] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [McElroy, Daniel L.; Ostrov, David A.] Univ Florida & Shands, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA; [Haas, Kimberly; Childers, Wayne] Temple Univ, Sch Pharm, Moulder Ctr Drug Discovery Res, Philadelphia, PA 19140 USA; [Hromas, Robert] Univ Florida & Shands, Coll Med, Dept Med, Gainesville, FL 32610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida	Skorski, T (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.; Skorski, T (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA.	tskorski@temple.edu			NIH [1R01 CA134458, 1R01 CA186238]; NATIONAL CANCER INSTITUTE [R01CA186238, T32CA078586, R01CA134458, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R01 CA134458 and 1R01 CA186238 (T. Skorski).	Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Budke B, 2012, NUCL ACIDS RES; Chandramouly G, 2015, CHEM BIOL, V22, P1491, DOI 10.1016/j.chembiol.2015.10.003; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HOWIE C, 1990, J CHEM SOC PERK T 1, P3129, DOI 10.1039/p19900003129; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Podszywalow-Bartnicka P, 2014, CELL CYCLE, V13, P3727, DOI 10.4161/15384101.2014.965013; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tiefenbrunn T, 2014, CHEM BIOL DRUG DES, V83, P141, DOI 10.1111/cbdd.12227; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang G, 2015, BIOORGAN MED CHEM, V23, P7359, DOI 10.1016/j.bmc.2015.10.023; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Zimmermann MO, 2014, FUTURE MED CHEM, V6, P617, DOI [10.4155/FMC.14.20, 10.4155/fmc.14.20]	29	44	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147230	10.1371/journal.pone.0147230	http://dx.doi.org/10.1371/journal.pone.0147230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784987	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400127
J	Zabelina, DL; Colzato, L; Beeman, M; Hommel, B				Zabelina, Darya L.; Colzato, Lorenza; Beeman, Mark; Hommel, Bernhard			Dopamine and the Creative Mind: Individual Differences in Creativity Are Predicted by Interactions between Dopamine Genes DAT and COMT	PLOS ONE			English	Article							TRANSPORTER AVAILABILITY; DIVERGENT THINKING; GENOTYPE; ASSOCIATION; INHIBITION; ACHIEVEMENT; PERSONALITY; MODULATION; SCHIZOTYPY; OPENNESS	The dopaminergic (DA) system may be involved in creativity, however results of past studies are mixed. We attempted to clarify this putative relation by considering the mediofrontal and the nigrostriatal DA pathways, uniquely and in combination, and their contribution to two different measures of creativity-an abbreviated version of the Torrance Test of Creative Thinking, assessing divergent thinking, and a real-world creative achievement index. We found that creativity can be predicted from interactions between genetic polymorphisms related to frontal (COMT) and striatal (DAT) DA pathways. Importantly, the Torrance test and the real-world creative achievement index related to different genetic patterns, suggesting that these two measures tap into different aspects of creativity, and depend on distinct, but interacting, DA sub-systems. Specifically, we report that successful performance on the Torrance test is linked with dopaminergic polymorphisms associated with good cognitive flexibility and medium top-down control, or with weak cognitive flexibility and strong top-down control. The latter is particularly true for the originality factor of divergent thinking. High real-world creative achievement, on the other hand, as assessed by the Creative Achievement Questionnaire, is linked with dopaminergic polymorphisms associated with weak cognitive flexibility and weak top-down control. Taken altogether, our findings support the idea that human creativity relies on dopamine, and on the interaction between frontal and striatal dopaminergic pathways in particular. This interaction may help clarify some apparent inconsistencies in the prior literature, especially if the genes and/or creativity measures were analyzed separately.	[Zabelina, Darya L.] Northwestern Univ, Med Social Sci, Chicago, IL 60611 USA; [Colzato, Lorenza; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [Colzato, Lorenza; Hommel, Bernhard] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Beeman, Mark] Northwestern Univ, Dept Psychol, Evanston, IL USA	Northwestern University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Northwestern University	Zabelina, DL (corresponding author), Northwestern Univ, Med Social Sci, Chicago, IL 60611 USA.	darya.zabelina@u.northwestern.edu	Hommel, Bernhard/F-8173-2010; Zabelina, Darya/AAD-1985-2022	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	John Templeton Foundation [24467]; NSF Graduate Student Fellowship; NIH [T32 NS047987]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	John Templeton Foundation; NSF Graduate Student Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by John Templeton Foundation Grant # 24467 to MB (http://www.templeton.org), NSF Graduate Student Fellowship to DLZ (https://www.nsfgrfp.org), and NIH T32 NS047987 grant to DLZ (http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=t32&Search_Type=Activity).	ACTInc, 2014, NAT RANKS TEST SCOR; [Anonymous], 2015, SCOPUS; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Batey M, 2006, GENET SOC GEN PSYCH, V132, P355, DOI 10.3200/MONO.132.4.355-430; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Carson SH, 2005, CREATIVITY RES J, V17, P37, DOI 10.1207/s15326934crj1701_4; Carson SH, 2003, J PERS SOC PSYCHOL, V85, P499, DOI 10.1037/0022-3514.85.3.499; Carson SH, 2011, CAN J PSYCHIAT, V56, P144, DOI 10.1177/070674371105600304; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen KC, 2012, PSYCHIAT RES-NEUROIM, V201, P218, DOI 10.1016/j.pscychresns.2011.07.003; Chermahini SA, 2010, COGNITION, V115, P458, DOI 10.1016/j.cognition.2010.03.007; College Board, 2012, COLL BOUND SEN TOT G; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Cools R, 2009, DOPAMINERGIC MODULAT; Cools R, 2008, NEUROSCIENTIST, V14, P381, DOI 10.1177/1073858408317009; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Coyle TR, 2008, INTELLIGENCE, V36, P719, DOI 10.1016/j.intell.2008.05.001; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; DeYoung CG, 2011, J RES PERS, V45, P364, DOI 10.1016/j.jrp.2011.04.002; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Garcia-Garcia M, 2010, EUR J NEUROSCI, V31, P754, DOI 10.1111/j.1460-9568.2010.07102.x; Goff K., 2002, ABBREVIATED TORRANCE; GUILFORD JP, 1957, PSYCHOL REV, V64, P110, DOI 10.1037/h0048280; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hommel B, 2015, ADV MOTIVATION SCI; Jauk E, 2014, EUR J PERSONALITY, V28, P95, DOI 10.1002/per.1941; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kasof J, 1997, CREATIVITY RES J, V10, P303, DOI 10.1207/s15326934crj1004_2; Kunugi H, 1997, NEUROSCI LETT, V221, P202, DOI 10.1016/S0304-3940(96)13289-4; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Mayseless N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00502; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Mohr C, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00184; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Murphy M, 2013, CREATIVITY RES J, V25, P147, DOI 10.1080/10400419.2013.752305; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Nusbaum EC, 2011, INTELLIGENCE, V39, P36, DOI 10.1016/j.intell.2010.11.002; Olincy A, 2010, SCHIZOPHR RES, V119, P175, DOI 10.1016/j.schres.2010.03.004; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Rokem A, 2012, CEREB CORTEX, V22, P1133, DOI 10.1093/cercor/bhr185; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Runco MA, 2011, CREATIVITY RES J, V23, P376, DOI 10.1080/10400419.2011.621859; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Silvia PJ, 2009, J RES PERS, V43, P1087, DOI 10.1016/j.jrp.2009.04.015; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Torrance EP, 1974, TORRANCE TESTS CREAT; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; Wegbreit E, 2012, J PROBL SOLVING, V4, P94, DOI 10.7771/1932-6246.1127; Winterer G, 2006, NEUROIMAGE, V32, P1722, DOI 10.1016/j.neuroimage.2006.05.058; Zabelina DL, 2015, NEUROPSYCHOLOGIA, V69, P77, DOI 10.1016/j.neuropsychologia.2015.01.034; Zabelina DL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01029; Zabelina DL, 2010, PSYCHOL AESTHET CREA, V4, P136, DOI 10.1037/a0017379; Zabelina DL, MEM COGNITI IN PRESS; Zhang S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00222	67	44	47	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146768	10.1371/journal.pone.0146768	http://dx.doi.org/10.1371/journal.pone.0146768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26783754	gold, Green Published			2022-12-27	WOS:000368528400064
J	Gurdita, A; Vovko, H; Ungrin, M				Gurdita, Akshay; Vovko, Heather; Ungrin, Mark			A Simple and Low-Cost Monitoring System to Investigate Environmental Conditions in a Biological Research Laboratory	PLOS ONE			English	Article							GROWTH-RATE; TEMPERATURE; REPRODUCIBILITY; DROSOPHILA	Basic equipment such as incubation and refrigeration systems plays a critical role in nearly all aspects of the traditional biological research laboratory. Their proper functioning is therefore essential to ensure reliable and repeatable experimental results. Despite this fact, in many academic laboratories little attention is paid to validating and monitoring their function, primarily due to the cost and/or technical complexity of available commercial solutions. We have therefore developed a simple and low-cost monitoring system that combines a "Raspberry Pi" single-board computer with USB-connected sensor interfaces to track and log parameters such as temperature and pressure, and send email alert messages as appropriate. The system is controlled by open-source software, and we have also generated scripts to automate software setup so that no background in programming is required to install and use it. We have applied it to investigate the behaviour of our own equipment, and present here the results along with the details of the monitoring system used to obtain them.	[Gurdita, Akshay; Vovko, Heather; Ungrin, Mark] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary	Ungrin, M (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.	mark.ungrin@ucalgary.ca		Gurdita, Akshay/0000-0002-4168-9866; Ungrin, Mark/0000-0002-7410-1491				Bronikowski AM, 2001, EVOLUTION, V55, P33; Buck S, 2015, SCIENCE, V348, P1403, DOI 10.1126/science.aac8041; Cellan-Jones R, 2011, 15 POUND COMPUTER IN; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cutting Rachel, 2004, Hum Fertil (Camb), V7, P119, DOI 10.1080/14647270410001709188; Freedman LP, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7112; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; GERWECK L, 1976, RADIAT RES, V67, P508, DOI 10.2307/3574347; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Kelion L., 2015, BBC NEWS; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Muller HJ, 1928, GENETICS, V13, P279; Noyes K, 2012, DEBIAN LINUX NAMED M; Upton E., 2012, MEET RASPBERRY PI; WATANABE I, 1967, J CELL BIOL, V32, P309, DOI 10.1083/jcb.32.2.309; Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002	17	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147140	10.1371/journal.pone.0147140	http://dx.doi.org/10.1371/journal.pone.0147140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771659	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300064
J	Tay, WT; Kerr, PJ; Jermiin, LS				Tay, W. T.; Kerr, P. J.; Jermiin, L. S.			Population Genetic Structure and Potential Incursion Pathways of the Bluetongue Virus Vector Culicoides brevitarsis (Diptera: Ceratopogonidae) in Australia	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; RIBOSOMAL-RNA GENE; MITOCHONDRIAL-DNA; BITING MIDGES; SPECIES COMPLEXES; KIEFFER DIPTERA; CLIMATE-CHANGE; IDENTIFICATION; TAXONOMY; IMICOLA	Culicoides brevitarsis is a vector of the bluetongue virus (BTV), which infects sheep and cattle. It is an invasive species in Australia with an assumed Asian/South East Asian origin. Using one mitochondrial marker (i.e., part of the cytochrome oxidase subunit I gene) and six nuclear markers, we inferred population genetic structure and possible incursion pathways for Australian C. brevitarsis. Nine mitochondrial haplotypes, with low nucleotide sequence diversity (0.0-0.7%) among these, were identified in a sample of 70 individuals from seven sites. Both sets of markers revealed a homogeneous population structure, albeit with evidence of isolation by distance and two genetically distinct clusters distributed along a north-to-south cline. No evidence of a cryptic species complex was found. The geographical distribution of the mitochondrial haplotypes is consistent with at least two incursion pathways into Australia since the arrival of suitable livestock hosts. By contrast, 15 mitochondrial haplotypes, with up to four times greater nucleotide sequence diversity (0.0-2.9%) among these, were identified in a sample of 16 individuals of the endemic C. marksi (sampled from a site in South Australia and another in New South Wales). A phylogenetic tree inferred using the mitochondrial marker revealed that the Australian and Japanese samples of C. brevitarsis are as evolutionarily different from one another as some of the other Australian species (e.g., C. marksi, C. henryi, C. pallidothorax) are. The phylogenetic tree placed four of the species endemic to Australia (C. pallidothorax, C. bundyensis, C. marksi, C. henryi) in a clade, with a fifth such species (C. bunrooensis) sharing a common ancestor with that clade and a clade comprising two Japanese species (C. verbosus, C. kibunensis).	[Tay, W. T.; Kerr, P. J.; Jermiin, L. S.] CSIRO, Black Mt Labs, Canberra, ACT 2601, Australia; [Kerr, P. J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Tay, WT (corresponding author), CSIRO, Black Mt Labs, Canberra, ACT 2601, Australia.	weetek.tay@csiro.au	Tay, Wee Tek/C-1818-2008; Jermiin, Lars Sommer/AAQ-7033-2020; Tay, Wee Tek/GPF-6142-2022; Jermiin, Lars Sommer/C-2458-2009	Tay, Wee Tek/0000-0002-8451-0811; Jermiin, Lars Sommer/0000-0002-9619-3809; Tay, Wee Tek/0000-0002-8451-0811; Jermiin, Lars Sommer/0000-0002-9619-3809	Australian Biosecurity CRC	Australian Biosecurity CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding was by the Australian Biosecurity CRC. The funder has no role in the project design, data analyses, and interpretation of results.	Ababneh F, 2006, BIOINFORMATICS, V22, P1225, DOI 10.1093/bioinformatics/btl064; Ababneh F., 2006, J MATH MODEL ALGOR, V5, P291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ander M, 2013, MED VET ENTOMOL, V27, P323, DOI 10.1111/j.1365-2915.2012.01050.x; Augot D, 2013, J VECTOR ECOL, V38, P260, DOI 10.1111/j.1948-7134.2013.12039.x; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Bellis G, 2014, ZOOTAXA, V 3768, P401, DOI 10.11646/zootaxa.3768.4.1; Bellis GA, 2015, AUSTRAL ENTOMOL, V54, P332, DOI 10.1111/aen.12131; Bellis Glenn A., 2005, Arbovirus Research in Australia, V9, P33; BEVERIDGE I, 1981, J AUST ENTOMOL SOC, V20, P39; BISHOP AL, 1995, J AUST ENTOMOL SOC, V34, P289; Borkent A, 1997, B AM MUS NAT HIST, P5; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Brokent A, 2012, WORLD SPECIES BITING; Bryant D, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P33; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; CAMPBELL MM, 1976, AUST J ZOOL, V24, P75, DOI 10.1071/ZO9760075; Cannon L. R. G., 1966, Journal of the Entomological Society of Queensland, V5, P7; Carew ME, 1997, INSECT SOC, V44, P7, DOI 10.1007/s000400050018; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Cetre-Sossah C, 2004, VET RES, V35, P325, DOI 10.1051/vetres:2004015; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conflitti IM, 2013, J MED ENTOMOL, V50, P1250, DOI 10.1603/ME13063; Cooper ED, 2014, TRENDS PLANT SCI, V19, P576, DOI 10.1016/j.tplants.2014.06.006; Dallas JF, 2003, MED VET ENTOMOL, V17, P379, DOI 10.1111/j.1365-2915.2003.00454.x; Daniels PW, 2004, VETER ITAL SER, V40, P94; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Doyle KA, 1992, OVERVIEW PERSPECTIVE; Dyce A.L., 2007, PICTORIAL ATLAS AUST, V1st; Dyce AL, 1989, BLUETONGUE VECTORS A; Dyce AL, 1982, P 3 S; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gomulski LM, 2005, SYST ENTOMOL, V30, P619, DOI 10.1111/j.1365-3113.2005.00286.x; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Gordon Karl, 2010, P219; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hadj-Henni L, 2015, INFECT GENET EVOL, V33, P324, DOI 10.1016/j.meegid.2015.05.024; Harrup LE, 2015, INFECT GENET EVOL, V30, P249, DOI 10.1016/j.meegid.2014.12.018; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Holbrook FR, 1996, MED VET ENTOMOL, V10, P173, DOI 10.1111/j.1365-2915.1996.tb00725.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jayaswal V, 2005, EVOL BIOINFORM, V1, P62; Jayaswal V, 2014, SYST BIOL, V63, P726, DOI 10.1093/sysbio/syu036; Jermiin Lars Sommer, 2008, V452, P331, DOI 10.1007/978-1-60327-159-2_16; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; JERMIIN LS, 1994, J MOL EVOL, V39, P160; KAY BH, 1978, J AUST ENTOMOL SOC, V17, P145; Kettle DS, 1998, MED VET ENTOMOL, V12, P367, DOI 10.1046/j.1365-2915.1998.00119.x; KETTLE DS, 1962, ANNU REV ENTOMOL, V7, P401, DOI 10.1146/annurev.en.07.010162.002153; Klee J, 2006, J INVERTEBR PATHOL, V91, P98, DOI 10.1016/j.jip.2005.10.012; Lee DJ, 1953, P LINNEAN SOC NEW S, V77, P269; Lehr MA, 2005, ANN ENTOMOL SOC AM, V98, P908, DOI 10.1603/0013-8746(2005)098[0908:CSITAN]2.0.CO;2; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meiswinkel R, 2004, VETER ITAL SER, V40, P345; Muller M J, 1982, P 3 S; MULLER MJ, 1977, AUST J ZOOL, V25, P75, DOI 10.1071/ZO9770075; MURRAY MD, 1970, AUST VET J, V46, P138, DOI 10.1111/j.1751-0813.1970.tb01975.x; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Nolan DV, 2004, VETER ITAL SER, V40, P352; O'Mahony EM, 2007, J EUKARYOT MICROBIOL, V54, P103, DOI 10.1111/j.1550-7408.2006.00232.x; Onyango MG, 2015, VET RES, V46, DOI 10.1186/s13567-015-0250-8; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quezada-Euan JJG, 2007, APIDOLOGIE, V38, P247, DOI 10.1051/apido:2007006; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ritchie A, 2004, GENOME, V47, P546, DOI [10.1139/g04-003, 10.1139/G04-003]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider S., 2000, ARLEQUIN VERSION 20; Sebastiani F, 2001, MOL ECOL, V10, P1773, DOI 10.1046/j.0962-1083.2001.01319.x; SLATKIN M, 1995, GENETICS, V139, P457; Staden R, 2000, Methods Mol Biol, V132, P115; Standfast HA, 1992, P 2 INT S; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2016, PEST MANAG SCI, V72, P1250, DOI 10.1002/ps.3805; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Tay WT, 2011, MYRMECOL NEWS, V15, P67; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Tay WT, 1997, MOL ECOL, V6, P403, DOI 10.1046/j.1365-294X.1997.t01-1-00198.x; Tay WT, 2001, MOL ECOL, V10, P167, DOI 10.1046/j.1365-294X.2001.01167.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Yanase T, 2013, J MED ENTOMOL, V50, P1105, DOI 10.1603/ME11235; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	100	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146699	10.1371/journal.pone.0146699	http://dx.doi.org/10.1371/journal.pone.0146699			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771743	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300030
J	Ishii, A; Kimura, T; Sadahiro, H; Kawano, H; Takubo, K; Suzuki, M; Ikeda, E				Ishii, Aya; Kimura, Tokuhiro; Sadahiro, Hirokazu; Kawano, Hiroo; Takubo, Keiyo; Suzuki, Michiyasu; Ikeda, Eiji			Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in Glioblastoma	PLOS ONE			English	Article							INITIATING CELLS; PERIVASCULAR NICHE; HYPOXIA-MARKER; POPULATION; GROWTH; PROLIFERATION; HIF-1-ALPHA; EXPRESSION; PATHWAY; PHOSPHORYLATION	Background Characterization of the niches for stem-like tumor cells is important to understand and control the behavior of glioblastomas. Cell-cycle quiescence might be a common mechanism underlying the long-term maintenance of stem-cell function in normal and neoplastic stem cells, and our previous study demonstrated that quiescence induced by hypoxia-inducible factor (HIF)-1a is associated with a high long-term repopulation capacity of hematopoietic stem cells. Based on this, we examined human astrocytoma tissues for HIF-la-regulated quiescent stem-like tumor cells as a candidate for long-term tumorigenic cells and characterized their niche histologically. Methods Multi-color immunohistochemistry was used to visualize HIF-1 alpha-expressing (HIF-1 alpha+) quiescent stem-like tumor cells and their niche in astrocytoma (WHO grade I I IV) tissues. This niche was modeled using spheroids of cultured glioblastoma cells and its contribution to tumorigenicity was evaluated by sphere formation assay. Results A small subpopulation of HIF-1 alpha+ quiescent stem-like tumor cells was found in glioblastomas but not in lower-grade astrocytomas. These cells were concentrated in the zone between large ischemic necroses and blood vessels and were closer to the necrotic tissues than to the blood vessels, which suggested that a moderately hypoxic microenvironment is their niche. We successfully modeled this niche containing cells of HIF-1 alpha+ quiescent stem like phenotype by incubating glioblastoma cell spheroids under an appropriately hypoxic condition, and the emergence of HIF-1 alpha+ quiescent stem-like cells was shown to be associated with an enhanced sphere-forming activity. Conclusions These data suggest that the "peri-necrotic niche" harboring HIF-1 alpha+ quiescent stem-like cells confers a higher tumorigenic potential on glioblastoma cells and therefore may be a therapeutic target to control the behavior of glioblastomas.	[Ishii, Aya; Kimura, Tokuhiro; Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 755, Japan; [Sadahiro, Hirokazu; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 755, Japan; [Kawano, Hiroo] Yamaguchi Univ, Grad Sch Med, Dept Basic Lab Sci, Ube, Yamaguchi 755, Japan; [Takubo, Keiyo] Res Inst Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University	Kimura, T; Ikeda, E (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Pathol, Ube, Yamaguchi 755, Japan.	tkimura@yamaguchi-u.ac.jp; ikedae@yamaguchi-u.ac.jp	Takubo, Keiyo/AAX-5546-2020	Takubo, Keiyo/0000-0002-1736-7592; Ishii, Aya/0000-0002-3329-3634	Ministry of Education, Culture, Sports, Science and Technology of Japan [24592164, 26460434]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/) (24592164 to EI; 26460434 to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Beasley NJP, 2001, CANCER RES, V61, P5262; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Deleyrolle LP, 2011, BRAIN, V134, P1331, DOI 10.1093/brain/awr081; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Freter R, 2010, STEM CELLS, V28, P1571, DOI 10.1002/stem.476; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Mashiko R, 2011, J NEURO-ONCOL, V102, P43, DOI 10.1007/s11060-010-0292-8; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ortmann B, 2014, CELL MOL LIFE SCI, V71, P3569, DOI 10.1007/s00018-014-1645-9; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sundar SJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14494; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; The WHO, 2020, CLASSIFICATION TUMOU; Tonn J-C, 2006, NEUROONCOLOGY CNS TU; Vartanian A, 2014, NEURO-ONCOLOGY, V16, P1167, DOI 10.1093/neuonc/nou035; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; Yan GN, 2014, J PATHOL, V234, P11, DOI 10.1002/path.4349; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	50	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147366	10.1371/journal.pone.0147366	http://dx.doi.org/10.1371/journal.pone.0147366			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799577	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300100
J	Semmler, T; Harrison, EM; Lubke-Becker, A; Ulrich, RG; Wieler, LH; Guenther, S; Stamm, I; Hanssen, AM; Holmes, MA; Vincze, S; Walther, B				Semmler, Torsten; Harrison, Ewan M.; Luebke-Becker, Antina; Ulrich, Rainer G.; Wieler, Lothar H.; Guenther, Sebastian; Stamm, Ivonne; Hanssen, Anne-Merethe; Holmes, Mark A.; Vincze, Szilvia; Walther, Birgit			A Look into the Melting Pot: The mecC-Harboring Region Is a Recombination Hot Spot in Staphylococcus stepanovicii	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN RESISTANCE; AUREUS; GENE; HOMOLOG; SCCMEC; POPULATIONS; PREVALENCE; PATHOGENS	Introduction Horizontal gene transfer (HGT) is an important driver for resistance-and virulence factor accumulation in pathogenic bacteria such as Staphylococcus aureus. Methods Here, we have investigated the downstream region of the bacterial chromosomal attachment site (attB) for the staphylococcal cassette chromosome mec (SCCmec) element of a commensal mecC-positive Staphylococcus stepanovicii strain (IMT28705; ODD4) with respect to genetic composition and indications of HGT. S. stepanovicii IMT28705 was isolated from a fecal sample of a trapped wild bank vole (Myodes glareolus) during a screening study (National Network on "Rodent-Borne Pathogens") in Germany. Whole genome sequencing (WGS) of IMT28705 together with the mecC-negative type strain CM7717 was conducted in order to comparatively investigate the genomic region downstream of attB (GenBank accession no. KR732654 and KR732653). Results The bank vole isolate (IMT28705) harbors a mecC gene which shares 99.2% nucleotide (and 98.5% amino acid) sequence identity with mecC of MRSA_LGA251. In addition, the mecC-encoding region harbors the typical blaZ-mecC-mecR1-mecI structure, corresponding with the class E mec complex. While the sequences downstream of attB in both S. stepanovicii isolates (IMT28705 and CM7717) are partitioned by 15 bp direct repeats, further comparison revealed a remarkable low concordance of gene content, indicating a chromosomal "hot spot" for foreign DNA integration and exchange. Conclusion Our data highlight the necessity for further research on transmission routes of resistance encoding factors from the environmental and wildlife resistome.	[Semmler, Torsten; Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany; [Harrison, Ewan M.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Luebke-Becker, Antina; Guenther, Sebastian; Vincze, Szilvia; Walther, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Ulrich, Rainer G.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Stamm, Ivonne] Vet Med Labor GmbH, Div IDEXX Labs, Ludwigsburg, Germany; [Hanssen, Anne-Merethe] UiT, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	Robert Koch Institute; University of Cambridge; Free University of Berlin; Friedrich Loeffler Institute; Vet Med Labor GmbH; UiT The Arctic University of Tromso	Walther, B (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany.	birgit.walther@fu-berlin.de	Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Harrison, Ewan/I-5003-2013; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Walther, Birgit/0000-0003-3112-5722; Harrison, Ewan/0000-0003-2720-0507; Guenther, Sebastian/0000-0003-0173-7314; Wieler, Lothar H./0000-0003-4365-3717	Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph) [01KI1301F]; Network "Rodent-borne Pathogens"; (NaUPa-net) [01KI1018, 01KI1303]; BMBF grant FBI-Zoo [01KI1012A]; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph)(Federal Ministry of Education & Research (BMBF)); Network "Rodent-borne Pathogens"; (NaUPa-net); BMBF grant FBI-Zoo(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funder provided support in the form of salaries for authors [IS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was not financially supported by IDEXX. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by the Federal Ministry of Education and Research (BMBF) through the National Research Platform for Zoonoses (MedVet-Staph, grant no. 01KI1301F to BW) and Network "Rodent-borne Pathogens"; (NaUPa-net; grant nos. 01KI1018 and 01KI1303 to RGU). TS was financed through BMBF grant FBI-Zoo (grant no. 01KI1012A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arede P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002816; Balakuntla J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094293; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Boundy S, 2013, J BIOL CHEM, V288, P132, DOI 10.1074/jbc.M112.385138; Chlebowicz MA, 2014, INT J MED MICROBIOL, V304, P764, DOI 10.1016/j.ijmm.2014.05.010; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2013, VET01 S2 PERF STAND, p32/2; Couto I, 2003, J BACTERIOL, V185, P645, DOI 10.1128/JB.185.2.645-653.2003; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Deurenberg RH, 2005, ANTIMICROB AGENTS CH, V49, P4263, DOI 10.1128/AAC.49.10.4263-4271.2005; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Frey Y, 2013, J DAIRY SCI, V96, P2247, DOI 10.3168/jds.2012-6091; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gomez P, 2014, J ANTIMICROB CHEMOTH, V69, P2061, DOI 10.1093/jac/dku100; Hanselman BA, 2009, CAN VET J, V50, P954; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Harrison EM, 2014, J ANTIMICROB CHEMOTH, V69, P911, DOI 10.1093/jac/dkt452; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Hauschild T, 2010, SYST APPL MICROBIOL, V33, P457, DOI 10.1016/j.syapm.2010.08.007; Hauschild T, 2010, SYST APPL MICROBIOL, V33, P183, DOI 10.1016/j.syapm.2010.03.004; Hiramatsu K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/ic.2013.45.2.117; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jacob J, 2014, BUNDESGESUNDHEITSBLA, V57, P511, DOI 10.1007/s00103-013-1924-x; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Loncaric I, 2013, J ANTIMICROB CHEMOTH, V68, P2222, DOI 10.1093/jac/dkt186; Malyszko I, 2014, J ANTIMICROB CHEMOTH, V69, P2003, DOI 10.1093/jac/dku043; McRobbie AM, 2012, BIOCHEM J, V442, P77, DOI 10.1042/BJ20111903; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Scharn CR, 2013, ANTIMICROB AGENTS CH, V57, P5233, DOI 10.1128/AAC.01058-13; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Skov R, 2014, J ANTIMICROB CHEMOTH, V69, P133, DOI 10.1093/jac/dkt341; Stepanovic S, 2006, J CLIN MICROBIOL, V44, P934, DOI 10.1128/JCM.44.3.934-937.2006; Tsubakishita S, 2010, ANTIMICROB AGENTS CH, V54, P4352, DOI 10.1128/AAC.00356-10; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Wang L, 2012, J BACTERIOL, V194, P486, DOI 10.1128/JB.05047-11; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	46	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147150	10.1371/journal.pone.0147150	http://dx.doi.org/10.1371/journal.pone.0147150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799070	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300063
J	Tin, SPP; Lam, WWT; Yoon, S; Zhang, N; Xia, N; Zhang, WW; Ma, K; Fielding, R				Tin, Sze Pui Pamela; Lam, Wendy W. T.; Yoon, Sungwon; Zhang, Na; Xia, Nan; Zhang, Weiwei; Ma, Ke; Fielding, Richard			Workplace Health Promotion: Assessing the Cardiopulmonary Risks of the Construction Workforce in Hong Kong	PLOS ONE			English	Article							METABOLIC SYNDROME; PHYSICAL-ACTIVITY; EARLY RETIREMENT; MARITAL-STATUS; PREVALENCE; WORKERS; INTERVENTIONS; DISABILITY; BEHAVIOR; INDUSTRY	Objective Health needs of different employee subgroups within an industry can differ. We report the results of a workplace cardiopulmonary risk assessment targeting workers and support staff in the construction industry. Methods A free worksite-based cardiopulmonary risk assessment for 1,903 workers on infrastructural contracts across Hong Kong was initiated in May 2014. Cardiopulmonary risk screening was performed in 60-minute blocks for approximately 30 workers/block with individualized feedback and lifestyle counseling. Risk profiles stratified by occupational roles are differentiated using the. 2-test for categorical and Student's t-test for continuous variables. Results Most construction workers and clerks/professionals were male (83.2% and 71.2%, respectively) and Chinese (78.7% and 90.9%, respectively). Construction workers were older (mean: 44.9 years, SD 11.5) and less well-educated (6.1% received tertiary education) than clerks/professionals (35.0 years, 10.7; 72.6% received tertiary education), but more likely to be hypertensive (22.6% vs. 15.4%, p<0.001), overweight/obese (71.7% vs. 56.6%, p<0.001), centrally obese (53.1% vs. 35.5%, p<0.001), and have undesirable levels of high-density lipoprotein (41.6% vs. 35.8%, p<0.05) and diabetic levels of non-fasting blood glucose (4.3% vs. 1.6%, p<0.05). Up to 12.6% of construction workers and 9.7% of office clerks/professions had three or more metabolic syndrome risk factors. While construction workers were more likely than clerks/professionals to be daily smokers, they reported better work-related physical activity and diet. Conclusions Simple worksite health risk screening can identify potentially high-cardiopulmonary-risk construction industry employee subgroups for onward confirmatory referral. Separate cardiopulmonary health promotion strategies that account for the varying lifestyle profiles of the two employee subgroups in the industry appear justified.	[Tin, Sze Pui Pamela; Lam, Wendy W. T.; Yoon, Sungwon; Zhang, Na; Xia, Nan; Zhang, Weiwei; Ma, Ke; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, 5-F William MW Mong Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tin, SPP (corresponding author), Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, 5-F William MW Mong Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	pamtin@hku.hk	Xia, Nan/ABG-4600-2021; Lam, Wendy Wing Tak/C-4319-2009	Zhang, Na/0000-0003-3719-4008; Yoon, Sungwon/0000-0001-9458-6097; Lam, Wendy Wing Tak/0000-0003-2383-0149	QBE Hong Kong & Shanghai Insurance Limited	QBE Hong Kong & Shanghai Insurance Limited	This work was funded by QBE Hong Kong & Shanghai Insurance Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Arndt V, 2005, OCCUP ENVIRON MED, V62, P559, DOI 10.1136/oem.2004.018135; Biggs HC, 2012, VULNERABLE GROUPS IN, P3; Brenner H, 2000, OCCUP ENVIRON MED, V57, P615, DOI 10.1136/oem.57.9.615; Broderick JM, 2014, BRIT J CANCER, V111, P2377, DOI 10.1038/bjc.2014.248; Burton J., 2010, WHO HLTH WORKPLACE F; Centre_ for_ Health_ Protection, 2012, STAT BEH RISK FACT B; Construction Industry Council Hong Kong SAR, 2011, IND PERF REP 2011; Damman OC, 2014, J OCCUP ENVIRON MED, V56, P92, DOI 10.1097/JOM.0000000000000041; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Government of the Hong Kong SAR, 2012, REP MANP PROJ 2018; Groeneveld IF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-836; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Groeneveld IF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-80; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Krause N, 2007, SCAND J WORK ENV HEA, V33, P405, DOI 10.5271/sjweh.1171; Poon SW, 2013, INT J CONSTR MANAG, V13, P69, DOI 10.1080/15623599.2013.10773206; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Raum E, 2007, ANN EPIDEMIOL, V17, P417, DOI 10.1016/j.annepidem.2006.12.008; Rothenbacher D, 1998, J OCCUP ENVIRON MED, V40, P63, DOI 10.1097/00043764-199801000-00012; Ruzic L, 2003, OCCUP ENVIRON MED, V60, P983, DOI 10.1136/oem.60.12.983; Santini M, 2011, GIORNALE ITALIANO S, V34, P521; Sito P., 2014, S CHINA MORNING POST; Siu P., 2014, S CHINA MORNING POST; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; St George A, 2012, HEALTH PROMOT J AUST, V23, P134, DOI 10.1071/HE12134; State Building & Construction Trades Council of California, 2015, BUILT SEC BUILT 2015; Thabit H, 2013, DIABETES VASC DIS RE; Verweij LM, 2011, OBES REV, V12, P406, DOI 10.1111/j.1467-789X.2010.00765.x; Wang GR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-599; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organziation Western Pacific Region, 2000, AS PAC PERSP RED OB	36	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146286	10.1371/journal.pone.0146286	http://dx.doi.org/10.1371/journal.pone.0146286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799393	Green Published, Green Submitted, gold			2022-12-27	WOS:000368655300018
J	Pietila, I; Prunskaite-Hyyrylainen, R; Kaisto, S; Tika, E; van Eerde, AM; Salo, AM; Garma, L; Miinalainen, I; Feitz, WF; Bongers, EMHF; Juffer, A; Knoers, NVAM; Renkema, KY; Myllyharju, J; Vainio, SJ				Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Tika, Elisavet; van Eerde, Albertien M.; Salo, Antti M.; Garma, Leonardo; Miinalainen, Ilkka; Feitz, Wout F.; Bongers, Ernie M. H. F.; Juffer, Andre; Knoers, Nine V. A. M.; Renkema, Kirsten Y.; Myllyharju, Johanna; Vainio, Seppo J.			Wnt5a Deficiency Leads to Anomalies in Ureteric Tree Development, Tubular Epithelial Cell Organization and Basement Membrane Integrity Pointing to a Role in Kidney Collecting Duct Patterning	PLOS ONE			English	Article							METANEPHRIC MESENCHYME; ORGANOGENESIS; EXPRESSION; TRANSFORMATION; MORPHOGENESIS; INDUCTION; PATHWAYS; COLLAGEN; NEPHRON; CATENIN	The Wnts can be considered as candidates for the Congenital Anomaly of Kidney and Urinary Tract, CAKUT diseases since they take part in the control of kidney organogenesis. Of them Wnt5a is expressed in ureteric bud (UB) and its deficiency leads to duplex collecting system (13/90) uni-or bilateral kidney agenesis (10/90), hypoplasia with altered pattern of ureteric tree organization (42/90) and lobularization defects with partly fused ureter trunks (25/90) unlike in controls. The UB had also notably less tips due to Wnt5a deficiency being at E15.5 306 and at E16.5 765 corresponding to 428 and 1022 in control (p<0.02; p<0.03) respectively. These changes due to Wnt5a knock out associated with anomalies in the ultrastructure of the UB daughter epithelial cells. The basement membrane (BM) was malformed so that the BM thickness increased from 46.3 nm to 71.2 nm (p<0.01) at E16.5 in the Wnt5a knock out when compared to control. Expression of a panel of BM components such as laminin and of type IV collagen was also reduced due to the Wnt5a knock out. The P4ha1 gene that encodes a catalytic subunit of collagen prolyl 4-hydroxylase I (C-P4H-I) in collagen synthesis expression and the overall C-P4H enzyme activity were elevated by around 26% due to impairment in Wnt5a function from control. The compound Wnt5a(+/-); P4ha1(+/-) embryos demonstrated Wnt5a(-/-) related defects, for example local hyperplasia in the UB tree. A R260H WNT5A variant was identified from renal human disease cohort. Functional studies of the consequence of the corresponding mouse variant in comparison to normal ligand reduced Wnt5a-signalling in vitro. Together Wnt5a has a novel function in kidney organogenesis by contributing to patterning of UB derived collecting duct development contributing putatively to congenital disease.	[Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland; [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Vainio, Seppo J.] Infotech Oulu, Oulu, Finland; [Pietila, Ilkka; Prunskaite-Hyyrylainen, Renata; Kaisto, Susanna; Salo, Antti M.; Myllyharju, Johanna; Vainio, Seppo J.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Tika, Elisavet; van Eerde, Albertien M.; Knoers, Nine V. A. M.; Renkema, Kirsten Y.] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, Utrecht, Netherlands; [Salo, Antti M.; Myllyharju, Johanna] Bioctr Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Garma, Leonardo; Juffer, Andre] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, Oulu, Finland; [Miinalainen, Ilkka] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Feitz, Wout F.] Radboud Univ Nijmegen, Med Ctr, Radboudumc Amalia Childrens Hosp, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Bongers, Ernie M. H. F.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	University of Oulu; University of Oulu; University of Oulu; Utrecht University; Utrecht University Medical Center; University of Oulu; University of Oulu; University of Oulu; Radboud University Nijmegen; Radboud University Nijmegen	Vainio, SJ (corresponding author), Bioctr Oulu, Oulu Ctr Cell Matrix Res, Dev Biol Lab, Oulu, Finland.; Vainio, SJ (corresponding author), Infotech Oulu, Oulu, Finland.; Vainio, SJ (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	Seppo.Vainio@oulu.fi	Renkema, Kirsten Y./V-2385-2019; Feitz, W.F.J./H-8028-2014	Juffer, Andre/0000-0003-3533-0520; Miinalainen, Ilkka/0000-0002-3922-3442; Garma, Leonardo Daniel/0000-0003-1220-8397; van Eerde, Albertien M./0000-0001-5953-5956; Prunskaite-Hyyrylainen, Renata/0000-0001-5453-2983; Vainio, Seppo/0000-0001-9319-3566; Kaisto, Susanna/0000-0002-0484-1670	Academy of Finland [206038, 121647, 250900, 260056]; Centre of Excellence grant of the Academy of Finland [251314]; Sigrid Juselius Foundation; European Community [305608]; Dutch Kidney Foundation [KSTP10.004, KSTP12.010, CP11.18]; Fonds NutsOhra [1303-070]	Academy of Finland(Academy of Finland); Centre of Excellence grant of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Community(European Commission); Dutch Kidney Foundation; Fonds NutsOhra	This work was supported by the Academy of Finland (206038, 121647, 250900 and 260056), Centre of Excellence grant 2012-2017 of the Academy of Finland (251314), [http://www.aka.fi/en] to SV; the Sigrid Juselius Foundation, [http://www.sigridjuselius.fi/foundation] to SV; the European Community's Seventh Framework Program FP7/2009 under grant agreement 305608 (EURenOmics: European Consortium for High-Throughput Research in Rare Kidney Diseases) [http://eurenomics.eu/] to SV and NK; the Dutch Kidney Foundation (KSTP10.004, KSTP12.010, and CP11.18) [http://www.nierstichting.nl] to NK; and Fonds NutsOhra (1303-070) [http://www.fondsnutsohra.nl] to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chi LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027676; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Enzo Maria Vittoria, 2015, Mol Cell Ther, V3, P1, DOI 10.1186/s40591-015-0038-2; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Huang LW, 2014, NEPHRON EXP NEPHROL, V128, P80, DOI 10.1159/000368411; Itaranta P, 2002, GENESIS, V32, P259, DOI 10.1002/gene.10079; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lin YF, 2001, DEV DYNAM, V222, P26, DOI 10.1002/dvdy.1164; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pietila I, 2014, NEPHRON EXP NEPHROL, V126, P40, DOI 10.1159/000360659; Queisser-Luft A., 2002, Archives of Gynecology and Obstetrics, V266, P163, DOI 10.1007/s00404-001-0265-4; Railo A, 2008, EXP CELL RES, V314, P2389, DOI 10.1016/j.yexcr.2008.04.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Seikaly MG, 2003, PEDIATR NEPHROL, V18, P796, DOI 10.1007/s00467-003-1158-5; Shi S, 2015, KIDNEY INT; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto H, 2015, J CELL SCI, V128, P1051, DOI 10.1242/jcs.163683; Yang DH, 2011, DEVELOPMENT, V138, P4535, DOI 10.1242/dev.071266; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Yun K., 2014, HUM MOL GENET; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	37	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0147171	10.1371/journal.pone.0147171	http://dx.doi.org/10.1371/journal.pone.0147171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794322	Green Submitted, Green Published, gold			2022-12-27	WOS:000368530300021
J	Venter, WDF; Fairlie, L; Feldman, C; Cleaton-Jones, P; Chersich, M				Venter, Willem Daniel Francois; Fairlie, Lee; Feldman, Charles; Cleaton-Jones, Peter; Chersich, Matthew			Views of Medical Doctors Regarding the 2013 WHO Adult HIV Treatment Guidelines Indicate Variable Applicability for Routine Patient Monitoring, for Their Family Members and for Themselves, in South-Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTION; WOMEN	South African doctors (n = 211) experienced in antiretroviral therapy use were asked via an online questionnaire about the WHO 2013 adult antiretroviral integrated guidelines, as well as clinical and personal issues, in three hypothetical scenarios: directing the Minister of Health, advising a family member requiring therapy amidst unstable antiretroviral supplies, and where doctors themselves were HIV-positive. Doctors (54%) favoured the 500 cells/mu l WHO initiation threshold if advising the Minister; a third recommended retaining the 350 cells/mu l threshold used at the time of the survey. However, they favoured a higher initiation threshold for their family member. Doctors were 4.9 fold more likely to initiate modern treatment, irrespective of their CD4 cell count, for themselves than for public-sector patients (95% CI odds ratio = 3.33-7.33; P<0.001, although lower if limited to stavudine-containing regimens. Doctors were equally concerned about stavudine-induced lactic acidosis and lipoatrophy. The majority (84%) would use WHO-recommended first-line therapy, with concerns split between tenofovir-induced nephrotoxicity (55%), and efavirenz central nervous system effects (29%). A majority (61%), if HIV-positive, would pay for a pre-initiation resistance test, use influenza-prophylaxis (85%), but not INH-prophylaxis (61%), and treat their cholesterol and blood pressure concerns conventionally (63% and 60%). Over 60% wanted viral loads and creatinine measured six monthly. A third felt CD4 monitoring only necessary if clinically indicated or if virological failure occurred. They would use barrier prevention (83%), but not recommend pre-exposure prophylaxis, if their sexual partner was HIV-negative (68%). A minority would be completely open about their HIV status, but the majority would disclose to their sexual partners, close family and friends. Respondents were overwhelmingly in favour of continued antiretrovirals after breastfeeding. In conclusion, doctors largely supported adult WHO guidelines as public policy, although would initiate treatment at higher CD4 counts for their family and themselves. Resistance to INH-prophylaxis is unexpected and warrants investigation.	[Venter, Willem Daniel Francois; Fairlie, Lee; Chersich, Matthew] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst RHI, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Cleaton-Jones, Peter] Univ Witwatersrand, Fac Hlth Sci, Steve Biko Ctr Bioeth, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Venter, WDF (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst RHI, Johannesburg, South Africa.	fventer@wrhi.ac.za	Cleaton-Jones, Peter E/L-4090-2016; Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; Venter, Willem/0000-0002-4157-732X; chersich, matthew/0000-0002-4320-9168	President's Emergency Plan for AIDS Relief (PEPFAR); National Research Foundation (NRF); National Research Foundation	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Research Foundation (NRF); National Research Foundation	WDFV and LF are supported by the President's Emergency Plan for AIDS Relief (PEPFAR). CF is supported by the National Research Foundation (NRF).; PEPFAR supports WDFV and LF. Charles Feldman is supported by the National Research Foundation (SA). Thanks to the Southern African HIV Clinicians Society for distributing the survey to members.	[Anonymous], 2014, UNAIDS GAP REPORT; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bristow CC, 2012, INT J TUBERC LUNG D, V16, P1020, DOI 10.5588/ijtld.11.0744; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Doherty M., 2015, IAS 2015; Easterbrook PJ, 2014, AIDS, V28, pS93, DOI 10.1097/QAD.0000000000000253; Gallant JE, 2013, CLIN INFECT DIS, V57, P884, DOI 10.1093/cid/cit382; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Tudor C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-891	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2016	11	1							e0145911	10.1371/journal.pone.0145911	http://dx.doi.org/10.1371/journal.pone.0145911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5CE	26794907	gold, Green Submitted, Green Published			2022-12-27	WOS:000368530300004
J	Stapleton, JA; Kim, J; Hamilton, JP; Wu, M; Irber, LC; Maddamsetti, R; Briney, B; Newton, L; Burton, DR; Brown, CT; Chan, C; Buell, CR; Whitehead, TA				Stapleton, James A.; Kim, Jeongwoon; Hamilton, John P.; Wu, Ming; Irber, Luiz C.; Maddamsetti, Rohan; Briney, Bryan; Newton, Linsey; Burton, Dennis R.; Brown, C. Titus; Chan, Christina; Buell, C. Robin; Whitehead, Timothy A.			Haplotype-Phased Synthetic Long Reads from Short-Read Sequencing	PLOS ONE			English	Article							RNA-SEQ EXPERIMENTS; ESCHERICHIA-COLI; GENOME SEQUENCE; HIGH-THROUGHPUT; SINGLE CELLS; TRANSCRIPTOME; ACCURATE; REVEALS; CONSTRUCTION; REPERTOIRE	Next-generation DNA sequencing has revolutionized the study of biology. However, the short read lengths of the dominant instruments complicate assembly of complex genomes and haplotype phasing of mixtures of similar sequences. Here we demonstrate a method to reconstruct the sequences of individual nucleic acid molecules up to 11.6 kilobases in length from short (150-bp) reads. We show that our method can construct 99.97%-accurate synthetic reads from bacterial, plant, and animal genomic samples, full-length mRNA sequences from human cancer cell lines, and individual HIV env gene variants from a mixture. The preparation of multiple samples can be multiplexed into a single tube, further reducing effort and cost relative to competing approaches. Our approach generates sequencing libraries in three days from less than one microgram of DNA in a single-tube format without custom equipment or specialized expertise.	[Stapleton, James A.; Chan, Christina; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Kim, Jeongwoon; Hamilton, John P.; Newton, Linsey; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wu, Ming] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Irber, Luiz C.; Brown, C. Titus] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Irber, Luiz C.; Brown, C. Titus] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Maddamsetti, Rohan] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Maddamsetti, Rohan] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Briney, Bryan; Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Brown, C. Titus] Univ Calif Davis, Populat Hlth & Reprod, Davis, CA 95616 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan; Michigan State University; Michigan State University; Michigan State University; Michigan State University; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; University of California System; University of California Davis; Michigan State University	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.; Whitehead, TA (corresponding author), Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA.	taw@egr.msu.edu	Irber, Luiz/ABE-1486-2021; Hamilton, John P/G-1379-2016	Irber, Luiz/0000-0003-4371-9659; Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIGMS [F32GM099291]; National Institutes of Health [5R21CA176854-02]; MIIE Commercialization Grant [AGR 2014-0200]; MSF from the State of Michigan [Case-48166]; NATIONAL CANCER INSTITUTE [R21CA176854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099291] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIGMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIIE Commercialization Grant; MSF from the State of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award F32GM099291 from the NIGMS to JAS, National Institutes of Health (5R21CA176854-02), MIIE Commercialization Grant (AGR 2014-0200), and Grant Case-48166 of the 21st Century Jobs Trust Fund received through the MSF from the State of Michigan to TAW. Funds for the G. sempervirens genome and transcriptome analyses were provided by Michigan State University to CRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Bishara A, 2015, GENOME RES, V25, P1570, DOI 10.1101/gr.191189.115; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hong LZ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0517-9; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Li H., 2013, ARXIV 13033997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lundin S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01186; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Menon R, 2014, J PROTEOME RES, V13, P212, DOI 10.1021/pr400773v; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Souza V, 1997, J EVOLUTION BIOL, V10, P743; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Tilgner H, 2015, NAT BIOTECHNOL, V33, P736, DOI 10.1038/nbt.3242; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097505; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147229	10.1371/journal.pone.0147229	http://dx.doi.org/10.1371/journal.pone.0147229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789840	Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100070
J	Wang, Y; Yan, FS; Lian, JM; Dou, SW				Wang, Ying; Yan, Feng-Shan; Lian, Jian-Min; Dou, She-Wei			Effects of Gestational Magnetic Resonance Imaging on Methylation Status of Leptin Promoter in the Placenta and Cord Blood	PLOS ONE			English	Article							IN-UTERO EXPOSURE; HIGH-FAT-DIET; DNA METHYLATION; MR EXPOSURE; FETAL-GROWTH; BODY-WEIGHT; EPIGENETICS; PREGNANCY; MOUSE; CHICK	Over the past two decades, magnetic resonance imaging (MRI) has been widely used for diagnosis in gestational women. Though it has several advantages, animal and human studies on the safety of MRI for the fetus remain inconclusive. Epigenetic modifications, which are crucial for cellular functioning, are prone to being affected by environmental changes. Therefore, we hypothesized that MRI during gestation may cause epigenetic modification alterations. Here, we investigated DNA methylation patterns of leptin promoter in the placenta and cord blood of women exposed to MRI during gestation. Results showed that average methylation levels of leptin in the placenta and cord blood were not affected by MRI. We also found that the methylation levels in the placenta and cord blood were not affected by different magnetic fields (1.5T and 3.0T MRI). However, if pregnant women were exposed to MRI at 15 to 20 weeks of gestation, the methylation level of leptin in cord blood was visibly lower than that of pregnant women exposed to MRI after 20-weeks of gestation (P = 0.037). mRNA expression level of leptin in cord blood was also altered, though mRNA expression of leptin in the placenta was not significantly affected. Therefore, we concluded that gestational MRI may not have major effects on the methylation level of leptin in cord blood and the placenta except for MRI applied before 20 weeks of gestation.	[Wang, Ying; Yan, Feng-Shan; Lian, Jian-Min; Dou, She-Wei] Zhengzhou Univ, Dept Radiol, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Dou, SW (corresponding author), Zhengzhou Univ, Dept Radiol, Peoples Hosp, Henan Prov Peoples Hosp, Zhengzhou 450052, Henan, Peoples R China.	doushewei2000@163.com						BAKER PN, 1994, AM J OBSTET GYNECOL, V170, P32; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BEHR KP, 1991, DEUT TIERARZTL WOCH, V98, P149; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Briffa JF, 2015, AM J PHYSIOL-ENDOC M, V308, pE335, DOI 10.1152/ajpendo.00312.2014; Bulas D, 2013, SEMIN PERINATOL, V37, P301, DOI 10.1053/j.semperi.2013.06.005; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Carnes KI, 1996, MAGN RESON IMAGING, V14, P263, DOI 10.1016/0730-725X(95)02099-F; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Coakley FV, 2004, AM J ROENTGENOL, V182, P243, DOI 10.2214/ajr.182.1.1820243; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Friedman Jeffrey M., 2011, Keio Journal of Medicine, V60, P1, DOI 10.2302/kjm.60.1; Garcia-Cardona MC, 2014, INT J OBESITY, V38, P1457, DOI 10.1038/ijo.2014.30; Ge ZJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118141; Ge ZJ, 2014, ENVIRON HEALTH PERSP, V122, P159, DOI 10.1289/ehp.1307047; Giudicelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068268; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; HEINRICHS WL, 1988, MAGN RESON IMAGING, V6, P305, DOI 10.1016/0730-725X(88)90407-9; KANAL E, 1993, RADIOLOGY, V187, P395, DOI 10.1148/radiology.187.2.8475280; Khalyfa A, 2013, INT J OBESITY, V37, P1481, DOI 10.1038/ijo.2013.12; Lepercq J, 2001, J CLIN ENDOCR METAB, V86, P2409, DOI 10.1210/jc.86.6.2409; Lesseur C, 2013, MOL CELL ENDOCRINOL, V381, P160, DOI 10.1016/j.mce.2013.07.024; Magin RL, 2000, J MAGN RESON IMAGING, V12, P140, DOI 10.1002/1522-2586(200007)12:1<140::AID-JMRI15>3.0.CO;2-D; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; MEVISSEN M, 1994, TERATOLOGY, V50, P229, DOI 10.1002/tera.1420500308; Michel SCA, 2003, AM J ROENTGENOL, V180, P1159, DOI 10.2214/ajr.180.4.1801159; Myers C, 1998, BRIT J RADIOL, V71, P549, DOI 10.1259/bjr.71.845.9691901; Okuda Yasuyuki, 1999, Journal of Toxicological Sciences, V24, P79; Poutamo J, 1998, PRENATAL DIAG, V18, P1149, DOI 10.1002/(SICI)1097-0223(199811)18:11<1149::AID-PD421>3.0.CO;2-K; Schrey S, 2013, MOL HUM REPROD, V19, P764, DOI 10.1093/molehr/gat048; Shen WW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05282; Strizek B, 2015, RADIOLOGY, V275, P530, DOI 10.1148/radiol.14141382; Triulzi F, 2011, RADIOL MED, V116, P337, DOI 10.1007/s11547-011-0633-5; Vadeyar SH, 2000, AM J OBSTET GYNECOL, V182, P666, DOI 10.1067/mob.2000.103938; YIP YP, 1995, JMRI-J MAGN RESON IM, V5, P457, DOI 10.1002/jmri.1880050416; YIP YP, 1994, JMRI-J MAGN RESON IM, V4, P742, DOI 10.1002/jmri.1880040518; YIP YP, 1994, JMRI-J MAGN RESON IM, V4, P799, DOI 10.1002/jmri.1880040610; Yousefi M, 2013, INT J MOL EPIDEMIOL, V4, P86	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147371	10.1371/journal.pone.0147371	http://dx.doi.org/10.1371/journal.pone.0147371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789724	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100083
J	Han, HJ; Kwon, N; Choi, MA; Jung, KO; Piao, JY; Ngo, HKC; Kim, SJ; Kim, DH; Chung, JK; Cha, YN; Youn, H; Choi, BY; Min, SH; Surh, YJ				Han, Hyeong-Jun; Kwon, Nayoung; Choi, Min-A; Jung, Kyung Oh; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Kim, Su-Jung; Kim, Do-Hee; Chung, June-Key; Cha, Young-Nam; Youn, Hyewon; Choi, Bu Young; Min, Sang-Hyun; Surh, Young-Joon			Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1 alpha	PLOS ONE			English	Article							BREAST-CANCER; DIRECT PHOSPHORYLATION; FACTOR 1-ALPHA; GROWTH-FACTOR; BETA-CATENIN; CELL-CYCLE; FACTOR-I; S-PHASE; ANGIOGENESIS; EXPRESSION	Peptidyl prolyl isomerase (PIN1) regulates the functional activity of a subset of phosphoproteins through binding to phosphorylated Ser/Thr-Pro motifs and subsequently isomerization of the phosphorylated bonds. Interestingly, PIN1 is overexpressed in many types of malignancies including breast, prostate, lung and colon cancers. However, its oncogenic functions have not been fully elucidated. Here, we report that PIN1 directly interacts with hypoxia-inducible factor (HIF)-1 alpha in human colon cancer (HCT116) cells. PIN1 binding to HIF-1 alpha occurred in a phosphorylation-dependent manner. We also found that PIN1 interacted with HIF-1 alpha at both exogenous and endogenous levels. Notably, PIN1 binding stabilized the HIF-1 alpha protein, given that their levels were significantly increased under hypoxic conditions. The stabilization of HIF-1 alpha resulted in increased transcriptional activity, consequently upregulating expression of vascular endothelial growth factor, a major contributor to angiogenesis. Silencing of PIN1 or pharmacologic inhibition of its activity abrogated the angiogenesis. By utilizing a bioluminescence imaging technique, we were able to demonstrate that PIN1 inhibition dramatically reduced the tumor volume in a subcutaneous mouse xenograft model and angiogenesis as well as hypoxia-induced transcriptional activity of HIF-1 alpha. These results suggest that PIN1 interacting with HIF-1 alpha is a potential cancer chemopreventive and therapeutic target.	[Han, Hyeong-Jun; Kwon, Nayoung; Choi, Min-A; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Kim, Su-Jung; Kim, Do-Hee; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 151742, South Korea; [Han, Hyeong-Jun; Piao, Juan-Yu; Ngo, Hoang Kieu Chi; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Jung, Kyung Oh; Chung, June-Key; Youn, Hyewon] Seoul Natl Univ, Dept Nucl Med, Seoul 136742, South Korea; [Jung, Kyung Oh; Chung, June-Key] Seoul Natl Univ, Biomed Sci, Seoul 136742, South Korea; [Jung, Kyung Oh; Chung, June-Key; Youn, Hyewon; Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul 136742, South Korea; [Kim, Su-Jung; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Inchon, South Korea; [Youn, Hyewon] Seoul Natl Univ Hosp, Canc Imaging Ctr, Seoul 136742, South Korea; [Choi, Bu Young] Seowon Univ, Sch Convergence Biosci & Technol, Dept Pharmaceut Sci & Engn, Cheongju 361742, South Korea; [Min, Sang-Hyun] New Drug Dev Ctr DGMIF, Daegu 701310, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University; Seoul National University (SNU); Seoul National University Hospital; Seowon University	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 151742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul 136742, South Korea.; Surh, YJ (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea.	surh@snu.ac.kr		Youn, Hyewon/0000-0003-1006-2689	Global Core Research Center (GCRC) from the National Research Foundation (NRF), Republic of Korea [2012-0001184]	Global Core Research Center (GCRC) from the National Research Foundation (NRF), Republic of Korea	This work was supported by Global Core Research Center (GCRC) grant (No. 2012-0001184) from the National Research Foundation (NRF), Republic of Korea.	Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944; Bakker WJ, 2013, TRANSCR-AUSTIN, V4, P62, DOI 10.4161/trns.23680; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Driver JA, 2015, BBA-GEN SUBJECTS, V1850, P2069, DOI 10.1016/j.bbagen.2014.12.025; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukuda R, 2003, CANCER RES, V63, P2330; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jalouli M, 2014, CELL SIGNAL, V26, P1649, DOI 10.1016/j.cellsig.2014.04.005; Kim CJ, 2005, WORLD J GASTROENTERO, V11, P5006, DOI 10.3748/wjg.v11.i32.5006; Kim JH, 2014, PHYTOTHER RES, V28, P238, DOI 10.1002/ptr.4986; Kuramochi J, 2006, J SURG ONCOL, V94, P155, DOI 10.1002/jso.20510; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lonati E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00001; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma JH, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/160140; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Miyashita H, 2003, ONCOL REP, V10, P1045; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Nakamura K, 2012, MOL CELL BIOL, V32, P2966, DOI 10.1128/MCB.05688-11; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Toledo F, 2007, MOL CELL BIOL, V27, P1425, DOI 10.1128/MCB.00999-06; Tong Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.3; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JZ, 2013, MED HYPOTHESES, V81, P282, DOI 10.1016/j.mehy.2013.04.029; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	55	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0147038	10.1371/journal.pone.0147038	http://dx.doi.org/10.1371/journal.pone.0147038			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784107	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400098
J	Pienkowska, J; Gwozdziewicz, K; Skrobisz-Balandowska, K; Marek, I; Kostro, J; Szurowska, E; Studniarek, M				Pienkowska, Joanna; Gwozdziewicz, Katarzyna; Skrobisz-Balandowska, Katarzyna; Marek, Iwona; Kostro, Justyna; Szurowska, Edyta; Studniarek, Michal			Perfusion-CT - Can We Predict Acute Pancreatitis Outcome within the First 24 Hours from the Onset of Symptoms?	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ORGAN FAILURE; SEVERITY INDEX; ATLANTA CLASSIFICATION; NECROSIS; COMPLICATIONS; PERSISTENT; ISCHEMIA; SUPERIOR; IMPACT	Purpose Severe acute pancreatitis (AP) is still a significant clinical problem which is associated with a highly mortality. The aim of this study was the evaluation of prognostic value of CT regional perfusion measurement performed on the first day of onset of symptoms of AP, in assessing the risk of developing severe form of acute pancreatitis. Material and Methods 79 patients with clinical symptoms and biochemical criteria indicative of acute pancreatitis (acute upper abdominal pain, elevated levels of serum amylase and lipase) underwent perfusion CT within 24 hours after onset of symptoms. The follow-up examinations were performed after 4-6 days to detect progression of the disease. Perfusion parameters were compared in 41 people who developed severe form of AP (pancreatic and/or peripancreatic tissue necrosis) with parameters in 38 consecutive patients in whom course of AP was mild. Blood flow, blood volume, mean transit time and permeability surface area product were calculated in the three anatomic pancreatic subdivisions (head, body and tail). At the same time the patient's clinical status was assessed by APACHE II score and laboratory parameters such as CRP, serum lipase and amylase, AST, ALT, GGT, ALP and bilirubin were compared. Results Statistical differences in the perfusion parameters between the group of patients with mild and severe AP were shown. Blood flow, blood volume and mean transit time were significantly lower and permeability surface area product was significantly higher in patients who develop severe acute pancreatitis and presence of pancreatic and/or peripancreatic necrosis due to pancreatic ischemia. There were no statistically significant differences between the two groups in terms of evaluated on admission severity of pancreatitis assessed using APACHE II score and laboratory tests. Conclusions CT perfusion is a very useful indicator for prediction and selection patients in early stages of acute pancreatitis who are at risk of developing pancreatic and/or peripancreatic necrosis already on the first day of the onset of symptoms and can be used for treatment planning and monitoring of therapy of acute pancreatitis. Early suspicion of possible pancreatic necrosis both on the basis of scores based on clinical status and laboratory tests have low predictive value.	[Pienkowska, Joanna; Szurowska, Edyta] Med Univ Gdansk, Fac Hlth Sci, Dept Radiol 2, Gdansk, Poland; [Gwozdziewicz, Katarzyna; Skrobisz-Balandowska, Katarzyna; Studniarek, Michal] Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland; [Marek, Iwona] Med Univ Gdansk, Dept Gastroenterol & Hepatol, Gdansk, Poland; [Kostro, Justyna] Med Univ Gdansk, Dept Gen Endocrine & Transplant Surg, Gdansk, Poland; [Studniarek, Michal] Med Univ Warsaw, Dept Diagnost Imaging, Warsaw, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw	Gwozdziewicz, K (corresponding author), Med Univ Gdansk, Fac Med, Dept Radiol 1, Gdansk, Poland.	kgwozdziewicz@gumed.edu.pl	Skrobisz, Katarzyna/U-2132-2018; Pieńkowska, Joanna/U-6195-2018; Szurowska, Edyta/AAA-9505-2020	Skrobisz, Katarzyna/0000-0003-3710-9037; Pieńkowska, Joanna/0000-0002-7087-9888; Szurowska, Edyta/0000-0002-7042-4381; Studniarek, Michal/0000-0002-9200-1320	National Science Centre [G-86]	National Science Centre(National Science Centre, Poland)	This work was supported by the National Science Centre (https://www.ncn.gov.pl/) G-86 to JP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali MA, 2008, RADIOLOGY, V247, P115, DOI 10.1148/radiol.2471070685; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bize PE, 2006, AM J ROENTGENOL, V186, P114, DOI 10.2214/AJR.04.1416; Bollen TL, 2007, PANCREAS, V35, P107, DOI 10.1097/mpa.0b013e31804fa189; Casas JD, 2004, AM J ROENTGENOL, V182, P569, DOI 10.2214/ajr.182.3.1820569; Chatzicostas C, 2003, J CLIN GASTROENTEROL, V36, P253, DOI 10.1097/00004836-200303000-00013; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Delrue L, 2012, ABDOM IMAGING, V37, P595, DOI 10.1007/s00261-011-9783-0; Garg PK, 2005, CLIN GASTROENTEROL H, V3, P159, DOI 10.1016/S1542-3565(04)00665-2; Grozinger G, 2014, ROFO-FORTSCHR RONTG, V186, P1082, DOI 10.1055/s-0034-1384876; Halonen KI, 2002, CRIT CARE MED, V30, P1274, DOI 10.1097/00003246-200206000-00019; Jin X, 2009, ABDOM IMAGING, V34, P759, DOI [10.1007/s00261-009-9564-1, DOI 10.1007/S00261-009-9564-1]; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Klauss M, 2012, J COMPUT ASSIST TOMO, V36, P237, DOI 10.1097/RCT.0b013e31824a099e; Knoepfli AS, 2007, ABDOM IMAGING, V32, P111, DOI 10.1007/s00261-006-9034-y; Lenhart DK, 2008, AM J ROENTGENOL, V190, P643, DOI 10.2214/AJR.07.2761; Li HO, 2014, ABDOM IMAGING, V39, P40, DOI 10.1007/s00261-013-0045-1; Malmstrom ML, 2012, PANCREAS, V41, P271, DOI 10.1097/MPA.0b013e3182240552; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Mortele KJ, 2004, AM J ROENTGENOL, V183, P1261, DOI 10.2214/ajr.183.5.1831261; Motosugi U, 2012, EUR J RADIOL, V81, P2533, DOI 10.1016/j.ejrad.2011.11.054; O'Connor OJ, 2011, AM J ROENTGENOL, V197, pW221, DOI 10.2214/AJR.10.4338; Piacik M., 2011, TERAPIA, V5, P35; Roberts SE, 2013, ALIMENT PHARM THER, V38, P539, DOI 10.1111/apt.12408; Shinagare AB, 2015, ABDOM IMAGING, V40, P272, DOI 10.1007/s00261-014-0210-1; Spanier BWM, 2010, PANCREATOLOGY, V10, P222, DOI 10.1159/000243731; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Takeda K, 2005, PANCREAS, V30, P40; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tertulino FD, 2015, ABDOM IMAGING, V40, P265, DOI 10.1007/s00261-014-0205-y; Thandassery RB, 2013, HPB, V15, P523, DOI 10.1111/j.1477-2574.2012.00613.x; Thoeni RF, 2012, RADIOLOGY, V262, P751, DOI 10.1148/radiol.11110947; Triantopoulou C, 2007, PANCREAS, V35, P238, DOI 10.1097/MPA.0b013e3180619662; Tsuji Y, 2007, CLIN GASTROENTEROL H, V5, P1484, DOI 10.1016/j.cgh.2007.07.014; Tsuji Y, 2006, J GASTROEN HEPATOL, V21, P1506, DOI 10.1111/j.1440-1746.2006.04352.x; Tsuji Y, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/497386; Tsuji Y, 2010, J GASTROENTEROL, V45, P1155, DOI 10.1007/s00535-010-0267-8; Tsuji Y, 2010, PANCREAS, V39, P541, DOI 10.1097/MPA.0b013e3181c16037; Turkvatan A, 2015, DIAGN INTERV IMAG, V96, P161, DOI 10.1016/j.diii.2013.12.018; Turkvatan A, 2015, DIAGN INTERV IMAG, V96, P151, DOI 10.1016/j.diii.2013.12.017; Uhl W, 2002, PANCREAS, V24, P191, DOI 10.1097/00006676-200203000-00011; Wang X, 2013, PANCREAS, V42, P1255, DOI 10.1097/MPA.0b013e3182a5d6a7; Watanabe T, 2013, PANCREAS, V42, P180, DOI 10.1097/MPA.0b013e3182576295; Wichmann JL, 2014, EUR RADIOL, V24, P2927, DOI 10.1007/s00330-014-3300-0; Wig JD, 2009, J PANCREAS, V10, P271; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080468; Xu J, 2009, ABDOM IMAGING, V34, P759, DOI 10.1007/s00261-009-9564-1; Yadav AK, 2015, ABDOM IMAGING, V40, P488, DOI 10.1007/s00261-014-0226-6; Zaheer A, 2013, ABDOM IMAGING, V38, P125, DOI 10.1007/s00261-012-9908-0; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P351	53	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146965	10.1371/journal.pone.0146965	http://dx.doi.org/10.1371/journal.pone.0146965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784348	gold, Green Submitted, Green Published			2022-12-27	WOS:000368528400088
J	Seimon, RV; Shi, YC; Slack, K; Lee, K; Fernando, HA; Nguyen, AD; Zhang, L; Lin, S; Enriquez, RF; Lau, J; Herzog, H; Sainsbury, A				Seimon, Radhika V.; Shi, Yan-Chuan; Slack, Katy; Lee, Kailun; Fernando, Hamish A.; Nguyen, Amy D.; Zhang, Lei; Lin, Shu; Enriquez, Ronaldo F.; Lau, Jackie; Herzog, Herbert; Sainsbury, Amanda			Intermittent Moderate Energy Restriction Improves Weight Loss Efficiency in Diet-Induced Obese Mice	PLOS ONE			English	Article							DISEASE RISK MARKERS; CALORIC RESTRICTION; OVERWEIGHT WOMEN; NEUROPEPTIDE-Y; BODY-WEIGHT; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; GLYCEMIC CONTROL; FEEDING STATUS; MAINTENANCE	Background Intermittent severe energy restriction is popular for weight management. To investigate whether intermittent moderate energy restriction may improve this approach by enhancing weight loss efficiency, we conducted a study in mice, where energy intake can be controlled. Methods Male C57/Bl6 mice that had been rendered obese by an ad libitum diet high in fat and sugar for 22 weeks were then fed one of two energy-restricted normal chow diets for a 12-week weight loss phase. The continuous diet (CD) provided 82% of the energy intake of age-matched ad libitum chow-fed controls. The intermittent diet (ID) provided cycles of 82% of control intake for 5-6 consecutive days, and ad libitum intake for 1-3 days. Weight loss efficiency during this phase was calculated as (total weight change) divided by [(total energy intake of mice on CD or ID)-(total average energy intake of controls)]. Subsets of mice then underwent a 3-week weight regain phase involving ad libitum re-feeding. Results Mice on the ID showed transient hyperphagia relative to controls during each 1-3-day ad libitum feeding period, and overall ate significantly more than CD mice (91.1 +/- 1.0 versus 82.2 +/- 0.5% of control intake respectively, n = 10, P<0.05). There were no significant differences between CD and ID groups at the end of the weight loss or weight regain phases with respect to body weight, fat mass, circulating glucose or insulin concentrations, or the insulin resistance index. Weight loss efficiency was significantly greater with ID than with CD (0.042 +/- 0.007 versus 0.018 +/- 0.001 g/kJ, n = 10, P<0.01). Mice on the CD exhibited significantly greater hypothalamic mRNA expression of proopiomelanocortin (POMC) relative to ID and control mice, with no differences in neuropeptide Y or agouti-related peptide mRNA expression between energy-restricted groups. Conclusion Intermittent moderate energy restriction may offer an advantage over continuous moderate energy restriction, because it induces significantly greater weight loss relative to energy deficit in mice.	[Seimon, Radhika V.; Fernando, Hamish A.; Sainsbury, Amanda] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Shi, Yan-Chuan; Slack, Katy; Lee, Kailun; Nguyen, Amy D.; Zhang, Lei; Lin, Shu; Lau, Jackie; Herzog, Herbert; Sainsbury, Amanda] St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, Darlinghurst, NSW 2010, Australia; [Enriquez, Ronaldo F.] St Vincents Hosp, Garvan Inst Med Res, Bone Biol Div, Sydney, NSW 2010, Australia	University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Sainsbury, A (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia.; Sainsbury, A (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, Darlinghurst, NSW 2010, Australia.	amanda.salis@sydney.edu.au	Seimon, Radhika/I-7746-2018	Seimon, Radhika/0000-0002-3903-4801; Salis, Amanda/0000-0001-9176-1574; Nguyen, Amy/0000-0003-4603-564X; lin, shu/0000-0002-4239-2028; , Herbert/0000-0002-1713-1029	National Health and Medical Research Council (NHMRC) of Australia; Endocrine Society of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society of Australia	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia via research project grants to AS and HH, as well as an Early Career Fellowship to RVS, postgraduate scholarships to ADN and JL, a Career Development Award to SL, and Research Fellowships to HH and AS. The authors are also grateful to the Endocrine Society of Australia for a Postdoctoral Award to RVS.; We thank the staff of the Garvan Institute Biological Testing Facility for facilitation of these experiments. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia via research project grants to AS and HH, as well as an Early Career Fellowship to RVS, postgraduate scholarships to ADN and JL, a Career Development Award to SL, and Research Fellowships to HH and AS. We are also grateful to the Endocrine Society of Australia for a Postdoctoral Award to RVS.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arguin H, 2012, MENOPAUSE, V19, P870, DOI 10.1097/gme.0b013e318250a287; Ash S, 2003, INT J OBESITY, V27, P797, DOI 10.1038/sj.ijo.0802295; Bailey BW, 2008, DIS MANAGE, V11, P176, DOI 10.1089/dis.2007.0002; Barnosky AR, 2014, TRANSL RES, V164, P302, DOI 10.1016/j.trsl.2014.05.013; Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013; BECK B, 1990, BRAIN RES, V528, P245, DOI 10.1016/0006-8993(90)91664-3; Bonorden MJL, 2009, NUTR CANCER, V61, P265, DOI 10.1080/01635580802419798; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Camps SGJA, 2013, AM J CLIN NUTR, V98, P917, DOI 10.3945/ajcn.113.062935; Chausse B, 2014, ENDOCRINOLOGY, V155, P2456, DOI 10.1210/en.2013-2057; Christensen P, 2011, CLIN OBES, V1, P31, DOI 10.1111/j.1758-8111.2011.00006.x; Compagnucci CV, 2002, NEUROIMMUNOMODULAT, V10, P153, DOI 10.1159/000067177; DEGROOT LCPGM, 1989, AM J CLIN NUTR, V50, P1314, DOI 10.1093/ajcn/50.6.1314; Dixon JB, 2015, DIABETES OBES METAB, V17, P91, DOI 10.1111/dom.12389; Doucet E, 2000, INT J OBESITY, V24, P906, DOI 10.1038/sj.ijo.0801251; Drapeau V, 2007, APPETITE, V48, P159, DOI 10.1016/j.appet.2006.08.002; Dutia R, 2012, ENDOCRINOLOGY, V153, P4246, DOI 10.1210/en.2012-1166; FABBRI A, 1989, J STEROID BIOCHEM, V32, P145, DOI 10.1016/0022-4731(89)90155-6; Friedl KE, 2000, J APPL PHYSIOL, V88, P1820, DOI 10.1152/jappl.2000.88.5.1820; Ganesh CB, 2013, FISH PHYSIOL BIOCHEM, V39, P627, DOI 10.1007/s10695-012-9725-y; Gayle D, 1999, AM J PHYSIOL-REG I, V277, pR1188, DOI 10.1152/ajpregu.1999.277.4.R1188; Gilbert JA, 2009, APPETITE, V52, P809, DOI 10.1016/j.appet.2009.04.003; Harvie M, 2013, 2 DAY DIET DIET 2 DA; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; HILL JO, 1989, AM J CLIN NUTR, V50, P248, DOI 10.1093/ajcn/50.2.248; Horne BD, 2015, AM J CLIN NUTR, V102, P464, DOI 10.3945/ajcn.115.109553; Jang MY, 1998, J NUTR, V128, P2520, DOI 10.1093/jn/128.12.2520; Keogh JB, 2014, CLIN OBES, V4, P150, DOI 10.1111/cob.12052; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Markovic TP, 2009, MED J AUSTRALIA, V190, P149, DOI 10.5694/j.1326-5377.2009.tb02319.x; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Mosley M, 2013, FASTDIET LOSE WEIGHT; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111/j.1462-8902.2004.00335.x; Pedersen CR, 1999, AUTOIMMUNITY, V30, P243, DOI 10.3109/08916939908993805; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Rossner S, 1998, INT J OBESITY, V22, P190, DOI 10.1038/sj.ijo.0800563; Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621; Sainsbury A, 2012, OBES REV, V13, P234, DOI 10.1111/j.1467-789X.2011.00948.x; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Seimon RV, 2015, MOL CELL ENDOCRINOL, V418, P153, DOI 10.1016/j.mce.2015.09.014; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; SWEENEY ME, 1993, AM J CLIN NUTR, V57, P127, DOI 10.1093/ajcn/57.2.127; Varady KA, 2011, OBES REV, V12, pE593, DOI 10.1111/j.1467-789X.2011.00873.x; Varady KA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-119; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, P57, DOI 10.1038/sj.ijo.0802461; Williams KV, 1998, DIABETES CARE, V21, P2, DOI 10.2337/diacare.21.1.2; WING RR, 1994, AM J MED, V97, P354, DOI 10.1016/0002-9343(94)90302-6; Wing RR, 2003, OBES RES, V11, P287, DOI 10.1038/oby.2003.43	62	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0145157	10.1371/journal.pone.0145157	http://dx.doi.org/10.1371/journal.pone.0145157			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784324	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400011
J	Ando, K; Okada, Y; Akiba, M; Kondo, T; Kawamura, T; Okumura, M; Chen, FS; Date, H; Shiraishi, T; Iwasaki, A; Yamasaki, N; Nagayasu, T; Chida, M; Inoue, Y; Hirai, T; Seyama, K; Mishima, M				Ando, Katsutoshi; Okada, Yoshinori; Akiba, Miki; Kondo, Takashi; Kawamura, Tomohiro; Okumura, Meinoshin; Chen, Fengshi; Date, Hiroshi; Shiraishi, Takeshi; Iwasaki, Akinori; Yamasaki, Naoya; Nagayasu, Takeshi; Chida, Masayuki; Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki		Japanese Minist Hlth Labour Welf	Lung Transplantation for Lymphangioleiomyomatosis in Japan	PLOS ONE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS; RECURRENT LYMPHANGIOLEIOMYOMATOSIS; SIROLIMUS; EXPERIENCE; CHYLOTHORAX; MANAGEMENT; SOCIETY; HEART; GENE; TSC2	Background Lung transplantation has been established as the definitive treatment option for patients with advanced lymphangioleiomyomatosis (LAM). However, the prognosis after registration and the circumstances of lung transplantation with sirolimus therapy have never been reported. Methods In this national survey, we analyzed data from 98 LAM patients registered for lung transplantation in the Japan Organ Transplantation Network. Results Transplantation was performed in 57 patients as of March 2014. Survival rate was 86.7% at 1 year, 82.5% at 3 years, 73.7% at 5 years, and 73.7% at 10 years. Of the 98 patients, 21 had an inactive status and received sirolimus more frequently than those with an active history (67% vs. 5%, p<0.001). Nine of twelve patients who remained inactive as of March 2014 initiated sirolimus before or while on a waiting list, and remained on sirolimus thereafter. Although the statistical analysis showed no statistically significant difference, the survival rate after registration tended to be better for lung transplant recipients than for those who awaited transplantation (p = 0.053). Conclusions Lung transplantation is a satisfactory therapeutic option for advanced LAM, but the circumstances for pre-transplantation LAM patients are likely to alter with the use of sirolimus.	[Ando, Katsutoshi; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Ando, Katsutoshi; Seyama, Kuniaki] Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Okada, Yoshinori; Akiba, Miki; Kondo, Takashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, Seiryo Machi 4-1, Sendai, Miyagi 980, Japan; [Kawamura, Tomohiro; Okumura, Meinoshin] Osaka Univ, Dept Gen Thorac Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka, Japan; [Chen, Fengshi; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto, Japan; [Shiraishi, Takeshi; Iwasaki, Akinori] Fukuoka Univ, Sch Med, Dept Gen Thorac Breast & Pediat Surg, Jonan ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 81401, Japan; [Yamasaki, Naoya; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Dept Translat Med Sci, 1-7-1 Sakamoto, Nagasaki 852, Japan; [Chida, Masayuki] Dokkyo Med Univ, Dept Gen Thorac Surg, 880 Kitakobayashi, Mibu, Tochigi, Japan; [Inoue, Yoshikazu] Kinki Chuo Chest Med Ctr, Natl Hosp Org, Clin Res Ctr, Kita Ku, 1180 Nagasonecho, Sakai, Osaka, Japan; [Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Kyoto, Japan; [Inoue, Yoshikazu; Hirai, Toyohiro; Seyama, Kuniaki; Mishima, Michiaki] Minist Hlth Labour & Welf, Resp Failure Res Grp, Tokyo, Japan	Juntendo University; Tohoku University; Osaka University; Kyoto University; Fukuoka University; Nagasaki University; Dokkyo Medical University; Kyoto University	Seyama, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan.; Seyama, K (corresponding author), Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan.; Seyama, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Kyoto, Japan.; Seyama, K (corresponding author), Minist Hlth Labour & Welf, Resp Failure Res Grp, Tokyo, Japan.	kseyama@juntendo.ac.jp	Inoue, Yoshikazu/ABE-9772-2020		Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2013, RESPIR INVESTIG, V51, P175, DOI 10.1016/j.resinv.2013.03.002; Ando K, 2012, EUR J RADIOL, V81, P3925, DOI 10.1016/j.ejrad.2012.05.033; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Benden C, 2009, J HEART LUNG TRANSPL, V28, P1, DOI 10.1016/j.healun.2008.09.014; Boehler A, 1996, NEW ENGL J MED, V335, P1275, DOI 10.1056/NEJM199610243351704; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chen FS, 2009, ANN THORAC SURG, V87, pE6, DOI 10.1016/j.athoracsur.2008.07.107; ESTENNE M, 1984, LANCET, V1, P275; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Groetzner J, 2004, J HEART LUNG TRANSPL, V23, P632, DOI 10.1016/S1053-2498(03)00309-7; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Hussein M, 2014, ANN THORAC MED, V9, P124, DOI 10.4103/1817-1737.128862; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; King-Biggs MB, 2003, TRANSPLANTATION, V75, P1437, DOI 10.1097/01.TP.0000064083.02120.2C; Kpodonu J, 2005, J HEART LUNG TRANSPL, V24, P1247, DOI 10.1016/j.healun.2004.09.013; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Machuca TN, 2011, TRANSPL P, V43, P236, DOI 10.1016/j.transproceed.2010.12.051; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Morton JM, 2008, J HEART LUNG TRANSPL, V27, P462, DOI 10.1016/j.healun.2008.01.005; Ohara T, 2008, ANN THORAC SURG, V86, pE7, DOI 10.1016/j.athoracsur.2008.07.062; Pechet TT, 2004, J HEART LUNG TRANSPL, V23, P301, DOI 10.1016/S1053-2498(03)00195-5; Reynaud-Gatibert M, 2008, TRANSPLANTATION, V86, P515, DOI 10.1097/TP.0b013e31817c15df; Sato M, 2014, GEN THORAC CARDIOVAS, V62, P594, DOI 10.1007/s11748-014-0418-6; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sugimoto R, 2008, J HEART LUNG TRANSPL, V27, P921, DOI 10.1016/j.healun.2008.05.012; Taveira-DaSilva AM, 2007, CHEST, V132, P1573, DOI 10.1378/chest.07-1205; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	28	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146749	10.1371/journal.pone.0146749	http://dx.doi.org/10.1371/journal.pone.0146749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771878	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300031
J	Rodic, SZ; Knezevic, TI; Kisic-Tepavcevic, DB; Dackovic, JR; Dujmovic, I; Pekmezovic, TD; Drulovic, JS; Konstantinovic, LM				Rodic, Sindi Z.; Knezevic, Tatjana I.; Kisic-Tepavcevic, Darija B.; Dackovic, Jelena R.; Dujmovic, Irena; Pekmezovic, Tatjana D.; Drulovic, Jelena S.; Konstantinovic, Ljubica M.			Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88)	PLOS ONE			English	Article							GUIDELINES; QUALITY; IMPACT	Objective Multiple Sclerosis Spasticity Scale (MSSS)-88 has been developed for self-assessment of spasticity symptoms in patients with multiple sclerosis (MS). The objective of this study was to validate MSSS-88 and evaluate the psychometric properties in patients with MS in Serbia. Methods The study comprised 65 MS patients with spasticity. MSSS-88 consists of 88 items grouped in eight sections. Internal consistency of the MSSS-88(SR) subscales was determined using Cronbach's alpha coefficient. Test/retest reliability with an intra-class correlation coefficient (ICC) for each MSSS-88(SR) subscale was performed. Clinical validity of MSSS-88(SR) was determined by correlations with the Numeric Rating Scale (NRS) and the Modified Ashworth Scale (MAS). Results The range of Cronbach's alpha for all scales and ICC was 0.91-0.96 and 0.84-0.91, respectively. All ICCs were statistically significant (p<0.05). All evaluated subscales of MSSS-88 were significantly correlated with the NRS scale. The highest correlation coefficients were registered between the WL subscale and the EDSS and MAS, while the strongest relationship was observed between the MSS subscale and the NRS. Conclusion The Serbian translated version of this instrument may be useful as a clinical measure for spasticity and functionality in patients with MS.	[Rodic, Sindi Z.; Konstantinovic, Ljubica M.] Clin Rehabil Dr M Zotovic, Belgrade, Serbia; [Knezevic, Tatjana I.] Univ Chlidrens Hosp, Belgrade, Serbia; [Kisic-Tepavcevic, Darija B.; Dujmovic, Irena; Pekmezovic, Tatjana D.; Drulovic, Jelena S.; Konstantinovic, Ljubica M.] Univ Belgrade, Fac Med, Belgrade 11001, Serbia; [Kisic-Tepavcevic, Darija B.; Pekmezovic, Tatjana D.] Inst Epidemiol, Belgrade, Serbia; [Dackovic, Jelena R.; Dujmovic, Irena; Drulovic, Jelena S.] Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Rodic, SZ; Konstantinovic, LM (corresponding author), Clin Rehabil Dr M Zotovic, Belgrade, Serbia.; Konstantinovic, LM (corresponding author), Univ Belgrade, Fac Med, Belgrade 11001, Serbia.	sindirodic@gmail.com; ljkonstantinovic@yahoo.com	Konstantinovic, Ljubica/ACN-0358-2022	Konstantinovic, Ljubica/0000-0001-5906-1594				Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cook KF, 2007, J REHABIL RES DEV, V44, P363, DOI 10.1682/JRRD.2006.04.0036; Farrar JT, 2008, CLIN THER, V30, P974, DOI 10.1016/j.clinthera.2008.05.011; Flachenecker P, 2014, ACTA NEUROL SCAND, V129, P154, DOI 10.1111/ane.12202; Gothbi N, 2009, BRAIN INJURY, V23, P815, DOI 10.1080/02699050903200548; Haas Judith, 2011, Expert Rev Neurother, V11, P3; Henze T, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0119-y; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart JC, 2006, BRAIN, V129, P224, DOI 10.1093/brain/awh675; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McGuigan C, 2004, NEUROLOGY, V62, P2103, DOI 10.1212/01.WNL.0000127604.84575.0D; Mori F, 2011, J NEUROL, V258, P1281, DOI 10.1007/s00415-011-5924-1; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1080/13607860500090011; PATY DW, 1998, MULTIPLE SCLEROSIS; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Ware J., 1993, SF 36 HLTH SURVEY MA	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147042	10.1371/journal.pone.0147042	http://dx.doi.org/10.1371/journal.pone.0147042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771661	gold, Green Submitted, Green Published			2022-12-27	WOS:000368628300057
J	Sanroma, G; Penate-Sanchez, A; Alquezar, R; Serratosa, F; Moreno-Noguer, F; Andrade-Cetto, J; Ballester, MAG				Sanroma, Gerard; Penate-Sanchez, Adrian; Alquezar, Rene; Serratosa, Francesc; Moreno-Noguer, Francesc; Andrade-Cetto, Juan; Gonzalez Ballester, Miguel Angel			MSClique: Multiple Structure Discovery through the Maximum Weighted Clique Problem	PLOS ONE			English	Article							GRAPH; DISTANCE; PRIORS	We present a novel approach for feature correspondence and multiple structure discovery in computer vision. In contrast to existing methods, we exploit the fact that point-sets on the same structure usually lie close to each other, thus forming clusters in the image. Given a pair of input images, we initially extract points of interest and extract hierarchical representations by agglomerative clustering. We use the maximum weighted clique problem to find the set of corresponding clusters with maximum number of inliers representing the multiple structures at the correct scales. Our method is parameter-free and only needs two sets of points along with their tentative correspondences, thus being extremely easy to use. We demonstrate the effectiveness of our method in multiple-structure fitting experiments in both publicly available and in-house datasets. As shown in the experiments, our approach finds a higher number of structures containing fewer outliers compared to state-of-the-art methods.	[Sanroma, Gerard; Gonzalez Ballester, Miguel Angel] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona 08018, Spain; [Penate-Sanchez, Adrian] UCL, Dept Comp Sci, London WC1E 6BT, England; [Alquezar, Rene; Moreno-Noguer, Francesc; Andrade-Cetto, Juan] Univ Politecn Cataluna, Inst Robot & Informat Ind, E-08028 Barcelona, Spain; [Serratosa, Francesc] Univ Rovira & Virgili, Dept Engn Informat & Matemat, E-43007 Tarragona, Spain; [Gonzalez Ballester, Miguel Angel] ICREA, Barcelona 08010, Spain	Pompeu Fabra University; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut de Robotica i Informatica Industrial (IRII); Universitat Politecnica de Catalunya; Universitat Rovira i Virgili; ICREA	Sanroma, G (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Tanger 122-140, Barcelona 08018, Spain.	gsanroma@gmail.com	Andrade-Cetto, Juan/F-2576-2013; Andrade Cetto, Juan/HCI-2418-2022; Ballester, Miguel Angel Gonzalez/D-1349-2013; Serratosa, Francesc/Q-3359-2019; Andrade-Cetto, Juan/AAA-4131-2020; Ferrer, Miguel A A/L-3863-2013	Andrade-Cetto, Juan/0000-0002-6354-8941; Ballester, Miguel Angel Gonzalez/0000-0002-9227-6826; Serratosa, Francesc/0000-0001-6112-5913; Andrade-Cetto, Juan/0000-0002-6354-8941; Ferrer, Miguel A A/0000-0002-2924-1225; Penate-Sanchez, Adrian/0000-0003-2876-3301	Spanish Ministry of Economy and Competitiveness [DPI-2011-27510, TIN2014-58178-R, TIN2013-47245-C2-2-R, DPI2013-42458-P]; ERA-Net Chistera project [ViSen PCIN-2013-047]; EU [644271]; Marie Curie FP7-PEOPLE-COFUND Action [600387]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); ERA-Net Chistera project; EU(European Commission); Marie Curie FP7-PEOPLE-COFUND Action; ICREA(ICREA)	This work has been partially supported by the Spanish Ministry of Economy and Competitiveness under Project DPI-2011-27510 and the ERA-Net Chistera project ViSen PCIN-2013-047. This work has also been partially supported by EU H2020, Call H2020-ICT-23-2014-1 (RIA) under Project 644271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author is co-financed by the Marie Curie FP7-PEOPLE-2012-COFUND Action. Grant agreement no: 600387 This work has been supported by the Spanish Ministry of Economy and Competitiveness under Projects DPI-2011-27510, TIN2014-58178-R, TIN2013-47245-C2-2-R, DPI2013-42458-P and the ERA-Net Chistera project ViSen PCIN-2013-047. This work has also been partially supported by EU H2020, Call H2020-ICT-23-2014-1 (RIA) under Project 644271	Barrow H. G., 1976, Information Processing Letters, V4, P83, DOI 10.1016/0020-0190(76)90049-1; Chin TJ, 2012, IEEE T PATTERN ANAL, V34, P625, DOI 10.1109/TPAMI.2011.169; Cho M., 2009, ICCV; Du SY, 2010, PATTERN RECOGN LETT, V31, P791, DOI 10.1016/j.patrec.2010.01.020; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Isack H, 2012, INT J COMPUT VISION, V97, P123, DOI 10.1007/s11263-011-0474-7; Kanazawa Y., 2004, BRIT MACH VIS C, P247; Lazic N., 2009, P IEEE 12 INT C COMP; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Moreno-Noguer F, 2008, LECT NOTES COMPUT SC, V5303, P405, DOI 10.1007/978-3-540-88688-4_30; Ostergard P. R. J., 2001, Nordic Journal of Computing, V8, P424; Pelillo M, 1999, IEEE T PATTERN ANAL, V21, P1105, DOI 10.1109/34.809105; Penate-Sanchez A, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.82; Pham T. T., 2011, P C ADV NEUR INF PRO; Pham TT, 2014, IEEE T PATTERN ANAL, V36, P1658, DOI 10.1109/TPAMI.2013.2296310; Ren X., 2003, P 9 IEEE INT C COMP; Sanroma Gerard, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P954, DOI 10.1109/ICPR.2010.239; Sanroma G., 2010, VISAPP; Sanroma G, 2012, PATTERN RECOGN LETT, V33, P2029, DOI 10.1016/j.patrec.2012.04.008; Sanroma G, 2012, COMPUT VIS IMAGE UND, V116, P292, DOI 10.1016/j.cviu.2011.10.009; Sanroma G, 2011, LECT NOTES COMPUT SC, V6658, P142, DOI 10.1007/978-3-642-20844-7_15; Sanroma G, 2010, LECT NOTES COMPUT SC, V6218, P254, DOI 10.1007/978-3-642-14980-1_24; Serradell E, 2010, LECT NOTES COMPUT SC, V6313, P58; Serratosa F, 2007, LECT NOTES COMPUT SC, V4756, P115; Serratosa F, 2006, LECT NOTES COMPUT SC, V4109, P412; Serratosa F, 2008, INT J PATTERN RECOGN, V22, P1539, DOI 10.1142/S0218001408006880; Torsello A, 2003, PATTERN RECOGN LETT, V24, P1089, DOI 10.1016/S0167-8655(02)00255-6; Wong H. S., 2011, INT C COMP VIS ICCV; Wong HS, 2013, PATTERN RECOGN, V46, P257, DOI 10.1016/j.patcog.2012.07.005; Yu J, 2011, PROC CVPR IEEE; Zhang W, 2012, LECT NOTES COMPUT SC, V7572, P428, DOI 10.1007/978-3-642-33718-5_31; Zuliani M, 2005, IEEE IMAGE PROC, P2969	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145846	10.1371/journal.pone.0145846	http://dx.doi.org/10.1371/journal.pone.0145846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766071	Green Published, Green Submitted, gold			2022-12-27	WOS:000368459300009
J	Uddin, R; Sufian, M				Uddin, Reaz; Sufian, Muhammad			Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets	PLOS ONE			English	Article							ESSENTIAL GENES; PAN-GENOME; PROTEIN; HOST; PNEUMONIAE; DYNAMICS; UPDATE	Background Infections caused by Salmonella enterica, a Gram-negative facultative anaerobic bacteria belonging to the family of Enterobacteriaceae, are major threats to the health of humans and animals. The recent availability of complete genome data of pathogenic strains of the S. enterica gives new avenues for the identification of drug targets and drug candidates. We have used the genomic and metabolic pathway data to identify pathways and proteins essential to the pathogen and absent from the host. Methods We took the whole proteome sequence data of 42 strains of S. enterica and Homo sapiens along with KEGG-annotated metabolic pathway data, clustered proteins sequences using CD-HIT, identified essential genes using DEG database and discarded S. enterica homologs of human proteins in unique metabolic pathways (UMPs) and characterized hypothetical proteins with SVM-prot and InterProScan. Through this core proteomic analysis we have identified enzymes essential to the pathogen. Results The identification of 73 enzymes common in 42 strains of S. enterica is the real strength of the current study. We proposed all 73 unexplored enzymes as potential drug targets against the infections caused by the S. enterica. The study is comprehensive around S. enterica and simultaneously considered every possible pathogenic strain of S. enterica. This comprehensiveness turned the current study significant since, to the best of our knowledge it is the first subtractive core proteomic analysis of the unique metabolic pathways applied to any pathogen for the identification of drug targets. We applied extensive computational methods to shortlist few potential drug targets considering the druggability criteria e.g. Non-homologous to the human host, essential to the pathogen and playing significant role in essential metabolic pathways of the pathogen (i.e. S. enterica). In the current study, the subtractive proteomics through a novel approach was applied i.e. by considering only proteins of the unique metabolic pathways of the pathogens and mining the proteomic data of all completely sequenced strains of the pathogen, thus improving the quality and application of the results. We believe that the sharing of the knowledge from this study would eventually lead to bring about novel and unique therapeutic regimens against the infections caused by the S. enterica.	[Uddin, Reaz; Sufian, Muhammad] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan; [Uddin, Reaz] UNSW Australia, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Karachi; University of New South Wales Sydney	Uddin, R (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan.; Uddin, R (corresponding author), UNSW Australia, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia.	mriazuddin@iccs.edu	Sufian, Muhammad/K-4325-2016; Uddin, Reaz/I-5673-2017	Sufian, Muhammad/0000-0001-5944-2506; Uddin, Reaz/0000-0002-9928-4482	International Foundation for Science (IFS) [F/5378-1]; Higher Education Commission of Pakistan	International Foundation for Science (IFS)(International Foundation for Science); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The study was supported by International Foundation for Science (IFS) grant# F/5378-1. The authors would also like to gratefully acknowledge the Higher Education Commission of Pakistan for providing fellowship during the study.	Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Betancor Laura, 2012, Open Microbiol J, V6, P5, DOI 10.2174/1874285801206010005; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Hallam S., 2013, FAST BLAST 2013; Hao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015964; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lilburn TG, 2009, BIOINF SYST BIOL INT; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Mastroeni P, 2013, MICROBES INFECT, V15, P849, DOI 10.1016/j.micinf.2013.10.003; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; NCBI, 2014, NCBI FTP SERV 2014; NCBI, 2013, NCBI FTP SERVER 2013; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; PDB, 2014, RCSB PDB FTP SERVER; Popoff MY, 2003, RES MICROBIOL, V154, P173, DOI 10.1016/S0923-2508(03)00025-1; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ravooru N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00291; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sun JS, 2012, J VET MED SCI, V74, P285, DOI 10.1292/jvms.11-0366; Teh BA, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-7; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Wangdi T, 2012, GUT MICROBES, V3, P88, DOI 10.4161/gmic.18602; Yang L, 2015, P NATL ACAD SCI USA, V112, P10810, DOI 10.1073/pnas.1501384112; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089197	41	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146796	10.1371/journal.pone.0146796	http://dx.doi.org/10.1371/journal.pone.0146796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799565	gold, Green Submitted, Green Published			2022-12-27	WOS:000368655300036
J	Kaluza, J; Donald, RL; Gynther, IC; Leung, LKP; Allen, BL				Kaluza, Janina; Donald, R. Lesley; Gynther, Ian C.; Leung, Luke K-P.; Allen, Benjamin L.			The Distribution and Density of Water Mice (Xeromys myoides) in the Maroochy River of Southeast Queensland, Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITATS; MAMMALS; WORLD	The water mouse is a small and vulnerable rodent present in coastal areas of south-west Papua New Guinea, and eastern Queensland and the Northern Territory of Australia. Current knowledge regarding the distribution of the water mouse is incomplete and the loss of one local population has been documented in southeast Queensland, a region where pressures from urban and industrial development are increasing. Water mouse populations have not been studied intensively enough to enable the primary factors responsible for the local decline to be identified. We surveyed the distribution and density of the water mouse along the Maroochy River of southeast Queensland, near the southern extent of the species' range, to gather baseline data that may prove valuable for detecting any future decline in this population's size or health. All areas of suitable habitat were surveyed on foot or by kayak or boat over a three-year period. We found 180 water mouse nests, of which similar to 94% were active. Permanent camera monitoring of one nest and limited supplementary live trapping suggested that up to three individual mice occupied active nests. Water mouse density was estimated to be 0.44 per hectare of suitable habitat along the Maroochy River. Should future monitoring reveal an adverse change in the water mouse population on the Maroochy River, a concerted effort should be made to identify contributing factors and address proximate reasons for the decline.	[Kaluza, Janina; Leung, Luke K-P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Donald, R. Lesley] Dept Natl Pk Sport & Racing, Queensland Pk & Wildlife Serv, Maroochydore, Qld 4558, Australia; [Gynther, Ian C.] Dept Environm & Heritage Protect, Threatened Species Unit, Bellbowrie, Qld 4070, Australia; [Allen, Benjamin L.] Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia	University of Queensland; University of Southern Queensland	Kaluza, J (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia.	1mightywatermouse@gmail.com	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163; Leung, Luke/0000-0002-8829-4925	Commonwealth Government program 'Caring for Our Country'; Wetland Care Australia	Commonwealth Government program 'Caring for Our Country'; Wetland Care Australia	This project was supported by funds provided by the Commonwealth Government program 'Caring for Our Country', and also the 'Coastal 20' funding program by Wetland Care Australia, which was facilitated by Cheryl Bolzenius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball D, 2006, NZ MARINE SCI SOC RE, V47, P25; Ball Derek, 2004, Memoirs of the Queensland Museum, V49, P487; Benfer D, 2014, AUST J ZOOL, V62, P382, DOI 10.1071/ZO14019; Burnham M, 2000, NEW LOCALITY RECORDS; DERM (2010) National recovery plan for the water mouse (false water rat) Xeromys myoides, 2010, NAT REC WAT MOUS FAL; Duke NC, 2005, MAR POLLUT BULL, V51, P308, DOI 10.1016/j.marpolbul.2004.10.040; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Gynther I., 2008, MAMMALS AUSTR, P664; Higgins A, 2009, J WATER RESOURCE PRO, V4, P237; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; McDonald G, 2006, FUTURE USE SUNSHINE; Rayment GE, 2003, P AUSTR SOC SUGAR CA, V25, P1; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Russell TL, 2009, AUSTR MAMMALOGY, V31; Saintilan N., 2000, WETL AUST, V18, P49, DOI [10.31646/wa.228, DOI 10.1071/MF9880117, DOI 10.31646/WA.228]; Smith RJ, 2008, RIPARIAN WETLAND ARE; Tasker Elizabeth M., 2002, Australian Mammalogy, V23, P77; Van Dyck S, 2006, AUSTR MAMMAL SOC NEW, V65; Van Dyck S., 2012, QUEENSLANDS THREATEN, P408; Van Dyck Steve, 2003, Memoirs of the Queensland Museum, V49, P453; Van Dyck Steve, 1997, Memoirs of the Queensland Museum, V42, P337; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112	24	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146133	10.1371/journal.pone.0146133	http://dx.doi.org/10.1371/journal.pone.0146133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789521	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000368529100025
J	Kenney, WF; Brenner, M; Curtis, JH; Arnold, TE; Schelske, CL				Kenney, William F.; Brenner, Mark; Curtis, Jason H.; Arnold, T. Elliott; Schelske, Claire L.			A Holocene Sediment Record of Phosphorus Accumulation in Shallow Lake Harris, Florida (USA) Offers New Perspectives on Recent Cultural Eutrophication	PLOS ONE			English	Article							CHEMICAL NATURE; ORGANIC-MATTER; VEGETATION; EVOLUTION; CLIMATE; APOPKA	We studied a complete Holocene sediment record from shallow (z(max) = 9.7 m) Lake Harris, Florida (USA) to infer the historical development of the lake and its current eutrophic status. We used Pb-210 and C-14 to date the 5.9-m sediment sequence (core LH-6-13) and determined accumulation rates for bulk sediment, organic matter, calcium carbonate, phosphorus fractions and biogenic silica fractions. The chronology of changes in sediment characteristics for LH-6-13 is consistent with the general paleoenvironmental framework established by core studies from other Florida lakes. Lake Harris began to fill with water in the early Holocene, ca. 10,680 cal a BP. A shift from carbonate-dominated to organic-rich sediments ca. 5,540 cal a BP corresponds to a transition to wetter climate in the middle Holocene. A rapid increase in diatom biogenic silica concentrations and accumulation rates ca. 2,600 cal a BP signals that the lake had deepened to its modern limnetic state. In LH-6-13, an up-core decrease in rates of accumulation for several sediment variables indicates time-course oligotrophication of the lake through the Holocene. In near-surface sediments, abrupt increases in the accumulation rates of these same variables indicate progressive cultural eutrophication after ca. AD 1900. Comparison of the modern state of Lake Harris to its condition 50-100 years ago provides a measure of the impact of recent cultural eutrophication. Because the pre-disturbance trajectory of this lake was one of oligotrophication, the true impact of cultural eutrophication is even greater than what is inferred from the changes over the past century.	[Kenney, William F.] Univ Florida, Land Use & Environm Change Inst, Gainesville, FL 32611 USA; [Brenner, Mark; Curtis, Jason H.; Arnold, T. Elliott; Schelske, Claire L.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kenney, WF (corresponding author), Univ Florida, Land Use & Environm Change Inst, Gainesville, FL 32611 USA.	kenney@ufl.edu			Land Use and Environmental Change Institute at the University of Florida	Land Use and Environmental Change Institute at the University of Florida	This project received no external funding and was funded internally. Funding was provided by the Land Use and Environmental Change Institute at the University of Florida.	APPLEBY PG, 1986, HYDROBIOLOGIA, V143, P21, DOI 10.1007/BF00026640; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brenner M, 2006, J PALEOLIMNOL, V35, P129, DOI 10.1007/s10933-005-7881-0; Brenner M, 1996, HYDROBIOLOGIA, V331, P143, DOI 10.1007/BF00025415; Brenner M, 1995, LAKE RESERV MANAGE, V11, P255; CONLEY DJ, 1993, CAN J FISH AQUAT SCI, V50, P296, DOI 10.1139/f93-034; Danek LJ, 1991, BATHYMETRIC SEDIMENT; DAVIS MB, 1982, LIMNOL OCEANOGR, V27, P137, DOI 10.4319/lo.1982.27.1.0137; Donar C, 2009, NOVA HEDWIGIA, P57; ENGLEMAN EE, 1985, CHEM GEOL, V53, P125, DOI 10.1016/0009-2541(85)90025-7; Engstrom DR, 2000, NATURE, V408, P161, DOI 10.1038/35041500; [FDEP] Florida Department of Environmental Protection, 2001, BAS STAT REP; Fisher M.M., 1992, J PALEOLIMNOL, V7, P157; Fritz SC, 2004, HOLOCENE, V14, P828, DOI 10.1191/0959683604hl763rp; Fulton RS, 2008, LAKE RESERV MANAGE, V24, P139, DOI 10.1080/07438140809354057; Ginn BK, 2012, J GREAT LAKES RES, V38, P825, DOI 10.1016/j.jglr.2012.09.002; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Grimm EC, 2006, QUATERNARY SCI REV, V25, P2197, DOI 10.1016/j.quascirev.2006.04.008; Kenney WF, 2002, J PALEOLIMNOL, V27, P367, DOI 10.1023/A:1016075012581; Kenney WF, 2001, CAN J FISH AQUAT SCI, V58, P879, DOI 10.1139/cjfas-58-5-879; Kenney WF, 2016, ECOL INDIC, V60, P963, DOI 10.1016/j.ecolind.2015.08.046; Kenney WF, 2015, AQUAT GEOCHEM, V21, P1, DOI 10.1007/s10498-014-9241-z; Kenney WF, 2010, J PALEOLIMNOL, V44, P1039, DOI 10.1007/s10933-010-9472-y; Oldfield F., 1984, LAKE SEDIMENTS ENV H, P93; Riedinger-Whitmore MA, 2005, LAKE RESERV MANAGE, V21, P423, DOI 10.1080/07438140509354447; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; SCHELSKE CL, 1986, HYDROBIOLOGIA, V143, P79, DOI 10.1007/BF00026648; Schottler SP, 2006, J PALEOLIMNOL, V36, P19, DOI 10.1007/s10933-006-0007-5; Smith VH, 2014, LIMNOL OCEANOGR, V59, P2217, DOI 10.4319/lo.2014.59.6.2217; Torres IC, 2014, AQUAT GEOCHEM, V20, P437, DOI 10.1007/s10498-014-9228-9; Turner BL, 2015, AQUAT GEOCHEM, V21, P7, DOI 10.1007/s10498-014-9242-y; VOLLENWEIDER R A, 1975, Schweizerische Zeitschrift fuer Hydrologie, V37, P53, DOI 10.1007/BF02505178; Waters MN, 2005, J PALEOLIMNOL, V33, P53, DOI 10.1007/s10933-004-1691-7; WATTS WA, 1992, ECOLOGY, V73, P1056, DOI 10.2307/1940180; WATTS WA, 1975, GEOLOGY, V3, P344, DOI 10.1130/0091-7613(1975)3<344:ALQROV>2.0.CO;2; WATTS WA, 1969, GEOL SOC AM BULL, V80, P631, DOI 10.1130/0016-7606(1969)80[631:APDFML]2.0.CO;2; WATTS WA, 1980, SCIENCE, V210, P325, DOI 10.1126/science.210.4467.325; WATTS WA, 1980, ANNU REV ECOL SYST, V11, P387, DOI 10.1146/annurev.es.11.110180.002131; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; Whitmore TJ, 2006, J PALEOLIMNOL, V36, P353, DOI 10.1007/s10933-006-9000-2	41	11	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147331	10.1371/journal.pone.0147331	http://dx.doi.org/10.1371/journal.pone.0147331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789518	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100081
J	Lee, SI; Yi, JK; Bae, WJ; Lee, S; Cha, HJ; Kim, EC				Lee, Sang-Im; Yi, Jin-Kyu; Bae, Won-Jung; Lee, Soojung; Cha, Hee-Jae; Kim, Eun-Cheol			Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells	PLOS ONE			English	Article							NF-KAPPA-B; CREVICULAR FLUID LEVELS; REACTIVE OXYGEN; EXPRESSION; TISSUE; NICOTINE; RANKL; GENE; ACTIVATION; IMPAIRMENT	Background Recent reports suggest that thymosin beta-4 (T beta 4) is a key regulator for wound healing and anti-inflammation. However, the role of T beta 4 in osteoclast differentiation remains unclear. Purpose The purpose of this study was to evaluate T beta 4 expression in H2O2-stimulated human periodontal ligament cells (PDLCs), the effects of T beta 4 activation on inflammatory response in PDLCs and osteoclastic differentiation in mouse bone marrow-derived macrophages (BMMs), and identify the underlying mechanism. Methods Reverse transcription-polymerase chain reactions and Western blot analyses were used to measure mRNA and protein levels, respectively. Osteoclastic differentiation was assessed in mouse bone marrow-derived macrophages (BMMs) using conditioned medium (CM) from H2O2-treated PDLCs. Results T beta 4 was down-regulated in H2O2-exposed PDLCs in dose-and time-dependent manners. T beta 4 activation with a T beta 4 peptide attenuated the H2O2-induced production of NO and PGE(2) and up-regulated iNOS, COX-2, and osteoclastogenic cytokines (TNF-alpha, IL-1 beta, IL-6, IL-8, and IL-17) as well as reversed the effect on RANKL and OPG in PDLCs. T beta 4 peptide inhibited the effects of H2O2 on the activation of ERK and JNK MAPK, and NF-kappa B in PDLCs. Furthermore, T beta 4 peptide inhibited osteoclast differentiation, osteoclast-specific gene expression, and p38, ERK, and JNK phosphorylation and NF-kappa B activation in RANKL-stimulated BMMs. In addition, H2O2 up-regulated Wnt5a and its cell surface receptors, Frizzled and Ror2 in PDLCs. Wnt5a inhibition by Wnt5a siRNA enhanced the effects of T beta 4 on H2O2-mediated induction of pro-inflammatory cytokines and osteoclastogenic cytokines as well as helping osteoclastic differentiation whereas Wnt5a activation by Wnt5a peptide reversed it. Conclusion In conclusion, this study demonstrated, for the first time, that T beta 4 was down-regulated in ROS-stimulated PDLCs as well as T beta 4 activation exhibited anti-inflammatory effects and anti-osteoclastogenesis in vitro. Thus, T beta 4 activation might be a therapeutic target for inflammatory osteolytic disease, such as periodontitis.	Dankook Univ, Sch Hlth Sci, Dept Dent Hyg, Cheonan, South Korea; [Yi, Jin-Kyu] Kyung Hee Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea; [Bae, Won-Jung; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea; [Bae, Won-Jung; Kim, Eun-Cheol] Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Regenerat MRC, Seoul, South Korea; [Lee, Soojung] Kyung Hee Univ, Sch Dent, Dept Oral Physiol, Seoul, South Korea; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Busan, South Korea	Dankook University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, EC (corresponding author), Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Pathol, Seoul, South Korea.; Kim, EC (corresponding author), Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Regenerat MRC, Seoul, South Korea.	eckim@khu.ac.kr	Cha, Hee-Jae/AFO-8772-2022		National Research Foundation of Korea (NRF) - Korea government (MEST) [2012R1A5A2051384]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2012R1A5A2051384).	Abe D, 2011, J PERIODONTAL RES, V46, P345, DOI 10.1111/j.1600-0765.2011.01349.x; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Bao WK, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00149; Bolzoni M, 2013, LEUKEMIA, V27, P451, DOI 10.1038/leu.2012.190; Bostanci N, 2007, J CLIN PERIODONTOL, V34, P370, DOI 10.1111/j.1600-051X.2007.01061.x; Canakci CF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P619, DOI 10.1007/s10541-005-0161-9; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chen B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731039; Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144; Choi BD, 2012, INT J MOL MED, V29, P841, DOI 10.3892/ijmm.2012.913; Conte E, 2012, ANN NY ACAD SCI, V1269, P69, DOI 10.1111/j.1749-6632.2012.06694.x; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Frohm M, 1996, EUR J BIOCHEM, V237, P86, DOI 10.1111/j.1432-1033.1996.0086n.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193; Golz L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/986264; GOLDSTEI.AL, 1966, P NATL ACAD SCI USA, V56, P1010, DOI 10.1073/pnas.56.3.1010; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; HALL TJ, 1995, BIOCHEM BIOPH RES CO, V207, P280, DOI 10.1006/bbrc.1995.1184; HANNAPPEL E, 1987, J CHROMATOGR, V397, P279, DOI 10.1016/S0021-9673(01)85010-X; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Ho JHC, 2007, INVEST OPHTH VIS SCI, V48, P27, DOI 10.1167/iovs.06-0826; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Kwon E, 2013, J ADV ORAL RES, V4, P1; Lee HJ, 2009, J PERIODONTOL, V80, P1281, DOI 10.1902/jop.2009.090098; Lee SI, 2014, J DENT RES, V93, P678, DOI 10.1177/0022034514535214; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; Lee SK, 2013, J CELL BIOCHEM, V114, P1183, DOI 10.1002/jcb.24461; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuo K, 2012, OR SURG OR MED OR PA, V114, P17, DOI 10.1016/j.tripleo.2011.05.025; Moseley R, 1998, CONNECT TISSUE RES, V37, P13, DOI 10.3109/03008209809028897; Nachmias VT, 1993, CURR OPIN CELL BIOL, V5, P56, DOI 10.1016/S0955-0674(05)80008-0; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Philp D, 2004, MECH AGEING DEV, V125, P113, DOI 10.1016/j.mad.2003.11.005; Philp D, 2007, ANN NY ACAD SCI, V1112, P95, DOI 10.1196/annals.1415.009; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.3.CO;2-C; SHIMAMURA R, 1990, BLOOD, V76, P977; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Vattakuzhi Y, 2012, ARTHRITIS RHEUM-US, V64, P2201, DOI 10.1002/art.34403; Waddington RJ, 2000, ORAL DIS, V6, P138; Yamaza H, 2001, INT J DEV BIOL, V45, P675; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Yuan HW, 2010, INVEST OPHTH VIS SCI, V51, P2424, DOI 10.1167/iovs.09-3692; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523; Zhu TT, 2014, INT J MOL MED, V34, P816, DOI 10.3892/ijmm.2014.1832	62	21	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0146708	10.1371/journal.pone.0146708	http://dx.doi.org/10.1371/journal.pone.0146708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789270	Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100037
J	Weingarden, AR; Dosa, PI; DeWinter, E; Steer, CJ; Shaughnessy, MK; Johnson, JR; Khoruts, A; Sadowsky, MJ				Weingarden, Alexa R.; Dosa, Peter I.; DeWinter, Erin; Steer, Clifford J.; Shaughnessy, Megan K.; Johnson, James R.; Khoruts, Alexander; Sadowsky, Michael J.			Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth	PLOS ONE			English	Article							SPORE GERMINATION; PATHOGENICITY LOCUS; INFECTION; EPIDEMIOLOGY; POLYMORPHISM; STRAIN; SALTS	Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (R-CDI), but its mechanisms remain poorly understood. Emerging evidence suggests that gut bile acids have significant influence on the physiology of C. difficile, and therefore on patient susceptibility to recurrent infection. We analyzed spore germination of 10 clinical C. difficile isolates exposed to combinations of bile acids present in patient feces before and after FMT. Bile acids at concentrations found in patients' feces prior to FMT induced germination of C. difficile, although with variable potency across different strains. However, bile acids at concentrations found in patients after FMT did not induce germination and inhibited vegetative growth of all C. difficile strains. Sequencing of the newly identified germinant receptor in C. difficile, CspC, revealed a possible correspondence of variation in germination responses across isolates with mutations in this receptor. This may be related to interstrain variability in spore germination and vegetative growth in response to bile acids seen in this and other studies. These results support the idea that intra-colonic bile acids play a key mechanistic role in the success of FMT, and suggests that novel therapeutic alternatives for treatment of R-CDI may be developed by targeted manipulation of bile acid composition in the colon.	[Weingarden, Alexa R.] Univ Minnesota, Dept Microbiol & Immunol, St Paul, MN 55108 USA; [Weingarden, Alexa R.; DeWinter, Erin; Khoruts, Alexander; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Dosa, Peter I.] Univ Minnesota, Dept Med Chem, Inst Therapeut Discovery & Dev, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Shaughnessy, Megan K.; Johnson, James R.] Univ Minnesota, Dept Med, Div Infect Dis, Box 736 UMHC, Minneapolis, MN 55455 USA; [Shaughnessy, Megan K.; Johnson, James R.] Minneapolis Vet Affairs VA Healthcare Syst, Div Infect Dis, Minneapolis, MN USA; [Khoruts, Alexander] Univ Minnesota, Dept Med, Div Gastroenterol, Box 736 UMHC, Minneapolis, MN 55455 USA; [Khoruts, Alexander] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sadowsky, MJ (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.; Sadowsky, MJ (corresponding author), Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA.	Sadowsky@umn.edu	Sadowsky, Michael/J-2507-2016; Khoruts, Alexander/ABF-5119-2020	Sadowsky, Michael/0000-0001-8779-2781; Khoruts, Alexander/0000-0002-3205-3188; Dosa, Peter/0000-0002-0081-3867; Weingarden, Alexa/0000-0002-1567-1320	NIH [1R21-AI114722-01, UL1TR00114]; NIAID [R21AI-091907]; National Center for Allergy and Infectious Diseases [2T32AI055433-06A1]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091907, T32AI055433, R21AI114722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Allergy and Infectious Diseases; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant 1R21-AI114722-01 (AK, MJS, CC) and NIH Training Grant UL1TR00114 to University of Minnesota CTSI (ARW). Research reported in this publication was also supported, in part, by NIAID Grant R21AI-091907 (AK and MJS). MKS was supported by training grant award 2T32AI055433-06A1 from the National Center for Allergy and Infectious Diseases and the Office of Research and Development, Medical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Arroyo LG, 2005, J CLIN MICROBIOL, V43, P5341, DOI 10.1128/JCM.43.10.5341-5343.2005; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Khoruts A, 2015, CLIN GASTROENTEROL H, V13, P246, DOI 10.1016/j.cgh.2014.11.014; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Koenigsknecht MJ, 2015, INFECT IMMUN, V83, P934, DOI 10.1128/IAI.02768-14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; MOIR A, 1990, ANNU REV MICROBIOL, V44, P531, DOI 10.1146/annurev.mi.44.100190.002531; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Shankar V, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-13; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Surawicz CM, 2011, NAT REV GASTRO HEPAT, V8, P330, DOI 10.1038/nrgastro.2011.59; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135	44	109	113	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147210	10.1371/journal.pone.0147210	http://dx.doi.org/10.1371/journal.pone.0147210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789728	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100069
J	Basso, B; Giola, P; Dumont, B; Migliorati, MD; Cammarano, D; Pruneddu, G; Giunta, F				Basso, Bruno; Giola, Pietro; Dumont, Benjamin; Migliorati, Massimiliano De Antoni; Cammarano, Davide; Pruneddu, Giovanni; Giunta, Francesco			Tradeoffs between Maize Silage Yield and Nitrate Leaching in a Mediterranean Nitrate-Vulnerable Zone under Current and Projected Climate Scenarios	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; CROPPING SYSTEM; SOIL CARBON; WHEAT; MANAGEMENT; MODEL; AGRICULTURE; FERTILIZER; TILLAGE; SLURRY	Future climatic changes may have profound impacts on cropping systems and affect the agronomic and environmental sustainability of current N management practices. The objectives of this work were to i) evaluate the ability of the SALUS crop model to reproduce experimental crop yield and soil nitrate dynamics results under different N fertilizer treatments in a farmer's field, ii) use the SALUS model to estimate the impacts of different N fertilizer treatments on NO3- leaching under future climate scenarios generated by twenty nine different global circulation models, and iii) identify the management system that best minimizes NO3- leaching and maximizes yield under projected future climate conditions. A field experiment (maize-triticale rotation) was conducted in a nitrate vulnerable zone on the west coast of Sardinia, Italy to evaluate N management strategies that include urea fertilization (NMIN), conventional fertilization with dairy slurry and urea (CONV), and no fertilization (N0). An ensemble of 29 global circulation models (GCM) was used to simulate different climate scenarios for two Representative Circulation Pathways (RCP6.0 and RCP8.5) and evaluate potential nitrate leaching and biomass production in this region over the next 50 years. Data collected from two growing seasons showed that the SALUS model adequately simulated both nitrate leaching and crop yield, with a relative error that ranged between 0.4% and 13%. Nitrate losses under RCP8.5 were lower than under RCP6.0 only for NMIN. Accordingly, levels of plant N uptake, N use efficiency and biomass production were higher under RCP8.5 than RCP6.0. Simulations under both RCP scenarios indicated that the NMIN treatment demonstrated both the highest biomass production and NO3- losses. The newly proposed best management practice (BMP), developed from crop N uptake data, was identified as the optimal N fertilizer management practice since it minimized NO3- leaching and maximized biomass production over the long term.	[Basso, Bruno; Dumont, Benjamin] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Basso, Bruno; Dumont, Benjamin] Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA; [Giola, Pietro; Pruneddu, Giovanni; Giunta, Francesco] Univ Sassari, Dipartimento Agr, Sez Sci Agron Coltivaz Erbacee & Genet SACEG, I-07100 Sassari, Italy; [Migliorati, Massimiliano De Antoni] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Cammarano, Davide] James Hutton Inst, Dundee DD2 5DA, Scotland	Michigan State University; Michigan State University; University of Sassari; Queensland University of Technology (QUT); James Hutton Institute	Basso, B (corresponding author), Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA.; Basso, B (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA.	basso@msu.edu	Basso, Bruno/AAF-1271-2019; Cammarano, Davide/CAF-3057-2022	Basso, Bruno/0000-0003-2090-4616; De Antoni Migliorati, Massimiliano/0000-0002-5651-5834; Dumont, Benjamin/0000-0001-8411-3990; Cammarano, Davide/0000-0003-0918-550X	Sardinian Regional Authorities (P.O.R. Sardegna F.S.E.); USDA NIFA Award [2015-68007-23133, 2011-68002-30190]	Sardinian Regional Authorities (P.O.R. Sardegna F.S.E.); USDA NIFA Award	This work has been partly supported by the Sardinian Regional Authorities (P.O.R. Sardegna F.S.E. 2007-2013) and USDA NIFA Award no. 2015-68007-23133 and 2011-68002-30190. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus JF, 2001, AUST J EXP AGR, V41, P277, DOI 10.1071/EA00141; Basso B, 2005, AGR ECOSYST ENVIRON, V108, P329, DOI 10.1016/j.agee.2005.01.011; Basso B., 2015, ECOLOGY AGR LANDSCAP, P252; Basso B, 2007, EUR J AGRON, V26, P82, DOI 10.1016/j.eja.2006.08.008; Basso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127333; Basso B, 2012, BIOSYST ENG, V113, P103, DOI 10.1016/j.biosystemseng.2012.06.012; Basso B, 2011, EUR J AGRON, V35, P215, DOI 10.1016/j.eja.2011.06.004; Basso B, 2011, EUR J AGRON, V35, P83, DOI 10.1016/j.eja.2011.04.002; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Carneiro JP, 2012, AGR ECOSYST ENVIRON, V160, P29, DOI 10.1016/j.agee.2011.09.001; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cau P, 2007, HYDROL EARTH SYST SC, V4, P747, DOI DOI 10.5194/HESSD-4-747-2007; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Cubasch U., 2013, CLIMATE CHANGE 2013; Dauden A, 2004, EUR J AGRON, V21, P7, DOI 10.1016/S1161-0301(03)00056-X; Duan YH, 2014, FIELD CROP RES, V157, P47, DOI 10.1016/j.fcr.2013.12.012; Dumont B, 2015, EUR J AGRON, V65, P10, DOI 10.1016/j.eja.2015.01.003; Dzotsi KA, 2015, AGR SYST, V135, P31, DOI 10.1016/j.agsy.2014.12.003; Dzotsi KA, 2013, ECOL MODEL, V260, P62, DOI 10.1016/j.ecolmodel.2013.03.017; Edenhofer O., 2014, CONTRIBUTION WORKING; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; FOX RH, 1978, SOIL SCI SOC AM J, V42, P751, DOI 10.2136/sssaj1978.03615995004200050019x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Giola P, 2012, EUR J AGRON, V38, P43, DOI 10.1016/j.eja.2011.12.001; HENZELL E. F., 1968, Transactions. 9th int. Congr. Soil Sci., Adelaide, 1968, V3, P513; INDORANTE SJ, 1990, SOIL SCI SOC AM J, V54, P560, DOI 10.2136/sssaj1990.03615995005400020047x; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Jones J. W., 1998, Understanding options for agricultural production., P157; Kolberg RL, 1996, J PROD AGRIC, V9, P517, DOI 10.2134/jpa1996.0517; LECLERC B, 1995, BIOL AGRIC HORTIC, V11, P301, DOI 10.1080/01448765.1995.9754714; Ludwig B, 2011, J PLANT NUTR SOIL SC, V174, P350, DOI 10.1002/jpln.201000040; Michalczyk A, 2014, NUTR CYCL AGROECOSYS, V98, P203, DOI 10.1007/s10705-014-9606-0; MOSHREFI N, 1993, SOIL SCI, V155, P245, DOI 10.1097/00010694-199304000-00002; NORWOOD CA, 1990, J PROD AGRIC, V3, P356, DOI 10.2134/jpa1990.0356; OLeary GJ, 1996, AGR SYST, V52, P31, DOI 10.1016/0308-521X(96)00002-9; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Raper SCB, 2001, CLIM DYNAM, V17, P601, DOI 10.1007/PL00007931; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Rode M, 2008, WATER SA, V34, P490; Salazar F, 2012, AGR ECOSYST ENVIRON, V160, P23, DOI 10.1016/j.agee.2012.04.018; Sanchez JE, 2004, AGRON J, V96, P769, DOI 10.2134/agronj2004.0769; Saseendran SA, 2004, AGRON J, V96, P615, DOI 10.2134/agronj2004.0615; Senthilkumar S, 2009, SOIL SCI SOC AM J, V73, P2078, DOI 10.2136/sssaj2009.0044; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Tafteh A, 2012, INT J PLANT PROD, V6, P93; van der Laan M, 2014, AGR WATER MANAGE, V133, P74, DOI 10.1016/j.agwat.2013.10.017; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Velthof GL, 2009, J ENVIRON QUAL, V38, P402, DOI 10.2134/jeq2008.0108; Volk M, 2009, LAND USE POLICY, V26, P580, DOI 10.1016/j.landusepol.2008.08.005; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Whetton P. H., 2005, AUSTR CLIMATE CHANGE; Zavattaro L, 2012, AGR ECOSYST ENVIRON, V147, P24, DOI 10.1016/j.agee.2011.05.020; Zhou MH, 2014, PLANT SOIL, V374, P977, DOI 10.1007/s11104-013-1876-9; Zhou MH, 2012, ENVIRON POLLUT, V162, P361, DOI 10.1016/j.envpol.2011.12.001	58	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146360	10.1371/journal.pone.0146360	http://dx.doi.org/10.1371/journal.pone.0146360			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784113	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400032
J	Tyx, RE; Stanfill, SB; Keong, LM; Rivera, AJ; Satten, GA; Watson, CH				Tyx, Robert E.; Stanfill, Stephen B.; Keong, Lisa M.; Rivera, Angel J.; Satten, Glen A.; Watson, Clifford H.			Characterization of Bacterial Communities in Selected Smokeless Tobacco Products Using 16S rDNA Analysis	PLOS ONE			English	Article							NITRATE REDUCTION; TOTAL NICOTINE; UNITED-STATES; SWEDISH SNUS; NITRITE; SILVA; CORYNEBACTERIUM; NITROSAMINES; RESPIRATION; METABOLISM	The bacterial communities present in smokeless tobacco (ST) products have not previously reported. In this study, we used Next Generation Sequencing to study the bacteria present in U.S.-made dry snuff, moist snuff and Sudanese toombak. Sample diversity and taxonomic abundances were investigated in these products. A total of 33 bacterial families from four phyla, Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes, were identified. U.S.-produced dry snuff products contained a diverse distribution of all four phyla. Moist snuff products were dominated by Firmicutes. Toombak samples contained mainly Actinobacteria and Firmicutes (Aerococcaceae, Enterococcaceae, and Staphylococcaceae). The program PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) was used to impute the prevalence of genes encoding selected bacterial toxins, antibiotic resistance genes and other pro-inflammatory molecules. PICRUSt also predicted the presence of specific nitrate reductase genes, whose products can contribute to the formation of carcinogenic nitrosamines. Characterization of microbial community abundances and their associated genomes gives us an indication of the presence or absence of pathways of interest and can be used as a foundation for further investigation into the unique microbiological and chemical environments of smokeless tobacco products.	[Tyx, Robert E.; Stanfill, Stephen B.; Keong, Lisa M.; Rivera, Angel J.; Watson, Clifford H.] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA; [Satten, Glen A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Rivera, Angel J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Keong, Lisa M.] Battelle Analyt Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Tyx, RE (corresponding author), Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA.	wyu3@cdc.gov	Rivera, Ángel/GRJ-2093-2022; Rivera, Angel J/ABF-3918-2021	Rivera, Angel J/0000-0002-0715-6273; Tyx, Robert/0000-0002-7514-9286	Battelle Analytical Services; U.S. Centers for Disease control and Prevention	Battelle Analytical Services; U.S. Centers for Disease control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Battelle Analytical Services, through a contract with U.S. Centers for Disease control and Prevention, provided support in the form of salaries for authors (LMK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN RA, 1991, J AGR FOOD CHEM, V39, P1280, DOI 10.1021/jf00007a017; Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Bernard KA, 2010, INT J SYST EVOL MICR, V60, P874, DOI 10.1099/ijs.0.012641-0; Bokulich NA, 2012, PLOS ONE, V7; Borgerding MF, 2012, REGUL TOXICOL PHARM, V64, P367, DOI 10.1016/j.yrtph.2012.09.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Control and Prevention, 2019, OV CANC STAT; COCKRELL W T JR, 1989, Tobacco Science, V33, P55; Darwin A.J., 1996, REGULATION GENE EXPR, P343; Di Giacomo M, 2007, APPL ENVIRON MICROB, V73, P825, DOI 10.1128/AEM.02378-06; Fast B, 1996, ARCH MICROBIOL, V166, P361, DOI 10.1007/BF01682980; Fisher MT, 2012, FOOD CHEM TOXICOL, V50, P942, DOI 10.1016/j.fct.2011.11.035; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hartig E, 1999, J BACTERIOL, V181, P3658; Hempfling WPBG, 2004, METHOD REDUCTION TOB; Huang JW, 2010, APPL MICROBIOL BIOT, V88, P553, DOI 10.1007/s00253-010-2763-4; IARC, 2007, SMOK TOB SOM TOB SPE; IDRIS AM, 1991, CARCINOGENESIS, V12, P1115, DOI 10.1093/carcin/12.6.1115; Idris AM, 1998, ORAL ONCOL, V34, P558, DOI 10.1016/S1368-8375(98)00047-5; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsson Lennart, 2008, Tob Induc Dis, V4, P4, DOI 10.1186/1617-9625-4-4; Lawler TS, 2013, FOOD CHEM TOXICOL, V57, P380, DOI 10.1016/j.fct.2013.03.011; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; Mainar MS, 2015, INT J FOOD MICROBIOL, V212, P60, DOI 10.1016/j.ijfoodmicro.2015.03.009; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Richter P, 2008, NICOTINE TOB RES, V10, P1645, DOI 10.1080/14622200802412937; Rickert WS, 2009, REGUL TOXICOL PHARM, V53, P121, DOI 10.1016/j.yrtph.2008.12.004; ROWE JJ, 1994, MOL MICROBIOL, V12, P579, DOI 10.1111/j.1365-2958.1994.tb01044.x; Rubinstein I, 2002, CLIN DIAGN LAB IMMUN, V9, P1057, DOI 10.1128/CDLI.9.5.1057-1060.2002; Rutqvist LE, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-11; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; SPIEGELHALDER B, 1991, CRIT REV TOXICOL, V21, P241, DOI 10.3109/10408449109017911; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Su C, 2011, APPL MICROBIOL BIOT, V92, P1033, DOI 10.1007/s00253-011-3367-3; Vigliotta G, 2007, APPL MICROBIOL BIOT, V75, P633, DOI 10.1007/s00253-007-0867-2; Wahlberg I, 1999, AGRO FOOD IND HI TEC, V10, P23; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zakiullah, 2012, TOB CONTROL, V21, P396, DOI 10.1136/tc.2010.042630; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Zitomer N, 2015, J AGR FOOD CHEM	52	45	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146939	10.1371/journal.pone.0146939	http://dx.doi.org/10.1371/journal.pone.0146939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26784944	Green Published, Green Submitted, gold			2022-12-27	WOS:000368528400081
J	Nanavaty, V; Lama, R; Sandhu, R; Zhong, B; Kulman, D; Bobba, V; Zhao, AR; Li, BB; Su, B				Nanavaty, Vishal; Lama, Rati; Sandhu, Ranjodh; Zhong, Bo; Kulman, Daniel; Bobba, Viharika; Zhao, Anran; Li, Bibo; Su, Bin			Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents	PLOS ONE			English	Article							ANTITRYPANOSOMAL AGENTS; SLEEPING SICKNESS; BRUCEI; IDENTIFICATION	Objectives There is an urgent need to develop a safe, effective, orally active, and inexpensive therapy for African trypanosomiasis due to the drawbacks of current drugs. Selective tubulin inhibitors have the potential to be promising drug candidates for the treatment of this disease, which is based on the tubulin protein structural difference between mammalian and trypanosome cells. We propose to identify novel tubulin inhibitors from a compound library developed based on the lead compounds that selectively target trypanosomiasis. Methods We used Trypanosoma brucei brucei as the parasite model, and human normal kidney cells and mouse microphage cells as the host model. Growth rates of both trypanosomes and mammalian cells were determined as a means to screen compounds that selectively inhibit the proliferation of parasites. Furthermore, we examined the cell cycle profile of the parasite and compared tubulin polymerization dynamics before and after the treatment using identified compounds. Last, in vivo anti-parasite activities of these compounds were determined in T. brucei-infected mice. Results Three compounds were selected that are 100 fold more effective against the growth of T. brucei cells than mammalian cells. These compounds caused cell cycle progression defects in T. brucei cells. Western analyses indicated that these compounds decreased tubulin polymerization in T. brucei cells. The in vivo investigation revealed that these compounds, when admitted orally, inhibited T. brucei cell proliferation in mouse blood. However, they were not potent enough to clear up the infection completely. Conclusions These compounds are promising lead compounds as orally active agents for drug development of anti-trypanosome agents. A more detail structure activity relationship (SAR) was summarized that will be used to guide future lead optimization to improve the selectivity and potency of the current compounds.	[Nanavaty, Vishal; Sandhu, Ranjodh; Kulman, Daniel; Li, Bibo] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Biol Geo & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Lama, Rati; Zhong, Bo; Bobba, Viharika; Zhao, Anran; Su, Bin] Cleveland State Univ, Coll Sci & Hlth Profess, Dept Chem, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Li, Bibo; Su, Bin] Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Li, BB (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Dept Biol Geo & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Su, B (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Dept Chem, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Li, BB; Su, B (corresponding author), Cleveland State Univ, Coll Sci & Hlth Profess, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	b.li37@csuohio.edu; B.su@csuohio.edu	Bobba, Viharika/GLT-9560-2022; Sandhu, Ranjodh/AAN-5645-2020	Bobba, Viharika/0000-0003-3958-9388; Nanavaty, Vishal/0000-0001-7946-8076; Sandhu, Ranjodh/0000-0002-6459-7542	National Institutes of Health [R15AI 103889]; McNair scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI103889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant R15AI 103889 (B. Su) from National Institutes of Health, http://www.nih.gov/, and Daniel Kulman was supported by a McNair scholarship.	Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Frankish H, 2003, LANCET, V362, P135, DOI 10.1016/S0140-6736(03)13900-1; Gudin S, 2006, EXP PARASITOL, V114, P118, DOI 10.1016/j.exppara.2006.02.018; Gull K, 2002, CURR PHARM DESIGN, V8, P241, DOI 10.2174/1381612023396212; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Heald R, 2002, J CELL SCI, V115, P3; Issa VS, 2010, LANCET, V376, P768, DOI 10.1016/S0140-6736(10)61372-4; Kuppens IELM, 2006, CURR CLIN PHARMACOL, V1, P57, DOI 10.2174/157488406775268200; Lama R, 2012, BIOORG MED CHEM LETT, V22, P5508, DOI 10.1016/j.bmcl.2012.07.023; OKUNO M, 1981, J CELL BIOL, V91, P689, DOI 10.1083/jcb.91.3.689; Steverding D, 2005, EXPERT OPIN INV DRUG, V14, P939, DOI 10.1517/13543784.14.8.939; Werbovetz KA, 2003, MOL PHARMACOL, V64, P1325, DOI 10.1124/mol.64.6.1325; Werbovetz KA, 2002, MINI-REV MED CHEM, V2, P519, DOI 10.2174/1389557023405648; Yi X, 2012, J MED CHEM, V55, P3425, DOI 10.1021/jm300100d; Zhong B, 2014, EUR J MED CHEM, V80, P243, DOI 10.1016/j.ejmech.2014.04.038; Zhong B, 2013, J MED CHEM, V56, P5306, DOI 10.1021/jm4004736	19	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146289	10.1371/journal.pone.0146289	http://dx.doi.org/10.1371/journal.pone.0146289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771307	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300012
J	Naouar, I; Boussoffara, T; Chenik, M; Gritli, S; Ben Ahmed, M; Hmida, NB; Bahi-Jaber, N; Bardi, R; Gorgi, Y; Ben Salah, A; Louzir, H				Naouar, Ikbel; Boussoffara, Thouraya; Chenik, Mehdi; Gritli, Sami; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Bahi-Jaber, Narges; Bardi, Rafika; Gorgi, Yousr; Ben Salah, Afif; Louzir, Hechmi			Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production	PLOS ONE			English	Article							IN-VITRO; INFECTED MACROPHAGES; MEDIATED-IMMUNITY; ANTIGEN; ELONGATION; PEPTIDE; CYTOTOXICITY; DONOVANI; MUCOSAL; RESPONSES	Leishmania-specific cytotoxic T cell response is part of the acquired immune response developed against the parasite and contributes to resistance to reinfection. Herein, we have used an immune-informatic approach for the identification, among Leishmania major potentially excreted/secreted proteins previously described, those generating peptides that could be targeted by the cytotoxic immune response. Seventy-eight nonameric peptides that are predicted to be loaded by HLA-A*0201 molecule were generated and their binding capacity to HLA-A2 was evaluated. These peptides were grouped into 20 pools and their immunogenicity was evaluated by in vitro stimulation of peripheral blood mononuclear cells from HLA-A(2+)-immune individuals with a history of zoonotic cutaneous leishmaniasis. Six peptides were identified according to their ability to elicit production of granzyme B. Furthermore, among these peptides 3 showed highest affinity to HLA-A*0201, one derived from an elongation factor 1-alpha and two from an unknown protein. These proteins could constitute potential vaccine candidates against leishmaniasis.	[Naouar, Ikbel; Boussoffara, Thouraya; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Bahi-Jaber, Narges; Ben Salah, Afif; Louzir, Hechmi] Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11 PT, Tunis, Tunisia; [Naouar, Ikbel; Boussoffara, Thouraya; Chenik, Mehdi; Ben Ahmed, Melika; Hmida, Nabil Belhadj; Ben Salah, Afif; Louzir, Hechmi] Univ Tunis El Manar, Tunis, Tunisia; [Chenik, Mehdi] Pasteur Inst Tunis, Lab Med Parasitol Biotechnol & Biomol, LR11-IPT-06, Tunis, Tunisia; [Gritli, Sami] Charles Nicolle Hosp, Dept Pathol, Tunis, Tunisia; [Gritli, Sami] Fac Med Tunis, Tunis, Tunisia; [Bahi-Jaber, Narges] UPSP EGEAL Inst Polytech LaSalle Beauvais, Beauvais, France; [Bardi, Rafika; Gorgi, Yousr] Charles Nicolle Hosp, Immunol Lab, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Hopital Charles Nicolle; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Tunis-El-Manar; Hopital Charles Nicolle	Boussoffara, T (corresponding author), Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11 PT, Tunis, Tunisia.; Boussoffara, T (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	thouraya.boussoffara@pasteur.rns.tn	Ben Salah, Afif/AGW-8941-2022	Ben Salah, Afif/0000-0002-6696-4713; Ben Ahmed, Melika/0000-0002-3179-1648	National Institute of Allergy and Infection diseases [P50AI074178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074178] Funding Source: NIH RePORTER	National Institute of Allergy and Infection diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by P50AI074178 from the National Institute of Allergy and Infection diseases to HL and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayed Khaled, 2003, Saudi J Kidney Dis Transpl, V14, P39; BARRALNETTO M, 1995, PARASITE IMMUNOL, V17, P21, DOI 10.1111/j.1365-3024.1995.tb00962.x; Basu R, 2007, J INFECT DIS, V195, P1373, DOI 10.1086/513439; Bertholet S, 2005, INFECT IMMUN, V73, P6620, DOI 10.1128/IAI.73.10.6620-6628.2005; Bertholet S, 2006, J IMMUNOL, V177, P3525, DOI 10.4049/jimmunol.177.6.3525; Bousoffara T, 2004, J INFECT DIS, V189, P1265, DOI 10.1086/382031; Brodskyn CI, 1997, J IMMUNOL, V159, P4467; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; CASTES M, 1983, CLIN IMMUNOL IMMUNOP, V27, P176, DOI 10.1016/0090-1229(83)90068-5; Chenik M, 2006, PARASITOLOGY, V132, P493, DOI 10.1017/S0031182005009546; Choi Christine M, 2002, Am J Clin Dermatol, V3, P91, DOI 10.2165/00128071-200203020-00003; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Daryani A, 2003, VET PARASITOL, V113, P123, DOI 10.1016/S0304-4017(03)00044-X; Das S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008222; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KEMP M, 1994, CLIN EXP IMMUNOL, V96, P410, DOI 10.1111/j.1365-2249.1994.tb06043.x; Kima PE, 1997, J IMMUNOL, V159, P1828; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Mansueto P, 2007, INT J IMMUNOPATH PH, V20, P435, DOI 10.1177/039463200702000302; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2003, BIOCHEM BIOPH RES CO, V302, P646, DOI 10.1016/S0006-291X(03)00216-X; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Naouar I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/636039; Novais FO, 2015, SEMIN IMMUNOPATHOL, V37, P251, DOI 10.1007/s00281-015-0475-7; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Pelte C, 2004, J IMMUNOL, V172, P6783, DOI 10.4049/jimmunol.172.11.6783; Piscopo TV, 2006, POSTGRAD MED J, V82, P649, DOI 10.1136/pgmj.2006.047340; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Roberts M. T. M., 2006, BR MED B, V75-76, P115, DOI [10.1093/bmb/ldl003, DOI 10.1093/BMB/ID1003]; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Seyed N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001295; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Stager S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00005; Suneetha PV, 2009, J IMMUNOL METHODS, V342, P33, DOI 10.1016/j.jim.2008.11.020; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147076	10.1371/journal.pone.0147076	http://dx.doi.org/10.1371/journal.pone.0147076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771180	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300060
J	Peng, HK; Lee, HC; Pan, JY; Marculescu, R				Peng, Huan-Kai; Lee, Hao-Chih; Pan, Jia-Yu; Marculescu, Radu			Data-Driven Engineering of Social Dynamics: Pattern Matching and Profit Maximization	PLOS ONE			English	Article								In this paper, we define a new problem related to social media, namely, the data-driven engineering of social dynamics. More precisely, given a set of observations from the past, we aim at finding the best short-term intervention that can lead to predefined long-term outcomes. Toward this end, we propose a general formulation that covers two useful engineering tasks as special cases, namely, pattern matching and profit maximization. By incorporating a deep learning model, we derive a solution using convex relaxation and quadratic-programming transformation. Moreover, we propose a data-driven evaluation method in place of the expensive field experiments. Using a Twitter dataset, we demonstrate the effectiveness of our dynamics engineering approach for both pattern matching and profit maximization, and study the multifaceted interplay among several important factors of dynamics engineering, such as solution validity, pattern-matching accuracy, and intervention cost. Finally, the method we propose is general enough to work with multi-dimensional time series, so it can potentially be used in many other applications.	[Peng, Huan-Kai; Marculescu, Radu] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Lee, Hao-Chih] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Pan, Jia-Yu] Google Inc, Mountain View, CA USA	Carnegie Mellon University; Carnegie Mellon University; Google Incorporated	Peng, HK (corresponding author), Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA.	pumbaapeng@gmail.com	Marculescu, Radu/AAR-5320-2021	Marculescu, Radu/0000-0003-1826-7646	United States National Science Foundation [CCF-1314876]; Google Inc.	United States National Science Foundation(National Science Foundation (NSF)); Google Inc.(Google Incorporated)	HP and RM are both funded by the United States National Science Foundation Grant CCF-1314876 (http://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JP is supported by Google Inc. in the form of salary. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], P ICWSM; [Anonymous], ADV NEURAL INF PROCE, DOI DOI 10.1109/ICIP.2001.958968; Asur S, 2011, P ICWSM; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Boyd S., 2004, CONVEX OPTIMIZATION; Chen W, 2010, P ICDM DEC; Click A., 2009, TIME; Dow P, P ICWSM; Dumais S, 2012, P WWW; Gerber A.S., 2012, FIELD EXPT DESIGN AN; Gupta M, 2012, P AM SOC INFORM SCI; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Kleinberg Jon, 2002, P KDD; Lee H., 2009, P ANN INT C MACH LEA, P609; Lehmann J., 2012, P WWW; Leskovec J., 2005, P KDD; Lin Y, 2008, P WWW; Lin Y. -R., 2013, P ICWSM; Matsubara Y., 2012, P KDD; Naaman M, 2011, J AM SOC INF SCI TEC, V62, P902, DOI 10.1002/asi.21489; Peng HK, 2014, ASE INT C SOC COMP; Peng HK, 2013, P ASONAM; Peng HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118309; Romero D. M., 2011, P WWW; Szabo G., 2010, COMMUNICATIONS ACM; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Wasserman L., 2005, ALL NONPARAMETRIC ST; Yang Jaewon, 2011, P WSDM	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146490	10.1371/journal.pone.0146490	http://dx.doi.org/10.1371/journal.pone.0146490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771830	Green Published, Green Submitted, gold			2022-12-27	WOS:000368628300023
J	Schmidt, B; Gemeinholzer, B; Treloar, A				Schmidt, Birgit; Gemeinholzer, Birgit; Treloar, Andrew			Open Data in Global Environmental Research: The Belmont Forum's Open Data Survey	PLOS ONE			English	Article							DATA-MANAGEMENT; BIG DATA; CHALLENGES; SCIENTISTS; REUSE; COMMERCIALIZATION; REQUIREMENTS; REPOSITORIES; ECOLOGY	This paper presents the findings of the Belmont Forum's survey on Open Data which targeted the global environmental research and data infrastructure community. It highlights users' perceptions of the term "open data", expectations of infrastructure functionalities, and barriers and enablers for the sharing of data. A wide range of good practice examples was pointed out by the respondents which demonstrates a substantial uptake of data sharing through e-infrastructures and a further need for enhancement and consolidation. Among all policy responses, funder policies seem to be the most important motivator. This supports the conclusion that stronger mandates will strengthen the case for data sharing.	[Schmidt, Birgit] Univ Gottingen, State & Univ Lib, D-37073 Gottingen, Germany; [Gemeinholzer, Birgit] Univ Giessen, Systemat Bot, D-35390 Giessen, Germany; [Treloar, Andrew] Australian Natl Data Serv, Melbourne, Vic, Australia	University of Gottingen; Justus Liebig University Giessen	Schmidt, B (corresponding author), Univ Gottingen, State & Univ Lib, D-37073 Gottingen, Germany.	bschmidt@sub.uni-goettingen.de	Treloar, Andrew E/E-4356-2010; Gemeinholzer, Birgit/AAF-6401-2020; Schmidt, Birgit/AAB-6299-2022	Treloar, Andrew E/0000-0002-8911-3081; Schmidt, Birgit/0000-0001-8036-5859; gemeinholzer, birgit/0000-0002-9145-9284	US National Science Foundation [1358990]; UK Natural Environment Research Council [NE/LO14319/1]	US National Science Foundation(National Science Foundation (NSF)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors received no direct funding for this work; however, the work was done in the context of the Belmont Forum's E-Infrastructure and Data Management Collaborative Research Action (CRA), http://www.bfe-inf.org/. (See the note on the website: The Belmont Forum E-Infrastructures and Data Management Collaborative Research Action is supported by the participating Belmont Forum members listed at http://www.bfe-inf.org/info/participating-countries. This site is managed by a joint United States-United Kingdom Secretariat, supported by the US National Science Foundation under Grant No. 1358990 and the UK Natural Environment Research Council under Grant Ref NE/LO14319/1.)	AKERS K, 2013, INT J DIGITAL CURATI, V0008; [Anonymous], 2009, PATT INF US EXCH CAS, P2009; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Bach K, 2012, ECOL INFORM, V11, P16, DOI 10.1016/j.ecoinf.2011.11.008; Bendix J, 2012, ECOL INFORM, V11, P1, DOI 10.1016/j.ecoinf.2012.04.001; Bolukbasi B, 2013, SCIENCE, V342, P1041, DOI 10.1126/science.342.6162.1041-b; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Bryer J, 2013, LIKERT R PACKAGE ANA; Candela L, 2015, ECOL INFORM, V26, P162, DOI 10.1016/j.ecoinf.2014.07.006; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; CRANE D, 1969, AM SOCIOL REV, V34, P335, DOI 10.2307/2092499; Diekema AR, 2014, J ACAD LIBR, V40, P322, DOI 10.1016/j.acalib.2014.04.010; Duke CS, 2013, BIOSCIENCE, V63, P483, DOI 10.1525/bio.2013.63.6.10; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Expert Advisory Group on Data Access [EAGDA], 2014, EST INC CHANG CULT S; Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053; Feijen M., 2007, ARIADNE; Global Earth Observation System of Systems (GEOSS), 2010, GEOSS DAT SHAR ACT P; Haff T, 2014, SURVEY RESULTS ROCHE; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Henty M, 2008, INVESTIGATING DATA M; Hertzfeld HR, 2006, RES POLICY, V35, P825, DOI 10.1016/j.respol.2006.04.006; Hsu L, 2015, GEOMORPHOLOGY, V244, P180, DOI 10.1016/j.geomorph.2015.03.039; Huang XL, 2011, TRENDS ECOL EVOL, V26, P377, DOI 10.1016/j.tree.2011.05.006; Klump J, 2010, EGU GEN ASS C, P4923; Kratz John, 2014, F1000Res, V3, P94, DOI 10.12688/f1000research.3979.3; Kratz JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117619; Kuipers T, 2009, INSIGHT DIGITAL PRES; Lam A, 2011, RES POLICY, V40, P1354, DOI 10.1016/j.respol.2011.09.002; Lee D, 2014, OEPN DATA IRELAND BE; Lee D, 2014, OEPN DATA IRELAND OP; Lee D, 2014, OPEN DATA IRELAND OP; Luna-Reyes LF, 2008, SYST DYNAM REV, V24, P265, DOI 10.1002/sdr.404; Lyon E, 2007, DEALING RELATIONSHIP; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Michener W, 2011, TRENDS ECOL EVOL, P17; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; OECD, 2007, PRINC GUID ACC RES D; Parr CS, 2005, TRENDS ECOL EVOL, V20, P362, DOI 10.1016/j.tree.2005.04.023; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Peters DPC, 2010, TRENDS ECOL EVOL, V25, P592, DOI 10.1016/j.tree.2010.07.005; Piwowar HA, 2013, PEERJ, V1, DOI 10.7717/peerj.175; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Schmidt B, 2015, BELMONT FORUM OPEN D; Specht A, 2015, SCI TOTAL ENVIRON, V534, P144, DOI 10.1016/j.scitotenv.2015.03.092; Stern S, 2004, MANAGE SCI, V50, P835, DOI 10.1287/mnsc.1040.0241; Swan A, 2008, SHARE NOT SHARE PUBL; Tennison J, 2014, OPEN DATA I BLO 0317; Tenopir C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134826; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Van Noorden Richard, 2013, Nature, V500, P243; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wood J, 2010, RIDING WAVE EUROPE C	56	52	53	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146695	10.1371/journal.pone.0146695	http://dx.doi.org/10.1371/journal.pone.0146695			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB6ME	26771577	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300029
J	Su, ML; Huang, WD; Zhu, BH				Su, Meiling; Huang, Wendong; Zhu, Banghao			Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; LITHOSPERMUM-ERYTHRORHIZON; PERILIPIN-A; SHIKONIN; STORAGE; CELLS	Various drugs have been developed to treat obesity, but these have undesirable secondary effects, and an efficient but non-toxic anti-obesity drug from natural sources is desired. This study investigated the anti-obesity effects and mechanisms of action of acetylshikonin (AS)-which is used in traditional Chinese medicine-in rats on a high-fat diet (HFD). Rats were fed a normal diet or an HFD; the latter group was received no treatment or were treated with 100, 300, or 900 mg/kg AS extract by intragastric administration for 6 weeks. In addition, 3T3-L1 adipocytes were treated with AS and the effects on adipogenesis and lipolysis were evaluated by western blot analysis of adipogenic transcription factors and lipidmetabolizing enzyme levels and the phosphorylation status of protein kinase (PK) A and hormone-sensitive lipase (HSL). AS prevented HFD-induced obesity including reduction in body weight, white adipose tissue content, liver mass, and serum triglyceride and free fatty acid levels in rats. It also suppressed the expression of adipogenic differentiation transcription factors and decreased the expression of the adipocyte-specific proteins HSL and adipose triglyceride lipase (ATGL). Furthermore, AS treatment induced lipolysis, leading to the release of glycerol and increased in PKA and HSL phosphorylation. These findings demonstrate that AS has anti-obesity effects in a rat model and may be a safe treatment for obesity in humans.	[Su, Meiling; Huang, Wendong; Zhu, Banghao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhu, BH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhubh@mail.sysu.edu.cn			Joint Project of National Education Ministry and Guangdong province [2007B090400089, 2007A032702001]	Joint Project of National Education Ministry and Guangdong province	This study was supported by grants from the Joint Project of National Education Ministry and Guangdong province (Nos. 2007B090400089) and (2007A032702001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2001, ANN ENDOCRINOL-PARIS, V62, pS43; Akkol EK, 2009, J ETHNOPHARMACOL, V124, P137, DOI 10.1016/j.jep.2009.03.019; Andujar I, 2013, PLANTA MED, V79, P1685, DOI 10.1055/s-0033-1350934; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Gwon SY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-207; Gwon SY, 2012, J AGR FOOD CHEM, V60, P9089, DOI 10.1021/jf3017404; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim GW, 2014, CLIN PHARMACOL THER, V95, P53, DOI 10.1038/clpt.2013.204; Kratky D, 2014, BIOCHIMIE, V96, P106, DOI 10.1016/j.biochi.2013.06.023; Labib M, 2003, J CLIN PATHOL, V56, P17, DOI 10.1136/jcp.56.1.17; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lee H, 2011, LIFE SCI, V88, P294, DOI 10.1016/j.lfs.2010.12.004; Lee H, 2010, PHYTOTHER RES, V24, P344, DOI 10.1002/ptr.2942; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Liu LR, 2011, OBESITY, V19, P2301, DOI 10.1038/oby.2011.176; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sabin MA, 2015, BEST PRACT RES CL EN, V29, P327, DOI 10.1016/j.beem.2015.04.003; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seo JB, 2012, BIOCHEM BIOPH RES CO, V417, P800, DOI 10.1016/j.bbrc.2011.12.039; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; Stich V, 2004, P NUTR SOC, V63, P369, DOI 10.1079/PNS2004350; Sung RJ, 2015, J ETHNOPHARMACOL; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; TABATA M, 1975, YAKUGAKU ZASSHI, V95, P1376, DOI 10.1248/yakushi1947.95.11_1376; TANAKA S, 1986, J NAT PROD, V49, P466, DOI 10.1021/np50045a014; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zeng Z, 2014, J ETHNOPHARMACOL, V154, P653, DOI 10.1016/j.jep.2014.04.038; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	42	23	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146884	10.1371/journal.pone.0146884	http://dx.doi.org/10.1371/journal.pone.0146884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771185	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300039
J	Janakiraman, U; Manivasagam, T; Thenmozhi, AJ; Essa, MM; Barathidasan, R; SaravanaBabu, C; Guillemin, GJ; Khan, MAS				Janakiraman, Udaiyappan; Manivasagam, Thamilarasan; Thenmozhi, Arokiasamy Justin; Essa, Musthafa Mohamed; Barathidasan, Rajamani; SaravanaBabu, Chidambaram; Guillemin, Gilles J.; Khan, Mohammed A. S.			Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice	PLOS ONE			English	Article							INDUCED PARKINSONS-DISEASE; VENTRAL TEGMENTAL AREA; DORSAL RAPHE NUCLEUS; DOPAMINE RELEASE; MOUSE MODEL; RAT STRIATUM; IN-VIVO; DEPRESSION; DISORDERS; MPTP	Parkinson's disease (PD) is regarded as a movement disorder mainly affecting the elderly population and occurs due to progressive loss of dopaminergic (DAergic) neurons in nigrostriatal pathway. Patients suffer from non-motor symptoms (NMS) such as depression, anxiety, fatigue and sleep disorders, which are not well focussed in PD research. Depression in PD is a predominant/complex symptom and its pathology lies exterior to the nigrostriatal system. The main aim of this study is to explore the causative or progressive effect of chronic mild stress (CMS), a paradigm developed as an animal model of depression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (25 mg/kg. body wt.) with probenecid (250 mg/kg, s.c.) (MPTP/p) induced mice model of PD. After ten i.p. injections (once in 3.5 days for 5 weeks) of MPTP/p or exposure to CMS for 4 weeks, the behavioural (motor and non-motor) impairments, levels and expressions of dopamine (DA), serotonin (5-HT), DAergic markers such as tyrosine hydroxylase (TH), dopamine transporter (DAT), vesicular monoamine transporters-2 (VMAT 2) and alpha-synuclein in nigrostriatal (striatum (ST) and substantia nigra (SN)) and extra-nigrostriatal (hippocampus, cortex and cerebellum) tissues were analysed. Significantly decreased DA and 5-HT levels, TH, DAT and VMAT 2 expressions and increased motor deficits, anhedonia-like behaviour and a-synuclein expression were found in MPTP/p treated mice. Pre and/or post exposure of CMS to MPTP/p mice further enhanced the MPTP/p induced DA and 5-HT depletion, behaviour abnormalities and protein expressions. Our results could strongly confirm that the exposure of stress after MPTP/p injections worsens the symptoms and neurochemicals status of PD.	[Janakiraman, Udaiyappan; Manivasagam, Thamilarasan; Thenmozhi, Arokiasamy Justin] Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, CAMS, Dept Food Sci & Nutr, Muscat, Oman; [Essa, Musthafa Mohamed] Sultan Qaboos Univ, Ageing & Dementia Res Grp, Muscat, Oman; [Barathidasan, Rajamani; SaravanaBabu, Chidambaram] Sri Ramachandra Univ, Ctr Toxicol & Dev Res, Madras 600116, Tamil Nadu, India; [Guillemin, Gilles J.] Macquarie Univ, Fac Med & Hlth Sci, Deb Bailey MND Res Lab, Neuropharmacol Grp, N Ryde, NSW 2109, Australia; [Khan, Mohammed A. S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children, Boston, MA 02114 USA	Annamalai University; Sultan Qaboos University; Sultan Qaboos University; Sri Ramachandra Institute of Higher Education & Research; Macquarie University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Manivasagam, T (corresponding author), Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar 608002, Tamil Nadu, India.	mani_pdresearchlab@rediff.com	Guillemin, Gilles J/C-3878-2015; Manivasagam, Thamilarasan/U-3209-2019; A, Justinthenmozhi/W-4465-2019; Thenmozhi, Arokiasamy Justin/U-7619-2019	Guillemin, Gilles J/0000-0001-8105-4470; Manivasagam, Thamilarasan/0000-0003-4440-7323; Manivasagam, Thamilarasan/0000-0002-3948-8328; Musthafa Mohamed, Essa/0000-0001-7505-9785; Justin Thenmozhi, Arokiasamy/0000-0001-8822-4751	Department of Biotechnology, New Delhi [BT/PR4958/MED/30/748/2012]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	Financial assistance in the form of Neuroscience task force project (BT/PR4958/MED/30/748/2012), Department of Biotechnology, New Delhi, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Ahmad SO, 2009, NEUROSCI LETT, V450, P102, DOI 10.1016/j.neulet.2008.11.065; Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Anandhan A, 2012, BRAIN RES, V1433, P104, DOI 10.1016/j.brainres.2011.11.021; ANISMAN H, 1982, BEHAV BRAIN SCI, V5, P89, DOI 10.1017/S0140525X00010633; BENLOUCIF S, 1993, J PHARMACOL EXP THER, V265, P373; BENLOUCIF S, 1991, EUR J PHARMACOL, V200, P1, DOI 10.1016/0014-2999(91)90658-D; Bhattacharya Salil K., 2000, Indian Journal of Experimental Biology, V38, P119; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; Crabbe JC, 2003, J APPL PHYSIOL, V95, P1338, DOI 10.1152/japplphysiol.00132.2003; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; De Deurwaerdere P, 2004, J NEUROSCI, V24, P3235, DOI 10.1523/JNEUROSCI.0112-04.2004; DEUTCH AY, 1985, BRAIN RES, V333, P143, DOI 10.1016/0006-8993(85)90134-9; DEUTCH AY, 1993, LIMBIC MOTOR CIRCUIT, P45; Di Matteo V, 2002, PHARMACOL BIOCHEM BE, V71, P727, DOI 10.1016/S0091-3057(01)00705-5; Dremencov E, 2005, NEUROPHARMACOLOGY, V48, P34, DOI 10.1016/j.neuropharm.2004.09.013; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin K., 2007, MOUSE BRAIN STEREOTA; GOETZ CG, 1990, NEUROLOGY, V40, P273, DOI 10.1212/WNL.40.2.273; Harrison AA, 2001, J PHARMACOL EXP THER, V297, P316; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; HEIKKILA RE, 1992, NEUROCHEM INT, V20, pS299; Hemmerle AM, 2014, MOL PSYCHIATR, V19, P638, DOI 10.1038/mp.2013.108; Hirsch EC, 2003, ADV NEUROL, V91, P29; Hornykiewicz O, 1975, Natl Inst Drug Abuse Res Monogr Ser, P13; IKAWA K, 1993, EUR J PHARMACOL, V250, P261, DOI 10.1016/0014-2999(93)90390-4; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Jay TM, 2004, NEUROTOX RES, V6, P233, DOI 10.1007/BF03033225; KEEFE KA, 1990, BRAIN RES, V527, P350, DOI 10.1016/0006-8993(90)91158-D; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu B, 2004, BIOL PHARM BULL, V27, P1245, DOI 10.1248/bpb.27.1245; Lohle M, 2009, J NEURAL TRANSM, V116, P1483, DOI 10.1007/s00702-009-0274-1; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchtman DW, 2012, BEHAV BRAIN RES, V226, P386, DOI 10.1016/j.bbr.2011.09.033; Luchtman DW, 2009, PHYSIOL BEHAV, V98, P130, DOI 10.1016/j.physbeh.2009.04.021; Mayeux R, 1984, Adv Neurol, V40, P241; MAYEUX R, 1990, J CLIN PSYCHIAT, V51, P20; McDonald WA, 2003, BIOL PSYCHIAT, V54, P363, DOI 10.1016/S0006-3223(03)00530-4; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Miller GW, 1999, EXP NEUROL, V156, P138, DOI 10.1006/exnr.1998.7008; Modugno N, 2013, ARCH ITAL BIOL, V151, P148; Monroe SM, 2006, J CONSULT CLIN PSYCH, V74, P112, DOI 10.1037/0022-006X.74.1.112; NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pain S, 2013, EXP TOXICOL PATHOL, V65, P689, DOI 10.1016/j.etp.2012.09.001; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rasheed N, 2011, NEUROSCI LETT, V504, P151, DOI 10.1016/j.neulet.2011.09.021; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Smith AD, 2002, PHYSIOL BEHAV, V77, P527, DOI 10.1016/S0031-9384(02)00939-3; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; TREVES TA, 1990, MOVEMENT DISORD, V5, P11; UC EY, 2012, EUROPEAN NEUROLOGICA, V7, P35; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; VANPRAAG HM, 1979, PSYCHIAT RES, V1, P219, DOI 10.1016/0165-1781(79)90002-7; Vriend C, 2014, NEUROSCI BIOBEHAV R, V38, P60, DOI 10.1016/j.neubiorev.2013.11.001; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306	72	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146671	10.1371/journal.pone.0146671	http://dx.doi.org/10.1371/journal.pone.0146671			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26765842	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300033
J	Weisschuh, N; Mayer, AK; Strom, TM; Kohl, S; Glockle, N; Schubach, M; Andreasson, S; Bernd, A; Birch, DG; Hamel, CP; Heckenlively, JR; Jacobson, SG; Kamme, C; Kellner, U; Kunstmann, E; Maffei, P; Reiff, CM; Rohrschneider, K; Rosenberg, T; Rudolph, G; Vamos, R; Varsanyi, B; Weleber, RG; Wissinger, B				Weisschuh, Nicole; Mayer, Anja K.; Strom, Tim M.; Kohl, Susanne; Gloeckle, Nicola; Schubach, Max; Andreasson, Sten; Bernd, Antje; Birch, David G.; Hamel, Christian P.; Heckenlively, John R.; Jacobson, Samuel G.; Kamme, Christina; Kellner, Ulrich; Kunstmann, Erdmute; Maffei, Pietro; Reiff, Charlotte M.; Rohrschneider, Klaus; Rosenberg, Thomas; Rudolph, Guenther; Vamos, Rita; Varsanyi, Balazs; Weleber, Richard G.; Wissinger, Bernd			Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; LINKED RETINITIS-PIGMENTOSA; COPY-NUMBER VARIATION; CONE-ROD DYSTROPHY; MOLECULAR DIAGNOSIS; IDENTIFY MUTATIONS; TRANSPORTER GENE; BEST-DISEASE; ABCR GENE; SPECTRUM	Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61% was achieved including mutations in 34 known and two novel RD genes. A total of 69 distinct mutations were identified, including 39 novel mutations. Notably, genetic findings in several families were not consistent with the initial clinical diagnosis. Clinical reassessment resulted in refinement of the clinical diagnosis in some of these families and confirmed the broad clinical spectrum associated with mutations in RD genes.	[Weisschuh, Nicole; Mayer, Anja K.; Kohl, Susanne; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany; [Strom, Tim M.] Helmholtz Zentrum Muenchen, Inst Human Genet, Neuherberg, Germany; [Gloeckle, Nicola] CeGaT GmbH, Tubingen, Germany; [Schubach, Max] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Andreasson, Sten; Kamme, Christina] Lund Univ, Dept Ophthalmol, Lund, Sweden; [Bernd, Antje] Univ Tubingen, Ctr Ophthalmol, Univ Eye Hosp, Tubingen, Germany; [Birch, David G.] Retina Fdn SW, Dallas, TX USA; [Hamel, Christian P.] CHU Montpellier, Genet Sensory Dis, Montpellier, France; [Heckenlively, John R.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kellner, Ulrich] MVZ ADTC Siegburg GmbH, AugenZentrum Siegburg, Rare Retinal Dis Ctr, Siegburg, Germany; [Kunstmann, Erdmute] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; [Maffei, Pietro] Univ Hosp Padua, Dept Med, Padua, Italy; [Reiff, Charlotte M.] Univ Freiburg, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany; [Rohrschneider, Klaus] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Rosenberg, Thomas] Glostrup Cty Hosp, Dept Ophthalmol, Natl Eye Clin, Glostrup, Denmark; [Rudolph, Guenther] Univ Munich, Univ Eye Hosp, Munich, Germany; [Vamos, Rita; Varsanyi, Balazs] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Varsanyi, Balazs] Univ Pecs, Sch Med, Dept Ophthalmol, Pecs, Hungary; [Weleber, Richard G.] Oregon Hlth & Sci Univ, Oregon Retinal Degenerat Ctr, Casey Eye Inst, Portland, OR 97201 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; CeGaT; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Lund University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Retina Foundation of the Southwest; Universite de Montpellier; CHU de Montpellier; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of Wurzburg; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Freiburg; Ruprecht Karls University Heidelberg; University of Copenhagen; University of Munich; Semmelweis University; University of Pecs; Oregon Health & Science University	Weisschuh, N (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany.	nicole.weisschuh@uni-tuebingen.de	Schubach, Max/AAE-4017-2019	Schubach, Max/0000-0002-2032-6679; Maffei, Pietro/0000-0002-1717-263X; Kohl, Susanne/0000-0002-6438-6331; Rohrschneider, Klaus/0000-0003-1996-7935; Jacobson, Samuel/0000-0003-2122-169X	German Ministry for Education and Research [01GM1105A, 01GM1108A]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported through grants (01GM1105A to BW and 01GM1108A to BW and SK) from the German Ministry for Education and Research, http://www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori M, 2010, AM J HUM GENET, V87, P424, DOI 10.1016/j.ajhg.2010.08.009; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Almoguera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133624; Bauwens M, 2015, HUM MUTAT, V36, P39, DOI 10.1002/humu.22716; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Boulanger-Scemama E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0300-3; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Bujakowska KM, 2015, HUM MOL GENET, V24, P230, DOI 10.1093/hmg/ddu441; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Estrada-Cuzcano A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1425, DOI 10.1001/archophthalmol.2012.2434; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Gu SM, 1998, LANCET, V351, P1103, DOI 10.1016/S0140-6736(05)79384-3; Hebrard M, 2011, EUR J HUM GENET, V19, P1256, DOI 10.1038/ejhg.2011.133; Hipp S, 2015, ACTA OPHTHALMOL, V93, pE281, DOI 10.1111/aos.12573; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Jaeger W, 1981, P C NEUR NEUR ZUR, P241; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Marshall JD, 2015, HUM MUTAT, V36, P660, DOI 10.1002/humu.22796; Mayer AK, 2015, EUR J HUM GENET; Naruto T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11334; Neidhardt J, 2008, MOL VIS, V14, P1081; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Ozgul Riza Koksal, 2004, Hum Mutat, V23, P523, DOI 10.1002/humu.9236; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Sankila E M, 2000, Hum Mutat, V16, P94, DOI 10.1002/1098-1004(200007)16:1<94::AID-HUMU25>3.0.CO;2-T; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Shan MG, 2005, MOL VIS, V11, P738; Shevach E, 2015, JAMA OPHTHALMOL, V133, P312, DOI 10.1001/jamaophthalmol.2014.5251; Song J, 2011, INVEST OPHTH VIS SCI, V52, P9053, DOI 10.1167/iovs.11-7978; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Steele-Stallard HB, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-122; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P4579, DOI 10.1167/iovs.06-0440; Tan RJ, 2014, HUM MUTAT, V35, P899, DOI 10.1002/humu.22537; Vache C, 2012, HUM MUTAT, V33, P104, DOI 10.1002/humu.21634; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Wang F, 2014, HUM GENET, V133, P331, DOI 10.1007/s00439-013-1381-5; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; Xu M, 2015, HUM GENET; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7	60	74	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0145951	10.1371/journal.pone.0145951	http://dx.doi.org/10.1371/journal.pone.0145951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766544	Green Published, gold, Green Submitted			2022-12-27	WOS:000368459300011
J	Cahill, CM; Zhu, WS; Oziolor, E; Yang, YJ; Tam, B; Rajanala, S; Rogers, JT; Walker, WA				Cahill, Catherine M.; Zhu, Weishu; Oziolor, Elias; Yang, Yao-Jong; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.; Walker, W. Allan			Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1 beta Induction of Interleukin 6 in the Developing Enterocyte	PLOS ONE			English	Article							DEVELOPING HUMAN INTESTINE; C-JUN; SIGNAL-TRANSDUCTION; AP-1; IL-6; INJURY; HOMODIMERS; PHENOTYPE; STRESS; LIVER	The innate immune response is characterized by activation of transcription factors, nuclear factor kappa B and activator protein-1 and their downstream targets, the pro-inflammatory cytokines including interleukin 1 beta and interleukin 6. Normal development of this response in the intestine is critical to survival of the human neonate and delays can cause the onset of devastating inflammatory diseases such as necrotizing enterocolitis. Previous studies have addressed the role of nuclear factor kappa B in the development of the innate immune response in the enterocyte, however despite its central role in the control of multiple pro-inflammatory cytokine genes, little is known on the role of Activator Protein 1 in this response in the enterocyte. Here we show that the canonical Activator Protein 1 members, cJun and cFos and their upstream kinases JNK and p38 play an essential role in the regulation of interleukin 6 in the immature enterocyte. Our data supports a model whereby the cFos/cJun heterodimer and the more potent cJun homodimer downstream of JNK are replaced by less efficient JunD containing dimers, contributing to the decreased responsiveness to interleukin 1 beta and decreased interleukin 6 secretion observed in the mature enterocyte. The tissue specific expression of JunB in colonocytes and colon derived tissues together with its ability to repress Interleukin-1 beta induction of an Interleukin-6 gene reporter in the NCM-460 colonocyte suggests that induction of JunB containing dimers may offer an attractive therapeutic strategy for the control of IL-6 secretion during inflammatory episodes in this area of the intestine	[Cahill, Catherine M.; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.] Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA; [Cahill, Catherine M.; Zhu, Weishu; Tam, Bosco; Rajanala, Susruthi; Rogers, Jack T.; Walker, W. Allan] Harvard Univ, Sch Med, Charlestown, MA USA; [Zhu, Weishu; Walker, W. Allan] Massachusetts Gen Hosp Children, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Charlestown, MA USA; [Oziolor, Elias] Baylor Univ, Dept Environm Sci, One Bear Pl 97266, Waco, TX 76798 USA; [Yang, Yao-Jong] Natl Cheng Kung Univ, Dept Pediat, Tainan 701, Taiwan; [Yang, Yao-Jong] Natl Cheng Kung Univ, Dept Internal Med, Tainan 701, Taiwan	Harvard University; Massachusetts General Hospital; Harvard University; Baylor University; National Cheng Kung University; National Cheng Kung University	Cahill, CM (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA.	ccahill@helix.mgh.harvard.edu	Oziolor, Elias/P-6961-2016	Oziolor, Elias/0000-0002-4078-1054; Rogers, Jack/0000-0003-1262-8578	National Institute of Child Health and Human Development [R01HD012437Supplement29, R01HD012437]; National Institute of Neurological Disorders and Stroke [NS077079-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077079] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	External Funding was obtained as follows: CMC R01HD012437Supplement29 (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx), WAW R01HD012437 (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx), JTR NS077079-01A1 (National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Chan KYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036977; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006; Ding QM, 1998, LIFE SCI, V64, P175, DOI 10.1016/S0024-3205(98)00549-9; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Gomard T, 2010, PLOS ONE, V5, pA178, DOI 10.1371/journal.pone.0009585; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lu C, 2009, GENE, V433, P56, DOI 10.1016/j.gene.2008.11.015; Luther J, 2011, J CELL SCI, V124, P1465, DOI 10.1242/jcs.079855; Marden JJ, 2008, J BIOL CHEM, V283, P6687, DOI 10.1074/jbc.M705606200; Meng D, 2015, PEDIATR RES, V77, P416, DOI 10.1038/pr.2014.207; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2012, JPEN-PARENTER ENTER, V36, p30S, DOI 10.1177/0148607111422068; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Rautava S, J PEDIAT GASTROENTER, V54, P630, DOI [10.1097/MPG.0b013e31823e7c29, DOI 10.1097/MPG.0B013E31823E7E29]; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; SANDERSON IR, 1995, INT ARCH ALLERGY IMM, V107, P396, DOI 10.1159/000237051; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Savidge TC, 2001, PEDIATR RES, V50, P196, DOI 10.1203/00006450-200108000-00006; SAVIDGE TC, 1995, DIFFERENTIATION, V58, P361, DOI 10.1046/j.1432-0436.1995.5850361.x; Smart DE, 2001, J BIOL CHEM, V276, P24414, DOI 10.1074/jbc.M101840200; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0145184	10.1371/journal.pone.0145184	http://dx.doi.org/10.1371/journal.pone.0145184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799482	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300003
J	Gao, SS; Li, FM; Li, HM; Huang, YB; Liu, Y; Chen, YX				Gao, Shanshan; Li, Fangmin; Li, Huimin; Huang, Yibing; Liu, Yu; Chen, Yuxin			Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; MYOKINE IRISIN; FAT; METABOLISM; EXPRESSION; OBESITY; GENES; ATGL; HSL	Irisin, which was recently identified as a myokine and an adipokine, transforms white adipose tissue to brown adipose tissue and has increasingly caught the attention of the medical and scientific community. However, the signaling pathway of irisin and the molecular mechanisms responsible for the lipolysis effect remain unclear. In this study, we established an efficient system for the expression and purification of GST-irisin in Escherichia coli. The biological activity of GST-irisin was verified using the cell counting kit-8 assay and by detecting the mRNA expression of uncoupling protein 1. Our data showed that GST-irisin regulates mRNA levels of lipolysis-related genes such as adipose triglyceride lipase and hormone-sensitive lipase and proteins such as the fatty acid-binding protein 4, leading to increased secretion of glycerol and decreased lipid accumulation in 3T3-L1 adipocytes. In addition, exogenous GST-irisin can increase its autocrine function in vitro by regulating the expression of fibronectin type III domain-containing protein 5. GST-irisin could regulate glucose uptake in 3T3-L1 adipocytes. Hence, we believe that recombinant GST-irisin could promote lipolysis and its secretion in vitro and can potentially prevent obesity and related metabolic diseases.	[Gao, Shanshan; Li, Fangmin; Huang, Yibing; Chen, Yuxin] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China; [Gao, Shanshan; Li, Fangmin; Li, Huimin; Huang, Yibing; Chen, Yuxin] Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China; [Huang, Yibing; Chen, Yuxin] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130041, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Chen, YX (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China.; Chen, YX (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130012, Peoples R China.; Chen, YX (corresponding author), Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China.; Liu, Y (corresponding author), Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130041, Peoples R China.	drliuyu@jlu.edu.cn; chen_yuxin@jlu.edu.cn	Huang, Yibing/M-9462-2018	Huang, Yibing/0000-0002-2655-535X	National Natural Science Foundation of China [81373445, 21442001, 30971398, 81170746]; Natural Science Foundation of Jilin Province [20150101189JC, 20140101042JC]; Norman Bethune Program of Jilin University [2012214]; Science and Technology Development Program of Jilin Province [20140101183JC, 20150519013JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Norman Bethune Program of Jilin University; Science and Technology Development Program of Jilin Province	This work was supported by the National Natural Science Foundation of China (no. 81373445, YXC, no. 21442001, YBH, no. 30971398, YL, and no. 81170746, YL), the Natural Science Foundation of Jilin Province (no. 20150101189JC, YXC and no. 20140101042JC, YBH), Norman Bethune Program of Jilin University (no. 2012214, YL), and Science and Technology Development Program of Jilin Province (no. 20140101183JC, YL and no. 20150519013JH, YL).	Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Bag S, 2015, J THEOR BIOL, V364, P344, DOI 10.1016/j.jtbi.2014.09.034; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catalan V, 2012, HISTOL HISTOPATHOL, V27, P1515, DOI 10.14670/HH-27.1515; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Langfort J, 2010, BIOCHEM BIOPH RES CO, V399, P670, DOI 10.1016/j.bbrc.2010.07.140; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Mahajan RD, 2013, INDIAN J CLIN BIOCHE, V28, P102, DOI 10.1007/s12291-012-0255-2; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Morak M, 2012, MOL CELL PROTEOMICS, V11, P1777, DOI 10.1074/mcp.M111.015743; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rodriguez A, 2015, INT J OBESITY, V39, P397, DOI 10.1038/ijo.2014.166; Sanchis-Gomar F, 2012, J DIABETES, V4, P196, DOI 10.1111/j.1753-0407.2012.00194.x; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Unger RE, 2014, BIOMATERIALS, V35, P3180, DOI 10.1016/j.biomaterials.2013.12.059; Vaughan RA, 2014, DIABETES OBES METAB, V16, P711, DOI 10.1111/dom.12268; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104; Zhao XY, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/581093; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	38	28	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0147480	10.1371/journal.pone.0147480	http://dx.doi.org/10.1371/journal.pone.0147480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	26799325	Green Published, gold, Green Submitted			2022-12-27	WOS:000368655300113
J	Biju, SD; Senevirathne, G; Garg, S; Mahony, S; Kamei, RG; Thomas, A; Shouche, Y; Raxworthy, CJ; Meegaskumbura, M; Van Bocxlaer, I				Biju, S. D.; Senevirathne, Gayani; Garg, Sonali; Mahony, Stephen; Kamei, Rachunliu G.; Thomas, Ashish; Shouche, Yogesh; Raxworthy, Christopher J.; Meegaskumbura, Madhava; Van Bocxlaer, Ines			Frankixalus, a New Rhacophorid Genus of Tree Hole Breeding Frogs with Oophagous Tadpoles	PLOS ONE			English	Article							CHIRIXALUS-EIFFINGERI-RHACOPHORIDAE; VAMPYRUS ANURA RHACOPHORIDAE; WESTERN-GHATS; REPRODUCTIVE MODES; ACRIS-CREPITANS; SYSTEMATICS; PHYLOGENY; EVOLUTION; AMPHIBIA; FAMILY	Despite renewed interest in the biogeography and evolutionary history of Old World tree frogs (Rhacophoridae), this family still includes enigmatic frogs with ambiguous phylogenetic placement. During fieldwork in four northeastern states of India, we discovered several populations of tree hole breeding frogs with oophagous tadpoles. We used molecular data, consisting of two nuclear and three mitochondrial gene fragments for all known rhacophorid genera, to investigate the phylogenetic position of these new frogs. Our analyses identify a previously overlooked, yet distinct evolutionary lineage of frogs that warrants recognition as a new genus and is here described as Frankixalus gen. nov. This genus, which contains the enigmatic 'Polypedates' jerdonii described by Gunther in 1876, forms the sister group of a clade containing Kurixalus, Pseudophilautus, Raorchestes, Mercurana and Beddomixalus. The distinctiveness of this evolutionary lineage is also corroborated by the external morphology of adults and tadpoles, adult osteology, breeding ecology, and life history features.	[Biju, S. D.; Garg, Sonali; Mahony, Stephen; Kamei, Rachunliu G.; Thomas, Ashish] Univ Delhi, Systemat Lab, Dept Environm Studies, Delhi 110007, India; [Senevirathne, Gayani; Meegaskumbura, Madhava] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Mahony, Stephen] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland; [Kamei, Rachunliu G.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Thomas, Ashish] Univ Delhi, Hindu Coll, Dept Environm Studies, Delhi 110007, India; [Shouche, Yogesh] Natl Ctr Cell Sci, Microbial Culture Collect, NCCS Complex,Pune Univ Campus, Pune 411007, Maharashtra, India; [Raxworthy, Christopher J.] Amer Museum Nat Hist, Herpetol Dept, Cent Pk West & 79th St, New York, NY 10024 USA; [Van Bocxlaer, Ines] VUB, Amphibian Evolut Lab, Dept Biol, Pl Laan 2, B-1050 Brussels, Belgium	University of Delhi; University of Peradeniya; University College Dublin; Natural History Museum London; University of Delhi; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); American Museum of Natural History (AMNH); Vrije Universiteit Brussel	Biju, SD (corresponding author), Univ Delhi, Systemat Lab, Dept Environm Studies, Delhi 110007, India.; Meegaskumbura, M (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.; Van Bocxlaer, I (corresponding author), VUB, Amphibian Evolut Lab, Dept Biol, Pl Laan 2, B-1050 Brussels, Belgium.	sdbiju@es.du.ac.in; madhava88m@gmail.com; ivbocxla@vub.ac.be	Senevirathne, Gayani/ABD-5713-2021; Van Bocxlaer, Ines/L-4852-2015; Meegaskumbura, Madhava/F-8782-2013; Mahony, Stephen/N-9061-2015	Meegaskumbura, Madhava/0000-0002-4599-6724; Mahony, Stephen/0000-0002-8263-6832; Senevirathne, Gayani/0000-0001-6704-9691; Kamei, Rachunliu/0000-0003-3054-9785; THOMAS, ASHISH/0000-0002-0189-7580	DU/DST Purse Grant, Department of Science and Technology, Ministry of Science and Technology, Government of India [2009/868]; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR7833/NDB/51/153/2006]; University of Delhi Research and Development [2007/130, 2007/858, 2008/302, 2014/110]; FWO-Vlaanderen; National Research Council of Sri Lanka [NRC 11-124]; Council for Scientific and Industrial Research, India (CSIR) [9/45(1381)/2015-EMR-I]; Marie Sklodowska-Curie Fellowship [PIIF-GA-2013-625870]	DU/DST Purse Grant, Department of Science and Technology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University of Delhi Research and Development; FWO-Vlaanderen(FWO); National Research Council of Sri Lanka; Council for Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Marie Sklodowska-Curie Fellowship	This study was supported by the following grants to SDB: DU/DST Purse Grant '2009/868', Department of Science and Technology, Ministry of Science and Technology, Government of India; 'BT/PR7833/NDB/51/153/2006', Department of Biotechnology, Ministry of Science and Technology, Government of India; University of Delhi Research and Development Grants '2007/130', '2007/858', '2008/302', '2014/110'. IVB is supported by a post-doctoral fellowship from FWO-Vlaanderen. MM is supported by the National Research Council of Sri Lanka (# NRC 11-124); SG is supported by a research fellowship from the Council for Scientific and Industrial Research, India (CSIR No. 9/45(1381)/2015-EMR-I); RGK is supported by Marie Sklodowska-Curie Fellowship (PIIF-GA-2013-625870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RK, 2013, ZOOTAXA, V3640, P177, DOI 10.11646/zootaxa.3640.2.3; Ahl E., 1931, TIERREICH, V55; AmphibiaWeb, 2015, INF AMPH BIOL CONS W; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Biju SD, 2014, CONTRIB ZOOL, V83, P269, DOI 10.1163/18759866-08304004; Biju SD, 2010, CURR SCI INDIA, V98, P1119; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju SD, 2008, ORG DIVERS EVOL, V8, P267, DOI 10.1016/j.ode.2007.11.004; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F., 2001, ZEYLANICA, V6, P1; Boulenger GA, 1882, CATALOGUE BATRACHIA; Bowatte Gayan, 2011, Ceylon Journal of Science Biological Sciences, V40, P109; Chen YH, 2001, HERPETOLOGICA, V57, P438; Chiu CT, 2006, BEHAVIOUR, V143, P123, DOI 10.1163/156853906775133605; Das Indraneil, 1998, Hamadryad, V23, P63; Delorme Magali, 2005, Bulletin Mensuel de la Societe Linneenne de Lyon, V74, P165; Dubois A., 1987, ALYTES, V5, P7; Duellman W., 1986, BIOL AMPHIBIANS; Dutta S.K., 1997, AMPHIBIANS INDIA SRI; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gosner K. L., 1960, Herpetologica, V16, P183; Grosjean S, 2008, J ZOOL SYST EVOL RES, V46, P169, DOI 10.1111/j.1439-0469.2007.00451.x; GUNTHER A., 1876, P ZOOLOGICAL SOC LON, V1875, P567; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Hertwig ST, 2012, ZOOL SCR, V41, P29, DOI 10.1111/j.1463-6409.2011.00499.x; Kam YC, 1996, J HERPETOL, V30, P52, DOI 10.2307/1564706; Kamei RG, 2013, ZOOTAXA, V3666, P401, DOI 10.11646/zootaxa.3666.4.1; Kamei RG, 2012, P ROY SOC B-BIOL SCI, V279, P2396, DOI 10.1098/rspb.2012.0150; KURAMOTO M, 1987, COPEIA, P931; Li JT, 2008, MOL PHYLOGENET EVOL, V48, P302, DOI 10.1016/j.ympev.2008.03.023; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; Li JT, 2012, ZOOL SCR, V41, P557, DOI 10.1111/j.1463-6409.2012.00557.x; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; LIEM S S, 1970, Fieldiana Zoology, V57, P1; Maddison D. R., 2000, MACCLADE ANAL PHYLOG; Maglia AM, 2007, J MORPHOL, V268, P194, DOI 10.1002/jmor.10508; Matsui M, 2004, ZOOL SCI, V21, P671, DOI 10.2108/zsj.21.671; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Meegaskumbura M, 2015, ZOOL SCR, V44, P509, DOI 10.1111/zsc.12121; Meegaskumbura Madhava, 2010, Ceylon Journal of Science Biological Sciences, V39, P75; Miller M.A., 2010, P GAT COMP ENV WORKS; Mittermeier Russell A., 2004, P1; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pugener LA, 2009, J MORPHOL, V270, P52, DOI 10.1002/jmor.10665; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; Rowley JJL, 2012, J NAT HIST, V46, P2969, DOI 10.1080/00222933.2012.732622; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarkar A, 2006, STATE FAUNA SERIES 1, V13, P285; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Nguyen TT, 2015, MOL PHYLOGENET EVOL, V85, P59, DOI 10.1016/j.ympev.2015.02.003; Tao Thien Nguyen, 2014, Current Herpetology, V33, P101, DOI 10.5358/hsj.33.101; TAYLOR EDWARD H., 1962, UNIV KANSAS SCI BULL, V43, P265; TAYLOR W R, 1985, Cybium, V9, P107; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trueb L., 1973, P65; Vassilieva AB, 2013, J HERPETOL, V47, P607, DOI 10.1670/12-180; Vijayakumar SP, 2014, ZOOTAXA, V3893, P451, DOI 10.11646/zootaxa.3893.4.1; WASSERSUG RJ, 1981, J HERPETOL, V15, P41, DOI 10.2307/1563645; Wells KD., 2007, ECOLOGY BEHAV AMPHIB; Wolf S., 1936, Bulletin of the Raffles Museum Singapore, V12, P137; Yu GH, 2013, BIOCHEM SYST ECOL, V47, P31, DOI 10.1016/j.bse.2012.09.023; Yu GH, 2010, MOL PHYLOGENET EVOL, V56, P942, DOI 10.1016/j.ympev.2010.05.008	69	35	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145727	10.1371/journal.pone.0145727	http://dx.doi.org/10.1371/journal.pone.0145727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26790105	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100016
J	Franklin, ZC; Holmes, PS; Smith, NC; Fowler, NE				Franklin, Zoe C.; Holmes, Paul S.; Smith, Nickolas C.; Fowler, Neil E.			Personality Type Influences Attentional Bias in Individuals with Chronic Back Pain	PLOS ONE			English	Article							HIGH-ANXIOUS INDIVIDUALS; SOCIAL DESIRABILITY SCALE; CHRONIC-FATIGUE-SYNDROME; DEFENSIVE COPING STYLES; TRAIT ANXIETY; PHOTOGRAPH SERIES; INFORMATION; REPRESSORS; METAANALYSIS; THREAT	Attentional biases reflect an individual's selective attention to salient stimuli within their environment, for example an experience of back pain. Eysenck suggests that different personality types show different attentional biases to threatening information. This study is the first to test Eysenck's theory within a chronic back pain population by investigating the attentional biases of four different personality types using a back pain specific dot-probe paradigm. Participants were 70 volunteers (45 female) recruited from a back rehabilitation program at an NHS Trust. The four groups were selected on their trait anxiety and defensiveness scores: defensive high-anxious; high-anxious; repressor and non-extreme. Participants completed a dot probe task comprising 20 practice trials and 250 experimental trials. The experimental trials contained 100 threat-neutral pairs, 100 positive-neutral pairs and 50 neutral-neutral image pairings. The threat images were taken from the Photograph Series of Daily Activities (PHODA) and the neutral and positive images from the International Affective Picture System (IAPS) image bank. The results provided partial support for Eysenck's theory; defensive high-anxious individuals showed an attentional bias for threatening information compared to high-anxious individuals who demonstrated no bias. Repressors showed an avoidant bias to threatening images and an attentional bias to positive stimuli relative to neutral images. The clear difference in responses demonstrated by high-anxious individuals who vary in defensiveness highlight the need for separate investigation of these heterogeneous groups and help to explain the cognitive processes of defensive high-anxious individuals within a pain population. The demonstration of an attentional bias in this group to threatening information could explain why defensive high-anxious individuals are more likely to re-present for treatment.	[Franklin, Zoe C.; Holmes, Paul S.; Smith, Nickolas C.; Fowler, Neil E.] Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe Campus,Crewe Green Rd, Crewe CW1 5DU, Cheshire, England	Manchester Metropolitan University	Franklin, ZC (corresponding author), Manchester Metropolitan Univ, Ctr Hlth Exercise & Act Living, Crewe Campus,Crewe Green Rd, Crewe CW1 5DU, Cheshire, England.	z.franklin@mmu.ac.uk		Fowler, Neil/0000-0001-7452-3056; Franklin, Zoe/0000-0001-6130-8787	Institute for Performance Research at Manchester Metropolitan University as part of a PhD programme	Institute for Performance Research at Manchester Metropolitan University as part of a PhD programme	This research was funded by the Institute for Performance Research at Manchester Metropolitan University as part of a PhD programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barke A, 2012, PAIN, V153, P540, DOI 10.1016/j.pain.2011.11.012; Brosschot JF, 1999, PERS INDIV DIFFER, V26, P777, DOI 10.1016/S0191-8869(98)00173-1; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Creswell C, 2001, J PSYCHOSOM RES, V51, P607, DOI 10.1016/S0022-3999(01)00267-7; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Dehghani M, 2004, EUR J PAIN, V8, P585, DOI 10.1016/j.ejpain.2004.02.003; Dehghani M, 2003, PAIN, V105, P37, DOI 10.1016/S0304-3959(03)00224-0; Derakshan N, 2001, ANXIETY STRESS COPIN, V14, P285, DOI 10.1080/10615800108248358; Derakshan N, 2001, ANXIETY STRESS COPIN, V14, P173, DOI 10.1080/10615800108248353; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Eysenck M. W., 1997, ANXIETY COGNITION UN; Eysenck MW, 1997, PERS INDIV DIFFER, V22, P597, DOI 10.1016/S0191-8869(96)00258-9; FOX E, 1993, COGNITION EMOTION, V7, P207, DOI 10.1080/02699939308409185; Franklin ZC, 2014, PERS INDIV DIFFER, V64, P84, DOI 10.1016/j.paid.2014.02.020; Frasure-Smith N, 2002, PSYCHOSOM MED, V64, P571, DOI 10.1097/01.PSY.0000021950.04969.F8; HOLTGRAVES T, 1995, J RES PERS, V29, P306, DOI 10.1006/jrpe.1995.1018; Hou R, 2008, J PSYCHOSOM RES, V65, P47, DOI 10.1016/j.jpsychores.2008.03.008; Ioannou MC, 2004, PERS INDIV DIFFER, V36, P1879, DOI 10.1016/j.paid.2003.08.018; Jones KA, 2004, ANXIETY STRESS COPIN, V17, P187, DOI 10.1080/10615800410001710870; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Kugler K., 1999, PHOTOGRAPH SERIES DA, V1; Lang P.J., 2008, A8 U FLOR; Leeuw M, 2007, J PAIN, V8, P840, DOI 10.1016/j.jpain.2007.05.013; Lewis SE, 2012, PHYSIOTHERAPY, V98, P86, DOI 10.1016/j.physio.2011.10.003; Mogg K, 2000, PERS INDIV DIFFER, V28, P1063, DOI 10.1016/S0191-8869(99)00157-9; Myers LB, 1998, PERS INDIV DIFFER, V24, P299, DOI 10.1016/S0191-8869(97)00180-3; Prasertsri N, 2011, LUNG CANCER, V71, P235, DOI 10.1016/j.lungcan.2010.05.009; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Roelofs J, 2005, J PAIN, V6, P294, DOI 10.1016/j.jpain.2004.12.011; Schoth DE, 2013, COGN BEHAV THERAPY, V42, P233, DOI 10.1080/16506073.2013.777105; Schoth DE, 2012, CLIN PSYCHOL REV, V32, P13, DOI 10.1016/j.cpr.2011.09.004; Schoth DE, 2010, CLIN J PAIN, V26, P244, DOI 10.1097/AJP.0b013e3181bed0f9; Sharpe L, 2012, PAIN, V153, P722, DOI 10.1016/j.pain.2011.12.014; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; Todd J, 2015, PAIN, V156, P1589, DOI 10.1097/j.pain.0000000000000214; Trost Z, 2009, PAIN, V141, P276, DOI 10.1016/j.pain.2008.11.016; Waechter S, 2014, COGNITIVE THER RES, V38, P313, DOI 10.1007/s10608-013-9588-2; WEINBERGER DA, 1979, J ABNORM PSYCHOL, V88, P369, DOI 10.1037/0021-843X.88.4.369; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.	43	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147035	10.1371/journal.pone.0147035	http://dx.doi.org/10.1371/journal.pone.0147035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BW	26789517	Green Submitted, gold, Green Published			2022-12-27	WOS:000368529100053
J	Liu, SC; Jin, JQ; Ma, JQ; Yao, MZ; Ma, CL; Li, CF; Ding, ZT; Chen, L				Liu, Sheng-Chuan; Jin, Ji-Qiang; Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Li, Chun-Fang; Ding, Zhao-Tang; Chen, Liang			Transcriptomic Analysis of Tea Plant Responding to Drought Stress and Recovery	PLOS ONE			English	Article							GENE-EXPRESSION; SALICYLIC-ACID; DEHYDRATION; ACTIVATION; TOLERANCE; RESPONSES	Tea plant (Camellia sinensis) is an economically important beverage crop. Drought stress (DS) seriously limits the growth and development of tea plant, thus affecting crop yield and quality. To elucidate the molecular mechanisms of tea plant responding to DS, we performed transcriptomic analysis of tea plant during the three stages [control (CK) and during DS, and recovery (RC) after DS] using RNA sequencing (RNA-Seq). Totally 378.08 million high-quality trimmed reads were obtained and assembled into 59,674 unigenes, which were extensively annotated. There were 5,955 differentially expressed genes (DEGs) among the three stages. Among them, 3,948 and 1,673 DEGs were up-regulated under DS and RC, respectively. RNA-Seq data were further confirmed by qRT-PCR analysis. Genes involved in abscisic acid (ABA), ethylene, and jasmonic acid biosynthesis and signaling were generally up-regulated under DS and down-regulated during RC. Tea plant potentially used an exchange pathway for biosynthesis of indole-3-acetic acid (IAA) and salicylic acid under DS. IAA signaling was possibly decreased under DS but increased after RC. Genes encoding enzymes involved in cytokinin synthesis were up-regulated under DS, but down-regulated during RC. It seemed probable that cytokinin signaling was slightly enhanced under DS. In total, 762 and 950 protein kinases belonging to 26 families were differentially expressed during DS and RC, respectively. Overall, 547 and 604 transcription factor (TF) genes belonging to 58 families were induced in the DS vs. CK and RC vs. DS libraries, respectively. Most members of the 12 TF families were up-regulated under DS. Under DS, genes related to starch synthesis were down-regulated, while those related to starch decomposition were up-regulated. Mannitol, trehalose and sucrose synthesis-related genes were up-regulated under DS. Proline was probably mainly biosynthesized from glutamate under DS and RC. The mechanism by which ABA regulated stomatal movement under DS and RC was partly clarified. These results document the global and novel responses of tea plant during DS and RC. These data will serve as a valuable resource for drought-tolerance research and will be useful for breeding drought-resistant tea cultivars.	[Liu, Sheng-Chuan; Jin, Ji-Qiang; Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Li, Chun-Fang; Chen, Liang] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Liu, Sheng-Chuan] Guizhou Tea Res Inst, Guiyang, Guizhou, Peoples R China; [Ding, Zhao-Tang] Qingdao Agr Univ, Tea Res Inst, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou Academy of Agricultural Sciences; Qingdao Agricultural University	Chen, L (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	liangchen@tricaas.com	Chen, Liang/R-4438-2019; MINGZHE, YAO/AAH-7748-2021	Chen, Liang/0000-0002-7507-3947; 	Earmarked Fund for China Agriculture Research System [CARS-023]; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2014-TRICAAS]; National Natural Science Foundation of China [31170624, 31100504, 31400581]; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province [2012C12905]	Earmarked Fund for China Agriculture Research System; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-023), the Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2014-TRICAAS) to LC, the National Natural Science Foundation of China (nos. 31170624, 31100504 and 31400581) and the Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province (2012C12905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Chen LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-687; Cheruiyot EK, 2010, J PLANT NUTR, V33, P115, DOI 10.1080/01904160903392659; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Das A, 2015, J ENVIRON BIOL, V36, P875; Das A, 2012, PLANT MOL BIOL REP, V30, P1088, DOI 10.1007/s11105-012-0422-x; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Djilianov DL, 2013, J PLANT GROWTH REGUL, V32, P564, DOI 10.1007/s00344-013-9323-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farre G, 2014, ANNU REV PLANT BIOL, V65, P187, DOI 10.1146/annurev-arplant-050213-035825; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Gao F, 2015, PLOS ONE, V4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granot D, 2014, J EXP BOT, V65, P809, DOI 10.1093/jxb/ert400; Gupta S, 2013, MOL BIOTECHNOL, V53, P237, DOI 10.1007/s12033-012-9517-8; Gupta S, 2012, FUNCT INTEGR GENOMIC, V12, P543, DOI 10.1007/s10142-012-0277-0; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iyer NJ, 2013, PLANT CELL ENVIRON, V36, P706, DOI 10.1111/pce.12008; Jimenez S, 2013, TREE PHYSIOL, V33, P1061, DOI 10.1093/treephys/tpt074; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Kang NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079248; Kang Y, 2013, PLANT CELL ENVIRON, V36, P706; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Klein T, 2014, TREE PHYSIOL, V34, P981, DOI 10.1093/treephys/tpu071; Komatsu K, 2013, NATURE, V4, P3219, DOI DOI 10.1038/NC0M; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Kumar V, 2013, TRANSGENIC RES, V22, P359, DOI 10.1007/s11248-012-9652-9; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li M. R., 2013, ELECT J DIFFERENTIAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0059582; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Liu JY, 2014, PLOS ONE, V5; Liu SC, 2015, SCI HORTIC-AMSTERDAM, V184, P129, DOI 10.1016/j.scienta.2014.12.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma HS, 2010, J EXP BOT, V61, P4011, DOI 10.1093/jxb/erq217; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahouachi J, 2007, PLANT GROWTH REGUL, V53, P43, DOI 10.1007/s10725-007-9202-2; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Maritim TK, 2015, J HORTIC SCI BIOTECH, V90, P395, DOI 10.1080/14620316.2015.11513200; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song SS, 2014, CURR OPIN PLANT BIOL, V21, P112, DOI 10.1016/j.pbi.2014.07.005; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Wan LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025216; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weijers D, 2009, CELL, V136, P1172, DOI 10.1016/j.cell.2009.03.009; Wu J, 2014, PLOS ONE, V10; Xia ST, 2013, PLANT PHYSIOL, V162, P1694, DOI 10.1104/pp.113.214551; Yang YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YW, 2014, NEUROSCI LETT, V562, P1, DOI 10.1016/j.neulet.2014.01.006	69	149	158	18	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0147306	10.1371/journal.pone.0147306	http://dx.doi.org/10.1371/journal.pone.0147306			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26788738	Green Published, gold, Green Submitted			2022-12-27	WOS:000368529100074
J	Matowo, NS; Koekemoer, LL; Moore, SJ; Mmbando, AS; Mapua, SA; Coetzee, M; Okumu, FO				Matowo, Nancy S.; Koekemoer, Lizette L.; Moore, Sarah J.; Mmbando, Arnold S.; Mapua, Salum A.; Coetzee, Maureen; Okumu, Fredros O.			Combining Synthetic Human Odours and Low-Cost Electrocuting Grids to Attract and Kill Outdoor-Biting Mosquitoes: Field and Semi-Field Evaluation of an Improved Mosquito Landing Box	PLOS ONE			English	Article							VECTOR ANOPHELES-ARABIENSIS; POLYMERASE-CHAIN-REACTION; INSECTICIDE-TREATED NETS; EXPERIMENTAL HUT TRIALS; BLOOD-FEEDING BEHAVIOR; HOST-SEEKING BEHAVIOR; MALARIA TRANSMISSION; PLASMODIUM-FALCIPARUM; CARBON-DIOXIDE; WESTERN KENYA	Background On-going malaria transmission is increasingly mediated by outdoor-biting vectors, especially where indoor insecticidal interventions such as long-lasting insecticide treated nets (LLINs) are widespread. Often, the vectors are also physiologically resistant to insecticides, presenting major obstacles for elimination. We tested a combination of electrocuting grids with synthetic odours as an alternative killing mechanism against outdoor-biting mosquitoes. Methods An odour-baited device, the Mosquito Landing Box (MLB), was improved by fitting it with low-cost electrocuting grids to instantly kill mosquitoes attracted to the odour lure, and automated photo switch to activate attractant-dispensing and mosquito-killing systems between dusk and dawn. MLBs fitted with one, two or three electrocuting grids were compared outdoors in a malaria endemic village in Tanzania, where vectors had lost susceptibility to pyrethroids. MLBs with three grids were also tested in a large semi-field cage (9.6x9.6x4.5m), to assess effects on biting-densities of laboratory-reared Anopheles arabiensis on volunteers sitting near MLBs. Results Significantly more mosquitoes were killed when MLBs had two or three grids, than one grid in wet and dry seasons (P<0.05). The MLBs were highly efficient against Mansonia species and malaria vector, An. arabiensis. Of all mosquitoes, 99% were non-blood fed, suggesting host-seeking status. In the semi-field, the MLBs reduced mean number of malaria mosquitoes attempting to bite humans fourfold. Conclusion The improved odour-baited MLBs effectively kill outdoor-biting malaria vector mosquitoes that are behaviourally and physiologically resistant to insecticidal interventions e.g. LLINs. The MLBs reduce human-biting vector densities even when used close to humans, and are insecticide-free, hence potentially antiresistance. The devices could either be used as surveillance tools or complementary mosquito control interventions to accelerate malaria elimination where outdoor transmission is significant.	[Matowo, Nancy S.; Moore, Sarah J.; Mmbando, Arnold S.; Mapua, Salum A.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm & Ecol Sci Themat Grp, Dar Es Salaam, Tanzania; [Matowo, Nancy S.; Koekemoer, Lizette L.; Coetzee, Maureen] Univ Witwatersrand, Sch Pathol, Wits Res Inst Malaria, Fac Hlth Sci, Johannesburg, South Africa; [Koekemoer, Lizette L.; Coetzee, Maureen] Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Infect, Johannesburg, South Africa; [Moore, Sarah J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Moore, Sarah J.] Univ Basel, Basel, Switzerland; [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa	Ifakara Health Institute; University of Witwatersrand; National Institute for Communicable Diseases (NICD); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Witwatersrand	Matowo, NS (corresponding author), Ifakara Hlth Inst, Environm & Ecol Sci Themat Grp, Dar Es Salaam, Tanzania.; Matowo, NS (corresponding author), Univ Witwatersrand, Sch Pathol, Wits Res Inst Malaria, Fac Hlth Sci, Johannesburg, South Africa.	nstephen@ihi.or.tz	Coetzee, Maureen/AAI-1413-2020; Mapua, Salum Abdallah/HGB-8797-2022; Coetzee, Maureen/AAW-4739-2020; Moore, Sarah J/HGE-7143-2022	Coetzee, Maureen/0000-0003-2019-866X; Mapua, Salum Abdallah/0000-0002-3309-4328; Moore, Sarah J/0000-0002-0938-6654; Koekemoer, Lizette/0000-0003-4236-6345; Matowo, Nancy/0000-0002-2302-3796	Bill and Melinda Gates Foundation [53214, OPP103574]; Low and Middle Income Countries Stars in Global Health Program at the Grand Challenges Canada [0012-01-01-01-01]; Wellcome Trust [WT104029/Z/14/Z, WT102350/Z/13/Z]; DST/NRF South African Research Chairs Initiative grant; Bill & Melinda Gates Foundation [OPP1081737]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Low and Middle Income Countries Stars in Global Health Program at the Grand Challenges Canada; Wellcome Trust(Wellcome TrustEuropean Commission); DST/NRF South African Research Chairs Initiative grant(Department of Science & Technology (India)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Global Health Discovery program of the Bill and Melinda Gates Foundation through Grand Challenges Explorations Award (Grant Number: 53214 and OPP103574), the Low and Middle Income Countries Stars in Global Health Program at the Grand Challenges Canada (Grant Number: 0012-01-01-01-01) awarded to FOO. Websites links available at http://gcgh.grandchallenges.org/explorations/pages/introduction.aspx and http://www.grandchallenges.ca/. Wellcome Trust Masters Fellowship (Grant number: WT104029/Z/14/Z) awarded to the lead author, NSM. http://www.wellcome.ac.uk/. FOO is also supported by a Wellcome Trust Intermediate Research Fellowship (Grant number: WT102350/Z/13/Z). http://www.wellcome.ac.uk/. MC is supported by a DST/NRF South African Research Chairs Initiative grant. SJM is supported by Bill & Melinda Gates Foundation OPP1081737 administered by Notre Dame University, http://gcgh.grandchallenges.org/ explorations/pages/introduction.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; [Anonymous], 1987, JPSAIM; Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; BEIER JC, 1990, J MED ENTOMOL, V27, P377, DOI 10.1093/jmedent/27.3.377; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Biogents, 2014, BIOG MIM HUM SCENT; Bolker B., 2012, GETTING STARTED GLMM; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briet OJT, 2003, TROP MED INT HEALTH, V8, P439, DOI 10.1046/j.1365-3156.2003.01054.x; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Costantini C., 1993, Parassitologia (Rome), V35, P5; DAVIDSON G, 1953, B ENTOMOL RES, V44, P231, DOI 10.1017/S0007485300023051; Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104; Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005; ELLIOTT R, 1968, B WORLD HEALTH ORGAN, V38, P239; ESRF U, 2014, TANZ HUM DEV REP; Ferguson HM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-158; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Frick TB, 1996, ENTOMOL NEWS, V107, P77; GILLIES M. T., 1960, BULL ENT RES, V51, P243, DOI 10.1017/S0007485300057953; Gillies M. T., 1968, S A Inst med Res Johannesburg Publ, VNo. 54, P1; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Hiscox A, 2012, MALAR J S1, V11, P45; Huho B, 2012, MALARIA J, V11, pP50; Kawada H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-230; Knols BGJ, 1998, MED VET ENTOMOL, V12, P116, DOI 10.1046/j.1365-2915.1998.00087.x; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Koekemoer LL, 2001, J AM MOSQUITO CONTR, V17, P160; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Lwetoijera D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-161; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Majambere S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-53; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mboera LEG, 1997, B ENTOMOL RES, V87, P173, DOI 10.1017/S0007485300027322; McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614; MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Moiroux N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104967; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; MUIRHEAD-THOMSON R C, 1960, Bull World Health Organ, V22, P721; Mukabana WR, 2002, THESIS WAGENINGEN U; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mweresa CK, 2014, MALARIA J, V13, P1; National Bureau of Statistics (NBS) [Tanzania] & ICF Macro, 2010, TANZ DEM HLTH SURV; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; Ng'habi KRN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-356; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu Fredros O, 2012, Malar J, V11, P378, DOI 10.1186/1475-2875-11-378; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; R Core Team, 2012, R LANG ENV STAT COMP; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x; Ratovonjato J, 2011, VECTOR-BORNE ZOONOT, V11, P753, DOI 10.1089/vbz.2010.0031; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314; STEPHENS C, 1995, B WORLD HEALTH ORGAN, V73, P97; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; TORR SJ, 1988, PHYSIOL ENTOMOL, V13, P453, DOI 10.1111/j.1365-3032.1988.tb01130.x; Urban JE, 2000, CURR MICROBIOL, V41, P267, DOI 10.1007/s002840010132; VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059; VALE GA, 1974, B ENTOMOL RES, V64, P199, DOI 10.1017/S0007485300031084; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2013, TEST PROC INREMO; Wilkes TJ, 1996, MED VET ENTOMOL, V10, P108, DOI 10.1111/j.1365-2915.1996.tb00092.x; World Health Organization, 2012, WHO GLOB MAL PROGR G; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	93	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2016	11	1							e0145653	10.1371/journal.pone.0145653	http://dx.doi.org/10.1371/journal.pone.0145653			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BW	26789733	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000368529100013
J	Schobel, M; Rieskamp, J; Huber, R				Schoebel, Markus; Rieskamp, Joerg; Huber, Rafael			Social Influences in Sequential Decision Making	PLOS ONE			English	Article							INFORMATION CASCADES; CONFORMITY; RULE; OVERCONFIDENCE	People often make decisions in a social environment. The present work examines social influence on people's decisions in a sequential decision-making situation. In the first experimental study, we implemented an information cascade paradigm, illustrating that people infer information from decisions of others and use this information to make their own decisions. We followed a cognitive modeling approach to elicit the weight people give to social as compared to private individual information. The proposed social influence model shows that participants overweight their own private information relative to social information, contrary to the normative Bayesian account. In our second study, we embedded the abstract decision problem of Study 1 in a medical decision-making problem. We examined whether in a medical situation people also take others' authority into account in addition to the information that their decisions convey. The social influence model illustrates that people weight social information differentially according to the authority of other decision makers. The influence of authority was strongest when an authority's decision contrasted with private information. Both studies illustrate how the social environment provides sources of information that people integrate differently for their decisions.	[Schoebel, Markus; Rieskamp, Joerg; Huber, Rafael] Univ Basel, Econ Psychol, Dept Psychol, Basel, Switzerland	University of Basel	Schobel, M (corresponding author), Univ Basel, Econ Psychol, Dept Psychol, Basel, Switzerland.	m.schoebel@unibas.ch	Rieskamp, Joerg/D-4004-2013	Rieskamp, Joerg/0000-0003-2632-8015				ALLEN VL, 1965, ADV EXP SOC PSYCHOL, V2, P133; ALLEN VL, 1971, J EXP SOC PSYCHOL, V7, P48, DOI 10.1016/0022-1031(71)90054-0; Anderson LR, 1997, AM ECON REV, V87, P847; Anderson LR, 2001, ECON INQ, V39, P609, DOI 10.1093/ei/39.4.609; Asch S.E., 1951, GROUPS LEADERSHIP ME, P177, DOI DOI 10.1037/10025-01; Asch SE, 1951, PSYCHOL MONOGR, V70, P1; Bernardo AE, 2001, J ECON MANAGE STRAT, V10, P301, DOI 10.1111/j.1430-9134.2001.00301.x; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bugental DB, 2000, PSYCHOL BULL, V126, P187, DOI 10.1037/0033-2909.126.2.187; Chaiken S., 1996, SOCIAL PSYCHOL HDB B, P702; Cialdini R. B., 1999, SHARED COGNITION ORG, P195; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Edwards W., 1968, FORMAL REPRESENTATIO, P17; Epley N, 1999, J EXP SOC PSYCHOL, V35, P578, DOI 10.1006/jesp.1999.1390; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Goeree JK, 2007, REV ECON STUD, V74, P733, DOI 10.1111/j.1467-937X.2007.00438.x; GRETHER DM, 1980, Q J ECON, V95, P537, DOI 10.2307/1885092; Huck S, 2000, J ECON PSYCHOL, V21, P661, DOI 10.1016/S0167-4870(00)00025-8; Hung AA, 2001, AM ECON REV, V91, P1508, DOI 10.1257/aer.91.5.1508; INSKO CA, 1983, J EXP SOC PSYCHOL, V19, P341, DOI 10.1016/0022-1031(83)90027-6; KAPLAN MF, 1987, J PERS SOC PSYCHOL, V53, P306, DOI 10.1037/0022-3514.53.2.306; Kaplan MF, 1983, BASIC GROUP PROCESSE, P65; Kaplan MF, 1987, REV PERSONALITY SOCI, P188; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Kruschke J. K., 2011, DOING BAYESIAN DATA; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Kruschke JK, 2010, TRENDS COGN SCI, V14, P293, DOI 10.1016/j.tics.2010.05.001; Kubler D, 2005, J EUR ECON ASSOC, V3, P330, DOI 10.1162/jeea.2005.3.2-3.330; Laughlin P.R., 1980, PROGR SOCIAL PSYCHOL, V1, P127; Levine JM, 1987, REV PERSONALITY SOCI, V8, P13; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Noth M, 2003, ECON J, V113, P166, DOI 10.1111/1468-0297.00091; Pendry L, 2001, EUR J SOC PSYCHOL, V31, P83, DOI 10.1002/ejsp.33; PHILLIPS LD, 1966, J EXP PSYCHOL, V72, P346, DOI 10.1037/h0023653; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Sherif M., 1935, STUDY SOME SOCIAL FA, DOI DOI 10.1037/H0060783; Tajfel, 1969, HDB SOCIAL PSYCHOL; Weizsacker G, 2010, AM ECON REV, V100, P2340, DOI 10.1257/aer.100.5.2340; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539	41	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146536	10.1371/journal.pone.0146536	http://dx.doi.org/10.1371/journal.pone.0146536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB5BP	26784448	Green Submitted, gold, Green Published			2022-12-27	WOS:000368528400045
J	Teixeira, C; Barbault, F; Couesnon, T; Gomes, JRB; Gomes, P; Maurel, F				Teixeira, Catia; Barbault, Florent; Couesnon, Thierry; Gomes, Jose R. B.; Gomes, Paula; Maurel, Francois			Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target?	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CONFORMATIONAL TRANSITION; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; SIMULATION; PROTEIN; FUSION; STATE; CORE	HIV-1 gp41 facilitates the viral fusion through a conformational switch involving the association of three C-terminal helices along the conserved hydrophobic grooves of three N-terminal helices coiled-coil. The control of these structural rearrangements is thought to be central to HIV-1 entry and, therefore, different strategies of intervention are being developed. Herewith, we describe a procedure to simulate the folding of an HIV-1 gp41 simplified model. This procedure is based on the construction of plausible conformational pathways, which describe protein transition between non-fusogenic and fusogenic conformations. The calculation of the paths started with 100 molecular dynamics simulations of the non-fusogenic conformation, which were found to converge to different intermediate states. Those presenting defined criteria were selected for separate targeted molecular dynamics simulations, subjected to a force constant imposing a movement towards the gp41 fusogenic conformation. Despite significant diversity, a preferred sequence of events emerged when the simulations were analyzed in terms of the formation, breakage and evolution of the contacts. We pointed out 29 residues as the most relevant for the movement of gp41; also, 2696 possible interactions were reduced to only 48 major interactions, which reveals the efficiency of the method. The analysis of the evolution of the main interactions lead to the detection of four main behaviors for those contacts: stable, increasing, decreasing and repulsive interactions. Altogether, these results suggest a specific small cavity of the HIV-1 gp41 hydrophobic groove as the preferred target to small molecules.	[Teixeira, Catia; Barbault, Florent; Couesnon, Thierry; Maurel, Francois] Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst ITODY, CNRS, UMR 7086, 15 Rue Jean Antoine Baif, F-75205 Paris 13, France; [Teixeira, Catia; Gomes, Paula] Univ Aveiro, Dept Quim, CICECO, Inst Mat Aveiro, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Teixeira, Catia; Gomes, Paula] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, Rua Campo Alegre 687, P-4169007 Oporto, Portugal	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universidade de Aveiro; Universidade do Porto	Teixeira, C (corresponding author), Univ Paris 07, Lab Interfaces Traitements Org & Dynam Syst ITODY, CNRS, UMR 7086, 15 Rue Jean Antoine Baif, F-75205 Paris 13, France.; Teixeira, C (corresponding author), Univ Aveiro, Dept Quim, CICECO, Inst Mat Aveiro, Campus Univ Santiago, P-3810193 Aveiro, Portugal.; Teixeira, C (corresponding author), Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, Rua Campo Alegre 687, P-4169007 Oporto, Portugal.	ca.teixeira@ua.pt	Barbault, Florent/F-6779-2010; Teixeira, Cátia/AEG-3309-2022; Teixeira, Cátia AS/B-5680-2011; Barbault, Florent/X-8525-2019; Gomes, José R. B./D-5442-2009; Gomes, Paula A. C./C-6698-2008	Teixeira, Cátia/0000-0001-9506-3781; Teixeira, Cátia AS/0000-0001-9506-3781; Barbault, Florent/0000-0002-6082-3194; Gomes, José R. B./0000-0001-5993-1385; Gomes, Paula A. C./0000-0002-6018-4724	FCT/MEC [POCI-01-0145-FEDER-007679, UID/CTM/50011/2013, UID/MULTI/04378/2013]; FEDER [FCOMP-01-0124-FEDER-041066]; Portuguese National Funds through FCT/MEC [EXPL/QEQ-COM/0927/2013]; FCT [SFRH/BPD/62967/2009]; European Union [SFRH/BPD/62967/2009]	FCT/MEC; FEDER(European Commission); Portuguese National Funds through FCT/MEC; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Union(European Commission)	This work was developed within the scope of the projects CICECO-Aveiro Institute of Materials, POCI-01-0145-FEDER-007679 (FCT Ref. UID/CTM/50011/2013), and UCIBIO-Research Unit on Applied Molecular Biosciences, (FCT Ref. UID/MULTI/04378/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. This research work was mainly supported by FEDER funds through "Programa Operacional Factores de Competitividade" - COMPETE (ref FCOMP-01-0124-FEDER-041066 and PT2020 Partnership Agreement) and by Portuguese National Funds through FCT/MEC (ref EXPL/QEQ-COM/0927/2013). CT and JRBG thank the FCT for the post-doctoral grant (SFRH/BPD/62967/2009) and the "Investigador FCT" program, respectively. SFRH/BPD/62967/2009 is part of the European & Developing Countries Clinical Trials Partnership (EDCTP2) program supported by the European Union.; .	[Anonymous], SYBYL 7 3; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Ferrara P, 2000, PROTEINS, V39, P252, DOI 10.1002/(SICI)1097-0134(20000515)39:3<252::AID-PROT80>3.0.CO;2-3; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Kohn JE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000911; Kruger P, 2001, PROTEIN SCI, V10, P798, DOI 10.1110/ps.40401; Li CQ, 2014, INT J MOL SCI, V15, P5553, DOI 10.3390/ijms15045553; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Markwick PRL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000168; Milne JLS, 2013, FEBS J, V280, P28, DOI 10.1111/febs.12078; Sanders RW, 2002, HIV SEQUENCE COMPEND; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Teixeira C, 2011, EUR J MED CHEM, V46, P979, DOI 10.1016/j.ejmech.2011.01.046; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0	24	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2016	11	1							e0146743	10.1371/journal.pone.0146743	http://dx.doi.org/10.1371/journal.pone.0146743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB5BP	26785380	Green Submitted, Green Published, gold			2022-12-27	WOS:000368528400063
J	Marques, ARA; Gabriel, TL; Aten, J; van Roomen, CPAA; Ottenhoff, R; Claessen, N; Alfonso, P; Irun, P; Giraldo, P; Aerts, JMFG; van Eijk, M				Marques, Andre R. A.; Gabriel, Tanit L.; Aten, Jan; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Claessen, Nike; Alfonso, Pilar; Irun, Pilar; Giraldo, Pilar; Aerts, Johannes M. F. G.; van Eijk, Marco			Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease	PLOS ONE			English	Article							LIPID STORAGE DISORDER; GAUCHER-DISEASE; CHOLESTEROL; MOUSE; MACROPHAGES; EXPRESSION; LIVER; TRAFFICKING; METABOLISM; INHIBITORS	Impaired function of NPC1 or NPC2 lysosomal proteins leads to the intracellular accumulation of unesterified cholesterol, the primary defect underlying Niemann-Pick type C (NPC) disease. In addition, glycosphingolipids (GSLs) accumulate in lysosomes as well. Intralysosomal lipid accumulation triggers the activation of a set of genes, including potential biomarkers. Transcript levels of Gpnmb have been shown to be elevated in various tissues of an NPC mouse model. We speculated that Gpnmb could serve as a marker for visceral lipid accumulation in NPC disease. We report that Gpnmb expression is increased at protein level in macrophages in the viscera of Npc1(nih/nih) mice. Interestingly, soluble Gpnmb was also found to be increased in murine and NPC patient plasma. Exposure of RAW264.7 macrophages to the NPC-phenotype-inducing drug U18666A also upregulated Gpnmb expression. Inhibition of GSL synthesis with the glucosylceramide synthase (GCS) inhibitor N-butyl-1-deoxynojirimycin prevented U18666A-induced Gpnmb induction and secretion. In summary, we show that Gpnmb is upregulated in NPC mice and patients, most likely due to GSL accumulation.	[Marques, Andre R. A.; Gabriel, Tanit L.; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; Aerts, Johannes M. F. G.; van Eijk, Marco] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan; Claessen, Nike] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Alfonso, Pilar; Irun, Pilar; Giraldo, Pilar] Ctr Invest Biomed Red Enfermedades Raras, Unidad Invest Traslac, Zaragoza, Spain; [Aerts, Johannes M. F. G.; van Eijk, Marco] Leiden Univ, Dept Biochem, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Leiden University; Leiden University - Excl LUMC	van Eijk, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; van Eijk, M (corresponding author), Leiden Univ, Dept Biochem, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands.	m.c.van.eijk@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Aerts, Johannes/A-1028-2009; Irun, Pilar/ABG-9652-2020	Marques, André R. A./0000-0001-9674-3017; Aerts, Johannes/0000-0001-8168-2565; Irun, Pilar/0000-0003-3392-7200; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112	ERC-advanced program of the EU [290836]	ERC-advanced program of the EU	Johannes Aerts was supported by the ERC-advanced (290836) program of the EU.	Alam MS, 2014, J BIOL CHEM, V289, P8051, DOI 10.1074/jbc.M113.526392; Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; BESLEY GTN, 1983, BIOCHIM BIOPHYS ACTA, V752, P54, DOI 10.1016/0005-2760(83)90232-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2006, J INHERIT METAB DIS, V29, P564, DOI 10.1007/s10545-006-0318-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2014, J INHERIT METAB DIS, V37, P83, DOI 10.1007/s10545-013-9610-6; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; German DC, 2001, NEUROSCIENCE, V105, P999, DOI 10.1016/S0306-4522(01)00230-5; Giese AK, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0274-1; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; HEIDER JG, 1978, J LIPID RES, V19, P514; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lombardo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038520; Lopez ME, 2012, HUM MOL GENET, V21, P2946, DOI 10.1093/hmg/dds126; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; MORRIS MD, 1982, AM J PATHOL, V108, P140; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; PLATT FM, 1994, J BIOL CHEM, V269, P27108; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Ries M, 2006, J INHERIT METAB DIS, V29, P647, DOI 10.1007/s10545-006-0363-3; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Salvioli R, 2004, J BIOL CHEM, V279, P17674, DOI 10.1074/jbc.M313517200; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Sillence DJ, 2013, MOL GENET METAB, V109, P194, DOI 10.1016/j.ymgme.2013.03.015; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Welford RWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114669; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zigdon H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120194	52	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147208	10.1371/journal.pone.0147208	http://dx.doi.org/10.1371/journal.pone.0147208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771826	Green Published, gold, Green Submitted			2022-12-27	WOS:000368628300072
J	Naidu, VV; Ismail, K; Amiel, S; Kohli, R; Crosby-Nwaobi, R; Sivaprasad, S; Stewart, R				Naidu, Vasanth Venkat; Ismail, Khalida; Amiel, Stephanie; Kohli, Reena; Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha; Stewart, Robert			Associations between Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Control Study	PLOS ONE			English	Article							VASCULAR TORTUOSITY; TELEPHONE INTERVIEW; STATUS TICS; RETINOPATHY; DEMENTIA; RISK; ABNORMALITIES; HYPERTENSION; DECLINE; ANGIOGENESIS	Objective To investigate associations between retinal microvascular changes and cognitive impairment in newly diagnosed type 2 diabetes mellitus. Design Case control study. Setting A primary care cohort with newly diagnosed type 2 diabetes mellitus. Methods For this analysis, we compared 69 cases with lowest decile scores (for the cohort) on the Modified Telephone Interview for Cognitive Status and 68 controls randomly selected from the remainder of the cohort. Retinal images were rated and the following measures compared between cases and controls: retinal vessel calibre, arterio-venous ratio, retinal fractal dimension, and simple and curvature retinal vessel tortuosity. Results Total and venular (but not arteriolar) simple retinal vessel tortuosity levels were significantly higher in cases than controls (t = 2.45, p = 0.015; t = 2.53, p = 0.013 respectively). The associations persisted after adjustment for demographic factors, retinopathy, neuropathy, obesity and blood pressure. There were no other significant differences between cases and controls in retinal measures. Conclusions A novel association was found between higher venular tortuosity and cognitive impairment in newly diagnosed type 2 diabetes mellitus. This might be accounted for by factors such as hypoxia, thrombus formation, increased vasoendothelial growth factor release and inflammation affecting both the visible retinal and the unobserved cerebral microvasculature.	[Naidu, Vasanth Venkat; Ismail, Khalida; Amiel, Stephanie; Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha; Stewart, Robert] Kings Coll London, London WC2R 2LS, England; [Kohli, Reena] Kent & Medway NHS & Social Care Partnership Trust, Maidstone, Kent, England; [Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha] NIHR Moorfields Biomed Res Ctr, London, England	University of London; King's College London	Naidu, VV (corresponding author), Kings Coll London, London WC2R 2LS, England.	vasanth.naidu@kcl.ac.uk	Stewart, Robert/B-1667-2010; Sivaprasad, S./D-6876-2015	Stewart, Robert/0000-0002-4435-6397; Sivaprasad, S./0000-0001-8952-0659; Ismail, Khalida/0000-0001-6084-449X	King's College Hospital R&D research initiative grant [KCH1039]; National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research [RP-PG-0606-1142] Funding Source: researchfish	King's College Hospital R&D research initiative grant; National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grant KCH1039, King's College Hospital R&D research initiative grant. The funding was received by Sobha Sivaprasad (SS). Robert Stewart (RS) is part-funded by the National Institute of Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London.	Arden GB, 2011, CURR DIABETES REV, V7, P291, DOI 10.2174/157339911797415620; Ba-Tin L, 2011, CARDIOVASCULAR PSYCH, V2011; Barber M, 2004, INT J GERIATR PSYCH, V19, P75, DOI 10.1002/gps.1041; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chesnutt JKW, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005478; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cines DB, 1998, BLOOD, V91, P3527; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Crosby-Nwaobi R, 2012, DIABETES RES CLIN PR, V96, P101, DOI 10.1016/j.diabres.2011.11.010; Crosby-Nwaobi R, 2012, OPHTHALMOLOGICA, V228, P84, DOI 10.1159/000337252; Crosby-Nwaobi RR, 2013, DIABETES CARE, V36, P3177, DOI 10.2337/dc12-2141; de Bresser J, 2010, DEMENT GERIATR COGN, V30, P381, DOI 10.1159/000321354; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Gasecki D, 2013, CURR HYPERTENS REP, V15, P547, DOI 10.1007/s11906-013-0398-4; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58; Hughes AD, 2006, J HYPERTENS, V24, P889, DOI 10.1097/01.hjh.0000222759.61735.98; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kadoi Y, 2005, J THORAC CARDIOV SUR, V129, P576, DOI 10.1016/j.jtcvs.2004.07.012; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; MacCormick IJC, 2012, HIGH ALT MED BIOL, V13, P263, DOI 10.1089/ham.2011.1097; Mariani E, 2007, J ALZHEIMERS DIS, V12, P23; Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; Sasongko MB, 2010, DIABETES CARE, V33, P1331, DOI 10.2337/dc10-0055; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Seo EH, 2011, ARCH GERONTOL GERIAT, V52, pE26, DOI 10.1016/j.archger.2010.04.008; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Winkley K, 2013, DIABETOLOGIA, V56, P1272, DOI 10.1007/s00125-013-2873-5; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yau JWY, 2010, DIABETOLOGIA, V53, P2042, DOI 10.1007/s00125-010-1811-z	43	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147160	10.1371/journal.pone.0147160	http://dx.doi.org/10.1371/journal.pone.0147160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771382	Green Submitted, Green Published, gold			2022-12-27	WOS:000368628300068
J	Semlali, A; Parine, NR; Arafah, M; Mansour, L; Azzi, A; Al Shahrani, O; Al Amri, A; Shaik, JP; Aljebreen, AM; Alharbi, O; Almadi, MA; Azzam, NA; Kohailan, M; Rouabhia, M; Alanazi, MS				Semlali, Abdelhabib; Parine, Narasimha Reddy; Arafah, Maha; Mansour, Lamjed; Azzi, Arezki; Al Shahrani, Omair; Al Amri, Abdullah; Shaik, Jilani P.; Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali; Kohailan, Muhammad; Rouabhia, Mahmoud; Alanazi, Mohammad Saud			Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-kappa B Mediated Inflammation in Colon Cancer Patients	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PATTERN-RECOGNITION RECEPTORS; DOUBLE-EDGED-SWORD; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; THR399ILE POLYMORPHISMS; SIGNAL-TRANSDUCTION; INNATE IMMUNITY; BREAST-CANCER	Our aim was to evaluate the association between the expression and the polymorphism of TLR4/NF-kappa B pathways and colon cancer. TLR4 (rs4986790, rs10759932, rs10759931 and rs2770150) were genotyped in blood samples from Colorectal patients and healthy controls. TLR4 and cytokines inflammatory expression were evaluated by real time PCR on 40 matching normal and colon tissues and the protein level by Immunohistochemistry. The high level of TLR4 expression in colon cancer tissues is mainly due to infections by bacteria in the human colon and leads to induction of an acute secretion of inflammatory cytokines mediated by NF-kappa B. Also, we report here a clear evidence for an association between TLR4 rs10759931 polymorphism (OR = 0.086, CI: 0.04-0.18, P = <0.00001). This polymorphism affects the entire population without being specific to either gender or to any age group. In contrast, the rs2770150 is associated with colon cancer in women aged over 50 years and is closely linked with the decreased levels of female sex hormones during the post-menopausal period (OR = 0.188, CI: 0.074-0.48, P = <0.00084). rs10759932 and rs4986790 appear to have any association with colon cancer. Our data suggest that TLR4 SNPs could possibly serve as biomarkers for decision making in colon cancer treatment.	[Semlali, Abdelhabib; Parine, Narasimha Reddy; Al Shahrani, Omair; Al Amri, Abdullah; Shaik, Jilani P.; Kohailan, Muhammad; Alanazi, Mohammad Saud] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Arafah, Maha; Aljebreen, Abdulrahman M.; Alharbi, Othman; Azzam, Nahla Ali] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Aljebreen, Abdulrahman M.; Alharbi, Othman; Almadi, Majid A.; Azzam, Nahla Ali] King Saud Univ, King Khalid Univ Hosp, Div Gastroenterol, Riyadh, Saudi Arabia; [Almadi, Majid A.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada; [Rouabhia, Mahmoud] Univ Laval, Fac Med Dent, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Mansour, Lamjed] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Azzi, Arezki] Al Imam Muhammad Ibn Saud Islamic Univ IMSIU, Coll Med, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Khalid University Hospital; McGill University; Laval University; King Saud University; Imam Mohammad Ibn Saud Islamic University (IMSIU)	Semlali, A (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	asemlali@ksu.edu.sa	MANSOUR, Lamjed/AAO-6201-2020; Parine, Narasimha Reddy/B-7975-2011; Mansour, Lamjed/AAD-8613-2019; Alamri, Abdullah M/C-3108-2012; Mansour, Lamjed/U-3028-2017; Arafah, Maha/GZM-4328-2022; Almadi, Majid A/K-7819-2017; Semlali, Abdelhabib/AAP-7043-2020	MANSOUR, Lamjed/0000-0002-9415-9383; Parine, Narasimha Reddy/0000-0002-0765-9022; Alamri, Abdullah M/0000-0002-3045-1350; Mansour, Lamjed/0000-0002-9415-9383; Arafah, Maha/0000-0003-4966-2358; Almadi, Majid A/0000-0001-9917-2758; Semlali, Abdelhabib/0000-0002-1643-0377; Rouabhia, Mahmoud/0000-0003-2205-8281	Kingdom of Saudi Arabia [RGP-VPP-260]	Kingdom of Saudi Arabia	This work was supported by Grant number RGP-VPP-260, http://dsrs.ksu.edu.sa/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the research group program (number RGP-VPP-260) in the Kingdom of Saudi Arabia.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahmed A, 2013, ANN SURG ONCOL, V20, pS389, DOI 10.1245/s10434-012-2595-9; Al-Azzawi F, 2002, CLIMACTERIC, V5, P3, DOI 10.1080/713605194; Alanazi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085541; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Barzi A, 2013, CLIN CANCER RES, V19, P5842, DOI 10.1158/1078-0432.CCR-13-0325; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bergmann C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-139; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Culig Z, 2005, J UROLOGY, V174, P417, DOI 10.1097/01.ju.0000171014.31670.a8; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gambara G, 2013, J CELL MOL MED, V17, P713, DOI 10.1111/jcmm.12055; Garcia-Tunon I, 2005, HISTOPATHOLOGY, V47, P82, DOI 10.1111/j.1365-2559.2005.02178.x; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; HENDRICKSE CW, 1993, BRIT J SURG, V80, P636, DOI 10.1002/bjs.1800800531; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jeon JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105212; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Kastritis E, 2009, TARGET ONCOL, V4, P23, DOI 10.1007/s11523-008-0102-9; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Lavole A, 2014, REV MAL RESPIR, V31, P133, DOI 10.1016/j.rmr.2013.07.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marino M, 2014, WORLD J GASTRO ONCOL, V6, P67, DOI 10.4251/wjgo.v6.i3.67; Medvedev A, 2012, J IMMUNOL, P188; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Mukherjee S, 2014, CELL SIGNAL, V26, P2674, DOI 10.1016/j.cellsig.2014.08.009; Niedzielska I, 2009, J PHYSIOL PHARMACOL, V60, P65; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Okamoto M, 2001, INT IMMUNOPHARMACOL, V1, P1789, DOI 10.1016/S1567-5769(01)00103-5; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Priyadarshini Anjali, 2013, Indian J Urol, V29, P37, DOI 10.4103/0970-1591.109982; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Rizzo A, 2011, WORLD J GASTROENTERO, V17, P3092, DOI 10.3748/wjg.v17.i26.3092; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Semlali A, 2011, PEPTIDES, V32, P859, DOI 10.1016/j.peptides.2011.01.020; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; Simiantonaki N, 2007, INT J MOL MED, V20, P21; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Smith Sinead M, 2014, World J Gastrointest Pathophysiol, V5, P133, DOI 10.4291/wjgp.v5.i3.133; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Stevens VL, 2008, INT J CANCER, V123, P2644, DOI 10.1002/ijc.23826; Tahara T, 2008, DIGEST DIS SCI, V53, P919, DOI 10.1007/s10620-007-9950-x; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tang XY, 2012, ONCOL RES, V20, P15, DOI 10.3727/096504012X13425470196092; Vogel SN, 2003, BIOCHEM SOC T, V31, P664, DOI 10.1042/bst0310664; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yuan X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.334; Zhao S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00352	71	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0146333	10.1371/journal.pone.0146333	http://dx.doi.org/10.1371/journal.pone.0146333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	26771524	gold, Green Published, Green Submitted			2022-12-27	WOS:000368628300014
J	Lee, H; Bae, K; Kang, SW; Woo, SJ; Ryoo, NK; Kim, SJ; Han, G				Lee, Hoyoung; Bae, Kunho; Kang, Se Woong; Woo, Se Joon; Ryoo, Na-Kyung; Kim, Sang Jin; Han, Gyule			Morphologic Characteristics of Choroid in the Major Choroidal Thickening Diseases, Studied by Optical Coherence Tomography	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; KOYANAGI-HARADA-DISEASE; INDOCYANINE GREEN VIDEOANGIOGRAPHY; VASCULAR HYPERPERMEABILITY; THICKNESS MEASUREMENTS; MACULAR DEGENERATION; VASCULOPATHY; FEATURES; EYES; REPRODUCIBILITY	We investigated morphologic features of choroid in the choroidal thickening diseases, including central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV), and Vogt-Koyanagi-Harada disease (VKH), by a novel tomographic classification system of the choroid. This cross-sectional study involved 30 patients with active CSC, 30 patients with active PCV, and 27 patients with active VKH, and 30 normal controls. Utilizing enhanced depth imaging optical coherence tomography, we classified the morphology of the choroid into five categories: 1) Standard (S), 2) Dilated outer layer and Attenuated inner layer (DA), 3) Darkened (D), 4) Marbled (M), and 5) Pauci-Vascular (PV) types. Additional tomographic characteristics of the choroid such as choroidal vascular dilation, convolution, scleral invisibility, and choroidal hyper-or hypo-thickening were identified as well. The distribution of five choroidal tomographic morphology and additional tomographic characteristics in each group were analyzed. The DA type was observed in the CSC group more frequently than in the normal control group (53.3% vs 3.3%, P < 0.001). Additional tomographic characteristics, such as choroidal vascular dilation (76.7%), and choroidal hyper-thickening (36.7%), were more prevalent in the CSC group than in the control group. The PCV group showed higher prevalence of DA type (33.3% vs. 3.3%, P = 0.006) than the control group. The VKH group showed a significantly higher frequency of the D type (63.0%), convolution (40.7%), and scleral invisibility (70.4%) than controls (0% for all three findings). In conclusion, CSC and PCV shared common morphologic characteristics of choroid, including dilated outer vascular layer and focally attenuated innermost layer. Dense hypo-reflectivity and convolution of choroid were the specific tomographic markers for acute VKH. A new tomographic classification system of choroid may provide discrimination ability and insight into major pachychoroidopathies.	[Lee, Hoyoung; Bae, Kunho; Kang, Se Woong; Kim, Sang Jin; Han, Gyule] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Woo, Se Joon; Ryoo, Na-Kyung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Kang, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	swkang@skku.edu						Adhi M, 2013, JAMA OPHTHALMOL, V131, P1267, DOI 10.1001/jamaophthalmol.2013.4321; Ahuja RM, 2001, OPHTHALMOLOGY, V108, P1009, DOI 10.1016/S0161-6420(00)00614-X; Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ferrara D, 2014, OPHTHALMOLOGY, V121, P719, DOI 10.1016/j.ophtha.2013.10.014; Fong AHC, 2011, RETINA-J RET VIT DIS, V31, P502, DOI 10.1097/IAE.0b013e3182083beb; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Gupta V, 2009, AM J OPHTHALMOL, V147, P148, DOI 10.1016/j.ajo.2008.07.028; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; HEE MR, 1995, AM J OPHTHALMOL, V120, P65, DOI 10.1016/S0002-9394(14)73760-2; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hosoda Y, 2014, AM J OPHTHALMOL, V157, P1056, DOI 10.1016/j.ajo.2014.01.015; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Ishihara K, 2009, OPHTHALMOLOGY, V116, P1799, DOI 10.1016/j.ophtha.2009.04.002; Kato Y, 2013, JPN J OPHTHALMOL, V57, P90, DOI 10.1007/s10384-012-0212-x; Kim JH, 2013, AM J OPHTHALMOL, V155, P743, DOI 10.1016/j.ajo.2012.11.001; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Lee CS, 2014, OPHTHALMOLOGY, V121, P1029, DOI 10.1016/j.ophtha.2013.11.043; Lehmann M, 2013, BRIT J OPHTHALMOL, V97, P1181, DOI 10.1136/bjophthalmol-2012-302974; Lin DS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-87; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Okunuki Y, 2015, JPN J OPHTHALMOL, V59, P103, DOI 10.1007/s10384-014-0367-8; Ozawa S, 2009, RETINA-J RET VIT DIS, V29, P793, DOI 10.1097/IAE.0b013e3181a3b7d9; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Park SJ, 2014, AM J OPHTHALMOL, V158, P1155, DOI 10.1016/j.ajo.2014.08.010; PICCOLINO FC, 1994, RETINA-J RET VIT DIS, V14, P231, DOI 10.1097/00006982-199414030-00008; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Rao Narsing A., 2007, International Ophthalmology, V27, P81, DOI 10.1007/s10792-006-9029-2; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Ruiz-Medrano J, 2015, AM J OPHTHALMOL, V160, P596, DOI 10.1016/j.ajo.2015.05.027; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P820, DOI 10.1097/00006982-200312000-00013; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Spitznas M., 1986, CLIN EXP OPHTHALMOL, V224, P321; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Wu WJ, 2007, AM J OPHTHALMOL, V143, P900, DOI 10.1016/j.ajo.2006.11.050; Yannuzzi LA, 2010, AM J OPHTHALMOL, V149, P361, DOI 10.1016/j.ajo.2009.11.017	45	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0147139	10.1371/journal.pone.0147139	http://dx.doi.org/10.1371/journal.pone.0147139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	26766530	gold, Green Published, Green Submitted			2022-12-27	WOS:000368459300071
J	Zhang, YN; Tang, ET; Du, ZQ				Zhang, Yanni; Tang, En-Tzu; Du, Zhiqiang			Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; C-MET; AMPLIFICATION; QUANTITATION; EXPRESSION; TISSUE; HER2	Purpose The analysis of MET gene copy number (CN) has been considered to be a potential bio-marker to predict the response to MET-targeted therapies in various cancers. However, the current standard methods to determine MET CN are SNP 6.0 in the genomic DNA of cancer cell lines and fluorescence in situ hybridization (FISH) in tumor models, respectively, which are costly and require advanced technical skills and result in relatively subjective judgments. Therefore, we employed a novel method, droplet digital PCR (ddPCR), to determine the MET gene copy number with high accuracy and precision. Methods The genomic DNA of cancer cell lines or tumor models were tested and compared with the MET gene CN and MET/CEN-7 ratio determined by SNP 6.0 and FISH, respectively. Results In cell lines, the linear association of the MET CN detected by ddPCR and SNP 6.0 is strong (Pearson correlation = 0.867). In tumor models, the MET CN detected by ddPCR was significantly different between the MET gene amplification and non-amplification groups according to FISH (mean: 15.4 vs 2.1; P = 0.044). Given that MET gene amplification is defined as MET CN >5.5 by ddPCR, the concordance rate between ddPCR and FISH was 98.0%, and Cohen's kappa coefficient was 0.760 (95% CI, 0.498-1.000; P < 0.001). Conclusions The results demonstrated that the ddPCR method has the potential to quantify the MET gene copy number with high precision and accuracy as compared with the results from SNP 6.0 and FISH in cancer cell lines and tumor samples, respectively.	[Zhang, Yanni; Tang, En-Tzu; Du, Zhiqiang] Amgen Biopharmaceut Res & Dev Shanghai Co Ltd, Shanghai, Peoples R China		Du, ZQ (corresponding author), Amgen Biopharmaceut Res & Dev Shanghai Co Ltd, Shanghai, Peoples R China.	zhiqiang@amgen.com	Zhang, Ying/O-2727-2019		Amgen Inc.	Amgen Inc.(Amgen)	This study was funded by Amgen Inc. All authors are employees of Amgen Inc. The funder provided support in the form of salaries for YZ, ET, and ZD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	An X, 2014, CANCER-AM CANCER SOC, V120, P675, DOI 10.1002/cncr.28454; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hong SJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-138; Huang JT, 2015, CLIN CHEM, V61, P290, DOI 10.1373/clinchem.2014.230227; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Park WS, 1999, CANCER RES, V59, P307; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Yakicier MC, 2001, ONCOGENE, V20, P5232, DOI 10.1038/sj.onc.1204674	16	61	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146784	10.1371/journal.pone.0146784	http://dx.doi.org/10.1371/journal.pone.0146784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	27977794	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300044
J	Zhang, Y; Thomas, T; Brussel, MJG; van Maarseveen, MFAM				Zhang, Ying; Thomas, Tom; Brussel, M. J. G.; van Maarseveen, M. F. A. M.			Expanding Bicycle-Sharing Systems: Lessons Learnt from an Analysis of Usage	PLOS ONE			English	Article							SHARED BICYCLES; IMPACT; PROGRAM; WEATHER	Bike-sharing programs, with initiatives to increase bike use and improve accessibility of urban transit, have received increasing attention in growing number of cities across the world. The latest generation of bike-sharing systems has employed smart card technology that produces station-based data or trip-level data. This facilitates the studies of the practical use of these systems. However, few studies have paid attention to the changes in users and system usage over the years, as well as the impact of system expansion on its usage. Monitoring the changes of system usage over years enables the identification of system performance and can serve as an input for improving the location-allocation of stations. The objective of this study is to explore the impact of the expansion of a bicycle-sharing system on the usage of the system. This was conducted for a bicycle-sharing system in Zhongshan (China), using operational usage data of different years following system expansion. To this end, we performed statistical and spatial analyses to examine the changes in both users and system usage between before and after the system expansion. The findings show that there is a big variation in users and aggregate usage following the system expansion. However, the trend in spatial distribution of demand shows no substantial difference over the years, i.e. the same high-demand and low-demand areas appear. There are decreases in demand for some old stations over the years, which can be attributed to either the negative performance of the system or the competition of nearby new stations. Expanding the system not only extends the original users' ability to reach new areas but also attracts new users to use bike-sharing systems. In the conclusions, we present and discuss the findings, and offer recommendations for the further expansion of system.	[Zhang, Ying; Brussel, M. J. G.; van Maarseveen, M. F. A. M.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands; [Thomas, Tom] Univ Twente, Ctr Transport studies, Enschede, Netherlands	University of Twente; University of Twente	Zhang, Y (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands.	y.zhang-4@utwente.nl	Zhang, Ying/O-2727-2019		China Scholarship Council [2011627129]; ITC Research Fund [93002823]	China Scholarship Council(China Scholarship Council); ITC Research Fund	This work was supported by the China Scholarship Council (No. 2011627129, www.csc.edu.cn) and co-funded by ITC Research Fund (No. 93002823, www.itc.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham R, 2014, TRANSPORT PLAN TECHN, V37, P83, DOI 10.1080/03081060.2013.844903; Borgnat P, 2011, ADV COMPLEX SYST, V14, P415, DOI 10.1142/S0219525911002950; Buck D., 2012, P TRANSPORTATION RES; Corcoran J, 2014, J TRANSP GEOGR, V41, P292, DOI 10.1016/j.jtrangeo.2014.09.003; Corcoran J, 2014, J TRANSP GEOGR, V41, P268, DOI 10.1016/j.jtrangeo.2014.09.005; Daddio D. W., 2012, THESIS; DeMaio P., 2009, PUBLIC TRANSPORTATIO, V12, P16; El-Assi W, 2015, TRANSPORTATION, DOI [10.1007/s11116-015-9669-z:1-25, DOI 10.1007/S11116-015-9669-Z:1~25]; Faghih-Imani A, 2016, J TRANSP GEOGR, V54, P218, DOI 10.1016/j.jtrangeo.2016.06.008; Faghih-Imani A, 2015, J TRANSP GEOGR, V44, P53, DOI 10.1016/j.jtrangeo.2015.03.005; Faghih-Imani A, 2014, J TRANSP GEOGR, V41, P306, DOI 10.1016/j.jtrangeo.2014.01.013; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Frade I, 2014, PROCD SOC BEHV, V111, P518, DOI 10.1016/j.sbspro.2014.01.085; Froehlich J. E., 2009, 21 INT JOINT C ART I; Fuller D, 2012, PREV MED, V54, P74, DOI 10.1016/j.ypmed.2011.09.021; Gebhart K, 2014, TRANSPORTATION, V41, P1205, DOI 10.1007/s11116-014-9540-7; Gonzalez F, 2016, TRANSPORTATION, V43, P407, DOI 10.1007/s11116-015-9581-6; Goodman A, 2014, J TRANSPORT GEOGRAPH, V41; Iori M, 2016, COMPUT OPER RES; Jappinen S, 2013, APPL GEOGR, V43, P13, DOI 10.1016/j.apgeog.2013.05.010; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Kadri A, 2016, COMPUTERS IND ENG; Kaltenbrunner A, 2010, PERVASIVE MOB COMPUT, V6, P455, DOI 10.1016/j.pmcj.2010.07.002; Keijer MJN, 2000, TRANSPORT PLAN TECHN, V23, P215, DOI 10.1080/03081060008717650; Krizek KJ, 2009, J URBAN PLAN DEV, V135, P66, DOI 10.1061/(ASCE)0733-9488(2009)135:2(66); Lathia N, 2012, TRANSPORT RES C-EMER, V22, P88, DOI 10.1016/j.trc.2011.12.004; Martens K, 2007, TRANSPORT RES A-POL, V41, P326, DOI 10.1016/j.tra.2006.09.010; Nair R, 2013, INT J SUSTAIN TRANSP, V7, P85, DOI 10.1080/15568318.2012.660115; Neumann-Saavedra BA, 2015, TRANSP RES PROC, V10, P355, DOI 10.1016/j.trpro.2015.09.085; O'Brien O, 2014, J TRANSP GEOGR, V34, P262, DOI 10.1016/j.jtrangeo.2013.06.007; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rixey RA, 2013, TRANSPORT RES REC, P46, DOI 10.3141/2387-06; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Vogel M, 2014, J TRANSP GEOGR, V41, P280, DOI 10.1016/j.jtrangeo.2014.07.005; Vogel P., 2011, PROCEDIA SOC BEHAV S, V20, P514, DOI DOI 10.1016/J.SBSPR0.2011.08.058; Wang XZ, 2016, J URBAN PLAN DEV, V142, DOI 10.1061/(ASCE)UP.1943-5444.0000273; Zhao J, 2015, TRANSPORT RES C-EMER, V58, P251, DOI 10.1016/j.trc.2015.01.030; Zhao JB, 2014, TRANSPORT POLICY, V35, P253, DOI 10.1016/j.tranpol.2014.06.008; ZhongshanStatisticsBureau, 2014, ZHONGSH STAT YB 2014; Zhou XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137922	40	61	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168604	10.1371/journal.pone.0168604	http://dx.doi.org/10.1371/journal.pone.0168604			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977794	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400121
